Disease on EC 5.4.99.7 - Lanosterol synthase
Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Abnormalities, Multiple
A Rare Presentation of Os Odontoideum with Multiple Vertebral Fusion in Type III Klippel-Feil Syndrome (KFS) - A Case Report.
Abscess
Infiltrating aggressive epitheliosis of the temporal bone: a newly described disease entity.
Abscess
Multiple Abscesses With Osteomyelitis and Destruction of Both the Atlas and the Axis in a 4-week-old Infant.
Abscess
[Atlas of the clinico-pathological study of neurological diseases. 1. Otogenic cerebellar abscess]
Achondroplasia
Foramen magnum stenosis from overgrowth of the opisthion in a child with achondroplasia.
Acquired Immunodeficiency Syndrome
Complications of hip prostheses: an atlas of new preventive technical aids.
Acquired Immunodeficiency Syndrome
Data harmonization process for creating the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Atlas.
Acquired Immunodeficiency Syndrome
Describing, analysing and understanding the effects of the introduction of HIV self-testing in West Africa through the ATLAS programme in Côte d'Ivoire, Mali and Senegal.
Acquired Immunodeficiency Syndrome
Factors Associated With Self-Reported Hearing Aid Management Skills and Knowledge.
Acquired Immunodeficiency Syndrome
FETAX interlaboratory validation study: phase III--Part 1 testing.
Acquired Immunodeficiency Syndrome
Open Access Publishing of Textbooks and Guidelines for Otolaryngologists in Developing Countries.
Acquired Immunodeficiency Syndrome
Symmetric diffeomorphic registration of fibre orientation distributions.
Acquired Immunodeficiency Syndrome
Using micro-computed tomography to reveal the anatomy of adult Diaphorina citri Kuwayama (Insecta: Hemiptera, Liviidae) and how it pierces and feeds within a citrus leaf.
Acquired Immunodeficiency Syndrome
Validation of a digitally displayed photographic food portion-size estimation aid among women in urban and rural Malawi.
Acquired Immunodeficiency Syndrome
Whole mouse brain reconstruction and registration to a reference atlas with standard histochemical processing of coronal sections.
Acute Coronary Syndrome
Autoantibodies to phosphorylcholine and cardiovascular outcomes in patients with acute coronary syndromes in the ATLAS ACS-TIMI 46 trial.
Acute Coronary Syndrome
Comparison of the efficacy and safety of two rivaroxaban doses in acute coronary syndrome (from ATLAS ACS 2-TIMI 51).
Acute Coronary Syndrome
D-Dimer Levels and Effect of Rivaroxaban on Those Levels and Outcomes in Patients With Acute Coronary Syndrome (An ATLAS ACS-TIMI 46 Trial Substudy).
Acute Coronary Syndrome
Mortality in the TRACER and ATLAS ACS 2 Trials: Two More Reasons to Audit Vital Records in PLATO.
Acute Coronary Syndrome
Relation of White Blood Cell Count to Bleeding and Ischemic Events in Patients With Acute Coronary Syndrome (from the ATLAS ACS 2-TIMI 51 Trial).
Acute Coronary Syndrome
Rivaroxaban for stroke prevention in atrial fibrillation and secondary prevention in patients with a recent acute coronary syndrome.
Acute Coronary Syndrome
Rivaroxaban in Acute Coronary Syndromes: We Have a Compass and an Atlas, But Where Are We Headed?
Acute Coronary Syndrome
Rivaroxaban: An Evaluation of its Cardiovascular Benefit-Risk Profile Across Indications Based on Numbers Needed to Treat or Harm, and on Clinically Meaningful Endpoint Comparisons.
Acute Coronary Syndrome
Safety and efficacy of rivaroxaban for the secondary prevention following acute coronary syndromes among biomarker-positive patients: Insights from the ATLAS ACS 2-TIMI 51 trial.
Acute Coronary Syndrome
The "Dual-Pathway" Strategy after Acute Coronary Syndrome: Rivaroxaban and Antiplatelet Agents in the ATLAS ACS 2-TIMI 51 Trial.
Acute Coronary Syndrome
The ATLAS ACS 2-TIMI 51 Trial and the Burden of Missing Data: (Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects With Acute Coronary Syndrome ACS 2-Thrombolysis In Myocardial Infarction 51).
Acute Coronary Syndrome
The treatment of missing data in a large cardiovascular clinical outcomes study.
Acute Coronary Syndrome
[Practical Aspects of the Use of Oral Anticoagulant Rivaroxaban for the Prevention of Adverse Outcomes After Acute Coronary Syndrome].
Acute Coronary Syndrome
[Rivarobaxan for patients with recent acute coronary syndrome : ATLAS ACS 2-TIMI 51].
Adenocarcinoma
20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes: A Systematic Review of 157,258 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
Adenocarcinoma
A fluorescence-coupled assay for gamma aminobutyric acid (GABA) reveals metabolic stress-induced modulation of GABA content in neuroendocrine cancer.
Adenocarcinoma
A gastric cancer LncRNAs model for MSI and survival prediction based on support vector machine.
Adenocarcinoma
A miRNA signature of chemoresistant mesenchymal phenotype identifies novel molecular targets associated with advanced pancreatic cancer.
Adenocarcinoma
A panel of collagen genes are associated with prognosis of patients with gastric cancer and regulated by microRNA-29c-3p: an integrated bioinformatics analysis and experimental validation.
Adenocarcinoma
Aberrant S100A16 expression might be an independent prognostic indicator of unfavorable survival in non-small cell lung adenocarcinoma.
Adenocarcinoma
Aberrant splicing isoforms detected by full-length transcriptome sequencing as transcripts of potential neoantigens in non-small cell lung cancer.
Adenocarcinoma
Adenocarcinoma of the Uterine Cervix Shows Impaired Recruitment of cDC1 and CD8+ T Cells and Elevated ?-Catenin Activation Compared with Squamous Cell Carcinoma.
Adenocarcinoma
Alternative polyadenylation drives oncogenic gene expression in pancreatic ductal adenocarcinoma.
Adenocarcinoma
Alternative splicing events implicated in carcinogenesis and prognosis of colorectal cancer.
Adenocarcinoma
AMP?activated protein kinase family member 5 is an independent prognostic indicator of pancreatic adenocarcinoma: A study based on The Cancer Genome Atlas.
Adenocarcinoma
An Integrated Pan-Cancer Analysis and Structure-Based Virtual Screening of GPR15.
Adenocarcinoma
Analysis of cyclin E co-expression genes reveals nuclear transcription factor Y subunit alpha is an oncogene in gastric cancer.
Adenocarcinoma
Apolipoprotein C1 (APOC1) promotes tumor progression via MAPK signaling pathways in colorectal cancer.
Adenocarcinoma
Autophagy-related genes are potential diagnostic and prognostic biomarkers in prostate cancer.
Adenocarcinoma
aWCluster: A Novel Integrative Network-based Clustering of Multiomics for Subtype Analysis of Cancer Data.
Adenocarcinoma
Bioinformatic analysis reveals an exosomal miRNA-mRNA network in colorectal cancer.
Adenocarcinoma
Bioinformatics analysis reveals TSPAN1 as a candidate biomarker of progression and prognosis in pancreatic cancer.
Adenocarcinoma
Biomarker Identification through Multiomics Data Analysis of Prostate Cancer Prognostication Using a Deep Learning Model and Similarity Network Fusion.
Adenocarcinoma
C-Reactive Protein (CRP) is a Promising Diagnostic Immunohistochemical Marker for Intrahepatic Cholangiocarcinoma and is Associated With Better Prognosis.
Adenocarcinoma
Cancer-Specific Production of N-Acetylaspartate via NAT8L Overexpression in Non-Small Cell Lung Cancer and Its Potential as a Circulating Biomarker.
Adenocarcinoma
Case Report: Novel RPGRIP1L Gene Mutations Identified by Whole Exome Sequencing in a Patient With Multiple Primary Tumors.
Adenocarcinoma
CGB5 expression is independently associated with poor overall survival and recurrence-free survival in patients with advanced gastric cancer.
Adenocarcinoma
Chromosomal breaks at FRA18C: association with reduced DOK6 expression, altered oncogenic signaling and increased gastric cancer survival.
Adenocarcinoma
Clinicopathological, immune and molecular correlates of PD-L2 methylation in gastric adenocarcinomas.
Adenocarcinoma
Combined Inactivation of TP53 and MIR34A Promotes Colorectal Cancer Development and Progression in Mice Via Increasing Levels of IL6R and PAI1.
Adenocarcinoma
Combined Simplified Molecular Classification of Gastric Adenocarcinoma, Enhanced by Lymph Node Status: An Integrative Approach.
Adenocarcinoma
Combined Transcriptome and Proteome Analysis of Immortalized Human Keratinocytes Expressing Human Papillomavirus 16 (HPV16) Oncogenes Reveals Novel Key Factors and Networks in HPV-Induced Carcinogenesis.
Adenocarcinoma
Comparative bioinformatical analysis of pancreatic head cancer and pancreatic body/tail cancer.
Adenocarcinoma
Comparative Proteome Identifies Complement Component 3-Mediated Immune Response as Key Difference of Colon Adenocarcinoma and Rectal Adenocarcinoma.
Adenocarcinoma
Competitive Endogenous RNA (ceRNA) Regulation Network of lncRNA-miRNA-mRNA in Colorectal Carcinogenesis.
Adenocarcinoma
Comprehensive Analysis Identifying Wnt Ligands Gene Family for Biochemical Recurrence in Prostate Adenocarcinoma and Construction of a Nomogram.
Adenocarcinoma
Comprehensive analysis of ceRNA networks in HPV16- and HPV18-mediated cervical cancers reveals XIST as a pivotal competing endogenous RNA.
Adenocarcinoma
Comprehensive Analysis of Expression, Clinicopathological Association and Potential Prognostic Significance of RABs in Pancreatic Cancer.
Adenocarcinoma
Comprehensive analysis of long non-coding RNAs in ovarian cancer reveals global patterns and targeted DNA amplification.
Adenocarcinoma
Comprehensive analysis of prognostic alternative splicing signature in cervical cancer.
Adenocarcinoma
Comprehensive Computational Pathological Image Analysis Predicts Lung Cancer Prognosis.
Adenocarcinoma
Comprehensive data analysis of genomics, epigenomics, and transcriptomics to identify specific biomolecular markers for prostate adenocarcinoma.
Adenocarcinoma
Comprehensive investigation of a novel differentially expressed lncRNA expression profile signature to assess the survival of patients with colorectal adenocarcinoma.
Adenocarcinoma
Computational analysis of fused co-expression networks for the identification of candidate cancer gene biomarkers.
Adenocarcinoma
Computational assessment of stomach tumor volume from multi-slice computerized tomography images in presence of type 2 cancer.
Adenocarcinoma
Conditional deletion of ELL2 induces murine prostate intraepithelial neoplasia.
Adenocarcinoma
Construction of a Competitive Endogenous RNA Network and Identification of Potential Regulatory Axis in Gastric Cancer.
Adenocarcinoma
Construction of a five-gene prognostic model based on immune-related genes for the prediction of survival in pancreatic cancer.
Adenocarcinoma
Copy neutral loss of heterozygosity is more frequent in older ovarian cancer patients.
Adenocarcinoma
CpG island methylator phenotype in adenocarcinomas from the digestive tract: Methods, conclusions, and controversies.
Adenocarcinoma
Crosstalk Between the MSI Status and Tumor Microenvironment in Colorectal Cancer.
Adenocarcinoma
Curation of the Pancreatic Ductal Adenocarcinoma Subset of the Cancer Genome Atlas Is Essential for Accurate Conclusions about Survival-Related Molecular Mechanisms.
Adenocarcinoma
Data mining analysis of the prognostic impact of N6-methyladenosine regulators in patients with endometrial adenocarcinoma.
Adenocarcinoma
Database Mining of Genes of Prognostic Value for the Prostate Adenocarcinoma Microenvironment Using the Cancer Gene Atlas.
Adenocarcinoma
DCBLD1 is associated with the integrin signaling pathway and has prognostic value in non-small cell lung and invasive breast carcinoma.
Adenocarcinoma
Decreased Tumoral Expression of Colon-Specific Water Channel Aquaporin 8 Is Associated With Reduced Overall Survival in Colon Adenocarcinoma.
Adenocarcinoma
Deep Learning for Automatic Subclassification of Gastric Carcinoma Using Whole-Slide Histopathology Images.
Adenocarcinoma
Deep-Hipo: Multi-scale receptive field deep learning for histopathological image analysis.
Adenocarcinoma
Development and validation of an autophagy-related prognostic signature in esophageal cancer.
Adenocarcinoma
Development and validation of the trans-omics model for pancreatic adenocarcinoma.
Adenocarcinoma
Development of somatic mutation signatures for risk stratification and prognosis in lung and colorectal adenocarcinomas.
Adenocarcinoma
Diagnostic and prognostic biomarkers of common urological cancers based on aberrant DNA methylation.
Adenocarcinoma
Diagnostic and therapeutic potencies of miR-18a-5p in mixed-type gastric adenocarcinoma.
Adenocarcinoma
Differential microRNA expression profiles associated with microsatellite status reveal possible epigenetic regulation of microsatellite instability in gastric adenocarcinoma.
Adenocarcinoma
Dishevelled segment polarity protein 3 (DVL3): a novel and easily applicable recurrence predictor in localised prostate adenocarcinoma.
Adenocarcinoma
DNA Damage Repair Gene Mutations Are Indicative of a Favorable Prognosis in Colorectal Cancer Treated With Immune Checkpoint Inhibitors.
Adenocarcinoma
DNA methylation profiling reliably distinguishes pulmonary enteric adenocarcinoma from metastatic colorectal cancer.
Adenocarcinoma
DNA methylation-based chromatin compartments and ChIP-seq profiles reveal transcriptional drivers of prostate carcinogenesis.
Adenocarcinoma
DNA Promoter Methylation and ERG Regulate the Expression of CD24 in Prostate Cancer.
Adenocarcinoma
Downregulation of G Protein-Coupled Estrogen Receptor (GPER) is Associated with Reduced Prognosis in Patients with Gastric Cancer.
Adenocarcinoma
Dynamic Control of Mitochondrial Ca2+ Levels as a Survival Strategy of Cancer Cells.
Adenocarcinoma
Early B-cell factors involve in the tumorigenesis and predict the overall survival of gastric cancer.
Adenocarcinoma
eEF2K as a novel metastatic and prognostic biomarker in gastric cancer patients.
Adenocarcinoma
EMP3 is induced by TWIST1/2 and regulates epithelial-to-mesenchymal transition of gastric cancer cells.
Adenocarcinoma
Establishment of a Macrophage Phenotypic Switch Related Prognostic Signature in Patients With Pancreatic Cancer.
Adenocarcinoma
Evaluation of K-ras and p53 expression in pancreatic adenocarcinoma using the cancer genome atlas.
Adenocarcinoma
Evaluation of somatic copy number estimation tools for whole-exome sequencing data.
Adenocarcinoma
Exceptional Chemotherapy Response in Metastatic Colorectal Cancer Associated With Hyper-Indel-Hypermutated Cancer Genome and Comutation of POLD1 and MLH1.
Adenocarcinoma
Expression and clinicopathological implication of DcR3 in lung cancer tissues: a tissue microarray study with 365 cases.
Adenocarcinoma
Expression level of long non-coding RNA colon adenocarcinoma hypermethylated serves as a novel prognostic biomarker in patients with thyroid carcinoma.
Adenocarcinoma
Expression of PAM50 Genes in Lung Cancer: Evidence that Interactions between Hormone Receptors and HER2/HER3 Contribute to Poor Outcome.
Adenocarcinoma
Favorable outcome of patients with lung adenocarcinoma harboring POLE mutations and expressing high PD-L1.
Adenocarcinoma
Galectin-1 fosters an immunosuppressive microenvironment in colorectal cancer by reprogramming CD8+ regulatory T cells.
Adenocarcinoma
Gastric hepatoid adenocarcinomas are a genetically heterogenous group; most tumors show chromosomal instability, but MSI tumors do exist.
Adenocarcinoma
Gene Expression Changes and Associated Pathways Involved in the Progression of Prostate Cancer Advanced Stages.
Adenocarcinoma
Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate.
Adenocarcinoma
Genetics: New molecular classification of gastric adenocarcinoma proposed by The Cancer Genome Atlas.
Adenocarcinoma
Genetics: new molecular classification of gastric adenocarcinoma proposed by The Cancer Genome Atlas.
Adenocarcinoma
Genome-scale analysis to identify prognostic microRNA biomarkers in patients with early stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy.
Adenocarcinoma
Genome-wide methylation and expression profiling identify a novel epigenetic signature in gastrointestinal pan-adenocarcinomas.
Adenocarcinoma
Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer.
Adenocarcinoma
Germline and somatic SDHx alterations in apparently sporadic differentiated thyroid cancer.
Adenocarcinoma
Global Analysis of Microbiota Signatures in Four Major Types of Gastrointestinal Cancer.
Adenocarcinoma
Glycolysis-Based Genes Associated with the Clinical Outcome of Pancreatic Ductal Adenocarcinoma Identified by The Cancer Genome Atlas Data Analysis.
Adenocarcinoma
Heterogeneity of MSI-H gastric cancer identifies a subtype with worse survival.
Adenocarcinoma
High KCNQ1OT1 expression might independently predict shorter survival of colon adenocarcinoma.
Adenocarcinoma
High KRT8 Expression Independently Predicts Poor Prognosis for Lung Adenocarcinoma Patients.
Adenocarcinoma
High-throughput Single-cell Mass Spectrometry Reveals Abnormal Lipid Metabolism in Pancreatic Ductal Adenocarcinoma.
Adenocarcinoma
Histopathological Terminology Standards for the Reporting of Prostatic Epithelial Lesions in Dogs.
Adenocarcinoma
Hypoxia-related lncRNAs to build prognostic classifier and reveal the immune characteristics of EGFR wild type and low expression of PD-L1 squamous and adenocarcinoma NSCLC.
Adenocarcinoma
Identification of a 14-lncRNA Signature and Construction of a Prognostic Nomogram Predicting Overall Survival of Gastric Cancer.
Adenocarcinoma
Identification of a 6-gene signature predicting prognosis for colorectal cancer.
Adenocarcinoma
Identification of a key role of widespread epigenetic drift in Barrett's esophagus and esophageal adenocarcinoma.
Adenocarcinoma
Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
Adenocarcinoma
Identification of a novel six-gene signature with potential prognostic and therapeutic value in cervical cancer.
Adenocarcinoma
Identification of an extracellular vesicle-related gene signature in the prediction of pancreatic cancer clinical prognosis.
Adenocarcinoma
Identification of DNA methylation signature to predict prognosis in gastric adenocarcinoma.
Adenocarcinoma
Identification of gene biomarkers and immune cell infiltration characteristics in rectal cancer.
Adenocarcinoma
Identification of key genes controlling cancer stem cell characteristics in gastric cancer.
Adenocarcinoma
Identification of key genes in prostate cancer gene expression profile by bioinformatics.
Adenocarcinoma
Identification of key miRNAs and genes associated with stomach adenocarcinoma from The Cancer Genome Atlas database.
Adenocarcinoma
Identification of low abundance microbiome in clinical samples using whole genome sequencing.
Adenocarcinoma
Identification of Metabolism-Associated Prostate Cancer Subtypes and Construction of a Prognostic Risk Model.
Adenocarcinoma
Identification of PIK3CA multigene mutation patterns associated with superior prognosis in stomach cancer.
Adenocarcinoma
Identification of pivotal genes associated with the prognosis of gastric carcinoma through integrated analysis.
Adenocarcinoma
Identification of potential biomarkers and their clinical significance in gastric cancer using bioinformatics analysis methods.
Adenocarcinoma
Identification of Potential Key Genes for Pathogenesis and Prognosis in Prostate Cancer by Integrated Analysis of Gene Expression Profiles and the Cancer Genome Atlas.
Adenocarcinoma
Identification of prognostic miRNA biomarkers for esophageal cancer based on The Cancer Genome Atlas and Gene Expression Omnibus.
Adenocarcinoma
Identification of prognostic tumor-infiltrating immune cells in endometrial adenocarcinoma.
Adenocarcinoma
Identification of targeted therapy options for gastric adenocarcinoma by comprehensive analysis of genomic data.
Adenocarcinoma
Identification of the hub genes and prognostic indicators of gastric cancer and correlation of indicators with tumor-infiltrating immune cell levels.
Adenocarcinoma
Identification of the immune cell infiltration landscape in pancreatic cancer to assist immunotherapy.
Adenocarcinoma
Identification of two novel biomarkers of rectal carcinoma progression and prognosis via co-expression network analysis.
Adenocarcinoma
Images from the Haematologica Atlas of Hematologic Cytology: bone marrow metastases from gastric adenocarcinoma.
Adenocarcinoma
Immune landscape of human prostate cancer: immune evasion mechanisms and biomarkers for personalized immunotherapy.
Adenocarcinoma
Immune signature profiling identified prognostic factors for gastric cancer.
Adenocarcinoma
Immunity-Related Gene Signature Identifies Subtypes Benefitting From Adjuvant Chemotherapy or Potentially Responding to PD1/PD-L1 Blockage in Pancreatic Cancer.
Adenocarcinoma
Immunohistochemistry as a surrogate for molecular subtyping of gastric adenocarcinoma.
Adenocarcinoma
Integrative bioinformatics analysis of prognostic alternative splicing signatures in gastric cancer.
Adenocarcinoma
Integrative CAGE and DNA Methylation Profiling Identify Epigenetically Regulated Genes in NSCLC.
Adenocarcinoma
Integrative molecular characterization of Chinese prostate cancer specimens.
Adenocarcinoma
Integrin ?5 subunit is required for the tumor supportive role of fibroblasts in colorectal adenocarcinoma and serves as a potential stroma prognostic marker.
Adenocarcinoma
KIT performed as a driver gene candidate affecting the survival status of patients with stomach adenocarcinoma.
Adenocarcinoma
LINC00346 promotes pancreatic cancer progression through the CTCF-mediated Myc transcription.
Adenocarcinoma
Linking patient outcome to high throughput protein expression data identifies novel regulators of colorectal adenocarcinoma aggressiveness.
Adenocarcinoma
LncRNA HOTAIR promotes the growth and metastasis of gastric cancer by sponging miR-1277-5p and upregulating COL5A1.
Adenocarcinoma
LncRNA RAD51-AS1/miR-29b/c-3p/NDRG2 crosstalk repressed proliferation, invasion and glycolysis of colorectal cancer.
Adenocarcinoma
Long-chain noncoding ribonucleic acids affect the survival and prognosis of patients with esophageal adenocarcinoma through the autophagy pathway: construction of a prognostic model.
Adenocarcinoma
MET in gastric cancer with liver metastasis: The relationship between MET amplification and Met overexpression in primary stomach tumors and liver metastasis.
Adenocarcinoma
Migration of mitochondrial DNA in the nuclear genome of colorectal adenocarcinoma.
Adenocarcinoma
Mining The Cancer Genome Atlas gene expression data for lineage markers in distinguishing bladder urothelial carcinoma and prostate adenocarcinoma.
Adenocarcinoma
MiR-374b-5p inhibits KDM5B-induced epithelial-mesenchymal transition in pancreatic cancer.
Adenocarcinoma
Modeling Gene-Wise Dependencies Improves the Identification of Drug Response Biomarkers in Cancer Studies.
Adenocarcinoma
Molecular classification of gastric adenocarcinoma: translating new insights from the cancer genome atlas research network.
Adenocarcinoma
Multiomics integrative analysis for gene signatures and prognostic values of m6A regulators in pancreatic adenocarcinoma: a retrospective study in The Cancer Genome Atlas project.
Adenocarcinoma
Mutated CEACAMs Disrupt Transforming Growth Factor Beta Signaling and Alter the Intestinal Microbiome to Promote Colorectal Carcinogenesis.
Adenocarcinoma
Mutations of p53 associated with pancreatic cancer and therapeutic implications.
Adenocarcinoma
Nicotinamide N-Methyltransferase Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric Cancer.
Adenocarcinoma
Notch and mTOR Signaling Pathways Promote Human Gastric Cancer Cell Proliferation.
Adenocarcinoma
Pathologic evolution-related Gene Analysis based on both single-cell and bulk transcriptomics in Colorectal Cancer.
Adenocarcinoma
PICOT binding to chromatin-associated EED negatively regulates cyclin D2 expression by increasing H3K27me3 at the CCND2 gene promoter.
Adenocarcinoma
Plk2 Loss Commonly Occurs in Colorectal Carcinomas but not Adenomas: Relationship to mTOR Signaling.
Adenocarcinoma
Potential prognostic impact of EBV RNA-seq reads in gastric cancer: a reanalysis of The Cancer Genome Atlas cohort.
Adenocarcinoma
Prognostic alternative splicing signatures and underlying regulatory network in esophageal carcinoma.
Adenocarcinoma
Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers.
Adenocarcinoma
Prognostic Implication of the m6A RNA Methylation Regulators in Rectal Cancer.
Adenocarcinoma
Prognostic targets recognition of rectal adenocarcinoma based on transcriptomics.
Adenocarcinoma
Prognostic Value of BIRC5 in Lung Adenocarcinoma Lacking EGFR, KRAS, and ALK Mutations by Integrated Bioinformatics Analysis.
Adenocarcinoma
Prognostic value of Glypican family genes in early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy and possible mechanisms.
Adenocarcinoma
Prognostic value of minichromosome maintenance mRNA expression in early-stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy.
Adenocarcinoma
Prostate epithelial genes define therapy-relevant prostate cancer molecular subtype.
Adenocarcinoma
Quality control of single amino acid variations detected by tandem mass spectrometry.
Adenocarcinoma
Reconstruction and analysis of circRNA?miRNA?mRNA network in the pathology of cervical cancer.
Adenocarcinoma
Reduced expression of the DNA glycosylase gene MUTYH is associated with an increased number of somatic mutations via a reduction in the DNA repair capacity in prostate adenocarcinoma.
Adenocarcinoma
Robust semiparametric gene-environment interaction analysis using sparse boosting.
Adenocarcinoma
S100P acts as a target of miR-495 in pancreatic cancer through bioinformatics analysis and experimental verification.
Adenocarcinoma
Screening and Identification of Prognostic Tumor-Infiltrating Immune Cells and Genes of Endometrioid Endometrial Adenocarcinoma: Based on The Cancer Genome Atlas Database and Bioinformatics.
Adenocarcinoma
Silencing Smad4 attenuates sensitivity of colorectal cancer cells to cetuximab by promoting epithelial?mesenchymal transition.
Adenocarcinoma
Single-nucleotide polymorphism rs13426236 contributes to an increased prostate cancer risk via regulating MLPH splicing variant 4.
Adenocarcinoma
Smoking correlates with increased cytoskeletal protein-related coding region mutations in the lung and head and neck datasets of the cancer genome atlas.
Adenocarcinoma
Specific DNA methylation markers in the diagnosis and prognosis of esophageal cancer.
Adenocarcinoma
SSRP1 influences colorectal cancer cell growth and apoptosis via the AKT pathway.
Adenocarcinoma
Survival-associated alternative splicing signatures in esophageal carcinoma.
Adenocarcinoma
Systematic mutation analysis in rare colorectal cancer presenting ovarian metastases.
Adenocarcinoma
Target identification in Fusobacterium nucleatum by subtractive genomics approach and enrichment analysis of host-pathogen protein-protein interactions.
Adenocarcinoma
TGFB1-induced autophagy affects the pattern of pancreatic cancer progression in distinct ways depending on SMAD4 status.
Adenocarcinoma
The CNPY2 enhances epithelial-mesenchymal transition via activating the AKT/GSK3? pathway in non-small cell lung cancer.
Adenocarcinoma
The Early Diagnostic Value of Serum Interleukin-8 in Esophagogastric Junction Adenocarcinoma.
Adenocarcinoma
The Expression and Survival Significance of Glucose Transporter-1 in Pancreatic Cancer: Meta-Analysis, Bioinformatics Analysis and Retrospective Study.
Adenocarcinoma
The Histone Demethylase KDM3A, Increased in Human Pancreatic Tumors, Regulates Expression of DCLK1 in and Promotes Tumorigenesis in Mice.
Adenocarcinoma
The Identification of Critical m6A RNA Methylation Regulators as Malignant Prognosis Factors in Prostate Adenocarcinoma.
Adenocarcinoma
The integrative knowledge base for miRNA-mRNA expression in colorectal cancer.
Adenocarcinoma
The interplay between AR, EGF receptor and MMP-9 signaling pathways in invasive prostate cancer.
Adenocarcinoma
The prognostic value and potential subtypes of immune activity scores in three major urological cancers.
Adenocarcinoma
The Prognostic Value of m6A RNA Methylation Regulators in Colon Adenocarcinoma.
Adenocarcinoma
The Somatic Mutation Landscape and RNA Prognostic Markers in Stomach Adenocarcinoma.
Adenocarcinoma
The tumor immune microenvironmental analysis of 2,033 transcriptomes across 7 cancer types.
Adenocarcinoma
The urokinase-type plasminogen activator and inhibitors in resectable lung adenocarcinoma.
Adenocarcinoma
The YTH Domain Family of N6-Methyladenosine "Readers" in the Diagnosis and Prognosis of Colonic Adenocarcinoma.
Adenocarcinoma
Therapeutic potential of anti-VEGF receptor 2 therapy targeting for M2-tumor-associated macrophages in colorectal cancer.
Adenocarcinoma
Transcriptome analysis reveals the effect of oral contraceptive use on cervical cancer.
Adenocarcinoma
Transcriptome sequencing identifies key pathways and genes involved in gastric adenocarcinoma.
Adenocarcinoma
Translational genomics in pancreatic ductal adenocarcinoma: A review with re-analysis of TCGA dataset.
Adenocarcinoma
TRIM25 blockade by RNA interference inhibited migration and invasion of gastric cancer cells through TGF-? signaling.
Adenocarcinoma
Tumor CDKN2A-Associated JAK2 Loss and Susceptibility to Immunotherapy Resistance.
Adenocarcinoma
Tumor Immune Microenvironment Clusters in Localized Prostate Adenocarcinoma: Prognostic Impact of Macrophage Enriched/Plasma Cell Non-Enriched Subtypes.
Adenocarcinoma
Tumor microenvironment evaluation promotes precise checkpoint immunotherapy of advanced gastric cancer.
Adenocarcinoma
Two critical positions in zinc finger domains are heavily mutated in three human cancer types.
Adenocarcinoma
Upregulated GAPLINC predicts a poor prognosis in bladder cancer patients and promotes tumor proliferation and invasion.
Adenocarcinoma
Upregulated long-non-coding RNA DLEU2 exon 9 expression was an independent indicator of unfavorable overall survival in patients with esophageal adenocarcinoma.
Adenocarcinoma
Upregulation of exosomal microRNA?21 in pancreatic stellate cells promotes pancreatic cancer cell migration and enhances Ras/ERK pathway activity.
Adenocarcinoma
Upregulation of ZBTB7A exhibits a tumor suppressive role in gastric cancer cells.
Adenocarcinoma
UXT antisense RNA 1 sever as a novel prognostic long non-coding RNA in early stage pancreatic ductal adenocarcinoma patients after receiving pancreaticoduodenectomy.
Adenocarcinoma
Verification of expressions of lncRNA FOXCUT in gastric adenocarcinoma patients and its effects on cell biological function based on TCGA database.
Adenocarcinoma
Weighted gene co-expression network analysis of gene modules for the prognosis of esophageal cancer.
Adenocarcinoma
Where is the limit of prostate cancer biomarker research? Systematic investigation of potential prognostic and diagnostic biomarkers.
Adenocarcinoma
Whole exome sequencing and deep sequencing of esophageal squamous cell carcinoma and adenocarcinoma in Japanese patients using the Japanese version of the Genome Atlas, JCGA.
Adenocarcinoma of Lung
A functional variant in miR-155 regulation region contributes to lung cancer risk and survival.
Adenocarcinoma of Lung
A Methodology for Texture Feature-based Quality Assessment in Nucleus Segmentation of Histopathology Image.
Adenocarcinoma of Lung
A methylation-based nomogram for predicting survival in patients with lung adenocarcinoma.
Adenocarcinoma of Lung
A novel autophagy-related lncRNA survival model for lung adenocarcinoma.
Adenocarcinoma of Lung
A prognostic model for lung adenocarcinoma patient survival with a focus on four miRNAs.
Adenocarcinoma of Lung
A Seven-Gene Signature with Close Immune Correlation Was Identified for Survival Prediction of Lung Adenocarcinoma.
Adenocarcinoma of Lung
A transcriptional miRNA-gene network associated with lung adenocarcinoma metastasis based on the TCGA database.
Adenocarcinoma of Lung
Akt kinase LANCL2 functions as a key driver in EGFR-mutant lung adenocarcinoma tumorigenesis.
Adenocarcinoma of Lung
An EGFR signature predicts cell line and patient sensitivity to multiple tyrosine kinase inhibitors.
Adenocarcinoma of Lung
An individualized gene expression signature for prediction of lung adenocarcinoma metastases.
Adenocarcinoma of Lung
An Integrative Analysis of Transcriptome and Epigenome Features of ASCL1-Positive Lung Adenocarcinomas.
Adenocarcinoma of Lung
Analysis of genomic and transcriptomic variations as prognostic signature for lung adenocarcinoma.
Adenocarcinoma of Lung
Analysis of the clinicopathological characteristics, genetic phenotypes, and prognostic of pure mucinous adenocarcinoma.
Adenocarcinoma of Lung
Association between immunotherapy biomarkers and glucose metabolism from F-18 FDG PET.
Adenocarcinoma of Lung
Association of Omics Features with Histopathology Patterns in Lung Adenocarcinoma.
Adenocarcinoma of Lung
Association of specific gene mutations derived from machine learning with survival in lung adenocarcinoma.
Adenocarcinoma of Lung
AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma.
Adenocarcinoma of Lung
Autocrine TGF? Is a Survival Factor for Monocytes and Drives Immunosuppressive Lineage Commitment.
Adenocarcinoma of Lung
Bioinformatics analyses of the differences between lung adenocarcinoma and squamous cell carcinoma using The Cancer Genome Atlas expression data.
Adenocarcinoma of Lung
Bioinformatics and functional analyses of key genes in smoking-associated lung adenocarcinoma.
Adenocarcinoma of Lung
C-terminal binding protein-2 is a prognostic marker for lung adenocarcinomas.
Adenocarcinoma of Lung
Cancer-associated fibroblasts are associated with poor prognosis in solid type of lung adenocarcinoma in a machine learning analysis.
Adenocarcinoma of Lung
Cancer-Associated Point Mutations in the DLC1 Tumor Suppressor and Other Rho-GAPs Occur Frequently and Are Associated with Decreased Function.
Adenocarcinoma of Lung
Cancer-testis gene PIWIL1 promotes cell proliferation, migration, and invasion in lung adenocarcinoma.
Adenocarcinoma of Lung
Cascaded Wx: A Novel Prognosis-Related Feature Selection Framework in Human Lung Adenocarcinoma Transcriptomes.
Adenocarcinoma of Lung
CCAAT/Enhancer Binding Protein ? Is Dispensable for Development of Lung Adenocarcinoma.
Adenocarcinoma of Lung
CERNA SEARCH METHOD IDENTIFIED A MET-ACTIVATED SUBGROUP AMONG EGFR DNA AMPLIFIED LUNG ADENOCARCINOMA PATIENTS.
Adenocarcinoma of Lung
Characterization of a ferroptosis and iron-metabolism related lncRNA signature in lung adenocarcinoma.
Adenocarcinoma of Lung
circCCND1 Regulates Oxidative Stress and FGF9 to Enhance Chemoresistance of Non-Small Cell Lung Cancer via Sponging miR-187-3p.
Adenocarcinoma of Lung
Classification of lung adenocarcinoma transcriptome subtypes from pathological images using deep convolutional networks.
Adenocarcinoma of Lung
Classifying non-small cell lung cancer types and transcriptomic subtypes using convolutional neural networks.
Adenocarcinoma of Lung
Clinical Utility of Patient-Derived Xenografts to Determine Biomarkers of Prognosis and Map Resistance Pathways in EGFR-Mutant Lung Adenocarcinoma.
Adenocarcinoma of Lung
Clinical Value and Prospective Pathway Signaling of MicroRNA-375 in Lung Adenocarcinoma: A Study Based on the Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO) and Bioinformatics Analysis.
Adenocarcinoma of Lung
Clinical value of miR-452-5p expression in lung adenocarcinoma: A retrospective quantitative real-time polymerase chain reaction study and verification based on The Cancer Genome Atlas and Gene Expression Omnibus databases.
Adenocarcinoma of Lung
Clinicopathological significance of microRNA-21 in extracellular vesicles of pleural lavage fluid of lung adenocarcinoma and its functions inducing the mesothelial to mesenchymal transition.
Adenocarcinoma of Lung
Clinicopathological, gene expression and genetic features of stage I lung adenocarcinoma with necrosis.
Adenocarcinoma of Lung
Coexisting EGFR and TP53 Mutations in Lung Adenocarcinoma Patients Are Associated With COMP and ITGB8 Upregulation and Poor Prognosis.
Adenocarcinoma of Lung
Comparative Study of Autoantibody Responses between Lung Adenocarcinoma and Benign Pulmonary Nodules.
Adenocarcinoma of Lung
Comprehensive Analysis of Aberrantly Expressed Profiles of lncRNAs and miRNAs with Associated ceRNA Network in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Adenocarcinoma of Lung
Comprehensive Analysis of Competing Endogenous RNA (ceRNA) Network Based on RNAs Differentially Expressed in Lung Adenocarcinoma Using The Cancer Genome Atlas (TCGA) Database.
Adenocarcinoma of Lung
Comprehensive analysis of competitive endogenous RNA associated with immune infiltration in lung adenocarcinoma.
Adenocarcinoma of Lung
Comprehensive characterization of functional eRNAs in lung adenocarcinoma reveals novel regulators and a prognosis-related molecular subtype.
Adenocarcinoma of Lung
Construction and validation of a 15-gene ferroptosis signature in lung adenocarcinoma.
Adenocarcinoma of Lung
Construction of a Novel Lung Adenocarcinoma Immune-Related lncRNA Pair Signature.
Adenocarcinoma of Lung
Correlation between EZH2 and CEP55 and lung adenocarcinoma prognosis.
Adenocarcinoma of Lung
CREB targets define the gene expression signature of malignancies having reduced levels of the tumor suppressor tristetraprolin.
Adenocarcinoma of Lung
CYP4B1 is a prognostic biomarker and potential therapeutic target in lung adenocarcinoma.
Adenocarcinoma of Lung
Deep Sequencing Analysis Reveals That KRAS Mutation Is a Marker of Poor Prognosis in Patients with Pulmonary Sarcomatoid Carcinoma.
Adenocarcinoma of Lung
Deregulated microRNAs Are Associated with Patient Survival and Predicted to Target Genes That Modulate Lung Cancer Signaling Pathways.
Adenocarcinoma of Lung
Determining the Clinical Value and Critical Pathway of GTPBP4 in Lung Adenocarcinoma Using a Bioinformatics Strategy: A Study Based on Datasets from The Cancer Genome Atlas.
Adenocarcinoma of Lung
Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer.
Adenocarcinoma of Lung
Development of a miRNA-seq based prognostic signature in lung adenocarcinoma.
Adenocarcinoma of Lung
Development of a novel prognostic score combining clinicopathologic variables, gene expression, and mutation profiles for lung adenocarcinoma.
Adenocarcinoma of Lung
Development of a novel prognostic signature of long non-coding RNAs in lung adenocarcinoma.
Adenocarcinoma of Lung
Development of a RNA-Seq Based Prognostic Signature in Lung Adenocarcinoma.
Adenocarcinoma of Lung
Development of somatic mutation signatures for risk stratification and prognosis in lung and colorectal adenocarcinomas.
Adenocarcinoma of Lung
Differential expression and significance of PD-L1, IDO-1 and B7-H4 in human lung cancer.
Adenocarcinoma of Lung
Differential expression of critical cellular genes in human lung adenocarcinomas and squamous cell carcinomas in comparison to normal lung tissues.
Adenocarcinoma of Lung
Dissecting the multi-omics atlas of the exosomes released by human lung adenocarcinoma stem-like cells.
Adenocarcinoma of Lung
DNA methylation biomarkers for the occurrence of lung adenocarcinoma from TCGA data mining.
Adenocarcinoma of Lung
DNA methylation signature of smoking in lung cancer is enriched for exposure signatures in newborn and adult blood.
Adenocarcinoma of Lung
Elevated integrin ?6 expression is involved in the occurrence and development of lung adenocarcinoma, and predicts a poor prognosis: a study based on immunohistochemical analysis and bioinformatics.
Adenocarcinoma of Lung
Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma.
Adenocarcinoma of Lung
Elevated TOP2A and UBE2C expressions correlate with poor prognosis in patients with surgically resected lung adenocarcinoma: a study based on immunohistochemical analysis and bioinformatics.
Adenocarcinoma of Lung
Elucidating Genomic Characteristics of Lung Cancer Progression from In Situ to Invasive Adenocarcinoma.
Adenocarcinoma of Lung
Epigenetically Regulated Chromosome 14q32 miRNA Cluster Induces Metastasis and Predicts Poor Prognosis in Lung Adenocarcinoma Patients.
Adenocarcinoma of Lung
Epigenome-wide association study of smoking and DNA methylation in non-small cell lung neoplasms.
Adenocarcinoma of Lung
Epithelial-mesenchymal transition is associated with a distinct tumor microenvironment including elevation of inflammatory signals and multiple immune checkpoints in lung adenocarcinoma.
Adenocarcinoma of Lung
Establishment and validation of a 7-microRNA prognostic signature for non-small cell lung cancer.
Adenocarcinoma of Lung
Examination of Independent Prognostic Power of Gene Expressions and Histopathological Imaging Features in Cancer.
Adenocarcinoma of Lung
Exploration of estrogen receptor-associated hub genes and potential molecular mechanisms in non-smoking females with lung adenocarcinoma using integrated bioinformatics analysis.
Adenocarcinoma of Lung
Exploration of the Tumor-Suppressive Immune Microenvironment by Integrated Analysis in EGFR-Mutant Lung Adenocarcinoma.
Adenocarcinoma of Lung
Exploring the Effect of Differentially Expressed Long Non-coding RNAs Driven by Copy Number Variation on Competing Endogenous RNA Network by Mining Lung Adenocarcinoma Data.
Adenocarcinoma of Lung
Exploring the survival prognosis of lung adenocarcinoma based on the cancer genome atlas database using artificial neural network.
Adenocarcinoma of Lung
Expression and clinical significance of AURKB gene in lung adenocarcinoma: Analysis based on the data-mining of bioinformatic database.
Adenocarcinoma of Lung
Expression and clinicopathological implication of DcR3 in lung cancer tissues: a tissue microarray study with 365 cases.
Adenocarcinoma of Lung
Expression and prognostic analysis of Rho GTPase-activating protein 11A in lung adenocarcinoma.
Adenocarcinoma of Lung
Expression of SUMO1P3 Compared with SUMO1 is an Independent Predictor of Patient Outcome in Lung Adenocarcinoma.
Adenocarcinoma of Lung
Expression of the receptor for hyaluronic acid mediated motility (RHAMM) is associated with poor prognosis and metastasis in non-small cell lung carcinoma.
Adenocarcinoma of Lung
Expression of UBE2C in lung adenocarcinoma based on database analysis and its clinical significance.
Adenocarcinoma of Lung
Expression Profiles of microRNAs in Drug-Resistant Non-Small Cell Lung Cancer Cell Lines Using microRNA Sequencing.
Adenocarcinoma of Lung
Expression profiling of ubiquitin-related genes in LKB1 mutant lung adenocarcinoma.
Adenocarcinoma of Lung
EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells.
Adenocarcinoma of Lung
FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing.
Adenocarcinoma of Lung
Factor analysis for survival time prediction with informative censoring and diverse covariates.
Adenocarcinoma of Lung
FBXW7 deletion contributes to lung tumor development and confers resistance to gefitinib therapy.
Adenocarcinoma of Lung
Feasibility of lung cancer RNA acquisition from a single transbronchial or transthoracic needle pass (FASTT trial).
Adenocarcinoma of Lung
FGFR4 Gene Polymorphism Reduces the Risk of Distant Metastasis in Lung Adenocarcinoma in Taiwan.
Adenocarcinoma of Lung
FHIT loss-induced DNA damage creates optimal APOBEC substrates: Insights into APOBEC-mediated mutagenesis.
Adenocarcinoma of Lung
FURIN correlated with immune infiltration serves as a potential biomarker in SARS-CoV-2 infection-related lung adenocarcinoma.
Adenocarcinoma of Lung
Gastric-type gene expression and phenotype in non-terminal respiratory unit type adenocarcinoma of the lung with invasive mucinous adenocarcinoma morphology.
Adenocarcinoma of Lung
Gene and MicroRNA Perturbations of Cellular Response to Pemetrexed Implicate Biological Networks and Enable Imputation of Response in Lung Adenocarcinoma.
Adenocarcinoma of Lung
Gene landscape and correlation between B-cell infiltration and programmed death ligand 1 expression in lung adenocarcinoma patients from The Cancer Genome Atlas data set.
Adenocarcinoma of Lung
Gene signatures of 6-methyladenine regulators in women with lung adenocarcinoma and development of a risk scoring system: a retrospective study using the cancer genome atlas database.
Adenocarcinoma of Lung
Genetic defects of the IRF1-mediated major histocompatibility complex class I antigen presentation pathway occur prevalently in the
Adenocarcinoma of Lung
Genetic variants in regulatory regions of microRNAs are associated with lung cancer risk.
Adenocarcinoma of Lung
Genome-wide DNA methylation analyses in lung adenocarcinomas: Association with EGFR, KRAS and TP53 mutation status, gene expression and prognosis.
Adenocarcinoma of Lung
Genomic data from NSCLC tumors reveals correlation between SHP-2 activity and PD-L1 expression and suggests synergy in combining SHP-2 and PD-1/PD-L1 inhibitors.
Adenocarcinoma of Lung
Genomic signatures defining responsiveness to allopurinol and combination therapy for lung cancer identified by systems therapeutics analyses.
Adenocarcinoma of Lung
Global Transcriptome Analysis of RNA Abundance Regulation by ADAR in Lung Adenocarcinoma.
Adenocarcinoma of Lung
High expression levels of pyrimidine metabolic rate-limiting enzymes are adverse prognostic factors in lung adenocarcinoma: a study based on The Cancer Genome Atlas and Gene Expression Omnibus datasets.
Adenocarcinoma of Lung
High expression of RRM2 as an independent predictive factor of poor prognosis in patients with lung adenocarcinoma.
Adenocarcinoma of Lung
Histopathological Imaging?Environment Interactions in Cancer Modeling.
Adenocarcinoma of Lung
HLA class I binding of mutant EGFR peptides in NSCLC is associated with improved survival.
Adenocarcinoma of Lung
HOXC13 promotes proliferation of lung adenocarcinoma via modulation of CCND1 and CCNE1.
Adenocarcinoma of Lung
HSD17B4, ACAA1, and PXMP4 in Peroxisome Pathway Are Down-Regulated and Have Clinical Significance in Non-small Cell Lung Cancer.
Adenocarcinoma of Lung
HUWE1 controls the development of non-small cell lung cancer through down-regulation of p53.
Adenocarcinoma of Lung
Hypermethylation of CCND2 in Lung and Breast Cancer Is a Potential Biomarker and Drug Target.
Adenocarcinoma of Lung
Hypermethylation of the PTTG1IP promoter leads to low expression in early-stage non-small cell lung cancer.
Adenocarcinoma of Lung
Identification and validation of an immune cell infiltrating score predicting survival in patients with lung adenocarcinoma.
Adenocarcinoma of Lung
Identification and validation of novel DNA methylation markers for early diagnosis of lung adenocarcinoma.
Adenocarcinoma of Lung
Identification immunophenotyping of lung adenocarcinomas based on the tumor microenvironment.
Adenocarcinoma of Lung
Identification of a Hypoxia-Associated Signature for Lung Adenocarcinoma.
Adenocarcinoma of Lung
Identification of an Immunologic Signature of Lung Adenocarcinomas Based on Genome-Wide Immune Expression Profiles.
Adenocarcinoma of Lung
Identification of CDK2-Related Immune Forecast Model and ceRNA in Lung Adenocarcinoma, a Pan-Cancer Analysis.
Adenocarcinoma of Lung
Identification of four methylation-driven genes as candidate biomarkers for monitoring single-walled carbon nanotube-induced malignant transformation of the lung.
Adenocarcinoma of Lung
Identification of genes associated with cancer progression and prognosis in lung adenocarcinoma: Analyses based on microarray from Oncomine and The Cancer Genome Atlas databases.
Adenocarcinoma of Lung
Identification of Novel microRNA Prognostic Markers Using Cascaded Wx, a Neural Network-Based Framework, in Lung Adenocarcinoma Patients.
Adenocarcinoma of Lung
Identification of Prognostic Genes and Pathways in Lung Adenocarcinoma Using a Bayesian Approach.
Adenocarcinoma of Lung
Identification of recurrence-associated microRNAs in stage I lung adenocarcinoma.
Adenocarcinoma of Lung
Identifying cancer type specific oncogenes and tumor suppressors using limited size data.
Adenocarcinoma of Lung
Identifying prognostic biomarkers of non-small cell lung cancer by transcriptome analysis.
Adenocarcinoma of Lung
Identifying the prognostic significance of B3GNT3 with PD-L1 expression in lung adenocarcinoma.
Adenocarcinoma of Lung
Immune-Stromal Score Signature: Novel Prognostic Tool of the Tumor Microenvironment in Lung Adenocarcinoma.
Adenocarcinoma of Lung
Immunogenomic Gene Signature of Cell-Death Associated Genes with Prognostic Implications in Lung Cancer.
Adenocarcinoma of Lung
Immunoscore Predicts Survival in Early-Stage Lung Adenocarcinoma Patients.
Adenocarcinoma of Lung
Impact of Concurrent Genomic Alterations Detected by Comprehensive Genomic Sequencing on Clinical Outcomes in East-Asian Patients with EGFR-Mutated Lung Adenocarcinoma.
Adenocarcinoma of Lung
Impact of genetic alterations on outcomes of patients with stage I nonsmall cell lung cancer: An analysis of the cancer genome atlas data.
Adenocarcinoma of Lung
IMPACT: a whole-exome sequencing analysis pipeline for integrating molecular profiles with actionable therapeutics in clinical samples.
Adenocarcinoma of Lung
Increased CX3CL1 mRNA expression level is a positive prognostic factor in patients with lung adenocarcinoma.
Adenocarcinoma of Lung
Increased Expression of KNSTRN in Lung Adenocarcinoma Predicts Poor Prognosis: A Bioinformatics Analysis Based on TCGA Data.
Adenocarcinoma of Lung
Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma.
Adenocarcinoma of Lung
Increased VEGF-A in solid type of lung adenocarcinoma reduces the patients' survival.
Adenocarcinoma of Lung
Inhibition of Thioredoxin/Thioredoxin Reductase Induces Synthetic Lethality in Lung Cancers with Compromised Glutathione Homeostasis.
Adenocarcinoma of Lung
Integrated TCGA analysis implicates lncRNA CTB-193M12.5 as a prognostic factor in lung adenocarcinoma.
Adenocarcinoma of Lung
Integrating germline and somatic genetics to identify genes associated with lung cancer.
Adenocarcinoma of Lung
Integration and comparison of different genomic data for outcome prediction in cancer.
Adenocarcinoma of Lung
Integrative Genomic and Transcriptomic Analyses of Tumor Suppressor Genes and Their Role on Tumor Microenvironment and Immunity in Lung Squamous Cell Carcinoma.
Adenocarcinoma of Lung
Investigation of Potential Mechanisms Associated with Non-small Cell Lung Cancer.
Adenocarcinoma of Lung
IRGS: an immune-related gene classifier for lung adenocarcinoma prognosis.
Adenocarcinoma of Lung
KIF18B as a regulator in microtubule movement accelerates tumor progression and triggers poor outcome in lung adenocarcinoma.
Adenocarcinoma of Lung
KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung.
Adenocarcinoma of Lung
KRT6A Promotes EMT and Cancer Stem Cell Transformation in Lung Adenocarcinoma.
Adenocarcinoma of Lung
Landscape of epigenetically regulated lncRNAs and DNA methylation in smokers with lung adenocarcinoma.
Adenocarcinoma of Lung
Ligand-receptor interaction atlas within and between tumor cells and T cells in lung adenocarcinoma.
Adenocarcinoma of Lung
Lipid metabolism gene-wide profile and survival signature of lung adenocarcinoma.
Adenocarcinoma of Lung
LncRNA PPP1R14B-AS1 Promotes Tumor Cell Proliferation and Migration via the Enhancement of Mitochondrial Respiration.
Adenocarcinoma of Lung
Long noncoding RNA POU6F2-AS1 regulates lung cancer aggressiveness through sponging miR-34c-5p to modulate KCNJ4 expression.
Adenocarcinoma of Lung
Loss of FGL1 induces epithelial?mesenchymal transition and angiogenesis in LKB1 mutant lung adenocarcinoma.
Adenocarcinoma of Lung
Low-Level Expression of MTUS1 Is Associated with Poor Survival in Patients with Lung Adenocarcinoma.
Adenocarcinoma of Lung
LUADpp: an effective prediction model on prognosis of lung adenocarcinomas based on somatic mutational features.
Adenocarcinoma of Lung
Lung adenocarcinoma patients have higher risk of SARS-CoV-2 infection.
Adenocarcinoma of Lung
m6A RNA Methylation Regulators Participate in the Malignant Progression and Have Clinical Prognostic Value in Lung Adenocarcinoma.
Adenocarcinoma of Lung
Machine-Learning Prediction of Tumor Antigen Immunogenicity in the Selection of Therapeutic Epitopes.
Adenocarcinoma of Lung
MAPK4 overexpression promotes tumor progression via noncanonical activation of AKT/mTOR signaling.
Adenocarcinoma of Lung
Mechanism of Fuzheng Kang'ai Formula () Regulating Tumor Microenvironment in Non-Small Cell Lung Cancer.
Adenocarcinoma of Lung
Metastasis suppressor 1 (MTSS1) expression is associated with reduced in-vivo metastasis and enhanced patient survival in lung adenocarcinoma.
Adenocarcinoma of Lung
MGA Mutation as a Novel Biomarker for Immune Checkpoint Therapies in Non-Squamous Non-Small Cell Lung Cancer.
Adenocarcinoma of Lung
MHC class II restricted neoantigen peptides predicted by clonal mutation analysis in lung adenocarcinoma patients: implications on prognostic immunological biomarker and vaccine design.
Adenocarcinoma of Lung
Microarray expression profile of microRNAs in lung adenocarcinoma patients with the Cancer Genome Atlas and its clinical validation.
Adenocarcinoma of Lung
MicroRNA expression profiles predict progression and clinical outcome in lung adenocarcinoma.
Adenocarcinoma of Lung
MicroRNA-204 deregulation in lung adenocarcinoma controls the biological behaviors of endothelial cells potentially by modulating Janus kinase 2-signal transducer and activator of transcription 3 pathway.
Adenocarcinoma of Lung
MiR-195 restrains lung adenocarcinoma by regulating CD4+ T cell activation via the CCDC88C/Wnt signaling pathway: a study based on the Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO) and bioinformatic analysis.
Adenocarcinoma of Lung
miR-195 targets cyclin D3 and survivin to modulate the tumorigenesis of non-small cell lung cancer.
Adenocarcinoma of Lung
MiR-320a is associated with cisplatin resistance in lung adenocarcinoma and its clinical value in non-small cell lung cancer: A comprehensive analysis based on microarray data.
Adenocarcinoma of Lung
MiR-34a and miR-34b/c have distinct effects on the suppression of lung adenocarcinomas.
Adenocarcinoma of Lung
MiR-374a suppresses lung adenocarcinoma cell proliferation and invasion by targeting TGFA gene expression.
Adenocarcinoma of Lung
miR?888 regulates cancer progression by targeting multiple targets in lung adenocarcinoma.
Adenocarcinoma of Lung
MNX1-AS1 is a novel biomarker for predicting clinical progression and poor prognosis in lung adenocarcinoma.
Adenocarcinoma of Lung
Modeling Gene-Wise Dependencies Improves the Identification of Drug Response Biomarkers in Cancer Studies.
Adenocarcinoma of Lung
Modeling the Genetic Regulation of Cancer Metabolism: Interplay between Glycolysis and Oxidative Phosphorylation.
Adenocarcinoma of Lung
Molecular characteristics of primary pulmonary lymphoepithelioma-like carcinoma based on integrated genomic analyses.
Adenocarcinoma of Lung
Molecular characterization of lung adenocarcinoma from Korean patients using next generation sequencing.
Adenocarcinoma of Lung
Molecular gene mutation profiles, TMB and the impact of prognosis in Caucasians and east Asian patients with lung adenocarcinoma.
Adenocarcinoma of Lung
Molecular subtypes based on DNA promoter methylation predict prognosis in lung adenocarcinoma patients.
Adenocarcinoma of Lung
Multi-omics analysis identifies potential mechanisms of AURKB in mediating poor outcome of lung adenocarcinoma.
Adenocarcinoma of Lung
Multi-omics integrative analysis and survival risk model construction of non-small cell lung cancer based on The Cancer Genome Atlas datasets.
Adenocarcinoma of Lung
Mutations in genes connected with the TCF7L2 transcription factor are associated with a poor prognosis in non-small cell lung cancer.
Adenocarcinoma of Lung
Network-adjusted Kendall's Tau Measure for Feature Screening with Application to High-dimensional Survival Genomic Data.
Adenocarcinoma of Lung
New insights into the molecular profile of lung adenocarcinoma and implications for therapy.
Adenocarcinoma of Lung
Novel immune subtypes of lung adenocarcinoma identified through bioinformatic analysis.
Adenocarcinoma of Lung
Overexpression of eIF3D in Lung Adenocarcinoma Is a New Independent Prognostic Marker of Poor Survival.
Adenocarcinoma of Lung
Overexpression of HOTTIP promotes proliferation and drug resistance of lung adenocarcinoma by regulating AKT signaling pathway.
Adenocarcinoma of Lung
Overexpression of S100A14 contributes to malignant progression and predicts poor prognosis of lung adenocarcinoma.
Adenocarcinoma of Lung
P38 pathway as a key downstream signal of connective tissue growth factor to regulate metastatic potential in non-small-cell lung cancer.
Adenocarcinoma of Lung
p53-inducible gene 3 promotes cell migration and invasion by activating the FAK/Src pathway in lung adenocarcinoma.
Adenocarcinoma of Lung
Pan-cancer analysis of TCGA data reveals notable signaling pathways.
Adenocarcinoma of Lung
Patterns of Transposable Element Expression and Insertion in Cancer.
Adenocarcinoma of Lung
PD-L1 and PD-L2 expression correlated genes in non-small-cell lung cancer.
Adenocarcinoma of Lung
Phosphoinositide specific phospholipase C?1 inhibition-driven autophagy caused cell death in human lung adenocarcinoma A549 cells in vivo and in vitro.
Adenocarcinoma of Lung
Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image features.
Adenocarcinoma of Lung
Predicting the Clinical Outcome of Lung Adenocarcinoma Using a Novel Gene Pair Signature Related to RNA-Binding Protein.
Adenocarcinoma of Lung
Prognostic Implication of the Expression Level of PECAM-1 in Non-small Cell Lung Cancer.
Adenocarcinoma of Lung
Prognostic significance of an invasive leader cell-derived mutation cluster on chromosome 16q.
Adenocarcinoma of Lung
Prognostic significance of CDC25C in lung adenocarcinoma: An analysis of TCGA data.
Adenocarcinoma of Lung
Protein Kinase C Isozymes Associated With Relapse Free Survival in Non-Small Cell Lung Cancer Patients.
Adenocarcinoma of Lung
Pseudogene CHIAP2 inhibits proliferation and invasion of lung adenocarcinoma cells by means of the WNT pathway.
Adenocarcinoma of Lung
Reference genome and annotation updates lead to contradictory prognostic predictions in gene expression signatures: a case study of resected stage I lung adenocarcinoma.
Adenocarcinoma of Lung
Role of INSL4 Signaling in Sustaining the Growth and Viability of LKB1-Inactivated Lung Cancer.
Adenocarcinoma of Lung
Role of upregulated miR-136-5p in lung adenocarcinoma: A study of 1242 samples utilizing bioinformatics analysis.
Adenocarcinoma of Lung
Screening for tumor suppressors: Loss of ephrin receptor A2 cooperates with oncogenic KRas in promoting lung adenocarcinoma.
Adenocarcinoma of Lung
Screening of important lncRNAs associated with the prognosis of lung adenocarcinoma, based on integrated bioinformatics analysis.
Adenocarcinoma of Lung
SIFORM: shared informative factor models for integration of multi-platform bioinformatic data.
Adenocarcinoma of Lung
Signaling Complexity Measured by Shannon Entropy and Its Application in Personalized Medicine.
Adenocarcinoma of Lung
Silencing of ARL14 Gene Induces Lung Adenocarcinoma Cells to a Dormant State.
Adenocarcinoma of Lung
Silencing of CASC8 inhibits non-small cell lung cancer cells function and promotes sensitivity to osimertinib via FOXM1.
Adenocarcinoma of Lung
Single-cell transcriptome atlas of lung adenocarcinoma featured with ground glass nodules.
Adenocarcinoma of Lung
Smoking correlates with increased cytoskeletal protein-related coding region mutations in the lung and head and neck datasets of the cancer genome atlas.
Adenocarcinoma of Lung
Somatic Mutations in miRNA Genes in Lung Cancer-Potential Functional Consequences of Non-Coding Sequence Variants.
Adenocarcinoma of Lung
SPC25 upregulation increases cancer stem cell properties in non-small cell lung adenocarcinoma cells and independently predicts poor survival.
Adenocarcinoma of Lung
Spindle pole body component 25 homolog expressed by ECM stiffening is required for lung cancer cell proliferation.
Adenocarcinoma of Lung
Stable and discriminating radiomic predictor of recurrence in early stage non-small cell lung cancer: Multi-site study.
Adenocarcinoma of Lung
STK11/LKB1 Loss of Function Is Associated with Global DNA Hypomethylation and S-Adenosyl-Methionine Depletion in Human Lung Adenocarcinoma.
Adenocarcinoma of Lung
SUMO1P3 is associated clinical progression and facilitates cell migration and invasion through regulating miR-136 in non-small cell lung cancer.
Adenocarcinoma of Lung
Suppression of cleavage factor Im 25 promotes the proliferation of lung cancer cells through alternative polyadenylation.
Adenocarcinoma of Lung
Suppression of Mig-6 overcomes the acquired EGFR-TKI resistance of lung adenocarcinoma.
Adenocarcinoma of Lung
Taxane-mediated radiosensitization derives from chromosomal missegregation on tripolar mitotic spindles orchestrated by AURKA and TPX2.
Adenocarcinoma of Lung
TCF19 contributes to cell proliferation of non-small cell lung cancer by inhibiting FOXO1.
Adenocarcinoma of Lung
Testis-specific protein, Y-linked 1 activates PI3K/AKT and RAS signaling pathways through suppressing IGFBP3 expression during tumor progression.
Adenocarcinoma of Lung
TGF?2-mediated epithelial-mesenchymal transition and NF-?B pathway activation contribute to osimertinib resistance.
Adenocarcinoma of Lung
The Combined Detection of Immune Genes for Predicting the Prognosis of Patients With Non-Small Cell Lung Cancer.
Adenocarcinoma of Lung
The expression of HOXA13 in lung adenocarcinoma and its clinical significance: A study based on The Cancer Genome Atlas, Oncomine and reverse transcription-quantitative polymerase chain reaction.
Adenocarcinoma of Lung
The genomic alterations of lung adenocarcinoma and lung squamous cell carcinoma can explain the differences of their overall survival rates.
Adenocarcinoma of Lung
The M1/M2 spectrum and plasticity of malignant pleural effusion-macrophage in advanced lung cancer.
Adenocarcinoma of Lung
The mitochondrial fission factor FIS1 promotes stemness of human lung cancer stem cells via mitophagy.
Adenocarcinoma of Lung
The prognostic landscape of tumor-infiltrating immune cell and immunomodulators in lung cancer.
Adenocarcinoma of Lung
The prognostic value of PKM2 and its correlation with tumour cell PD-L1 in lung adenocarcinoma.
Adenocarcinoma of Lung
The pseudogene-derived long noncoding RNA SFTA1P is down-regulated and suppresses cell migration and invasion in lung adenocarcinoma.
Adenocarcinoma of Lung
The signature lncRNAs associated with the lung adenocarcinoma patients prognosis.
Adenocarcinoma of Lung
The Significance of Secreted Phosphoprotein 1 in Multiple Human Cancers.
Adenocarcinoma of Lung
The up-regulation of Myb may help mediate EGCG inhibition effect on mouse lung adenocarcinoma.
Adenocarcinoma of Lung
The urokinase-type plasminogen activator and inhibitors in resectable lung adenocarcinoma.
Adenocarcinoma of Lung
Threonine Tyrosine Kinase Inhibition Eliminates Lung Cancers by Augmenting Apoptosis and Polyploidy.
Adenocarcinoma of Lung
Thrombospondin 2 promotes tumor metastasis by inducing matrix metalloproteinase-13 production in lung cancer cells.
Adenocarcinoma of Lung
TP53 Status, Patient Sex, and the Immune Response as Determinants of Lung Cancer Patient Survival.
Adenocarcinoma of Lung
Transcriptome Based Estrogen Related Genes Biomarkers for Diagnosis and Prognosis in Non-small Cell Lung Cancer.
Adenocarcinoma of Lung
TRIM28 is a distinct prognostic biomarker that worsens the tumor immune microenvironment in lung adenocarcinoma.
Adenocarcinoma of Lung
TRIM59 as a novel molecular biomarker to predict the prognosis of patients with NSCLC.
Adenocarcinoma of Lung
UBE2T promotes autophagy via the p53/AMPK/mTOR signaling pathway in lung adenocarcinoma.
Adenocarcinoma of Lung
Uncovering Prognosis-Related Genes and Pathways by Multi-Omics Analysis in Lung Cancer.
Adenocarcinoma of Lung
Upregulation of glucosamine-phosphate N-acetyltransferase 1 is a promising diagnostic and predictive indicator for poor survival in patients with lung adenocarcinoma.
Adenocarcinoma of Lung
Upregulation of LIMK1 Is Correlated With Poor Prognosis and Immune Infiltrates in Lung Adenocarcinoma.
Adenocarcinoma of Lung
USP4 expression independently predicts favorable survival in lung adenocarcinoma.
Adenocarcinoma of Lung
VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research.
Adenocarcinoma of Lung
Weighted gene coexpression network analysis identifies hub genes related to KRAS mutant lung adenocarcinoma.
Adenocarcinoma of Lung
Whole exome sequencing characterization of individuals presenting extreme phenotypes of high and low risk of developing tobacco-induced lung adenocarcinoma.
Adenocarcinoma of Lung
Whole transcriptome targeted gene quantification provides new insights on pulmonary sarcomatoid carcinomas.
Adenocarcinoma of Lung
ZNF692 promotes proliferation and cell mobility in lung adenocarcinoma.
Adenocarcinoma of Lung
[Expression of RASGRP2 in Lung Adenocarcinoma and Its Effect ?on Immune Microenvironment].
Adenocarcinoma of Lung
[FOXC1 Knockdown Reverses Gefitinib Resistance in Non-small Cell Lung Cancer].
Adenocarcinoma of Lung
[Immune Microenvironment Comparation Study between EGFR Mutant and EGFR Wild Type Lung Adenocarcinoma Patients Based on TCGA Database].
Adenocarcinoma of Lung
[Prognosis-related miRNA bioinformatics screening of lung adenocarcinoma and its clinical significance].
Adenocarcinoma, Mucinous
Analysis of the clinicopathological characteristics, genetic phenotypes, and prognostic of pure mucinous adenocarcinoma.
Adenocarcinoma, Mucinous
KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung.
Adenocarcinoma, Mucinous
Unique Genetic and Survival Characteristics of Invasive Mucinous Adenocarcinoma of the Lung.
Adenoma
Identification of key genes controlling cancer stem cell characteristics in gastric cancer.
Adenoma
The frequency of promoter DNA hypermethylation is decreased in colorectal neoplasms of familial adenomatous polyposis.
Adenoma
Update on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine Tumours.
Adenoma, Oxyphilic
Development of a DNA Methylation-Based Diagnostic Signature to Distinguish Benign Oncocytoma From Renal Cell Carcinoma.
Adenoma, Oxyphilic
DNA methylation profiling distinguishes histological subtypes of renal cell carcinoma.
Adenoma, Oxyphilic
FOXI1 expression in chromophobe renal cell carcinoma and renal oncocytoma: a study of The Cancer Genome Atlas transcriptome-based outlier mining and immunohistochemistry.
Adenomatous Polyposis Coli
Application of open-access databases to determine functional connectivity between resveratrol-binding protein QR2 and colorectal carcinoma.
Adenomatous Polyposis Coli
Circular RNA hsa_circ_0005114-miR-142-3p/miR-590-5p-adenomatous polyposis coli protein axis as a potential target for treatment of glioma.
Adrenal Cortex Neoplasms
Molecular genomic profiling of adrenocortical cancers in clinical practice.
Adrenocortical Carcinoma
Adrenocortical cancer cell line mutational profile reveals aggressive genetic background.
Adrenocortical Carcinoma
Adrenocortical tumors have a distinct, long, non-coding RNA expression profile and LINC00271 is downregulated in malignancy.
Adrenocortical Carcinoma
Expression of FSCN1 and FOXM1 are associated with poor prognosis of adrenocortical carcinoma patients.
Adrenocortical Carcinoma
Multiplatform computational analysis of mast cells in adrenocortical carcinoma tumor microenvironment.
Adrenocortical Carcinoma
Over expression of DNA damage and cell cycle dependent proteins are associated with poor survival in patients with adrenocortical carcinoma.
Albuminuria
Evaluation of the Urine Protein/Creatinine Ratio Measured with the Dipsticks Clinitek Atlas PRO 12.
Alopecia
Biallelic pathogenic variants in the lanosterol synthase gene LSS involved in the cholesterol biosynthesis cause alopecia with intellectual disability, a rare recessive neuroectodermal syndrome.
Alopecia
Optical Coherence Tomography in the Evaluation of the Scalp and Hair: Common Features and Clinical Utility.
Alzheimer Disease
A Comparative Atlas-Based Recognition of Mild Cognitive Impairment With Voxel-Based Morphometry.
Alzheimer Disease
A computational atlas of the hippocampal formation using ex vivo, ultra-high resolution MRI: Application to adaptive segmentation of in vivo MRI.
Alzheimer Disease
A multi-omic atlas of the human frontal cortex for aging and Alzheimer's disease research.
Alzheimer Disease
A probabilistic atlas of locus coeruleus pathways to transentorhinal cortex for connectome imaging in Alzheimer's disease.
Alzheimer Disease
A probabilistic atlas of the human thalamic nuclei combining ex vivo MRI and histology.
Alzheimer Disease
A single-cell atlas of entorhinal cortex from individuals with Alzheimer's disease reveals cell-type-specific gene expression regulation.
Alzheimer Disease
Accurate segmentation of brain images into 34 structures combining a non-stationary adaptive statistical atlas and a multi-atlas with applications to Alzheimer's disease.
Alzheimer Disease
Accurate Whole-Brain Segmentation for Alzheimer's Disease Combining an Adaptive Statistical Atlas and Multi-atlas.
Alzheimer Disease
An atlas of cortical circular RNA expression in Alzheimer disease brains demonstrates clinical and pathological associations.
Alzheimer Disease
An MRI-Based Atlas for Correlation of Imaging and Pathologic Findings in Alzheimer's Disease.
Alzheimer Disease
Atlas based sparse logistic regression for Alzheimer's Disease classification.
Alzheimer Disease
Atlas stumbled: kinesin light chain-1 variant E triggers a vicious cycle of axonal transport disruption and amyloid-? generation in Alzheimer's disease.
Alzheimer Disease
Automated Multi-Atlas Segmentation of Hippocampal and Extrahippocampal Subregions in Alzheimer's Disease at 3T and 7T: What Atlas Composition Works Best?
Alzheimer Disease
Automated ventricular mapping with multi-atlas fluid image alignment reveals genetic effects in Alzheimer's disease.
Alzheimer Disease
Characterizing the human hippocampus in aging and Alzheimer's disease using a computational atlas derived from ex vivo MRI and histology.
Alzheimer Disease
Co-occurrent Alterations of Alzheimer's Genes and Prostate Cancer Genes in Prostate Cancer.
Alzheimer Disease
Comparative Evaluation of Diffusion Kurtosis Imaging and Diffusion Tensor Imaging in Detecting Cerebral Microstructural Changes in Alzheimer Disease.
Alzheimer Disease
Comparison of cholinergic drug effects on regional brain glucose consumption in rats and humans by means of autoradiography and position emission tomography.
Alzheimer Disease
Cortical change in Alzheimer's disease detected with a disease-specific population-based brain atlas.
Alzheimer Disease
Fully Automated Atlas-Based Hippocampus Volumetry for Clinical Routine: Validation in Subjects with Mild Cognitive Impairment from the ADNI Cohort.
Alzheimer Disease
Genomic atlas of the proteome from brain, CSF and plasma prioritizes proteins implicated in neurological disorders.
Alzheimer Disease
High-resolution magnetic resonance imaging reveals nuclei of the human amygdala: manual segmentation to automatic atlas.
Alzheimer Disease
Incorporating parameter uncertainty in Bayesian segmentation models: application to hippocampal subfield volumetry.
Alzheimer Disease
Mathematical/computational challenges in creating deformable and probabilistic atlases of the human brain.
Alzheimer Disease
Meta-Analysis of the Alzheimer's Disease Human Brain Transcriptome and Functional Dissection in Mouse Models.
Alzheimer Disease
Operationalizing hippocampal volume as an enrichment biomarker for amnestic mild cognitive impairment trials: effect of algorithm, test-retest variability, and cut point on trial cost, duration, and sample size.
Alzheimer Disease
Sex Moderates Amyloid and Apolipoprotein ?4 Effects on Default Mode Network Connectivity at Rest.
Alzheimer Disease
Stereotactic PET atlas of the human brain: aid for visual interpretation of functional brain images.
Alzheimer Disease
Two-dimensional Enrichment Analysis for Mining High-level Imaging Genetic Associations.
Alzheimer Disease
Two-dimensional enrichment analysis for mining high-level imaging genetic associations.
Alzheimer Disease
Use of brain MRI atlases to determine boundaries of age-related pathology: the importance of statistical method.
Alzheimer Disease
Zebrafish brain RNA sequencing reveals that cell adhesion molecules are critical in brain aging.
Amyotrophic Lateral Sclerosis
Identification of 17 Highly Expressed Genes within Mouse Lumbar Spinal Cord Anterior Horn Region from an In-Situ Hybridization Atlas of 3430 Genes: Implications for Motor Neuron Disease.
Amyotrophic Lateral Sclerosis
MAPT (Tau) expression is a biomarker for an increased rate of survival in pediatric neuroblastoma.
Amyotrophic Lateral Sclerosis
Quantitative diffusion tensor imaging in amyotrophic lateral sclerosis: Revisited.
Aneurysm
Cerebrovascular disorders associated with von Recklinghausen's neurofibromatosis: a case report.
Aneurysm
Clinical Safety and Effectiveness of Stent-Assisted Coil Embolization with Neuroform Atlas Stent in Intracranial Aneurysm.
Aneurysm
Commentary: Neuroform Atlas Stent for Treatment of Middle Cerebral Artery Aneurysms: 1-Year Outcomes From Neuroform Atlas Stent Pivotal Trial.
Aneurysm
Comparison of Clinical Outcomes After Stent-Assisted Coiling with 3 Types of Self-Expanding Laser-Cut Stents in Patients with Wide-Necked Intracranial Aneurysms.
Aneurysm
Direct suction decompression and fenestrated clip reconstruction of complex paraclinoid carotid artery aneurysm: operative video and nuances of skull base technique.
Aneurysm
Double stent assisted coiling of intracranial bifurcation aneurysms in Y and X configurations with the Neuroform ATLAS stent: immediate and mid term angiographic and clinical follow-up.
Aneurysm
Early Multicenter Experience With the Neuroform Atlas Stent: Feasibility, Safety, and Efficacy.
Aneurysm
Early post-Humanitarian Device Exemption experience with the Neuroform Atlas stent.
Aneurysm
Experiences with intraluminal occlusion with the Fogarty catheter in the treatment of carotid-cavernous sinus fistulas and other lesions at the base of the skull.
Aneurysm
Initial multicentre experience using the neuroform atlas stent for the treatment of un-ruptured saccular cerebral aneurysms.
Aneurysm
Low-Profile Laser-Cut Stents for Endovascular Treatment of Intracranial Aneurysms : Incidence, Clinical Presentation and Risk Factors of Thromboembolic Events.
Aneurysm
Low-profile visualized intraluminal support Blue stenting within a Neuroform Atlas stent for a large wide-necked aneurysm: A case report and a bench-top experiment.
Aneurysm
Low-Profile Visualized Intraluminal Support Jr Braided Stent Versus Atlas Self-Expandable Stent for Treatment of Intracranial Aneurysms: A Single Center Experience.
Aneurysm
Modified "Extended" Suboccipital Subtonsillar Clipping of a Ruptured Proximal Pica Aneurysm: Technical Note with Relevant Anatomical Demonstration.
Aneurysm
Multi-centric European post-market follow-up study of the Neuroform Atlas Stent System: primary results.
Aneurysm
Neuroform Atlas stent deployment through the Barrel vascular reconstruction device for the treatment of a wide-necked acutely ruptured basilar aneurysm.
Aneurysm
Neuroform Atlas Stent for Treatment of Middle Cerebral Artery Aneurysms: 1-Year Outcomes From Neuroform Atlas Stent Pivotal Trial.
Aneurysm
Neuroform Atlas Stent System for the treatment of intracranial aneurysm: primary results of the Atlas Humanitarian Device Exemption cohort.
Aneurysm
Outcomes of Stent-Assisted Coiling Using the Neuroform Atlas Stent in Unruptured Wide-Necked Intracranial Aneurysms.
Aneurysm
Pivotal Trial of the Neuroform Atlas Stent for Treatment of Anterior Circulation Aneurysms: One-Year Outcomes.
Aneurysm
Pivotal trial of the Neuroform Atlas stent for treatment of posterior circulation aneurysms: one-year outcomes.
Aneurysm
Preliminary experience of stent-assisted coiling of wide-necked intracranial aneurysms with a single microcatheter.
Aneurysm
Pulmonary vasculitis in Hughes-Stovin syndrome (HSS): a reference atlas and computed tomography pulmonary angiography guide-a report by the HSS International Study Group.
Aneurysm
Safety and Efficacy of Stent-Assisted Coiling of Unruptured Intracranial Aneurysms Using Low-Profile Stents in Small Parent Arteries.
Aneurysm
Safety and efficacy of the Neuroform Atlas for stent-assisted coiling of intracranial aneurysms: A multicenter experience.
Aneurysm
Safety and Efficacy of the Neuroform Atlas Stent for Treatment of Intracranial Aneurysms : A Systematic Review and Meta-Analysis.
Aneurysm
Stent-Assisted Coiling of a Sidewall Aneurysm of the Distal Middle Cerebral Artery: 2-Dimensional Operative Video.
Aneurysm
Stent-assisted coiling of cerebral aneurysms: Head to head comparison between the Neuroform Atlas and EZ stents.
Aneurysm
The Geometry of Y-Stent Configurations Used for Wide-Necked Aneurysm Treatment: Analyzing Double-Barrel Stents In Vitro Using Flat-Panel Computed Tomography.
Aneurysm
The Neuroform Atlas stent to assist coil embolization of intracranial aneurysms: a multicentre experience.
Aneurysm
Two-center experience with Neuroform Atlas stent-assisted coil occlusion of broad-based intracranial aneurysms.
Aneurysm
Usefulness of pointwise encoding time reduction with radial acquisition sequence in subtraction-based magnetic resonance angiography for follow-up of the Neuroform Atlas stent-assisted coil embolization for cerebral aneurysms.
Aneurysm
Vertebro-PICA aneurysms: midline suboccipital approach and laminectomy of the atlas.
Aneurysm
Y-Stent-Assisted Coiling With Low-Profile Neuroform Atlas Stents for Endovascular Treatment of Wide-Necked Complex Intracranial Bifurcation Aneurysms.
Aneurysm
[Treatment by a direct surgical approach of a false arterio-venous traumatic aneurysm between the vertebral artery and the internal jugular vein at the level of the atlas (author's transl)]
Aneurysm, False
Spontaneous parapharyngeal haematoma caused by a leaking vertebral artery pseudoaneurysm.
Angiomyolipoma
A genome-wide association study implicates NR2F2 in lymphangioleiomyomatosis pathogenesis.
Ankylosis
Relationship between the morphology of the atlanto-occipital joint and the radiographic results in patients with atlanto-axial subluxation due to rheumatoid arthritis.
Anomia
Probabilistic map of critical functional regions of the human cerebral cortex: Broca's area revisited.
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Histopathological atlas of renal diseases: ANCA-associated vasculitis (first part).
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Histopathological atlas of renal diseases: ANCA-associated vasculitis (Second part).
Anus Neoplasms
Australasian Gastrointestinal Trials Group (AGITG) Contouring Atlas and Planning Guidelines for Intensity-Modulated Radiotherapy in Anal Cancer.
Anus Neoplasms
Genital invasion or perigenital spread may pose a risk of marginal misses for Intensity Modulated Radiotherapy (IMRT) in anal cancer.
Aortic Valve Disease
Cell-Type Transcriptome Atlas of Human Aortic Valves Reveal Cell Heterogeneity and Endothelial to Mesenchymal Transition Involved in Calcific Aortic Valve Disease.
Aortic Valve Disease
Spatiotemporal Multi-Omics-Derived Atlas of Calcific Aortic Valve Disease.
Arachnoiditis
[The neurologic manifestations of malformations of the occipito-atloid joint; a case of occipitalization of the atlas accompanied by cystic arachnoiditis, and treated surgically.]
Arnold-Chiari Malformation
Congenital reducible atlantoaxial dislocation: classification and surgical considerations.
Arnold-Chiari Malformation
Successful treatment of adult Arnold-Chiari malformation associated with basilar impression and syringomyelia by the transoral anterior approach.
Arnold-Chiari Malformation
[A case of hypoplasia and unilateral assimilation of the atlas with platybasia, basilar impression and Arnold-Chiari deformity.]
Arrhythmias, Cardiac
Evaluation of predictive scores for late and very late recurrence after cryoballoon-based ablation of atrial fibrillation.
Arteriovenous Fistula
Gunshot wound with fracture of the atlas and arteriovenous fistula of the vertebral artery. Case report.
Arteriovenous Fistula
[Treatment by a direct surgical approach of a false arterio-venous traumatic aneurysm between the vertebral artery and the internal jugular vein at the level of the atlas (author's transl)]
Arthritis
Atlas of MRI findings of sacroiliitis in pediatric sacroiliac joints to accompany the updated preliminary OMERACT pediatric JAMRIS (Juvenile Idiopathic Arthritis MRI Score) scoring system: Part I: Active lesions.
Arthritis
Atlas of MRI findings of sacroiliitis in pediatric sacroiliac joints to accompany the updated preliminary OMERACT pediatric JAMRIS (Juvenile Idiopathic Arthritis MRI Score) scoring system: Part II: Structural damage lesions.
Arthritis
Development and reliability of a novel ultrasonographic joint-specific scoring system for synovitis with reference atlas for patients with juvenile idiopathic arthritis.
Arthritis
MR atlas for articular cartilage morphology: potential to detect shape differences.
Arthritis
Radiographically defined osteoarthritis of the hand and knee in young and middle-aged African American and Caucasian women.
Arthritis
Temporomandibular joint atlas for detection and grading of juvenile idiopathic arthritis involvement by magnetic resonance imaging.
Arthritis
[Two rare cases of development of metastatic arthritis in atlas epistropheus with torticollis (Grisel's disease), and its treatment.]
Arthritis, Experimental
An Accord of Nuclear Receptor Expression in CD4+ T Cells in Rheumatoid Arthritis.
Arthritis, Infectious
Osteomyelitis of the atlanto-occipital region as a sequela to a pharyngeal stick injury.
Arthritis, Juvenile
Development and reliability of a novel ultrasonographic joint-specific scoring system for synovitis with reference atlas for patients with juvenile idiopathic arthritis.
Arthritis, Juvenile
Temporomandibular joint atlas for detection and grading of juvenile idiopathic arthritis involvement by magnetic resonance imaging.
Arthritis, Rheumatoid
3- to 11-year followup of occipitocervical fusion for rheumatoid arthritis.
Arthritis, Rheumatoid
An introduction to the EULAR-OMERACT rheumatoid arthritis MRI reference image atlas.
Arthritis, Rheumatoid
Atlantoaxial joint distraction for treatment of basilar invagination secondary to rheumatoid arthritis.
Arthritis, Rheumatoid
Backward tilting of the posterior atlantal arch in rheumatoid arthritis.
Arthritis, Rheumatoid
Biomechanical rationale for the pathology of rheumatoid arthritis in the craniovertebral junction.
Arthritis, Rheumatoid
Examination of intra and interrater reliability with a new ultrasonographic reference atlas for scoring of synovitis in patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Functional genomics atlas of synovial fibroblasts defining rheumatoid arthritis heritability.
Arthritis, Rheumatoid
Lateral subluxation of the atlas in rheumatoid arthritis: a case report and post-mortem study.
Arthritis, Rheumatoid
Magnetic resonance imaging in rheumatoid arthritis advances and research priorities.
Arthritis, Rheumatoid
Nonreducible rotational head tilt and atlantoaxial lateral mass collapse. Clinical and roentgenographic features in patients with juvenile rheumatoid arthritis and ankylosing spondylitis.
Arthritis, Rheumatoid
Regeneration of the skeleton by recombinant human bone morphogenetic proteins.
Arthritis, Rheumatoid
Spontaneous dislocation of the atlas as a complication in rheumatoid arthritis.
Arthritis, Rheumatoid
Spontaneous fracture of atlas of cervical spine affected by rheumatoid arthritis.
Arthritis, Rheumatoid
Surgical treatment of craniovertebral junction instability : clinical outcomes and effectiveness in personal experience.
Arthritis, Rheumatoid
The development of the EULAR-OMERACT rheumatoid arthritis MRI reference image atlas.
Arthritis, Rheumatoid
The EULAR-OMERACT rheumatoid arthritis MRI reference image atlas: the metacarpophalangeal joints.
Arthritis, Rheumatoid
The EULAR-OMERACT rheumatoid arthritis MRI reference image atlas: the wrist joint.
Arthritis, Rheumatoid
The relationship between the degree of displacement of the atlas to axis and the clinical data in atlanto-axial subluxation due to rheumatoid arthritis.
Arthritis, Rheumatoid
Three-dimensional motion of the upper cervical spine in rheumatoid arthritis.
Arthritis, Rheumatoid
Vertical settling in rheumatoid arthritis. Diagnostic value of the Ranawat and Redlund-Johnell methods.
Arthritis, Rheumatoid
[Spontaneous atlas dislocation in a child with trisomy 21 and rheumatoid arthritis]
Arthritis, Rheumatoid
[Surgical treatment of spontaneous dislocation of the atlas and axis in rheumatoid arthritis]
Arthritis, Rheumatoid
[Ventral decompression techniques in patients with traumatic and non-traumatic atlanto-axial dislocations].
Asthma
Protein profiles of CCL5, HPGDS, and NPSR1 in plasma reveal association with childhood asthma.
Astigmatism
Clinical outcomes of laser in situ keratomileusis using combined topography and refractive wavefront treatments for myopic astigmatism.
Astigmatism
Keratometry versus total corneal refractive power: Analysis of measurement repeatability with 5 different devices in normal eyes with low astigmatism.
Astigmatism
Repeatability and comparability of corneal power and corneal astigmatism obtained from a point-source color light-emitting diode topographer, a Placido-based corneal topographer, and a low-coherence reflectometer.
Astrocytoma
Analysis of Cellular Feature Differences of Astrocytomas with Distinct Mutational Profiles Using Digitized Histopathology Images.
Astrocytoma
Chromatin-regulating genes are associated with postoperative prognosis and isocitrate dehydrogenase mutation in astrocytoma.
Astrocytoma
Genetic and Epigenetic Features of Rapidly Progressing IDH-Mutant Astrocytomas.
Astrocytoma
In silico analysis identifies a putative cell-of-origin for BRAF fusion-positive cerebellar pilocytic astrocytoma.
Astrocytoma
Landscape of Germline Genetic Variants in AGT, MGMT, and TP53 in Mexican Adult Patients with Astrocytoma.
Astrocytoma
Prognostic Importance of Age, Tumor Location, and Tumor Grade in Grade II Astrocytomas: An Integrated Analysis of the Cancer Genome Atlas and the Surveillance, Epidemiology, and End Results Database.
Astrocytoma
PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status.
Astrocytoma
The Fibronectin Expression Determines the Distinct Progressions of Malignant Gliomas via Transforming Growth Factor-Beta Pathway.
Astrocytoma
Total copy number variation as a prognostic factor in adult astrocytoma subtypes.
Astrocytoma
[Preliminary analysis on the gene expression profiles of different types of gliomas with cDNA array]
Atherosclerosis
Adventitial Cell Atlas of wt (Wild Type) and ApoE (Apolipoprotein E)-Deficient Mice Defined by Single-Cell RNA Sequencing.
Atherosclerosis
Atlas of the Immune Cell Repertoire in Mouse Atherosclerosis Defined by Single-Cell RNA-Sequencing and Mass Cytometry.
Atherosclerosis
Insight Mechanism of the Selective Lanosterol Synthase Inhibitor: Molecular Modeling, Docking and Density Functional Theory Approaches.
Atherosclerosis
Left ventricular shape variation in asymptomatic populations: the Multi-Ethnic Study of Atherosclerosis.
Atherosclerosis
Metabolic Phenotyping of Atherosclerotic Plaques Reveals Latent Associations between Free Cholesterol and Ceramide Metabolism in Atherogenesis.
Atherosclerosis
The vertebral artery: a review of anatomical, histopathological and functional factors influencing blood flow to the hindbrain.
Atherosclerosis
[Angiographic examination of the vertebral artery at the atlantoxial joint during head rotation]
Atrial Fibrillation
Development and validation of a risk score for predicting atrial fibrillation recurrence after a first catheter ablation procedure - ATLAS score.
Atrial Fibrillation
Development and validation of a risk score for predicting atrial fibrillation recurrence after a first catheter ablation procedure: ATLAS score-Author's reply.
Atrial Fibrillation
Poincaré Plot Image and Rhythm-Specific Atlas for Atrial Bigeminy and Atrial Fibrillation Detection.
Atrial Fibrillation
Surgical Closure of the Left Atrial Appendage: The Past, The Present, The Future.
Atypical Squamous Cells of the Cervix
Review of the Bethesda System atlas does not improve reproducibility or accuracy in the classification of atypical squamous cells of undetermined significance smears.
Autoimmune Diseases
A Single-Cell Transcriptomic Atlas of Thymus Organogenesis Resolves Cell Types and Developmental Maturation.
Autoimmune Diseases
An Autoantigen Profile of Human A549 Lung Cells Reveals Viral and Host Etiologic Molecular Attributes of Autoimmunity in COVID-19.
Autoimmune Diseases
An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19.
Autoimmune Diseases
An Autoantigen-ome from HS-Sultan B-Lymphoblasts Offers a Molecular Map for Investigating Autoimmune Sequelae of COVID-19.
Axial Spondyloarthritis
A Benchmarking Study Evaluating Axial Spondyloarthritis Burden in Spain and Other European Countries. Results from the Spanish Atlas and the European Map of Axial Spondyloarthritis (EMAS) Studies.
Axial Spondyloarthritis
Atlas of Axial Spondyloarthritis in Spain 2017: Study Design and Population.
Axial Spondyloarthritis
Similarities and differences between non-radiographic and radiographic axial spondyloarthritis: The patient perspective from the Spanish atlas.
Axial Spondyloarthritis
The Impact of Axial Spondyloarthritis on Mental Health: Results from the Atlas.
Bacteremia
Telavancin in the Treatment of Concurrent Staphylococcus aureus Bacteremia: A Retrospective Analysis of ATLAS and ATTAIN Studies.
Bacterial Infections
Defining Host Responses during Systemic Bacterial Infection through Construction of a Murine Organ Proteome Atlas.
Bacteriuria
Comparison of three automated urinalysis systems--Bayer Clinitek Atlas, Roche Urisys 2400 and Arkray Aution Max for testing urine chemistry and detection of bacteriuria.
Barrett Esophagus
Identification of a key role of widespread epigenetic drift in Barrett's esophagus and esophageal adenocarcinoma.
Barrett Esophagus
Specific DNA methylation markers in the diagnosis and prognosis of esophageal cancer.
Biliary Atresia
Mass spectrometry-based abundance atlas of ABC transporters in human liver, gut, kidney, brain and skin.
Blindness
Eye clinic attendance at the olympic and paralympic games Rio 2016 and its correlation to the WHO indicators on eye health.
Blindness
Progress Towards Elimination of Trachoma as a Public Health Problem in Eritrea: Results of a Systematic Review and Nine Population-based Prevalence Surveys Conducted in 2014.
Bone Cysts
Aneurysmal bone cyst of the atlas: operative removal through an anterolateral approach. A case report.
Bone Cysts
Aneurysmal bone cyst of the atlas: successful treatment through selective arterial embolization: case report.
Bone Cysts
Characterisation of first metatarsophalangeal joint osteoarthritis using magnetic resonance imaging.
Bone Cysts
Homeodomain-containing gene 10 inhibits cell apoptosis and promotes cell invasion and migration in osteosarcoma cell lines.
Bone Cysts
Reconstruction of C-1 lateral mass with titanium mesh cage after resection of an aneurysmal bone cyst of the atlas.
Bone Cysts, Aneurysmal
Surgical approaches: postoperative care and complications "posterolateral-far lateral transcondylar approach to the ventral foramen magnum and upper cervical spinal canal".
Bone Diseases, Developmental
Bone Dysplasias. An Atlas of Genetic Disorders of Skeletal Development (Fourth Edition).
Bone Diseases, Developmental
Bone Dysplasias: An Atlas of Genetic Disorders of Skeletal Development, Second Edition.
Bone Resorption
Odontoid compression of the brain stem in a patient with rheumatoid arthritis. Case report.
Brain Abscess
William Macewen and the treatment of brain abscesses: revisited after one hundred years.
Brain Concussion
Specific cord damage at the atlas level as a pathogenic mechanism in cerebral concussion.
Brain Diseases
Age-Related Prevalence of Periodontoid Calcification and Its Associations with Acute Cervical Pain.
Brain Diseases
Atlas of brain proton magnetic resonance spectra. Part II: Inherited metabolic encephalopathies.
Brain Diseases
Atlas-based hippocampus segmentation in Alzheimer's disease and mild cognitive impairment.
Brain Diseases
Atlasing the frontal lobe connections and their variability due to age and education: a spherical deconvolution tractography study.
Brain Diseases
Developing Neuroimaging Biomarker for Brain Diseases with a Machine Learning Framework and the Brainnetome Atlas.
Brain Diseases
In silico prioritization based on coexpression can aid epileptic encephalopathy gene discovery.
Brain Diseases
Longitudinal atlas for normative human brain development and aging over the lifespan using quantitative susceptibility mapping.
Brain Diseases, Metabolic
Atlas of brain proton magnetic resonance spectra. Part II: Inherited metabolic encephalopathies.
Brain Infarction
Statistical atlas of acute stroke from magnetic resonance diffusion-weighted-images of the brain.
Brain Injuries
High Resolution Computed Tomography Atlas of the Porcine Temporal Bone and Skull Base: Anatomical Correlates for Traumatic Brain Injury Research.
Brain Injuries
Single-cell atlas reveals meningeal leukocyte heterogeneity in the developing mouse brain.
Brain Injuries, Traumatic
High Resolution Computed Tomography Atlas of the Porcine Temporal Bone and Skull Base: Anatomical Correlates for Traumatic Brain Injury Research.
Brain Injuries, Traumatic
Performance Evaluation of a Pre-computed Brain Response Atlas in Dummy Head Impacts.
Brain Injuries, Traumatic
SPECT brain perfusion abnormalities in mild or moderate traumatic brain injury.
Brain Injuries, Traumatic
Stereotactic Atlas-Guided Laser Capture Microdissection of Brain Regions Affected by Traumatic Injury.
Brain Ischemia
Detection of an unkown peak at 1.2 ppm in proton magnetic resonance spectra of cats with cerebral ischemic necrosis.
Brain Neoplasms
A Deep Network for Joint Registration and Reconstruction of Images with Pathologies.
Brain Neoplasms
A novel small-molecule activator of Sirtuin-1 induces autophagic cell death/mitophagy as a potential therapeutic strategy in glioblastoma.
Brain Neoplasms
A pediatric brain tumor atlas of genes deregulated by somatic genomic rearrangement.
Brain Neoplasms
An anatomically curated fiber clustering white matter atlas for consistent white matter tract parcellation across the lifespan.
Brain Neoplasms
annoFuse: an R Package to annotate, prioritize, and interactively explore putative oncogenic RNA fusions.
Brain Neoplasms
Atlas to patient registration with brain tumor based on a mesh-free method.
Brain Neoplasms
Automated delineation of brain structures in patients undergoing radiotherapy for primary brain tumors: From atlas to dose-volume histograms.
Brain Neoplasms
Automatic brain tumor segmentation by subject specific modification of atlas priors.
Brain Neoplasms
Characterization and Correction of Geometric Distortions in 814 Diffusion Weighted Images.
Brain Neoplasms
Commentary: Planning Brain Tumor Resection Using a Probabilistic Atlas of Cortical and Subcortical Structures Critical for Functional Processing: A Proof of Concept.
Brain Neoplasms
Concurrent tumor segmentation and registration with uncertainty-based sparse non-uniform graphs.
Brain Neoplasms
DeepSurvNet: deep survival convolutional network for brain cancer survival rate classification based on histopathological images.
Brain Neoplasms
Deformable registration of brain tumor images via a statistical model of tumor-induced deformation.
Brain Neoplasms
Delineation atlas of the Circle of Willis and the large intracranial arteries for evaluation of doses to neurovascular structures in pediatric brain tumor patients treated with radiation therapy.
Brain Neoplasms
Expression of lncRNAs in Low-Grade Gliomas and Glioblastoma Multiforme: An In Silico Analysis.
Brain Neoplasms
Faceted Visualization of Three Dimensional Neuroanatomy By Combining Ontology with Faceted Search.
Brain Neoplasms
Histopathological Image Classification Using Discriminative Feature-Oriented Dictionary Learning.
Brain Neoplasms
Imaging-AMARETTO: An Imaging Genomics Software Tool to Interrogate Multiomics Networks for Relevance to Radiography and Histopathology Imaging Biomarkers of Clinical Outcomes.
Brain Neoplasms
Machine learning workflows to estimate class probabilities for precision cancer diagnostics on DNA methylation microarray data.
Brain Neoplasms
Mapping of long-term cognitive and motor deficits in pediatric cerebellar brain tumor survivors into a cerebellar white matter atlas.
Brain Neoplasms
NUT midline carcinomas and their differentials by a single molecular profiling method: a new promising diagnostic strategy illustrated by a case report.
Brain Neoplasms
ORBIT: a multiresolution framework for deformable registration of brain tumor images.
Brain Neoplasms
Planning Brain Tumor Resection Using a Probabilistic Atlas of Cortical and Subcortical Structures Critical for Functional Processing: A Proof of Concept.
Brain Neoplasms
Presence of viral DNA in whole-genome sequencing of brain tumor tissues from the cancer genome atlas.
Brain Neoplasms
Profilin 3 genetic architecture in glioma formalin fixed paraffin embedded (FFPE) archive.
Brain Neoplasms
Prognostic implications of immune-related eight-gene signature in pediatric brain tumors.
Brain Neoplasms
Rare but recurrent ROS1 fusions resulting from chromosome 6q22 microdeletions are targetable oncogenes in glioma.
Brain Neoplasms
The human secretome atlas initiative: Implications in health and disease conditions.
Brain Neoplasms
Unsupervised Resolution of Histomorphologic Heterogeneity in Renal Cell Carcinoma Using a Brain Tumor-Educated Neural Network.
Brain Stem Infarctions
A new method to investigate brain stem structural-functional correlations using digital post-processing MRI--reliability in ischemic internuclear ophthalmoplegia.
Breast Diseases
Chinese association of ultrasound in medicine and engineering, superficial organs and peripheral vessels committee expert consensus on clinical frequently asked questions in breast ultrasonography, June 2018.
Breast Neoplasms
4-Hydroxytamoxifen enhances sensitivity of estrogen receptor ?-positive breast cancer to docetaxel in an estrogen and ZNF423 SNP-dependent fashion.
Breast Neoplasms
6-lncRNA Assessment Model for Monitoring and Prognosis of HER2-Positive Breast Cancer: Based on Transcriptome Data.
Breast Neoplasms
A 23 gene-based molecular prognostic score precisely predicts overall survival of breast cancer patients.
Breast Neoplasms
A bioinformatics approach to identify novel long, non-coding RNAs in breast cancer cell lines from an existing RNA-sequencing dataset.
Breast Neoplasms
A Cell-Line-Specific Atlas of PARP-Mediated Protein Asp/Glu-ADP-Ribosylation in Breast Cancer.
Breast Neoplasms
A comprehensive analysis of breast cancer microbiota and host gene expression.
Breast Neoplasms
A Comprehensive cis-eQTL Analysis Revealed Target Genes in Breast Cancer Susceptibility Loci Identified in Genome-wide Association Studies.
Breast Neoplasms
A comprehensive function analysis of LMO2 in different breast cancer subtypes.
Breast Neoplasms
A ferroptosis-associated gene signature for the prediction of prognosis and therapeutic response in luminal-type breast carcinoma.
Breast Neoplasms
A Five-Gene-Pair-Based Prognostic Signature for Predicting the Relapse Risk of Early Stage ER+ Breast Cancer.
Breast Neoplasms
A four-gene signature for prognosis in breast cancer patients with hypermethylated IL15RA.
Breast Neoplasms
A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study.
Breast Neoplasms
A Joint Graphical Model for Inferring Gene Networks Across Multiple Subpopulations and Data Types.
Breast Neoplasms
A JUN N-terminal kinase inhibitor induces ectodomain shedding of the cancer-associated membrane protease Prss14/epithin via protein kinase C?II.
Breast Neoplasms
A key genomic subtype associated with lymphovascular invasion in invasive breast cancer.
Breast Neoplasms
A lincRNA connected to cell mortality and epigenetically-silenced in most common human cancers.
Breast Neoplasms
A Multi-Source Data Fusion Framework for Revealing the Regulatory Mechanism of Breast Cancer Immune Evasion.
Breast Neoplasms
A murine preclinical syngeneic transplantation model for breast cancer precision medicine.
Breast Neoplasms
A new prognostic factor of breast cancer: High carboxyl ester lipase expression related to poor survival.
Breast Neoplasms
A novel immune-related prognostic index for predicting breast cancer overall survival.
Breast Neoplasms
A Novel lncRNA HOXC-AS3 Acts as a miR-3922-5p Sponge to Promote Breast Cancer Metastasis.
Breast Neoplasms
A pilot study on the prevalence of DNA palindromes in breast cancer genomes.
Breast Neoplasms
A potential peptide therapeutic derived from the juxtamembrane domain of the epidermal growth factor receptor.
Breast Neoplasms
A powerful nonparametric method for detecting differentially co-expressed genes: distance correlation screening and edge-count test.
Breast Neoplasms
A radiosensitivity gene signature and PD-L1 status predict clinical outcome of patients with invasive breast carcinoma in The Cancer Genome Atlas (TCGA) dataset.
Breast Neoplasms
A Random Walk Based Cluster Ensemble Approach for Data Integration and Cancer Subtyping.
Breast Neoplasms
A Signature of Autophagy-Related Long Non-coding RNA to Predict the Prognosis of Breast Cancer.
Breast Neoplasms
A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer.
Breast Neoplasms
A six-long non-coding RNAs signature as a potential prognostic marker for survival prediction of ER-positive breast cancer patients.
Breast Neoplasms
A Translational Pipeline for Overall Survival Prediction of Breast Cancer Patients by Decision-Level Integration of Multi-Omics Data.
Breast Neoplasms
ABC-GWAS: Functional Annotation of Estrogen Receptor-Positive Breast Cancer Genetic Variants.
Breast Neoplasms
Abnormally elevated USP37 expression in breast cancer stem cells regulates stemness, epithelial-mesenchymal transition and cisplatin sensitivity.
Breast Neoplasms
Absence of AIF1L contributes to cell migration and a poor prognosis of breast cancer.
Breast Neoplasms
Acetyl-11-keto-?-boswellic Acid Inhibits Precancerous Breast Lesion MCF-10AT Cells via Regulation of LINC00707/miR-206 that Reduces Estrogen Receptor-?.
Breast Neoplasms
Actionable gene alterations in an Asian population with triple-negative breast cancer.
Breast Neoplasms
Activity of distinct growth factor receptor network components in breast tumors uncovers two biologically relevant subtypes.
Breast Neoplasms
Adjuvant endocrine treatment for estrogen receptor (ER)-positive/HER2-negative breast cancer.
Breast Neoplasms
Age-associated genes in human mammary gland drive human breast cancer progression.
Breast Neoplasms
AKT1 and AKT2 isoforms play distinct roles during breast cancer progression through the regulation of specific downstream proteins.
Breast Neoplasms
Aldehyde Dehydrogenase 1-related Genes in Triple-negative Breast Cancer Investigated Using Network Analysis.
Breast Neoplasms
Alterations in histone deacetylase 8 lead to cell migration and poor prognosis in breast cancer.
Breast Neoplasms
Alterations in Immune-Related Genes as Potential Marker of Prognosis in Breast Cancer.
Breast Neoplasms
Altered gene expression in glycolysis-cholesterol synthesis axis correlates with outcome of triple-negative breast cancer.
Breast Neoplasms
Amplification of the CD24 Gene Is an Independent Predictor for Poor Prognosis of Breast Cancer.
Breast Neoplasms
An atlas of histone deacetylase expression in breast cancer: fluorescence methodology for comparative semi-quantitative analysis.
Breast Neoplasms
An immune-related risk gene signature predicts the prognosis of breast cancer.
Breast Neoplasms
An Improved, Assay Platform Agnostic, Absolute Single Sample Breast Cancer Subtype Classifier.
Breast Neoplasms
An Information Theoretical Multilayer Network Approach to Breast Cancer Transcriptional Regulation.
Breast Neoplasms
An integrated bioinformatical analysis to evaluate the role of KIF4A as a prognostic biomarker for breast cancer.
Breast Neoplasms
An integrated bioinformatics analysis of potential therapeutic targets among matrix metalloproteinases in breast cancer.
Breast Neoplasms
An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.
Breast Neoplasms
An investigation of the association of genetic susceptibility risk with somatic mutation burden in breast cancer.
Breast Neoplasms
An mRNA characterization model predicting survival in patients with invasive breast cancer based on The Cancer Genome Atlas database.
Breast Neoplasms
Analysis of gene expression of secreted factors associated with breast cancer metastases in breast cancer subtypes.
Breast Neoplasms
Ancestry-associated transcriptomic profiles of breast cancer in patients of African, Arab, and European ancestry.
Breast Neoplasms
Angiopoietin pathway gene expression associated with poor breast cancer survival.
Breast Neoplasms
ANLN and KDR Are Jointly Prognostic of Breast Cancer Survival and Can Be Modulated for Triple Negative Breast Cancer Control.
Breast Neoplasms
Annexin A1 Preferentially Predicts Poor Prognosis of Basal-Like Breast Cancer Patients by Activating mTOR-S6 Signaling.
Breast Neoplasms
ANXA4 Activates JAK-STAT3 Signaling by Interacting with ANXA1 in Basal-Like Breast Cancer.
Breast Neoplasms
APOBEC3B expression in breast cancer cell lines and tumors depends on the estrogen receptor status.
Breast Neoplasms
APOBEC3B expression in breast cancer reflects cellular proliferation, while a deletion polymorphism is associated with immune activation.
Breast Neoplasms
Assessing breast cancer cell lines as tumour models by comparison of mRNA expression profiles.
Breast Neoplasms
Assessing the efficacy of androgen receptor and Sox10 as independent markers of the triple-negative breast cancer subtype by transcriptome profiling.
Breast Neoplasms
Association Between Genomic Metrics and Immune Infiltration in Triple-Negative Breast Cancer.
Breast Neoplasms
Association between histone lysine methyltransferase KMT2C mutation and clinicopathological factors in breast cancer.
Breast Neoplasms
Association between plasma diacetylspermine and tumor spermine synthase with outcome in triple negative breast cancer.
Breast Neoplasms
Association of BRCA1- and BRCA2-deficiency with mutation burden, expression of PD-L1/PD-1, immune infiltrates, and T cell-inflamed signature in breast cancer.
Breast Neoplasms
Associations of two-pore domain potassium channels and triple negative breast cancer subtype in The Cancer Genome Atlas: systematic evaluation of gene expression and methylation.
Breast Neoplasms
Atezolizumab potentiates Tcell-mediated cytotoxicity and coordinates with FAK to suppress cell invasion and motility in PD-L1+ triple negative breast cancer cells.
Breast Neoplasms
Atlas of breast cancer infiltrated B-lymphocytes revealed by paired single-cell RNA-sequencing and antigen receptor profiling.
Breast Neoplasms
Atlas of sentinel lymph nodes in early breast cancer using single-photon emission computed tomography: implication for lymphatic contouring.
Breast Neoplasms
Atlas Sampling for Prone Breast Automatic Segmentation of Organs at Risk: The Importance of Patients' Body Mass Index and Breast Cup Size for an Optimized Contouring of the Heart and the Coronary Vessels.
Breast Neoplasms
Atlas-based auto-segmentation for delineating the heart and cardiac substructures in breast cancer radiation therapy.
Breast Neoplasms
Attenuated transforming growth factor beta signaling promotes metastasis in a model of HER2 mammary carcinogenesis.
Breast Neoplasms
Automated deconvolution of structured mixtures from heterogeneous tumor genomic data.
Breast Neoplasms
Automatic Detection of the Circulating Cell-Free Methylated DNA Pattern of GCM2, ITPRIPL1 and CCDC181 for Detection of Early Breast Cancer and Surgical Treatment Response.
Breast Neoplasms
aWCluster: A Novel Integrative Network-based Clustering of Multiomics for Subtype Analysis of Cancer Data.
Breast Neoplasms
B-CAN: a resource sharing platform to improve the operation, visualization and integrated analysis of TCGA breast cancer data.
Breast Neoplasms
Bayesian Network Marker Selection via the Thresholded Graph Laplacian Gaussian Prior.
Breast Neoplasms
BCL11A confers cell invasion and migration in androgen receptor-positive triple-negative breast cancer.
Breast Neoplasms
BCL2 Regulation According to Molecular Subtype of Breast Cancer by Analysis of The Cancer Genome Atlas Database.
Breast Neoplasms
Bcl9 Depletion Modulates Endothelial Cell in Tumor Immune Microenvironment in Colorectal Cancer Tumor.
Breast Neoplasms
Benzodiazepines use and breast cancer risk: A population-based study and gene expression profiling evidence.
Breast Neoplasms
Beyond the one-locus-one-miRNA paradigm: microRNA isoforms enable deeper insights into breast cancer heterogeneity.
Breast Neoplasms
Biglycan-mediated upregulation of MHC class I expression in HER-2/neu-transformed cells.
Breast Neoplasms
Bioinformatic profiling of prognosis-related genes in the breast cancer immune microenvironment.
Breast Neoplasms
Bioinformatics Analysis Identifies IL6ST as a Potential Tumor Suppressor Gene for Triple-Negative Breast Cancer.
Breast Neoplasms
Bioinformatics analysis of prognosis-related long non-coding RNAs in invasive breast carcinoma.
Breast Neoplasms
Biomarker discovery using a comparative omics approach in a mouse model developing heterogeneous mammary cancer subtypes.
Breast Neoplasms
Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer.
Breast Neoplasms
Bone marrow stromal antigen 2 expressed in cancer cells promotes mammary tumor growth and metastasis.
Breast Neoplasms
Bone morphogenetic protein 2 (BMP-2) induces sequential changes of Id gene expression in the breast cancer cell line MCF-7.
Breast Neoplasms
BRAF/MEK Pathway is Associated With Breast Cancer in ER-dependent Mode and Improves ER Status-based Cancer Recurrence Prediction.
Breast Neoplasms
BrcaSeg: A Deep Learning Approach for Tissue Quantification and Genomic Correlations of Histopathological Images.
Breast Neoplasms
Breast cancer classification: linking molecular mechanisms to disease prognosis.
Breast Neoplasms
Breast MRI radiomics: comparison of computer- and human-extracted imaging phenotypes.
Breast Neoplasms
Bromodomain-containing Protein 4 Is a Favourable Prognostic Factor in Breast Cancer Patients.
Breast Neoplasms
BSSV: Bayesian based somatic structural variation identification with whole genome DNA-seq data.
Breast Neoplasms
Building radiation-resistant model in triple-negative breast cancer to screen radioresistance-related molecular markers.
Breast Neoplasms
c-myc regulates the sensitivity of breast cancer cells to palbociclib via c-myc/miR-29b-3p/CDK6 axis.
Breast Neoplasms
C16?ceramide and sphingosine 1?phosphate/S1PR2 have opposite effects on cell growth through mTOR signaling pathway regulation.
Breast Neoplasms
CaDrA: A Computational Framework for Performing Candidate Driver Analyses Using Genomic Features.
Breast Neoplasms
Cancer Progression Prediction Using Gene Interaction Regularized Elastic Net.
Breast Neoplasms
CBX6 is negatively regulated by EZH2 and plays a potential tumor suppressor role in breast cancer.
Breast Neoplasms
Cd11b(+) myeloid cells support hepatic metastasis through down-regulation of angiopoietin-like 7 in cancer cells.
Breast Neoplasms
CEACAM Gene Family Mutations Associated With Inherited Breast Cancer Risk - A Comparative Oncology Approach to Discovery.
Breast Neoplasms
CeNETs analysis reveals the prognostic value of a signature integration from five lncRNAs in breast cancer.
Breast Neoplasms
ceRNA network development and tumour-infiltrating immune cell analysis of metastatic breast cancer to bone.
Breast Neoplasms
Characterization of frequently mutated cancer genes in Chinese breast tumors: a comparison of Chinese and TCGA cohorts.
Breast Neoplasms
Cholesterol biosynthesis inhibitors as potent novel anti-cancer agents: suppression of hormone-dependent breast cancer by the oxidosqualene cyclase inhibitor RO 48-8071.
Breast Neoplasms
Cholesterol synthesis inhibitor RO 48-8071 suppresses transcriptional activity of human estrogen and androgen receptor.
Breast Neoplasms
CIBERSORT analysis of TCGA and METABRIC identifies subgroups with better outcomes in triple negative breast cancer.
Breast Neoplasms
circRNA-associated ceRNA network construction reveals the circRNAs involved in the progression and prognosis of breast cancer.
Breast Neoplasms
Classical pathology and mutational load of breast cancer - integration of two worlds.
Breast Neoplasms
Classification of breast cancer patients using somatic mutation profiles and machine learning approaches.
Breast Neoplasms
Classification of Genes Based on Age-Related Differential Expression in Breast Cancer.
Breast Neoplasms
CLDN10 single nucleotide polymorphism rs1325774 alters the risk of breast cancer in south chinese women.
Breast Neoplasms
Clinical and molecular relevance of mutant-allele tumor heterogeneity in breast cancer.
Breast Neoplasms
Clinical Implementation of Novel Targeted Therapeutics in Advanced Breast Cancer.
Breast Neoplasms
Clinical outcome and global gene expression data support the existence of the estrogen receptor-negative/progesterone receptor-positive invasive breast cancer phenotype.
Breast Neoplasms
Clinical Relevance of microRNA Expressions in Breast Cancer Validated Using the Cancer Genome Atlas (TCGA).
Breast Neoplasms
Clinical Value of miR-101-3p and Biological Analysis of its Prospective Targets in Breast Cancer: A Study Based on The Cancer Genome Atlas (TCGA) and Bioinformatics.
Breast Neoplasms
Clinicopathological and prognostic significance of Ras association and pleckstrin homology domains 1 (RAPH1) in breast cancer.
Breast Neoplasms
Coagulation factor V is a marker of tumor-infiltrating immune cells in breast cancer.
Breast Neoplasms
Coexpression Analysis of the EZH2 Gene Using The Cancer Genome Atlas and Oncomine Databases Identifies Coexpressed Genes Involved in Biological Networks in Breast Cancer, Glioblastoma, and Prostate Cancer.
Breast Neoplasms
Coexpression Network Analysis of Genes Related to the Characteristics of Tumor Stemness in Triple-Negative Breast Cancer.
Breast Neoplasms
Comments on: Improving Breast Cancer Surgery: A Classification and Quadrant per Quadrant Atlas for Oncoplastic Surgery (Clough KB, Kaufman GJ, et al. ASO DOI 10.1245/s10434-009-0792-y).
Breast Neoplasms
Common polymorphic inversions at 17q21.31 and 8p23.1 associate with cancer prognosis.
Breast Neoplasms
Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas.
Breast Neoplasms
Comparison of TCGA and GENIE genomic datasets for the detection of clinically actionable alterations in breast cancer.
Breast Neoplasms
Comparison of the Genomic Landscape Between Primary Breast Cancer in African American Versus White Women and the Association of Racial Differences With Tumor Recurrence.
Breast Neoplasms
Comprehensive Analysis of Metabolic Genes in Breast Cancer Based on Multi-Omics Data.
Breast Neoplasms
Comprehensive analysis of potential immunotherapy genomic biomarkers in 1000 Chinese patients with cancer.
Breast Neoplasms
Comprehensive analysis of the association between tumor glycolysis and immune/inflammation function in breast cancer.
Breast Neoplasms
Comprehensive analysis of the GATA transcription factor gene family in breast carcinoma using gene microarrays, online databases and integrated bioinformatics.
Breast Neoplasms
Comprehensive analysis of the homeobox family genes in breast cancer demonstrates their similar roles in cancer and development.
Breast Neoplasms
Comprehensive expression-based isoform biomarkers predictive of drug responses based on isoform co-expression networks and clinical data.
Breast Neoplasms
Comprehensive Review of Molecular Mechanisms and Clinical Features of Invasive Lobular Cancer.
Breast Neoplasms
Comprehensive transcriptomic analysis of heat shock proteins in the molecular subtypes of human breast cancer.
Breast Neoplasms
Computational Detection of Breast Cancer Invasiveness with DNA Methylation Biomarkers.
Breast Neoplasms
Computational identification of micro-structural variations and their proteogenomic consequences in cancer.
Breast Neoplasms
Computational Identification of Sex-Biased Biomarker MicroRNAs and Genes Associated with Immune Infiltration in Breast Cancer.
Breast Neoplasms
Condition-adaptive fused graphical lasso (CFGL): An adaptive procedure for inferring condition-specific gene co-expression network.
Breast Neoplasms
CONFIGURE: A pipeline for identifying context specific regulatory modules from gene expression data and its application to breast cancer.
Breast Neoplasms
Consensus Analysis of Whole Transcriptome Profiles from Two Breast Cancer Patient Cohorts Reveals Long Non-Coding RNAs Associated with Intrinsic Subtype and the Tumour Microenvironment.
Breast Neoplasms
Construction and Analysis of a Long Non-Coding RNA-Associated Competing Endogenous RNA Network Identified Potential Prognostic Biomarkers in Luminal Breast Cancer.
Breast Neoplasms
Construction and validation of an immunity-related prognostic signature for breast cancer.
Breast Neoplasms
Contouring Guidelines for the Axillary Lymph Nodes for the Delivery of Radiation Therapy in Breast Cancer: Evaluation of the RTOG Breast Cancer Atlas.
Breast Neoplasms
Copy Number Profiling of MammaPrint Genes Reveals Association with the Prognosis of Breast Cancer Patients.
Breast Neoplasms
Copy number profiling of Oncotype DX genes reveals association with survival of breast cancer patients.
Breast Neoplasms
Correlation between gene expression and mutator phenotype predicts homologous recombination deficiency and outcome in ovarian cancer.
Breast Neoplasms
CREB targets define the gene expression signature of malignancies having reduced levels of the tumor suppressor tristetraprolin.
Breast Neoplasms
CREDO: Highly confident disease-relevant A-to-I RNA-editing discovery in breast cancer.
Breast Neoplasms
Crosstalk between microRNA expression and DNA methylation drives the hormone-dependent phenotype of breast cancer.
Breast Neoplasms
Crumbs protein homolog 3 (CRB3) expression is associated with oestrogen and progesterone receptor positivity in breast cancer.
Breast Neoplasms
CXCL10 potentiates immune checkpoint blockade therapy in homologous recombination-deficient tumors.
Breast Neoplasms
CXCR3 Expression and Genome-Wide 3' Splice Site Selection in the TCGA Breast Cancer Cohort.
Breast Neoplasms
Cyclooxygenase and lipoxygenase gene expression in the inflammogenesis of breast cancer.
Breast Neoplasms
Cytotoxic T-lymphocyte infiltration and chemokine predict long-term patient survival independently of tumor mutational burden in triple-negative breast cancer.
Breast Neoplasms
D-CCA: A Decomposition-based Canonical Correlation Analysis for High-Dimensional Datasets.
Breast Neoplasms
Data mining of micrornas in breast carcinogenesis which may be a potential target for cancer prevention.
Breast Neoplasms
DCBLD1 is associated with the integrin signaling pathway and has prognostic value in non-small cell lung and invasive breast carcinoma.
Breast Neoplasms
De novo, systemic, deleterious amino acid substitutions are common in large cytoskeleton-related protein coding regions.
Breast Neoplasms
Deciphering the Correlation between Breast Tumor Samples and Cell Lines by Integrating Copy Number Changes and Gene Expression Profiles.
Breast Neoplasms
Deciphering the Oncogenic Role of VPS28 Modulated by miR-491-5p in Breast Cancer Cells Using In Silico and Functional Analysis.
Breast Neoplasms
Deconvolution and phylogeny inference of structural variations in tumor genomic samples.
Breast Neoplasms
Deconvolution of DNA methylation identifies differentially methylated gene regions on 1p36 across breast cancer subtypes.
Breast Neoplasms
Decreased BECN1 mRNA Expression in Human Breast Cancer is Associated with Estrogen Receptor-Negative Subtypes and Poor Prognosis.
Breast Neoplasms
Deep learning predicts chromosomal instability from histopathology images.
Breast Neoplasms
Deep-Learning-Based Characterization of Tumor-Infiltrating Lymphocytes in Breast Cancers From Histopathology Images and Multiomics Data.
Breast Neoplasms
Defining the Na(+)/H(+) exchanger NHE1 interactome in triple-negative breast cancer cells.
Breast Neoplasms
Delineation of Supraclavicular Target Volumes in Breast Cancer Radiation Therapy.
Breast Neoplasms
Delineation of target volumes and organs at risk in adjuvant radiotherapy of early breast cancer: National guidelines and contouring atlas by the Danish Breast Cancer Cooperative Group.
Breast Neoplasms
Detection of miRNA regulatory effect on triple negative breast cancer transcriptome.
Breast Neoplasms
Detection of recurrent alternative splicing switches in tumor samples reveals novel signatures of cancer.
Breast Neoplasms
Developing a radiosensitivity gene signature for Caucasian patients with breast cancer.
Breast Neoplasms
Developing ZNF Gene Signatures Predicting Radiosensitivity of Patients with Breast Cancer.
Breast Neoplasms
Development and Validation of a Heart Atlas To Study Cardiac Exposure to Radiation Following Treatment for Breast Cancer.
Breast Neoplasms
Development of human serine protease-based therapeutics targeting Fn14 and identification of Fn14 as a new target overexpressed in TNBC.
Breast Neoplasms
Differences in gene-expression profiles in breast cancer between African and European-ancestry women.
Breast Neoplasms
Differences in race, molecular and tumor characteristics among women diagnosed with invasive ductal and lobular breast carcinomas.
Breast Neoplasms
Differential prognostic impact of interleukin-34 mRNA expression and infiltrating immune cell composition in intrinsic breast cancer subtypes.
Breast Neoplasms
Differentially expressed genes and key molecules of BRCA1/2-mutant breast cancer: evidence from bioinformatics analyses.
Breast Neoplasms
Differentially expressed transcripts and dysregulated signaling pathways and networks in African American breast cancer.
Breast Neoplasms
DIGITAL BREAST TOMOSYNTHESIS AND FULL-FIELD DIGITAL MAMMOGRAPHY IN BREAST CANCER DETECTION ASSOCIATED WITH FOUR ASYMMETRY TYPES.
Breast Neoplasms
Discovering DNA methylation patterns for long non-coding RNAs associated with cancer subtypes.
Breast Neoplasms
Discovery of a small molecule targeting ULK1-modulated cell death of triple negative breast cancer in vitro and in vivo.
Breast Neoplasms
Discovery of a Small-Molecule Bromodomain-Containing Protein 4 (BRD4) Inhibitor That Induces AMP-Activated Protein Kinase-Modulated Autophagy-Associated Cell Death in Breast Cancer.
Breast Neoplasms
Disparity in Tumor Immune Microenvironment of Breast Cancer and Prognostic Impact: Asian versus Western Populations.
Breast Neoplasms
Dissecting tRNA-derived fragment complexities using personalized transcriptomes reveals novel fragment classes and unexpected dependencies.
Breast Neoplasms
Distinct pattern of one-carbon metabolism, a nutrient-sensitive pathway, in invasive breast cancer: A metabolomic study.
Breast Neoplasms
Distribution and prognostic value of tumor?infiltrating T cells in breast cancer.
Breast Neoplasms
DNA Methylation Based Molecular Subtypes Predict Prognosis in Breast Cancer Patients.
Breast Neoplasms
DNA methylation mediated silencing of microRNA-874 is a promising diagnosis and prognostic marker in breast cancer.
Breast Neoplasms
DNA Methylation Patterns Can Estimate Nonequivalent Outcomes of Breast Cancer with the Same Receptor Subtypes.
Breast Neoplasms
DNA Methylation Targets Influenced by Bisphenol A and/or Genistein Are Associated with Survival Outcomes in Breast Cancer Patients.
Breast Neoplasms
DNA Repair Gene Expression Adjusted by the PCNA Metagene Predicts Survival in Multiple Cancers.
Breast Neoplasms
DNASE1L2, as a Carcinogenic Marker, Affects the Phenotype of Breast Cancer Cells Via Regulating Epithelial-Mesenchymal Transition Process.
Breast Neoplasms
DNMT3B7 expression promotes tumor progression to a more aggressive phenotype in breast cancer cells.
Breast Neoplasms
Dosimetric assessment of an Atlas based automated segmentation for loco-regional radiation therapy of early breast cancer in the Skagen Trial 1: A multi-institutional study.
Breast Neoplasms
Downregulated expression of ARHGAP10 correlates with advanced stage and high Ki-67 index in breast cancer.
Breast Neoplasms
Downregulated miR-1247-5p associates with poor prognosis and facilitates tumor cell growth via DVL1/Wnt/?-catenin signaling in breast cancer.
Breast Neoplasms
Downregulation of long non-coding RNA MR4435-2HG suppresses breast cancer progression via the Wnt/?-catenin signaling pathway.
Breast Neoplasms
Druggable Nucleolin Identifies Breast Tumours Associated with Poor Prognosis That Exhibit Different Biological Processes.
Breast Neoplasms
DSN1 is a prognostic biomarker and correlated with clinical characterize in breast cancer.
Breast Neoplasms
Dual inhibition of glutaminase and carnitine palmitoyltransferase decreases growth and migration of glutaminase inhibition-resistant triple-negative breast cancer cells.
Breast Neoplasms
Dysregulated lncRNA-miRNA-mRNA Network Reveals Patient Survival-Associated Modules and RNA Binding Proteins in Invasive Breast Carcinoma.
Breast Neoplasms
Ectodermal-neural cortex 1 as a novel biomarker predicts poor prognosis and induces metastasis in breast cancer by promoting Wnt/?-catenin pathway.
Breast Neoplasms
eEF2K--a new target in breast cancers with combined inactivation of p53 and PTEN.
Breast Neoplasms
Effect of estrogen receptor ? binding on functional DNA methylation in breast cancer.
Breast Neoplasms
Effects of AKT1 E17K mutation hotspots on the biological behavior of breast cancer cells.
Breast Neoplasms
Effects of CORO2A on Cell Migration and Proliferation and Its Potential Regulatory Network in Breast Cancer.
Breast Neoplasms
Eight immune-related genes predict survival outcomes and immune characteristics in breast cancer.
Breast Neoplasms
Elevated EXO1 expression is associated with breast carcinogenesis and poor prognosis.
Breast Neoplasms
Elevated expression of protein arginine methyltransferase 5 predicts the poor prognosis of breast cancer.
Breast Neoplasms
Elevated Resistin Gene Expression in African American Estrogen and Progesterone Receptor Negative Breast Cancer.
Breast Neoplasms
Elucidating cancer metabolic plasticity by coupling gene regulation with metabolic pathways.
Breast Neoplasms
Enhanced expression of histone chaperone APLF associate with breast cancer.
Breast Neoplasms
Epigenetic and genetic burden measures are associated with tumor characteristics in invasive breast carcinoma.
Breast Neoplasms
Epigenetic silencing of triple negative breast cancer hallmarks by Withaferin A.
Breast Neoplasms
Epigenetically regulated Fibronectin leucine rich transmembrane protein 2 (FLRT2) shows tumor suppressor activity in breast cancer cells.
Breast Neoplasms
Epigenomic Deconvolution of Breast Tumors Reveals Metabolic Coupling between Constituent Cell Types.
Breast Neoplasms
Eps15 Homology Domain-Containing Protein 3 Hypermethylation as a Prognostic and Predictive Marker for Colorectal Cancer.
Breast Neoplasms
ER?-related chromothripsis enhances concordant gene transcription on chromosome 17q11.1-q24.1 in luminal breast cancer.
Breast Neoplasms
ESM1 promotes triple-negative breast cancer cell proliferation through activating AKT/NF-?B/Cyclin D1 pathway.
Breast Neoplasms
Establishment of a novel CNV-related prognostic signature predicting prognosis in patients with breast cancer.
Breast Neoplasms
Estrogen receptor ? is involved in the regulation of ITGA8 methylation in estrogen receptor-positive breast cancer.
Breast Neoplasms
Estrogen receptor alpha (ER?/ESR1) mediates the p53-independent overexpression of MDM4/MDMX and MDM2 in human breast cancer.
Breast Neoplasms
Estrogen Receptor Downregulates Expression of PD-1/PD-L1 and Infiltration of CD8+ T Cells by Inhibiting IL-17 Signaling Transduction in Breast Cancer.
Breast Neoplasms
Estrogen-activated MDM2 disrupts mammary tissue architecture through a p53-independent pathway.
Breast Neoplasms
ETS1 Suppresses Tumorigenesis of Human Breast Cancer via Trans-Activation of Canonical Tumor Suppressor Genes.
Breast Neoplasms
Evaluation of a delineation software for cardiac atlas-based autosegmentation: An example of the use of artificial intelligence in modern radiotherapy.
Breast Neoplasms
Evaluation of a software for automatic delineation of the mammary gland and organs at risk in patients treated for breast cancer in lateral position.
Breast Neoplasms
Evaluation of integrative clustering methods for the analysis of multi-omics data.
Breast Neoplasms
Exploring immune-related genes with prognostic value in microenvironment of breast cancer from TCGA database.
Breast Neoplasms
Expression and Circulating Levels of Perlecan in Breast Cancer - Implications for Oestrogen Dependent Stromal Remodeling.
Breast Neoplasms
Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups.
Breast Neoplasms
Expression and Prognostic Characteristics of m6 A RNA Methylation Regulators in Breast Cancer.
Breast Neoplasms
Expression and prognostic value of transcription-associated cyclin-dependent kinases in human breast cancer.
Breast Neoplasms
Expression of an estrogen-regulated variant transcript of the peroxisomal branched chain fatty acid oxidase ACOX2 in breast carcinomas.
Breast Neoplasms
Expression of the BAD pathway is a marker of triple-negative status and poor outcome.
Breast Neoplasms
Expression pattern of m6A regulators is significantly correlated with malignancy and antitumor immune response of breast cancer.
Breast Neoplasms
Expression patterns and the prognostic value of the SMYD family members in human breast carcinoma using integrative bioinformatics analysis.
Breast Neoplasms
Expression patterns of E2F transcription factors and their potential prognostic roles in breast cancer.
Breast Neoplasms
Expression, clinical significance, and receptor identification of the newest B7 family member HHLA2 protein.
Breast Neoplasms
Extended adjuvant endocrine therapy in hormone-receptor positive breast cancer.
Breast Neoplasms
Fatty Acid Synthase Confers Tamoxifen Resistance to ER+/HER2+ Breast Cancer.
Breast Neoplasms
Feasibility of multi-atlas cardiac segmentation from thoracic planning CT in a probabilistic framework.
Breast Neoplasms
Feature Selection for Breast Cancer Classification by Integrating Somatic Mutation and Gene Expression.
Breast Neoplasms
FGF2 induces breast cancer growth through ligand-independent activation and recruitment of ER? and PRB?4 isoform to MYC regulatory sequences.
Breast Neoplasms
Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk.
Breast Neoplasms
Frailness and resilience of gene networks predicted by detection of co-occurring mutations via a stochastic perturbative approach.
Breast Neoplasms
Gene expression profiles of human endometrial cancer samples using a cDNA-expression array technique: assessment of an analysis method.
Breast Neoplasms
Gene expression profiles with activation of the estrogen receptor alpha-selective estrogen receptor modulator complex in breast cancer cells expressing wild-type estrogen receptor.
Breast Neoplasms
Gene expression profiling in women with breast cancer in a Saudi population.
Breast Neoplasms
Gene-based comparative analysis of tools for estimating copy number alterations using whole-exome sequencing data.
Breast Neoplasms
Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium.
Breast Neoplasms
Genome-Wide Analysis of Methylation-Driven Genes and Identification of an Eight-Gene Panel for Prognosis Prediction in Breast Cancer.
Breast Neoplasms
Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis.
Breast Neoplasms
Genomic characteristics of trastuzumab-resistant Her2-positive metastatic breast cancer.
Breast Neoplasms
Genomic Profiling of the Steroidogenic Acute Regulatory Protein in Breast Cancer: In Silico Assessments and a Mechanistic Perspective.
Breast Neoplasms
Geometric and dosimetric evaluation of atlas based auto-segmentation of cardiac structures in breast cancer patients.
Breast Neoplasms
Germline and somatic KLLN alterations in breast cancer dysregulate G2 arrest.
Breast Neoplasms
Germline and somatic SDHx alterations in apparently sporadic differentiated thyroid cancer.
Breast Neoplasms
Germline cytoskeletal and extra-cellular matrix-related single nucleotide variations associated with distinct cancer survival rates.
Breast Neoplasms
Germline Genetic Association between Stromal Interaction Molecule 1 (STIM1) and Clinical Outcomes in Breast Cancer Patients.
Breast Neoplasms
Gestational high-fat diet and bisphenol A exposure heightens mammary cancer risk.
Breast Neoplasms
Global Analysis of miRNA-mRNA Interaction Network in Breast Cancer with Brain Metastasis.
Breast Neoplasms
GTSE1 is involved in breast cancer progression in p53 mutation-dependent manner.
Breast Neoplasms
HARVESTMAN: a framework for hierarchical feature learning and selection from whole genome sequencing data.
Breast Neoplasms
Heat shock proteins create a signature to predict the clinical outcome in breast cancer.
Breast Neoplasms
Heterogeneity of genomic profile in patients with HER2-positive breast cancer.
Breast Neoplasms
HIF3A DNA methylation, obesity and weight gain, and breast cancer risk among Mexican American women.
Breast Neoplasms
High BMI1 Expression with Low CD8+ and CD4+ T Cell Activity Could Promote Breast Cancer Cell Survival: A Machine Learning Approach.
Breast Neoplasms
High BRCA2 Gene Expression is Associated with Aggressive and Highly Proliferative Breast Cancer.
Breast Neoplasms
High expression of bone morphogenetic protein (BMP) 6 and BMP7 are associated with higher immune cell infiltration and better survival in estrogen receptor?positive breast cancer.
Breast Neoplasms
High expression of DLG3 is associated with decreased survival from breast cancer.
Breast Neoplasms
High Expression of FGD3, a Putative Regulator of Cell Morphology and Motility, Is Prognostic of Favorable Outcome in Multiple Cancers.
Breast Neoplasms
High Expression of microRNA-143 is Associated with Favorable Tumor Immune Microenvironment and Better Survival in Estrogen Receptor Positive Breast Cancer.
Breast Neoplasms
High Expression of miR-34a Associated with Less Aggressive Cancer Biology but Not with Survival in Breast Cancer.
Breast Neoplasms
High expression of MKK3 is associated with worse clinical outcomes in African American breast cancer patients.
Breast Neoplasms
High KDM1A Expression Associated with Decreased CD8+T Cells Reduces the Breast Cancer Survival Rate in Patients with Breast Cancer.
Breast Neoplasms
High MMP-11 expression associated with low CD8+ T cells decreases the survival rate in patients with breast cancer.
Breast Neoplasms
High peroxidasin-like expression is a potential and independent prognostic biomarker in breast cancer.
Breast Neoplasms
High Tumor Mutation Burden and Other Immunotherapy Response Predictors in Breast Cancers: Associations and Therapeutic Opportunities.
Breast Neoplasms
High-dimensional genomic data bias correction and data integration using MANCIE.
Breast Neoplasms
Highly connected, non-redundant microRNA functional control in breast cancer molecular subtypes.
Breast Neoplasms
Highly robust model of transcription regulator activity predicts breast cancer overall survival.
Breast Neoplasms
Histone H3 lysine 23 acetylation is associated with oncogene TRIM24 expression and a poor prognosis in breast cancer.
Breast Neoplasms
HLA class-I and class-II restricted neoantigen loads predict overall survival in breast cancer.
Breast Neoplasms
Homeobox B4 inhibits breast cancer cell migration by directly binding to StAR-related lipid transfer domain protein 13.
Breast Neoplasms
Hormone Receptor-Status Prediction in Breast Cancer Using Gene Expression Profiles and Their Macroscopic Landscape.
Breast Neoplasms
HOX Transcript Antisense RNA HOTAIR Abrogates Vasculogenic Mimicry by Targeting the AngiomiR-204/FAK Axis in Triple Negative Breast Cancer Cells.
Breast Neoplasms
Humanin Promotes Tumor Progression in Experimental Triple Negative Breast Cancer.
Breast Neoplasms
Humanized yeast genetic interaction mapping predicts synthetic lethal interactions of FBXW7 in breast cancer.
Breast Neoplasms
Hybrid Stem Cell States: Insights Into the Relationship Between Mammary Development and Breast Cancer Using Single-Cell Transcriptomics.
Breast Neoplasms
Hypermethylation of CCND2 in Lung and Breast Cancer Is a Potential Biomarker and Drug Target.
Breast Neoplasms
Hypoxia-Associated Prognostic Markers and Competing Endogenous RNA Co-Expression Networks in Breast Cancer.
Breast Neoplasms
Identification and validation of a combined hypoxia and immune index for triple-negative breast cancer.
Breast Neoplasms
Identification and Validation of an Autophagy-Related lncRNA Signature for Patients With Breast Cancer.
Breast Neoplasms
Identification and Validation of Circulating MicroRNA Signatures for Breast Cancer Early Detection Based on Large Scale Tissue-Derived Data.
Breast Neoplasms
Identification and validation of prognostic signature for breast cancer based on genes potentially involved in autophagy.
Breast Neoplasms
Identification of a 15-pseudogene based prognostic signature for predicting survival and antitumor immune response in breast cancer.
Breast Neoplasms
Identification of a four-long non-coding RNA signature in predicting breast cancer survival.
Breast Neoplasms
Identification of a Rat Mammary Tumor Risk Locus That Is Syntenic with the Commonly Amplified 8q12.1 and 8q22.1 Regions in Human Breast Cancer Patients.
Breast Neoplasms
Identification of an immune-related long noncoding RNA signature that predicts prognosis in breast cancer patients.
Breast Neoplasms
Identification of breast cancer associated variants that modulate transcription factor binding.
Breast Neoplasms
Identification of breast cancer prognostic modules via differential module selection based on weighted gene Co-expression network analysis.
Breast Neoplasms
Identification of candidate cancer drivers by integrative Epi-DNA and Gene Expression (iEDGE) data analysis.
Breast Neoplasms
Identification of CTLA-4 associated with tumor microenvironment and competing interactions in triple negative breast cancer by co-expression network analysis.
Breast Neoplasms
Identification of differentially expressed miRNAs in individual breast cancer patient and application in personalized medicine.
Breast Neoplasms
Identification of epigenetic modulators in human breast cancer by integrated analysis of DNA methylation and RNA-Seq data.
Breast Neoplasms
Identification of FOXM1 as a specific marker for triple?negative breast cancer.
Breast Neoplasms
Identification of FPR3 as a Unique Biomarker for Targeted Therapy in the Immune Microenvironment of Breast Cancer.
Breast Neoplasms
Identification of genes associated with survival of breast cancer patients.
Breast Neoplasms
Identification of Jun loss promotes resistance to histone deacetylase inhibitor entinostat through Myc signaling in luminal breast cancer.
Breast Neoplasms
Identification of key genes unique to the luminal a and basal-like breast cancer subtypes via bioinformatic analysis.
Breast Neoplasms
Identification of Key lncRNA-mRNA Pairs and Functional lncRNAs in Breast Cancer by Integrative Analysis of TCGA Data.
Breast Neoplasms
Identification of lncRNA TRPM2-AS/miR-140-3p/PYCR1 axis's proliferates and anti-apoptotic effect on breast cancer using co-expression network analysis.
Breast Neoplasms
Identification of methylation sites and signature genes with prognostic value for luminal breast cancer.
Breast Neoplasms
Identification of MicroRNAs as Breast Cancer Prognosis Markers through the Cancer Genome Atlas.
Breast Neoplasms
Identification of MicroRNAs as Diagnostic Biomarkers for Breast Cancer Based on the Cancer Genome Atlas.
Breast Neoplasms
Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers.
Breast Neoplasms
Identification of Novel Biomarkers Associated With the Prognosis and Potential Pathogenesis of Breast Cancer via Integrated Bioinformatics Analysis.
Breast Neoplasms
Identification of potential key genes and pathways predicting pathogenesis and prognosis for triple-negative breast cancer.
Breast Neoplasms
Identification of potential oncogenes in triple-negative breast cancer based on bioinformatics analyses.
Breast Neoplasms
Identification of potential prognostic biomarkers for breast cancer using WGCNA and PPI integrated techniques.
Breast Neoplasms
Identification of Prognostic Candidate Genes in Breast Cancer by Integrated Bioinformatic Analysis.
Breast Neoplasms
Identification of putative actionable alterations in clinically relevant genes in breast cancer.
Breast Neoplasms
Identification of the copy number variant biomarkers for breast cancer subtypes.
Breast Neoplasms
Identification of unanimous immune subtypes for different hormone receptor phenotypes of human breast cancer with potential prognostic significance.
Breast Neoplasms
Identifying cancer type specific oncogenes and tumor suppressors using limited size data.
Breast Neoplasms
Identifying causal networks linking cancer processes and anti-tumor immunity using Bayesian network inference and metagene constructs.
Breast Neoplasms
Identifying Functional Modules in Co-Regulatory Networks Through Overlapping Spectral Clustering.
Breast Neoplasms
Identifying the Antiproliferative Effect of Astragalus Polysaccharides on Breast Cancer: Coupling Network Pharmacology With Targetable Screening From the Cancer Genome Atlas.
Breast Neoplasms
IFI30 expression predicts patient prognosis in breast cancer and dictates breast cancer cells proliferation via regulating autophagy.
Breast Neoplasms
Immune and Stroma Related Genes in Breast Cancer: A Comprehensive Analysis of Tumor Microenvironment Based on the Cancer Genome Atlas (TCGA) Database.
Breast Neoplasms
Immune gene expression profiling reveals heterogeneity in luminal breast tumors.
Breast Neoplasms
Immune receptor recombinations from breast cancer exome files, independently and in combination with specific HLA alleles, correlate with better survival rates.
Breast Neoplasms
Immune-related lncRNAs as predictors of survival in breast cancer: a prognostic signature.
Breast Neoplasms
Immunoglobulin superfamily genes are novel prognostic biomarkers for breast cancer.
Breast Neoplasms
Immunoglobulin superfamily member 10 is a novel prognostic biomarker for breast cancer.
Breast Neoplasms
Immunological Differences Between Immune-Rich Estrogen Receptor-Positive and Immune-Rich Triple-Negative Breast Cancers.
Breast Neoplasms
Impact of miRNA sequence on miRNA expression and correlation between miRNA expression and cell cycle regulation in breast cancer cells.
Breast Neoplasms
Improving breast cancer surgery: a classification and quadrant per quadrant atlas for oncoplastic surgery.
Breast Neoplasms
In silico study of cancer stage-specific DNA methylation pattern in White breast cancer patients based on TCGA dataset.
Breast Neoplasms
Increased expression of TMED2 is an unfavorable prognostic factor in patients with breast cancer.
Breast Neoplasms
Increased Proportion of Variance Explained and Prediction Accuracy of Survival of Breast Cancer Patients with Use of Whole-Genome Multiomic Profiles.
Breast Neoplasms
Increased RNA Expression of von Willebrand Factor Gene Is Associated With Infiltrating Lobular Breast Cancer and Normal PAM50 Subtype.
Breast Neoplasms
Induction of Wnt-inducible signaling protein-1 correlates with invasive breast cancer oncogenesis and reduced type 1 cell-mediated cytotoxic immunity: a retrospective study.
Breast Neoplasms
Information theoretic sub-network mining characterizes breast cancer subtypes in terms of cancer core mechanisms.
Breast Neoplasms
Inhibition of 17beta-hydroxysteroid dehydrogenase type 7 modulates breast cancer protein profile and enhances apoptosis by down-regulating GRP78.
Breast Neoplasms
Inhibition of insulin-like growth factor 1 signaling synergistically enhances the tumor suppressive role of triptolide in triple-negative breast cancer cells.
Breast Neoplasms
Institut Curie guidelines on breast target volume delineation for patients treated in lateral position.
Breast Neoplasms
INTEGRATE: gene fusion discovery using whole genome and transcriptome data.
Breast Neoplasms
Integrated Analysis of ceRNA Network Reveals Prognostic and Metastasis Associated Biomarkers in Breast Cancer.
Breast Neoplasms
Integrated Analysis of mRNA-miRNA-lncRNA ceRNA Network in Human HR+/Her-2- Breast Cancer and Triple Negative Breast Cancer.
Breast Neoplasms
Integrated bioinformatics analysis to identify 15 hub genes in breast cancer.
Breast Neoplasms
Integrated omics-based pathway analyses uncover CYP epoxygenase-associated networks as theranostic targets for metastatic triple negative breast cancer.
Breast Neoplasms
Integrated Profiling Identifies CCNA2 as a Potential Biomarker of Immunotherapy in Breast Cancer.
Breast Neoplasms
Integrating multi-omics for uncovering the architecture of cross-talking pathways in breast cancer.
Breast Neoplasms
Integrating mutation and gene expression cross-sectional data to infer cancer progression.
Breast Neoplasms
Integrating spatial gene expression and breast tumour morphology via deep learning.
Breast Neoplasms
Integration and comparison of different genomic data for outcome prediction in cancer.
Breast Neoplasms
Integration of microRNA signatures of distinct mammary epithelial cell types with their gene expression and epigenetic portraits.
Breast Neoplasms
Integration of Multi-omics Data for Gene Regulatory Network Inference and Application to Breast Cancer.
Breast Neoplasms
Integration of transcriptomic data and metabolic networks in cancer samples reveals highly significant prognostic power.
Breast Neoplasms
Integration of transcriptomic data in a genome-scale metabolic model to investigate the link between obesity and breast cancer.
Breast Neoplasms
Integrative analysis of common genes and driver mutations implicated in hormone stimulation for four cancers in women.
Breast Neoplasms
Integrative analysis of DNA methylation and gene expression profiles identified potential breast cancer-specific diagnostic markers.
Breast Neoplasms
Integrative clustering of high-dimensional data with joint and individual clusters.
Breast Neoplasms
Integrative gene set analysis of multi-platform data with sample heterogeneity.
Breast Neoplasms
Integrative genomic analysis identifies associations of molecular alterations to APOBEC and BRCA1/2 mutational signatures in breast cancer.
Breast Neoplasms
Integrative molecular profiling identifies a novel cluster of estrogen receptor-positive breast cancer in very young women.
Breast Neoplasms
Integrative transcriptome data mining for identification of core lncRNAs in breast cancer.
Breast Neoplasms
Integrative, multi-omics, analysis of blood samples improves model predictions: applications to cancer.
Breast Neoplasms
Internal and external validation of an ESTRO delineation guideline - dependent automated segmentation tool for loco-regional radiation therapy of early breast cancer.
Breast Neoplasms
Intersectin 1 (ITSN1) identified by comprehensive bioinformatic analysis and experimental validation as a key candidate biological target in breast cancer.
Breast Neoplasms
Intra-Tumoral Angiogenesis Is Associated with Inflammation, Immune Reaction and Metastatic Recurrence in Breast Cancer.
Breast Neoplasms
Intratumor heterogeneity of HMCN1 mutant alleles associated with poor prognosis in patients with breast cancer.
Breast Neoplasms
Intratumoral Adipocyte-High Breast Cancer Enrich for Metastatic and Inflammation-Related Pathways but Associated with Less Cancer Cell Proliferation.
Breast Neoplasms
Invalidation of mitophagy by FBP1-mediated repression promotes apoptosis in breast cancer.
Breast Neoplasms
Investigating a multigene prognostic assay based on significant pathways for Luminal A breast cancer through gene expression profile analysis.
Breast Neoplasms
IODNE: An integrated optimization method for identifying the deregulated subnetwork for precision medicine in cancer.
Breast Neoplasms
isma: an R package for the integrative analysis of mutations detected by multiple pipelines.
Breast Neoplasms
JAK2 expression is correlated with the molecular and clinical features of breast cancer as a favorable prognostic factor.
Breast Neoplasms
Joint reconstruction of multiple gene networks by simultaneously capturing inter-tumor and intra-tumor heterogeneity.
Breast Neoplasms
Kallikrein-related peptidase 5 induces miRNA-mediated anti-oncogenic pathways in breast cancer.
Breast Neoplasms
KIF11 Functions as an Oncogene and Is Associated with Poor Outcomes from Breast Cancer.
Breast Neoplasms
Kinase-substrate Edge Biomarkers Provide a More Accurate Prognostic Prediction in ER-negative Breast Cancer.
Breast Neoplasms
KMT2C is a potential biomarker of prognosis and chemotherapy sensitivity in breast cancer.
Breast Neoplasms
Knockdown of RAC1 and VASP gene expression inhibits breast cancer cell migration.
Breast Neoplasms
KRAS signaling enriched triple negative breast cancer is associated with favorable tumor immune microenvironment and better survival.
Breast Neoplasms
Lactate Dehydrogenase-A (LDH-A) Preserves Cancer Stemness and Recruitment of Tumor-Associated Macrophages to Promote Breast Cancer Progression.
Breast Neoplasms
Leptin Signaling Affects Survival and Chemoresistance of Estrogen Receptor Negative Breast Cancer.
Breast Neoplasms
LIN28A Modulates Splicing and Gene Expression Programs in Breast Cancer Cells.
Breast Neoplasms
LincIN, a novel NF90-binding long non-coding RNA, is overexpressed in advanced breast tumors and involved in metastasis.
Breast Neoplasms
LincK contributes to breast tumorigenesis by promoting proliferation and epithelial-to-mesenchymal transition.
Breast Neoplasms
Lipocalin-1 Expression as a Prognosticator Marker of Survival in Breast Cancer Patients.
Breast Neoplasms
LMSM: A modular approach for identifying lncRNA related miRNA sponge modules in breast cancer.
Breast Neoplasms
lncRNA FOXD3-AS1 is associated with clinical progression and regulates cell migration and invasion in breast cancer.
Breast Neoplasms
LncRNA MIR100HG promotes cell proliferation in triple-negative breast cancer through triplex formation with p27 loci.
Breast Neoplasms
LncRNA RP11-19E11 is an E2F1 target required for proliferation and survival of basal breast cancer.
Breast Neoplasms
LncRNA SNHG6/miR-125b-5p/BMPR1B Axis: A New Therapeutic Target for Triple-Negative Breast Cancer.
Breast Neoplasms
LOC550643, a Long Non-coding RNA, Acts as Novel Oncogene in Regulating Breast Cancer Growth and Metastasis.
Breast Neoplasms
Long intergenic non-coding RNA expression signature in human breast cancer.
Breast Neoplasms
Long non-coding RNA (lncRNA) transcriptional landscape in breast cancer identifies LINC01614 as non-favorable prognostic biomarker regulated by TGF? and focal adhesion kinase (FAK) signaling.
Breast Neoplasms
Long non-coding RNA MALAT1 regulates BLCAP mRNA expression through binding to miR-339-5p and promotes poor prognosis in breast cancer.
Breast Neoplasms
Long non-coding RNA MIAT promotes breast cancer progression and functions as ceRNA to regulate DUSP7 expression by sponging miR-155-5p.
Breast Neoplasms
Long Non-Coding RNA TUG1 Expression Is Associated with Different Subtypes in Human Breast Cancer.
Breast Neoplasms
Long non?coding RNA SNHG1 promotes breast cancer progression by regulation of LMO4.
Breast Neoplasms
Long noncoding RNA Linc00339 promotes triple-negative breast cancer progression through miR-377-3p/HOXC6 signaling pathway.
Breast Neoplasms
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Breast Neoplasms
Lower frequency of TLR9 variant associated with protection from breast cancer among African Americans.
Breast Neoplasms
Lymphovascular invasion in breast cancer is associated with gene expression signatures of cell proliferation but not lymphangiogenesis or immune response.
Breast Neoplasms
LYN-activating mutations mediate antiestrogen resistance in estrogen receptor-positive breast cancer.
Breast Neoplasms
M1 Polarization Markers Are Upregulated in Basal-Like Breast Cancer Molecular Subtype and Associated With Favorable Patient Outcome.
Breast Neoplasms
m6A RNA Methylation Regulator YTHDF1 Correlated With Immune Microenvironment Predicts Clinical Outcomes and Therapeutic Efficacy in Breast Cancer.
Breast Neoplasms
MAGI2-AS3 inhibits breast cancer by downregulating DNA methylation of MAGI2.
Breast Neoplasms
Mammary cell gene expression atlas links epithelial cell remodeling events to breast carcinogenesis.
Breast Neoplasms
Mammary epithelial morphogenesis and early breast cancer. Evidence of involvement of basal components of the RNA Polymerase I transcription machinery.
Breast Neoplasms
Manganese Superoxide Dismutase Expression Regulates the Switch Between an Epithelial and a Mesenchymal-Like Phenotype in Breast Carcinoma.
Breast Neoplasms
MARCH8 Suppresses Tumor Metastasis and Mediates Degradation of STAT3 and CD44 in Breast Cancer Cells.
Breast Neoplasms
MeCP2 facilitates breast cancer growth via promoting ubiquitination-mediated P53 degradation by inhibiting RPL5/RPL11 transcription.
Breast Neoplasms
Methylation of the claudin 1 promoter is associated with loss of expression in estrogen receptor positive breast cancer.
Breast Neoplasms
microRNA regulation of mammalian target of rapamycin expression and activity controls estrogen receptor function and RAD001 sensitivity.
Breast Neoplasms
microRNA-200c/141 upregulates SerpinB2 to promote breast cancer cell metastasis and reduce patient survival.
Breast Neoplasms
MicroRNA-20a-mediated loss of autophagy contributes to breast tumorigenesis by promoting genomic damage and instability.
Breast Neoplasms
microRNA-21 promotes breast cancer proliferation and metastasis by targeting LZTFL1.
Breast Neoplasms
MicroRNA-301a-3p promotes triple-negative breast cancer progression through downregulating MEOX2.
Breast Neoplasms
MicroRNA-3613-3p functions as a tumor suppressor and represents a novel therapeutic target in breast cancer.
Breast Neoplasms
MicroRNA-99a-5p suppresses breast cancer progression and cell-cycle pathway through downregulating CDC25A.
Breast Neoplasms
Mining immune-related genes with prognostic value in the tumor microenvironment of breast invasive ductal carcinoma.
Breast Neoplasms
Mining the prognostic significance of the GINS2 gene in human breast cancer using bioinformatics analysis.
Breast Neoplasms
MiR-100 is a predictor of endocrine responsiveness and prognosis in patients with operable luminal breast cancer.
Breast Neoplasms
miR-148b-3p, miR-190b, and miR-429 Regulate Cell Progression and Act as Potential Biomarkers for Breast Cancer.
Breast Neoplasms
miR-195/miR-497 Regulate CD274 Expression of Immune Regulatory Ligands in Triple-Negative Breast Cancer.
Breast Neoplasms
miR-301b and NR3C2 co-regulate cells malignant properties and have the potential to be independent prognostic factors in breast cancer.
Breast Neoplasms
MiR-301b-3p Promotes the Occurrence and Development of Breast Cancer Cells via Targeting HOXA5.
Breast Neoplasms
miRGTF-net: Integrative miRNA-gene-TF network analysis reveals key drivers of breast cancer recurrence.
Breast Neoplasms
Mitigating the Impact of Coronavirus Disease (COVID-19) Vaccinations on Patients Undergoing Breast Imaging Examinations: A Pragmatic Approach.
Breast Neoplasms
MMP24 as a Target of YAP is a Potential Prognostic Factor in Cancer Patients.
Breast Neoplasms
Model based on GA and DNN for prediction of mRNA-Smad7 expression regulated by miRNAs in breast cancer.
Breast Neoplasms
Molecular and Clinical Characterization of CCT2 Expression and Prognosis via Large-Scale Transcriptome Profile of Breast Cancer.
Breast Neoplasms
Molecular and epigenetic profiles of BRCA1-like hormone-receptor-positive breast tumors identified with development and application of a copy-number-based classifier.
Breast Neoplasms
Molecular Biological Features of Nottingham Histological Grade 3 Breast Cancers.
Breast Neoplasms
Molecular features and survival outcomes of the intrinsic subtypes within HER2-positive breast cancer.
Breast Neoplasms
Molecular Insights into the Classification of Luminal Breast Cancers: The Genomic Heterogeneity of Progesterone-Negative Tumors.
Breast Neoplasms
Molecular mechanisms linking high body mass index to breast cancer etiology in post-menopausal breast tumor and tumor-adjacent tissues.
Breast Neoplasms
Molecular Subtype-Specific Expression of MicroRNA-29c in Breast Cancer Is Associated with CpG Dinucleotide Methylation of the Promoter.
Breast Neoplasms
Monocarboxylate transporters in breast cancer and adipose tissue are novel biomarkers and potential therapeutic targets.
Breast Neoplasms
MTBP Is Overexpressed in Triple-Negative Breast Cancer and Contributes to Its Growth and Survival.
Breast Neoplasms
MUC1-C integrates activation of the IFN-? pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer.
Breast Neoplasms
Multi-Objective Optimization Algorithm to Discover Condition-Specific Modules in Multiple Networks.
Breast Neoplasms
Multi-Stability and Consequent Phenotypic Plasticity in AMPK-Akt Double Negative Feedback Loop in Cancer Cells.
Breast Neoplasms
Multiple breast cancer risk variants are associated with differential transcript isoform expression in tumors.
Breast Neoplasms
Multiple network algorithm for epigenetic modules via the integration of genome-wide DNA methylation and gene expression data.
Breast Neoplasms
MuPIT interactive: webserver for mapping variant positions to annotated, interactive 3D structures.
Breast Neoplasms
Mutational landscape differences between young-onset and older-onset breast cancer patients.
Breast Neoplasms
Mutational Profile of Metastatic Breast Cancers: A Retrospective Analysis.
Breast Neoplasms
Mutational Profiling Can Establish Clonal or Independent Origin in Synchronous Bilateral Breast and Other Tumors.
Breast Neoplasms
Needles in a haystack: finding recurrent genomic changes in breast cancer.
Breast Neoplasms
Network-Based Approach to Identify the Antiproliferative Mechanisms of Bruceine D in Breast Cancer From the Cancer Genome Atlas.
Breast Neoplasms
Network-Based Isoform Quantification with RNA-Seq Data for Cancer Transcriptome Analysis.
Breast Neoplasms
Non-coding single nucleotide variants affecting estrogen receptor binding and activity.
Breast Neoplasms
Novel immune-related genes in the tumor microenvironment with prognostic value in breast cancer.
Breast Neoplasms
Novel mechanistic targets of forkhead box Q1 transcription factor in human breast cancer cells.
Breast Neoplasms
Novel methylated biomarkers and a robust assay to detect circulating tumor DNA in metastatic breast cancer.
Breast Neoplasms
Novel MicroRNA-Based Risk Score Identified by Integrated Analyses to Predict Metastasis and Poor Prognosis in Breast Cancer.
Breast Neoplasms
NR2F2 Orphan Nuclear Receptor is Involved in Estrogen Receptor Alpha-Mediated Transcriptional Regulation in Luminal A Breast Cancer Cells.
Breast Neoplasms
Nucleolar protein 10 (NOP10) predicts poor prognosis in invasive breast cancer.
Breast Neoplasms
Octogenarians' Breast Cancer Is Associated with an Unfavorable Tumor Immune Microenvironment and Worse Disease-Free Survival.
Breast Neoplasms
Omission of adjuvant radiation therapy in elderly patients with low risk breast cancer undergoing breast-conserving surgery - two center experience.
Breast Neoplasms
Oncogenic Role and Prognostic Value of MicroRNA-937-3p in Patients with Breast Cancer.
Breast Neoplasms
Oncoplastic surgery for breast cancer based on tumour location and a quadrant-per-quadrant atlas.
Breast Neoplasms
Optimal systemic therapy for premenopausal women with hormone receptor-positive breast cancer.
Breast Neoplasms
OSbrca: A Web Server for Breast Cancer Prognostic Biomarker Investigation With Massive Data From Tens of Cohorts.
Breast Neoplasms
Overexpressed somatic alleles are enriched in functional elements in Breast Cancer.
Breast Neoplasms
Overexpression of NuSAP1 is predictive of an unfavourable prognosis and promotes proliferation and invasion of triple-negative breast cancer cells via the Wnt/?-catenin/EMT signalling axis.
Breast Neoplasms
Overexpression of suppressive microRNAs, miR-30a and miR-200c are associated with improved survival of breast cancer patients.
Breast Neoplasms
Overexpression of Tumor Protein p53-regulated Apoptosis-inducing Protein 1 Regulates Proliferation and Apoptosis of Breast Cancer Cells through the PI3K/Akt Pathway.
Breast Neoplasms
Overlapping clustering of gene expression data using penalized weighted normalized cut.
Breast Neoplasms
Pannexin1 Is Associated with Enhanced Epithelial-To-Mesenchymal Transition in Human Patient Breast Cancer Tissues and in Breast Cancer Cell Lines.
Breast Neoplasms
Pathophysiological Role of Histamine H4 Receptor in Cancer: Therapeutic Implications.
Breast Neoplasms
Patterns of Mutation Enrichment in Metastatic Triple-Negative Breast Cancer.
Breast Neoplasms
PEG3 mutation is associated with elevated tumor mutation burden and poor prognosis in breast cancer.
Breast Neoplasms
PFKFB4 Promotes Breast Cancer Metastasis via Induction of Hyaluronan Production in a p38-Dependent Manner.
Breast Neoplasms
Phenethyl Isothiocyanate Suppresses Stemness in the Chemo- and Radio-Resistant Triple-Negative Breast Cancer Cell Line MDA-MB-231/IR Via Downregulation of Metadherin.
Breast Neoplasms
Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancer.
Breast Neoplasms
Pokemon Inhibits Transforming Growth Factor ?-Smad4-Related Cell Proliferation Arrest in Breast Cancer through Specificity Protein 1.
Breast Neoplasms
Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction.
Breast Neoplasms
Population-dependent Intron Retention and DNA Methylation in Breast Cancer.
Breast Neoplasms
Potential functional variants of KIAA genes are associated with breast cancer risk in a case control study.
Breast Neoplasms
Potential value of MicroRNA-21 as a biomarker for predicting the prognosis of patients with breast cancer: A protocol for meta-analysis and bioinformatics analysis.
Breast Neoplasms
Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.
Breast Neoplasms
Predicting censored survival data based on the interactions between meta-dimensional omics data in breast cancer.
Breast Neoplasms
Prediction of clinical phenotypes in invasive breast carcinomas from the integration of radiomics and genomics data.
Breast Neoplasms
Prevalence and clinical relevance of tumor-associated tissue eosinophilia (TATE) in breast cancer.
Breast Neoplasms
Prioritizing Potentially Druggable Mutations with dGene: An Annotation Tool for Cancer Genome Sequencing Data.
Breast Neoplasms
Profile of the breast cancer susceptibility marker rs4245739 identifies a role for miRNAs.
Breast Neoplasms
Profiling human breast epithelial cells using single cell RNA sequencing identifies cell diversity.
Breast Neoplasms
Prognostic Impact of HOTAIR Expression is Restricted to ER-Negative Breast Cancers.
Breast Neoplasms
Prognostic role of elevated mir-24-3p in breast cancer and its association with the metastatic process.
Breast Neoplasms
Prognostic significance of heat shock protein 90AA1 (HSP90?) in invasive breast cancer.
Breast Neoplasms
Proliferation-associated long noncoding RNA, TMPO-AS1, is a potential therapeutic target for triple-negative breast cancer.
Breast Neoplasms
Proper Use of Allele-Specific Expression Improves Statistical Power for cis-eQTL Mapping with RNA-Seq Data.
Breast Neoplasms
Prostate-specific membrane antigen in breast cancer: a comprehensive evaluation of expression and a case report of radionuclide therapy.
Breast Neoplasms
Proteins with Evolutionarily Hypervariable Domains are Associated with Immune Response and Better Survival of Basal-like Breast Cancer Patients.
Breast Neoplasms
PRRG4 promotes breast cancer metastasis through the recruitment of NEDD4 and downregulation of Robo1.
Breast Neoplasms
PSMD2 regulates breast cancer cell proliferation and cell cycle progression by modulating p21 and p27 proteasomal degradation.
Breast Neoplasms
Putative Breast Cancer Driver Mutations in TBX3 Cause Impaired Transcriptional Repression.
Breast Neoplasms
Radiogenomic Analysis of Breast Cancer: Luminal B Molecular Subtype Is Associated with Enhancement Dynamics at MR Imaging.
Breast Neoplasms
Radiotherapy dose distribution prediction for breast cancer using deformable image registration.
Breast Neoplasms
RANK-c attenuates aggressive properties of ER-negative breast cancer by inhibiting NF-?B activation and EGFR signaling.
Breast Neoplasms
Regulation of mRNA expression in breast cancer - a cis-tematic trans-action.
Breast Neoplasms
Regulators associated with clinical outcomes revealed by DNA methylation data in breast cancer.
Breast Neoplasms
Regulatory network reconstruction of five essential microRNAs for survival analysis in breast cancer by integrating miRNA and mRNA expression datasets.
Breast Neoplasms
Relationships Between Human-Extracted MRI Tumor Phenotypes of Breast Cancer and Clinical Prognostic Indicators Including Receptor Status and Molecular Subtype.
Breast Neoplasms
Reply to Comments on: Improving Breast Cancer Surgery: A Classification and Quadrant per Quadrant Atlas for Oncoplastic Surgery.
Breast Neoplasms
RNA m6A Methylation Regulators Subclassify Luminal Subtype in Breast Cancer.
Breast Neoplasms
RNA Sequencing in Comparison to Immunohistochemistry for Measuring Cancer Biomarkers in Breast Cancer and Lung Cancer Specimens.
Breast Neoplasms
RNA-seq analysis identified hormone-related genes associated with prognosis of triple negative breast cancer.
Breast Neoplasms
Roadmap of DNA methylation in breast cancer identifies novel prognostic biomarkers.
Breast Neoplasms
Role of exchange protein directly activated by cAMP (EPAC1) in breast cancer cell migration and apoptosis.
Breast Neoplasms
Role of Krüppel-like Factor 4-p21CIP1 Axis in Breast Cancer Stem-like Cell Inhibition by Benzyl Isothiocyanate.
Breast Neoplasms
S-score: a scoring system for the identification and prioritization of predicted cancer genes.
Breast Neoplasms
SEC61G promotes breast cancer development and metastasis via modulating glycolysis and is transcriptionally regulated by E2F1.
Breast Neoplasms
Selective expression of long non-coding RNAs in a breast cancer cell progression model.
Breast Neoplasms
Sensitivity to differential NRF1 gene signatures contributes to breast cancer disparities.
Breast Neoplasms
SETD7 is a prognosis predicting factor of breast cancer and regulates redox homeostasis.
Breast Neoplasms
Shift in GATA3 functions, and GATA3 mutations, control progression and clinical presentation in breast cancer.
Breast Neoplasms
Shikonin inhibits migration and invasion of triple-negative breast cancer cells by suppressing epithelial-mesenchymal transition via miR-17-5p/PTEN/Akt pathway.
Breast Neoplasms
shRNA knockdown of DNA helicase ERCC6L expression inhibits human breast cancer growth.
Breast Neoplasms
Simplified rules for everyday delineation of lymph node areas for breast cancer radiotherapy.
Breast Neoplasms
Single-Cell RNA Sequencing of a Postmenopausal Normal Breast Tissue Identifies Multiple Cell Types That Contribute to Breast Cancer.
Breast Neoplasms
SIRT7 Is a Prognostic Biomarker Associated With Immune Infiltration in Luminal Breast Cancer.
Breast Neoplasms
Somatic mutation load of estrogen receptor-positive breast tumors predicts overall survival: an analysis of genome sequence data.
Breast Neoplasms
Somatic Mutations in LRRK2 Identify a Subset of Invasive Mammary Carcinomas Associated with High Mutation Burden.
Breast Neoplasms
SPTBN1 inhibits growth and epithelial-mesenchymal transition in breast cancer by downregulating miR-21.
Breast Neoplasms
SRY-related high-mobility-group box 6 suppresses cell proliferation and is downregulated in breast cancer.
Breast Neoplasms
Statin use, HMGCR expression, and breast cancer survival - The Malmö Diet and Cancer Study.
Breast Neoplasms
Statistical analysis of array expression data as applied to the problem of tamoxifen resistance.
Breast Neoplasms
Stromal-associated cytokines bias the interplay between gene expression and DNA methylation in human breast cancers.
Breast Neoplasms
Subgrouping breast cancer patients based on immune evasion mechanisms unravels a high involvement of transforming growth factor-beta and decoy receptor 3.
Breast Neoplasms
Survival of patients with structurally-grouped TP53 mutations in ovarian and breast cancers.
Breast Neoplasms
Systematic Identification and Assessment of Therapeutic Targets for Breast Cancer Based on Genome-Wide RNA Interference Transcriptomes.
Breast Neoplasms
Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancer.
Breast Neoplasms
Targeting of lactate dehydrogenase C dysregulates the cell cycle and sensitizes breast cancer cells to DNA damage response targeted therapy.
Breast Neoplasms
Testing equality of means in partially paired data with incompleteness in single response.
Breast Neoplasms
TGF? isoforms and receptors mRNA expression in breast tumours: prognostic value and clinical implications.
Breast Neoplasms
Th2 cell infiltrations predict neoadjuvant chemotherapy response of estrogen receptor-positive breast cancer.
Breast Neoplasms
The association between copy number aberration, DNA methylation and gene expression in tumor samples.
Breast Neoplasms
The association of CMTM6 expression with prognosis and PD-L1 expression in triple-negative breast cancer.
Breast Neoplasms
The Association of Modifiable Breast Cancer Risk Factors and Somatic Genomic Alterations in Breast Tumors: The Cancer Genome Atlas Network.
Breast Neoplasms
The BIRC Family Genes Expression in Patients with Triple Negative Breast Cancer.
Breast Neoplasms
The Breast Imaging Reporting and Data System (BI-RADS) in the Dutch breast cancer screening programme: its role as an assessment and stratification tool.
Breast Neoplasms
The construction and analysis of ceRNA networks in invasive breast cancer: a study based on The Cancer Genome Atlas.
Breast Neoplasms
The effect of centromere protein U silencing by lentiviral mediated RNA interference on the proliferation and apoptosis of breast cancer.
Breast Neoplasms
The eSNV-detect: a computational system to identify expressed single nucleotide variants from transcriptome sequencing data.
Breast Neoplasms
The exploration of contrasting pathways in Triple Negative Breast Cancer (TNBC).
Breast Neoplasms
The expression of the tumour suppressor HBP1 is down-regulated by growth factors via the PI3K/PKB/FOXO pathway.
Breast Neoplasms
The G Protein-Coupled Estrogen Receptor (GPER) Expression Correlates with Pro-Metastatic Pathways in ER-Negative Breast Cancer: A Bioinformatics Analysis.
Breast Neoplasms
The genomic map of breast cancer: which roads lead to better targeted therapies?
Breast Neoplasms
The IL1?-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs).
Breast Neoplasms
The immune-related gene CD52 is a favorable biomarker for breast cancer prognosis.
Breast Neoplasms
The impact of HER2 overexpression on the miRNA and circRNA transcriptomes in two breast cell lines and their vesicles.
Breast Neoplasms
The Landscape of Chromosome Instability in Breast Cancers and Associations with the Tumor Mutation Burden: An Analysis of Data from TCGA.
Breast Neoplasms
The LZIP: A Bayesian latent factor model for correlated zero-inflated counts.
Breast Neoplasms
The m6A readers YTHDF1 and YTHDF3 aberrations associated with metastasis and predict poor prognosis in breast cancer patients.
Breast Neoplasms
The m6A-related gene signature for predicting the prognosis of breast cancer.
Breast Neoplasms
The Mammalian Ecdysoneless Protein Interacts with RNA Helicase DDX39A To Regulate Nuclear mRNA Export.
Breast Neoplasms
The Metallophosphoesterase-Domain-Containing Protein 2 (MPPED2) Gene Acts as Tumor Suppressor in Breast Cancer.
Breast Neoplasms
The microRNA target site landscape is a novel molecular feature associating alternative polyadenylation with immune evasion activity in breast cancer.
Breast Neoplasms
The mRNA-edited form of GABRA3 suppresses GABRA3-mediated Akt activation and breast cancer metastasis.
Breast Neoplasms
The MS-lincRNA landscape reveals a novel lincRNA BCLIN25 that contributes to tumorigenesis by upregulating ERBB2 expression via epigenetic modification and RNA-RNA interactions in breast cancer.
Breast Neoplasms
The Novel Marker GATA3 is Significantly More Sensitive Than Traditional Markers Mammaglobin and GCDFP15 for Identifying Breast Cancer in Surgical and Cytology Specimens of Metastatic and Matched Primary Tumors.
Breast Neoplasms
The Relationship Between Mismatch Repair Deficiency and PD-L1 Expression in Breast Carcinoma.
Breast Neoplasms
The Role of CHK1 Varies with the Status of Oestrogen-receptor and Progesterone-receptor in the Targeted Therapy for Breast Cancer.
Breast Neoplasms
The role of IRAK1 in breast cancer patients treated with neoadjuvant chemotherapy.
Breast Neoplasms
The Thyroid Hormone Receptor-RUNX2 Axis: A Novel Tumor Suppressive Pathway in Breast Cancer.
Breast Neoplasms
The transcription factor CBFB mutations indicate an improved survival in HR+/HER2- breast cancer.
Breast Neoplasms
The transcriptional landscape of lncRNAs reveals the oncogenic function of LINC00511 in ER-negative breast cancer.
Breast Neoplasms
TIGIT-related transcriptome profile and its association with tumor immune microenvironment in breast cancer.
Breast Neoplasms
Tim-3 promotes cell aggressiveness and paclitaxel resistance through NF-?B/STAT3 signalling pathway in breast cancer cells.
Breast Neoplasms
Time-Varying Differential Network Analysis for Revealing Network Rewiring over Cancer Progression.
Breast Neoplasms
Tools for consensus analysis of experts' contours for radiotherapy structure definitions.
Breast Neoplasms
Topological integration of RPPA proteomic data with multi-omics data for survival prediction in breast cancer via pathway activity inference.
Breast Neoplasms
Towards clinically more relevant dissection of patient heterogeneity via survival-based Bayesian clustering.
Breast Neoplasms
TP53 protein levels, RNA-based pathway assessment, and race among invasive breast cancer cases.
Breast Neoplasms
TRAF2 Cooperates with Focal Adhesion Signaling to Regulate Cancer Cell Susceptibility to Anoikis.
Breast Neoplasms
Transcriptome- and proteome-oriented identification of dysregulated eIF4G, STAT3, and Hippo pathways altered by PIK3CA (H1047R) in HER2/ER-positive breast cancer.
Breast Neoplasms
Transgelin-2 expression in breast cancer and its relationships with clinicopathological features and patient outcome.
Breast Neoplasms
Translational database selection and multiplexed sequence capture for up front filtering of reliable breast cancer biomarker candidates.
Breast Neoplasms
Triple-Negative Breast Cancer with High Levels of Annexin A1 Expression Is Associated with Mast Cell Infiltration, Inflammation, and Angiogenesis.
Breast Neoplasms
TRPM4 is overexpressed in breast cancer associated with estrogen response and epithelial-mesenchymal transition gene sets.
Breast Neoplasms
TSDLPP: A Novel Two-stage Deep Learning Framework for Prognosis Prediction Based on Whole Slide Histopathological Images.
Breast Neoplasms
Tumor Microenvironment Subtypes and Immune-Related Signatures for the Prognosis of Breast Cancer.
Breast Neoplasms
Tumor mutational burden is a determinant of immune-mediated survival in breast cancer.
Breast Neoplasms
Tuning Parameter Selection in Cox Proportional Hazards Model with a Diverging Number of Parameters.
Breast Neoplasms
Two forms of gonadotropin-releasing hormone (GnRH) are expressed in human breast tissue and overexpressed in breast cancer: a putative mechanism for the antiproliferative effect of GnRH by down-regulation of acidic ribosomal phosphoproteins P1 and P2.
Breast Neoplasms
UBASH3B promotes tamoxifen resistance and could be negatively regulated by ESR1.
Breast Neoplasms
Ubiquitin-like modifier-activating enzyme 7 as a marker for the diagnosis and prognosis of breast cancer.
Breast Neoplasms
Ultrasound characteristics of sclerosing adenosis mimicking breast carcinoma.
Breast Neoplasms
Uncovering the Subtype-Specific Molecular Characteristics of Breast Cancer by Multiomics Analysis of Prognosis-Associated Genes, Driver Genes, Signaling Pathways, and Immune Activity.
Breast Neoplasms
Unravelling triple-negative breast cancer molecular heterogeneity using an integrative multiomic analysis.
Breast Neoplasms
Up-regulation of L Antigen Family Member 3 Associates With Aggressive Progression of Breast Cancer.
Breast Neoplasms
Upregulation of Long Non-Coding RNA DRAIC Correlates with Adverse Features of Breast Cancer.
Breast Neoplasms
Utility of ankyrin 3 as a prognostic marker in androgen-receptor-positive breast cancer.
Breast Neoplasms
Utilizing Automated Breast Cancer Detection to Identify Spatial Distributions of Tumor-Infiltrating Lymphocytes in Invasive Breast Cancer.
Breast Neoplasms
Variability of target and normal structure delineation for breast cancer radiotherapy: an RTOG Multi-Institutional and Multiobserver Study.
Breast Neoplasms
VGLL1 expression is associated with a triple-negative basal-like phenotype in breast cancer.
Breast Neoplasms
WBP2 promotes BTRC mRNA stability to drive migration and invasion in triple-negative breast cancer via NF-?B activation.
Breast Neoplasms
XPF -673C>T variation is associated with the susceptibility to breast cancer.
Breast Neoplasms
XRCC1 promotes replication restart, nascent fork degradation and mutagenic DNA repair in BRCA2-deficient cells.
Breast Neoplasms
[Adjuvant tamoxifen duration: more large-scale randomized evidence is needed]
Breast Neoplasms
[Breast cancer mortality in women in the Schleswig-Holstein district 1981 to 1995]
Breast Neoplasms
[Evaluation of an automatic delineation system for organs at risk and target lymph nodes volumes for patients treated for breast cancer].
Breast Neoplasms
[For how long should breast cancer patients take Tamoxifen? The International Program ATLAS will answer this question]
Bursitis
An equine cadaver study investigating the relationship between cervical flexion, nuchal ligament elongation and pressure at the first and second cervical vertebra.
CADASIL
Cortical Superficial Siderosis in Different Types of Cerebral Small Vessel Disease.
Carcinogenesis
A probabilistic method for leveraging functional annotations to enhance estimation of the temporal order of pathway mutations during carcinogenesis.
Carcinogenesis
ALK gene alterations in cancer: biological aspects and therapeutic implications.
Carcinogenesis
Alternative splicing events implicated in carcinogenesis and prognosis of colorectal cancer.
Carcinogenesis
Assessing the functional bias of commercial microarrays using the onto-compare database.
Carcinogenesis
Author Correction: Mammary cell gene expression atlas links epithelial cell remodeling events to breast carcinogenesis.
Carcinogenesis
Benzodiazepines use and breast cancer risk: A population-based study and gene expression profiling evidence.
Carcinogenesis
circRNA-associated ceRNA network construction reveals the circRNAs involved in the progression and prognosis of breast cancer.
Carcinogenesis
Clinical roles of the aberrantly expressed lncRNAs in lung squamous cell carcinoma: a study based on RNA-sequencing and microarray data mining.
Carcinogenesis
Competitive Endogenous RNA (ceRNA) Regulation Network of lncRNA-miRNA-mRNA in Colorectal Carcinogenesis.
Carcinogenesis
Differences in key genes in human alveolar macrophages between phenotypically normal smokers and nonsmokers: diagnostic and prognostic value in lung cancer.
Carcinogenesis
EGFRvIII-specific CAR-T cells produced by piggyBac transposon exhibit efficient growth suppression against hepatocellular carcinoma.
Carcinogenesis
Elevated high mobility group A2 expression in liver cancer predicts poor patient survival.
Carcinogenesis
Elevated KLF7 levels may serve as a prognostic signature and might contribute to progression of squamous carcinoma.
Carcinogenesis
Epigenetic silencing of the synthesis of immunosuppressive Siglec ligand glycans by NF-?B/EZH2/YY1 axis in early-stage colon cancers.
Carcinogenesis
Feature Selection for Breast Cancer Classification by Integrating Somatic Mutation and Gene Expression.
Carcinogenesis
Genome-wide DNA methylation profiles altered by Helicobacter pylori in gastric mucosa and blood leukocyte DNA.
Carcinogenesis
HSPD1 repressed E-cadherin expression to promote cell invasion and migration for poor prognosis in oral squamous cell carcinoma.
Carcinogenesis
Hypermethylation of heparanase 2 promotes colorectal cancer proliferation and is associated with poor prognosis.
Carcinogenesis
Identification and Validation of the Prognostic Stemness Biomarkers in Bladder Cancer Bone Metastasis.
Carcinogenesis
Identification of MicroRNA-Related Tumorigenesis Variants and Genes in the Cancer Genome Atlas (TCGA) Data.
Carcinogenesis
Identification of oncogenic long noncoding RNAs CASC9 and LINC00152 in oral carcinoma through genome-wide comprehensive analysis.
Carcinogenesis
Impaired expression of the cell cycle regulator BTG2 is common in clear cell renal cell carcinoma.
Carcinogenesis
Integrating genomics in head and neck cancer treatment: Promises and pitfalls.
Carcinogenesis
Integrative analysis of lncRNAs and miRNAs with coding RNAs associated with ceRNA crosstalk network in triple negative breast cancer.
Carcinogenesis
Joint bioinformatics analysis of underlying potential functions of hsa-let-7b-5p and core genes in human glioma.
Carcinogenesis
LncRNA CASC9 interacts with CPSF3 to regulate TGF-? signaling in colorectal cancer.
Carcinogenesis
Long noncoding RNA RP11-547D24.1 regulates proliferation and migration in papillary thyroid carcinoma: Identification and validation of a novel long noncoding RNA through integrated analysis of TCGA database.
Carcinogenesis
Mammary cell gene expression atlas links epithelial cell remodeling events to breast carcinogenesis.
Carcinogenesis
Mechanistic Modeling of Gene Regulation and Metabolism Identifies Potential Targets for Hepatocellular Carcinoma.
Carcinogenesis
MicroRNA-3690 promotes cell proliferation and cell cycle progression by altering DKK3 expression in human thyroid cancer.
Carcinogenesis
MicroRNA?mRNA integrated analysis based on a case of well?differentiated thyroid cancer with both metastasis and metastatic recurrence.
Carcinogenesis
miR-3174 Contributes to Apoptosis and Autophagic Cell Death Defects in Gastric Cancer Cells by Targeting ARHGAP10.
Carcinogenesis
Modeling Gene-Wise Dependencies Improves the Identification of Drug Response Biomarkers in Cancer Studies.
Carcinogenesis
Molecular profiling of transcription factors pinpoints MYC-estrogen related receptor ?-regulatory factor X5 panel for characterizing the immune microenvironment and predicting the efficacy of immune checkpoint inhibitors in renal cell carcinoma.
Carcinogenesis
Multi-faceted computational assessment of risk and progression in oligodendroglioma implicates NOTCH and PI3K pathways.
Carcinogenesis
Multiscale Modeling of Inflammation-Induced Tumorigenesis Reveals Competing Oncogenic and Oncoprotective Roles for Inflammation.
Carcinogenesis
Myeloid translocation genes differentially regulate colorectal cancer programs.
Carcinogenesis
Over-expression of long non-coding RNA insulin-like growth factor 2-antisense suppressed hepatocellular carcinoma cell proliferation and metastasis by regulating the microRNA-520h/cyclin-dependent kinase inhibitor 1A signaling pathway.
Carcinogenesis
Pan-Cancer Analysis of Head-to-Head Gene Pairs in Terms of Transcriptional Activity, Co-expression and Regulation.
Carcinogenesis
Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics.
Carcinogenesis
Potential role for targeted therapy in muscle-invasive bladder cancer: lessons from the cancer genome atlas and beyond.
Carcinogenesis
Potential therapeutic targets of TP53 gene in the context of its classically canonical functions and its latest non-canonical functions in human cancer.
Carcinogenesis
Prediction of survival and recurrence in patients with pancreatic cancer by integrating multi-omics data.
Carcinogenesis
Predictive value of WHO classification for PD-L1 and Her2/Neu expression and distinct associations with protein expression based classification in gastric carcinoma.
Carcinogenesis
Profiling of differentially expressed genes in LRRC4 overexpressed glioblastoma cells by cDNA array.
Carcinogenesis
Proteome atlas of human chromosome 8 and its multiple 8p deficiencies in tumorigenesis of the stomach, colon, and liver.
Carcinogenesis
Proteomic Features of Colorectal Cancer Identify Tumor Subtypes Independent of Oncogenic Mutations and Independently Predict Relapse-Free Survival.
Carcinogenesis
Risk factors predisposing to cardia gastric adenocarcinoma: Insights and new perspectives.
Carcinogenesis
Shift in GATA3 functions, and GATA3 mutations, control progression and clinical presentation in breast cancer.
Carcinogenesis
Significance of TP53 Mutation in Cellular Process and Disease Progression in Lung Adenocarcinoma.
Carcinogenesis
Stress-triggered atavistic reprogramming (STAR) addiction: driving force behind head and neck cancer?
Carcinogenesis
The USP21/YY1/SNHG16 axis contributes to tumor proliferation, migration, and invasion of non-small-cell lung cancer.
Carcinogenesis
The X-linked tumor suppressor TSPX downregulates cancer-drivers/oncogenes in prostate cancer in a C-terminal acidic domain dependent manner.
Carcinogenesis
Ultraviolet-A radiation induces changes in cyclin G gene expression in mouse melanoma B16-F1 cells.
Carcinoid Tumor
[Scintigraphy atlas of somatostatin receptors in neuroendocrine tumors of the pancreas and carcinoid tumors]
Carcinoma
(S,R)3-(4-Hydroxyphenyl)-4,5-Dihydro-5-Isoxazole Acetic Acid Methyl Ester Inhibits Epithelial-to-Mesenchymal Transition through TGF-?/Smad4 Axis in Nasopharyngeal Carcinoma.
Carcinoma
53 years old is a reasonable cut-off value to define young and old patients in clear cell renal cell carcinoma: a study based on TCGA and SEER database.
Carcinoma
?Np63 Inhibits Oxidative Stress-Induced Cell Death, Including Ferroptosis, and Cooperates with the BCL-2 Family to Promote Clonogenic Survival.
Carcinoma
A 10?microRNA prognosis scoring system in esophageal squamous cell carcinoma constructed using bioinformatic methods.
Carcinoma
A BAP1 synonymous mutation results in exon skipping, loss of function and worse patient prognosis.
Carcinoma
A Bayesian integrative approach for multi-platform genomic data: A kidney cancer case study.
Carcinoma
A BRCA1/2 mutational signature and survival in ovarian high grade serous carcinoma.
Carcinoma
A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targets.
Carcinoma
A combination of intra-tumor genetic heterogeneity, estrogen receptor alpha and human papillomavirus status predicts outcomes in head and neck squamous cell carcinoma following chemoradiotherapy.
Carcinoma
A comparison of adult rhabdomyosarcoma and high-grade neuroendocrine carcinoma of the urinary bladder reveals novel PPP1R12A fusions in rhabdomyosarcoma.
Carcinoma
A fluorescence-coupled assay for gamma aminobutyric acid (GABA) reveals metabolic stress-induced modulation of GABA content in neuroendocrine cancer.
Carcinoma
A Galaxy Implementation of Next-Generation Clustered Heatmaps for Interactive Exploration of Molecular Profiling Data.
Carcinoma
A graph-embedded deep feedforward network for disease outcome classification and feature selection using gene expression data.
Carcinoma
A hidden Markov modeling approach for identifying tumor subclones in next-generation sequencing studies.
Carcinoma
A micro-peptide encoded by HOXB-AS3 promotes the proliferation and viability of oral squamous cell carcinoma cell lines by directly binding with IGF2BP2 to stabilize c-Myc.
Carcinoma
A New ?0-Regularized Log-Linear Poisson Graphical Model with Applications to RNA Sequencing Data.
Carcinoma
A New Survival Model Based on Cholesterol Biosynthesis-Related Genes for Prognostic Prediction in Clear Cell Renal Cell Carcinoma.
Carcinoma
A new survival model based on ferroptosis-related genes for prognostic prediction in clear cell renal cell carcinoma.
Carcinoma
A nomogram based on 9-lncRNAs signature for improving prognostic prediction of clear cell renal cell carcinoma.
Carcinoma
A novel 12-gene signature as independent prognostic model in stage IA and IB lung squamous cell carcinoma patients.
Carcinoma
A novel machine learning approach reveals latent vascular phenotypes predictive of renal cancer outcome.
Carcinoma
A Novel Prognostic Model Based on Ferroptosis-Related Gene Signature for Bladder Cancer.
Carcinoma
A novel prognostic prediction model based on seven immune-related RNAs for predicting overall survival of patients in early cervical squamous cell carcinoma.
Carcinoma
A Panel of Four-lncRNA Signature as a Potential Biomarker for Predicting Survival in Clear Cell Renal Cell Carcinoma.
Carcinoma
A panel of Transcription factors identified by data mining can predict the prognosis of head and neck squamous cell carcinoma.
Carcinoma
A potential role of heat shock proteins and nicotinamide N-methyl transferase in predicting response to radiation in bladder cancer.
Carcinoma
A prognostic 11 long noncoding RNA expression signature for breast invasive carcinoma.
Carcinoma
A radiosensitivity MiRNA signature validated by the TCGA database for head and neck squamous cell carcinomas.
Carcinoma
A risk score system based on DNA methylation levels and a nomogram survival model for lung squamous cell carcinoma.
Carcinoma
A seven long-noncoding RNA signature predicts prognosis of lung squamous cell carcinoma.
Carcinoma
A six-gene expression signature related to angiolymphatic invasion is associated with poor survival in laryngeal squamous cell carcinoma.
Carcinoma
A six-mRNA prognostic model to predict survival in head and neck squamous cell carcinoma.
Carcinoma
A tale of two cancers: Complete genetic analysis of chromophobe renal cell carcinoma contrasts with clear cell renal cell carcinoma.
Carcinoma
A three-lncRNA signature derived from the Atlas of ncRNA in cancer (TANRIC) database predicts the survival of patients with head and neck squamous cell carcinoma.
Carcinoma
A Transcriptomic Analysis of Head and Neck Squamous Cell Carcinomas for Prognostic Indications.
Carcinoma
Aberrations of Chromosomes 1 and 16 in Breast Cancer: A Framework for Cooperation of Transcriptionally Dysregulated Genes.
Carcinoma
Accounting for differential variability in detecting differentially methylated regions.
Carcinoma
ADAMTS16 mutations sensitize ovarian cancer cells to platinum-based chemotherapy.
Carcinoma
ADH7, miR-3065 and LINC01133 are associated with cervical cancer progression in different age groups.
Carcinoma
Adjuvant therapy for high-risk renal cell carcinoma after nephrectomy how many trials are positive? Only one or more than one.
Carcinoma
Adverse Drug Event-based Stratification of Tumor Mutations: A Case Study of Breast Cancer Patients Receiving Aromatase Inhibitors.
Carcinoma
AKT3 Is a Novel Regulator of Cancer-Associated Fibroblasts in Head and Neck Squamous Cell Carcinoma.
Carcinoma
Amplification of the bromodomain-containing protein 4 gene in ovarian high-grade serous carcinoma is associated with worse prognosis and survival.
Carcinoma
Amplification of the ch19p13.2 NACC1 locus in ovarian high-grade serous carcinoma.
Carcinoma
An autophagy-related long non-coding RNA prognostic signature accurately predicts survival outcomes in bladder urothelial carcinoma patients.
Carcinoma
An eight-mRNA signature predicts the prognosis of patients with bladder urothelial carcinoma.
Carcinoma
An eleven gene molecular signature for extra-capsular spread in oral squamous cell carcinoma serves as a prognosticator of outcome in patients without nodal metastases.
Carcinoma
An improved clear cell renal cell carcinoma stage prediction model based on gene sets.
Carcinoma
An integrative genomic approach identifies p73 and p63 as activators of miR-200 microRNA family transcription.
Carcinoma
Analysis of bladder cancer tumor CpG methylation and gene expression within The Cancer Genome Atlas identifies
Carcinoma
Analysis of mutational signatures in primary and metastatic endometrial cancer reveals distinct patterns of DNA repair defects and shifts during tumor progression.
Carcinoma
Analysis of renal cancer cell lines from two major resources enables genomics-guided cell line selection.
Carcinoma
Analysis of The Cancer Genome Atlas sequencing data reveals novel properties of the human papillomavirus 16 genome in head and neck squamous cell carcinoma.
Carcinoma
Analysis of the Role and Regulation Mechanism of hsa-miR-147b in Lung Squamous Cell Carcinoma Based on The Cancer Genome Atlas Database.
Carcinoma
Anatomic distribution of supraclavicular lymph node in patients with esophageal cancer.
Carcinoma
APOBEC-mediated cytosine deamination links PIK3CA helical domain mutations to human papillomavirus-driven tumor development.
Carcinoma
Apoptosis signaling molecules as treatment targets in head and neck squamous cell carcinoma.
Carcinoma
APPL1 promotes the migration of gastric cancer cells by regulating Akt2 phosphorylation.
Carcinoma
Assessing reliability of intra-tumor heterogeneity estimates from single sample whole exome sequencing data.
Carcinoma
Assessment for prognostic value of differentially expressed genes in immune microenvironment of clear cell renal cell carcinoma.
Carcinoma
Assessment of Renal Cell Carcinoma by Texture Analysis in Clinical Practice: A Six-Site, Six-Platform Analysis of Reliability.
Carcinoma
Association between immunotherapy biomarkers and glucose metabolism from F-18 FDG PET.
Carcinoma
Associations between proteasomal activator PA28? and outcome of oral squamous cell carcinoma: Evidence from cohort studies and functional analyses.
Carcinoma
Atlas of the thoracic lymph nodal delineation and recommendations for lymph nodal CTV of esophageal squamous cell cancer in radiation therapy from China.
Carcinoma
ATLAS OF TRANSBRONCHIAL BIOPSY: Early Diagnosis of Peripheral Pulmonary Carcinomas.
Carcinoma
ATLAS trial of adjuvant axitinib in patients with renal cell carcinoma: subgroup analyses with focus on axitinib dosing and racial groups.
Carcinoma
Atlas-based delineation of lymph node levels in head and neck computed tomography images.
Carcinoma
Automatic upstaging of tongue squamous cell carcinoma with lateral extrinsic muscle involvement is not justified.
Carcinoma
aWCluster: A Novel Integrative Network-based Clustering of Multiomics for Subtype Analysis of Cancer Data.
Carcinoma
Axitinib versus placebo as an adjuvant treatment of renal cell carcinoma: results from the phase III, randomized ATLAS trial.
Carcinoma
BAP1 is Overexpressed in Black Compared with White patients with Mx-M1 Clear Cell Renal Cell Carcinoma: A report from the Cancer Genome Atlas.
Carcinoma
Beyond conventional chemotherapy: Emerging molecular targeted and immunotherapy strategies in urothelial carcinoma.
Carcinoma
Binning somatic mutations based on biological knowledge for predicting survival: an application in renal cell carcinoma.
Carcinoma
Bioinformatic Exploration for Prognostic Significance of Sphingolipid Metabolism-Related Genes in Invasive Ductal Carcinoma Using the Cancer Genome Atlas Cohort.
Carcinoma
Bioinformatics analyses of the differences between lung adenocarcinoma and squamous cell carcinoma using The Cancer Genome Atlas expression data.
Carcinoma
Bioinformatics analysis of gene expression profiles of esophageal squamous cell carcinoma.
Carcinoma
Bioinformatics analysis suggests that COL4A1 may play an important role in gastric carcinoma recurrence.
Carcinoma
Biomarker Screening and Prognostic Significance Analysis for Renal Cell Carcinoma.
Carcinoma
BRCA1 immunohistochemistry in a molecularly characterized cohort of ovarian high-grade serous carcinomas.
Carcinoma
Cancer-Specific Production of N-Acetylaspartate via NAT8L Overexpression in Non-Small Cell Lung Cancer and Its Potential as a Circulating Biomarker.
Carcinoma
Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.
Carcinoma
CanDrA: cancer-specific driver missense mutation annotation with optimized features.
Carcinoma
Caspase 4 Overexpression as a Prognostic Marker in Clear Cell Renal Cell Carcinoma: A Study Based on the Cancer Genome Atlas Data Mining.
Carcinoma
CDK11p110 plays a critical role in the tumorigenicity of esophageal squamous cell carcinoma cells and is a potential drug target.
Carcinoma
Characterization of functionally active gene fusions in human papillomavirus related oropharyngeal squamous cell carcinoma.
Carcinoma
Characterization of the immune profile of oral tongue squamous cell carcinomas with advancing disease.
Carcinoma
Chromatin-regulatory genes served as potential therapeutic targets for patients with urothelial bladder carcinoma.
Carcinoma
Classifying non-small cell lung cancer types and transcriptomic subtypes using convolutional neural networks.
Carcinoma
Clear Cell Papillary Renal Cell Carcinoma Shares Distinct Molecular Characteristics and may be Significantly Associated With Higher Risk of Developing Second Primary Malignancy.
Carcinoma
Clinical and genetic signatures of local recurrence in oral squamous cell carcinoma.
Carcinoma
Clinical applications of The Cancer Genome Atlas project (TCGA) for squamous cell lung carcinoma.
Carcinoma
Clinical signi?cance and prognostic value of SOX7 expression in liver and pancreatic carcinoma.
Carcinoma
Clinical Significance and the Role of Guanylate-Binding Protein 5 in Oral Squamous Cell Carcinoma.
Carcinoma
Combined Transcriptome and Proteome Analysis of Immortalized Human Keratinocytes Expressing Human Papillomavirus 16 (HPV16) Oncogenes Reveals Novel Key Factors and Networks in HPV-Induced Carcinogenesis.
Carcinoma
Combining DNA methylation and RNA sequencing data of cancer for supervised knowledge extraction.
Carcinoma
Comparing gene expression data from formalin-fixed, paraffin embedded tissues and qPCR with that from snap-frozen tissue and microarrays for modeling outcomes of patients with ovarian carcinoma.
Carcinoma
Comprehensive Analysis of Aberrantly Expressed Profiles of lncRNAs and miRNAs with Associated ceRNA Network in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Carcinoma
Comprehensive analysis of ceRNA networks in HPV16- and HPV18-mediated cervical cancers reveals XIST as a pivotal competing endogenous RNA.
Carcinoma
Comprehensive Analysis of Driver Genes in Personal Genomes of Clear Cell Renal Cell Carcinoma.
Carcinoma
Comprehensive analysis of prognostic alternative splicing signature in cervical cancer.
Carcinoma
Comprehensive Analysis of the ATP-binding Cassette Subfamily B Across Renal Cancers Identifies ABCB8 Overexpression in Phenotypically Aggressive Clear Cell Renal Cell Carcinoma.
Carcinoma
Comprehensive analysis of The Cancer Genome Atlas reveals a unique gene and non-coding RNA signature of fibrolamellar carcinoma.
Carcinoma
Comprehensive analysis of the lncRNA-miRNA-mRNA regulatory network for bladder cancer.
Carcinoma
Comprehensive Analysis of the PD-L1 and Immune Infiltrates of m6A RNA Methylation Regulators in Head and Neck Squamous Cell Carcinoma.
Carcinoma
Comprehensive characterization of tumor mutation burden in clear cell renal cell carcinoma based on the three independent cohorts.
Carcinoma
Comprehensive Computational Pathological Image Analysis Predicts Lung Cancer Prognosis.
Carcinoma
Comprehensive genomic characterization of head and neck squamous cell carcinomas.
Carcinoma
Comprehensive Transcriptomic Analysis Identifies ST8SIA1 as a Survival-Related Sialyltransferase Gene in Breast Cancer.
Carcinoma
Computational analysis of fused co-expression networks for the identification of candidate cancer gene biomarkers.
Carcinoma
Consensus Recommendations for Radiation Therapy Contouring and Treatment of Vulvar Carcinoma.
Carcinoma
Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients.
Carcinoma
Copy number variability analysis of pharmacogenes in patients with lymphoma, leukemia, hepatocellular, and lung carcinoma using The Cancer Genome Atlas data.
Carcinoma
CORO6 Promotes Cell Growth and Invasion of Clear Cell Renal Cell Carcinoma via Activation of WNT Signaling.
Carcinoma
CREB targets define the gene expression signature of malignancies having reduced levels of the tumor suppressor tristetraprolin.
Carcinoma
Cytoplasmic Pattern p53 Immunoexpression in Pelvic and Endometrial Carcinomas With TP53 Mutation Involving Nuclear Localization Domains: An Uncommon But Potential Diagnostic Pitfall With Clinical Implications.
Carcinoma
da Vinci robotic partial nephrectomy for renal cell carcinoma: an atlas of the four-arm technique.
Carcinoma
Deciphering Genomic Underpinnings of Quantitative MRI-based Radiomic Phenotypes of Invasive Breast Carcinoma.
Carcinoma
Decreased expression of SLC16A12 mRNA predicts poor prognosis of patients with clear cell renal cell carcinoma.
Carcinoma
Deep Learning Predicts Molecular Subtype of Muscle-invasive Bladder Cancer from Conventional Histopathological Slides.
Carcinoma
Deep-Hipo: Multi-scale receptive field deep learning for histopathological image analysis.
Carcinoma
Delta-like ligand-Notch1 signalling is selectively modulated by HPV16 E6 to promote squamous cell proliferation and correlates with cervical cancer prognosis.
Carcinoma
Deregulated microRNAs Are Associated with Patient Survival and Predicted to Target Genes That Modulate Lung Cancer Signaling Pathways.
Carcinoma
Development and validation of an autophagy-related prognostic signature in esophageal cancer.
Carcinoma
Development of a novel six-long noncoding RNA signature predicting survival of patients with bladder urothelial carcinoma.
Carcinoma
Diagnosis value of aberrantly expressed microRNA profiles in lung squamous cell carcinoma: a study based on the Cancer Genome Atlas.
Carcinoma
Diagnostic and prognostic biomarkers of common urological cancers based on aberrant DNA methylation.
Carcinoma
Diagnostic model of combined ceRNA and DNA methylation related genes in esophageal carcinoma.
Carcinoma
Diagnostic value of a comprehensive, urothelial carcinoma-specific next-generation sequencing panel in urine cytology and bladder tumor specimens.
Carcinoma
Diagnostic Variation in p53 Usage for Endometrial Carcinoma Diagnosis: Implications for Molecular Subtyping.
Carcinoma
Differences in gastric carcinoma microenvironment stratify according to EBV infection intensity: implications for possible immune adjuvant therapy.
Carcinoma
Differential expression analysis of clear cell renal cell carcinomas in THE CANCER GENOME ATLAS distinguishes an aggressive subset enriched with chromosome 7 and 12 gains.
Carcinoma
Differential expression of critical cellular genes in human lung adenocarcinomas and squamous cell carcinomas in comparison to normal lung tissues.
Carcinoma
Differential Interactome Proposes Subtype-Specific Biomarkers and Potential Therapeutics in Renal Cell Carcinomas.
Carcinoma
Differentially expressed autophagy-related genes are potential prognostic and diagnostic biomarkers in clear-cell renal cell carcinoma.
Carcinoma
Differentiating rectal carcinoma by an immunohistological analysis of carcinomas of pelvic organs based on the NCBI Literature Survey and the Human Protein Atlas database.
Carcinoma
Digital Immune-Related Gene Expression Signatures In High-Grade Serous Ovarian Carcinoma: Developing Prediction Models For Platinum Response.
Carcinoma
Disruption of TP63-miR-27a* feedback loop by mutant TP53 in head and neck cancer.
Carcinoma
Distinct preoperative clinical features predict four histopathological subtypes of high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum.
Carcinoma
DNA methylation of metallothionein genes is associated with the clinical features of renal cell carcinoma.
Carcinoma
DNA methylation profiling reveals novel diagnostic biomarkers in renal cell carcinoma.
Carcinoma
Downregulation of miR-374b-5p promotes chemotherapeutic resistance in pancreatic cancer by upregulating multiple anti-apoptotic proteins.
Carcinoma
Dysregulation of miR-200 family microRNAs and epithelial-mesenchymal transition markers in oral squamous cell carcinoma.
Carcinoma
Dysregulation of the miRNA biogenesis components DICER1, DROSHA, DGCR8 and AGO2 in clear cell renal cell carcinoma in both a Korean cohort and the cancer genome atlas kidney clear cell carcinoma cohort.
Carcinoma
EARN: an ensemble machine learning algorithm to predict driver genes in metastatic breast cancer.
Carcinoma
Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS).
Carcinoma
Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma.
Carcinoma
Elevated ZNF703 Protein Expression Is an Independent Unfavorable Prognostic Factor for Survival of the Patients with Head and Neck Squamous Cell Carcinoma.
Carcinoma
Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma.
Carcinoma
Enhanced immortalization, HUWE1 mutations and other biological drivers of breast invasive carcinoma in Black/African American patients.
Carcinoma
Epstein-Barr Virus-Associated Gastric Carcinoma and Specific Features of the Accompanying Immune Response.
Carcinoma
ESCC ATLAS: A population wide compendium of biomarkers for Esophageal Squamous Cell Carcinoma.
Carcinoma
ESR1-stabilizing lncRNA TMPO-AS1 promotes hormone-refractory breast cancer progression.
Carcinoma
Estrogen receptor alpha (ER?/ESR1) mediates the p53-independent overexpression of MDM4/MDMX and MDM2 in human breast cancer.
Carcinoma
Evaluation of human tissue kallikrein-related peptidases 6 and 10 expression in early gastroesophageal adenocarcinoma.
Carcinoma
Evaluation of somatic copy number estimation tools for whole-exome sequencing data.
Carcinoma
Evaluation of the Risk of Grade 3 Oral and Pharyngeal Dysphagia Using Atlas-Based Method and Multivariate Analyses of Individual Patient Dose Distributions.
Carcinoma
Evidence for APOBEC3B mRNA and protein expression in oral squamous cell carcinomas.
Carcinoma
Expression and clinical value of CD105 in renal cell carcinoma based on data mining in The Cancer Genome Atlas.
Carcinoma
Expression and clinicopathological implication of DcR3 in lung cancer tissues: a tissue microarray study with 365 cases.
Carcinoma
Expression and Regulatory Network Analysis of MiR-139-3p, a New Potential Serum Biomarker for Esophageal Squamous Cell Carcinoma Based on Bioinformatics Analysis.
Carcinoma
Expression of lactate/H? symporters MCT1 and MCT4 and their chaperone CD147 predicts tumor progression in clear cell renal cell carcinoma: immunohistochemical and The Cancer Genome Atlas data analyses.
Carcinoma
Expression of miR-1304 in patients with esophageal carcinoma and risk factors for recurrence.
Carcinoma
Expression of NGF family and their receptors in gastric carcinoma: a cDNA microarray study.
Carcinoma
Expression of PAM50 Genes in Lung Cancer: Evidence that Interactions between Hormone Receptors and HER2/HER3 Contribute to Poor Outcome.
Carcinoma
Expression of SUMO1P3 Compared with SUMO1 is an Independent Predictor of Patient Outcome in Lung Adenocarcinoma.
Carcinoma
Expression of the receptor for hyaluronic acid mediated motility (RHAMM) is associated with poor prognosis and metastasis in non-small cell lung carcinoma.
Carcinoma
Expression profile analysis of head and neck squamous cell carcinomas using data from The Cancer Genome Atlas.
Carcinoma
EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells.
Carcinoma
Factor analysis for survival time prediction with informative censoring and diverse covariates.
Carcinoma
Favorable outcome of patients with lung adenocarcinoma harboring POLE mutations and expressing high PD-L1.
Carcinoma
FBXW7 deletion contributes to lung tumor development and confers resistance to gefitinib therapy.
Carcinoma
Feasibility of lung cancer RNA acquisition from a single transbronchial or transthoracic needle pass (FASTT trial).
Carcinoma
Fibroblast growth factor receptor 3 protein is overexpressed in oral and oropharyngeal squamous cell carcinoma.
Carcinoma
Fifteen-gene expression based model predicts the survival of clear cell renal cell carcinoma.
Carcinoma
Five extracellular matrix-associated genes upregulated in oral tongue squamous cell carcinoma: An integrated bioinformatics analysis.
Carcinoma
For robust big data analyses: a collection of 150 important pro-metastatic genes.
Carcinoma
FOXF2 promoter methylation is associated with prognosis in esophageal squamous cell carcinoma.
Carcinoma
FOXI1 expression in chromophobe renal cell carcinoma and renal oncocytoma: a study of The Cancer Genome Atlas transcriptome-based outlier mining and immunohistochemistry.
Carcinoma
FOXL2 expression might be a novel prognostic biomarker in patients with laryngeal squamous cell carcinoma.
Carcinoma
Frequent KRAS Mutations in Oncocytic Papillary Renal Neoplasm with Inverted Nuclei.
Carcinoma
G3BP1 may serve as a potential biomarker of proliferation, apoptosis, and prognosis in oral squamous cell carcinoma.
Carcinoma
Gender-specific Stratification of Survival Following Immune Checkpoint Inhibitor Therapy Based on Intratumoral Expression of a B cell Gene Signature.
Carcinoma
Gene expression patterns associated with tumor-infiltrating CD4+ and CD8+ T cells in invasive breast carcinomas.
Carcinoma
Gene expression profile in oral squamous cell carcinomas and matching normal oral mucosal tissues from black Africans and white Caucasians: the case of the Sudan vs. Norway.
Carcinoma
Gene networks and expression quantitative trait loci associated with adjuvant chemotherapy response in high-grade serous ovarian cancer.
Carcinoma
Gene promoter-associated CpG island hypermethylation in squamous cell carcinoma of the tongue.
Carcinoma
Genetic alteration in notch pathway is associated with better prognosis in renal cell carcinoma.
Carcinoma
Genetic analysis of microglandular adenosis and acinic cell carcinomas of the breast provides evidence for the existence of a low-grade triple-negative breast neoplasia family.
Carcinoma
Genetic defects of the IRF1-mediated major histocompatibility complex class I antigen presentation pathway occur prevalently in the
Carcinoma
Genetic Variants Were Associated With the Prognosis of Head and Neck Squamous Carcinoma.
Carcinoma
Genome-Wide CRISPR Screen Reveals Cancer Cell Resistance to NK Cells Induced by NK-Derived IFN-?.
Carcinoma
Genome-wide discovery of viral microRNAs based on phylogenetic analysis and structural evolution of various human papillomavirus subtypes.
Carcinoma
Genome-Wide Profiling of Acquired Uniparental Disomy Reveals Prognostic Factors in Head and Neck Squamous Cell Carcinoma.
Carcinoma
Genomic alterations in gynecological malignancies: histotype-associated driver mutations, molecular subtyping schemes, and tumorigenic mechanisms.
Carcinoma
Genomic and Transcriptomic Characterization Links Cell Lines with Aggressive Head and Neck Cancers.
Carcinoma
Genomic Characterization of Renal Cell Carcinoma with Sarcomatoid Dedifferentiation Pinpoints Recurrent Genomic Alterations.
Carcinoma
Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas.
Carcinoma
Global Analysis of Microbiota Signatures in Four Major Types of Gastrointestinal Cancer.
Carcinoma
HAO2 inhibits malignancy of clear cell renal cell carcinoma by promoting lipid catabolic process.
Carcinoma
HEDGEHOG/GLI Modulates the PRR11-SKA2 Bidirectional Transcription Unit in Lung Squamous Cell Carcinomas.
Carcinoma
Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinoma.
Carcinoma
High expression of DLL3 is associated with a poor prognosis and immune infiltration in invasive breast cancer patients.
Carcinoma
High KRT8 Expression Independently Predicts Poor Prognosis for Lung Adenocarcinoma Patients.
Carcinoma
High-affinity peptide ligand LXY30 for targeting ?3?1 integrin in non-small cell lung cancer.
Carcinoma
High-resolution profiling of histone h3 lysine 36 trimethylation in metastatic renal cell carcinoma.
Carcinoma
Higher programmed cell death 1 ligand 1 (PD-L1) mRNA level in clear cell renal cell carcinomas is associated with a favorable outcome due to the active immune responses in tumor tissues.
Carcinoma
Histone deacetylase inhibitor-induced cell death in bladder cancer is associated with chromatin modification and modifying protein expression: A proteomic approach.
Carcinoma
Histopathological Terminology Standards for the Reporting of Prostatic Epithelial Lesions in Dogs.
Carcinoma
Hormone Receptor-Status Prediction in Breast Cancer Using Gene Expression Profiles and Their Macroscopic Landscape.
Carcinoma
hsegHMM: hidden Markov model-based allele-specific copy number alteration analysis accounting for hypersegmentation.
Carcinoma
Hypermethylation of the PTTG1IP promoter leads to low expression in early-stage non-small cell lung cancer.
Carcinoma
Hypoxic stress suppresses lung tumor-secreted exosomal miR101 to activate macrophages and induce inflammation.
Carcinoma
Identification and analysis of long non-coding RNA related miRNA sponge regulatory network in bladder urothelial carcinoma.
Carcinoma
Identification of 9-Core Immune-Related Genes in Bladder Urothelial Carcinoma Prognosis.
Carcinoma
Identification of a 26-lncRNAs Risk Model for Predicting Overall Survival of Cervical Squamous Cell Carcinoma Based on Integrated Bioinformatics Analysis.
Carcinoma
Identification of a Four Hypoxia-Associated Long Non-Coding RNA Signature and Establishment of a Nomogram Predicting Prognosis of Clear Cell Renal Cell Carcinoma.
Carcinoma
Identification of a Gene Prognostic Signature for Oral Squamous Cell Carcinoma by RNA Sequencing and Bioinformatics.
Carcinoma
Identification of a Human Papillomavirus-Associated Oncogenic miRNA Panel in Human Oropharyngeal Squamous Cell Carcinoma Validated by Bioinformatics Analysis of The Cancer Genome Atlas.
Carcinoma
Identification of a Novel Immune-Related Prognostic Biomarker and Small-Molecule Drugs in Clear Cell Renal Cell Carcinoma (ccRCC) by a Merged Microarray-Acquired Dataset and TCGA Database.
Carcinoma
Identification of a novel six-gene signature with potential prognostic and therapeutic value in cervical cancer.
Carcinoma
Identification of a six-gene signature associated with tumor mutation burden for predicting prognosis in patients with invasive breast carcinoma.
Carcinoma
Identification of a universal 6-lncRNA prognostic signature for three pathologic subtypes of renal cell carcinoma.
Carcinoma
Identification of an 11-Autophagy-Related-Gene Signature as Promising Prognostic Biomarker for Bladder Cancer Patients.
Carcinoma
Identification of an immune-related long non-coding RNA signature and nomogram as prognostic target for muscle-invasive bladder cancer.
Carcinoma
Identification of an lncRNA?miRNA?mRNA interaction mechanism in breast cancer based on bioinformatic analysis.
Carcinoma
Identification of an m6A-Related lncRNA Signature for Predicting the Prognosis in Patients With Kidney Renal Clear Cell Carcinoma.
Carcinoma
Identification of Candidate Genes Associated with Susceptibility to Ovarian Clear Cell Adenocarcinoma Using cis-eQTL Analysis.
Carcinoma
Identification of DNA methylation-driven genes in esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas.
Carcinoma
Identification of four methylation-driven genes as candidate biomarkers for monitoring single-walled carbon nanotube-induced malignant transformation of the lung.
Carcinoma
Identification of Genetic and Epigenetic Variants Associated with Breast Cancer Prognosis by Integrative Bioinformatics Analysis.
Carcinoma
Identification of immune-enhanced molecular subtype associated with BRCA1 mutations, immune checkpoints and clinical outcome in ovarian carcinoma.
Carcinoma
Identification of ITGA3 as an Oncogene in Human Tongue Cancer via Integrated Bioinformatics Analysis.
Carcinoma
Identification of key classification features of early cervical squamous cell carcinoma.
Carcinoma
Identification of key genes and microRNA regulatory network in development and progression of urothelial bladder carcinoma.
Carcinoma
Identification of Key Genes in Association with Progression and Prognosis in Cervical Squamous Cell Carcinoma.
Carcinoma
Identification of Key Genes Related to Lung Squamous Cell Carcinoma Using Bioinformatics Analysis.
Carcinoma
Identification of lncRNA functions in lung cancer based on associated protein-protein interaction modules.
Carcinoma
Identification of methylation-driven genes related to the prognosis of papillary renal cell carcinoma: a study based on The Cancer Genome Atlas.
Carcinoma
Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
Carcinoma
Identification of molecular targets for esophageal carcinoma diagnosis using miRNA-seq and RNA-seq data from The Cancer Genome Atlas: a study of 187 cases.
Carcinoma
Identification of PGRMC1 as a Candidate Oncogene for Head and Neck Cancers and Its Involvement in Metabolic Activities.
Carcinoma
Identification of Prognosis Associated microRNAs in HNSCC Subtypes Based on TCGA Dataset.
Carcinoma
Identification of prognostic marker genes in head and neck squamous cell carcinoma: A study based on The Cancer Genome Atlas database and experimental validation.
Carcinoma
Identification of prognostic microRNA candidates for head and neck squamous cell carcinoma.
Carcinoma
Identification of prognostic miRNA biomarkers for esophageal cancer based on The Cancer Genome Atlas and Gene Expression Omnibus.
Carcinoma
Identification of Significant Gene Signatures and Prognostic Biomarkers for Patients With Cervical Cancer by Integrated Bioinformatic Methods.
Carcinoma
Identification of specific feed-forward apoptosis mechanisms and associated higher survival rates for low grade glioma and lung squamous cell carcinoma.
Carcinoma
Identification of topological features in renal tumor microenvironment associated with patient survival.
Carcinoma
Identifying cancer type specific oncogenes and tumor suppressors using limited size data.
Carcinoma
Identifying Clear Cell Renal Cell Carcinoma Coexpression Networks Associated with Opioid Signaling and Survival.
Carcinoma
Identifying molecular genetic features and oncogenic pathways of clear cell renal cell carcinoma through the anatomical (PADUA) scoring system.
Carcinoma
Identifying prognostic biomarkers of non-small cell lung cancer by transcriptome analysis.
Carcinoma
Identifying the clonal origin of synchronous multifocal tumors in the hepatobiliary and pancreatic system using multi-omic platforms.
Carcinoma
IGF2BP2 Polymorphisms Are Associated with Clinical Characteristics and Development of Oral Cancer.
Carcinoma
Imaging-genomic pipeline for identifying gene mutations using three-dimensional intra-tumor heterogeneity features.
Carcinoma
Imaging-Genomic Study of Head and Neck Squamous Cell Carcinoma: Associations Between Radiomic Phenotypes and Genomic Mechanisms via Integration of The Cancer Genome Atlas and The Cancer Imaging Archive.
Carcinoma
Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment.
Carcinoma
Immune-Inhibitory Gene Expression is Positively Correlated with Overall Immune Activity and Predicts Increased Survival Probability of Cervical and Head and Neck Cancer Patients.
Carcinoma
Impact of endothelial nitric oxide synthase polymorphisms on urothelial cell carcinoma development.
Carcinoma
Impact of Gene Polymorphisms in GAS5 on Urothelial Cell Carcinoma Development and Clinical Characteristics.
Carcinoma
Impact of genetic alterations on outcomes of patients with stage I nonsmall cell lung cancer: An analysis of the cancer genome atlas data.
Carcinoma
Impact of novel oncogenic pathways regulated by antitumor miR-451a in renal cell carcinoma.
Carcinoma
Improving target volume delineation in intact cervical carcinoma: Literature review and step-by-step pictorial atlas to aid contouring.
Carcinoma
In silico analysis of differential gene expressions in biliary stricture and hepatic carcinoma.
Carcinoma
In silico analysis reveals a shared immune signature in CASP8-mutated carcinomas with varying correlations to prognosis.
Carcinoma
Incorporating genetic networks into case-control association studies with high-dimensional DNA methylation data.
Carcinoma
Increased expression of RUNX1 in clear cell renal cell carcinoma predicts poor prognosis.
Carcinoma
Increased Expression of TICRR Predicts Poor Clinical Outcomes: A Potential Therapeutic Target for Papillary Renal Cell Carcinoma.
Carcinoma
Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma.
Carcinoma
Inferring gene expression networks with hubs using a degree weighted Lasso approach.
Carcinoma
Inhibition of MIR4435-2HG on Invasion, Migration, and EMT of Gastric Carcinoma Cells by Mediating MiR-138-5p/Sox4 Axis.
Carcinoma
Insights into Impact of DNA Copy Number Alteration and Methylation on the Proteogenomic Landscape of Human Ovarian Cancer via a Multi-omics Integrative Analysis.
Carcinoma
Insights into the Genetic Basis of the Renal Cell Carcinomas from The Cancer Genome Atlas.
Carcinoma
Integrated analysis of deregulation microRNA expression in head and neck squamous cell carcinoma.
Carcinoma
Integrated analysis of the prognostic values of RNA-binding proteins in head and neck squamous cell carcinoma.
Carcinoma
Integrated genomic analysis identifies subclasses and prognosis signatures of kidney cancer.
Carcinoma
Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer.
Carcinoma
Integrating multi-platform genomic datasets for kidney renal clear cell carcinoma subtyping using stacked denoising autoencoders.
Carcinoma
Integrating omics data and protein interaction networks to prioritize driver genes in cancer.
Carcinoma
Integrative analysis of DNA methylation and gene expression in papillary renal cell carcinoma.
Carcinoma
Integrative analysis of genetic and epigenetic profiling of lung squamous cell carcinoma (LSCC) patients to identify smoking level relevant biomarkers.
Carcinoma
Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4/MUC16/MUC20 signature is associated with poor survival in human carcinomas.
Carcinoma
Integrative Epigenetic and Gene Expression Analysis of Renal Tumor Progression to Metastasis.
Carcinoma
Integrative Genomic and Transcriptomic Analyses of Tumor Suppressor Genes and Their Role on Tumor Microenvironment and Immunity in Lung Squamous Cell Carcinoma.
Carcinoma
Integrative Histologic and Bioinformatics Analysis of BIRC5/Survivin Expression in Oral Squamous Cell Carcinoma.
Carcinoma
Integrative omics analysis reveals effective stratification and potential prognosis markers of pan-gastrointestinal cancers.
Carcinoma
Integrin ?1 orchestrates the abnormal cell-matrix attachment and invasive behaviour of E-cadherin dysfunctional cells.
Carcinoma
Interference of tumour mutational burden with outcome of patients with head and neck cancer treated with definitive chemoradiation: a multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group.
Carcinoma
Interferon-?-induced p27KIP1 binds to and targets MYC for proteasome-mediated degradation.
Carcinoma
Investigating resistin like beta (RETNLB) as a tumor promoter for oral squamous cell carcinoma.
Carcinoma
IPI59: An Actionable Biomarker to Improve Treatment Response in Serous Ovarian Carcinoma Patients.
Carcinoma
Kidney cancer: Creating a molecular atlas of clear cell renal cell carcinoma genetics.
Carcinoma
LAMC1 upregulation via TGF? induces inflammatory cancer-associated fibroblasts in esophageal squamous cell carcinoma via NF-?B-CXCL1-STAT3.
Carcinoma
Landscape of expression profiles in esophageal carcinoma by The Cancer Genome Atlas data.
Carcinoma
LAT, HOXD3 and NFE2L3 identified as novel DNA methylation-driven genes and prognostic markers in human clear cell renal cell carcinoma by integrative bioinformatics approaches.
Carcinoma
LGALS4 as a Prognostic Factor in Urothelial Carcinoma of Bladder Affects Cell Functions.
Carcinoma
LINC02738 Participates in the Development of Kidney Cancer Through the miR-20b/Sox4 Axis.
Carcinoma
LncNetP, a systematical lncRNA prioritization approach based on ceRNA and disease phenotype association assumptions.
Carcinoma
LncRNA MALAT1 functions as a competing endogenous RNA to regulate ZEB2 expression by sponging miR-200s in clear cell kidney carcinoma.
Carcinoma
LncRNA PCAT6: A potential biomarker for diagnosis and prognosis of bladder cancer.
Carcinoma
Long non-coding RNA FAM66C is associated with clinical progression and promotes cell proliferation by inhibiting proteasome pathway in prostate cancer.
Carcinoma
Long non-coding RNA Linc00152 is a positive prognostic factor for and demonstrates malignant biological behavior in clear cell renal cell carcinoma.
Carcinoma
Long non-coding RNA MEG3 suppresses the development of bladder urothelial carcinoma by regulating miR-96 and TPM1.
Carcinoma
Long non-coding RNA WT1-AS inhibits cell aggressiveness via miR-203a-5p/FOXN2 axis and is associated with prognosis in cervical cancer.
Carcinoma
Long non?coding RNA SNHG1 promotes breast cancer progression by regulation of LMO4.
Carcinoma
Long noncoding RNA PVT1 inhibits renal cancer cell apoptosis by up-regulating Mcl-1.
Carcinoma
Loss of ALDH1A1 expression is an early event in the pathogenesis of ovarian high-grade serous carcinoma.
Carcinoma
Low Expression Levels of SLC22A12 Indicates a Poor Prognosis and Progresses Clear Cell Renal Cell Carcinoma.
Carcinoma
Low microRNA150 expression is associated with activated carcinogenic pathways and a poor prognosis in patients with breast cancer.
Carcinoma
LOXL2 Expression Status Is Correlated With Molecular Characterizations of Cervical Carcinoma and Associated With Poor Cancer Survival via Epithelial-Mesenchymal Transition (EMT) Phenotype.
Carcinoma
LRRC19-A Bridge between Selenium Adjuvant Therapy and Renal Clear Cell Carcinoma: A Study Based on Datamining.
Carcinoma
Lymph node metastasis in lung squamous cell carcinoma and identification of metastasis-related genes based on the Cancer Genome Atlas.
Carcinoma
m6A demethylase FTO facilitates tumor progression in lung squamous cell carcinoma by regulating MZF1 expression.
Carcinoma
Matrix-metalloproteinases in head and neck carcinoma-cancer genome atlas analysis and fluorescence imaging in mice.
Carcinoma
MCTS1 Directly Binds to TWF1 and Synergistically Modulate Cyclin D1 and C-Myc Translation in Luminal A/B Breast Cancer Cells.
Carcinoma
MDM2 gene amplification as selection tool for innovative targeted approaches in PD-L1 positive or negative muscle-invasive urothelial bladder carcinoma.
Carcinoma
Medullary carcinoma of the colon: a distinct morphology reveals a distinctive immunoregulatory microenvironment.
Carcinoma
Methylation of RAD51B, XRCC3 and other homologous recombination genes is associated with expression of immune checkpoints and an inflammatory signature in squamous cell carcinoma of the head and neck, lung and cervix.
Carcinoma
Methylation Signature Genes Identification of the Lung Squamous Cell Carcinoma Occurrence and Recognition Research.
Carcinoma
MicroRNA hsa-mir-3923 serves as a diagnostic and prognostic biomarker for gastric carcinoma.
Carcinoma
MicroRNA-211 Enhances the Oncogenicity of Carcinogen-Induced Oral Carcinoma by Repressing TCF12 and Increasing Antioxidant Activity.
Carcinoma
Mining TCGA database for screening and identification of hub genes in kidney renal clear cell carcinoma microenvironment.
Carcinoma
Mining The Cancer Genome Atlas gene expression data for lineage markers in distinguishing bladder urothelial carcinoma and prostate adenocarcinoma.
Carcinoma
miR-195 targets cyclin D3 and survivin to modulate the tumorigenesis of non-small cell lung cancer.
Carcinoma
miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
Carcinoma
miRNA-target gene regulatory networks: A Bayesian integrative approach to biomarker selection with application to kidney cancer.
Carcinoma
MKP-1 is required to limit myeloid-cell mediated oral squamous cell carcinoma progression and regional extension.
Carcinoma
MNX1-AS1 is a novel biomarker for predicting clinical progression and poor prognosis in lung adenocarcinoma.
Carcinoma
Model establishment of prognostic-related immune genes in laryngeal squamous cell carcinoma.
Carcinoma
Molecular Alterations of TP53 are a Defining Feature of Ovarian High-Grade Serous Carcinoma: A Rereview of Cases Lacking TP53 Mutations in The Cancer Genome Atlas Ovarian Study.
Carcinoma
Molecular characteristics of primary pulmonary lymphoepithelioma-like carcinoma based on integrated genomic analyses.
Carcinoma
Molecular pathogenesis of renal cell carcinoma: Impact of the anti-tumor miR-29 family on gene regulation.
Carcinoma
Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma.
Carcinoma
MUC1-C integrates activation of the IFN-? pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer.
Carcinoma
Multi-Omics Integrative Analysis Uncovers Molecular Subtypes and mRNAs as Therapeutic Targets for Liver Cancer.
Carcinoma
Mutations in DNA repair genes are associated with increased neoantigen burden and a distinct immunophenotype in lung squamous cell carcinoma.
Carcinoma
Mutations in genes connected with the TCF7L2 transcription factor are associated with a poor prognosis in non-small cell lung cancer.
Carcinoma
MYCT1 Inhibits the Adhesion and Migration of Laryngeal Cancer Cells Potentially Through Repressing Collagen VI.
Carcinoma
NCALD affects drug resistance and prognosis by acting as a ceRNA of CX3CL1 in ovarian cancer.
Carcinoma
NEIL1 p.Gln282Stop variant is predominantly localized in the cytoplasm and exhibits reduced activity in suppressing mutations.
Carcinoma
NF-kappa B Signaling-Related Signatures Are Connected with the Mesenchymal Phenotype of Circulating Tumor Cells in Non-Metastatic Breast Cancer.
Carcinoma
NFAT Overexpression Correlates with CA72-4 and Poor Prognosis of Ovarian Clear-Cell Carcinoma Subtype.
Carcinoma
Nicotine and oxidative stress induced exomic variations are concordant and overrepresented in cancer-associated genes.
Carcinoma
Nicotine promotes the development of non-small cell lung cancer through activating LINC00460 and PI3K/Akt signaling.
Carcinoma
Notch Signaling Activation Is Associated with Patient Mortality and Increased FGF1-Mediated Invasion in Squamous Cell Carcinoma of the Oral Cavity.
Carcinoma
Notch3 interactome analysis identified WWP2 as a negative regulator of Notch3 signaling in ovarian cancer.
Carcinoma
Oncogenic Chromatin Modifier KAT2A Activates MCT1 to Drive the Glycolytic Process and Tumor Progression in Renal Cell Carcinoma.
Carcinoma
Otoferlin is a prognostic biomarker in patients with clear cell renal cell carcinoma: A systematic expression analysis.
Carcinoma
Overexpression of B7-H4 promotes renal cell carcinoma progression by recruiting tumor-associated neutrophils via upregulation of CXCL8.
Carcinoma
Overexpression of BMP1 reflects poor prognosis in clear cell renal cell carcinoma.
Carcinoma
Overexpression of G6PD Represents a Potential Prognostic Factor in Clear Cell Renal Cell Carcinoma.
Carcinoma
Overexpression of ICAM-1 Predicts Poor Survival in High-Grade Serous Ovarian Carcinoma: A Study Based on TCGA and GEO Databases and Tissue Microarray.
Carcinoma
p53-inducible gene 3 promotes cell migration and invasion by activating the FAK/Src pathway in lung adenocarcinoma.
Carcinoma
PAK1 expression determines poor prognosis and immune evasion in metastatic renal cell carcinoma patients.
Carcinoma
Para-aortic lymph node metastasis in lower Thoracic Esophageal Squamous Cell Carcinoma after Radical Esophagectomy: a CT-based atlas and its clinical implications for Adjuvant Radiotherapy.
Carcinoma
Pathomic Fusion: An Integrated Framework for Fusing Histopathology and Genomic Features for Cancer Diagnosis and Prognosis.
Carcinoma
PD-L1 Expression in Endometrial Carcinoma Cells and Intratumoral Immune Cells: Differences Across Histologic and TCGA-based Molecular Subgroups.
Carcinoma
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma.
Carcinoma
PHENOTYPIC CHARACTERIZATION OF BREAST INVASIVE CARCINOMA VIA TRANSFERABLE TISSUE MORPHOMETRIC PATTERNS LEARNED FROM GLIOBLASTOMA MULTIFORME.
Carcinoma
Phospho?STAT1 expression as a potential biomarker for anti?PD?1/anti?PD?L1 immunotherapy for breast cancer.
Carcinoma
PINCAGE: Probabilistic integration of cancer genomics data for perturbed gene identification and sample classification.
Carcinoma
Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image features.
Carcinoma
Prediction of head and neck squamous cell carcinoma survival based on the expression of 15 lncRNAs.
Carcinoma
Predictive modeling using a somatic mutational profile in ovarian high grade serous carcinoma.
Carcinoma
Predictive value of single-nucleotide polymorphism signature for recurrence in localised renal cell carcinoma: a retrospective analysis and multicentre validation study.
Carcinoma
Predictive value of WHO classification for PD-L1 and Her2/Neu expression and distinct associations with protein expression based classification in gastric carcinoma.
Carcinoma
Primary Renal Paragangliomas and Renal Neoplasia Associated with Pheochromocytoma/Paraganglioma: Analysis of von Hippel-Lindau (VHL), Succinate Dehydrogenase (SDHX) and Transmembrane Protein 127 (TMEM127).
Carcinoma
Profile of sphingolipid-related genes and its association with prognosis highlights sphingolipid metabolism in oral cancer.
Carcinoma
Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC.
Carcinoma
Profiling of differentially expressed genes in human gastric carcinoma by cDNA expression array.
Carcinoma
Prognostic alternative splicing signatures and underlying regulatory network in esophageal carcinoma.
Carcinoma
Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers.
Carcinoma
Prognostic gene signature identification using causal structure learning: applications in kidney cancer.
Carcinoma
Prognostic microRNA signatures derived from The Cancer Genome Atlas for head and neck squamous cell carcinomas.
Carcinoma
Prognostic role of PHYH for overall survival (OS) in clear cell renal cell carcinoma (ccRCC).
Carcinoma
Prognostic signature associated with radioresistance in head and neck cancer via transcriptomic and bioinformatic analyses.
Carcinoma
Prognostic significance of an invasive leader cell-derived mutation cluster on chromosome 16q.
Carcinoma
Prognostic value of aberrantly expressed methylation gene profiles in lung squamous cell carcinoma: A study based on The Cancer Genome Atlas.
Carcinoma
Prognostic value of long noncoding RNA urothelial carcinoma-associated 1 in esophageal carcinoma: A protocol for meta-analysis, TCGA data and bioinformatics analysis.
Carcinoma
Prognostic Value of RNASEH2A-, CDK1-, and CD151-Related Pathway Gene Profiling for Kidney Cancers.
Carcinoma
Protein tyrosine phosphatase, receptor type B is a potential biomarker and facilitates cervical cancer metastasis via epithelial-mesenchymal transition.
Carcinoma
Proteomic analysis of colon and rectal carcinoma using standard and customized databases.
Carcinoma
Proteomic Analysis of Ubiquitin Ligase KEAP1 Reveals Associated Proteins That Inhibit NRF2 Ubiquitination.
Carcinoma
PTRF/CAVIN1, regulated by SHC1 through the EGFR pathway, is found in urine exosomes as a potential biomarker of ccRCC.
Carcinoma
QKI, a miR-200 target gene, suppresses epithelial-to-mesenchymal transition and tumor growth.
Carcinoma
Quantitative tumour necrosis is an independent predictor of overall survival in clear cell renal cell carcinoma.
Carcinoma
Radiomic analysis identifies tumor subtypes associated with distinct molecular and microenvironmental factors in head and neck squamous cell carcinoma.
Carcinoma
Rapidly and Slowly Growing Lineages in Chromosomal Instability-Type Gland-Forming Gastric Carcinomas as Revealed by Multisampling Analysis of DNA Copy-Number Profile.
Carcinoma
Re: Axitinib versus Placebo as an Adjuvant Treatment of Renal Cell Carcinoma: Results from the Phase III, Randomized ATLAS Trial.
Carcinoma
Recent advances in genitourinary tumors: A review focused on biology and systemic treatment.
Carcinoma
Reciprocal loop of hypoxia-inducible factor-1? (HIF-1?) and metastasis-associated protein 2 (MTA2) contributes to the progression of pancreatic carcinoma by suppressing E-cadherin transcription.
Carcinoma
Reconstruction and analysis of circRNA?miRNA?mRNA network in the pathology of cervical cancer.
Carcinoma
Renal cell tumors with clear cell histology and intact VHL and chromosome 3p: a histological review of tumors from the Cancer Genome Atlas database.
Carcinoma
Replisome genes regulation by antitumor miR-101-5p in clear cell renal cell carcinoma.
Carcinoma
Revealing Biological Pathways Implicated in Lung Cancer from TCGA Gene Expression Data Using Gene Set Enrichment Analysis.
Carcinoma
RIPK2 is an unfavorable prognosis marker and a potential therapeutic target in human kidney renal clear cell carcinoma.
Carcinoma
RNA Sequencing of Collecting Duct Renal Cell Carcinoma Suggests an Interaction between miRNA and Target Genes and a Predominance of Deregulated Solute Carrier Genes.
Carcinoma
Robust identification of target genes and outliers in triple-negative breast cancer data.
Carcinoma
Role of EphB3 Receptor in Mediating Head and Neck Tumor Growth, Cell Migration, and Response to PI3K Inhibitor.
Carcinoma
Role of pre-miR-532 (miR-532-5p and miR-532-3p) in regulation of gene expression and molecular pathogenesis in renal cell carcinoma.
Carcinoma
Screening and Identification of an Immune-Associated lncRNA Prognostic Signature in Ovarian Carcinoma: Evidence from Bioinformatic Analysis.
Carcinoma
Short-term RANKL exposure initiates a neoplastic transcriptional program in the basal epithelium of the murine salivary gland.
Carcinoma
SigFuge: single gene clustering of RNA-seq reveals differential isoform usage among cancer samples.
Carcinoma
Signaling Complexity Measured by Shannon Entropy and Its Application in Personalized Medicine.
Carcinoma
SLAMF7 Signaling Reprograms T Cells toward Exhaustion in the Tumor Microenvironment.
Carcinoma
SMAC Mimetic Birinapant plus Radiation Eradicates Human Head and Neck Cancers with Genomic Amplifications of Cell Death Genes FADD and BIRC2.
Carcinoma
Smoking correlates with increased cytoskeletal protein-related coding region mutations in the lung and head and neck datasets of the cancer genome atlas.
Carcinoma
Smoking status, usual adult occupation, and risk of recurrent urothelial bladder carcinoma: data from The Cancer Genome Atlas (TCGA) Project.
Carcinoma
Somatic mutations favorable to patient survival are predominant in ovarian carcinomas.
Carcinoma
Somatic Mutations in miRNA Genes in Lung Cancer-Potential Functional Consequences of Non-Coding Sequence Variants.
Carcinoma
SPC25 upregulation increases cancer stem cell properties in non-small cell lung adenocarcinoma cells and independently predicts poor survival.
Carcinoma
Specific DNA methylation markers in the diagnosis and prognosis of esophageal cancer.
Carcinoma
Stable and discriminating radiomic predictor of recurrence in early stage non-small cell lung cancer: Multi-site study.
Carcinoma
STIP1 down-regulation inhibits glycolysis by suppressing PKM2 and LDHA and inactivating the Wnt/?-catenin pathway in cervical carcinoma cells.
Carcinoma
Stress-triggered atavistic reprogramming (STAR) addiction: driving force behind head and neck cancer?
Carcinoma
Stromal tumor-infiltrating lymphocytes evaluated on H&E-stained slides are an independent prognostic factor in epithelial ovarian cancer and ovarian serous carcinoma.
Carcinoma
Study of the G Protein Nucleolar 2 Value in Liver Hepatocellular Carcinoma Treatment and Prognosis.
Carcinoma
Study on Attenuating Angiogenesis and Epithelial-Mesenchymal Transition (EMT) of Non-Small Cell Lung Carcinoma (NSCLC) by Regulating MAGEC2.
Carcinoma
Study on HOXBs of Clear Cell Renal Cell Carcinoma and Detection of New Molecular Target.
Carcinoma
SUMO1P3 is associated clinical progression and facilitates cell migration and invasion through regulating miR-136 in non-small cell lung cancer.
Carcinoma
Suppression of cleavage factor Im 25 promotes the proliferation of lung cancer cells through alternative polyadenylation.
Carcinoma
Survival analysis for long noncoding RNAs identifies TP53TG1 as an antioncogenic target for the breast cancer.
Carcinoma
Synthesis of diagnostic quality cancer pathology images by generative adversarial networks.
Carcinoma
Systematic analysis of survival-associated alternative splicing signatures in clear cell renal cell carcinoma.
Carcinoma
Systematic Chromatin Accessibility Analysis Based on Different Immunological Subtypes of Clear Cell Renal Cell Carcinoma.
Carcinoma
Systematic profiling identifies PDLIM2 as a novel prognostic predictor for oesophageal squamous cell carcinoma (ESCC).
Carcinoma
Targeted Imaging of the Atypical Chemokine Receptor 3 (ACKR3/CXCR7) in Human Cancer Xenografts.
Carcinoma
Targeting fibroblast growth factor receptors and immune checkpoint inhibitors for the treatment of advanced bladder cancer: New direction and New Hope.
Carcinoma
Targeting POLE2 Creates a Novel Vulnerability in Renal Cell Carcinoma via Modulating Stanniocalcin 1.
Carcinoma
TCF19 contributes to cell proliferation of non-small cell lung cancer by inhibiting FOXO1.
Carcinoma
TCGA based integrated genomic analyses of ceRNA network and novel subtypes revealing potential biomarkers for the prognosis and target therapy of tongue squamous cell carcinoma.
Carcinoma
TFEB-VEGFA (6p21.1) co-amplified renal cell carcinoma: a distinct entity with potential implications for clinical management.
Carcinoma
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.
Carcinoma
The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications.
Carcinoma
The CNPY2 enhances epithelial-mesenchymal transition via activating the AKT/GSK3? pathway in non-small cell lung cancer.
Carcinoma
The Combined Detection of Immune Genes for Predicting the Prognosis of Patients With Non-Small Cell Lung Cancer.
Carcinoma
The construction and analysis of competitive endogenous RNA (ceRNA) networks in metastatic renal cell carcinoma: a study based on The Cancer Genome Atlas.
Carcinoma
The conundrum of the Epstein-Barr virus-associated gastric carcinoma in the Americas.
Carcinoma
The Early Diagnostic and Prognostic Value of BIRC5 in Clear-Cell Renal Cell Carcinoma Based on the Cancer Genome Atlas Data.
Carcinoma
The evolution of endometrial carcinoma classification through application of immunohistochemistry and molecular diagnostics: past, present and future.
Carcinoma
The genomic alterations of lung adenocarcinoma and lung squamous cell carcinoma can explain the differences of their overall survival rates.
Carcinoma
The impact of estimated tumour purity on gene expression-based drug repositioning of Clear Cell Renal Cell Carcinoma samples.
Carcinoma
The Impact of Normalization Approaches to Automatically Detect Radiogenomic Phenotypes Characterizing Breast Cancer Receptors Status.
Carcinoma
The impact on high-grade serous ovarian cancer of obesity and lipid metabolism-related gene expression patterns: the underestimated driving force affecting prognosis.
Carcinoma
The long non-coding RNA LINC00460 predicts the prognosis and promotes the proliferation and migration of cells in bladder urothelial carcinoma.
Carcinoma
The long noncoding RNA urothelial carcinoma-associated 1 overexpression as a poor prognostic biomarker in clear cell renal cell carcinoma.
Carcinoma
The management of localized esophageal squamous cell carcinoma: Western approach.
Carcinoma
The modularity and dynamicity of miRNA-mRNA interactions in high-grade serous ovarian carcinomas and the prognostic implication.
Carcinoma
The molecular landscape of the University of Michigan laryngeal squamous cell carcinoma cell line panel.
Carcinoma
The natural compound neobractatin inhibits tumor metastasis by upregulating the RNA-binding-protein MBNL2.
Carcinoma
The oncogenic potentials and diagnostic significance of long non-coding RNA LINC00310 in breast cancer.
Carcinoma
The potential of biologic network models in understanding the etiopathogenesis of ovarian cancer.
Carcinoma
The prognostic and predictive value of tumor infiltrating Macrophage and Neutrophil in patient with clear cell renal cell carcinoma: Tumor infiltrating lymphocytes in renal cell carcinoma.
Carcinoma
The prognostic landscape of tumor-infiltrating immune cell and immunomodulators in lung cancer.
Carcinoma
The prognostic value and potential subtypes of immune activity scores in three major urological cancers.
Carcinoma
The tumor immune microenvironmental analysis of 2,033 transcriptomes across 7 cancer types.
Carcinoma
Tobacco Smoking-Associated Alterations in the Immune Microenvironment of Squamous Cell Carcinomas.
Carcinoma
Toward the precision breast cancer survival prediction utilizing combined whole genome-wide expression and somatic mutation analysis.
Carcinoma
TP53 hot spot mutations in ovarian cancer: selective resistance to microtubule stabilizers in vitro and differential survival outcomes from The Cancer Genome Atlas.
Carcinoma
TP53 mutations and CDKN2A mutations/deletions are highly recurrent molecular alterations in the malignant progression of sinonasal papillomas.
Carcinoma
TP53 Mutations in Head and Neck Squamous Cell Carcinoma and Their Impact on Disease Progression and Treatment Response.
Carcinoma
TP53 Status, Patient Sex, and the Immune Response as Determinants of Lung Cancer Patient Survival.
Carcinoma
TPX2 as a prognostic indicator and potential therapeutic target in clear cell renal cell carcinoma.
Carcinoma
Transcription Factors BARX1 and DLX4 Contribute to Progression of Clear Cell Renal Cell Carcinoma via Promoting Proliferation and Epithelial-Mesenchymal Transition.
Carcinoma
Transcription factors CP2 and YY1 as prognostic markers in head and neck squamous cell carcinoma: analysis of The Cancer Genome Atlas and a second independent cohort.
Carcinoma
Transcription of human papillomavirus oncogenes in head and neck squamous cell carcinomas.
Carcinoma
Transcriptome analysis reveals the effect of oral contraceptive use on cervical cancer.
Carcinoma
Transcriptome Based Estrogen Related Genes Biomarkers for Diagnosis and Prognosis in Non-small Cell Lung Cancer.
Carcinoma
Transcriptomics analysis for the identification of potential age-related genes and cells associated with three major urogenital cancers.
Carcinoma
TRIM2 downregulation in clear cell renal cell carcinoma affects cell proliferation, migration, and invasion and predicts poor patients' survival.
Carcinoma
TRIM59 as a novel molecular biomarker to predict the prognosis of patients with NSCLC.
Carcinoma
Tumor CDKN2A-Associated JAK2 Loss and Susceptibility to Immunotherapy Resistance.
Carcinoma
Tumor immune microenvironment-based classifications of bladder cancer for enhancing the response rate of immunotherapy.
Carcinoma
Tumors masquerading as type 2 papillary renal cell carcinoma: pathologists' ever-expanding differential diagnosis for a heterogeneous group of entities.
Carcinoma
Tyrosine Kinase c-MET as Therapeutic Target for Radiosensitization of Head and Neck Squamous Cell Carcinomas.
Carcinoma
Ubiquitination of PPAR-gamma by pVHL inhibits ACLY expression and lipid metabolism, is implicated in tumor progression.
Carcinoma
Unsupervised Resolution of Histomorphologic Heterogeneity in Renal Cell Carcinoma Using a Brain Tumor-Educated Neural Network.
Carcinoma
Update on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine Tumours.
Carcinoma
Upregulated glycolysis correlates with tumor progression and immune evasion in head and neck squamous cell carcinoma.
Carcinoma
Upregulated long-non-coding RNA DLEU2 exon 9 expression was an independent indicator of unfavorable overall survival in patients with esophageal adenocarcinoma.
Carcinoma
Upregulated VEGFA and DLL4 act as potential prognostic genes for clear cell renal cell carcinoma.
Carcinoma
Urothelial Carcinoma Detection Based on Copy Number Profiles of Urinary Cell-Free DNA by Shallow Whole-Genome Sequencing.
Carcinoma
Validation of Selected Head and Neck Cancer Prognostic Markers from the Pathology Atlas in an Oral Tongue Cancer Cohort.
Carcinoma
VSTM2A Overexpression Is a Sensitive and Specific Biomarker for Mucinous Tubular and Spindle Cell Carcinoma (MTSCC) of the Kidney.
Carcinoma
WBP2 promotes BTRC mRNA stability to drive migration and invasion in triple-negative breast cancer via NF-?B activation.
Carcinoma
Weighted gene co-expression network analysis in identification of metastasis-related genes of lung squamous cell carcinoma based on the Cancer Genome Atlas database.
Carcinoma
Whole exome sequencing and deep sequencing of esophageal squamous cell carcinoma and adenocarcinoma in Japanese patients using the Japanese version of the Genome Atlas, JCGA.
Carcinoma
Whole transcriptome targeted gene quantification provides new insights on pulmonary sarcomatoid carcinomas.
Carcinoma
Whole-Exome Sequencing Identifies Somatic Mutations Associated With Mortality in Metastatic Clear Cell Kidney Carcinoma.
Carcinoma
Whole-transcriptome sequencing identified gene expression signatures associated with aggressive clear cell renal cell carcinoma.
Carcinoma
Widespread alternative exon usage in clinically distinct subtypes of Invasive Ductal Carcinoma.
Carcinoma
[Data mining of esophageal squamous cell carcinoma from The Cancer Genome Atlas database].
Carcinoma
[Expression and Clinical Significance of Late Endosomal/Lysosomal Adaptor,Mitogen-activated Protein Kinase and Mammalian Target of Rapamycin Activator 3 in Bladder Carcinoma].
Carcinoma
[Implications of TCGA Network Data on 2nd Generation Immunotherapy Concepts Based on PD-L1 and PD-1 Target Structures].
Carcinoma
[In situ carcinoma; considerations on Hinselmann's 32 theories and Mestwerdt's Atlas of colposcopy.]
Carcinoma
[In situ carcinoma; considerations on Hinselmann's 32 theories and on Mestwerdt's Atlas of colposcopy.]
Carcinoma
[Study on the Difference of Gene Expression between Central and Peripheral Lung Squamous Cell Carcinoma Based on TCGA Database].
Carcinoma, Acinar Cell
Genetic analysis of microglandular adenosis and acinic cell carcinomas of the breast provides evidence for the existence of a low-grade triple-negative breast neoplasia family.
Carcinoma, Ductal
Bioinformatic Exploration for Prognostic Significance of Sphingolipid Metabolism-Related Genes in Invasive Ductal Carcinoma Using the Cancer Genome Atlas Cohort.
Carcinoma, Ductal
Comprehensive analysis of long non-coding RNAs in human breast cancer clinical subtypes.
Carcinoma, Ductal
DNASE1L2, as a Carcinogenic Marker, Affects the Phenotype of Breast Cancer Cells Via Regulating Epithelial-Mesenchymal Transition Process.
Carcinoma, Ductal
Loss of amphiregulin reduces myoepithelial cell coverage of mammary ducts and alters breast tumor growth.
Carcinoma, Ductal
Prognostic microRNA/mRNA signature from the integrated analysis of patients with invasive breast cancer.
Carcinoma, Ductal
Similarities and Differences in Gene Expression Networks Between the Breast Cancer Cell Line Michigan Cancer Foundation-7 and Invasive Human Breast Cancer Tissues.
Carcinoma, Ductal
SYK allelic loss and the role of Syk-regulated genes in breast cancer survival.
Carcinoma, Ductal
The Landscape of Somatic Genetic Alterations in Metaplastic Breast Carcinomas.
Carcinoma, Ductal
Widespread alternative exon usage in clinically distinct subtypes of Invasive Ductal Carcinoma.
Carcinoma, Endometrioid
Clinicopathological analysis of endometrial carcinomas harboring somatic POLE exonuclease domain mutations.
Carcinoma, Endometrioid
DNMT3A/3B overexpression might be correlated with poor patient survival, hypermethylation and low expression of ESR1/PGR in endometrioid carcinoma: an analysis of The Cancer Genome Atlas.
Carcinoma, Endometrioid
Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists.
Carcinoma, Endometrioid
Glucose-regulated protein 94 deficiency induces squamous cell metaplasia and suppresses PTEN-null driven endometrial epithelial tumor development.
Carcinoma, Hepatocellular
A five lncRNA signature for prognosis prediction in hepatocellular carcinoma.
Carcinoma, Hepatocellular
A human liver cell atlas reveals heterogeneity and epithelial progenitors.
Carcinoma, Hepatocellular
A metabolism-related gene signature for predicting the prognosis and therapeutic responses in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
A novel prognostic models for identifying the risk of hepatocellular carcinoma based on epithelial-mesenchymal transition-associated genes.
Carcinoma, Hepatocellular
A Primer on a Hepatocellular Carcinoma Bioresource Bank Using the Cancer Genome Atlas Guidelines: Practical Issues and Pitfalls.
Carcinoma, Hepatocellular
A prognostic model composed of four long noncoding RNAs predicts the overall survival of Asian patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
A Prognostic Model of 15 Immune-Related Gene Pairs Associated With Tumor Mutation Burden for Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
A qRT-PCR and Gene Functional Enrichment Study Focused on Downregulation of miR-141-3p in Hepatocellular Carcinoma and Its Clinicopathological Significance.
Carcinoma, Hepatocellular
A Seven-microRNA Expression Signature Predicts Survival in Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Aberrant KIF20A expression might independently predict poor overall survival and recurrence-free survival of hepatocellular carcinoma.
Carcinoma, Hepatocellular
An ancestry informative marker panel design for individual ancestry estimation of Hispanic population using whole exome sequencing data.
Carcinoma, Hepatocellular
Analysis of m6A RNA Methylation-Related Genes in Liver Hepatocellular Carcinoma and Their Correlation with Survival.
Carcinoma, Hepatocellular
Analysis of the Cancer Genome Atlas Data Reveals Novel Putative ncRNAs Targets in Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Analysis of the cancer genome atlas data to determine the correlation between PROX1 and TERT in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma.
Carcinoma, Hepatocellular
AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma.
Carcinoma, Hepatocellular
Bioinformatic analysis of the prognostic value of the lncRNAs encoding snoRNAs in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Bioinformatics analysis of the interactions among lncRNA, miRNA and mRNA expression, genetic mutations and epigenetic modifications in hepatocellular carcinoma.
Carcinoma, Hepatocellular
CASC15 promotes epithelial to mesenchymal transition and facilitates malignancy of hepatocellular carcinoma cells by increasing TWIST1 gene expression via miR-33a-5p sponging.
Carcinoma, Hepatocellular
Characterization of Hepatocellular Carcinoma Cell Lines Using a Fractionation-Then-Sequencing Approach Reveals Nuclear-Enriched HCC-Associated lncRNAs.
Carcinoma, Hepatocellular
Cinobufagin Triggers Defects in Spindle Formation and Cap-Dependent Translation in Liver Cancer Cells by Inhibiting the AURKA-mTOR-eIF4E Axis.
Carcinoma, Hepatocellular
Circulating Exosomal MicroRNA-1307-5p as a Predictor for Metastasis in Patients with Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Clinical significance of APOB inactivation in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Clinical Significance of TRMT6 in Hepatocellular Carcinoma: A Bioinformatics-Based Study.
Carcinoma, Hepatocellular
Comprehensive analysis of potential immunotherapy genomic biomarkers in 1000 Chinese patients with cancer.
Carcinoma, Hepatocellular
Comprehensive analysis of tumour mutation burden and the immune microenvironment in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Computational analysis of fused co-expression networks for the identification of candidate cancer gene biomarkers.
Carcinoma, Hepatocellular
Correlation of zinc finger protein 2, a prognostic biomarker, with immune infiltrates in liver cancer.
Carcinoma, Hepatocellular
CRIF1 overexpression facilitates tumor growth and metastasis through inducing ROS/NF?B pathway in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Data mining of the expression and regulatory role of BCAT1 in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Decreased expression of ARID1A invasively downregulates the expression of ribosomal proteins in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Deregulation of the Genes that Are Involved in Drug Absorption, Distribution, Metabolism, and Excretion in Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Development and External Validation of a Novel Immune Checkpoint-Related Gene Signature for Prediction of Overall Survival in Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Development of an Aerobic Glycolysis Index for Predicting the Sorafenib Sensitivity and Prognosis of Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Diagnostic and prognostic roles of IRAK1 in hepatocellular carcinoma tissues: an analysis of immunohistochemistry and RNA-sequencing data from the cancer genome atlas.
Carcinoma, Hepatocellular
Disturbed mitochondrial acetylation in accordance with the availability of acetyl groups in hepatocellular carcinoma.
Carcinoma, Hepatocellular
DNA methylation changes involved in the tumor increase in F2 males born to gestationally arsenite-exposed F1 male mice.
Carcinoma, Hepatocellular
DPM1 expression as a potential prognostic tumor marker in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Effects of a 2,3-oxidosqualene-lanosterol cyclase inhibitor 2,3:22,23-dioxidosqualene and 24,25-epoxycholesterol on the regulation of cholesterol biosynthesis in human hepatoma cell line HepG2.
Carcinoma, Hepatocellular
EGFRvIII-specific CAR-T cells produced by piggyBac transposon exhibit efficient growth suppression against hepatocellular carcinoma.
Carcinoma, Hepatocellular
Elevated high mobility group A2 expression in liver cancer predicts poor patient survival.
Carcinoma, Hepatocellular
EMT-related long non-coding RNA in hepatocellular carcinoma: A study with TCGA database.
Carcinoma, Hepatocellular
Examination of Independent Prognostic Power of Gene Expressions and Histopathological Imaging Features in Cancer.
Carcinoma, Hepatocellular
Exploring the Role of Endoplasmic Reticulum Stress in Hepatocellular Carcinoma through mining of the Human Protein Atlas.
Carcinoma, Hepatocellular
Expression and gene regulation network of RBM8A in hepatocellular carcinoma based on data mining.
Carcinoma, Hepatocellular
Expression of cell cycle/growth regulator genes in human hepatocellular carcinoma and adjacent normal liver tissues.
Carcinoma, Hepatocellular
Expression of genes that control core fucosylation in hepatocellular carcinoma: Systematic review.
Carcinoma, Hepatocellular
Expression of the Long Intergenic Non-Protein Coding RNA 665 (LINC00665) Gene and the Cell Cycle in Hepatocellular Carcinoma Using The Cancer Genome Atlas, the Gene Expression Omnibus, and Quantitative Real-Time Polymerase Chain Reaction.
Carcinoma, Hepatocellular
Expression of the Wnt ligands gene family and its relationship to prognosis in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Expression of yhwaz and gene regulation network in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Extracellular matrix transcriptome dynamics in hepatocellular carcinoma.
Carcinoma, Hepatocellular
For robust big data analyses: a collection of 150 important pro-metastatic genes.
Carcinoma, Hepatocellular
Four Immune-Related Long Non-coding RNAs for Prognosis Prediction in Patients With Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Gene Expression Profile and Prognostic Value of m6A RNA Methylation Regulators in Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Gene expression profiles of liver cancer cell lines reveal two hepatocyte-like and fibroblast-like clusters.
Carcinoma, Hepatocellular
Genetic Alterations and Transcriptional Expression of m6A RNA Methylation Regulators Drive a Malignant Phenotype and Have Clinical Prognostic Impact in Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.
Carcinoma, Hepatocellular
Genomic Identification of RNA Editing Through Integrating Omics Datasets and the Clinical Relevance in Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Gestational arsenite exposure augments hepatic tumors of C3H mice by promoting senescence in F1 and F2 offspring via different pathways.
Carcinoma, Hepatocellular
Glucosamine-6-Phosphate Isomerase 1 Promotes Tumor Progression and Indicates Poor Prognosis in Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
High expression of FOXO3 is associated with poor prognosis in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
High expression of PARD3 predicts poor prognosis in hepatocellular carcinoma.
Carcinoma, Hepatocellular
High miR-139-3p expression predicts a better prognosis for hepatocellular carcinoma: a pooled analysis.
Carcinoma, Hepatocellular
High MYBL2 expression and transcription regulatory activity is associated with poor overall survival in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
High Somatic Mutation and Neoantigen Burden Do Not Correlate with Decreased Progression-Free Survival in HCC Patients not Undergoing Immunotherapy.
Carcinoma, Hepatocellular
High Trophinin-Associated Protein Expression Is an Independent Predictor of Poor Survival in Liver Cancer.
Carcinoma, Hepatocellular
Higher variety and quantity of microRNA-139-5p isoforms confer suppressive role in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Huanglian decoction suppresses the growth of hepatocellular carcinoma cells by reducing CCNB1 expression.
Carcinoma, Hepatocellular
Hypermethylation of the PZP gene is associated with hepatocellular carcinoma cell proliferation, invasion and migration.
Carcinoma, Hepatocellular
Identification and Validation of Ubiquitin-Specific Proteases as a Novel Prognostic Signature for Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Identification of a Novel Epithelial-to-Mesenchymal-related Gene Signature in Predicting Survival of Patients with Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Identification of an eight-gene signature for survival prediction for patients with hepatocellular carcinoma based on integrated bioinformatics analysis.
Carcinoma, Hepatocellular
Identification of Energy Metabolism Genes for the Prediction of Survival in Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Identification of hepatocellular carcinoma-related genes associated with macrophage differentiation based on bioinformatics analyses.
Carcinoma, Hepatocellular
Identification of immune subtypes and prognosis of hepatocellular carcinoma based on immune checkpoint gene expression profile.
Carcinoma, Hepatocellular
Identification of immunological subtypes of hepatocellular carcinoma with expression profiling of immune-modulating genes.
Carcinoma, Hepatocellular
Identification of LINC01615 as potential metastasis-related long noncoding RNA in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Identification of Long Noncoding RNA Biomarkers for Hepatocellular Carcinoma Using Single-Sample Networks.
Carcinoma, Hepatocellular
Identification of Methylation-Regulated Differentially Expressed Genes and Related Pathways in Hepatocellular Carcinoma: A Study Based on TCGA Database and Bioinformatics Analysis.
Carcinoma, Hepatocellular
Identification of METTL3 as an Adverse Prognostic Biomarker in Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Identification of modules and novel prognostic biomarkers in liver cancer through integrated bioinformatics analysis.
Carcinoma, Hepatocellular
Identification of Potential Biomarkers From Hepatocellular Carcinoma With MT1 Deletion.
Carcinoma, Hepatocellular
Identification of Potential Prognostic Long Non-Coding RNA Biomarkers for Predicting Survival in Patients with Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Identification of potential prognostic microRNA biomarkers for predicting survival in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Identification of Rad51 as a prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Identifying the clonal origin of synchronous multifocal tumors in the hepatobiliary and pancreatic system using multi-omic platforms.
Carcinoma, Hepatocellular
Immune Cytolytic Activity for Comprehensive Understanding of Immune Landscape in Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Implications of driver genes associated with a high tumor mutation burden identified using next-generation sequencing on immunotherapy in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Insights into the etiology-associated gene regulatory networks in hepatocellular carcinoma from The Cancer Genome Atlas.
Carcinoma, Hepatocellular
Integrated analyses identify miR-34c-3p/MAGI3 axis for the Warburg metabolism in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Integrated analysis of competing endogenous RNA network revealing potential prognostic biomarkers of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Integrated analysis of hypoxia-induced miR-210 signature as a potential prognostic biomarker of hepatocellular carcinoma: a study based on The Cancer Genome Atlas.
Carcinoma, Hepatocellular
Integration of miRNA-regulatory networks in hepatic stellate cells identifies TIMP3 as a key factor in chronic liver disease.
Carcinoma, Hepatocellular
Integrin gene expression profiles of human hepatocellular carcinoma.
Carcinoma, Hepatocellular
Iron metabolism gene expression and prognostic features of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Knockdown of Anillin Actin Binding Protein Blocks Cytokinesis in Hepatocytes and Reduces Liver Tumor Development in Mice Without Affecting Regeneration.
Carcinoma, Hepatocellular
Knockdown of THOC1 reduces the proliferation of hepatocellular carcinoma and increases the sensitivity to cisplatin.
Carcinoma, Hepatocellular
Lactate-mediated mitoribosomal defects impair mitochondrial oxidative phosphorylation and promote hepatoma cell invasiveness.
Carcinoma, Hepatocellular
Lactic acidosis caused by repressed lactate dehydrogenase subunit B expression down-regulates mitochondrial oxidative phosphorylation via the pyruvate dehydrogenase (PDH)-PDH kinase axis.
Carcinoma, Hepatocellular
LI-RADS categorization of benign and likely benign findings in patients at risk of hepatocellular carcinoma: a pictorial atlas.
Carcinoma, Hepatocellular
LncRNA ROR1?AS1 high expression and its prognostic significance in liver cancer.
Carcinoma, Hepatocellular
Long Noncoding RNA LINC01134 Promotes Hepatocellular Carcinoma Metastasis via Activating AKT1S1 and NF-?B Signaling.
Carcinoma, Hepatocellular
Metabolic Pathways Enhancement Confers Poor Prognosis in p53 Exon Mutant Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients.
Carcinoma, Hepatocellular
Mir-1287 suppresses the proliferation, invasion, and migration in hepatocellular carcinoma by targeting PIK3R3.
Carcinoma, Hepatocellular
miR-142-3p inhibits aerobic glycolysis and cell proliferation in hepatocellular carcinoma via targeting LDHA.
Carcinoma, Hepatocellular
miR-3677-5p promotes the proliferation, migration and invasion of hepatocellular carcinoma cells and is associated with prognosis.
Carcinoma, Hepatocellular
miRNA-mRNA Regulatory Network and Factors Associated with Prediction of Prognosis in Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Mitochondrial Respiratory Defect Enhances Hepatoma Cell Invasiveness via STAT3/NFE2L1/STX12 Axis.
Carcinoma, Hepatocellular
Model based on five tumour immune microenvironment-related genes for predicting hepatocellular carcinoma immunotherapy outcomes.
Carcinoma, Hepatocellular
Modularity of the metabolic gene network as a prognostic biomarker for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Molecular characterization of long-term survivors of hepatocellular carcinoma.
Carcinoma, Hepatocellular
MRGBP is a potential novel prognostic biomarker and is correlated with immune infiltrates in hepatocellular carcinoma.
Carcinoma, Hepatocellular
NEpiC: a network-assisted algorithm for epigenetic studies using mean and variance combined signals.
Carcinoma, Hepatocellular
OCIAD2 suppressed tumor growth and invasion via AKT pathway in Hepatocelluar carcinoma.
Carcinoma, Hepatocellular
Over-expression of TFB2M facilitates cell growth and metastasis via activating ROS-Akt-NF-?B signaling in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Paradoxical effects of cellular senescence-inhibited gene involved in hepatocellular carcinoma migration and proliferation by ERK pathway and mesenchymal-like markers.
Carcinoma, Hepatocellular
PARP-1 serves as a novel molecular marker for hepatocellular carcinoma in a Southern Chinese Zhuang population.
Carcinoma, Hepatocellular
Plasma proteome atlas for differentiating tumor stage and post-surgical prognosis of hepatocellular carcinoma and cholangiocarcinoma.
Carcinoma, Hepatocellular
Potential clinical value and putative biological function of miR-122-5p in hepatocellular carcinoma: A comprehensive study using microarray and RNA sequencing data.
Carcinoma, Hepatocellular
Prognostic analysis of tumor mutation burden and immune infiltration in hepatocellular carcinoma based on TCGA data.
Carcinoma, Hepatocellular
Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers.
Carcinoma, Hepatocellular
Prognostic and immunological potential of PPM1G in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Prognostic implications of aberrantly expressed methylation?driven genes in hepatocellular carcinoma: A study based on The Cancer Genome Atlas.
Carcinoma, Hepatocellular
Prognostic roles of metabolic reprogramming-associated genes in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Prognostic value of carbonic anhydrase XII (CA XII) overexpression in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Prognostic Value of Phosphotyrosine Phosphatases in Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Prognostic value of ubiquitin-conjugating enzyme E2 S overexpression in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Protective effect of LNA-anti-miR-132 therapy on liver fibrosis in mice.
Carcinoma, Hepatocellular
Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase: search for the enzyme's repressor derived from mevalonate.
Carcinoma, Hepatocellular
Regulation of UDP-Glucuronosyltransferases UGT2B4 and UGT2B7 by MicroRNAs in Liver Cancer Cells.
Carcinoma, Hepatocellular
Serum deprivation-response protein induces apoptosis in hepatocellular carcinoma through ASK1-JNK/p38 MAPK pathways.
Carcinoma, Hepatocellular
Serum small extracellular vesicle-derived LINC00853 as a novel diagnostic marker for early hepatocellular carcinoma.
Carcinoma, Hepatocellular
Signatures of gene expression, DNA methylation and microRNAs of hepatocellular carcinoma with vascular invasion.
Carcinoma, Hepatocellular
Single-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Carcinoma, Hepatocellular
SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma.
Carcinoma, Hepatocellular
STAT3-induced upregulation of lncRNA CASC11 promotes the cell migration, invasion and epithelial-mesenchymal transition in hepatocellular carcinoma by epigenetically silencing PTEN and activating PI3K/AKT signaling pathway.
Carcinoma, Hepatocellular
Systematic analysis and prediction model construction of alternative splicing events in hepatocellular carcinoma: a study on the basis of large-scale spliceseq data from The Cancer Genome Atlas.
Carcinoma, Hepatocellular
Systemic Expression Analysis Reveals Prognostic Significance of WIPI3 in Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
T-cell immune regulator 1 enhances metastasis in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Testis-specific protein, Y-linked 1 activates PI3K/AKT and RAS signaling pathways through suppressing IGFBP3 expression during tumor progression.
Carcinoma, Hepatocellular
TGF?1- miR-140-5p axis mediated up-regulation of Flap Endonuclease 1 promotes epithelial-mesenchymal transition in hepatocellular carcinoma.
Carcinoma, Hepatocellular
The Cancer Genome Atlas (TCGA) based m6A methylation-related genes predict prognosis in hepatocellular carcinoma.
Carcinoma, Hepatocellular
The clinical significance of microRNA-122 in predicting the prognosis of patients with hepatocellular carcinoma: A meta-analysis validated by the Cancer Genome Atlas dataset.
Carcinoma, Hepatocellular
The diagnostic and prognostic value of H2AFY in hepatocellular carcinoma.
Carcinoma, Hepatocellular
The expression and prognostic value of GLYATL1 and its potential role in hepatocellular carcinoma.
Carcinoma, Hepatocellular
The HGF-MET axis coordinates liver cancer metabolism and autophagy for chemotherapeutic resistance.
Carcinoma, Hepatocellular
The overexpression and prognostic role of DCAF13 in hepatocellular carcinoma.
Carcinoma, Hepatocellular
TMEM206 is a potential prognostic marker of hepatocellular carcinoma.
Carcinoma, Hepatocellular
TMEM88, CCL14 and CLEC3B as prognostic biomarkers for prognosis and palindromia of human hepatocellular carcinoma.
Carcinoma, Hepatocellular
Transcriptomic analyses of RNA-binding proteins reveal eIF3c promotes cell proliferation in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Transcriptomic analysis links hepatocellular carcinoma (HCC) in HZE ion irradiated mice to a human HCC subtype with favorable outcomes.
Carcinoma, Hepatocellular
Transcriptomic and Proteomic Analysis of Steatohepatitic Hepatocellular Carcinoma Reveals Novel Distinct Biologic Features.
Carcinoma, Hepatocellular
Transforming Growth Factor Beta Promotes Liver Tumorigenesis in Mice via Upregulation of Snail.
Carcinoma, Hepatocellular
Tribbles pseudokinase 3 (TRIB3) contributes to the progression of hepatocellular carcinoma by activating the mitogen-activated protein kinase pathway.
Carcinoma, Hepatocellular
Tumor Fibroblast Growth Factor Receptor 4 Level Predicts the Efficacy of Lenvatinib in Patients With Advanced Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
UCK2 upregulation might serve as an indicator of unfavorable prognosis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Uncovering the potential differentially expressed miRNAs as diagnostic biomarkers for hepatocellular carcinoma based on machine learning in The Cancer Genome Atlas database.
Carcinoma, Hepatocellular
Upregulation of miR-200b Inhibits Hepatocellular Carcinoma Cell Proliferation and Migration by Targeting HMGB3 Protein.
Carcinoma, Hepatocellular
ZBP-89 and Sp1 contribute to Bak expression in hepatocellular carcinoma cells.
Carcinoma, Hepatocellular
[Exploring of a prognostic long non-coding RNA signature of hepatocellular carcinoma by using public database].
Carcinoma, Hepatocellular
[Integrated analysis of DNA methylation and gene expression profiles of hepatocellular carcinoma to construct miR-1180-3p relevant ceRNA regulatory network].
Carcinoma, Hepatocellular
[Studies on the role of chromobox protein homolog 2 in the inhibition of progression of hepatoma].
Carcinoma, Intraductal, Noninfiltrating
Characteristics of ultrasonographic images of ductal carcinoma in situ with abnormalities of the ducts.
Carcinoma, Intraductal, Noninfiltrating
SYK allelic loss and the role of Syk-regulated genes in breast cancer survival.
Carcinoma, Intraductal, Noninfiltrating
Whole-Exome Sequencing Analysis of the Progression from Non-Low-Grade Ductal Carcinoma In Situ to Invasive Ductal Carcinoma.
Carcinoma, Medullary
Medullary carcinoma of the colon: a distinct morphology reveals a distinctive immunoregulatory microenvironment.
Carcinoma, Non-Small-Cell Lung
A comprehensive analysis of the predicted targets of miR-642b-3p associated with the long non-coding RNA HOXA11-AS in NSCLC cells.
Carcinoma, Non-Small-Cell Lung
Association and clinical implication of the USP10 and MSH2 proteins in non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Association of MUC16 Mutation With Response to Immune Checkpoint Inhibitors in Solid Tumors.
Carcinoma, Non-Small-Cell Lung
Bioinformatics analysis of LINC00426 expression in lung cancer and its correlation with patients' prognosis.
Carcinoma, Non-Small-Cell Lung
Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.
Carcinoma, Non-Small-Cell Lung
Clinical Significance of miR-210 and its Prospective Signaling Pathways in Non-Small Cell Lung Cancer: Evidence from Gene Expression Omnibus and the Cancer Genome Atlas Data Mining with 2763 Samples and Validation via Real-Time Quantitative PCR.
Carcinoma, Non-Small-Cell Lung
Clinical value of miR-145-5p in NSCLC and potential molecular mechanism exploration: A retrospective study based on GEO, qRT-PCR, and TCGA data.
Carcinoma, Non-Small-Cell Lung
CNOT3 targets negative cell cycle regulators in non-small cell lung cancer development.
Carcinoma, Non-Small-Cell Lung
Comparison between atlas and convolutional neural network based automatic segmentation of multiple organs at risk in non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Contouring variations and the role of atlas in non-small cell lung cancer radiation therapy: Analysis of a multi-institutional preclinical trial planning study.
Carcinoma, Non-Small-Cell Lung
Distribution Atlas of Proliferating Bone Marrow in Non-Small Cell Lung Cancer Patients Measured by FLT-PET/CT Imaging, With Potential Applicability in Radiation Therapy Planning.
Carcinoma, Non-Small-Cell Lung
Erlotinib as maintenance therapy in patients with advanced non-small cell lung cancer: a pooled analysis of three randomized trials.
Carcinoma, Non-Small-Cell Lung
Expression and prognostic value of E2F3 transcription factor in non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Genetic defects of the IRF1-mediated major histocompatibility complex class I antigen presentation pathway occur prevalently in the
Carcinoma, Non-Small-Cell Lung
Identification of a MET-eIF4G1 translational regulation axis that controls HIF-1? levels under hypoxia.
Carcinoma, Non-Small-Cell Lung
Impact of genetic alterations on outcomes of patients with stage I nonsmall cell lung cancer: An analysis of the cancer genome atlas data.
Carcinoma, Non-Small-Cell Lung
Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma.
Carcinoma, Non-Small-Cell Lung
Long Noncoding RNA SNHG10 Sponges miR-543 to Upregulate Tumor Suppressive SIRT1 in Nonsmall Cell Lung Cancer.
Carcinoma, Non-Small-Cell Lung
Mining and validating the expression pattern and prognostic value of acetylcholine receptors in non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Molecular characteristics of non-small cell lung cancer with reduced CHFR expression in The Cancer Genome Atlas (TCGA) project.
Carcinoma, Non-Small-Cell Lung
Multi-omics integrative analysis and survival risk model construction of non-small cell lung cancer based on The Cancer Genome Atlas datasets.
Carcinoma, Non-Small-Cell Lung
Mutant-allele fraction heterogeneity is associated with non-small cell lung cancer patient survival.
Carcinoma, Non-Small-Cell Lung
Nicotine promotes the development of non-small cell lung cancer through activating LINC00460 and PI3K/Akt signaling.
Carcinoma, Non-Small-Cell Lung
PHLPP2 as a novel metastatic and prognostic biomarker in non-small cell lung cancer patients.
Carcinoma, Non-Small-Cell Lung
Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma.
Carcinoma, Non-Small-Cell Lung
Predicting Deep Learning Based Multi-Omics Parallel Integration Survival Subtypes in Lung Cancer Using Reverse Phase Protein Array Data.
Carcinoma, Non-Small-Cell Lung
Prognostic Value of the Tumor Immune Microenvironment for Early-stage, Non-Small Cell Lung Cancer.
Carcinoma, Non-Small-Cell Lung
pTuneos: prioritizing tumor neoantigens from next-generation sequencing data.
Carcinoma, Non-Small-Cell Lung
Role of Dusp6 Phosphatase as a Tumor Suppressor in Non-Small Cell Lung Cancer.
Carcinoma, Non-Small-Cell Lung
Semiparametric integrative interaction analysis for non-small-cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Silencing of CASC8 inhibits non-small cell lung cancer cells function and promotes sensitivity to osimertinib via FOXM1.
Carcinoma, Non-Small-Cell Lung
Somatic copy number alterations are predictive of progression-free survival in patients with lung adenocarcinoma undergoing radiotherapy.
Carcinoma, Non-Small-Cell Lung
Study on Attenuating Angiogenesis and Epithelial-Mesenchymal Transition (EMT) of Non-Small Cell Lung Carcinoma (NSCLC) by Regulating MAGEC2.
Carcinoma, Non-Small-Cell Lung
Survival analysis and functional annotation of long non-coding RNAs in lung adenocarcinoma.
Carcinoma, Non-Small-Cell Lung
The Cytoplasmic DNA Sensor cGAS Promotes Mitotic Cell Death.
Carcinoma, Non-Small-Cell Lung
The functional landscape of Golgi membrane protein 1 (GOLM1) phosphoproteome reveal GOLM1 regulating P53 that promotes malignancy.
Carcinoma, Non-Small-Cell Lung
TP53 Status, Patient Sex, and the Immune Response as Determinants of Lung Cancer Patient Survival.
Carcinoma, Non-Small-Cell Lung
Tumor suppressor miR-29c regulates radioresistance in lung cancer cells.
Carcinoma, Ovarian Epithelial
A polygenic methylation prediction model associated with response to chemotherapy in epithelial ovarian cancer.
Carcinoma, Ovarian Epithelial
Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study.
Carcinoma, Ovarian Epithelial
Digital Immune-Related Gene Expression Signatures In High-Grade Serous Ovarian Carcinoma: Developing Prediction Models For Platinum Response.
Carcinoma, Ovarian Epithelial
MARCKS contributes to stromal cancer-associated fibroblast activation and facilitates ovarian cancer metastasis.
Carcinoma, Ovarian Epithelial
Nuclear envelope structural defect underlies the main cause of aneuploidy in ovarian carcinogenesis.
Carcinoma, Ovarian Epithelial
TP53 hot spot mutations in ovarian cancer: selective resistance to microtubule stabilizers in vitro and differential survival outcomes from The Cancer Genome Atlas.
Carcinoma, Papillary
Expression profiles of pivotal microRNAs and targets in thyroid papillary carcinoma: an analysis of The Cancer Genome Atlas.
Carcinoma, Papillary
Follicular cell thyroid neoplasia: insights from genomics and The Cancer Genome Atlas research network.
Carcinoma, Papillary
Loss of amphiregulin reduces myoepithelial cell coverage of mammary ducts and alters breast tumor growth.
Carcinoma, Papillary
Microsatellite Instability Occurs in a Subset of Follicular Thyroid Cancers.
Carcinoma, Renal Cell
53 years old is a reasonable cut-off value to define young and old patients in clear cell renal cell carcinoma: a study based on TCGA and SEER database.
Carcinoma, Renal Cell
A BAP1 synonymous mutation results in exon skipping, loss of function and worse patient prognosis.
Carcinoma, Renal Cell
A Bayesian integrative approach for multi-platform genomic data: A kidney cancer case study.
Carcinoma, Renal Cell
A fluorescence-coupled assay for gamma aminobutyric acid (GABA) reveals metabolic stress-induced modulation of GABA content in neuroendocrine cancer.
Carcinoma, Renal Cell
A hidden Markov modeling approach for identifying tumor subclones in next-generation sequencing studies.
Carcinoma, Renal Cell
A New Survival Model Based on Cholesterol Biosynthesis-Related Genes for Prognostic Prediction in Clear Cell Renal Cell Carcinoma.
Carcinoma, Renal Cell
A new survival model based on ferroptosis-related genes for prognostic prediction in clear cell renal cell carcinoma.
Carcinoma, Renal Cell
A nomogram based on 9-lncRNAs signature for improving prognostic prediction of clear cell renal cell carcinoma.
Carcinoma, Renal Cell
A novel machine learning approach reveals latent vascular phenotypes predictive of renal cancer outcome.
Carcinoma, Renal Cell
A tale of two cancers: Complete genetic analysis of chromophobe renal cell carcinoma contrasts with clear cell renal cell carcinoma.
Carcinoma, Renal Cell
Adjuvant therapy for high-risk renal cell carcinoma after nephrectomy how many trials are positive? Only one or more than one.
Carcinoma, Renal Cell
An improved clear cell renal cell carcinoma stage prediction model based on gene sets.
Carcinoma, Renal Cell
Analysis of renal cancer cell lines from two major resources enables genomics-guided cell line selection.
Carcinoma, Renal Cell
Assessment of Renal Cell Carcinoma by Texture Analysis in Clinical Practice: A Six-Site, Six-Platform Analysis of Reliability.
Carcinoma, Renal Cell
ATLAS trial of adjuvant axitinib in patients with renal cell carcinoma: subgroup analyses with focus on axitinib dosing and racial groups.
Carcinoma, Renal Cell
aWCluster: A Novel Integrative Network-based Clustering of Multiomics for Subtype Analysis of Cancer Data.
Carcinoma, Renal Cell
Axitinib versus placebo as an adjuvant treatment of renal cell carcinoma: results from the phase III, randomized ATLAS trial.
Carcinoma, Renal Cell
BAP1 is Overexpressed in Black Compared with White patients with Mx-M1 Clear Cell Renal Cell Carcinoma: A report from the Cancer Genome Atlas.
Carcinoma, Renal Cell
Binning somatic mutations based on biological knowledge for predicting survival: an application in renal cell carcinoma.
Carcinoma, Renal Cell
Caspase 4 Overexpression as a Prognostic Marker in Clear Cell Renal Cell Carcinoma: A Study Based on the Cancer Genome Atlas Data Mining.
Carcinoma, Renal Cell
Clear Cell Papillary Renal Cell Carcinoma Shares Distinct Molecular Characteristics and may be Significantly Associated With Higher Risk of Developing Second Primary Malignancy.
Carcinoma, Renal Cell
Comprehensive analysis of competing endogenous RNA network and 3-mRNA signature predicting survival in papillary renal cell cancer.
Carcinoma, Renal Cell
Comprehensive Analysis of Driver Genes in Personal Genomes of Clear Cell Renal Cell Carcinoma.
Carcinoma, Renal Cell
Comprehensive Analysis of the ATP-binding Cassette Subfamily B Across Renal Cancers Identifies ABCB8 Overexpression in Phenotypically Aggressive Clear Cell Renal Cell Carcinoma.
Carcinoma, Renal Cell
Comprehensive characterization of tumor mutation burden in clear cell renal cell carcinoma based on the three independent cohorts.
Carcinoma, Renal Cell
da Vinci robotic partial nephrectomy for renal cell carcinoma: an atlas of the four-arm technique.
Carcinoma, Renal Cell
Deciphering Immune-Associated Genes to Predict Survival in Clear Cell Renal Cell Cancer.
Carcinoma, Renal Cell
Decreased expression of SLC16A12 mRNA predicts poor prognosis of patients with clear cell renal cell carcinoma.
Carcinoma, Renal Cell
Differential expression analysis of clear cell renal cell carcinomas in THE CANCER GENOME ATLAS distinguishes an aggressive subset enriched with chromosome 7 and 12 gains.
Carcinoma, Renal Cell
Differential Interactome Proposes Subtype-Specific Biomarkers and Potential Therapeutics in Renal Cell Carcinomas.
Carcinoma, Renal Cell
Differentially expressed autophagy-related genes are potential prognostic and diagnostic biomarkers in clear-cell renal cell carcinoma.
Carcinoma, Renal Cell
DNA methylation profiling reveals novel diagnostic biomarkers in renal cell carcinoma.
Carcinoma, Renal Cell
DNA Methylation Signature Reveals Cell Ontogeny of Renal Cell Carcinomas.
Carcinoma, Renal Cell
Dysregulation of the miRNA biogenesis components DICER1, DROSHA, DGCR8 and AGO2 in clear cell renal cell carcinoma in both a Korean cohort and the cancer genome atlas kidney clear cell carcinoma cohort.
Carcinoma, Renal Cell
Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma.
Carcinoma, Renal Cell
Expression and clinical value of CD105 in renal cell carcinoma based on data mining in The Cancer Genome Atlas.
Carcinoma, Renal Cell
Expression of lactate/H? symporters MCT1 and MCT4 and their chaperone CD147 predicts tumor progression in clear cell renal cell carcinoma: immunohistochemical and The Cancer Genome Atlas data analyses.
Carcinoma, Renal Cell
Fifteen-gene expression based model predicts the survival of clear cell renal cell carcinoma.
Carcinoma, Renal Cell
For robust big data analyses: a collection of 150 important pro-metastatic genes.
Carcinoma, Renal Cell
FOXI1 expression in chromophobe renal cell carcinoma and renal oncocytoma: a study of The Cancer Genome Atlas transcriptome-based outlier mining and immunohistochemistry.
Carcinoma, Renal Cell
Frequent KRAS Mutations in Oncocytic Papillary Renal Neoplasm with Inverted Nuclei.
Carcinoma, Renal Cell
Genomic Characterization of Renal Cell Carcinoma with Sarcomatoid Dedifferentiation Pinpoints Recurrent Genomic Alterations.
Carcinoma, Renal Cell
hsegHMM: hidden Markov model-based allele-specific copy number alteration analysis accounting for hypersegmentation.
Carcinoma, Renal Cell
Identification of Candidate Genes Associated with Susceptibility to Ovarian Clear Cell Adenocarcinoma Using cis-eQTL Analysis.
Carcinoma, Renal Cell
Identification of methylation-driven genes related to the prognosis of papillary renal cell carcinoma: a study based on The Cancer Genome Atlas.
Carcinoma, Renal Cell
Identification of topological features in renal tumor microenvironment associated with patient survival.
Carcinoma, Renal Cell
Identifying Clear Cell Renal Cell Carcinoma Coexpression Networks Associated with Opioid Signaling and Survival.
Carcinoma, Renal Cell
Identifying molecular genetic features and oncogenic pathways of clear cell renal cell carcinoma through the anatomical (PADUA) scoring system.
Carcinoma, Renal Cell
Imaging-genomic pipeline for identifying gene mutations using three-dimensional intra-tumor heterogeneity features.
Carcinoma, Renal Cell
Impact of novel oncogenic pathways regulated by antitumor miR-451a in renal cell carcinoma.
Carcinoma, Renal Cell
Increased expression of RUNX1 in clear cell renal cell carcinoma predicts poor prognosis.
Carcinoma, Renal Cell
Insights into the Genetic Basis of the Renal Cell Carcinomas from The Cancer Genome Atlas.
Carcinoma, Renal Cell
Integrated genomic analysis identifies subclasses and prognosis signatures of kidney cancer.
Carcinoma, Renal Cell
Integrative analysis of DNA methylation and gene expression in papillary renal cell carcinoma.
Carcinoma, Renal Cell
Integrative Analysis of Multi-Genomic Data for Kidney Renal Cell Carcinoma.
Carcinoma, Renal Cell
Integrative Epigenetic and Gene Expression Analysis of Renal Tumor Progression to Metastasis.
Carcinoma, Renal Cell
Kidney cancer: Creating a molecular atlas of clear cell renal cell carcinoma genetics.
Carcinoma, Renal Cell
LAT, HOXD3 and NFE2L3 identified as novel DNA methylation-driven genes and prognostic markers in human clear cell renal cell carcinoma by integrative bioinformatics approaches.
Carcinoma, Renal Cell
LINC02738 Participates in the Development of Kidney Cancer Through the miR-20b/Sox4 Axis.
Carcinoma, Renal Cell
LncNetP, a systematical lncRNA prioritization approach based on ceRNA and disease phenotype association assumptions.
Carcinoma, Renal Cell
Long non-coding RNA Linc00152 is a positive prognostic factor for and demonstrates malignant biological behavior in clear cell renal cell carcinoma.
Carcinoma, Renal Cell
Long non-coding RNAs as prognostic biomarkers in papillary renal cell carcinoma.
Carcinoma, Renal Cell
Long noncoding RNA PVT1 inhibits renal cancer cell apoptosis by up-regulating Mcl-1.
Carcinoma, Renal Cell
Loss of histone H3 lysine 36 trimethylation is associated with an increased risk of renal cell carcinoma-specific death.
Carcinoma, Renal Cell
Low Expression Levels of SLC22A12 Indicates a Poor Prognosis and Progresses Clear Cell Renal Cell Carcinoma.
Carcinoma, Renal Cell
Low expression of ferritinophagy-related NCOA4 gene in relation to unfavorable outcome and defective immune cells infiltration in clear cell renal carcinoma.
Carcinoma, Renal Cell
LRRC19-A Bridge between Selenium Adjuvant Therapy and Renal Clear Cell Carcinoma: A Study Based on Datamining.
Carcinoma, Renal Cell
miRNA-target gene regulatory networks: A Bayesian integrative approach to biomarker selection with application to kidney cancer.
Carcinoma, Renal Cell
Molecular pathogenesis of renal cell carcinoma: Impact of the anti-tumor miR-29 family on gene regulation.
Carcinoma, Renal Cell
Nonsense-mediated decay factor SMG7 sensitizes cells to TNF?-induced apoptosis via CYLD tumor suppressor and the noncoding oncogene Pvt1.
Carcinoma, Renal Cell
Nuclear and stromal expression of Manic fringe in renal cell carcinoma.
Carcinoma, Renal Cell
Otoferlin is a prognostic biomarker in patients with clear cell renal cell carcinoma: A systematic expression analysis.
Carcinoma, Renal Cell
Overexpression of G6PD Represents a Potential Prognostic Factor in Clear Cell Renal Cell Carcinoma.
Carcinoma, Renal Cell
Parallel evolution of tumour subclones mimics diversity between tumours.
Carcinoma, Renal Cell
Pathomic Fusion: An Integrated Framework for Fusing Histopathology and Genomic Features for Cancer Diagnosis and Prognosis.
Carcinoma, Renal Cell
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma.
Carcinoma, Renal Cell
PON1 hypermethylation is associated with progression of renal cell carcinoma.
Carcinoma, Renal Cell
Predictive value of single-nucleotide polymorphism signature for recurrence in localised renal cell carcinoma: a retrospective analysis and multicentre validation study.
Carcinoma, Renal Cell
Primary Renal Paragangliomas and Renal Neoplasia Associated with Pheochromocytoma/Paraganglioma: Analysis of von Hippel-Lindau (VHL), Succinate Dehydrogenase (SDHX) and Transmembrane Protein 127 (TMEM127).
Carcinoma, Renal Cell
Prognostic gene signature identification using causal structure learning: applications in kidney cancer.
Carcinoma, Renal Cell
Prognostic role of PHYH for overall survival (OS) in clear cell renal cell carcinoma (ccRCC).
Carcinoma, Renal Cell
Prognostic Value of RNASEH2A-, CDK1-, and CD151-Related Pathway Gene Profiling for Kidney Cancers.
Carcinoma, Renal Cell
Quantitative tumour necrosis is an independent predictor of overall survival in clear cell renal cell carcinoma.
Carcinoma, Renal Cell
Re: Axitinib versus Placebo as an Adjuvant Treatment of Renal Cell Carcinoma: Results from the Phase III, Randomized ATLAS Trial.
Carcinoma, Renal Cell
Recent advances in genitourinary tumors: A review focused on biology and systemic treatment.
Carcinoma, Renal Cell
Renal cell tumors with clear cell histology and intact VHL and chromosome 3p: a histological review of tumors from the Cancer Genome Atlas database.
Carcinoma, Renal Cell
Replisome genes regulation by antitumor miR-101-5p in clear cell renal cell carcinoma.
Carcinoma, Renal Cell
RNA Sequencing of Collecting Duct Renal Cell Carcinoma Suggests an Interaction between miRNA and Target Genes and a Predominance of Deregulated Solute Carrier Genes.
Carcinoma, Renal Cell
Role of pre-miR-532 (miR-532-5p and miR-532-3p) in regulation of gene expression and molecular pathogenesis in renal cell carcinoma.
Carcinoma, Renal Cell
SLAMF7 Signaling Reprograms T Cells toward Exhaustion in the Tumor Microenvironment.
Carcinoma, Renal Cell
Study on HOXBs of Clear Cell Renal Cell Carcinoma and Detection of New Molecular Target.
Carcinoma, Renal Cell
TFEB-VEGFA (6p21.1) co-amplified renal cell carcinoma: a distinct entity with potential implications for clinical management.
Carcinoma, Renal Cell
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.
Carcinoma, Renal Cell
The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications.
Carcinoma, Renal Cell
The construction and analysis of competitive endogenous RNA (ceRNA) networks in metastatic renal cell carcinoma: a study based on The Cancer Genome Atlas.
Carcinoma, Renal Cell
The Early Diagnostic and Prognostic Value of BIRC5 in Clear-Cell Renal Cell Carcinoma Based on the Cancer Genome Atlas Data.
Carcinoma, Renal Cell
The impact of estimated tumour purity on gene expression-based drug repositioning of Clear Cell Renal Cell Carcinoma samples.
Carcinoma, Renal Cell
The long noncoding RNA urothelial carcinoma-associated 1 overexpression as a poor prognostic biomarker in clear cell renal cell carcinoma.
Carcinoma, Renal Cell
The prognostic and predictive value of tumor infiltrating Macrophage and Neutrophil in patient with clear cell renal cell carcinoma: Tumor infiltrating lymphocytes in renal cell carcinoma.
Carcinoma, Renal Cell
TPX2 as a prognostic indicator and potential therapeutic target in clear cell renal cell carcinoma.
Carcinoma, Renal Cell
Transcriptomics analysis for the identification of potential age-related genes and cells associated with three major urogenital cancers.
Carcinoma, Renal Cell
Tumors masquerading as type 2 papillary renal cell carcinoma: pathologists' ever-expanding differential diagnosis for a heterogeneous group of entities.
Carcinoma, Renal Cell
Unsupervised Resolution of Histomorphologic Heterogeneity in Renal Cell Carcinoma Using a Brain Tumor-Educated Neural Network.
Carcinoma, Renal Cell
UQCRH downregulation promotes Warburg effect in renal cell carcinoma cells.
Carcinoma, Renal Cell
VSTM2A Overexpression Is a Sensitive and Specific Biomarker for Mucinous Tubular and Spindle Cell Carcinoma (MTSCC) of the Kidney.
Carcinoma, Renal Cell
[Implications of TCGA Network Data on 2nd Generation Immunotherapy Concepts Based on PD-L1 and PD-1 Target Structures].
Carcinoma, Small Cell
Urothelial-to-Neural Plasticity Drives Progression to Small Cell Bladder Cancer.
Carcinoma, Squamous Cell
(S,R)3-(4-Hydroxyphenyl)-4,5-Dihydro-5-Isoxazole Acetic Acid Methyl Ester Inhibits Epithelial-to-Mesenchymal Transition through TGF-?/Smad4 Axis in Nasopharyngeal Carcinoma.
Carcinoma, Squamous Cell
?Np63 Inhibits Oxidative Stress-Induced Cell Death, Including Ferroptosis, and Cooperates with the BCL-2 Family to Promote Clonogenic Survival.
Carcinoma, Squamous Cell
A novel 12-gene signature as independent prognostic model in stage IA and IB lung squamous cell carcinoma patients.
Carcinoma, Squamous Cell
A novel prognostic prediction model based on seven immune-related RNAs for predicting overall survival of patients in early cervical squamous cell carcinoma.
Carcinoma, Squamous Cell
A panel of Transcription factors identified by data mining can predict the prognosis of head and neck squamous cell carcinoma.
Carcinoma, Squamous Cell
A radiosensitivity MiRNA signature validated by the TCGA database for head and neck squamous cell carcinomas.
Carcinoma, Squamous Cell
A risk score system based on DNA methylation levels and a nomogram survival model for lung squamous cell carcinoma.
Carcinoma, Squamous Cell
A seven long-noncoding RNA signature predicts prognosis of lung squamous cell carcinoma.
Carcinoma, Squamous Cell
A six-gene expression signature related to angiolymphatic invasion is associated with poor survival in laryngeal squamous cell carcinoma.
Carcinoma, Squamous Cell
A six-mRNA prognostic model to predict survival in head and neck squamous cell carcinoma.
Carcinoma, Squamous Cell
A three-lncRNA signature derived from the Atlas of ncRNA in cancer (TANRIC) database predicts the survival of patients with head and neck squamous cell carcinoma.
Carcinoma, Squamous Cell
A Transcriptomic Analysis of Head and Neck Squamous Cell Carcinomas for Prognostic Indications.
Carcinoma, Squamous Cell
ADH7, miR-3065 and LINC01133 are associated with cervical cancer progression in different age groups.
Carcinoma, Squamous Cell
AKT3 Is a Novel Regulator of Cancer-Associated Fibroblasts in Head and Neck Squamous Cell Carcinoma.
Carcinoma, Squamous Cell
Alterations of immune response of Non-Small Cell Lung Cancer with Azacytidine.
Carcinoma, Squamous Cell
An eleven gene molecular signature for extra-capsular spread in oral squamous cell carcinoma serves as a prognosticator of outcome in patients without nodal metastases.
Carcinoma, Squamous Cell
Analysis of The Cancer Genome Atlas sequencing data reveals novel properties of the human papillomavirus 16 genome in head and neck squamous cell carcinoma.
Carcinoma, Squamous Cell
Analysis of the Role and Regulation Mechanism of hsa-miR-147b in Lung Squamous Cell Carcinoma Based on The Cancer Genome Atlas Database.
Carcinoma, Squamous Cell
APOBEC-mediated cytosine deamination links PIK3CA helical domain mutations to human papillomavirus-driven tumor development.
Carcinoma, Squamous Cell
Apoptosis signaling molecules as treatment targets in head and neck squamous cell carcinoma.
Carcinoma, Squamous Cell
Association between immunotherapy biomarkers and glucose metabolism from F-18 FDG PET.
Carcinoma, Squamous Cell
Association of Estrogen Receptor Alpha Expression With Survival in Oropharyngeal Cancer Following Chemoradiation Therapy.
Carcinoma, Squamous Cell
Association of LINC00673 Genetic Variants with Progression of Oral Cancer.
Carcinoma, Squamous Cell
Associations between proteasomal activator PA28? and outcome of oral squamous cell carcinoma: Evidence from cohort studies and functional analyses.
Carcinoma, Squamous Cell
Atlas-based delineation of lymph node levels in head and neck computed tomography images.
Carcinoma, Squamous Cell
Bioinformatics analyses of the differences between lung adenocarcinoma and squamous cell carcinoma using The Cancer Genome Atlas expression data.
Carcinoma, Squamous Cell
Cancer-Specific Production of N-Acetylaspartate via NAT8L Overexpression in Non-Small Cell Lung Cancer and Its Potential as a Circulating Biomarker.
Carcinoma, Squamous Cell
Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.
Carcinoma, Squamous Cell
Characterization of functionally active gene fusions in human papillomavirus related oropharyngeal squamous cell carcinoma.
Carcinoma, Squamous Cell
Characterization of the immune profile of oral tongue squamous cell carcinomas with advancing disease.
Carcinoma, Squamous Cell
Classifying non-small cell lung cancer types and transcriptomic subtypes using convolutional neural networks.
Carcinoma, Squamous Cell
Clinical Significance and the Role of Guanylate-Binding Protein 5 in Oral Squamous Cell Carcinoma.
Carcinoma, Squamous Cell
Combined Transcriptome and Proteome Analysis of Immortalized Human Keratinocytes Expressing Human Papillomavirus 16 (HPV16) Oncogenes Reveals Novel Key Factors and Networks in HPV-Induced Carcinogenesis.
Carcinoma, Squamous Cell
Comprehensive Analysis of Aberrantly Expressed Profiles of lncRNAs and miRNAs with Associated ceRNA Network in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Carcinoma, Squamous Cell
Comprehensive analysis of ceRNA networks in HPV16- and HPV18-mediated cervical cancers reveals XIST as a pivotal competing endogenous RNA.
Carcinoma, Squamous Cell
Comprehensive analysis of prognostic alternative splicing signature in cervical cancer.
Carcinoma, Squamous Cell
Comprehensive Analysis of the PD-L1 and Immune Infiltrates of m6A RNA Methylation Regulators in Head and Neck Squamous Cell Carcinoma.
Carcinoma, Squamous Cell
Comprehensive Computational Pathological Image Analysis Predicts Lung Cancer Prognosis.
Carcinoma, Squamous Cell
Comprehensive genomic characterization of head and neck squamous cell carcinomas.
Carcinoma, Squamous Cell
Comprehensive genomic characterization of squamous cell lung cancers.
Carcinoma, Squamous Cell
Correlation between RNA-Seq and microarrays results using TCGA data.
Carcinoma, Squamous Cell
CREB targets define the gene expression signature of malignancies having reduced levels of the tumor suppressor tristetraprolin.
Carcinoma, Squamous Cell
Deregulated microRNAs Are Associated with Patient Survival and Predicted to Target Genes That Modulate Lung Cancer Signaling Pathways.
Carcinoma, Squamous Cell
Detailed analysis of adenosine A2a receptor (ADORA2A) and CD73 (5'-nucleotidase, ecto, NT5E) methylation and gene expression in head and neck squamous cell carcinoma patients.
Carcinoma, Squamous Cell
Diagnosis value of aberrantly expressed microRNA profiles in lung squamous cell carcinoma: a study based on the Cancer Genome Atlas.
Carcinoma, Squamous Cell
Differential expression of critical cellular genes in human lung adenocarcinomas and squamous cell carcinomas in comparison to normal lung tissues.
Carcinoma, Squamous Cell
Disruption of TP63-miR-27a* feedback loop by mutant TP53 in head and neck cancer.
Carcinoma, Squamous Cell
Dysregulation of miR-200 family microRNAs and epithelial-mesenchymal transition markers in oral squamous cell carcinoma.
Carcinoma, Squamous Cell
Elevated KLF7 levels may serve as a prognostic signature and might contribute to progression of squamous carcinoma.
Carcinoma, Squamous Cell
Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma.
Carcinoma, Squamous Cell
Elevated ZNF703 Protein Expression Is an Independent Unfavorable Prognostic Factor for Survival of the Patients with Head and Neck Squamous Cell Carcinoma.
Carcinoma, Squamous Cell
Evaluation of the Risk of Grade 3 Oral and Pharyngeal Dysphagia Using Atlas-Based Method and Multivariate Analyses of Individual Patient Dose Distributions.
Carcinoma, Squamous Cell
Evidence for APOBEC3B mRNA and protein expression in oral squamous cell carcinomas.
Carcinoma, Squamous Cell
Expression and clinicopathological implication of DcR3 in lung cancer tissues: a tissue microarray study with 365 cases.
Carcinoma, Squamous Cell
Expression of PAM50 Genes in Lung Cancer: Evidence that Interactions between Hormone Receptors and HER2/HER3 Contribute to Poor Outcome.
Carcinoma, Squamous Cell
Expression of SUMO1P3 Compared with SUMO1 is an Independent Predictor of Patient Outcome in Lung Adenocarcinoma.
Carcinoma, Squamous Cell
Expression profile analysis of head and neck squamous cell carcinomas using data from The Cancer Genome Atlas.
Carcinoma, Squamous Cell
EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells.
Carcinoma, Squamous Cell
Factor analysis for survival time prediction with informative censoring and diverse covariates.
Carcinoma, Squamous Cell
Favorable outcome of patients with lung adenocarcinoma harboring POLE mutations and expressing high PD-L1.
Carcinoma, Squamous Cell
FBXW7 deletion contributes to lung tumor development and confers resistance to gefitinib therapy.
Carcinoma, Squamous Cell
Feasibility of lung cancer RNA acquisition from a single transbronchial or transthoracic needle pass (FASTT trial).
Carcinoma, Squamous Cell
Fibroblast growth factor receptor 3 protein is overexpressed in oral and oropharyngeal squamous cell carcinoma.
Carcinoma, Squamous Cell
Five extracellular matrix-associated genes upregulated in oral tongue squamous cell carcinoma: An integrated bioinformatics analysis.
Carcinoma, Squamous Cell
FOXL2 expression might be a novel prognostic biomarker in patients with laryngeal squamous cell carcinoma.
Carcinoma, Squamous Cell
Gene promoter-associated CpG island hypermethylation in squamous cell carcinoma of the tongue.
Carcinoma, Squamous Cell
Genetic defects of the IRF1-mediated major histocompatibility complex class I antigen presentation pathway occur prevalently in the
Carcinoma, Squamous Cell
Genetic Variants Were Associated With the Prognosis of Head and Neck Squamous Carcinoma.
Carcinoma, Squamous Cell
Genome-Wide Profiling of Acquired Uniparental Disomy Reveals Prognostic Factors in Head and Neck Squamous Cell Carcinoma.
Carcinoma, Squamous Cell
Genomic and Transcriptomic Characterization Links Cell Lines with Aggressive Head and Neck Cancers.
Carcinoma, Squamous Cell
Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas.
Carcinoma, Squamous Cell
HEDGEHOG/GLI Modulates the PRR11-SKA2 Bidirectional Transcription Unit in Lung Squamous Cell Carcinomas.
Carcinoma, Squamous Cell
Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinoma.
Carcinoma, Squamous Cell
High KRT8 Expression Independently Predicts Poor Prognosis for Lung Adenocarcinoma Patients.
Carcinoma, Squamous Cell
High-affinity peptide ligand LXY30 for targeting ?3?1 integrin in non-small cell lung cancer.
Carcinoma, Squamous Cell
HSD17B4, ACAA1, and PXMP4 in Peroxisome Pathway Are Down-Regulated and Have Clinical Significance in Non-small Cell Lung Cancer.
Carcinoma, Squamous Cell
HUWE1 controls the development of non-small cell lung cancer through down-regulation of p53.
Carcinoma, Squamous Cell
Hypermethylation of the PTTG1IP promoter leads to low expression in early-stage non-small cell lung cancer.
Carcinoma, Squamous Cell
Hypoxia-related lncRNAs to build prognostic classifier and reveal the immune characteristics of EGFR wild type and low expression of PD-L1 squamous and adenocarcinoma NSCLC.
Carcinoma, Squamous Cell
Hypoxic stress suppresses lung tumor-secreted exosomal miR101 to activate macrophages and induce inflammation.
Carcinoma, Squamous Cell
Identification of a 26-lncRNAs Risk Model for Predicting Overall Survival of Cervical Squamous Cell Carcinoma Based on Integrated Bioinformatics Analysis.
Carcinoma, Squamous Cell
Identification of a Gene Prognostic Signature for Oral Squamous Cell Carcinoma by RNA Sequencing and Bioinformatics.
Carcinoma, Squamous Cell
Identification of a novel six-gene signature with potential prognostic and therapeutic value in cervical cancer.
Carcinoma, Squamous Cell
Identification of four methylation-driven genes as candidate biomarkers for monitoring single-walled carbon nanotube-induced malignant transformation of the lung.
Carcinoma, Squamous Cell
Identification of ITGA3 as an Oncogene in Human Tongue Cancer via Integrated Bioinformatics Analysis.
Carcinoma, Squamous Cell
Identification of key classification features of early cervical squamous cell carcinoma.
Carcinoma, Squamous Cell
Identification of Key Genes in Association with Progression and Prognosis in Cervical Squamous Cell Carcinoma.
Carcinoma, Squamous Cell
Identification of Key Genes Related to Lung Squamous Cell Carcinoma Using Bioinformatics Analysis.
Carcinoma, Squamous Cell
Identification of lncRNA functions in lung cancer based on associated protein-protein interaction modules.
Carcinoma, Squamous Cell
Identification of PGRMC1 as a Candidate Oncogene for Head and Neck Cancers and Its Involvement in Metabolic Activities.
Carcinoma, Squamous Cell
Identification of Prognosis Associated microRNAs in HNSCC Subtypes Based on TCGA Dataset.
Carcinoma, Squamous Cell
Identification of prognostic marker genes in head and neck squamous cell carcinoma: A study based on The Cancer Genome Atlas database and experimental validation.
Carcinoma, Squamous Cell
Identification of prognostic microRNA candidates for head and neck squamous cell carcinoma.
Carcinoma, Squamous Cell
Identification of Significant Gene Signatures and Prognostic Biomarkers for Patients With Cervical Cancer by Integrated Bioinformatic Methods.
Carcinoma, Squamous Cell
Identification of specific feed-forward apoptosis mechanisms and associated higher survival rates for low grade glioma and lung squamous cell carcinoma.
Carcinoma, Squamous Cell
Identifying cancer type specific oncogenes and tumor suppressors using limited size data.
Carcinoma, Squamous Cell
Identifying prognostic biomarkers of non-small cell lung cancer by transcriptome analysis.
Carcinoma, Squamous Cell
IGF2BP2 Polymorphisms Are Associated with Clinical Characteristics and Development of Oral Cancer.
Carcinoma, Squamous Cell
Imaging-Genomic Study of Head and Neck Squamous Cell Carcinoma: Associations Between Radiomic Phenotypes and Genomic Mechanisms via Integration of The Cancer Genome Atlas and The Cancer Imaging Archive.
Carcinoma, Squamous Cell
Immune-Inhibitory Gene Expression is Positively Correlated with Overall Immune Activity and Predicts Increased Survival Probability of Cervical and Head and Neck Cancer Patients.
Carcinoma, Squamous Cell
Impact of genetic alterations on outcomes of patients with stage I nonsmall cell lung cancer: An analysis of the cancer genome atlas data.
Carcinoma, Squamous Cell
Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma.
Carcinoma, Squamous Cell
Integrated analysis of deregulation microRNA expression in head and neck squamous cell carcinoma.
Carcinoma, Squamous Cell
Integrated analysis of the prognostic values of RNA-binding proteins in head and neck squamous cell carcinoma.
Carcinoma, Squamous Cell
Integrating omics data and protein interaction networks to prioritize driver genes in cancer.
Carcinoma, Squamous Cell
Integrative analysis of genetic and epigenetic profiling of lung squamous cell carcinoma (LSCC) patients to identify smoking level relevant biomarkers.
Carcinoma, Squamous Cell
Integrative genome-scale analysis of immune infiltration in esophageal carcinoma.
Carcinoma, Squamous Cell
Integrative Genomic and Transcriptomic Analyses of Tumor Suppressor Genes and Their Role on Tumor Microenvironment and Immunity in Lung Squamous Cell Carcinoma.
Carcinoma, Squamous Cell
Interference of tumour mutational burden with outcome of patients with head and neck cancer treated with definitive chemoradiation: a multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group.
Carcinoma, Squamous Cell
LMX1B mRNA expression and its gene body CpG methylation are valuable prognostic biomarkers for laryngeal squamous cell carcinoma.
Carcinoma, Squamous Cell
Long noncoding RNA HOXC13-AS positively affects cell proliferation and invasion in nasopharyngeal carcinoma via modulating miR-383-3p/HMGA2 axis.
Carcinoma, Squamous Cell
LRH1 Acts as an Oncogenic Driver in Human Osteosarcoma and Pan-Cancer.
Carcinoma, Squamous Cell
Lymph node metastasis in lung squamous cell carcinoma and identification of metastasis-related genes based on the Cancer Genome Atlas.
Carcinoma, Squamous Cell
m6A demethylase FTO facilitates tumor progression in lung squamous cell carcinoma by regulating MZF1 expression.
Carcinoma, Squamous Cell
Matrix-metalloproteinases in head and neck carcinoma-cancer genome atlas analysis and fluorescence imaging in mice.
Carcinoma, Squamous Cell
Methylation of RAD51B, XRCC3 and other homologous recombination genes is associated with expression of immune checkpoints and an inflammatory signature in squamous cell carcinoma of the head and neck, lung and cervix.
Carcinoma, Squamous Cell
Methylation Signature Genes Identification of the Lung Squamous Cell Carcinoma Occurrence and Recognition Research.
Carcinoma, Squamous Cell
miR-195 targets cyclin D3 and survivin to modulate the tumorigenesis of non-small cell lung cancer.
Carcinoma, Squamous Cell
miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
Carcinoma, Squamous Cell
miRNA profiling of primary lung and head and neck squamous cell carcinomas: Addressing a diagnostic dilemma.
Carcinoma, Squamous Cell
MNX1-AS1 is a novel biomarker for predicting clinical progression and poor prognosis in lung adenocarcinoma.
Carcinoma, Squamous Cell
Molecular characteristics of primary pulmonary lymphoepithelioma-like carcinoma based on integrated genomic analyses.
Carcinoma, Squamous Cell
Multiple mutations of lung squamous cell carcinoma shared common mechanisms.
Carcinoma, Squamous Cell
Mutations in DNA repair genes are associated with increased neoantigen burden and a distinct immunophenotype in lung squamous cell carcinoma.
Carcinoma, Squamous Cell
Mutations in genes connected with the TCF7L2 transcription factor are associated with a poor prognosis in non-small cell lung cancer.
Carcinoma, Squamous Cell
MYCT1 Inhibits the Adhesion and Migration of Laryngeal Cancer Cells Potentially Through Repressing Collagen VI.
Carcinoma, Squamous Cell
Notch Signaling Activation Is Associated with Patient Mortality and Increased FGF1-Mediated Invasion in Squamous Cell Carcinoma of the Oral Cavity.
Carcinoma, Squamous Cell
p53-inducible gene 3 promotes cell migration and invasion by activating the FAK/Src pathway in lung adenocarcinoma.
Carcinoma, Squamous Cell
Pan-cancer analysis of TCGA data reveals notable signaling pathways.
Carcinoma, Squamous Cell
Patterns of Transposable Element Expression and Insertion in Cancer.
Carcinoma, Squamous Cell
PD-L1 and PD-L2 expression correlated genes in non-small-cell lung cancer.
Carcinoma, Squamous Cell
Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image features.
Carcinoma, Squamous Cell
Prediction of head and neck squamous cell carcinoma survival based on the expression of 15 lncRNAs.
Carcinoma, Squamous Cell
Profile of sphingolipid-related genes and its association with prognosis highlights sphingolipid metabolism in oral cancer.
Carcinoma, Squamous Cell
Prognostic alternative splicing signature in cervical squamous cell carcinoma.
Carcinoma, Squamous Cell
Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers.
Carcinoma, Squamous Cell
Prognostic microRNA signatures derived from The Cancer Genome Atlas for head and neck squamous cell carcinomas.
Carcinoma, Squamous Cell
Prognostic signature associated with radioresistance in head and neck cancer via transcriptomic and bioinformatic analyses.
Carcinoma, Squamous Cell
Prognostic significance of an invasive leader cell-derived mutation cluster on chromosome 16q.
Carcinoma, Squamous Cell
Prognostic value of aberrantly expressed methylation gene profiles in lung squamous cell carcinoma: A study based on The Cancer Genome Atlas.
Carcinoma, Squamous Cell
Protein tyrosine phosphatase, receptor type B is a potential biomarker and facilitates cervical cancer metastasis via epithelial-mesenchymal transition.
Carcinoma, Squamous Cell
QKI, a miR-200 target gene, suppresses epithelial-to-mesenchymal transition and tumor growth.
Carcinoma, Squamous Cell
Radiomic analysis identifies tumor subtypes associated with distinct molecular and microenvironmental factors in head and neck squamous cell carcinoma.
Carcinoma, Squamous Cell
Reconstruction and analysis of circRNA?miRNA?mRNA network in the pathology of cervical cancer.
Carcinoma, Squamous Cell
Research on circadian clock genes in non-small-cell lung carcinoma.
Carcinoma, Squamous Cell
Revealing Biological Pathways Implicated in Lung Cancer from TCGA Gene Expression Data Using Gene Set Enrichment Analysis.
Carcinoma, Squamous Cell
Role of EphB3 Receptor in Mediating Head and Neck Tumor Growth, Cell Migration, and Response to PI3K Inhibitor.
Carcinoma, Squamous Cell
Short-term RANKL exposure initiates a neoplastic transcriptional program in the basal epithelium of the murine salivary gland.
Carcinoma, Squamous Cell
SigFuge: single gene clustering of RNA-seq reveals differential isoform usage among cancer samples.
Carcinoma, Squamous Cell
Signaling Complexity Measured by Shannon Entropy and Its Application in Personalized Medicine.
Carcinoma, Squamous Cell
SMAC Mimetic Birinapant plus Radiation Eradicates Human Head and Neck Cancers with Genomic Amplifications of Cell Death Genes FADD and BIRC2.
Carcinoma, Squamous Cell
Smoking correlates with increased cytoskeletal protein-related coding region mutations in the lung and head and neck datasets of the cancer genome atlas.
Carcinoma, Squamous Cell
Somatic Mutations in miRNA Genes in Lung Cancer-Potential Functional Consequences of Non-Coding Sequence Variants.
Carcinoma, Squamous Cell
SPC25 upregulation increases cancer stem cell properties in non-small cell lung adenocarcinoma cells and independently predicts poor survival.
Carcinoma, Squamous Cell
Stable and discriminating radiomic predictor of recurrence in early stage non-small cell lung cancer: Multi-site study.
Carcinoma, Squamous Cell
Stress-triggered atavistic reprogramming (STAR) addiction: driving force behind head and neck cancer?
Carcinoma, Squamous Cell
SUMO1P3 is associated clinical progression and facilitates cell migration and invasion through regulating miR-136 in non-small cell lung cancer.
Carcinoma, Squamous Cell
Suppression of cleavage factor Im 25 promotes the proliferation of lung cancer cells through alternative polyadenylation.
Carcinoma, Squamous Cell
Targeted Imaging of the Atypical Chemokine Receptor 3 (ACKR3/CXCR7) in Human Cancer Xenografts.
Carcinoma, Squamous Cell
TCF19 contributes to cell proliferation of non-small cell lung cancer by inhibiting FOXO1.
Carcinoma, Squamous Cell
TCGA based integrated genomic analyses of ceRNA network and novel subtypes revealing potential biomarkers for the prognosis and target therapy of tongue squamous cell carcinoma.
Carcinoma, Squamous Cell
The CNPY2 enhances epithelial-mesenchymal transition via activating the AKT/GSK3? pathway in non-small cell lung cancer.
Carcinoma, Squamous Cell
The Combined Detection of Immune Genes for Predicting the Prognosis of Patients With Non-Small Cell Lung Cancer.
Carcinoma, Squamous Cell
The genomic alterations of lung adenocarcinoma and lung squamous cell carcinoma can explain the differences of their overall survival rates.
Carcinoma, Squamous Cell
The management of localized esophageal squamous cell carcinoma: Western approach.
Carcinoma, Squamous Cell
The molecular landscape of the University of Michigan laryngeal squamous cell carcinoma cell line panel.
Carcinoma, Squamous Cell
The prognostic landscape of tumor-infiltrating immune cell and immunomodulators in lung cancer.
Carcinoma, Squamous Cell
The Significance of Secreted Phosphoprotein 1 in Multiple Human Cancers.
Carcinoma, Squamous Cell
The Study of the Expression of CGB1 and CGB2 in Human Cancer Tissues.
Carcinoma, Squamous Cell
Tobacco Smoking-Associated Alterations in the Immune Microenvironment of Squamous Cell Carcinomas.
Carcinoma, Squamous Cell
TP53 mutations and CDKN2A mutations/deletions are highly recurrent molecular alterations in the malignant progression of sinonasal papillomas.
Carcinoma, Squamous Cell
TP53 Mutations in Head and Neck Squamous Cell Carcinoma and Their Impact on Disease Progression and Treatment Response.
Carcinoma, Squamous Cell
TP53 Status, Patient Sex, and the Immune Response as Determinants of Lung Cancer Patient Survival.
Carcinoma, Squamous Cell
Transcription factors CP2 and YY1 as prognostic markers in head and neck squamous cell carcinoma: analysis of The Cancer Genome Atlas and a second independent cohort.
Carcinoma, Squamous Cell
Transcription of human papillomavirus oncogenes in head and neck squamous cell carcinomas.
Carcinoma, Squamous Cell
Transcriptome Based Estrogen Related Genes Biomarkers for Diagnosis and Prognosis in Non-small Cell Lung Cancer.
Carcinoma, Squamous Cell
TRIM59 as a novel molecular biomarker to predict the prognosis of patients with NSCLC.
Carcinoma, Squamous Cell
Tumor CDKN2A-Associated JAK2 Loss and Susceptibility to Immunotherapy Resistance.
Carcinoma, Squamous Cell
Tyrosine Kinase c-MET as Therapeutic Target for Radiosensitization of Head and Neck Squamous Cell Carcinomas.
Carcinoma, Squamous Cell
Upregulated glycolysis correlates with tumor progression and immune evasion in head and neck squamous cell carcinoma.
Carcinoma, Squamous Cell
Validation of Selected Head and Neck Cancer Prognostic Markers from the Pathology Atlas in an Oral Tongue Cancer Cohort.
Carcinoma, Squamous Cell
Weighted gene co-expression network analysis in identification of metastasis-related genes of lung squamous cell carcinoma based on the Cancer Genome Atlas database.
Carcinoma, Squamous Cell
Weighted gene co-expression network analysis of gene modules for the prognosis of esophageal cancer.
Carcinoma, Squamous Cell
Whole exome sequencing and deep sequencing of esophageal squamous cell carcinoma and adenocarcinoma in Japanese patients using the Japanese version of the Genome Atlas, JCGA.
Carcinoma, Squamous Cell
Whole transcriptome targeted gene quantification provides new insights on pulmonary sarcomatoid carcinomas.
Carcinoma, Squamous Cell
[Study on the Difference of Gene Expression between Central and Peripheral Lung Squamous Cell Carcinoma Based on TCGA Database].
Carcinosarcoma
Analysis of mutational signatures in primary and metastatic endometrial cancer reveals distinct patterns of DNA repair defects and shifts during tumor progression.
Carcinosarcoma
Genomic alterations in gynecological malignancies: histotype-associated driver mutations, molecular subtyping schemes, and tumorigenic mechanisms.
Carcinosarcoma
RNA-seq Identification of RACGAP1 as a Metastatic Driver in Uterine Carcinosarcoma.
Carcinosarcoma
The pan-cancer analysis of the two types of uterine cancer uncovered clinical and prognostic associations with m6A RNA methylation regulators.
Cardiomyopathies
Ontological labels for automated location of anatomical shape differences.
Cardiomyopathy, Dilated
Regional Multi-view Learning for Cardiac Motion Analysis: Application to Identification of Dilated Cardiomyopathy Patients.
Cardiomyopathy, Hypertrophic
Construction of a 4D statistical atlas of the cardiac anatomy and its use in classification.
Cardiomyopathy, Hypertrophic
Segmentation of 4D cardiac MR images using a probabilistic atlas and the EM algorithm.
Cardiomyopathy, Hypertrophic
Shocking truths about implantable cardioverter defibrillator monitoring zones.
Cardiotoxicity
Development and Validation of a Heart Atlas To Study Cardiac Exposure to Radiation Following Treatment for Breast Cancer.
Cardiovascular Diseases
A multimodal spatiotemporal cardiac motion atlas from MR and ultrasound data.
Cardiovascular Diseases
Cardiovascular disease risk factors and preventive practices among adults--United States, 1994: a behavioral risk factor atlas. Behavioral Risk Factor Surveillance System State Coordinators.
Cardiovascular Diseases
Cardiovascular disease statistics from the European atlas: inequalities between high- and middle-income member countries of the ESC.
Cardiovascular Diseases
Epidemiology of cardiovascular disease: the new ESC Atlas and beyond.
Cardiovascular Diseases
European Society of Cardiology: Cardiovascular Disease Statistics 2017.
Cardiovascular Diseases
European Society of Cardiology: Cardiovascular Disease Statistics 2019.
Cardiovascular Diseases
Global Atlas of Cardiovascular Disease 2000-2016: The Path to Prevention and Control.
Cardiovascular Diseases
Introducing the Canadian Women's Heart Health Alliance ATLAS on the Epidemiology, Diagnosis, and Management of Cardiovascular Diseases in Women.
Cardiovascular Diseases
Stakeholder engagement for the New Zealand Atlas of Healthcare Variation: cardiovascular disease secondary prevention: VIEW-3.
Cardiovascular Diseases
The Canadian Women's Heart Health Alliance ATLAS on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women-Chapter 2: Scope of the Problem.
Cardiovascular Diseases
The Canadian Women's Heart Health Alliance Atlas on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women-Chapter 3: Patient Perspectives.
Carotid Artery Injuries
Anatomic relationship of the internal carotid artery to the C1 vertebra: A case report of cervical reconstruction for chordoma and pilot study to assess the risk of screw fixation of the atlas.
Carotid Stenosis
Measuring cerebrovascular reactivity: the dynamic response to a step hypercapnic stimulus.
Carotid-Cavernous Sinus Fistula
Experiences with intraluminal occlusion with the Fogarty catheter in the treatment of carotid-cavernous sinus fistulas and other lesions at the base of the skull.
Cataract
Biallelic pathogenic variants in the lanosterol synthase gene LSS involved in the cholesterol biosynthesis cause alopecia with intellectual disability, a rare recessive neuroectodermal syndrome.
Cataract
Direct perturbation of lens membrane structure may contribute to cataracts caused by U18666A, an oxidosqualene cyclase inhibitor.
Cataract
Identification of Differential Gene Expression Pattern in Lens Epithelial Cells Derived from Cataractous and Noncataractous Lenses of Shumiya Cataract Rat.
Cataract
Lanosterol synthase mutations cause cholesterol deficiency-associated cataracts in the Shumiya cataract rat.
Cataract
Lanosterol Synthase Pathway Alleviates Lens Opacity in Age-Related Cortical Cataract.
Cataract
Two cases of severe congenital hypotrichosis caused by compound heterozygous mutations in the LSS gene.
Central Nervous System Diseases
Current Status of Tissue Clearing and the Path Forward in Neuroscience.
Central Serous Chorioretinopathy
CHORIORETINAL FOLDS IN PATIENTS WITH CENTRAL SEROUS CHORIORETINOPATHY.
Cerebral Cortical Thinning
Cellular correlates of cortical thinning throughout the lifespan.
Cerebral Cortical Thinning
Cortical thickness and gyrification index measuring cognition in Parkinson's disease.
Cerebral Cortical Thinning
CSF sTREM2 and Tau Work Together in Predicting Increased Temporal Lobe Atrophy in Older Adults.
Cerebral Hemorrhage
[Neuroprotective effect of batroxobin on experimental intracerebral hemorrhage in rats]
Cerebral Hemorrhage
[Protective effect of procyanidins on experimental rats with intracerebral hemorrhage]
Cerebral Infarction
Regional cerebral blood flow changes in stroke imaged by Tc-99m HMPAO SPECT with corresponding anatomic image comparison.
Cerebral Infarction
Supratentorial Cerebral Arterial Territories for Computed Tomograms: A Mapping Study in 1160 Large Artery Infarcts.
Cerebral Infarction
[A case of cerebral infarction in young adult resulting in thrombotic occlusion of vertebral artery due to repeated contact stimulation of cervical rotation accompanied to systemic malformations such as atlantoaxial subluxation and atlas dysplasia].
Cerebral Palsy
Atlantoaxial rotatory subluxation, congenital absence of the posterior arch of the atlas, and cerebral palsy: an unusual triad.
Cerebral Palsy
Quantitative analysis of brain pathology based on MRI and brain atlases-Applications for cerebral palsy.
Cerebrospinal Fluid Leak
[Syringomyelia as a rare cause of respiratory insufficiency requiring ventilation]
Cerebrovascular Disorders
A Colour Atlas of Stroke: Cerebrovascular Disease and its Management.
Cerebrovascular Disorders
Computational atlases of severity of white matter lesions in elderly subjects with MRI.
Cerebrovascular Disorders
Probabilistic anatomic mapping of cerebral blood flow distribution of the middle cerebral artery.
Chagas Disease
Analogs of squalene and oxidosqualene inhibit oxidosqualene cyclase of Trypanosoma cruzi expressed in Saccharomyces cerevisiae.
Chagas Disease
Atlas of Mexican Triatominae (Reduviidae: Hemiptera) and vector transmission of Chagas disease.
Chediak-Higashi Syndrome
Images from the Haematologica atlas of hematologic cytology: Chediak-Higashi syndrome.
Cholangiocarcinoma
A Novel NIPBL-NACC1 Gene Fusion is Characteristic of the Cholangioblastic Variant of Intrahepatic Cholangiocarcinoma.
Cholangiocarcinoma
A novel three?miRNA signature predicts survival in cholangiocarcinoma based on RNA?Seq data.
Cholangiocarcinoma
BAP1 dependent expression of long non-coding RNA NEAT-1 contributes to sensitivity to gemcitabine in cholangiocarcinoma.
Cholangiocarcinoma
Cholangiocarcinoma: anatomical location-dependent clinical, prognostic, and genetic disparities.
Cholangiocarcinoma
Clinicopathological Significance of Syndecan-1 in Cholangiocarcinoma: A Study Based on Immunohistochemistry and Public Sequencing Data.
Cholangiocarcinoma
EVI1 expression is associated with aggressive behavior in intrahepatic cholangiocarcinoma.
Cholangiocarcinoma
Identification of Mutator-Derived Alternative Splicing Signatures of Genomic Instability for Improving the Clinical Outcome of Cholangiocarcinoma.
Cholangiocarcinoma
Identifying the clonal origin of synchronous multifocal tumors in the hepatobiliary and pancreatic system using multi-omic platforms.
Cholangiocarcinoma
Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
Cholangiocarcinoma
Methylation and transcription patterns are distinct in IDH mutant gliomas compared to other IDH mutant cancers.
Cholangiocarcinoma
MRPL27 contributes to unfavorable overall survival and disease-free survival from cholangiocarcinoma patients.
Cholangiocarcinoma
Plasma proteome atlas for differentiating tumor stage and post-surgical prognosis of hepatocellular carcinoma and cholangiocarcinoma.
Cholangiocarcinoma
Prognostic factors and patterns of recurrence after curative resection for patients with distal cholangiocarcinoma.
Cholangiocarcinoma
Single-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Cholangiocarcinoma
TESC Promotes TGF-?/EGFR-FOXM1-Mediated Tumor Progression in Cholangiocarcinoma.
Cholangiocarcinoma
Upregulation of miR?132?3p in cholangiocarcinoma tissues: A study based on RT?qPCR, The Cancer Genome Atlas miRNA sequencing, Gene Expression Omnibus microarray data and bioinformatics analyses.
Cholangitis, Sclerosing
Single-cell atlas of hepatic T cells reveals expansion of liver-resident naive-like CD4+ T cells in primary sclerosing cholangitis.
Cholelithiasis
Cholesterol synthesis inhibition distal to squalene upregulates biliary phospholipid secretion and counteracts cholelithiasis in the genetically prone C57L/J mouse.
Chondrocalcinosis
Acute neck pain and fever as the first manifestation of chondrocalcinosis with calcification of the transverse ligament of the atlas. Five case-reports with a literature review.
Chondrocalcinosis
Age-Related Prevalence of Periodontoid Calcification and Its Associations with Acute Cervical Pain.
Chondrocalcinosis
Calcification of the transverse ligament of the atlas in chondrocalcinosis.
Chondrocalcinosis
Calcification of the transverse ligament of the atlas in chondrocalcinosis: computed tomography study.
Chondrocalcinosis
Calcium pyrophosphate dihydrate deposition in the transverse ligament of the atlas: an unusual cause of cervical myelopathy.
Chondrocalcinosis
Characterisation of size and direction of osteophyte in knee osteoarthritis: a radiographic study.
Chondrocalcinosis
[Calcium pyrophosphate dihydrate deposition disease in the transverse ligament of the atlas]
Chondroma
Transoral-transpharyngeal approach to the anterior craniocervical junction. Ten-year experience with 72 patients.
Chondrosarcoma
Gene expression profiles in chondrosarcoma cells subjected to cyclic stretching and hydrostatic pressure. A cDNA array study.
Chordoma
Anatomic relationship of the internal carotid artery to the C1 vertebra: A case report of cervical reconstruction for chordoma and pilot study to assess the risk of screw fixation of the atlas.
Chordoma
Transnasal Endoscopic Biopsy Approach to Atlas Tumor with X-ray Assisted and Related Radiographic Measure.
Chordoma
Transoral-transpharyngeal approach to the anterior craniocervical junction. Ten-year experience with 72 patients.
Choriocarcinoma
Differential gene expression pattern between normal human trophoblast and choriocarcinoma cell lines: downregulation of heat shock protein-27 in choriocarcinoma in vitro and in vivo.
Choriocarcinoma
Down-regulation and promoter methylation of tissue inhibitor of metalloproteinase 3 in choriocarcinoma.
Cleft Lip
Another "new" form, the palagonia type of acrofacial dysostosis in a Sicilian family.
Clostridium Infections
Application of the ATLAS score for evaluating the severity of Clostridium difficile infection in teaching hospitals in Mexico.
Clostridium Infections
Concordance of the SHEA-IDSA severity classification for Clostridium difficile infection and the ATLAS bedside scoring system in hospitalized adult patients.
Clostridium Infections
Evaluation of a bedside scoring system for predicting clinical cure and recurrence of Clostridium difficile infections.
Coinfection
The origins and relatedness structure of mixed infections vary with local prevalence of P. falciparum malaria.
Colitis, Ulcerative
Endoscopic and chromoendoscopic atlas featuring dysplastic lesions in surveillance colonoscopy for patients with long-standing ulcerative colitis.
Colonic Neoplasms
A 15-gene signature for prediction of colon cancer recurrence and prognosis based on SVM.
Colonic Neoplasms
A comparative analysis and guidance for individualized chemotherapy of stage II and III colorectal cancer patients based on pathological markers.
Colonic Neoplasms
A Competing Endogenous RNA Network Reveals Novel Potential lncRNA, miRNA, and mRNA Biomarkers in the Prognosis of Human Colon Adenocarcinoma.
Colonic Neoplasms
A machine learning-based prognostic predictor for stage III colon cancer.
Colonic Neoplasms
A microRNA expression signature as a predictor of survival for colon adenocarcinoma.
Colonic Neoplasms
A network view of microRNA and gene interactions in different pathological stages of colon cancer.
Colonic Neoplasms
Abnormal expression of ABCD3 is an independent prognostic factor for colorectal cancer.
Colonic Neoplasms
Aldolase B impairs DNA mismatch repair and induces apoptosis in colon adenocarcinoma.
Colonic Neoplasms
Alternative splicing events implicated in carcinogenesis and prognosis of colorectal cancer.
Colonic Neoplasms
An immune-related model based on INHBA, JAG2 and CCL19 to predict the prognoses of colon cancer patients.
Colonic Neoplasms
An Integrated Approach for Identifying Molecular Subtypes in Human Colon Cancer Using Gene Expression Data.
Colonic Neoplasms
An Integrated miRNA-lncRNA Signature Predicts the Survival of Stage II Colon Cancer.
Colonic Neoplasms
An Integrated Pan-Cancer Analysis and Structure-Based Virtual Screening of GPR15.
Colonic Neoplasms
Analysis of multi-omics differences in left-side and right-side colon cancer.
Colonic Neoplasms
Analysis of the Circadian Regulation of Cancer Hallmarks by a Cross-Platform Study of Colorectal Cancer Time-Series Data Reveals an Association with Genes Involved in Huntington's Disease.
Colonic Neoplasms
Analysis of the molecular nature associated with microsatellite status in colon cancer identifies clinical implications for immunotherapy.
Colonic Neoplasms
Anti-metastatic effect of metformin via repression of interleukin 6-induced epithelial-mesenchymal transition in human colon cancer cells.
Colonic Neoplasms
Apigenin inhibits epithelial-mesenchymal transition of human colon cancer cells through NF-?B/Snail signaling pathway.
Colonic Neoplasms
Automated classification of protein subcellular localization in immunohistochemistry images to reveal biomarkers in colon cancer.
Colonic Neoplasms
Bcl9 Depletion Modulates Endothelial Cell in Tumor Immune Microenvironment in Colorectal Cancer Tumor.
Colonic Neoplasms
Bioinformatic analysis reveals an exosomal miRNA-mRNA network in colorectal cancer.
Colonic Neoplasms
BRAF Mutation as a Potential Therapeutic Target for Checkpoint Inhibitors: A Comprehensive Analysis of Immune Microenvironment in BRAF Mutated Colon Cancer.
Colonic Neoplasms
Bringing Structural Implications and Deep Learning-Based Drug Identification for KRAS Mutants.
Colonic Neoplasms
c-Myc directly targets an over-expression of pyruvate carboxylase in highly invasive breast cancer.
Colonic Neoplasms
CD80 expression is upregulated by TP53 activation in human cancer epithelial cells.
Colonic Neoplasms
Chromosomal Density of Cancer Up-Regulated Genes, Aberrant Enhancer Activity and Cancer Fitness Genes Are Associated with Transcriptional Cis-Effects of Broad Copy Number Gains in Colorectal Cancer.
Colonic Neoplasms
Classification of Colon Cancer Patients Based on the Methylation Patterns of Promoters.
Colonic Neoplasms
Clinical Correlation of Wnt2 and COL8A1 With Colon Adenocarcinoma Prognosis.
Colonic Neoplasms
CMTM6 and PD-L1 coexpression is associated with an active immune microenvironment and a favorable prognosis in colorectal cancer.
Colonic Neoplasms
Colon cancer combined with obesity indicates improved survival- research on relevant mechanism.
Colonic Neoplasms
Colon Cancer Tumor Location Defined by Gene Expression May Disagree With Anatomic Tumor Location.
Colonic Neoplasms
Comparative Proteome Identifies Complement Component 3-Mediated Immune Response as Key Difference of Colon Adenocarcinoma and Rectal Adenocarcinoma.
Colonic Neoplasms
Competitive Endogenous RNA (ceRNA) Regulation Network of lncRNA-miRNA-mRNA in Colorectal Carcinogenesis.
Colonic Neoplasms
Comprehensive analysis of differential expression profiles of mRNAs and lncRNAs and identification of a 14-lncRNA prognostic signature for patients with colon adenocarcinoma.
Colonic Neoplasms
Comprehensive Analysis of lncRNA-miRNA- mRNA Network Ascertains Prognostic Factors in Patients with Colon Cancer.
Colonic Neoplasms
Comprehensive analysis of microRNA/mRNA signature in colon adenocarcinoma.
Colonic Neoplasms
Construction and analysis for differentially expressed long non-coding RNAs and MicroRNAs mediated competing endogenous RNA network in colon cancer.
Colonic Neoplasms
Construction and validation of a metabolic risk model predicting prognosis of colon cancer.
Colonic Neoplasms
Construction of a CXC Chemokine-Based Prediction Model for the Prognosis of Colon Cancer.
Colonic Neoplasms
Controlling for cellular heterogeneity using single-cell deconvolution of gene expression reveals novel markers of colorectal tumors exhibiting microsatellite instability.
Colonic Neoplasms
CREB targets define the gene expression signature of malignancies having reduced levels of the tumor suppressor tristetraprolin.
Colonic Neoplasms
CYB5R1 links epithelial-mesenchymal transition and poor prognosis in colorectal cancer.
Colonic Neoplasms
Decreased Tumoral Expression of Colon-Specific Water Channel Aquaporin 8 Is Associated With Reduced Overall Survival in Colon Adenocarcinoma.
Colonic Neoplasms
Deep Convolutional Neural Network-Based Lymph Node Metastasis Prediction for Colon Cancer Using Histopathological Images.
Colonic Neoplasms
Deep learning-based tumor microenvironment analysis in colon adenocarcinoma histopathological whole-slide images.
Colonic Neoplasms
Deep-Hipo: Multi-scale receptive field deep learning for histopathological image analysis.
Colonic Neoplasms
Detecting Prognosis Risk Biomarkers for Colon Cancer Through Multi-Omics-Based Prognostic Analysis and Target Regulation Simulation Modeling.
Colonic Neoplasms
Development and validation of a DNA repair gene signature for prognosis prediction in Colon Cancer.
Colonic Neoplasms
Development of Prognostic Indicator Based on Autophagy-Related lncRNA Analysis in Colon Adenocarcinoma.
Colonic Neoplasms
Diagnosis and prognostic value of C-X-C motif chemokine ligand 1 in colon adenocarcinoma based on The Cancer Genome Atlas and Guangxi cohort.
Colonic Neoplasms
Diagnostic and prognostic values of forkhead box D4 gene in colonic adenocarcinoma.
Colonic Neoplasms
Differential chromatin accessibility landscape of gain-of-function mutant p53 tumours.
Colonic Neoplasms
Discovering the molecular differences between right- and left-sided colon cancer using machine learning methods.
Colonic Neoplasms
Distinguishable Prognostic Signatures of Left- and Right-Sided Colon Cancer: a Study Based on Sequencing Data.
Colonic Neoplasms
Distinguishing Rectal Cancer from Colon Cancer Based on the Support Vector Machine Method and RNA-sequencing Data.
Colonic Neoplasms
DNA-Sensing and Nuclease Gene Expressions as Markers for Colorectal Cancer Progression.
Colonic Neoplasms
Downregulated ARID1A by miR-185 Is Associated With Poor Prognosis and Adverse Outcomes in Colon Adenocarcinoma.
Colonic Neoplasms
Downregulation of PRMT1, a histone arginine methyltransferase, by sodium propionate induces cell apoptosis in colon cancer.
Colonic Neoplasms
Effect of Different Expression of Immune-Related lncRNA on Colon Adenocarcinoma and Its Relation to Prognosis.
Colonic Neoplasms
Egr?1 inhibits colon cancer cell proliferation, migration and invasion via regulating CDKL1 at the transcriptional level.
Colonic Neoplasms
Elevated Ras related GTP binding B (RRAGB) expression predicts poor overall survival and constructs a prognostic nomogram for colon adenocarcinoma.
Colonic Neoplasms
Enhanced expression of GABRD predicts poor prognosis in patients with colon adenocarcinoma.
Colonic Neoplasms
Epigenetic inactivation of HOXD10 is associated with human colon cancer via inhibiting the RHOC/AKT/MAPK signaling pathway.
Colonic Neoplasms
Epistasis analysis of microRNAs on pathological stages in colon cancer based on an Empirical Bayesian Elastic Net method.
Colonic Neoplasms
Establishing a three-miRNA signature as a prognostic model for colorectal cancer through bioinformatics analysis.
Colonic Neoplasms
Establishment of a 12-gene expression signature to predict colon cancer prognosis.
Colonic Neoplasms
Evaluation of genome-wide genotyping concordance between tumor tissues and peripheral blood.
Colonic Neoplasms
Exploration of the Associations of lncRNA Expression Patterns with Tumor Mutation Burden and Prognosis in Colon Cancer.
Colonic Neoplasms
Expression of Hippo pathway genes and their clinical significance in colon adenocarcinoma.
Colonic Neoplasms
Extracellular vesicles from human umbilical cord mesenchymal stem cells treated with siRNA against ELFN1-AS1 suppress colon adenocarcinoma proliferation and migration.
Colonic Neoplasms
EZH2 inhibition enhances the efficacy of an EGFR inhibitor in suppressing colon cancer cells.
Colonic Neoplasms
FOXA2 promotes the proliferation, migration and invasion, and epithelial mesenchymal transition in colon cancer.
Colonic Neoplasms
Framing the potential of public frameshift peptides as immunotherapy targets in colon cancer.
Colonic Neoplasms
Functional network analysis reveals an immune tolerance mechanism in cancer.
Colonic Neoplasms
FXR silencing in human colon cancer by DNA methylation and KRAS signaling.
Colonic Neoplasms
G-DOC Plus - an integrative bioinformatics platform for precision medicine.
Colonic Neoplasms
GABRD promotes progression and predicts poor prognosis in colorectal cancer.
Colonic Neoplasms
Gene expression network analysis of lymph node involvement in colon cancer identifies AHSA2, CDK10, and CWC22 as possible prognostic markers.
Colonic Neoplasms
Gene Regulatory Network Analysis Identifies Sex-Linked Differences in Colon Cancer Drug Metabolism.
Colonic Neoplasms
Gene Signature in Sessile Serrated Polyps Identifies Colon Cancer Subtype.
Colonic Neoplasms
GeneGazer: A Toolkit Integrating Two Pipelines for Personalized Profiling and Biosignature Identification.
Colonic Neoplasms
Genome?scale analysis to identify potential prognostic microRNA biomarkers for predicting overall survival in patients with colon adenocarcinoma.
Colonic Neoplasms
Genomic and immunological features of microsatellite instability in colon cancer.
Colonic Neoplasms
Global Analysis of Microbiota Signatures in Four Major Types of Gastrointestinal Cancer.
Colonic Neoplasms
HER2 and APC Mutations Promote Altered Crypt-Villus Morphology and Marked Hyperplasia in the Intestinal Epithelium.
Colonic Neoplasms
High expression of PLAC1 in colon cancer as a predictor of poor prognosis: A study based on TCGA data.
Colonic Neoplasms
Higher ETV5 Expression Associates With Poor 5-Florouracil-Based Adjuvant Therapy Response in Colon Cancer.
Colonic Neoplasms
HOXD13 promotes the malignant progression of colon cancer by upregulating PTPRN2.
Colonic Neoplasms
Identification and Validation of a Four-Long Non-coding RNA Signature Associated With Immune Infiltration and Prognosis in Colon Cancer.
Colonic Neoplasms
Identification and verification of HCAR3 and INSL5 as new potential therapeutic targets of colorectal cancer.
Colonic Neoplasms
Identification of a 6-gene signature predicting prognosis for colorectal cancer.
Colonic Neoplasms
Identification of a Genome Instability-Associated LncRNA Signature for Prognosis Prediction in Colon Cancer.
Colonic Neoplasms
Identification of a Tumor Microenvironment-Related Gene Signature Indicative of Disease Prognosis and Treatment Response in Colon Cancer.
Colonic Neoplasms
Identification of an Immune-Related Nine-lncRNA Signature Predictive of Overall Survival in Colon Cancer.
Colonic Neoplasms
Identification of differentially expressed genes regulated by methylation in colon cancer based on bioinformatics analysis.
Colonic Neoplasms
Identification of Distinct Molecular Patterns and a Four-Gene Signature in Colon Cancer Based on Invasion-Related Genes.
Colonic Neoplasms
Identification of DNA methylation markers for early detection of CRC indicates a role for nervous system-related genes in CRC.
Colonic Neoplasms
Identification of PIK3CA multigene mutation patterns associated with superior prognosis in stomach cancer.
Colonic Neoplasms
Identification of prognostic biomarkers and drug target prediction for colon cancer according to a competitive endogenous RNA network.
Colonic Neoplasms
Identification of Prognostic Biomarkers and Drugs Targeting Them in Colon Adenocarcinoma: A Bioinformatic Analysis.
Colonic Neoplasms
Identification of prognostic miRNA biomarkers for predicting overall survival of colon adenocarcinoma and bioinformatics analysis: A study based on The Cancer Genome Atlas database.
Colonic Neoplasms
Identification of regulatory role of DNA methylation in colon cancer gene expression via systematic bioinformatics analysis.
Colonic Neoplasms
Identifying cancer type specific oncogenes and tumor suppressors using limited size data.
Colonic Neoplasms
Identifying miRNA and gene modules of colon cancer associated with pathological stage by weighted gene co-expression network analysis.
Colonic Neoplasms
Identifying molecular subtypes in human colon cancer using gene expression and DNA methylation microarray data.
Colonic Neoplasms
Immunogenomics of colorectal adenocarcinoma: Survival distinctions represented by immune receptor, CDR3 chemical features and high expression of BTN gene family members.
Colonic Neoplasms
Impact of FGFR4 Gene Polymorphism on the Progression of Colorectal Cancer.
Colonic Neoplasms
Improving the Prognosis of Colon Cancer through Knowledge-Based Clinical-Molecular Integrated Analysis.
Colonic Neoplasms
Increased Expression of Long Non-coding RNA H19 is Associated With Colon Cancer Recurrence.
Colonic Neoplasms
Infiltrating T-cell abundance combined with EMT-related gene expression as a prognostic factor of colon cancer.
Colonic Neoplasms
Integrated analysis of gene expression signatures associated with colon cancer from three datasets.
Colonic Neoplasms
Integrated Bioinformatics Analysis to Identify Abnormal Methylated Differentially Expressed Genes for Predicting Prognosis of Human Colon Cancer.
Colonic Neoplasms
Integrative genomic approaches to dissect clinically-significant relationships between the VDR cistrome and gene expression in primary colon cancer.
Colonic Neoplasms
Kruppel-like factor 2 mediated anti-proliferative and anti-metastasis effects of simvastatin in p53 mutant colon cancer.
Colonic Neoplasms
LINC00491 as a new molecular marker can promote the proliferation, migration and invasion of colon adenocarcinoma cells.
Colonic Neoplasms
Long noncoding RNA LINC01234 promotes serine hydroxymethyltransferase 2 expression and proliferation by competitively binding miR-642a-5p in colon cancer.
Colonic Neoplasms
MEGF6 Promotes the Epithelial-to-Mesenchymal Transition via the TGF?/SMAD Signaling Pathway in Colorectal Cancer Metastasis.
Colonic Neoplasms
Methylation associated transcriptional repression of ELOVL5 in novel colorectal cancer cell lines.
Colonic Neoplasms
Migration of mitochondrial DNA in the nuclear genome of colorectal adenocarcinoma.
Colonic Neoplasms
Mining the potential prognostic value of synaptosomal-associated protein 25 (SNAP25) in colon cancer based on stromal-immune score.
Colonic Neoplasms
MLH1 Deficiency Down-Regulates TLR4 Expression in Sporadic Colorectal Cancer.
Colonic Neoplasms
Molecular heterogeneity of guanine nucleotide binding-protein ? subunit 4 in left- and right-sided colon cancer.
Colonic Neoplasms
Molecular subtypes based on DNA methylation predict prognosis in colon adenocarcinoma patients.
Colonic Neoplasms
Mucin 4 mutation is associated with tumor mutation burden and promotes antitumor immunity in colon cancer patients.
Colonic Neoplasms
Novel Epigenetic Eight-Gene Signature Predictive of Poor Prognosis and MSI-Like Phenotype in Human Metastatic Colorectal Carcinomas.
Colonic Neoplasms
Pattern discovery and cancer gene identification in integrated cancer genomic data.
Colonic Neoplasms
PPFIA4 Promotes Colon Cancer Cell Proliferation and Migration by Enhancing Tumor Glycolysis.
Colonic Neoplasms
Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers.
Colonic Neoplasms
Prognostic lncRNAs, miRNAs, and mRNAs Form a Competing Endogenous RNA Network in Colon Cancer.
Colonic Neoplasms
Prognostic significance of chemokines CCL11 and CCL5 modulated by low-density lipoprotein cholesterol in colon cancer patients with normal body mass index.
Colonic Neoplasms
Prognostic value of chloride channel accessory mRNA expression in colon cancer.
Colonic Neoplasms
Proliferative and Invasive Colorectal Tumors in Pet Dogs Provide Unique Insights into Human Colorectal Cancer.
Colonic Neoplasms
Proteomic characterization of peroxisome proliferator-activated receptor-? (PPAR?) overexpressing or silenced colorectal cancer cells unveils a novel protein network associated with an aggressive phenotype.
Colonic Neoplasms
Proteomic profiling reveals a signature for optimizing prognostic prediction in Colon Cancer.
Colonic Neoplasms
Pseudouridylate Synthase 7 Promotes Cell Proliferation and Invasion in Colon Cancer Through Activating PI3K/AKT/mTOR Signaling Pathway.
Colonic Neoplasms
Quantitative analysis of insulin-like growth factor 2 receptor and insulin-like growth factor binding proteins to identify control mechanisms for insulin-like growth factor 1 receptor phosphorylation.
Colonic Neoplasms
RNA N6-methyladenosine reader IGF2BP3 regulates cell cycle and angiogenesis in colon cancer.
Colonic Neoplasms
RNA-Seq Analysis of Colorectal Tumor-Infiltrating Myeloid-Derived Suppressor Cell Subsets Revealed Gene Signatures of Poor Prognosis.
Colonic Neoplasms
Role of B7-H4 siRNA in Proliferation, Migration, and Invasion of LOVO Colorectal Carcinoma Cell Line.
Colonic Neoplasms
SASS6 overexpression is associated with mitotic chromosomal abnormalities and a poor prognosis in patients with colorectal cancer.
Colonic Neoplasms
Screening of Differentiation-Specific Molecular Biomarkers for Colon Cancer.
Colonic Neoplasms
SERPINE1 associated with remodeling of the tumor microenvironment in colon cancer progression: a novel therapeutic target.
Colonic Neoplasms
Single-cell genomic profile-based analysis of tissue differentiation in colorectal cancer.
Colonic Neoplasms
Small RNA sequencing of sessile serrated polyps identifies microRNA profile associated with colon cancer.
Colonic Neoplasms
Systematic analysis of the function and prognostic value of RNA binding proteins in Colon Adenocarcinoma.
Colonic Neoplasms
The association between copy number aberration, DNA methylation and gene expression in tumor samples.
Colonic Neoplasms
The Prognostic Value of m6A RNA Methylation Regulators in Colon Adenocarcinoma.
Colonic Neoplasms
The tumor immune microenvironmental analysis of 2,033 transcriptomes across 7 cancer types.
Colonic Neoplasms
Tumor-Infiltrating Lymphoid Cells in Colorectal Cancer Patients with Varying Disease Stages and Microsatellite Instability-High/Stable Tumors.
Colorectal Neoplasms
A chemical genetics approach identifies PTP4A3 as a regulator of colon cancer cell adhesion.
Colorectal Neoplasms
A comparative analysis and guidance for individualized chemotherapy of stage II and III colorectal cancer patients based on pathological markers.
Colorectal Neoplasms
A MicroRNA Signature Associated With Metastasis of T1 Colorectal Cancers to Lymph Nodes.
Colorectal Neoplasms
A single-cell atlas of liver metastases of colorectal cancer reveals reprogramming of the tumor microenvironment in response to preoperative chemotherapy.
Colorectal Neoplasms
Abnormal Eating Patterns Cause Circadian Disruption and Promote Alcohol-Associated Colon Carcinogenesis.
Colorectal Neoplasms
ALKAL1 gene silencing prevents colorectal cancer progression via suppressing Sonic Hedgehog (SHH) signaling pathway.
Colorectal Neoplasms
Alternative splicing events implicated in carcinogenesis and prognosis of colorectal cancer.
Colorectal Neoplasms
An atlas of the nonpolypoid colorectal neoplasms in inflammatory bowel disease.
Colorectal Neoplasms
An Autophagy-Related Long Noncoding RNA Signature Contributes to Poor Prognosis in Colorectal Cancer.
Colorectal Neoplasms
An Integrated Bioinformatics Analysis Repurposes an Antihelminthic Drug Niclosamide for Treating HMGA2-Overexpressing Human Colorectal Cancer.
Colorectal Neoplasms
Analysis of Genes Involved in Ulcerative Colitis Activity and Tumorigenesis Through Systematic Mining of Gene Co-expression Networks.
Colorectal Neoplasms
Antagonistic Effects of p53 and HIF1A on microRNA-34a Regulation of PPP1R11 and STAT3 and Hypoxia-induced Epithelial to Mesenchymal Transition in Colorectal Cancer Cells.
Colorectal Neoplasms
Application of open-access databases to determine functional connectivity between resveratrol-binding protein QR2 and colorectal carcinoma.
Colorectal Neoplasms
ARID1A Mutation May Define an Immunologically Active Subgroup in Patients with Microsatellite Stable Colorectal Cancer.
Colorectal Neoplasms
Assessment of intra-tumoural colorectal cancer prognostic biomarkers using RNA in situ hybridisation.
Colorectal Neoplasms
Association of Epigenetic Clock with Consensus Molecular Subtypes and Overall Survival of Colorectal Cancer.
Colorectal Neoplasms
Association of mRNA expression of TP53 and the TP53 codon 72 Arg/Pro gene polymorphism with colorectal cancer risk in Asian population: a bioinformatics analysis and meta-analysis.
Colorectal Neoplasms
Association study of genetic variants in estrogen metabolic pathway genes and colorectal cancer risk and survival.
Colorectal Neoplasms
BHLHA15-Positive Secretory Precursor Cells Can Give Rise to Tumors in Intestine and Colon in Mice.
Colorectal Neoplasms
BRD4 Inhibitor AZD5153 Suppresses the Proliferation of Colorectal Cancer Cells and Sensitizes the Anticancer Effect of PARP Inhibitor.
Colorectal Neoplasms
Cancer stem cell associated eight gene-based signature predicts clinical outcomes of colorectal cancer.
Colorectal Neoplasms
Characteristic Analysis of Featured Genes Associated With Stemness Indices in Colorectal Cancer.
Colorectal Neoplasms
CILP2 overexpression correlates with tumor progression and poor prognosis in patients with colorectal cancer in The Cancer Genome Atlas (TCGA) study.
Colorectal Neoplasms
Circulating Long RNAs in Serum Extracellular Vesicles: Their Characterization and Potential Application as Biomarkers for Diagnosis of Colorectal Cancer.
Colorectal Neoplasms
Clinical, Pathology, Genetic, and Molecular Features of Colorectal Tumors in Adolescents and Adults 25 Years or Younger.
Colorectal Neoplasms
CMTM4 inhibits cell proliferation and migration via AKT, ERK1/2, and STAT3 pathway in colorectal cancer.
Colorectal Neoplasms
Colorectal cancer atlas: An integrative resource for genomic and proteomic annotations from colorectal cancer cell lines and tissues.
Colorectal Neoplasms
Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer.
Colorectal Neoplasms
Colorectal Cancer Prognosis is Not Associated with BRAF and KRAS Mutations-A STROBE Compliant Study.
Colorectal Neoplasms
Competing Endogenous RNA of Snail and Zeb1 UTR in Therapeutic Resistance of Colorectal Cancer.
Colorectal Neoplasms
Comprehensive Analysis of Prognostic and Genetic Signatures for General Transcription Factor III (GTF3) in Clinical Colorectal Cancer Patients Using Bioinformatics Approaches.
Colorectal Neoplasms
Comprehensive analysis of prognostic immune-related genes in the tumor microenvironment of colorectal cancer.
Colorectal Neoplasms
Comprehensive analysis of the transcriptome-wide m6A methylome in colorectal cancer by MeRIP sequencing.
Colorectal Neoplasms
Correlation of tumor mutational burden and treatment outcomes in patients with colorectal cancer.
Colorectal Neoplasms
CXCL8 Associated Dendritic Cell Activation Marker Expression and Recruitment as Indicators of Favorable Outcomes in Colorectal Cancer.
Colorectal Neoplasms
CYB5R1 links epithelial-mesenchymal transition and poor prognosis in colorectal cancer.
Colorectal Neoplasms
De Novo Fatty Acid Synthesis-Driven Sphingolipid Metabolism Promotes Metastatic Potential of Colorectal Cancer.
Colorectal Neoplasms
Decoding the S-Nitrosoproteomic Atlas in Individualized Human Colorectal Cancer Tissues Using a Label-Free Quantitation Strategy.
Colorectal Neoplasms
Decreased copy-neutral loss of heterozygosity in African American colorectal cancers.
Colorectal Neoplasms
Development and interpretation of a pathomics-based model for the prediction of microsatellite instability in Colorectal Cancer.
Colorectal Neoplasms
Developmental genes significantly afflicted by aberrant promoter methylation and somatic mutation predict overall survival of late-stage colorectal cancer.
Colorectal Neoplasms
Differential Expression of PEG10 Contributes to Aggressive Disease in Early Versus Late-Onset Colorectal Cancer.
Colorectal Neoplasms
DNA methylation at an enhancer of the three prime repair exonuclease 2 gene (TREX2) is linked to gene expression and survival in laryngeal cancer.
Colorectal Neoplasms
Down-regulation of FN1 inhibits colorectal carcinogenesis by suppressing proliferation, migration, and invasion.
Colorectal Neoplasms
eIF6 Promotes Colorectal Cancer Proliferation and Invasion by Regulating AKT-Related Signaling Pathways.
Colorectal Neoplasms
ELF3 is an antagonist of oncogenic-signalling-induced expression of EMT-TF ZEB1.
Colorectal Neoplasms
Elucidating the Reprograming of Colorectal Cancer Metabolism Using Genome-Scale Metabolic Modeling.
Colorectal Neoplasms
Empowering biologists with multi-omics data: colorectal cancer as a paradigm.
Colorectal Neoplasms
Epidemiology and Molecular-Pathologic Characteristics of CpG Island Methylator Phenotype (CIMP) in Colorectal Cancer.
Colorectal Neoplasms
ER stress-related ATF6 upregulates CIP2A and contributes to poor prognosis of colon cancer.
Colorectal Neoplasms
ERBB4 is over-expressed in human colon cancer and enhances cellular transformation.
Colorectal Neoplasms
Establishment of multiple diagnosis models for colorectal cancer with artificial neural networks.
Colorectal Neoplasms
Estrogen receptor beta reduces colon cancer metastasis through a novel miR-205 - PROX1 mechanism.
Colorectal Neoplasms
Evaluating patient-derived colorectal cancer-xenografts as preclinical models by comparison with patient clinical data.
Colorectal Neoplasms
Explore prognostic marker of colorectal cancer based on ceRNA network.
Colorectal Neoplasms
Expression and gene regulation network of TYMS and BCL2L1 in colorectal cancer based on data mining.
Colorectal Neoplasms
Expression of Free Fatty Acid Receptor 2 by Dendritic Cells Prevents Their Expression of Interleukin 27 and Is Required for Maintenance of Mucosal Barrier and Immune Response Against Colorectal Tumors in Mice.
Colorectal Neoplasms
FAM98A associates with DDX1-C14orf166-FAM98B in a novel complex involved in colorectal cancer progression.
Colorectal Neoplasms
Fatty acid-binding protein 1 is preferentially lost in microsatellite instable colorectal carcinomas and is immune modulated via the interferon ? pathway.
Colorectal Neoplasms
Frequent PIK3CA Mutations in Colorectal and Endometrial Tumors With 2 or More Somatic Mutations in Mismatch Repair Genes.
Colorectal Neoplasms
Functional analysis of the gene expression profiles of colorectal cancer cell lines in relation to oxaliplatin and cisplatin cytotoxicity.
Colorectal Neoplasms
Gender-related prognostic value and genomic pattern of intra-tumor heterogeneity in colorectal cancer.
Colorectal Neoplasms
Gene expression analysis of combined RNA-seq experiments using a receiver operating characteristic calibrated procedure.
Colorectal Neoplasms
Genetic variants in Hippo signalling pathway-related genes affect the risk of colorectal cancer.
Colorectal Neoplasms
Genome-Wide Profiling of Prognostic Alternative Splicing Signature in Colorectal Cancer.
Colorectal Neoplasms
Genomic Landscape of Early-stage Colorectal Neoplasia Developing From the Ulcerative Colitis Mucosa in the Japanese Population.
Colorectal Neoplasms
HER2 activating mutations are targets for colorectal cancer treatment.
Colorectal Neoplasms
High Expression and Clinical Significance of Elafin in Colorectal Cancer.
Colorectal Neoplasms
High expression of IQGAP3 indicates poor prognosis in colorectal cancer patients.
Colorectal Neoplasms
High expression of SLC17A9 correlates with poor prognosis in colorectal cancer.
Colorectal Neoplasms
High-risk Stage III colon cancer patients identified by a novel five-gene mutational signature are characterized by upregulation of IL-23A and gut bacterial translocation of the tumor microenvironment.
Colorectal Neoplasms
Histopathological atlas of desmoplastic reaction characterization in colorectal cancer.
Colorectal Neoplasms
Histopathology classification and localization of colorectal cancer using global labels by weakly supervised deep learning.
Colorectal Neoplasms
How Can Next-Generation Sequencing (Genomics) Help Us in Treating Colorectal Cancer?
Colorectal Neoplasms
HOXD8 exerts a tumor-suppressing role in colorectal cancer as an apoptotic inducer.
Colorectal Neoplasms
HS3ST2 and Its Related Molecules as Potential Biomarkers for Predicting Lymph Node Metastasis in Patients with Colorectal Cancer.
Colorectal Neoplasms
Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction.
Colorectal Neoplasms
Hypermethylation of DMTN promotes the metastasis of colorectal cancer cells by regulating the actin cytoskeleton through Rac1 signaling activation.
Colorectal Neoplasms
Hypermutated tumours across 11 cancer types show three distinct immune subtypes.
Colorectal Neoplasms
Identification of a 6-gene signature predicting prognosis for colorectal cancer.
Colorectal Neoplasms
Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
Colorectal Neoplasms
Identification of hub genes in colorectal cancer based on weighted gene co-expression network analysis and clinical data from The Cancer Genome Atlas.
Colorectal Neoplasms
Identification of key genes and biological processes contributing to colitis associated dysplasia in ulcerative colitis.
Colorectal Neoplasms
Identification of prognostic immune-related signature predicting the overall survival for colorectal cancer.
Colorectal Neoplasms
Identification of Targetable Kinase Alterations in Patients with Colorectal Carcinoma That are Preferentially Associated with Wild-Type RAS/RAF.
Colorectal Neoplasms
Identification of the miRNA signature and key genes in colorectal cancer lymph node metastasis.
Colorectal Neoplasms
Identification of tumor microenvironment-related prognostic genes in colorectal cancer based on bioinformatic methods.
Colorectal Neoplasms
Immune overdrive signature in colorectal tumor subset predicts poor clinical outcome.
Colorectal Neoplasms
Immune Profiling of Premalignant Lesions in Patients With Lynch Syndrome.
Colorectal Neoplasms
Immunogenomic pathways associated with cytotoxic lymphocyte infiltration and survival in colorectal cancer.
Colorectal Neoplasms
Implications of Circadian Rhythm Regulation by microRNAs in Colorectal Cancer.
Colorectal Neoplasms
In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.
Colorectal Neoplasms
In silico pathway analysis and tissue specific cis-eQTL for colorectal cancer GWAS risk variants.
Colorectal Neoplasms
In Vitro and In Silico Mechanistic Insights into miR-21-5p-Mediated Topoisomerase Drug Resistance in Human Colorectal Cancer Cells.
Colorectal Neoplasms
INHBB Is a Novel Prognostic Biomarker Associated with Cancer-Promoting Pathways in Colorectal Cancer.
Colorectal Neoplasms
Integrated Analysis of the Immune Infiltrates and PD-L1 Expression of N6-Methyladenosine-Related Long Non-Coding RNAs in Colorectal Cancer.
Colorectal Neoplasms
Integrated multi-omics data analyses for exploring the co-occurring and mutually exclusive gene alteration events in colorectal cancer.
Colorectal Neoplasms
Integration and Analysis of Heterogeneous Colorectal Cancer Data for Translational Research.
Colorectal Neoplasms
Integrative Genome-Scale DNA Methylation Analysis of a Large and Unselected Cohort Reveals 5 Distinct Subtypes of Colorectal Adenocarcinomas.
Colorectal Neoplasms
Integrative Omics Analysis Reveals Post-Transcriptionally Enhanced Protective Host Response in Colorectal Cancers with Microsatellite Instability.
Colorectal Neoplasms
Intestinal Epithelial TBK1 Prevents Differentiation of T-helper 17 Cells and Tumorigenesis in Mice.
Colorectal Neoplasms
Japanese version of The Cancer Genome Atlas, JCGA, established using fresh frozen tumors obtained from 5143 cancer patients.
Colorectal Neoplasms
LINC00460 Hypomethylation Promotes Metastasis in Colorectal Carcinoma.
Colorectal Neoplasms
LncRNA MIR4435-2HG predicts poor prognosis in patients with colorectal cancer.
Colorectal Neoplasms
Long non-coding RNA ADAMTS9-AS1 suppresses colorectal cancer by inhibiting the Wnt/?-catenin signalling pathway and is a potential diagnostic biomarker.
Colorectal Neoplasms
LSD1 and Aberrant DNA Methylation Mediate Persistence of Enteroendocrine Progenitors That Support BRAF-Mutant Colorectal Cancer.
Colorectal Neoplasms
Membrane expression of thymidine kinase 1 and potential clinical relevance in lung, breast, and colorectal malignancies.
Colorectal Neoplasms
Methylation analysis of Gasdermin E shows great promise as a biomarker for colorectal cancer.
Colorectal Neoplasms
MFG-E8 overexpression promotes colorectal cancer progression via AKT/MMPs signalling.
Colorectal Neoplasms
MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients.
Colorectal Neoplasms
MicroRNA-320 suppresses colorectal cancer by targeting SOX4, FOXM1, and FOXQ1.
Colorectal Neoplasms
miRNA-148a-3p Regulates Immunosuppression in DNA Mismatch Repair-Deficient Colorectal Cancer by Targeting PD-L1.
Colorectal Neoplasms
Mitotic checkpoint regulator RAE1 promotes tumor growth in colorectal cancer.
Colorectal Neoplasms
MLH1-Silenced and Non-Silenced Subgroups of Hypermutated Colorectal Carcinomas Have Distinct Mutational Landscapes.
Colorectal Neoplasms
Molecular and Functional Characterization of the Somatic PIWIL1/piRNA Pathway in Colorectal Cancer Cells.
Colorectal Neoplasms
Morphological characterization of colorectal cancers in The Cancer Genome Atlas reveals distinct morphology-molecular associations: clinical and biological implications.
Colorectal Neoplasms
Mucinous adenocarcinoma is a pharmacogenomically distinct subtype of colorectal cancer.
Colorectal Neoplasms
Multiregion single-cell sequencing reveals the transcriptional landscape of the immune microenvironment of colorectal cancer.
Colorectal Neoplasms
Oncogenic Activity of Wrap53 in Human Colorectal Cancer In Vitro and in Nude Mouse Xenografts.
Colorectal Neoplasms
Oncogenic effect of PHLDB2 is associated with epithelial-mesenchymal transition and E-cadherin regulation in colorectal cancer.
Colorectal Neoplasms
Oncogenic splicing abnormalities induced by DEAD-Box Helicase 56 amplification in colorectal cancer.
Colorectal Neoplasms
Overexpression of the transcription factor ATF3 with a regulatory molecular signature associates with the pathogenic development of colorectal cancer.
Colorectal Neoplasms
Patients with mesenchymal tumours and high Fusobacteriales prevalence have worse prognosis in colorectal cancer (CRC).
Colorectal Neoplasms
Pattern discovery and cancer gene identification in integrated cancer genomic data.
Colorectal Neoplasms
Predicting responses to platin chemotherapy agents with biochemically-inspired machine learning.
Colorectal Neoplasms
Prognostic impact of cancer stem cell markers ABCB1, NEO1 and HIST1H2AE in colorectal cancer.
Colorectal Neoplasms
Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer.
Colorectal Neoplasms
Prognostic impact of tumor budding in endometrial carcinoma within distinct molecular subgroups.
Colorectal Neoplasms
Proteomics of Colorectal Cancer in a Genomic Context: First Large-Scale Mass Spectrometry-Based Analysis from the Cancer Genome Atlas.
Colorectal Neoplasms
PTGS2 Over-Expression: A Colorectal Carcinoma Initiator not an Invasive Factor.
Colorectal Neoplasms
Putative DNA/RNA helicase Schlafen-11 (SLFN11) sensitizes cancer cells to DNA-damaging agents.
Colorectal Neoplasms
pyCancerSig: subclassifying human cancer with comprehensive single nucleotide, structural and microsatellite mutational signature deconstruction from whole genome sequencing.
Colorectal Neoplasms
Quality control of single amino acid variations detected by tandem mass spectrometry.
Colorectal Neoplasms
Ribosome Assembly Factor URB1 Contributes to Colorectal Cancer Proliferation via Transcriptional Activation of ATF4.
Colorectal Neoplasms
Sampling Based Tumor Recognition in Whole-slide Histology Image with Deep Learning Approaches.
Colorectal Neoplasms
Simultaneous inference of cancer pathways and tumor progression from cross-sectional mutation data.
Colorectal Neoplasms
Somatic microsatellite variability as a predictive marker for colorectal cancer and liver cancer progression.
Colorectal Neoplasms
STAT1 as a potential prognosis marker for poor outcomes of early stage colorectal cancer with microsatellite instability.
Colorectal Neoplasms
Synergistic effect of fasting-mimicking diet and vitamin C against KRAS mutated cancers.
Colorectal Neoplasms
The clinical implications of immunogenomics in colorectal cancer: A path for precision medicine.
Colorectal Neoplasms
The Clinicopathological Characteristics of Alpha-Fetoprotein-Producing Adenocarcinoma of the Gastrointestinal Tract-A Single-Center Retrospective Study.
Colorectal Neoplasms
The Doppelgänger Effect: Hidden Duplicates in Databases of Transcriptome Profiles.
Colorectal Neoplasms
The efficacy of anti-EGFR therapy in treating metastatic colorectal cancer differs between the middle/low rectum and the left-sided colon.
Colorectal Neoplasms
The frequency of promoter DNA hypermethylation is decreased in colorectal neoplasms of familial adenomatous polyposis.
Colorectal Neoplasms
The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients.
Colorectal Neoplasms
The miR-608 rs4919510 polymorphism may modify cancer susceptibility based on type.
Colorectal Neoplasms
The roles and prognostic significance of ABI1-TSV-11 expression in patients with left-sided colorectal cancer.
Colorectal Neoplasms
TNNT1, negatively regulated by miR-873, promotes the progression of colorectal cancer.
Colorectal Neoplasms
Transcriptome analysis of copper homeostasis genes reveals coordinated upregulation of SLC31A1,SCO1, and COX11 in colorectal cancer.
Colorectal Neoplasms
TTPAL Promotes Colorectal Tumorigenesis by Stabilizing TRIP6 to Activate Wnt/?-Catenin Signaling.
Colorectal Neoplasms
Tumor suppressive autophagy in intestinal stem cells controls gut homeostasis.
Colorectal Neoplasms
Twist1 and AP-1 cooperatively upregulate integrin ?5 expression to induce invasion and the epithelial-mesenchymal transition.
Colorectal Neoplasms
Twist1/2 activates MMP2 expression via binding to its promoter in colorectal cancer.
Colorectal Neoplasms
Upregulation of SLC2A3 gene and prognosis in colorectal carcinoma: analysis of TCGA data.
Colorectal Neoplasms
WISP3 is highly expressed in a subset of colorectal carcinomas with a better prognosis.
Colorectal Neoplasms
[Downregulation of OGDHL expression is associated with promoter hypermethylation in colorectal cancer].
Coma
Location of Subcortical Microbleeds and Recovery of Consciousness After Severe Traumatic Brain Injury.
Communicable Diseases
A cooperative study of sarcoidosis in Asia and Africa: analytic epidemiology.
Communicable Diseases
A systematic examination of international funding flows for Ebola virus and Zika virus outbreaks 2014-2019: donors, recipients and funding purposes.
Communicable Diseases
Rapid single cell evaluation of human disease and disorder targets using REVEAL: SingleCell.
Communicable Diseases
[Actual problems of creation of informational-analytical system for rapid control of epidemics of infectious diseases].
Communicable Diseases
[Banks of biological resources in the system of basic epidemiological and clinical studies].
Confusion
Characterizing spatially varying performance to improve multi-atlas multi-label segmentation.
Congenital Abnormalities
A Manual and Atlas of Orthopedic Surgery, General and Special, Including the History, Etiology, Pathology, Diagnosis, Prognosis, Prophylaxis and Treatment of Deformities.
Congenital Abnormalities
An atlas vertebra with a centrum? A case report of an abnormal atlas and axis.
Congenital Abnormalities
An unusual form of occipitocervical assimilation presenting with spastic tetraparesis in a child.
Congenital Abnormalities
Anteroposterior spondyloschisis of atlas with incurving of the posterior arch causing compressive myelopathy.
Congenital Abnormalities
Aplasia of anterior arch of atlas associated with multiple congenital disorders: Case report.
Congenital Abnormalities
Atlantoaxial dislocation with congenital "sandwich fusion" in the craniovertebral junction: a retrospective case series of 70 patients.
Congenital Abnormalities
Atlantoaxial rotatory fixation. Radiographic study of its mechanism.
Congenital Abnormalities
Cervical myelopathy caused by hypoplasia of the atlas: two case reports and review of the literature.
Congenital Abnormalities
Cervical myelopathy caused by invaginated laminae of the axis associated with occipitalizaion of the atlas: Case report and literature review.
Congenital Abnormalities
Clinical management of cranio-vertebral instability after whiplash, when guidelines should be adapted: A case report.
Congenital Abnormalities
Congenital absence of the posterior arch of the atlas associated with a fracture of the anterior arch.
Congenital Abnormalities
Congenital anomaly of the atlas misdiagnosed as posterior arch fracture of the atlas and atlantoaxial subluxation.
Congenital Abnormalities
Congenital anterior midline cleft of the atlas and posterior atlanto-occipital fusion associated with symptomatic anterior atlantoaxial subluxation.
Congenital Abnormalities
Congenital defect of the anterior arch of the atlas: a case report and review of the literature.
Congenital Abnormalities
Congenital defect of the atlas and axis. A cause of misdiagnose when evaluating an acute neck trauma.
Congenital Abnormalities
Congenital defects of the posterior arch of the atlas: a report of seven cases including an affected mother and son.
Congenital Abnormalities
Congenital deformities of the hand: an atlas of their surgical treatment.
Congenital Abnormalities
Congenital partial aplasia of the posterior arch of the atlas causing myelopathy: case report and review of the literature.
Congenital Abnormalities
Creating a virtual surgical atlas of craniofacial procedures: Part I. Three-dimensional digital models of craniofacial deformities.
Congenital Abnormalities
Incidence of congenital anomalies in a rural population of Jammu - A prospective study.
Congenital Abnormalities
Incidental findings of posterior arch defects of the atlas in orthodontic patients: A case series.
Congenital Abnormalities
Painful torticollis due to tubercular atlantoaxial rotatory fixation: A case report.
Congenital Abnormalities
Posterior arch defects of the atlas: significance in trauma and literature review.
Congenital Abnormalities
Primary Internal Fixation of Unilateral C1 Lateral Mass Sagittal Split Fractures: A Series of 3 Cases.
Congenital Abnormalities
Quantitative Measurements of the Skull Base and Craniovertebral Junction in Congenital Occipitalization of the Atlas: A Computed Tomography-Based Anatomic Study.
Congenital Abnormalities
Rotatory Subluxation and Facet Deformity in the Atlanto-occipital Joint in Patients with Chronic Atlantoaxial Rotatory Fixation: Two Case Reports.
Congenital Abnormalities
Spinal compression due to atlantal vertebral malformation in two African lions (Panthera leo).
Congenital Abnormalities
The frequency and clinical significance of congenital defects of the posterior and anterior arch of the atlas.
Congenital Abnormalities
Three-dimensional morphology and kinematics of the craniovertebral junction in rheumatoid arthritis.
Congenital Abnormalities
Transoral osteosynthesis c1 as a function-preserving option in the treatment of bipartite atlas deformity: a case report.
Congenital Abnormalities
Unsuspected atlas fracture and instability associated with oropharyngeal injury: case report.
Congenital Abnormalities
Variants and deformities of atlas vertebrae in Eastern Anatolian people.
Congenital Abnormalities
[2 cases of bone deformity at the cranio-vertebral junction, accompanying occipitalization of atlas and basilar impression]
Congenital Abnormalities
[Application of spiral CT reconstruction in the forensic identification of atlantoaxial injuries]
Congenital Abnormalities
[Capacity of monitoring system on birth defects during 1990s in China]
Congenital Abnormalities
[Case of the month. Chiari I deformity and osteochondroma of the atlas]
Congenital Abnormalities
[Diagnostic imaging in congenital abnormalities of the posterior arch of the atlas. Report of 2 cases and review of the literature]
Congenital Abnormalities
[Mucopolysaccharidosis 6-A (Maroteaux-Lamy disease): comparison of clinical and pathologico-anatomic findings in a 27-year-old patient]
Congenital Abnormalities
[Roles of computed tomography in the diagnosis and treatment of complex atlas pillow deformity].
Congenital Abnormalities
[Sclerosis of the anterior arch of the atlas. A rare congenital abnormality]
Congenital Abnormalities
[The frequency and practical significance of congenital defect of the posterior arch of the atlas]
Congenital Microtia
Complete occipitalization of the atlas with bilateral external auditory canal atresia.
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Aplasia of anterior arch of atlas associated with multiple congenital disorders: Case report.
Corneal Wavefront Aberration
Custom optimization of intraocular lens asphericity.
Coronary Artery Disease
A collaborative resource to build consensus for automated left ventricular segmentation of cardiac MR images.
Coronary Disease
Coronary heart disease and hypertension among Jews immigrated to Israel from the Atlas Mountain region of North Africa.
Coronary Disease
Insight Mechanism of the Selective Lanosterol Synthase Inhibitor: Molecular Modeling, Docking and Density Functional Theory Approaches.
Coronavirus Infections
A transcriptional regulatory atlas of coronavirus infection of human cells.
COVID-19
A single-cell and spatial atlas of autopsy tissues reveals pathology and cellular targets of SARS-CoV-2.
COVID-19
A Single-Cell Atlas of Lymphocyte Adaptive Immune Repertoires and Transcriptomes Reveals Age-Related Differences in Convalescent COVID-19 Patients.
COVID-19
A single-cell atlas of the peripheral immune response in patients with severe COVID-19.
COVID-19
An atlas connecting shared genetic architecture of human diseases and molecular phenotypes provides insight into COVID-19 susceptibility.
COVID-19
An Autoantigen Atlas from Human Lung HFL1 Cells Offers Clues to Neurological and Diverse Autoimmune Manifestations of COVID-19.
COVID-19
An Autoantigen Profile of Human A549 Lung Cells Reveals Viral and Host Etiologic Molecular Attributes of Autoimmunity in COVID-19.
COVID-19
An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19.
COVID-19
An Autoantigen-ome from HS-Sultan B-Lymphoblasts Offers a Molecular Map for Investigating Autoimmune Sequelae of COVID-19.
COVID-19
Collective aeromedical evacuations of SARS-CoV-2-related ARDS patients in a military tactical plane: a retrospective descriptive study.
COVID-19
COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas.
COVID-19
COVID-19: complexity of disease severity revealed by systemic and localized single cell immune atlas.
COVID-19
COVID-19: Once upon a time in Portugal: A brief atlas of ongoing pandemic Portuguese research.
COVID-19
Expansion of Single Cell Transcriptomics Data of SARS-CoV Infection in Human Bronchial Epithelial Cells to COVID-19.
COVID-19
High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa.
COVID-19
In silico exploration of enzymes involved in sialic acid biosynthesis and their possible role in SARS-CoV-2 infection.
COVID-19
Introducing and Implementing HIV Self-Testing in Côte d'Ivoire, Mali, and Senegal: What Can We Learn From ATLAS Project Activity Reports in the Context of the COVID-19 Crisis?
COVID-19
Longitudinal Peripheral Blood Transcriptional Analysis Reveals Molecular Signatures of Disease Progression in COVID-19 Patients.
COVID-19
Rapid single cell evaluation of human disease and disorder targets using REVEAL: SingleCell.
COVID-19
SARS-CoV-2 receptor is co-expressed with elements of the kinin-kallikrein, renin-angiotensin and coagulation systems in alveolar cells.
COVID-19
T-CoV: a comprehensive portal of HLA-peptide interactions affected by SARS-CoV-2 mutations.
Coxa Vara
Risk factors of myelopathy at the atlantoaxial level in spondyloepiphyseal dysplasia congenita.
Cranial Nerve Diseases
Occipital condyle fractures: clinical presentation and radiologic detection.
Craniocerebral Trauma
A single administration of the peptide NAP induces long-term protective changes against the consequences of head injury: gene Atlas array analysis.
Craniocerebral Trauma
Computation of axonal elongation in head trauma finite element simulation.
Craniocerebral Trauma
Fractures of the atlas: can we rely on the NICE guidelines for imaging the cervical spine after head injury?
Craniopharyngioma
Endoscopic endonasal transplanum transtuberculum approach for resection of retrochiasmatic craniopharyngioma.
Craniopharyngioma
Modified one-piece extended transbasal approach for translamina terminalis resection of retrochiasmatic third ventricular craniopharyngioma.
Craniopharyngioma
Orbitopterional Craniotomy Resection of Pediatric Suprasellar Craniopharyngioma.
Craniosynostoses
Morphogenesis of Canine Chiari Malformation and Secondary Syringomyelia: Disorders of Cerebrospinal Fluid Circulation.
Crohn Disease
A cross-platform informatics system for the Gut Cell Atlas: integrating clinical, anatomical and histological data.
Crohn Disease
Small Bowel Crohn Disease at CT and MR Enterography: Imaging Atlas and Glossary of Terms.
Cross Infection
First year of mandatory reporting of healthcare-associated infections, pennsylvania: an infection control-chart abstractor collaboration.
Cryptorchidism
Pivotal role of the muscle-contraction pathway in cryptorchidism and evidence for genomic connections with cardiomyopathy pathways in RASopathies.
Cushing Syndrome
Atlas of iodocholesterol scintigraphy (NP-59) in Cushing's syndrome with CT and MR correlation.
Cystadenocarcinoma, Serous
A five-DNA methylation signature act as a novel prognostic biomarker in patients with ovarian serous cystadenocarcinoma.
Cystadenocarcinoma, Serous
A novel scoring system for pivotal autophagy-related genes predicts outcomes after chemotherapy in advanced ovarian cancer patients.
Cystadenocarcinoma, Serous
Beclin-1 expression is retained in high-grade serous ovarian cancer yet is not essential for autophagy induction in vitro.
Cystadenocarcinoma, Serous
Biological Interpretation of Morphological Patterns in Histopathological Whole-Slide Images.
Cystadenocarcinoma, Serous
Chemoresistance-associated alternative splicing signatures in serous ovarian cancer.
Cystadenocarcinoma, Serous
Combination of Immune-Related Genomic Alterations Reveals Immune Characterization and Prediction of Different Prognostic Risks in Ovarian Cancer.
Cystadenocarcinoma, Serous
Discovery of microarray-identified genes associated with ovarian cancer progression.
Cystadenocarcinoma, Serous
Dynamic TF-lncRNA Regulatory Networks Revealed Prognostic Signatures in the Development of Ovarian Cancer.
Cystadenocarcinoma, Serous
Evaluation of hierarchical models for integrative genomic analyses.
Cystadenocarcinoma, Serous
Focal Recurrent Copy Number Alterations Characterize Disease Relapse in High Grade Serous Ovarian Cancer Patients with Good Clinical Prognosis: A Pilot Study.
Cystadenocarcinoma, Serous
Integration and comparison of different genomic data for outcome prediction in cancer.
Cystadenocarcinoma, Serous
Knockdown of TMEM14A expression by RNAi inhibits the proliferation and invasion of human ovarian cancer cells.
Cystadenocarcinoma, Serous
NFAT Overexpression Correlates with CA72-4 and Poor Prognosis of Ovarian Clear-Cell Carcinoma Subtype.
Cystadenocarcinoma, Serous
Prognostic Role of Zinc Finger Homeobox 4 in Ovarian Serous Cystadenocarcinoma.
Cystadenocarcinoma, Serous
The Study of the Expression of CGB1 and CGB2 in Human Cancer Tissues.
Cystadenocarcinoma, Serous
Two protein-coding genes act as a novel clinical signature to predict prognosis in patients with ovarian serous cystadenocarcinoma.
Cystic Fibrosis
Varied clinical significance of ATP-binding cassette C sub-family members for lung adenocarcinoma.
Cystitis, Interstitial
Comment on "Presenting an Atlas of Hunner lesions in interstitial cystitis which can be identified with office cystoscopy" by Ronstrom and Lai, Neurourology and Urodynamics 2020;1-7. https://doi.org/10.1002/nau.24500.
Cystitis, Interstitial
Presenting an atlas of Hunner lesions in interstitial cystitis which can be identified with office cystoscopy.
Cysts
Development and reproducibility of a first metatarsophalangeal joint osteoarthritis magnetic resonance imaging scoring system.
Cysts
Surgical approach for synovial cyst of the atlantoaxial joint: a case report and review of the literature.
Cysts
[Vertebrobasilar arterial thrombosis secondary to aneurysmatic cysts of the atlas and the epistropheus]
Deglutition Disorders
Abnormal bony protuberance of anterior atlas causing dysphagia. A rare congenital anomaly.
Deglutition Disorders
Evaluation of the Risk of Grade 3 Oral and Pharyngeal Dysphagia Using Atlas-Based Method and Multivariate Analyses of Individual Patient Dose Distributions.
Deglutition Disorders
High-resolution manometry: an atlas of esophageal motility disorders and findings of GERD using esophageal pressure topography.
Deglutition Disorders
The photographic atlas of Spanish food consistency: a new tool for the treatment of dysphagia.
Deglutition Disorders
[Atlantoaxial malformation as a rare cause of dysphagia and snoring.]
Dehydration
Assessment of nutritional status in the Amazigh children of Amizmiz (Azgour Valley, High Atlas and Morocco).
Dehydration
[Study of acute dehydration in infants in a summer resort in the Middle Atlas: El Ksiba.]
Delirium
Relationships between preoperative cortical thickness, postoperative electroencephalogram slowing, and postoperative delirium.
Dementia
A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: reliability and validation against manual measurement of total intracranial volume.
Dementia
Alzheimer Gene BIN1 may Simultaneously Influence Dementia Risk and Androgen Deprivation Therapy Dosage in Prostate Cancer.
Dementia
Co-occurrent Alterations of Alzheimer's Genes and Prostate Cancer Genes in Prostate Cancer.
Dementia
New computer-aided diagnosis of dementia using positron emission tomography: brain regional sensitivity-mapping method.
Dementia
Operationalizing hippocampal volume as an enrichment biomarker for amnestic mild cognitive impairment trials: effect of algorithm, test-retest variability, and cut point on trial cost, duration, and sample size.
Dementia
[Analysis of cerebral blood flow SPECT imaging on standard brain atlas in patients with dementia of Alzheimer type]
Dementia
[Stepwise analysis of cerebral blood flow SPECT imaging on standard brain atlas in patients with dementia of Alzheimer's type]
Demyelinating Diseases
Myelin Water Atlas: A Template for Myelin Distribution in the Brain.
Demyelinating Diseases
White matter atlas of the human spinal cord with estimation of partial volume effect.
Dermatitis
A prospective picture collection study for a grading atlas of radiation dermatitis for clinical trials in head-and-neck cancer patients.
Dermatitis, Atopic
Scoring of atopic dermatitis by SCORAD using a training atlas by investigators from different disciplines. ETAC Study Group. Early Treatment of the Atopic Child.
Dextrocardia
Review of myocardial viability using Nuclear Medicine imaging in rare cardiac malposition of dextrocardia - understanding right approach.
Diabetes Complications
Research Resource: dkCOIN, the National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK) Consortium Interconnectivity Network: A Pilot Program to Aggregate Research Resources Generated by Multiple Research Consortia.
Diabetes Mellitus
Comparison of type 2 diabetes prevalence estimates in Saudi Arabia from a validated Markov model against the International Diabetes Federation and other modelling studies.
Diabetes Mellitus
Diabetes, Epstein-Barr virus and extranodal natural killer/T-cell lymphoma in India: Unravelling the plausible nexus.
Diabetes Mellitus
Do we have enough ophthalmologists to manage vision-threatening diabetic retinopathy? A global perspective.
Diabetes Mellitus
Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trial.
Diabetes Mellitus
T2DiACoD: A Gene Atlas of Type 2 Diabetes Mellitus Associated Complex Disorders.
Diabetes Mellitus
TAXUS Liberté attenuates the risk of restenosis in patients with medically treated diabetes mellitus: results from the TAXUS ATLAS program.
Diabetes Mellitus, Type 1
Diabetes in the young - a global view and worldwide estimates of numbers of children with type 1 diabetes.
Diabetes Mellitus, Type 1
MicroRNA expression in alpha and beta cells of human pancreatic islets.
Diabetes Mellitus, Type 1
Single-cell RNA sequencing of murine islets shows high cellular complexity at all stages of autoimmune diabetes.
Diabetes Mellitus, Type 1
WITHDRAWN: IDF Diabetes Atlas: Worldwide Estimates of Incidence, Prevalence and Mortality of Type 1 Diabetes in Children and Adolescents: Results from the International Diabetes Federation Diabetes Atlas, 9th edition.
Diabetes Mellitus, Type 2
An atlas on risk factors for type 2 diabetes: a wide-angled Mendelian randomisation study.
Diabetes Mellitus, Type 2
Comparison of type 2 diabetes prevalence estimates in Saudi Arabia from a validated Markov model against the International Diabetes Federation and other modelling studies.
Diabetes Mellitus, Type 2
Determination of the mutational landscape in Taiwanese patients with papillary thyroid cancer by whole-exome sequencing.
Diabetes Mellitus, Type 2
Patient-led versus physician-led titration of insulin glargine in patients with uncontrolled type 2 diabetes: a randomized multinational atlas study.
Diabetes Mellitus, Type 2
SGI: Automatic clinical subgroup identification in omics datasets.
Diabetes Mellitus, Type 2
T2DiACoD: A Gene Atlas of Type 2 Diabetes Mellitus Associated Complex Disorders.
Diabetes Mellitus, Type 2
The dietetic workforce distribution geographic atlas provides insight into the inequitable access for dietetic services for people with type 2 diabetes in Australia.
DiGeorge Syndrome
DGCR8/ZFAT-AS1 Promotes CDX2 Transcription in a PRC2 Complex-Dependent Manner to Facilitate the Malignant Biological Behavior of Glioma Cells.
Digestive System Neoplasms
The Impact of MicroRNA-133a on Prognosis and Clinicopathological Parameters for Digestive System Cancers: a Comprehensive Study Based on Meta-Analysis and TCGA Database.
Down Syndrome
Congenital defects of C1 arches and odontoid process in a child with Down's syndrome: A case presentation.
Down Syndrome
Intraobserver reproducibility and interobserver reliability of cervical spine measurements.
Down Syndrome
Occult spinal canal stenosis due to C-1 hypoplasia in children with Down syndrome.
Down Syndrome
Persistent torticollis, facial asymmetry, grooved tongue, and dolicho-odontoid process in connection with atlas malformation complex in three family subjects.
Down Syndrome
Screw fixation of the upper cervical spine in the pediatric population. Clinical article.
Down Syndrome
Simulated Keratometry Repeatability in Subjects with and without Down Syndrome.
Down Syndrome
Subluxation of the atlas causing spinal cord compression in a case of Down's syndrome with a "manifestation of an occipital vertebra".
Down Syndrome
The relationship between atlas hypoplasia and os odontoideum in children with Down syndrome: a preliminary case report.
Down Syndrome
[Spinal stenosis at the level of atlas in a boy with Down syndrome. A case report and literature review.]
Down Syndrome
[Spontaneous atlas dislocation in a child with trisomy 21 and rheumatoid arthritis]
Drug-Related Side Effects and Adverse Reactions
An atlas of G-protein coupled receptor expression and function in human subcutaneous adipose tissue.
Drug-Related Side Effects and Adverse Reactions
Drug-Induced Rhabdomyolysis Atlas (DIRA) for idiosyncratic adverse drug reaction management.
Dupuytren Contracture
Cellular census of human fibrosis defines functionally distinct stromal cell types and states.
Dysarthria
Probabilistic map of critical functional regions of the human cerebral cortex: Broca's area revisited.
Dyslipidemias
Ethnicity and socioeconomic status influence use of primary angioplasty in patients presenting with acute myocardial infarction.
Dysplastic Nevus Syndrome
A natural history of melanomas and dysplastic nevi: an atlas of lesions in melanoma-prone families.
Dystonia
Reduction of cervical dystonia after an extended course of chiropractic manipulation: a case report.
Dystonia
Spatial reorganization of putaminal dopamine D2-like receptors in cranial and hand dystonia.
Dystonia
The optimal pallidal target in deep brain stimulation for dystonia: a study using a functional atlas based on nonlinear image registration.
Dystonic Disorders
Connectome-Wide Phenotypical and Genotypical Associations in Focal Dystonia.
Echinococcosis
Community perception and knowledge of cystic echinococcosis in the High Atlas Mountains, Morocco.
Echinococcosis
Control of cystic echinococcosis in the Middle Atlas, Morocco: Field evaluation of the EG95 vaccine in sheep and cesticide treatment in dogs.
Echinococcosis
Cystic echinococcosis in the Berber of the Mid Atlas mountains, Morocco: new insights into the natural history of the disease in humans.
Echinococcosis
Cystic Echinococcosis in Three Locations in the Middle Atlas, Morocco: Estimation of the Infection Rate in the Dog Reservoir.
Echinococcosis
Human cystic echinococcosis in Morocco: Ultrasound screening in the Mid Atlas through an Italian-Moroccan partnership.
Ehlers-Danlos Syndrome
[Atlanto-axial, Atlanto-occipital dislocations, developmental cervical canal stenosis in the Ehlers-Danlos syndrome (author's transl)]
Elephantiasis
Mapping the geographical distribution of podoconiosis in Cameroon using parasitological, serological, and clinical evidence to exclude other causes of lymphedema.
Elephantiasis, Filarial
Complex emergencies and the control and elimination of neglected tropical diseases in Africa: developing a practical approach for implementing safe and effective mapping and intervention strategies.
Encephalitis
Microarray analysis of cytokine and chemokine genes in the brains of macaques with SHIV-encephalitis.
Encephalitis
[Atlas of nervous system diseases. 6. Autopsy case of subacute necrotic encephalitis]
Encephalitis, Tick-Borne
[The "natural focal diseases" medical and geographical atlas of Russia as a tool to analyze their incidence in the population].
Encephalocele
[Duraplasty with Neuropatch versus autologous fascia lata for Chiari I malformation with syringomyelia: a comparative study]
Encephalomyelitis
[Atlas series in neuropathology. (14). Pathology of encephalomyelitis. (2). Tuberculous meningitis]
Encephalomyelitis
[NEUROPATHOLOGICAL ATLAS. 3. PATHOLOGY OF DEMYELINATING ENCEPHALOMYELITIS (1)]
Endemic Diseases
Longevity and selenium deficiency: evidence from the People's Republic of China.
Endocarditis
Infective endocarditis: An atlas of disease progression for describing, staging, coding, and understanding the pathology.
Endometrial Neoplasms
A 4-Gene Signature Associated With Recurrence in Low- and Intermediate-Risk Endometrial Cancer.
Endometrial Neoplasms
A clinically applicable molecular-based classification for endometrial cancers.
Endometrial Neoplasms
A genome-wide view of microsatellite instability: old stories of cancer mutations revisited with new sequencing technologies.
Endometrial Neoplasms
A long noncoding RNAs signature to improve survival prediction in endometrioid endometrial cancer.
Endometrial Neoplasms
A Risk Signature with Nine Stemness Index-Associated Genes for Predicting Survival of Patients with Uterine Corpus Endometrial Carcinoma.
Endometrial Neoplasms
Activating ESR1 mutations in hormone-resistant metastatic breast cancer.
Endometrial Neoplasms
Adjuvant therapy for endometrial cancer in the era of molecular classification: radiotherapy, chemoradiation and novel targets for therapy.
Endometrial Neoplasms
Adjuvant Treatment Recommendations in Early-Stage Endometrial Cancer: What Changes With the Introduction of The Integrated Molecular-Based Risk Assessment.
Endometrial Neoplasms
Amplification of the NSD3-BRD4-CHD8 pathway in pelvic high-grade serous carcinomas of tubo-ovarian and endometrial origin.
Endometrial Neoplasms
An integrated autophagy-related gene signature predicts prognosis in human endometrial Cancer.
Endometrial Neoplasms
An Integrated Autophagy-Related Long Noncoding RNA Signature as a Prognostic Biomarker for Human Endometrial Cancer: A Bioinformatics-Based Approach.
Endometrial Neoplasms
An miRNA signature associated with tumor mutation burden in endometrial cancer.
Endometrial Neoplasms
Analysis of carcinogenic signaling networks in endometrial cancer identifies RAB17 as a potential target.
Endometrial Neoplasms
ARID1A and CTNNB1/?-Catenin Molecular Status Affects the Clinicopathologic Features and Prognosis of Endometrial Carcinoma: Implications for an Improved Surrogate Molecular Classification.
Endometrial Neoplasms
Association between differential gene expression and body mass index among endometrial cancers from The Cancer Genome Atlas Project.
Endometrial Neoplasms
Association between endometrial cancer risk classification and gene expression in the cancer genome atlas database.
Endometrial Neoplasms
aWCluster: A Novel Integrative Network-based Clustering of Multiomics for Subtype Analysis of Cancer Data.
Endometrial Neoplasms
Bioinformatic analysis of four miRNAs relevant to metastasis-regulated processes in endometrial carcinoma.
Endometrial Neoplasms
Characterization of immune regulatory molecules B7-H4 and PD-L1 in low and high grade endometrial tumors.
Endometrial Neoplasms
Classification of Endometrial Carcinoma: New Perspectives Beyond Morphology.
Endometrial Neoplasms
Clinical value screening, prognostic significance and key pathway identification of miR-204-5p in endometrial carcinoma: A study based on the Cancer Genome Atlas (TCGA), and bioinformatics analysis.
Endometrial Neoplasms
Clinicopathologic and Genomic Analysis of TP53-Mutated Endometrial Carcinomas.
Endometrial Neoplasms
Clinicopathological analysis of endometrial carcinomas harboring somatic POLE exonuclease domain mutations.
Endometrial Neoplasms
Clinicopathological and molecular characterisation of 'multiple-classifier' endometrial carcinomas.
Endometrial Neoplasms
CNR1 may reverse progesterone-resistance of endometrial cancer through the ERK pathway.
Endometrial Neoplasms
Comprehensive genomic profiling of recurrent endometrial cancer: Implications for selection of systemic therapy.
Endometrial Neoplasms
Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer.
Endometrial Neoplasms
Construction of a Competitive Endogenous RNA Network in Uterine Corpus Endometrial Carcinoma.
Endometrial Neoplasms
Construction of a Glycolysis-related long noncoding RNA signature for predicting survival in endometrial cancer.
Endometrial Neoplasms
Cooperative driver pathway discovery via fusion of multi-relational data of genes, miRNAs and pathways.
Endometrial Neoplasms
DACH1 mutation frequency in endometrial cancer is associated with high tumor mutation burden.
Endometrial Neoplasms
Decreased secretoglobin family 2A member 1expression is associated with poor outcomes in endometrial cancer.
Endometrial Neoplasms
Defining a mutational signature for endometrial cancer screening and early detection.
Endometrial Neoplasms
Deregulation of cell adhesion molecules is associated with progression and poor outcomes in endometrial cancer: Analysis of The Cancer Genome Atlas data.
Endometrial Neoplasms
Diagnostic Accuracy of Immunohistochemistry for Mismatch Repair Proteins as Surrogate of Microsatellite Instability Molecular Testing in Endometrial Cancer.
Endometrial Neoplasms
Discovery and validation of methylation markers for endometrial cancer.
Endometrial Neoplasms
DNA Methylation Signatures in Vaginal Fluid Samples for Detection of Cervical and Endometrial Cancer.
Endometrial Neoplasms
DNMT3A/3B overexpression might be correlated with poor patient survival, hypermethylation and low expression of ESR1/PGR in endometrioid carcinoma: an analysis of The Cancer Genome Atlas.
Endometrial Neoplasms
Downregulation of HOXA11 enhances endometrial cancer malignancy and cisplatin resistance via activating PTEN/AKT signaling pathway.
Endometrial Neoplasms
Endometrial cancer gene panels: clinical diagnostic vs research germline DNA testing.
Endometrial Neoplasms
Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists.
Endometrial Neoplasms
Expression of neurotensin receptor 1 in endometrial adenocarcinoma is correlated with histological grade and clinical outcome.
Endometrial Neoplasms
Expression of the Receptor for Hyaluronic Acid-Mediated Motility (RHAMM) in Endometrial Cancer is Associated With Adverse Histologic Parameters and Tumor Progression.
Endometrial Neoplasms
Final Validation of the ProMisE Molecular Classifier for Endometrial Carcinoma in a Large Population-based Case Series.
Endometrial Neoplasms
Frequent Homologous Recombination Deficiency in High-grade Endometrial Carcinomas.
Endometrial Neoplasms
Frequent mutations in the RPL22 gene and its clinical and functional implications.
Endometrial Neoplasms
Gene expression profiles of human endometrial cancer samples using a cDNA-expression array technique: assessment of an analysis method.
Endometrial Neoplasms
Genome-wide analysis of gynecologic cancer: The Cancer Genome Atlas in ovarian and endometrial cancer.
Endometrial Neoplasms
Genomic alterations in gynecological malignancies: histotype-associated driver mutations, molecular subtyping schemes, and tumorigenic mechanisms.
Endometrial Neoplasms
Genomic Analysis of Uterine Lavage Fluid Detects Early Endometrial Cancers and Reveals a Prevalent Landscape of Driver Mutations in Women without Histopathologic Evidence of Cancer: A Prospective Cross-Sectional Study.
Endometrial Neoplasms
High APOBEC1 Complementation Factor Expression Positively Modulates the Proliferation, Invasion, and Migration of Endometrial Cancer Cells Through Regulating P53/P21 Signaling Pathway.
Endometrial Neoplasms
High stathmin expression is a marker for poor clinical outcome in endometrial cancer: An NRG oncology group/gynecologic oncology group study.
Endometrial Neoplasms
High-Grade Endometrial Carcinomas: Classification with Molecular Insights.
Endometrial Neoplasms
Identification and Development of Subtypes With Poor Prognosis in Pan-Gynecological Cancer Based on Gene Expression in the Glycolysis-Cholesterol Synthesis Axis.
Endometrial Neoplasms
Identification and Function Analysis of a Five-Long Noncoding RNA Prognostic Signature for Endometrial Cancer Patients.
Endometrial Neoplasms
Identification of candidate target genes for endometrial cancer, such as ANO1, using weighted gene co-expression network analysis.
Endometrial Neoplasms
Identification of novel prognosis-related genes in the endometrial cancer immune microenvironment.
Endometrial Neoplasms
Immune infiltration and a ferroptosis-associated gene signature for predicting the prognosis of patients with endometrial cancer.
Endometrial Neoplasms
Impact of endometrial carcinoma histotype on the prognostic value of the TCGA molecular subgroups.
Endometrial Neoplasms
Inactivating Mutations of the IK Gene Weaken Ku80/Ku70-Mediated DNA Repair and Sensitize Endometrial Cancer to Chemotherapy.
Endometrial Neoplasms
Interobserver Agreement in Endometrial Carcinoma Histotype Diagnosis Varies Depending on The Cancer Genome Atlas (TCGA)-based Molecular Subgroup.
Endometrial Neoplasms
Keratin 17 is a negative prognostic biomarker in high-grade endometrial carcinomas.
Endometrial Neoplasms
L1CAM is an independent predictor of poor survival in endometrial cancer - An analysis of The Cancer Genome Atlas (TCGA).
Endometrial Neoplasms
Label propagation defines signaling networks associated with recurrently mutated cancer genes.
Endometrial Neoplasms
Loss of ASRGL1 expression is an independent biomarker for disease-specific survival in endometrioid endometrial carcinoma.
Endometrial Neoplasms
LYL1 gene amplification predicts poor survival of patients with uterine corpus endometrial carcinoma: analysis of the Cancer genome atlas data.
Endometrial Neoplasms
Minichromosome maintenance complex component 6 (MCM6) expression correlates with histological grade and survival in endometrioid endometrial adenocarcinoma.
Endometrial Neoplasms
MiR-29a-5p inhibits proliferation and invasion and induces apoptosis in endometrial carcinoma via targeting TPX2.
Endometrial Neoplasms
Mismatch repair deficiency as a predictive marker for response to adjuvant radiotherapy in endometrial cancer.
Endometrial Neoplasms
Mixed endometrial carcinomas with a "low-grade serous"-like component: a clinicopathologic, immunohistochemical, and molecular genetic study.
Endometrial Neoplasms
Molecular characterization in the prediction of disease extent in endometrial carcinoma.
Endometrial Neoplasms
Molecular characterization of endometrial cancer and therapeutic implications.
Endometrial Neoplasms
Molecular genetic heterogeneity in undifferentiated endometrial carcinomas.
Endometrial Neoplasms
Molecular-based classification algorithm for endometrial carcinoma categorizes ovarian endometrioid carcinoma into prognostically significant groups.
Endometrial Neoplasms
Molecular-targeted therapies and precision medicine for endometrial cancer.
Endometrial Neoplasms
New Pathological and Clinical Insights in Endometrial Cancer in View of the Updated ESGO/ESTRO/ESP Guidelines.
Endometrial Neoplasms
Oncomorphic TP53 Mutations in Gynecologic Cancers Lose the Normal Protein:Protein Interactions with the microRNA Microprocessing Complex.
Endometrial Neoplasms
Ornithine decarboxylase as a therapeutic target for endometrial cancer.
Endometrial Neoplasms
p53abn Endometrial Cancer: understanding the most aggressive endometrial cancers in the era of molecular classification.
Endometrial Neoplasms
Pathophysiological Role of Histamine H4 Receptor in Cancer: Therapeutic Implications.
Endometrial Neoplasms
PD-L1 Expression in Endometrial Carcinoma Cells and Intratumoral Immune Cells: Differences Across Histologic and TCGA-based Molecular Subgroups.
Endometrial Neoplasms
Polymerase Epsilon Exonuclease Domain Mutations in Ovarian Endometrioid Carcinoma.
Endometrial Neoplasms
Possible Human Papillomavirus 38 Contamination of Endometrial Cancer RNA Sequencing Samples in The Cancer Genome Atlas Database.
Endometrial Neoplasms
Prognostic impact of tumor budding in endometrial carcinoma within distinct molecular subgroups.
Endometrial Neoplasms
PROGNOSTIC INTEGRATED IMAGE-BASED IMMUNE AND MOLECULAR PROFILING IN EARLY-STAGE ENDOMETRIAL CANCER.
Endometrial Neoplasms
Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancer.
Endometrial Neoplasms
Proteomic analysis of malignant and benign endometrium according to obesity and insulin-resistance status using Reverse Phase Protein Array.
Endometrial Neoplasms
PTEN mutation: A potential prognostic factor associated with immune infiltration in endometrial carcinoma.
Endometrial Neoplasms
Racial differences in endometrial cancer molecular portraits in The Cancer Genome Atlas.
Endometrial Neoplasms
Reclassifying endometrial carcinomas with a combined morphological and molecular approach.
Endometrial Neoplasms
Recurrent hormone-binding domain truncated ESR1 amplifications in primary endometrial cancers suggest their implication in hormone independent growth.
Endometrial Neoplasms
Response to ERBB3-Directed Targeted Therapy in NRG1-Rearranged Cancers.
Endometrial Neoplasms
RNASeq analysis reveals biological processes governing the clinical behaviour of endometrioid and serous endometrial cancers.
Endometrial Neoplasms
Significance of survivin as a prognostic factor and a therapeutic target in endometrial cancer.
Endometrial Neoplasms
STAT1-induced upregulation of lncRNA LINC01123 predicts poor prognosis and promotes the progression of endometrial cancer through miR-516b/KIF4A.
Endometrial Neoplasms
Stratification of endometrioid endometrial cancer patients into risk levels using somatic mutations.
Endometrial Neoplasms
Survival of microsatellite-stable endometrioid endometrial cancer patients after minimally invasive surgery: An analysis of the Cancer Genome Atlas data.
Endometrial Neoplasms
Systematic dissection of the mechanisms underlying progesterone receptor downregulation in endometrial cancer.
Endometrial Neoplasms
Targeting dopamine receptor D2 as a novel therapeutic strategy in endometrial cancer.
Endometrial Neoplasms
TCGA Classification of Endometrial Cancer: the Place of Carcinosarcoma.
Endometrial Neoplasms
TCGA molecular groups of endometrial cancer: Pooled data about prognosis.
Endometrial Neoplasms
The emerging role of molecular pathology in directing the systemic treatment of endometrial cancer.
Endometrial Neoplasms
The evolution of endometrial carcinoma classification through application of immunohistochemistry and molecular diagnostics: past, present and future.
Endometrial Neoplasms
The Genomic Heterogeneity of FIGO Grade 3 Endometrioid Carcinoma Impacts Diagnostic Accuracy and Reproducibility.
Endometrial Neoplasms
The landscape and prognostic value of immune characteristics in uterine corpus endometrial cancer.
Endometrial Neoplasms
The mutational spectrum of FOXA2 in endometrioid endometrial cancer points to a tumor suppressor role.
Endometrial Neoplasms
The pan-cancer analysis of the two types of uterine cancer uncovered clinical and prognostic associations with m6A RNA methylation regulators.
Endometrial Neoplasms
The PVT1/miR-612/CENP-H/CDK1 axis promotes malignant progression of advanced endometrial cancer.
Endometrial Neoplasms
The Study of the Expression of CGB1 and CGB2 in Human Cancer Tissues.
Endometrial Neoplasms
Triple-high expression of phosphatase and tensin homolog (PTEN), estrogen receptor (ER) and progesterone receptor (PR) may predict favorable prognosis for patients with Type I endometrial carcinoma.
Endometrial Neoplasms
Tumor Molecular Features Predict Endometrial Cancer Patients' Survival After Open or Minimally Invasive Surgeries.
Endometrial Neoplasms
Two critical positions in zinc finger domains are heavily mutated in three human cancer types.
Endometrial Neoplasms
Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) Promotes Uterine Serous Cancer Cell Proliferation and Cell Cycle Progression.
Endometrial Neoplasms
Upregulated delta-like protein 3 expression is a diagnostic and prognostic marker in endometrial cancer: A retrospective study.
Endometrial Neoplasms
Utility of a custom designed next generation DNA sequencing gene panel to molecularly classify endometrial cancers according to The Cancer Genome Atlas subgroups.
Endometrial Neoplasms
[Clinical application of TCGA molecular classification in endometrial endometrioid carcinoma].
Endometriosis
Single-cell transcriptomic analysis of endometriosis provides insights into fibroblast fates and immune cell heterogeneity.
Eosinophilic Granuloma
Eosinophilic granuloma of the atlas and the occipital condyle in an adult.
Eosinophilic Granuloma
Eosinophilic granuloma of the atlas presenting as torticollis in a child.
Eosinophilic Granuloma
Eosinophilic granuloma of the spine involving C1 and pulmonary infiltration in young children - Presentation of two cases with a follow-up over 10 years including review of the literature.
Ependymoma
Nucleoporin TPR (translocated promoter region, nuclear basket protein) upregulation alters MTOR-HSF1 trails and suppresses autophagy induction in ependymoma.
Ependymoma
[Preliminary analysis on the gene expression profiles of different types of gliomas with cDNA array]
Epilepsies, Partial
Development and Implementation of a Corriedale Ovine Brain Atlas for Use in Atlas-Based Segmentation.
Epilepsies, Partial
Validation of semi-automated anatomically labeled SEEG contacts in a brain atlas for mapping connectivity in focal epilepsy.
Epilepsy
A high-resolution computational atlas of the human hippocampus from postmortem magnetic resonance imaging at 9.4 T.
Epilepsy
A neurophysiological brain map: Spectral parameterization of the human intracranial electroencephalogram.
Epilepsy
A systems-level analysis highlights microglial activation as a modifying factor in common epilepsies.
Epilepsy
Ablation dynamics during laser interstitial thermal therapy for mesiotemporal epilepsy.
Epilepsy
Atlas of neuropathological lesions in epilepsy surgery: Hippocampal sclerosis, ILAE Type 1
Epilepsy
Atlas of neuropathological lesions in epilepsy surgery: Hippocampal sclerosis, ILAE Type 2 (CA1 - predominant neuronal loss)
Epilepsy
Atlas of neuropathological lesions in epilepsy surgery: Hippocampal sclerosis, ILAE Type 3 (CA4 predominant neuronal loss)
Epilepsy
Atlas of neuropathological lesions in epilepsy surgery: No hippocampal sclerosis (ILAE classification 2013)
Epilepsy
Automated white-matter tractography using a probabilistic diffusion tensor atlas: Application to temporal lobe epilepsy.
Epilepsy
Automatic labeling of the fanning and curving shape of Meyer's loop for epilepsy surgery: an atlas extracted from high-definition fiber tractography.
Epilepsy
Comparative study of joint bioinformatics analysis of underlying potential of 'neurimmiR', miR-212-3P/miR-132-3P, being involved in epilepsy and its emerging role in human cancer.
Epilepsy
Construction of a neuroanatomical shape complex atlas from 3D MRI brain structures.
Epilepsy
Electrical Stimulation of the Anterior Thalamus for Epilepsy: Clinical Outcome and Analysis of Efficient Target.
Epilepsy
Epilepsy Care in the World: results of an ILAE/IBE/WHO Global Campaign Against Epilepsy survey.
Epilepsy
FDG-PET images quantified by probabilistic atlas of brain and surgical prognosis of temporal lobe epilepsy.
Epilepsy
In vivo normative atlas of the hippocampal subfields using multi-echo susceptibility imaging at 7 Tesla.
Epilepsy
MicroRNA-128 expression not associated with glioma-associated epilepsy in WHO grades 2 glioma: Data from the Cancer Genome Atlas (TCGA) project.
Epilepsy
Objective PET study of glucose metabolism asymmetries in children with epilepsy: Implications for normal brain development.
Epilepsy
Quantification of F-18 FDG PET images in temporal lobe epilepsy patients using probabilistic brain atlas.
Epilepsy
The Epileptor model: a systematic mathematical analysis linked to the dynamics of seizures, refractory status epilepticus and depolarization block.
Epilepsy
The Posterior Insula Shows Disrupted Brain Functional Connectivity in Female Migraineurs Without Aura Based on Brainnetome Atlas.
Epilepsy
VEP atlas: An anatomic and functional human brain atlas dedicated to epilepsy patients.
Epilepsy, Temporal Lobe
A high-resolution computational atlas of the human hippocampus from postmortem magnetic resonance imaging at 9.4 T.
Epilepsy, Temporal Lobe
Automated white-matter tractography using a probabilistic diffusion tensor atlas: Application to temporal lobe epilepsy.
Epilepsy, Temporal Lobe
FDG-PET images quantified by probabilistic atlas of brain and surgical prognosis of temporal lobe epilepsy.
Epilepsy, Temporal Lobe
Quantification of F-18 FDG PET images in temporal lobe epilepsy patients using probabilistic brain atlas.
Epstein-Barr Virus Infections
Interpretation of EBV infection in pan-cancer genome considering viral life cycle: LiEB (Life cycle of Epstein-Barr virus).
Erythema
Efficacy of a topical formulation of henna (Lawsonia inermis L.) in contact dermatitis in patients using prosthesis: A double-blind randomized placebo-controlled clinical trial.
Esophageal Atresia
A case series study of therapeutic implications of type IIIb4: a rare variant of esophageal atresia and distal tracheoesophageal fistula.
Esophageal Atresia
Isolated esophageal atresia with spontaneous recanalization: case report.
Esophageal Motility Disorders
High-resolution manometry: an atlas of esophageal motility disorders and findings of GERD using esophageal pressure topography.
Esophageal Neoplasms
A genome-wide analysis of long noncoding RNA profile identifies differentially expressed lncRNAs associated with Esophageal cancer.
Esophageal Neoplasms
Atlas of the thoracic lymph nodal delineation and recommendations for lymph nodal CTV of esophageal squamous cell cancer in radiation therapy from China.
Esophageal Neoplasms
Cancer-related long noncoding RNAs show aberrant expression profiles and competing endogenous RNA potential in esophageal adenocarcinoma.
Esophageal Neoplasms
Comprehensive Analysis of lncRNAs Related to the Prognosis of Esophageal Cancer Based on ceRNA Network and Cox Regression Model.
Esophageal Neoplasms
Comprehensive analysis of potential immunotherapy genomic biomarkers in 1000 Chinese patients with cancer.
Esophageal Neoplasms
Comprehensive multi-omics analysis identified core molecular processes in esophageal cancer and revealed GNGT2 as a potential prognostic marker.
Esophageal Neoplasms
Epigenetically upregulated oncoprotein PLCE1 drives esophageal carcinoma angiogenesis and proliferation via activating the PI-PLC?-NF-?B signaling pathway and VEGF-C/ Bcl-2 expression.
Esophageal Neoplasms
Eps15 Homology Domain-Containing Protein 3 Hypermethylation as a Prognostic and Predictive Marker for Colorectal Cancer.
Esophageal Neoplasms
ESCC ATLAS: A population wide compendium of biomarkers for Esophageal Squamous Cell Carcinoma.
Esophageal Neoplasms
Expert Consensus Contouring Guidelines for Intensity Modulated Radiation Therapy in Esophageal and Gastroesophageal Junction Cancer.
Esophageal Neoplasms
Five miRNAs Considered as Molecular Targets for Predicting Esophageal Cancer.
Esophageal Neoplasms
Identification of cluster of differentiation molecule-associated microRNAs as potential therapeutic targets for gastrointestinal cancer immunotherapy.
Esophageal Neoplasms
Identification of prognostic miRNA biomarkers for esophageal cancer based on The Cancer Genome Atlas and Gene Expression Omnibus.
Esophageal Neoplasms
Identification of serum prognostic marker miRNAs and construction of microRNA-mRNA networks of esophageal cancer.
Esophageal Neoplasms
LincRNA-ROR promotes metastasis and invasion of esophageal squamous cell carcinoma by regulating miR-145/FSCN1.
Esophageal Neoplasms
Long noncoding RNA SNHG12 suppresses esophageal squamous cell carcinoma progression through competing endogenous RNA networks.
Esophageal Neoplasms
MicroRNA-301b and its target gene synaptosome-associated protein 91 as important modulators in esophageal cancer: functional experiments.
Esophageal Neoplasms
Multiomic Analysis of Methylation and Transcriptome Reveals a Novel Signature in Esophageal Cancer.
Esophageal Neoplasms
Simultaneous targeting PI3K and PERK pathways promotes cell death and improves the clinical prognosis in esophageal squamous carcinoma.
Esophageal Neoplasms
The cox-filter method identifies respective subtype-specific lncRNA prognostic signatures for two human cancers.
Esophageal Neoplasms
The long non-coding RNA maternally expressed gene 3 activates p53 and is downregulated in esophageal squamous cell cancer.
Esophageal Neoplasms
The use of large-scale cDNA analysis to profile differential gene expression in KYSE 410 human esophageal cancer cells after irradiation.
Esophageal Neoplasms
Weighted gene co-expression network analysis of gene modules for the prognosis of esophageal cancer.
Esophageal Squamous Cell Carcinoma
A 10?microRNA prognosis scoring system in esophageal squamous cell carcinoma constructed using bioinformatic methods.
Esophageal Squamous Cell Carcinoma
Anatomic distribution of supraclavicular lymph node in patients with esophageal cancer.
Esophageal Squamous Cell Carcinoma
Atlas of the thoracic lymph nodal delineation and recommendations for lymph nodal CTV of esophageal squamous cell cancer in radiation therapy from China.
Esophageal Squamous Cell Carcinoma
Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.
Esophageal Squamous Cell Carcinoma
CDK11p110 plays a critical role in the tumorigenicity of esophageal squamous cell carcinoma cells and is a potential drug target.
Esophageal Squamous Cell Carcinoma
Development and validation of an autophagy-related prognostic signature in esophageal cancer.
Esophageal Squamous Cell Carcinoma
Emerging Multimodality Approaches to Treat Localized Esophageal Cancer.
Esophageal Squamous Cell Carcinoma
ESCC ATLAS: A population wide compendium of biomarkers for Esophageal Squamous Cell Carcinoma.
Esophageal Squamous Cell Carcinoma
Expression and Regulatory Network Analysis of MiR-139-3p, a New Potential Serum Biomarker for Esophageal Squamous Cell Carcinoma Based on Bioinformatics Analysis.
Esophageal Squamous Cell Carcinoma
FOXF2 promoter methylation is associated with prognosis in esophageal squamous cell carcinoma.
Esophageal Squamous Cell Carcinoma
Global Analysis of Microbiota Signatures in Four Major Types of Gastrointestinal Cancer.
Esophageal Squamous Cell Carcinoma
Identification of DNA methylation-driven genes in esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas.
Esophageal Squamous Cell Carcinoma
Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
Esophageal Squamous Cell Carcinoma
Identification of prognostic miRNA biomarkers for esophageal cancer based on The Cancer Genome Atlas and Gene Expression Omnibus.
Esophageal Squamous Cell Carcinoma
Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment.
Esophageal Squamous Cell Carcinoma
LAMC1 upregulation via TGF? induces inflammatory cancer-associated fibroblasts in esophageal squamous cell carcinoma via NF-?B-CXCL1-STAT3.
Esophageal Squamous Cell Carcinoma
Para-aortic lymph node metastasis in lower Thoracic Esophageal Squamous Cell Carcinoma after Radical Esophagectomy: a CT-based atlas and its clinical implications for Adjuvant Radiotherapy.
Esophageal Squamous Cell Carcinoma
Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC.
Esophageal Squamous Cell Carcinoma
Prognostic alternative splicing signatures and underlying regulatory network in esophageal carcinoma.
Esophageal Squamous Cell Carcinoma
Specific DNA methylation markers in the diagnosis and prognosis of esophageal cancer.
Esophageal Squamous Cell Carcinoma
Survival-associated alternative splicing signatures in esophageal carcinoma.
Esophageal Squamous Cell Carcinoma
Whole exome sequencing and deep sequencing of esophageal squamous cell carcinoma and adenocarcinoma in Japanese patients using the Japanese version of the Genome Atlas, JCGA.
Esophageal Squamous Cell Carcinoma
[Data mining of esophageal squamous cell carcinoma from The Cancer Genome Atlas database].
Essential Hypertension
Lanosterol Synthase Gene Polymorphisms and Changes in Endogenous Ouabain in the Response to Low Sodium Intake.
Essential Tremor
Network Fingerprint of Stimulation-Induced Speech Impairment in Essential Tremor.
Exostoses
Rare association of anatomical variations of the atlas and the occipital in a case with cranial deformation.
Exostoses
The vertebral artery: a review of anatomical, histopathological and functional factors influencing blood flow to the hindbrain.
Eyelid Diseases
Diagnostic atlas of common eyelid diseases, johnathan j. Dutton, gregg s. Gavre, alan d. Proia.
Fanconi Syndrome
Mutation analysis of the GLUT2 gene in three unrelated Egyptian families with Fanconi-Bickel syndrome: revisited gene atlas for renumbering.
Fatty Liver
Hepatocyte nuclear factor 1? suppresses steatosis-associated liver cancer by inhibiting PPAR? transcription.
Fatty Liver
High Squalene Epoxidase in Tumors Predicts Worse Survival in Patients With Hepatocellular Carcinoma: Integrated Bioinformatic Analysis on NAFLD and HCC.
Fetal Alcohol Spectrum Disorders
Magnetic Resonance Microscopy Defines Ethanol-Induced Brain Abnormalities in Prenatal Mice: Effects of Acute Insult on Gestational Day 8.
Fibrocystic Breast Disease
Genetic analysis of microglandular adenosis and acinic cell carcinomas of the breast provides evidence for the existence of a low-grade triple-negative breast neoplasia family.
Fibromuscular Dysplasia
A 10-year follow-up of extracranial-intracranial bypass for the treatment of bilateral giant internal carotid artery aneurysms in a patient with fibromuscular dysplasia: case report.
Fibrosarcoma
High expression level of MMP9 is associated with poor prognosis in patients with clear cell renal carcinoma.
Focal Infection
[The "natural focal diseases" medical and geographical atlas of Russia as a tool to analyze their incidence in the population].
Fractures, Spontaneous
Spontaneous fracture of atlas of cervical spine affected by rheumatoid arthritis.
Fractures, Spontaneous
[Contribution to the study of dislocation of the atlas caused by pathological fracture of the dentata of the epistropheus.]
Fractures, Spontaneous
[Pathologic fracture of the odontoid process with lateral dislocation of the atlas]
Fractures, Spontaneous
[Primary osteosynthesis of the odontoid process: a multicenter study]
Fragile X Syndrome
Application of an automated parcellation method to the analysis of pediatric brain volumes.
Friedreich Ataxia
Pattern of Cerebellar Atrophy in Friedreich's Ataxia-Using the SUIT Template.
Frontotemporal Dementia
Analysis of brain atrophy and local gene expression in genetic frontotemporal dementia.
Frontotemporal Lobar Degeneration
The power of neuroimaging biomarkers for screening frontotemporal dementia.
Funnel Chest
Minor sternum and vertebral column congenital defects in Lisbon Identified Skeletal Collection.
Fused Kidney
[A case of cerebral infarction in young adult resulting in thrombotic occlusion of vertebral artery due to repeated contact stimulation of cervical rotation accompanied to systemic malformations such as atlantoaxial subluxation and atlas dysplasia].
Gallbladder Neoplasms
An atlas for clinical target volume definition, including elective nodal irradiation in definitive radiotherapy of biliary cancer.
Gallbladder Neoplasms
Single-cell RNA-sequencing atlas reveals an MDK-dependent immunosuppressive environment in ErbB pathway-mutated gallbladder cancer.
Gallstones
Cholesterol synthesis inhibition distal to squalene upregulates biliary phospholipid secretion and counteracts cholelithiasis in the genetically prone C57L/J mouse.
Ganglioglioma
Subependymal giant cell astrocytomas are characterized by mTORC1 hyperactivation, a very low somatic mutation rate, and a unique gene expression profile.
Gastroesophageal Reflux
High-resolution manometry: an atlas of esophageal motility disorders and findings of GERD using esophageal pressure topography.
Gastrointestinal Neoplasms
An Integrated Bioinformatics Analysis Repurposes an Antihelminthic Drug Niclosamide for Treating HMGA2-Overexpressing Human Colorectal Cancer.
Gastrointestinal Neoplasms
Effect of ISM1 on the Immune Microenvironment and Epithelial-Mesenchymal Transition in Colorectal Cancer.
Gastrointestinal Neoplasms
Global Analysis of Microbiota Signatures in Four Major Types of Gastrointestinal Cancer.
Gastrointestinal Neoplasms
Modeling the Dynamics of Let-7-Coupled Gene Regulatory Networks Linking Cell Proliferation to Malignant Transformation.
Gastrointestinal Neoplasms
Pathophysiological Role of Histamine H4 Receptor in Cancer: Therapeutic Implications.
Gastrointestinal Neoplasms
Structural impact due to PPQEE deletion in multiple cancer associated protein - Integrin ?V: An In silico exploration.
Gastrointestinal Neoplasms
Toxicogenomic outcomes predictive of forestomach carcinogenesis following exposure to benzo(a)pyrene: Relevance to human cancer risk.
Genetic Diseases, Inborn
Atlas of genetics and cytogenetics in oncology and haematology in 2013.
Genetic Diseases, Inborn
Bone Dysplasias. An Atlas of Genetic Disorders of Skeletal Development (Fourth Edition).
Genetic Diseases, Inborn
Bone Dysplasias: An Atlas of Genetic Disorders of Skeletal Development, Second Edition.
Genetic Diseases, Inborn
Facial malformation atlas aims to aid diagnosis of genetic disorders in patients of non-European descent: National Human Genome Research Institute launches online database of facial phenotypes targeting diverse populations.
Genetic Diseases, Inborn
Review of: 'Bone dysplasia-an atlas of genetic disorders of skeletal development (fourth edition)' Edited by: Jürgen W Spranger, Paula W Brill, Christine Hall, Gen Nishimura, Andrea Superti-Furga, Sheila Unger. Published by: Oxford University Press, 2018.
Glaucoma
Cell atlas of aqueous humor outflow pathways in eyes of humans and four model species provides insight into glaucoma pathogenesis.
Glaucoma, Open-Angle
Data-Driven Parcellation Approaches Based on Functional Connectivity of Visual Cortices in Primary Open-Angle Glaucoma.
Glioblastoma
334?A Functional Screen Identifies miRNAs that Induce Radioresistance in Glioblastomas.
Glioblastoma
A 35-gene signature discriminates between rapidly- and slowly-progressing glioblastoma multiforme and predicts survival in known subtypes of the cancer.
Glioblastoma
A classification model for distinguishing copy number variants from cancer-related alterations.
Glioblastoma
A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models.
Glioblastoma
A comprehensive analysis of the angiogenesis-related genes in glioblastoma multiforme vs. brain lower grade glioma.
Glioblastoma
A deep convolutional neural network for segmentation of whole-slide pathology images identifies novel tumour cell-perivascular niche interactions that are associated with poor survival in glioblastoma.
Glioblastoma
A Five Immune-Related lncRNA Signature as a Prognostic Target for Glioblastoma.
Glioblastoma
A Five-lncRNAs Signature-Derived Risk Score Based on TCGA and CGGA for Glioblastoma: Potential Prospects for Treatment Evaluation and Prognostic Prediction.
Glioblastoma
A functional screen identifies miRs that induce radioresistance in glioblastomas.
Glioblastoma
A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study.
Glioblastoma
A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.
Glioblastoma
A mathematical methodology for determining the temporal order of pathway alterations arising during gliomagenesis.
Glioblastoma
A New Epigenetic Model to Stratify Glioma Patients According to Their Immunosuppressive State.
Glioblastoma
A novel cell cycle-associated lncRNA, HOXA11-AS, is transcribed from the 5-prime end of the HOXA transcript and is a biomarker of progression in glioma.
Glioblastoma
A Prognostic Microenvironment-Related Immune Signature via ESTIMATE (PROMISE Model) Predicts Overall Survival of Patients With Glioma.
Glioblastoma
A Radiosensitivity Gene Signature and PD-L1 Status Predict Clinical Outcome of Patients with Glioblastoma Multiforme in The Cancer Genome Atlas Dataset.
Glioblastoma
A Serum Proteomic Signature Predicting Survival in Patients with Glioblastoma.
Glioblastoma
A survey of intragenic breakpoints in glioblastoma identifies a distinct subset associated with poor survival.
Glioblastoma
Actin-capping protein CapG is associated with prognosis, proliferation and metastasis in human glioma.
Glioblastoma
Allelic selection of amplicons in glioblastoma revealed by combining somatic and germline analysis.
Glioblastoma
An Immune-Related Six-lncRNA Signature to Improve Prognosis Prediction of Glioblastoma Multiforme.
Glioblastoma
An Inflammatory Landscape for Preoperative Neurologic Deficits in Glioblastoma.
Glioblastoma
An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma.
Glioblastoma
Analysis of the cancer genome atlas (TCGA) database identifies an inverse relationship between interleukin-13 receptor ?1 and ?2 gene expression and poor prognosis and drug resistance in subjects with glioblastoma multiforme.
Glioblastoma
Annexin A2-STAT3-Oncostatin M receptor axis drives phenotypic and mesenchymal changes in glioblastoma.
Glioblastoma
Application of the differential hybridization of Atlas Human expression arrays technique in the identification of differentially expressed genes in human glioblastoma multiforme tumor tissue.
Glioblastoma
Bayesian genome- and epigenome-wide association studies with gene level dependence.
Glioblastoma
Bayesian variable selection with graphical structure learning: Applications in integrative genomics.
Glioblastoma
Big data visualization identifies the multidimensional molecular landscape of human gliomas.
Glioblastoma
C-type lectin domain family 5, member A (CLEC5A, MDL-1) promotes brain glioblastoma tumorigenesis by regulating PI3K/Akt signalling.
Glioblastoma
CanDrA: cancer-specific driver missense mutation annotation with optimized features.
Glioblastoma
Cannabidiol inhibits human glioma by induction of lethal mitophagy through activating TRPV4.
Glioblastoma
CDK5 Knockdown inhibits proliferation and induces apoptosis and Cell Cycle Arrest in Human Glioblastoma.
Glioblastoma
Coexpression analysis of CD133 and CD44 identifies proneural and mesenchymal subtypes of glioblastoma multiforme.
Glioblastoma
Coexpression Analysis of the EZH2 Gene Using The Cancer Genome Atlas and Oncomine Databases Identifies Coexpressed Genes Involved in Biological Networks in Breast Cancer, Glioblastoma, and Prostate Cancer.
Glioblastoma
COL4A1 as a novel oncogene associated with the clinical characteristics of malignancy predicts poor prognosis in glioma.
Glioblastoma
Comparative evaluation of isoform-level gene expression estimation algorithms for RNA-seq and exon-array platforms.
Glioblastoma
Computational Identification of Tumor Anatomic Location Associated with Survival in 2 Large Cohorts of Human Primary Glioblastomas.
Glioblastoma
Concordance of Gene Expression and Functional Correlation Patterns across the NCI-60 Cell Lines and the Cancer Genome Atlas Glioblastoma Samples.
Glioblastoma
Construction of a competitive endogenous RNA network and analysis of potential regulatory axis targets in glioblastoma.
Glioblastoma
Correlation between lower balance of Th2 helper T-cells and expression of PD-L1/PD-1 axis genes enables prognostic prediction in patients with glioblastoma.
Glioblastoma
Correlation of somatic mutation and expression identifies genes important in human glioblastoma progression and survival.
Glioblastoma
CXCR-4, a chemokine receptor, is overexpressed in and required for proliferation of glioblastoma tumor cells.
Glioblastoma
Cytotoxic effects of combination of oxidosqualene cyclase inhibitors with atorvastatin in human cancer cells.
Glioblastoma
Data-Driven Computational Modeling Identifies Determinants of Glioblastoma Response to SHP2 Inhibition.
Glioblastoma
Decorin expression is associated with predictive diffusion MR phenotypes of anti-VEGF efficacy in glioblastoma.
Glioblastoma
DEMARCATE: Density-based magnetic resonance image clustering for assessing tumor heterogeneity in cancer.
Glioblastoma
Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma.
Glioblastoma
Detection of Isocitrate Dehydrogenase Mutated Glioblastomas Through Anomaly Detection Analytics.
Glioblastoma
Development and Validation of an Mesenchymal-Related Long Non-Coding RNA Prognostic Model in Glioma.
Glioblastoma
Development of a prediction model for radiosensitivity using the expression values of genes and long non-coding RNAs.
Glioblastoma
Differential Expression Profile of NLRs and AIM2 in Glioma and Implications for NLRP12 in Glioblastoma.
Glioblastoma
Differentiated glioblastoma cells accelerate tumor progression by shaping the tumor microenvironment via CCN1-mediated macrophage infiltration.
Glioblastoma
Dissecting Prognosis Modules and Biomarkers in Glioblastoma Based on Weighted Gene Co-Expression Network Analysis.
Glioblastoma
DMBT1 Homozygous Deletion in Diffuse Astrocytomas Is Associated With Unfavorable Clinical Outcome.
Glioblastoma
DNA fragmentation simulation method (FSM) and fragment size matching improve aCGH performance of FFPE tissues.
Glioblastoma
DNA Methylation Analysis Identifies Patterns in Progressive Glioma Grades to Predict Patient Survival.
Glioblastoma
Double Minute Chromosomes in Glioblastoma Multiforme Are Revealed by Precise Reconstruction of Oncogenic Amplicons.
Glioblastoma
EGFR/c-myc axis regulates TGF?/Hippo/Notch pathway via epigenetic silencing miR-524 in gliomas.
Glioblastoma
Elevated lymphocyte specific protein 1 expression is involved in the regulation of leukocyte migration and immunosuppressive microenvironment in glioblastoma.
Glioblastoma
Enrichment of Aldolase C Correlates with Low Non-Mutated IDH1 Expression and Predicts a Favorable Prognosis in Glioblastomas.
Glioblastoma
Epidermal Growth Factor Receptor (EGFR) as a molecular determinant of glioblastoma response to dopamine receptor 2 (DRD2) inhibitors.
Glioblastoma
Epidermal growth factor receptor and ligand family expression and activity in glioblastoma.
Glioblastoma
Estimation of parent specific DNA copy number in tumors using high-density genotyping arrays.
Glioblastoma
Exploratory analysis of the copy number alterations in glioblastoma multiforme.
Glioblastoma
Expression of amyloid precursor-like protein 2 (APLP2) in glioblastoma is associated with patient prognosis.
Glioblastoma
Expression of SREBP2 and cholesterol metabolism related genes in TCGA glioma cohorts.
Glioblastoma
Expression Profiling of the MAP Kinase Phosphatase Family Reveals a Role for DUSP1 in the Glioblastoma Stem Cell Niche.
Glioblastoma
Factor analysis for survival time prediction with informative censoring and diverse covariates.
Glioblastoma
FAM46A expression is elevated in glioblastoma and predicts poor prognosis of patients.
Glioblastoma
Fibroblast growth factor 13 regulates glioma cell invasion and is important for bevacizumab-induced glioma invasion.
Glioblastoma
Gene expression profiling distinguishes proneural glioma stem cells from mesenchymal glioma stem cells.
Glioblastoma
Genetic and Epigenetic Features of Rapidly Progressing IDH-Mutant Astrocytomas.
Glioblastoma
Genetic and Lineage Classification of Glioma-Initiating Cells Identifies a Clinically Relevant Glioblastoma Model.
Glioblastoma
Genomic copy number variation correlates with survival outcomes in WHO grade IV glioma.
Glioblastoma
Glioblastoma Distance From the Subventricular Neural Stem Cell Niche Does Not Correlate With Survival.
Glioblastoma
GliomaDB: A Web Server for Integrating Glioma Omics Data and Interactive Analysis.
Glioblastoma
Gliomasphere marker combinatorics: multidimensional flow cytometry detects CD44+/CD133+/ITGA6+/CD36+ signature.
Glioblastoma
Glycosyltransferase Gene Expression Profiles Classify Cancer Types and Propose Prognostic Subtypes.
Glioblastoma
HERC3-Mediated SMAD7 Ubiquitination Degradation Promotes Autophagy-Induced EMT and Chemoresistance in Glioblastoma.
Glioblastoma
High EMP3 expression might independently predict poor overall survival in glioblastoma and its expression is related to DNA methylation.
Glioblastoma
High expression of RFX4 is associated with tumor progression and poor prognosis in patients with glioblastoma.
Glioblastoma
High expression of TIG3 predicts poor survival in patients with primary glioblastoma.
Glioblastoma
High expression of WDR1 in primary glioblastoma is associated with poor prognosis.
Glioblastoma
High FREM2 Gene and Protein Expression Are Associated with Favorable Prognosis of IDH-WT Glioblastomas.
Glioblastoma
High levels of WNT-5A in human glioma correlate with increased presence of tumor-associated microglia/monocytes.
Glioblastoma
High-Performance Computational Analysis of Glioblastoma Pathology Images with Database Support Identifies Molecular and Survival Correlates.
Glioblastoma
Highly Expressed CYBRD1 Associated with Glioma Recurrence Regulates the Immune Response of Glioma Cells to Interferon.
Glioblastoma
Highly expressed genes in human high grade gliomas: immunohistochemical analysis of data from the human protein atlas.
Glioblastoma
HOXC10 promotes proliferation and invasion and induces immunosuppressive gene expression in glioma.
Glioblastoma
Human Hematopoietic Signal peptide-containing Secreted 1 (hHSS1) modulates genes and pathways in glioma: implications for the regulation of tumorigenicity and angiogenesis.
Glioblastoma
Hypervascular tumor volume estimated by comparison to a large-scale cerebral blood volume radiographic atlas predicts survival in recurrent glioblastoma treated with bevacizumab.
Glioblastoma
Hypoxia-induced acetylation of PAK1 enhances autophagy and promotes brain tumorigenesis via phosphorylating ATG5.
Glioblastoma
Hypoxic Roadmap of Glioblastoma-Learning about Directions and Distances in the Brain Tumor Environment.
Glioblastoma
Id4 suppresses MMP2-mediated invasion of glioblastoma-derived cells by direct inactivation of Twist1 function.
Glioblastoma
Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma.
Glioblastoma
Identification of a cullin5-RING E3 ligase transcriptome signature in glioblastoma multiforme.
Glioblastoma
Identification of a Specific Gene Module for Predicting Prognosis in Glioblastoma Patients.
Glioblastoma
Identification of Core Genes and Screening of Potential Targets in Glioblastoma Multiforme by Integrated Bioinformatic Analysis.
Glioblastoma
Identification of Novel Transcriptome Signature as a Potential Prognostic Biomarker for Anti-Angiogenic Therapy in Glioblastoma Multiforme.
Glioblastoma
Identification of prognostic gene signatures of glioblastoma: a study based on TCGA data analysis.
Glioblastoma
iGlioSub: an integrative transcriptomic and epigenomic classifier for glioblastoma molecular subtypes.
Glioblastoma
ILK silencing inhibits migration and invasion of more invasive glioblastoma cells by downregulating ROCK1 and Fascin-1.
Glioblastoma
Imaging-AMARETTO: An Imaging Genomics Software Tool to Interrogate Multiomics Networks for Relevance to Radiography and Histopathology Imaging Biomarkers of Clinical Outcomes.
Glioblastoma
Immune Heterogeneity of Glioblastoma Subtypes: Extrapolation from the Cancer Genome Atlas.
Glioblastoma
Immunogenomic Profiling Demonstrate AC003092.1 as an Immune-Related eRNA in Glioblastoma Multiforme.
Glioblastoma
Immunohistochemical analysis-based proteomic subclassification of newly diagnosed glioblastomas.
Glioblastoma
Increased epithelial membrane protein 2 expression in glioblastoma after treatment with bevacizumab.
Glioblastoma
Increased Vascular Adhesion Protein 1 (VAP-1) Levels are Associated with Alternative M2 Macrophage Activation and Poor Prognosis for Human Gliomas.
Glioblastoma
Inhibition of the Spectraplakin Protein Microtubule Actin Crosslinking Factor 1 Sensitizes Glioblastomas to Radiation.
Glioblastoma
Integrated Analysis to Evaluate the Prognostic Value of Signature mRNAs in Glioblastoma Multiforme.
Glioblastoma
Integrated Cox's model for predicting survival time of glioblastoma multiforme.
Glioblastoma
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.
Glioblastoma
Integrated morphologic analysis for the identification and characterization of disease subtypes.
Glioblastoma
Integrated Transcriptomic Analysis of Necrosis-related Gene in Diffuse Gliomas.
Glioblastoma
Integrating cullin2-RING E3 ligase as a potential biomarker for glioblastoma multiforme prognosis and radiosensitivity profiling.
Glioblastoma
Integrating Genomic Data with Transcriptomic Data for Improved Survival Prediction for Adult Diffuse Glioma.
Glioblastoma
Integration and comparison of different genomic data for outcome prediction in cancer.
Glioblastoma
Integrative Analysis of Multi-Omics Data Based on Blockwise Sparse Principal Components.
Glioblastoma
Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship.
Glioblastoma
Integrative, multimodal analysis of glioblastoma using TCGA molecular data, pathology images, and clinical outcomes.
Glioblastoma
Interleukin-8/CXCR2 signaling regulates therapy-induced plasticity and enhances tumorigenicity in glioblastoma.
Glioblastoma
Invariant Delineation of Nuclear Architecture in Glioblastoma Multiforme from The Cancer Genome Atlas Cohort.
Glioblastoma
Ion channel expression patterns in glioblastoma stem cells with functional and therapeutic implications for malignancy.
Glioblastoma
Key molecular alterations in endothelial cells in human glioblastoma uncovered through single-cell RNA sequencing.
Glioblastoma
Key nodes of a microRNA network associated with the integrated mesenchymal subtype of high-grade serous ovarian cancer.
Glioblastoma
Large-Scale Transcriptomics-Driven Approach Revealed Overexpression of CRNDE as a Poor Survival Prognosis Biomarker in Glioblastoma.
Glioblastoma
Latent Feature Decompositions for Integrative Analysis of Multi-Platform Genomic Data.
Glioblastoma
Leveraging molecular datasets for biomarker-based clinical trial design in glioblastoma.
Glioblastoma
LncRNA SNHG4 regulates miR-138/c-Met axis to promote the proliferation of glioblastoma cells.
Glioblastoma
Long non-coding RNA LBX2-AS1 enhances glioma proliferation through downregulating microRNA-491-5p.
Glioblastoma
Longitudinal assessment of tumor development using cancer avatars derived from genetically engineered pluripotent stem cells.
Glioblastoma
Major Contribution of Caspase-9 to Honokiol-Induced Apoptotic Insults to Human Drug-Resistant Glioblastoma Cells.
Glioblastoma
Mesenchymal stem cells as natural biofactories for exosomes carrying miR-124a in the treatment of gliomas.
Glioblastoma
MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status.
Glioblastoma
microRNA Regulatory Network Inference Identifies miR-34a as a Novel Regulator of TGF-? Signaling in Glioblastoma.
Glioblastoma
MicroRNA signatures predict prognosis of patients with glioblastoma multiforme through the Cancer Genome Atlas.
Glioblastoma
MicroRNA-1468-5p inhibits glioma cell proliferation and induces cell cycle arrest by targeting RRM1.
Glioblastoma
miR-4725-3p targeting stromal interacting molecule 1 signaling is involved in xanthohumol inhibition of glioma cell invasion.
Glioblastoma
MIR93 (microRNA -93) regulates tumorigenicity and therapy response of glioblastoma by targeting autophagy.
Glioblastoma
MIRAGAA--a methodology for finding coordinated effects of microRNA expression changes and genome aberrations in cancer.
Glioblastoma
miRConnect 2.0: identification of oncogenic, antagonistic miRNA families in three human cancers.
Glioblastoma
Molecular and clinical characterization of CD163 expression via large-scale analysis in glioma.
Glioblastoma
Molecular differences in IDH wildtype glioblastoma according to MGMT promoter methylation.
Glioblastoma
Monosomy of chromosome 10 associated with dysregulation of epidermal growth factor signaling in glioblastomas.
Glioblastoma
MR Imaging Predictors of Molecular Profile and Survival: Multi-institutional Study of the TCGA Glioblastoma Data Set.
Glioblastoma
MRI Atlas of IDH Wild-Type Supratentorial Glioblastoma: Probabilistic Maps of Phenotype, Management, and Outcomes.
Glioblastoma
MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance.
Glioblastoma
Multi-dimensional omics characterization in glioblastoma identifies the purity-associated pattern and prognostic gene signatures.
Glioblastoma
Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival.
Glioblastoma
Multivariate Analysis of Preoperative Magnetic Resonance Imaging Reveals Transcriptomic Classification of de novo Glioblastoma Patients.
Glioblastoma
Near haploidization is a genomic hallmark which defines a molecular subgroup of giant cell glioblastoma.
Glioblastoma
Netrin-4 promotes glioblastoma cell proliferation through integrin ?4 signaling.
Glioblastoma
Network analysis of genomic alteration profiles reveals co-altered functional modules and driver genes for glioblastoma.
Glioblastoma
Network modeling of the transcriptional effects of copy number aberrations in glioblastoma.
Glioblastoma
Network-based integrative clustering of multiple types of genomic data using non-negative matrix factorization.
Glioblastoma
New strategies in the molecular targeting of glioblastoma: how do you hit a moving target?
Glioblastoma
NNMT Silencing Activates Tumor Suppressor PP2A, Inactivates Oncogenic STKs, and Inhibits Tumor Forming Ability.
Glioblastoma
Norepinephrine inhibits migration and invasion of human glioblastoma cell cultures possibly via MMP-11 inhibition.
Glioblastoma
Novel genotype-phenotype associations in human cancers enabled by advanced molecular platforms and computational analysis of whole slide images.
Glioblastoma
Nuclear exclusion of TET1 is associated with loss of 5-hydroxymethylcytosine in IDH1 wild-type gliomas.
Glioblastoma
Nuclear-encoded cytochrome c oxidase subunit 4 regulates BMI1 expression and determines proliferative capacity of high-grade gliomas.
Glioblastoma
Outer Radial Glia-like Cancer Stem Cells Contribute to Heterogeneity of Glioblastoma.
Glioblastoma
Overexpression of G-protein-coupled receptors 65 in glioblastoma predicts poor patient prognosis.
Glioblastoma
Overexpression of GBP1 predicts poor prognosis and promotes tumor growth in human glioblastoma multiforme.
Glioblastoma
Oxidative Stress-Part of the Solution or Part of the Problem in the Hypoxic Environment of a Brain Tumor.
Glioblastoma
PAGE-Net: Interpretable and Integrative Deep Learning for Survival Analysis Using Histopathological Images and Genomic Data.
Glioblastoma
Parameter optimization for constructing competing endogenous RNA regulatory network in glioblastoma multiforme and other cancers.
Glioblastoma
PDGF Family Expression in Glioblastoma Multiforme: Data Compilation from Ivy Glioblastoma Atlas Project Database.
Glioblastoma
Percentage of mesenchymal stem cells in high-grade glioma tumor samples correlates with patient survival.
Glioblastoma
Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma.
Glioblastoma
PHENOTYPIC CHARACTERIZATION OF BREAST INVASIVE CARCINOMA VIA TRANSFERABLE TISSUE MORPHOMETRIC PATTERNS LEARNED FROM GLIOBLASTOMA MULTIFORME.
Glioblastoma
Potential Drug Prediction of Glioblastoma Based on Drug Perturbation-Induced Gene Expression Signatures.
Glioblastoma
Primary glioblastoma cultures: can profiling of stem cell markers predict radiotherapy sensitivity?
Glioblastoma
Prognostic Correlation of Autophagy-Related Gene Expression-Based Risk Signature in Patients with Glioblastoma.
Glioblastoma
Prognostic Role of Chicken Ovalbumin Upstream Promoter Transcription Factor II in Isocitrate Dehydrogenase-Mutant Glioma with 1p19q Co-Deletion.
Glioblastoma
Prognostic role of Epidermal growth factor receptor variant III (EGFRvIII) positivity in EGFR-amplified primary and recurrent glioblastomas.
Glioblastoma
Proteomic profiling of patient-derived glioblastoma xenografts identifies a subset with activated EGFR: implications for drug development.
Glioblastoma
PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status.
Glioblastoma
Quantitative assessment of intragenic receptor tyrosine kinase deletions in primary glioblastomas: their prevalence and molecular correlates.
Glioblastoma
RADIO-IBAG: RADIOMICS-BASED INTEGRATIVE BAYESIAN ANALYSIS OF MULTIPLATFORM GENOMIC DATA.
Glioblastoma
Radiologically defined ecological dynamics and clinical outcomes in glioblastoma multiforme: preliminary results.
Glioblastoma
Rap2B promotes the proliferation and migration of human glioma cells via activation of the ERK pathway.
Glioblastoma
Rare but recurrent ROS1 fusions resulting from chromosome 6q22 microdeletions are targetable oncogenes in glioma.
Glioblastoma
Relation between Established Glioma Risk Variants and DNA Methylation in the Tumor.
Glioblastoma
Relationship between Glioblastoma Heterogeneity and Survival Time: An MR Imaging Texture Analysis.
Glioblastoma
Reproducibility analysis of multi-institutional paired expert annotations and radiomic features of the Ivy Glioblastoma Atlas Project (Ivy GAP) dataset.
Glioblastoma
Reproducibility of SNV-calling in multiple sequencing runs from single tumors.
Glioblastoma
Retrospective clinical trial experimentally validates glioblastoma genome-wide pattern of DNA copy-number alterations predictor of survival.
Glioblastoma
Ribosomal Proteins RPS11 and RPS20, Two Stress-Response Markers of Glioblastoma Stem Cells, Are Novel Predictors of Poor Prognosis in Glioblastoma Patients.
Glioblastoma
Serine Incorporator 2 (SERINC2) Expression Predicts an Unfavorable Prognosis of Low-Grade Glioma (LGG): Evidence from Bioinformatics Analysis.
Glioblastoma
Simultaneous inference of cancer pathways and tumor progression from cross-sectional mutation data.
Glioblastoma
Single-Cell Atlas Reveals Complexity of the Immunosuppressive Microenvironment of Initial and Recurrent Glioblastoma.
Glioblastoma
Small-molecule inhibition of prostaglandin E receptor 2 impairs cyclooxygenase-associated malignant glioma growth.
Glioblastoma
SNAP25 Inhibits Glioma Progression by Regulating Synapse Plasticity via GLS-Mediated Glutaminolysis.
Glioblastoma
Somatic intronic microsatellite loci differentiate glioblastoma from lower-grade gliomas.
Glioblastoma
Spatial habitats from multiparametric MR imaging are associated with signaling pathway activities and survival in glioblastoma.
Glioblastoma
Specific glioblastoma multiforme prognostic-subtype distinctions based on DNA methylation patterns.
Glioblastoma
Subependymal giant cell astrocytomas are characterized by mTORC1 hyperactivation, a very low somatic mutation rate, and a unique gene expression profile.
Glioblastoma
Subtyping glioblastoma by combining miRNA and mRNA expression data using compressed sensing-based approach.
Glioblastoma
Suppression of G-protein-coupled receptor kinase 3 expression is a feature of classical GBM that is required for maximal growth.
Glioblastoma
Survival impact of time to initiation of chemoradiotherapy after resection of newly diagnosed glioblastoma.
Glioblastoma
Survival of glioblastoma in relation to tumor location: a statistical tumor atlas of a population-based cohort.
Glioblastoma
SVD identifies transcript length distribution functions from DNA microarray data and reveals evolutionary forces globally affecting GBM metabolism.
Glioblastoma
Systematic genetic analysis identifies Cis-eQTL target genes associated with glioblastoma patient survival.
Glioblastoma
Texture Feature Ratios from Relative CBV Maps of Perfusion MRI Are Associated with Patient Survival in Glioblastoma.
Glioblastoma
The association between copy number aberration, DNA methylation and gene expression in tumor samples.
Glioblastoma
The Cancer Genome Atlas Analysis Predicts MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma.
Glioblastoma
The human secretome atlas initiative: Implications in health and disease conditions.
Glioblastoma
The IFN-?/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy.
Glioblastoma
The lncRNA RP3-439F8.1 promotes GBM cell proliferation and progression by sponging miR-139-5p to upregulate NR5A2.
Glioblastoma
The prognostic value of a seven-microRNA classifier as a novel biomarker for the prediction and detection of recurrence in glioma patients.
Glioblastoma
The proneural molecular signature is enriched in oligodendrogliomas and predicts improved survival among diffuse gliomas.
Glioblastoma
The transcription factor PPAR? is overexpressed and is associated with a favourable prognosis in IDH-wildtype primary glioblastoma.
Glioblastoma
The tumor immune microenvironmental analysis of 2,033 transcriptomes across 7 cancer types.
Glioblastoma
The tumor microenvironment strongly impacts master transcriptional regulators and gene expression class of glioblastoma.
Glioblastoma
Thrombospondin-1 is a prognostic biomarker and is correlated with tumor immune microenvironment in glioblastoma.
Glioblastoma
Tissue Proteome Analysis of Different Grades of Human Gliomas Provides Major Cues for Glioma Pathogenesis.
Glioblastoma
Tissue-specific isoform switch and DNA hypomethylation of the pyruvate kinase PKM gene in human cancers.
Glioblastoma
Transcriptional signatures in histologic structures within glioblastoma tumors may predict personalized drug sensitivity and survival.
Glioblastoma
Transmembrane protein DCBLD2 is correlated with poor prognosis and affects phenotype by regulating epithelial-mesenchymal transition in human glioblastoma cells.
Glioblastoma
Tumor Habitat-derived Radiomic Features at Pretreatment MRI That Are Prognostic for Progression-free Survival in Glioblastoma Are Associated with Key Morphologic Attributes at Histopathologic Examination: A Feasibility Study.
Glioblastoma
Upregulation of DLX2 Confers a Poor Prognosis in Glioblastoma Patients by Inducing a Proliferative Phenotype.
Glioblastoma
Use of a deformable atlas to identify cryptic critical structures in the treatment of glioblastoma multiforme.
Glioblastoma
Utilizing Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Analyze Interstitial Fluid Flow and Transport in Glioblastoma and the Surrounding Parenchyma in Human Patients.
Glioblastoma
Whole exome sequencing-based analysis to identify DNA damage repair deficiency as a major contributor to gliomagenesis in adult diffuse gliomas.
Glioblastoma
Whole-genome mRNA expression profiling identifies functional and prognostic signatures in patients with mesenchymal glioblastoma multiforme.
Glioblastoma
[Cathepsin S (CTSS) is highly expressed in temozolomide-resistant glioblastoma T98G cells and associated with poor prognosis].
Glioma
A 1p/19q Codeletion-Associated Immune Signature for Predicting Lower Grade Glioma Prognosis.
Glioma
A Candidate Prognostic Biomarker Complement Factor I Promotes Malignant Progression in Glioma.
Glioma
A Comparative Study of the Molecular Characteristics of Familial Gliomas and Other Cancers.
Glioma
A comprehensive analysis of the angiogenesis-related genes in glioblastoma multiforme vs. brain lower grade glioma.
Glioma
A comprehensive next generation sequencing-based virome assessment in brain tissue suggests no major virus - tumor association.
Glioma
A comprehensive prognostic signature for glioblastoma patients based on transcriptomics and single cell sequencing.
Glioma
A Five-lncRNAs Signature-Derived Risk Score Based on TCGA and CGGA for Glioblastoma: Potential Prospects for Treatment Evaluation and Prognostic Prediction.
Glioma
A five-microRNA signature for individualized prognosis evaluation and radiotherapy guidance in patients with diffuse lower-grade glioma.
Glioma
A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients.
Glioma
A machine learning analysis of a "normal-like" IDH-WT diffuse glioma transcriptomic subgroup associated with prolonged survival reveals novel immune and neurotransmitter-related actionable targets.
Glioma
A Methodology for Texture Feature-based Quality Assessment in Nucleus Segmentation of Histopathology Image.
Glioma
A New Epigenetic Model to Stratify Glioma Patients According to Their Immunosuppressive State.
Glioma
A new glioma grading model based on histopathology and Bone Morphogenetic Protein 2 mRNA expression.
Glioma
A novel analytical model of MGMT methylation pyrosequencing offers improved predictive performance in patients with gliomas.
Glioma
A novel cell cycle-associated lncRNA, HOXA11-AS, is transcribed from the 5-prime end of the HOXA transcript and is a biomarker of progression in glioma.
Glioma
A novel DNA damage response signature of IDH-mutant grade II and grade III astrocytoma at transcriptional level.
Glioma
A novel gene signature based on five glioblastoma stem-like cell relevant genes predicts the survival of primary glioblastoma.
Glioma
A Novel Glucose Metabolism-Related Gene Signature for Overall Survival Prediction in Patients with Glioblastoma.
Glioma
A Novel Inflammatory lncRNAs Prognostic Signature for Predicting the Prognosis of Low-Grade Glioma Patients.
Glioma
A novel miR-7156-3p-HOXD13 axis modulates glioma progression by regulating tumor cell stemness.
Glioma
A novel serum microRNA-based identification and classification biomarker of human glioma.
Glioma
A Novel Signature Constructed by RNA-Binding Protein Coding Genes to Improve Overall Survival Prediction of Glioma Patients.
Glioma
A novel tailored immune gene pairs signature for overall survival prediction in lower-grade gliomas.
Glioma
A Potential Prognostic Gene Signature for Predicting Survival for Glioblastoma Patients.
Glioma
A Prognostic DNA Damage Repair Genes Signature and Its Impact on Immune Cell Infiltration in Glioma.
Glioma
A Prognostic Microenvironment-Related Immune Signature via ESTIMATE (PROMISE Model) Predicts Overall Survival of Patients With Glioma.
Glioma
A radiomic signature as a non-invasive predictor of progression-free survival in patients with lower-grade gliomas.
Glioma
A radiosensitivity gene signature and PD-L1 predict the clinical outcomes of patients with lower grade glioma in TCGA.
Glioma
A Radiosensitivity Gene Signature and XPO1 Predict Clinical Outcomes for Glioma Patients.
Glioma
A Revised Diagnostic Classification of Canine Glioma: Towards Validation of the Canine Glioma Patient as a Naturally Occurring Preclinical Model for Human Glioma.
Glioma
A Risk Signature Consisting of Eight m6A Methylation Regulators Predicts the Prognosis of Glioma.
Glioma
A risk signature of four aging-related genes has clinical prognostic value and is associated with a tumor immune microenvironment in glioma.
Glioma
A RNA sequencing-based six-gene signature for survival prediction in patients with glioblastoma.
Glioma
A three-gene signature for prognosis in patients with MGMT promoter-methylated glioblastoma.
Glioma
A Transcriptional Signature of PDGF-DD Activated Natural Killer Cells Predicts More Favorable Prognosis in Low-Grade Glioma.
Glioma
Aberrations in the Iron Regulatory Gene Signature Are Associated with Decreased Survival in Diffuse Infiltrating Gliomas.
Glioma
Abnormally high expression of HOXA2 as an independent factor for poor prognosis in glioma patients.
Glioma
ACTL6A knockdown inhibits cell migration by suppressing the AKT signaling pathway and enhances the sensitivity of glioma cells to temozolomide.
Glioma
ADAMTSL4, a Secreted Glycoprotein, Is a Novel Immune-Related Biomarker for Primary Glioblastoma Multiforme.
Glioma
ADAR3 expression is an independent prognostic factor in lower-grade diffuse gliomas and positively correlated with the editing level of GRIA2Q607R.
Glioma
Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT.
Glioma
Advanced Age Increases Immunosuppression in the Brain and Decreases Immunotherapeutic Efficacy in Subjects with Glioblastoma.
Glioma
Advancing The Cancer Genome Atlas glioma MRI collections with expert segmentation labels and radiomic features.
Glioma
Aging-related tumor associated fibroblasts changes could worsen the prognosis of GBM patients.
Glioma
Alpha 1-antichymotrypsin contributes to stem cell characteristics and enhances tumorigenicity of glioblastoma.
Glioma
Amino acid metabolism-related gene expression-based risk signature can better predict overall survival for glioma.
Glioma
An autophagic gene-based signature to predict the survival of patients with low-grade gliomas.
Glioma
An Autophagy-Related Gene Signature Associated With Clinical Prognosis and Immune Microenvironment in Gliomas.
Glioma
Analysis of expression and prognostic significance of vimentin and the response to temozolomide in glioma patients.
Glioma
Analysis of long non-coding RNAs in glioblastoma for prognosis prediction using weighted gene co-expression network analysis, Cox regression, and L1-LASSO penalization.
Glioma
Analysis of the EGFR Amplification and CDKN2A Deletion Regulated Transcriptomic Signatures Reveals the Prognostic Significance of SPATS2L in Patients With Glioma.
Glioma
ANXA1 as a Prognostic and Immune Microenvironmental Marker for Gliomas Based on Transcriptomic Analysis and Experimental Validation.
Glioma
Association between small heat shock protein B11 and the prognostic value of MGMT promoter methylation in patients with high-grade glioma.
Glioma
Association of genomic subtypes of lower-grade gliomas with shape features automatically extracted by a deep learning algorithm.
Glioma
Association of IDH mutation and 1p19q co-deletion with tumor immune microenvironment in lower-grade glioma.
Glioma
Automatic disease stage classification of glioblastoma multiforme histopathological images using deep convolutional neural network.
Glioma
BICD Cargo Adaptor 1 (BICD1) Downregulation Correlates with a Decreased Level of PD-L1 and Predicts a Favorable Prognosis in Patients with IDH1-Mutant Lower-Grade Gliomas.
Glioma
Big data visualization identifies the multidimensional molecular landscape of human gliomas.
Glioma
Bioinformatic analysis of gene expression and methylation regulation in glioblastoma.
Glioma
Bioinformatic Profiling Identifies a Fatty Acid Metabolism-Related Gene Risk Signature for Malignancy, Prognosis, and Immune Phenotype of Glioma.
Glioma
Bioinformatic Profiling Identifies a Glucose-Related Risk Signature for the Malignancy of Glioma and the Survival of Patients.
Glioma
Bioinformatic profiling identifies an immune-related risk signature for glioblastoma.
Glioma
Bioinformatical analysis of Gene Expression Omnibus (GEO) database associates TAF7/CCNB1, TAF7/CCNA2, and GTF2E2/CDC20 pathways with glioblastoma development and prognosis.
Glioma
Bioinformatics Analysis of the Expression of ATP Binding Cassette Subfamily C Member 3 (ABCC3) in Human Glioma.
Glioma
Blockade of Cell Volume Regulatory Protein NKCC1 Increases TMZ-Induced Glioma Apoptosis and Reduces Astrogliosis.
Glioma
Blocking Wnt/?-catenin Signal Amplifies Anti-PD-1 Therapeutic Efficacy by Inhibiting Tumor Growth, Migration, and Promoting Immune Infiltration in Glioblastomas.
Glioma
Brain atlas for assessing the impact of tumor location on perioperative quality of life in patients with high-grade glioma: A prospective population-based cohort study.
Glioma
Cannabidiol inhibits human glioma by induction of lethal mitophagy through activating TRPV4.
Glioma
CARD-Associated Risk Score Features the Immune Landscape and Predicts the Responsiveness to Anti-PD-1 Therapy in IDH Wild-Type Gliomas.
Glioma
CDH2 expression is of prognostic significance in glioma and predicts the efficacy of temozolomide therapy in patients with glioblastoma.
Glioma
CDK5 Knockdown inhibits proliferation and induces apoptosis and Cell Cycle Arrest in Human Glioblastoma.
Glioma
CeRNA Network Analysis Representing Characteristics of Different Tumor Environments Based on 1p/19q Codeletion in Oligodendrogliomas.
Glioma
Characterization and prognostic significance of alternative splicing events in lower-grade diffuse gliomas.
Glioma
Characterization of an endoplasmic reticulum stress-related signature to evaluate immune features and predict prognosis in glioma.
Glioma
Characterization of ferroptosis signature to evaluate the predict prognosis and immunotherapy in glioblastoma.
Glioma
Characterization of Hypoxia Signature to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Glioma Groups.
Glioma
Characterization of the Clinical Significance of PD-1/PD-Ls Expression and Methylation in Patients With Low-Grade Glioma.
Glioma
Characterization of transcriptome profile and clinical features of a novel immunotherapy target CD204 in diffuse glioma.
Glioma
Chinese Glioma Genome Atlas (CGGA): A Comprehensive Resource with Functional Genomic Data from Chinese Glioma Patients.
Glioma
CKAP2 expression is associated with glioma tumor growth and acts as a prognostic factor in high?grade glioma.
Glioma
CKAP2L Knockdown Exerts Antitumor Effects by Increasing miR-4496 in Glioblastoma Cell Lines.
Glioma
CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
Glioma
Clinical and Biological Significances of a Ferroptosis-Related Gene Signature in Glioma.
Glioma
Clinical and Biological Significances of a Methyltransferase-Related Signature in Diffuse Glioma.
Glioma
Clinical characterization, genetic profiling, and immune infiltration of TOX in diffuse gliomas.
Glioma
Clinical Significance and Systematic Expression Analysis of the Thyroid Receptor Interacting Protein 13 (TRIP13) as Human Gliomas Biomarker.
Glioma
COL4A1 as a novel oncogene associated with the clinical characteristics of malignancy predicts poor prognosis in glioma.
Glioma
Combinations of four or more CpGs methylation present equivalent predictive value for MGMT expression and temozolomide therapeutic prognosis in gliomas.
Glioma
Combined Therapy Sensitivity Index Based on a 13-Gene Signature Predicts Prognosis for IDH Wild-type and MGMT Promoter Unmethylated Glioblastoma Patients.
Glioma
Comparative Analysis of Matrix Metalloproteinase Family Members Reveals That MMP9 Predicts Survival and Response to Temozolomide in Patients with Primary Glioblastoma.
Glioma
Comprehensive analysis of a long non-coding RNA-associated competing endogenous RNA network in glioma.
Glioma
Comprehensive analysis of genes based on chr1p/19q co-deletion reveals a robust 4-gene prognostic signature for lower grade glioma.
Glioma
Comprehensive analysis of multi-omics data of recurrent gliomas identifies a recurrence-related signature as a novel prognostic marker.
Glioma
Comprehensive Analysis of PD-1 Gene Expression, Immune Characteristics and Prognostic Significance in 1396 Glioma Patients.
Glioma
Comprehensive Analysis Reveals a 4-Gene Signature in Predicting Response to Temozolomide in Low-Grade Glioma Patients.
Glioma
Comprehensive exploration of tumor mutational burden and immune infiltration in diffuse glioma.
Glioma
Comprehensive landscape of STEAP family functions and prognostic prediction value in glioblastoma.
Glioma
Comprehensive profiling identifies a novel signature with robust predictive value and reveals the potential drug resistance mechanism in glioma.
Glioma
Comprehensive RNA-seq transcriptomic profiling in the malignant progression of gliomas.
Glioma
Comprehensive Transcriptomic Analysis and Experimental Validation Identify lncRNA HOXA-AS2/miR-184/COL6A2 as the Critical ceRNA Regulation Involved in Low-Grade Glioma Recurrence.
Glioma
Connective tissue growth factor as an unfavorable prognostic marker promotes the proliferation, migration, and invasion of gliomas.
Glioma
Constitutive Expression of the Immunosuppressive Tryptophan Dioxygenase TDO2 in Glioblastoma Is Driven by the Transcription Factor C/EBP?.
Glioma
Construction of a Prognostic Gene Signature Associated with Immune Infiltration in Glioma: A Comprehensive Analysis Based on the CGGA.
Glioma
Copy number profiling across glioblastoma populations has implications for clinical trial design.
Glioma
Correlation of alteration of HLA-F expression and clinical characterization in 593 brain glioma samples.
Glioma
Cullin-7 (CUL7) is overexpressed in glioma cells and promotes tumorigenesis via NF-?B activation.
Glioma
Decreased CDKL2 expression is correlated with the progression and poor prognosis of glioma.
Glioma
Deep Radiogenomics of Lower-Grade Gliomas: Convolutional Neural Networks Predict Tumor Genomic Subtypes Using MR Images.
Glioma
Deep Transfer Learning and Radiomics Feature Prediction of Survival of Patients with High-Grade Gliomas.
Glioma
Deficiency of very large G-protein-coupled receptor-1 is a risk factor of tumor-related epilepsy: a whole transcriptome sequencing analysis.
Glioma
Defining neoplastic diseases differently: An emerging paradigm from The Cancer Genome Atlas lower-grade gliomas project.
Glioma
Deformable Registration of Glioma Images Using EM Algorithm and Diffusion Reaction Modeling.
Glioma
Developing a lncRNA Signature to Predict the Radiotherapy Response of Lower-Grade Gliomas Using Co-expression and ceRNA Network Analysis.
Glioma
Development and Validation of a Tumor Mutation Burden-Related Immune Prognostic Model for Lower-Grade Glioma.
Glioma
Development and Validation of an Immune-Related Long Non-coding RNA Prognostic Model in Glioma.
Glioma
Development and Validation of an Mesenchymal-Related Long Non-Coding RNA Prognostic Model in Glioma.
Glioma
Development of a Prognostic Five-Gene Signature for Diffuse Lower-Grade Glioma Patients.
Glioma
Development of Autophagy Signature-Based Prognostic Nomogram for Refined Glioma Survival Prognostication.
Glioma
Differential Expression Profile of NLRs and AIM2 in Glioma and Implications for NLRP12 in Glioblastoma.
Glioma
Diffuse gliomas in patients aged 55?years or over: A suggestion for IDH mutation testing.
Glioma
Dissecting Prognosis Modules and Biomarkers in Glioblastoma Based on Weighted Gene Co-Expression Network Analysis.
Glioma
DNA Methylation Analysis Identifies Patterns in Progressive Glioma Grades to Predict Patient Survival.
Glioma
Downregulation of ?-l-fucosidase 1 suppresses glioma progression by enhancing autophagy and inhibiting macrophage infiltration.
Glioma
Dysregulation of microRNA-128 expression in WHO grades 2 glioma is associated with glioma-associated epilepsy: Down-regulation of miR-128 induces glioma-associated seizure.
Glioma
Effect of CCL2 siRNA on proliferation and apoptosis in the U251 human glioma cell line.
Glioma
EGFR/c-myc axis regulates TGF?/Hippo/Notch pathway via epigenetic silencing miR-524 in gliomas.
Glioma
Elevated lymphocyte specific protein 1 expression is involved in the regulation of leukocyte migration and immunosuppressive microenvironment in glioblastoma.
Glioma
Elevated Na/H exchanger 1 (SLC9A1) emerges as a marker for tumorigenesis and prognosis in gliomas.
Glioma
Enhanced B7-H4 expression in gliomas with low PD-L1 expression identifies super-cold tumors.
Glioma
Enhanced Expression of TGFBI Promotes the Proliferation and Migration of Glioma Cells.
Glioma
Establishment and validation of an immune-based prognostic score model in glioblastoma.
Glioma
Establishment of an Immune-Related Gene Signature for Risk Stratification for Patients with Glioma.
Glioma
Evidence for potentials and limitations of brain plasticity using an atlas of functional resectability of WHO grade II gliomas: Towards a "minimal common brain"
Glioma
Examination of Epigenetic and other Molecular Factors Associated with mda-9/Syntenin Dysregulation in Cancer Through Integrated Analyses of Public Genomic Datasets.
Glioma
Expert-validated CSF segmentation of MNI atlas enhances accuracy of virtual glioma growth patterns.
Glioma
Expression and Prognostic Value of ARID5A and its Correlation With Tumor-Infiltrating Immune Cells in Glioma.
Glioma
Expression of SREBP2 and cholesterol metabolism related genes in TCGA glioma cohorts.
Glioma
Expression profile analysis of antisense long non-coding RNA identifies WDFY3-AS2 as a prognostic biomarker in diffuse glioma.
Glioma
Expression profiles and prognostic significance of WNT family members in glioma via bioinformatic analysis.
Glioma
Expression Profiling of Glioblastoma Cell Lines Reveals Novel Extracellular Matrix-Receptor Genes Correlated With the Responsiveness of Glioma Patients to Ionizing Radiation.
Glioma
Factor analysis for survival time prediction with informative censoring and diverse covariates.
Glioma
Ferroptosis-Related Gene Signature Predicts Glioma Cell Death and Glioma Patient Progression.
Glioma
FGFR3, as a receptor tyrosine kinase, is associated with differentiated biological functions and improved survival of glioma patients.
Glioma
Fibroblast growth factor 13 regulates glioma cell invasion and is important for bevacizumab-induced glioma invasion.
Glioma
FOXO4 expression is associated with the occurrence and outcome of seizures: An RNA-sequencing analysis of low-grade gliomas.
Glioma
GAL-9: A predictive biomarker negatively regulating immune response in glioma patients.
Glioma
Gene Expression Profiling Stratifies IDH-Wildtype Glioblastoma With Distinct Prognoses.
Glioma
Gene signatures based on therapy responsiveness provide guidance for combined radiotherapy and chemotherapy for lower grade glioma.
Glioma
Genetic and clinical characterization of B7-H3 (CD276) expression and epigenetic regulation in diffuse brain glioma.
Glioma
Genetic, cellular, and connectomic characterization of the brain regions commonly plagued by glioma.
Glioma
Genomic profiling of lower-grade gliomas uncovers cohesive disease groups: implications for diagnosis and treatment.
Glioma
Genotype prediction of ATRX mutation in lower-grade gliomas using an MRI radiomics signature.
Glioma
Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations.
Glioma
Glioma cells with the IDH1 mutation modulate metabolic fractional flux through pyruvate carboxylase.
Glioma
Glioma stem cell-derived exosomal miR-944 reduces glioma growth and angiogenesis by inhibiting AKT/ERK signaling.
Glioma
Glioma Through the Looking GLASS: Molecular Evolution of Diffuse Gliomas and the Glioma Longitudinal AnalySiS Consortium.
Glioma
Glioma-Associated Stromal Cells Stimulate Glioma Malignancy by Regulating the Tumor Immune Microenvironment.
Glioma
Gliomas display distinct sex-based differential methylation patterns based on molecular subtype.
Glioma
HDAC3 Expression Correlates with the Prognosis and Grade of Patients with Glioma: A Diversification Analysis Based on Transcriptome and Clinical Evidence.
Glioma
Heme Biosynthesis mRNA Expression Signature: Towards a Novel Prognostic Biomarker in Patients with Diffusely Infiltrating Gliomas.
Glioma
Heterozygous IDH1R132H/WT created by "single base editing" inhibits human astroglial cell growth by downregulating YAP.
Glioma
High expression of COPB2 predicts adverse outcomes: A potential therapeutic target for glioma.
Glioma
High expression of GPNMB indicates an unfavorable prognosis in glioma: Combination of data from the GEO and CGGA databases and validation in tissue microarray.
Glioma
High expression of PYCARD is an independent predictor of unfavorable prognosis and chemotherapy resistance in glioma.
Glioma
High expression of stromal signatures correlated with macrophage infiltration, angiogenesis and poor prognosis in glioma microenvironment.
Glioma
High levels of WNT-5A in human glioma correlate with increased presence of tumor-associated microglia/monocytes.
Glioma
High-dose radiation associated with improved survival in IDH-wildtype low-grade glioma.
Glioma
Highly expressed genes in human high grade gliomas: immunohistochemical analysis of data from the human protein atlas.
Glioma
Highly expressed of SERPINA3 indicated poor prognosis and involved in immune suppression in glioma.
Glioma
HOXC10 promotes proliferation and invasion and induces immunosuppressive gene expression in glioma.
Glioma
Hsa-mir-127 impairs survival of patients with glioma and promotes proliferation, migration and invasion of cancerous cells by modulating replication initiator 1.
Glioma
Hypoxia-induced acetylation of PAK1 enhances autophagy and promotes brain tumorigenesis via phosphorylating ATG5.
Glioma
Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS.
Glioma
Identification and validation of a risk signature based on extracellular matrix-related genes in gliomas.
Glioma
Identification and validation of a three-gene signature as a candidate prognostic biomarker for lower grade glioma.
Glioma
Identification and Validation of an 11-Ferroptosis Related Gene Signature and Its Correlation With Immune Checkpoint Molecules in Glioma.
Glioma
Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma.
Glioma
Identification and validation of RNA-binding protein-related gene signature revealed potential associations with immunosuppression and drug sensitivity in glioma.
Glioma
Identification of a 6-cytokine prognostic signature in patients with primary glioblastoma harboring M2 microglia/macrophage phenotype relevance.
Glioma
Identification of a cullin5-RING E3 ligase transcriptome signature in glioblastoma multiforme.
Glioma
Identification of a DNA Repair-Related Multigene Signature as a Novel Prognostic Predictor of Glioblastoma.
Glioma
Identification of a Glycolysis-Related LncRNA Signature to Predict Survival in Diffuse Glioma Patients.
Glioma
Identification of a Good-Prognosis IDH-Mutant-Like Population of Patients with Diffuse Gliomas.
Glioma
Identification of an 8-miRNA signature as a potential prognostic biomarker for glioma.
Glioma
Identification of an autophagy-related 10-lncRNA-mRNA signature for distinguishing glioblastoma multiforme from lower?grade glioma and prognosis prediction.
Glioma
Identification of an epithelial-mesenchymal transition related long non-coding RNA (LncRNA) signature in Glioma.
Glioma
Identification of an N6-methyladenosine (m6A)-related signature associated with clinical prognosis, immune response, and chemotherapy in primary glioblastomas.
Glioma
Identification of biomarkers for the transition from low-grade glioma to secondary glioblastoma by an integrated bioinformatic analysis.
Glioma
Identification of COL6A1 as the Key Gene Associated with Antivascular Endothelial Growth Factor Therapy in Glioblastoma Multiforme.
Glioma
Identification of Core Genes and Screening of Potential Targets in Glioblastoma Multiforme by Integrated Bioinformatic Analysis.
Glioma
Identification of Four Enhancer-Associated Genes as Risk Signature for Diffuse Glioma Patients.
Glioma
Identification of genes associated with cancer prognosis in glioma: In silico data analyses of Chinese Glioma Genome Atlas (CGGA) and The Cancer Genome Atlas (TCGA).
Glioma
Identification of Glioma Cancer Stem Cell Characteristics Based on Weighted Gene Prognosis Module Co-Expression Network Analysis of Transcriptome Data Stemness Indices.
Glioma
Identification of Histological Correlates of Overall Survival in Lower Grade Gliomas Using a Bag-of-words Paradigm: A Preliminary Analysis Based on Hematoxylin & Eosin Stained Slides from the Lower Grade Glioma Cohort of The Cancer Genome Atlas.
Glioma
Identification of IDH-mutant gliomas by a prognostic signature according to gene expression profiling.
Glioma
Identification of Immune Cell Infiltration and Immune-Related Genes in the Tumor Microenvironment of Glioblastomas.
Glioma
Identification of Immune-Related Genes Contributing to the Development of Glioblastoma Using Weighted Gene Co-expression Network Analysis.
Glioma
Identification of immunologic subtype and prognosis of GBM based on TNFSF14 and immune checkpoint gene expression profiling.
Glioma
Identification of key genes involved in the recurrence of glioblastoma multiforme using weighted gene co-expression network analysis and differential expression analysis.
Glioma
Identification of N6-methyladenosine-related lncRNAs for patients with primary glioblastoma.
Glioma
Identification of Novel Transcriptome Signature as a Potential Prognostic Biomarker for Anti-Angiogenic Therapy in Glioblastoma Multiforme.
Glioma
Identification of Retinol Binding Protein 1 Promoter Hypermethylation in Isocitrate Dehydrogenase 1 and 2 Mutant Gliomas.
Glioma
Identification of RNA: 5-Methylcytosine Methyltransferases-Related Signature for Predicting Prognosis in Glioma.
Glioma
Identification of robust diagnostic and prognostic gene signatures in different grades of gliomas: a retrospective study.
Glioma
Identification of SEC61G as a Novel Prognostic Marker for Predicting Survival and Response to Therapies in Patients with Glioblastoma.
Glioma
Identification of Secreted Phosphoprotein 1 (SPP1) as a Prognostic Factor in Lower-Grade Gliomas.
Glioma
Identification of specific feed-forward apoptosis mechanisms and associated higher survival rates for low grade glioma and lung squamous cell carcinoma.
Glioma
Identification of survival?associated key genes and long non?coding RNAs in glioblastoma multiforme by weighted gene co?expression network analysis.
Glioma
Identification of the role of TRPM8 in glioblastoma and its effect on proliferation, apoptosis and invasion of the U251 human glioblastoma cell line.
Glioma
Identification of three glioblastoma subtypes and a six-gene prognostic risk index based on the expression of growth factors and cytokines.
Glioma
Identification of WHO II/III gliomas by 16 prognostic-related gene signatures using machine learning methods.
Glioma
Identifying Predictive Gene Expression and Signature Related to Temozolomide Sensitivity of Glioblastomas.
Glioma
IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligand expression.
Glioma
IDH mutation status is associated with distinct vascular gene expression signatures in lower-grade gliomas.
Glioma
IDH-mutated astrocytomas with 19q-loss constitute a subgroup that confers better prognosis.
Glioma
IDH1-R132H mutation radiosensitizes U87MG glioma cells via epigenetic downregulation of TIGAR.
Glioma
IFI30 Is a Novel Immune-Related Target with Predicting Value of Prognosis and Treatment Response in Glioblastoma.
Glioma
IGF-1-enhanced miR-513a-5p signaling desensitizes glioma cells to temozolomide by targeting the NEDD4L-inhibited Wnt/?-catenin pathway.
Glioma
Imaging-AMARETTO: An Imaging Genomics Software Tool to Interrogate Multiomics Networks for Relevance to Radiography and Histopathology Imaging Biomarkers of Clinical Outcomes.
Glioma
In silico identification of the prognostic biomarkers and therapeutic targets associated with cancer stem cell characteristics of glioma.
Glioma
Increased expression of von Willebrand factor gene is associated with poorer survival in primary lower grade glioma.
Glioma
Increased M1 Macrophages Infiltration Correlated With Poor Survival Outcomes and Radiation Response in Gliomas.
Glioma
Increased microglia/macrophage gene expression in a subset of adult and pediatric astrocytomas.
Glioma
Increased Vascular Adhesion Protein 1 (VAP-1) Levels are Associated with Alternative M2 Macrophage Activation and Poor Prognosis for Human Gliomas.
Glioma
Inflammation and lymphocyte infiltration are associated with shorter survival in patients with high-grade glioma.
Glioma
Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis.
Glioma
Integrated Analysis of the Clinical and Molecular Characteristics of IDH Wild-Type Gliomas in the Chinese Glioma Genome Atlas.
Glioma
Integrated analysis of the genomic and transcriptional profile of high-grade gliomas in different age groups.
Glioma
Integrated Analysis Reveals Prognostic Value and Immune Correlates of CD86 Expression in Lower Grade Glioma.
Glioma
Integrated Gene Expression and Methylation Analyses Identify DLL3 as a Biomarker for Prognosis of Malignant Glioma.
Glioma
Integrated metabolomics and lipidomics analyses reveal metabolic reprogramming in human glioma with IDH1 mutation.
Glioma
Integrated microenvironment-associated genomic profiles identify LRRC15 mediating recurrent glioblastoma-associated macrophages infiltration.
Glioma
Integrated profiling identifies caveolae-associated protein 1 as a prognostic biomarker of malignancy in glioblastoma patients.
Glioma
Integrating cullin2-RING E3 ligase as a potential biomarker for glioblastoma multiforme prognosis and radiosensitivity profiling.
Glioma
Integrating Genomic Data with Transcriptomic Data for Improved Survival Prediction for Adult Diffuse Glioma.
Glioma
Integrative Analysis of Cellular Morphometric Context Reveals Clinically Relevant Signatures in Lower Grade Glioma.
Glioma
Integrin Beta 5 Is a Prognostic Biomarker and Potential Therapeutic Target in Glioblastoma.
Glioma
Investigation of Genetic Determinants of Glioma Immune Phenotype by Integrative Immunogenomic Scale Analysis.
Glioma
IRF7 as an Immune-Related Prognostic Biomarker and Associated with Tumor Microenvironment in Low-Grade Glioma.
Glioma
Isocitrate dehydrogenase 1 Gene Mutation Is Associated with Prognosis in Clinical Low-Grade Gliomas.
Glioma
Jagged1 is Clinically Prognostic and Promotes Invasion of Glioma-Initiating Cells by Activating NF-?B(p65) Signaling.
Glioma
Joint bioinformatics analysis of underlying potential functions of hsa-let-7b-5p and core genes in human glioma.
Glioma
Joint segmentation and deformable registration of brain scans guided by a tumor growth model.
Glioma
Ki-67 and MCM6 labeling indices are correlated with overall survival in anaplastic oligodendroglioma, IDH1-mutant and 1p/19q-codeleted: a multicenter study from the French POLA network.
Glioma
KIF23 is an independent prognostic biomarker in glioma, transcriptionally regulated by TCF-4.
Glioma
Knockdown of long non-coding RNA SLC8A1-AS1 attenuates cell invasion and migration in glioma via suppression of Wnt/?-catenin signaling pathways.
Glioma
Knockdown of MRPL42 suppresses glioma cell proliferation by inducing cell cycle arrest and apoptosis.
Glioma
Large-scale analysis reveals the specific clinical and immune features of B7-H3 in glioma.
Glioma
Large-Scale Analysis Reveals the Specific Clinical and Immune Features of DGCR5 in Glioma.
Glioma
Large-Scale Transcriptomics-Driven Approach Revealed Overexpression of CRNDE as a Poor Survival Prognosis Biomarker in Glioblastoma.
Glioma
LINC00467 promotes proliferation and invasion in glioma via interacting with miRNA-485-5p.
Glioma
LncRNA PCED1B-AS1 activates the proliferation and restricts the apoptosis of glioma through cooperating with miR-194-5p/PCED1B axis.
Glioma
lncRNA TPTEP1 inhibits stemness and radioresistance of glioma through miR?106a?5p?mediated P38 MAPK signaling.
Glioma
Local Delivery of Minocycline and Vorinostat Targets the Tumor Microenvironment to Inhibit the Recurrence of Glioma.
Glioma
Long non-coding RNA EWSAT1 contributes to the proliferation and invasion of glioma by sponging miR-152-3p.
Glioma
Long Non-coding RNA Expression Profiling Identifies a Four-Long Non-coding RNA Prognostic Signature for Isocitrate Dehydrogenase Mutant Glioma.
Glioma
Long non-coding RNA Fer-1-like family member 4 is overexpressed in human glioblastoma and regulates the tumorigenicity of glioma cells.
Glioma
Long non-coding RNA HCG11 modulates glioma progression through cooperating with miR-496/CPEB3 axis.
Glioma
Long non-coding RNA LBX2-AS1 enhances glioma proliferation through downregulating microRNA-491-5p.
Glioma
Long non-coding RNA LINC00346 regulates proliferation and apoptosis by targeting miR-128-3p/SZRD1 axis in glioma.
Glioma
Long Non-Coding RNA LINC00662 Regulated Proliferation and Migration by Targeting miR-34a-5p/LMAN2L Axis in Glioma.
Glioma
Long non-coding RNA TP73-AS1 is a potential immune related prognostic biomarker for glioma.
Glioma
Long non-coding RNA, HOTAIRM1, promotes glioma malignancy by forming a ceRNA network.
Glioma
Long Noncoding RNA ASB16-AS1 Promotes Proliferation, Migration, and Invasion in Glioma Cells.
Glioma
Long noncoding RNA LINC00152 is a potential prognostic biomarker in patients with high-grade glioma.
Glioma
Long noncoding RNA LINC01426 promotes glioma progression through PI3K/AKT signaling pathway and serves as a prognostic biomarker.
Glioma
Longer genotypically-estimated leukocyte telomere length is associated with increased adult glioma risk.
Glioma
Longitudinal assessment of tumor development using cancer avatars derived from genetically engineered pluripotent stem cells.
Glioma
Loss of COPZ1 induces NCOA4 mediated autophagy and ferroptosis in glioblastoma cell lines.
Glioma
Low Expression of APOB mRNA or Its Hypermethylation Predicts Favorable Overall Survival in Patients with Low-Grade Glioma.
Glioma
Machine learning and radiomic phenotyping of lower grade gliomas: improving survival prediction.
Glioma
Magnetic Resonance Features of Lower-grade Gliomas in Prediction of the Reverse Phase Protein A.
Glioma
MAPK4 overexpression promotes tumor progression via noncanonical activation of AKT/mTOR signaling.
Glioma
Mapping chromatin accessibility and active regulatory elements reveals pathological mechanisms in human gliomas.
Glioma
MAPT (Tau) expression is a biomarker for an increased rate of survival for low?grade glioma.
Glioma
Mesenchymal stem cells as natural biofactories for exosomes carrying miR-124a in the treatment of gliomas.
Glioma
Metabolic expression profiling stratifies diffuse lower-grade glioma into three distinct tumour subtypes.
Glioma
Methylation and transcription patterns are distinct in IDH mutant gliomas compared to other IDH mutant cancers.
Glioma
MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status.
Glioma
MicroRNA-10b inhibition reduces E2F1-mediated transcription and miR-15/16 activity in glioblastoma.
Glioma
MicroRNA-128 expression not associated with glioma-associated epilepsy in WHO grades 2 glioma: Data from the Cancer Genome Atlas (TCGA) project.
Glioma
MicroRNA-1298-3p inhibits proliferation and invasion of glioma cells by downregulating Nidogen-1.
Glioma
MicroRNA-1468-5p inhibits glioma cell proliferation and induces cell cycle arrest by targeting RRM1.
Glioma
MicroRNA-195 reverses the resistance to temozolomide through targeting cyclin E1 in glioma cells.
Glioma
MicroRNA-21 expression in the prognosis of low-grade gliomas: data from the cancer genome atlas (TCGA) project.
Glioma
MicroRNA-7 directly targets insulin-like growth factor 1 receptor to inhibit cellular growth and glucose metabolism in gliomas.
Glioma
MicroRNA?301a/ZNRF3/wnt/??catenin signal regulatory crosstalk mediates glioma progression.
Glioma
MicroRNA?422a functions as a tumor suppressor in glioma by regulating the Wnt/??catenin signaling pathway via RPN2.
Glioma
Mining TCGA database for genes of prognostic value in glioblastoma microenvironment.
Glioma
miR-130a can predict response to temozolomide in patients with glioblastoma multiforme, independently of O6-methylguanine-DNA methyltransferase.
Glioma
MiR-137 inhibits the proliferation, invasion and migration of glioma via targeting to regulate EZH2.
Glioma
miR-17-5p-CXCL14 axis related transcriptome profile and clinical outcome in diffuse gliomas.
Glioma
miR-193a-3p Promotes the Invasion, Migration, and Mesenchymal Transition in Glioma through Regulating BTRC.
Glioma
MiR-206 is down-regulated and suppresses cell proliferation by targeting FOXP1 in brain gliomas.
Glioma
MiR-218 Inhibited Growth and Metabolism of Human Glioblastoma Cells by Directly Targeting E2F2.
Glioma
miR-34a repression in proneural malignant gliomas upregulates expression of its target PDGFRA and promotes tumorigenesis.
Glioma
miR-542-3p Contributes to the HK2-Mediated High Glycolytic Phenotype in Human Glioma Cells.
Glioma
MIR93 (microRNA -93) regulates tumorigenicity and therapy response of glioblastoma by targeting autophagy.
Glioma
miRNA array screening reveals cooperative MGMT-regulation between miR-181d-5p and miR-409-3p in glioblastoma.
Glioma
miRNA-182 and the regulation of the glioblastoma phenotype - toward miRNA-based precision therapeutics.
Glioma
Molecular and Clinical Characterization of a Novel Prognostic and Immunologic Biomarker FAM111A in Diffuse Lower-Grade Glioma.
Glioma
Molecular and clinical characterization of CD163 expression via large-scale analysis in glioma.
Glioma
Molecular and clinical characterization of IDH associated immune signature in lower-grade gliomas.
Glioma
Molecular and clinical characterization of PTPN2 expression from RNA-seq data of 996 brain gliomas.
Glioma
Molecular and Clinical Characterization of UBE2S in Glioma as a Biomarker for Poor Prognosis and Resistance to Chemo-Radiotherapy.
Glioma
Molecular and Clinicopathological Characterization of a Prognostic Immune Gene Signature Associated With MGMT Methylation in Glioblastoma.
Glioma
Molecular classification of IDH-mutant glioblastomas based on gene expression profiles.
Glioma
Molecular differences in IDH wildtype glioblastoma according to MGMT promoter methylation.
Glioma
Molecular Mechanisms of KDELC2 on Glioblastoma Tumorigenesis and Temozolomide Resistance.
Glioma
Molecular profiles of tumor contrast enhancement: A radiogenomic analysis in anaplastic gliomas.
Glioma
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma.
Glioma
Molecular subtype impacts surgical resection in low-grade gliomas: A Chinese Glioma Genome Atlas database analysis.
Glioma
Molecular Subtypes Based on the Stemness Index Predict Prognosis in Glioma Patients.
Glioma
Molecular subtyping reveals immune alterations in IDH wild-type lower-grade diffuse glioma.
Glioma
Monosomy of chromosome 10 associated with dysregulation of epidermal growth factor signaling in glioblastomas.
Glioma
MRI Features May Predict Molecular Features of Glioblastoma in Isocitrate Dehydrogenase Wild-Type Lower-Grade Gliomas.
Glioma
Mucin O-glycosylating enzyme GALNT2 facilitates the malignant character of glioma by activating the EGFR/PI3K/Akt/mTOR axis.
Glioma
Multi-faceted computational assessment of risk and progression in oligodendroglioma implicates NOTCH and PI3K pathways.
Glioma
Multi-project and Multi-profile joint Non-negative Matrix Factorization for cancer omic datasets.
Glioma
Multicellular gene network analysis identifies a macrophage-related gene signature predictive of therapeutic response and prognosis of gliomas.
Glioma
Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery.
Glioma
Multigene signature for predicting prognosis of patients with 1p19q co-deletion diffuse glioma.
Glioma
Multiomics Profiling and Clustering of Low-Grade Gliomas Based on the Integrated Stress Status.
Glioma
Mutant IDH1 Differently Affects Redox State and Metabolism in Glial Cells of Normal and Tumor Origin.
Glioma
Mutant IDH1 expression is associated with down-regulation of monocarboxylate transporters.
Glioma
Mutant-allele tumor heterogeneity in malignant glioma effectively predicts neoplastic recurrence.
Glioma
Mutant-IDH1-dependent chromatin state reprogramming, reversibility, and persistence.
Glioma
MYD88 Is a Potential Prognostic Gene and Immune Signature of Tumor Microenvironment for Gliomas.
Glioma
N6-methyladenine-related genes affect biological behavior and the prognosis of glioma.
Glioma
N6-Methylandenosine-Related lncRNAs Are Potential Biomarkers for Predicting the Overall Survival of Lower-Grade Glioma Patients.
Glioma
Network-based integrative clustering of multiple types of genomic data using non-negative matrix factorization.
Glioma
Neurofibromin knockdown in glioma cell lines is associated with changes in cytokine and chemokine secretion in vitro.
Glioma
Neuroimaging-Based Classification Algorithm for Predicting 1p/19q-Codeletion Status in IDH-Mutant Lower Grade Gliomas.
Glioma
Non-Invasive Estimation of Glioma IDH1 Mutation and VEGF Expression by Histogram Analysis of Dynamic Contrast-Enhanced MRI.
Glioma
Notch1 is a prognostic factor that is distinctly activated in the classical and proneural subtype of glioblastoma and that promotes glioma cell survival via the NF-?B(p65) pathway.
Glioma
Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma.
Glioma
Novel internal regulators and candidate miRNAs within miR-379/miR-656 miRNA cluster can alter cellular phenotype of human glioblastoma.
Glioma
Omics-based integrated analysis identified ATRX as a biomarker associated with glioma diagnosis and prognosis.
Glioma
Orphan nuclear receptor TLX promotes immunosuppression via its transcriptional activation of PD-L1 in glioma.
Glioma
Overexpression of Cell-Surface Marker SLC16A1 Shortened Survival in Human High-Grade Gliomas.
Glioma
Overexpression of EP300-interacting inhibitor of differentiation 3 predicts poor prognosis in patients with glioblastoma multiforme.
Glioma
Overexpression of GBP1 predicts poor prognosis and promotes tumor growth in human glioblastoma multiforme.
Glioma
Overexpression of oncostatin M receptor regulates local immune response in glioblastoma.
Glioma
Overexpression of Paxillin Correlates with Tumor Progression and Predicts Poor Survival in Glioblastoma.
Glioma
Overexpression of PSAT1 Gene is a Favorable Prognostic Marker in Lower-Grade Gliomas and Predicts a Favorable Outcome in Patients with IDH1 Mutations and Chromosome 1p19q Codeletion.
Glioma
Overexpression of Transforming Acidic Coiled Coil?Containing Protein 3 Reflects Malignant Characteristics and Poor Prognosis of Glioma.
Glioma
Overexpression of TREM2 enhances glioma cell proliferation and invasion: a therapeutic target in human glioma.
Glioma
Pan-cancer analyses reveal regulation and clinical outcome association of the shelterin complex in cancer.
Glioma
PARP1 expression and its correlation with survival is tumour molecular subtype dependent in glioblastoma.
Glioma
Pathomic Fusion: An Integrated Framework for Fusing Histopathology and Genomic Features for Cancer Diagnosis and Prognosis.
Glioma
PD-1 (PDCD1) Promoter Methylation Is a Prognostic Factor in Patients With Diffuse Lower-Grade Gliomas Harboring Isocitrate Dehydrogenase (IDH) Mutations.
Glioma
PD-L2 expression is correlated with the molecular and clinical features of glioma, and acts as an unfavorable prognostic factor.
Glioma
PDIA3 Expression in Glioblastoma Modulates Macrophage/Microglia Pro-Tumor Activation.
Glioma
Percentage of mesenchymal stem cells in high-grade glioma tumor samples correlates with patient survival.
Glioma
Phospholipase C Beta 1: a Candidate Signature Gene for Proneural Subtype High-Grade Glioma.
Glioma
Phytanoyl-CoA 2-Hydroxylase-Interacting Protein-Like Gene Is a Therapeutic Target Gene for Glioblastoma Multiforme.
Glioma
Plasminogen Activator Urokinase Receptor Implies Immunosuppressive Features and Acts as an Unfavorable Prognostic Biomarker in Glioma.
Glioma
PODNL1 promotes cell proliferation and migration in glioma via regulating Akt/mTOR pathway.
Glioma
Pre-treatment neutrophils count as a prognostic marker to predict chemotherapeutic response and survival outcomes in glioma: a single-center analysis of 288 cases.
Glioma
Predicting Genotype and Survival in Glioma Using Standard Clinical MR Imaging Apparent Diffusion Coefficient Images: A Pilot Study from The Cancer Genome Atlas.
Glioma
Predicting the likelihood of postoperative seizure status based on mRNA sequencing in low-grade gliomas.
Glioma
Prediction and analysis of hub genes between glioblastoma and low-grade glioma using bioinformatics analysis.
Glioma
Profiles of immune-related genes and immune cell infiltration in the tumor microenvironment of diffuse lower-grade gliomas.
Glioma
Profiling pro-neural to mesenchymal transition identifies a lncRNA signature in glioma.
Glioma
Prognosis Analysis and Validation of m6A Signature and Tumor Immune Microenvironment in Glioma.
Glioma
Prognostic and Predictive Value of Immune-Related Gene Pair Signature in Primary Lower-Grade Glioma Patients.
Glioma
Prognostic Biomarker ZNF311 and Its Correlation With Tumor Progression and Immune Infiltrates in Glioma.
Glioma
Prognostic Correlation of Autophagy-Related Gene Expression-Based Risk Signature in Patients with Glioblastoma.
Glioma
Prognostic microRNAs in high-grade glioma reveal a link to oligodendrocyte precursor differentiation.
Glioma
Prognostic Role of Chicken Ovalbumin Upstream Promoter Transcription Factor II in Isocitrate Dehydrogenase-Mutant Glioma with 1p19q Co-Deletion.
Glioma
Prognostic role of mitochondrial pyruvate carrier in isocitrate dehydrogenase-mutant glioma.
Glioma
Prognostic value of a microRNA signature as a novel biomarker in patients with lower-grade gliomas.
Glioma
Prognostic value of a nine-gene signature in glioma patients based on tumor-associated macrophages expression profiling.
Glioma
Prognostic Value of a Stemness Index-Associated Signature in Primary Lower-Grade Glioma.
Glioma
Prognostic Value of an Autophagy-Related Five-Gene Signature for Lower-Grade Glioma Patients.
Glioma
Prognostic value of miR-21 in gliomas: comprehensive study based on meta-analysis and TCGA dataset validation.
Glioma
Prognostic Value of Preoperative MRI Metrics for Diffuse Lower-Grade Glioma Molecular Subtypes.
Glioma
Protein disulphide isomerase can predict the clinical prognostic value and contribute to malignant progression in gliomas.
Glioma
PTPN1 promotes the progression of glioma by activating the MAPK/ERK and PI3K/AKT pathways and is associated with poor patient survival.
Glioma
Quiescin Sulfhydryl Oxidase 1 Regulates the Proliferation, Migration and Invasion of Human Glioblastoma Cells via PI3K/Akt Pathway.
Glioma
RAB38 confers a poor prognosis, associated with malignant progression and subtype preference in glioma.
Glioma
Rabeprazole has efficacy per se and reduces resistance to temozolomide in glioma via EMT inhibition.
Glioma
Radiation combined with temozolomide contraindicated for young adults diagnosed with anaplastic glioma.
Glioma
Radiogenomic analysis of PTEN mutation in glioblastoma using preoperative multi-parametric magnetic resonance imaging.
Glioma
Radiogenomics correlation between MR imaging features and mRNA-based subtypes in lower-grade glioma.
Glioma
Radiogenomics of lower-grade glioma: algorithmically-assessed tumor shape is associated with tumor genomic subtypes and patient outcomes in a multi-institutional study with The Cancer Genome Atlas data.
Glioma
Rap2B promotes the proliferation and migration of human glioma cells via activation of the ERK pathway.
Glioma
Recent Advances on the Molecular Pathology of Glial Neoplasms in Children and Adults.
Glioma
Receptor tyrosine kinase expression in high-grade gliomas before and after chemoradiotherapy.
Glioma
Recovery of T-cell receptor V(D)J recombination reads from lower grade glioma exome files correlates with reduced survival and advanced cancer grade.
Glioma
Reduced expression of microRNA?206 regulates cell proliferation via cyclinD2 in gliomas.
Glioma
Regional specificity of 1p/19q co-deletion combined with radiological features for predicting the survival outcomes of anaplastic oligodendroglial tumor patients.
Glioma
RelB, a good prognosis predictor, links cell-cycle and migration to glioma tumorigenesis.
Glioma
RELB: A novel prognostic marker for glioblastoma as identified by population-based analysis.
Glioma
RELL1, a novel oncogene, accelerates tumor progression and regulates immune infiltrates in glioma.
Glioma
Reproducible imaging-based prediction of molecular subtype and risk stratification of gliomas across different experience levels using a structured reporting system.
Glioma
Reprogramming the immunosuppressive microenvironment of IDH1 wild-type glioblastoma by blocking Wnt signaling between microglia and cancer cells.
Glioma
Retrospective Validation of a 168-Gene Expression Signature for Glioma Classification on a Single Molecule Counting Platform.
Glioma
RNA processing genes characterize RNA splicing and further stratify lower-grade glioma.
Glioma
RNA sequencing and Immunohistochemistry Reveal ZFN7 as a Stronger Marker of Survival than Molecular Subtypes in G-CIMP-negative Glioblastoma.
Glioma
Role of RHOC in evaluating an adverse prognosis in patients with glioma and its potential prognostic value.
Glioma
RUNX1 and REXO2 are associated with the heterogeneity and prognosis of IDH wild type lower grade glioma.
Glioma
RUNX1 contributes to the mesenchymal subtype of glioblastoma in a TGF? pathway-dependent manner.
Glioma
Screening and functional prediction of differentially expressed circular RNAs in human glioma of different grades.
Glioma
Serine Incorporator 2 (SERINC2) Expression Predicts an Unfavorable Prognosis of Low-Grade Glioma (LGG): Evidence from Bioinformatics Analysis.
Glioma
Serum-free culture success of glial tumors is related to specific molecular profiles and expression of extracellular matrix-associated gene modules.
Glioma
Set-Wise Differential Interaction Between Copy Number Alterations and Gene Expressions of Lower-Grade Glioma Reveals Prognosis-Associated Pathways.
Glioma
Shugosin 2 is a biomarker for pathological grading and survival prediction in patients with gliomas.
Glioma
Silencing of HAS2-AS1 mediates PI3K/AKT signaling pathway to inhibit cell proliferation, migration, and invasion in glioma.
Glioma
Simulation of anisotropic growth of low-grade gliomas using diffusion tensor imaging.
Glioma
Simultaneous blockade of interacting CK2 and EGFR pathways by tumor-targeting nanobioconjugates increases therapeutic efficacy against glioblastoma multiforme.
Glioma
Small-molecule inhibition of prostaglandin E receptor 2 impairs cyclooxygenase-associated malignant glioma growth.
Glioma
SNAP25 Inhibits Glioma Progression by Regulating Synapse Plasticity via GLS-Mediated Glutaminolysis.
Glioma
Somatic intronic microsatellite loci differentiate glioblastoma from lower-grade gliomas.
Glioma
Somatostatin receptor 2A protein expression characterizes anaplastic oligodendrogliomas with favorable outcome.
Glioma
Subependymal giant cell astrocytomas are characterized by mTORC1 hyperactivation, a very low somatic mutation rate, and a unique gene expression profile.
Glioma
Surgery of Insular Diffuse Gliomas-Part 2: Probabilistic Cortico-Subcortical Atlas of Critical Eloquent Brain Structures and Probabilistic Resection Map During Transcortical Awake Resection.
Glioma
Systematic and Multi-Omics Prognostic Analysis of Lysine Acetylation Regulators in Glioma.
Glioma
Systematic evaluation of cancer-specific genetic risk score for 11 types of cancer in The Cancer Genome Atlas and Electronic Medical Records and Genomics cohorts.
Glioma
Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
Glioma
Systematically characterize the clinical and biological significances of 1p19q genes in 1p/19q non-codeletion glioma.
Glioma
Systematically profiling the expression of eIF3 subunits in glioma reveals the expression of eIF3i has prognostic value in IDH-mutant lower grade glioma.
Glioma
T cell immune regulator 1 is a prognostic marker associated with immune infiltration in glioblastoma multiforme.
Glioma
T-Cell Exhaustion Status Under High and Low Levels of Hypoxia-Inducible Factor 1? Expression in Glioma.
Glioma
TCGA mRNA Expression Analysis of the Heme Biosynthesis Pathway in Diffusely Infiltrating Gliomas: A Comparison of Typically 5-ALA Fluorescent and Non-Fluorescent Gliomas.
Glioma
TEAD4 is a novel independent predictor of prognosis in LGG patients with IDH mutation.
Glioma
Ten genes associated with MGMT promoter methylation predict the prognosis of patients with glioma.
Glioma
TERT Mutation Is Accompanied by Neutrophil Infiltration and Contributes to Poor Survival in Isocitrate Dehydrogenase Wild-Type Glioma.
Glioma
The "go or grow" potential of gliomas is linked to the neuropeptide processing enzyme carboxypeptidase E and mediated by metabolic stress.
Glioma
The association between copy number aberration, DNA methylation and gene expression in tumor samples.
Glioma
The Cancer Genome Atlas Analysis Predicts MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma.
Glioma
The increasing expression of GPX7 related to the malignant clinical features leading to poor prognosis of glioma patients.
Glioma
The Landscape of Viral Expression Reveals Clinically Relevant Viruses with Potential Capability of Promoting Malignancy in Lower-Grade Glioma.
Glioma
The Neurogenic Compound P7C3 Regulates the Aerobic Glycolysis by Targeting Phosphoglycerate Kinase 1 in Glioma.
Glioma
The polo-like kinase 1 inhibitor volasertib synergistically increases radiation efficacy in glioma stem cells.
Glioma
The Prognostic Role of Glutathione Peroxidase 1 and Immune Infiltrates in Glioma Investigated Using Public Datasets.
Glioma
The Prognostic Value of EMT in Glioma and its Role in the Glioma Immune Microenvironment.
Glioma
The R132H mutation in IDH1 promotes the recruitment of NK cells through CX3CL1/CX3CR1 chemotaxis and is correlated with a better prognosis in gliomas.
Glioma
The relationship between PLOD1 expression level and glioma prognosis investigated using public databases.
Glioma
The role of epigenetic modifications, long-range contacts, enhancers and topologically associating domains in the regulation of glioma grade-specific genes.
Glioma
The transcription factor USF1 promotes glioma cell invasion and migration by activating lncRNA HAS2-AS1.
Glioma
The tumor suppressor prostate apoptosis response-4 (Par-4) is regulated by mutant IDH1 and kills glioma stem cells.
Glioma
Therapeutic Targeting of Histone Modifications in Adult and Pediatric High-Grade Glioma.
Glioma
Three Immune-Associated Subtypes of Diffuse Glioma Differ in Immune Infiltration, Immune Checkpoint Molecules, and Prognosis.
Glioma
Thrombospondin-1 is a prognostic biomarker and is correlated with tumor immune microenvironment in glioblastoma.
Glioma
Tissue Proteome Analysis of Different Grades of Human Gliomas Provides Major Cues for Glioma Pathogenesis.
Glioma
Transcription factor AP-4 (TFAP4)-upstream ORF coding 66 aa inhibits the malignant behaviors of glioma cells by suppressing the TFAP4/long noncoding RNA 00520/microRNA-520f-3p feedback loop.
Glioma
Transcription factor NRF2 uses the Hippo pathway effector TAZ to induce tumorigenesis in glioblastomas.
Glioma
Transcriptional expression of ZICs as an independent indicator of survival in gliomas.
Glioma
Transcriptomic profiling identifies a DNA repair-related signature as a novel prognostic marker in lower-grade gliomas.
Glioma
Transmembrane protein DCBLD2 is correlated with poor prognosis and affects phenotype by regulating epithelial-mesenchymal transition in human glioblastoma cells.
Glioma
Tumor microenvironment is associated with clinical and genetic properties of diffuse gliomas and predicts overall survival.
Glioma
Tumor mutational burden predicts survival in patients with low-grade gliomas expressing mutated IDH1.
Glioma
Tumor-associated macrophages based signaling pathway analysis and hub genes identification in glioma.
Glioma
Ultrasensitive immunoprofiling of plasma extracellular vesicles identifies syndecan-1 as a potential tool for minimally invasive diagnosis of glioma.
Glioma
Unveiling new interdependencies between significant DNA methylation sites, gene expression profiles and glioma patients survival.
Glioma
Up-regulation of ANKDR49, a poor prognostic factor, regulates cell proliferation of gliomas.
Glioma
Up-regulation of MARVEL domain-containing protein 1 (MARVELD1) accelerated the malignant phenotype of glioma cancer cells via mediating JAK/STAT signaling pathway.
Glioma
Upregulated Tripartite Motif 47 Could Facilitate Glioma Cell Proliferation and Metastasis as a Tumorigenesis Promoter.
Glioma
Upregulation of DLX2 Confers a Poor Prognosis in Glioblastoma Patients by Inducing a Proliferative Phenotype.
Glioma
Upregulation of the NLRC4 inflammasome contributes to poor prognosis in glioma patients.
Glioma
Uridine phosphorylase 1 is a novel immune-related target and predicts worse survival in brain glioma.
Glioma
Uronic acid metabolic process-related gene expression-based signature predicts overall survival of glioma.
Glioma
Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.
Glioma
von Willebrand Factor Gene Expression in Primary Lower Grade Glioma: Mutually Co-Occurring Mutations in von Willebrand Factor, ATRX, and TP53.
Glioma
Weighted gene correlation network analysis identifies microenvironment-related genes signature as prognostic candidate for Grade II/III glioma.
Glioma
Whole exome sequencing-based analysis to identify DNA damage repair deficiency as a major contributor to gliomagenesis in adult diffuse gliomas.
Glioma
Whole-transcriptome sequencing profiling identifies functional and prognostic signatures in patients with PTPRZ1-MET fusion-negative secondary glioblastoma multiforme.
Glioma
Zyxin (ZYX) promotes invasion and acts as a biomarker for aggressive phenotypes of human glioblastoma multiforme.
Glioma
[Cathepsin S (CTSS) is highly expressed in temozolomide-resistant glioblastoma T98G cells and associated with poor prognosis].
Glioma
[Increased TRIM5 is associated with a poor prognosis and immune infiltration in glioma patients].
Glomerulonephritis
AJKD Atlas of Renal Pathology: Anti-Glomerular Basement Membrane Antibody-Mediated Glomerulonephritis.
Glomerulonephritis
AJKD Atlas of Renal Pathology: Pauci-immune Necrotizing Crescentic Glomerulonephritis.
Glomerulonephritis
AJKD Atlas of Renal Pathology: Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits.
Glomerulonephritis
AJKD Atlas of Renal Pathology: Subacute Bacterial Endocarditis-Associated Glomerulonephritis.
Glomerulonephritis
Histopathological atlas of renal diseases. Membranoproliferative glomerulonephritis.
Glomerulonephritis
Histopathological atlas of renal diseases: Acute post-streptococcal glomerulonephritis.
Glomerulonephritis, Membranoproliferative
AJKD Atlas of Renal Pathology: Dense Deposit Disease.
Glomerulonephritis, Membranoproliferative
AJKD Atlas of Renal Pathology: Membranoproliferative Glomerulonephritis.
Glomerulonephritis, Membranoproliferative
Histopathological atlas of renal diseases. Membranoproliferative glomerulonephritis.
Glomerulonephritis, Membranous
Histopathological atlas of renal diseases: membranous glomerulonephritis.
Glomerulosclerosis, Focal Segmental
AJKD Atlas of Renal Pathology: Cellular Variant of Focal Segmental Glomerulosclerosis.
Glomerulosclerosis, Focal Segmental
AJKD Atlas of Renal Pathology: Focal Segmental Glomerulosclerosis.
Glomerulosclerosis, Focal Segmental
AJKD Atlas of Renal Pathology: Hilar Variant of Focal Segmental Glomerulosclerosis.
Glomerulosclerosis, Focal Segmental
AJKD Atlas of Renal Pathology: Tip Lesion Variant of Focal Segmental Glomerulosclerosis.
Glomerulosclerosis, Focal Segmental
Histopathological atlas of renal diseases: Minimal Change disease and focal glomerulosclerosis.
Goldenhar Syndrome
Persistent torticollis, facial asymmetry, grooved tongue, and dolicho-odontoid process in connection with atlas malformation complex in three family subjects.
Granuloma
Combined transmastoid middle fossa approach for giant cholesterol granuloma of the petrous apex: technique for "dual exhaust" drainage.
Head and Neck Neoplasms
An oral keratinocyte life cycle model identifies novel host genome regulation by human papillomavirus 16 relevant to HPV positive head and neck cancer.
Head and Neck Neoplasms
Apoptosis signaling molecules as treatment targets in head and neck squamous cell carcinoma.
Head and Neck Neoplasms
Assessment of circularized E7 RNA, GLUT1, and PD-L1 in anal squamous cell carcinoma.
Head and Neck Neoplasms
CD44(+) tumor cells promote early angiogenesis in head and neck squamous cell carcinoma.
Head and Neck Neoplasms
Chrysosplenol D Triggers Apoptosis through Heme Oxygenase-1 and Mitogen-Activated Protein Kinase Signaling in Oral Squamous Cell Carcinoma.
Head and Neck Neoplasms
Clinical validation and applications for CT-based atlas for contouring the lower cranial nerves for head and neck cancer radiation therapy.
Head and Neck Neoplasms
Correction: intra-tumor genetic heterogeneity and mortality in head and neck cancer: analysis of data from the Cancer Genome Atlas.
Head and Neck Neoplasms
Correction: Intra-tumor Genetic Heterogeneity and Mortality in Head and Neck Cancer: Analysis of Data from The Cancer Genome Atlas.
Head and Neck Neoplasms
Expression profiles analysis identifies a novel three-mRNA signature to predict overall survival in oral squamous cell carcinoma.
Head and Neck Neoplasms
Expression profiling of long non-coding RNA identifies linc-RoR as a prognostic biomarker in oral cancer.
Head and Neck Neoplasms
Gene Expression Subtype Predicts Nodal Metastasis and Survival in Human Papillomavirus-Negative Head and Neck Cancer.
Head and Neck Neoplasms
Genetic Landscape of Human Papillomavirus-Associated Head and Neck Cancer and Comparison to Tobacco-Related Tumors.
Head and Neck Neoplasms
Genomic and human papillomavirus profiling of an oral cancer cohort identifies TP53 as a predictor of overall survival.
Head and Neck Neoplasms
High expression of MMP14 is associated with progression and poor short-term prognosis in muscle-invasive bladder cancer.
Head and Neck Neoplasms
Human Endogenous Retrovirus Expression Is Associated with Head and Neck Cancer and Differential Survival.
Head and Neck Neoplasms
Human Papillomavirus 16 E2 Regulates Keratinocyte Gene Expression Relevant to Cancer and the Viral Life Cycle.
Head and Neck Neoplasms
Identification of Hub Genes Associated With Development of Head and Neck Squamous Cell Carcinoma by Integrated Bioinformatics Analysis.
Head and Neck Neoplasms
Identification of the Immune-Related Genes in Tumor Microenvironment That Associated With the Recurrence of Head and Neck Squamous Cell Carcinoma.
Head and Neck Neoplasms
Identifying potential prognostic biomarkers in head and neck cancer based on the analysis of microRNA expression profiles in TCGA database.
Head and Neck Neoplasms
IL-10 and integrin signaling pathways are associated with head and neck cancer progression.
Head and Neck Neoplasms
Immune Cluster and PPI Network Analyses Identified CXCR3 as a Key Node of Immunoregulation in Head and Neck Cancer.
Head and Neck Neoplasms
Intensity-modulated radiotherapy increases dose to the brachial plexus compared with conventional radiotherapy for head and neck cancer.
Head and Neck Neoplasms
Intra-tumor Genetic Heterogeneity and Mortality in Head and Neck Cancer: Analysis of Data from The Cancer Genome Atlas.
Head and Neck Neoplasms
Longitudinal detection of somatic mutations in saliva and plasma for the surveillance of oral squamous cell carcinomas.
Head and Neck Neoplasms
Mass spectrometric analysis of SOX11-binding proteins in head and neck cancer cells demonstrates the interaction of SOX11 and HSP90?.
Head and Neck Neoplasms
MicroRNA-Target Network Inference and Local Network Enrichment Analysis Identify Two microRNA Clusters with Distinct Functions in Head and Neck Squamous Cell Carcinoma.
Head and Neck Neoplasms
Multiatlas approach with local registration goodness weighting for MRI-based electron density mapping of head and neck anatomy.
Head and Neck Neoplasms
Novel deep learning-based survival prediction for oral cancer by analyzing tumor-infiltrating lymphocyte profiles through CIBERSORT.
Head and Neck Neoplasms
Open Access Publishing of Textbooks and Guidelines for Otolaryngologists in Developing Countries.
Head and Neck Neoplasms
Past and future impact of next-generation sequencing in head and neck cancer.
Head and Neck Neoplasms
Proteomic profiling identifies PTK2/FAK as a driver of radioresistance in HPV negative head and neck cancer.
Head and Neck Neoplasms
Purine Metabolites in Tumor-Derived Exosomes May Facilitate Immune Escape of Head and Neck Squamous Cell Carcinoma.
Head and Neck Neoplasms
Reformed smokers have survival benefits after head and neck cancer.
Head and Neck Neoplasms
Targeted DNA profiling and the prevalence of NTRK aberrations in Chinese patients with head and neck cancer.
Head and Neck Neoplasms
The Cancer Genome Atlas findings in head and neck cancer: a renewed hope.
Head and Neck Neoplasms
The Significance of Secreted Phosphoprotein 1 in Multiple Human Cancers.
Head and Neck Neoplasms
Therapeutic insights from genomic studies of head and neck squamous cell carcinomas.
Head and Neck Neoplasms
TRBV and TRBJ usage, when paired with specific HLA alleles, associates with distinct head and neck cancer survival rates.
Head and Neck Neoplasms
Tumor Infiltrating Lymphocytes Signature as a New Pan-Cancer Predictive Biomarker of Anti PD-1/PD-L1 Efficacy.
Head and Neck Neoplasms
Use of a novel atlas for muscles of mastication to reduce inter observer variability in head and neck radiotherapy contouring.
Head and Neck Neoplasms
Validation of Selected Head and Neck Cancer Prognostic Markers from the Pathology Atlas in an Oral Tongue Cancer Cohort.
Head and Neck Neoplasms
[Effect of silencing LASP1 on biological behaviors of oral squamous cell carcinoma cells and IC50 of three anti-tumor drugs].
Head Injuries, Closed
Traumatic posterior atlantoaxial dislocation without neurological deficit: case report.
Headache Disorders
Delivery of care for migraine in the Asian Oceanian region: A cross-sectional study.
Headache Disorders
Prevalence and burden of headache in children and adolescents in Austria - a nationwide study in a representative sample of pupils aged 10-18?years.
Hearing Loss
Kimmerle's anomaly as a possible causative factor of chronic tension-type headaches and neurosensory hearing loss: case report and literature review.
Heart Block
Cell atlas of the fetal human heart and implications for autoimmune-mediated congenital heart block.
Heart Defects, Congenital
A colour atlas of cardiac surgery: congenital heart disease. Vol 2.
Heart Defects, Congenital
AN ATLAS OF CONGENITAL HEART DISEASE: Compiled from the Museum of Congenital Heart Disease at Children's Hospital of Pittsburgh.
Heart Defects, Congenital
Nomenclature for Pediatric and Congenital Cardiac Care: Unification of Clinical and Administrative Nomenclature - The 2021 International Paediatric and Congenital Cardiac Code (IPCCC) and the Eleventh Revision of the International Classification of Diseases (ICD-11).
Heart Defects, Congenital
Transcriptional atlas of cardiogenesis maps congenital heart disease interactome.
Heart Defects, Congenital
Voxelwise atlas rating for computer assisted diagnosis: Application to congenital heart diseases of the great arteries.
Heart Defects, Congenital
[A case of aplasia of the anterior arch of the atlas associated with cleft of the posterior arches of C1 and C2 and a congenital heart disease]
Heart Defects, Congenital
[A case of applasia of the anterior arch of the atlas associated with cleft of the posterior arches of C1 and C2 and a congenital heart diseases]
Heart Diseases
Atlas of geographic and racial/ethnic disparities in heart disease death rates for US men.
Heart Diseases
Atlas-based auto-segmentation for delineating the heart and cardiac substructures in breast cancer radiation therapy.
Heart Diseases
Heart disease mortality in women: racial, ethnic, and geographic disparities.
Heart Diseases
Human atlas of the cardiac fiber architecture: study on a healthy population.
Heart Diseases
Nomenclature for Pediatric and Congenital Cardiac Care: Unification of Clinical and Administrative Nomenclature - The 2021 International Paediatric and Congenital Cardiac Code (IPCCC) and the Eleventh Revision of the International Classification of Diseases (ICD-11).
Heart Diseases
Poverty, a risk factor overlooked: a cross-sectional cohort study comparing poverty rate and cardiovascular disease outcomes in the state of Florida.
Heart Diseases
Structural and Social Determinants of Health Factors Associated with County-Level Variation in Non-Adherence to Antihypertensive Medication Treatment.
Heart Diseases
William Osler, Maude Abbott, Paul Dudley White, and Helen Taussig: the origins of congenital heart disease in North America.
Heart Failure
Association of hospice utilization and publicly reported outcomes following hospitalization for pneumonia or heart failure: a retrospective cohort study.
Heart Failure
Baseline clinical characteristics of patients recruited into the assessment of treatment with lisinopril and survival study.
Heart Failure
Cardiovascular critical event pathways for the progression of heart failure; a report from the ATLAS study.
Heart Failure
Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.
Heart Failure
Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trial.
Heart Failure
Heart Failure Atlas, a major project of the Heart Failure Association in concert with the European Society of Cardiology.
Heart Failure
Impact of hospitals' Referral Region racial and ethnic diversity on 30-day readmission rates of older adults.
Heart Failure
Introduction to the Canadian Cardiovascular Outcomes Research Team's (CCORT) Canadian Cardiovascular Atlas project.
Heart Failure
Low doses vs. high doses of the angiotensin converting-enzyme inhibitor lisinopril in chronic heart failure: a cost-effectiveness analysis based on the Assessment of Treatment with Lisinopril and Survival (ATLAS) study. The ATLAS Study Group.
Heart Failure
The Heart Failure Association Atlas: Heart Failure Epidemiology and Management Statistics 2019.
Heart Failure
The influence of dose of angiotensin I-converting enzyme inhibitor on systolic blood pressure variability in heart failure: a substudy of the Assessment of Treatment with Lisinopril and Survival in heart failure (ATLAS) trial.
Heart Failure
Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and Survival.
Heart Failure
What does ATLAS really tell us about "high" dose angiotensin-converting enzyme inhibition in heart failure?
Heart Failure
[Cardiac insufficiency: what treatment? what dose? For which patients? Converting enzyme inhibitors and diuretics]
Heart Neoplasms
Clinical classification of cardiovascular tumors and tumor-like lesions, and its incidences.
Heart Septal Defects, Atrial
[A case of cerebral infarction in young adult resulting in thrombotic occlusion of vertebral artery due to repeated contact stimulation of cervical rotation accompanied to systemic malformations such as atlantoaxial subluxation and atlas dysplasia].
Hemangiosarcoma
Angiosarcoma heterogeneity and potential therapeutic vulnerability to immune checkpoint blockade: insights from genomic sequencing.
Hematologic Diseases
Diseases of the Blood and Atlas of Hematology with Clinical and Hematologic Descriptions of the Blood Diseases Including a Section on Technic and Terminology.
Hematologic Neoplasms
An atlas of chromosomes in hematological malignancies. Example: 11q23 and MLL partners.
Hematologic Neoplasms
Yin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implication.
Hematoma, Subdural
[An atlas of the clinico-pathological study of diseases of the nervous system. 2. Chronic subdural hematoma with spotaneous remission]
Hematoma, Subdural, Acute
Traumatic posterior atlantoaxial dislocation without neurological deficit: case report.
Hematoma, Subdural, Chronic
[An atlas of the clinico-pathological study of diseases of the nervous system. 2. Chronic subdural hematoma with spotaneous remission]
Hemifacial Spasm
Endoscopic-Assisted Microvascular Decompression of Ectatic Vertebral Artery for Hemifacial Spasm: Operative Video and Technical Nuances.
Hemiplegia
The Pathology of Rigors: Illustrated by a Case of Hemiplegia, from Dislocation of the Atlas, Preceded and Accompanied by Constant Shivering and Sense of Coldness.
Hemochromatosis
Validation of a radiographic scoring system for haemochromatosis arthropathy.
Hemoptysis
Pulmonary vasculitis in Hughes-Stovin syndrome (HSS): a reference atlas and computed tomography pulmonary angiography guide-a report by the HSS International Study Group.
Hepatitis
Alcohol and hepatitis virus-dysregulated lncRNAs as potential biomarkers for hepatocellular carcinoma.
Hepatitis
Data harmonization process for creating the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Atlas.
Hepatitis
Several microRNAs could predict survival in patients with hepatitis B-related liver cancer.
Hepatitis B
Analysis of clinical significance and prospective molecular mechanism of main elements of the JAK/STAT pathway in hepatocellular carcinoma.
Hepatitis B
Etiology-Specific Analysis of Hepatocellular Carcinoma Transcriptome Reveals Genetic Dysregulation in Pathways Implicated in Immunotherapy Efficacy.
Herpes Zoster
Computed three-dimensional atlas of subthalamic nucleus and its adjacent structures for deep brain stimulation in Parkinson's disease.
Herpes Zoster
The raphe nuclei of the cat brain stem: a topographical atlas of their efferent projections as revealed by autoradiography.
Hidradenitis Suppurativa
An atlas of the morphological manifestations of hidradenitis suppurativa.
Hirschsprung Disease
A Colour Atlas of Surgery for Hirschsprung's Disease: Single Surgical Procedures, vol 21.
Histiocytosis
Atlantoaxial Langerhans cell histiocytosis radiographic characteristics and corresponding prognosis analysis.
Histiocytosis
Basilar Invagination Caused by Langerhans Cell Histiocytosis of the Atlas in an Adult: A Case Report.
Histiocytosis
CT-guided biopsy for Langerhans cell histiocytosis of the atlas: a case report and literature review.
Histiocytosis
Expert's comment concerning Grand Rounds case entitled "Langerhans cell histiocytosis of the atlas in an adult" (by Wo Quan Zhong, Liang Jiang, Qing Jun Ma, Zhong Jun Liu, Xiao Guang Liu, Feng Wei, Hui Shu Yuan, Geng Ting Dang).
Histiocytosis
Langerhans cell histiocytosis of the atlas in the pediatric spine: total reconstitution of the bone lesion after nonoperative treatment. A report of two cases.
Histiocytosis, Langerhans-Cell
Atlantoaxial Langerhans cell histiocytosis radiographic characteristics and corresponding prognosis analysis.
Histiocytosis, Langerhans-Cell
Basilar Invagination Caused by Langerhans Cell Histiocytosis of the Atlas in an Adult: A Case Report.
Histiocytosis, Langerhans-Cell
CT-guided biopsy for Langerhans cell histiocytosis of the atlas: a case report and literature review.
Histiocytosis, Langerhans-Cell
Langerhans cell histiocytosis of the atlas in a female adult.
Histiocytosis, Langerhans-Cell
Langerhans cell histiocytosis of the atlas in the pediatric spine: total reconstitution of the bone lesion after nonoperative treatment. A report of two cases.
Histiocytosis, Langerhans-Cell
Langerhans cell histiocytosis of the atlas. A report of three cases.
HIV Infections
An atlas of HIV-associated oral lesions: a new classification and diagnostic criteria.
Hoarseness
Plasmacytoma of the atlas presenting as hoarseness: a rare cause of unilateral vocal fold palsy.
Holoprosencephaly
Structure of the human Lanosterol synthase gene and its analysis as a candidate for holoprosencephaly (HPE1).
Huntington Disease
An imaging mass spectrometry atlas of lipids in the human neurologically normal and Huntington's disease caudate nucleus.
Huntington Disease
Brain Regions Showing White Matter Loss in Huntington's Disease Are Enriched for Synaptic and Metabolic Genes.
Hydrocephalus
Fiber feature map based landmark initialization for highly deformable DTI registration.
Hydrocephalus
Multi-atlas segmentation of the hydrocephalus brain using an adaptive ventricle atlas.
Hydrocephalus
[Mucopolysaccharidosis IV-A (Maroteaux-Lamy disease, severe form): incipient compressive myelopathy, cerebrospinal fluid fistula and tracheal stenosis in an adult patient]
Hypercholesterolemia
Lord of the rings--the mechanism for oxidosqualene:lanosterol cyclase becomes crystal clear.
Hyperlipidemias
Adventitial Cell Atlas of wt (Wild Type) and ApoE (Apolipoprotein E)-Deficient Mice Defined by Single-Cell RNA Sequencing.
Hyperostosis
Cervical myelopathy caused by pseudoarthrosis between the atlas and axis associated with diffuse idiopathic skeletal hyperostosis.
Hyperostosis
The aetiology behind torticollis and variable spine defects in patients with Müllerian duct/renal aplasia-cervicothoracic somite dysplasia syndrome: 3D CT scan analysis.
Hyperostosis, Diffuse Idiopathic Skeletal
Cervical myelopathy caused by pseudoarthrosis between the atlas and axis associated with diffuse idiopathic skeletal hyperostosis.
Hypersensitivity
Atlas of Transcription Factor Binding Sites from ENCODE DNase Hypersensitivity Data across 27 Tissue Types.
Hypersensitivity
Dataset reporting 4654 cow milk proteins listed according to lactation stages and milk fractions.
Hypersensitivity
Effect of estrogen receptor ? binding on functional DNA methylation in breast cancer.
Hypersensitivity
Long non-coding RNAs discriminate the stages and gene regulatory states of human humoral immune response.
Hypertension
Association of Processed Meats and Alcohol Consumption with Renal Cell Carcinoma: A Worldwide Population-Based Study.
Hypertension
Compression of the internal jugular vein by the transverse process of the atlas as the cause of cerebellar hemorrhage after supratentorial craniotomy.
Hypertension
Coronary heart disease and hypertension among Jews immigrated to Israel from the Atlas Mountain region of North Africa.
Hypertension
Independent Left Ventricular Morphometric Atlases Show Consistent Relationships with Cardiovascular Risk Factors: A UK Biobank Study.
Hypertension, Pulmonary
Cell landscape atlas for patients with chronic thromboembolic pulmonary hypertension after pulmonary endarterectomy constructed using single-cell RNA sequencing.
Hypesthesia
[A surgical case of cervical canal stenosis caused by atlas hypoplasia in an elderly patient]
Hypoalbuminemia
Laboratory markers predictive of fulminant Clostridioides difficile infection refractory to fluid resuscitation.
Hypoglossal Nerve Diseases
[Hypoglossal nerve palsy caused by hypoplasia of the atlas and ossification of the posterior longitudinal ligament]
Hypoglycemia
A New Preventive Strategy for Hypoglycemia Incorporating Added Food Diet in Patients with Type 2 Diabetes Who Received Sitagliptin Therapy.
Hypotrichosis
Bi-allelic Mutations in LSS, Encoding Lanosterol Synthase, Cause Autosomal-Recessive Hypotrichosis Simplex.
Hypotrichosis
Two cases of severe congenital hypotrichosis caused by compound heterozygous mutations in the LSS gene.
Hypoventilation
The AR-8800--a new impedance pneumograph (plethysmograph) respiratory monitor.
Idiopathic Pulmonary Fibrosis
Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis.
Ileus
Laboratory markers predictive of fulminant Clostridioides difficile infection refractory to fluid resuscitation.
Infarction, Middle Cerebral Artery
A digital map of middle cerebral artery infarcts associated with middle cerebral artery trunk and branch occlusion.
Infarction, Middle Cerebral Artery
Detection of an unkown peak at 1.2 ppm in proton magnetic resonance spectra of cats with cerebral ischemic necrosis.
Infarction, Middle Cerebral Artery
Rat brain digital stereotaxic white matter atlas with fine tract delineation in Paxinos space and its automated applications in DTI data analysis.
Infarction, Posterior Cerebral Artery
Digital map of posterior cerebral artery infarcts associated with posterior cerebral artery trunk and branch occlusion.
Infections
A Topographical Atlas of Shiga Toxin 2e Receptor Distribution in the Tissues of Weaned Piglets.
Infections
Active contour regularized semi-supervised learning for COVID-19 CT infection segmentation with limited annotations.
Infections
Alcohol and hepatitis virus-dysregulated lncRNAs as potential biomarkers for hepatocellular carcinoma.
Infections
Antimicrobial resistance prevalence, rates of hospitalization with septicemia and rates of mortality with sepsis in adults in different US states.
Infections
Application of the ATLAS score for evaluating the severity of Clostridium difficile infection in teaching hospitals in Mexico.
Infections
ATLAS trials: efficacy and safety of telavancin compared with vancomycin for the treatment of skin infections.
Infections
Bilateral atlas laminar hook combined with transarticular screw fixation for an unstable bursting atlantal fracture.
Infections
Changes in Racial and Ethnic Disparities in Estimated Diagnosis Rates of Heterosexually-acquired HIV Infection among Heterosexual Males in the United States, 2014-2018.
Infections
Clinical features and characteristics of Clostridium difficile PCR-ribotype 176 infection: results from a 1-year university hospital internal ward study.
Infections
Clostridioides difficile infections: Epidemiology, correlations and treatment in a Lebanese cohort with use of ATLAS scoring.
Infections
Co?expression of peripheral olfactory receptors with SARS?CoV?2 infection mediators: Potential implications beyond loss of smell as a COVID?19 symptom.
Infections
Concordance of the SHEA-IDSA severity classification for Clostridium difficile infection and the ATLAS bedside scoring system in hospitalized adult patients.
Infections
Contemporary epidemiological overview of malaria in Madagascar: operational utility of reported routine case data for malaria control planning.
Infections
Cystic Echinococcosis in Three Locations in the Middle Atlas, Morocco: Estimation of the Infection Rate in the Dog Reservoir.
Infections
Defining Host Responses during Systemic Bacterial Infection through Construction of a Murine Organ Proteome Atlas.
Infections
Describing, analysing and understanding the effects of the introduction of HIV self-testing in West Africa through the ATLAS programme in Côte d'Ivoire, Mali and Senegal.
Infections
Developing a continental atlas of the distribution and trypanosomal infection of tsetse flies (Glossina species).
Infections
Epidemiological surveys of, and research on, soil-transmitted helminths in Southeast Asia: a systematic review.
Infections
Establishment of a sentinel surveillance network for sexually transmissible infections and blood borne viruses in Aboriginal primary care services across Australia: the ATLAS project.
Infections
Estimating the global distribution and disease burden of intestinal nematode infections: Adding up the numbers - a review.
Infections
Evaluation of a bedside scoring system for predicting clinical cure and recurrence of Clostridium difficile infections.
Infections
Evaluation of the Atlas Helicobacter pylori stool antigen test for diagnosis of infection in adult patients.
Infections
Experience of nursing students regarding clinical support in the management of TB and HIV patients in a primary healthcare setting: a phenomenological study.
Infections
Factors affecting the geographic variability of antibiotic-resistant healthcare-associated infections in the United States using the CDC Antibiotic Resistance Patient Safety Atlas.
Infections
Feasibility of informing syndrome-level empiric antibiotic recommendations using publicly available antibiotic resistance datasets.
Infections
First year of mandatory reporting of healthcare-associated infections, pennsylvania: an infection control-chart abstractor collaboration.
Infections
Gastrointestinal and pulmonary nematode infections decrease goat productivity in Moroccan semi-arid conditions.
Infections
Geographical distribution of soil transmitted helminths and the effects of community type in South Asia and South East Asia - A systematic review.
Infections
Global numbers of infection and disease burden of soil transmitted helminth infections in 2010.
Infections
GPX-Macrophage Expression Atlas: a database for expression profiles of macrophages challenged with a variety of pro-inflammatory, anti-inflammatory, benign and pathogen insults.
Infections
Helicobacter pylori infection induced alteration of gene expression in human gastric cells.
Infections
High resolution mass spectrometry imaging of plant tissues: towards a plant metabolite atlas.
Infections
Human cystic echinococcosis in Morocco: Ultrasound screening in the Mid Atlas through an Italian-Moroccan partnership.
Infections
Identification of long noncoding RNAs biomarkers in patients with hepatitis B virus-associated hepatocellular carcinoma.
Infections
Malaria impact of large dams in sub-Saharan Africa: maps, estimates and predictions.
Infections
MicroRNA expression profile in Lampetra morii upon Vibrio anguillarum infection and miR-4561 characterization targeting lip.
Infections
NMR-based metabolic characterization of chicken tissues and biofluids: a model for avian research.
Infections
Otorhinolaryngology as "Made in Germany" since 1921: an international perspective.
Infections
Radionuclide Imaging of Infection and Inflammation: A Pictorial Case-Based Atlas.
Infections
RNA atlas of human bacterial pathogens uncovers stress dynamics linked to infection.
Infections
RNA-Seq Based Identification of Candidate Parasitism Genes of Cereal Cyst Nematode (Heterodera avenae) during Incompatible Infection to Aegilops variabilis.
Infections
Root system architecture and receptivity to mycorrhizal infection in seedlings of Cedrus atlantica as affected by nitrogen source and concentration.
Infections
Seroprevalence atlas of infections with oncogenic and non-oncogenic human papillomaviruses in Finland in the 1980s and 1990s.
Infections
Spectrum-Malaria: a user-friendly projection tool for health impact assessment and strategic planning by malaria control programmes in sub-Saharan Africa.
Infections
Susceptibility of clinical isolates of meticillin-resistant Staphylococcus aureus and phenotypic non-extended-spectrum ?-lactamase-producing Klebsiella pneumoniae to ceftaroline in Taiwan: Results from Antimicrobial Testing Leadership and Surveillance (ATLAS) in 2012-2018 and Surveillance of Multicentre Antimicrobial Resistance in Taiwan (SMART) in 2018-2019.
Infections
System-wide coordinates of higher order functions in host-pathogen environment upon Mycobacterium tuberculosis infection.
Infections
Telavancin for Acute Bacterial Skin and Skin Structure Infections, a Post Hoc Analysis of the Phase 3 ATLAS Trials in Light of the 2013 FDA Guidance.
Infections
Telavancin: a novel semisynthetic lipoglycopeptide agent to counter the challenge of resistant Gram-positive pathogens.
Infections
The global atlas of helminth infection: mapping the way forward in neglected tropical disease control.
Infections
Towards an atlas of human helminth infection in sub-Saharan Africa: the use of geographical information systems (GIS).
Infections
TP53 mutations and CDKN2A mutations/deletions are highly recurrent molecular alterations in the malignant progression of sinonasal papillomas.
Infections
[Actual problems of creation of informational-analytical system for rapid control of epidemics of infectious diseases].
Inferior Wall Myocardial Infarction
Atlas of paced body surface QRS integral maps for localization of the site of origin of postinfarction ventricular tachycardia.
Infertility, Male
The Male Fertility Gene Atlas: a web tool for collecting and integrating OMICS data in the context of male infertility.
Inflammatory Bowel Diseases
An atlas of the nonpolypoid colorectal neoplasms in inflammatory bowel disease.
Inflammatory Bowel Diseases
Target identification in Fusobacterium nucleatum by subtractive genomics approach and enrichment analysis of host-pathogen protein-protein interactions.
Inflammatory Bowel Diseases
The association of tissue anti-TNF drug levels with serological and endoscopic disease activity in inflammatory bowel disease: the ATLAS study.
Influenza, Human
The Ontario Pharmacy Evidence Network Atlas of Community Pharmacy Influenza Immunizations.
Insulin Resistance
An atlas of G-protein coupled receptor expression and function in human subcutaneous adipose tissue.
Intellectual Disability
Atlas of Mental Retardation Syndromes. Visual Diagnosis of Facies and Physical Findings.
Intellectual Disability
Atlas of Mental Retardation Syndromes: Visual Diagnosis of Facies and Physical Findings.
Intellectual Disability
ATLAS OF MENTAL RETARDATION SYNDROMES: VISUAL DIAGNOSIS OF FACIES AND PHYSICAL FINDINGS.
Intellectual Disability
Biallelic pathogenic variants in the lanosterol synthase gene LSS involved in the cholesterol biosynthesis cause alopecia with intellectual disability, a rare recessive neuroectodermal syndrome.
Intellectual Disability
Mental retardation: An atlas of diseases with associated physical abnormalities.
Intellectual Disability
Mental Retardation: An Atlas of Diseases with Associated Physical Abnormalities.
Intellectual Disability
The WHO atlas on global resources for persons with intellectual disabilities: a right to health perspective.
Intervertebral Disc Degeneration
Congenital posterior atlas defect associated with anterior rachischisis and early cervical degenerative disc disease: a case study and review of the literature.
Intervertebral Disc Degeneration
Intervertebral disc degeneration in a naturally occurring primate model: radiographic and biomechanical evidence.
Intervertebral Disc Displacement
Complex cervical spondylotic myelopathy: a report of two cases and literature review.
Intervertebral Disc Displacement
Lumbar discectomy is associated with higher rates of lumbar fusion.
Intestinal Polyposis
An atlas of oral lesions observed in the syndrome of oral melanosis with associated intestinal polyposis (Peutz-Jeghers syndrome).
Intestinal Polyposis
Atlas of oral lesions observed in the syndrome of oral melanosis with associated intestinal polyposis (Peutz-Jeghers syndrome).
Intracranial Aneurysm
An angiographic atlas of intracranial arterial diameters associated with cerebral aneurysms.
Intracranial Aneurysm
Clinical Safety and Effectiveness of Stent-Assisted Coil Embolization with Neuroform Atlas Stent in Intracranial Aneurysm.
Intracranial Aneurysm
Initial experience and one-year follow-up with Neuroform Atlas Stent System for the treatment of brain aneurysms.
Intracranial Aneurysm
Initial multicentre experience using the neuroform atlas stent for the treatment of un-ruptured saccular cerebral aneurysms.
Intracranial Aneurysm
Letter: Low-Profile Visualized Intraluminal Support Jr Braided Stent Versus Atlas Self-Expandable Stent for Treatment of Intracranial Aneurysms: A Single Center Experience.
Intracranial Aneurysm
Low-Profile Visualized Intraluminal Support Jr Braided Stent Versus Atlas Self-Expandable Stent for Treatment of Intracranial Aneurysms: A Single Center Experience.
Intracranial Aneurysm
Midterm Outcomes After Low-Profile Visualization Endoluminal Support or Atlas Stent-Assisted Coiling of Intracranial Aneurysms: A Propensity Score Matching Analysis.
Intracranial Aneurysm
Multicenter Postmarket Analysis of the Neuroform Atlas Stent for Stent-Assisted Coil Embolization of Intracranial Aneurysms.
Intracranial Aneurysm
Neuroform Atlas Stent System for the treatment of intracranial aneurysm: primary results of the Atlas Humanitarian Device Exemption cohort.
Intracranial Aneurysm
Neuroform Atlas stent-assisted coiling of ruptured intracranial aneurysms: A multicenter study.
Intracranial Aneurysm
Outcomes of Stent-Assisted Coiling Using the Neuroform Atlas Stent in Unruptured Wide-Necked Intracranial Aneurysms.
Intracranial Aneurysm
Pivotal Trial of the Neuroform Atlas Stent for Treatment of Anterior Circulation Aneurysms: One-Year Outcomes.
Intracranial Aneurysm
Pivotal trial of the Neuroform Atlas stent for treatment of posterior circulation aneurysms: one-year outcomes.
Intracranial Aneurysm
Preliminary experience of stent salvage using Neuroform Atlas stent for procedure-related complication during coil embolization of intracranial aneurysms.
Intracranial Aneurysm
Preliminary experience of stent-assisted coiling of wide-necked intracranial aneurysms with a single microcatheter.
Intracranial Aneurysm
Rescue Stenting Using Neuroform Atlas Stent During Coiling Protrusion for Ruptured Intracranial Aneurysms.
Intracranial Aneurysm
Safety and efficacy of the Neuroform Atlas for stent-assisted coiling of intracranial aneurysms: A multicenter experience.
Intracranial Aneurysm
Safety and Efficacy of the Neuroform Atlas Stent for Treatment of Intracranial Aneurysms : A Systematic Review and Meta-Analysis.
Intracranial Aneurysm
Stent-assisted coiling of cerebral aneurysms with the Neuroform Atlas stent.
Intracranial Aneurysm
Stent-assisted coiling of cerebral aneurysms: Head to head comparison between the Neuroform Atlas and EZ stents.
Intracranial Aneurysm
The low-profile Neuroform Atlas stent in the treatment of wide-necked intracranial aneurysms - immediate and midterm results: An Italian multicenter registry.
Intracranial Aneurysm
The Neuroform Atlas stent to assist coil embolization of intracranial aneurysms: a multicentre experience.
Intracranial Aneurysm
Two-center experience with Neuroform Atlas stent-assisted coil occlusion of broad-based intracranial aneurysms.
Intracranial Aneurysm
Usefulness of pointwise encoding time reduction with radial acquisition sequence in subtraction-based magnetic resonance angiography for follow-up of the Neuroform Atlas stent-assisted coil embolization for cerebral aneurysms.
Intracranial Aneurysm
Visualization of stent apposition after stent-assisted coiling of intracranial aneurysms using high resolution 3D fusion images acquired by C-arm CT.
Ischemic Attack, Transient
Safety and efficacy of rivaroxaban for the secondary prevention following acute coronary syndromes among biomarker-positive patients: Insights from the ATLAS ACS 2-TIMI 51 trial.
Ischemic Stroke
Association of Computed Tomography Ischemic Lesion Location With Functional Outcome in Acute Large Vessel Occlusion Ischemic Stroke.
Ischemic Stroke
Development of a photochemical thrombosis investigation system to obtain a rabbit ischemic stroke model.
Ischemic Stroke
Fatal or Irreversible Bleeding and Ischemic Events With Rivaroxaban in Acute Coronary Syndrome.
Ischemic Stroke
Population-based Stroke Atlas for outcome prediction: method and preliminary results for ischemic stroke from CT.
Ischemic Stroke
Significance of early CT signs in acute stroke. A CT scan-diffusion MRI study.
Ischemic Stroke
Usefulness of brain atlases in neuroradiology: Current status and future potential.
Joint Diseases
Scoring haemophilic arthropathy on X-rays: improving inter- and intra-observer reliability and agreement using a consensus atlas.
Joint Diseases
Validation of a radiographic scoring system for haemochromatosis arthropathy.
Joint Diseases
[Persistent cervico-occipital neuralgic syndrome caused by an unusual morphological abnormality of the atlas, simulating vertebral arthropathy.]
Joint Instability
3D-Printed Screw-Rod Auxiliary System for Unstable Atlas Fractures: A Retrospective Analysis.
Joint Instability
A hypoplastic atlas and long odontoid process in a girl manifesting phenotypic features resembling spondyloepimetaphyseal dysplasia joint laxity syndrome.
Joint Instability
Atlantoaxial Langerhans cell histiocytosis radiographic characteristics and corresponding prognosis analysis.
Kashin-Beck Disease
Accidental or linked: separated odontoid process fused to the enlarged anterior arch of the atlas associated with atlantoaxial subluxation in a Kashin-Beck disease patient.
Keratoconus
Comparison of Keratoconus Cone Location of Different Topo/tomographical Parameters.
Keratoconus
Differentiating contact lens induced warpage from true keratoconus using corneal topography.
Keratoconus
Stability of LASIK in topographically suspect keratoconus confirmed non-keratoconic by Artemis VHF digital ultrasound epithelial thickness mapping: 1-year follow-up.
Kidney Diseases
A Multi-layered Quantitative In Vivo Expression Atlas of the Podocyte Unravels Kidney Disease Candidate Genes.
Kidney Diseases
AJKD Atlas of Renal Pathology: HIV-Associated Immune Complex Kidney Disease (HIVICK).
Kidney Diseases
Availability, coverage, and scope of health information systems for kidney care across world countries and regions.
Kidney Diseases
Global access of patients with kidney disease to health technologies and medications: findings from the Global Kidney Health Atlas project.
Kidney Diseases
Global coverage of health information systems for kidney disease: availability, challenges, and opportunities for development.
Kidney Diseases
International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Africa.
Kidney Diseases
International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in South Asia.
Kidney Diseases
Kidney Single-Cell Atlas Reveals Myeloid Heterogeneity in Progression and Regression of Kidney Disease.
Kidney Diseases
The Nuclear Receptor Signaling Atlas: development of a functional atlas of nuclear receptors.
Kidney Failure, Chronic
'United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States.
Kidney Failure, Chronic
Excerpts from the United States Renal Data System 2003 Annual Data Report: atlas of end-stage renal disease in the United States.
Kidney Failure, Chronic
Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States.
Kidney Failure, Chronic
Excerpts from the United States Renal Data Systems 2002 annual report: Atlas of end-stage renal disease in the United States.
Kidney Failure, Chronic
Quantification of Tc-99m-ethyl cysteinate dimer brain single photon emission computed tomography images using statistical probabilistic brain atlas in depressive end-stage renal disease patients: Correlation with disease severity and symptom factors.
Kidney Failure, Chronic
Worldwide Epidemiology of Diabetes-Related End-Stage Renal Disease, 2000-2015.
Kidney Neoplasms
An Accurate Tool for Uncovering Cancer Subtypes by Fast Kernel Learning Method to Integrate Multiple Profile Data.
Kidney Neoplasms
Analysis of renal cancer cell lines from two major resources enables genomics-guided cell line selection.
Kidney Neoplasms
Bcl9 Depletion Modulates Endothelial Cell in Tumor Immune Microenvironment in Colorectal Cancer Tumor.
Kidney Neoplasms
Clinical use of a machine learning histopathological image signature in diagnosis and survival prediction of clear cell renal cell carcinoma.
Kidney Neoplasms
Cyclin-dependent kinase 5 acts as a promising biomarker in clear cell Renal Cell Carcinoma.
Kidney Neoplasms
DeepSec: a deep learning framework for secreted protein discovery in human body fluids.
Kidney Neoplasms
DNA methylation profiling reveals novel diagnostic biomarkers in renal cell carcinoma.
Kidney Neoplasms
Evaluating the clinical significance of SHMT2 and its co-expressed gene in human kidney cancer.
Kidney Neoplasms
FOXI1 expression in chromophobe renal cell carcinoma and renal oncocytoma: a study of The Cancer Genome Atlas transcriptome-based outlier mining and immunohistochemistry.
Kidney Neoplasms
High expression of MMP14 is associated with progression and poor short-term prognosis in muscle-invasive bladder cancer.
Kidney Neoplasms
Kidney cancer: Creating a molecular atlas of clear cell renal cell carcinoma genetics.
Kidney Neoplasms
Low neighbor of Brca1 gene expression predicts poor clinical outcome and resistance of sunitinib in clear cell renal cell carcinoma.
Kidney Neoplasms
Pathophysiological Role of Histamine H4 Receptor in Cancer: Therapeutic Implications.
Kidney Neoplasms
SEC61G is upregulated and required for tumor progression in human kidney cancer.
Kidney Neoplasms
Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy response.
Kidney Neoplasms
Transcriptomic characterization and innovative molecular classification of clear cell renal cell carcinoma in the Chinese population.
Klippel-Feil Syndrome
A Rare Presentation of Os Odontoideum with Multiple Vertebral Fusion in Type III Klippel-Feil Syndrome (KFS) - A Case Report.
Klippel-Feil Syndrome
Anomalous atlantoaxial portions of vertebral and posterior inferior cerebellar arteries.
Klippel-Feil Syndrome
Anomalous vertebral arteries in Klippel-Feil syndrome with occipitalized atlas: CT angiography.
Klippel-Feil Syndrome
Aplasia of anterior arch of atlas associated with multiple congenital disorders: Case report.
Klippel-Feil Syndrome
Cervical myelopathy caused by pseudoarthrosis between posterior arch of the atlas and lamina of the axis in Klippel-Feil syndrome: a case report.
Klippel-Feil Syndrome
Chiari I malformation accompanied by assimilation of the atlas, Klippel-Feil syndrome, and syringomyelia: case report.
Klippel-Feil Syndrome
Complete bipartition of the atlas in the Klippel-Feil syndrome. A radiologically illustrated case report.
Klippel-Feil Syndrome
Duplicated odontoid process and atlas clefts associated to Klippel-Feil syndrome.
Klippel-Feil Syndrome
Occipital-C2 Transarticular Fixation for Occipitocervical Instability Associated With Occipitalization of the Atlas in Klippel-Feil Syndrome Patients by Using Intraoperative 3-Dimensional Navigation System.
Klippel-Feil Syndrome
Surgical treatment of Klippel-Feil syndrome with basilar invagination.
Klippel-Feil Syndrome
Surgical Treatment of Occipitocervical Dislocation with Atlas Assimilation and Klippel-Feil Syndrome Using Occipitalized C1 lateral Mass and C2 Fixation and Reduction Technique.
Kyphosis
Odontoid fractures complicated by fractures of the posterior arch of the atlas in the elderly over 85 years with severe thoracic kyphosis secondary to osteoporosis.
Kyphosis
[Chiropractic diagnosis of the atlanto-occipital joint with reference to the Palmer-Sandberg-Gutman functional aspects from the traditional medic-radiologic viewpoint]
Kyphosis
[Instability and misdiagnosed or neglected dislocations of the upper cervical spine in children. Apropos of 20 cases]
lanosterol synthase deficiency
Plant oxidosqualene metabolism: cycloartenol synthase-dependent sterol biosynthesis in Nicotiana benthamiana.
lanosterol synthase deficiency
Skeletal anomalies and normal variants in patients with palatally displaced canines.
lanosterol synthase deficiency
The human lanosterol synthase gene maps to chromosome 21q22.3.
Laryngeal Neoplasms
Acquired Uniparental Disomy Regions Are Associated with Disease Outcome in Patients with Oral Cavity and Oropharynx But Not Larynx Cancers.
Laryngeal Neoplasms
An autophagy-related model of 4 key genes for predicting prognosis of patients with laryngeal cancer.
Laryngeal Neoplasms
Five genes as a novel signature for predicting the prognosis of patients with laryngeal cancer.
Laryngeal Neoplasms
LncRNA LINC00888 upregulation predicts a worse survival of laryngeal cancer patients and accelerates the growth and mobility of laryngeal cancer cells through regulation of miR-378g/TFRC.
Laryngeal Neoplasms
MicroRNA-548ac induces apoptosis in laryngeal squamous cell carcinoma cells by targeting transmembrane protein 158.
Laryngeal Neoplasms
NSD1- and NSD2-damaging mutations define a subset of laryngeal tumors with favorable prognosis.
Laryngeal Neoplasms
Signature microRNAs and long noncoding RNAs in laryngeal cancer recurrence identified using a competing endogenous RNA network.
Leiomyoma
Gene expression profile of leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy.
Leiomyoma
Molecular differential analysis of uterine leiomyomas and leiomyosarcomas through weighted gene network and pathway tracing approaches.
Leiomyosarcoma
Molecular differential analysis of uterine leiomyomas and leiomyosarcomas through weighted gene network and pathway tracing approaches.
Leiomyosarcoma
OSlms: A Web Server to Evaluate the Prognostic Value of Genes in Leiomyosarcoma.
Leiomyosarcoma
The Nanocind Signature Is an Independent Prognosticator of Recurrence and Death in Uterine Leiomyosarcomas.
Leishmaniasis
Entomological inventory of Phlebotomine sand flies and epidemiological study of leishmaniasis in Afourer, Azilal province, High Atlas, Morocco.
Leishmaniasis, Cutaneous
Epidemiologic study and molecular detection of Leishmania and sand fly species responsible of cutaneous leishmaniasis in Foum Jamâa (Azilal, Atlas of Morocco).
Leishmaniasis, Cutaneous
Phlebotomus sergenti in a cutaneous leishmaniasis focus in Azilal province (High Atlas, Morocco): molecular detection and genotyping of Leishmania tropica, and feeding behavior.
Leishmaniasis, Cutaneous
Wing size and shape variation of Phlebotomus papatasi (Diptera: Psychodidae) populations from the south and north slopes of the Atlas Mountains in Morocco.
Leishmaniasis, Visceral
Images from the Haematologica Atlas of Hematologic Cytology: visceral leishmaniasis.
Leukemia
5-Methylcytosine RNA Modifications Promote Retrovirus Replication in an ALYREF Reader Protein-Dependent Manner.
Leukemia
A PML/RAR? direct target atlas redefines transcriptional deregulation in acute promyelocytic leukemia.
Leukemia
A Semantic Web-based System for Mining Genetic Mutations in Cancer Clinical Trials.
Leukemia
Characterization of ZC3H15 as a potential TRAF-2-interacting protein implicated in the NF?B pathway and overexpressed in AML.
Leukemia
Copy number variability analysis of pharmacogenes in patients with lymphoma, leukemia, hepatocellular, and lung carcinoma using The Cancer Genome Atlas data.
Leukemia
Gene expression profiling to identify the toxicities and potentially relevant disease outcomes due to endosulfan exposure.
Leukemia
Leukemia gene atlas--a public platform for integrative exploration of genome-wide molecular data.
Leukemia
Obesity is a risk factor for acute promyelocytic leukemia: evidence from population and cross-sectional studies studies and correlation with flt3 mutations and polyunsaturated fatty acid metabolism.
Leukemia
Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers.
Leukemia
Role of alternative polyadenylation dynamics in acute myeloid leukaemia at single-cell resolution.
Leukemia
The association between copy number aberration, DNA methylation and gene expression in tumor samples.
Leukemia, Lymphoid
Long noncoding RNA DLEU2 predicts a poor prognosis and enhances malignant properties in laryngeal squamous cell carcinoma through the miR-30c-5p/PIK3CD/Akt axis.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.
Leukemia, Myeloid
A comprehensive surface proteome analysis of myeloid leukemia cell lines for therapeutic antibody development.
Leukemia, Myeloid, Acute
A 3-miRNA signature predicts prognosis of pediatric and adolescent cytogenetically normal acute myeloid leukemia.
Leukemia, Myeloid, Acute
A Novel Scoring System for Risk Assessment of Elderly Patients With Cytogenetically Normal Acute Myeloid Leukemia Based on Expression of Three AQP1 DNA Methylation-Associated Genes.
Leukemia, Myeloid, Acute
An atlas of bloodstream-accessible bone marrow proteins for site-directed therapy of acute myeloid leukemia.
Leukemia, Myeloid, Acute
An order independent algorithm for inferring gene regulatory network using quantile value for conditional independence tests.
Leukemia, Myeloid, Acute
Arpp19 Promotes Myc and Cip2a Expression and Associates with Patient Relapse in Acute Myeloid Leukemia.
Leukemia, Myeloid, Acute
Bioinformatics Analysis to Determine Prognostic Mutations of 72 de novo Acute Myeloid Leukemia Cases from the Cancer Genome Atlas (TCGA) with 23 Most Common Mutations and no Abnormal Cytogenetics.
Leukemia, Myeloid, Acute
Bipartite network analysis reveals metabolic gene expression profiles that are highly associated with the clinical outcomes of acute myeloid leukemia.
Leukemia, Myeloid, Acute
Characterization of ZC3H15 as a potential TRAF-2-interacting protein implicated in the NF?B pathway and overexpressed in AML.
Leukemia, Myeloid, Acute
Clinical and preclinical characterization of CD99 isoforms in acute myeloid leukemia.
Leukemia, Myeloid, Acute
Clinical features and prognosis of normal karyotype acute myeloid leukemia pediatric patients with WT1 mutations: an analysis based on TCGA database.
Leukemia, Myeloid, Acute
Eya2, a Target Activated by Plzf, Is Critical for PLZF-RARA-Induced Leukemogenesis.
Leukemia, Myeloid, Acute
Genome-Wide CRISPR Screen Reveals Cancer Cell Resistance to NK Cells Induced by NK-Derived IFN-?.
Leukemia, Myeloid, Acute
High expression of microRNA-500 is associated with poor prognosis in patients with acute myeloid leukemia receiving allogeneic hematopoietic stem cell transplantation.
Leukemia, Myeloid, Acute
ICN: Extracting interconnected communities in gene Co-expression networks.
Leukemia, Myeloid, Acute
Identification of distinctive long noncoding RNA competitive interactions and a six-methylated-gene prognostic signature in acute myeloid leukemia with -5/del(5q) or -7/del(7q).
Leukemia, Myeloid, Acute
Identification of long non-coding RNA competing interactions and biological pathways associated with prognosis in pediatric and adolescent cytogenetically normal acute myeloid leukemia.
Leukemia, Myeloid, Acute
Interpretation of personal genome sequencing data in terms of disease ranks based on mutual information.
Leukemia, Myeloid, Acute
lncRNA TP73-AS1 Regulates miR-21/PTEN Axis to Affect Cell Proliferation in Acute Myeloid Leukemia.
Leukemia, Myeloid, Acute
LncRNA VPS9D1-AS1 promotes cell proliferation in acute lymphoblastic leukemia through modulating GPX1 expression by miR-491-5p and miR-214-3p evasion.
Leukemia, Myeloid, Acute
Local sequence assembly reveals a high-resolution profile of somatic structural variations in 97 cancer genomes.
Leukemia, Myeloid, Acute
MicroRNA-363-3p promote the development of acute myeloid leukemia with RUNX1 mutation by targeting SPRYD4 and FNDC3B.
Leukemia, Myeloid, Acute
MiR-29b-3p cooperates with miR-29c-3p to affect the malignant biological behaviors in T-cell acute lymphoblastic leukemia via TFAP2C/GPX1 axis.
Leukemia, Myeloid, Acute
Myeloid cell-targeted miR-146a mimic inhibits NF-?B-driven inflammation and leukemia progression in vivo.
Leukemia, Myeloid, Acute
PIP4K2A and PIP4K2C transcript levels are associated with cytogenetic risk and survival outcomes in acute myeloid leukemia.
Leukemia, Myeloid, Acute
Scalable Nonparametric Prescreening Method for Searching Higher-Order Genetic Interactions Underlying Quantitative Traits.
Leukemia, Myeloid, Acute
Screening the Cancer Genome Atlas Database for Genes of Prognostic Value in Acute Myeloid Leukemia.
Leukemia, Myeloid, Acute
SIRT2 is an unfavorable prognostic biomarker in patients with acute myeloid leukemia.
Leukemia, Myeloid, Acute
Somatic Functional Deletions of Upstream Open Reading Frame-Associated Initiation and Termination Codons in Human Cancer.
Leukemia, Myeloid, Acute
The hidden genomic landscape of acute myeloid leukemia: subclonal structure revealed by undetected mutations.
Leukemia, Myeloid, Acute
The Prognostic Significance of PDE7B in Cytogenetically Normal Acute Myeloid Leukemia.
Leukemia, Myeloid, Acute
Transposable Element Expression in Acute Myeloid Leukemia Transcriptome and Prognosis.
Leukemia, Myeloid, Acute
U2AF1 mutation promotes tumorigenicity through facilitating autophagy flux mediated by FOXO3a activation in myelodysplastic syndromes.
Leukemia, Myeloid, Acute
Unsupervised Feature Selection Using an Integrated Strategy of Hierarchical Clustering with Singular Value Decomposition: An Integrative Biomarker Discovery Method with Application to Acute Myeloid Leukemia.
Leukemia, Promyelocytic, Acute
A PML/RAR? direct target atlas redefines transcriptional deregulation in acute promyelocytic leukemia.
Leukodystrophy, Globoid Cell
DTI registration in atlas based fiber analysis of infantile Krabbe disease.
Leukoencephalopathies
Characterization of Structural Connectivity of the Default Mode Network in Dogs using Diffusion Tensor Imaging.
Liposarcoma
A Rapid and Cost-Effective Gene Expression Assay for the Diagnosis of Well-Differentiated and Dedifferentiated Liposarcomas.
Liver Diseases
The Human Liver Proteome Project (HLPP) Workshop during the 4(th) HUPO World Congress.
Liver Neoplasms
A Comprehensive Analysis of Argonaute-CLIP Data Identifies Novel, Conserved and Species-Specific Targets of miR-21 in Human Liver and Hepatocellular Carcinoma.
Liver Neoplasms
A Five-Gene Signature Based on Stromal/Immune Scores in the Tumor Microenvironment and Its Clinical Implications for Liver Cancer.
Liver Neoplasms
Aberrant expression of peroxiredoxin 1 and its clinical implications in liver cancer.
Liver Neoplasms
AICAR and compound C negatively modulate HCC-induced primary human hepatic stellate cell activation in vitro.
Liver Neoplasms
Big Data-Based Identification of Multi-Gene Prognostic Signatures in Liver Cancer.
Liver Neoplasms
Caprin-1 promotes HepG2 cell proliferation, invasion and migration and is associated with poor prognosis in patients with liver cancer.
Liver Neoplasms
CBX3/HP1? promotes tumor proliferation and predicts poor survival in hepatocellular carcinoma.
Liver Neoplasms
Clinical Significance of TRMT6 in Hepatocellular Carcinoma: A Bioinformatics-Based Study.
Liver Neoplasms
Clinicopathological significance of miR-27b targeting Golgi protein 73 in patients with hepatocellular carcinoma.
Liver Neoplasms
Comparative clinical evaluation of atlas and deep-learning-based auto-segmentation of organ structures in liver cancer.
Liver Neoplasms
Comprehensive evaluation of SPATS2 expression and its prognostic potential in liver cancer.
Liver Neoplasms
Construction of circRNA-Based ceRNA Network to Reveal the Role of circRNAs in the Progression and Prognosis of Hepatocellular Carcinoma.
Liver Neoplasms
Construction of Novel lncRNA-miRNA-mRNA Network Associated With Recurrence and Identification of Immune-Related Potential Regulatory Axis in Hepatocellular Carcinoma.
Liver Neoplasms
Core liver homeostatic co-expression networks are preserved but respond to perturbations in an organism- and disease-specific manner.
Liver Neoplasms
Design of a liver cancer-specific selector for the analysis of circulating tumor DNA.
Liver Neoplasms
Downregulation of nucleolar and spindle-associated protein 1 expression suppresses liver cancer cell function.
Liver Neoplasms
Downregulation of orosomucoid 2 acts as a prognostic factor associated with cancer-promoting pathways in liver cancer.
Liver Neoplasms
E2F3 promotes liver cancer progression under the regulation of circ-PRKAR1B.
Liver Neoplasms
Elevated high mobility group A2 expression in liver cancer predicts poor patient survival.
Liver Neoplasms
Expression of eukaryotic translation initiation factor 3 subunit B in liver cancer and its prognostic significance.
Liver Neoplasms
Expression of La Ribonucleoprotein Domain Family Member 4B (LARP4B) in Liver Cancer and Their Clinical and Prognostic Significance.
Liver Neoplasms
Gene expression profiling to identify the toxicities and potentially relevant disease outcomes due to endosulfan exposure.
Liver Neoplasms
Gene profiling of HepG2 cells following nitidine chloride treatment: An investigation with microarray and Connectivity Mapping.
Liver Neoplasms
GPSM2 Serves as an Independent Prognostic Biomarker for Liver Cancer Survival.
Liver Neoplasms
HDNA methylation data-based molecular subtype classification related to the prognosis of patients with hepatocellular carcinoma.
Liver Neoplasms
Hematopoietic-substrate-1 associated protein X-1 (HAX-1) regulates liver cancer cells growth, metastasis, and angiogenesis through Akt.
Liver Neoplasms
Hepatocyte nuclear factor 1? suppresses steatosis-associated liver cancer by inhibiting PPAR? transcription.
Liver Neoplasms
High EIF2B5 mRNA expression and its prognostic significance in liver cancer: a study based on the TCGA and GEO database.
Liver Neoplasms
High MAST2 mRNA expression and its role in diagnosis and prognosis of liver cancer.
Liver Neoplasms
High miR-454-3p expression predicts poor prognosis in hepatocellular carcinoma.
Liver Neoplasms
High Trophinin-Associated Protein Expression Is an Independent Predictor of Poor Survival in Liver Cancer.
Liver Neoplasms
Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma.
Liver Neoplasms
Identification of copy number variation-driven genes for liver cancer via bioinformatics analysis.
Liver Neoplasms
Identification of FOS as a Candidate Risk Gene for Liver Cancer by Integrated Bioinformatic Analysis.
Liver Neoplasms
Identification of hub genes associated with prognosis, diagnosis, immune infiltration and therapeutic drug in liver cancer by integrated analysis.
Liver Neoplasms
Identification of Prognostic Stromal-Immune Score-Based Genes in Hepatocellular Carcinoma Microenvironment.
Liver Neoplasms
Identification of Rad51 as a prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma.
Liver Neoplasms
Identification of the potential therapeutic target gene UBE2C in human hepatocellular carcinoma: An investigation based on GEO and TCGA databases.
Liver Neoplasms
Inhibition of EPS8L3 suppresses liver cancer progression and enhances efficacy of sorafenib treatment.
Liver Neoplasms
Integrated genomic analysis for prediction of survival for patients with liver cancer using The Cancer Genome Atlas.
Liver Neoplasms
Integrative single-cell transcriptome analysis reveals a subpopulation of fibroblasts associated with favorable prognosis of liver cancer patients.
Liver Neoplasms
Interplay between base excision repair protein XRCC1 and ALDH2 predicts overall survival in lung and liver cancer patients.
Liver Neoplasms
LncRNA PPP1R14B-AS1 Promotes Tumor Cell Proliferation and Migration via the Enhancement of Mitochondrial Respiration.
Liver Neoplasms
Long non-coding RNA BACE1-AS is an independent unfavorable prognostic factor in liver cancer.
Liver Neoplasms
Long Noncoding RNA SNHG10 Sponges miR-543 to Upregulate Tumor Suppressive SIRT1 in Nonsmall Cell Lung Cancer.
Liver Neoplasms
MAGEC2 Correlates With Unfavorable Prognosis And Promotes Tumor Development In HCC Via Epithelial-Mesenchymal Transition.
Liver Neoplasms
MicroRNA-144 inhibits cell proliferation, migration and invasion in human hepatocellular carcinoma by targeting CCNB1.
Liver Neoplasms
MicroRNA?486?5p functions as a tumor suppressor of proliferation and cancer stem?like cell properties by targeting Sirt1 in liver cancer.
Liver Neoplasms
Multilevel regulation of RUVBL2 expression predicts poor prognosis in hepatocellular carcinoma.
Liver Neoplasms
PopInf: An Approach for Reproducibly Visualizing and Assigning Population Affiliation in Genomic Samples of Uncertain Origin.
Liver Neoplasms
Predicting Functional Modules of Liver Cancer Based on Differential Network Analysis.
Liver Neoplasms
PRIM1 promotes the proliferation of hepatocellular carcinoma cells in vitro and in vivo.
Liver Neoplasms
Prognostic Value of a Novel Signature With Nine Hepatitis C Virus-Induced Genes in Hepatic Cancer by Mining GEO and TCGA Databases.
Liver Neoplasms
Role of miR-182-5p overexpression in trichloroethylene-induced abnormal cell cycle functions in human HepG2 cells.
Liver Neoplasms
Several microRNAs could predict survival in patients with hepatitis B-related liver cancer.
Liver Neoplasms
Sex-biased differences in the correlation between epithelial-to-mesenchymal transition-associated genes in cancer cell lines.
Liver Neoplasms
Silencing of WWP2 inhibits adhesion, invasion, and migration in liver cancer cells.
Liver Neoplasms
Single-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Liver Neoplasms
Small Nucleolar RNA Host Gene 1 (SNHG1) and Chromosome 2 Open Reading Frame 48 (C2orf48) as Potential Prognostic Signatures for Liver Cancer by Constructing Regulatory Networks.
Liver Neoplasms
Tescalcin is an unfavorable prognosis factor that regulats cell proliferation and survival in hepatocellular carcinoma patients.
Liver Neoplasms
The impact of high co-expression of Sp1 and HIF1? on prognosis of patients with hepatocellular cancer.
Liver Neoplasms
The Prediction and Prognostic Significance of INPP5K Expression in Patients with Liver Cancer.
Liver Neoplasms
The prognostic value of lncRNA SNHG4 and its potential mechanism in liver cancer.
Liver Neoplasms
Up-regulated RFC2 predicts unfavorable progression in hepatocellular carcinoma.
Liver Neoplasms
Upregulation of CEP55 Predicts Dismal Prognosis in Patients with Liver Cancer.
Liver Neoplasms
Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
Liver Neoplasms
[Expression and clinical significance of chemokine CXCL10 and its receptor CXCR3 in hepatocellular carcinoma].
Liver Neoplasms
[Expression of microRNA-107 in hepatocellular carcinoma and its clinical significance].
Lordosis
Analysis of the cranio-cervical curvatures in subjects with migraine with and without neck pain.
Lordosis
Impact of Isometric Contraction of Anterior Cervical Muscles on Cervical Lordosis.
Lordosis
Incidence and Risk Factors of Anterior Arch Fracture of The Atlas Following C1 Laminectomy Without Fusion.
Lordosis
Pediatric cervical spine in emergency: radiographic features of normal anatomy, variants and pitfalls.
Lordosis
The correlation between surface measurement of head and neck posture and the anatomic position of the upper cervical vertebrae.
Lordosis
[Chiropractic diagnosis of the atlanto-occipital joint with reference to the Palmer-Sandberg-Gutman functional aspects from the traditional medic-radiologic viewpoint]
Lung Diseases
Diagnostic atlas of non-neoplastic lung disease: a practical guide for surgical pathologists.
Lung Diseases, Interstitial
Interactive high-resolution computed tomography digital atlas of interstitial lung disease.
Lung Diseases, Interstitial
Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis.
Lung Injury
High-voltage electrocution-induced pulmonary injury and cerebellar hemorrhage with fractures in atlas.
Lung Neoplasms
A comprehensive analysis of the predicted targets of miR-642b-3p associated with the long non-coding RNA HOXA11-AS in NSCLC cells.
Lung Neoplasms
A cross-platform comparison of affymetrix and Agilent microarrays reveals discordant miRNA expression in lung tumors of c-Raf transgenic mice.
Lung Neoplasms
A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study.
Lung Neoplasms
A geometric atlas to predict lung tumor shrinkage for radiotherapy treatment planning.
Lung Neoplasms
A modifiable risk factors atlas of lung cancer: A Mendelian randomization study.
Lung Neoplasms
A Novel Long Noncoding RNA (lncRNA), LL22NC03-N64E9.1, Promotes the Proliferation of Lung Cancer Cells and is a Potential Prognostic Molecular Biomarker for Lung Cancer.
Lung Neoplasms
A Pan-Cancer Review of ALK Mutations: Implications for Carcinogenesis and Therapy.
Lung Neoplasms
A polymorphism in miR-1262 regulatory region confers the risk of lung cancer in Chinese population.
Lung Neoplasms
A probabilistic method for leveraging functional annotations to enhance estimation of the temporal order of pathway mutations during carcinogenesis.
Lung Neoplasms
A prognostic 4-lncRNA expression signature for lung squamous cell carcinoma.
Lung Neoplasms
Addressing the challenge of proper delineation of lymph node stations in modern radiotherapy for lung cancer.
Lung Neoplasms
ALCHEMIST Trials: A Golden Opportunity to Transform Outcomes in Early-Stage Non-Small Cell Lung Cancer.
Lung Neoplasms
Aldo-keto reductases are biomarkers of NRF2 activity and are co-ordinately overexpressed in non-small cell lung cancer.
Lung Neoplasms
An Accurate Tool for Uncovering Cancer Subtypes by Fast Kernel Learning Method to Integrate Multiple Profile Data.
Lung Neoplasms
An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers.
Lung Neoplasms
Antimalarial drug pyrimethamine plays a dual role in anti-tumor proliferation and metastasis through targeting DHFR and TP.
Lung Neoplasms
Approaching the Increasing Complexity of Non-Small Cell Lung Cancer Taxonomy.
Lung Neoplasms
ARHGAP30 suppressed lung cancer cell proliferation, migration, and invasion through inhibition of the Wnt/?-catenin signaling pathway.
Lung Neoplasms
Association and clinical implication of the USP10 and MSH2 proteins in non-small cell lung cancer.
Lung Neoplasms
Association of MUC16 Mutation With Response to Immune Checkpoint Inhibitors in Solid Tumors.
Lung Neoplasms
ATLAS: Randomized, Double-Blind, Placebo-Controlled, Phase IIIB Trial Comparing Bevacizumab Therapy With or Without Erlotinib, After Completion of Chemotherapy, With Bevacizumab for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer.
Lung Neoplasms
B-cell Receptor Recombinations in Lung Adenocarcinoma Exome Files Correlate With a Higher Overall Survival Rate.
Lung Neoplasms
Bioinformatics analysis of LINC00426 expression in lung cancer and its correlation with patients' prognosis.
Lung Neoplasms
Biomarker analyses from a randomized, placebo-controlled, phase IIIb trial comparing bevacizumab with or without erlotinib as maintenance therapy for the treatment of advanced non-small-cell lung cancer (ATLAS).
Lung Neoplasms
Cancer cells are highly susceptible to accumulation of templated insertions linked to MMBIR.
Lung Neoplasms
Cancer prevention with green tea and monitoring by a new biomarker, hnRNP B1.
Lung Neoplasms
Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.
Lung Neoplasms
Cell division cycle 20 overexpression predicts poor prognosis for patients with lung adenocarcinoma.
Lung Neoplasms
Centromere protein U expression promotes non-small-cell lung cancer cell proliferation through FOXM1 and predicts poor survival.
Lung Neoplasms
CLCA2 as a novel immunohistochemical marker for differential diagnosis of squamous cell carcinoma from adenocarcinoma of the lung.
Lung Neoplasms
Clinical applications of The Cancer Genome Atlas project (TCGA) for squamous cell lung carcinoma.
Lung Neoplasms
Clinical evaluation of atlas and deep learning based automatic contouring for lung cancer.
Lung Neoplasms
Clinical Significance of miR-210 and its Prospective Signaling Pathways in Non-Small Cell Lung Cancer: Evidence from Gene Expression Omnibus and the Cancer Genome Atlas Data Mining with 2763 Samples and Validation via Real-Time Quantitative PCR.
Lung Neoplasms
Clinical value of miR-145-5p in NSCLC and potential molecular mechanism exploration: A retrospective study based on GEO, qRT-PCR, and TCGA data.
Lung Neoplasms
CNOT3 targets negative cell cycle regulators in non-small cell lung cancer development.
Lung Neoplasms
Co-active receptor tyrosine kinases mitigate the effect of FGFR inhibitors in FGFR1-amplified lung cancers with low FGFR1 protein expression.
Lung Neoplasms
Comparison between atlas and convolutional neural network based automatic segmentation of multiple organs at risk in non-small cell lung cancer.
Lung Neoplasms
Comprehensive analysis of the expression and prognosis for TFAP2 in human lung carcinoma.
Lung Neoplasms
Comprehensive Analysis of the Immune Implication of ACK1 Gene in Non-small Cell Lung Cancer.
Lung Neoplasms
Comprehensive Computational Pathological Image Analysis Predicts Lung Cancer Prognosis.
Lung Neoplasms
Comprehensive identification of microRNA arm selection preference in lung cancer: miR-324-5p and -3p serve oncogenic functions in lung cancer.
Lung Neoplasms
Computed tomographic atlas for the new international lymph node map for lung cancer: A radiation oncologist perspective.
Lung Neoplasms
Contouring variations and the role of atlas in non-small cell lung cancer radiation therapy: Analysis of a multi-institutional preclinical trial planning study.
Lung Neoplasms
Correlations of UGT1A1 gene polymorphisms with onset and prognosis of non-small cell lung cancer.
Lung Neoplasms
CPSF3 is a promising prognostic biomarker and predicts recurrence of non-small cell lung cancer.
Lung Neoplasms
Dartmouth Atlas Area-Level Estimates of End-of-Life Expenditures: How Well Do They Reflect Expenditures for Prospectively Identified Advanced Lung Cancer Patients?
Lung Neoplasms
DeepLRHE: A Deep Convolutional Neural Network Framework to Evaluate the Risk of Lung Cancer Recurrence and Metastasis From Histopathology Images.
Lung Neoplasms
DEK promotes the proliferation and invasion of lung cancers and indicates poor prognosis in lung adenocarcinomas.
Lung Neoplasms
Deubiquitinating enzyme USP41 promotes lung cancer cell proliferation and migration.
Lung Neoplasms
Differences in key genes in human alveolar macrophages between phenotypically normal smokers and nonsmokers: diagnostic and prognostic value in lung cancer.
Lung Neoplasms
Differences in molecular epidemiology of lung cancer among ethnicities (Asian vs. Caucasian).
Lung Neoplasms
Differential binding affinity of mutated peptides for MHC class I is a predictor of survival in advanced lung cancer and melanoma.
Lung Neoplasms
Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Lung Neoplasms
Distribution Atlas of Proliferating Bone Marrow in Non-Small Cell Lung Cancer Patients Measured by FLT-PET/CT Imaging, With Potential Applicability in Radiation Therapy Planning.
Lung Neoplasms
DNAJC12 promotes lung cancer growth by regulating the activation of ??catenin.
Lung Neoplasms
Dual disruption of aldehyde dehydrogenases 1 and 3 promotes functional changes in the glutathione redox system and enhances chemosensitivity in nonsmall cell lung cancer.
Lung Neoplasms
Ectodermal?neural cortex 1 affects the biological function of lung cancer through the MAPK pathway.
Lung Neoplasms
EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small cell lung cancer.
Lung Neoplasms
eIF2?, a subunit of translation-initiation factor EIF2, is a potential therapeutic target for non-small cell lung cancer.
Lung Neoplasms
Endoplasmic reticulum chaperone GRP78/BiP is critical for mutant Kras-driven lung tumorigenesis.
Lung Neoplasms
Epithelial-mesenchymal transition is associated with a distinct tumor microenvironment including elevation of inflammatory signals and multiple immune checkpoints in lung adenocarcinoma.
Lung Neoplasms
Eps15 Homology Domain-Containing Protein 3 Hypermethylation as a Prognostic and Predictive Marker for Colorectal Cancer.
Lung Neoplasms
Erlotinib as maintenance therapy in patients with advanced non-small cell lung cancer: a pooled analysis of three randomized trials.
Lung Neoplasms
Evaluation of the Oncogene Function of GOLPH3 and Correlated Regulatory Network in Lung Adenocarcinoma.
Lung Neoplasms
Exploring spatial patterns of mortality: the new atlas of United States mortality.
Lung Neoplasms
Expression and clinicopathological implication of DcR3 in lung cancer tissues: a tissue microarray study with 365 cases.
Lung Neoplasms
Expression and prognostic value of E2F3 transcription factor in non-small cell lung cancer.
Lung Neoplasms
Expression and the potential functions of TRIM32 in lung cancer tumorigenesis.
Lung Neoplasms
Expression of Osteoprotegrin Is Enhanced in Lung Cancer Tissues and Promotes Aggressive Cellular Traits in H3122 Lung Cancer Cells.
Lung Neoplasms
Expression of the Vesicular Monoamine Transporter Gene Solute Carrier Family 18 Member 1 (SLC18A1) in Lung Cancer.
Lung Neoplasms
Expression profile, clinical significance, and biological function of insulin-like growth factor 2 messenger RNA-binding proteins in non-small cell lung cancer.
Lung Neoplasms
Expression Profiles of microRNAs in Drug-Resistant Non-Small Cell Lung Cancer Cell Lines Using microRNA Sequencing.
Lung Neoplasms
FBXO17 promotes cell proliferation through activation of Akt in lung adenocarcinoma cells.
Lung Neoplasms
FOXH1 promotes lung cancer progression by activating the Wnt/?-catenin signaling pathway.
Lung Neoplasms
FRA1 contributes to MEK-ERK pathway-dependent PD-L1 upregulation by KRAS mutation in premalignant human bronchial epithelial cells.
Lung Neoplasms
Gene Panel of Persister Cells as a Prognostic Indicator for Tumor Repopulation After Radiation.
Lung Neoplasms
Genetic and Immune Profiles of Solid Predominant Lung Adenocarcinoma Reveal Potential Immunotherapeutic Strategies.
Lung Neoplasms
Genetic defects of the IRF1-mediated major histocompatibility complex class I antigen presentation pathway occur prevalently in the
Lung Neoplasms
Genomic analyses based on pulmonary adenocarcinoma in situ reveal early lung cancer signature.
Lung Neoplasms
Genomic Common Data Model for Seamless Interoperation of Biomedical Data in Clinical Practice: Retrospective Study.
Lung Neoplasms
Genomic data from NSCLC tumors reveals correlation between SHP-2 activity and PD-L1 expression and suggests synergy in combining SHP-2 and PD-1/PD-L1 inhibitors.
Lung Neoplasms
HER2-Mutated Breast Cancer Responds to Treatment With Single-Agent Neratinib, a Second-Generation HER2/EGFR Tyrosine Kinase Inhibitor.
Lung Neoplasms
High-depth, high-accuracy microsatellite genotyping enables precision lung cancer risk classification.
Lung Neoplasms
High-Throughput Genomic Profiling of Adult Solid Tumors Reveals Novel Insights into Cancer Pathogenesis.
Lung Neoplasms
Histone-Related Genes Are Hypermethylated in Lung Cancer and Hypermethylated HIST1H4F Could Serve as a Pan-Cancer Biomarker.
Lung Neoplasms
HUWE1 controls the development of non-small cell lung cancer through down-regulation of p53.
Lung Neoplasms
Hypermethylation of CCND2 in Lung and Breast Cancer Is a Potential Biomarker and Drug Target.
Lung Neoplasms
Hypermethylation of tumor necrosis factor decoy receptor gene in non-small cell lung cancer.
Lung Neoplasms
Identification of a MET-eIF4G1 translational regulation axis that controls HIF-1? levels under hypoxia.
Lung Neoplasms
Identification of angiotensin-converting enzyme 2 (ACE2) protein as the potential biomarker in SARS-CoV-2 infection-related lung cancer using computational analysis.
Lung Neoplasms
Identification of downstream signaling cascades of ACK1 and prognostic classifiers in non-small cell lung cancer.
Lung Neoplasms
Identification of lncRNA biomarkers for lung cancer through integrative cross-platform data analyses.
Lung Neoplasms
Identification of Prognostic and Chemopredictive microRNAs for Non-Small-Cell Lung Cancer by Integrating SEER-Medicare Data.
Lung Neoplasms
Identification of Survival-Associated Gene Signature in Lung Cancer Coexisting With COPD.
Lung Neoplasms
Impact of genetic alterations on outcomes of patients with stage I nonsmall cell lung cancer: An analysis of the cancer genome atlas data.
Lung Neoplasms
Increased CX3CL1 mRNA expression level is a positive prognostic factor in patients with lung adenocarcinoma.
Lung Neoplasms
Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma.
Lung Neoplasms
Individualized analysis of differentially expressed miRNAs with application to the identification of miRNAs deregulated commonly in lung cancer tissues.
Lung Neoplasms
Inhibition of lung cancer cells and Ras/Raf/MEK/ERK signal transduction by ectonucleoside triphosphate phosphohydrolase-7 (ENTPD7).
Lung Neoplasms
Integrating germline and somatic genetics to identify genes associated with lung cancer.
Lung Neoplasms
Integrative CAGE and DNA Methylation Profiling Identify Epigenetically Regulated Genes in NSCLC.
Lung Neoplasms
Integrative oncogene-dependency mapping identifies RIT1 vulnerabilities and synergies in lung cancer.
Lung Neoplasms
Interferon regulatory factor 6 correlates with the progression of non-small cell lung cancer and can be regulated by miR-320.
Lung Neoplasms
Japanese version of The Cancer Genome Atlas, JCGA, established using fresh frozen tumors obtained from 5143 cancer patients.
Lung Neoplasms
Key Common Genes in Obstructive Sleep Apnea and Lung Cancer are Associated with Prognosis of Lung Cancer Patients.
Lung Neoplasms
KLF4 regulates adult lung tumor-initiating cells and represses K-Ras-mediated lung cancer.
Lung Neoplasms
Knockdown of SOX12 expression inhibits the proliferation and metastasis of lung cancer cells.
Lung Neoplasms
Knockdown of TRIM65 inhibits lung cancer cell proliferation, migration and invasion: A therapeutic target in human lung cancer.
Lung Neoplasms
Label-free quantitative proteomic analysis identifies the oncogenic role of FOXA1 in BaP-transformed 16HBE cells.
Lung Neoplasms
LINC00460 promotes proliferation and inhibits apoptosis of non-small cell lung cancer cells through targeted regulation of miR-539.
Lung Neoplasms
LINC00501 Inhibits the Growth and Metastasis of Lung Cancer by Mediating miR-129-5p/HMGB1.
Lung Neoplasms
LKB1 Down-Modulation by miR-17 Identifies Patients With NSCLC Having Worse Prognosis Eligible for Energy-Stress-Based Treatments.
Lung Neoplasms
lncRNA FLVCR1-AS1 silencing inhibits lung cancer cell proliferation, migration, and invasion by inhibiting the activity of the Wnt/?-catenin signaling pathway.
Lung Neoplasms
lncRNA RPPH1 promotes non-small cell lung cancer progression through the miR-326/WNT2B axis.
Lung Neoplasms
Long non-coding RNA-HAGLR suppressed tumor growth of lung adenocarcinoma through epigenetically silencing E2F1.
Lung Neoplasms
Long noncoding RNA lung cancer associated transcript 1 promotes proliferation and invasion of clear cell renal cell carcinoma cells by negatively regulating miR-495-3p.
Lung Neoplasms
Long Noncoding RNA SNHG10 Sponges miR-543 to Upregulate Tumor Suppressive SIRT1 in Nonsmall Cell Lung Cancer.
Lung Neoplasms
Loss of CDKN2A at chromosome 9 has a poor clinical prognosis and promotes lung cancer progression.
Lung Neoplasms
Low Mutation Burden in Ovarian Cancer May Limit the Utility of Neoantigen-Targeted Vaccines.
Lung Neoplasms
MCM2-regulated functional networks in lung cancer by multi-dimensional proteomic approach.
Lung Neoplasms
MCMC implementation of the optimal Bayesian classifier for non-Gaussian models: model-based RNA-Seq classification.
Lung Neoplasms
MET Receptor Tyrosine Kinase Regulates the Expression of Co-Stimulatory and Co-Inhibitory Molecules in Tumor Cells and Contributes to PD-L1-Mediated Suppression of Immune Cell Function.
Lung Neoplasms
Methylation of RILP in lung cancer promotes tumor cell proliferation and invasion.
Lung Neoplasms
MicroRNA-218 functions as a tumor suppressor in lung cancer by targeting IL-6/STAT3 and negatively correlates with poor prognosis.
Lung Neoplasms
Minichromosome maintenance protein 10 as a marker for proliferation and prognosis in lung cancer.
Lung Neoplasms
Mining and validating the expression pattern and prognostic value of acetylcholine receptors in non-small cell lung cancer.
Lung Neoplasms
miR-1269 promotes cell survival and proliferation by targeting tp53 and caspase-9 in lung cancer.
Lung Neoplasms
miR?146a?5p targets TCSF and influences cell growth and apoptosis to repress NSCLC progression.
Lung Neoplasms
Modeling clinical and molecular covariates of mutational process activity in cancer.
Lung Neoplasms
Molecular and Morphological Profiling of Lung Cancer: A Foundation for "Next-Generation" Pathologists and Oncologists.
Lung Neoplasms
Molecular characteristics of non-small cell lung cancer with reduced CHFR expression in The Cancer Genome Atlas (TCGA) project.
Lung Neoplasms
Multi-omics integrative analysis and survival risk model construction of non-small cell lung cancer based on The Cancer Genome Atlas datasets.
Lung Neoplasms
Mutant-allele fraction heterogeneity is associated with non-small cell lung cancer patient survival.
Lung Neoplasms
Mutations in genes connected with the TCF7L2 transcription factor are associated with a poor prognosis in non-small cell lung cancer.
Lung Neoplasms
National practice trends for the surgical management of lung cancer in the CMS population: an atlas of care.
Lung Neoplasms
Network-Based Isoform Quantification with RNA-Seq Data for Cancer Transcriptome Analysis.
Lung Neoplasms
Nicotine and oxidative stress induced exomic variations are concordant and overrepresented in cancer-associated genes.
Lung Neoplasms
Nicotine promotes the development of non-small cell lung cancer through activating LINC00460 and PI3K/Akt signaling.
Lung Neoplasms
Notch1 Deficiency Induces Tumor Cell Accumulation Inside the Bronchiolar Lumen and Increases TAZ Expression in an Autochthonous Kras LSL-G12V Driven Lung Cancer Mouse Model.
Lung Neoplasms
Pathophysiological Role of Histamine H4 Receptor in Cancer: Therapeutic Implications.
Lung Neoplasms
PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee.
Lung Neoplasms
Penalized integrative semiparametric interaction analysis for multiple genetic datasets.
Lung Neoplasms
PHLPP2 as a novel metastatic and prognostic biomarker in non-small cell lung cancer patients.
Lung Neoplasms
Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma.
Lung Neoplasms
Potential Benefits of Bevacizumab Combined With Platinum-Based Chemotherapy in Advanced Non-Small-Cell Lung Cancer Patients With EGFR Mutation.
Lung Neoplasms
Potentially functional genetic variants in the TNF/TNFR signaling pathway genes predict survival of patients with non-small cell lung cancer in the PLCO cancer screening trial.
Lung Neoplasms
Predicting Deep Learning Based Multi-Omics Parallel Integration Survival Subtypes in Lung Cancer Using Reverse Phase Protein Array Data.
Lung Neoplasms
Prediction of prognosis of patients with lung cancer in combination with the immune score.
Lung Neoplasms
Prediction of Target-Drug Therapy by Identifying Gene Mutations in Lung Cancer With Histopathological Stained Image and Deep Learning Techniques.
Lung Neoplasms
Prioritizing Potentially Druggable Mutations with dGene: An Annotation Tool for Cancer Genome Sequencing Data.
Lung Neoplasms
Prognostic Value of the Tumor Immune Microenvironment for Early-stage, Non-Small Cell Lung Cancer.
Lung Neoplasms
pTuneos: prioritizing tumor neoantigens from next-generation sequencing data.
Lung Neoplasms
Reference-free deconvolution, visualization and interpretation of complex DNA methylation data using DecompPipeline, MeDeCom and FactorViz.
Lung Neoplasms
Repurposing Methotrexate in Dampening SARS-CoV2-S1-Mediated IL6 Expression: Lessons Learnt from Lung Cancer.
Lung Neoplasms
RICTOR Amplification Defines a Novel Subset of Patients with Lung Cancer Who May Benefit from Treatment with mTORC1/2 Inhibitors.
Lung Neoplasms
RNA Sequencing in Comparison to Immunohistochemistry for Measuring Cancer Biomarkers in Breast Cancer and Lung Cancer Specimens.
Lung Neoplasms
Role of Dusp6 Phosphatase as a Tumor Suppressor in Non-Small Cell Lung Cancer.
Lung Neoplasms
Serous IFNA3 predicts unfavorable prognosis in lung cancer via abnormal activation of AKT signaling.
Lung Neoplasms
Sestrin2 Expression Has Regulatory Properties and Prognostic Value in Lung Cancer.
Lung Neoplasms
Silencing of CASC8 inhibits non-small cell lung cancer cells function and promotes sensitivity to osimertinib via FOXM1.
Lung Neoplasms
Somatic copy number alterations are predictive of progression-free survival in patients with lung adenocarcinoma undergoing radiotherapy.
Lung Neoplasms
Somatic Mutations and Splicing Variants of Focal Adhesion Kinase in Non-Small Cell Lung Cancer.
Lung Neoplasms
Survival analysis and functional annotation of long non-coding RNAs in lung adenocarcinoma.
Lung Neoplasms
Targeted Imaging of the Atypical Chemokine Receptor 3 (ACKR3/CXCR7) in Human Cancer Xenografts.
Lung Neoplasms
The expression and prognostic significance of Drp1 in lung cancer: A bioinformatics analysis and immunohistochemistry.
Lung Neoplasms
The functional landscape of Golgi membrane protein 1 (GOLM1) phosphoproteome reveal GOLM1 regulating P53 that promotes malignancy.
Lung Neoplasms
The Immune Heterogeneity Between Pulmonary Adenocarcinoma and Squamous Cell Carcinoma: A Comprehensive Analysis Based on lncRNA Model.
Lung Neoplasms
The International Association for the Study of Lung Cancer Lymph Node Map: A Radiologic Atlas and Review.
Lung Neoplasms
The Japan Lung Cancer Society-Japanese Society for Radiation Oncology consensus-based computed tomographic atlas for defining regional lymph node stations in radiotherapy for lung cancer.
Lung Neoplasms
The long non-coding RNA EPB41L4A-AS2 inhibits tumor proliferation and is associated with favorable prognoses in breast cancer and other solid tumors.
Lung Neoplasms
The miR-608 rs4919510 polymorphism may modify cancer susceptibility based on type.
Lung Neoplasms
The Outer Retinal Membrane Protein 1 Could Inhibit Lung Cancer Progression as a Tumor Suppressor.
Lung Neoplasms
The PI3K/mTOR Pathway Is Targeted by Rare Germline Variants in Patients with Both Melanoma and Renal Cell Carcinoma.
Lung Neoplasms
The USP21/YY1/SNHG16 axis contributes to tumor proliferation, migration, and invasion of non-small-cell lung cancer.
Lung Neoplasms
TLR4 has a TP53-dependent dual role in regulating breast cancer cell growth.
Lung Neoplasms
TMEM196 hypermethylation as a novel diagnostic and prognostic biomarker for lung cancer.
Lung Neoplasms
TMEM45B, up-regulated in human lung cancer, enhances tumorigenicity of lung cancer cells.
Lung Neoplasms
TP53 Status, Patient Sex, and the Immune Response as Determinants of Lung Cancer Patient Survival.
Lung Neoplasms
Transcriptome meta-analysis of lung cancer reveals recurrent aberrations in NRG1 and Hippo pathway genes.
Lung Neoplasms
Trophinin-associated protein expression is an independent prognostic biomarker in lung adenocarcinoma.
Lung Neoplasms
Uncovering the Pharmacological Mechanism of 2-Dodecyl-6-Methoxycyclohexa-2,5 -Diene-1,4-Dione Against Lung Cancer Based on Network Pharmacology and Experimental Evaluation.
Lung Neoplasms
Upregulation of SPP1 Is a Marker for Poor Lung Cancer Prognosis and Contributes to Cancer Progression and Cisplatin Resistance.
Lung Neoplasms
Validating a Predictive Atlas of Tumor Shrinkage for Adaptive Radiotherapy of Locally Advanced Lung Cancer.
Lung Neoplasms
Variance component tests of multivariate mediation effects under composite null hypotheses.
Lung Neoplasms
[DNA damage associated genetic variants contribute to lung cancer susceptibility in a Han Chinese population].
Lung Neoplasms
[Inframunicipality distribution of lung cancer in the urban area of Grenoble]
Lupus Nephritis
AJKD Atlas of Renal Pathology: Focal and Diffuse Lupus Nephritis (ISN/RPS Class III and IV).
Lupus Nephritis
AJKD Atlas of Renal Pathology: Membranous Lupus Nephritis, ISN/RPS Class V.
Lupus Nephritis
AJKD Atlas of Renal Pathology: Minimal Mesangial and Mesangial Proliferative Lupus Nephritis (ISN/RPS Class I and II).
Lymphadenopathy
Radiogenomics of High-Grade Serous Ovarian Cancer: Multireader Multi-Institutional Study from the Cancer Genome Atlas Ovarian Cancer Imaging Research Group.
Lymphatic Metastasis
A MicroRNA Signature Associated With Metastasis of T1 Colorectal Cancers to Lymph Nodes.
Lymphatic Metastasis
A miRNA-clinicopathological nomogram for the prediction of central lymph node metastasis in papillary thyroid carcinoma-analysis from TCGA database.
Lymphatic Metastasis
Actin-Associated Gene Expression is Associated with Early Regional Metastasis of Tongue Cancer.
Lymphatic Metastasis
Comprehensive Analysis of Survival-Related lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Gastric Cancer.
Lymphatic Metastasis
Correlations of lncRNAs with cervical lymph node metastasis and prognosis of papillary thyroid carcinoma.
Lymphatic Metastasis
CXC Chemokine/Receptor Axis Profile and Metastasis in Prostate Cancer.
Lymphatic Metastasis
DDX49 is a novel biomarker and therapeutic target for lung cancer metastases.
Lymphatic Metastasis
Development and validation of hub genes for lymph node metastasis in patients with prostate cancer.
Lymphatic Metastasis
High expression of growth factor receptor-bound protein 14 predicts poor prognosis for colorectal cancer patients.
Lymphatic Metastasis
HOXB5 acts as an oncogenic driver in head and neck squamous cell carcinoma via EGFR/Akt/Wnt/?-catenin signaling axis.
Lymphatic Metastasis
HOXC13 promotes cervical cancer proliferation, invasion and Warburg effect through ?-catenin/c-Myc signaling pathway.
Lymphatic Metastasis
Identification of differentially expressed miRNAs in early-stage cervical cancer with lymph node metastasis across The Cancer Genome Atlas datasets.
Lymphatic Metastasis
Integrated analysis of deregulation microRNA expression in head and neck squamous cell carcinoma.
Lymphatic Metastasis
Integrin ?4 promotes invasion and anoikis resistance of papillary thyroid carcinoma and is consistently overexpressed in lymphovascular tumor thrombus.
Lymphatic Metastasis
Long non-coding RNA LINC00997 silencing inhibits the progression and metastasis of colorectal cancer by sponging miR-512-3p.
Lymphatic Metastasis
Low metallothionein 1M (MT1M) is associated with thyroid cancer cell lines progression.
Lymphatic Metastasis
Lymph node metastasis in lung squamous cell carcinoma and identification of metastasis-related genes based on the Cancer Genome Atlas.
Lymphatic Metastasis
miR-224, miR-147b and miR-31 associated with lymph node metastasis and prognosis for lung adenocarcinoma by regulating PRPF4B, WDR82 or NR3C2.
Lymphatic Metastasis
NECTIN4 promotes papillary thyroid cancer cell proliferation, migration, and invasion and triggers EMT by activating AKT.
Lymphatic Metastasis
Overexpression of transcription factor activating enhancer binding protein 4 (TFAP4) predicts poor prognosis for colorectal cancer patients.
Lymphatic Metastasis
p53-inducible gene 3 promotes cell migration and invasion by activating the FAK/Src pathway in lung adenocarcinoma.
Lymphatic Metastasis
Para-aortic lymph node metastasis in lower Thoracic Esophageal Squamous Cell Carcinoma after Radical Esophagectomy: a CT-based atlas and its clinical implications for Adjuvant Radiotherapy.
Lymphatic Metastasis
Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers.
Lymphatic Metastasis
Prognostic and Predictive Value of Three DNA Methylation Signatures in Lung Adenocarcinoma.
Lymphatic Metastasis
Role of INSL4 Signaling in Sustaining the Growth and Viability of LKB1-Inactivated Lung Cancer.
Lymphatic Metastasis
The long non-coding RNA maternally expressed gene 3 activates p53 and is downregulated in esophageal squamous cell cancer.
Lymphatic Metastasis
The roles and prognostic significance of ABI1-TSV-11 expression in patients with left-sided colorectal cancer.
Lymphatic Metastasis
Upregulation Of Protein Tyrosine Phosphatase Receptor Type C Associates To The Combination Of Hashimoto's Thyroiditis And Papillary Thyroid Carcinoma And Is Predictive Of A Poor Prognosis.
Lymphatic Metastasis
WISP-1 Promotes Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma Cells Via the miR-153-3p/Snail Axis.
Lymphoma
Copy number variability analysis of pharmacogenes in patients with lymphoma, leukemia, hepatocellular, and lung carcinoma using The Cancer Genome Atlas data.
Lymphoma
Detection of differentially expressed genes in lymphomas using cDNA arrays: identification of clusterin as a new diagnostic marker for anaplastic large-cell lymphomas.
Lymphoma
Hypertext atlas of dermatopathology with expert system for epithelial tumors of the skin.
Lymphoma
SPAG6 promotes cell proliferation and inhibits apoptosis through the PTEN/PI3K/AKT pathway in Burkitt lymphoma.
Lymphoma
Utility and diagnostic pitfalls of SOX11 monoclonal antibodies in mantle cell lymphoma and other lymphoproliferative disorders.
Lymphoma, B-Cell
Apoptosis signaling molecules as treatment targets in head and neck squamous cell carcinoma.
Lymphoma, B-Cell
Network-adjusted Kendall's Tau Measure for Feature Screening with Application to High-dimensional Survival Genomic Data.
Lymphoma, B-Cell
Prediction of Target Genes and Pathways Associated With Cetuximab Insensitivity in Colorectal Cancer.
Lymphoma, B-Cell
Utility and diagnostic pitfalls of SOX11 monoclonal antibodies in mantle cell lymphoma and other lymphoproliferative disorders.
Lymphoma, Large B-Cell, Diffuse
Network-adjusted Kendall's Tau Measure for Feature Screening with Application to High-dimensional Survival Genomic Data.
Lymphoproliferative Disorders
Utility and diagnostic pitfalls of SOX11 monoclonal antibodies in mantle cell lymphoma and other lymphoproliferative disorders.
Macular Degeneration
Integration of eQTL and a Single-Cell Atlas in the Human Eye Identifies Causal Genes for Age-Related Macular Degeneration.
Macular Degeneration
Research resource: nuclear receptor atlas of human retinal pigment epithelial cells: potential relevance to age-related macular degeneration.
Macular Degeneration
Single-cell transcriptomic atlas of the human retina identifies cell types associated with age-related macular degeneration.
Malaria
A comprehensive gene expression atlas of sex- and tissue-specificity in the malaria vector, Anopheles gambiae.
Malaria
A global model of malaria climate sensitivity: comparing malaria response to historic climate data based on simulation and officially reported malaria incidence.
Malaria
A regional-scale, high resolution dynamical malaria model that accounts for population density, climate and surface hydrology.
Malaria
A systematic review of changing malaria disease burden in sub-Saharan Africa since 2000: comparing model predictions and empirical observations.
Malaria
A validation of the Malaria Atlas Project maps and development of a new map of malaria transmission in Sokoto, Nigeria: a cross-sectional study using geographic information systems.
Malaria
Assembling a global database of malaria parasite prevalence for the Malaria Atlas Project.
Malaria
Contemporary epidemiological overview of malaria in Madagascar: operational utility of reported routine case data for malaria control planning.
Malaria
Distribution of malaria exposure in endemic countries in Africa considering country levels of effective treatment.
Malaria
High resolution population maps for low income nations: combining land cover and census in East Africa.
Malaria
HIV-malaria co-infection: effects of malaria on the prevalence of HIV in East sub-Saharan Africa.
Malaria
Human population, urban settlement patterns and their impact on Plasmodium falciparum malaria endemicity.
Malaria
Impact of malaria interventions on child mortality in endemic African settings: comparison and alignment between LiST and Spectrum-Malaria model.
Malaria
Malaria around large dams in Africa: effect of environmental and transmission endemicity factors.
Malaria
Malaria Data by District: An open-source web application for increasing access to malaria information.
Malaria
Malaria impact of large dams in sub-Saharan Africa: maps, estimates and predictions.
Malaria
Malaria mortality in Africa and Asia: evidence from INDEPTH health and demographic surveillance system sites.
Malaria
malariaAtlas: an R interface to global malariometric data hosted by the Malaria Atlas Project.
Malaria
Nets versus spraying: A spatial modelling approach reveals indoor residual spraying targets Anopheles mosquito habitats better than mosquito nets in Tanzania.
Malaria
Possession of bed nets in Haut-Katanga (DRC): prevalence-elastic behaviour or performance of health care system delivery?
Malaria
Quantifying Inequitable Access to Rapid Burn and Reconstructive Care through Geospatial Mapping.
Malaria
Re-examining environmental correlates of Plasmodium falciparum malaria endemicity: a data-intensive variable selection approach.
Malaria
Single-Cell RNA Sequencing Reveals Cellular Heterogeneity and Stage Transition under Temperature Stress in Synchronized Plasmodium falciparum Cells.
Malaria
Spectrum-Malaria: a user-friendly projection tool for health impact assessment and strategic planning by malaria control programmes in sub-Saharan Africa.
Malaria
The dominant Anopheles vectors of human malaria in the Americas: occurrence data, distribution maps and bionomic précis.
Malaria
The impact of large and small dams on malaria transmission in four basins in Africa.
Malaria
The Malaria Cell Atlas: Single parasite transcriptomes across the complete Plasmodium life cycle.
Malaria
The origins and relatedness structure of mixed infections vary with local prevalence of P. falciparum malaria.
Malaria
There and back again: malaria parasite single-cell transcriptomics comes full circle.
Malaria
Vertical and horizontal equity of funding for malaria control: a global multisource funding analysis for 2006-2010.
Malformations of Cortical Development
Brain Source Imaging in Preclinical Rat Models of Focal Epilepsy using High-Resolution EEG Recordings.
Malnutrition
Assessment of nutritional status in the Amazigh children of Amizmiz (Azgour Valley, High Atlas and Morocco).
Malocclusion
Ethnic differences in craniofacial and upper spine morphology between European and Asian children with skeletal Class III malocclusion.
Malocclusion
Treatment effects of functional appliances in children with Class II malocclusion with and without morphologic deviations in the upper spine.
Mandibular Fractures
Mandibular condylar fractures and acute atlanto-axial subluxation. Part 1 - A new clinical and nosographic evidente.
Megacolon
Laboratory markers predictive of fulminant Clostridioides difficile infection refractory to fluid resuscitation.
Melanoma
"Small" melanomas: relation of prognostic variables to diameter of primary superficial spreading melanomas.
Melanoma
7-dehydrocholesterol suppresses melanoma cell proliferation and invasion via Akt1/NF-?B signaling.
Melanoma
?-Catenin-mediated immune evasion pathway frequently operates in primary cutaneous melanomas.
Melanoma
A component overlapping attribute clustering (COAC) algorithm for single-cell RNA sequencing data analysis and potential pathobiological implications.
Melanoma
A four-gene signature predicts survival and anti-CTLA4 immunotherapeutic responses based on immune classification of melanoma.
Melanoma
A Gene Signature Predicting Natural Killer Cell Infiltration and Improved Survival in Melanoma Patients.
Melanoma
A hypergraph-based method for large-scale dynamic correlation study at the transcriptomic scale.
Melanoma
A Leukocyte Infiltration Score Defined by a Gene Signature Predicts Melanoma Patient Prognosis.
Melanoma
A natural history of melanomas and dysplastic nevi: an atlas of lesions in melanoma-prone families.
Melanoma
A Novel Autophagy-Related lncRNA Gene Signature to Improve the Prognosis of Patients with Melanoma.
Melanoma
A novel immune checkpoint-related seven-gene signature for predicting prognosis and immunotherapy response in melanoma.
Melanoma
A secondary role for hypoxia and HIF1 in the regulation of (IFN?-induced) PD-L1 expression in melanoma.
Melanoma
A systems approach reveals distinct metabolic strategies among the NCI-60 cancer cell lines.
Melanoma
A Targeted Proteomic Approach for Heat Shock Proteins Reveals DNAJB4 as a Suppressor for Melanoma Metastasis.
Melanoma
A Targeted Quantitative Proteomic Approach Assesses the Reprogramming of Small GTPases during Melanoma Metastasis.
Melanoma
A Targeted Quantitative Proteomic Method Revealed a Substantial Reprogramming of Kinome during Melanoma Metastasis.
Melanoma
Aberrant CpG methylation of the TFAP2A gene constitutes a mechanism for loss of TFAP2A expression in human metastatic melanoma.
Melanoma
Aberrant NEK2 expression might be an independent predictor for poor recurrence-free survival and overall survival of skin cutaneous melanoma.
Melanoma
Accuracy of The Cancer Genome Atlas Classification vs American Joint Committee on Cancer Classification for Prediction of Metastasis in Patients With Uveal Melanoma.
Melanoma
ALDH1A3 is epigenetically regulated during melanocyte transformation and is a target for melanoma treatment.
Melanoma
An Empirical Antigen Selection Method Identifies Neoantigens That Either Elicit Broad Antitumor T-cell Responses or Drive Tumor Growth.
Melanoma
An Integrative Gene Expression and Mathematical Flux Balance Analysis Identifies Targetable Redox Vulnerabilities in Melanoma Cells.
Melanoma
Antisense targeting of CD47 enhances human cytotoxic T-cell activity and increases survival of mice bearing B16 melanoma when combined with anti-CTLA4 and tumor irradiation.
Melanoma
Assembly-based inference of B-cell receptor repertoires from short read RNA sequencing data with V'DJer.
Melanoma
Assessing microenvironment immunogenicity using tumor specimen exomes: Co-detection of TcR-?/? V(D)J recombinations correlates with PD-1 expression.
Melanoma
Association of MUC16 Mutation With Response to Immune Checkpoint Inhibitors in Solid Tumors.
Melanoma
Association of PD-1/PD-L axis expression with cytolytic activity, mutational load, and prognosis in melanoma and other solid tumors.
Melanoma
AutoEncoder-Based Computational Framework for Tumor Microenvironment Decomposition and Biomarker Identification in Metastatic Melanoma.
Melanoma
Better prognostic determination and feature characterization of cutaneous melanoma through integrative genomic analysis.
Melanoma
Bioinformatic Analysis Identifies Potential Key Genes in the Pathogenesis of Melanoma.
Melanoma
Bioinformatics analysis to identify the critical genes, microRNAs and long noncoding RNAs in melanoma.
Melanoma
Bringing Down Cancer Aircraft: Searching for Essential Hypomutated Proteins in Skin Melanoma.
Melanoma
Burden of Nonsynonymous Mutations among TCGA Cancers and Candidate Immune Checkpoint Inhibitor Responses.
Melanoma
Cancer Stem Cells and the Slow Cycling Phenotype: How to Cut the Gordian Knot Driving Resistance to Therapy in Melanoma.
Melanoma
Cancer systems biology of TCGA SKCM: efficient detection of genomic drivers in melanoma.
Melanoma
Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.
Melanoma
Cannabinoid Receptor Type-2 in B Cells Is Associated with Tumor Immunity in Melanoma.
Melanoma
CD36 promotes vasculogenic mimicry in melanoma by mediating adhesion to the extracellular matrix.
Melanoma
CDKN2A Deletion in Melanoma Excludes T Cell Infiltration by Repressing Chemokine Expression in a Cell Cycle-Dependent Manner.
Melanoma
Cell-type-specific meQTLs extend melanoma GWAS annotation beyond eQTLs and inform melanocyte gene-regulatory mechanisms.
Melanoma
Characterization of Immune Infiltration and Construction of a Prediction Model for Overall Survival in Melanoma Patients.
Melanoma
Characterization of the immune profile of oral tongue squamous cell carcinomas with advancing disease.
Melanoma
Clinical diagnosis of pigmented lesions using digital epiluminescence microscopy. Grading protocol and atlas.
Melanoma
Clinical genome sequencing uncovers potentially targetable truncations and fusions of MAP3K8 in spitzoid and other melanomas.
Melanoma
Clinical implications of ALDH1A1 and ALDH1A3 mRNA expression in melanoma subtypes.
Melanoma
Co-expression modules construction by WGCNA and identify potential prognostic markers of uveal melanoma.
Melanoma
Coexpression network analysis identified that plakophilin 1 is associated with the metastasis in human melanoma.
Melanoma
Combining texture features of whole slide images improves prognostic prediction of recurrence-free survival for cutaneous melanoma patients.
Melanoma
Comparative genomics reveals that loss of lunatic fringe (LFNG) promotes melanoma metastasis.
Melanoma
Comparing the genomes of cutaneous melanoma tumors to commercially available cell lines.
Melanoma
Comprehensive Analysis of a Competing Endogenous RNA Network Identifies Seven-lncRNA Signature as a Prognostic Biomarker for Melanoma.
Melanoma
Comprehensive analysis of prognostic immune-related genes in the tumor microenvironment of cutaneous melanoma.
Melanoma
Comprehensive analysis of tumor necrosis factor receptor TNFRSF9 (4-1BB) DNA methylation with regard to molecular and clinicopathological features, immune infiltrates, and response prediction to immunotherapy in melanoma.
Melanoma
Comprehensive molecular profiling of UV-induced metastatic melanoma in Nme1/Nme2-deficient mice reveals novel markers of survival in human patients.
Melanoma
Connecting the Dots: Therapy-Induced Senescence and a Tumor-Suppressive Immune Microenvironment.
Melanoma
CTLA4 methylation predicts response to anti-PD-1 and anti-CTLA-4 immunotherapy in melanoma patients.
Melanoma
Cyanidin-3-o-Glucoside Pharmacologically Inhibits Tumorigenesis via Estrogen Receptor ? in Melanoma Mice.
Melanoma
Data mining of immune-related prognostic genes in metastatic melanoma microenvironment.
Melanoma
De Novo Mutation in Non-Tyrosine Kinase Domain of ROS1 as a Potential Predictor of Immune Checkpoint Inhibitors in Melanoma.
Melanoma
Density of immunogenic antigens does not explain the presence or absence of the T-cell-inflamed tumor microenvironment in melanoma.
Melanoma
Desmoglein 2 promotes vasculogenic mimicry in melanoma and is associated with poor clinical outcome.
Melanoma
Development and application of high-throughput screens for the discovery of compounds that disrupt ErbB4 signaling: Candidate cancer therapeutics.
Melanoma
Development and validation of an immune and stromal prognostic signature in uveal melanoma to guide clinical therapy.
Melanoma
Development and validation of autophagy-related-gene biomarker and nomogram for predicting the survival of cutaneous melanoma.
Melanoma
Differential binding affinity of mutated peptides for MHC class I is a predictor of survival in advanced lung cancer and melanoma.
Melanoma
Discovery of KIRREL as a biomarker for prognostic stratification of patients with thin melanoma.
Melanoma
Distinguishing Tumor and Stromal Sources of MicroRNAs Linked to Metastasis in Cutaneous Melanoma.
Melanoma
Downregulation of RIG-I mediated by ITGB3/c-SRC/STAT3 signaling confers resistance to interferon-?-induced apoptosis in tumor-repopulating cells of melanoma.
Melanoma
Ectopic expression of KLK6 in MDA-MB-435 melanoma cells reduces tumorigenicity in vivo.
Melanoma
Effect of EphA2 knockdown on melanoma metastasis depends on intrinsic ephrinA1 level.
Melanoma
Effects of RNA methylation N6-methyladenosine regulators on malignant progression and prognosis of melanoma.
Melanoma
Epigenetic Regulation of KPC1 Ubiquitin Ligase Affects the NF-?B Pathway in Melanoma.
Melanoma
ErbB3 Targeting Enhances the Effects of MEK Inhibitor in Wild-Type BRAF/NRAS Melanoma.
Melanoma
Evaluation of melanoma antigen (MAGE) gene expression in human cancers using The Cancer Genome Atlas.
Melanoma
Evolved Resistance to Placental Invasion Secondarily Confers Increased Survival in Melanoma Patients.
Melanoma
Examination of Epigenetic and other Molecular Factors Associated with mda-9/Syntenin Dysregulation in Cancer Through Integrated Analyses of Public Genomic Datasets.
Melanoma
Examining transcriptional changes to DNA replication and repair factors over uveal melanoma subtypes.
Melanoma
Exploration of the immune cell infiltration-related gene signature in the prognosis of melanoma.
Melanoma
Exploration of the Immune-Related Signatures and Immune Infiltration Analysis in Melanoma.
Melanoma
Expression of the Circadian Clock Gene BMAL1 Positively Correlates With Antitumor Immunity and Patient Survival in Metastatic Melanoma.
Melanoma
Expressions of HLA Class II Genes in Cutaneous Melanoma Were Associated with Clinical Outcome: Bioinformatics Approaches and Systematic Analysis of Public Microarray and RNA-Seq Datasets.
Melanoma
FARP1 Facilitates Cell Proliferation Through Modulating MAPK Signaling Pathway in Cutaneous Melanoma.
Melanoma
FUT8-AS1 Inhibits the Malignancy of Melanoma Through Promoting miR-145-5p Biogenesis and Suppressing NRAS/MAPK Signaling.
Melanoma
Gene expression and promoter methylation of angiogenic and lymphangiogenic factors as prognostic markers in melanoma.
Melanoma
Gene Instability-Related lncRNA Prognostic Model of Melanoma Patients via Machine Learning Strategy.
Melanoma
Genetic Analysis of Uveal Melanoma in 658 Patients Using the Cancer Genome Atlas Classification of Uveal Melanoma as A, B, C, and D.
Melanoma
Genome-wide analysis of endogenously expressed ZEB2 binding sites reveals inverse correlations between ZEB2 and GalNAc-transferase GALNT3 in human tumors.
Melanoma
Genome-Wide DNA Methylation Analysis in Melanoma Reveals the Importance of CpG Methylation in MITF Regulation.
Melanoma
Genome-Wide Screen for MicroRNAs Reveals a Role for miR-203 in Melanoma Metastasis.
Melanoma
Germline and somatic albinism variants in amelanotic/hypomelanotic melanoma: Increased carriage of TYR and OCA2 variants.
Melanoma
Glypican 6 is a putative biomarker for metastatic progression of cutaneous melanoma.
Melanoma
High GILT Expression and an Active and Intact MHC Class II Antigen Presentation Pathway Are Associated with Improved Survival in Melanoma.
Melanoma
Hypermutation of DPYD Deregulates Pyrimidine Metabolism and Promotes Malignant Progression.
Melanoma
Identification and validation of immune-related lncRNA prognostic signatures for melanoma.
Melanoma
Identification and Validation of Prognostically Relevant Gene Signature in Melanoma.
Melanoma
Identification of a five-miRNA signature predicting survival in cutaneous melanoma cancer patients.
Melanoma
Identification of a gene expression signature associated with the metastasis suppressor function of NME1: prognostic value in human melanoma.
Melanoma
Identification of gene expression levels in primary melanoma associated with clinically meaningful characteristics.
Melanoma
Identification of Long Non-coding and Messenger RNAs Differentially Expressed Between Primary and Metastatic Melanoma.
Melanoma
Identification of Prognostic Biomarkers of Cutaneous Melanoma Based on Analysis of Tumor Mutation Burden.
Melanoma
Identification of prognostic genes and construction of a novel gene signature in the skin melanoma based on the tumor microenvironment.
Melanoma
Identification of Prognostic Signatures for Predicting the Overall Survival of Uveal Melanoma Patients.
Melanoma
Identification of Targetable Recurrent MAP3K8 Rearrangements in Melanomas Lacking Known Driver Mutations.
Melanoma
Immune Microenvironment Related Competitive Endogenous RNA Network as Powerful Predictors for Melanoma Prognosis Based on WGCNA Analysis.
Melanoma
Immunological analyses reveal an immune subtype of uveal melanoma with a poor prognosis.
Melanoma
Impact of aging on host immune response and survival in melanoma: an analysis of 3 patient cohorts.
Melanoma
Improved T-cell Receptor Diversity Estimates Associate with Survival and Response to Anti-PD-1 Therapy.
Melanoma
In-depth genomic data analyses revealed complex transcriptional and epigenetic dysregulations of BRAFV600E in melanoma.
Melanoma
Increased Expression of T-Box Transcription Factor Protein 21 (TBX21) in Skin Cutaneous Melanoma Predicts Better Prognosis: A Study Based on The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) Databases.
Melanoma
Integrated case-control and somatic-germline interaction analyses of melanoma susceptibility genes.
Melanoma
Interleukin-33 modulates immune responses in cutaneous melanoma in a context-specific way.
Melanoma
Intratumor Heterogeneity Correlates With Reduced Immune Activity and Worse Survival in Melanoma Patients.
Melanoma
Kinesin family member 18B: A contributor and facilitator in the proliferation and metastasis of cutaneous melanoma.
Melanoma
Long non-coding RNA LINC00520 promotes the proliferation and metastasis of malignant melanoma by inducing the miR-125b-5p/EIF5A2 axis.
Melanoma
Long noncoding RNA LINC00518 acts as a competing endogenous RNA to promote the metastasis of malignant melanoma via miR-204-5p/AP1S2 axis.
Melanoma
Long noncoding RNA LINC01291 promotes the aggressive properties of melanoma by functioning as a competing endogenous RNA for microRNA-625-5p and subsequently increasing IGF-1R expression.
Melanoma
Low expression of pro-apoptotic proteins Bax, Bak and Smac indicates prolonged progression-free survival in chemotherapy-treated metastatic melanoma.
Melanoma
Lymphoscintigraphy in cutaneous melanoma: a total body atlas of sentinel node mapping.
Melanoma
Lymphoscintigraphy in cutaneous melanoma: an updated total body atlas of sentinel node mapping.
Melanoma
Marked Global DNA Hypomethylation Is Associated with Constitutive PD-L1 Expression in Melanoma.
Melanoma
Melanoma Is Skin Deep: A 3D Reconstruction Technique for Computerized Dermoscopic Skin Lesion Classification.
Melanoma
Metastasis of Uveal Melanoma with Monosomy-3 Is Associated with a Less Glycogenetic Gene Expression Profile and the Dysregulation of Glycogen Storage.
Melanoma
Methylation and transcription patterns are distinct in IDH mutant gliomas compared to other IDH mutant cancers.
Melanoma
Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma.
Melanoma
MicroRNA-365 Inhibits Cell Growth and Promotes Apoptosis in Melanoma by Targeting BCL2 and Cyclin D1 (CCND1).
Melanoma
MicroRNA-92 Expression in CD133+ Melanoma Stem Cells Regulates Immunosuppression in the Tumor Microenvironment via Integrin-Dependent Activation of TGF?.
Melanoma
MicroRNA-driven deregulation of cytokine expression helps development of drug resistance in metastatic melanoma.
Melanoma
miRNA and mRNA expression profiling reveals potential biomarkers for metastatic cutaneous melanoma.
Melanoma
MMP7 sensitivity of mutant ECM proteins: An indicator of melanoma survival rates and T-cell infiltration.
Melanoma
Modeling clinical and molecular covariates of mutational process activity in cancer.
Melanoma
Molecular characterisation of cutaneous melanoma: creating a framework for targeted and immune therapies.
Melanoma
Molecular Characteristics of Uveal Melanoma: Insights from the Cancer Genome Atlas (TCGA) Project.
Melanoma
Molecular, clinicopathological, and immune correlates of LAG3 promoter DNA methylation in melanoma.
Melanoma
Multi-Platform Omics Analysis for Identification of Molecular Characteristics and Therapeutic Targets of Uveal Melanoma.
Melanoma
NAMPT Over-Expression Recapitulates the BRAF Inhibitor Resistant Phenotype Plasticity in Melanoma.
Melanoma
NEDD4 Negatively Regulates GITR via Ubiquitination in Immune Microenvironment of Melanoma.
Melanoma
Network Rewiring in Cancer: Applications to Melanoma Cell Lines and the Cancer Genome Atlas Patients.
Melanoma
NRASQ61K melanoma tumor formation is reduced by p38-MAPK14 activation in zebrafish models and NRAS-mutated human melanoma cells.
Melanoma
Pathogenic germline variants are associated with poor survival in stage III/IV melanoma patients.
Melanoma
Penalized integrative semiparametric interaction analysis for multiple genetic datasets.
Melanoma
PLK1 and NOTCH Positively Correlate in Melanoma and Their Combined Inhibition Results in Synergistic Modulations of Key Melanoma Pathways.
Melanoma
Potential Prognostic Predictors and Molecular Targets for Skin Melanoma Screened by Weighted Gene Co-expression Network Analysis.
Melanoma
Potential role of cyclin F mRNA expression in the survival of skin melanoma patients: Comprehensive analysis of the pathways altered due to cyclin F upregulation.
Melanoma
Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.
Melanoma
Predicting the Risk of Melanoma Metastasis Using an Immune Risk Score in the Melanoma Cohort.
Melanoma
Prognostic and predictive value of PD-L2 DNA methylation and mRNA expression in melanoma.
Melanoma
Prognostic genes of melanoma identified by weighted gene co-expression network analysis and drug repositioning using a network-based method.
Melanoma
Prognostic Implications of Metabolism Related Gene Signature in Cutaneous Melanoma.
Melanoma
Prognostic value of intratumoral lymphocyte-to-monocyte ratio and M0 macrophage enrichment in tumor immune microenvironment of melanoma.
Melanoma
Prognostic value of the expression of chemokines and their receptors in regional lymph nodes of melanoma patients.
Melanoma
Prognostication of uveal melanoma is simple and highly predictive using The Cancer Genome Atlas (TCGA) classification: A review.
Melanoma
Promoter Methylation of PTEN Is a Significant Prognostic Factor in Melanoma Survival.
Melanoma
Proteogenomic analysis of melanoma brain metastases from distinct anatomical sites identifies pathways of metastatic progression.
Melanoma
Quantitative Proteomics Identifies Activation of Hallmark Pathways of Cancer in Patient Melanoma.
Melanoma
Rare Variant, Gene-Based Association Study of Hereditary Melanoma Using Whole-Exome Sequencing.
Melanoma
Regorafenib Promotes Antitumor Immunity via Inhibiting PD-L1 and IDO1 Expression in Melanoma.
Melanoma
RMEL3, a novel BRAFV600E-associated long noncoding RNA, is required for MAPK and PI3K signaling in melanoma.
Melanoma
Robust semiparametric gene-environment interaction analysis using sparse boosting.
Melanoma
Role of Elevated PHIP Copy Number as a Prognostic and Progression Marker for Cutaneous Melanoma.
Melanoma
Role of Immune Response, Inflammation, and Tumor Immune Response-Related Cytokines/Chemokines in Melanoma Progression.
Melanoma
Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients.
Melanoma
Significance of Tumor Mutation Burden in Immune Infiltration and Prognosis in Cutaneous Melanoma.
Melanoma
Simultaneously Inhibiting BCL2 and MCL1 Is a Therapeutic Option for Patients with Advanced Melanoma.
Melanoma
Single-Cell Characterization of the Immune Microenvironment of Melanoma Brain and Leptomeningeal Metastases.
Melanoma
Somatic Copy Number Amplification and Hyperactivating Somatic Mutations of EZH2 Correlate With DNA Methylation and Drive Epigenetic Silencing of Genes Involved in Tumor Suppression and Immune Responses in Melanoma.
Melanoma
Study of the Female Sex Survival Advantage in Melanoma-A Focus on X-Linked Epigenetic Regulators and Immune Responses in Two Cohorts.
Melanoma
Study on Attenuating Angiogenesis and Epithelial-Mesenchymal Transition (EMT) of Non-Small Cell Lung Carcinoma (NSCLC) by Regulating MAGEC2.
Melanoma
Superpixel-Based Conditional Random Fields (SuperCRF): Incorporating Global and Local Context for Enhanced Deep Learning in Melanoma Histopathology.
Melanoma
Systematic evaluation of cancer-specific genetic risk score for 11 types of cancer in The Cancer Genome Atlas and Electronic Medical Records and Genomics cohorts.
Melanoma
Systems analysis of barrier molecule and ARNT-related gene expression regulation in melanoma.
Melanoma
Targeted next-generation sequencing reveals high frequency of mutations in epigenetic regulators across treatment-naïve patient melanomas.
Melanoma
Ten-year outcomes of uveal melanoma based on The Cancer Genome Atlas (TCGA) classification in 1001 cases.
Melanoma
The Association of MUC16 Mutation with Tumor Mutation Burden and Its Prognostic Implications in Cutaneous Melanoma.
Melanoma
The Autocrine FGF/FGFR System in both Skin and Uveal Melanoma: FGF Trapping as a Possible Therapeutic Approach.
Melanoma
The Construction and Comprehensive Analysis of ceRNA Networks and Tumor-Infiltrating Immune Cells in Bone Metastatic Melanoma.
Melanoma
The FOXC2 Transcription Factor Promotes Melanoma Outgrowth and Regulates Expression of Genes Associated With Drug Resistance and Interferon Responsiveness.
Melanoma
The Identification and Validation of a Robust Immune-Associated Gene Signature in Cutaneous Melanoma.
Melanoma
The Integrative Analysis Identifies Three Cancer Subtypes and Stemness Features in Cutaneous Melanoma.
Melanoma
The Molecular Context of Vulnerability for CDK9 Suppression in Triple Wild-Type Melanoma.
Melanoma
The PI3K/mTOR Pathway Is Targeted by Rare Germline Variants in Patients with Both Melanoma and Renal Cell Carcinoma.
Melanoma
The Potential Role of Selected miRNA in Uveal Melanoma Primary Tumors as Early Biomarkers of Disease Progression.
Melanoma
The prognostic landscape of adaptive immune resistance signatures and infiltrating immune cells in the tumor microenvironment of uveal melanoma.
Melanoma
The Prognostic Significance of Low-Frequency Somatic Mutations in Metastatic Cutaneous Melanoma.
Melanoma
The relationship between RASSF1A gene promoter methylation and the susceptibility and prognosis of melanoma: A meta-analysis and bioinformatics.
Melanoma
The tumor immune microenvironmental analysis of 2,033 transcriptomes across 7 cancer types.
Melanoma
Toll-like receptors 7 and 8 expression correlates with the expression of immune biomarkers and positively predicts the clinical outcome of patients with melanoma.
Melanoma
Topological Tumor Graphs: A Graph-Based Spatial Model to Infer Stromal Recruitment for Immunosuppression in Melanoma Histology.
Melanoma
Toward predicting metastatic progression of melanoma based on gene expression data.
Melanoma
TP53 Mutation as Potential Negative Predictor for Response of Anti-CTLA-4 Therapy in Metastatic Melanoma.
Melanoma
Tumor Infiltrating Lymphocytes Signature as a New Pan-Cancer Predictive Biomarker of Anti PD-1/PD-L1 Efficacy.
Melanoma
Tumor microenvironment immune-related lncRNA signature for patients with melanoma.
Melanoma
Underexpression of Specific Interferon Genes Is Associated with Poor Prognosis of Melanoma.
Melanoma
Unraveling the human protein atlas of metastatic melanoma in the course of ultraviolet radiation-derived photo-therapy.
Melanoma
Vitamin D-VDR Signaling Inhibits Wnt/?-Catenin-Mediated Melanoma Progression and Promotes Antitumor Immunity.
Melanoma
Whole transcriptome analysis reveals correlation of long noncoding RNA ZEB1-AS1 with invasive profile in melanoma.
Melanosis
An atlas of oral lesions observed in the syndrome of oral melanosis with associated intestinal polyposis (Peutz-Jeghers syndrome).
Melanosis
Atlas of oral lesions observed in the syndrome of oral melanosis with associated intestinal polyposis (Peutz-Jeghers syndrome).
Meningioma
Cervical to Petrous Carotid Artery High-Flow Bypass for Carotid Artery Pseudoaneurysm Through Zygomatic Approach: 2-Dimensional Operative Video.
Meningioma
Clipping of Multiple Cerebral Aneurysms Through Cranioorbital Zygomatic Approach: 2-Dimensional Operative Video.
Meningioma
Combined Microscopic-Endoscopic Transmastoid Resection of a Petrous Meningioma: 2-Dimensional Operative Video.
Meningioma
Combined Petrosal Approach for Resection of Petroclival Meningioma with Endoscopic Assistance: Operative Video and Technical Nuances.
Meningioma
Diaphragm Sellae Meningioma: Distinct Clinical, Anatomic, and Surgical Considerations: 2-Dimensional Operative Video.
Meningioma
Foramen Magnum Meningioma-The Attainment of the Intra-Arachnoidal Dissection: 2-Dimensional Operative Video.
Meningioma
Foramen Magnum Meningioma: Microsurgical Endoscopic-Controlled Resection via a Lateral Suboccipital Retrocondylar Approach with Preservation of Posterior Arch of Atlas Integrity.
Meningioma
Microsurgical Resection of a Parasellar Meningioma Invading the Cavernous Sinus, Bone, and Optic Canal: 2-Dimensional Operative Video.
Meningioma
Resection of Giant Invasive Parasagittal Atypical Meningioma With a Venous Graft Reconstruction of the Sagittal Sinus: 2-Dimensional Operative Video.
Meningioma
Resection of Pontine Cavernoma Through the Anterior Transpetrosal Approach: 2-Dimensional Operative Video.
Meningioma
Retrosigmoid Suprameatal Approach for Resection of Petrotentorial Cerebellopontine Angle Meningioma: Operative Video and Technical Nuances.
Meningioma
Simpson Grade I Removal of Tuberculum Sella Meningioma Through the Supraorbital Approach: 2-Dimensional Operative Video.
Meningioma
Simpson Grade I Resection of Type II Clinoidal Meningiomal Through Cranio-orbital Zygomatic Approach: 2-Dimensional Operative Video.
Meningioma
Surgical Treatment of Bilateral Optic Nerve Sheath Meningioma: 2-Dimensional Operative Video.
Meningioma
Transcondylar Approach for Resection of Medullary Cavernous Malformation: 2-Dimensional Operative Video.
Meningioma
Voxel-based lesion mapping of meningioma: a comprehensive lesion location mapping of 260 lesions.
Meningitis
[Atlas of clinico-pathological study of diseases of the nervous system. 3. Case of cryptococcus meningitis]
Meningitis
[Atlas series in neuropathology. (14). Pathology of encephalomyelitis. (2). Tuberculous meningitis]
Meningocele
Tethering of the vertebral artery in the congenital arcuate foramen of the atlas vertebra: a possible cause of vertebral artery dissection in children.
Mesothelioma
Cisplatin and Pemetrexed Activate AXL and AXL Inhibitor BGB324 Enhances Mesothelioma Cell Death from Chemotherapy.
Mesothelioma
The use of a next-generation sequencing-derived machine-learning risk-prediction model (OncoCast-MPM) for malignant pleural mesothelioma: a retrospective study.
Mesothelioma
V-domain Ig-containing suppressor of T-cell activation (VISTA), a potentially targetable immune checkpoint molecule, is highly expressed in epithelioid malignant pleural mesothelioma.
Mesothelioma, Malignant
Comprehensive immunoproteogenomic analyses of malignant pleural mesothelioma.
Mesothelioma, Malignant
MicroRNA-98 is a prognostic factor for asbestos-induced mesothelioma.
Mesothelioma, Malignant
Somatic Epigenetic Silencing of RIPK3 Inactivates Necroptosis and Contributes to Chemoresistance in Malignant Mesothelioma.
Mesothelioma, Malignant
The use of a next-generation sequencing-derived machine-learning risk-prediction model (OncoCast-MPM) for malignant pleural mesothelioma: a retrospective study.
Mesothelioma, Malignant
V-domain Ig-containing suppressor of T-cell activation (VISTA), a potentially targetable immune checkpoint molecule, is highly expressed in epithelioid malignant pleural mesothelioma.
Metabolic Diseases
A practical guide for your daily activity: Atlas of Metabolic Diseases - Second Edition.
Metabolic Diseases
Atlas of common lysosomal and peroxisomal disorders - manual of metabolic diseases
Metabolic Diseases
Metabolic Clinic Atlas: Organization of Care for Children with Inherited Metabolic Disease in Canada.
Metabolic Diseases
Single-cell analysis of human adipose tissue identifies depot and disease specific cell types.
Metabolic Syndrome
Comparative Transcriptional Profiling in HIV-Infected Patients Using Human Stress Arrays: Clues to Metabolic Syndrome.
methylenetetrahydrofolate dehydrogenase (nad+) deficiency
Shifting landscapes of human MTHFR missense-variant effects.
Metrorrhagia
A histological atlas for the Palinuridae (Crustacea: Decapoda: Achelata): A guide to parasite discovery and spotting the abnormal in spiny lobsters.
Metrorrhagia
[Double gunshot head injury with lesion of the upper cervical vertebrae in a case of attempted suicide]
Migraine Disorders
Effect of Atlas Vertebrae Realignment in Subjects with Migraine: An Observational Pilot Study.
Migraine Disorders
Electro-acupuncture inhibits C-fiber-evoked WDR neuronal activity of the trigeminocervical complex: Neurophysiological hypothesis of a complementary therapy for acute migraine modeled rats.
Migraine Disorders
Estimating the savings associated with a migraine-free life: results from the Spanish Atlas.
Migraine Disorders
Gene co-expression analysis identifies brain regions and cell types involved in migraine pathophysiology: a GWAS-based study using the Allen Human Brain Atlas.
Migraine Disorders
Impact of monthly headache days on anxiety, depression and disability in migraine patients: results from the Spanish Atlas.
Migraine Disorders
Incidence of ponticulus posterior of the atlas in migraine and cervicogenic headache.
Migraine Disorders
Neck associated factors related to migraine in adolescents with painful temporomandibular disorders.
Migraine Disorders
White matter changes in chronic and episodic migraine: a diffusion tensor imaging study.
Motor Neuron Disease
Identification of 17 Highly Expressed Genes within Mouse Lumbar Spinal Cord Anterior Horn Region from an In-Situ Hybridization Atlas of 3430 Genes: Implications for Motor Neuron Disease.
Mouth Neoplasms
A library-based ecological study to investigate the contribution of ethnicity to the incidence of oral cancer within health authorities in England and Wales.
Mouth Neoplasms
Cancer Stem Cell based molecular predictors of tumor recurrence in Oral squamous cell carcinoma.
Mouth Neoplasms
Clinical Significance and the Role of Guanylate-Binding Protein 5 in Oral Squamous Cell Carcinoma.
Mouth Neoplasms
DLX6 promotes cell proliferation and survival in oral squamous cell carcinoma.
Mouth Neoplasms
Epigenetic mediated silencing of EYA4 contributes to tumorigenesis in oral dysplastic cells.
Mouth Neoplasms
HSPD1 repressed E-cadherin expression to promote cell invasion and migration for poor prognosis in oral squamous cell carcinoma.
Mouth Neoplasms
Identification of a six-gene prognostic signature for oral squamous cell carcinoma.
Mouth Neoplasms
Index of Cancer-Associated Fibroblasts Is Superior to the Epithelial-Mesenchymal Transition Score in Prognosis Prediction.
Mouth Neoplasms
Oral submucous fibrosis stimulates invasion and epithelial-mesenchymal transition in oral squamous cell carcinoma by activating MMP-2 and IGF-IR.
Mouth Neoplasms
Overexpression of carbonic anhydrase IX induces cell motility by activating matrix metalloproteinase-9 in human oral squamous cell carcinoma cells.
Mouth Neoplasms
Transcriptional Biomarkers in Oral Cancer: An Integrative Analysis and the Cancer Genome Atlas Validation.
Mouth Neoplasms
UBE2C is a Potential Biomarker for Tumorigenesis and Prognosis in Tongue Squamous Cell Carcinoma.
Mouth Neoplasms
WISP-1 Promotes Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma Cells Via the miR-153-3p/Snail Axis.
Movement Disorders
Imaging of Anterior Nucleus of Thalamus Using 1.5T MRI for Deep Brain Stimulation Targeting in Refractory Epilepsy.
Movement Disorders
Morphometric MRI profiles of multiple system atrophy variants and implications for differential diagnosis.
Movement Disorders
Targeting of the Subthalamic Nucleus for Deep Brain Stimulation: A Survey Among Parkinson Disease Specialists.
Movement Disorders
[Cephalization of the atlas as cause of spontaneous movement disorders in the vertebral artery region]
Mucopolysaccharidoses
[Mucopolysaccharidosis 6-A (Maroteaux-Lamy disease): comparison of clinical and pathologico-anatomic findings in a 27-year-old patient]
Mucopolysaccharidosis II
Vascular Ultrasound Measurements After Atlas Orthogonal Chiropractic Care in a Patient With Bow Hunter Syndrome.
Mucopolysaccharidosis IV
Persistent torticollis, facial asymmetry, grooved tongue, and dolicho-odontoid process in connection with atlas malformation complex in three family subjects.
Multiple Myeloma
Images from the Haematologica Atlas of Hematologic Cytology: plasma cell myeloma.
Multiple Myeloma
Widespread intronic polyadenylation diversifies immune cell transcriptomes.
Multiple Sclerosis
An atlas on risk factors for multiple sclerosis: a Mendelian randomization study.
Multiple Sclerosis
Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity.
Multiple Sclerosis
Atlas-based vs. individual-based deterministic tractography of corpus callosum in multiple sclerosis.
Multiple Sclerosis
Correlating MR lesions and functional deficits in multiple sclerosis patients. Anatomical atlas registration.
Multiple Sclerosis
Evaluation of Clinical Gait Analysis parameters in patients affected by Multiple Sclerosis: Analysis of kinematics.
Multiple Sclerosis
Group specific vein-atlasing: An application for analyzing the venous system under normal and multiple sclerosis conditions.
Multiple Sclerosis
Multicentre absolute myelin water content mapping: Development of a whole brain atlas and application to low-grade multiple sclerosis.
Multiple Sclerosis
Multiple Sclerosis Atlas: A Molecular Map of Brain Lesion Stages in Progressive Multiple Sclerosis.
Multiple Sclerosis
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition.
Multiple Sclerosis
Thalamus Optimized Multi Atlas Segmentation (THOMAS): fast, fully automated segmentation of thalamic nuclei from structural MRI.
Multiple Sclerosis
The 150th anniversary of the first depiction of the lesions of multiple sclerosis.
Multiple Sclerosis
The effect of template selection on diffusion tensor voxel-based analysis results.
Multiple Sclerosis
White matter atlas of the human spinal cord with estimation of partial volume effect.
Muscle Hypotonia
Acquired progressive hypotonia in infancy: consider compressive cervical myelopathy.
Muscle Spasticity
Spinal cord compression caused by ossification of the transverse ligament of the atlas.
Muscle Spasticity
[A surgical case of cervical canal stenosis caused by atlas hypoplasia in an elderly patient]
Muscle Spasticity
[Unusual coincidence of dens aplasia and atlas malformation with early childhood spastic tetraparesis. Case report on the differential diagnosis of inflammatory atlantoaxial dislocation]
Muscular Atrophy
[Atlas of nervous system diseases. 4. Autopsy case of progressive spinal muscular atrophy]
Muscular Atrophy, Spinal
[Atlas of nervous system diseases. 4. Autopsy case of progressive spinal muscular atrophy]
Muscular Diseases
Development of the zebrafish myoseptum with emphasis on the myotendinous junction.
Myasthenia Gravis
The Cancer Genome Atlas dataset-based analysis of aberrantly expressed genes by GeneAnalytics in thymoma associated myasthenia gravis: focusing on T cells.
Mycetoma
[Mycetoma due to Streptomyces somaliensis seen in Algeria in the South area of the Atlas mountains]
Myocardial Infarction
A collaborative resource to build consensus for automated left ventricular segmentation of cardiac MR images.
Myocardial Infarction
A novel paclitaxel-eluting stent with an ultrathin abluminal biodegradable polymer 9-month outcomes with the JACTAX HD stent.
Myocardial Infarction
A randomized trial to compare the safety of rivaroxaban vs aspirin in addition to either clopidogrel or ticagrelor in acute coronary syndrome: The design of the GEMINI-ACS-1 phase II study.
Myocardial Infarction
Atlas-based quantification of cardiac remodeling due to myocardial infarction.
Myocardial Infarction
Ethnicity and socioeconomic status influence use of primary angioplasty in patients presenting with acute myocardial infarction.
Myocardial Infarction
Fatal or Irreversible Bleeding and Ischemic Events With Rivaroxaban in Acute Coronary Syndrome.
Myocardial Infarction
Impact of hospitals' Referral Region racial and ethnic diversity on 30-day readmission rates of older adults.
Myocardial Infarction
Influence of model-predicted rivaroxaban exposure and patient characteristics on efficacy and safety outcomes in patients with acute coronary syndrome.
Myocardial Infarction
Information maximizing component analysis of left ventricular remodeling due to myocardial infarction.
Myocardial Infarction
Introduction to the Canadian Cardiovascular Outcomes Research Team's (CCORT) Canadian Cardiovascular Atlas project.
Myocardial Infarction
Long non-coding RNA MIAT promotes breast cancer progression and functions as ceRNA to regulate DUSP7 expression by sponging miR-155-5p.
Myocardial Infarction
Orthogonal decomposition of left ventricular remodelling in myocardial infarction.
Myocardial Infarction
Reduced risk of restenosis in small vessels and reduced risk of myocardial infarction in long lesions with the new thin-strut TAXUS Liberté stent: 1-year results from the TAXUS ATLAS program.
Myocardial Infarction
Rivaroxaban in Patients Stabilized after a ST-Elevation Myocardial Infarction: Results from the ATLAS ACS 2-TIMI 51 Trial.
Myocardial Infarction
Stenting for ST-segment elevation myocardial infarction is associated with less neointimal hyperplasia in the pooled IVUS analysis from HORIZONS-AMI and the TAXUS IV and V and ATLAS workhorse, long lesion, and direct stent studies.
Myocardial Infarction
The "Dual-Pathway" Strategy after Acute Coronary Syndrome: Rivaroxaban and Antiplatelet Agents in the ATLAS ACS 2-TIMI 51 Trial.
Myocardial Infarction
The ATLAS ACS 2-TIMI 51 Trial and the Burden of Missing Data: (Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects With Acute Coronary Syndrome ACS 2-Thrombolysis In Myocardial Infarction 51).
Myocardial Infarction
The effect of rivaroxaban on myocardial infarction in the ATLAS ACS 2 - TIMI 51 trial.
Myocardial Infarction
The treatment of missing data in a large cardiovascular clinical outcomes study.
Myoma
Torsion of a Subserosal Myoma Managed by Gasless Laparoendoscopic Single-Site Myomectomy with In-Bag Manual Extraction.
Nasopharyngeal Carcinoma
Identification of differentially expressed genes in nasopharyngeal carcinoma by means of the Atlas human cancer cDNA expression array.
Nasopharyngeal Carcinoma
MIR106A-5p upregulation suppresses autophagy and accelerates malignant phenotype in nasopharyngeal carcinoma.
Nasopharyngeal Carcinoma
Recommendation for a contouring method and atlas of organs at risk in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy.
Nasopharyngeal Neoplasms
Identification of differentially expressed genes in nasopharyngeal carcinoma by means of the Atlas human cancer cDNA expression array.
Nasopharyngeal Neoplasms
Molecular characteristics of primary pulmonary lymphoepithelioma-like carcinoma based on integrated genomic analyses.
Neoplasm Metastasis
A functional variant in miR-155 regulation region contributes to lung cancer risk and survival.
Neoplasm Metastasis
A MicroRNA Signature Associated With Metastasis of T1 Colorectal Cancers to Lymph Nodes.
Neoplasm Metastasis
A miRNA-clinicopathological nomogram for the prediction of central lymph node metastasis in papillary thyroid carcinoma-analysis from TCGA database.
Neoplasm Metastasis
A novel prognostic models for identifying the risk of hepatocellular carcinoma based on epithelial-mesenchymal transition-associated genes.
Neoplasm Metastasis
A single-cell atlas of liver metastases of colorectal cancer reveals reprogramming of the tumor microenvironment in response to preoperative chemotherapy.
Neoplasm Metastasis
A Targeted Quantitative Proteomic Approach Assesses the Reprogramming of Small GTPases during Melanoma Metastasis.
Neoplasm Metastasis
Accuracy of The Cancer Genome Atlas Classification vs American Joint Committee on Cancer Classification for Prediction of Metastasis in Patients With Uveal Melanoma.
Neoplasm Metastasis
Actin-Associated Gene Expression is Associated with Early Regional Metastasis of Tongue Cancer.
Neoplasm Metastasis
AKNA Is a Potential Prognostic Biomarker in Gastric Cancer and Function as a Tumor Suppressor by Modulating EMT-Related Pathways.
Neoplasm Metastasis
ALDH3A1 driving tumor metastasis is mediated by p53/BAG1 in lung adenocarcinoma.
Neoplasm Metastasis
Alternative splicing of estrogen receptor alpha in hepatocellular carcinoma.
Neoplasm Metastasis
ANGPTL1 is a potential biomarker for differentiated thyroid cancer diagnosis and recurrence.
Neoplasm Metastasis
Antagonistic Effects of p53 and HIF1A on microRNA-34a Regulation of PPP1R11 and STAT3 and Hypoxia-induced Epithelial to Mesenchymal Transition in Colorectal Cancer Cells.
Neoplasm Metastasis
Antimetastatic effect of salvicine on human breast cancer MDA-MB-435 orthotopic xenograft is closely related to Rho-dependent pathway.
Neoplasm Metastasis
Antimetastatic effects of norcantharidin on hepatocellular carcinoma cells by up-regulating FAM46C expression.
Neoplasm Metastasis
ASPP1 deficiency promotes epithelial-mesenchymal transition, invasion and metastasis in colorectal cancer.
Neoplasm Metastasis
Bioinformatic analysis of four miRNAs relevant to metastasis-regulated processes in endometrial carcinoma.
Neoplasm Metastasis
Block-Constraint Robust Principal Component Analysis and its Application to Integrated Analysis of TCGA Data.
Neoplasm Metastasis
C-Reactive Protein (CRP) is a Promising Diagnostic Immunohistochemical Marker for Intrahepatic Cholangiocarcinoma and is Associated With Better Prognosis.
Neoplasm Metastasis
ceRNA network development and tumour-infiltrating immune cell analysis of metastatic breast cancer to bone.
Neoplasm Metastasis
Co-Expression Network Analysis Identified Gene Signatures in Osteosarcoma as a Predictive Tool for Lung Metastasis and Survival.
Neoplasm Metastasis
Comprehensive Analysis of a Competing Endogenous RNA Network Identifies Seven-lncRNA Signature as a Prognostic Biomarker for Melanoma.
Neoplasm Metastasis
Comprehensive Analysis of Survival-Related lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Gastric Cancer.
Neoplasm Metastasis
Construction of Bone Metastasis-Specific Regulation Network Based on Prognostic Stemness-Related Signatures in Breast Invasive Carcinoma.
Neoplasm Metastasis
Correlations of lncRNAs with cervical lymph node metastasis and prognosis of papillary thyroid carcinoma.
Neoplasm Metastasis
DDX49 is a novel biomarker and therapeutic target for lung cancer metastases.
Neoplasm Metastasis
Delineation of the neck node levels for head and neck tumors: A 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines.
Neoplasm Metastasis
Development and validation of hub genes for lymph node metastasis in patients with prostate cancer.
Neoplasm Metastasis
Direct Targeting of CREB1 with Imperatorin Inhibits TGF?2-ERK Signaling to Suppress Esophageal Cancer Metastasis.
Neoplasm Metastasis
Distinctive Desmoplastic 3D Morphology Associated With BRAFV600E in Papillary Thyroid Cancers.
Neoplasm Metastasis
Dopamine receptor D2 genetic variations is associated with the risk and clinicopathological variables of urothelial cell carcinoma in a Taiwanese population.
Neoplasm Metastasis
Downregulation of Collagen COL4A6 Is Associated with Prostate Cancer Progression and Metastasis.
Neoplasm Metastasis
Dual Regulatory Mechanisms of Expression and Mutation Involving Metabolism-Related Genes FDFT1 and UQCR5 during CLM.
Neoplasm Metastasis
Elevated expression of PTCD3 correlates with tumor progression and predicts poor prognosis in patients with prostate cancer.
Neoplasm Metastasis
Epigenetic Regulation of NAMPT by NAMPT-AS Drives Metastatic Progression in Triple-Negative Breast Cancer.
Neoplasm Metastasis
Establishment and Validation of a Comprehensive Prognostic Model for Patients With HNSCC Metastasis.
Neoplasm Metastasis
Exploring the mechanism of clear cell renal cell carcinoma metastasis and key genes based on multi-tool joint analysis.
Neoplasm Metastasis
Eya2 Is Overexpressed in Human Prostate Cancer and Regulates Docetaxel Sensitivity and Mitochondrial Membrane Potential through AKT/Bcl-2 Signaling.
Neoplasm Metastasis
FOXC2 and CLIP4 : a potential biomarker for synchronous metastasis of ?7-cm clear cell renal cell carcinomas.
Neoplasm Metastasis
GADD45B Facilitates Metastasis of Ovarian Cancer Through Epithelial-Mesenchymal Transition.
Neoplasm Metastasis
Global-scale profiling of differential expressed lysine acetylated proteins in colorectal cancer tumors and paired liver metastases.
Neoplasm Metastasis
Glutaminase 1 expression in colorectal cancer cells is induced by hypoxia and required for tumor growth, invasion, and metastatic colonization.
Neoplasm Metastasis
Glypican 6 is a putative biomarker for metastatic progression of cutaneous melanoma.
Neoplasm Metastasis
High expression of growth factor receptor-bound protein 14 predicts poor prognosis for colorectal cancer patients.
Neoplasm Metastasis
HOXB5 acts as an oncogenic driver in head and neck squamous cell carcinoma via EGFR/Akt/Wnt/?-catenin signaling axis.
Neoplasm Metastasis
HOXC13 promotes cervical cancer proliferation, invasion and Warburg effect through ?-catenin/c-Myc signaling pathway.
Neoplasm Metastasis
Hypertonicity-Affected Genes Are Differentially Expressed in Clear Cell Renal Cell Carcinoma and Correlate with Cancer-Specific Survival.
Neoplasm Metastasis
Identification and Validation of the Prognostic Stemness Biomarkers in Bladder Cancer Bone Metastasis.
Neoplasm Metastasis
Identification of differentially expressed miRNAs in early-stage cervical cancer with lymph node metastasis across The Cancer Genome Atlas datasets.
Neoplasm Metastasis
Identification of hepatocellular carcinoma-related genes associated with macrophage differentiation based on bioinformatics analyses.
Neoplasm Metastasis
Identification of key genes involved in the metastasis of clear cell renal cell carcinoma.
Neoplasm Metastasis
Identification of Key mRNAs as Prediction Models for Early Metastasis of Pancreatic Cancer Based on LASSO.
Neoplasm Metastasis
Identification of prognostic and bone metastatic alternative splicing signatures in bladder cancer.
Neoplasm Metastasis
Identification of the potential biomarkers for the metastasis of rectal adenocarcinoma.
Neoplasm Metastasis
Images from the Haematologica Atlas of Hematologic Cytology: bone marrow metastases from gastric adenocarcinoma.
Neoplasm Metastasis
Imaging atlas for eligibility and on-study safety of potential shoulder adverse events in anti-NGF studies (Part 3).
Neoplasm Metastasis
Impact of endothelial nitric oxide synthase polymorphisms on urothelial cell carcinoma development.
Neoplasm Metastasis
Impact of FGFR4 Gene Polymorphism on the Progression of Colorectal Cancer.
Neoplasm Metastasis
Insulin-Like Growth Factor 2 mRNA-Binding Protein 1 (IGF2BP1) Is a Prognostic Biomarker and Associated with Chemotherapy Responsiveness in Colorectal Cancer.
Neoplasm Metastasis
Integrated analysis of deregulation microRNA expression in head and neck squamous cell carcinoma.
Neoplasm Metastasis
Integrated analysis of dysregulated long non-coding RNAs/microRNAs/mRNAs in metastasis of lung adenocarcinoma.
Neoplasm Metastasis
Integrin ?4 promotes invasion and anoikis resistance of papillary thyroid carcinoma and is consistently overexpressed in lymphovascular tumor thrombus.
Neoplasm Metastasis
Kinase Gene Expression Profiling of Metastatic Clear Cell Renal Cell Carcinoma Tissue Identifies Potential New Therapeutic Targets.
Neoplasm Metastasis
KLF9 suppresses gastric cancer cell invasion and metastasis through transcriptional inhibition of MMP28.
Neoplasm Metastasis
Knockdown of TRIM65 inhibits lung cancer cell proliferation, migration and invasion: A therapeutic target in human lung cancer.
Neoplasm Metastasis
Leptin Overexpression as a Poor Prognostic Factor for Colorectal Cancer.
Neoplasm Metastasis
lncRNA PVT1 identified as an independent biomarker for prognosis surveillance of solid tumors based on transcriptome data and meta-analysis.
Neoplasm Metastasis
Long Non-coding RNA LINC00941 as a Potential Biomarker Promotes the Proliferation and Metastasis of Gastric Cancer.
Neoplasm Metastasis
Long non-coding RNA LINC00997 silencing inhibits the progression and metastasis of colorectal cancer by sponging miR-512-3p.
Neoplasm Metastasis
Long noncoding RNA H19 participates in metformin-mediated inhibition of gastric cancer cell invasion.
Neoplasm Metastasis
Long noncoding RNA SNHG12 indicates the prognosis of prostate cancer and accelerates tumorigenesis via sponging miR-133b.
Neoplasm Metastasis
Low metallothionein 1M (MT1M) is associated with thyroid cancer cell lines progression.
Neoplasm Metastasis
Lymph node metastasis in lung squamous cell carcinoma and identification of metastasis-related genes based on the Cancer Genome Atlas.
Neoplasm Metastasis
m6A regulators are associated with osteosarcoma metastasis and have prognostic significance: A study based on public databases.
Neoplasm Metastasis
Metastasis to the occipitocervical junction: A case report and review of the literature.
Neoplasm Metastasis
MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma.
Neoplasm Metastasis
MicroRNA?mRNA integrated analysis based on a case of well?differentiated thyroid cancer with both metastasis and metastatic recurrence.
Neoplasm Metastasis
MIIP haploinsufficiency induces chromosomal instability and promotes tumour progression in colorectal cancer.
Neoplasm Metastasis
miR-205 regulation of ICT1 has an oncogenic potential via promoting the migration and invasion of gastric cancer cells.
Neoplasm Metastasis
miR-223 regulates oral squamous cell carcinoma metastasis through the Wnt/?-catenin signaling pathway.
Neoplasm Metastasis
miR-224, miR-147b and miR-31 associated with lymph node metastasis and prognosis for lung adenocarcinoma by regulating PRPF4B, WDR82 or NR3C2.
Neoplasm Metastasis
Molecular Correlates of Metastasis by Systematic Pan-Cancer Analysis Across The Cancer Genome Atlas.
Neoplasm Metastasis
Multilayer modelling of the human transcriptome and biological mechanisms of complex diseases and traits.
Neoplasm Metastasis
Multiregion single-cell sequencing reveals the transcriptional landscape of the immune microenvironment of colorectal cancer.
Neoplasm Metastasis
Multiresolution Application of Artificial Intelligence in Digital Pathology for Prediction of Positive Lymph Nodes From Primary Tumors in Bladder Cancer.
Neoplasm Metastasis
NAMPT Over-Expression Recapitulates the BRAF Inhibitor Resistant Phenotype Plasticity in Melanoma.
Neoplasm Metastasis
NECTIN4 promotes papillary thyroid cancer cell proliferation, migration, and invasion and triggers EMT by activating AKT.
Neoplasm Metastasis
Overexpression and biological function of IQGAP3 in human pancreatic cancer.
Neoplasm Metastasis
Overexpression of transcription factor activating enhancer binding protein 4 (TFAP4) predicts poor prognosis for colorectal cancer patients.
Neoplasm Metastasis
Overexpression of TREM2 enhances glioma cell proliferation and invasion: a therapeutic target in human glioma.
Neoplasm Metastasis
p53-inducible gene 3 promotes cell migration and invasion by activating the FAK/Src pathway in lung adenocarcinoma.
Neoplasm Metastasis
Painful osteolytic metastasis of the atlas: treatment with percutaneous vertebroplasty.
Neoplasm Metastasis
Para-aortic lymph node metastasis in lower Thoracic Esophageal Squamous Cell Carcinoma after Radical Esophagectomy: a CT-based atlas and its clinical implications for Adjuvant Radiotherapy.
Neoplasm Metastasis
Polo-like kinase 3 is associated with poor prognosis and regulates proliferation and metastasis in prostate cancer.
Neoplasm Metastasis
Predictive value of protease-activated receptor-2 (PAR2 ) in cervical cancer metastasis.
Neoplasm Metastasis
Profiling of differentially expressed genes in LRRC4 overexpressed glioblastoma cells by cDNA array.
Neoplasm Metastasis
Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers.
Neoplasm Metastasis
Prognostic and Predictive Value of Three DNA Methylation Signatures in Lung Adenocarcinoma.
Neoplasm Metastasis
Radiogenomics of High-Grade Serous Ovarian Cancer: Multireader Multi-Institutional Study from the Cancer Genome Atlas Ovarian Cancer Imaging Research Group.
Neoplasm Metastasis
Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis.
Neoplasm Metastasis
Role of INSL4 Signaling in Sustaining the Growth and Viability of LKB1-Inactivated Lung Cancer.
Neoplasm Metastasis
Silencing of Growth Differentiation Factor-15 Promotes Breast Cancer Cell Invasion by Down-regulating Focal Adhesion Genes.
Neoplasm Metastasis
Single-Cell Characterization of the Immune Microenvironment of Melanoma Brain and Leptomeningeal Metastases.
Neoplasm Metastasis
Systematic mutation analysis in rare colorectal cancer presenting ovarian metastases.
Neoplasm Metastasis
Ten-year outcomes of uveal melanoma based on The Cancer Genome Atlas (TCGA) classification in 1001 cases.
Neoplasm Metastasis
The Afirma Xpression Atlas for thyroid nodules and thyroid cancer metastases: Insights to inform clinical decision-making from a fine-needle aspiration sample.
Neoplasm Metastasis
The cholesterol biosynthesis enzyme oxidosqualene cyclase is a new target to impair tumour angiogenesis and metastasis dissemination.
Neoplasm Metastasis
The Construction and Comprehensive Analysis of ceRNA Networks and Tumor-Infiltrating Immune Cells in Bone Metastatic Melanoma.
Neoplasm Metastasis
The long non-coding RNA maternally expressed gene 3 activates p53 and is downregulated in esophageal squamous cell cancer.
Neoplasm Metastasis
The roles and prognostic significance of ABI1-TSV-11 expression in patients with left-sided colorectal cancer.
Neoplasm Metastasis
Topoisomerase II-binding protein 1 promotes the progression of prostate cancer via ATR-CHK1 signaling pathway.
Neoplasm Metastasis
TP53 Mutation and Extraneural Metastasis of Glioblastoma: Insights From an Institutional Experience and Comprehensive Literature Review.
Neoplasm Metastasis
Transcriptome profiling reveals liver metastasis-associated genes in pancreatic ductal adenocarcinoma.
Neoplasm Metastasis
Tumor Progression Locus 2 (Tpl2) Kinase Contributes Tumor Growth and Metastasis of Clear Cell Renal Cell Carcinoma.
Neoplasm Metastasis
Tumor?suppressive microRNA?223 targets WDR62 directly in bladder cancer.
Neoplasm Metastasis
Ultraviolet-A radiation induces changes in cyclin G gene expression in mouse melanoma B16-F1 cells.
Neoplasm Metastasis
Unforeseen clonal evolution of tumor cell population in recurrent and metastatic dermatofibrosarcoma protuberans.
Neoplasm Metastasis
Upregulation Of Protein Tyrosine Phosphatase Receptor Type C Associates To The Combination Of Hashimoto's Thyroiditis And Papillary Thyroid Carcinoma And Is Predictive Of A Poor Prognosis.
Neoplasm Metastasis
Vitamin D-VDR Signaling Inhibits Wnt/?-Catenin-Mediated Melanoma Progression and Promotes Antitumor Immunity.
Neoplasm Metastasis
Weighted gene co-expression network analysis in identification of metastasis-related genes of lung squamous cell carcinoma based on the Cancer Genome Atlas database.
Neoplasm Metastasis
WISP-1 Promotes Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma Cells Via the miR-153-3p/Snail Axis.
Neoplasm Metastasis
[Clinicopathological and molecular characteristics of Epstein-Barr virus associated gastric cancer: a single center large sample case investigation].
Neoplasm Metastasis
[Sarcoma of the proximal end of the humerus; metastasis to the atlas, localized by tomography.]
Neoplasm, Residual
Evidence for potentials and limitations of brain plasticity using an atlas of functional resectability of WHO grade II gliomas: Towards a "minimal common brain"
Neoplasm, Residual
Four- and five-color flow cytometry analysis of leukocyte differentiation pathways in normal bone marrow: A reference document based on a systematic approach by the GTLLF and GEIL.
Neoplasm, Residual
Preoperative estimation of residual volume for WHO grade II glioma resected with intraoperative functional mapping.
Neoplasms
(S,R)3-(4-Hydroxyphenyl)-4,5-Dihydro-5-Isoxazole Acetic Acid Methyl Ester Inhibits Epithelial-to-Mesenchymal Transition through TGF-?/Smad4 Axis in Nasopharyngeal Carcinoma.
Neoplasms
13-lncRNAs Signature to Improve Diagnostic and Prognostic Prediction of Hepatocellular Carcinoma.
Neoplasms
14-3-3? binds to and stabilizes phospho-beclin 1S295 and induces autophagy in hepatocellular carcinoma cells.
Neoplasms
14-CpG-Based Signature Improves the Prognosis Prediction of Hepatocellular Carcinoma Patients.
Neoplasms
15-lncRNA-Based Classifier-Clinicopathologic Nomogram Improves the Prediction of Recurrence in Patients with Hepatocellular Carcinoma.
Neoplasms
18F-FDG PET/CT Uptake Classification in Lymphoma and Lung Cancer by Using Deep Convolutional Neural Networks.
Neoplasms
19q12 amplified and non-amplified subsets of high grade serous ovarian cancer with overexpression of cyclin E1 differ in their molecular drivers and clinical outcomes.
Neoplasms
20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes: A Systematic Review of 157,258 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
Neoplasms
217?YAP Is Ready to Rac and Rho: Elucidation of a Novel YAP-Driven Network That Potentiates Brain Cancer Cell Dispersal and Confers Poor Survival in Patients.
Neoplasms
29 immune-related genes pairs signature predict the prognosis of cervical cancer patients.
Neoplasms
31 gene expression-based signatures serve as indicators of prognosis for patients with glioma.
Neoplasms
334?A Functional Screen Identifies miRNAs that Induce Radioresistance in Glioblastomas.
Neoplasms
3D modelling identifies novel genetic dependencies associated with breast cancer progression in the isogenic MCF10 model.
Neoplasms
3D spatial organization and network-guided comparison of mutation profiles in Glioblastoma reveals similarities across patients.
Neoplasms
4-1BB Delineates Distinct Activation Status of Exhausted Tumor-Infiltrating CD8+ T cells in Hepatocellular Carcinoma.
Neoplasms
4-Hydroxytamoxifen enhances sensitivity of estrogen receptor ?-positive breast cancer to docetaxel in an estrogen and ZNF423 SNP-dependent fashion.
Neoplasms
53 years old is a reasonable cut-off value to define young and old patients in clear cell renal cell carcinoma: a study based on TCGA and SEER database.
Neoplasms
6-lncRNA Assessment Model for Monitoring and Prognosis of HER2-Positive Breast Cancer: Based on Transcriptome Data.
Neoplasms
7-dehydrocholesterol suppresses melanoma cell proliferation and invasion via Akt1/NF-?B signaling.
Neoplasms
7-lncRNA Assessment Model for Monitoring and Prognosis of Breast Cancer Patients: Based on Cox Regression and Co-expression Analysis.
Neoplasms
8q24 clear cell renal cell carcinoma germline variant is associated with VHL mutation status and clinical aggressiveness.
Neoplasms
99mTc-A1 as a Novel Imaging Agent Targeting Mesothelin-Expressing Pancreatic Ductal Adenocarcinoma.
Neoplasms
?-Actinin1 promotes tumorigenesis and epithelial-mesenchymal transition of gastric cancer via the AKT/GSK3?/?-Catenin pathway.
Neoplasms
?-Catenin-mediated immune evasion pathway frequently operates in primary cutaneous melanomas.
Neoplasms
?-hydroxybutyrate does not alter the effects of glucose deprivation on breast cancer cells.
Neoplasms
?2A-Adrenergic Receptor Inhibits the Progression of Cervical Cancer Through Blocking PI3K/AKT/mTOR Pathway.
Neoplasms
??elemene inhibits the generation of peritoneum effusion in pancreatic cancer via suppression of the HIF1A?VEGFA pathway based on network pharmacology.
Neoplasms
?Np63 Inhibits Oxidative Stress-Induced Cell Death, Including Ferroptosis, and Cooperates with the BCL-2 Family to Promote Clonogenic Survival.
Neoplasms
?Np63?/SRC/Slug Signaling Axis Promotes Epithelial-to-Mesenchymal Transition in Squamous Cancers.
Neoplasms
A 10-gene expression signature of Notch pathway predicts recurrence in ovarian carcinoma.
Neoplasms
A 10-gene signature as a predictor of biochemical recurrence after radical prostatectomy in patients with prostate cancer and a Gleason score ?7.
Neoplasms
A 10-gene-methylation-based signature for prognosis prediction of colorectal cancer.
Neoplasms
A 10?microRNA prognosis scoring system in esophageal squamous cell carcinoma constructed using bioinformatic methods.
Neoplasms
A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes.
Neoplasms
A 13-Gene Metabolic Prognostic Signature Is Associated With Clinical and Immune Features in Stomach Adenocarcinoma.
Neoplasms
A 13-gene risk score system and a nomogram survival model for predicting the prognosis of clear cell renal cell carcinoma.
Neoplasms
A 14 immune-related gene signature predicts clinical outcomes of kidney renal clear cell carcinoma.
Neoplasms
A 14-gene gemcitabine resistance gene signature is significantly associated with the prognosis of pancreatic cancer patients.
Neoplasms
A 14-Marker Multiplexed Imaging Panel for Prognostic Biomarkers and Tumor Heterogeneity in Head and Neck Squamous Cell Carcinoma.
Neoplasms
A 14-Methylation-Driven Differentially Expressed RNA as a Signature for Overall Survival Prediction in Patients with Uterine Corpus Endometrial Carcinoma.
Neoplasms
A 15-Gene Immune, Stromal, and Proliferation Gene Signature that Significantly Associates with Poor Survival in Patients with Pancreatic Ductal Adenocarcinoma.
Neoplasms
A 15-Gene Signature and Prognostic Nomogram for Predicting Overall Survival in Non-Distant Metastatic Oral Tongue Squamous Cell Carcinoma.
Neoplasms
A 15-gene signature for prediction of colon cancer recurrence and prognosis based on SVM.
Neoplasms
A 15-lncRNA signature predicts survival and functions as a ceRNA in patients with colorectal cancer.
Neoplasms
A 16-gene expression signature to distinguish stage I from stage II lung squamous carcinoma.
Neoplasms
A 16-gene signature predicting prognosis of patients with oral tongue squamous cell carcinoma.
Neoplasms
A 16-mRNA signature optimizes recurrence-free survival prediction of Stages II and III gastric cancer.
Neoplasms
A 19?miRNA Support Vector Machine classifier and a 6?miRNA risk score system designed for ovarian cancer patients.
Neoplasms
A 1p/19q Codeletion-Associated Immune Signature for Predicting Lower Grade Glioma Prognosis.
Neoplasms
A 21?gene Support Vector Machine classifier and a 10?gene risk score system constructed for patients with gastric cancer.
Neoplasms
A 23 gene-based molecular prognostic score precisely predicts overall survival of breast cancer patients.
Neoplasms
A 3-DNA methylation signature as a novel prognostic biomarker in patients with sarcoma by bioinformatics analysis.
Neoplasms
A 3-miRNA signature predicts prognosis of pediatric and adolescent cytogenetically normal acute myeloid leukemia.
Neoplasms
A 35-gene signature discriminates between rapidly- and slowly-progressing glioblastoma multiforme and predicts survival in known subtypes of the cancer.
Neoplasms
A 4-Gene Signature Associated With Recurrence in Low- and Intermediate-Risk Endometrial Cancer.
Neoplasms
A 4-gene-based hypoxia signature is associated with tumor immune microenvironment and predicts the prognosis of pancreatic cancer patients.
Neoplasms
A 4-microRNA signature for survival prognosis in pediatric and adolescent acute myeloid leukemia.
Neoplasms
A 44-gene set constructed for predicting the prognosis of clear cell renal cell carcinoma.
Neoplasms
A 5-lncRNA Signature Associated with Smoking Predicts the Overall Survival of Patients with Muscle-Invasive Bladder Cancer.
Neoplasms
A 5-MicroRNA Signature Identified from Serum MicroRNA Profiling Predicts Survival in Patients with Advanced Stage Non-Small Cell Lung Cancer.
Neoplasms
A 6 lncRNA-Based Risk Score System for Predicting the Recurrence of Colon Adenocarcinoma Patients.
Neoplasms
A 6?gene risk score system constructed for predicting the clinical prognosis of pancreatic adenocarcinoma patients.
Neoplasms
A 9?lncRNA risk score system for predicting the prognosis of patients with hepatitis B virus?positive hepatocellular carcinoma.
Neoplasms
A B7-CD28 family based signature demonstrates significantly different prognoses and tumor immune landscapes in lung adenocarcinoma.
Neoplasms
A BAP1 Mutation-specific MicroRNA Signature Predicts Clinical Outcomes in Clear Cell Renal Cell Carcinoma Patients with Wild-type BAP1.
Neoplasms
A BAP1 synonymous mutation results in exon skipping, loss of function and worse patient prognosis.
Neoplasms
A Bayesian integrative approach for multi-platform genomic data: A kidney cancer case study.
Neoplasms
A Bayesian Network Model of Head and Neck Squamous Cell Carcinoma Incorporating Gene Expression Profiles.
Neoplasms
A bioinformatic analysis: the overexpression and clinical significance of FCGBP in ovarian cancer.
Neoplasms
A bioinformatics approach to identify novel long, non-coding RNAs in breast cancer cell lines from an existing RNA-sequencing dataset.
Neoplasms
A BRCA1/2 mutational signature and survival in ovarian high grade serous carcinoma.
Neoplasms
A cancer drug atlas enables synergistic targeting of independent drug vulnerabilities.
Neoplasms
A cancer tissue-specific FAM72 expression profile defines a novel glioblastoma multiform (GBM) gene-mutation signature.
Neoplasms
A Candidate Prognostic Biomarker Complement Factor I Promotes Malignant Progression in Glioma.
Neoplasms
A Carcinogen-induced mouse model recapitulates the molecular alterations of human muscle invasive bladder cancer.
Neoplasms
A Cartography of Siglecs and Sialyltransferases in Gynecologic Malignancies: Is There a Road Towards a Sweet Future?
Neoplasms
A CD133-related gene expression signature identifies an aggressive glioblastoma subtype with excessive mutations.
Neoplasms
A ceRNA network and a potential regulatory axis in gastric cancer with different degrees of immune cell infiltration.
Neoplasms
A ceRNA-associated risk model predicts the poor prognosis for head and neck squamous cell carcinoma patients.
Neoplasms
A chemical genetics approach identifies PTP4A3 as a regulator of colon cancer cell adhesion.
Neoplasms
A cis-eQTL genetic variant in PLK4 confers high risk of hepatocellular carcinoma.
Neoplasms
A classification model for distinguishing copy number variants from cancer-related alterations.
Neoplasms
A clinical, biologic and mechanistic analysis of the role of ZNF692 in cervical cancer.
Neoplasms
A clinico-genomic analysis of soft tissue sarcoma patients reveals CDKN2A deletion as a biomarker for poor prognosis.
Neoplasms
A cloud-based workflow to quantify transcript-expression levels in public cancer compendia.
Neoplasms
A cluster of metabolism-related genes predict prognosis and progression of clear cell renal cell carcinoma.
Neoplasms
A co-expression network for differentially expressed genes in bladder cancer and a risk score model for predicting survival.
Neoplasms
A Co-Expression Network Reveals the Potential Regulatory Mechanism of lncRNAs in Relapsed Hepatocellular Carcinoma.
Neoplasms
A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models.
Neoplasms
A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targets.
Neoplasms
A combination of intra-tumor genetic heterogeneity, estrogen receptor alpha and human papillomavirus status predicts outcomes in head and neck squamous cell carcinoma following chemoradiotherapy.
Neoplasms
A Combined Effect of Expression Levels of Obesity-Related Genes and Clinical Factors on Cancer Survival Rate.
Neoplasms
A Combined four-mRNA Signature Associated with Lymphatic Metastasis for Prognosis of Colorectal Cancer.
Neoplasms
A combined hypoxia and immune gene signature for predicting survival and risk stratification in triple-negative breast cancer.
Neoplasms
A Combined RNA Signature Predicts Recurrence Risk of Stage I-IIIA Lung Squamous Cell Carcinoma.
Neoplasms
A comparative analysis and guidance for individualized chemotherapy of stage II and III colorectal cancer patients based on pathological markers.
Neoplasms
A comparative genomics analysis of lung adenocarcinoma for Chinese population by using panel of recurrent mutations.
Neoplasms
A Comparative in Silico Analysis of CD24's Prognostic Value in Human and Canine Prostate Cancer.
Neoplasms
A Comparative Meta-Analysis and in silico Analysis of Differentially Expressed Genes and Proteins in Canine and Human Bladder Cancer.
Neoplasms
A comparative study of multiple instance learning methods for cancer detection using T-cell receptor sequences.
Neoplasms
A Comparative Study of the Molecular Characteristics of Familial Gliomas and Other Cancers.
Neoplasms
A comparison of adult rhabdomyosarcoma and high-grade neuroendocrine carcinoma of the urinary bladder reveals novel PPP1R12A fusions in rhabdomyosarcoma.
Neoplasms
A comparison of immune receptor recombination databases sourced from tumour exome or RNAseq files: Verifications of immunological distinctions between primary and metastatic melanoma.
Neoplasms
A comparison of survival analysis methods for cancer gene expression RNA-Sequencing data.
Neoplasms
A Competing Endogenous RNA Network and an 8-lncRNA Prognostic Signature Identify MYO16-AS1 as an Oncogenic lncRNA in Bladder Cancer.
Neoplasms
A Competing Endogenous RNA Network Reveals Novel lncRNA, miRNA and mRNA Biomarkers With Diagnostic and Prognostic Value for Early Breast Cancer.
Neoplasms
A Competing Endogenous RNA Network Reveals Novel Potential lncRNA, miRNA, and mRNA Biomarkers in the Prognosis of Human Colon Adenocarcinoma.
Neoplasms
A competing-risks nomogram for predicting probability of death from CRC in Chinese Han patients with Stage I-III CRC.
Neoplasms
A component overlapping attribute clustering (COAC) algorithm for single-cell RNA sequencing data analysis and potential pathobiological implications.
Neoplasms
A Comprehensive Analysis of Argonaute-CLIP Data Identifies Novel, Conserved and Species-Specific Targets of miR-21 in Human Liver and Hepatocellular Carcinoma.
Neoplasms
A comprehensive analysis of immune infiltration in the tumor microenvironment of osteosarcoma.
Neoplasms
A comprehensive analysis of prognosis prediction models based on pathway?level, gene?level and clinical information for glioblastoma.
Neoplasms
A comprehensive analysis of SNPs and CNVs identifies novel markers associated with disease outcomes in colorectal cancer.
Neoplasms
A comprehensive analysis of the angiogenesis-related genes in glioblastoma multiforme vs. brain lower grade glioma.
Neoplasms
A comprehensive analysis of the predicted targets of miR-642b-3p associated with the long non-coding RNA HOXA11-AS in NSCLC cells.
Neoplasms
A comprehensive characterization of mitochondrial DNA mutations in glioblastoma multiforme.
Neoplasms
A comprehensive characterization of the cell-free transcriptome reveals tissue- and subtype-specific biomarkers for cancer detection.
Neoplasms
A Comprehensive cis-eQTL Analysis Revealed Target Genes in Breast Cancer Susceptibility Loci Identified in Genome-wide Association Studies.
Neoplasms
A comprehensive genome-wide profiling comparison between HBV and HCV infected hepatocellular carcinoma.
Neoplasms
A comprehensive genomic pan-cancer classification using The Cancer Genome Atlas gene expression data.
Neoplasms
A comprehensive insight into the clinicopathologic significance of miR-144-3p in hepatocellular carcinoma.
Neoplasms
A comprehensive investigation using meta-analysis and bioinformatics on miR-34a-5p expression and its potential role in head and neck squamous cell carcinoma.
Neoplasms
A comprehensive molecular characterization of the 8q22.2 region reveals the prognostic relevance of OSR2 mRNA in muscle invasive bladder cancer.
Neoplasms
A Comprehensive Multiomics Analysis Identified Ubiquilin 4 as a Promising Prognostic Biomarker of Immune-Related Therapy in Pan-Cancer.
Neoplasms
A Comprehensive Network Pharmacology-Based Strategy to Investigate Multiple Mechanisms of HeChan Tablet on Lung Cancer.
Neoplasms
A comprehensive next generation sequencing-based virome assessment in brain tissue suggests no major virus - tumor association.
Neoplasms
A comprehensive overview of genomic imprinting in breast and its deregulation in cancer.
Neoplasms
A Comprehensive Pan-Cancer Analysis of 33 Human Cancers Reveals the Immunotherapeutic Value of Aryl Hydrocarbon Receptor.
Neoplasms
A Comprehensive PDX Gastric Cancer Collection Captures Cancer Cell-Intrinsic Transcriptional MSI Traits.
Neoplasms
A Comprehensive Prognostic and Immunological Analysis of a New Three-Gene Signature in Hepatocellular Carcinoma.
Neoplasms
A comprehensive prognostic signature for glioblastoma patients based on transcriptomics and single cell sequencing.
Neoplasms
A Comprehensive RNA Expression Signature for Cervical Squamous Cell Carcinoma Prognosis.
Neoplasms
A comprehensive study of epigenetic alterations in hepatocellular carcinoma identifies potential therapeutic targets.
Neoplasms
A comprehensively characterized cell line panel highly representative of clinical ovarian high-grade serous carcinomas.
Neoplasms
A consensus-based guideline defining the clinical target volume for pelvic lymph nodes in external beam radiotherapy for uterine cervical cancer.
Neoplasms
A CpG-methylation-based assay to predict survival in clear cell renal cell carcinoma.
Neoplasms
A critical re-assessment of DNA repair gene promoter methylation in non-small cell lung carcinoma.
Neoplasms
A cross-cancer metastasis signature in the microRNA-mRNA axis of paired tissue samples.
Neoplasms
A deep convolutional neural network for segmentation of whole-slide pathology images identifies novel tumour cell-perivascular niche interactions that are associated with poor survival in glioblastoma.
Neoplasms
A deep imputation and inference framework for estimating personalized and race-specific causal effects of genomic alterations on PSA.
Neoplasms
A Deep Network for Joint Registration and Reconstruction of Images with Pathologies.
Neoplasms
A Description of the Clinical Proteomic Tumor Analysis Consortium (CPTAC) Common Data Analysis Pipeline.
Neoplasms
A Designer Cross-reactive DNA Immunotherapeutic Vaccine that Targets Multiple MAGE-A Family Members Simultaneously for Cancer Therapy.
Neoplasms
A Dexamethasone-regulated Gene Signature Is Prognostic for Poor Survival in Glioblastoma Patients.
Neoplasms
A Disintegrin and Metalloproteinase 9 (ADAM9) in Advanced Hepatocellular Carcinoma and Their Role as a Biomarker During Hepatocellular Carcinoma Immunotherapy.
Neoplasms
A DNA methylation-associated nomogram predicts the overall survival of osteosarcoma.
Neoplasms
A drug-biomarker interaction model to predict the key targets of Scutellaria barbata D. Don in adverse-risk acute myeloid leukaemia.
Neoplasms
A dual immune signature of CD8+ T cells and MMP9 improves the survival of patients with hepatocellular carcinoma.
Neoplasms
A Dynamic Scale-Free Network Particle Swarm Optimization for Extracting Features on Multi-Omics Data.
Neoplasms
A ferroptosis-associated gene signature for the prediction of prognosis and therapeutic response in luminal-type breast carcinoma.
Neoplasms
A ferroptosis-related gene signature predicts overall survival in patients with lung adenocarcinoma.
Neoplasms
A five-DNA methylation signature act as a novel prognostic biomarker in patients with ovarian serous cystadenocarcinoma.
Neoplasms
A Five-Gene Prognostic Nomogram Predicting Disease-Free Survival of Differentiated Thyroid Cancer.
Neoplasms
A Five-Gene Signature Based on Stromal/Immune Scores in the Tumor Microenvironment and Its Clinical Implications for Liver Cancer.
Neoplasms
A five-gene signature for predicting overall survival of esophagus adenocarcinoma.
Neoplasms
A five-gene signature may predict sunitinib sensitivity and serve as prognostic biomarkers for renal cell carcinoma.
Neoplasms
A Five-Gene Signature Predicts Prognosis in Patients with Kidney Renal Clear Cell Carcinoma.
Neoplasms
A five-gene signature to predict the overall survival time of patients with esophageal squamous cell carcinoma.
Neoplasms
A Five-Gene-Pair-Based Prognostic Signature for Predicting the Relapse Risk of Early Stage ER+ Breast Cancer.
Neoplasms
A Five-Genes-Based Prognostic Signature for Cervical Cancer Overall Survival Prediction.
Neoplasms
A Five-lncRNAs Signature-Derived Risk Score Based on TCGA and CGGA for Glioblastoma: Potential Prospects for Treatment Evaluation and Prognostic Prediction.
Neoplasms
A five-long non-coding RNA signature to improve prognosis prediction of clear cell renal cell carcinoma.
Neoplasms
A five-long non-coding RNA signature with the ability to predict overall survival of patients with lung adenocarcinoma.
Neoplasms
A Five-microRNA Signature as Prognostic Biomarker in Colorectal Cancer by Bioinformatics Analysis.
Neoplasms
A five-microRNA signature for individualized prognosis evaluation and radiotherapy guidance in patients with diffuse lower-grade glioma.
Neoplasms
A Five-microRNA Signature for Survival Prognosis in Pancreatic Adenocarcinoma based on TCGA Data.
Neoplasms
A five-miRNA signature predicts survival in gastric cancer using bioinformatics analysis.
Neoplasms
A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients.
Neoplasms
A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses.
Neoplasms
A five-mRNA signature associated with post-translational modifications can better predict recurrence and survival in cervical cancer.
Neoplasms
A fluorescence-coupled assay for gamma aminobutyric acid (GABA) reveals metabolic stress-induced modulation of GABA content in neuroendocrine cancer.
Neoplasms
A Four-Chemokine Signature Is Associated with a T-cell-Inflamed Phenotype in Primary and Metastatic Pancreatic Cancer.
Neoplasms
A four-DNA methylation signature as a novel prognostic biomarker for survival of patients with gastric cancer.
Neoplasms
A four-gene signature associated with clinical features can better predict prognosis in prostate cancer.
Neoplasms
A four-gene signature for prognosis in breast cancer patients with hypermethylated IL15RA.
Neoplasms
A four-gene signature in the tumor microenvironment that significantly associates with the prognosis of patients with breast cancer.
Neoplasms
A four-gene signature predicts survival and anti-CTLA4 immunotherapeutic responses based on immune classification of melanoma.
Neoplasms
A Four-Gene-Based Prognostic Model Predicts Overall Survival in Patients With Cutaneous Melanoma.
Neoplasms
A four-gene-based prognostic model predicts overall survival in patients with hepatocellular carcinoma.
Neoplasms
A four-hypoxia-genes-based prognostic signature for oral squamous cell carcinoma.
Neoplasms
A four-lncRNA signature for predicting prognosis of recurrence patients with gastric cancer.
Neoplasms
A four-long noncoding RNA signature predicts survival of hepatocellular carcinoma patients.
Neoplasms
A Four-Methylated lncRNAs-Based Prognostic Signature for Hepatocellular Carcinoma.
Neoplasms
A four-protein expression prognostic signature predicts clinical outcome of lower-grade glioma.
Neoplasms
A fourteen-lncRNA risk score system for prognostic prediction of patients with non-small cell lung cancer.
Neoplasms
A framework for identifying dysregulated chromatin regulators as master regulators in human cancer.
Neoplasms
A framework for organizing cancer-related variations from existing databases, publications and NGS data using a High-performance Integrated Virtual Environment (HIVE).
Neoplasms
A fully Bayesian latent variable model for integrative clustering analysis of multi-type omics data.
Neoplasms
A functional network of gastric-cancer-associated splicing events controlled by dysregulated splicing factors.
Neoplasms
A functional screen identifies miRs that induce radioresistance in glioblastomas.
Neoplasms
A functional variant in miR-155 regulation region contributes to lung cancer risk and survival.
Neoplasms
A future of cancer prevention and cures: highlights of the Centennial Meeting of the American Association for Cancer Research.
Neoplasms
A FXYD5/TGF??/SMAD positive feedback loop drives epithelial?to?mesenchymal transition and promotes tumor growth and metastasis in ovarian cancer.
Neoplasms
A Galaxy Implementation of Next-Generation Clustered Heatmaps for Interactive Exploration of Molecular Profiling Data.
Neoplasms
A gastric cancer LncRNAs model for MSI and survival prediction based on support vector machine.
Neoplasms
A gene expression assay for simultaneous measurement of microsatellite instability and anti-tumor immune activity.
Neoplasms
A gene expression profile associated with perineural invasion identifies a subset of HNSCC at risk of post-surgical recurrence.
Neoplasms
A gene expression signature for predicting response to neoadjuvant chemoradiotherapy in pancreatic ductal adenocarcinoma.
Neoplasms
A gene expression signature of Retinoblastoma loss-of-function is a predictive biomarker of resistance to palbociclib in breast cancer cell lines and is prognostic in patients with ER positive early breast cancer.
Neoplasms
A gene expression-based single sample predictor of lung adenocarcinoma molecular subtype and prognosis.
Neoplasms
A Gene Gravity Model for the Evolution of Cancer Genomes: A Study of 3,000 Cancer Genomes across 9 Cancer Types.
Neoplasms
A gene signature associated with prognosis and immune processes in head and neck squamous cell carcinoma.
Neoplasms
A gene signature for immune subtyping of desert, excluded, and inflamed ovarian tumors.
Neoplasms
A Gene Signature Predicting Natural Killer Cell Infiltration and Improved Survival in Melanoma Patients.
Neoplasms
A gene-based risk score model for predicting recurrence-free survival in patients with hepatocellular carcinoma.
Neoplasms
A generalizable data-driven multicellular model of pancreatic ductal adenocarcinoma.
Neoplasms
A genetic risk score for glioblastoma multiforme based on copy number variations.
Neoplasms
A Genetic Vaccine Encoding Shared Cancer Neoantigens to Treat Tumors with Microsatellite Instability.
Neoplasms
A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study.
Neoplasms
A genome-wide analysis of long noncoding RNA profile identifies differentially expressed lncRNAs associated with Esophageal cancer.
Neoplasms
A genome-wide association study implicates NR2F2 in lymphangioleiomyomatosis pathogenesis.
Neoplasms
A genome-wide comprehensively analyses of long noncoding RNA profiling and metastasis associated lncRNAs in renal cell carcinoma.
Neoplasms
A genome-wide positioning systems network algorithm for in silico drug repurposing.
Neoplasms
A genome-wide view of microsatellite instability: old stories of cancer mutations revisited with new sequencing technologies.
Neoplasms
A Genomic-Clinicopathologic Nomogram for the Prediction of Lymph Node Invasion in Prostate Cancer.
Neoplasms
A Genomic-Clinicopathologic Nomogram Predicts Survival for Patients with Laryngeal Squamous Cell Carcinoma.
Neoplasms
A Genomic-Pathologic Annotated Risk Model to Predict Recurrence in Early-Stage Lung Adenocarcinoma.
Neoplasms
A geographic analysis of prostate cancer mortality in the United States, 1970-89.
Neoplasms
A geometric atlas to predict lung tumor shrinkage for radiotherapy treatment planning.
Neoplasms
A global integrated analysis of UNC5C down-regulation in cancers: insights from mechanism and combined treatment strategy.
Neoplasms
A glycolysis-based 4-mRNA signature correlates with the prognosis and cell cycle process in patients with bladder cancer.
Neoplasms
A Glycolysis-Based Long Non-coding RNA Signature Accurately Predicts Prognosis in Renal Carcinoma Patients.
Neoplasms
A glycolysis-based three-gene signature predicts survival in patients with lung squamous cell carcinoma.
Neoplasms
A Glycolysis-Related Five-Gene Signature Predicts Biochemical Recurrence-Free Survival in Patients With Prostate Adenocarcinoma.
Neoplasms
A glycolysis-related gene pairs signature predicts prognosis in patients with hepatocellular carcinoma.
Neoplasms
A glycolysis-related gene signature predicts prognosis of patients with esophageal adenocarcinoma.
Neoplasms
A graph-based multi-sample test for identifying pathways associated with cancer progression.
Neoplasms
A graph-embedded deep feedforward network for disease outcome classification and feature selection using gene expression data.
Neoplasms
A hepatocyte differentiation model reveals two subtypes of liver cancer with different oncofetal properties and therapeutic targets.
Neoplasms
A hidden Markov modeling approach for identifying tumor subclones in next-generation sequencing studies.
Neoplasms
A High Epigenetic Risk Score Shapes the Non-Inflamed Tumor Microenvironment in Breast Cancer.
Neoplasms
A high-resolution transcriptome map of cell cycle reveals novel connections between periodic genes and cancer.
Neoplasms
A human protein atlas for normal and cancer tissues based on antibody proteomics.
Neoplasms
A Hybrid Ensemble Approach for Identifying Robust Differentially Methylated Loci in Pan-Cancers.
Neoplasms
A hypergraph-based method for large-scale dynamic correlation study at the transcriptomic scale.
Neoplasms
A hypothesis-driven approach identifies CDK4 and CDK6 inhibitors as candidate drugs for treatments of adrenocortical carcinomas.
Neoplasms
A hypoxia related long non-coding RNA signature could accurately predict survival outcomes in patients with bladder cancer.
Neoplasms
A hypoxia-related signature for clinically predicting diagnosis, prognosis and immune microenvironment of hepatocellular carcinoma patients.
Neoplasms
A innovative prognostic symbol based on neutrophil extracellular traps (NETs)-related lncRNA signature in non-small-cell lung cancer.
Neoplasms
A Joint Graphical Model for Inferring Gene Networks Across Multiple Subpopulations and Data Types.
Neoplasms
A JUN N-terminal kinase inhibitor induces ectodomain shedding of the cancer-associated membrane protease Prss14/epithin via protein kinase C?II.
Neoplasms
A key genomic subtype associated with lymphovascular invasion in invasive breast cancer.
Neoplasms
A large cohort study identifying a novel prognosis prediction model for lung adenocarcinoma through machine learning strategies.
Neoplasms
A large collection of integrated genomically characterized patient-derived xenografts highlighting the heterogeneity of triple-negative breast cancer.
Neoplasms
A Leukocyte Infiltration Score Defined by a Gene Signature Predicts Melanoma Patient Prognosis.
Neoplasms
A library-based ecological study to investigate the contribution of ethnicity to the incidence of oral cancer within health authorities in England and Wales.
Neoplasms
A lincRNA connected to cell mortality and epigenetically-silenced in most common human cancers.
Neoplasms
A Liquid-Liquid Phase Separation-Related Gene Signature as Prognostic Biomarker for Epithelial Ovarian Cancer.
Neoplasms
A liver-specific lncRNA, FAM99B, suppresses hepatocellular carcinoma progression through inhibition of cell proliferation, migration, and invasion.
Neoplasms
A long non-coding RNA expression signature to predict survival of patients with colon adenocarcinoma.
Neoplasms
A long non-coding RNA signature for predicting survival in patients with colorectal cancer.
Neoplasms
A long non-coding RNA signature to improve prognostic prediction in clear cell renal cell carcinoma.
Neoplasms
A long noncoding RNA-microRNA expression signature predicts metastatic signature in pheochromocytomas and paragangliomas.
Neoplasms
A long noncoding RNAs signature to improve survival prediction in endometrioid endometrial cancer.
Neoplasms
A low DNA methylation epigenotype in lung squamous cell carcinoma and its association with idiopathic pulmonary fibrosis and poorer prognosis.
Neoplasms
A lymph node metastasis-related protein-coding genes combining with long noncoding RNA signature for breast cancer survival prediction.
Neoplasms
A machine learning analysis of a "normal-like" IDH-WT diffuse glioma transcriptomic subgroup associated with prolonged survival reveals novel immune and neurotransmitter-related actionable targets.
Neoplasms
A machine learning approach to identify predictive molecular markers for cisplatin chemosensitivity following surgical resection in ovarian cancer.
Neoplasms
A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.
Neoplasms
A mathematical methodology for determining the temporal order of pathway alterations arising during gliomagenesis.
Neoplasms
A mechanistic insight into the anti-metastatic role of the prostate specific antigen.
Neoplasms
A meta-analysis and The Cancer Genome Atlas data of prostate cancer risk and prognosis using epithelial cell adhesion molecule (EpCAM) expression.
Neoplasms
A Metabolic Gene Signature to Predict Overall Survival in Head and Neck Squamous Cell Carcinoma.
Neoplasms
A metabolism-related gene signature for predicting the prognosis and therapeutic responses in patients with hepatocellular carcinoma.
Neoplasms
A Methodology for Texture Feature-based Quality Assessment in Nucleus Segmentation of Histopathology Image.
Neoplasms
A methylation-based nomogram for predicting survival in patients with lung adenocarcinoma.
Neoplasms
A micro-peptide encoded by HOXB-AS3 promotes the proliferation and viability of oral squamous cell carcinoma cell lines by directly binding with IGF2BP2 to stabilize c-Myc.
Neoplasms
A microRNA disease signature associated with lymph node metastasis of lung adenocarcinoma.
Neoplasms
A microRNA expression profile for vascular invasion can predict overall survival in hepatocellular carcinoma.
Neoplasms
A microRNA expression signature as a predictor of survival for colon adenocarcinoma.
Neoplasms
A MicroRNA Expression Signature as Prognostic Marker for Oropharyngeal Squamous Cell Carcinoma.
Neoplasms
A MicroRNA Signature Associated With Metastasis of T1 Colorectal Cancers to Lymph Nodes.
Neoplasms
A MicroRNA Signature Identifies Pancreatic Ductal Adenocarcinoma Patients at Risk for Lymph Node Metastases.
Neoplasms
A microRNA-based signature predicts local-regional failure and overall survival after pancreatic cancer resection.
Neoplasms
A microRNA-clinical prognosis model to predict the overall survival for kidney renal clear cell carcinoma.
Neoplasms
A microRNA-Messenger RNA Regulatory Network and Its Prognostic Value in Cervical Cancer.
Neoplasms
A Minimal DNA Methylation Signature in Oral Tongue Squamous Cell Carcinoma Links Altered Methylation with Tumor Attributes.
Neoplasms
A miRNA signature of chemoresistant mesenchymal phenotype identifies novel molecular targets associated with advanced pancreatic cancer.
Neoplasms
A miRNA-clinicopathological nomogram for the prediction of central lymph node metastasis in papillary thyroid carcinoma-analysis from TCGA database.
Neoplasms
A model for predicting prognosis in patients with esophageal squamous cell carcinoma based on joint representation learning.
Neoplasms
A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma.
Neoplasms
A model of twenty-three metabolic-related genes predicting overall survival for lung adenocarcinoma.
Neoplasms
A Modern Approach to Endometrial Carcinoma: Will Molecular Classification Improve Precision Medicine in the Future?
Neoplasms
A Molecular Epidemiological Analysis Of Programmed Cell Death Ligand-1 (PD-L1) Protein Expression, Mutations And Survival In Non-Small Cell Lung Cancer.
Neoplasms
A molecular signature of well-differentiated oral squamous cell carcinoma reveals a resistance mechanism to metronomic chemotherapy and novel therapeutic candidates.
Neoplasms
A Molecular Stratification of Chilean Gastric Cancer Patients with Potential Clinical Applicability.
Neoplasms
A Molecular Subtype Model for Liver HBV-Related Hepatocellular Carcinoma Patients Based on Immune-Related Genes.
Neoplasms
A multi-cancer mesenchymal transition gene expression signature is associated with prolonged time to recurrence in glioblastoma.
Neoplasms
A Multi-Gene Model Effectively Predicts the Overall Prognosis of Stomach Adenocarcinomas With Large Genetic Heterogeneity Using Somatic Mutation Features.
Neoplasms
A multi-omics approach for identifying important pathways and genes in human cancer.
Neoplasms
A multi-scale integrated analysis identifies KRT8 as a pan-cancer early biomarker.
Neoplasms
A Multi-Source Data Fusion Framework for Revealing the Regulatory Mechanism of Breast Cancer Immune Evasion.
Neoplasms
A Multidisciplinary Biospecimen Bank of Renal Cell Carcinomas Compatible with Discovery Platforms at Mayo Clinic, Scottsdale, Arizona.
Neoplasms
A Multigene Assay Identifying Distinct Prognostic Subtypes of Clear Cell Renal Cell Carcinoma with Differential Response to Tyrosine Kinase Inhibition.
Neoplasms
A multilevel assessment of the social determinants associated with the late stage diagnosis of breast cancer.
Neoplasms
A Multiomics Graph Database System for Biological Data Integration and Cancer Informatics.
Neoplasms
A multiscale statistical mechanical framework integrates biophysical and genomic data to assemble cancer networks.
Neoplasms
A murine preclinical syngeneic transplantation model for breast cancer precision medicine.
Neoplasms
A naive Bayes algorithm for tissue origin diagnosis (TOD-Bayes) of synchronous multifocal tumors in the hepatobiliary and pancreatic system.
Neoplasms
A network medicine approach to build a comprehensive atlas for the prognosis of human cancer.
Neoplasms
A network view of microRNA and gene interactions in different pathological stages of colon cancer.
Neoplasms
A network-based drug repositioning infrastructure for precision cancer medicine through targeting significantly mutated genes in the human cancer genomes.
Neoplasms
A Network-Based Model of Oncogenic Collaboration for Prediction of Drug Sensitivity.
Neoplasms
A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer.
Neoplasms
A network-based signature to predict the survival of non-smoking lung adenocarcinoma.
Neoplasms
A network-pathway based module identification for predicting the prognosis of ovarian cancer patients.
Neoplasms
A Neural Network Framework for Predicting the Tissue-of-Origin of 15 Common Cancer Types Based on RNA-Seq Data.
Neoplasms
A New ?0-Regularized Log-Linear Poisson Graphical Model with Applications to RNA Sequencing Data.
Neoplasms
A New Epigenetic Model to Stratify Glioma Patients According to Their Immunosuppressive State.
Neoplasms
A new ferroptosis-related gene model for prognostic prediction of papillary thyroid carcinoma.
Neoplasms
A new glioma grading model based on histopathology and Bone Morphogenetic Protein 2 mRNA expression.
Neoplasms
A new m6A methylation-related gene signature for prognostic value in patient with urothelial carcinoma of the bladder.
Neoplasms
A new method for mining information of co-expression network based on multi-cancers integrated data.
Neoplasms
A new prognosis prediction model combining TNM stage with MAP2K4 and JNK in postoperative pancreatic cancer patients.
Neoplasms
A new prognostic factor of breast cancer: High carboxyl ester lipase expression related to poor survival.
Neoplasms
A new prognostic strategy based on four DNA repair-associated lncRNAs for hepatocellular carcinoma.
Neoplasms
A New RBPs-Related Signature Predicts the Prognosis of Colon Adenocarcinoma Patients.
Neoplasms
A new risk stratification system of prostate cancer to identify high-risk biochemical recurrence patients.
Neoplasms
A new spontaneously transformed syngeneic model of high-grade serous ovarian cancer with a tumor-initiating cell population.
Neoplasms
A New Survival Model Based on Cholesterol Biosynthesis-Related Genes for Prognostic Prediction in Clear Cell Renal Cell Carcinoma.
Neoplasms
A new survival model based on ferroptosis-related genes for prognostic prediction in clear cell renal cell carcinoma.
Neoplasms
A new thinking: extended application of genomic selection to screen multiomics data for development of novel hypoxia-immune biomarkers and target therapy of clear cell renal cell carcinoma.
Neoplasms
A newly identified lncRNA H1FX-AS1 targets DACT1 to inhibit cervical cancer via sponging miR-324-3p.
Neoplasms
A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer.
Neoplasms
A NF-?B signature predicts low-grade glioma prognosis: a precision medicine approach based on patient-derived stem cells.
Neoplasms
A nine-long non-coding RNA signature for prognosis prediction of patients with lung squamous cell carcinoma.
Neoplasms
A nine-miRNA signature as a potential diagnostic marker for breast carcinoma: An integrated study of 1,110 cases.
Neoplasms
A nomogram based on 9-lncRNAs signature for improving prognostic prediction of clear cell renal cell carcinoma.
Neoplasms
A nomogram based on a gene signature for predicting the prognosis of patients with head and neck squamous cell carcinoma.
Neoplasms
A Nomogram Based on a Three-Gene Signature Derived from AATF Coexpressed Genes Predicts Overall Survival of Hepatocellular Carcinoma Patients.
Neoplasms
A nomogram combining long non-coding RNA expression profiles and clinical factors predicts survival in patients with bladder cancer.
Neoplasms
A nomogram combining PPAR? expression profiles and clinical factors predicts survival in patients with hepatocellular carcinoma.
Neoplasms
A nomogram for individualized estimation of survival among adult patients with adrenocortical carcinoma after surgery: a retrospective analysis and multicenter validation study.
Neoplasms
A non-negative matrix factorization method for detecting modules in heterogeneous omics multi-modal data.
Neoplasms
A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma.
Neoplasms
A novel 12-gene signature as independent prognostic model in stage IA and IB lung squamous cell carcinoma patients.
Neoplasms
A novel 12-marker panel of cancer-associated fibroblasts involved in progression of hepatocellular carcinoma.
Neoplasms
A novel 13 RNA binding proteins (RBPs) signature could predict prostate cancer biochemical recurrence.
Neoplasms
A novel 4-gene signature for overall survival prediction in lung adenocarcinoma patients with lymph node metastasis.
Neoplasms
A Novel 85-Gene Expression Signature Predicts Unfavorable Prognosis in Acute Myeloid Leukemia.
Neoplasms
A novel alternative approach for prediction of radiation response of squamous cell carcinoma of head and neck.
Neoplasms
A NOVEL AND EFFICIENT ALGORITHM FOR DE NOVO DISCOVERY OF MUTATED DRIVER PATHWAYS IN CANCER.
Neoplasms
A Novel and Robust Long Noncoding RNA Panel to Predict the Prognosis of Pancreatic Cancer.
Neoplasms
A Novel Apoptosis-Related Gene Signature Predicts Biochemical Recurrence of Localized Prostate Cancer After Radical Prostatectomy.
Neoplasms
A Novel Approach to Evaluating Cancer Driver Gene Mutation Densities: Cytoskeleton-related Gene Candidates.
Neoplasms
A novel approach to the discovery of survival biomarkers in glioblastoma using a joint analysis of DNA methylation and gene expression.
Neoplasms
A novel autophagy-related genes prognostic risk model and validation of autophagy-related oncogene VPS35 in breast cancer.
Neoplasms
A Novel Autophagy-Related IncRNAs Signature for Prognostic Prediction and Clinical Value in Patients With Pancreatic Cancer.
Neoplasms
A Novel Autophagy-Related lncRNA Gene Signature to Improve the Prognosis of Patients with Melanoma.
Neoplasms
A novel cell cycle-associated lncRNA, HOXA11-AS, is transcribed from the 5-prime end of the HOXA transcript and is a biomarker of progression in glioma.
Neoplasms
A Novel Circulating MiRNA-Based Signature for the Diagnosis and Prognosis Prediction of Early-Stage Cervical Cancer.
Neoplasms
A novel clinical multidimensional transcriptome signature predicts prognosis in bladder cancer.
Neoplasms
A Novel CpG Methylation Risk Indicator for Predicting Prognosis in Bladder Cancer.
Neoplasms
A novel CpG-based signature for survival prediction of lung adenocarcinoma patients.
Neoplasms
A novel defined pyroptosis-related gene signature for predicting the prognosis of ovarian cancer.
Neoplasms
A novel definition of microvessel density in renal cell carcinoma: Angiogenesis plus vasculogenic mimicry.
Neoplasms
A novel discriminating colorectal cancer model for differentiating normal and tumor tissues.
Neoplasms
A novel DNA damage response signature of IDH-mutant grade II and grade III astrocytoma at transcriptional level.
Neoplasms
A Novel DNA Methylation Signature as an Independent Prognostic Factor in Muscle-Invasive Bladder Cancer.
Neoplasms
A novel DNA methylation-based model that effectively predicts prognosis in hepatocellular carcinoma.
Neoplasms
A Novel Early-Stage Lung Adenocarcinoma Prognostic Model Based on Feature Selection With Orthogonal Regression.
Neoplasms
A Novel Epigenetic Machine Learning Model to Define Risk of Progression for Hepatocellular Carcinoma Patients.
Neoplasms
A novel epigenetic signature for overall survival prediction in patients with breast cancer.
Neoplasms
A novel ferroptosis related gene signature is associated with prognosis in patients with ovarian serous cystadenocarcinoma.
Neoplasms
A Novel Ferroptosis-Associated Gene Signature to Predict Prognosis in Patients with Uveal Melanoma.
Neoplasms
A novel ferroptosis-related 12-gene signature predicts clinical prognosis and reveals immune relevancy in clear cell renal cell carcinoma.
Neoplasms
A Novel Ferroptosis-Related Biomarker Signature to Predict Overall Survival of Esophageal Squamous Cell Carcinoma.
Neoplasms
A Novel Ferroptosis-Related Gene Model for Overall Survival Predictions of Bladder Urothelial Carcinoma Patients.
Neoplasms
A novel ferroptosis-related gene signature for predicting outcomes in cervical cancer.
Neoplasms
A novel ferroptosis-related gene signature for prognostic prediction of patients with lung adenocarcinoma.
Neoplasms
A novel ferroptosis-related genes model for prognosis prediction of lung adenocarcinoma.
Neoplasms
A Novel Ferroptosis-Related Prognostic Signature Reveals Macrophage Infiltration and EMT Status in Bladder Cancer.
Neoplasms
A novel five-lncRNA signature panel improves high-risk survival prediction in patients with cholangiocarcinoma.
Neoplasms
A novel four-gene of iron metabolism-related and methylated for prognosis prediction of hepatocellular carcinoma.
Neoplasms
A Novel Four-Gene Score to Predict Pathologically Complete (R0) Resection and Survival in Pancreatic Cancer.
Neoplasms
A novel Foxp3-related immune prognostic signature for glioblastoma multiforme based on immunogenomic profiling.
Neoplasms
A novel fully automated MRI-based deep-learning method for classification of 1p/19q co-deletion status in brain gliomas.
Neoplasms
A novel fully automated MRI-based deep-learning method for classification of IDH mutation status in brain gliomas.
Neoplasms
A Novel Functional Splice Variant of AKT3 Defined by Analysis of Alternative Splice Expression in HPV-Positive Oropharyngeal Cancers.
Neoplasms
A novel gene panel for prediction of lymph-node metastasis and recurrence in patients with thyroid cancer.
Neoplasms
A novel gene signature combination improves the prediction of overall survival in urinary bladder cancer.
Neoplasms
A novel gene signature to predict immune infiltration and outcome in patients with prostate cancer.
Neoplasms
A novel genomic-clinicopathologic nomogram to improve prognosis prediction of hepatocellular carcinoma.
Neoplasms
A Novel Identified Long Non-coding RNA, lncRNA MEF2C-AS1, Inhibits Cervical Cancer via Regulation of miR-592/RSPO1.
Neoplasms
A novel immune checkpoint-related seven-gene signature for predicting prognosis and immunotherapy response in melanoma.
Neoplasms
A Novel Immune-Related Competing Endogenous RNA Network Predicts Prognosis of Acute Myeloid Leukemia.
Neoplasms
A novel immune-related gene pair prognostic signature for predicting overall survival in bladder cancer.
Neoplasms
A Novel Immune-Related lncRNA-Based Model for Survival Prediction in Clear Cell Renal Cell Carcinoma.
Neoplasms
A novel immune-related long non-coding RNA signature improves the prognosis prediction in the context of head and neck squamous cell carcinoma.
Neoplasms
A novel immune-related prognostic index for predicting breast cancer overall survival.
Neoplasms
A Novel Immune-Related Prognostic Model for Response to Immunotherapy and Survival in Patients With Lung Adenocarcinoma.
Neoplasms
A Novel Immune-Related Prognostic Signature in Head and Neck Squamous Cell Carcinoma.
Neoplasms
A Novel Immune-Related Seventeen-Gene Signature for Predicting Early Stage Lung Squamous Cell Carcinoma Prognosis.
Neoplasms
A Novel Inflammatory lncRNAs Prognostic Signature for Predicting the Prognosis of Low-Grade Glioma Patients.
Neoplasms
A Novel Integrated Metabolism-Immunity Gene Expression Model Predicts the Prognosis of Lung Adenocarcinoma Patients.
Neoplasms
A novel integrative risk index of papillary thyroid cancer progression combining genomic alterations and clinical factors.
Neoplasms
A Novel Intercellular Communication-Associated Gene Signature for Prognostic Prediction and Clinical Value in Patients With Lung Adenocarcinoma.
Neoplasms
A Novel lncRNA HOXC-AS3 Acts as a miR-3922-5p Sponge to Promote Breast Cancer Metastasis.
Neoplasms
A novel lncRNA signature prediction effect and comparison with clinical staging systems for postoperative HBV-HCC patients.
Neoplasms
A novel lncRNA-miRNA-mRNA competing endogenous RNA regulatory network in lung adenocarcinoma and kidney renal papillary cell carcinoma.
Neoplasms
A novel lncRNA-miRNA-mRNA competitive endogenous RNA network for uveal melanoma prognosis constructed by weighted gene co-expression network analysis.
Neoplasms
A novel long non-coding RNA-based prognostic signature for renal cell carcinoma patients with stage IV and histological grade G4.
Neoplasms
A Novel Long Noncoding RNA (lncRNA), LL22NC03-N64E9.1, Promotes the Proliferation of Lung Cancer Cells and is a Potential Prognostic Molecular Biomarker for Lung Cancer.
Neoplasms
A Novel m6A Gene Signature Associated With Regulatory Immune Function for Prognosis Prediction in Clear-Cell Renal Cell Carcinoma.
Neoplasms
A novel machine learning approach reveals latent vascular phenotypes predictive of renal cancer outcome.
Neoplasms
A novel metabolic function of Myc in regulation of fatty acid synthesis in prostate cancer.
Neoplasms
A novel metabolic gene signature-based nomogram to predict overall survival in breast cancer.
Neoplasms
A Novel Metabolism-Related Signature as a Candidate Prognostic Biomarker for Hepatocellular Carcinoma.
Neoplasms
A Novel Method for Cancer Subtyping and Risk Prediction Using Consensus Factor Analysis.
Neoplasms
A Novel Method to Detect Functional microRNA Regulatory Modules by Bicliques Merging.
Neoplasms
A novel microRNA signature for pathological grading in lung adenocarcinoma based on TCGA and GEO data.
Neoplasms
A novel microRNA signature predicts survival in liver hepatocellular carcinoma after hepatectomy.
Neoplasms
A novel microRNA signature predicts vascular invasion in hepatocellular carcinoma.
Neoplasms
A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.
Neoplasms
A novel miR-0308-3p revealed by miRNA-seq of HBV-positive hepatocellular carcinoma suppresses cell proliferation and promotes G1/S arrest by targeting double CDK6/Cyclin D1 genes.
Neoplasms
A novel miR-7156-3p-HOXD13 axis modulates glioma progression by regulating tumor cell stemness.
Neoplasms
A novel miRNA inhibits metastasis of prostate cancer via decreasing CREBBP-mediated histone acetylation.
Neoplasms
A Novel MKL Method for GBM Prognosis Prediction by Integrating Histopathological Image and Multi-omics Data.
Neoplasms
A novel model for identification of prognostic indicator for clinical outcome of squamous cell lung carcinoma.
Neoplasms
A novel molecular-clinicopathologic nomogram to improve prognosis prediction of hepatocellular carcinoma.
Neoplasms
A novel multidimensional signature predicts prognosis in hepatocellular carcinoma patients.
Neoplasms
A novel network control model for identifying personalized driver genes in cancer.
Neoplasms
A Novel Nine Apoptosis-Related Genes Signature Predicting Overall Survival for Kidney Renal Clear Cell Carcinoma and its Associations with Immune Infiltration.
Neoplasms
A Novel NIPBL-NACC1 Gene Fusion is Characteristic of the Cholangioblastic Variant of Intrahepatic Cholangiocarcinoma.
Neoplasms
A Novel Nomogram Based on Machine Learning-Pathomics Signature and Neutrophil to Lymphocyte Ratio for Survival Prediction of Bladder Cancer Patients.
Neoplasms
A novel predictive model incorporating immune-related gene signatures for overall survival in melanoma patients.
Neoplasms
A Novel Prognostic Biomarker of Luminal Breast Cancer: High CD39 Expression Is Related to Poor Survival.
Neoplasms
A Novel Prognostic Index Based on Alternative Splicing in Papillary Renal Cell Carcinoma.
Neoplasms
A Novel Prognostic Index Based on the Analysis of Glycolysis-Related Genes in Head and Neck Squamous Cell Carcinomas.
Neoplasms
A novel prognostic index of hepatocellular carcinoma based on immunogenomic landscape analysis.
Neoplasms
A novel prognostic model based on epithelial-mesenchymal transition-related genes predicts patient survival in gastric cancer.
Neoplasms
A Novel Prognostic Model Based on Ferroptosis-Related Gene Signature for Bladder Cancer.
Neoplasms
A Novel Prognostic Model of Early-Stage Lung Adenocarcinoma Integrating Methylation and Immune Biomarkers.
Neoplasms
A novel prognostic models for identifying the risk of hepatocellular carcinoma based on epithelial-mesenchymal transition-associated genes.
Neoplasms
A novel prognostic nomogram based on 5 long non-coding RNAs in clear cell renal cell carcinoma.
Neoplasms
A novel prognostic prediction model based on seven immune-related RNAs for predicting overall survival of patients in early cervical squamous cell carcinoma.
Neoplasms
A novel prognostic signature of immune-related genes for patients with colorectal cancer.
Neoplasms
A novel prognostic signature of immune-related lncRNA pairs in lung adenocarcinoma.
Neoplasms
A novel prognostic signature of seven genes for the prediction in patients with thymoma.
Neoplasms
A Novel Prognostic Signature of Transcription Factors for the Prediction in Patients With GBM.
Neoplasms
A Novel Promoter CpG-Based Signature for Long-Term Survival Prediction of Breast Cancer Patients.
Neoplasms
A novel retroviral mutagenesis screen identifies prognostic genes in RUNX1 mediated myeloid leukemogenesis.
Neoplasms
A Novel Risk Model Based on Autophagy Pathway Related Genes for Survival Prediction in Lung Adenocarcinoma.
Neoplasms
A Novel Risk Model Based on Lipid Metabolism-Associated Genes Predicts Prognosis and Indicates Immune Microenvironment in Breast Cancer.
Neoplasms
A novel risk score based on a combined signature of 10 immune system genes to predict bladder cancer prognosis.
Neoplasms
A novel risk score model based on eight genes and a nomogram for predicting overall survival of patients with osteosarcoma.
Neoplasms
A novel risk score model for stomach adenocarcinoma based on the expression levels of 10 genes.
Neoplasms
A novel risk score system of immune genes associated with prognosis in endometrial cancer.
Neoplasms
A novel RNA binding protein-associated prognostic model to predict overall survival in hepatocellular carcinoma patients.
Neoplasms
A Novel RNA Binding Protein-Related Prognostic Signature for Hepatocellular Carcinoma.
Neoplasms
A novel RNA sequencing-based miRNA signature predicts with recurrence and outcome of hepatocellular carcinoma.
Neoplasms
A novel RNA sequencing-based prognostic nomogram to predict survival for patients with cutaneous melanoma: Clinical trial/experimental study.
Neoplasms
A novel RNA sequencing-based risk score model to predict papillary thyroid carcinoma recurrence.
Neoplasms
A Novel RNA-Binding Protein-Based Nomogram for Predicting Survival of Patients with Gastric Cancer.
Neoplasms
A novel scoring method based on RNA-Seq immunograms describing individual cancer-immunity interactions.
Neoplasms
A novel scoring system for acute myeloid leukemia risk assessment based on the expression levels of six genes.
Neoplasms
A novel scoring system for gastric cancer risk assessment based on the expression of three CLIP4 DNA methylation-associated genes.
Neoplasms
A novel scoring system for pivotal autophagy-related genes predicts outcomes after chemotherapy in advanced ovarian cancer patients.
Neoplasms
A Novel Scoring System for Risk Assessment of Elderly Patients With Cytogenetically Normal Acute Myeloid Leukemia Based on Expression of Three AQP1 DNA Methylation-Associated Genes.
Neoplasms
A novel sensitive detection method for DNA methylation in circulating free DNA of pancreatic cancer.
Neoplasms
A novel serum microRNA-based identification and classification biomarker of human glioma.
Neoplasms
A Novel Set of Immune-associated Gene Signature predicts Biochemical Recurrence in Localized Prostate Cancer Patients after Radical Prostatectomy.
Neoplasms
A novel seven-gene signature as Prognostic Biomarker in Hepatocellular Carcinoma.
Neoplasms
A novel seven?miRNA prognostic model to predict overall survival in head and neck squamous cell carcinoma patients.
Neoplasms
A Novel Seventeen-Gene Metabolic Signature for Predicting Prognosis in Colon Cancer.
Neoplasms
A novel signature based on microvascular invasion predicts the recurrence of HCC.
Neoplasms
A novel signature constructed by ferroptosis-associated genes (FAGs) for the prediction of prognosis in bladder urothelial carcinoma (BLCA) and associated with immune infiltration.
Neoplasms
A Novel Signature Constructed by Immune-Related LncRNA Predicts the Immune Landscape of Colorectal Cancer.
Neoplasms
A Novel Signature Constructed by RNA-Binding Protein Coding Genes to Improve Overall Survival Prediction of Glioma Patients.
Neoplasms
A Novel Signature for Predicting Prognosis of Smoking-Related Squamous Cell Carcinoma.
Neoplasms
A Novel Signature of 23 Immunity-Related Gene Pairs Is Prognostic of Cutaneous Melanoma.
Neoplasms
A novel signature of two long non-coding RNAs in BRCA mutant ovarian cancer to predict prognosis and efficiency of chemotherapy.
Neoplasms
A novel similarity score based on gene ranks to reveal genetic relationships among diseases.
Neoplasms
A Novel Six-Gene-Based Prognostic Model Predicts Survival and Clinical Risk Score for Gastric Cancer.
Neoplasms
A novel six-microRNA-based model to improve prognosis prediction of breast cancer.
Neoplasms
A Novel Six-mRNA Signature Predicts Survival of Patients With Glioblastoma Multiforme.
Neoplasms
A novel small-molecule activator of Sirtuin-1 induces autophagic cell death/mitophagy as a potential therapeutic strategy in glioblastoma.
Neoplasms
A novel splice variant of LOXL2 promotes progression of human papillomavirus-negative head and neck squamous cell carcinoma.
Neoplasms
A novel strategy to identify candidate diagnostic and prognostic biomarkers for gastric cancer.
Neoplasms
A Novel Sulforaphane-Regulated Gene Network in Suppression of Breast Cancer-Induced Osteolytic Bone Resorption.
Neoplasms
A novel survival model based on a Ferroptosis-related gene signature for predicting overall survival in bladder cancer.
Neoplasms
A novel tailored immune gene pairs signature for overall survival prediction in lower-grade gliomas.
Neoplasms
A Novel Three-miRNA Signature Identified Using Bioinformatics Predicts Survival in Esophageal Carcinoma.
Neoplasms
A novel three?miRNA signature predicts survival in cholangiocarcinoma based on RNA?Seq data.
Neoplasms
A Novel Transcription Factor-Based Prognostic Signature in Endometrial Cancer: Establishment and Validation.
Neoplasms
A novel tumor mutational burden estimation model as a predictive and prognostic biomarker in NSCLC patients.
Neoplasms
A P53-related microRNA model for predicting the prognosis of hepatocellular carcinoma patients.
Neoplasms
A pan-cancer analysis based on weighted gene co-expression network analysis identifies the biomarker utility of lamin B1 in human tumors.
Neoplasms
A pan-cancer analysis of alternative splicing events reveals novel tumor-associated splice variants of matriptase.
Neoplasms
A pan-cancer analysis of driver gene mutations, DNA methylation and gene expressions reveals that chromatin remodeling is a major mechanism inducing global changes in cancer epigenomes.
Neoplasms
A pan-cancer analysis of HER2 index revealed transcriptional pattern for precise selection of HER2-targeted therapy.
Neoplasms
A pan-cancer analysis of the clinical and genetic portraits of somatostatin receptor expressing tumor as a potential target of peptide receptor imaging and therapy.
Neoplasms
A Pan-cancer Analysis of the Expression and Clinical Relevance of Small Nucleolar RNAs in Human Cancer.
Neoplasms
A pan-cancer analysis of the human tumor coagulome and its link to the tumor immune microenvironment.
Neoplasms
A Pan-Cancer Analysis of the Oncogenic Role of Twinfilin Actin Binding Protein 1 in Human Tumors.
Neoplasms
A pan-cancer analysis of the prognostic and immunological role of ?-actin (ACTB) in human cancers.
Neoplasms
A Pan-Cancer Analysis of the Prognostic Value and Expression of Adenylate Cyclase 7 (ADCY7) in Human Tumors.
Neoplasms
A pan-cancer analysis of transcriptome changes associated with somatic mutations in U2AF1 reveals commonly altered splicing events.
Neoplasms
A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-? Superfamily.
Neoplasms
A Pan-Cancer Approach to Predict Responsiveness to Immune Checkpoint Inhibitors by Machine Learning.
Neoplasms
A Pan-Cancer Compendium of Genes Deregulated by Somatic Genomic Rearrangement across More Than 1,400 Cases.
Neoplasms
A pan-cancer genome-wide analysis reveals tumour dependencies by induction of nonsense-mediated decay.
Neoplasms
A pan-cancer modular regulatory network analysis to identify common and cancer-specific network components.
Neoplasms
A pan-cancer perspective analysis reveals the opposite prognostic significance of CD133 in lower grade glioma and papillary renal cell carcinoma.
Neoplasms
A pan-cancer perspective of matrix metalloproteases (MMP) gene expression profile and their diagnostic/prognostic potential.
Neoplasms
A Pan-Cancer Review of ALK Mutations: Implications for Carcinogenesis and Therapy.
Neoplasms
A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells.
Neoplasms
A Pan-Cancer Study of Epidermal Growth Factor-Like Domains 6/7/8 as Therapeutic Targets in Cancer.
Neoplasms
A pan-cancer study of the transcriptional regulation of uricogenesis in human tumours: pathological and pharmacological correlates.
Neoplasms
A pan-cancer transcriptomic study showing tumor specific alterations in central metabolism.
Neoplasms
A pancancer overview of FBN1, asprosin and its cognate receptor OR4M1 with detailed expression profiling in ovarian cancer.
Neoplasms
A panel of 13-miRNA signature as a potential biomarker for predicting survival in pancreatic cancer.
Neoplasms
A panel of 7 prognosis-related long non-coding RNAs to improve platinum-based chemoresistance prediction in ovarian cancer.
Neoplasms
A panel of 8-lncRNA predicts prognosis of breast cancer patients and migration of breast cancer cells.
Neoplasms
A panel of collagen genes are associated with prognosis of patients with gastric cancer and regulated by microRNA-29c-3p: an integrated bioinformatics analysis and experimental validation.
Neoplasms
A panel of DNA methylation markers for the classification of consensus molecular subtypes 2 and 3 in patients with colorectal cancer.
Neoplasms
A panel of eight autophagy-related long non-coding RNAs is a good predictive parameter for clear cell renal cell carcinoma.
Neoplasms
A Panel of Four-lncRNA Signature as a Potential Biomarker for Predicting Survival in Clear Cell Renal Cell Carcinoma.
Neoplasms
A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder.
Neoplasms
A panel of novel detection and prognostic methylated DNA markers in primary non-small cell lung cancer and serum DNA.
Neoplasms
A panel of Transcription factors identified by data mining can predict the prognosis of head and neck squamous cell carcinoma.
Neoplasms
A pathologist-designed imaging system for anatomic pathology signout, teaching, and research.
Neoplasms
A Pipeline to Call Multilevel Expression Changes between Cancer and Normal Tissues and Its Applications in Repurposing Drugs Effective for Gastric Cancer.
Neoplasms
A polycomb-mediated epigenetic field defect precedes invasive cervical carcinoma.
Neoplasms
A polygenic methylation prediction model associated with response to chemotherapy in epithelial ovarian cancer.
Neoplasms
A polymorphism in miR-1262 regulatory region confers the risk of lung cancer in Chinese population.
Neoplasms
A Positive Feedback Loop Between DICER1 and Differentiation Transcription Factors Is Important for Thyroid Tumorigenesis.
Neoplasms
A positive feedback loop consisting of C12orf59/NF-?B/CDH11 promotes gastric cancer invasion and metastasis.
Neoplasms
A Potential Immune-Related Long Non-coding RNA Prognostic Signature for Ovarian Cancer.
Neoplasms
A potential panel of four-long noncoding RNA signature in prostate cancer predicts biochemical recurrence-free survival and disease-free survival.
Neoplasms
A potential peptide therapeutic derived from the juxtamembrane domain of the epidermal growth factor receptor.
Neoplasms
A Potential Prognostic Gene Signature for Predicting Survival for Glioblastoma Patients.
Neoplasms
A potential prognostic lncRNA signature for predicting survival in patients with bladder urothelial carcinoma.
Neoplasms
A Potential Prognostic Long Noncoding RNA Signature to Predict Recurrence among ER-positive Breast Cancer Patients Treated with Tamoxifen.
Neoplasms
A potential prognostic marker and therapeutic target: SPOCK1 promotes the proliferation, metastasis, and apoptosis of pancreatic ductal adenocarcinoma cells.
Neoplasms
A potential prognostic model based on miRNA expression profile in The Cancer Genome Atlas for bladder cancer patients.
Neoplasms
A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures.
Neoplasms
A potential signaling axis between RON kinase receptor and hypoxia-inducible factor-1 alpha in pancreatic cancer.
Neoplasms
A powerful nonparametric method for detecting differentially co-expressed genes: distance correlation screening and edge-count test.
Neoplasms
A pre-neoplastic epigenetic field defect in HCV-infected liver at transcription factor binding sites and polycomb targets.
Neoplasms
A Prediction Model for Preoperative Risk Assessment in Endometrial Cancer Utilizing Clinical and Molecular Variables.
Neoplasms
A predictive analysis approach for paediatric and adult high-grade glioma: miRNAs and network insight.
Neoplasms
A preliminary analysis of interleukin-1 ligands as potential predictive biomarkers of response to cetuximab.
Neoplasms
A Preliminary Investigation of PVT1 on the Effect and Mechanisms of Hepatocellular Carcinoma: Evidence from Clinical Data, a Meta-Analysis of 840 Cases, and In Vivo Validation.
Neoplasms
A Primer on a Hepatocellular Carcinoma Bioresource Bank Using the Cancer Genome Atlas Guidelines: Practical Issues and Pitfalls.
Neoplasms
A probabilistic method for leveraging functional annotations to enhance estimation of the temporal order of pathway mutations during carcinogenesis.
Neoplasms
A probabilistic multi-omics data matching method for detecting sample errors in integrative analysis.
Neoplasms
A profiling analysis on the receptor ACE2 expression reveals the potential risk of different type of cancers vulnerable to SARS-CoV-2 infection.
Neoplasms
A prognosis-predictive nomogram of ovarian cancer with two immune-related genes: CDC20B and PNPLA5.
Neoplasms
A prognosis-related based method for miRNA selection on liver hepatocellular carcinoma prediction.
Neoplasms
A prognostic 11 long noncoding RNA expression signature for breast invasive carcinoma.
Neoplasms
A Prognostic 14-Gene Expression Signature for Lung Adenocarcinoma: A Study Based on TCGA Data Mining.
Neoplasms
A Prognostic Autophagy-Related Gene Pair Signature and Small-Molecule Drugs for Hepatocellular Carcinoma.
Neoplasms
A Prognostic DNA Damage Repair Genes Signature and Its Impact on Immune Cell Infiltration in Glioma.
Neoplasms
A prognostic index based on a fourteen long non-coding RNA signature to predict the recurrence-free survival for muscle-invasive bladder cancer patients.
Neoplasms
A prognostic long non-coding RNA-associated competing endogenous RNA network in head and neck squamous cell carcinoma.
Neoplasms
A Prognostic Microenvironment-Related Immune Signature via ESTIMATE (PROMISE Model) Predicts Overall Survival of Patients With Glioma.
Neoplasms
A Prognostic Model Based on Immune-Related Long Non-Coding RNAs for Patients With Cervical Cancer.
Neoplasms
A Prognostic Model Based on RNA Binding Protein Predicts Clinical Outcomes in Hepatocellular Carcinoma Patients.
Neoplasms
A prognostic model based on seven immune-related genes predicts the overall survival of patients with hepatocellular carcinoma.
Neoplasms
A prognostic model composed of four long noncoding RNAs predicts the overall survival of Asian patients with hepatocellular carcinoma.
Neoplasms
A prognostic model for hepatocellular carcinoma based on apoptosis-related genes.
Neoplasms
A prognostic model for lung adenocarcinoma patient survival with a focus on four miRNAs.
Neoplasms
A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study.
Neoplasms
A Prognostic Model of 15 Immune-Related Gene Pairs Associated With Tumor Mutation Burden for Hepatocellular Carcinoma.
Neoplasms
A Prognostic Molecular Signature of N?-Methyladenosine Methylation Regulators for Soft-Tissue Sarcoma from The Cancer Genome Atlas Database.
Neoplasms
A prognostic mRNA expression signature of four 16q24.3 genes in radio(chemo)therapy-treated head and neck squamous cell carcinoma (HNSCC).
Neoplasms
A prognostic mutation panel for predicting cancer recurrence in stages II and III colorectal cancer.
Neoplasms
A Prognostic Nomogram Based on Immune Scores Predicts Postoperative Survival for Patients with Hepatocellular Carcinoma.
Neoplasms
A Prognostic Nomogram Combining Immune-Related Gene Signature and Clinical Factors Predicts Survival in Patients With Lung Adenocarcinoma.
Neoplasms
A prognostic nomogram for lung adenocarcinoma based on immune-infiltrating Treg-related genes: from bench to bedside.
Neoplasms
A Prognostic Nomogram for Predicting Overall Survival in Pediatric Wilms Tumor Based on an Autophagy-related Gene Signature.
Neoplasms
A Prognostic Nomogram Model Based on mRNA Expression of DNA Methylation-Driven Genes for Gastric Cancer.
Neoplasms
A Prognostic Prediction Model Developed Based on Four CpG Sites and Weighted Correlation Network Analysis Identified DNAJB1 as a Novel Biomarker for Pancreatic Cancer.
Neoplasms
A prognostic prediction system for hepatocellular carcinoma based on gene co-expression network.
Neoplasms
A prognostic predictive model constituted with gene mutations of APC, BRCA2, CDH1, SMO, and TSC2 in colorectal cancer.
Neoplasms
A prognostic predictor panel with DNA methylation biomarkers for early-stage lung adenocarcinoma in Asian and Caucasian populations.
Neoplasms
A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
Neoplasms
A Prognostic Signature Constructed by CTHRC1 and LRFN4 in Stomach Adenocarcinoma.
Neoplasms
A Proof of Concept for Biomarker-Guided Targeted Therapy against Ovarian Cancer Based on Patient-Derived Tumor Xenografts.
Neoplasms
A prospective picture collection study for a grading atlas of radiation dermatitis for clinical trials in head-and-neck cancer patients.
Neoplasms
A prospective study revealing the role of an immune-related eRNA, WAKMAR2, in breast cancer.
Neoplasms
A Protective Role for Androgen Receptor in Clear Cell Renal Cell Carcinoma Based on Mining TCGA Data.
Neoplasms
A Protective Role for RHOJ in NonSmall Cell Lung Cancer Based on Integrated Bioinformatics Analysis.
Neoplasms
A Proteomic Approach to Understand the Clinical Significance of Acute Myeloid Leukemia-Derived Extracellular Vesicles Reflecting Essential Characteristics of Leukemia.
Neoplasms
A Proteotranscriptomic-Based Computational Drug-Repositioning Method for Alzheimer's Disease.
Neoplasms
A putative competing endogenous RNA network in cisplatin-resistant lung adenocarcinoma cells identifying potentially rewarding research targets.
Neoplasms
A qRT-PCR and Gene Functional Enrichment Study Focused on Downregulation of miR-141-3p in Hepatocellular Carcinoma and Its Clinicopathological Significance.
Neoplasms
A quantitative model based on clinically relevant MRI features differentiates lower grade gliomas and glioblastoma.
Neoplasms
A quantitative study of shape descriptors from glioblastoma multiforme phenotypes for predicting survival outcome.
Neoplasms
A radiomic signature as a non-invasive predictor of progression-free survival in patients with lower-grade gliomas.
Neoplasms
A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Neoplasms
A radiomics nomogram based on multiparametric MRI might stratify glioblastoma patients according to survival.
Neoplasms
A radiosensitivity gene signature and PD-L1 predict the clinical outcomes of patients with lower grade glioma in TCGA.
Neoplasms
A Radiosensitivity Gene Signature and PD-L1 Status Predict Clinical Outcome of Patients with Glioblastoma Multiforme in The Cancer Genome Atlas Dataset.
Neoplasms
A radiosensitivity gene signature and PD-L1 status predict clinical outcome of patients with invasive breast carcinoma in The Cancer Genome Atlas (TCGA) dataset.
Neoplasms
A Radiosensitivity Gene Signature and XPO1 Predict Clinical Outcomes for Glioma Patients.
Neoplasms
A radiosensitivity MiRNA signature validated by the TCGA database for head and neck squamous cell carcinomas.
Neoplasms
A random forest classifier predicts recurrence risk in patients with ovarian cancer.
Neoplasms
A Random Walk Based Cluster Ensemble Approach for Data Integration and Cancer Subtyping.
Neoplasms
A Rapid and Cost-Effective Gene Expression Assay for the Diagnosis of Well-Differentiated and Dedifferentiated Liposarcomas.
Neoplasms
A Rational Approach to Target the Epidermal Growth Factor Receptor in Glioblastoma.
Neoplasms
A reactive oxygen species scoring system predicts cisplatin sensitivity and prognosis in ovarian cancer patients.
Neoplasms
A Recurrence-Specific Gene-Based Prognosis Prediction Model for Lung Adenocarcinoma through Machine Learning Algorithm.
Neoplasms
A reference profile-free deconvolution method to infer cancer cell-intrinsic subtypes and tumor-type-specific stromal profiles.
Neoplasms
A regulatory loop among CD276, miR-29c-3p, and Myc exists in cancer cells against natural killer cell cytotoxicity.
Neoplasms
A reported 20-gene expression signature to predict lymph node-positive disease at radical cystectomy for muscle-invasive bladder cancer is clinically not applicable.
Neoplasms
A resource of ribosomal RNA-depleted RNA-Seq data from different normal adult and fetal human tissues.
Neoplasms
A Review of Small-Molecule Inhibitors of One-Carbon Enzymes: SHMT2 and MTHFD2 in the Spotlight.
Neoplasms
A risk model developed based on tumor microenvironment predicts overall survival and associates with tumor immunity of patients with lung adenocarcinoma.
Neoplasms
A risk prediction model of DNA methylation improves prognosis evaluation and indicates gene targets in prostate cancer.
Neoplasms
A Risk Score Model Based on Nine Differentially Methylated mRNAs for Predicting Prognosis of Patients with Clear Cell Renal Cell Carcinoma.
Neoplasms
A risk score model with five long non-coding RNAs for predicting prognosis in gastric cancer: an integrated analysis combining TCGA and GEO datasets.
Neoplasms
A risk score staging system based on the expression of seven genes predicts the outcome of bladder cancer.
Neoplasms
A risk score system based on DNA methylation levels and a nomogram survival model for lung squamous cell carcinoma.
Neoplasms
A Risk Signature Consisting of Eight m6A Methylation Regulators Predicts the Prognosis of Glioma.
Neoplasms
A risk signature of four aging-related genes has clinical prognostic value and is associated with a tumor immune microenvironment in glioma.
Neoplasms
A Risk Signature with Autophagy-Related Long Noncoding RNAs for Predicting the Prognosis of Clear Cell Renal Cell Carcinoma: Based on the TCGA Database and Bioinformatics.
Neoplasms
A Risk Signature with Nine Stemness Index-Associated Genes for Predicting Survival of Patients with Uterine Corpus Endometrial Carcinoma.
Neoplasms
A RNA sequencing-based six-gene signature for survival prediction in patients with glioblastoma.
Neoplasms
A RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer.
Neoplasms
A robust 11-genes prognostic model can predict overall survival in bladder cancer patients based on five cohorts.
Neoplasms
A Robust 6-lncRNA Prognostic Signature for Predicting the Prognosis of Patients With Colorectal Cancer Metastasis.
Neoplasms
A Robust Circular RNA-Associated Three-Gene Prognostic Signature for Patients with Gastric Cancer.
Neoplasms
A robust ferroptosis-related gene signature predicts overall survival in clear cell renal cell carcinoma.
Neoplasms
A Robust Hypoxia Risk Score Predicts the Clinical Outcomes and Tumor Microenvironment Immune Characters in Bladder Cancer.
Neoplasms
A robust nine-gene prognostic signature associated with tumour doubling time for hepatocellular carcinoma.
Neoplasms
A Robust Prognostic Gene Signature Based on eRNAs-Driven Genes in Prostate Cancer.
Neoplasms
A robust signature associated with patient prognosis and tumor immune microenvironment based on immune-related genes in lung squamous cell carcinoma.
Neoplasms
A robust signature of immune-related long non-coding RNA to predict the prognosis of bladder cancer.
Neoplasms
A robust six-gene prognostic signature for prediction of both disease-free and overall survival in non-small cell lung cancer.
Neoplasms
A robust six-miRNA prognostic signature for head and neck squamous cell carcinoma.
Neoplasms
A robust twelve-gene signature for prognosis prediction of hepatocellular carcinoma.
Neoplasms
A role for BMP-induced homeobox gene MIXL1 in acute myelogenous leukemia and identification of type I BMP receptor as a potential target for therapy.
Neoplasms
A secondary role for hypoxia and HIF1 in the regulation of (IFN?-induced) PD-L1 expression in melanoma.
Neoplasms
A secreted PD-L1 splice variant that covalently dimerizes and mediates immunosuppression.
Neoplasms
A Sensitive NanoString-Based Assay to Score STK11 (LKB1) Pathway Disruption in Lung Adenocarcinoma.
Neoplasms
A Set of Markers Related to Viral Infection Has a Sex-sensitive Prognostic Value in Papillary Thyroid Carcinoma.
Neoplasms
A set of molecular markers predicts chemosensitivity to Mitomycin-C following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastasis.
Neoplasms
A Seven Immune-Related lncRNAs Model to Increase the Predicted Value of Lung Adenocarcinoma.
Neoplasms
A seven long-noncoding RNA signature predicts prognosis of lung squamous cell carcinoma.
Neoplasms
A seven-DNA methylation signature as a novel prognostic biomarker in breast cancer.
Neoplasms
A seven-gene prognostic model related to immune checkpoint PD-1 revealing overall survival in patients with lung adenocarcinoma.
Neoplasms
A seven-gene prognostic signature for rapid determination of head and neck squamous cell carcinoma survival.
Neoplasms
A seven-gene prognostic signature predicts overall survival of patients with lung adenocarcinoma (LUAD).
Neoplasms
A seven-gene signature model predicts overall survival in kidney renal clear cell carcinoma.
Neoplasms
A Seven-Gene Signature with Close Immune Correlation Was Identified for Survival Prediction of Lung Adenocarcinoma.
Neoplasms
A seven-lncRNA signature predicts overall survival in esophageal squamous cell carcinoma.
Neoplasms
A Seven-Long Non-coding RNA Signature Improves Prognosis Prediction of Lung Adenocarcinoma: An Integrated Competing Endogenous RNA Network Analysis.
Neoplasms
A seven-long noncoding RNA signature predicts overall survival for patients with early stage non-small cell lung cancer.
Neoplasms
A seven-m6A regulator-related CpG site-based prognostic signature for endometrial carcinoma.
Neoplasms
A Seven-microRNA Expression Signature Predicts Survival in Hepatocellular Carcinoma.
Neoplasms
A seven-miRNA expression-based prognostic signature and its corresponding potential competing endogenous RNA network in early pancreatic cancer.
Neoplasms
A signature of 13 autophagy?related gene pairs predicts prognosis in hepatocellular carcinoma.
Neoplasms
A signature of 14 immune-related gene pairs predicts overall survival in gastric cancer.
Neoplasms
A signature of 18 immune-related gene pairs to predict the prognosis of pancreatic cancer patients.
Neoplasms
A signature of 24 aging?related gene pairs predict overall survival in gastric cancer.
Neoplasms
A signature of 33 immune-related gene pairs predicts clinical outcome in hepatocellular carcinoma.
Neoplasms
A Signature of Autophagy-Related Long Non-coding RNA to Predict the Prognosis of Breast Cancer.
Neoplasms
A signature of estimate-stromal-immune score-based genes associated with the prognosis of lung adenocarcinoma.
Neoplasms
A Signature of Nine lncRNA Methylated Genes Predicts Survival in Patients With Glioma.
Neoplasms
A signature of seven immune-related genes predicts overall survival in male gastric cancer patients.
Neoplasms
A signature of tumor DNA repair genes associated with the prognosis of surgically-resected lung adenocarcinoma.
Neoplasms
A Simple Competing Endogenous RNA Network Identifies Novel mRNA, miRNA, and lncRNA Markers in Human Cholangiocarcinoma.
Neoplasms
A single-cell atlas of liver metastases of colorectal cancer reveals reprogramming of the tumor microenvironment in response to preoperative chemotherapy.
Neoplasms
A six-gene expression signature related to angiolymphatic invasion is associated with poor survival in laryngeal squamous cell carcinoma.
Neoplasms
A six-gene prognostic model predicts overall survival in bladder cancer patients.
Neoplasms
A six-gene-based prognostic signature for hepatocellular carcinoma overall survival prediction.
Neoplasms
A six-gene-based signature for breast cancer radiotherapy sensitivity estimation.
Neoplasms
A Six-lncRNA Signature for Immunophenotype Prediction of Glioblastoma Multiforme.
Neoplasms
A six-long non-coding RNAs signature as a potential prognostic marker for survival prediction of ER-positive breast cancer patients.
Neoplasms
A six-microRNA risk score model predicts prognosis in esophageal squamous cell carcinoma.
Neoplasms
A six-microRNA signature can better predict overall survival of patients with esophagus adenocarcinoma.
Neoplasms
A six-microRNA signature predicts survival of patients with uterine corpus endometrial carcinoma.
Neoplasms
A six-mRNA prognostic model to predict survival in head and neck squamous cell carcinoma.
Neoplasms
A small-molecule activator induces ULK1-modulating autophagy-associated cell death in triple negative breast cancer.
Neoplasms
A Somatic Mutation-Derived LncRNA Signature of Genomic Instability Predicts Prognosis for Patients With Liver Cancer.
Neoplasms
A Sparse and Low-Rank Regression Model for Identifying the Relationships Between DNA Methylation and Gene Expression Levels in Gastric Cancer and the Prediction of Prognosis.
Neoplasms
A stemness-based eleven-gene signature correlates with the clinical outcome of hepatocellular carcinoma.
Neoplasms
A strategy to identify housekeeping genes suitable for analysis in breast cancer diseases.
Neoplasms
A subset of diffuse-type gastric cancer is susceptible to mTOR inhibitors and checkpoint inhibitors.
Neoplasms
A Subset of Localized Prostate Cancer Displays an Immunogenic Phenotype Associated with Losses of Key Tumor Suppressor Genes.
Neoplasms
A subset of patients with MSS/MSI-low-colorectal cancer showed increased CD8(+) TILs together with up-regulated IFN-?.
Neoplasms
A subtype of oral, laryngeal, esophageal, and lung, squamous cell carcinoma with high levels of TrkB-T1 neurotrophin receptor mRNA.
Neoplasms
A survey and evaluation of Web-based tools/databases for variant analysis of TCGA data.
Neoplasms
A survey of intragenic breakpoints in glioblastoma identifies a distinct subset associated with poor survival.
Neoplasms
A Survey of Regulatory Interactions Among RNA Binding Proteins and MicroRNAs in Cancer.
Neoplasms
A SUV39H1-low chromatin state characterises and promotes migratory properties of cervical cancer cells.
Neoplasms
A systematic analysis of a potential metabolism-related prognostic signature for breast cancer patients.
Neoplasms
A Systematic Analysis of the Relationship of CDH13 Promoter Methylation and Breast Cancer Risk and Prognosis.
Neoplasms
A systematic and genome-wide correlation meta-analysis of PD-L1 expression and targetable NSCLC driver genes.
Neoplasms
A systematic atlas of chaperome deregulation topologies across the human cancer landscape.
Neoplasms
A Systematic Evaluation of Feature Selection and Classification Algorithms Using Simulated and Real miRNA Sequencing Data.
Neoplasms
A systematic view of computational methods for identifying driver genes based on somatic mutation data.
Neoplasms
A systems-based framework to computationally describe putative transcription factors and signaling pathways regulating glycan biosynthesis.
Neoplasms
A tale of two cancers: Complete genetic analysis of chromophobe renal cell carcinoma contrasts with clear cell renal cell carcinoma.
Neoplasms
A Targeted Bioinformatics Assessment of Adrenocortical Carcinoma Reveals Prognostic Implications of GABA System Gene Expression.
Neoplasms
A Targeted Proteomic Approach for Heat Shock Proteins Reveals DNAJB4 as a Suppressor for Melanoma Metastasis.
Neoplasms
A Targeted Quantitative Proteomic Approach Assesses the Reprogramming of Small GTPases during Melanoma Metastasis.
Neoplasms
A Targeted Quantitative Proteomic Method Revealed a Substantial Reprogramming of Kinome during Melanoma Metastasis.
Neoplasms
A ten-long non-coding RNA signature for predicting prognosis of patients with cervical cancer.
Neoplasms
A Ten-N6-Methyladenosine (m6A)-Modified Gene Signature Based on a Risk Score System Predicts Patient Prognosis in Rectum Adenocarcinoma.
Neoplasms
A three gene immunohistochemical panel serves as an adjunct to clinical staging of patients with head and neck cancer.
Neoplasms
A Three Long Noncoding RNA-Based Signature for Oral Squamous Cell Carcinoma Prognosis Prediction.
Neoplasms
A Three Protein-Coding Gene Prognostic Model Predicts Overall Survival in Bladder Cancer Patients.
Neoplasms
A Three-Gene Classifier Associated With MicroRNA-Mediated Regulation Predicts Prostate Cancer Recurrence After Radical Prostatectomy.
Neoplasms
A three-gene expression signature associated with positive surgical margins in tongue squamous cell carcinomas: Predicting surgical resectability from tumour biology?
Neoplasms
A three-gene expression-based risk score can refine the European LeukemiaNet AML classification.
Neoplasms
A three-gene signature for prognosis in patients with MGMT promoter-methylated glioblastoma.
Neoplasms
A three-lncRNA expression signature predicts survival in head and neck squamous cell carcinoma (HNSCC).
Neoplasms
A three-lncRNA signature derived from the Atlas of ncRNA in cancer (TANRIC) database predicts the survival of patients with head and neck squamous cell carcinoma.
Neoplasms
A three-lncRNA signature predicts clinical outcomes in low-grade glioma patients after radiotherapy.
Neoplasms
A Three-Metabolic-Genes Risk Score Model Predicts Overall Survival in Clear Cell Renal Cell Carcinoma Patients.
Neoplasms
A three-microRNA signature as a diagnostic and prognostic marker in clear cell renal cancer: An In Silico analysis.
Neoplasms
A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes.
Neoplasms
A three-mRNA status risk score has greater predictive ability compared with a lncRNA-based risk score for predicting prognosis in patients with hepatocellular carcinoma.
Neoplasms
A three?lncRNA signature for prognosis prediction of acute myeloid leukemia in patients.
Neoplasms
A tool to facilitate clinical biomarker studies - a tissue dictionary based on the Human Protein Atlas.
Neoplasms
A TP53 mutation model for the prediction of prognosis and therapeutic responses in head and neck squamous cell carcinoma.
Neoplasms
A TP53-Associated Immune Prognostic Signature for the Prediction of Overall Survival and Therapeutic Responses in Muscle-Invasive Bladder Cancer.
Neoplasms
A transcriptional miRNA-gene network associated with lung adenocarcinoma metastasis based on the TCGA database.
Neoplasms
A Transcriptional Signature of PDGF-DD Activated Natural Killer Cells Predicts More Favorable Prognosis in Low-Grade Glioma.
Neoplasms
A transcriptome-wide association study identifies novel candidate susceptibility genes for prostate cancer risk.
Neoplasms
A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer.
Neoplasms
A Transcriptomic Analysis of Head and Neck Squamous Cell Carcinomas for Prognostic Indications.
Neoplasms
A Transcriptomic Signature for Risk-Stratification and Recurrence Prediction in Intrahepatic Cholangiocarcinoma.
Neoplasms
A transcriptomic signature of tertiary Gleason 5 predicts worse clinicopathological outcome.
Neoplasms
A transcriptomic study for identifying cardia- and non-cardia-specific gastric cancer prognostic factors using genetic algorithm-based methods.
Neoplasms
A Translational Pipeline for Overall Survival Prediction of Breast Cancer Patients by Decision-Level Integration of Multi-Omics Data.
Neoplasms
A tropomyosin receptor kinase family protein, NTRK2 is a potential predictive biomarker for lung adenocarcinoma.
Neoplasms
A tumor microenvironment-related mRNA-ncRNA signature for prediction early relapse and chemotherapeutic sensitivity in early-stage lung adenocarcinoma.
Neoplasms
A tumor-associated splice-isoform of MAP2K7 drives dedifferentiation in MBNL1-low cancers via JNK activation.
Neoplasms
A two-circular RNA signature as a noninvasive diagnostic biomarker for lung adenocarcinoma.
Neoplasms
A Two-DNA Methylation Signature to Improve Prognosis Prediction of Clear Cell Renal Cell Carcinoma.
Neoplasms
A two-microRNA signature as a diagnostic and prognostic marker of pancreatic adenocarcinoma.
Neoplasms
A Unique Subset of Epithelial Ovarian Cancers with Platinum Sensitivity and PARP Inhibitor Resistance.
Neoplasms
A united risk model of 11 immune?related gene pairs and clinical stage for prediction of overall survival in clear cell renal cell carcinoma patients.
Neoplasms
A User-Friendly, Web-Based Integrative Tool (ESurv) for Survival Analysis: Development and Validation Study.
Neoplasms
A validated integrated clinical and molecular glioblastoma long-term survival-predictive nomogram.
Neoplasms
A web-based tool for in silico biomarker discovery based on tissue-specific protein profiles in normal and cancer tissues.
Neoplasms
A YAP/TAZ-Regulated Molecular Signature Is Associated with Oral Squamous Cell Carcinoma.
Neoplasms
A zinc finger protein gene signature enables bladder cancer treatment stratification.
Neoplasms
AACR White Paper: Shaping the Future of Cancer Prevention - A Roadmap for Advancing Science and Public Health.
Neoplasms
ABAT and ALDH6A1, regulated by transcription factor HNF4A, suppress tumorigenic capability in clear cell renal cell carcinoma.
Neoplasms
ABC-GWAS: Functional Annotation of Estrogen Receptor-Positive Breast Cancer Genetic Variants.
Neoplasms
ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: A comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas.
Neoplasms
ABCC9, NKAPL, and TMEM132C are potential diagnostic and prognostic markers in triple-negative breast cancer.
Neoplasms
Aberrant brain-expressed X-linked 4 (BEX4) expression is a novel prognostic biomarker in gastric cancer.
Neoplasms
Aberrant CpG methylation of the TFAP2A gene constitutes a mechanism for loss of TFAP2A expression in human metastatic melanoma.
Neoplasms
Aberrant Dyskerin Expression Is Related to Proliferation and Poor Survival in Endometrial Cancer.
Neoplasms
Aberrant Epidermal Growth Factor Receptor RNA Splice Products Are Among the Most Frequent Somatic Alterations in Clear Cell Renal Cell Carcinoma and Are Associated with a Poor Response to Immunotherapy.
Neoplasms
Aberrant expression of CPSF1 promotes head and neck squamous cell carcinoma via regulating alternative splicing.
Neoplasms
Aberrant expression of peroxiredoxin 1 and its clinical implications in liver cancer.
Neoplasms
Aberrant expression of PlncRNA-1 and TUG1: potential biomarkers for gastric cancer diagnosis and clinically monitoring cancer progression.
Neoplasms
Aberrant expression of stress-induced phosphoprotein 1 in colorectal cancer and its clinicopathologic significance.
Neoplasms
Aberrant FAM64A mRNA expression is an independent predictor of poor survival in pancreatic cancer.
Neoplasms
Aberrant Hypomethylation of Solute Carrier Family 6 Member 12 Promoter Induces Metastasis of Ovarian Cancer.
Neoplasms
Aberrant KIF20A expression might independently predict poor overall survival and recurrence-free survival of hepatocellular carcinoma.
Neoplasms
Aberrant lactate dehydrogenase A signaling contributes metabolic signatures in pancreatic cancer.
Neoplasms
Aberrant methylation of mutL homolog 1 is associated with increased risk of non-small cell lung cancer.
Neoplasms
Aberrant methylation?mediated decrease of lncRNA HNF1A?AS1 contributes to malignant progression of laryngeal squamous cell carcinoma via EMT.
Neoplasms
Aberrant miR-1246 expression promotes radioresistance in non-small cell lung cancer: a potential prognostic biomarker and radiotherapy sensitization target.
Neoplasms
Aberrant MUC1-TRIM46-KRTCAP2 Chimeric RNAs in High-Grade Serous Ovarian Carcinoma.
Neoplasms
Aberrant NEK2 expression might be an independent predictor for poor recurrence-free survival and overall survival of skin cutaneous melanoma.
Neoplasms
Aberrant over-expression of COX-1 intersects multiple pro-tumorigenic pathways in high-grade serous ovarian cancer.
Neoplasms
Aberrant promoter hypermethylation of PBRM1, BAP1, SETD2, KDM6A and other chromatin-modifying genes is absent or rare in clear cell RCC.
Neoplasms
Aberrant promoter methylation profiles and association with survival in patients with hepatocellular carcinoma.
Neoplasms
Aberrant S100A16 expression might be an independent prognostic indicator of unfavorable survival in non-small cell lung adenocarcinoma.
Neoplasms
Aberrant splicing isoforms detected by full-length transcriptome sequencing as transcripts of potential neoantigens in non-small cell lung cancer.
Neoplasms
Aberrantly Methylated and Expressed Genes as Prognostic Epigenetic Biomarkers for Colon Cancer.
Neoplasms
Aberrantly methylated-differentially expressed genes and pathways in Epstein-Barr virus-associated gastric cancer.
Neoplasms
Aberration hubs in protein interaction networks highlight actionable targets in cancer.
Neoplasms
Aberrations in the Iron Regulatory Gene Signature Are Associated with Decreased Survival in Diffuse Infiltrating Gliomas.
Neoplasms
Aberrations of Chromosomes 1 and 16 in Breast Cancer: A Framework for Cooperation of Transcriptionally Dysregulated Genes.
Neoplasms
Aberrations of m6A regulators are associated with tumorigenesis and metastasis in head and neck squamous cell carcinoma.
Neoplasms
ABL1, Overexpressed in Hepatocellular Carcinomas, Regulates Expression of NOTCH1 and Promotes Development of Liver Tumors in Mice.
Neoplasms
Abnormal Eating Patterns Cause Circadian Disruption and Promote Alcohol-Associated Colon Carcinogenesis.
Neoplasms
Abnormal expression of ABCD3 is an independent prognostic factor for colorectal cancer.
Neoplasms
Abnormal expression of mRNA, microRNA alteration and aberrant DNA methylation patterns in rectal adenocarcinoma.
Neoplasms
Abnormal Expressions of DNA Glycosylase Genes NEIL1, NEIL2, and NEIL3 Are Associated with Somatic Mutation Loads in Human Cancer.
Neoplasms
Abnormally elevated USP37 expression in breast cancer stem cells regulates stemness, epithelial-mesenchymal transition and cisplatin sensitivity.
Neoplasms
Abnormally expressed JunB transactivated by IL-6/STAT3 signaling promotes uveal melanoma aggressiveness via epithelial-mesenchymal transition.
Neoplasms
Abnormally high expression of HOXA2 as an independent factor for poor prognosis in glioma patients.
Neoplasms
Abrogation of USP7 is an alternative strategy to downregulate PD-L1 and sensitize gastric cancer cells to T cells killing.
Neoplasms
Absence of AIF1L contributes to cell migration and a poor prognosis of breast cancer.
Neoplasms
Absent in melanoma 1-like (AIM1L) serves as a novel candidate for overall survival in hepatocellular carcinoma.
Neoplasms
Abundant NDRG2 Expression Is Associated with Aggressiveness and Unfavorable Patients' Outcome in Basal-Like Breast Cancer.
Neoplasms
ACBD3 is up-regulated in gastric cancer and promotes cell cycle G1-to-S transition in an AKT-dependent manner.
Neoplasms
Accessible Pipeline for Translational Research Using TCGA: Examples of Relating Gene Mechanism to Disease-Specific Outcomes.
Neoplasms
Accounting for differential variability in detecting differentially methylated regions.
Neoplasms
Accounting for intraoperative brain shift ascribable to cavity collapse during intracranial tumor resection.
Neoplasms
Accounting for tumor purity improves cancer subtype classification from DNA methylation data.
Neoplasms
Accuracy of The Cancer Genome Atlas Classification vs American Joint Committee on Cancer Classification for Prediction of Metastasis in Patients With Uveal Melanoma.
Neoplasms
Accurate and reproducible invasive breast cancer detection in whole-slide images: A Deep Learning approach for quantifying tumor extent.
Neoplasms
Accurate Segmentation of Nuclear Regions with Multi-Organ Histopathology Images Using Artificial Intelligence for Cancer Diagnosis in Personalized Medicine.
Neoplasms
Accurity: Accurate tumor purity and ploidy inference from tumor-normal WGS data by jointly modelling somatic copy number alterations and heterozygous germline single-nucleotide-variants.
Neoplasms
ACE2 and TMPRSS2 expression by clinical, HLA, immune, and microbial correlates across 34 human cancers and matched normal tissues: implications for SARS-CoV-2 COVID-19.
Neoplasms
ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients.
Neoplasms
ACE: A Workbench using Evolutionary Genetic Algorithms for analyzing association in TCGA Data.
Neoplasms
Acetyl-11-keto-?-boswellic Acid Inhibits Precancerous Breast Lesion MCF-10AT Cells via Regulation of LINC00707/miR-206 that Reduces Estrogen Receptor-?.
Neoplasms
ACLY (ATP Citrate Lyase) Mediates Radioresistance in Head and Neck Squamous Cell Carcinomas and is a Novel Predictive Radiotherapy Biomarker.
Neoplasms
ACOX2 is a prognostic marker and impedes the progression of hepatocellular carcinoma via PPAR? pathway.
Neoplasms
Acquired resistance to PRMT5 inhibition induces concomitant collateral sensitivity to paclitaxel.
Neoplasms
Acquired Uniparental Disomy Regions Are Associated with Disease Outcome in Patients with Oral Cavity and Oropharynx But Not Larynx Cancers.
Neoplasms
Actin-Associated Gene Expression is Associated with Early Regional Metastasis of Tongue Cancer.
Neoplasms
Actin-binding protein Profilin1 promotes aggressiveness of clear cell renal cell carcinoma cells.
Neoplasms
Actin-capping protein CapG is associated with prognosis, proliferation and metastasis in human glioma.
Neoplasms
Actin-Like Protein 8 Promotes the Progression of Triple-Negative Breast Cancer via Activating PI3K/AKT/mTOR Pathway.
Neoplasms
Actin?like protein 8 executes a promoting function in the malignant progression of endometrial cancer: identification of a promising biomarker.
Neoplasms
Actionable gene alterations in an Asian population with triple-negative breast cancer.
Neoplasms
Actionable gene-based classification toward precision medicine in gastric cancer.
Neoplasms
Activation of an endogenous retrovirus-associated long non-coding RNA in human adenocarcinoma.
Neoplasms
Activation of dopamine receptor D1 inhibits glioblastoma tumorigenicity by regulating autophagic activity.
Neoplasms
Activation of EHF via STAT3 phosphorylation by LMP2A in Epstein-Barr virus-positive gastric cancer.
Neoplasms
Activation of insulin-like growth factor 1 receptor in patients with non-small cell lung cancer.
Neoplasms
Activation of the DDR Pathway Leads to the Down-Regulation of the TGF? Pathway and a Better Response to ICIs in Patients With Metastatic Urothelial Carcinoma.
Neoplasms
Activation of the Dickkopf1-CKAP4 pathway is associated with poor prognosis of esophageal cancer and anti-CKAP4 antibody may be a new therapeutic drug.
Neoplasms
Active deformation fields: Dense deformation field estimation for atlas-based segmentation using the active contour framework.
Neoplasms
ActiveDriverDB: human disease mutations and genome variation in post-translational modification sites of proteins.
Neoplasms
Activity of distinct growth factor receptor network components in breast tumors uncovers two biologically relevant subtypes.
Neoplasms
ACTL6A knockdown inhibits cell migration by suppressing the AKT signaling pathway and enhances the sensitivity of glioma cells to temozolomide.
Neoplasms
Acute Tumor Transition Angle on Computed Tomography Predicts Chromosomal Instability Status of Primary Gastric Cancer: Radiogenomics Analysis from TCGA and Independent Validation.
Neoplasms
Acyl-CoA Thioesterase 8 and 11 as Novel Biomarkers for Clear Cell Renal Cell Carcinoma.
Neoplasms
ADAM and ADAMTS Proteins, New Players in the Regulation of Hepatocellular Carcinoma Microenvironment.
Neoplasms
ADAMTS12 acts as a cancer promoter in colorectal cancer via activating the Wnt/?-catenin signaling pathway in vitro.
Neoplasms
ADAMTS12 acts as a tumor microenvironment related cancer promoter in gastric cancer.
Neoplasms
ADAMTS16 mutations sensitize ovarian cancer cells to platinum-based chemotherapy.
Neoplasms
Adaptation of a 3D prostate cancer atlas for transrectal ultrasound guided target-specific biopsy.
Neoplasms
Adaptive Multiview Nonnegative Matrix Factorization Algorithm for Integration of Multimodal Biomedical Data.
Neoplasms
ADAR1 expression is associated with tumour-infiltrating lymphocytes in triple-negative breast cancer.
Neoplasms
Additive effects of variants of unknown significance in replication repair-associated DNA polymerase genes on mutational burden and prognosis across diverse cancers.
Neoplasms
Adenocarcinoma of the Uterine Cervix Shows Impaired Recruitment of cDC1 and CD8+ T Cells and Elevated ?-Catenin Activation Compared with Squamous Cell Carcinoma.
Neoplasms
Adenylate kinase 7 is a prognostic indicator of overall survival in ovarian cancer.
Neoplasms
Adenylosuccinate lyase is oncogenic in colorectal cancer by causing mitochondrial dysfunction and independent activation of NRF2 and mTOR-MYC-axis.
Neoplasms
ADH7, miR-3065 and LINC01133 are associated with cervical cancer progression in different age groups.
Neoplasms
Adjuvant therapy for endometrial cancer in the era of molecular classification: radiotherapy, chemoradiation and novel targets for therapy.
Neoplasms
Adjuvant treatment of endometrial cancer in molecular era: Are we ready to move on?
Neoplasms
Adjuvant Treatment Recommendations in Early-Stage Endometrial Cancer: What Changes With the Introduction of The Integrated Molecular-Based Risk Assessment.
Neoplasms
ADRB1 was identified as a potential biomarker for breast cancer by the co-analysis of tumor mutational burden and immune infiltration.
Neoplasms
Adrenocortical cancer cell line mutational profile reveals aggressive genetic background.
Neoplasms
Adrenocortical Carcinoma Steroid Profiles: In Silico Pan-Cancer Analysis of TCGA Data Uncovers Immunotherapy Targets for Potential Improved Outcomes.
Neoplasms
Adrenocortical tumors have a distinct, long, non-coding RNA expression profile and LINC00271 is downregulated in malignancy.
Neoplasms
Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT.
Neoplasms
Advanced Age Increases Immunosuppression in the Brain and Decreases Immunotherapeutic Efficacy in Subjects with Glioblastoma.
Neoplasms
Advanced Non-Small Cell Lung Cancer Patients With Low Tumor Mutation Burden Might Derive Benefit From Immunotherapy.
Neoplasms
Advances of Fibroblast Growth Factor/Receptor Signaling Pathway in Hepatocellular Carcinoma and its Pharmacotherapeutic Targets.
Neoplasms
Advancing The Cancer Genome Atlas glioma MRI collections with expert segmentation labels and radiomic features.
Neoplasms
Adverse Drug Event-based Stratification of Tumor Mutations: A Case Study of Breast Cancer Patients Receiving Aromatase Inhibitors.
Neoplasms
Adverse Drug Events-based Tumor Stratification for Ovarian Cancer Patients Receiving Platinum Therapy.
Neoplasms
Affinity proteomics for systematic protein profiling of chromosome 21 gene products in human tissues.
Neoplasms
Age and Mutations as Predictors of the Response to Immunotherapy in Head and Neck Squamous Cell Cancer.
Neoplasms
Age at diagnosis, obesity, smoking, and molecular subtypes in muscle-invasive bladder cancer.
Neoplasms
Age, sex, and specific gene mutations affect the effects of immune checkpoint inhibitors in colorectal cancer.
Neoplasms
Age-associated genes in human mammary gland drive human breast cancer progression.
Neoplasms
Age-related copy number variations and expression levels of F-box protein FBXL20 predict ovarian cancer prognosis.
Neoplasms
Age-Related Differences in Molecular Profiles for Immune Checkpoint Blockade Therapy.
Neoplasms
Age-related mutations associated with clonal hematopoietic expansion and malignancies.
Neoplasms
Age-specific genome-wide association study in glioblastoma identifies increased proportion of 'lower grade glioma'-like features associated with younger age.
Neoplasms
Age-specific signatures of glioblastoma at the genomic, genetic, and epigenetic levels.
Neoplasms
Aggregate analysis based on TCGA: TTN missense mutation correlates with favorable prognosis in lung squamous cell carcinoma.
Neoplasms
Aggregation of cohorts for histopathological diagnosis with deep morphological analysis.
Neoplasms
Aggresome-Autophagy Associated Gene HDAC6 Is a Potential Biomarker in Pan-Cancer, Especially in Colon Adenocarcinoma.
Neoplasms
Aggressive and recurrent ovarian cancers upregulate ephrinA5, a non-canonical effector of EphA2 signaling duality.
Neoplasms
Aging-Associated Alterations in Mammary Epithelia and Stroma Revealed by Single-Cell RNA Sequencing.
Neoplasms
Aging-related tumor associated fibroblasts changes could worsen the prognosis of GBM patients.
Neoplasms
AHNAK Nucleoprotein 2 Performs a Promoting Role in the Proliferation and Migration of Uveal Melanoma Cells.
Neoplasms
AICAR and compound C negatively modulate HCC-induced primary human hepatic stellate cell activation in vitro.
Neoplasms
Ajuba overexpression regulates mitochondrial potential and glucose uptake through YAP/Bcl-xL/GLUT1 in human gastric cancer.
Neoplasms
AKNA Is a Potential Prognostic Biomarker in Gastric Cancer and Function as a Tumor Suppressor by Modulating EMT-Related Pathways.
Neoplasms
Akt kinase LANCL2 functions as a key driver in EGFR-mutant lung adenocarcinoma tumorigenesis.
Neoplasms
AKT1 and AKT2 isoforms play distinct roles during breast cancer progression through the regulation of specific downstream proteins.
Neoplasms
AKT3 Is a Novel Regulator of Cancer-Associated Fibroblasts in Head and Neck Squamous Cell Carcinoma.
Neoplasms
ALCHEMIST Trials: A Golden Opportunity to Transform Outcomes in Early-Stage Non-Small Cell Lung Cancer.
Neoplasms
Alcohol and hepatitis virus-dysregulated lncRNAs as potential biomarkers for hepatocellular carcinoma.
Neoplasms
Aldehyde Dehydrogenase 1-related Genes in Triple-negative Breast Cancer Investigated Using Network Analysis.
Neoplasms
Aldehyde oxidase 1 promoted the occurrence and development of colorectal cancer by up-regulation of expression of CD133.
Neoplasms
ALDH1 expression correlates with an epithelial-like phenotype and favorable prognosis in lung adenocarcinoma: a study based on immunohistochemistry and mRNA expression data.
Neoplasms
ALDH5A1 acts as a tumour promoter and has a prognostic impact in papillary thyroid carcinoma.
Neoplasms
Aldo-keto reductases are biomarkers of NRF2 activity and are co-ordinately overexpressed in non-small cell lung cancer.
Neoplasms
ALDOLASE A regulates invasion of bladder cancer cells via E-cadherin-EGFR signaling.
Neoplasms
Aldolase B impairs DNA mismatch repair and induces apoptosis in colon adenocarcinoma.
Neoplasms
ALKAL1 gene silencing prevents colorectal cancer progression via suppressing Sonic Hedgehog (SHH) signaling pathway.
Neoplasms
ALKBH5 gene is a novel biomarker that predicts the prognosis of pancreatic cancer: A retrospective multicohort study.
Neoplasms
All HPV-negative head and neck cancers are not the same: Analysis of the TCGA dataset reveals that anatomical sites have distinct mutation, transcriptome, hypoxia, and tumor microenvironment profiles.
Neoplasms
Allelic selection of amplicons in glioblastoma revealed by combining somatic and germline analysis.
Neoplasms
Alpha 1-antichymotrypsin contributes to stem cell characteristics and enhances tumorigenicity of glioblastoma.
Neoplasms
Alpha-enolase is a potential prognostic marker in clear cell renal cell carcinoma.
Neoplasms
ALPL regulates the aggressive potential of high grade serous ovarian cancer cells via a non-canonical WNT pathway.
Neoplasms
Alteration and prognostic values of collagen gene expression in patients with gastric cancer under different treatments.
Neoplasms
Alteration of Metabolic Conditions Impacts the Regulation of IGF-II/H19 Imprinting Status in Prostate Cancer.
Neoplasms
Alteration of tumor-associated macrophage subtypes mediated by KRT6A in pancreatic ductal adenocarcinoma.
Neoplasms
Alterations in cancer stem-cell marker CD44 expression predict oncologic outcome in soft-tissue sarcomas.
Neoplasms
Alterations in Eukaryotic Elongation Factor complex proteins (EEF1s) in cancer and their implications in epigenetic regulation.
Neoplasms
Alterations in glycolytic/cholesterogenic gene expression in hepatocellular carcinoma.
Neoplasms
Alterations in histone deacetylase 8 lead to cell migration and poor prognosis in breast cancer.
Neoplasms
Alterations in Immune-Related Genes as Potential Marker of Prognosis in Breast Cancer.
Neoplasms
Alterations in the Gut Microbiome and Suppression of Histone Deacetylases by Resveratrol Are Associated with Attenuation of Colonic Inflammation and Protection Against Colorectal Cancer.
Neoplasms
Alterations in TP53 Are a Potential Biomarker of Bladder Cancer Patients Who Benefit From Immune Checkpoint Inhibition.
Neoplasms
Alterations of DNA repair genes in the NCI-60 cell lines and their predictive value for anticancer drug activity.
Neoplasms
Altered editing level of microRNAs is a potential biomarker in lung adenocarcinoma.
Neoplasms
Altered expression and splicing of ESRP1 in malignant melanoma correlates with epithelial-mesenchymal status and tumor-associated immune cytolytic activity.
Neoplasms
Altered gene expression along the glycolysis-cholesterol synthesis axis is associated with outcome in pancreatic cancer.
Neoplasms
Altered gene expression in glycolysis-cholesterol synthesis axis correlates with outcome of triple-negative breast cancer.
Neoplasms
Altered glycosylation in cancer: A promising target for biomarkers and therapeutics.
Neoplasms
Altered interactions between unicellular and multicellular genes drive hallmarks of transformation in a diverse range of solid tumors.
Neoplasms
Altered molecular profile in thyroid cancers from patients affected by the Three Mile Island nuclear accident.
Neoplasms
Altered mRNA expression levels of the major components of sphingolipid metabolism, ceramide synthases and their clinical implication in colorectal cancer.
Neoplasms
Altered PPP2R2A and Cyclin D1 expression defines a subgroup of aggressive luminal-like breast cancer.
Neoplasms
Altered RNA editing in 3' UTR perturbs microRNA-mediated regulation of oncogenes and tumor-suppressors.
Neoplasms
Alternative polyadenylation drives oncogenic gene expression in pancreatic ductal adenocarcinoma.
Neoplasms
Alternative preprocessing of RNA-Sequencing data in The Cancer Genome Atlas leads to improved analysis results.
Neoplasms
Alternative splicing associated with cancer stemness in kidney renal clear cell carcinoma.
Neoplasms
Alternative Splicing Events and Splicing Factors Are Prognostic in Adrenocortical Carcinoma.
Neoplasms
Alternative splicing events implicated in carcinogenesis and prognosis of colorectal cancer.
Neoplasms
Alzheimer Gene BIN1 may Simultaneously Influence Dementia Risk and Androgen Deprivation Therapy Dosage in Prostate Cancer.
Neoplasms
Amino acid metabolism-related gene expression-based risk signature can better predict overall survival for glioma.
Neoplasms
Aminothiol WR1065 induces differential gene expression in the presence of wild-type p53.
Neoplasms
AMP?activated protein kinase family member 5 is an independent prognostic indicator of pancreatic adenocarcinoma: A study based on The Cancer Genome Atlas.
Neoplasms
AMPK Inhibition Suppresses the Malignant Phenotype of Pancreatic Cancer Cells in Part by Attenuating Aerobic Glycolysis.
Neoplasms
Amplification of 1q32.1 refines the molecular classification of endometrial carcinoma.
Neoplasms
Amplification of DNA damage-inducible transcript 3 (DDIT3) is associated with myxoid liposarcoma-like morphology and homologous lipoblastic differentiation in dedifferentiated liposarcoma.
Neoplasms
Amplification of the bromodomain-containing protein 4 gene in ovarian high-grade serous carcinoma is associated with worse prognosis and survival.
Neoplasms
Amplification of the CD24 Gene Is an Independent Predictor for Poor Prognosis of Breast Cancer.
Neoplasms
Amplification of the ch19p13.2 NACC1 locus in ovarian high-grade serous carcinoma.
Neoplasms
Amplification of the NSD3-BRD4-CHD8 pathway in pelvic high-grade serous carcinomas of tubo-ovarian and endometrial origin.
Neoplasms
An 11-lncRNA expression could be potential prognostic biomarkers in head and neck squamous cell carcinoma.
Neoplasms
An 18-gene signature based on glucose metabolism and DNA methylation improves prognostic prediction for urinary bladder cancer.
Neoplasms
An 8 miRNA-Based Risk Score System for Predicting the Prognosis of Patients With Papillary Thyroid Cancer.
Neoplasms
An 8-gene DNA methylation signature predicts the recurrence risk of cervical cancer.
Neoplasms
An 8?gene signature predicts the prognosis of cervical cancer following radiotherapy.
Neoplasms
An aberrant DNA methylation signature for predicting the prognosis of head and neck squamous cell carcinoma.
Neoplasms
An Accurate Tool for Uncovering Cancer Subtypes by Fast Kernel Learning Method to Integrate Multiple Profile Data.
Neoplasms
An aggressive subtype of stage I lung adenocarcinoma with molecular and prognostic characteristics typical of advanced lung cancers.
Neoplasms
An Aging-Related Gene Signature-Based Model for Risk Stratification and Prognosis Prediction in Lung Adenocarcinoma.
Neoplasms
An alternative splicing signature model for predicting hepatocellular carcinoma-specific survival.
Neoplasms
An analysis of mutational signatures of synonymous mutations across 15 cancer types.
Neoplasms
An ancestry informative marker panel design for individual ancestry estimation of Hispanic population using whole exome sequencing data.
Neoplasms
An angiogenesis-related long noncoding RNA signature correlates with prognosis in patients with hepatocellular carcinoma.
Neoplasms
An atlas for clinical target volume definition, including elective nodal irradiation in definitive radiotherapy of biliary cancer.
Neoplasms
An Atlas of the Human Kinome Reveals the Mutational Landscape Underlying Dysregulated Phosphorylation Cascades in Cancer.
Neoplasms
An atlas of the tissue and blood metagenome in cancer reveals novel links between bacteria, viruses and cancer.
Neoplasms
An Atlas of Tumours Involving the Central Nervous System.
Neoplasms
An autophagic gene-based signature to predict the survival of patients with low-grade gliomas.
Neoplasms
An Autophagy-Related Gene Signature Associated With Clinical Prognosis and Immune Microenvironment in Gliomas.
Neoplasms
An autophagy-related long non-coding RNA prognostic signature accurately predicts survival outcomes in bladder urothelial carcinoma patients.
Neoplasms
An autophagy-related long non-coding RNA signature for patients with colorectal cancer.
Neoplasms
An Autophagy-Related Long Noncoding RNA Signature Contributes to Poor Prognosis in Colorectal Cancer.
Neoplasms
An autophagy-related model of 4 key genes for predicting prognosis of patients with laryngeal cancer.
Neoplasms
An autophagy-related prognostic signature associated with immune microenvironment features of uveal melanoma.
Neoplasms
An Effective Hypoxia-Related Long Non-Coding RNAs Assessment Model for Prognosis of Clear Cell Renal Carcinoma.
Neoplasms
An EGFR signature predicts cell line and patient sensitivity to multiple tyrosine kinase inhibitors.
Neoplasms
An Eight-CpG-based Methylation Classifier for Preoperative Discriminating Early and Advanced-Late Stage of Colorectal Cancer.
Neoplasms
An eight-long non-coding RNA signature as a candidate prognostic biomarker for bladder cancer.
Neoplasms
An eight-mRNA signature predicts the prognosis of patients with bladder urothelial carcinoma.
Neoplasms
An eleven gene molecular signature for extra-capsular spread in oral squamous cell carcinoma serves as a prognosticator of outcome in patients without nodal metastases.
Neoplasms
An Empirical Antigen Selection Method Identifies Neoantigens That Either Elicit Broad Antitumor T-cell Responses or Drive Tumor Growth.
Neoplasms
An energy metabolism-based eight-gene signature correlates with the clinical outcome of esophagus carcinoma.
Neoplasms
An epigenetic signature of adhesion molecules predicts poor prognosis of ovarian cancer patients.
Neoplasms
An epithelial-mesenchymal transition-related 5-gene signature predicting the prognosis of hepatocellular carcinoma patients.
Neoplasms
An epithelial-mesenchymal transition-related long non-coding RNA signature to predict overall survival and immune microenvironment in kidney renal clear cell carcinoma.
Neoplasms
An ER-associated miRNA signature predicts prognosis in ER-positive breast cancer.
Neoplasms
An Expression Signature as an Aid to the Histologic Classification of Non-Small Cell Lung Cancer.
Neoplasms
An Immune Cell-Based Signature Associating With EMT Phenotype Predicts Postoperative Overall Survival of ESCC.
Neoplasms
An immune relevant signature for predicting prognoses and immunotherapeutic responses in patients with muscle-invasive bladder cancer (MIBC).
Neoplasms
An immune scores-based nomogram for predicting overall survival in patients with clear cell renal cell carcinoma.
Neoplasms
An immune-centric exploration of BRCA1 and BRCA2 germline mutation related breast and ovarian cancers.
Neoplasms
An Immune-Gene-Based Classifier Predicts Prognosis in Patients With Cervical Squamous Cell Carcinoma.
Neoplasms
An Immune-Related Gene Prognostic Index for Head and Neck Squamous Cell Carcinoma.
Neoplasms
An immune-related gene signature for predicting survival and immunotherapy efficacy in hepatocellular carcinoma.
Neoplasms
An immune-related lncRNA signature for the prognosis of pancreatic adenocarcinoma.
Neoplasms
An immune-related model based on INHBA, JAG2 and CCL19 to predict the prognoses of colon cancer patients.
Neoplasms
An immune-related pseudogene signature to improve prognosis prediction of endometrial carcinoma patients.
Neoplasms
An immune-related seven-lncRNA signature for head and neck squamous cell carcinoma.
Neoplasms
An immune-related signature that to improve prognosis prediction of breast cancer.
Neoplasms
An Immune-Related Six-lncRNA Signature to Improve Prognosis Prediction of Glioblastoma Multiforme.
Neoplasms
An Immunogenomic Investigation of Oral Cavity Squamous Cell Carcinoma in Patients Aged 45?Years and Younger.
Neoplasms
An immunogenomic signature for molecular classification in hepatocellular carcinoma.
Neoplasms
An immunogenomic stratification of colorectal cancer: Implications for development of targeted immunotherapy.
Neoplasms
An Immunogram for an Individualized Assessment of the Antitumor Immune Response in Patients With Hepatocellular Carcinoma.
Neoplasms
An immunohistochemical panel of three small ubiquitin-like modifier genes predicts outcomes of patients with triple-negative breast cancer.
Neoplasms
An improved clear cell renal cell carcinoma stage prediction model based on gene sets.
Neoplasms
An Improved, Assay Platform Agnostic, Absolute Single Sample Breast Cancer Subtype Classifier.
Neoplasms
An independent poor-prognosis subtype of hepatocellular carcinoma based on the tumor microenvironment.
Neoplasms
An individualized gene expression signature for prediction of lung adenocarcinoma metastases.
Neoplasms
An individualized prognostic signature and multi?omics distinction for early stage hepatocellular carcinoma patients with surgical resection.
Neoplasms
An individualized prognostic signature for gastric cancer patients treated with 5-Fluorouracil-based chemotherapy and distinct multi-omics characteristics of prognostic groups.
Neoplasms
An Inflammation-Immunity Classifier of 11 Chemokines for Prediction of Overall Survival in Head and Neck Squamous Cell Carcinoma.
Neoplasms
An Informatics-assisted Label-free Approach for Personalized Tissue Membrane Proteomics: Case Study on Colorectal Cancer.
Neoplasms
An Information Theoretical Multilayer Network Approach to Breast Cancer Transcriptional Regulation.
Neoplasms
An Innovative Immune Score-Based Prognostic Nomogram for Patients with Cervical Cancer.
Neoplasms
An Innovative Prognostic Model Based on Four Genes in Asian Patient with Gastric Cancer.
Neoplasms
An insight into the promoter methylation of PHF20L1 and the gene association with metastasis in breast cancer.
Neoplasms
An integrated analysis for long noncoding RNAs and microRNAs with the mediated competing endogenous RNA network in papillary renal cell carcinoma.
Neoplasms
An integrated analysis of genome-wide DNA methylation and gene expression data in hepatocellular carcinoma.
Neoplasms
An integrated analysis of germline and somatic, genetic and epigenetic alterations at 9p21.3 in glioblastoma.
Neoplasms
An integrated analysis of key microRNAs, regulatory pathways and clinical relevance in bladder cancer.
Neoplasms
An integrated analysis reveals the oncogenic function of lncRNA LINC00511 in human ovarian cancer.
Neoplasms
An Integrated Approach for Identifying Molecular Subtypes in Human Colon Cancer Using Gene Expression Data.
Neoplasms
An integrated approach to biomarker discovery reveals gene signatures highly predictive of cancer progression.
Neoplasms
An integrated autophagy-related gene signature predicts prognosis in human endometrial Cancer.
Neoplasms
An Integrated Autophagy-Related Long Noncoding RNA Signature as a Prognostic Biomarker for Human Endometrial Cancer: A Bioinformatics-Based Approach.
Neoplasms
An integrated bioinformatical analysis to evaluate the role of KIF4A as a prognostic biomarker for breast cancer.
Neoplasms
An integrated bioinformatics analysis of potential therapeutic targets among matrix metalloproteinases in breast cancer.
Neoplasms
An Integrated Bioinformatics Analysis Repurposes an Antihelminthic Drug Niclosamide for Treating HMGA2-Overexpressing Human Colorectal Cancer.
Neoplasms
An integrated classifier improves prognostic accuracy in non-metastatic gastric cancer.
Neoplasms
An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.
Neoplasms
An integrated inspection of the somatic mutations in a lung squamous cell carcinoma using next-generation sequencing.
Neoplasms
An Integrated Meta-Analysis of Secretome and Proteome Identify Potential Biomarkers of Pancreatic Ductal Adenocarcinoma.
Neoplasms
An Integrated Microarray Analysis Reveals Significant Diagnostic and Prognostic Biomarkers in Pancreatic Cancer.
Neoplasms
An Integrated miRNA-lncRNA Signature Predicts the Survival of Stage II Colon Cancer.
Neoplasms
An Integrated Model Based on a Six-Gene Signature Predicts Overall Survival in Patients With Hepatocellular Carcinoma.
Neoplasms
An integrated model of clinical information and gene expression for prediction of survival in ovarian cancer patients.
Neoplasms
An Integrated Molecular Analysis of Lung Adenocarcinomas Identifies Potential Therapeutic Targets among TTF1-Negative Tumors, Including DNA Repair Proteins and Nrf2.
Neoplasms
An Integrated Pan-Cancer Analysis and Structure-Based Virtual Screening of GPR15.
Neoplasms
An integrated prediction model of recurrence in endometrial endometrioid cancers.
Neoplasms
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics.
Neoplasms
An Integrated Three-Long Non-coding RNA Signature Predicts Prognosis in Colorectal Cancer Patients.
Neoplasms
An integration architecture designed to deal with the issues of biological scope, scale and complexity.
Neoplasms
An integrative analysis of the age-associated multi-omic landscape across cancers.
Neoplasms
An Integrative Analysis of Transcriptome and Epigenome Features of ASCL1-Positive Lung Adenocarcinomas.
Neoplasms
An Integrative Analysis Reveals the Underlying Association Between CTNNB1 Mutation and Immunotherapy in Hepatocellular Carcinoma.
Neoplasms
An integrative characterization of recurrent molecular aberrations in glioblastoma genomes.
Neoplasms
An Integrative Computational Approach Based on Expression Similarity Signatures to Identify Protein-Protein Interaction Networks in Female-Specific Cancers.
Neoplasms
An Integrative Gene Expression and Mathematical Flux Balance Analysis Identifies Targetable Redox Vulnerabilities in Melanoma Cells.
Neoplasms
An integrative genomic approach identifies p73 and p63 as activators of miR-200 microRNA family transcription.
Neoplasms
An integrative genomics approach for identifying novel functional consequences of PBRM1 truncated mutations in clear cell renal cell carcinoma (ccRCC).
Neoplasms
An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma.
Neoplasms
An Integrative Model of miRNA and mRNA Expression Signature for Patients of Breast Invasive Carcinoma with Radiotherapy Prognosis.
Neoplasms
An integrative somatic mutation analysis to identify pathways linked with survival outcomes across 19 cancer types.
Neoplasms
An interactive network of alternative splicing events with prognostic value in geriatric lung adenocarcinoma via the regulation of splicing factors.
Neoplasms
An investigation of the association of genetic susceptibility risk with somatic mutation burden in breast cancer.
Neoplasms
An m6A-Related Prognostic Biomarker Associated With the Hepatocellular Carcinoma Immune Microenvironment.
Neoplasms
An mRNA characterization model predicting survival in patients with invasive breast cancer based on The Cancer Genome Atlas database.
Neoplasms
An N6-Methyladenosine-Related Gene Set Variation Score as a Prognostic Tool for Lung Adenocarcinoma.
Neoplasms
An Online Atlas for Exploring Spatio-Temporal Patterns of Cancer Mortality (1972-2011) and Incidence (1995-2008) in Taiwan.
Neoplasms
An ontology-based method for assessing batch effect adjustment approaches in heterogeneous datasets.
Neoplasms
An optimal prognostic model based on gene expression for clear cell renal cell carcinoma.
Neoplasms
An oral keratinocyte life cycle model identifies novel host genome regulation by human papillomavirus 16 relevant to HPV positive head and neck cancer.
Neoplasms
An order independent algorithm for inferring gene regulatory network using quantile value for conditional independence tests.
Neoplasms
An Original Ferroptosis-Related Gene Signature Effectively Predicts the Prognosis and Clinical Status for Colorectal Cancer Patients.
Neoplasms
An overactive neddylation pathway serves as a therapeutic target and MLN4924 enhances the anticancer activity of cisplatin in pancreatic cancer.
Neoplasms
An RNA-sequencing-based transcriptome for a significantly prognostic novel driver signature identification in bladder urothelial carcinoma.
Neoplasms
Analyses of expressions and prognostic values of Polo-like kinases in non-small cell lung cancer.
Neoplasms
Analysis and comparison of somatic mutations in paired primary and recurrent epithelial ovarian cancer samples.
Neoplasms
Analysis and Validation of circRNA-miRNA Network in Regulating m6A RNA Methylation Modulators Reveals CircMAP2K4/miR-139-5p/YTHDF1 Axis Involving the Proliferation of Hepatocellular Carcinoma.
Neoplasms
Analysis of 2019-nCoV receptor ACE2 expression in different tissues and its significance study.
Neoplasms
Analysis of 7,815 cancer exomes reveals associations between mutational processes and somatic driver mutations.
Neoplasms
Analysis of ALK, IDH1, IDH2 and MMP8 somatic mutations in differentiated thyroid cancers.
Neoplasms
Analysis of bladder cancer tumor CpG methylation and gene expression within The Cancer Genome Atlas identifies
Neoplasms
Analysis of Bulk RNA Sequencing Data Reveals Novel Transcription Factors Associated With Immune Infiltration Among Multiple Cancers.
Neoplasms
Analysis of carcinogenic signaling networks in endometrial cancer identifies RAB17 as a potential target.
Neoplasms
Analysis of Cellular Feature Differences of Astrocytomas with Distinct Mutational Profiles Using Digitized Histopathology Images.
Neoplasms
Analysis of chemotherapeutic response in ovarian cancers using publicly available high-throughput data.
Neoplasms
Analysis of Class I Major Histocompatibility Complex Gene Transcription in Human Tumors Caused by Human Papillomavirus Infection.
Neoplasms
Analysis of clinical characteristics of macrophage capping protein (CAPG) gene expressed in glioma based on TCGA data and clinical experiments.
Neoplasms
Analysis of clinical significance and prospective molecular mechanism of main elements of the JAK/STAT pathway in hepatocellular carcinoma.
Neoplasms
Analysis of Collagen type X alpha 1 (COL10A1) expression and prognostic significance in gastric cancer based on bioinformatics.
Neoplasms
Analysis of Colorectal Cancer-Associated Alternative Splicing Based on Transcriptome.
Neoplasms
Analysis of competing endogenous RNA network to identify the key RNAs associated with prostate adenocarcinoma.
Neoplasms
Analysis of copy number loss of the ErbB4 receptor tyrosine kinase in glioblastoma.
Neoplasms
Analysis of cyclin E co-expression genes reveals nuclear transcription factor Y subunit alpha is an oncogene in gastric cancer.
Neoplasms
Analysis of Cyclin-Dependent Kinase 1 as an Independent Prognostic Factor for Gastric Cancer Based on Statistical Methods.
Neoplasms
Analysis of differentially expressed genes in hepatocellular carcinoma using cDNA arrays.
Neoplasms
Analysis of differentially expressed genes, clinical value and biological pathways in prostate cancer.
Neoplasms
Analysis of DNA methylation and gene expression in radiation-resistant head and neck tumors.
Neoplasms
Analysis of DNA methylation-driven genes for predicting the prognosis of patients with colorectal cancer.
Neoplasms
Analysis of Expression and Its Clinical Significance of the Secreted Phosphoprotein 1 in Lung Adenocarcinoma.
Neoplasms
Analysis of gene co?expression network reveals prognostic significance of CNFN in patients with head and neck cancer.
Neoplasms
Analysis of gene expression of secreted factors associated with breast cancer metastases in breast cancer subtypes.
Neoplasms
Analysis of Genes Involved in Ulcerative Colitis Activity and Tumorigenesis Through Systematic Mining of Gene Co-expression Networks.
Neoplasms
Analysis of Genetic Alteration Signatures and Prognostic Values of m6A Regulatory Genes in Head and Neck Squamous Cell Carcinoma.
Neoplasms
Analysis of Genetic Alterations Related to DNA Methylation in Testicular Germ Cell Tumors Based on Data Mining.
Neoplasms
Analysis of Genomes and Transcriptomes of Hepatocellular Carcinomas Identifies Mutations and Gene Expression Changes in the Transforming Growth Factor beta Pathway Short title: Prognostic significance of TGF-? signature in liver cancer.
Neoplasms
Analysis of genomic and transcriptomic variations as prognostic signature for lung adenocarcinoma.
Neoplasms
Analysis of immune subtypes based on immunogenomic profiling identifies prognostic signature for cutaneous melanoma.
Neoplasms
Analysis of immune-related signatures of colorectal cancer identifying two different immune phenotypes: Evidence for immune checkpoint inhibitor therapy.
Neoplasms
Analysis of immune-related signatures of lung adenocarcinoma identified two distinct subtypes: implications for immune checkpoint blockade therapy.
Neoplasms
Analysis of interactions between the epigenome and structural mutability of the genome using Genboree Workbench tools.
Neoplasms
Analysis of Interleukin-1 Signaling Alterations of Colon Adenocarcinoma Identified Implications for Immunotherapy.
Neoplasms
Analysis of key genes and signaling pathways involved in Helicobacter pylori-associated gastric cancer based on The Cancer Genome Atlas database and RNA sequencing data.
Neoplasms
Analysis of Key Genes Regulating the Warburg Effect in Patients with Gastrointestinal Cancers and Selective Inhibition of This Metabolic Pathway in Liver Cancer Cells.
Neoplasms
Analysis of key genes reveal lysine demethylase 5B promotes prostate cancer progression.
Neoplasms
Analysis of LAGEs Family Gene Signature and Prognostic Relevance in Breast Cancer.
Neoplasms
Analysis of lncRNA-Associated ceRNA Network Reveals Potential lncRNA Biomarkers in Human Colon Adenocarcinoma.
Neoplasms
Analysis of lncRNA-Mediated ceRNA Crosstalk and Identification of Prognostic Signature in Head and Neck Squamous Cell Carcinoma.
Neoplasms
Analysis of m6A RNA Methylation-Related Genes in Liver Hepatocellular Carcinoma and Their Correlation with Survival.
Neoplasms
Analysis of m6A-Related Signatures in the Tumor Immune Microenvironment and Identification of Clinical Prognostic Regulators in Adrenocortical Carcinoma.
Neoplasms
Analysis of Matched Tumor and Normal Profiles Reveals Common Transcriptional and Epigenetic Signals Shared across Cancer Types.
Neoplasms
Analysis of methylation-driven genes for predicting the prognosis of patients with head and neck squamous cell carcinoma.
Neoplasms
Analysis of microRNA expression profiles reveals a 5?microRNA prognostic signature for predicting overall survival time in patients with gastric adenocarcinoma.
Neoplasms
Analysis of morphological characteristics of IDH-mutant/wildtype brain tumors using whole-lesion phenotype analysis.
Neoplasms
Analysis of mRNA expression differences in bladder cancer metastasis based on TCGA datasets.
Neoplasms
Analysis of mutational signatures in primary and metastatic endometrial cancer reveals distinct patterns of DNA repair defects and shifts during tumor progression.
Neoplasms
Analysis of NTRK Alterations in Pan-Cancer Adult and Pediatric Malignancies: Implications for NTRK-Targeted Therapeutics.
Neoplasms
Analysis of Over 140,000 European Descendants Identifies Genetically Predicted Blood Protein Biomarkers Associated with Prostate Cancer Risk.
Neoplasms
Analysis of PD-1 related immune transcriptional profile in different cancer types.
Neoplasms
Analysis of PMEPA1 Isoforms (a and b) as Selective Inhibitors of Androgen and TGF-? Signaling Reveals Distinct Biological and Prognostic Features in Prostate Cancer.
Neoplasms
Analysis of prognostic genes in the tumor microenvironment of lung adenocarcinoma.
Neoplasms
Analysis of renal cancer cell lines from two major resources enables genomics-guided cell line selection.
Neoplasms
Analysis of RNA expression of normal and cancer tissues reveals high correlation of COP9 gene expression with respiratory chain complex components.
Neoplasms
Analysis of single nucleotide variants of HFE gene and association to survival in The Cancer Genome Atlas GBM data.
Neoplasms
Analysis of single-cell transcriptomes links enrichment of olfactory receptors with cancer cell differentiation status and prognosis.
Neoplasms
Analysis of TGCA data reveals genetic and epigenetic changes and biological function of MUC family genes in colorectal cancer.
Neoplasms
Analysis of the "centrosome-ome" identifies MCPH1 deletion as a cause of centrosome amplification in human cancer.
Neoplasms
Analysis of the breast cancer methylome using formalin-fixed paraffin-embedded tumour.
Neoplasms
Analysis of the cancer genome atlas (TCGA) database identifies an inverse relationship between interleukin-13 receptor ?1 and ?2 gene expression and poor prognosis and drug resistance in subjects with glioblastoma multiforme.
Neoplasms
Analysis of the Cancer Genome Atlas Data Reveals Novel Putative ncRNAs Targets in Hepatocellular Carcinoma.
Neoplasms
Analysis of the cancer genome atlas data to determine the correlation between PROX1 and TERT in hepatocellular carcinoma.
Neoplasms
Analysis of The Cancer Genome Atlas sequencing data reveals novel properties of the human papillomavirus 16 genome in head and neck squamous cell carcinoma.
Neoplasms
Analysis of the Circadian Regulation of Cancer Hallmarks by a Cross-Platform Study of Colorectal Cancer Time-Series Data Reveals an Association with Genes Involved in Huntington's Disease.
Neoplasms
Analysis of the clinicopathological characteristics, genetic phenotypes, and prognostic of pure mucinous adenocarcinoma.
Neoplasms
Analysis of the EGFR Amplification and CDKN2A Deletion Regulated Transcriptomic Signatures Reveals the Prognostic Significance of SPATS2L in Patients With Glioma.
Neoplasms
Analysis of the exome aggregation consortium (ExAC) database suggests that the BAP1-tumor predisposition syndrome is underreported in cancer patients.
Neoplasms
Analysis of the expression and potential molecular mechanism of interleukin-1 receptor antagonist (IL1RN) in papillary thyroid cancer via bioinformatics methods.
Neoplasms
Analysis of the HNF4A isoform-regulated transcriptome identifies CCL15 as a downstream target in gastric carcinogenesis.
Neoplasms
Analysis of the inhibitors of apoptosis identifies BIRC3 as a facilitator of malignant progression in glioma.
Neoplasms
Analysis of the molecular nature associated with microsatellite status in colon cancer identifies clinical implications for immunotherapy.
Neoplasms
Analysis of the PD-1 Ligands Among Gastrointestinal Cancer Patients: Focus on Cancer Immunity.
Neoplasms
Analysis of the Prognostic Value and Potential Molecular Mechanisms of TREM-1 Overexpression in Papillary Thyroid Cancer via Bioinformatics Methods.
Neoplasms
Analysis of the Role and Regulation Mechanism of hsa-miR-147b in Lung Squamous Cell Carcinoma Based on The Cancer Genome Atlas Database.
Neoplasms
Analysis of the Role and Regulatory Mechanism of hsa-miR-504 in Cervical Cancer Based on The Cancer Genome Atlas Database.
Neoplasms
Analysis of the TCGA Dataset Reveals that Subsites of Laryngeal Squamous Cell Carcinoma are Molecularly Distinct.
Neoplasms
Analysis of tumor mutation burden combined with immune infiltrates in endometrial cancer.
Neoplasms
Analysis of tumor-infiltrating NK and T cells highlights IL-15 stimulation and TIGIT blockade as a combination immunotherapy strategy for soft tissue sarcomas.
Neoplasms
Analytical Platforms 3: Processing Samples via the RPPA Pipeline to Generate Large-Scale Data for Clinical Studies.
Neoplasms
Analyzing cancer gene expression data through the lens of normal tissue-specificity.
Neoplasms
Analyzing the characteristics of immune cell infiltration in lung adenocarcinoma via bioinformatics to predict the effect of immunotherapy.
Neoplasms
Analyzing the disease module associated with osteosarcoma via a network- and pathway-based approach.
Neoplasms
Analyzing the influence of IL18 in regulation of YAP1 in breast oncogenesis using cBioportal.
Neoplasms
Analyzing the LncRNA, miRNA, and mRNA Regulatory Network in Prostate Cancer with Bioinformatics Software.
Neoplasms
Anatomical specificity of O6-methylguanine DNA methyltransferase protein expression in glioblastomas.
Neoplasms
Ancestry-associated transcriptomic profiles of breast cancer in patients of African, Arab, and European ancestry.
Neoplasms
Androgen attenuates the inactivating phospho-Ser-127 modification of yes-associated protein 1 (YAP1) and promotes YAP1 nuclear abundance and activity.
Neoplasms
Androgen Receptor mRNA Expression in Urothelial Carcinoma of the Bladder: A Retrospective Analysis of Two Independent Cohorts.
Neoplasms
Androgen Triggers the Pro-Migratory CXCL12/CXCR4 Axis in AR-Positive Breast Cancer Cell Lines: Underlying Mechanism and Possible Implications for the Use of Aromatase Inhibitors in Breast Cancer.
Neoplasms
Angiogenesis-Related Gene Expression Signatures Predicting Prognosis in Gastric Cancer Patients.
Neoplasms
Angiogenesis-Related Immune Signatures Correlate With Prognosis, Tumor Microenvironment, and Therapeutic Sensitivity in Hepatocellular Carcinoma.
Neoplasms
Angiogenic Factor with G Patch and FHA Domains 1 (AGGF1) Acts as Diagnostic Biomarker and Adverse Prognostic Factor of Hepatocellular Carcinoma (HCC): Evidence from Bioinformatic Analysis.
Neoplasms
Angiogenic gene signature in human pancreatic cancer correlates with TGF-beta and inflammatory transcriptomes.
Neoplasms
Angiopoietin pathway gene expression associated with poor breast cancer survival.
Neoplasms
Angiosarcoma heterogeneity and potential therapeutic vulnerability to immune checkpoint blockade: insights from genomic sequencing.
Neoplasms
ANGPTL1 is a potential biomarker for differentiated thyroid cancer diagnosis and recurrence.
Neoplasms
ANGPTL3 inhibits renal cell carcinoma metastasis by inhibiting VASP phosphorylation.
Neoplasms
Anillin is a prognostic factor and is correlated with genovariation in pancreatic cancer based on databases analysis.
Neoplasms
ANK1 Methylation regulates expression of MicroRNA-486-5p and discriminates lung tumors by histology and smoking status.
Neoplasms
ANLN and KDR Are Jointly Prognostic of Breast Cancer Survival and Can Be Modulated for Triple Negative Breast Cancer Control.
Neoplasms
ANLN and TLE2 in Muscle Invasive Bladder Cancer: A Functional and Clinical Evaluation Based on In Silico and In Vitro Data.
Neoplasms
Anlotinib as a promising inhibitor on tumor growth of oral squamous cell carcinoma through cell apoptosis and mitotic catastrophe.
Neoplasms
Annexin A1 Expression Is Associated with Epithelial-Mesenchymal Transition (EMT), Cell Proliferation, Prognosis, and Drug Response in Pancreatic Cancer.
Neoplasms
Annexin A1 Preferentially Predicts Poor Prognosis of Basal-Like Breast Cancer Patients by Activating mTOR-S6 Signaling.
Neoplasms
Annexin A2 and S100A10 are independent predictors of serous ovarian cancer outcome.
Neoplasms
Annexin A2-STAT3-Oncostatin M receptor axis drives phenotypic and mesenchymal changes in glioblastoma.
Neoplasms
Antagonistic Effects of p53 and HIF1A on microRNA-34a Regulation of PPP1R11 and STAT3 and Hypoxia-induced Epithelial to Mesenchymal Transition in Colorectal Cancer Cells.
Neoplasms
Anti-metastatic effect of metformin via repression of interleukin 6-induced epithelial-mesenchymal transition in human colon cancer cells.
Neoplasms
Anti-parasite drug ivermectin can suppress ovarian cancer by regulating lncRNA-EIF4A3-mRNA axes.
Neoplasms
Anti-tumor effect of CDK inhibitors on CDKN2A-defective squamous cell lung cancer cells.
Neoplasms
Antibodies for profiling the human proteome-The Human Protein Atlas as a resource for cancer research.
Neoplasms
Antimalarial drug pyrimethamine plays a dual role in anti-tumor proliferation and metastasis through targeting DHFR and TP.
Neoplasms
Antimetastatic effect of salvicine on human breast cancer MDA-MB-435 orthotopic xenograft is closely related to Rho-dependent pathway.
Neoplasms
Antimetastatic effects of norcantharidin on hepatocellular carcinoma cells by up-regulating FAM46C expression.
Neoplasms
Antineoplastic effects of selective CDK9 inhibition with atuveciclib on cancer stem-like cells in triple-negative breast cancer.
Neoplasms
Antioxidant Gene Signature Impacts the Immune Infiltration and Predicts the Prognosis of Kidney Renal Clear Cell Carcinoma.
Neoplasms
Antisense targeting of CD47 enhances human cytotoxic T-cell activity and increases survival of mice bearing B16 melanoma when combined with anti-CTLA4 and tumor irradiation.
Neoplasms
Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma.
Neoplasms
Antiviral T Cell Receptor Complementarity Determining Region-3 Sequences Are Associated with a Worse Cancer Outcome: A Pancancer Analysis.
Neoplasms
ANXA1 as a Prognostic and Immune Microenvironmental Marker for Gliomas Based on Transcriptomic Analysis and Experimental Validation.
Neoplasms
ANXA4 Activates JAK-STAT3 Signaling by Interacting with ANXA1 in Basal-Like Breast Cancer.
Neoplasms
AP-2? expression in papillary thyroid carcinoma predicts tumor progression and poor prognosis.
Neoplasms
AP001056.1, A Prognosis-Related Enhancer RNA in Squamous Cell Carcinoma of the Head and Neck.
Neoplasms
APELA promotes tumour growth and cell migration in ovarian cancer in a p53-dependent manner.
Neoplasms
Apigenin inhibits epithelial-mesenchymal transition of human colon cancer cells through NF-?B/Snail signaling pathway.
Neoplasms
APOBEC-mediated cytosine deamination links PIK3CA helical domain mutations to human papillomavirus-driven tumor development.
Neoplasms
APOBEC-mediated mutagenesis in urothelial carcinoma is associated with improved survival, mutations in DNA damage response genes, and immune response.
Neoplasms
APOBEC3B expression in breast cancer cell lines and tumors depends on the estrogen receptor status.
Neoplasms
APOBEC3B expression in breast cancer reflects cellular proliferation, while a deletion polymorphism is associated with immune activation.
Neoplasms
Apolipoprotein C1 (APOC1) promotes tumor progression via MAPK signaling pathways in colorectal cancer.
Neoplasms
ApoM is an important potential protective factor in the pathogenesis of primary liver cancer.
Neoplasms
Apoptosis signaling molecules as treatment targets in head and neck squamous cell carcinoma.
Neoplasms
APPL1 promotes the migration of gastric cancer cells by regulating Akt2 phosphorylation.
Neoplasms
Application of a co?expression network for the analysis of aggressive and non?aggressive breast cancer cell lines to predict the clinical outcome of patients.
Neoplasms
Application of a Neural Network Whole Transcriptome-Based Pan-Cancer Method for Diagnosis of Primary and Metastatic Cancers.
Neoplasms
Application of amplicon-based targeted sequencing with the molecular barcoding system to detect uncommon minor EGFR mutations in patients with treatment-naïve lung adenocarcinoma.
Neoplasms
Application of ARID1A to murine formalin-fixed paraffin embedded tissue using immunohistochemistry.
Neoplasms
Application of comparative genomic hybridization, spectral karyotyping, and microarray analysis in the identification of subtype-specific patterns of genomic changes in rhabdomyosarcoma.
Neoplasms
Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma.
Neoplasms
Application of Machine Learning in Developing a Novelty Five-Pseudogene Signature to Predict Prognosis of Head and Neck Squamous Cell Carcinoma: A New Aspect of "Junk Genes" in Biomedical Practice.
Neoplasms
Application of the differential hybridization of Atlas Human expression arrays technique in the identification of differentially expressed genes in human glioblastoma multiforme tumor tissue.
Neoplasms
Application of the High-throughput TAB-Array for the Discovery of Novel 5-Hydroxymethylcytosine Biomarkers in Pancreatic Ductal Adenocarcinoma.
Neoplasms
Applying graph database technology for analyzing perturbed co-expression networks in cancer.
Neoplasms
AR negative triple negative or "quadruple negative" breast cancers in African American women have an enriched basal and immune signature.
Neoplasms
Are Immunohistochemical Markers Useful in Phenotypic Gastric Cancer Classification?
Neoplasms
ARF6, induced by mutant Kras, promotes proliferation and Warburg effect in pancreatic cancer.
Neoplasms
ARHGAP10, downregulated in ovarian cancer, suppresses tumorigenicity of ovarian cancer cells.
Neoplasms
ARHGAP25 Inhibits Pancreatic Adenocarcinoma Growth by Suppressing Glycolysis via AKT/mTOR Pathway.
Neoplasms
ARHGAP30 suppressed lung cancer cell proliferation, migration, and invasion through inhibition of the Wnt/?-catenin signaling pathway.
Neoplasms
ARHGAP6 Promotes Apoptosis and Inhibits Glycolysis in Lung Adenocarcinoma Through STAT3 Signaling Pathway.
Neoplasms
ARID1A and CTNNB1/?-Catenin Molecular Status Affects the Clinicopathologic Features and Prognosis of Endometrial Carcinoma: Implications for an Improved Surrogate Molecular Classification.
Neoplasms
ARID1A deficiency in EBV-positive gastric cancer is partially regulated by EBV-encoded miRNAs, but not by DNA promotor hypermethylation.
Neoplasms
ARID1A loss correlates with mismatch repair deficiency and intact p53 expression in high-grade endometrial carcinomas.
Neoplasms
ARID1A Mutation May Define an Immunologically Active Subgroup in Patients with Microsatellite Stable Colorectal Cancer.
Neoplasms
ARNT-dependent CCR8 reprogrammed LDH isoform expression correlates with poor clinical outcomes of prostate cancer.
Neoplasms
Arpp19 Promotes Myc and Cip2a Expression and Associates with Patient Relapse in Acute Myeloid Leukemia.
Neoplasms
Array-based analysis of gene expression in childhood acute lymphoblastic leukemia.
Neoplasms
Arthur Purdy Stout (1885-1967), a pioneer of surgical pathology: a survey of his Notes on the Education of an "Oncological" Surgical Pathologist.
Neoplasms
Artificial intelligence grading of breast cancer: a promising method to refine prognostic classification for management precision.
Neoplasms
Artificial Intelligence-based Detection of FGFR3 Mutational Status Directly from Routine Histology in Bladder Cancer: A Possible Preselection for Molecular Testing?
Neoplasms
Artificial neural networks for multi-omics classifications of hepato-pancreato-biliary cancers: towards the clinical application of genetic data.
Neoplasms
Aryl hydrocarbon receptor nuclear translocator promotes the proliferation and invasion of clear cell renal cell carcinoma cells potentially by affecting the glycolytic pathway.
Neoplasms
ASH2L drives proliferation and sensitivity to bleomycin and other genotoxins in Hodgkin's lymphoma and testicular cancer cells.
Neoplasms
ASPP1 deficiency promotes epithelial-mesenchymal transition, invasion and metastasis in colorectal cancer.
Neoplasms
Assembly-based inference of B-cell receptor repertoires from short read RNA sequencing data with V'DJer.
Neoplasms
Assessing breast cancer cell lines as tumour models by comparison of mRNA expression profiles.
Neoplasms
Assessing microenvironment immunogenicity using tumor specimen exomes: Co-detection of TcR-?/? V(D)J recombinations correlates with PD-1 expression.
Neoplasms
Assessing reliability of intra-tumor heterogeneity estimates from single sample whole exome sequencing data.
Neoplasms
Assessing reproducibility and veracity across machine learning techniques in biomedicine: A case study using TCGA data.
Neoplasms
Assessing the clinical use of clear cell renal cell carcinoma molecular subtypes identified by RNA expression analysis.
Neoplasms
Assessing the clinical utility of cancer genomic and proteomic data across tumor types.
Neoplasms
Assessing the efficacy of androgen receptor and Sox10 as independent markers of the triple-negative breast cancer subtype by transcriptome profiling.
Neoplasms
Assessing the miRNA sponge potential of RUNX1T1 in t(8;21) acute myeloid leukemia.
Neoplasms
Assessing the Relationship Between Leukocyte Telomere Length and Cancer Risk/Mortality in UK Biobank and TCGA Datasets With the Genetic Risk Score and Mendelian Randomization Approaches.
Neoplasms
Assessment for prognostic value of differentially expressed genes in immune microenvironment of clear cell renal cell carcinoma.
Neoplasms
Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non-Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene Panel.
Neoplasms
Assessment of circularized E7 RNA, GLUT1, and PD-L1 in anal squamous cell carcinoma.
Neoplasms
Assessment of intra-tumoural colorectal cancer prognostic biomarkers using RNA in situ hybridisation.
Neoplasms
Assessment of intratumoral heterogeneity with mutations and gene expression profiles.
Neoplasms
Assessment of isochromosome 12p and 12p abnormalities in germ cell tumors using fluorescence in situ hybridization, single-nucleotide polymorphism arrays, and next-generation sequencing/mate-pair sequencing.
Neoplasms
Assessment of Potential Prognostic Value of Peroxiredoxin 1 in Oral Squamous Cell Carcinoma.
Neoplasms
Assessment of prognostic implication of a panel of oncogenes in bladder cancer and identification of a 3-gene signature associated with recurrence and progression risk in non-muscle-invasive bladder cancer.
Neoplasms
Assessment of proliferation in breast cancer: cell cycle or mitosis? An observational study.
Neoplasms
Assessment of Renal Cell Carcinoma by Texture Analysis in Clinical Practice: A Six-Site, Six-Platform Analysis of Reliability.
Neoplasms
Assessment of the expression of the immune checkpoint molecules PD-1, CTLA4, TIM-3 and LAG-3 across different cancers in relation to treatment response, tumor-infiltrating immune cells and survival.
Neoplasms
Associating lncRNAs with small molecules via bilevel optimization reveals cancer-related lncRNAs.
Neoplasms
Association Analysis between Body Mass Index and Genomic DNA Methylation across 15 Major Cancer Types.
Neoplasms
Association analysis of a chemo-response signature identified within The Cancer Genome Atlas aimed at predicting genetic risk for chemo-response in ovarian cancer.
Neoplasms
Association Analysis of Driver Gene-Related Genetic Variants Identified Novel Lung Cancer Susceptibility Loci with 20,871 Lung Cancer Cases and 15,971 Controls.
Neoplasms
Association and clinical implication of the USP10 and MSH2 proteins in non-small cell lung cancer.
Neoplasms
Association between angiogenesis and cytotoxic signatures in the tumor microenvironment of gastric cancer.
Neoplasms
Association between breast cancer risk and disease aggressiveness: Characterizing underlying gene expression patterns.
Neoplasms
Association between copy-number alteration of +20q, -14q and -18p and cross-sensitivity to tyrosine kinase inhibitors in clear-cell renal cell carcinoma.
Neoplasms
Association between dense PAX1 promoter methylation and HPV16 infection in cervical squamous epithelial neoplasms of Xin Jiang Uyghur and Han women.
Neoplasms
Association between differential gene expression and body mass index among endometrial cancers from The Cancer Genome Atlas Project.
Neoplasms
Association between DNA damage repair gene somatic mutations and immune-related gene expression in ovarian cancer.
Neoplasms
Association between endometrial cancer risk classification and gene expression in the cancer genome atlas database.
Neoplasms
Association between expression of random gene sets and survival is evident in multiple cancer types and may be explained by sub-classification.
Neoplasms
Association between FAT1 mutation and overall survival in patients with human papillomavirus-negative head and neck squamous cell carcinoma.
Neoplasms
Association Between FSIP2 Mutation and an Improved Efficacy of Immune Checkpoint Inhibitors in Patients With Skin Cutaneous Melanoma.
Neoplasms
Association between Genetic and Immunological Background of Hepatocellular Carcinoma and Expression of Programmed Cell Death-1.
Neoplasms
Association Between Genomic Metrics and Immune Infiltration in Triple-Negative Breast Cancer.
Neoplasms
Association between histone lysine methyltransferase KMT2C mutation and clinicopathological factors in breast cancer.
Neoplasms
Association Between Hypoxia-Inducible Factor-2? (HIF-2?) Expression and Colorectal Cancer and Its Prognostic Role: a Systematic Analysis.
Neoplasms
Association between immunotherapy biomarkers and glucose metabolism from F-18 FDG PET.
Neoplasms
Association between loss of Y chromosome and poor prognosis in male head and neck squamous cell carcinoma.
Neoplasms
Association between Morphologic CT Imaging Traits and Prognostically Relevant Gene Signatures in Women with High-Grade Serous Ovarian Cancer: A Hypothesis-generating Study.
Neoplasms
Association between plasma diacetylspermine and tumor spermine synthase with outcome in triple negative breast cancer.
Neoplasms
Association Between Sex and Immune-Related Adverse Events During Immune Checkpoint Inhibitor Therapy.
Neoplasms
Association between small heat shock protein B11 and the prognostic value of MGMT promoter methylation in patients with high-grade glioma.
Neoplasms
Association Between the Microsatellite Instability Status and the Efficacy of Postoperative Adjuvant Chemoradiotherapy in Patients With Gastric Cancer.
Neoplasms
Association between tumor architecture derived from generalized Q-space MRI and survival in glioblastoma.
Neoplasms
Association between tumor mutation burden and immune infiltration in ovarian cancer.
Neoplasms
Association of a cytarabine chemosensitivity related gene expression signature with survival in cytogenetically normal acute myeloid leukemia.
Neoplasms
Association of a novel endometrial cancer biomarker panel with prognostic risk, platinum insensitivity, and targetable therapeutic options.
Neoplasms
Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer.
Neoplasms
Association of BAX hypermethylation with coronary heart disease is specific to individuals aged over 70.
Neoplasms
Association of BRCA1- and BRCA2-deficiency with mutation burden, expression of PD-L1/PD-1, immune infiltrates, and T cell-inflamed signature in breast cancer.
Neoplasms
Association of C8orf4 expression with its methylation status, aberrant ?-catenin expression, and the development of cervical squamous cell carcinoma.
Neoplasms
Association of cancer mortality with postdiagnosis overweight and obesity using body mass index.
Neoplasms
Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer.
Neoplasms
Association of Circadian Clock Gene Expression with Glioma Tumor Microenvironment and Patient Survival.
Neoplasms
Association of Copy Number Variation Signature and Survival in Patients With Serous Ovarian Cancer.
Neoplasms
Association of CpG island methylator phenotype and EREG/AREG methylation and expression in colorectal cancer.
Neoplasms
Association of CXCL13 and Immune Cell Infiltration Signature in Clear Cell Renal Cell Carcinoma.
Neoplasms
Association of cyclin-dependent kinase inhibitor 2B antisense RNA 1 gene expression and rs2383207 variant with breast cancer risk and survival.
Neoplasms
Association of drug transporter expression with mortality and progression-free survival in stage IV head and neck squamous cell carcinoma.
Neoplasms
Association of Epigenetic Clock with Consensus Molecular Subtypes and Overall Survival of Colorectal Cancer.
Neoplasms
Association of Estrogen Receptor Alpha Expression With Survival in Oropharyngeal Cancer Following Chemoradiation Therapy.
Neoplasms
Association of expression quantitative trait loci for long noncoding RNAs with lung cancer risk in Asians.
Neoplasms
Association of genomic subtypes of lower-grade gliomas with shape features automatically extracted by a deep learning algorithm.
Neoplasms
Association of Germline Variants in Natural Killer Cells With Tumor Immune Microenvironment Subtypes, Tumor-Infiltrating Lymphocytes, Immunotherapy Response, Clinical Outcomes, and Cancer Risk.
Neoplasms
Association of IDH mutation and 1p19q co-deletion with tumor immune microenvironment in lower-grade glioma.
Neoplasms
Association of imputed prostate cancer transcriptome with disease risk reveals novel mechanisms.
Neoplasms
Association of lnc-IL17RA-11 with increased radiation sensitivity and improved prognosis of HPV-positive HNSCC.
Neoplasms
Association of Long Noncoding RNA Biomarkers With Clinical Immune Subtype and Prediction of Immunotherapy Response in Patients With Cancer.
Neoplasms
Association of metabolic and genetic heterogeneity in head and neck squamous cell carcinoma with prognostic implications: integration of FDG PET and genomic analysis.
Neoplasms
Association of mRNA expression of TP53 and the TP53 codon 72 Arg/Pro gene polymorphism with colorectal cancer risk in Asian population: a bioinformatics analysis and meta-analysis.
Neoplasms
Association of MSH2 Expression With Tumor Mutational Burden and the Immune Microenvironment in Lung Adenocarcinoma.
Neoplasms
Association of MUC16 Mutation With Response to Immune Checkpoint Inhibitors in Solid Tumors.
Neoplasms
Association of MUC16 Mutation With Tumor Mutation Load and Outcomes in Patients With Gastric Cancer.
Neoplasms
Association of Omics Features with Histopathology Patterns in Lung Adenocarcinoma.
Neoplasms
Association of PD-1/PD-L axis expression with cytolytic activity, mutational load, and prognosis in melanoma and other solid tumors.
Neoplasms
Association of Polo-Like Kinase 3 and PhosphoT273 Caspase 8 Levels With Disease-Related Outcomes Among Cervical Squamous Cell Carcinoma Patients Treated With Chemoradiation and Brachytherapy.
Neoplasms
Association of Polymerase e-Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1.
Neoplasms
Association of Processed Meats and Alcohol Consumption with Renal Cell Carcinoma: A Worldwide Population-Based Study.
Neoplasms
Association of PTPRD/PTPRT Mutation With Better Clinical Outcomes in NSCLC Patients Treated With Immune Checkpoint Blockades.
Neoplasms
Association of RYR2 Mutation With Tumor Mutation Burden, Prognosis, and Antitumor Immunity in Patients With Esophageal Adenocarcinoma.
Neoplasms
Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancer.
Neoplasms
Association of Somatic Mutations of ADAMTS Genes With Chemotherapy Sensitivity and Survival in High-Grade Serous Ovarian Carcinoma.
Neoplasms
Association of specific gene mutations derived from machine learning with survival in lung adenocarcinoma.
Neoplasms
Association of Tumor Protein p53 and Ataxia-Telangiectasia Mutated Comutation With Response to Immune Checkpoint Inhibitors and Mortality in Patients With Non-Small Cell Lung Cancer.
Neoplasms
Association of variably methylated tumour DNA regions with overall survival for invasive lobular breast cancer.
Neoplasms
Association study between genetic variants in retinol metabolism pathway genes and prostate cancer risk.
Neoplasms
Association study of genetic variants in estrogen metabolic pathway genes and colorectal cancer risk and survival.
Neoplasms
Associations between gene expression profiles of invasive breast cancer and Breast Imaging Reporting and Data System MRI lexicon.
Neoplasms
Associations between proteasomal activator PA28? and outcome of oral squamous cell carcinoma: Evidence from cohort studies and functional analyses.
Neoplasms
Associations of high expression of miR-106b-5p detected from FFPE sample with poor prognosis of RCC patients.
Neoplasms
Associations of individual and joint expressions of ERCC6 and ERCC8 with clinicopathological parameters and prognosis of gastric cancer.
Neoplasms
Associations of PGK1 promoter hypomethylation and PGK1-mediated PDHK1 phosphorylation with cancer stage and prognosis: a TCGA pan-cancer analysis.
Neoplasms
Associations of PIK3CA mutations with clinical features and prognosis in gastric cancer.
Neoplasms
Associations of two-pore domain potassium channels and triple negative breast cancer subtype in The Cancer Genome Atlas: systematic evaluation of gene expression and methylation.
Neoplasms
ASXL1 promotes adrenocortical carcinoma and is associated with chemoresistance to EDP regimen.
Neoplasms
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial.
Neoplasms
Atezolizumab potentiates Tcell-mediated cytotoxicity and coordinates with FAK to suppress cell invasion and motility in PD-L1+ triple negative breast cancer cells.
Neoplasms
Atlas construction and spatial normalisation to facilitate radiation-induced late effects research in childhood cancer.
Neoplasms
Atlas of cancer mortality in the European Union and the European Economic Area 1993-1997.
Neoplasms
Atlas of cancer mortality in the People's Republic of China. An aid for cancer control and research.
Neoplasms
Atlas of Cancer Signalling Network: a systems biology resource for integrative analysis of cancer data with Google Maps.
Neoplasms
Atlas of Ex Vivo Prostate Tissue and Cancer Images Using Confocal Laser Endomicroscopy: A Project for Intraoperative Positive Surgical Margin Detection During Radical Prostatectomy.
Neoplasms
Atlas of the thoracic lymph nodal delineation and recommendations for lymph nodal CTV of esophageal squamous cell cancer in radiation therapy from China.
Neoplasms
Atlas of Tumor Pathology: Sect. II, Fasc. 6. Tumors of the Peripheral Nervous System.
Neoplasms
Atlas-based automatic segmentation of MR images: validation study on the brainstem in radiotherapy context.
Neoplasms
Atlas-based segmentation of brain tumor images using a Markov random field-based tumor growth model and non-rigid registration.
Neoplasms
Atlas-based segmentation of pathological MR brain images using a model of lesion growth.
Neoplasms
ATM mutations as an independent prognostic factor and potential biomarker for immune checkpoint therapy in endometrial cancer.
Neoplasms
ATM Mutations Benefit Bladder Cancer Patients Treated With Immune Checkpoint Inhibitors by Acting on the Tumor Immune Microenvironment.
Neoplasms
ATP binding cassette (ABC) transporters: expression and clinical value in glioblastoma.
Neoplasms
ATP binding cassette subfamily B member 9 (ABCB9) is a prognostic indicator of overall survival in ovarian cancer.
Neoplasms
ATP5A1 and ATP5B are highly expressed in glioblastoma tumor cells and endothelial cells of microvascular proliferation.
Neoplasms
Attenuated RND1 Expression Confers Malignant Phenotype and Predicts Poor Prognosis in Hepatocellular Carcinoma.
Neoplasms
Attenuated transforming growth factor beta signaling promotes metastasis in a model of HER2 mammary carcinogenesis.
Neoplasms
Atypical Chemokine Receptor 1 (DARC/ACKR1) in Breast Tumors Is Associated with Survival, Circulating Chemokines, Tumor-Infiltrating Immune Cells, and African Ancestry.
Neoplasms
Atypical de Quervain's thyroiditis diagnosed as atypia of undetermined significance by cytology and suspicious for cancer by Afirma Genomic Sequencing Classifier.
Neoplasms
Augmentation of response to chemotherapy by microRNA-506 through regulation of RAD51 in serous ovarian cancers.
Neoplasms
AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma.
Neoplasms
Aurora A Functional Single Nucleotide Polymorphism (SNP) Correlates With Clinical Outcome in Patients With Advanced Solid Tumors Treated With Alisertib, an Investigational Aurora A Kinase Inhibitor.
Neoplasms
Aurovertin B exerts potent antitumor activity against triple-negative breast cancer in vivo and in vitro via regulating ATP synthase activity and DUSP1 expression.
Neoplasms
Authentication of differential gene expression in oral squamous cell carcinoma using machine learning applications.
Neoplasms
Autocrine signaling by receptor tyrosine kinases in urothelial carcinoma of the bladder.
Neoplasms
Autocrine TGF? Is a Survival Factor for Monocytes and Drives Immunosuppressive Lineage Commitment.
Neoplasms
Autocrined leptin promotes proliferation of non-small cell lung cancer (NSCLC) via PI3K/AKT and p53 pathways.
Neoplasms
Autoencoded DNA methylation data to predict breast cancer recurrence: Machine learning models and gene-weight significance.
Neoplasms
AutoEncoder-Based Computational Framework for Tumor Microenvironment Decomposition and Biomarker Identification in Metastatic Melanoma.
Neoplasms
Autologous reference types can confound the detection of somatic mutation in solid cancers.
Neoplasms
Automated analysis of immunohistochemistry images identifies candidate location biomarkers for cancers.
Neoplasms
Automated clear cell renal carcinoma grade classification with prognostic significance.
Neoplasms
AUTOMATED COMPARISON OF PROTEIN SUBCELLULAR LOCATION PATTERNS BETWEEN IMAGES OF NORMAL AND CANCEROUS TISSUES.
Neoplasms
Automated deconvolution of structured mixtures from heterogeneous tumor genomic data.
Neoplasms
Automated Grading of Gliomas using Deep Learning in Digital Pathology Images: A modular approach with ensemble of convolutional neural networks.
Neoplasms
Automatic Detection of the Circulating Cell-Free Methylated DNA Pattern of GCM2, ITPRIPL1 and CCDC181 for Detection of Early Breast Cancer and Surgical Treatment Response.
Neoplasms
Automatic disease stage classification of glioblastoma multiforme histopathological images using deep convolutional neural network.
Neoplasms
Autophagy induced by overexpression of DCTPP1 promotes tumor progression and predicts poor clinical outcome in prostate cancer.
Neoplasms
Autophagy-related gene P4HB: a novel diagnosis and prognosis marker for kidney renal clear cell carcinoma.
Neoplasms
Autophagy-related genes are potential diagnostic and prognostic biomarkers in prostate cancer.
Neoplasms
Autophagy-related genes contribute to malignant progression and have a clinical prognostic impact in colon adenocarcinoma.
Neoplasms
Autophagy-Related Long Non-coding RNA Is a Prognostic Indicator for Bladder Cancer.
Neoplasms
Autophagy-Related Long Non-coding RNA Signature as Indicators for the Prognosis of Uveal Melanoma.
Neoplasms
Autophagy-related long noncoding RNAs can predict prognosis in patients with bladder cancer.
Neoplasms
Autophagy-Related Three-Gene Prognostic Signature for Predicting Survival in Esophageal Squamous Cell Carcinoma.
Neoplasms
Autotaxin, a lysophospholipase D with pleomorphic effects in oncogenesis and cancer progression.
Neoplasms
aWCluster: A Novel Integrative Network-based Clustering of Multiomics for Subtype Analysis of Cancer Data.
Neoplasms
B-CAN: a resource sharing platform to improve the operation, visualization and integrated analysis of TCGA breast cancer data.
Neoplasms
B-cell Receptor Recombinations in Lung Adenocarcinoma Exome Files Correlate With a Higher Overall Survival Rate.
Neoplasms
B-Myb Induces APOBEC3B Expression Leading to Somatic Mutation in Multiple Cancers.
Neoplasms
B3GNT3: A prognostic biomarker associated with immune cell infiltration in pancreatic adenocarcinoma.
Neoplasms
B7-H3 and B7-H4 Expression in Breast Cancer and Their Association with Clinicopathological Variables and T Cell Infiltration.
Neoplasms
B7-H3-Targeted CAR-T Cells Exhibit Potent Antitumor Effects on Hematologic and Solid Tumors.
Neoplasms
BACH1 promotes the progression of esophageal squamous cell carcinoma by inducing the epithelial-mesenchymal transition and angiogenesis.
Neoplasms
BAG2 Overexpression Correlates with Growth and Poor Prognosis of Esophageal Squamous Cell Carcinoma.
Neoplasms
Banding Together: A Systematic Comparison of The Cancer Genome Atlas and the Mitelman Database.
Neoplasms
BAP1 dependent expression of long non-coding RNA NEAT-1 contributes to sensitivity to gemcitabine in cholangiocarcinoma.
Neoplasms
BAP1 functions as a tumor promoter in prostate cancer cells through EMT regulation.
Neoplasms
BAP1 is Overexpressed in Black Compared with White patients with Mx-M1 Clear Cell Renal Cell Carcinoma: A report from the Cancer Genome Atlas.
Neoplasms
BarH-like homeobox 1 induces the progression of cell malignant phenotype in endometrial carcinoma through the regulation of ERK/MEK signaling pathway.
Neoplasms
Base of tongue cancer-is it tongue cancer located at the base of the tongue, or is it a type of lingual tonsil cancer? The perspective from a genomic analysis.
Neoplasms
Based on Integrated Bioinformatics Analysis Identification of Biomarkers in Hepatocellular Carcinoma Patients from Different Regions.
Neoplasms
Bayesian genome- and epigenome-wide association studies with gene level dependence.
Neoplasms
Bayesian Hierarchical Varying-sparsity Regression Models with Application to Cancer Proteogenomics.
Neoplasms
Bayesian inference for latent biologic structure with determinantal point processes (DPP).
Neoplasms
Bayesian Network Marker Selection via the Thresholded Graph Laplacian Gaussian Prior.
Neoplasms
Bayesian semi-nonnegative matrix tri-factorization to identify pathways associated with cancer phenotypes.
Neoplasms
Bayesian variable selection for parametric survival model with applications to cancer omics data.
Neoplasms
Bayesian variable selection with graphical structure learning: Applications in integrative genomics.
Neoplasms
BBCancer: an expression atlas of blood-based biomarkers in the early diagnosis of cancers.
Neoplasms
BCAT1 Overexpression Promotes Proliferation, Invasion, and Wnt Signaling in Non-Small Cell Lung Cancers.
Neoplasms
BCAT1 overexpression regulates proliferation and c?Myc/GLUT1 signaling in head and neck squamous cell carcinoma.
Neoplasms
BCL11A confers cell invasion and migration in androgen receptor-positive triple-negative breast cancer.
Neoplasms
BCL2 overexpression: clinical implication and biological insights in acute myeloid leukemia.
Neoplasms
BCL2 Regulation According to Molecular Subtype of Breast Cancer by Analysis of The Cancer Genome Atlas Database.
Neoplasms
BCL7B is a potential novel diagnosis and prognosis biomarker for sarcomas using bioinformatics analysis.
Neoplasms
Bcl9 Depletion Modulates Endothelial Cell in Tumor Immune Microenvironment in Colorectal Cancer Tumor.
Neoplasms
BCL9 regulates CD226 and CD96 checkpoints in CD8+ T cells to improve PD-1 response in cancer.
Neoplasms
BCNTB bioinformatics: the next evolutionary step in the bioinformatics of breast cancer tissue banking.
Neoplasms
Beclin-1 expression is retained in high-grade serous ovarian cancer yet is not essential for autophagy induction in vitro.
Neoplasms
Before and After: Comparison of Legacy and Harmonized TCGA Genomic Data Commons' Data.
Neoplasms
Benchmark of long non-coding RNA quantification for RNA sequencing of cancer samples.
Neoplasms
Benzimidazoles induce concurrent apoptosis and pyroptosis of human glioblastoma cells via arresting cell cycle.
Neoplasms
Benzodiazepines use and breast cancer risk: A population-based study and gene expression profiling evidence.
Neoplasms
BET, SRC, and BCL2 family inhibitors are synergistic drug combinations with PARP inhibitors in ovarian cancer.
Neoplasms
Beta-1 syntrophin (SNTB1) regulates colorectal cancer progression and stemness via regulation of the Wnt/?-catenin signaling pathway.
Neoplasms
Better prognostic determination and feature characterization of cutaneous melanoma through integrative genomic analysis.
Neoplasms
Beyond conventional chemotherapy: Emerging molecular targeted and immunotherapy strategies in urothelial carcinoma.
Neoplasms
Beyond genomics: critical evaluation of cell line utility for ovarian cancer research.
Neoplasms
Beyond Synthetic Lethality: Charting the Landscape of Pairwise Gene Expression States Associated with Survival in Cancer.
Neoplasms
Beyond the one-locus-one-miRNA paradigm: microRNA isoforms enable deeper insights into breast cancer heterogeneity.
Neoplasms
BGN and COL11A1 Regulatory Network Analysis in Colorectal Cancer (CRC) Reveals That BGN Influences CRC Cell Biological Functions and Interacts with miR-6828-5p.
Neoplasms
BHLHA15-Positive Secretory Precursor Cells Can Give Rise to Tumors in Intestine and Colon in Mice.
Neoplasms
BI-RADS Category 5 Assessments at Diagnostic Breast Imaging:Outcomes Analysis Based on Lesion Descriptors.
Neoplasms
Biased Expression of the FOXP3?3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance.
Neoplasms
BICC1 as a novel prognostic biomarker in gastric cancer correlating with immune infiltrates.
Neoplasms
BICD Cargo Adaptor 1 (BICD1) Downregulation Correlates with a Decreased Level of PD-L1 and Predicts a Favorable Prognosis in Patients with IDH1-Mutant Lower-Grade Gliomas.
Neoplasms
Bidirectional regulation of adenosine-to-inosine (A-to-I) RNA editing by DEAH box helicase 9 (DHX9) in cancer.
Neoplasms
Big data visualization identifies the multidimensional molecular landscape of human gliomas.
Neoplasms
Big data-based identification of methylated genes associated with drug resistance and prognosis in ovarian cancer.
Neoplasms
Big Data-Based Identification of Multi-Gene Prognostic Signatures in Liver Cancer.
Neoplasms
Biglycan-mediated upregulation of MHC class I expression in HER-2/neu-transformed cells.
Neoplasms
Binning somatic mutations based on biological knowledge for predicting survival: an application in renal cell carcinoma.
Neoplasms
Biocomputing: Numerical simulation of glioblastoma growth and comparison with conventional irradiation margins.
Neoplasms
Biocomputing: numerical simulation of glioblastoma growth using diffusion tensor imaging.
Neoplasms
Biodistribution of the ¹?F-FPPRGD? PET radiopharmaceutical in cancer patients: an atlas of SUV measurements.
Neoplasms
Bioinformatic analyses reveal a distinct Notch activation induced by STAT3 phosphorylation in the mesenchymal subtype of glioblastoma.
Neoplasms
Bioinformatic analyses reveal the key pathways and genes in the CXCR4 mediated mesenchymal subtype of glioblastoma.
Neoplasms
Bioinformatic analysis and in vitro validation of a five-microRNA signature as a prognostic biomarker of hepatocellular carcinoma.
Neoplasms
Bioinformatic Analysis Identifies Potential Key Genes in the Pathogenesis of Melanoma.
Neoplasms
Bioinformatic analysis of four miRNAs relevant to metastasis-regulated processes in endometrial carcinoma.
Neoplasms
Bioinformatic analysis of gene expression and methylation regulation in glioblastoma.
Neoplasms
Bioinformatic Analysis of Hepatocellular Carcinoma Cell Lines to the Efficacy of Nimotuzumab.
Neoplasms
Bioinformatic analysis of PFN2 dysregulation and its prognostic value in head and neck squamous carcinoma.
Neoplasms
Bioinformatic analysis of RNA-seq data unveiled critical genes in rectal adenocarcinoma.
Neoplasms
Bioinformatic analysis of the prognostic value of the lncRNAs encoding snoRNAs in hepatocellular carcinoma.
Neoplasms
Bioinformatic analysis reveals an exosomal miRNA-mRNA network in colorectal cancer.
Neoplasms
Bioinformatic Analysis Reveals an Immune/Inflammatory-Related Risk Signature for Oral Cavity Squamous Cell Carcinoma.
Neoplasms
Bioinformatic Analysis Suggests That Three Hub Genes May Be a Vital Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma.
Neoplasms
Bioinformatic and integrated analysis identifies an lncRNA-miRNA-mRNA interaction mechanism in gastric adenocarcinoma.
Neoplasms
Bioinformatic Exploration for Prognostic Significance of Sphingolipid Metabolism-Related Genes in Invasive Ductal Carcinoma Using the Cancer Genome Atlas Cohort.
Neoplasms
Bioinformatic exploration of OLFML2B overexpression in gastric cancer base on multiple analyzing tools.
Neoplasms
Bioinformatic identification of differentially expressed genes associated with prognosis of locally advanced lymph node-positive prostate cancer.
Neoplasms
Bioinformatic Identification of Hub Genes and Analysis of Prognostic Values in Colorectal Cancer.
Neoplasms
Bioinformatic identification of key genes and analysis of prognostic values in clear cell renal cell carcinoma.
Neoplasms
Bioinformatic identification of prognostic signature defined by copy number alteration and expression of CCNE1 in non-muscle invasive bladder cancer.
Neoplasms
Bioinformatic identification of renal cell carcinoma microenvironment-associated biomarkers with therapeutic and prognostic value.
Neoplasms
Bioinformatic Methods and Bridging of Assay Results for Reliable Tumor Mutational Burden Assessment in Non-Small-Cell Lung Cancer.
Neoplasms
Bioinformatic Profiling Identifies a Fatty Acid Metabolism-Related Gene Risk Signature for Malignancy, Prognosis, and Immune Phenotype of Glioma.
Neoplasms
Bioinformatic Profiling Identifies a Glucose-Related Risk Signature for the Malignancy of Glioma and the Survival of Patients.
Neoplasms
Bioinformatic profiling identifies a platinum-resistant-related risk signature for ovarian cancer.
Neoplasms
Bioinformatic profiling identifies an immune-related risk signature for glioblastoma.
Neoplasms
Bioinformatic profiling of prognosis-related genes in the breast cancer immune microenvironment.
Neoplasms
Bioinformatic screening and experimental analysis identify SFRP1 as a prognostic biomarker for tongue squamous cell carcinomas.
Neoplasms
Bioinformatical analysis of Gene Expression Omnibus (GEO) database associates TAF7/CCNB1, TAF7/CCNA2, and GTF2E2/CDC20 pathways with glioblastoma development and prognosis.
Neoplasms
Bioinformatical identification of key genes regulated by IGF2BP2-mediated RNA N6-methyladenosine and prediction of prognosis in hepatocellular carcinoma.
Neoplasms
Bioinformatics analyses and biological function of lncRNA ZFPM2-AS1 and ZFPM2 gene in hepatocellular carcinoma.
Neoplasms
Bioinformatics Analyses Indicate That Cathepsin G (CTSG) is a Potential Immune-Related Biomarker in Oral Squamous Cell Carcinoma (OSCC).
Neoplasms
Bioinformatics Analyses of Potential miRNA-mRNA Regulatory Axis in HBV-related Hepatocellular Carcinoma.
Neoplasms
Bioinformatics analyses of significant prognostic risk markers for thyroid papillary carcinoma.
Neoplasms
Bioinformatics analyses of the differences between lung adenocarcinoma and squamous cell carcinoma using The Cancer Genome Atlas expression data.
Neoplasms
Bioinformatics analysis based on immune-autophagy-related lncRNAs combined with immune infiltration in bladder cancer.
Neoplasms
Bioinformatics analysis combined with experiments predicts CENPK as a potential prognostic factor for lung adenocarcinoma.
Neoplasms
Bioinformatics analysis combined with experiments to explore potential prognostic factors for pancreatic cancer.
Neoplasms
Bioinformatics Analysis Finds Immune Gene Markers Related to the Prognosis of Bladder Cancer.
Neoplasms
Bioinformatics analysis for the identification of differentially expressed genes and related signaling pathways in H. pylori-CagA transfected gastric cancer cells.
Neoplasms
Bioinformatics Analysis Identifies IL6ST as a Potential Tumor Suppressor Gene for Triple-Negative Breast Cancer.
Neoplasms
Bioinformatics Analysis Identifies Key Genes and Pathways in Acute Myeloid Leukemia Associated with DNMT3A Mutation.
Neoplasms
Bioinformatics Analysis of a Prognostic miRNA Signature and Potential Key Genes in Pancreatic Cancer.
Neoplasms
Bioinformatics Analysis of Differentially Expressed Genes and miRNAs in Low-Grade Gliomas.
Neoplasms
Bioinformatics analysis of esophageal cancer unveils an integrated mRNA-lncRNA signature for predicting prognosis.
Neoplasms
Bioinformatics analysis of gene expression data for the identification of critical genes in breast invasive carcinoma.
Neoplasms
Bioinformatics analysis of gene expression profiles of esophageal squamous cell carcinoma.
Neoplasms
Bioinformatics analysis of gene expression profiles to identify causal genes in luminal B2 breast cancer.
Neoplasms
Bioinformatics Analysis of KIF1A Expression and Gene Regulation Network in Ovarian Carcinoma.
Neoplasms
Bioinformatics analysis of laryngeal squamous cell carcinoma: seeking key candidate genes and pathways.
Neoplasms
Bioinformatics analysis of LINC00426 expression in lung cancer and its correlation with patients' prognosis.
Neoplasms
Bioinformatics analysis of multi-omics data identifying molecular biomarker candidates and epigenetically regulatory targets associated with retinoblastoma.
Neoplasms
Bioinformatics analysis of prognosis-related long non-coding RNAs in invasive breast carcinoma.
Neoplasms
Bioinformatics Analysis of Prognostic Tumor Microenvironment-Related Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
Neoplasms
Bioinformatics analysis of RNA sequencing data reveals multiple key genes in uterine corpus endometrial carcinoma.
Neoplasms
Bioinformatics analysis of RNA-seq data revealed critical genes in colon adenocarcinoma.
Neoplasms
Bioinformatics analysis of the clinical value and potential mechanisms of AHNAK2 in papillary thyroid carcinoma.
Neoplasms
Bioinformatics analysis of the expression and role of microRNA-221-3p in head and neck squamous cell carcinoma.
Neoplasms
Bioinformatics Analysis of the Expression of ATP Binding Cassette Subfamily C Member 3 (ABCC3) in Human Glioma.
Neoplasms
Bioinformatics Analysis of the Expression of Key Long Intergenic Non-Protein Coding RNA Genes in Bladder Cancer.
Neoplasms
Bioinformatics analysis of the interactions among lncRNA, miRNA and mRNA expression, genetic mutations and epigenetic modifications in hepatocellular carcinoma.
Neoplasms
Bioinformatics analysis of the prognosis and biological significance of VCAN in gastric cancer.
Neoplasms
Bioinformatics analysis of the transcriptional expression of minichromosome maintenance proteins as potential indicators of survival in patients with cervical cancer.
Neoplasms
Bioinformatics analysis of thousands of TCGA tumors to determine the involvement of epigenetic regulators in human cancer.
Neoplasms
Bioinformatics Analysis Reveals an Association Between Cancer Cell Stemness, Gene Mutations, and the Immune Microenvironment in Stomach Adenocarcinoma.
Neoplasms
Bioinformatics analysis reveals biomarkers with cancer stem cell characteristics in kidney renal clear cell carcinoma.
Neoplasms
Bioinformatics Analysis Reveals Biomarkers With Cancer Stem Cell Characteristics in Lung Squamous Cell Carcinoma.
Neoplasms
Bioinformatics analysis reveals meaningful markers and outcome predictors in HBV-associated hepatocellular carcinoma.
Neoplasms
Bioinformatics analysis reveals the competing endogenous RNA (ceRNA) coexpression network in the tumor microenvironment and prognostic biomarkers in soft tissue sarcomas.
Neoplasms
Bioinformatics analysis reveals TSPAN1 as a candidate biomarker of progression and prognosis in pancreatic cancer.
Neoplasms
Bioinformatics analysis suggests that COL4A1 may play an important role in gastric carcinoma recurrence.
Neoplasms
Bioinformatics Analysis Suggests the Combined Expression of AURKB and KIF18B Being an Important Event in the Development of Clear Cell Renal Cell Carcinoma.
Neoplasms
Bioinformatics Analysis to Determine Prognostic Mutations of 72 de novo Acute Myeloid Leukemia Cases from the Cancer Genome Atlas (TCGA) with 23 Most Common Mutations and no Abnormal Cytogenetics.
Neoplasms
Bioinformatics analysis to identify the critical genes, microRNAs and long noncoding RNAs in melanoma.
Neoplasms
Bioinformatics analysis to identify the key genes affecting the progression and prognosis of hepatocellular carcinoma.
Neoplasms
Bioinformatics analysis to screen key prognostic genes in the breast cancer tumor microenvironment.
Neoplasms
Bioinformatics Analysis to Screen the Key Prognostic Genes in Tumor Microenvironment of Bladder Cancer.
Neoplasms
Bioinformatics and functional analyses of key genes in smoking-associated lung adenocarcinoma.
Neoplasms
Bioinformatics and machine learning methodologies to identify the effects of central nervous system disorders on glioblastoma progression.
Neoplasms
Bioinformatics combined with quantitative proteomics analyses and identification of potential biomarkers in cholangiocarcinoma.
Neoplasms
Bioinformatics identification of lncRNA biomarkers associated with the progression of esophageal squamous cell carcinoma.
Neoplasms
Bioinformatics profiling identifies seven immune-related risk signatures for hepatocellular carcinoma.
Neoplasms
Bioinformatics profiling integrating a four immune-related long non-coding RNAs signature as a prognostic model for papillary renal cell carcinoma.
Neoplasms
Bioinformatics profiling integrating a three immune-related long non-coding RNA signature as a prognostic model for clear cell renal cell carcinoma.
Neoplasms
Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer.
Neoplasms
Bioinformatics-based analysis of the association between the A1-chimaerin (CHN1) gene and gastric cancer.
Neoplasms
Bioinformatics-Based Identification of Methylated-Differentially Expressed Genes and Related Pathways in Gastric Cancer.
Neoplasms
Biologic Pathways Underlying Prognostic Radiomics Phenotypes from Paired MRI and RNA Sequencing in Glioblastoma.
Neoplasms
Biological and clinical influences of NPM1 in acute myeloid leukemia patients with DNMT3A mutations.
Neoplasms
Biological and Clinical Significance of GATA3 Detected from TCGA Database and FFPE Sample in Bladder Cancer Patients.
Neoplasms
Biological and Clinicopathological Implications of Beta-3-N-acetylglucosaminyltransferase 8 in Triple-negative Breast Cancer.
Neoplasms
Biological Features of Human Papillomavirus-related Head and Neck Cancers Contributing to Improved Response.
Neoplasms
Biological information and functional analysis reveal the role of discoidin domain receptor 1 in oral squamous cell carcinoma.
Neoplasms
Biological Interpretation of Morphological Patterns in Histopathological Whole-Slide Images.
Neoplasms
Biological role and clinical value of miR-99a-5p in head and neck squamous cell carcinoma (HNSCC): A bioinformatics-based study.
Neoplasms
Biological Validation of RNA Sequencing Data from Formalin-Fixed Paraffin-Embedded Primary Melanomas.
Neoplasms
Biologics in combination with chemotherapy for gastric cancer: is this the answer?
Neoplasms
Biology of the Triple-Negative Breast Cancer: Immunohistochemical, RNA, and DNA Features.
Neoplasms
Biomarker and competing endogenous RNA potential of tumor-specific long noncoding RNA in chromophobe renal cell carcinoma.
Neoplasms
Biomarker expression analysis in different age groups revealed age was a risk factor for breast cancer.
Neoplasms
Biomarker Identification through Multiomics Data Analysis of Prostate Cancer Prognostication Using a Deep Learning Model and Similarity Network Fusion.
Neoplasms
Biomarker Screening and Prognostic Significance Analysis for Renal Cell Carcinoma.
Neoplasms
Biomarkers in Tumor Microenvironment? Upregulation of Fibroblast Activation Protein-? Correlates with Gastric Cancer Progression and Poor Prognosis.
Neoplasms
Biomarkers of erlotinib response in non-small cell lung cancer tumors that do not harbor the more common epidermal growth factor receptor mutations.
Neoplasms
BioXpress: an integrated RNA-seq-derived gene expression database for pan-cancer analysis.
Neoplasms
Bipartite network analysis reveals metabolic gene expression profiles that are highly associated with the clinical outcomes of acute myeloid leukemia.
Neoplasms
Biphasic regulation of tumorigenesis by PTK7 expression level in esophageal squamous cell carcinoma.
Neoplasms
Black Lives Matter Worldwide: Retooling Precision Oncology for True Equity of Cancer Care.
Neoplasms
Bladder cancer survival nomogram: Development and validation of a prediction tool, using the SEER and TCGA databases.
Neoplasms
Block-Constraint Robust Principal Component Analysis and its Application to Integrated Analysis of TCGA Data.
Neoplasms
Blockade of Cell Volume Regulatory Protein NKCC1 Increases TMZ-Induced Glioma Apoptosis and Reduces Astrogliosis.
Neoplasms
Blockade of the Short Form of Prolactin Receptor Induces FOXO3a/EIF-4EBP1-Mediated Cell Death in Uterine Cancer.
Neoplasms
Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer.
Neoplasms
Blocking siglec-10hi tumor-associated macrophages improves anti-tumor immunity and enhances immunotherapy for hepatocellular carcinoma.
Neoplasms
Blocking the PD-1/PD-L1 axis in dendritic cell-stimulated Cytokine-Induced Killer Cells with pembrolizumab enhances their therapeutic effects against hepatocellular carcinoma.
Neoplasms
Blocking Wnt/?-catenin Signal Amplifies Anti-PD-1 Therapeutic Efficacy by Inhibiting Tumor Growth, Migration, and Promoting Immune Infiltration in Glioblastomas.
Neoplasms
Blood and tissue biomarker analysis in dogs with osteosarcoma treated with palliative radiation and intra-tumoral autologous natural killer cell transfer.
Neoplasms
Blood-derived DNA methylation predictors of mortality discriminate tumor and healthy tissue in multiple organs.
Neoplasms
BMI, irAE, and gene expression signatures associate with resistance to immune-checkpoint inhibition and outcomes in renal cell carcinoma.
Neoplasms
BMI1 activates P-glycoprotein via transcription repression of miR-3682-3p and enhances chemoresistance of bladder cancer cell.
Neoplasms
Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations.
Neoplasms
Body mass index-associated molecular characteristics involved in tumor immune and metabolic pathways.
Neoplasms
Bone marrow stromal antigen 2 (BST-2) DNA is demethylated in breast tumors and breast cancer cells.
Neoplasms
Bone marrow stromal antigen 2 expressed in cancer cells promotes mammary tumor growth and metastasis.
Neoplasms
Bone sialoprotein-?v?3 integrin axis promotes breast cancer metastasis to the bone.
Neoplasms
Bottom-up, integrated -omics analysis identifies broadly dosage-sensitive genes in breast cancer samples from TCGA.
Neoplasms
BRAF Mutation as a Potential Therapeutic Target for Checkpoint Inhibitors: A Comprehensive Analysis of Immune Microenvironment in BRAF Mutated Colon Cancer.
Neoplasms
BRAF mutations are associated with increased iron regulatory protein-2 expression in colorectal tumorigenesis.
Neoplasms
BRAF-positive multifocal and unifocal papillary thyroid cancer show different messenger RNA expressions.
Neoplasms
BRAF/MEK Pathway is Associated With Breast Cancer in ER-dependent Mode and Improves ER Status-based Cancer Recurrence Prediction.
Neoplasms
BRAFnon-V600E more frequently co-occurs with IDH1/2 mutations in adult patients with gliomas than in patients harboring BRAFV600E but without a survival advantage.
Neoplasms
BRAFV600E-Associated Gene Expression Profile: Early Changes in the Transcriptome, Based on a Transgenic Mouse Model of Papillary Thyroid Carcinoma.
Neoplasms
BRAFV600E-induced KRT19 expression in thyroid cancer promotes lymph node metastasis via EMT.
Neoplasms
Brain atlas deformation in the presence of small and large space-occupying tumors.
Neoplasms
Brain atlas for assessing the impact of tumor location on perioperative quality of life in patients with high-grade glioma: A prospective population-based cohort study.
Neoplasms
Brain cancer mortality in the United States, 1986 to 1995: a geographic analysis.
Neoplasms
Brain regions associated with telomerase reverse transcriptase promoter mutations in primary glioblastomas.
Neoplasms
BRCA 1/2-Mutation Related and Sporadic Breast and Ovarian Cancers: More Alike than Different.
Neoplasms
BRCA1 immunohistochemistry in a molecularly characterized cohort of ovarian high-grade serous carcinomas.
Neoplasms
BRCA1-Associated Protein Is a Potential Prognostic Biomarker and Is Correlated With Immune Infiltration in Liver Hepatocellular Carcinoma: A Pan-Cancer Analysis.
Neoplasms
BrcaSeg: A Deep Learning Approach for Tissue Quantification and Genomic Correlations of Histopathological Images.
Neoplasms
BRD4 Inhibitor AZD5153 Suppresses the Proliferation of Colorectal Cancer Cells and Sensitizes the Anticancer Effect of PARP Inhibitor.
Neoplasms
Breast and prostate cancers harbor common somatic copy number alterations that consistently differ by race and are associated with survival.
Neoplasms
Breast Cancer Case Identification Based on Deep Learning and Bioinformatics Analysis.
Neoplasms
Breast cancer in neurofibromatosis type 1: overrepresentation of unfavourable prognostic factors.
Neoplasms
Breast MRI radiomics: comparison of computer- and human-extracted imaging phenotypes.
Neoplasms
BRG1 knockdown inhibits proliferation through multiple cellular pathways in prostate cancer.
Neoplasms
Bringing Down Cancer Aircraft: Searching for Essential Hypomutated Proteins in Skin Melanoma.
Neoplasms
Bringing Structural Implications and Deep Learning-Based Drug Identification for KRAS Mutants.
Neoplasms
Brn3a/Pou4f1 Functions as a Tumor Suppressor by Targeting c-MET/STAT3 Signaling in Thyroid Cancer.
Neoplasms
Broadening Drug Design and Targets to Tumor Microenvironment? Cancer-Associated Fibroblast Marker Expression in Cancers and Relevance for Survival Outcomes.
Neoplasms
Bromodomain protein BRD4 inhibitor JQ1 regulates potential prognostic molecules in advanced renal cell carcinoma.
Neoplasms
Bromodomain-containing Protein 4 Is a Favourable Prognostic Factor in Breast Cancer Patients.
Neoplasms
BSND and ATP6V1G3: Novel Immunohistochemical Markers for Chromophobe Renal Cell Carcinoma.
Neoplasms
BSSV: Bayesian based somatic structural variation identification with whole genome DNA-seq data.
Neoplasms
BTG1 inhibits malignancy as a novel prognosis signature in endometrial carcinoma.
Neoplasms
BTK Has Potential to Be a Prognostic Factor for Lung Adenocarcinoma and an Indicator for Tumor Microenvironment Remodeling: A Study Based on TCGA Data Mining.
Neoplasms
BTNL9 is frequently downregulated and inhibits proliferation and metastasis via the P53/CDC25C and P53/GADD45 pathways in breast cancer.
Neoplasms
BUB1B promotes hepatocellular carcinoma progression via activation of the mTORC1 signaling pathway.
Neoplasms
Building a Competing Endogenous RNA Network to Find Potential Long Non-Coding RNA Biomarkers for Pheochromocytoma.
Neoplasms
Building a semantic web-based metadata repository for facilitating detailed clinical modeling in cancer genome studies.
Neoplasms
Building radiation-resistant model in triple-negative breast cancer to screen radioresistance-related molecular markers.
Neoplasms
Burden of Nonsynonymous Mutations among TCGA Cancers and Candidate Immune Checkpoint Inhibitor Responses.
Neoplasms
c-Myc directly targets an over-expression of pyruvate carboxylase in highly invasive breast cancer.
Neoplasms
c-myc regulates the sensitivity of breast cancer cells to palbociclib via c-myc/miR-29b-3p/CDK6 axis.
Neoplasms
C-Reactive Protein (CRP) is a Promising Diagnostic Immunohistochemical Marker for Intrahepatic Cholangiocarcinoma and is Associated With Better Prognosis.
Neoplasms
C-type lectin domain family 5, member A (CLEC5A, MDL-1) promotes brain glioblastoma tumorigenesis by regulating PI3K/Akt signalling.
Neoplasms
C16?ceramide and sphingosine 1?phosphate/S1PR2 have opposite effects on cell growth through mTOR signaling pathway regulation.
Neoplasms
C1q-like 1 is frequently up-regulated in lung adenocarcinoma and contributes to the proliferation and invasion of tumor cells.
Neoplasms
C1QTNF6 as a Novel Diagnostic and Prognostic Biomarker for Clear Cell Renal Cell Carcinoma.
Neoplasms
C3, C3AR1, HLA-DRA, and HLA-E as potential prognostic biomarkers for renal clear cell carcinoma.
Neoplasms
C8orf48 inhibits the tumorigenesis of colorectal cancer by regulating the MAPK signaling pathway.
Neoplasms
CA9 Silencing Promotes Mitochondrial Biogenesis, Increases Putrescine Toxicity and Decreases Cell Motility to Suppress ccRCC Progression.
Neoplasms
CacyBP/SIP promotes tumor progression by regulating apoptosis and arresting the cell cycle in osteosarcoma.
Neoplasms
Cadherins Associate with Distinct Stem Cell-Related Transcription Factors to Coordinate the Maintenance of Stemness in Triple-Negative Breast Cancer.
Neoplasms
CaDrA: A Computational Framework for Performing Candidate Driver Analyses Using Genomic Features.
Neoplasms
CAF-induced placental growth factor facilitates neoangiogenesis in hepatocellular carcinoma.
Neoplasms
CAFE MOCHA: An Integrated Platform for Discovering Clinically Relevant Molecular Changes in Cancer-An Example of Distant Metastasis- and Recurrence-Linked Classifiers in Head and Neck Squamous Cell Carcinoma.
Neoplasms
Calculated identification of mutator-derived lncRNA signatures of genomic instability to predict the clinical outcome of muscle-invasive bladder cancer.
Neoplasms
Calponin 3 suppresses proliferation, migration and invasion of non-small cell lung cancer cells.
Neoplasms
CAMUR: Knowledge extraction from RNA-seq cancer data through equivalent classification rules.
Neoplasms
CamurWeb: a classification software and a large knowledge base for gene expression data of cancer.
Neoplasms
Cancer Associated Fibroblasts and Senescent Thyroid Cells in the Invasive Front of Thyroid Carcinoma.
Neoplasms
Cancer Association Study of Aminoacyl-tRNA Synthetase Signaling Network in Glioblastoma.
Neoplasms
Cancer beyond organ and tissue specificity: next-generation-sequencing gene mutation data reveal complex genetic similarities across major cancers.
Neoplasms
Cancer cells are highly susceptible to accumulation of templated insertions linked to MMBIR.
Neoplasms
Cancer Digital Slide Archive: an informatics resource to support integrated in silico analysis of TCGA pathology data.
Neoplasms
Cancer driver gene discovery through an integrative genomics approach in a non-parametric Bayesian framework.
Neoplasms
Cancer driver mutation prediction through Bayesian integration of multi-omic data.
Neoplasms
Cancer Essential Genes Stratified Lung Adenocarcinoma Patients with Distinct Survival Outcomes and Identified a Subgroup from the Terminal Respiratory Unit Type with Different Proliferative Signatures in Multiple Cohorts.
Neoplasms
Cancer gene expression profiles associated with clinical outcomes to chemotherapy treatments.
Neoplasms
Cancer Genomic Profiling in Colorectal Cancer: Current Challenges in Subtyping Colorectal Cancers Based on Somatic and Germline Variants.
Neoplasms
Cancer genomic research at the crossroads: realizing the changing genetic landscape as intratumoral spatial and temporal heterogeneity becomes a confounding factor.
Neoplasms
Cancer in silico drug discovery: a systems biology tool for identifying candidate drugs to target specific molecular tumor subtypes.
Neoplasms
Cancer Markers Selection Using Network-Based Cox Regression: A Methodological and Computational Practice.
Neoplasms
Cancer Morbidity Atlas of the Saarland: an outline of the model project for the analysis of health and environmental data in the Saarland.
Neoplasms
Cancer mutational burden is shaped by G4 DNA, replication stress and mitochondrial dysfunction.
Neoplasms
Cancer prognosis prediction using somatic point mutation and copy number variation data: a comparison of gene-level and pathway-based models.
Neoplasms
Cancer Progression Prediction Using Gene Interaction Regularized Elastic Net.
Neoplasms
Cancer research in the era of next-generation sequencing and big data calls for intelligent modeling.
Neoplasms
Cancer Specific Long Noncoding RNAs Show Differential Expression Patterns and Competing Endogenous RNA Potential in Hepatocellular Carcinoma.
Neoplasms
Cancer stem cell associated eight gene-based signature predicts clinical outcomes of colorectal cancer.
Neoplasms
Cancer Stem Cell based molecular predictors of tumor recurrence in Oral squamous cell carcinoma.
Neoplasms
Cancer Stem Cell Marker CD44 Plays Multiple Key Roles in Human Cancers: Immune Suppression/Evasion, Drug Resistance, Epithelial-Mesenchymal Transition, and Metastasis.
Neoplasms
Cancer Stem Cell Marker DCLK1 Correlates with Tumorigenic Immune Infiltrates in the Colon and Gastric Adenocarcinoma Microenvironments.
Neoplasms
Cancer Stem Cell Markers in Relation to Patient Survival Outcomes: Lessons for Integrative Diagnostics and Next-Generation Anticancer Drug Development.
Neoplasms
Cancer Stem Cells and the Slow Cycling Phenotype: How to Cut the Gordian Knot Driving Resistance to Therapy in Melanoma.
Neoplasms
Cancer stem cells with increased metastatic potential as a therapeutic target for esophageal cancer.
Neoplasms
Cancer Stemness Associated With Prognosis and the Efficacy of Immunotherapy in Adrenocortical Carcinoma.
Neoplasms
Cancer Subtype Recognition Based on Laplacian Rank Constrained Multiview Clustering.
Neoplasms
Cancer Susceptibility Candidate 9 (CASC9) Promotes Colorectal Cancer Carcinogenesis via mTOR-Dependent Autophagy and Epithelial-Mesenchymal Transition Pathways.
Neoplasms
Cancer systems biology of TCGA SKCM: efficient detection of genomic drivers in melanoma.
Neoplasms
Cancer type-dependent correlations between TP53 mutations and antitumor immunity.
Neoplasms
Cancer-associated fibroblasts are associated with poor prognosis in solid type of lung adenocarcinoma in a machine learning analysis.
Neoplasms
Cancer-Associated Fibroblasts Positively Correlate with Dedifferentiation and Aggressiveness of Thyroid Cancer.
Neoplasms
Cancer-Associated Fibroblasts Promote Immunosuppression by Inducing ROS-Generating Monocytic MDSCs in Lung Squamous Cell Carcinoma.
Neoplasms
Cancer-associated mutations in DICER1 RNase IIIa and IIIb domains exert similar effects on miRNA biogenesis.
Neoplasms
Cancer-associated mutations in the ribosomal protein L5 gene dysregulate the HDM2/p53-mediated ribosome biogenesis checkpoint.
Neoplasms
Cancer-Associated Point Mutations in the DLC1 Tumor Suppressor and Other Rho-GAPs Occur Frequently and Are Associated with Decreased Function.
Neoplasms
Cancer-Associated Stemness and Epithelial-to-Mesenchymal Transition Signatures Related to Breast Invasive Carcinoma Prognostic.
Neoplasms
Cancer-driven IgG promotes the development of prostate cancer though the SOX2-CIgG pathway.
Neoplasms
Cancer-related long noncoding RNAs show aberrant expression profiles and competing endogenous RNA potential in esophageal adenocarcinoma.
Neoplasms
Cancer-specific expression quantitative loci are affected by expression dysregulation.
Neoplasms
Cancer-Specific Immune Prognostic Signature in Solid Tumors and Its Relation to Immune Checkpoint Therapies.
Neoplasms
Cancer-Specific Production of N-Acetylaspartate via NAT8L Overexpression in Non-Small Cell Lung Cancer and Its Potential as a Circulating Biomarker.
Neoplasms
Cancer-Specific Thresholds Adjust for Whole Exome Sequencing-based Tumor Mutational Burden Distribution.
Neoplasms
Cancer-Testis Antigen Expression in Serous Endometrial Cancer with Loss of X Chromosome Inactivation.
Neoplasms
Cancer-testis gene PIWIL1 promotes cell proliferation, migration, and invasion in lung adenocarcinoma.
Neoplasms
Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.
Neoplasms
Cancerin: A computational pipeline to infer cancer-associated ceRNA interaction networks.
Neoplasms
CancerMIRNome: an interactive analysis and visualization database for miRNome profiles of human cancer.
Neoplasms
CancerSiamese: one-shot learning for predicting primary and metastatic tumor types unseen during model training.
Neoplasms
CancerSplicingQTL: a database for genome-wide identification of splicing QTLs in human cancer.
Neoplasms
Candidate genes in gastric cancer identified by constructing a weighted gene co-expression network.
Neoplasms
Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer.
Neoplasms
Candidate serological biomarkers for cancer identified from the secretomes of 23 cancer cell lines and the human protein atlas.
Neoplasms
CanDrA: cancer-specific driver missense mutation annotation with optimized features.
Neoplasms
CanDriS: posterior profiling of cancer-driving sites based on two-component evolutionary model.
Neoplasms
Cannabidiol inhibits human glioma by induction of lethal mitophagy through activating TRPV4.
Neoplasms
Cannabinoid Receptor Type-2 in B Cells Is Associated with Tumor Immunity in Melanoma.
Neoplasms
Cannabinoids promote progression of HPV positive head and neck squamous cell carcinoma via p38 MAPK activation.
Neoplasms
CAPRI: efficient inference of cancer progression models from cross-sectional data.
Neoplasms
Caprin-1 promotes HepG2 cell proliferation, invasion and migration and is associated with poor prognosis in patients with liver cancer.
Neoplasms
Carbonic Anhydrase 4 serves as a Clinicopathological Biomarker for Outcomes and Immune Infiltration in Renal Cell Carcinoma, Lower Grade Glioma, Lung Adenocarcinoma and Uveal Melanoma.
Neoplasms
Carbonic-anhydrase IX expression is increased in thyroid cancer tissue and represents a potential therapeutic target to eradicate thyroid tumor-initiating cells.
Neoplasms
Carbonyl reductase 1 is a new target to improve the effect of radiotherapy on head and neck squamous cell carcinoma.
Neoplasms
Carcinoembryonic antigen cell adhesion molecule 6 (CEACAM6) in Pancreatic Ductal Adenocarcinoma (PDA): An integrative analysis of a novel therapeutic target.
Neoplasms
Carcinogenesis effects of E2F transcription factor 8 (E2F8) in hepatocellular carcinoma outcomes: an integrated bioinformatic report.
Neoplasms
CARD-Associated Risk Score Features the Immune Landscape and Predicts the Responsiveness to Anti-PD-1 Therapy in IDH Wild-Type Gliomas.
Neoplasms
CARD11 alteration as a candidate biomarker of skin cutaneous melanoma treated with immune checkpoint blockade.
Neoplasms
CARD11 is a prognostic biomarker and correlated with immune infiltrates in uveal melanoma.
Neoplasms
CARS as a Prognosis Factor in Clear Cell Renal Cell Carcinoma and Its Association with Tumor Immunity.
Neoplasms
Cartilage oligomeric matrix protein is a prognostic factor and biomarker of colon cancer and promotes cell proliferation by activating the Akt pathway.
Neoplasms
CAS-viewer: web-based tool for splicing-guided integrative analysis of multi-omics cancer data.
Neoplasms
CASC15 promotes epithelial to mesenchymal transition and facilitates malignancy of hepatocellular carcinoma cells by increasing TWIST1 gene expression via miR-33a-5p sponging.
Neoplasms
Cascaded Wx: A Novel Prognosis-Related Feature Selection Framework in Human Lung Adenocarcinoma Transcriptomes.
Neoplasms
Case Report: Exome sequencing reveals recurrent RETSAT mutations and a loss-of-function POLDIP2 mutation in a rare undifferentiated tongue sarcoma.
Neoplasms
Case Report: Novel RPGRIP1L Gene Mutations Identified by Whole Exome Sequencing in a Patient With Multiple Primary Tumors.
Neoplasms
Caspase 4 Overexpression as a Prognostic Marker in Clear Cell Renal Cell Carcinoma: A Study Based on the Cancer Genome Atlas Data Mining.
Neoplasms
Caspase Recruitment Domain Containing Protein 9 Suppresses Non-Small Cell Lung Cancer Proliferation and Invasion via Inhibiting MAPK/p38 Pathway.
Neoplasms
Catenin Alpha-2 Mutation Changes the Immune Microenvironment in Lung Adenocarcinoma Patients Receiving Immune Checkpoint Inhibitors.
Neoplasms
Cathepsin A knockdown decreases the proliferation and invasion of A549 lung adenocarcinoma cells.
Neoplasms
Causal Network Models for Predicting Compound Targets and Driving Pathways in Cancer.
Neoplasms
Causes of hOCT1-Dependent Cholangiocarcinoma Resistance to Sorafenib and Sensitization by Tumor-Selective Gene Therapy.
Neoplasms
CBX2 identified as driver of anoikis escape and dissemination in high grade serous ovarian cancer.
Neoplasms
CBX2 is a functional target of miRNA let-7a and acts as a tumor promoter in osteosarcoma.
Neoplasms
CBX3 Promotes Gastric Cancer Progression and Affects Factors Related to Immunotherapeutic Responses.
Neoplasms
CBX3/heterochromatin protein 1 gamma is significantly upregulated in patients with non-small cell lung cancer.
Neoplasms
CBX3/HP1? promotes tumor proliferation and predicts poor survival in hepatocellular carcinoma.
Neoplasms
CBX6 is negatively regulated by EZH2 and plays a potential tumor suppressor role in breast cancer.
Neoplasms
CCAAT/Enhancer Binding Protein ? Is Dispensable for Development of Lung Adenocarcinoma.
Neoplasms
CCAR1 and CCAR2 as gene chameleons with antagonistic duality: Preclinical, human translational, and mechanistic basis.
Neoplasms
CCDC137 Is a Prognostic Biomarker and Correlates With Immunosuppressive Tumor Microenvironment Based on Pan-Cancer Analysis.
Neoplasms
CCL2 produced by pancreatic ductal adenocarcinoma is essential for the accumulation and activation of monocytic myeloid-derived suppressor cells.
Neoplasms
CCNB2 and AURKA overexpression may cause atypical mitosis in Japanese cortisol-producing adrenocortical carcinoma with TP53 somatic variant.
Neoplasms
CCNB2, NUSAP1 and TK1 are associated with the prognosis and progression of hepatocellular carcinoma, as revealed by co-expression analysis.
Neoplasms
CCND1 Amplification Contributes to Immunosuppression and Is Associated With a Poor Prognosis to Immune Checkpoint Inhibitors in Solid Tumors.
Neoplasms
CCNE1 and BRD4 co-amplification in high-grade serous ovarian cancer is associated with poor clinical outcomes.
Neoplasms
CCR4, CCR8, and P2RY14 as Prognostic Factors in Head and Neck Squamous Cell Carcinoma Are Involved in the Remodeling of the Tumor Microenvironment.
Neoplasms
CCR5 blockade inflames antitumor immunity in BAP1-mutant clear cell renal cell carcinoma.
Neoplasms
CCR7 Has Potential to Be a Prognosis Marker for Cervical Squamous Cell Carcinoma and an Index for Tumor Microenvironment Change.
Neoplasms
CCR8 blockade primes anti-tumor immunity through intratumoral regulatory T cells destabilization in muscle-invasive bladder cancer.
Neoplasms
CD103+ tumor-resident CD8+ T cell numbers underlie improved patient survival in oropharyngeal squamous cell carcinoma.
Neoplasms
CD105 Is Expressed in Ovarian Cancer Precursor Lesions and Is Required for Metastasis to the Ovary.
Neoplasms
Cd11b(+) myeloid cells support hepatic metastasis through down-regulation of angiopoietin-like 7 in cancer cells.
Neoplasms
CD19+ tumor-infiltrating B-cells prime CD4+ T-cell immunity and predict platinum-based chemotherapy efficacy in muscle-invasive bladder cancer.
Neoplasms
CD2 Is a Novel Immune-Related Prognostic Biomarker of Invasive Breast Carcinoma That Modulates the Tumor Microenvironment.
Neoplasms
CD36 promotes vasculogenic mimicry in melanoma by mediating adhesion to the extracellular matrix.
Neoplasms
CD36 upregulates DEK transcription and promotes cell migration and invasion via GSK-3?/?-catenin-mediated epithelial-to-mesenchymal transition in gastric cancer.
Neoplasms
CD38 Predicts Favorable Prognosis by Enhancing Immune Infiltration and Antitumor Immunity in the Epithelial Ovarian Cancer Microenvironment.
Neoplasms
CD40 DNA hypermethylation in primary gastric tumors; as a novel diagnostic biomarker.
Neoplasms
CD44 SNP rs187115: A novel biomarker signature that predicts survival in resectable pancreatic ductal adenocarcinoma.
Neoplasms
CD44(+) tumor cells promote early angiogenesis in head and neck squamous cell carcinoma.
Neoplasms
CD44-Mediated Adhesion to Hyaluronic Acid Contributes to Mechanosensing and Invasive Motility.
Neoplasms
CD52 Is a Prognostic Biomarker and Associated With Tumor Microenvironment in Breast Cancer.
Neoplasms
CD70 as a target for chimeric antigen receptor T cells in head and neck squamous cell carcinoma.
Neoplasms
CD73 Overexpression Promotes Progression and Recurrence of Papillary Thyroid Carcinoma.
Neoplasms
CD74+ macrophages are associated with favorable prognosis and immune contexture in hepatocellular carcinoma.
Neoplasms
CDC20 and PTTG1 are Important Biomarkers and Potential Therapeutic Targets for Metastatic Prostate Cancer.
Neoplasms
CDC25B induces cellular senescence and correlates with tumor suppression in a p53-dependent manner.
Neoplasms
CDCA2 Inhibits Apoptosis and Promotes Cell Proliferation in Prostate Cancer and Is Directly Regulated by HIF-1? Pathway.
Neoplasms
CDCA2 promotes the proliferation of colorectal cancer cells by activating the AKT/CCND1 pathway in vitro and in vivo.
Neoplasms
CDCA2 promotes tumorigenesis and induces radioresistance in oesophageal squamous cell carcinoma cells.
Neoplasms
CDH1, DLEC1 and SFRP5 methylation panel as a prognostic marker for advanced epithelial ovarian cancer.
Neoplasms
CDH2 expression is of prognostic significance in glioma and predicts the efficacy of temozolomide therapy in patients with glioblastoma.
Neoplasms
CDK1/2/5 inhibition overcomes IFNG-mediated adaptive immune resistance in pancreatic cancer.
Neoplasms
CDK11p110 plays a critical role in the tumorigenicity of esophageal squamous cell carcinoma cells and is a potential drug target.
Neoplasms
CDK5 Knockdown inhibits proliferation and induces apoptosis and Cell Cycle Arrest in Human Glioblastoma.
Neoplasms
CDK6 inhibits lymphoid cell infiltration and represents a prognostic marker in HPV+ squamous cell carcinoma of head and neck.
Neoplasms
CDKN1C as a prognostic biomarker correlated with immune infiltrates and therapeutic responses in breast cancer patients.
Neoplasms
CDKN2A Copy Number Loss Is an Independent Prognostic Factor in HPV-Negative Head and Neck Squamous Cell Carcinoma.
Neoplasms
CDKN2A Deletion in Melanoma Excludes T Cell Infiltration by Repressing Chemokine Expression in a Cell Cycle-Dependent Manner.
Neoplasms
CDKN2C-Null Leiomyosarcoma: A Novel, Genomically Distinct Class of TP53/RB1-Wild-Type Tumor With Frequent CIC Genomic Alterations and 1p/19q-Codeletion.
Neoplasms
CDKN3 expression predicates poor prognosis and regulates adriamycin sensitivity in hepatocellular carcinoma in vitro.
Neoplasms
cDNA expression array analysis of DNA repair genes in human glioma cells that lack or express DNA-PK.
Neoplasms
CDO1 promoter methylation is associated with gene silencing and is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients.
Neoplasms
CDX2 and Muc2 immunohistochemistry as prognostic markers in stage II colon cancer.
Neoplasms
CEACAM Gene Family Mutations Associated With Inherited Breast Cancer Risk - A Comparative Oncology Approach to Discovery.
Neoplasms
CEACAM6 promotes cisplatin resistance in lung adenocarcinoma and is regulated by microRNA-146a and microRNA-26a.
Neoplasms
Celastrol induces lipophagy via the LXR?/ABCA1 pathway in clear cell renal cell carcinoma.
Neoplasms
Cell Cycle Genes Are Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma.
Neoplasms
Cell cycle progression score predicts metastatic progression of clear cell renal cell carcinoma after resection.
Neoplasms
Cell division cycle 20 overexpression predicts poor prognosis for patients with lung adenocarcinoma.
Neoplasms
Cell division cycle 45 promotes papillary thyroid cancer progression via regulating cell cycle.
Neoplasms
Cell Polarity Protein Pals1-Associated Tight Junction Expression Is a Favorable Prognostic Marker in Clear Cell Renal Cell Carcinoma.
Neoplasms
Cell surface GRP78 regulates BACE2 via lysosome-dependent manner to maintain mesenchymal phenotype of glioma stem cells.
Neoplasms
Cell Surface Proteomics of N-Linked Glycoproteins for Typing of Human Lymphocytes.
Neoplasms
Cell-Free DNA Analysis by Whole-Exome Sequencing for Hepatocellular Carcinoma: A Pilot Study in Thailand.
Neoplasms
Cell-free DNA analysis reveals POLR1D-mediated resistance to bevacizumab in colorectal cancer.
Neoplasms
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.
Neoplasms
Cell-type deconvolution analysis identifies cancer-associated myofibroblast component as a poor prognostic factor in multiple cancer types.
Neoplasms
Cell-type-specific meQTLs extend melanoma GWAS annotation beyond eQTLs and inform melanocyte gene-regulatory mechanisms.
Neoplasms
Cellular models of development of ovarian high-grade serous carcinoma: A review of cell of origin and mechanisms of carcinogenesis.
Neoplasms
CELSR3 mRNA expression is increased in hepatocellular carcinoma and indicates poor prognosis.
Neoplasms
CeNETs analysis reveals the prognostic value of a signature integration from five lncRNAs in breast cancer.
Neoplasms
Centromere Protein F (CENPF) Serves as a Potential Prognostic Biomarker and Target for Human Hepatocellular Carcinoma.
Neoplasms
Centromere protein N may be a novel malignant prognostic biomarker for hepatocellular carcinoma.
Neoplasms
Centromere protein U expression promotes non-small-cell lung cancer cell proliferation through FOXM1 and predicts poor survival.
Neoplasms
Ceramide Pathway Regulators Predict Clinical Prognostic Risk and Affect the Tumor Immune Microenvironment in Lung Adenocarcinoma.
Neoplasms
Ceramide species are elevated in human breast cancer and are associated with less aggressiveness.
Neoplasms
Cerebellar 'transcriptome' reveals cell-type and stage-specific expression during postnatal development and tumorigenesis.
Neoplasms
CeRNA Network Analysis Representing Characteristics of Different Tumor Environments Based on 1p/19q Codeletion in Oligodendrogliomas.
Neoplasms
ceRNA network development and tumor-infiltrating immune cell analysis in hepatocellular carcinoma.
Neoplasms
ceRNA network development and tumour-infiltrating immune cell analysis of metastatic breast cancer to bone.
Neoplasms
CERNA SEARCH METHOD IDENTIFIED A MET-ACTIVATED SUBGROUP AMONG EGFR DNA AMPLIFIED LUNG ADENOCARCINOMA PATIENTS.
Neoplasms
Cervical chordoma in a domestic ferret (Mustela putorius furo) with pulmonary metastasis.
Neoplasms
Cervical myelopathy caused by atlas osteochondroma and pseudoarthrosis between the osteochondroma and lamina of the axis: case report.
Neoplasms
cg04448376, cg24387542, cg08548498, and cg14621323 as a Novel Signature to Predict Prognosis in Kidney Renal Papillary Cell Carcinoma.
Neoplasms
CGB5 expression is independently associated with poor overall survival and recurrence-free survival in patients with advanced gastric cancer.
Neoplasms
Challenges and opportunities in the proteomic characterization of clear cell renal cell carcinoma (ccRCC): A critical step towards the personalized care of renal cancers.
Neoplasms
Challenges in molecular targeted therapy for gastric cancer: considerations for efficacy and safety.
Neoplasms
Changes in correlation between promoter methylation and gene expression in cancer.
Neoplasms
Changes in gene expression profile induced by the anticancer agent Aplidine in Molt-4 leukemic cell lines.
Neoplasms
Changes in microRNA expression associated with metastasis and survival in patients with uveal melanoma.
Neoplasms
Changes in WT1 splicing are associated with a specific gene expression profile in Wilms' tumour.
Neoplasms
Chaperonin-Containing TCP1 Subunit 6A Is a Prognostic Potential Biomarker That Correlates With the Presence of Immune Infiltrates in Colorectal Cancer.
Neoplasms
Characterising cis-regulatory variation in the transcriptome of histologically normal and tumour-derived pancreatic tissues.
Neoplasms
Characteristic Analysis of Featured Genes Associated With Stemness Indices in Colorectal Cancer.
Neoplasms
Characteristic miRNA expression signature and random forest survival analysis identify potential cancer-driving miRNAs in a broad range of head and neck squamous cell carcinoma subtypes.
Neoplasms
Characteristics of B lymphocyte infiltration in HPV+ head and neck squamous cell carcinoma.
Neoplasms
Characteristics of The Cancer Genome Atlas cases relative to U.S. general population cancer cases.
Neoplasms
Characterization and prognostic significance of alternative splicing events in lower-grade diffuse gliomas.
Neoplasms
Characterization of a 4 lncRNAs-based prognostic risk scoring system in adults with acute myeloid leukemia.
Neoplasms
Characterization of a ferroptosis and iron-metabolism related lncRNA signature in lung adenocarcinoma.
Neoplasms
Characterization of a five-microRNA signature as a prognostic biomarker for esophageal squamous cell carcinoma.
Neoplasms
Characterization of a non-coding RNA-associated ceRNA network in metastatic lung adenocarcinoma.
Neoplasms
Characterization of a prognostic four?gene methylation signature associated with radiotherapy for head and neck squamous cell carcinoma.
Neoplasms
Characterization of Alternative Splicing Events in HPV-Negative Head and Neck Squamous Cell Carcinoma Identifies an Oncogenic DOCK5 Variant.
Neoplasms
Characterization of an endoplasmic reticulum stress-related signature to evaluate immune features and predict prognosis in glioma.
Neoplasms
Characterization of bidirectional gene pairs in The Cancer Genome Atlas (TCGA) dataset.
Neoplasms
Characterization of cancer-related somatic mutations in the adenosine A2B receptor.
Neoplasms
Characterization of cell lines derived from tumors induced by TC-1 cells in mice preimmunized against HPV16 E7 oncoprotein.
Neoplasms
Characterization of ceRNA network to reveal potential prognostic biomarkers in triple-negative breast cancer.
Neoplasms
Characterization of Clinical Cases of Advanced Papillary Renal Cell Carcinoma via Comprehensive Genomic Profiling.
Neoplasms
Characterization of copy number alterations in a mouse model of fibrosis-associated hepatocellular carcinoma reveals concordance with human disease.
Neoplasms
Characterization of ferroptosis signature to evaluate the predict prognosis and immunotherapy in glioblastoma.
Neoplasms
Characterization of Frequently Mutated Cancer Genes and Tumor Mutation Burden in Chinese Breast Cancer.
Neoplasms
Characterization of frequently mutated cancer genes in Chinese breast tumors: a comparison of Chinese and TCGA cohorts.
Neoplasms
Characterization of functionally active gene fusions in human papillomavirus related oropharyngeal squamous cell carcinoma.
Neoplasms
Characterization of fusion genes in common and rare epithelial ovarian cancer histologic subtypes.
Neoplasms
Characterization of gene expression profiles of esophageal cancer patients with different nonsynonymous tumor mutation burden.
Neoplasms
Characterization of hazard infiltrating immune cells and relative risk genes in bladder urothelial carcinoma.
Neoplasms
Characterization of HCC Mouse Models: Towards an Etiology-Oriented Subtyping Approach.
Neoplasms
Characterization of hepatitis B virus DNA integration patterns in intrahepatic cholangiocarcinoma.
Neoplasms
Characterization of Hepatocellular Carcinoma Cell Lines Using a Fractionation-Then-Sequencing Approach Reveals Nuclear-Enriched HCC-Associated lncRNAs.
Neoplasms
Characterization of Histone Deacetylase Expression Within In Vitro and In Vivo Bladder Cancer Model Systems.
Neoplasms
Characterization of Hypoxia Signature to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Glioma Groups.
Neoplasms
Characterization of Hypoxia-associated Molecular Features to Aid Hypoxia-Targeted Therapy.
Neoplasms
Characterization of Immune Infiltration and Construction of a Prediction Model for Overall Survival in Melanoma Patients.
Neoplasms
Characterization of immune regulatory molecules B7-H4 and PD-L1 in low and high grade endometrial tumors.
Neoplasms
Characterization of kallikrein-related peptidase 4 (KLK4) mRNA expression in tumor tissue of advanced high-grade serous ovarian cancer patients.
Neoplasms
Characterization of long non-coding RNA and messenger RNA profiles in laryngeal cancer by weighted gene co-expression network analysis.
Neoplasms
Characterization of long non-coding RNA transcriptome in clear-cell renal cell carcinoma by next-generation deep sequencing.
Neoplasms
Characterization of long non-coding RNAs to reveal potential prognostic biomarkers in hepatocellular carcinoma.
Neoplasms
Characterization of mRNA Expression and Endogenous RNA Profiles in Bladder Cancer Based on The Cancer Genome Atlas (TCGA) Database.
Neoplasms
Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features.
Neoplasms
Characterization of PHGDH expression in bladder cancer: potential targeting therapy with gemcitabine/cisplatin and the contribution of promoter DNA hypomethylation.
Neoplasms
Characterization of ROS Metabolic Equilibrium Reclassifies Pan-Cancer Samples and Guides Pathway Targeting Therapy.
Neoplasms
Characterization of SLC22A18 as a tumor suppressor and novel biomarker in colorectal cancer.
Neoplasms
Characterization of somatic mutation-associated microenvironment signatures in acute myeloid leukemia patients based on TCGA analysis.
Neoplasms
Characterization of TERT and BRAF copy number variation in papillary thyroid carcinoma: An analysis of the cancer genome atlas study.
Neoplasms
Characterization of the Clinical Significance of PD-1/PD-Ls Expression and Methylation in Patients With Low-Grade Glioma.
Neoplasms
Characterization of the dual functional effects of heat shock proteins (HSPs) in cancer hallmarks to aid development of HSP inhibitors.
Neoplasms
Characterization of the fatty acid metabolism in colorectal cancer to guide clinical therapy.
Neoplasms
Characterization of the immune profile of oral tongue squamous cell carcinomas with advancing disease.
Neoplasms
Characterization of tissue histopathology via predictive sparse decomposition and spatial pyramid matching.
Neoplasms
Characterization of transcriptome profile and clinical features of a novel immunotherapy target CD204 in diffuse glioma.
Neoplasms
Characterization of Tumor Blood Vasculature Expression of Human Invasive Bladder Cancer by Laser Capture Microdissection and Transcriptional Profiling.
Neoplasms
Characterization of Tumor-Suppressor Gene Inactivation Events in 33 Cancer Types.
Neoplasms
Characterization of tumors with ultralow tumor mutational burden in Japanese cancer patients.
Neoplasms
Characterization of unique PMEPA1 gene splice variants (isoforms d and e) from RNA Seq profiling provides novel insights into prognostic evaluation of prostate cancer.
Neoplasms
Characterizing diversity in the tumor-immune microenvironment of distinct subclasses of gastroesophageal adenocarcinomas.
Neoplasms
Characterizing genomic differences of human cancer stratified by the TP53 mutation status.
Neoplasms
Characterizing recurrent and lethal small renal masses in clear cell renal cell carcinoma using recurrent somatic mutations.
Neoplasms
Characterizing the heterogeneity in 5-aminolevulinic acid-induced fluorescence in glioblastoma.
Neoplasms
Characterizing the heterogeneity of triple-negative breast cancers using microdissected normal ductal epithelium and RNA-sequencing.
Neoplasms
Characterizing the landscape of peritoneal exosomal microRNAs in patients with ovarian cancer by high-throughput sequencing.
Neoplasms
Charting a shared epigenetic pathway to CD8+ T cell dysfunction in infection and cancer.
Neoplasms
CHD4 as an important mediator in regulating the malignant behaviors of colorectal cancer.
Neoplasms
CHD4 regulates platinum sensitivity through MDR1 expression in ovarian cancer: A potential role of CHD4 inhibition as a combination therapy with platinum agents.
Neoplasms
Checkpoint Genes at the Cancer Side of the Immunological Synapse in Bladder Cancer.
Neoplasms
Checkpoint inhibitors in endometrial cancer: preclinical rationale and clinical activity.
Neoplasms
Chemical complementarity between immune receptors and cancer mutants, independent of antigen presentation protein binding, is associated with increased survival rates.
Neoplasms
Chemokine C-C motif ligand 21 synergized with programmed death-ligand 1 blockade restrains tumor growth.
Neoplasms
Chemokine receptor 4 expression is correlated with the occurrence and prognosis of gastric cancer.
Neoplasms
Chemoresistance-associated alternative splicing signatures in serous ovarian cancer.
Neoplasms
CHFR Promoter Hypermethylation Is Associated with Gastric Cancer and Plays a Protective Role in Gastric Cancer Process.
Neoplasms
CHFR?mediated epithelial?to?mesenchymal transition promotes metastasis in human breast cancer cells.
Neoplasms
ChimerDB 3.0: an enhanced database for fusion genes from cancer transcriptome and literature data mining.
Neoplasms
Chitinase 3-like-1 and fibronectin in the cargo of extracellular vesicles shed by human macrophages influence pancreatic cancer cellular response to gemcitabine.
Neoplasms
CHMP4C regulates lung squamous carcinogenesis and progression through cell cycle pathway.
Neoplasms
Cholangiocarcinoma: anatomical location-dependent clinical, prognostic, and genetic disparities.
Neoplasms
Cholangiolar pattern and albumin in situ hybridisation enable a diagnosis of intrahepatic cholangiocarcinoma.
Neoplasms
Chondroitin polymerizing factor promotes breast carcinoma cell proliferation, invasion and migration and affects expression of epithelial-mesenchymal transition-related markers.
Neoplasms
Chr20q Amplification Defines a Distinct Molecular Subtype of Microsatellite Stable Colorectal Cancer.
Neoplasms
Chromatin-regulating genes are associated with postoperative prognosis and isocitrate dehydrogenase mutation in astrocytoma.
Neoplasms
Chromatin-regulatory genes served as potential therapeutic targets for patients with urothelial bladder carcinoma.
Neoplasms
Chromosomal breaks at FRA18C: association with reduced DOK6 expression, altered oncogenic signaling and increased gastric cancer survival.
Neoplasms
Chromosomal Density of Cancer Up-Regulated Genes, Aberrant Enhancer Activity and Cancer Fitness Genes Are Associated with Transcriptional Cis-Effects of Broad Copy Number Gains in Colorectal Cancer.
Neoplasms
Chromosomal instability in untreated primary prostate cancer as an indicator of metastatic potential.
Neoplasms
Chromosomal Instability May Not Be a Predictor for Immune Checkpoint Inhibitors from a Comprehensive Bioinformatics Analysis.
Neoplasms
Chromosome 17p Homodisomy Is Associated With Better Outcome in 1p19q Non-Codeleted and IDH-Mutated Gliomas.
Neoplasms
Chromosome 20q Amplification Defines a Subtype of Microsatellite Stable, Left-sided Colon Cancers with Wild-type RAS/RAF and Better Overall Survival.
Neoplasms
Chrysosplenol D Triggers Apoptosis through Heme Oxygenase-1 and Mitogen-Activated Protein Kinase Signaling in Oral Squamous Cell Carcinoma.
Neoplasms
CIBERSORT analysis of TCGA and METABRIC identifies subgroups with better outcomes in triple negative breast cancer.
Neoplasms
CILP2 overexpression correlates with tumor progression and poor prognosis in patients with colorectal cancer in The Cancer Genome Atlas (TCGA) study.
Neoplasms
Cinobufagin Triggers Defects in Spindle Formation and Cap-Dependent Translation in Liver Cancer Cells by Inhibiting the AURKA-mTOR-eIF4E Axis.
Neoplasms
circ?0000212 promotes cell proliferation of colorectal cancer by sponging miR?491 and modulating FOXP4 expression.
Neoplasms
circCCND1 Regulates Oxidative Stress and FGF9 to Enhance Chemoresistance of Non-Small Cell Lung Cancer via Sponging miR-187-3p.
Neoplasms
circExp database: an online transcriptome platform for human circRNA expressions in cancers.
Neoplasms
CircMMP11 acts as a ce-circRNA in breast cancer progression by regulating miR-1204.
Neoplasms
circMTO1 sponges microRNA-219a-5p to enhance gallbladder cancer progression via the TGF-?/Smad and EGFR pathways.
Neoplasms
circRNA-associated ceRNA network construction reveals the circRNAs involved in the progression and prognosis of breast cancer.
Neoplasms
Circular RNA hsa_circ_0005114-miR-142-3p/miR-590-5p-adenomatous polyposis coli protein axis as a potential target for treatment of glioma.
Neoplasms
Circular RNA hsa_circ_0072995 promotes breast cancer cell migration and invasion through sponge for miR-30c-2-3p.
Neoplasms
Circular RNA regulatory network reveals cell-cell crosstalk in acute myeloid leukemia extramedullary infiltration.
Neoplasms
Circular RNA-Associated Competing Endogenous RNA Network and Prognostic Nomogram for Patients With Colorectal Cancer.
Neoplasms
Circular RNA_PDHX Promotes the Proliferation and Invasion of Prostate Cancer by Sponging MiR-378a-3p.
Neoplasms
Circulating and Tumor-Infiltrating NK Cells From Clear Cell Renal Cell Carcinoma Patients Exhibit a Predominantly Inhibitory Phenotype Characterized by Overexpression of CD85j, CD45, CD48 and PD-1.
Neoplasms
Circulating cell-free DNA-based methylation patterns for breast cancer diagnosis.
Neoplasms
Circulating Exosomal MicroRNA-1307-5p as a Predictor for Metastasis in Patients with Hepatocellular Carcinoma.
Neoplasms
Circulating let-7e-5p, miR-106a-5p, miR-28-3p, and miR-542-5p as a Promising microRNA Signature for the Detection of Colorectal Cancer.
Neoplasms
Circulating let-7f-5p improve risk prediction of prostate cancer in patients with benign prostatic hyperplasia.
Neoplasms
Circulating Long RNAs in Serum Extracellular Vesicles: Their Characterization and Potential Application as Biomarkers for Diagnosis of Colorectal Cancer.
Neoplasms
Circulating mRNAs and miRNAs as candidate markers for the diagnosis and prognosis of prostate cancer.
Neoplasms
Circulating PD-1 mRNA in Peripheral Blood is a Potential Biomarker for Predicting Survival of Breast Cancer Patients.
Neoplasms
Cisplatin and Pemetrexed Activate AXL and AXL Inhibitor BGB324 Enhances Mesothelioma Cell Death from Chemotherapy.
Neoplasms
Cistrome Cancer: A Web Resource for Integrative Gene Regulation Modeling in Cancer.
Neoplasms
CITED1 gene promotes proliferation, migration and invasion in papillary thyroid cancer.
Neoplasms
CITED1 promotes proliferation of papillary thyroid cancer cells via the regulation of p21 and p27.
Neoplasms
CK2 Activity Mediates the Aggressive Molecular Signature of Glioblastoma Multiforme by Inducing Nerve/Glial Antigen (NG)2 Expression.
Neoplasms
CKAP2 expression is associated with glioma tumor growth and acts as a prognostic factor in high?grade glioma.
Neoplasms
CKAP2L Knockdown Exerts Antitumor Effects by Increasing miR-4496 in Glioblastoma Cell Lines.
Neoplasms
CKMT1 and NCOA1 expression as a predictor of clinical outcome in patients with advanced-stage head and neck squamous cell carcinoma.
Neoplasms
CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
Neoplasms
CKS2 modulates cell-cycle progression of tongue squamous cell carcinoma cells partly via modulating the cellular distribution of DUTPase.
Neoplasms
Clarifying the biological significance of the CHK2 K373E somatic mutation discovered in The Cancer Genome Atlas database.
Neoplasms
Claspin Overexpression Promotes Tumor Progression and Predicts Poor Clinical Outcome in Prostate Cancer.
Neoplasms
Classic Chromophobe Renal Cell Carcinoma Incur a Larger Number of Chromosomal Losses Than Seen in the Eosinophilic Subtype.
Neoplasms
Classical pathology and mutational load of breast cancer - integration of two worlds.
Neoplasms
Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning.
Neoplasms
Classification and Prognosis Prediction from Histopathological Images of Hepatocellular Carcinoma by a Fully Automated Pipeline Based on Machine Learning.
Neoplasms
Classification models for clear cell renal carcinoma stage progression, based on tumor RNAseq expression trained supervised machine learning algorithms.
Neoplasms
Classification models for Invasive Ductal Carcinoma Progression, based on gene expression data-trained supervised machine learning.
Neoplasms
Classification of breast cancer patients using somatic mutation profiles and machine learning approaches.
Neoplasms
Classification of early and late stage liver hepatocellular carcinoma patients from their genomics and epigenomics profiles.
Neoplasms
Classification of Genes Based on Age-Related Differential Expression in Breast Cancer.
Neoplasms
Classification of High-Grade Serous Ovarian Carcinoma by Epithelial-to-Mesenchymal Transition Signature and Homologous Recombination Repair Genes.
Neoplasms
Classification of Histology Sections via Multispectral Convolutional Sparse Coding.
Neoplasms
Classification of Lung Adenocarcinoma Based on Immune Checkpoint and Screening of Related Genes.
Neoplasms
Classification of lung adenocarcinoma transcriptome subtypes from pathological images using deep convolutional networks.
Neoplasms
Classification of ovarian cancer associated with BRCA1 mutations, immune checkpoints, and tumor microenvironment based on immunogenomic profiling.
Neoplasms
Classifier of cross talk genes predicts the prognosis of hepatocellular carcinoma.
Neoplasms
Classifying Breast Cancer Subtypes Using Deep Neural Networks Based on Multi-Omics Data.
Neoplasms
Classifying cancer genome aberrations by their mutually exclusive effects on transcription.
Neoplasms
Classifying non-small cell lung cancer types and transcriptomic subtypes using convolutional neural networks.
Neoplasms
Claudin-6 is a single prognostic marker and functions as a tumor-promoting gene in a subgroup of intestinal type gastric cancer.
Neoplasms
Claudin-7 indirectly regulates the integrin/FAK signaling pathway in human colon cancer tissue.
Neoplasms
CLCA2 as a novel immunohistochemical marker for differential diagnosis of squamous cell carcinoma from adenocarcinoma of the lung.
Neoplasms
CLDN10 single nucleotide polymorphism rs1325774 alters the risk of breast cancer in south chinese women.
Neoplasms
Clear Cell Papillary Renal Cell Carcinoma Shares Distinct Molecular Characteristics and may be Significantly Associated With Higher Risk of Developing Second Primary Malignancy.
Neoplasms
CLEC3B is downregulated and inhibits proliferation in clear cell renal cell carcinoma.
Neoplasms
Clinical and biologic roles of PDGFRA in papillary thyroid cancer: a study based on immunohistochemical and in vitro analyses.
Neoplasms
Clinical and biological implications of IDH1/2 in acute myeloid leukemia with DNMT3Amut.
Neoplasms
Clinical and Biological Implications of Mutational Spectrum in Acute Myeloid Leukemia of FAB Subtypes M0 and M1.
Neoplasms
Clinical and biological significance of transcription termination factor, RNA polymerase I in human liver hepatocellular carcinoma.
Neoplasms
Clinical and Biological Significances of a Ferroptosis-Related Gene Signature in Glioma.
Neoplasms
Clinical and Biological Significances of a Methyltransferase-Related Signature in Diffuse Glioma.
Neoplasms
Clinical and genetic signatures of local recurrence in oral squamous cell carcinoma.
Neoplasms
Clinical and genomic characterization of neutral tumor evolution in Head and Neck Squamous Cell Carcinoma.
Neoplasms
Clinical and genomic landscape of hepatocellular carcinoma subtypes with various proportions of nonleukocyte stromal cells.
Neoplasms
Clinical and Molecular Correlates of Tumor Mutation Burden in Non-Small Cell Lung Cancer.
Neoplasms
Clinical and molecular relevance of mutant-allele tumor heterogeneity in breast cancer.
Neoplasms
Clinical and preclinical characterization of CD99 isoforms in acute myeloid leukemia.
Neoplasms
Clinical and prognostic effects of CDKN2A, CDKN2B and CDH13 promoter methylation in ovarian cancer: a study using meta-analysis and TCGA data.
Neoplasms
Clinical and prognostic value of chaperonin containing T-complex 1 subunit 3 in hepatocellular carcinoma: A Study based on microarray and RNA-sequencing with 4272 cases.
Neoplasms
Clinical and RNA expression integrated signature for urothelial bladder cancer prognosis.
Neoplasms
Clinical and Survival Impact of Sex-Determining Region Y-Box 2 in Colorectal Cancer: An Integrated Analysis of the Immunohistochemical Study and Bioinformatics Analysis.
Neoplasms
Clinical applicability of renin-angiotensin system inhibitors in cancer treatment.
Neoplasms
Clinical application of three-dimensional printing in the personalized treatment of complex spinal disorders.
Neoplasms
Clinical applications of The Cancer Genome Atlas project (TCGA) for squamous cell lung carcinoma.
Neoplasms
Clinical characteristics and prognostic significance of TCGA and ACRG classification in gastric cancer among the Chinese population.
Neoplasms
Clinical characterization, genetic profiling, and immune infiltration of TOX in diffuse gliomas.
Neoplasms
Clinical classification of cardiovascular tumors and tumor-like lesions, and its incidences.
Neoplasms
Clinical correlates of subventricular zone-contacting glioblastomas: a meta-analysis.
Neoplasms
Clinical effect of MUC1 and its relevance to BRAF V600E mutation in papillary thyroid carcinoma: a case-control study.
Neoplasms
Clinical evaluation of multi-atlas based segmentation of lymph node regions in head and neck and prostate cancer patients.
Neoplasms
Clinical features and prognosis of normal karyotype acute myeloid leukemia pediatric patients with WT1 mutations: an analysis based on TCGA database.
Neoplasms
Clinical genome sequencing uncovers potentially targetable truncations and fusions of MAP3K8 in spitzoid and other melanomas.
Neoplasms
Clinical Implementation of Novel Targeted Therapeutics in Advanced Breast Cancer.
Neoplasms
Clinical implications of a novel prognostic factor AIFM3 in breast cancer patients.
Neoplasms
Clinical Implications of Aberrant PD-1 and CTLA4 Expression for Cancer Immunity and Prognosis: A Pan-Cancer Study.
Neoplasms
Clinical implications of ALDH1A1 and ALDH1A3 mRNA expression in melanoma subtypes.
Neoplasms
Clinical Multigene Panel Sequencing Identifies Distinct Mutational Association Patterns in Metastatic Colorectal Cancer.
Neoplasms
Clinical outcome and global gene expression data support the existence of the estrogen receptor-negative/progesterone receptor-positive invasive breast cancer phenotype.
Neoplasms
Clinical performance of E2Fs 1-3 in kidney clear cell renal cancer, evidence from bioinformatics analysis.
Neoplasms
Clinical performance validation of PITX2 DNA methylation as prognostic biomarker in patients with head and neck squamous cell carcinoma.
Neoplasms
Clinical Prognostic Significance of HOXC9 Expression in Patients with Colorectal Cancer.
Neoplasms
Clinical Relevance of microRNA Expressions in Breast Cancer Validated Using the Cancer Genome Atlas (TCGA).
Neoplasms
Clinical response of a patient to anti-PD-1 immunotherapy and the immune landscape of testicular germ cell tumors.
Neoplasms
Clinical role and biological function of CDK5 in hepatocellular carcinoma: A study based on immunohistochemistry, RNA-seq and
Neoplasms
Clinical roles of the aberrantly expressed lncRNAs in lung squamous cell carcinoma: a study based on RNA-sequencing and microarray data mining.
Neoplasms
Clinical signi?cance and prognostic value of SOX7 expression in liver and pancreatic carcinoma.
Neoplasms
Clinical significance and biological mechanisms of glutathione S-transferase mu gene family in colon adenocarcinoma.
Neoplasms
Clinical significance and biological role of cancer-derived Type I collagen in lung and esophageal cancers.
Neoplasms
Clinical significance and effect of AEG-1 on the proliferation, invasion, and migration of NSCLC: a study based on immunohistochemistry, TCGA, bioinformatics, in vitro and in vivo verification.
Neoplasms
Clinical significance and effect of MTDH/AEG-1 in bladder urothelial cancer: a study based on immunohistochemistry, RNA-seq, and in vitro verification.
Neoplasms
Clinical Significance and Immunologic Landscape of a Five-IL(R)-Based Signature in Lung Adenocarcinoma.
Neoplasms
Clinical Significance And Integrative Analysis Of Kinesin Family Member 18B In Lung Adenocarcinoma.
Neoplasms
Clinical significance and potential mechanisms of miR-223-3p and miR-204-5p in squamous cell carcinoma of head and neck: a study based on TCGA and GEO.
Neoplasms
Clinical significance and prognostic role of an immune-related gene signature in gastric adenocarcinoma.
Neoplasms
Clinical significance and prospective molecular mechanism of C?C motif chemokine receptors in patients with early?stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy.
Neoplasms
Clinical significance and prospective molecular mechanism of MALAT1 in pancreatic cancer exploration: a comprehensive study based on the GeneChip, GEO, Oncomine, and TCGA databases.
Neoplasms
Clinical Significance and Systematic Expression Analysis of the Thyroid Receptor Interacting Protein 13 (TRIP13) as Human Gliomas Biomarker.
Neoplasms
Clinical Significance and the Role of Guanylate-Binding Protein 5 in Oral Squamous Cell Carcinoma.
Neoplasms
Clinical Significance of a Novel Tumor Progression-Associated Immune Signature in Colorectal Adenocarcinoma.
Neoplasms
Clinical Significance of an m6A Reader Gene, IGF2BP2, in Head and Neck Squamous Cell Carcinoma.
Neoplasms
Clinical significance of CDKN2A homozygous deletion in combination with methylated MGMT status for IDH-wildtype glioblastoma.
Neoplasms
Clinical significance of CTNNB1 mutation and Wnt pathway activation in endometrioid endometrial carcinoma.
Neoplasms
Clinical Significance of FANCD2 Gene Expression and its Association with Tumor Progression in Hepatocellular Carcinoma.
Neoplasms
Clinical Significance of Four Molecular Subtypes of Gastric Cancer Identified by The Cancer Genome Atlas Project.
Neoplasms
Clinical significance of high expression of miR-452-5p in lung squamous cell carcinoma.
Neoplasms
Clinical significance of long non-coding RNA DUXAP8 and its protein coding genes in hepatocellular carcinoma.
Neoplasms
Clinical significance of long non-coding RNA HOTTIP in early-stage non-small-cell lung cancer.
Neoplasms
Clinical significance of long noncoding RNA maternally expressed gene 3 in acute promyelocytic leukemia.
Neoplasms
Clinical significance of long noncoding RNA MNX1-AS1 in human cancers: a meta-analysis of cohort studies and bioinformatics analysis based on TCGA datasets.
Neoplasms
Clinical significance of LSECtin and its association with PVR in non-small-cell lung cancer patients.
Neoplasms
Clinical Significance of microRNA-196b-5p in Hepatocellular Carcinoma and its Potential Molecular Mechanism.
Neoplasms
Clinical Significance of miR-210 and its Prospective Signaling Pathways in Non-Small Cell Lung Cancer: Evidence from Gene Expression Omnibus and the Cancer Genome Atlas Data Mining with 2763 Samples and Validation via Real-Time Quantitative PCR.
Neoplasms
Clinical significance of miRNA host gene promoter methylation in prostate cancer.
Neoplasms
Clinical significance of PD-1/PD-Ls gene amplification and overexpression in patients with hepatocellular carcinoma.
Neoplasms
Clinical significance of signal regulatory protein alpha (SIRP?) expression in esophageal squamous cell carcinoma.
Neoplasms
Clinical Significance of the Interleukin 24 mRNA Level in Head and Neck Squamous Cell Carcinoma and Its Subgroups: An In Silico Investigation.
Neoplasms
Clinical Significance of TRMT6 in Hepatocellular Carcinoma: A Bioinformatics-Based Study.
Neoplasms
Clinical Significance of Tumor and Immune Cell PD-L1 Expression in Gastric Adenocarcinoma.
Neoplasms
Clinical significance of ZNF750 gene expression, a novel tumor suppressor gene, in esophageal squamous cell carcinoma.
Neoplasms
Clinical stratification of glioblastoma based on alterations in retinoblastoma tumor suppressor protein (RB1) and association with the proneural subtype.
Neoplasms
Clinical use of a machine learning histopathological image signature in diagnosis and survival prediction of clear cell renal cell carcinoma.
Neoplasms
Clinical use of machine learning-based pathomics signature for diagnosis and survival prediction of bladder cancer.
Neoplasms
Clinical usefulness of gastric adenocarcinoma predictive long intergenic noncoding RNA in human malignancies: A meta-analysis.
Neoplasms
Clinical Utility of Patient-Derived Xenografts to Determine Biomarkers of Prognosis and Map Resistance Pathways in EGFR-Mutant Lung Adenocarcinoma.
Neoplasms
Clinical utility of the S3-score for molecular prediction of outcome in non-metastatic and metastatic clear cell renal cell carcinoma.
Neoplasms
Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set.
Neoplasms
Clinical value and potential pathways of miR-183-5p in bladder cancer: A study based on miRNA-seq data and bioinformatics analysis.
Neoplasms
Clinical value and potential targets of miR-224-5p in hepatocellular carcinoma validated by a TCGA- and GEO- based study.
Neoplasms
Clinical Value and Prospective Pathway Signaling of MicroRNA-375 in Lung Adenocarcinoma: A Study Based on the Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO) and Bioinformatics Analysis.
Neoplasms
Clinical Value of lncRNA LUCAT1 Expression in Liver Cancer and its Potential Pathways.
Neoplasms
Clinical value of microRNA-198-5p downregulation in lung adenocarcinoma and its potential pathways.
Neoplasms
Clinical Value of miR-101-3p and Biological Analysis of its Prospective Targets in Breast Cancer: A Study Based on The Cancer Genome Atlas (TCGA) and Bioinformatics.
Neoplasms
Clinical value of miR-145-5p in NSCLC and potential molecular mechanism exploration: A retrospective study based on GEO, qRT-PCR, and TCGA data.
Neoplasms
Clinical value of miR-182-5p in lung squamous cell carcinoma: a study combining data from TCGA, GEO, and RT-qPCR validation.
Neoplasms
Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.
Neoplasms
Clinical value of miR-452-5p expression in lung adenocarcinoma: A retrospective quantitative real-time polymerase chain reaction study and verification based on The Cancer Genome Atlas and Gene Expression Omnibus databases.
Neoplasms
Clinical value of miRNA-122 in the diagnosis and prognosis of various types of cancer.
Neoplasms
Clinical value of preoperative methylated septin 9 in Chinese colorectal cancer patients.
Neoplasms
Clinical value screening, prognostic significance and key pathway identification of miR-204-5p in endometrial carcinoma: A study based on the Cancer Genome Atlas (TCGA), and bioinformatics analysis.
Neoplasms
Clinical, Pathology, Genetic, and Molecular Features of Colorectal Tumors in Adolescents and Adults 25 Years or Younger.
Neoplasms
Clinicopathologic and Genomic Factors Associated With Oncologic Outcome in Patients With Stage III to IV Chromophobe Renal Cell Carcinoma.
Neoplasms
Clinicopathologic significance of legumain overexpression in cancer: a systematic review and meta-analysis.
Neoplasms
Clinicopathological analysis of endometrial carcinomas harboring somatic POLE exonuclease domain mutations.
Neoplasms
Clinicopathological and molecular characterisation of 'multiple-classifier' endometrial carcinomas.
Neoplasms
Clinicopathological and Prognostic Characteristics of CD276 (B7-H3) Expression in Adrenocortical Carcinoma.
Neoplasms
Clinicopathological and Prognostic Characteristics of RAD51 in Colorectal Cancer.
Neoplasms
Clinicopathological and prognostic impact of somatic mutations in Chinese patients with clear cell renal cell carcinoma.
Neoplasms
Clinicopathological and prognostic significance of caveolin-1 and ATG4C expression in the epithelial ovarian cancer.
Neoplasms
Clinicopathological and prognostic significance of Ras association and pleckstrin homology domains 1 (RAPH1) in breast cancer.
Neoplasms
Clinicopathological and Prognostic Value of Long Noncoding RNA SNHG15 in Human Cancers: a Meta-Analysis and Bioinformatics.
Neoplasms
Clinicopathological Features of Triple-Negative Breast Cancer Epigenetic Subtypes.
Neoplasms
Clinicopathological Implication of Long Non-Coding RNAs SOX2 Overlapping Transcript and Its Potential Target Gene Network in Various Cancers.
Neoplasms
Clinicopathological significance of microRNA-21 in extracellular vesicles of pleural lavage fluid of lung adenocarcinoma and its functions inducing the mesothelial to mesenchymal transition.
Neoplasms
Clinicopathological significance of miR-27b targeting Golgi protein 73 in patients with hepatocellular carcinoma.
Neoplasms
Clinicopathological Significance of MTUS1 Expression in Patients With Renal Cell Carcinoma.
Neoplasms
Clinicopathological significance of multiple molecular features in undifferentiated and dedifferentiated endometrial carcinomas.
Neoplasms
Clinicopathological significance of ribosomal protein S6 kinase A6 in lung squamous cell carcinoma: an immunohistochemical and RNA-seq study.
Neoplasms
Clinicopathological Significance of Syndecan-1 in Cholangiocarcinoma: A Study Based on Immunohistochemistry and Public Sequencing Data.
Neoplasms
Clinicopathological, gene expression and genetic features of stage I lung adenocarcinoma with necrosis.
Neoplasms
Clinicopathological, immune and molecular correlates of PD-L2 methylation in gastric adenocarcinomas.
Neoplasms
Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine.
Neoplasms
CloneSig can jointly infer intra-tumor heterogeneity and mutational signature activity in bulk tumor sequencing data.
Neoplasms
Cloud-Scale Genomic Signals Processing for Robust Large-Scale Cancer Genomic Microarray Data Analysis.
Neoplasms
ClpP regulates breast cancer cell proliferation, invasion and apoptosis by modulating the Src/PI3K/Akt signaling pathway.
Neoplasms
Clustering analysis of microRNA and mRNA expression data from TCGA using maximum edge-weighted matching algorithms.
Neoplasms
Clusterization in head and neck squamous carcinomas based on lncRNA expression: molecular and clinical correlates.
Neoplasms
CMTM4 inhibits cell proliferation and migration via AKT, ERK1/2, and STAT3 pathway in colorectal cancer.
Neoplasms
CMTM6 and PD-L1 coexpression is associated with an active immune microenvironment and a favorable prognosis in colorectal cancer.
Neoplasms
CMTM6 is positively correlated with PD-L1 expression and immune cells infiltration in lung squamous carcinoma.
Neoplasms
CNAPE: A Machine Learning Method for Copy Number Alteration Prediction from Gene Expression.
Neoplasms
CNOT3 targets negative cell cycle regulators in non-small cell lung cancer development.
Neoplasms
CNOT4 enhances the efficacy of anti-PD-1 immunotherapy in a model of non-small cell lung cancer.
Neoplasms
CNR1 may reverse progesterone-resistance of endometrial cancer through the ERK pathway.
Neoplasms
CNV Analysis of the Correlation between Preoperative Lymph Node Metastasis and Prognosis of Early Tongue Cancer.
Neoplasms
Co-active receptor tyrosine kinases mitigate the effect of FGFR inhibitors in FGFR1-amplified lung cancers with low FGFR1 protein expression.
Neoplasms
Co-amplification of genes in chromosome 8q24: a robust prognostic marker in hepatocellular carcinoma.
Neoplasms
Co-expression analysis and ceRNA network reveal eight novel potential lncRNA biomarkers in hepatocellular carcinoma.
Neoplasms
Co-expression modules construction by WGCNA and identify potential prognostic markers of uveal melanoma.
Neoplasms
Co-expression network analysis identified CDH11 in association with progression and prognosis in gastric cancer.
Neoplasms
Co-Expression Network Analysis Identified Gene Signatures in Osteosarcoma as a Predictive Tool for Lung Metastasis and Survival.
Neoplasms
Co-Expression Network Analysis Identified LTF in Association with Metastasis Risk and Prognosis in Clear Cell Renal Cell Carcinoma.
Neoplasms
Co-expression Network Analysis Identifies Fourteen Hub Genes Associated with Prognosis in Clear Cell Renal Cell Carcinoma.
Neoplasms
Co-expression network analysis of long noncoding RNAs (IncRNAs) and cancer genes revealsSFTA1P and CASC2abnormalities in lung squamous cell carcinoma.
Neoplasms
Co-Expression of Coxsackievirus/Adenovirus Receptors and Desmoglein 2 in Lung Adenocarcinoma: A Comprehensive Analysis of Bioinformatics and Tissue Microarrays.
Neoplasms
Co-localized genomic regulation of miRNA and mRNA via DNA methylation affects survival in multiple tumor types.
Neoplasms
Co-occurrence and Mutual Exclusivity Analysis of DNA Methylation Reveals Distinct Subtypes in Multiple Cancers.
Neoplasms
Co-occurrent Alterations of Alzheimer's Genes and Prostate Cancer Genes in Prostate Cancer.
Neoplasms
Co-Occurring Alteration of NOTCH and DDR Pathways Serves as Novel Predictor to Efficacious Immunotherapy in NSCLC.
Neoplasms
Co?expression of peripheral olfactory receptors with SARS?CoV?2 infection mediators: Potential implications beyond loss of smell as a COVID?19 symptom.
Neoplasms
Coagulation factor V is a marker of tumor-infiltrating immune cells in breast cancer.
Neoplasms
Coexistence of YWHAZ amplification predicts better prognosis in muscle-invasive bladder cancer with CDKN2A or TP53 loss.
Neoplasms
Coexisting EGFR and TP53 Mutations in Lung Adenocarcinoma Patients Are Associated With COMP and ITGB8 Upregulation and Poor Prognosis.
Neoplasms
Coexpression analysis of CD133 and CD44 identifies proneural and mesenchymal subtypes of glioblastoma multiforme.
Neoplasms
Coexpression Analysis of the EZH2 Gene Using The Cancer Genome Atlas and Oncomine Databases Identifies Coexpressed Genes Involved in Biological Networks in Breast Cancer, Glioblastoma, and Prostate Cancer.
Neoplasms
Coexpression and expression quantitative trait loci analyses of the angiogenesis gene-gene interaction network in prostate cancer.
Neoplasms
Coexpression Module Construction by Weighted Gene Coexpression Network Analysis and Identify Potential Prognostic Markers of Breast Cancer.
Neoplasms
Coexpression network analysis identified that plakophilin 1 is associated with the metastasis in human melanoma.
Neoplasms
Coexpression Network Analysis Identifies a Novel Nine-RNA Signature to Improve Prognostic Prediction for Prostate Cancer Patients.
Neoplasms
Coexpression Network Analysis of Genes Related to the Characteristics of Tumor Stemness in Triple-Negative Breast Cancer.
Neoplasms
Cofilin-1, LIMK1 and SSH1 are differentially expressed in locally advanced colorectal cancer and according to consensus molecular subtypes.
Neoplasms
CoGAPS matrix factorization algorithm identifies transcriptional changes in AP-2alpha target genes in feedback from therapeutic inhibition of the EGFR network.
Neoplasms
Coiled-coil domain containing 109B is a HIF1?-regulated gene critical for progression of human gliomas.
Neoplasms
COL1A1 Is a Potential Prognostic Biomarker and Correlated with Immune Infiltration in Mesothelioma.
Neoplasms
COL4A1 as a novel oncogene associated with the clinical characteristics of malignancy predicts poor prognosis in glioma.
Neoplasms
COL5A2 Promotes Proliferation and Invasion in Prostate Cancer and Is One of Seven Gleason-Related Genes That Predict Recurrence-Free Survival.
Neoplasms
Collagen 1A1 (COL1A1) Is a Reliable Biomarker and Putative Therapeutic Target for Hepatocellular Carcinogenesis and Metastasis.
Neoplasms
Collagen type VI regulates the CDK4/6-p-Rb signaling pathway and promotes ovarian cancer invasiveness, stemness, and metastasis.
Neoplasms
Collective effects of long-range DNA methylations predict gene expressions and estimate phenotypes in cancer.
Neoplasms
Colon cancer combined with obesity indicates improved survival- research on relevant mechanism.
Neoplasms
Colon Cancer Tumor Location Defined by Gene Expression May Disagree With Anatomic Tumor Location.
Neoplasms
Colon cancer-specific diagnostic and prognostic biomarkers based on genome-wide abnormal DNA methylation.
Neoplasms
Colon Cancer-Upregulated Long Non-Coding RNA lincDUSP Regulates Cell Cycle Genes and Potentiates Resistance to Apoptosis.
Neoplasms
Colony-stimulating factor 3 signaling in colon and rectal cancers: Immune response and CMS classification in TCGA data.
Neoplasms
Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer.
Neoplasms
Colorectal Cancer Prognosis is Not Associated with BRAF and KRAS Mutations-A STROBE Compliant Study.
Neoplasms
Colorectal Cancer with Residual Polyp of Origin: A Model of Malignant Transformation.
Neoplasms
Combination of 35-Gene Mutation Profile and Radiotherapy Dosimetry Predicts the Therapeutic Outcome of Definitive Chemoradiation in Patients With Esophageal Squamous Cell Carcinoma.
Neoplasms
Combination of cyclin-dependent kinase and immune checkpoint inhibitors for the treatment of bladder cancer.
Neoplasms
Combination of Immune-Related Genomic Alterations Reveals Immune Characterization and Prediction of Different Prognostic Risks in Ovarian Cancer.
Neoplasms
Combination of lysine-specific demethylase 6A (KDM6A) and mismatch repair (MMR) status is a potential prognostic factor in colorectal cancer.
Neoplasms
Combination of microdissection and microarray analysis to identify gene expression changes between differentially located tumour cells in breast cancer.
Neoplasms
Combination of PD1 Inhibitor and OX40 Agonist Induces Tumor Rejection and Immune Memory in Mouse Models of Pancreatic Cancer.
Neoplasms
Combination of TNM staging and pathway based risk score models in patients with gastric cancer.
Neoplasms
Combination of tumor mutation burden and immune infiltrates for the prognosis of lung adenocarcinoma.
Neoplasms
Combinatorial Detection of Conserved Alteration Patterns for Identifying Cancer Subnetworks.
Neoplasms
Combinatorial Ranking of Gene Sets to Predict Disease Relapse: The Retinoic Acid Pathway in Early Prostate Cancer.
Neoplasms
Combined bi-occipital suboccipital transsinus transtentorial approach for resection of a pineal region falcotentorial meningioma: operative video and technical nuances.
Neoplasms
Combined Frontotemporal Transbasal Approach for the Resection of a Giant Rathke's Cleft Cyst: Operative Video and Technical Nuances.
Neoplasms
Combined homologous recombination repair deficiency and immune activation analysis for predicting intensified responses of anthracycline, cyclophosphamide and taxane chemotherapy in triple-negative breast cancer.
Neoplasms
Combined HSP90 and kinase inhibitor therapy: Insights from The Cancer Genome Atlas.
Neoplasms
Combined identification of three miRNAs in serum as effective diagnostic biomarkers for HNSCC.
Neoplasms
Combined Inactivation of TP53 and MIR34A Promotes Colorectal Cancer Development and Progression in Mice Via Increasing Levels of IL6R and PAI1.
Neoplasms
Combined inhibition of heat shock proteins 90 and 70 leads to simultaneous degradation of the oncogenic signaling proteins involved in muscle invasive bladder cancer.
Neoplasms
Combined Pre- and Retrovascular Extraoral Approach for Tumors at Lateral Mass of the Atlas.
Neoplasms
Combined signature of nine immune-related genes: a novel risk score for predicting prognosis in hepatocellular carcinoma.
Neoplasms
Combined Simplified Molecular Classification of Gastric Adenocarcinoma, Enhanced by Lymph Node Status: An Integrative Approach.
Neoplasms
Combined targeting of TGF-?, EGFR and HER2 suppresses lymphangiogenesis and metastasis in a pancreatic cancer model.
Neoplasms
Combined Therapy Sensitivity Index Based on a 13-Gene Signature Predicts Prognosis for IDH Wild-type and MGMT Promoter Unmethylated Glioblastoma Patients.
Neoplasms
Combined Transcriptome and Proteome Analysis of Immortalized Human Keratinocytes Expressing Human Papillomavirus 16 (HPV16) Oncogenes Reveals Novel Key Factors and Networks in HPV-Induced Carcinogenesis.
Neoplasms
Combined Tumor Suppressor Defects Characterize Clinically Defined Aggressive Variant Prostate Cancers.
Neoplasms
Combining Bioinformatics and Experiments to Identify and Verify Key Genes with Prognostic Values in Endometrial Carcinoma.
Neoplasms
Combining copy number, methylation markers, and mutations as a panel for endometrial cancer detection via intravaginal tampon collection.
Neoplasms
Combining data from TCGA and GEO databases and reverse transcription quantitative PCR validation to identify gene prognostic markers in lung cancer.
Neoplasms
Combining DNA methylation and RNA sequencing data of cancer for supervised knowledge extraction.
Neoplasms
Combining multi-dimensional data to identify a key signature (gene and miRNA) of cisplatin-resistant gastric cancer.
Neoplasms
Combining multi-dimensional data to identify key genes and pathways in gastric cancer.
Neoplasms
Combining multidimensional genomic measurements for predicting cancer prognosis: observations from TCGA.
Neoplasms
Combining texture features of whole slide images improves prognostic prediction of recurrence-free survival for cutaneous melanoma patients.
Neoplasms
Comment on "DNA damage is a pervasive cause of sequencing errors, directly confounding variant identification".
Neoplasms
Commentary on "Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation." Kapur P, Peña-Llopis S, Christie A, Zhrebker L, Pavía-Jiménez A, Rathmell WK, Xie XJ, Brugarolas J. Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX. Lancet Oncol 2013; 14(2):159-67. [Epub 2013 Jan 16]. doi: 10.1016/S1470-2045(12)70584-3.
Neoplasms
Commentary on: "An integrated metabolic atlas of clear cell renal cell carcinoma." Hakimi AA, Reznik E, Lee CH, Creighton CJ, Brannon AR, Luna A, Aksoy BA, Liu EM, Shen R, Lee W, Chen Y, Stirdivant SM, Russo P, Chen YB, Tickoo SK, Reuter VE, Cheng EH, Sander C, Hsieh JJ.: Cancer Cell. 2016 Jan 11;29(1):104-16.
Neoplasms
Commentary on: "Comprehensive molecular characterization of papillary renal-cell carcinoma." Cancer Genome Atlas Research Network.: N Engl J Med. 2016 Jan 14;374(2):135-45.
Neoplasms
Common polymorphic inversions at 17q21.31 and 8p23.1 associate with cancer prognosis.
Neoplasms
Common variation at 1q24.1 (ALDH9A1) is a potential risk factor for renal cancer.
Neoplasms
Comparative analyses of gene copy number and mRNA expression in GBM tumors and GBM xenografts.
Neoplasms
Comparative Analysis and in vitro Experiments of Signatures and Prognostic Value of Immune Checkpoint Genes in Colorectal Cancer.
Neoplasms
Comparative analysis of histologically classified oligodendrogliomas reveals characteristic molecular differences between subgroups.
Neoplasms
Comparative Analysis of Matrix Metalloproteinase Family Members Reveals That MMP9 Predicts Survival and Response to Temozolomide in Patients with Primary Glioblastoma.
Neoplasms
Comparative analysis of oncogenes identified by microarray and RNA-sequencing as biomarkers for clinical prognosis.
Neoplasms
Comparative analysis of prognostic histopathologic parameters in subtypes of epithelioid pleural mesothelioma.
Neoplasms
Comparative analysis of somatic copy-number alterations across different human cancer types reveals two distinct classes of breakpoint hotspots.
Neoplasms
Comparative analysis of transcriptomics based hypoxia signatures in head- and neck squamous cell carcinoma.
Neoplasms
Comparative Assessment of Diagnostic Homologous Recombination Deficiency-Associated Mutational Signatures in Ovarian Cancer.
Neoplasms
Comparative bioinformatical analysis of pancreatic head cancer and pancreatic body/tail cancer.
Neoplasms
Comparative evaluation of isoform-level gene expression estimation algorithms for RNA-seq and exon-array platforms.
Neoplasms
Comparative genomic analysis of esophageal squamous cell carcinoma between Asian and Caucasian patient populations.
Neoplasms
Comparative genomics reveals that loss of lunatic fringe (LFNG) promotes melanoma metastasis.
Neoplasms
Comparative methylome analysis in solid tumors reveals aberrant methylation at chromosome 6p in nasopharyngeal carcinoma.
Neoplasms
Comparative molecular characterization of typical and exceptional responders in glioblastoma.
Neoplasms
Comparative pan-cancer DNA methylation analysis reveals cancer common and specific patterns.
Neoplasms
Comparative Proteome Identifies Complement Component 3-Mediated Immune Response as Key Difference of Colon Adenocarcinoma and Rectal Adenocarcinoma.
Neoplasms
Comparative STAT3-Regulated Gene Expression Profile in Renal Cell Carcinoma Subtypes.
Neoplasms
Comparative Study of Autoantibody Responses between Lung Adenocarcinoma and Benign Pulmonary Nodules.
Neoplasms
Comparative transcriptomes of adenocarcinomas and squamous cell carcinomas reveal molecular similarities that span classical anatomic boundaries.
Neoplasms
Comparative transcriptome analysis of matched primary and distant metastatic ovarian carcinoma.
Neoplasms
Comparing gene expression data from formalin-fixed, paraffin embedded tissues and qPCR with that from snap-frozen tissue and microarrays for modeling outcomes of patients with ovarian carcinoma.
Neoplasms
Comparing the genomes of cutaneous melanoma tumors to commercially available cell lines.
Neoplasms
Comparison between two amplicon-based sequencing panels of different scales in the detection of somatic mutations associated with gastric cancer.
Neoplasms
Comparison of algorithms for the detection of cancer drivers at subgene resolution.
Neoplasms
Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas.
Neoplasms
Comparison of commonly used solid tumor targeted gene sequencing panels for estimating tumor mutation burden shows analytical and prognostic concordance within the cancer genome atlas cohort.
Neoplasms
Comparison of Genomic Characterization in Upper Tract Urothelial Carcinoma and Urothelial Carcinoma of the Bladder.
Neoplasms
Comparison of normalization approaches for gene expression studies completed with high-throughput sequencing.
Neoplasms
Comparison of TCGA and GENIE genomic datasets for the detection of clinically actionable alterations in breast cancer.
Neoplasms
Comparison of the Genomic Landscape Between Primary Breast Cancer in African American Versus White Women and the Association of Racial Differences With Tumor Recurrence.
Neoplasms
Comparison of triple-negative breast cancer molecular subtyping using RNA from matched fresh-frozen versus formalin-fixed paraffin-embedded tissue.
Neoplasms
Comparison of tumor related signaling pathways with known compounds to determine potential agents for lung adenocarcinoma.
Neoplasms
Competing endogenous RNA (ceRNA) hypothetic model based on comprehensive analysis of long non-coding RNA expression in lung adenocarcinoma.
Neoplasms
Competing Endogenous RNA and Coexpression Network Analysis for Identification of Potential Biomarkers and Therapeutics in association with Metastasis Risk and Progression of Prostate Cancer.
Neoplasms
Competing Endogenous RNA in Colorectal Cancer: An Analysis for Colon, Rectum, and Rectosigmoid Junction.
Neoplasms
Competing endogenous RNA network analysis reveals potential long non-coding RNAs as predictive biomarkers of gastric cancer.
Neoplasms
Competing endogenous RNA network and prognostic nomograms for hepatocellular carcinoma patients who underwent R0 resection.
Neoplasms
Competing endogenous RNA network of endometrial carcinoma: A comprehensive analysis.
Neoplasms
Competing Endogenous RNA of Snail and Zeb1 UTR in Therapeutic Resistance of Colorectal Cancer.
Neoplasms
Competitive Endogenous RNA (ceRNA) Regulation Network of lncRNA-miRNA-mRNA in Colorectal Carcinogenesis.
Neoplasms
Competitive Endogenous RNA Network Construction and Comparison of Lung Squamous Cell Carcinoma in Smokers and Nonsmokers.
Neoplasms
Competitive glucose metabolism as a target to boost bladder cancer immunotherapy.
Neoplasms
Complement and coagulation cascades pathway correlates with chemosensitivity and overall survival in patients with soft tissue sarcoma.
Neoplasms
Complement C1q (C1qA, C1qB, and C1qC) May Be a Potential Prognostic Factor and an Index of Tumor Microenvironment Remodeling in Osteosarcoma.
Neoplasms
Complete disease remission in a TP53 and KRAS co-mutated brain oligometastatic lung cancer patient after immuno-chemotherapy and surgical resection: a case report.
Neoplasms
Comprehensive analyses of competing endogenous RNA networks reveal potential biomarkers for predicting hepatocellular carcinoma recurrence.
Neoplasms
Comprehensive analyses of the heterogeneity and prognostic significance of tumor-infiltrating immune cells in non-small-cell lung cancer: Development and validation of an individualized prognostic model.
Neoplasms
Comprehensive Analyses of the Infiltrating Immune Cell Landscape and Its Clinical Significance in Hepatocellular Carcinoma.
Neoplasms
Comprehensive analysis and establishment of a prediction model of alternative splicing events reveal the prognostic predictor and immune microenvironment signatures in triple negative breast cancer.
Neoplasms
Comprehensive analysis and identification of key genes and signaling pathways in the occurrence and metastasis of cutaneous melanoma.
Neoplasms
Comprehensive analysis based on DNA methylation and RNA-seq reveals hypermethylation of the up-regulated WT1 gene with potential mechanisms in PAM50 subtypes of breast cancer.
Neoplasms
Comprehensive Analysis Identifying Wnt Ligands Gene Family for Biochemical Recurrence in Prostate Adenocarcinoma and Construction of a Nomogram.
Neoplasms
Comprehensive analysis of a ceRNA network reveals potential prognostic cytoplasmic lncRNAs involved in HCC progression.
Neoplasms
Comprehensive analysis of a chemokine- and chemokine receptor family-based signature for patients with lung adenocarcinoma.
Neoplasms
Comprehensive Analysis of a Competing Endogenous RNA Network Identifies Seven-lncRNA Signature as a Prognostic Biomarker for Melanoma.
Neoplasms
Comprehensive analysis of a long non-coding RNA-associated competing endogenous RNA network in glioma.
Neoplasms
Comprehensive analysis of a long noncoding RNA-associated competing endogenous RNA network in colorectal cancer.
Neoplasms
Comprehensive analysis of a new prognosis signature based on histone deacetylases in clear cell renal cell carcinoma.
Neoplasms
Comprehensive Analysis of a Nine-Gene Signature Related to Tumor Microenvironment in Lung Adenocarcinoma.
Neoplasms
Comprehensive analysis of a novel four-lncRNA signature as a prognostic biomarker for human gastric cancer.
Neoplasms
Comprehensive analysis of a novel lncRNA profile reveals potential prognostic biomarkers in clear cell renal cell carcinoma.
Neoplasms
Comprehensive Analysis of Aberrantly Expressed Competitive Endogenous RNA Network and Identification of Prognostic Biomarkers in Pheochromocytoma and Paraganglioma.
Neoplasms
Comprehensive analysis of aberrantly expressed microRNA profiles reveals potential biomarkers of human lung adenocarcinoma progression.
Neoplasms
Comprehensive Analysis of Aberrantly Expressed Profiles of lncRNAs and miRNAs with Associated ceRNA Network in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Neoplasms
Comprehensive analysis of aberrantly expressed profiles of lncRNAs and miRNAs with associated ceRNA network in muscle-invasive bladder cancer.
Neoplasms
Comprehensive analysis of aberrantly expressed profiles of lncRNAs, miRNAs and mRNAs with associated ceRNA network in cholangiocarcinoma.
Neoplasms
Comprehensive Analysis of Aerobic Exercise-Related Genes Identifies CDCA4 That Promotes the Progression of Osteosarcoma.
Neoplasms
Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients.
Neoplasms
Comprehensive analysis of alternative splicing profiling reveals novel events associated with prognosis and the infiltration of immune cells in prostate cancer.
Neoplasms
Comprehensive Analysis of Alternative Splicing Signature in Gastric Cancer Prognosis Based on The Cancer Genome Atlas (TCGA) and SpliceSeq Databases.
Neoplasms
Comprehensive analysis of an immune-related ceRNA network in identifying a novel lncRNA signature as a prognostic biomarker for hepatocellular carcinoma.
Neoplasms
Comprehensive Analysis of APA Events and Their Association With Tumor Microenvironment in Lung Adenocarcinoma.
Neoplasms
Comprehensive Analysis of ATP6V1s Family Members in Renal Clear Cell Carcinoma With Prognostic Values.
Neoplasms
Comprehensive Analysis of Autophagy-Associated lncRNAs Reveal Potential Prognostic Prediction in Pancreatic Cancer.
Neoplasms
Comprehensive Analysis of BAP1 Somatic Mutation in Clear Cell Renal Cell Carcinoma to Explore Potential Mechanisms in Silico.
Neoplasms
Comprehensive analysis of biomarkers for prostate cancer based on weighted gene co-expression network analysis.
Neoplasms
Comprehensive Analysis of Cancer-Proteogenome to Identify Biomarkers for the Early Diagnosis and Prognosis of Cancer.
Neoplasms
Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.
Neoplasms
Comprehensive analysis of ceRNA networks in HPV16- and HPV18-mediated cervical cancers reveals XIST as a pivotal competing endogenous RNA.
Neoplasms
Comprehensive analysis of ceRNA networks reveals prognostic lncRNAs related to immune infiltration in colorectal cancer.
Neoplasms
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing.
Neoplasms
Comprehensive analysis of circRNA expression pattern and circRNA-miRNA-mRNA network in oral squamous cell carcinoma.
Neoplasms
Comprehensive Analysis of Competing Endogenous RNA (ceRNA) Network Based on RNAs Differentially Expressed in Lung Adenocarcinoma Using The Cancer Genome Atlas (TCGA) Database.
Neoplasms
Comprehensive analysis of competing endogenous RNA network and 3-mRNA signature predicting survival in papillary renal cell cancer.
Neoplasms
Comprehensive Analysis of Competing Endogenous RNA Network Focusing on Long Noncoding RNA Involved in Cirrhotic Hepatocellular Carcinoma.
Neoplasms
Comprehensive analysis of competing endogenous RNA networks associated with cholangiocarcinoma.
Neoplasms
Comprehensive analysis of competitive endogenous RNA associated with immune infiltration in lung adenocarcinoma.
Neoplasms
Comprehensive analysis of competitive endogenous RNAs network associated with head and neck squamous cell carcinoma.
Neoplasms
Comprehensive analysis of competitive endogenous RNAs network reveals potential prognostic lncRNAs in gastric cancer.
Neoplasms
Comprehensive analysis of copy number aberrations in microsatellite stable colon cancer in view of stromal component.
Neoplasms
Comprehensive analysis of CTLA-4 in the tumor immune microenvironment of 33 cancer types.
Neoplasms
Comprehensive analysis of cytoskeleton regulatory genes identifies ezrin as a prognostic marker and molecular target in acute myeloid leukemia.
Neoplasms
Comprehensive analysis of differential expression profiles of mRNAs and lncRNAs and identification of a 14-lncRNA prognostic signature for patients with colon adenocarcinoma.
Neoplasms
Comprehensive analysis of differentially expressed genes reveals the promotive effects of UBE2T on colorectal cancer cell proliferation.
Neoplasms
Comprehensive analysis of differentially expressed profiles and reconstruction of a competing endogenous RNA network in papillary renal cell carcinoma.
Neoplasms
Comprehensive analysis of differentially expressed profiles of lncRNAs, mRNAs, and miRNAs in laryngeal squamous cell carcinoma in order to construct a ceRNA network and identify potential biomarkers.
Neoplasms
Comprehensive Analysis of Differentially Expressed Profiles of lncRNAs/mRNAs and miRNAs with Associated ceRNA Networks in Triple-Negative Breast Cancer.
Neoplasms
Comprehensive analysis of DNA methylation and gene expression profiles in cholangiocarcinoma.
Neoplasms
Comprehensive Analysis of Driver Genes in Personal Genomes of Clear Cell Renal Cell Carcinoma.
Neoplasms
Comprehensive analysis of dysregulated lncRNAs, miRNAs and mRNAs with associated ceRNA network in esophageal squamous cell carcinoma.
Neoplasms
Comprehensive Analysis of Expression and Prognostic Value of GATAs in Lung Cancer.
Neoplasms
Comprehensive Analysis of Expression and Prognostic Value of Sirtuins in Ovarian Cancer.
Neoplasms
Comprehensive analysis of expression profiles of long non?coding RNAs with associated ceRNA network involved in gastric cancer progression.
Neoplasms
Comprehensive Analysis of Expression Regulation for RNA m6A Regulators With Clinical Significance in Human Cancers.
Neoplasms
Comprehensive Analysis of Expression, Clinicopathological Association and Potential Prognostic Significance of RABs in Pancreatic Cancer.
Neoplasms
Comprehensive analysis of ferritin subunits expression and positive correlations with tumor-associated macrophages and T regulatory cells infiltration in most solid tumors.
Neoplasms
Comprehensive Analysis of Ferroptosis Regulators With Regard to PD-L1 and Immune Infiltration in Clear Cell Renal Cell Carcinoma.
Neoplasms
Comprehensive analysis of gene expression and DNA methylation data identifies potential biomarkers and functional epigenetic modules for lung adenocarcinoma.
Neoplasms
Comprehensive Analysis of Gene Expression Changes and Validation in Hepatocellular Carcinoma.
Neoplasms
Comprehensive Analysis of Gene Expression Profiles Identifies a P4HA1-Related Gene Panel as a Prognostic Model in Colorectal Cancer Patients.
Neoplasms
Comprehensive analysis of genes based on chr1p/19q co-deletion reveals a robust 4-gene prognostic signature for lower grade glioma.
Neoplasms
Comprehensive Analysis of Genetic Ancestry and Its Molecular Correlates in Cancer.
Neoplasms
Comprehensive Analysis of Glycolysis-Related Genes for Prognosis, Immune Features, and Candidate Drug Development in Colon Cancer.
Neoplasms
Comprehensive analysis of histone modification-associated genes on differential gene expression and prognosis in gastric cancer.
Neoplasms
Comprehensive analysis of immune-related prognostic genes in the tumour microenvironment of hepatocellular carcinoma.
Neoplasms
Comprehensive analysis of key genes, microRNAs and long non-coding RNAs in hepatocellular carcinoma.
Neoplasms
Comprehensive analysis of lncRNA expression profiles reveals a novel lncRNA signature to discriminate nonequivalent outcomes in patients with ovarian cancer.
Neoplasms
Comprehensive analysis of lncRNA-associated ceRNA network reveals the novel potential of lncRNA, miRNA and mRNA biomarkers in human rectosigmoid junction cancer.
Neoplasms
Comprehensive analysis of lncRNA-associated competing endogenous RNA network in tongue squamous cell carcinoma.
Neoplasms
Comprehensive Analysis of lncRNA-miRNA- mRNA Network Ascertains Prognostic Factors in Patients with Colon Cancer.
Neoplasms
Comprehensive Analysis of lncRNAs Associated with the Pathogenesis and Prognosis of Gastric Cancer.
Neoplasms
Comprehensive Analysis of lncRNAs Related to the Prognosis of Esophageal Cancer Based on ceRNA Network and Cox Regression Model.
Neoplasms
Comprehensive analysis of location-specific hub genes related to the pathogenesis of colon cancer.
Neoplasms
Comprehensive analysis of long non-coding RNA PVT1 gene interaction regulatory network in hepatocellular carcinoma using gene microarray and bioinformatics.
Neoplasms
Comprehensive analysis of long non-coding RNAs in human breast cancer clinical subtypes.
Neoplasms
Comprehensive analysis of long non-coding RNAs in ovarian cancer reveals global patterns and targeted DNA amplification.
Neoplasms
Comprehensive analysis of long non?coding RNA?messenger RNA?microRNA co?expression network identifies cell cycle?related lncRNA in hepatocellular carcinoma.
Neoplasms
Comprehensive analysis of long noncoding RNA-associated competing endogenous RNA network in cholangiocarcinoma.
Neoplasms
Comprehensive Analysis of Metabolic Genes in Breast Cancer Based on Multi-Omics Data.
Neoplasms
Comprehensive analysis of metastasis-related genes reveals a gene signature predicting the survival of colon cancer patients.
Neoplasms
Comprehensive analysis of multi Ewing sarcoma microarray datasets identifies several prognosis biomarkers.
Neoplasms
Comprehensive analysis of new prognostic signature based on ferroptosis-related genes in clear cell renal cell carcinoma.
Neoplasms
Comprehensive analysis of novel three-long noncoding RNA signatures as a diagnostic and prognostic biomarkers of human triple-negative breast cancer.
Neoplasms
Comprehensive Analysis of PD-1 Gene Expression, Immune Characteristics and Prognostic Significance in 1396 Glioma Patients.
Neoplasms
Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
Neoplasms
Comprehensive analysis of potential immunotherapy genomic biomarkers in 1000 Chinese patients with cancer.
Neoplasms
Comprehensive analysis of potential prognostic genes for the construction of a competing endogenous RNA regulatory network in hepatocellular carcinoma.
Neoplasms
Comprehensive analysis of prognostic alternative splicing signature in cervical cancer.
Neoplasms
Comprehensive Analysis of Prognostic Alternative Splicing Signatures in Endometrial Cancer.
Neoplasms
Comprehensive analysis of prognostic biomarkers in lung adenocarcinoma based on aberrant lncRNA-miRNA-mRNA networks and Cox regression models.
Neoplasms
Comprehensive analysis of prognostic gene signatures based on immune infiltration of ovarian cancer.
Neoplasms
Comprehensive analysis of prognostic immune-related genes associated with the tumor microenvironment of pancreatic ductal adenocarcinoma.
Neoplasms
Comprehensive analysis of prognostic immune-related genes in the tumor microenvironment of colorectal cancer.
Neoplasms
Comprehensive analysis of prognostic immune-related genes in the tumor microenvironment of cutaneous melanoma.
Neoplasms
Comprehensive Analysis of Prognostic Markers for Acute Myeloid Leukemia Based on Four Metabolic Genes.
Neoplasms
Comprehensive analysis of suppressor of cytokine signaling proteins in human breast Cancer.
Neoplasms
Comprehensive Analysis of Survival-Related lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Gastric Cancer.
Neoplasms
Comprehensive analysis of the aberrantly expressed lncRNA?associated ceRNA network in breast cancer.
Neoplasms
Comprehensive analysis of the association between tumor glycolysis and immune/inflammation function in breast cancer.
Neoplasms
Comprehensive analysis of the association between tumor-infiltrating immune cells and the prognosis of lung adenocarcinoma.
Neoplasms
Comprehensive Analysis of the ATP-binding Cassette Subfamily B Across Renal Cancers Identifies ABCB8 Overexpression in Phenotypically Aggressive Clear Cell Renal Cell Carcinoma.
Neoplasms
Comprehensive analysis of the cancer driver genes in breast cancer demonstrates their roles in cancer prognosis and tumor microenvironment.
Neoplasms
Comprehensive analysis of The Cancer Genome Atlas reveals a unique gene and non-coding RNA signature of fibrolamellar carcinoma.
Neoplasms
Comprehensive analysis of the competing endogenous circRNA-lncRNA-miRNA-mRNA network and identification of a novel potential biomarker for hepatocellular carcinoma.
Neoplasms
Comprehensive Analysis of the Expression and Prognosis for MCMs in Human Gastric Cancer.
Neoplasms
Comprehensive analysis of the expression and prognosis for TNFAIPs in head and neck cancer.
Neoplasms
Comprehensive analysis of the expression of SLC30A family genes and prognosis in human gastric cancer.
Neoplasms
Comprehensive analysis of the expression of sodium/potassium-ATPase ? subunits and prognosis of ovarian serous cystadenocarcinoma.
Neoplasms
Comprehensive analysis of the functions and prognostic significance of RNA-binding proteins in bladder urothelial carcinoma.
Neoplasms
Comprehensive Analysis of the Functions and Prognostic Value of RNA-Binding Proteins in Thyroid Cancer.
Neoplasms
Comprehensive analysis of the GATA transcription factor gene family in breast carcinoma using gene microarrays, online databases and integrated bioinformatics.
Neoplasms
Comprehensive analysis of the homeobox family genes in breast cancer demonstrates their similar roles in cancer and development.
Neoplasms
Comprehensive analysis of the HOXA gene family identifies HOXA13 as a novel oncogenic gene in kidney renal clear cell carcinoma.
Neoplasms
Comprehensive Analysis of the Immune and Prognostic Implication of COL6A6 in Lung Adenocarcinoma.
Neoplasms
Comprehensive Analysis of the Immune Implication of ACK1 Gene in Non-small Cell Lung Cancer.
Neoplasms
Comprehensive Analysis of the Immune Infiltrates and PD-L1 of m6A RNA Methylation Regulators in Hepatocellular Carcinoma.
Neoplasms
Comprehensive Analysis of the Immune-Oncology Targets and Immune Infiltrates of N 6-Methyladenosine-Related Long Noncoding RNA Regulators in Breast Cancer.
Neoplasms
Comprehensive analysis of the lncRNA-miRNA-mRNA regulatory network for bladder cancer.
Neoplasms
Comprehensive analysis of the lncRNA?associated competing endogenous RNA network in breast cancer.
Neoplasms
Comprehensive analysis of the long non-coding RNA-associated competitive endogenous RNA network reveals novel prognostic biomarkers in Wilms' tumor.
Neoplasms
Comprehensive analysis of the long noncoding RNA HOXA11-AS gene interaction regulatory network in NSCLC cells.
Neoplasms
Comprehensive Analysis of the PD-L1 and Immune Infiltrates of m6A RNA Methylation Regulators in Head and Neck Squamous Cell Carcinoma.
Neoplasms
Comprehensive Analysis of the Prognostic Role and Mutational Characteristics of m6A-Related Genes in Lung Squamous Cell Carcinoma.
Neoplasms
Comprehensive Analysis of the Relationship Between Metabolic Reprogramming and Immune Function in Prostate Cancer.
Neoplasms
Comprehensive Analysis of the Roles and Prognostic Value of RNA-Binding Proteins in Head and Neck Squamous Cell Carcinoma.
Neoplasms
Comprehensive analysis of the transcriptome-wide m6A methylome in colorectal cancer by MeRIP sequencing.
Neoplasms
Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma.
Neoplasms
Comprehensive analysis of Transcription Factors identified novel prognostic biomarker in human bladder cancer.
Neoplasms
Comprehensive analysis of tumor necrosis factor receptor TNFRSF9 (4-1BB) DNA methylation with regard to molecular and clinicopathological features, immune infiltrates, and response prediction to immunotherapy in melanoma.
Neoplasms
Comprehensive analysis of tumour mutation burden and the immune microenvironment in hepatocellular carcinoma.
Neoplasms
Comprehensive Analysis Reveals a 4-Gene Signature in Predicting Response to Temozolomide in Low-Grade Glioma Patients.
Neoplasms
Comprehensive analysis reveals a metabolic ten-gene signature in hepatocellular carcinoma.
Neoplasms
Comprehensive analysis reveals a prognostic and therapeutic biomarker CD3D in the breast carcinoma microenvironment.
Neoplasms
Comprehensive analysis to identify DLEU2L/TAOK1 axis as a prognostic biomarker in hepatocellular carcinoma.
Neoplasms
Comprehensive and Integrative Analysis Reveals the Diagnostic, Clinicopathological and Prognostic Significance of Polo-Like Kinase 1 in Hepatocellular Carcinoma.
Neoplasms
Comprehensive assessment gene signatures for clear cell renal cell carcinoma prognosis.
Neoplasms
Comprehensive assessment of PD-L1 and PD-L2 dysregulation in gastrointestinal cancers.
Neoplasms
Comprehensive assessment of TP53 loss of function using multiple combinatorial mutagenesis libraries.
Neoplasms
Comprehensive bioinformatics analysis of the characterization and determination underlying mechanisms of over-expression and co-expression of genes residing on 20q in colorectal cancer.
Neoplasms
Comprehensive bioinformation analysis of methylated and differentially expressed genes in esophageal squamous cell carcinoma.
Neoplasms
Comprehensive ceRNA network analysis and experimental studies identify an IGF2-AS/miR-150/IGF2 regulatory axis in colorectal cancer.
Neoplasms
Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications.
Neoplasms
Comprehensive Characterization of Alternative mRNA Splicing Events in Glioblastoma: Implications for Prognosis, Molecular Subtypes, and Immune Microenvironment Remodeling.
Neoplasms
Comprehensive Characterization of Cachexia-Inducing Factors in Diffuse Large B-Cell Lymphoma Reveals a Molecular Subtype and a Prognosis-Related Signature.
Neoplasms
Comprehensive characterization of cancer-testis genes in testicular germ cell tumor.
Neoplasms
Comprehensive characterization of functional eRNAs in lung adenocarcinoma reveals novel regulators and a prognosis-related molecular subtype.
Neoplasms
Comprehensive Characterization of Immunological Profiles and Clinical Significance in Hepatocellular Carcinoma.
Neoplasms
Comprehensive Characterization of Molecular Differences in Cancer between Male and Female Patients.
Neoplasms
Comprehensive Characterization of RNA Processing Factors in Gastric Cancer Identifies a Prognostic Signature for Predicting Clinical Outcomes and Therapeutic Responses.
Neoplasms
Comprehensive characterization of the alternative splicing landscape in head and neck squamous cell carcinoma reveals novel events associated with tumorigenesis and the immune microenvironment.
Neoplasms
Comprehensive characterization of the rRNA metabolism-related genes in human cancer.
Neoplasms
Comprehensive characterization of the tumor microenvironment for assessing immunotherapy outcome in patients with head and neck squamous cell carcinoma.
Neoplasms
Comprehensive characterization of tumor mutation burden in clear cell renal cell carcinoma based on the three independent cohorts.
Neoplasms
Comprehensive Computational Pathological Image Analysis Predicts Lung Cancer Prognosis.
Neoplasms
Comprehensive data analysis of genomics, epigenomics, and transcriptomics to identify specific biomolecular markers for prostate adenocarcinoma.
Neoplasms
Comprehensive DNA Methylation-transcriptome Profiles Association Analysis During the Treatment of Acute Myelocytic Leukemia.
Neoplasms
Comprehensive evaluation of FKBP10 expression and its prognostic potential in gastric cancer.
Neoplasms
Comprehensive Evaluation of Prostate-Specific Membrane Antigen Expression in the Vasculature of Renal Tumors: Implications for Imaging Studies and Prognostic Role.
Neoplasms
Comprehensive evaluation of SPATS2 expression and its prognostic potential in liver cancer.
Neoplasms
Comprehensive exploration of tumor mutational burden and immune infiltration in diffuse glioma.
Neoplasms
Comprehensive expression analysis of miRNA in breast cancer at the miRNA and isomiR levels.
Neoplasms
Comprehensive expression analysis suggests functional overlapping of human FOX transcription factors in cancer.
Neoplasms
Comprehensive expression-based isoform biomarkers predictive of drug responses based on isoform co-expression networks and clinical data.
Neoplasms
Comprehensive Genomic Analysis of Translocation Renal Cell Carcinoma Reveals Copy-Number Variations as Drivers of Disease Progression.
Neoplasms
Comprehensive genomic characterization defines human glioblastoma genes and core pathways.
Neoplasms
Comprehensive genomic characterization of head and neck squamous cell carcinomas.
Neoplasms
Comprehensive Genomic Characterization of Long Non-coding RNAs across Human Cancers.
Neoplasms
Comprehensive Genomic Profiling of Androgen-Receptor-Negative Canine Prostate Cancer.
Neoplasms
Comprehensive genomic profiling of lung cancer using a validated panel to explore therapeutic targets in East Asian patients.
Neoplasms
Comprehensive genomic profiling of recurrent endometrial cancer: Implications for selection of systemic therapy.
Neoplasms
Comprehensive identification of microRNA arm selection preference in lung cancer: miR-324-5p and -3p serve oncogenic functions in lung cancer.
Neoplasms
Comprehensive immunogenomic landscape analysis of prognosis-related genes in head and neck cancer.
Neoplasms
Comprehensive Immunohistochemical Study of the SWI/SNF Complex Expression Status in Gastric Cancer Reveals an Adverse Prognosis of SWI/SNF Deficiency in Genomically Stable Gastric Carcinomas.
Neoplasms
Comprehensive investigation of a novel differentially expressed lncRNA expression profile signature to assess the survival of patients with colorectal adenocarcinoma.
Neoplasms
Comprehensive investigation of alternative splicing and development of a prognostic risk score for prostate cancer based on six-gene signatures.
Neoplasms
Comprehensive investigation of key biomarkers and pathways in hepatitis B virus-related hepatocellular carcinoma.
Neoplasms
Comprehensive investigation of the clinical significance and molecular mechanisms of plasmacytoma variant translocation 1 in sarcoma using genome-wide RNA sequencing data.
Neoplasms
Comprehensive investigation of the clinical significance of long non-coding RNA HOXA-AS2 in acute myeloid leukemia using genome-wide RNA sequencing dataset.
Neoplasms
Comprehensive Landscape of Ovarian Cancer Immune Microenvironment Based on Integrated Multi-Omics Analysis.
Neoplasms
Comprehensive landscape of STEAP family functions and prognostic prediction value in glioblastoma.
Neoplasms
Comprehensive landscape of subtype-specific coding and non-coding RNA transcripts in breast cancer.
Neoplasms
Comprehensive microRNA profiling of prostate cancer cells after ionizing radiation treatment.
Neoplasms
Comprehensive molecular analyses of a TNF family-based signature with regard to prognosis, immune features, and biomarkers for immunotherapy in lung adenocarcinoma.
Neoplasms
Comprehensive molecular and clinical characterization of SLC1A5 in human cancers.
Neoplasms
Comprehensive molecular and immunological characterization of hepatocellular carcinoma.
Neoplasms
Comprehensive Molecular Characterization of Adenocarcinoma of the Gastroesophageal Junction Between Esophageal and Gastric Adenocarcinomas.
Neoplasms
Comprehensive molecular characterization of inhibitors of apoptosis proteins (IAPs) for therapeutic targeting in cancer.
Neoplasms
Comprehensive molecular characterization of mitochondrial genomes in human cancers.
Neoplasms
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer.
Neoplasms
Comprehensive molecular classification of localized prostate adenocarcinoma reveals a tumour subtype predictive of non-aggressive disease.
Neoplasms
Comprehensive molecular profiling of UV-induced metastatic melanoma in Nme1/Nme2-deficient mice reveals novel markers of survival in human patients.
Neoplasms
Comprehensive multi-omics analysis identified core molecular processes in esophageal cancer and revealed GNGT2 as a potential prognostic marker.
Neoplasms
Comprehensive network analysis of the molecular mechanisms associated with sorafenib resistance in hepatocellular carcinoma.
Neoplasms
Comprehensive pancancer genomic analysis reveals (RTK)-RAS-RAF-MEK as a key dysregulated pathway in cancer: Its clinical implications.
Neoplasms
Comprehensive pathway-related genes signature for prognosis and recurrence of ovarian cancer.
Neoplasms
Comprehensive Profile Analysis Identifies Three Key Genes Related to Stemness in Thyroid Carcinoma.
Neoplasms
Comprehensive profiling identifies a novel signature with robust predictive value and reveals the potential drug resistance mechanism in glioma.
Neoplasms
Comprehensive Profiling of Genomic and Transcriptomic Differences between Risk Groups of Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Neoplasms
Comprehensive Review of Molecular Mechanisms and Clinical Features of Invasive Lobular Cancer.
Neoplasms
Comprehensive Review of Numerical Chromosomal Aberrations in Chromophobe Renal Cell Carcinoma Including Its Variant Morphologies.
Neoplasms
Comprehensive RNA Sequencing in Adenoma-Cancer Transition Identified Predictive Biomarkers and Therapeutic Targets of Human CRC.
Neoplasms
Comprehensive transcriptome profiling of Taiwanese colorectal cancer implicates an ethnic basis for pathogenesis.
Neoplasms
Comprehensive Transcriptomic Analysis and Experimental Validation Identify lncRNA HOXA-AS2/miR-184/COL6A2 as the Critical ceRNA Regulation Involved in Low-Grade Glioma Recurrence.
Neoplasms
Comprehensive Transcriptomic Analysis Identifies ST8SIA1 as a Survival-Related Sialyltransferase Gene in Breast Cancer.
Neoplasms
Comprehensive transcriptomic analysis of cell lines as models of primary tumors across 22 tumor types.
Neoplasms
Comprehensive transcriptomic analysis of heat shock proteins in the molecular subtypes of human breast cancer.
Neoplasms
Comprehensive transcriptomic analysis of papillary thyroid cancer: potential biomarkers associated with tumor progression.
Neoplasms
Comprehensive Validation of Snapback Primer-Based Melting Curve Analysis to Detect Nucleotide Variation in the Codon 12 and 13 of KRAS Gene.
Neoplasms
Computational analysis for identification of the extracellular matrix molecules involved in endometrial cancer progression.
Neoplasms
Computational analysis of fused co-expression networks for the identification of candidate cancer gene biomarkers.
Neoplasms
Computational analysis of TP53 mutational landscape unveils key prognostic signatures and distinct pathobiological pathways in head and neck squamous cell cancer.
Neoplasms
Computational assessment of stomach tumor volume from multi-slice computerized tomography images in presence of type 2 cancer.
Neoplasms
Computational Characterization of Suppressive Immune Microenvironments in Glioblastoma.
Neoplasms
Computational Detection of Breast Cancer Invasiveness with DNA Methylation Biomarkers.
Neoplasms
Computational identification of micro-structural variations and their proteogenomic consequences in cancer.
Neoplasms
Computational Identification of Sex-Biased Biomarker MicroRNAs and Genes Associated with Immune Infiltration in Breast Cancer.
Neoplasms
Computational Identification of Tumor Anatomic Location Associated with Survival in 2 Large Cohorts of Human Primary Glioblastomas.
Neoplasms
Computational Methods and Correlation of Exon-skipping Events with Splicing, Transcription, and Epigenetic Factors.
Neoplasms
Computational staining of pathology images to study the tumor microenvironment in lung cancer.
Neoplasms
Computational Tumor Infiltration Phenotypes Enable the Spatial and Genomic Analysis of Immune Infiltration in Colorectal Cancer.
Neoplasms
Computerized axial tomography (CAT): the value in the diagnosis of bone and soft tissue tumours.
Neoplasms
Computerized Classification of Prostate Cancer Gleason Scores from Whole Slide Images.
Neoplasms
Concordance of Gene Expression and Functional Correlation Patterns across the NCI-60 Cell Lines and the Cancer Genome Atlas Glioblastoma Samples.
Neoplasms
Condition-adaptive fused graphical lasso (CFGL): An adaptive procedure for inferring condition-specific gene co-expression network.
Neoplasms
Conditional mutual inclusive information enables accurate quantification of associations in gene regulatory networks.
Neoplasms
CONFIGURE: A pipeline for identifying context specific regulatory modules from gene expression data and its application to breast cancer.
Neoplasms
Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer.
Neoplasms
Congenital irreducible atlantoaxial dislocation associated with cervical intramedullary astrocytoma causing progressive spastic quadriparesis.
Neoplasms
Connecting genomic alterations to cancer biology with proteomics: the NCI Clinical Proteomic Tumor Analysis Consortium.
Neoplasms
Connecting the Dots: Therapy-Induced Senescence and a Tumor-Suppressive Immune Microenvironment.
Neoplasms
Connective tissue growth factor as an unfavorable prognostic marker promotes the proliferation, migration, and invasion of gliomas.
Neoplasms
Connexin 43 C-terminus directly inhibits the hyperphosphorylation of Akt/ERK through protein-protein interactions in glioblastoma.
Neoplasms
Consensus Analysis of Whole Transcriptome Profiles from Two Breast Cancer Patient Cohorts Reveals Long Non-Coding RNAs Associated with Intrinsic Subtype and the Tumour Microenvironment.
Neoplasms
Consequences of anorectal cancer atlas implementation in the cooperative group setting: Radiobiologic analysis of a prospective randomized in silico target delineation study.
Neoplasms
Constitutive Expression of the Immunosuppressive Tryptophan Dioxygenase TDO2 in Glioblastoma Is Driven by the Transcription Factor C/EBP?.
Neoplasms
Construction and analysis for differentially expressed long non-coding RNAs and MicroRNAs mediated competing endogenous RNA network in colon cancer.
Neoplasms
Construction and analysis of a ceRNA network and patterns of immune infiltration in bladder cancer.
Neoplasms
Construction and analysis of a lncRNA-miRNA-mRNA network based on competitive endogenous RNA reveal functional lncRNAs in oral cancer.
Neoplasms
Construction and Analysis of a Long Non-Coding RNA-Associated Competing Endogenous RNA Network Identified Potential Prognostic Biomarkers in Luminal Breast Cancer.
Neoplasms
Construction and analysis of an aberrant lncRNA-miRNA-mRNA network associated with papillary thyroid cancer.
Neoplasms
Construction and analysis of circular RNA molecular regulatory networks in clear cell renal cell carcinoma.
Neoplasms
Construction and Analysis of Competing Endogenous RNA Networks for Breast Cancer Based on TCGA Dataset.
Neoplasms
Construction and analysis of dysregulated lncRNA-associated ceRNA network in colorectal cancer.
Neoplasms
Construction and analysis of macrophage infiltration related circRNA-miRNA-mRNA regulatory networks in hepatocellular carcinoma.
Neoplasms
Construction and Analysis of the Tumor-Specific mRNA-miRNA-lncRNA Network in Gastric Cancer.
Neoplasms
Construction and Comprehensive Analyses of a Competing Endogenous RNA Network in Tumor-Node-Metastasis Stage I Hepatocellular Carcinoma.
Neoplasms
Construction and Comprehensive Analysis for Dysregulated Long Non-Coding RNA (lncRNA)-Associated Competing Endogenous RNA (ceRNA) Network in Gastric Cancer.
Neoplasms
Construction and comprehensive analysis of dysregulated long non-coding RNA-associated competing endogenous RNA network in clear cell renal cell carcinoma.
Neoplasms
Construction and Comprehensive Prognostic Analysis of a lncRNA-miRNA-mRNA Regulatory Network and Tumor Immune Cell Infiltration in Colorectal Cancer.
Neoplasms
Construction and Evaluation of a Risk Score Model for Autophagy-Related Genes in Esophageal Adenocarcinoma.
Neoplasms
Construction and integrated analysis of crosstalking ceRNAs networks in laryngeal squamous cell carcinoma.
Neoplasms
Construction and Investigation of a lncRNA-Associated ceRNA Regulatory Network in Cholangiocarcinoma.
Neoplasms
Construction and Investigation of an LINC00284-Associated Regulatory Network in Serous Ovarian Carcinoma.
Neoplasms
Construction and investigation of lncRNA-associated ceRNA regulatory network in papillary thyroid cancer.
Neoplasms
Construction and Investigation of MicroRNA-mRNA Regulatory Network of Gastric Cancer with Helicobacter pylori Infection.
Neoplasms
Construction and validation of a 15-gene ferroptosis signature in lung adenocarcinoma.
Neoplasms
Construction and Validation of a 7-Immune Gene Model for Prognostic Assessment of Esophageal Carcinoma.
Neoplasms
Construction and Validation of a Ferroptosis-Related Prognostic Model for Gastric Cancer.
Neoplasms
Construction and validation of a metabolic risk model predicting prognosis of colon cancer.
Neoplasms
Construction and Validation of a Nomogram for Predicting Progression- Free Survival in Patients with Early-Stage Testicular Germ Cell Tumor.
Neoplasms
Construction and Validation of a Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Gastric Cancer.
Neoplasms
Construction and Validation of a Novel Eight-Gene Risk Signature to Predict the Progression and Prognosis of Bladder Cancer.
Neoplasms
Construction and validation of a novel prognostic signature of microRNAs in lung adenocarcinoma.
Neoplasms
Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach.
Neoplasms
Construction and validation of a prognostic signature using CNV-driven genes for hepatocellular carcinoma.
Neoplasms
Construction and Validation of a Protein Prognostic Model for Lung Squamous Cell Carcinoma.
Neoplasms
Construction and Validation of a Reliable Six-Gene Prognostic Signature Based on the TP53 Alteration for Hepatocellular Carcinoma.
Neoplasms
Construction and Validation of a Robust Cancer Stem Cell-Associated Gene Set-Based Signature to Predict Early Biochemical Recurrence in Prostate Cancer.
Neoplasms
Construction and validation of a seven-gene signature for predicting overall survival in patients with kidney renal clear cell carcinoma via an integrated bioinformatics analysis.
Neoplasms
Construction and validation of a seven-microRNA signature as a prognostic tool for lung squamous cell carcinoma.
Neoplasms
Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma.
Neoplasms
Construction and Validation of a Universal Applicable Prognostic Signature for Gastric Cancer Based on Seven Immune-Related Gene Correlated With Tumor Associated Macrophages.
Neoplasms
Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients.
Neoplasms
Construction and Validation of an Autophagy-Related Prognostic Risk Signature for Survival Predicting in Clear Cell Renal Cell Carcinoma Patients.
Neoplasms
Construction and Validation of an Immune-Based Prognostic Model for Pancreatic Adenocarcinoma Based on Public Databases.
Neoplasms
Construction and validation of an immunity-related prognostic signature for breast cancer.
Neoplasms
Construction and Validation of an m6A RNA Methylation Regulators-Based Prognostic Signature for Esophageal Cancer.
Neoplasms
Construction and validation of an N6-methyladenosine-associated prognostic signature in hepatocellular carcinoma.
Neoplasms
Construction and validation of an RNA-binding protein-associated prognostic model for colorectal cancer.
Neoplasms
Construction and Verification of a Hypoxia-Related 4-lncRNA Model for Prediction of Breast Cancer.
Neoplasms
Construction and verification of a prognostic risk model based on immunogenomic landscape analysis of bladder caner.
Neoplasms
Construction autophagy-related prognostic risk signature combined with clinicopathological validation analysis for survival prediction of kidney renal papillary cell carcinoma patients.
Neoplasms
Construction of a 13-Gene Signature as a Novel Prognostic Marker for Patients with Clear Cell Renal Cell Carcinoma and the Role of XCR1 in Cell Proliferation.
Neoplasms
Construction of a 13-microRNA-based signature and prognostic nomogram for predicting overall survival in patients with hepatocellular carcinoma.
Neoplasms
Construction of a 14-lncRNA risk score system predicting survival of children with acute myelocytic leukemia.
Neoplasms
Construction of a ceRNA network and a genomic-clinicopathologic nomogram to predict survival for HBV-related HCC.
Neoplasms
Construction of a ceRNA network of hub genes affecting immune infiltration in ovarian cancer identified by WGCNA.
Neoplasms
Construction of a circRNA-miRNA-mRNA Network Related to Macrophage Infiltration in Hepatocellular Carcinoma.
Neoplasms
Construction of a circRNA-miRNA-mRNA Regulatory Network Reveals Potential Mechanism and Treatment Options for Osteosarcoma.
Neoplasms
Construction of a circRNA-Related ceRNA Prognostic Regulatory Network in Breast Cancer.
Neoplasms
Construction of a circRNA-Related Prognostic Risk Score Model for Predicting the Immune Landscape of Lung Adenocarcinoma.
Neoplasms
Construction of a circular RNA-microRNA-messengerRNA regulatory network in stomach adenocarcinoma.
Neoplasms
Construction of a competing endogenous RNA network using differentially expressed lncRNAs, miRNAs and mRNAs in non?small cell lung cancer.
Neoplasms
Construction of a competitive endogenous RNA network and analysis of potential regulatory axis targets in glioblastoma.
Neoplasms
Construction of a Competitive Endogenous RNA Network and Identification of Potential Regulatory Axis in Gastric Cancer.
Neoplasms
Construction of a Competitive Endogenous RNA Network for Pancreatic Adenocarcinoma Based on Weighted Gene Co-expression Network Analysis and a Prognosis Model.
Neoplasms
Construction of a Competitive Endogenous RNA Network in Uterine Corpus Endometrial Carcinoma.
Neoplasms
Construction of a Comprehensive Multiomics Map of Hepatocellular Carcinoma and Screening of Possible Driver Genes.
Neoplasms
Construction of a CXC Chemokine-Based Prediction Model for the Prognosis of Colon Cancer.
Neoplasms
Construction of a disease-specific lncRNA-miRNA-mRNA regulatory network reveals potential regulatory axes and prognostic biomarkers for hepatocellular carcinoma.
Neoplasms
Construction of a five-gene prognostic model based on immune-related genes for the prediction of survival in pancreatic cancer.
Neoplasms
Construction of a Glycolysis-related long noncoding RNA signature for predicting survival in endometrial cancer.
Neoplasms
Construction of a lipid metabolism-related and immune-associated prognostic signature for hepatocellular carcinoma.
Neoplasms
Construction of a long non-coding RNA-associated ceRNA network reveals potential prognostic lncRNA biomarkers in hepatocellular carcinoma.
Neoplasms
Construction of a metastasis-associated ceRNA network reveals a prognostic signature in lung cancer.
Neoplasms
Construction of a MicroRNA-Based Nomogram for Prediction of Lung Metastasis in Breast Cancer Patients.
Neoplasms
Construction of a model to predict the prognosis of patients with cholangiocarcinoma using alternative splicing events.
Neoplasms
Construction of a Myc-associated ceRNA network reveals a prognostic signature in hepatocellular carcinoma.
Neoplasms
Construction of a nine DNA repair-related gene prognostic classifier to predict prognosis in patients with endometrial carcinoma.
Neoplasms
Construction of a Nomogram Based on a Hypoxia-Related lncRNA Signature to Improve the Prediction of Gastric Cancer Prognosis.
Neoplasms
Construction of a novel gene-based model for prognosis prediction of clear cell renal cell carcinoma.
Neoplasms
Construction of a Novel Immune-Related lncRNA Pair Signature with Prognostic Significance for Kidney Clear Cell Renal Cell Carcinoma.
Neoplasms
Construction of a Novel Lung Adenocarcinoma Immune-Related lncRNA Pair Signature.
Neoplasms
Construction of a novel methylation-related prognostic model for colorectal cancer based on microsatellite status.
Neoplasms
Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Neoplasms
Construction of a novel risk model based on the random forest algorithm to distinguish pancreatic cancers with different prognoses and immune microenvironment features.
Neoplasms
Construction of a prognosis-predicting model based on autophagy-related genes for hepatocellular carcinoma (HCC) patients.
Neoplasms
Construction of a Prognostic Immune Signature for Squamous-Cell Lung Cancer to Predict Survival.
Neoplasms
Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma.
Neoplasms
Construction of a prognostic model based on nine immune-related genes and identification of small molecule drugs for hepatocellular carcinoma (HCC).
Neoplasms
Construction of a prognostic model for lung squamous cell carcinoma based on seven N6-methylandenosine-related autophagy genes.
Neoplasms
Construction of a prognostic model with histone modification-related genes and identification of potential drugs in pancreatic cancer.
Neoplasms
Construction of a prognostic value model in papillary renal cell carcinoma by immune-related genes.
Neoplasms
Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
Neoplasms
Construction of a risk signature for adrenocortical carcinoma using immune-related genes.
Neoplasms
Construction of a robust prognostic model for adult adrenocortical carcinoma: Results from bioinformatics and real-world data.
Neoplasms
Construction of a Signature Composed of 14 Immune Genes to Judge the Prognosis and Immune Infiltration of Colon Cancer.
Neoplasms
Construction of an 11-microRNA-based signature and a prognostic nomogram to predict the overall survival of head and neck squamous cell carcinoma patients.
Neoplasms
Construction of an Immune-Associated Gene-Based Signature in Muscle-Invasive Bladder Cancer.
Neoplasms
Construction of an immune-related gene signature to predict survival and treatment outcome in gastric cancer.
Neoplasms
Construction of an immune-related genes nomogram for the preoperative prediction of axillary lymph node metastasis in triple-negative breast cancer.
Neoplasms
Construction of an immune-related signature with prognostic value for colon cancer.
Neoplasms
Construction of an Immune-Related Six-lncRNA Signature to Predict the Outcomes, Immune Cell Infiltration, and Immunotherapy Response in Patients With Hepatocellular Carcinoma.
Neoplasms
Construction of an initial microRNA regulation network in breast invasive carcinoma by bioinformatics analysis.
Neoplasms
Construction of Bone Metastasis-Specific Regulation Network Based on Prognostic Stemness-Related Signatures in Breast Invasive Carcinoma.
Neoplasms
Construction of ceRNA networks reveals differences between distal and proximal colon cancers.
Neoplasms
Construction of circRNA-Based ceRNA Network to Reveal the Role of circRNAs in the Progression and Prognosis of Hepatocellular Carcinoma.
Neoplasms
Construction of circRNA-based ceRNA network to reveal the role of circRNAs in the progression and prognosis of metastatic clear cell renal cell carcinoma.
Neoplasms
Construction of competing endogenous RNA network and identification of novel molecular biomarkers in colon cancer: A bioinformatic analysis.
Neoplasms
Construction of Competitive Endogenous RNA Network and Verification of 3-Key LncRNA Signature Associated With Distant Metastasis and Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma.
Neoplasms
Construction of Gene Modules and Analysis of Prognostic Biomarkers for Cervical Cancer by Weighted Gene Co-Expression Network Analysis.
Neoplasms
Construction of immune-related risk signature for renal papillary cell carcinoma.
Neoplasms
Construction of integrated microRNA and mRNA immune cell signatures to predict survival of patients with breast and ovarian cancer.
Neoplasms
Construction of liver hepatocellular carcinoma-specific lncRNA-miRNA-mRNA network based on bioinformatics analysis.
Neoplasms
Construction of lncRNA-associated ceRNA networks to identify prognostic lncRNA biomarkers for glioblastoma.
Neoplasms
Construction of Novel DNA Methylation-Based Prognostic Model to Predict Survival in Glioblastoma.
Neoplasms
Construction of Novel lncRNA-miRNA-mRNA Network Associated With Recurrence and Identification of Immune-Related Potential Regulatory Axis in Hepatocellular Carcinoma.
Neoplasms
Construction of prognostic microRNA signature for human invasive breast cancer by integrated analysis.
Neoplasms
Construction of prognostic predictor by comprehensive analyzing alternative splicing events for colon adenocarcinoma.
Neoplasms
Construction of prognostic risk prediction model of oral squamous cell carcinoma based on co-methylated genes.
Neoplasms
Construction of Protein-related Risk Score Model in Bladder Urothelial Carcinoma.
Neoplasms
Construction of the optimization prognostic model based on differentially expressed immune genes of lung adenocarcinoma.
Neoplasms
Construction of TME and Identification of crosstalk between malignant cells and macrophages by SPP1 in hepatocellular carcinoma.
Neoplasms
Construction on of a Ferroptosis-Related lncRNA-Based Model to Improve the Prognostic Evaluation of Gastric Cancer Patients Based on Bioinformatics.
Neoplasms
Consulting prostate cancer cohort data uncovers transcriptional control: Regulation of the MARCH6 gene.
Neoplasms
Context-Specific Coordinately Regulatory Network Prioritize Breast Cancer Genetic Risk Factors.
Neoplasms
ContrastRank: a new method for ranking putative cancer driver genes and classification of tumor samples.
Neoplasms
Contribution of upregulated aminoacyl-tRNA biosynthesis to metabolic dysregulation in gastric cancer.
Neoplasms
Contributions and prognostic values of m6 A RNA methylation regulators in non-small-cell lung cancer.
Neoplasms
Contributions and Prognostic Values of N6-Methyladenosine RNA Methylation Regulators in Hepatocellular Carcinoma.
Neoplasms
Controlling for cellular heterogeneity using single-cell deconvolution of gene expression reveals novel markers of colorectal tumors exhibiting microsatellite instability.
Neoplasms
Conventionally used reference genes are not outstanding for normalization of gene expression in human cancer research.
Neoplasms
Convergent Usage of Amino Acids in Human Cancers as A Reversed Process of Tissue Development.
Neoplasms
Convolutional neural network models for cancer type prediction based on gene expression.
Neoplasms
Cooperation Between the Inflammation and Coagulation Systems Promotes the Survival of Circulating Tumor Cells in Renal Cell Carcinoma Patients.
Neoplasms
Cooperative driver pathway discovery via fusion of multi-relational data of genes, miRNAs and pathways.
Neoplasms
Coordination of self-renewal in glioblastoma by integration of adhesion and microRNA signaling.
Neoplasms
Copy neutral loss of heterozygosity is more frequent in older ovarian cancer patients.
Neoplasms
Copy number alterations identify a smoking-associated expression signature predictive of poor outcome in head and neck squamous cell carcinoma.
Neoplasms
Copy Number Alterations in Tumor Genomes Deleting Antineoplastic Drug Targets Partially Compensated by Complementary Amplifications.
Neoplasms
Copy number analysis of whole-genome data using BIC-seq2 and its application to detection of cancer susceptibility variants.
Neoplasms
Copy Number Changes Are Associated with Response to Treatment with Carboplatin, Paclitaxel, and Sorafenib in Melanoma.
Neoplasms
Copy number gains at chr3p25 and chr11p11 are associated with lymph node involvement and survival in muscle-invasive bladder tumors.
Neoplasms
Copy number of 8q24.3 drives HSF1 expression and patient outcome in cancer: an individual patient data meta-analysis.
Neoplasms
Copy number profiling across glioblastoma populations has implications for clinical trial design.
Neoplasms
Copy Number Profiling of MammaPrint Genes Reveals Association with the Prognosis of Breast Cancer Patients.
Neoplasms
Copy number profiling of Oncotype DX genes reveals association with survival of breast cancer patients.
Neoplasms
Copy number variability analysis of pharmacogenes in patients with lymphoma, leukemia, hepatocellular, and lung carcinoma using The Cancer Genome Atlas data.
Neoplasms
Copy number variation: A prognostic marker for young patients with squamous cell carcinoma of the oral tongue.
Neoplasms
Copy-number variation of MCL1 predicts overall survival of non-small-cell lung cancer in a Southern Chinese population.
Neoplasms
Corded and Hyalinized and Spindled Endometrioid Endometrial Carcinoma: A Clinicopathologic and Molecular Analysis of 9 Tumors Based on the TCGA Classifier.
Neoplasms
Core liver homeostatic co-expression networks are preserved but respond to perturbations in an organism- and disease-specific manner.
Neoplasms
CORO6 Promotes Cell Growth and Invasion of Clear Cell Renal Cell Carcinoma via Activation of WNT Signaling.
Neoplasms
Correction to: The Cancer Omics Atlas: an integrative resource for cancer omics annotations.
Neoplasms
Correction: intra-tumor genetic heterogeneity and mortality in head and neck cancer: analysis of data from the Cancer Genome Atlas.
Neoplasms
Correction: Intra-tumor Genetic Heterogeneity and Mortality in Head and Neck Cancer: Analysis of Data from The Cancer Genome Atlas.
Neoplasms
Correlating bladder cancer risk genes with their targeting microRNAs using MMiRNA-Tar.
Neoplasms
Correlating Transcriptional Networks to Papillary Renal Cell Carcinoma Survival: A Large-Scale Co-expression Analysis and Clinical Validation.
Neoplasms
Correlation between gene expression and mutator phenotype predicts homologous recombination deficiency and outcome in ovarian cancer.
Neoplasms
Correlation Between High Expression of FOXA2 and Improved Overall Survival in Ovarian Cancer Patients.
Neoplasms
Correlation Between Infection Status of Epstein-Barr Virus and (18)F-Fluorodeoxyglucose Uptake in Patients with Advanced Gastric Cancer.
Neoplasms
Correlation between lower balance of Th2 helper T-cells and expression of PD-L1/PD-1 axis genes enables prognostic prediction in patients with glioblastoma.
Neoplasms
Correlation Between Prognostic Biomarker SLC1A5 and Immune Infiltrates in Various Types of Cancers Including Hepatocellular Carcinoma.
Neoplasms
Correlation between prognostic indicator AHNAK2 and immune infiltrates in lung adenocarcinoma.
Neoplasms
Correlation between telomerase reverse transcriptase messenger RNA expression and survival of patients with papillary thyroid carcinoma.
Neoplasms
Correlation of BRCA2 gene mutation and prognosis as well as variant genes in invasive urothelial carcinoma of the bladder.
Neoplasms
Correlation of carbonic anhydrase 9 (CA9) with pathological T-stage and prognosis in patients with oral tongue squamous cell carcinoma.
Neoplasms
Correlation of genetic alterations by whole-exome sequencing with clinical outcomes of glioblastoma patients from the Lebanese population.
Neoplasms
Correlation of NUF2 Over-expression with Poorer Patient Survival in Multiple Cancers.
Neoplasms
Correlation of somatic mutation and expression identifies genes important in human glioblastoma progression and survival.
Neoplasms
Correlation of tumor mutational burden and treatment outcomes in patients with colorectal cancer.
Neoplasms
Correlation of zinc finger protein 2, a prognostic biomarker, with immune infiltrates in liver cancer.
Neoplasms
Correlation Patterns Between DNA Methylation and Gene Expression in The Cancer Genome Atlas.
Neoplasms
Correlations between stemness indices for hepatocellular carcinoma, clinical characteristics, and prognosis.
Neoplasms
Correlations Between the Characteristics of Alternative Splicing Events, Prognosis, and the Immune Microenvironment in Breast Cancer.
Neoplasms
Correlations between tumor mutation burden and immune infiltrates and their prognostic value in pancreatic cancer by bioinformatic analysis.
Neoplasms
Correlations of lncRNAs with cervical lymph node metastasis and prognosis of papillary thyroid carcinoma.
Neoplasms
Correlations of UGT1A1 gene polymorphisms with onset and prognosis of non-small cell lung cancer.
Neoplasms
CoSMeD: a user-friendly web server to estimate 5-year survival probability of left-sided and right-sided colorectal cancer patients using molecular data.
Neoplasms
COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer.
Neoplasms
Cost-efficiency tradeoff is optimized in various cancer types revealed by genome-wide analysis.
Neoplasms
Cox-LASSO Analysis Reveals a Ten-lncRNA Signature to Predict Outcomes in Patients with High-Grade Serous Ovarian Cancer.
Neoplasms
CPEM: Accurate cancer type classification based on somatic alterations using an ensemble of a random forest and a deep neural network.
Neoplasms
CpG island methylator phenotype in adenocarcinomas from the digestive tract: Methods, conclusions, and controversies.
Neoplasms
CPNE1 Is a Useful Prognostic Marker and Is Associated with TNF Receptor-Associated Factor 2 (TRAF2) Expression in Prostate Cancer.
Neoplasms
CPSF3 is a promising prognostic biomarker and predicts recurrence of non-small cell lung cancer.
Neoplasms
Creation of a Prognostic Risk Prediction Model for Lung Adenocarcinoma Based on Gene Expression, Methylation, and Clinical Characteristics.
Neoplasms
CREB targets define the gene expression signature of malignancies having reduced levels of the tumor suppressor tristetraprolin.
Neoplasms
CREDO: Highly confident disease-relevant A-to-I RNA-editing discovery in breast cancer.
Neoplasms
Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations.
Neoplasms
CRIF1 overexpression facilitates tumor growth and metastasis through inducing ROS/NF?B pathway in hepatocellular carcinoma.
Neoplasms
CRISPR-cas9 Screening Identified Lethal Genes Enriched in Cell Cycle Pathway and of Prognosis Significance in Breast Cancer.
Neoplasms
CRISPR-Mediated VHL Knockout Generates an Improved Model for Metastatic Renal Cell Carcinoma.
Neoplasms
Critical genes in head and neck squamous cell carcinoma revealed by bioinformatic analysis of gene expression data.
Neoplasms
Critical genes of hepatocellular carcinoma revealed by network and module analysis of RNA-seq data.
Neoplasms
CRLF1 promotes malignant phenotypes of papillary thyroid carcinoma by activating the MAPK/ERK and PI3K/AKT pathways.
Neoplasms
CRMP5-associated GTPase (CRAG) Is a Candidate Driver Gene for Colorectal Cancer Carcinogenesis.
Neoplasms
Cross-cancer profiling of molecular alterations within the human autophagy interaction network.
Neoplasms
Cross-Database Analysis Reveals Sensitive Biomarkers for Combined Therapy for ERBB2+ Gastric Cancer.
Neoplasms
Cross-resistance to the synthetic retinoid CD437 in a paclitaxel-resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor-gamma.
Neoplasms
Cross-talk and clinical value of m[superscript 6]A regulatory gene in bladder cancer.
Neoplasms
Cross-validation of genes potentially associated with overall survival and drug resistance in ovarian cancer.
Neoplasms
CrossHub: a tool for multi-way analysis of The Cancer Genome Atlas (TCGA) in the context of gene expression regulation mechanisms.
Neoplasms
Crosstalk between microRNA expression and DNA methylation drives the hormone-dependent phenotype of breast cancer.
Neoplasms
Crosstalk Between the MSI Status and Tumor Microenvironment in Colorectal Cancer.
Neoplasms
Crumbs protein homolog 3 (CRB3) expression is associated with oestrogen and progesterone receptor positivity in breast cancer.
Neoplasms
CSE1L, as a novel prognostic marker, promotes pancreatic cancer proliferation by regulating the AKT/mTOR signaling pathway.
Neoplasms
CT-based Radiomic Signatures for Predicting Histopathologic Features in Head and Neck Squamous Cell Carcinoma.
Neoplasms
CT-detected extramural venous invasion-related gene signature for the overall survival prediction in patients with gastric cancer.
Neoplasms
CtBP2 is associated with angiogenesis and regulates the apoptosis of prostate cancer cells.
Neoplasms
CTLA4 methylation predicts response to anti-PD-1 and anti-CTLA-4 immunotherapy in melanoma patients.
Neoplasms
CTLA4 promoter hypomethylation is a negative prognostic biomarker at initial diagnosis but predicts response and favorable outcome to anti-PD-1 based immunotherapy in clear cell renal cell carcinoma.
Neoplasms
Cullin-5 (CUL5) as a potential prognostic marker in a pan-cancer analysis of human tumors.
Neoplasms
Cullin-7 (CUL7) is overexpressed in glioma cells and promotes tumorigenesis via NF-?B activation.
Neoplasms
CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence.
Neoplasms
Curation of the Pancreatic Ductal Adenocarcinoma Subset of the Cancer Genome Atlas Is Essential for Accurate Conclusions about Survival-Related Molecular Mechanisms.
Neoplasms
Curcumin Has Anti-Proliferative and Pro-Apoptotic Effects on Tongue Cancer in vitro: A Study with Bioinformatics Analysis and in vitro Experiments.
Neoplasms
Current dichotomy between traditional molecular biological and omic research in cancer biology and pharmacology.
Neoplasms
Cutaneous Melanoma: Mutational Status and Potential Links to Tertiary Lymphoid Structure Formation.
Neoplasms
CXCL10 is a Tumor Microenvironment and Immune Infiltration Related Prognostic Biomarker in Pancreatic Adenocarcinoma.
Neoplasms
CXCL10 potentiates immune checkpoint blockade therapy in homologous recombination-deficient tumors.
Neoplasms
CXCL11 Correlates With Antitumor Immunity and an Improved Prognosis in Colon Cancer.
Neoplasms
CXCL11-CXCR3 Axis Mediates Tumor Lymphatic Cross Talk and Inflammation-Induced Tumor, Promoting Pathways in Head and Neck Cancers.
Neoplasms
CXCL12 expression and PD-L1 expression serve as prognostic biomarkers in HCC and are induced by hypoxia.
Neoplasms
CXCL12 promoter methylation and PD-L1 expression as prognostic biomarkers in prostate cancer patients.
Neoplasms
CXCL13 shapes immunoactive tumor microenvironment and enhances the efficacy of PD-1 checkpoint blockade in high-grade serous ovarian cancer.
Neoplasms
CXCL13/CXCR5 Axis Predicts Poor Prognosis and Promotes Progression Through PI3K/AKT/mTOR Pathway in Clear Cell Renal Cell Carcinoma.
Neoplasms
CXCL3 overexpression affects the malignant behavior of oral squamous cell carcinoma cells via the MAPK signaling pathway.
Neoplasms
CXCL5 expression in tumor tissues is associated with poor prognosis in patients with pancreatic cancer.
Neoplasms
CXCL5 Has Potential to Be a Marker for Hepatocellular Carcinoma Prognosis and Was Correlating With Immune Infiltrates.
Neoplasms
CXCL5/CXCL8 is a promising potential prognostic and tumor microenvironment-related cluster in hepatocellular carcinoma.
Neoplasms
CXCL8 Associated Dendritic Cell Activation Marker Expression and Recruitment as Indicators of Favorable Outcomes in Colorectal Cancer.
Neoplasms
CXCR-4, a chemokine receptor, is overexpressed in and required for proliferation of glioblastoma tumor cells.
Neoplasms
CXCR1 expression predicts benefit from tyrosine kinase inhibitors therapy in patients with metastatic renal cell carcinoma.
Neoplasms
CXCR2-Dependent Accumulation of Tumor-Associated Neutrophils Regulates T-cell Immunity in Pancreatic Ductal Adenocarcinoma.
Neoplasms
CXCR3 Expression and Genome-Wide 3' Splice Site Selection in the TCGA Breast Cancer Cohort.
Neoplasms
Cyanidin-3-glucoside suppresses the progression of lung adenocarcinoma by downregulating TP53I3 and inhibiting PI3K/AKT/mTOR pathway.
Neoplasms
Cyanidin-3-o-Glucoside Pharmacologically Inhibits Tumorigenesis via Estrogen Receptor ? in Melanoma Mice.
Neoplasms
CYB5R1 links epithelial-mesenchymal transition and poor prognosis in colorectal cancer.
Neoplasms
Cyclin-Dependent Kinase 1 (CDK1) is Co-Expressed with CDCA5: Their Functions in Gastric Cancer Cell Line MGC-803.
Neoplasms
Cyclin-dependent kinase 5 acts as a promising biomarker in clear cell Renal Cell Carcinoma.
Neoplasms
Cyclin-Dependent Kinase and Antioxidant Gene Expression in Cancers with Poor Therapeutic Response.
Neoplasms
Cyclooxygenase and lipoxygenase gene expression in the inflammogenesis of breast cancer.
Neoplasms
CYP4B1 is a prognostic biomarker and potential therapeutic target in lung adenocarcinoma.
Neoplasms
Cystatin-B Negatively Regulates the Malignant Characteristics of Oral Squamous Cell Carcinoma Possibly Via the Epithelium Proliferation/Differentiation Program.
Neoplasms
Cysteine-Rich Intestinal Protein 1 Served as an Epithelial Ovarian Cancer Marker via Promoting Wnt/?-Catenin-Mediated EMT and Tumour Metastasis.
Neoplasms
Cytidine monophosphate N-acetylneuraminic acid synthetase enhances invasion of human triple-negative breast cancer cells.
Neoplasms
Cytogenetic alterations and their molecular genetic correlates in head and neck squamous cell carcinoma: a next generation window to the biology of disease.
Neoplasms
Cytolytic activity score as a biomarker for antitumor immunity and clinical outcome in patients with gastric cancer.
Neoplasms
Cytoplasmic Pattern p53 Immunoexpression in Pelvic and Endometrial Carcinomas With TP53 Mutation Involving Nuclear Localization Domains: An Uncommon But Potential Diagnostic Pitfall With Clinical Implications.
Neoplasms
Cytoplasmic SQSTM1/ P62 Accumulation Predicates a Poor Prognosis in Patients with Malignant Tumor.
Neoplasms
Cytoskeleton-associated membrane protein 4 is upregulated in tumor tissues and is associated with clinicopathological characteristics and prognosis in hepatocellular carcinoma.
Neoplasms
Cytotoxic effects of combination of oxidosqualene cyclase inhibitors with atorvastatin in human cancer cells.
Neoplasms
Cytotoxic T-cell-related gene expression signature predicts improved survival in muscle-invasive urothelial bladder cancer patients after radical cystectomy and adjuvant chemotherapy.
Neoplasms
Cytotoxic T-lymphocyte infiltration and chemokine predict long-term patient survival independently of tumor mutational burden in triple-negative breast cancer.
Neoplasms
D-CCA: A Decomposition-based Canonical Correlation Analysis for High-Dimensional Datasets.
Neoplasms
DACH1 mutation frequency in endometrial cancer is associated with high tumor mutation burden.
Neoplasms
Data Fusion Techniques for the Integration of Multi-Domain Genomic Data from Uveal Melanoma.
Neoplasms
Data mining analysis of the prognostic impact of N6-methyladenosine regulators in patients with endometrial adenocarcinoma.
Neoplasms
Data Mining and Expression Analysis of Differential lncRNA ADAMTS9-AS1 in Prostate Cancer.
Neoplasms
Data mining combined with experiments to validate CEP55 as a prognostic biomarker in colorectal cancer.
Neoplasms
Data Mining Identifies Six Proteins that Can Act as Prognostic Markers for Head and Neck Squamous Cell Carcinoma.
Neoplasms
Data mining in clinical big data: the frequently used databases, steps, and methodological models.
Neoplasms
Data mining of immune-related prognostic genes in metastatic melanoma microenvironment.
Neoplasms
Data mining of micrornas in breast carcinogenesis which may be a potential target for cancer prevention.
Neoplasms
Data mining of the expression and regulatory role of BCAT1 in hepatocellular carcinoma.
Neoplasms
Data mining-based study of collagen type III alpha 1 (COL3A1) prognostic value and immune exploration in pan-cancer.
Neoplasms
Data on SVCT2 transporter expression and localization in cancer cell lines and tissues.
Neoplasms
Data-Driven Computational Modeling Identifies Determinants of Glioblastoma Response to SHP2 Inhibition.
Neoplasms
Data-Driven Discovery of Molecular Targets for Antibody-Drug Conjugates in Cancer Treatment.
Neoplasms
Data-driven prioritization and preclinical evaluation of therapeutic targets in glioblastoma.
Neoplasms
Database Mining of Genes of Prognostic Value for the Prostate Adenocarcinoma Microenvironment Using the Cancer Gene Atlas.
Neoplasms
Database of genomic biomarkers for cancer drugs and clinical targetability in solid tumors.
Neoplasms
Dataset of segmented nuclei in hematoxylin and eosin stained histopathology images of ten cancer types.
Neoplasms
dbGENVOC: database of GENomic Variants of Oral Cancer, with special reference to India.
Neoplasms
DC-SIGN mediates gastric cancer progression by regulating the JAK2/STAT3 signaling pathway and affecting LncRNA RP11-181G12.2 expression.
Neoplasms
DCBLD1 is associated with the integrin signaling pathway and has prognostic value in non-small cell lung and invasive breast carcinoma.
Neoplasms
DDN-AS1-miR-15a/16-TCF3 feedback loop regulates tumor progression in cervical cancer.
Neoplasms
DDX17 promotes hepatocellular carcinoma progression via inhibiting Klf4 transcriptional activity.
Neoplasms
DDX39 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in patients with clear cell renal cell carcinoma.
Neoplasms
DDX3X is Epigenetically Repressed in Renal Cell Carcinoma and Serves as a Prognostic Indicator and Therapeutic Target in Cancer Progression.
Neoplasms
DDX3X promotes the biogenesis of a subset of miRNAs and the potential roles they played in cancer development.
Neoplasms
De Novo Fatty Acid Synthesis-Driven Sphingolipid Metabolism Promotes Metastatic Potential of Colorectal Cancer.
Neoplasms
De Novo Mutation in Non-Tyrosine Kinase Domain of ROS1 as a Potential Predictor of Immune Checkpoint Inhibitors in Melanoma.
Neoplasms
De novo, systemic, deleterious amino acid substitutions are common in large cytoskeleton-related protein coding regions.
Neoplasms
DEAD-box helicase 27 plays a tumor-promoter role by regulating the stem cell-like activity of human colorectal cancer cells.
Neoplasms
Deciphering Genomic Underpinnings of Quantitative MRI-based Radiomic Phenotypes of Invasive Breast Carcinoma.
Neoplasms
Deciphering Immune-Associated Genes to Predict Survival in Clear Cell Renal Cell Cancer.
Neoplasms
Deciphering N6-Methyladenosine-Related Genes Signature to Predict Survival in Lung Adenocarcinoma.
Neoplasms
Deciphering the associations between gene expression and copy number alteration using a sparse double Laplacian shrinkage approach.
Neoplasms
Deciphering the Correlation between Breast Tumor Samples and Cell Lines by Integrating Copy Number Changes and Gene Expression Profiles.
Neoplasms
Deciphering the effects of PYCR1 on cell function and its associated mechanism in hepatocellular carcinoma.
Neoplasms
Deciphering the genetic alterations in matrix metallo-proteinase gene family and its putative association with head and neck squamous cell carcinoma.
Neoplasms
Deciphering the genomic and lncRNA landscapes of aerobic glycolysis identifies potential therapeutic targets in pancreatic cancer.
Neoplasms
Deciphering the nexus between the tumor immune microenvironment and DNA methylation in subgrouping estrogen receptor-positive breast cancer.
Neoplasms
Deciphering the Oncogenic Role of VPS28 Modulated by miR-491-5p in Breast Cancer Cells Using In Silico and Functional Analysis.
Neoplasms
Decision tree-based classifiers for lung cancer diagnosis and subtyping using TCGA miRNA expression data.
Neoplasms
Decitabine enhances tumor recognition by T cells through upregulating the MAGE-A3 expression in esophageal carcinoma.
Neoplasms
Decoding and Systematization of Medical Imaging Features of Multiple Human Malignancies.
Neoplasms
Decoding human cancer with whole genome sequencing: a review of PCAWG Project studies published in February 2020.
Neoplasms
Decoding the LncRNA transcriptome of esophageal cancer: identification of clinically relevant LncRNAs.
Neoplasms
Deconvolution and network analysis of IDH-mutant lower grade glioma predict recurrence and indicate therapeutic targets.
Neoplasms
Deconvolution and phylogeny inference of structural variations in tumor genomic samples.
Neoplasms
Deconvolution of DNA methylation identifies differentially methylated gene regions on 1p36 across breast cancer subtypes.
Neoplasms
Deconvolution of the Genomic and Epigenomic Interaction Landscape of Triple-Negative Breast Cancer.
Neoplasms
Decorin expression is associated with predictive diffusion MR phenotypes of anti-VEGF efficacy in glioblastoma.
Neoplasms
Decreased BECN1 mRNA Expression in Human Breast Cancer is Associated with Estrogen Receptor-Negative Subtypes and Poor Prognosis.
Neoplasms
Decreased CDKL2 expression is correlated with the progression and poor prognosis of glioma.
Neoplasms
Decreased copy-neutral loss of heterozygosity in African American colorectal cancers.
Neoplasms
Decreased CSTA expression promotes lymphatic metastasis and predicts poor survival in oral squamous cell carcinoma.
Neoplasms
Decreased expression and hypomethylation of HDAC9 lead to poor prognosis and inhibit immune cell infiltration in clear cell renal cell carcinoma.
Neoplasms
Decreased expression of ARHGAP15 promotes the development of colorectal cancer through PTEN/AKT/FOXO1 axis.
Neoplasms
Decreased expression of ARID1A invasively downregulates the expression of ribosomal proteins in hepatocellular carcinoma.
Neoplasms
Decreased expression of CLCA2 and the correlating with immune infiltrates in patients with cervical squamous cell carcinoma: A bioinformatics analysis.
Neoplasms
Decreased expression of COLEC10 predicts poor overall survival in patients with hepatocellular carcinoma.
Neoplasms
Decreased Expression of CPEB3 Predicts a Poor Prognosis in Patients with Melanoma: A Study Based on TCGA Data.
Neoplasms
Decreased expression of HADH is related to poor prognosis and immune infiltration in kidney renal clear cell carcinoma.
Neoplasms
Decreased expression of HDAC8 indicates poor prognosis in patients with intrahepatic cholangiocarcinoma.
Neoplasms
Decreased expression of JAK1 associated with immune infiltration and poor prognosis in lung adenocarcinoma.
Neoplasms
Decreased expression of METTL14 predicts poor prognosis and construction of a prognostic signature for clear cell renal cell carcinoma.
Neoplasms
Decreased Expression of NUSAP1 Predicts Poor Overall Survival in Cervical Cancer.
Neoplasms
Decreased expression of peroxiredoxin1 inhibits proliferation, invasion, and metastasis of ovarian cancer cell.
Neoplasms
Decreased expression of serine protease inhibitor family G1 (SERPING1) in prostate cancer can help distinguish high-risk prostate cancer and predicts malignant progression.
Neoplasms
Decreased expression of SLC16A12 mRNA predicts poor prognosis of patients with clear cell renal cell carcinoma.
Neoplasms
Decreased Expression of SRSF2 Splicing Factor Inhibits Apoptotic Pathways in Renal Cancer.
Neoplasms
Decreased expression of TFAP2B in endometrial cancer predicts poor prognosis: A study based on TCGA data.
Neoplasms
Decreased expression of TRPM4 is associated with unfavorable prognosis and aggressive progression of endometrial carcinoma.
Neoplasms
Decreased expression of TXNIP predicts poor prognosis in patients with clear cell renal cell carcinoma.
Neoplasms
Decreased secretoglobin family 2A member 1expression is associated with poor outcomes in endometrial cancer.
Neoplasms
Decreased SMAD4 expression is associated with induction of epithelial-to-mesenchymal transition and cetuximab resistance in head and neck squamous cell carcinoma.
Neoplasms
Decreased Tumoral Expression of Colon-Specific Water Channel Aquaporin 8 Is Associated With Reduced Overall Survival in Colon Adenocarcinoma.
Neoplasms
Decreased vitamin C uptake mediated by SLC2A3 promotes leukaemia progression and impedes TET2 restoration.
Neoplasms
DECtp: Calling Differential Gene Expression Between Cancer and Normal Samples by Integrating Tumor Purity Information.
Neoplasms
Deep Convolutional Neural Network-Based Lymph Node Metastasis Prediction for Colon Cancer Using Histopathological Images.
Neoplasms
Deep learning assisted multi-omics integration for survival and drug-response prediction in breast cancer.
Neoplasms
Deep Learning for Automatic Subclassification of Gastric Carcinoma Using Whole-Slide Histopathology Images.
Neoplasms
Deep Learning Implicitly Handles Tissue Specific Phenomena to Predict Tumor DNA Accessibility and Immune Activity.
Neoplasms
Deep learning model for the prediction of microsatellite instability in colorectal cancer: a diagnostic study.
Neoplasms
Deep learning prediction of BRAF-RAS gene expression signature identifies noninvasive follicular thyroid neoplasms with papillary-like nuclear features.
Neoplasms
Deep Learning Predicts Molecular Subtype of Muscle-invasive Bladder Cancer from Conventional Histopathological Slides.
Neoplasms
Deep learning-based classification of mesothelioma improves prediction of patient outcome.
Neoplasms
Deep learning-based cross-classifications reveal conserved spatial behaviors within tumor histological images.
Neoplasms
Deep learning-based gene selection in comprehensive gene analysis in pancreatic cancer.
Neoplasms
Deep learning-based model for predicting progression in patients with head and neck squamous cell carcinoma.
Neoplasms
Deep Learning-Based Multi-Omics Integration Robustly Predicts Survival in Liver Cancer.
Neoplasms
Deep learning-based ovarian cancer subtypes identification using multi-omics data.
Neoplasms
Deep learning-based six-type classifier for lung cancer and mimics from histopathological whole slide images: a retrospective study.
Neoplasms
Deep learning-based survival prediction for multiple cancer types using histopathology images.
Neoplasms
Deep learning-based tumor microenvironment analysis in colon adenocarcinoma histopathological whole-slide images.
Neoplasms
Deep Neural Network Analysis of Pathology Images With Integrated Molecular Data for Enhanced Glioma Classification and Grading.
Neoplasms
Deep Radiogenomics of Lower-Grade Gliomas: Convolutional Neural Networks Predict Tumor Genomic Subtypes Using MR Images.
Neoplasms
Deep Sequencing Analysis Reveals That KRAS Mutation Is a Marker of Poor Prognosis in Patients with Pulmonary Sarcomatoid Carcinoma.
Neoplasms
Deep sequencing and comprehensive expression analysis identifies several molecules potentially related to human poorly differentiated hepatocellular carcinoma.
Neoplasms
Deep Transfer Learning and Radiomics Feature Prediction of Survival of Patients with High-Grade Gliomas.
Neoplasms
Deep-Hipo: Multi-scale receptive field deep learning for histopathological image analysis.
Neoplasms
Deep-Learning-Based Characterization of Tumor-Infiltrating Lymphocytes in Breast Cancers From Histopathology Images and Multiomics Data.
Neoplasms
deepBase v3.0: expression atlas and interactive analysis of ncRNAs from thousands of deep-sequencing data.
Neoplasms
DeepLRHE: A Deep Convolutional Neural Network Framework to Evaluate the Risk of Lung Cancer Recurrence and Metastasis From Histopathology Images.
Neoplasms
DeepRePath: Identifying the Prognostic Features of Early-Stage Lung Adenocarcinoma Using Multi-Scale Pathology Images and Deep Convolutional Neural Networks.
Neoplasms
DeepSec: a deep learning framework for secreted protein discovery in human body fluids.
Neoplasms
DeepSurvNet: deep survival convolutional network for brain cancer survival rate classification based on histopathological images.
Neoplasms
Deficiency of mismatch repair genes is less frequently observed in signet ring cell compared with non-signet ring cell gastric cancer.
Neoplasms
Defining a mutational signature for endometrial cancer screening and early detection.
Neoplasms
Defining neoplastic diseases differently: An emerging paradigm from The Cancer Genome Atlas lower-grade gliomas project.
Neoplasms
Defining Signatures of Arm-Wise Copy Number Change and Their Associated Drivers in Kidney Cancers.
Neoplasms
Defining the Na(+)/H(+) exchanger NHE1 interactome in triple-negative breast cancer cells.
Neoplasms
Definition of a novel vascular invasion-associated multi-gene signature for predicting survival in patients with hepatocellular carcinoma.
Neoplasms
Deformable registration of brain tumor images via a statistical model of tumor-induced deformation.
Neoplasms
Deformable Registration of Glioma Images Using EM Algorithm and Diffusion Reaction Modeling.
Neoplasms
DeFusion: a denoised network regularization framework for multi-omics integration.
Neoplasms
Degradation of CCNB1 mediated by APC11 through UBA52 ubiquitination promotes cell cycle progression and proliferation of non-small cell lung cancer cells.
Neoplasms
Degree of MDM2 Amplification Affects Clinical Outcomes in Dedifferentiated Liposarcoma.
Neoplasms
Dek overexpression in murine epithelia increases overt esophageal squamous cell carcinoma incidence.
Neoplasms
DEK promotes the proliferation and invasion of lung cancers and indicates poor prognosis in lung adenocarcinomas.
Neoplasms
Deletion and low expression of NFKBIA are associated with poor prognosis in lower-grade glioma patients.
Neoplasms
Deletion at 6q24.2-26 predicts longer survival of high-grade serous epithelial ovarian cancer patients.
Neoplasms
Deletion of p53 and Hyper-Activation of PIK3CA in Keratin-15+ Stem Cells Lead to the Development of Spontaneous Squamous Cell Carcinoma.
Neoplasms
Deletions at SLC18A1 increased the risk of CRC and lower SLC18A1 expression associated with poor CRC outcome.
Neoplasms
Delineation atlas of the Circle of Willis and the large intracranial arteries for evaluation of doses to neurovascular structures in pediatric brain tumor patients treated with radiation therapy.
Neoplasms
Delineation of the neck node levels for head and neck tumors: A 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines.
Neoplasms
Delineation of whole heart and substructures in thoracic radiation therapy: National guidelines and contouring atlas by the Danish Multidisciplinary Cancer Groups.
Neoplasms
Delta-like ligand-Notch1 signalling is selectively modulated by HPV16 E6 to promote squamous cell proliferation and correlates with cervical cancer prognosis.
Neoplasms
DEMARCATE: Density-based magnetic resonance image clustering for assessing tumor heterogeneity in cancer.
Neoplasms
Demethylation and Overexpression of CSF2 are Involved in Immune Response, Chemotherapy Resistance, and Poor Prognosis in Colorectal Cancer.
Neoplasms
Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma.
Neoplasms
Density of immunogenic antigens does not explain the presence or absence of the T-cell-inflamed tumor microenvironment in melanoma.
Neoplasms
Dependency of the Cancer-Specific Transcriptional Regulation Circuitry on the Promoter DNA Methylome.
Neoplasms
Depleting PTOV1 sensitizes non-small cell lung cancer cells to chemotherapy through attenuating cancer stem cell traits.
Neoplasms
Depletion of FOXM1 via MET targeting underlies establishment of a DNA damage-induced senescence program in gastric cancer.
Neoplasms
Depletion of UBE2C reduces ovarian cancer malignancy and reverses cisplatin resistance via downregulating CDK1.
Neoplasms
Depletion of VAX2 Restrains the Malignant Progression of Papillary Thyroid Carcinoma by Modulating ERK Signaling Pathway.
Neoplasms
Deregulated microRNAs Are Associated with Patient Survival and Predicted to Target Genes That Modulate Lung Cancer Signaling Pathways.
Neoplasms
Deregulation of cell adhesion molecules is associated with progression and poor outcomes in endometrial cancer: Analysis of The Cancer Genome Atlas data.
Neoplasms
Deregulation of the Genes that Are Involved in Drug Absorption, Distribution, Metabolism, and Excretion in Hepatocellular Carcinoma.
Neoplasms
Design of a liver cancer-specific selector for the analysis of circulating tumor DNA.
Neoplasms
Designing gene panels for tumor mutational burden estimation: the need to shift from 'correlation' to 'accuracy'.
Neoplasms
Desmoglein 2 promotes vasculogenic mimicry in melanoma and is associated with poor clinical outcome.
Neoplasms
Desmoglein 3 and Keratin 14 for Distinguishing Between Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Neoplasms
Detailed analysis of adenosine A2a receptor (ADORA2A) and CD73 (5'-nucleotidase, ecto, NT5E) methylation and gene expression in head and neck squamous cell carcinoma patients.
Neoplasms
Detailed Molecular and Immune Marker Profiling of Archival Prostate Cancer Samples Reveals an Inverse Association between TMPRSS2:ERG Fusion Status and Immune Cell Infiltration.
Neoplasms
Detect differentially methylated regions using non-homogeneous hidden Markov model for methylation array data.
Neoplasms
Detecting Disease Specific Pathway Substructures through an Integrated Systems Biology Approach.
Neoplasms
Detecting Prognosis Risk Biomarkers for Colon Cancer Through Multi-Omics-Based Prognostic Analysis and Target Regulation Simulation Modeling.
Neoplasms
Detecting the potential cancer association or metastasis by multi-omics data analysis.
Neoplasms
Detection and analysis of stable and flexible genes towards a genome signature framework in cancer.
Neoplasms
Detection of Bladder Cancer in Urine Sediments by a Novel Multicolor Fluorescence In Situ Hybridization (Quartet) Test.
Neoplasms
Detection of chromosome structural variation by targeted next-generation sequencing and a deep learning application.
Neoplasms
Detection of Isocitrate Dehydrogenase Mutated Glioblastomas Through Anomaly Detection Analytics.
Neoplasms
Detection of miRNA regulatory effect on triple negative breast cancer transcriptome.
Neoplasms
Detection of Productively Rearranged TcR-? V-J Sequences in TCGA Exome Files: Implications for Tumor Immunoscoring and Recovery of Antitumor T-cells.
Neoplasms
Detection of recurrent alternative splicing switches in tumor samples reveals novel signatures of cancer.
Neoplasms
Determination of hypoxia signature to predict prognosis and the tumor immune microenvironment in melanoma.
Neoplasms
Determination of the mutational landscape in Taiwanese patients with papillary thyroid cancer by whole-exome sequencing.
Neoplasms
Determining the Clinical Value and Critical Pathway of GTPBP4 in Lung Adenocarcinoma Using a Bioinformatics Strategy: A Study Based on Datasets from The Cancer Genome Atlas.
Neoplasms
Determining the molecular landscape and impact on prognosis in HPV-associated head and neck cancer.
Neoplasms
Determining the prognostic significance of alternative splicing events in soft tissue sarcoma using data from The Cancer Genome Atlas.
Neoplasms
Deubiquitinating enzyme USP41 promotes lung cancer cell proliferation and migration.
Neoplasms
Develop a circular RNA-related regulatory network associated with prognosis of gastric cancer.
Neoplasms
Developing a lncRNA Signature to Predict the Radiotherapy Response of Lower-Grade Gliomas Using Co-expression and ceRNA Network Analysis.
Neoplasms
Developing a Prognostic Gene Panel of Epithelial Ovarian Cancer Patients by a Machine Learning Model.
Neoplasms
Developing a radiosensitivity gene signature for Caucasian patients with breast cancer.
Neoplasms
Developing ZNF Gene Signatures Predicting Radiosensitivity of Patients with Breast Cancer.
Neoplasms
Development and application of high-throughput screens for the discovery of compounds that disrupt ErbB4 signaling: Candidate cancer therapeutics.
Neoplasms
Development and clinical validation of a 3-miRNA signature to predict prognosis of gastric cancer.
Neoplasms
Development and clinical validation of a novel 9-gene prognostic model based on multi-omics in pancreatic adenocarcinoma.
Neoplasms
Development and Clinical Validation of a Seven-Gene Prognostic Signature Based on Multiple Machine Learning Algorithms in Kidney Cancer.
Neoplasms
Development and evaluation of a deep neural network for histologic classification of renal cell carcinoma on biopsy and surgical resection slides.
Neoplasms
Development and External Validation of a Novel Immune Checkpoint-Related Gene Signature for Prediction of Overall Survival in Hepatocellular Carcinoma.
Neoplasms
Development and internal validation of a nine-lncRNA prognostic signature for prediction of overall survival in colorectal cancer patients.
Neoplasms
Development and internal validation of a novel model and markers to identify the candidates for lymph node metastasis in patients with prostate cancer.
Neoplasms
Development and interpretation of a pathomics-based model for the prediction of microsatellite instability in Colorectal Cancer.
Neoplasms
Development and validation of 3-CpG methylation prognostic signature based on different survival indicators for colorectal cancer.
Neoplasms
Development and validation of 9-long Non-coding RNA signature to predicting survival in hepatocellular carcinoma.
Neoplasms
Development and Validation of a 12-Gene Immune Relevant Prognostic Signature for Lung Adenocarcinoma Through Machine Learning Strategies.
Neoplasms
Development and validation of a 14-gene signature for prognosis prediction in hepatocellular carcinoma.
Neoplasms
Development and validation of a CIMP-associated prognostic model for hepatocellular carcinoma.
Neoplasms
Development and Validation of a Clinical Prognostic Model Based on Immune-Related Genes Expressed in Clear Cell Renal Cell Carcinoma.
Neoplasms
Development and Validation of a Combined Ferroptosis and Immune Prognostic Classifier for Hepatocellular Carcinoma.
Neoplasms
Development and Validation of a Combined Hypoxia and Immune Prognostic Classifier for Head and Neck Cancer.
Neoplasms
Development and validation of a CTNNB1-associated metabolic prognostic model for hepatocellular carcinoma.
Neoplasms
Development and Validation of a Deep-learning Model to Assist With Renal Cell Carcinoma Histopathologic Interpretation.
Neoplasms
Development and validation of a DNA repair gene signature for prognosis prediction in Colon Cancer.
Neoplasms
Development and Validation of a Ferroptosis-Related Gene Signature for Overall Survival Prediction in Lung Adenocarcinoma.
Neoplasms
Development and validation of a ferroptosis-related lncRNAs prognosis signature in colon cancer.
Neoplasms
Development and validation of a ferroptosis-related prognostic model in pancreatic cancer.
Neoplasms
Development and Validation of a Five-immune gene pair Signature in Endometrial carcinoma.
Neoplasms
Development and validation of a five-immune gene prognostic risk model in colon cancer.
Neoplasms
Development and validation of a five-lncRNA signature with prognostic value in colon cancer.
Neoplasms
Development and validation of a four-lipid metabolism gene signature for diagnosis of pancreatic cancer.
Neoplasms
Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
Neoplasms
Development and Validation of a Gene Signature for Prediction of Relapse in Stage I Testicular Germ Cell Tumors.
Neoplasms
Development and validation of a hypoxia-related prognostic signature for breast cancer.
Neoplasms
Development and Validation of a Hypoxia-Related Signature for Predicting Survival Outcomes in Patients With Bladder Cancer.
Neoplasms
Development and validation of a lipogenic genes panel for diagnosis and recurrence of colorectal cancer.
Neoplasms
Development and validation of a m6A RNA methylation regulators-based signature for predicting the prognosis of head and neck squamous cell carcinoma.
Neoplasms
Development and validation of a m6A-related gene signature for predicting the prognosis of hepatocellular carcinoma.
Neoplasms
Development and validation of a metabolic gene signature for predicting overall survival in patients with colon cancer.
Neoplasms
Development and Validation of a Metabolic Gene-Based Prognostic Signature for Hepatocellular Carcinoma.
Neoplasms
Development and Validation of a Metabolic-related Prognostic Model for Hepatocellular Carcinoma.
Neoplasms
Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study.
Neoplasms
Development and validation of a molecular prognostic index of bladder cancer based on immunogenomic landscape analysis.
Neoplasms
Development and Validation of a MRI-Based Radiomics Prognostic Classifier in Patients with Primary Glioblastoma Multiforme.
Neoplasms
Development and Validation of a Nine-Redox-Related Long Noncoding RNA Signature in Renal Clear Cell Carcinoma.
Neoplasms
Development and validation of a nomogram based on stromal score to predict progression-free survival of patients with papillary thyroid carcinoma.
Neoplasms
Development and validation of a nomogram for predicting survival in Chinese han patients with resected colorectal cancer.
Neoplasms
Development and validation of a nomogram with an epigenetic signature for predicting survival in patients with lung adenocarcinoma.
Neoplasms
Development and Validation of a Novel 11-Gene Prognostic Model for Serous Ovarian Carcinomas Based on Lipid Metabolism Expression Profile.
Neoplasms
Development and validation of a novel 15-CpG-based signature for predicting prognosis in triple-negative breast cancer.
Neoplasms
Development and Validation of a Novel 8 Immune Gene Prognostic Signature Based on the Immune Expression Profile for Hepatocellular Carcinoma.
Neoplasms
Development and validation of a novel glycolysis-related risk signature for predicting survival in pancreatic adenocarcinoma.
Neoplasms
Development and Validation of a Novel Immune-Gene Pairs Prognostic Model Associated with CTNNB1 Alteration in Hepatocellular Carcinoma.
Neoplasms
Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma.
Neoplasms
Development and validation of a novel immune-related prognostic model in lung squamous cell carcinoma.
Neoplasms
Development and validation of a novel metabolic signature for predicting prognosis in patients with laryngeal cancer.
Neoplasms
Development and Validation of a Novel Metabolic-Related Signature Predicting Overall Survival for Pancreatic Cancer.
Neoplasms
Development and validation of a novel mRNA signature for predicting early relapse in non-small cell lung cancer.
Neoplasms
Development and validation of a novel N6-methyladenosine (m6A)-related multi- long non-coding RNA (lncRNA) prognostic signature in pancreatic adenocarcinoma.
Neoplasms
Development and Validation of a Novel Prognostic Model for Acute Myeloid Leukemia Based on Immune-Related Genes.
Neoplasms
Development and validation of a novel pseudogene pair-based prognostic signature for prediction of overall survival in patients with hepatocellular carcinoma.
Neoplasms
Development and Validation of a Novel RNA Sequencing-Based Prognostic Score for Acute Myeloid Leukemia.
Neoplasms
Development and validation of a novel survival model for acute myeloid leukemia based on autophagy-related genes.
Neoplasms
Development and validation of a novel survival model for head and neck squamous cell carcinoma based on autophagy-related genes.
Neoplasms
Development and Validation of a Novel TP53 Mutation Signature That Predicts Risk of Metastasis in Primary Prostate Cancer.
Neoplasms
Development and validation of a prediction model for lung adenocarcinoma based on RNA-binding protein.
Neoplasms
Development and Validation of a Prognostic Gene Signature in Clear Cell Renal Cell Carcinoma.
Neoplasms
Development and validation of a prognostic immune-associated gene signature in clear cell renal cell carcinoma.
Neoplasms
Development and validation of a prognostic model for kidney renal clear cell carcinoma based on RNA binding protein expression.
Neoplasms
Development and Validation of a Prognostic Nomogram for Gastric Cancer Based on DNA Methylation-Driven Differentially Expressed Genes.
Neoplasms
Development and validation of a prognostic nomogram for patients with lung adenocarcinoma based on a novel 6-DNA repair-related gene signature.
Neoplasms
Development and validation of a prognostic nomogram for patients with triple-negative breast cancer with histology of infiltrating duct carcinoma.
Neoplasms
Development and Validation of a Prognostic Signature Based on Immune Genes in Cervical Cancer.
Neoplasms
Development and validation of a prognostic signature for preoperative prediction of overall survival in gastric cancer patients.
Neoplasms
Development and validation of a risk prediction model and nomogram for colon adenocarcinoma based on methylation-driven genes.
Neoplasms
Development and Validation of a RNA Binding Protein-Associated Prognostic Model for Hepatocellular Carcinoma.
Neoplasms
Development and validation of a RNA binding protein-associated prognostic model for lung adenocarcinoma.
Neoplasms
Development and validation of a robust epithelial-mesenchymal transition (EMT)-related prognostic signature for hepatocellular carcinoma.
Neoplasms
Development and Validation of a Robust Immune Prognostic Signature for Head and Neck Squamous Cell Carcinoma.
Neoplasms
Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
Neoplasms
Development and validation of a robust immune-related risk signature for hepatocellular carcinoma.
Neoplasms
Development and validation of a robust multigene signature as an aid to predict early relapse in stage I-III clear cell and papillary renal cell cancer.
Neoplasms
Development and validation of a Super learner-based model for predicting survival in Chinese Han patients with resected colorectal cancer.
Neoplasms
Development and validation of a survival model based on autophagy-associated genes for predicting prognosis of hepatocellular carcinoma.
Neoplasms
Development and validation of a survival model for esophageal adenocarcinoma based on autophagy-associated genes.
Neoplasms
Development and validation of a survival model for lung adenocarcinoma based on autophagy-associated genes.
Neoplasms
Development and Validation of a Three-gene Prognostic Signature for Patients with Hepatocellular Carcinoma.
Neoplasms
Development and validation of a three-immune-related gene signature prognostic risk model in papillary thyroid carcinoma.
Neoplasms
Development and validation of a three-long noncoding RNA signature for predicting prognosis of patients with gastric cancer.
Neoplasms
Development and Validation of a TNF Family-Based Signature for Predicting Prognosis, Tumor Immune Characteristics, and Immunotherapy Response in Colorectal Cancer Patients.
Neoplasms
Development and Validation of a Tumor Mutation Burden-Related Immune Prognostic Model for Lower-Grade Glioma.
Neoplasms
Development and validation of an autophagy-related prognostic signature in esophageal cancer.
Neoplasms
Development and validation of an immune and stromal prognostic signature in uveal melanoma to guide clinical therapy.
Neoplasms
Development and validation of an immune gene set-based prognostic signature in cutaneous melanoma.
Neoplasms
Development and validation of an immune gene-set based prognostic signature for soft tissue sarcoma.
Neoplasms
Development and validation of an immune prognostic classifier for clear cell renal cell carcinoma.
Neoplasms
Development and Validation of an Immune-Related Gene Pair Signature in Skin Cutaneous Melanoma.
Neoplasms
Development and Validation of an Immune-Related Long Non-coding RNA Prognostic Model in Glioma.
Neoplasms
Development and Validation of an Immune-Related Prognostic Signature for Ovarian Cancer Based on Weighted Gene Coexpression Network Analysis.
Neoplasms
Development and validation of an immune-related prognostic signature in lung adenocarcinoma.
Neoplasms
Development and validation of an individual alternative splicing prognostic signature in gastric cancer.
Neoplasms
Development and validation of an individualized diagnostic signature in thyroid cancer.
Neoplasms
Development and validation of an individualized gene expression-based signature to predict overall survival in metastatic colorectal cancer.
Neoplasms
Development and Validation of an Individualized Immune Prognostic Signature for Recurrent Prostate Cancer.
Neoplasms
Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer.
Neoplasms
Development and Validation of an Individualized Immune-Related Gene Pairs Prognostic Signature in Papillary Renal Cell Carcinoma.
Neoplasms
Development and validation of an integrative methylation signature and nomogram for predicting survival in clear cell renal cell carcinoma.
Neoplasms
Development and Validation of an m6A RNA Methylation Regulator-Based Signature for Prognostic Prediction in Cervical Squamous Cell Carcinoma.
Neoplasms
Development and Validation of an m6A RNA Methylation Regulators-Based Signature for Predicting the Prognosis of Adrenocortical Carcinoma.
Neoplasms
Development and Validation of an Mesenchymal-Related Long Non-Coding RNA Prognostic Model in Glioma.
Neoplasms
Development and validation of an oxidative stress-associated prognostic risk model for melanoma.
Neoplasms
Development and validation of an RNA binding protein-associated prognostic model for hepatocellular carcinoma.
Neoplasms
Development and Validation of an RNA-Binding Protein-Based Prognostic Model for Ovarian Serous Cystadenocarcinoma.
Neoplasms
Development and Validation of Autophagy-Related Gene Signature and Nomogram for Predicting Survival in Oral Squamous Cell Carcinoma.
Neoplasms
Development and validation of autophagy-related-gene biomarker and nomogram for predicting the survival of cutaneous melanoma.
Neoplasms
Development and Validation of Epigenetic Signature Predict Survival for Patients with Laryngeal Squamous Cell Carcinoma.
Neoplasms
Development and validation of ferroptosis-related lncRNAs signature for hepatocellular carcinoma.
Neoplasms
Development and validation of GMI signature based random survival forest prognosis model to predict clinical outcome in acute myeloid leukemia.
Neoplasms
Development and validation of hub genes for lymph node metastasis in patients with prostate cancer.
Neoplasms
Development and validation of m6A regulators' prognostic significance for endometrial cancer.
Neoplasms
Development and Validation of Nine-RNA Binding Protein Signature Predicting Overall Survival for Kidney Renal Clear Cell Carcinoma.
Neoplasms
Development and validation of nomogram with tumor microenvironment-related genes and clinical factors for predicting overall survival of endometrial cancer.
Neoplasms
Development and Validation of Novel Biomarkers Related to M2 Macrophages Infiltration by Weighted Gene Co-Expression Network Analysis in Prostate Cancer.
Neoplasms
Development and validation of prognostic gene signature for basal-like breast cancer and high-grade serous ovarian cancer.
Neoplasms
Development and validation of prognostic index based on autophagy-related genes in patient with head and neck squamous cell carcinoma.
Neoplasms
Development and validation of prognostic markers in sarcomas base on a multi-omics analysis.
Neoplasms
Development and validation of prognostic model based on the analysis of autophagy-related genes in colon cancer.
Neoplasms
Development and validation of radiomic signatures of head and neck squamous cell carcinoma molecular features and subtypes.
Neoplasms
Development and validation of RNA binding protein-applied prediction model for gastric cancer.
Neoplasms
Development and validation of the trans-omics model for pancreatic adenocarcinoma.
Neoplasms
Development and verification of an immune-related gene pairs prognostic signature in ovarian cancer.
Neoplasms
Development of a 12-biomarkers-based prognostic model for pancreatic cancer using multi-omics integrated analysis.
Neoplasms
Development of a DNA Methylation-Based Diagnostic Signature to Distinguish Benign Oncocytoma From Renal Cell Carcinoma.
Neoplasms
Development of a five-protein signature for predicting the prognosis of head and neck squamous cell carcinoma.
Neoplasms
Development of a four-gene prognostic model for clear cell renal cell carcinoma based on transcriptome analysis.
Neoplasms
Development of a Four-mRNA Expression-Based Prognostic Signature for Cutaneous Melanoma.
Neoplasms
Development of a Histopathology Informatics Pipeline for Classification and Prediction of Clinical Outcomes in Subtypes of Renal Cell Carcinoma.
Neoplasms
Development of a macrophages-related 4-gene signature and nomogram for the overall survival prediction of hepatocellular carcinoma based on WGCNA and LASSO algorithm.
Neoplasms
Development of a Nomogram With Alternative Splicing Signatures for Predicting the Prognosis of Glioblastoma: A Study Based on Large-Scale Sequencing Data.
Neoplasms
Development of a novel 7 immune-related genes prognostic model for oral cancer: A study based on TCGA database.
Neoplasms
Development of a Novel Autophagy-Related Prognostic Signature and Nomogram for Hepatocellular Carcinoma.
Neoplasms
Development of a Novel Autophagy-related Prognostic Signature for Serous Ovarian Cancer.
Neoplasms
Development of a novel gene signature in patients without Helicobacter pylori infection gastric cancer.
Neoplasms
Development of a Novel Immune Infiltration-Based Gene Signature to Predict Prognosis and Immunotherapy Response of Patients With Cervical Cancer.
Neoplasms
Development of a Novel Immune Infiltration-Related ceRNA Network and Prognostic Model for Sarcoma.
Neoplasms
Development of a novel prognostic score combining clinicopathologic variables, gene expression, and mutation profiles for lung adenocarcinoma.
Neoplasms
Development of a Novel Prognostic Signature Based on Antigen Processing and Presentation in Patients with Breast Cancer.
Neoplasms
Development of a novel prognostic signature for predicting the overall survival of bladder cancer patients.
Neoplasms
Development of a novel prognostic signature of long non-coding RNAs in lung adenocarcinoma.
Neoplasms
Development of a novel six-long noncoding RNA signature predicting survival of patients with bladder urothelial carcinoma.
Neoplasms
Development of a Novel Six-miRNA-Based Model to Predict Overall Survival Among Colon Adenocarcinoma Patients.
Neoplasms
Development of a poor-prognostic-mutations derived immune prognostic model for acute myeloid leukemia.
Neoplasms
Development of a prediction model for radiosensitivity using the expression values of genes and long non-coding RNAs.
Neoplasms
Development of a Prognostic Five-Gene Signature for Diffuse Lower-Grade Glioma Patients.
Neoplasms
Development of a prognostic index and screening of prognosis related genes based on an immunogenomic landscape analysis of bladder cancer.
Neoplasms
Development of a prognostic index based on an immunogenomic landscape analysis of papillary thyroid cancer.
Neoplasms
Development of a prognostic index of colon adenocarcinoma based on immunogenomic landscape analysis.
Neoplasms
Development of a Prognostic Nomogram for Acute Myeloid Leukemia on IGHD Gene Family.
Neoplasms
Development of a prognostic risk model for clear cell renal cell carcinoma by systematic evaluation of DNA methylation markers.
Neoplasms
Development of a Prognostic Signature Based on Autophagy-related Genes for Head and Neck Squamous Cell Carcinoma.
Neoplasms
Development of a prognostic signature for esophageal cancer based on nine immune related genes.
Neoplasms
Development of a radiosensitivity gene signature for patients with soft tissue sarcoma.
Neoplasms
Development of a RNA sequencing-based prognostic gene signature in multiple myeloma.
Neoplasms
Development of a Ten-lncRNA Signature Prognostic Model for Breast Cancer Survival: A Study with the TCGA Database.
Neoplasms
Development of Aggressive Pancreatic Ductal Adenocarcinomas Depends on Granulocyte Colony Stimulating Factor Secretion in Carcinoma Cells.
Neoplasms
Development of an Aerobic Glycolysis Index for Predicting the Sorafenib Sensitivity and Prognosis of Hepatocellular Carcinoma.
Neoplasms
Development of an Autophagy Score Signature for Predicting Overall Survival in Papillary Renal Cell Carcinoma.
Neoplasms
Development of an autophagy-related gene expression signature for prognosis prediction in prostate cancer patients.
Neoplasms
Development of an autophagy-related gene prognostic signature in lung adenocarcinoma and lung squamous cell carcinoma.
Neoplasms
Development of an IFN? response-related signature for predicting the survival of cutaneous melanoma.
Neoplasms
Development of an Immune Infiltration-Related Eight-Gene Prognostic Signature in Colorectal Cancer Microenvironment.
Neoplasms
Development of an immune-related prognostic index associated with hepatocellular carcinoma.
Neoplasms
Development of an Immune-Related Risk Signature in Patients with Bladder Urothelial Carcinoma.
Neoplasms
Development of an Immunogenomic Landscape-Based Prognostic Index of Head and Neck Squamous Cell Carcinoma.
Neoplasms
Development of an Individualized Ubiquitin Prognostic Signature for Clear Cell Renal Cell Carcinoma.
Neoplasms
Development of an oncogenic dedifferentiation SOX signature with prognostic significance in hepatocellular carcinoma.
Neoplasms
Development of an Oncogenic Driver Alteration Associated Immune-Related Prognostic Model for Stage I-II Lung Adenocarcinoma.
Neoplasms
Development of Autophagy Signature-Based Prognostic Nomogram for Refined Glioma Survival Prognostication.
Neoplasms
Development of human serine protease-based therapeutics targeting Fn14 and identification of Fn14 as a new target overexpressed in TNBC.
Neoplasms
Development of metastasis-associated seven gene signature for predicting lung adenocarcinoma prognosis using single-cell RNA sequencing data.
Neoplasms
Development of Multiscale Transcriptional Regulatory Network in Esophageal Cancer Based on Integrated Analysis.
Neoplasms
Development of Prognostic Indicator Based on Autophagy-Related lncRNA Analysis in Colon Adenocarcinoma.
Neoplasms
Development of prognostic signature based on immune-related genes in muscle-invasive bladder cancer: bioinformatics analysis of TCGA database.
Neoplasms
Development of prognostic signature based on RNA binding proteins related genes analysis in clear cell renal cell carcinoma.
Neoplasms
Development of prognostic signatures for intermediate-risk papillary thyroid cancer.
Neoplasms
Development of RNA binding proteins expression signature for prognosis prediction in gastric cancer patients.
Neoplasms
Development of somatic mutation signatures for risk stratification and prognosis in lung and colorectal adenocarcinomas.
Neoplasms
Development of the Australian Cancer Atlas: spatial modelling, visualisation, and reporting of estimates.
Neoplasms
Developmental genes significantly afflicted by aberrant promoter methylation and somatic mutation predict overall survival of late-stage colorectal cancer.
Neoplasms
Developmental profile and regulation of the glycolytic enzyme hexokinase 2 in normal brain and glioblastoma multiforme.
Neoplasms
Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma.
Neoplasms
DGAT1 Expression Promotes Ovarian Cancer Progression and Is Associated with Poor Prognosis.
Neoplasms
DGCR8/ZFAT-AS1 Promotes CDX2 Transcription in a PRC2 Complex-Dependent Manner to Facilitate the Malignant Biological Behavior of Glioma Cells.
Neoplasms
Diagnosis and prognostic value of C-X-C motif chemokine ligand 1 in colon adenocarcinoma based on The Cancer Genome Atlas and Guangxi cohort.
Neoplasms
Diagnosis value of aberrantly expressed microRNA profiles in lung squamous cell carcinoma: a study based on the Cancer Genome Atlas.
Neoplasms
Diagnosis, prognosis and bioinformatics analysis of lncRNAs in hepatocellular carcinoma.
Neoplasms
Diagnostic Accuracy of Immunohistochemistry for Mismatch Repair Proteins as Surrogate of Microsatellite Instability Molecular Testing in Endometrial Cancer.
Neoplasms
Diagnostic and prognostic biomarker potential of kallikrein family genes in different cancer types.
Neoplasms
Diagnostic and prognostic biomarkers of common urological cancers based on aberrant DNA methylation.
Neoplasms
Diagnostic and prognostic implications of ribosomal protein transcript expression patterns in human cancers.
Neoplasms
Diagnostic and prognostic roles of IRAK1 in hepatocellular carcinoma tissues: an analysis of immunohistochemistry and RNA-sequencing data from the cancer genome atlas.
Neoplasms
Diagnostic and prognostic value of ABC transporter family member ABCG1 gene in clear cell renal cell carcinoma.
Neoplasms
Diagnostic and prognostic value of CEP55 in clear cell renal cell carcinoma as determined by bioinformatics analysis.
Neoplasms
Diagnostic and prognostic value of FOXD1 expression in head and neck squamous cell carcinoma.
Neoplasms
Diagnostic and prognostic value of HABP2 as a novel biomarker for endometrial cancer.
Neoplasms
Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma.
Neoplasms
Diagnostic and prognostic value of MATN3 expression in gastric carcinoma: TCGA database mining.
Neoplasms
Diagnostic and prognostic value of MCM3 and its interacting proteins in hepatocellular carcinoma.
Neoplasms
Diagnostic and prognostic value of secreted protein acidic and rich in cysteine in the diffuse large B-cell lymphoma.
Neoplasms
Diagnostic and prognostic value of tumor-infiltrating B cells in lymph node metastases of papillary thyroid carcinoma.
Neoplasms
Diagnostic and prognostic value of WNT family gene expression in hepatitis B virus?related hepatocellular carcinoma.
Neoplasms
Diagnostic and prognostic values of forkhead box D4 gene in colonic adenocarcinoma.
Neoplasms
Diagnostic and prognostic values of integrin ? subfamily mRNA expression in colon adenocarcinoma.
Neoplasms
Diagnostic and prognostic values of upregulated SPC25 in patients with hepatocellular carcinoma.
Neoplasms
Diagnostic and therapeutic potencies of miR-18a-5p in mixed-type gastric adenocarcinoma.
Neoplasms
Diagnostic model of combined ceRNA and DNA methylation related genes in esophageal carcinoma.
Neoplasms
Diagnostic potential of extracellular vesicle-associated microRNA-10b and tumor markers for lung adenocarcinoma.
Neoplasms
Diagnostic significance and potential function of miR-338-5p in hepatocellular carcinoma: A bioinformatics study with microarray and RNA sequencing data.
Neoplasms
Diagnostic value of a comprehensive, urothelial carcinoma-specific next-generation sequencing panel in urine cytology and bladder tumor specimens.
Neoplasms
Diagnostic value of strand-specific miRNA-101-3p and miRNA-101-5p for hepatocellular carcinoma and a bioinformatic analysis of their possible mechanism of action.
Neoplasms
Diagnostic Variation in p53 Usage for Endometrial Carcinoma Diagnosis: Implications for Molecular Subtyping.
Neoplasms
Diallyl disulfide induces ERK phosphorylation and alters gene expression profiles in human colon tumor cells.
Neoplasms
Difference in tumor mutation burden between squamous cell carcinoma in the oral cavity and larynx.
Neoplasms
Differences between carcinoma of the cecum and ascending colon: Evidence based on clinical and embryological data.
Neoplasms
Differences in gastric carcinoma microenvironment stratify according to EBV infection intensity: implications for possible immune adjuvant therapy.
Neoplasms
Differences in gene-expression profiles in breast cancer between African and European-ancestry women.
Neoplasms
Differences in molecular epidemiology of lung cancer among ethnicities (Asian vs. Caucasian).
Neoplasms
Differences in race, molecular and tumor characteristics among women diagnosed with invasive ductal and lobular breast carcinomas.
Neoplasms
Differences in somatic mutation landscape of hepatocellular carcinoma in Asian American and European American populations.
Neoplasms
Differences in T cell immune-related lncRNA and mRNA expression patterns between right- and left-sided colorectal cancers.
Neoplasms
Differences in the early stage gene expression profiles of lung adenocarcinoma and lung squamous cell carcinoma.
Neoplasms
Differences in the mutational landscape of triple-negative breast cancer in African Americans and Caucasians.
Neoplasms
Differences in the prognosis of gastric cancer patients of different sexes and races and the molecular mechanisms involved.
Neoplasms
Different splicing isoforms of ERCC1 affect the expression of its overlapping genes CD3EAP and PPP1R13L, and indicate a potential application in non-small cell lung cancer treatment.
Neoplasms
Differential alternative RNA splicing and transcription events between tumors from African American and White patients in The Cancer Genome Atlas.
Neoplasms
Differential alternative splicing between hepatocellular carcinoma with normal and elevated serum alpha-fetoprotein.
Neoplasms
Differential alternative splicing regulation among hepatocellular carcinoma with different risk factors.
Neoplasms
Differential binding affinity of mutated peptides for MHC class I is a predictor of survival in advanced lung cancer and melanoma.
Neoplasms
Differential chromatin accessibility landscape of gain-of-function mutant p53 tumours.
Neoplasms
Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants.
Neoplasms
Differential effect of GLUT1 overexpression on survival and tumor immune microenvironment of human papilloma virus type 16-positive and -negative cervical cancer.
Neoplasms
Differential Effect of Smoking on Gene Expression in Head and Neck Cancer Patients.
Neoplasms
Differential expression analysis of clear cell renal cell carcinomas in THE CANCER GENOME ATLAS distinguishes an aggressive subset enriched with chromosome 7 and 12 gains.
Neoplasms
Differential Expression Analysis Revealing CLCA1 to Be a Prognostic and Diagnostic Biomarker for Colorectal Cancer.
Neoplasms
Differential expression and prognostic value of long non-coding RNA in HPV-negative head and neck squamous cell carcinoma.
Neoplasms
Differential expression and significance of PD-L1, IDO-1 and B7-H4 in human lung cancer.
Neoplasms
Differential Expression of a Panel of Ten CNTN1-Associated Genes during Prostate Cancer Progression and the Predictive Properties of the Panel Towards Prostate Cancer Relapse.
Neoplasms
Differential Expression of ADP/ATP Carriers as a Biomarker of Metabolic Remodeling and Survival in Kidney Cancers.
Neoplasms
Differential expression of alternatively spliced transcripts related to energy metabolism in colorectal cancer.
Neoplasms
Differential expression of circulating biomarkers of tumor phenotype and outcomes in previously treated non-small cell lung cancer patients receiving erlotinib vs. cytotoxic chemotherapy.
Neoplasms
Differential Expression of DNA Repair Genes in Prognostically-Favorable versus Unfavorable Uveal Melanoma.
Neoplasms
Differential expression of major histocompatibility complex class I in subtypes of breast cancer is associated with estrogen receptor and interferon signaling.
Neoplasms
Differential expression of PDGFRB and EGFR in microvascular proliferation in glioblastoma.
Neoplasms
Differential Expression of PEG10 Contributes to Aggressive Disease in Early Versus Late-Onset Colorectal Cancer.
Neoplasms
Differential expression of pyruvate dehydrogenase E1A and its inactive phosphorylated form among breast cancer subtypes.
Neoplasms
Differential Expression Profile of NLRs and AIM2 in Glioma and Implications for NLRP12 in Glioblastoma.
Neoplasms
Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Neoplasms
Differential expressions of integrin-linked kinase, ?-parvin and cofilin 1 in high-fat diet induced prostate cancer progression in a transgenic mouse model.
Neoplasms
Differential gene expression of tumor-infiltrating CD33+ myeloid cells in advanced- versus early-stage colorectal cancer.
Neoplasms
Differential gene expression of tumor-infiltrating CD4+ T cells in advanced versus early stage colorectal cancer and identification of a gene signature of poor prognosis.
Neoplasms
Differential gene expression of tumor-infiltrating CD8+ T cells in advanced versus early-stage colorectal cancer and identification of a gene signature of poor prognosis.
Neoplasms
Differential gene expression profiling of matched primary renal cell carcinoma and metastases reveals upregulation of extracellular matrix genes.
Neoplasms
Differential genetic mutations of ectoderm, mesoderm, and endoderm-derived tumors in TCGA database.
Neoplasms
Differential immune signatures in the tumor microenvironment are associated with colon cancer racial disparities.
Neoplasms
Differential Interactome Proposes Subtype-Specific Biomarkers and Potential Therapeutics in Renal Cell Carcinomas.
Neoplasms
Differential methylation relative to breast cancer subtype and matched normal tissue reveals distinct patterns.
Neoplasms
Differential microRNA expression profiles associated with microsatellite status reveal possible epigenetic regulation of microsatellite instability in gastric adenocarcinoma.
Neoplasms
Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells.
Neoplasms
Differential mutation spectrum and immune landscape in African Americans versus Whites: A possible determinant to health disparity in head and neck cancer.
Neoplasms
Differential prognostic impact of interleukin-34 mRNA expression and infiltrating immune cell composition in intrinsic breast cancer subtypes.
Neoplasms
Differential propagation of stroma and cancer stem cells dictates tumorigenesis and multipotency.
Neoplasms
Differential Regulation and Targeting of Estrogen Receptor ? Turnover in Invasive Lobular Breast Carcinoma.
Neoplasms
Differential regulation of TGF-?-induced, ALK-5-mediated VEGF release by SMAD2/3 versus SMAD1/5/8 signaling in glioblastoma.
Neoplasms
Differentially expressed and survival-related proteins of lung adenocarcinoma with bone metastasis.
Neoplasms
Differentially expressed autophagy-related genes are potential prognostic and diagnostic biomarkers in clear-cell renal cell carcinoma.
Neoplasms
Differentially expressed genes and key molecules of BRCA1/2-mutant breast cancer: evidence from bioinformatics analyses.
Neoplasms
Differentially Expressed Genes Associated With Prognosis in Locally Advanced Lymph Node-Negative Prostate Cancer.
Neoplasms
Differentially expressed long noncoding RNAs and regulatory mechanism of LINC02407 in human gastric adenocarcinoma.
Neoplasms
Differentially expressed microRNAs in lung adenocarcinoma invert effects of copy number aberrations of prognostic genes.
Neoplasms
Differentially expressed transcripts and dysregulated signaling pathways and networks in African American breast cancer.
Neoplasms
Differentiated glioblastoma cells accelerate tumor progression by shaping the tumor microenvironment via CCN1-mediated macrophage infiltration.
Neoplasms
Diffuse gliomas in patients aged 55?years or over: A suggestion for IDH mutation testing.
Neoplasms
DiffVar: a new method for detecting differential variability with application to methylation in cancer and aging.
Neoplasms
Digital Immune-Related Gene Expression Signatures In High-Grade Serous Ovarian Carcinoma: Developing Prediction Models For Platinum Response.
Neoplasms
Digital Inference of Immune Microenvironment Reveals Low-Risk Subtype of Early Lung Adenocarcinoma.
Neoplasms
Diminished LINC00173 expression induced miR-182-5p accumulation promotes cell proliferation, migration and apoptosis inhibition via AGER/NF-?B pathway in non-small-cell lung cancer.
Neoplasms
Dipeptidyl peptidase like 6 promoter methylation is a potential prognostic biomarker for pancreatic ductal adenocarcinoma.
Neoplasms
Direct inhibition of ACTN4 by ellagic acid limits breast cancer metastasis via regulation of ?-catenin stabilization in cancer stem cells.
Neoplasms
Direct Targeting of CREB1 with Imperatorin Inhibits TGF?2-ERK Signaling to Suppress Esophageal Cancer Metastasis.
Neoplasms
Discordance of Somatic Mutations Between Asian and Caucasian Patient Populations with Gastric Cancer.
Neoplasms
Discovering Cancer Subtypes via an Accurate Fusion Strategy on Multiple Profile Data.
Neoplasms
Discovering Condition-Specific Gene Co-Expression Patterns Using Gaussian Mixture Models: A Cancer Case Study.
Neoplasms
Discovering DNA methylation patterns for long non-coding RNAs associated with cancer subtypes.
Neoplasms
Discovering drugs to overcome chemoresistance in ovarian cancers based on the cancer genome atlas tumor transcriptome profile.
Neoplasms
Discovering functional impacts of miRNAs in cancers using a causal deep learning model.
Neoplasms
Discovering key regulatory mechanisms from single-factor and multi-factor regulations in glioblastoma utilizing multi-dimensional data.
Neoplasms
Discovering novel pharmacogenomic biomarkers by imputing drug response in cancer patients from large genomics studies.
Neoplasms
Discovering personalized driver mutation profiles of single samples in cancer by network control strategy.
Neoplasms
Discovering the mechanism and involvement of the methylation of cyclin-dependent kinase inhibitor 2A (CDKN2A) gene and its special locus region in gastric cancer.
Neoplasms
Discovering the molecular differences between right- and left-sided colon cancer using machine learning methods.
Neoplasms
DiscoverSL: An R package for Multi-omic data driven prediction of synthetic lethality in cancers.
Neoplasms
Discovery and development of differentially methylated regions in human papillomavirus-related oropharyngeal squamous cell carcinoma.
Neoplasms
Discovery and Validation of a Metastasis-Related Prognostic and Diagnostic Biomarker for Melanoma Based on Single Cell and Gene Expression Datasets.
Neoplasms
Discovery and Validation of Circulating EVL mRNA as a Prognostic Biomarker in Pancreatic Cancer.
Neoplasms
Discovery and Verification of an Immune-Related Gene Pairs Signature for Predicting Prognosis in Head and Neck Squamous Cell Carcinoma.
Neoplasms
Discovery in context: leveraging multidimensional glioblastoma datasets to identify targetable regulatory networks.
Neoplasms
Discovery of 5-Signature Predicting Survival of Patients with Lower-Grade Glioma.
Neoplasms
Discovery of a Novel Dual-Target Inhibitor of ERK1 and ERK5 That Induces Regulated Cell Death to Overcome Compensatory Mechanism in Specific Tumor Types.
Neoplasms
Discovery of a novel six-long non-coding RNA signature predicting survival of colorectal cancer patients.
Neoplasms
Discovery of a novel three-long non-coding RNA signature for predicting the prognosis of patients with gastric cancer.
Neoplasms
Discovery of a novel, potent and selective small-molecule inhibitor of PD-1/PD-L1 interaction with robust in vivo anti-tumour efficacy.
Neoplasms
Discovery of a small molecule targeting ULK1-modulated cell death of triple negative breast cancer in vitro and in vivo.
Neoplasms
Discovery of a Small-Molecule Bromodomain-Containing Protein 4 (BRD4) Inhibitor That Induces AMP-Activated Protein Kinase-Modulated Autophagy-Associated Cell Death in Breast Cancer.
Neoplasms
Discovery of bladder cancer biomarkers in paired pre- and postoperative urine samples.
Neoplasms
Discovery of candidate tumor biomarkers for treatment with intraperitoneal chemotherapy for ovarian cancer.
Neoplasms
Discovery of core genes in colorectal cancer by weighted gene co-expression network analysis.
Neoplasms
Discovery of KIRREL as a biomarker for prognostic stratification of patients with thin melanoma.
Neoplasms
Discovery of melanotransferrin as a serological marker of colorectal cancer by secretome analysis and quantitative proteomics.
Neoplasms
Discovery of microarray-identified genes associated with ovarian cancer progression.
Neoplasms
Discovery of multi-dimensional modules by integrative analysis of cancer genomic data.
Neoplasms
Discovery of Pancreatic Ductal Adenocarcinoma-Related Aberrant Glycosylations: A Multilateral Approach of Lectin Microarray-Based Tissue Glycomic Profiling With Public Transcriptomic Datasets.
Neoplasms
Discovery of two-level modular organization from matched genomic data via joint matrix tri-factorization.
Neoplasms
Discriminating early- and late-stage cancers using multiple kernel learning on gene sets.
Neoplasms
Disease characterization using a partial correlation-based sample-specific network.
Neoplasms
Dishevelled segment polarity protein 3 (DVL3): a novel and easily applicable recurrence predictor in localised prostate adenocarcinoma.
Neoplasms
DiSNEP: a Disease-Specific gene Network Enhancement to improve Prioritizing candidate disease genes.
Neoplasms
Disparity between Inter-Patient Molecular Heterogeneity and Repertoires of Target Drugs Used for Different Types of Cancer in Clinical Oncology.
Neoplasms
Disparity in Tumor Immune Microenvironment of Breast Cancer and Prognostic Impact: Asian versus Western Populations.
Neoplasms
Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer.
Neoplasms
Disruption of KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex components by multiple genetic mechanisms is associated with poor prognosis in head and neck cancer.
Neoplasms
Disruption of TP63-miR-27a* feedback loop by mutant TP53 in head and neck cancer.
Neoplasms
Dissecting Prognosis Modules and Biomarkers in Glioblastoma Based on Weighted Gene Co-Expression Network Analysis.
Neoplasms
Dissecting the biological relationship between TCGA miRNA and mRNA sequencing data using MMiRNA-Viewer.
Neoplasms
Dissecting the expression landscape of cytochromes P450 in hepatocellular carcinoma: towards novel molecular biomarkers.
Neoplasms
Dissecting the expression landscape of mitochondrial genes in lung squamous cell carcinoma and lung adenocarcinoma.
Neoplasms
Dissecting the single-cell transcriptome network underlying esophagus non-malignant tissues and esophageal squamous cell carcinoma.
Neoplasms
Dissecting tRNA-derived fragment complexities using personalized transcriptomes reveals novel fragment classes and unexpected dependencies.
Neoplasms
Distinct association of RUNX family expression with genetic alterations and clinical outcome in acute myeloid leukemia.
Neoplasms
Distinct co-expression networks using multi-omic data reveal novel interventional targets in HPV-positive and negative head-and-neck squamous cell cancer.
Neoplasms
Distinct diagnostic and prognostic values of ?-aminobutyric acid type A receptor family genes in patients with colon adenocarcinoma.
Neoplasms
Distinct Diagnostic and Prognostic Values of Kinesin Family Member Genes Expression in Patients with Breast Cancer.
Neoplasms
Distinct Diagnostic and Prognostic Values of Minichromosome Maintenance Gene Expression in Patients with Hepatocellular Carcinoma.
Neoplasms
Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
Neoplasms
Distinct genomic landscapes of gastroesophageal adenocarcinoma depending on PD-L1 expression identify mutations in RAS-MAPK pathway and TP53 as potential predictors of immunotherapy efficacy.
Neoplasms
Distinct Metabolic Features of Seminoma and Embryonal Carcinoma Revealed by Combined Transcriptome and Metabolome Analyses.
Neoplasms
Distinct Molecular Profiles and Immunotherapy Treatment Outcomes of V600E and V600K BRAF-Mutant Melanoma.
Neoplasms
Distinct pattern of one-carbon metabolism, a nutrient-sensitive pathway, in invasive breast cancer: A metabolomic study.
Neoplasms
Distinct Patterns of mRNA and lncRNA Expression Differences Between Lung Squamous Cell Carcinoma and Adenocarcinoma.
Neoplasms
Distinct preoperative clinical features predict four histopathological subtypes of high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum.
Neoplasms
Distinct prognostic value of dynactin subunit 4 (DCTN4) and diagnostic value of DCTN1, DCTN2, and DCTN4 in colon adenocarcinoma.
Neoplasms
Distinct prognostic value of mRNA expression of guanylate-binding protein genes in skin cutaneous melanoma.
Neoplasms
Distinct prognostic values of alcohol dehydrogenase mRNA expression in pancreatic adenocarcinoma.
Neoplasms
Distinct signatures of codon and codon pair usage in 32 primary tumor types in the novel database CancerCoCoPUTs for cancer-specific codon usage.
Neoplasms
Distinct signatures of lung cancer types: aberrant mucin O-glycosylation and compromised immune response.
Neoplasms
Distinct telomere length and molecular signatures in seminoma and non-seminoma of testicular germ cell tumor.
Neoplasms
Distinct TP63 Isoform-Driven Transcriptional Signatures Predict Tumor Progression and Clinical Outcomes.
Neoplasms
Distinctive Desmoplastic 3D Morphology Associated With BRAFV600E in Papillary Thyroid Cancers.
Neoplasms
Distinctive Expression and Amplification of Genes at 11q13 in Relation to HPV Status with Impact on Survival in Head and Neck Cancer Patients.
Neoplasms
Distinctive genomic characteristics in POLE/POLD1-mutant cancers can potentially predict beneficial clinical outcomes in patients who receive immune checkpoint inhibitor.
Neoplasms
Distinguishable Prognostic Signatures of Left- and Right-Sided Colon Cancer: a Study Based on Sequencing Data.
Neoplasms
Distinguishing potential bacteria-tumor associations from contamination in a secondary data analysis of public cancer genome sequence data.
Neoplasms
Distinguishing Rectal Cancer from Colon Cancer Based on the Support Vector Machine Method and RNA-sequencing Data.
Neoplasms
Distinguishing Tumor and Stromal Sources of MicroRNAs Linked to Metastasis in Cutaneous Melanoma.
Neoplasms
Distribution and clinical role of KIT gene mutations in melanoma according to subtype: a study of 492 Spanish patients.
Neoplasms
Distribution and prognostic significance of gluconeogenesis and glycolysis in lung cancer.
Neoplasms
Distribution and prognostic value of tumor?infiltrating T cells in breast cancer.
Neoplasms
Distribution Atlas of Proliferating Bone Marrow in Non-Small Cell Lung Cancer Patients Measured by FLT-PET/CT Imaging, With Potential Applicability in Radiation Therapy Planning.
Neoplasms
Distribution differences in prognostic copy number alteration profiles in IDH-wild-type glioblastoma cause survival discrepancies across cohorts.
Neoplasms
Distribution-based measures of tumor heterogeneity are sensitive to mutation calling and lack strong clinical predictive power.
Neoplasms
DIY: Visualizing the immune landscape of tumors using transcriptome and methylome data.
Neoplasms
DKC1 serves as a potential prognostic biomarker for human clear cell renal cell carcinoma and promotes its proliferation, migration and invasion via the NF??B pathway.
Neoplasms
DLC1 is the principal biologically-relevant down-regulated DLC family member in several cancers.
Neoplasms
DLX6-AS1/miR-204-5p/OCT1 positive feedback loop promotes tumor progression and epithelial-mesenchymal transition in gastric cancer.
Neoplasms
DMBT1 Homozygous Deletion in Diffuse Astrocytomas Is Associated With Unfavorable Clinical Outcome.
Neoplasms
DMCM: A Data-adaptive Mutation Clustering Method to Identify Cancer-related Mutation Clusters.
Neoplasms
DMDRMR-Mediated Regulation of m6A-Modified CDK4 by m6A Reader IGF2BP3 Drives ccRCC Progression.
Neoplasms
DNA damage is a pervasive cause of sequencing errors, directly confounding variant identification.
Neoplasms
DNA damage repair gene mutations and their association with tumor immune regulatory gene expression in muscle invasive bladder cancer subtypes.
Neoplasms
DNA Damage Repair Gene Mutations Are Indicative of a Favorable Prognosis in Colorectal Cancer Treated With Immune Checkpoint Inhibitors.
Neoplasms
DNA Damage Repair Gene Set as a Potential Biomarker for Stratifying Patients with High Tumor Mutational Burden.
Neoplasms
DNA defects, epigenetics, and gene expression in cancer-adjacent breast: a study from The Cancer Genome Atlas.
Neoplasms
DNA fragmentation simulation method (FSM) and fragment size matching improve aCGH performance of FFPE tissues.
Neoplasms
DNA hypermethylation contributes to colorectal cancer metastasis by regulating the binding of CEBPB and TFCP2 to the CPEB1 promoter.
Neoplasms
DNA hypermethylation of aurora kinase A in hepatitis C virus?positive hepatocellular carcinoma.
Neoplasms
DNA Methylation Analysis Identifies Patterns in Progressive Glioma Grades to Predict Patient Survival.
Neoplasms
DNA methylation and cis-regulation of gene expression by prostate cancer risk SNPs.
Neoplasms
DNA methylation and gene expression profiles characterize epigenetic regulation of lncRNAs in colon adenocarcinoma.
Neoplasms
DNA methylation at an enhancer of the three prime repair exonuclease 2 gene (TREX2) is linked to gene expression and survival in laryngeal cancer.
Neoplasms
DNA Methylation Based Molecular Subtypes Predict Prognosis in Breast Cancer Patients.
Neoplasms
DNA methylation biomarkers for the occurrence of lung adenocarcinoma from TCGA data mining.
Neoplasms
DNA methylation changes involved in the tumor increase in F2 males born to gestationally arsenite-exposed F1 male mice.
Neoplasms
DNA methylation data-based molecular subtype classification and prediction in patients with gastric cancer.
Neoplasms
DNA methylation data-based molecular subtype classification related to the prognosis of patients with cervical cancer.
Neoplasms
DNA methylation data-based prognosis-subtype distinctions in patients with esophageal carcinoma by bioinformatic studies.
Neoplasms
DNA Methylation in Breast Tumor from High-risk Women in the Breast Cancer Family Registry.
Neoplasms
DNA methylation in ductal carcinoma in situ related with future development of invasive breast cancer.
Neoplasms
DNA Methylation Markers from Negative Surgical Margins Can Predict Recurrence of Oral Squamous Cell Carcinoma.
Neoplasms
DNA methylation mediated silencing of microRNA-874 is a promising diagnosis and prognostic marker in breast cancer.
Neoplasms
DNA methylation of CRB3 is a prognostic biomarker in clear cell renal cell carcinoma.
Neoplasms
DNA methylation of Hugl-2 is a prognostic biomarker in kidney renal clear cell carcinoma.
Neoplasms
DNA methylation of individual repetitive elements in hepatitis C virus infection-induced hepatocellular carcinoma.
Neoplasms
DNA methylation of indoleamine 2,3-dioxygenase 1 (IDO1) in head and neck squamous cell carcinomas correlates with IDO1 expression, HPV status, patients' survival, immune cell infiltrates, mutational load, and interferon ? signature.
Neoplasms
DNA methylation of metallothionein genes is associated with the clinical features of renal cell carcinoma.
Neoplasms
DNA Methylation Patterns Can Estimate Nonequivalent Outcomes of Breast Cancer with the Same Receptor Subtypes.
Neoplasms
DNA methylation profiling analysis identifies a DNA methylation signature for predicting prognosis and recurrence of lung adenocarcinoma.
Neoplasms
DNA Methylation Profiling Discriminates between Malignant Pleural Mesothelioma and Neoplastic or Reactive Histologic Mimics.
Neoplasms
DNA methylation profiling distinguishes histological subtypes of renal cell carcinoma.
Neoplasms
DNA methylation profiling of non-small cell lung cancer reveals a COPD-driven immune-related signature.
Neoplasms
DNA methylation profiling reliably distinguishes pulmonary enteric adenocarcinoma from metastatic colorectal cancer.
Neoplasms
DNA methylation profiling reveals novel diagnostic biomarkers in renal cell carcinoma.
Neoplasms
DNA Methylation Profiling Reveals Prognostically Significant Groups in Pediatric Adrenocortical Tumors: A Report From the International Pediatric Adrenocortical Tumor Registry.
Neoplasms
DNA methylation profiling to predict recurrence risk in stage ? lung adenocarcinoma: Development and validation of a nomogram to clinical management.
Neoplasms
DNA Methylation Regulates Alternative Polyadenylation via CTCF and the Cohesin Complex.
Neoplasms
DNA methylation screening of primary prostate tumors identifies SRD5A2 and CYP11A1 as candidate markers for assessing risk of biochemical recurrence.
Neoplasms
DNA methylation signature of smoking in lung cancer is enriched for exposure signatures in newborn and adult blood.
Neoplasms
DNA methylation signatures for 2016 WHO classification subtypes of diffuse gliomas.
Neoplasms
DNA Methylation Signatures in Vaginal Fluid Samples for Detection of Cervical and Endometrial Cancer.
Neoplasms
DNA methylation subgroups in melanoma are associated with proliferative and immunological processes.
Neoplasms
DNA Methylation Targets Influenced by Bisphenol A and/or Genistein Are Associated with Survival Outcomes in Breast Cancer Patients.
Neoplasms
DNA methylation-based chromatin compartments and ChIP-seq profiles reveal transcriptional drivers of prostate carcinogenesis.
Neoplasms
DNA Methylation-Based Classifier for Accurate Molecular Diagnosis of Bone Sarcomas.
Neoplasms
DNA methylation-based immune response signature improves patient diagnosis in multiple cancers.
Neoplasms
DNA Methylation-Based Method to Differentiate Malignant from Benign Thyroid Lesions.
Neoplasms
DNA methylation-mediated Klotho silencing is an independent prognostic biomarker of head and neck squamous carcinoma.
Neoplasms
DNA methylation-mediated silencing of miR-204 is a potential prognostic marker for papillary thyroid carcinoma.
Neoplasms
DNA methylation-regulated microRNA pathways in ovarian serous cystadenocarcinoma: A meta-analysis.
Neoplasms
DNA methylome and transcriptome analysis established a model of four differentially methylated positions (DMPs) as a diagnostic marker in esophageal adenocarcinoma early detection.
Neoplasms
DNA methylome changes by estradiol benzoate and bisphenol A links early-life environmental exposures to prostate cancer risk.
Neoplasms
DNA polymerase theta repression enhances the docetaxel responsiveness in metastatic castration-resistant prostate cancer.
Neoplasms
DNA primase subunit 1 deteriorated progression of hepatocellular carcinoma by activating AKT/mTOR signaling and UBE2C-mediated P53 ubiquitination.
Neoplasms
DNA Promoter Methylation and ERG Regulate the Expression of CD24 in Prostate Cancer.
Neoplasms
DNA Repair Gene Expression Adjusted by the PCNA Metagene Predicts Survival in Multiple Cancers.
Neoplasms
DNA repair gene expression is associated with differential prognosis between HPV16 and HPV18 positive cervical cancer patients following radiation therapy.
Neoplasms
DNA repair gene expression is increased in HPV positive head and neck squamous cell carcinomas.
Neoplasms
DNA repair genes are associated with tumor tissue differentiation and immune environment in lung adenocarcinoma: a bioinformatics analysis based on big data.
Neoplasms
DNA topoisomerase 1 and 2A function as oncogenes in liver cancer and may be direct targets of nitidine chloride.
Neoplasms
DNA-Sensing and Nuclease Gene Expressions as Markers for Colorectal Cancer Progression.
Neoplasms
DNAH17-AS1 promotes pancreatic carcinoma by increasing PPME1 expression via inhibition of miR-432-5p.
Neoplasms
DNASE1L2, as a Carcinogenic Marker, Affects the Phenotype of Breast Cancer Cells Via Regulating Epithelial-Mesenchymal Transition Process.
Neoplasms
DNASE1L3 as an indicator of favorable survival in hepatocellular carcinoma patients following resection.
Neoplasms
DNF: A differential network flow method to identify rewiring drivers for gene regulatory networks.
Neoplasms
DNMT1-maintained hypermethylation of Krüppel-like factor 5 involves in the progression of clear cell renal cell carcinoma.
Neoplasms
DNMT3A and IDH mutations in acute myeloid leukemia and other myeloid malignancies: associations with prognosis and potential treatment strategies.
Neoplasms
DNMT3A overexpression is associated with aggressive behavior and enteroblastic differentiation of gastric adenocarcinoma.
Neoplasms
DNMT3A/3B overexpression might be correlated with poor patient survival, hypermethylation and low expression of ESR1/PGR in endometrioid carcinoma: an analysis of The Cancer Genome Atlas.
Neoplasms
DNMT3B7 expression promotes tumor progression to a more aggressive phenotype in breast cancer cells.
Neoplasms
DO CANCER CLINICAL TRIAL POPULATIONS TRULY REPRESENT CANCER PATIENTS? A COMPARISON OF OPEN CLINICAL TRIALS TO THE CANCER GENOME ATLAS.
Neoplasms
DOCK4 Is a Platinum-Chemosensitive and Prognostic-Related Biomarker in Ovarian Cancer.
Neoplasms
Does chromophobe renal cell carcinoma have better survival than clear cell renal cell carcinoma? A clinical-based cohort study and meta-analysis.
Neoplasms
Does tumour biology determine surgical success in the treatment of epithelial ovarian cancer? A systematic literature review.
Neoplasms
Dopamine receptor D2 genetic variations is associated with the risk and clinicopathological variables of urothelial cell carcinoma in a Taiwanese population.
Neoplasms
Dopamine Receptor D5 is a Modulator of Tumor Response to Dopamine Receptor D2 Antagonism.
Neoplasms
Double Minute Chromosomes in Glioblastoma Multiforme Are Revealed by Precise Reconstruction of Oncogenic Amplicons.
Neoplasms
Down-regulated expression of LINC00518 prevents epithelial cell growth and metastasis in breast cancer through the inhibition of CDX2 methylation and the Wnt signaling pathway.
Neoplasms
Down-regulated serum microRNA-101 is associated with aggressive progression and poor prognosis of cervical cancer.
Neoplasms
Down-regulation and clinical significance of miR-7-2-3p in papillary thyroid carcinoma with multiple detecting methods.
Neoplasms
Down-regulation and promoter methylation of tissue inhibitor of metalloproteinase 3 in choriocarcinoma.
Neoplasms
Down-regulation of 14q32-encoded miRNAs and tumor suppressor role for miR-654-3p in papillary thyroid cancer.
Neoplasms
Down-regulation of microRNA-144-3p and its clinical value in non-small cell lung cancer: a comprehensive analysis based on microarray, miRNA-sequencing, and quantitative real-time PCR data.
Neoplasms
Down-Regulation of MiR-181c-5p Promotes Epithelial-to-Mesenchymal Transition in Laryngeal Squamous Cell Carcinoma via Targeting SERPINE1.
Neoplasms
Down-regulation of MiR-365 as a novel indicator to assess the progression and metastasis of hepatocellular carcinoma.
Neoplasms
Down-regulation of RBP4 indicates a poor prognosis and correlates with immune cell infiltration in hepatocellular carcinoma.
Neoplasms
Down-regulation of solute carrier family 10 member 1 is associated with early recurrence and poorer prognosis of hepatocellular carcinoma.
Neoplasms
Down-regulation of the tumor suppressor miR-34a contributes to head and neck cancer by up-regulating the MET oncogene and modulating tumor immune evasion.
Neoplasms
Down-regulation of TROP-2 Predicts Poor Prognosis of Hepatocellular Carcinoma Patients.
Neoplasms
Downregulated ARID1A by miR-185 Is Associated With Poor Prognosis and Adverse Outcomes in Colon Adenocarcinoma.
Neoplasms
Downregulated expression of ARHGAP10 correlates with advanced stage and high Ki-67 index in breast cancer.
Neoplasms
Downregulated expression of CFHL1 is associated with unfavorable prognosis in postoperative patients with hepatocellular carcinoma.
Neoplasms
Downregulated miR-1247-5p associates with poor prognosis and facilitates tumor cell growth via DVL1/Wnt/?-catenin signaling in breast cancer.
Neoplasms
Downregulated miR-383-5p contributes to the proliferation and migration of gastric cancer cells and is associated with poor prognosis.
Neoplasms
Downregulated mRNA Expression of ZNF385B Is an Independent Predictor of Breast Cancer.
Neoplasms
Downregulated ZNF132 predicts unfavorable outcomes in breast Cancer via Hypermethylation modification.
Neoplasms
Downregulating CD26/DPPIV by apigenin modulates the interplay between Akt and Snail/Slug signaling to restrain metastasis of lung cancer with multiple EGFR statuses.
Neoplasms
Downregulation of ?-l-fucosidase 1 suppresses glioma progression by enhancing autophagy and inhibiting macrophage infiltration.
Neoplasms
Downregulation of ACE2 expression by SARS-CoV-2 worsens the prognosis of KIRC and KIRP patients via metabolism and immunoregulation.
Neoplasms
Downregulation of CCL22 and mutated NOTCH1 in tongue and mouth floor squamous cell carcinoma results in decreased Th2 cell recruitment and expression, predicting poor clinical outcome.
Neoplasms
Downregulation of CDCA5 Can Inhibit Cell Proliferation, Migration, and Invasion, and Induce Apoptosis of Prostate Cancer Cells.
Neoplasms
Downregulation of CDH16 in Papillary Thyroid Cancer and Its Potential Molecular Mechanism Analysed by qRT-PCR, TCGA and in silico Analysis.
Neoplasms
Downregulation of CISD2 Has Prognostic Value in Non-Small Cell Lung Cancer and Inhibits the Tumorigenesis by Inducing Mitochondrial Dysfunction.
Neoplasms
Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
Neoplasms
Downregulation of Collagen COL4A6 Is Associated with Prostate Cancer Progression and Metastasis.
Neoplasms
Downregulation of cyclin-dependent kinase 8 by microRNA-148a suppresses proliferation and invasiveness of papillary thyroid carcinomas.
Neoplasms
Downregulation of dystroglycan glycosyltransferases LARGE2 and ISPD associate with increased mortality in clear cell renal cell carcinoma.
Neoplasms
Downregulation of enhancer RNA EMX2OS is associated with poor prognosis in kidney renal clear cell carcinoma.
Neoplasms
Downregulation of FBP1 Promotes Tumor Metastasis and Indicates Poor Prognosis in Gastric Cancer via Regulating Epithelial-Mesenchymal Transition.
Neoplasms
Downregulation of fibroblast growth factor 5 inhibits cell growth and invasion of human nonsmall-cell lung cancer cells.
Neoplasms
Downregulation of G Protein-Coupled Estrogen Receptor (GPER) is Associated with Reduced Prognosis in Patients with Gastric Cancer.
Neoplasms
Downregulation of GNA14 in hepatocellular carcinoma indicates an unfavorable prognosis.
Neoplasms
Downregulation of HOXA11 enhances endometrial cancer malignancy and cisplatin resistance via activating PTEN/AKT signaling pathway.
Neoplasms
Downregulation of HOXA3 in lung adenocarcinoma and its relevant molecular mechanism analysed by RT-qPCR, TCGA and in silico analysis.
Neoplasms
Downregulation of lncRNA RPLP0P2 inhibits cell proliferation, invasion and migration, and promotes apoptosis in colorectal cancer.
Neoplasms
Downregulation of long non-coding RNA DUXAP10 inhibits proliferation, migration, and invasion of renal cell carcinoma.
Neoplasms
Downregulation of long non-coding RNA MR4435-2HG suppresses breast cancer progression via the Wnt/?-catenin signaling pathway.
Neoplasms
Downregulation of long noncoding RNA LINC00683 associated with unfavorable prognosis in prostate cancer based on TCGA.
Neoplasms
Downregulation Of microRNA-133b And Its Clinical Value In Non-Small Cell Lung Cancer.
Neoplasms
Downregulation of miR-145-5p in cancer cells and their derived exosomes may contribute to the development of ovarian cancer by targeting CT.
Neoplasms
Downregulation of miR-193a-3p is involved in the pathogenesis of hepatocellular carcinoma by targeting CCND1.
Neoplasms
Downregulation of miR-374b-5p promotes chemotherapeutic resistance in pancreatic cancer by upregulating multiple anti-apoptotic proteins.
Neoplasms
Downregulation of miR?136?5p in hepatocellular carcinoma and its clinicopathological significance.
Neoplasms
Downregulation of miR?486?5p in papillary thyroid carcinoma tissue: A study based on microarray and miRNA sequencing.
Neoplasms
Downregulation of miRNA-126-3p is associated with progression of and poor prognosis for lung squamous cell carcinoma.
Neoplasms
Downregulation of N-myc and STAT Interactor Protein Predicts Aggressive Tumor Behavior and Poor Prognosis in Invasive Ductal Carcinoma.
Neoplasms
Downregulation of NDUFB6 due to 9p24.1-p13.3 loss is implicated in metastatic clear cell renal cell carcinoma.
Neoplasms
Downregulation of nucleolar and spindle-associated protein 1 expression suppresses liver cancer cell function.
Neoplasms
Downregulation of NUSAP1 suppresses cell proliferation, migration, and invasion via inhibiting mTORC1 signalling pathway in gastric cancer.
Neoplasms
Downregulation of orosomucoid 2 acts as a prognostic factor associated with cancer-promoting pathways in liver cancer.
Neoplasms
Downregulation of PARVA promotes metastasis by modulating integrin-linked kinase activity and regulating MAPK/ERK and MLC2 signaling in prostate cancer.
Neoplasms
Downregulation of PDIA3 inhibits proliferation and invasion of human acute myeloid leukemia cells.
Neoplasms
Downregulation of PRMT1, a histone arginine methyltransferase, by sodium propionate induces cell apoptosis in colon cancer.
Neoplasms
Downregulation of regulator of G protein signaling 2 expression in breast invasive carcinoma of no special type: Clinicopathological associations and prognostic relevance.
Neoplasms
Downregulation of RIG-I mediated by ITGB3/c-SRC/STAT3 signaling confers resistance to interferon-?-induced apoptosis in tumor-repopulating cells of melanoma.
Neoplasms
Downregulation of SELENBP1 enhances oral squamous cell carcinoma chemoresistance through KEAP1-NRF2 signaling.
Neoplasms
Downregulation of SPINK13 Promotes Metastasis by Regulating uPA in Ovarian Cancer Cells.
Neoplasms
Downregulation of ST3GAL5 is associated with muscle invasion, high grade and a poor prognosis in patients with bladder cancer.
Neoplasms
Downregulation of the DNA Repair Gene DDB2 by Arecoline Is through p53's DNA-Binding Domain and Is Correlated with Poor Outcome of Head and Neck Cancer Patients with Betel Quid Consumption.
Neoplasms
Downregulation of transient receptor potential cation channel, subfamily C, member 1 contributes to drug resistance and high histological grade in ovarian cancer.
Neoplasms
Downregulation of TSPAN13 by miR-369-3p inhibits cell proliferation in papillary thyroid cancer (PTC).
Neoplasms
Downregulation of WDR20 due to loss of 14q is involved in the malignant transformation of clear cell renal cell carcinoma.
Neoplasms
Downregulations of miR-449a and miR-145-5p Act as Prognostic Biomarkers for Endometrial Cancer.
Neoplasms
Downstream Neighbor of SON (DONSON) Expression Is Enhanced in Phenotypically Aggressive Prostate Cancers.
Neoplasms
Downstream neighbor of SON (DONSON) is associated with unfavorable survival across diverse cancers with oncogenic properties in clear cell renal cell carcinoma.
Neoplasms
Dowregulation of OTX1 attenuates gastric cancer cell proliferation, migration and invasion.
Neoplasms
Doxorubicin effect is enhanced by sphingosine-1-phosphate signaling antagonist in breast cancer.
Neoplasms
DPP9: Comprehensive In Silico Analyses of Loss of Function Gene Variants and Associated Gene Expression Signatures in Human Hepatocellular Carcinoma.
Neoplasms
DR4-Ser424 O-GlcNAcylation Promotes Sensitization of TRAIL-Tolerant Persisters and TRAIL-Resistant Cancer Cells to Death.
Neoplasms
DriverML: a machine learning algorithm for identifying driver genes in cancer sequencing studies.
Neoplasms
Drug and disease signature integration identifies synergistic combinations in glioblastoma.
Neoplasms
Druggable Nucleolin Identifies Breast Tumours Associated with Poor Prognosis That Exhibit Different Biological Processes.
Neoplasms
DSG2 expression is correlated with poor prognosis and promotes early-stage cervical cancer.
Neoplasms
DSN1 is a prognostic biomarker and correlated with clinical characterize in breast cancer.
Neoplasms
Dual disruption of aldehyde dehydrogenases 1 and 3 promotes functional changes in the glutathione redox system and enhances chemosensitivity in nonsmall cell lung cancer.
Neoplasms
Dual Hyper-graph Regularized Supervised NMF for Selecting Differentially Expressed Genes and Tumor Classification.
Neoplasms
Dual inhibition of glutaminase and carnitine palmitoyltransferase decreases growth and migration of glutaminase inhibition-resistant triple-negative breast cancer cells.
Neoplasms
Dual oxidase 1 and NADPH oxidase 2 exert favorable effects in cervical cancer patients by activating immune response.
Neoplasms
Dual PI3K and Wnt pathway inhibition is a synergistic combination against triple negative breast cancer.
Neoplasms
Dual Regulatory Mechanisms of Expression and Mutation Involving Metabolism-Related Genes FDFT1 and UQCR5 during CLM.
Neoplasms
Dual Src and MEK Inhibition Decreases Ovarian Cancer Growth and Targets Tumor Initiating Stem-Like Cells.
Neoplasms
Dual Strands of Pre-miR-149 Inhibit Cancer Cell Migration and Invasion through Targeting FOXM1 in Renal Cell Carcinoma.
Neoplasms
Dual strands of the miR-223 duplex (miR-223-5p and miR-223-3p) inhibit cancer cell aggressiveness: targeted genes are involved in bladder cancer pathogenesis.
Neoplasms
DUBR suppresses migration and invasion of human lung adenocarcinoma cells via ZBTB11-mediated inhibition of oxidative phosphorylation.
Neoplasms
DUOX2 As a Potential Prognostic Marker which Promotes Cell Motility and Proliferation in Pancreatic Cancer.
Neoplasms
DUSP4/MKP2 overexpression is associated with BRAF(V600E) mutation and aggressive behavior of papillary thyroid cancer.
Neoplasms
Dusting off old books: comments on classic gynecologic pathology books of yesteryear.
Neoplasms
Dynamic changes of driver genes' mutations across clinical stages in nine cancer types.
Neoplasms
Dynamic chromosomal tuning of a novel GAU1 lncing driver at chr12p13.32 accelerates tumorigenesis.
Neoplasms
Dynamic Control of Mitochondrial Ca2+ Levels as a Survival Strategy of Cancer Cells.
Neoplasms
Dynamic TF-lncRNA Regulatory Networks Revealed Prognostic Signatures in the Development of Ovarian Cancer.
Neoplasms
Dynamics and predicted drug response of a gene network linking dedifferentiation with beta-catenin dysfunction in hepatocellular carcinoma.
Neoplasms
Dynamics of Genome Alterations in Crohn's Disease-Associated Colorectal Carcinogenesis.
Neoplasms
Dyregulation of the lncRNA TPT1-AS1 positively regulates QKI expression and predicts a poor prognosis for patients with breast cancer.
Neoplasms
DYSF expression in clear cell renal cell carcinoma: A retrospective study of 2 independent cohorts.
Neoplasms
Dysregulated lncRNA-miRNA-mRNA Network Reveals Patient Survival-Associated Modules and RNA Binding Proteins in Invasive Breast Carcinoma.
Neoplasms
Dysregulated microRNAs in laryngeal cancer: a comprehensive meta-analysis using a robust rank aggregation approach.
Neoplasms
Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer.
Neoplasms
Dysregulated transcription across diverse cancer types reveals the importance of RNA-binding protein in carcinogenesis.
Neoplasms
Dysregulation in nucleic acid-sensing pathway genes is associated with cancer patients' prognosis.
Neoplasms
Dysregulation of cystathionine ?-lyase promotes prostate cancer progression and metastasis.
Neoplasms
Dysregulation of DNA methylation patterns may identify patients with breast cancer resistant to endocrine therapy: A predictive classifier based on differentially methylated regions.
Neoplasms
Dysregulation of FOXD2-AS1 promotes cell proliferation and migration and predicts poor prognosis in oral squamous cell carcinoma: a study based on TCGA data.
Neoplasms
Dysregulation of KIF14 regulates the cell cycle and predicts poor prognosis in cervical cancer: a study based on integrated approaches.
Neoplasms
Dysregulation of miR-181c expression influences recurrence of endometrial endometrioid adenocarcinoma by modulating NOTCH2 expression: An NRG Oncology/Gynecologic Oncology Group study.
Neoplasms
Dysregulation of miR-200 family microRNAs and epithelial-mesenchymal transition markers in oral squamous cell carcinoma.
Neoplasms
Dysregulation of Sirtuin 2 (SIRT2) and histone H3K18 acetylation pathways associates with adverse prostate cancer outcomes.
Neoplasms
Dysregulation of sphingolipid metabolic enzymes leads to high levels of sphingosine-1-phosphate and ceramide in human hepatocellular carcinoma.
Neoplasms
Dysregulation of the Immune Microenvironment Contributes to Malignant Progression and Has Prognostic Value in Bladder Cancer.
Neoplasms
Dysregulation of the miR-25-IMPA2 axis promotes metastatic progression in clear cell renal cell carcinoma.
Neoplasms
Dysregulation of the miRNA biogenesis components DICER1, DROSHA, DGCR8 and AGO2 in clear cell renal cell carcinoma in both a Korean cohort and the cancer genome atlas kidney clear cell carcinoma cohort.
Neoplasms
Dysregulation, functional implications, and prognostic ability of the circadian clock across cancers.
Neoplasms
E26 transformation (ETS)?specific related transcription factor?3 (ELF3) orchestrates a positive feedback loop that constitutively activates the MAPK/Erk pathway to drive thyroid cancer.
Neoplasms
E2F, HSF2, and miR-26 in thyroid carcinoma: bioinformatic analysis of RNA-sequencing data.
Neoplasms
E2F8, a direct target of miR-144, promotes papillary thyroid cancer progression via regulating cell cycle.
Neoplasms
Early B-cell factors involve in the tumorigenesis and predict the overall survival of gastric cancer.
Neoplasms
Early detection of gastric cancer using global, genome-wide and IRF4, ELMO1, CLIP4 and MSC DNA methylation in endoscopic biopsies.
Neoplasms
Early Growth Response 1-Dependent Downregulation of Matrix Metalloproteinase 9 and Mouse Double Minute 2 Attenuates Head and Neck Squamous Cell Carcinoma Metastasis.
Neoplasms
Early Loss of Forkhead Transcription Factor, O Subgroup, Member 1 Protein in the Development of Pancreatic Ductal Adenocarcinoma.
Neoplasms
Early Stage Biomarkers Screening of Prostate Cancer Based on Weighted Gene Coexpression Network Analysis.
Neoplasms
Early-onset gastric cancer is a distinct disease with worrisome trends and oncogenic features.
Neoplasms
EARN: an ensemble machine learning algorithm to predict driver genes in metastatic breast cancer.
Neoplasms
Ectodermal-neural cortex 1 as a novel biomarker predicts poor prognosis and induces metastasis in breast cancer by promoting Wnt/?-catenin pathway.
Neoplasms
Ectodermal?neural cortex 1 affects the biological function of lung cancer through the MAPK pathway.
Neoplasms
Ectopic Otoconin 90 expression in triple negative breast cancer cell lines is associated with metastasis functions.
Neoplasms
Effect of AGER on the biological behavior of non?small cell lung cancer H1299 cells.
Neoplasms
Effect of CCL2 siRNA on proliferation and apoptosis in the U251 human glioma cell line.
Neoplasms
Effect of cell microenvironment on the drug sensitivity of hepatocellular cancer cells.
Neoplasms
Effect of claudin 1 on cell proliferation, migration and apoptosis in human cervical squamous cell carcinoma.
Neoplasms
Effect of COL4A1 Expression on the Survival of Neoadjuvant Chemotherapy Breast Cancer Patients.
Neoplasms
Effect of CXCR5-Positive Cell Infiltration on the Immune Contexture and Patient Prognosis in Head and Neck Squamous Cell Carcinoma.
Neoplasms
Effect of Different Expression of Immune-Related lncRNA on Colon Adenocarcinoma and Its Relation to Prognosis.
Neoplasms
Effect of EphA2 knockdown on melanoma metastasis depends on intrinsic ephrinA1 level.
Neoplasms
Effect of estrogen receptor ? binding on functional DNA methylation in breast cancer.
Neoplasms
Effect of high variation in transcript expression on identifying differentially expressed genes in RNA-seq analysis.
Neoplasms
Effect of ISM1 on the Immune Microenvironment and Epithelial-Mesenchymal Transition in Colorectal Cancer.
Neoplasms
Effect of LAMA4 on Prognosis and Its Correlation with Immune Infiltration in Gastric Cancer.
Neoplasms
Effect of let-7c on the PI3K/Akt/FoxO signaling pathway in hepatocellular carcinoma.
Neoplasms
Effect of m6A RNA Methylation Regulators on Malignant Progression and Prognosis in Renal Clear Cell Carcinoma.
Neoplasms
Effect of myeloid ecotropic viral integration site (MEIS) family genes on tumor microenvironment remodeling and its potential therapeutic effect.
Neoplasms
Effect of N6-Methyladenosine Regulators on Progression and Prognosis of Triple-Negative Breast Cancer.
Neoplasms
Effect of nicastrin on hepatocellular carcinoma proliferation and apoptosis through PI3K/AKT signalling pathway modulation.
Neoplasms
Effect of serpinE1 overexpression on the primary tumor and lymph node, and lung metastases in head and neck squamous cell carcinoma.
Neoplasms
Effect of TTN Mutations on Immune Microenvironment and Efficacy of Immunotherapy in Lung Adenocarcinoma Patients.
Neoplasms
Effect of upregulation of DD3 on early detection and prognosis in prostate cancer.
Neoplasms
Effects of ABT-737 combined with irradiation treatment on uterine cervical cancer cells.
Neoplasms
Effects of AKT1 E17K mutation hotspots on the biological behavior of breast cancer cells.
Neoplasms
Effects of Arsenic (+3 Oxidation State) Methyltransferase Gene Polymorphisms and Expression on Bladder Cancer: Evidence from a Systematic Review, Meta-analysis and TCGA Dataset.
Neoplasms
Effects of CORO2A on Cell Migration and Proliferation and Its Potential Regulatory Network in Breast Cancer.
Neoplasms
Effects of germline and somatic events in candidate BRCA-like genes on breast-tumor signatures.
Neoplasms
Effects of hub genes on the clinicopathological and prognostic features of lung adenocarcinoma.
Neoplasms
Effects of Hypoxia in Intestinal Tumors on Immune Cell Behavior in the Tumor Microenvironment.
Neoplasms
Effects of Kras activation and Pten deletion alone or in combination on MUC1 biology and epithelial-to-mesenchymal transition in ovarian cancer.
Neoplasms
Effects of NRP1 on angiogenesis and vascular maturity in endothelial cells are dependent on the expression of SEMA4D.
Neoplasms
Effects of RNA methylation N6-methyladenosine regulators on malignant progression and prognosis of melanoma.
Neoplasms
Effects of TP53 mutational status on gene expression patterns across 10 human cancer types.
Neoplasms
Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial.
Neoplasms
Efficacy and pharmacodynamics of niraparib in BRCA-mutant and wild-type intracranial triple-negative breast cancer murine models.
Neoplasms
Efficient exploration of pan-cancer networks by generalized covariance selection and interactive web content.
Neoplasms
Efficient generation of patient-matched malignant and normal primary cell cultures from clear cell renal cell carcinoma patients: clinically relevant models for research and personalized medicine.
Neoplasms
Efficient mutation screening for cervical cancers from circulating tumor DNA in blood.
Neoplasms
EFTUD2 maintains the survival of tumor cells and promotes hepatocellular carcinoma progression via the activation of STAT3.
Neoplasms
EGFR and PI3K Pathway Activities Might Guide Drug Repurposing in HPV-Negative Head and Neck Cancers.
Neoplasms
EGFR DNA Methylation Correlates With EGFR Expression, Immune Cell Infiltration, and Overall Survival in Lung Adenocarcinoma.
Neoplasms
EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small cell lung cancer.
Neoplasms
EGFR-ERK pathway regulates CSN6 to contribute to PD-L1 expression in glioblastoma.
Neoplasms
EGFRvIII-specific CAR-T cells produced by piggyBac transposon exhibit efficient growth suppression against hepatocellular carcinoma.
Neoplasms
EGLN2 DNA methylation and expression interact with HIF1A to affect survival of early-stage NSCLC.
Neoplasms
Egr?1 inhibits colon cancer cell proliferation, migration and invasion via regulating CDKL1 at the transcriptional level.
Neoplasms
EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancer.
Neoplasms
eIF2?, a subunit of translation-initiation factor EIF2, is a potential therapeutic target for non-small cell lung cancer.
Neoplasms
eIF6 Promotes Colorectal Cancer Proliferation and Invasion by Regulating AKT-Related Signaling Pathways.
Neoplasms
eIF6 promotes the malignant progression of human hepatocellular carcinoma via the mTOR signaling pathway.
Neoplasms
Eight immune-related genes predict survival outcomes and immune characteristics in breast cancer.
Neoplasms
Eight key long non-coding RNAs predict hepatitis virus positive hepatocellular carcinoma as prognostic targets.
Neoplasms
Eight-gene metabolic signature related with tumor-associated macrophages predicting overall survival for hepatocellular carcinoma.
Neoplasms
Eight-gene prognostic signature associated with hypoxia and ferroptosis for gastric cancer with general applicability.
Neoplasms
Elastic Net-Based Identification of a Multigene Combination Predicting the Survival of Patients with Cervical Cancer.
Neoplasms
Elective Clinical Target Volumes for Conformal Therapy in Anorectal Cancer: An Radiation Therapy Oncology Group Consensus Panel Contouring Atlas.
Neoplasms
Electrostatic Complementarity of T-Cell Receptor-Alpha CDR3 Domains and Mutant Amino Acids Is Associated with Better Survival Rates for Sarcomas.
Neoplasms
Elementary screening of lymph node metastatic-related genes in gastric cancer based on the co-expression network of messenger RNA, microRNA and long non-coding RNA.
Neoplasms
Elevated APOBEC mutational signatures implicate chronic injury in etiology of an aggressive head-and-neck squamous cell carcinoma: a case report.
Neoplasms
Elevated CDK5R1 predicts worse prognosis in hepatocellular carcinoma based on TCGA data.
Neoplasms
Elevated CELSR3 expression is associated with hepatocarcinogenesis and poor prognosis.
Neoplasms
Elevated circulating miR-182 acts as a diagnostic biomarker for early colorectal cancer.
Neoplasms
Elevated COX-2 Expression Promotes Angiogenesis Through EGFR/p38-MAPK/Sp1-Dependent Signalling in Pancreatic Cancer.
Neoplasms
Elevated DKK1 expression is an independent unfavorable prognostic indicator of survival in head and neck squamous cell carcinoma.
Neoplasms
Elevated double-strand break repair protein RAD50 predicts poor prognosis in hepatitis B virus-related hepatocellular carcinoma: A study based on Chinese high-risk cohorts.
Neoplasms
Elevated DSN1 expression is associated with poor survival in patients with hepatocellular carcinoma.
Neoplasms
Elevated EXO1 expression is associated with breast carcinogenesis and poor prognosis.
Neoplasms
Elevated expression of ASCL2 is an independent prognostic indicator in lung squamous cell carcinoma.
Neoplasms
Elevated expression of ASF1B correlates with poor prognosis in human lung adenocarcinoma.
Neoplasms
Elevated Expression of LYPD3 Is Associated with Lung Adenocarcinoma Carcinogenesis and Poor Prognosis.
Neoplasms
Elevated expression of NFE2L3 predicts the poor prognosis of pancreatic cancer patients.
Neoplasms
Elevated expression of podoplanin and its clinicopathological, prognostic, and therapeutic values in squamous non-small cell lung cancer.
Neoplasms
Elevated expression of protein arginine methyltransferase 5 predicts the poor prognosis of breast cancer.
Neoplasms
Elevated expression of PTCD3 correlates with tumor progression and predicts poor prognosis in patients with prostate cancer.
Neoplasms
Elevated expression of Twinfilin-1 is correlated with inferior prognosis of lung adenocarcinoma.
Neoplasms
Elevated FAM3C promotes cell epithelial- mesenchymal transition and cell migration in gastric cancer.
Neoplasms
Elevated Glutathione Peroxidase 2 Expression Promotes Cisplatin Resistance in Lung Adenocarcinoma.
Neoplasms
Elevated glypican-1 expression is associated with an unfavorable prognosis in pancreatic ductal adenocarcinoma.
Neoplasms
Elevated heparanase expression is associated with poor prognosis in breast cancer: a study based on systematic review and TCGA data.
Neoplasms
Elevated Heterogeneous Nuclear Ribonucleoprotein C Expression Correlates With Poor Prognosis in Patients With Surgically Resected Lung Adenocarcinoma.
Neoplasms
Elevated high mobility group A2 expression in liver cancer predicts poor patient survival.
Neoplasms
Elevated integrin ?6 expression is involved in the occurrence and development of lung adenocarcinoma, and predicts a poor prognosis: a study based on immunohistochemical analysis and bioinformatics.
Neoplasms
Elevated KLF7 levels may serve as a prognostic signature and might contribute to progression of squamous carcinoma.
Neoplasms
Elevated lymphocyte specific protein 1 expression is involved in the regulation of leukocyte migration and immunosuppressive microenvironment in glioblastoma.
Neoplasms
Elevated MRE11 expression associated with progression and poor outcome in prostate cancer.
Neoplasms
Elevated mRNA Levels of AURKA, CDC20 and TPX2 are associated with poor prognosis of smoking related lung adenocarcinoma using bioinformatics analysis.
Neoplasms
Elevated MYO10 Predicts Poor Prognosis and its Deletion Hampers Proliferation and Migration Potentials of Cells Through Rewiring PI3K/Akt Signaling in Cervical Cancer.
Neoplasms
Elevated Na/H exchanger 1 (SLC9A1) emerges as a marker for tumorigenesis and prognosis in gliomas.
Neoplasms
Elevated neoantigen levels in tumors with somatic mutations in the HLA-A, HLA-B, HLA-C and B2M genes.
Neoplasms
Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma.
Neoplasms
Elevated Ras related GTP binding B (RRAGB) expression predicts poor overall survival and constructs a prognostic nomogram for colon adenocarcinoma.
Neoplasms
Elevated Resistin Gene Expression in African American Estrogen and Progesterone Receptor Negative Breast Cancer.
Neoplasms
Elevated SLC2A1 Expression Correlates with Poor Prognosis in Patients with Surgically Resected Lung Adenocarcinoma: A Study Based on Immunohistochemical Analysis and Bioinformatics.
Neoplasms
Elevated SLC6A6 expression drives tumorigenesis and affects clinical outcomes in gastric cancer.
Neoplasms
Elevated TOP2A and UBE2C expressions correlate with poor prognosis in patients with surgically resected lung adenocarcinoma: a study based on immunohistochemical analysis and bioinformatics.
Neoplasms
Elevated ZNF703 Protein Expression Is an Independent Unfavorable Prognostic Factor for Survival of the Patients with Head and Neck Squamous Cell Carcinoma.
Neoplasms
Eleven immune-gene pairs signature associated with TP53 predicting the overall survival of gastric cancer: a retrospective analysis of large sample and multicenter from public database.
Neoplasms
ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cells.
Neoplasms
Elucidating cancer metabolic plasticity by coupling gene regulation with metabolic pathways.
Neoplasms
Elucidating feed-forward apoptosis signatures in breast cancer datasets: Higher FOS expression associated with a better outcome.
Neoplasms
Elucidating Genomic Characteristics of Lung Cancer Progression from In Situ to Invasive Adenocarcinoma.
Neoplasms
Elucidating the Reprograming of Colorectal Cancer Metabolism Using Genome-Scale Metabolic Modeling.
Neoplasms
Elucidating therapeutic molecular targets in premenopausal Asian women with recurrent breast cancers.
Neoplasms
Elucidation of Novel Therapeutic Targets for Acute Myeloid Leukemias with RUNX1-RUNX1T1 Fusion.
Neoplasms
Elucidation of Novel Therapeutic Targets for Breast Cancer with ESR1-CCDC170 Fusion.
Neoplasms
Elucidation of the Genomic-Epigenomic Interaction Landscape of Aggressive Prostate Cancer.
Neoplasms
Embedding of Genes Using Cancer Gene Expression Data: Biological Relevance and Potential Application on Biomarker Discovery.
Neoplasms
Emerging molecular classifications and therapeutic implications for gastric cancer.
Neoplasms
Emerging role of microRNAs in modulating endothelin-1 expression in gastric cancer.
Neoplasms
Emerging role of mutations in epigenetic regulators including MLL2 derived from The Cancer Genome Atlas for cervical cancer.
Neoplasms
EMP3 is induced by TWIST1/2 and regulates epithelial-to-mesenchymal transition of gastric cancer cells.
Neoplasms
Employing hypoxia characterization to predict tumour immune microenvironment, treatment sensitivity and prognosis in hepatocellular carcinoma.
Neoplasms
EMT- and stroma-related gene expression and resistance to PD-1 blockade in urothelial cancer.
Neoplasms
EMT-related long non-coding RNA in hepatocellular carcinoma: A study with TCGA database.
Neoplasms
EMTome: a resource for pan-cancer analysis of epithelial-mesenchymal transition genes and signatures.
Neoplasms
Enabling Precision Medicine in Cancer Care Through a Molecular Data Warehouse: The Moffitt Experience.
Neoplasms
Enabling transparent and collaborative computational analysis of 12 tumor types within The Cancer Genome Atlas.
Neoplasms
ENAM gene associated with T classification and inhibits proliferation in renal clear cell carcinoma.
Neoplasms
Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma.
Neoplasms
Endogenous retrovirus expression is associated with response to immune checkpoint blockade in clear cell renal cell carcinoma.
Neoplasms
Endometrial Adenocarcinomas With No Specific Molecular Profile: Morphologic Features and Molecular Alterations of "Copy-number Low" Tumors.
Neoplasms
Endometrial cancer gene panels: clinical diagnostic vs research germline DNA testing.
Neoplasms
Endometrial Cancer Molecular Characterization: The Key to Identifying High-Risk Patients and Defining Guidelines for Clinical Decision-Making?
Neoplasms
Endometrial Cancers in BRCA1 or BRCA2 Germline Mutation Carriers: Assessment of Homologous Recombination DNA Repair Defects.
Neoplasms
Endometrial Cancers With Activating KRas Mutations Have Activated Estrogen Signaling and Paradoxical Response to MEK Inhibition.
Neoplasms
Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists.
Neoplasms
Endometrial Carcinomas with a "Serous" Component in Young Women Are Enriched for DNA Mismatch Repair Deficiency, Lynch Syndrome, and POLE Exonuclease Domain Mutations.
Neoplasms
Endoplasmic reticulum chaperone GRP78/BiP is critical for mutant Kras-driven lung tumorigenesis.
Neoplasms
Endoscopic Endonasal Approach for Resection of a Pediatric Craniopharyngioma: Operative Video and Technical Nuances.
Neoplasms
Endoscopic ultrasound-guided fine-needle aspirate-derived preclinical pancreatic cancer models reveal panitumumab sensitivity in KRAS wild-type tumors.
Neoplasms
Endothelial cells promote triple-negative breast cancer cell metastasis via PAI-1 and CCL5 signaling.
Neoplasms
Endothelial-mesenchymal transition harnesses HSP90?-secreting M2-macrophages to exacerbate pancreatic ductal adenocarcinoma.
Neoplasms
Endothelin-1/endothelin A receptor-mediated biased signaling is a new player in modulating human ovarian cancer cell tumorigenesis.
Neoplasms
Engineering and Functional Characterization of Fusion Genes Identifies Novel Oncogenic Drivers of Cancer.
Neoplasms
Engrailed 1 overexpression as a potential prognostic marker in Lower Grade Glioma.
Neoplasms
Enhanced B7-H4 expression in gliomas with low PD-L1 expression identifies super-cold tumors.
Neoplasms
Enhanced cell migration and apoptosis resistance may underlie the association between high SERPINE1 expression and poor outcome in head and neck carcinoma patients.
Neoplasms
Enhanced CXCR4 Expression Associates with Increased Gene Body 5-Hydroxymethylcytosine Modification but not Decreased Promoter Methylation in Colorectal Cancer.
Neoplasms
Enhanced expression of FGF19 predicts poor prognosis in patients with non-small cell lung cancer.
Neoplasms
Enhanced expression of GABRD predicts poor prognosis in patients with colon adenocarcinoma.
Neoplasms
Enhanced expression of microtubule-associated protein 7 functioned as a contributor to cervical cancer cell migration and is predictive of adverse prognosis.
Neoplasms
Enhanced expression of queuine tRNA-ribosyltransferase 1 (QTRT1) predicts poor prognosis in lung adenocarcinoma.
Neoplasms
Enhanced expression of SRPK2 contributes to aggressive progression and metastasis in prostate cancer.
Neoplasms
Enhanced Expression of TGFBI Promotes the Proliferation and Migration of Glioma Cells.
Neoplasms
Enhanced expressions of FHL2 and iASPP predict poor prognosis in acute myeloid leukemia.
Neoplasms
Enhanced fatty acid oxidation mediated by CPT1C promotes gastric cancer progression.
Neoplasms
Enhanced GAB2 Expression Is Associated with Improved Survival in High-Grade Serous Ovarian Cancer and Sensitivity to PI3K Inhibition.
Neoplasms
Enhanced Hsa-miR-181d/p-STAT3 and Hsa-miR-181d/p-STAT5A Ratios Mediate the Anticancer Effect of Garcinol in STAT3/5A-Addicted Glioblastoma.
Neoplasms
Enhanced immortalization, HUWE1 mutations and other biological drivers of breast invasive carcinoma in Black/African American patients.
Neoplasms
Enhanced MAPK signaling drives ETS1-mediated induction of miR-29b leading to downregulation of TET1 and changes in epigenetic modifications in a subset of lung SCC.
Neoplasms
Enhanced SMARCD1, a subunit of the SWI/SNF complex, promotes liver cancer growth through the mTOR pathway.
Neoplasms
Enhancing the sensitivity of ovarian cancer cells to olaparib via microRNA-20b-mediated cyclin D1 targeting.
Neoplasms
ENKUR Is Involved in the Regulation of Cellular Biology in Colorectal Cancer Cells via PI3K/Akt Signaling Pathway.
Neoplasms
EnMCB: an R/bioconductor package for predicting disease progression based on methylation correlated blocks using ensemble models.
Neoplasms
Enolase 1 Correlated With Cancer Progression and Immune-Infiltrating in Multiple Cancer Types: A Pan-Cancer Analysis.
Neoplasms
Enolase-1 serves as a biomarker of diagnosis and prognosis in hepatocellular carcinoma patients.
Neoplasms
Enrichment of Aldolase C Correlates with Low Non-Mutated IDH1 Expression and Predicts a Favorable Prognosis in Glioblastomas.
Neoplasms
Enrichment of FGFR3-TACC3 Fusions in Patients With Bladder Cancer Who Are Young, Asian, or Have Never Smoked.
Neoplasms
enRoute: dynamic path extraction from biological pathway maps for exploring heterogeneous experimental datasets.
Neoplasms
Ensemble outlier detection and gene selection in triple-negative breast cancer data.
Neoplasms
EP300 mutation is associated with tumor mutation burden and promotes antitumor immunity in bladder cancer patients.
Neoplasms
Eph family co-expression patterns define unique clusters predictive of cancer phenotype.
Neoplasms
EPHA mutation as a predictor of immunotherapeutic efficacy in lung adenocarcinoma.
Neoplasms
EPHA7 mutation as a predictive biomarker for immune checkpoint inhibitors in multiple cancers.
Neoplasms
Ephrin-B2 overexpression predicts for poor prognosis and response to therapy in solid tumors.
Neoplasms
Epidemiology and Molecular-Pathologic Characteristics of CpG Island Methylator Phenotype (CIMP) in Colorectal Cancer.
Neoplasms
Epidermal growth factor module-containing mucin-like receptor 2 is a newly identified adhesion G protein-coupled receptor associated with poor overall survival and an invasive phenotype in glioblastoma.
Neoplasms
Epidermal Growth Factor Receptor (EGFR) as a molecular determinant of glioblastoma response to dopamine receptor 2 (DRD2) inhibitors.
Neoplasms
Epidermal growth factor receptor and ligand family expression and activity in glioblastoma.
Neoplasms
Epidermal Growth Factor Receptor Mutations in Resectable Non-Small Cell Lung Cancer Patients and their Potential Role in the Immune Landscape.
Neoplasms
Epididymal protein 3A is upregulated and promotes cell proliferation in non-small cell lung cancer.
Neoplasms
Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin.
Neoplasms
Epigenetic Age Acceleration of Stomach Adenocarcinoma Associated With Tumor Stemness Features, Immunoactivation, and Favorable Prognosis.
Neoplasms
Epigenetic Alterations and Canonical Pathway Disruption in Papillary Thyroid Cancer: A Genome-wide Methylation Analysis.
Neoplasms
Epigenetic Alterations Associated with the Overall Survival and Recurrence Free Survival among Oral Squamous Cell Carcinoma Patients.
Neoplasms
Epigenetic Alterations in Oesophageal Cancer: Expression and Role of the Involved Enzymes.
Neoplasms
Epigenetic analysis identifies factors driving racial disparity in prostate cancer.
Neoplasms
Epigenetic analysis of the Notch superfamily in high-grade serous ovarian cancer.
Neoplasms
Epigenetic and genetic burden measures are associated with tumor characteristics in invasive breast carcinoma.
Neoplasms
Epigenetic Biomarkers of Breast Cancer Risk: Across the Breast Cancer Prevention Continuum.
Neoplasms
Epigenetic hypomethylation and upregulation of GD3s in triple negative breast cancer.
Neoplasms
Epigenetic inactivation of HOXD10 is associated with human colon cancer via inhibiting the RHOC/AKT/MAPK signaling pathway.
Neoplasms
Epigenetic inactivation of the novel candidate tumor suppressor gene ITIH5 in colon cancer predicts unfavorable overall survival in the CpG island methylator phenotype.
Neoplasms
Epigenetic loss of putative tumor suppressor SFRP3 correlates with poor prognosis of lung adenocarcinoma patients.
Neoplasms
Epigenetic mediated silencing of EYA4 contributes to tumorigenesis in oral dysplastic cells.
Neoplasms
Epigenetic modifications of splicing factor genes in myelodysplastic syndromes and acute myeloid leukemia.
Neoplasms
Epigenetic profiling and mRNA expression reveal candidate genes as biomarkers for colorectal cancer.
Neoplasms
Epigenetic regulation of GATA2 and its impact on normal karyotype acute myeloid leukemia.
Neoplasms
Epigenetic regulation of IQGAP2 promotes ovarian cancer progression via activating Wnt/?-catenin signaling.
Neoplasms
Epigenetic Regulation of KPC1 Ubiquitin Ligase Affects the NF-?B Pathway in Melanoma.
Neoplasms
Epigenetic Regulation of NAMPT by NAMPT-AS Drives Metastatic Progression in Triple-Negative Breast Cancer.
Neoplasms
Epigenetic regulation on the gene expression signature in esophagus adenocarcinoma.
Neoplasms
Epigenetic Repression of CCDC37 and MAP1B Links Chronic Obstructive Pulmonary Disease to Lung Cancer.
Neoplasms
Epigenetic Scanning of KEAP1 CpG Sites Uncovers New Molecular-Driven Patterns in Lung Adeno and Squamous Cell Carcinomas.
Neoplasms
Epigenetic signature of Gleason score and prostate cancer recurrence after radical prostatectomy.
Neoplasms
Epigenetic silencing of AATK in acinar to ductal metaplasia in murine model of pancreatic cancer.
Neoplasms
Epigenetic silencing of Rab39a promotes epithelial to mesenchymal transition of cervical cancer through AKT signaling.
Neoplasms
Epigenetic silencing of the synthesis of immunosuppressive Siglec ligand glycans by NF-?B/EZH2/YY1 axis in early-stage colon cancers.
Neoplasms
Epigenetic silencing of ZIC4 contributes to cancer progression in hepatocellular carcinoma.
Neoplasms
Epigenetic Study of Esophageal Carcinoma Based on Methylation, Gene Integration and Weighted Correlation Network Analysis.
Neoplasms
Epigenetic Suppression of SERPINB1 Promotes Inflammation-Mediated Prostate Cancer Progression.
Neoplasms
Epigenetic upregulation of ARL4C, due to DNA hypomethylation in the 3'-untranslated region, promotes tumorigenesis of lung squamous cell carcinoma.
Neoplasms
Epigenetic Variation Analysis Leads to Biomarker Discovery in Gastric Adenocarcinoma.
Neoplasms
Epigenetic-Mediated Downregulation of Zinc Finger Protein 671 (ZNF671) Predicts Poor Prognosis in Multiple Solid Tumors.
Neoplasms
Epigenetic-smoking interaction reveals histologically heterogeneous effects of TRIM27 DNA methylation on overall survival among early-stage NSCLC patients.
Neoplasms
Epigenetically induced ectopic expression of UNCX impairs the proliferation and differentiation of myeloid cells.
Neoplasms
Epigenetically Regulated Chromosome 14q32 miRNA Cluster Induces Metastasis and Predicts Poor Prognosis in Lung Adenocarcinoma Patients.
Neoplasms
Epigenetically regulated Fibronectin leucine rich transmembrane protein 2 (FLRT2) shows tumor suppressor activity in breast cancer cells.
Neoplasms
Epigenetically regulated gene expression profiles reveal four molecular subtypes with prognostic and therapeutic implications in colorectal cancer.
Neoplasms
Epigenetically silenced candidate tumor suppressor genes in prostate cancer: identified by modelling methylation stratification and applied to progression prediction.
Neoplasms
Epigenetically upregulated oncoprotein PLCE1 drives esophageal carcinoma angiogenesis and proliferation via activating the PI-PLC?-NF-?B signaling pathway and VEGF-C/ Bcl-2 expression.
Neoplasms
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers.
Neoplasms
Epigenome-wide association study of smoking and DNA methylation in non-small cell lung neoplasms.
Neoplasms
Epigenome-Wide DNA Methylation Profiling Identifies Differential Methylation Biomarkers in High-Grade Bladder Cancer.
Neoplasms
Epigenomic and genomic analysis of transcriptome modulation in skin cutaneous melanoma.
Neoplasms
Epigenomic Deconvolution of Breast Tumors Reveals Metabolic Coupling between Constituent Cell Types.
Neoplasms
Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue.
Neoplasms
Epigenomic profiling of prostate cancer identifies differentially methylated genes in TMPRSS2:ERG fusion-positive versus fusion-negative tumors.
Neoplasms
Epistasis analysis of microRNAs on pathological stages in colon cancer based on an Empirical Bayesian Elastic Net method.
Neoplasms
Epithelial Hypoxia-Inducible Factor 2? Facilitates the Progression of Colon Tumors through Recruiting Neutrophils.
Neoplasms
Epithelial Splicing Regulatory Protein (ESPR1) Expression in an Unfavorable Prognostic Factor in Prostate Cancer Patients.
Neoplasms
Epithelial-mesenchymal transition is associated with a distinct tumor microenvironment including elevation of inflammatory signals and multiple immune checkpoints in lung adenocarcinoma.
Neoplasms
Epithelial-to-mesenchymal transition and its association with PD-L1 and CD8 in thyroid cancer.
Neoplasms
Epiviz File Server: Query, Transform and Interactively Explore Data from Indexed Genomic Files.
Neoplasms
Eps15 Homology Domain-Containing Protein 3 Hypermethylation as a Prognostic and Predictive Marker for Colorectal Cancer.
Neoplasms
Epstein-Barr Virus MicroRNA Expression Increases Aggressiveness of Solid Malignancies.
Neoplasms
Epstein-Barr Virus miR-BART17-5p Promotes Migration and Anchorage-Independent Growth by Targeting Kruppel-Like Factor 2 in Gastric Cancer.
Neoplasms
Epstein-Barr Virus-Associated Gastric Carcinoma and Specific Features of the Accompanying Immune Response.
Neoplasms
Epstein-Barr Virus-Associated Gastric Carcinoma: Use of Host Cell Machineries and Somatic Gene Mutations.
Neoplasms
ER stress-related ATF6 upregulates CIP2A and contributes to poor prognosis of colon cancer.
Neoplasms
ER?-related chromothripsis enhances concordant gene transcription on chromosome 17q11.1-q24.1 in luminal breast cancer.
Neoplasms
ERBB2 mRNA Expression and Response to Ado-Trastuzumab Emtansine (T-DM1) in HER2-Positive Breast Cancer.
Neoplasms
ERBB2 mutation is associated with a worse prognosis in patients with CDH1 altered invasive lobular cancer of the breast.
Neoplasms
ErbB3 Targeting Enhances the Effects of MEK Inhibitor in Wild-Type BRAF/NRAS Melanoma.
Neoplasms
ErbB4 acts as a suppressor in colitis and its associated carcinoma by negatively regulating cholesterol metabolism.
Neoplasms
ERBB4 is over-expressed in human colon cancer and enhances cellular transformation.
Neoplasms
ERCC6L that is up-regulated in high grade of renal cell carcinoma enhances cell viability in vitro and promotes tumor growth in vivo potentially through modulating MAPK signalling pathway.
Neoplasms
ERCC6L, a DNA helicase, is involved in cell proliferation and associated with survival and progress in breast and kidney cancers.
Neoplasms
ERK1/2 signaling regulates the immune microenvironment and macrophage recruitment in glioblastoma.
Neoplasms
ERR1 and PGC1? associated mitochondrial alterations correlate with pan-cancer disparity in African Americans.
Neoplasms
Error-prone DNA polymerase and oxidative stress increase the incidences of A to G mutations in tumors.
Neoplasms
Erythrocytosis in hepatocellular carcinoma portends poor prognosis by respiratory dysfunction secondary to mitochondrial DNA mutations.
Neoplasms
ESCO2 promotes lung adenocarcinoma progression by regulating hnRNPA1 acetylation.
Neoplasms
Ese-3 Inhibits the Proliferation, Migration, and Invasion of HaCaT Cells by Downregulating PSIP1 and NUCKS1.
Neoplasms
ESM1 promotes triple-negative breast cancer cell proliferation through activating AKT/NF-?B/Cyclin D1 pathway.
Neoplasms
Esophageal cancer lymph node metastasis-associated gene signature optimizes overall survival prediction of esophageal cancer.
Neoplasms
ESR1 as a recurrence-related gene in intrahepatic cholangiocarcinoma: a weighted gene coexpression network analysis.
Neoplasms
ESR1-stabilizing lncRNA TMPO-AS1 promotes hormone-refractory breast cancer progression.
Neoplasms
ESRP1 is overexpressed in ovarian cancer and promotes switching from mesenchymal to epithelial phenotype in ovarian cancer cells.
Neoplasms
Establish six-gene prognostic model for glioblastoma based on multi-omics data of TCGA database.
Neoplasms
Establishing a human adrenocortical carcinoma (ACC)-specific gene mutation signature.
Neoplasms
Establishing a three-miRNA signature as a prognostic model for colorectal cancer through bioinformatics analysis.
Neoplasms
Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project.
Neoplasms
Establishment and validation of a 7-microRNA prognostic signature for non-small cell lung cancer.
Neoplasms
Establishment and Validation of a Comprehensive Prognostic Model for Patients With HNSCC Metastasis.
Neoplasms
Establishment and validation of a novel autophagy-related gene signature for patients with breast cancer.
Neoplasms
Establishment and validation of a prognostic nomogram based on a novel five-DNA methylation signature for survival in endometrial cancer patients.
Neoplasms
Establishment and Validation of a Prognostic Risk Model for Autophagy-Related Genes in Clear Cell Renal Cell Carcinoma.
Neoplasms
Establishment and validation of a prognostic signature for lung adenocarcinoma based on metabolism-related genes.
Neoplasms
Establishment and validation of an immune-associated signature in lung adenocarcinoma.
Neoplasms
Establishment and validation of an immune-based prognostic score model in glioblastoma.
Neoplasms
Establishment and validation of immune microenvironmental gene signatures for predicting prognosis in patients with head and neck squamous cell carcinoma.
Neoplasms
Establishment of a 12-gene expression signature to predict colon cancer prognosis.
Neoplasms
Establishment of a 5-gene risk model related to regulatory T cells for predicting gastric cancer prognosis.
Neoplasms
Establishment of a 7-miRNA-Based Risk Score System for Predicting Prognosis of Pancreatic Cancer.
Neoplasms
Establishment of a CALU, AURKA, and MCM2 gene panel for discrimination of metastasis from primary colon and lung cancers.
Neoplasms
Establishment of a ferroptosis-related gene signature for prognosis in lung adenocarcinoma patients.
Neoplasms
Establishment of a Genomic-Clinicopathologic Nomogram for Predicting Early Recurrence of Hepatocellular Carcinoma After R0 Resection.
Neoplasms
Establishment of a Macrophage Phenotypic Switch Related Prognostic Signature in Patients With Pancreatic Cancer.
Neoplasms
Establishment of a Nomogram by Integrating Molecular Markers and Tumor-Node-Metastasis Staging System for Predicting the Prognosis of Hepatocellular Carcinoma.
Neoplasms
Establishment of a novel CNV-related prognostic signature predicting prognosis in patients with breast cancer.
Neoplasms
Establishment of a novel gene panel as a biomarker of immune checkpoint inhibitor response.
Neoplasms
Establishment of a novel glycolysis-related prognostic gene signature for ovarian cancer and its relationships with immune infiltration of the tumor microenvironment.
Neoplasms
Establishment of a Novel Histopathological Classification of High-Grade Serous Ovarian Carcinoma Correlated with Prognostically Distinct Gene Expression Subtypes.
Neoplasms
Establishment of a novel risk score model by comprehensively analyzing the immunogen database of bladder cancer to indicate clinical significance and predict prognosis.
Neoplasms
Establishment of a Plasticity-Associated Risk Model Based on a SOX2- and SOX9-Related Gene Set in Head and Neck Squamous Cell Carcinoma.
Neoplasms
Establishment of a Prognostic Model for Hepatocellular Carcinoma Based on Endoplasmic Reticulum Stress-Related Gene Analysis.
Neoplasms
Establishment of a prognostic model of four genes in gastric cancer based on multiple data sets.
Neoplasms
Establishment of a Prognostic Model Using Immune-Related Genes in Patients With Hepatocellular Carcinoma.
Neoplasms
Establishment of a Risk Signature Based on m6A RNA Methylation Regulators That Predicts Poor Prognosis in Renal Cell Carcinoma.
Neoplasms
Establishment of an immune microenvironment-based prognostic predictive model for gastric cancer.
Neoplasms
Establishment of an immune-related gene prognostic model for head and neck tumors.
Neoplasms
Establishment of an Immune-Related Gene Signature for Risk Stratification for Patients with Glioma.
Neoplasms
Establishment of cohesion 1 homolog 2 facilitates cell aggressive behaviors and induces poor prognosis in renal cell carcinoma.
Neoplasms
Establishment of Immune-related Gene Pair Signature to Predict Lung Adenocarcinoma Prognosis.
Neoplasms
Establishment of multiple diagnosis models for colorectal cancer with artificial neural networks.
Neoplasms
Establishment of Novel DNA Methylation-Based Prostate Cancer Subtypes and a Risk-Predicting Eight-Gene Signature.
Neoplasms
Establishment of Novel Prostate Cancer Risk Subtypes and A Twelve-Gene Prognostic Model.
Neoplasms
Establishment of the Prognosis Predicting Signature for Endometrial Cancer Patient.
Neoplasms
Estimating gene expression from DNA methylation and copy number variation: A deep learning regression model for multi-omics integration.
Neoplasms
Estimating relative mitochondrial DNA copy number using high throughput sequencing data.
Neoplasms
Estimation of Hub Genes and Infiltrating Immune Cells in Non-Smoking Females with Lung Adenocarcinoma by Integrated Bioinformatic Analysis.
Neoplasms
Estimation of parent specific DNA copy number in tumors using high-density genotyping arrays.
Neoplasms
Estimation of Prognostic Marker Genes by Public Microarray Data in Patients with Ovarian Serous Cystadenocarcinoma.
Neoplasms
Estimation of the proteomic cancer co-expression sub networks by using association estimators.
Neoplasms
Estrogen Attenuates the Growth of Human Papillomavirus-Positive Epithelial Cells.
Neoplasms
Estrogen receptor ? is involved in the regulation of ITGA8 methylation in estrogen receptor-positive breast cancer.
Neoplasms
Estrogen receptor alpha (ER?/ESR1) mediates the p53-independent overexpression of MDM4/MDMX and MDM2 in human breast cancer.
Neoplasms
Estrogen receptor beta reduces colon cancer metastasis through a novel miR-205 - PROX1 mechanism.
Neoplasms
Estrogen Receptor Downregulates Expression of PD-1/PD-L1 and Infiltration of CD8+ T Cells by Inhibiting IL-17 Signaling Transduction in Breast Cancer.
Neoplasms
Estrogen-activated MDM2 disrupts mammary tissue architecture through a p53-independent pathway.
Neoplasms
Estrogen-related receptor alpha copy number variation is associated with ovarian cancer histological grade.
Neoplasms
Etiology-Specific Analysis of Hepatocellular Carcinoma Transcriptome Reveals Genetic Dysregulation in Pathways Implicated in Immunotherapy Efficacy.
Neoplasms
ETS1 Suppresses Tumorigenesis of Human Breast Cancer via Trans-Activation of Canonical Tumor Suppressor Genes.
Neoplasms
Eukaryotic elongation factor-2 kinase expression is an independent prognostic factor in colorectal cancer.
Neoplasms
Eva-1 homolog A promotes papillary thyroid cancer progression and epithelial-mesenchymal transition via the Hippo signalling pathway.
Neoplasms
Evaluating DNA Methylation, Gene Expression, Somatic Mutation, and Their Combinations in Inferring Tumor Tissue-of-Origin.
Neoplasms
Evaluating patient-derived colorectal cancer-xenografts as preclinical models by comparison with patient clinical data.
Neoplasms
Evaluating prognostic value and relevant gene signatures of tumor microenvironment characterization in esophageal carcinoma.
Neoplasms
Evaluating the biological functions of the prognostic genes identified by the Pathology Atlas in bladder cancer.
Neoplasms
Evaluating the Predictability of Cancer Types from 536 Somatic Mutations: A New Dataset.
Neoplasms
Evaluating the Prognostic Value of microRNA-203 in Solid Tumors Based on a Meta-Analysis and the Cancer Genome Atlas (TCGA) Datasets.
Neoplasms
Evaluating the role of RAD52 and its interactors as novel potential molecular targets for hepatocellular carcinoma.
Neoplasms
Evaluation and prediction of hepatocellular carcinoma prognosis based on molecular classification.
Neoplasms
Evaluation framework for the multilevel macroscopic models of solid tumor growth in the glioma case.
Neoplasms
Evaluation of 30 DNA damage response and 6 mismatch repair gene mutations as biomarkers for immunotherapy outcomes across multiple solid tumor types.
Neoplasms
Evaluation of circulating small extracellular vesicles derived miRNAs as biomarkers of early colon cancer: a comparison with plasma total miRNAs.
Neoplasms
Evaluation of Clinicopathological and Molecular Parameters on Disease Recurrence of Papillary Thyroid Cancer Patient: A Retrospective Observational Study.
Neoplasms
Evaluation of delineating the target volume by radiation therapists in breast cancer patients.
Neoplasms
Evaluation of Elafin Immunohistochemical Expression as Marker of Cervical Cancer Severity.
Neoplasms
Evaluation of Epigenetic Drug Targeting of Heterogenous Tumor Cell Fractions Using Potential Biomarkers of Response in Ovarian Cancer.
Neoplasms
Evaluation of FGFR1 as a diagnostic biomarker for ovarian cancer using TCGA and GEO datasets.
Neoplasms
Evaluation of FGFR3 as a Therapeutic Target in Head and Neck Squamous Cell Carcinoma.
Neoplasms
Evaluation of genetic variants in autophagy pathway genes as prognostic biomarkers for breast cancer.
Neoplasms
Evaluation of genome-wide genotyping concordance between tumor tissues and peripheral blood.
Neoplasms
Evaluation of Glutaminase Expression in Prostate Adenocarcinoma and Correlation with Clinicopathologic Parameters.
Neoplasms
Evaluation of human tissue kallikrein-related peptidases 6 and 10 expression in early gastroesophageal adenocarcinoma.
Neoplasms
Evaluation of immune infiltrating of thyroid cancer based on the intrinsic correlation between pair-wise immune genes.
Neoplasms
Evaluation of integrative clustering methods for the analysis of multi-omics data.
Neoplasms
Evaluation of K-ras and p53 expression in pancreatic adenocarcinoma using the cancer genome atlas.
Neoplasms
Evaluation of MEDAG gene expression in papillary thyroid microcarcinoma: associations with histological features, regional lymph node metastasis and prognosis.
Neoplasms
Evaluation of melanoma antigen (MAGE) gene expression in human cancers using The Cancer Genome Atlas.
Neoplasms
Evaluation of potential regulatory function of breast cancer risk locus at 6q25.1.
Neoplasms
Evaluation of somatic copy number estimation tools for whole-exome sequencing data.
Neoplasms
Evaluation of the Cancer of Bladder Risk Assessment (COBRA) Score in the Cancer Genome Atlas (TCGA) Bladder Cancer Cohort.
Neoplasms
Evaluation of the HOXA11 level in patients with lung squamous cancer and insights into potential molecular pathways via bioinformatics analysis.
Neoplasms
Evaluation of the prognostic significances of ?-secretase genes in pancreatic cancer.
Neoplasms
Evaluation of the Prognostic Value of STEAP1 in Lung Adenocarcinoma and Insights Into Its Potential Molecular Pathways via Bioinformatic Analysis.
Neoplasms
Evaluation of the Role of hsa-mir-124 in Predicting Clinical Outcome in Breast Invasive Carcinoma Based on Bioinformatics Analysis.
Neoplasms
Evaluation on the diagnostic and prognostic values of long non-coding RNA BLACAT1 in common types of human cancer.
Neoplasms
EVI1 as a Prognostic and Predictive Biomarker of Clear Cell Renal Cell Carcinoma.
Neoplasms
EVI1 expression is associated with aggressive behavior in intrahepatic cholangiocarcinoma.
Neoplasms
EVI1 overexpression promotes ovarian cancer progression by regulating estrogen signaling.
Neoplasms
EVI2B Is a New Prognostic Biomarker in Metastatic Melanoma with IFNgamma Associated Immune Infiltration.
Neoplasms
Evidence for APOBEC3B mRNA and protein expression in oral squamous cell carcinomas.
Neoplasms
Evidence for potentials and limitations of brain plasticity using an atlas of functional resectability of WHO grade II gliomas: Towards a "minimal common brain"
Neoplasms
Evidence of Cooperation between Hippo Pathway and RAS Mutation in Thyroid Carcinomas.
Neoplasms
Evidence of Omics, Immune Infiltration, and Pharmacogenomic for SENP1 in the Pan-Cancer Cohort.
Neoplasms
Evidence that the viral oncoproteins E6 and E7 of HPV induce the expression of a functional IL-2R on cervical cancer cells.
Neoplasms
Evolutionary genetic algorithm identifies IL2RB as a potential predictive biomarker for immune-checkpoint therapy in colorectal cancer.
Neoplasms
Evolved Resistance to Placental Invasion Secondarily Confers Increased Survival in Melanoma Patients.
Neoplasms
Examination of Epigenetic and other Molecular Factors Associated with mda-9/Syntenin Dysregulation in Cancer Through Integrated Analyses of Public Genomic Datasets.
Neoplasms
Examination of Independent Prognostic Power of Gene Expressions and Histopathological Imaging Features in Cancer.
Neoplasms
Examination of the expression and prognostic significance of DLGAPs in gastric cancer using the TCGA database and bioinformatic analysis.
Neoplasms
Examining the key genes and pathways in hepatocellular carcinoma development from hepatitis B virus?positive cirrhosis.
Neoplasms
Examining transcriptional changes to DNA replication and repair factors over uveal melanoma subtypes.
Neoplasms
Exceptional Chemotherapy Response in Metastatic Colorectal Cancer Associated With Hyper-Indel-Hypermutated Cancer Genome and Comutation of POLD1 and MLH1.
Neoplasms
Exogenous interleukin-33 promotes hepatocellular carcinoma growth by remodelling the tumour microenvironment.
Neoplasms
Exogenous regucalcin negatively regulates the progression of cervical adenocarcinoma.
Neoplasms
Exome Sequencing in BRCA1- and BRCA2-Negative Greek Families Identifies MDM1 and NBEAL1 as Candidate Risk Genes for Hereditary Breast Cancer.
Neoplasms
Exome-Scale Discovery of Hotspot Mutation Regions in Human Cancer Using 3D Protein Structure.
Neoplasms
Exome-wide analysis of bi-allelic alterations identifies a Lynch phenotype in The Cancer Genome Atlas.
Neoplasms
Exome-Wide Association Study Identifies Low-Frequency Coding Variants in 2p23.2 and 7p11.2 Associated with Survival of Non-Small Cell Lung Cancer Patients.
Neoplasms
Exonuclease 1 expression is associated with clinical progression, metastasis, and survival prognosis of prostate cancer.
Neoplasms
Exosomal hsa-miR-129-2 and hsa-miR-889 from a 6-microRNA signature might be a potential biomarker for predicting prognosis of papillary thyroid carcinoma.
Neoplasms
Exosomal microRNAs as potential biomarkers for cancer cell migration and prognosis in hepatocellular carcinoma patient-derived cell models.
Neoplasms
Exosome-related lncRNAs as predictors of HCC patient survival: a prognostic model.
Neoplasms
Exostosin1 as a novel prognostic and predictive biomarker for squamous cell lung carcinoma: A study based on bioinformatics analysis.
Neoplasms
Experiences with intraluminal occlusion with the Fogarty catheter in the treatment of carotid-cavernous sinus fistulas and other lesions at the base of the skull.
Neoplasms
Expert Consensus Contouring Guidelines for Intensity Modulated Radiation Therapy in Esophageal and Gastroesophageal Junction Cancer.
Neoplasms
Exploration and validation of a novel prognostic signature based on comprehensive bioinformatics analysis in hepatocellular carcinoma.
Neoplasms
Exploration of a novel prognostic risk signatures and immune checkpoint molecules in endometrial carcinoma microenvironment.
Neoplasms
Exploration of DNA Methylation-Driven Genes in Papillary Thyroid Carcinoma Based on the Cancer Genome Atlas.
Neoplasms
Exploration of estrogen receptor-associated hub genes and potential molecular mechanisms in non-smoking females with lung adenocarcinoma using integrated bioinformatics analysis.
Neoplasms
Exploration of Exosomal Micro RNA Biomarkers Related to Epithelial-to-Mesenchymal Transition in Pancreatic Cancer.
Neoplasms
Exploration of gene expression profiles and immune microenvironment between high and low tumor mutation burden groups in prostate cancer.
Neoplasms
Exploration of Genomic, Proteomic, and Histopathological Image Data Integration Methods for Clinical Prediction.
Neoplasms
Exploration of Immune-Related Gene Expression in Osteosarcoma and Association With Outcomes.
Neoplasms
Exploration of predictive and prognostic alternative splicing signatures in lung adenocarcinoma using machine learning methods.
Neoplasms
Exploration of the Associations of lncRNA Expression Patterns with Tumor Mutation Burden and Prognosis in Colon Cancer.
Neoplasms
Exploration of the diagnostic value and molecular mechanism of miR?1 in prostate cancer: A study based on meta?analyses and bioinformatics.
Neoplasms
Exploration of the effects of the CYCLOPS gene RBM17 in hepatocellular carcinoma.
Neoplasms
Exploration of the immune cell infiltration-related gene signature in the prognosis of melanoma.
Neoplasms
Exploration of the immune-related signature and immune infiltration analysis for breast ductal and lobular carcinoma.
Neoplasms
Exploration of the Immune-Related Signatures and Immune Infiltration Analysis in Melanoma.
Neoplasms
Exploration of the relationship between tumor mutation burden and immune infiltrates in colon adenocarcinoma.
Neoplasms
Exploration of the relationships between tumor mutation burden with immune infiltrates in clear cell renal cell carcinoma.
Neoplasms
Exploration of the Tumor-Suppressive Immune Microenvironment by Integrated Analysis in EGFR-Mutant Lung Adenocarcinoma.
Neoplasms
Explore prognostic biomarker of bladder cancer based on competing endogenous network.
Neoplasms
Explore, Visualize, and Analyze Functional Cancer Proteomic Data Using the Cancer Proteome Atlas.
Neoplasms
Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma.
Neoplasms
Exploring epigenetic biomarkers of universal specificities and commonalities among pan-cancer cohorts in The Cancer Genome Atlas.
Neoplasms
Exploring immune-related genes with prognostic value in microenvironment of breast cancer from TCGA database.
Neoplasms
Exploring phenotype patterns of breast cancer within somatic mutations: a modicum in the intrinsic code.
Neoplasms
Exploring prognostic genes in ovarian cancer stage-related coexpression network modules.
Neoplasms
Exploring prognostic potential of long noncoding RNAs in colorectal cancer based on a competing endogenous RNA network.
Neoplasms
Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression.
Neoplasms
Exploring the differences between early-onset gastric cancer and traditional-onset gastric cancer.
Neoplasms
Exploring the Effect of Differentially Expressed Long Non-coding RNAs Driven by Copy Number Variation on Competing Endogenous RNA Network by Mining Lung Adenocarcinoma Data.
Neoplasms
Exploring the mechanism of aidi injection for lung cancer by network pharmacology approach and molecular docking validation.
Neoplasms
Exploring the mechanism of clear cell renal cell carcinoma metastasis and key genes based on multi-tool joint analysis.
Neoplasms
Exploring the Pathological Mechanism of Bladder Cancer Based on Tumor Mutational Burden Analysis.
Neoplasms
Exploring the role of Mir204/211 in HNSCC by the combination of bioinformatic analysis of ceRNA and transcription factor regulation.
Neoplasms
Exploring the survival prognosis of lung adenocarcinoma based on the cancer genome atlas database using artificial neural network.
Neoplasms
Expression Analysis and Significance of PD-1, LAG-3, and TIM-3 in Human Non-Small Cell Lung Cancer Using Spatially Resolved and Multiparametric Single-Cell Analysis.
Neoplasms
Expression analysis of microRNA as prognostic biomarkers in colorectal cancer.
Neoplasms
Expression and Bioinformatics-Based Functional Analysis of UAP1 in Lung Adenocarcinoma.
Neoplasms
Expression and Circulating Levels of Perlecan in Breast Cancer - Implications for Oestrogen Dependent Stromal Remodeling.
Neoplasms
Expression and clinical significance of AURKB gene in lung adenocarcinoma: Analysis based on the data-mining of bioinformatic database.
Neoplasms
Expression and clinical significance of PDK family in breast cancer based on data mining.
Neoplasms
Expression and clinical significance of pyruvate kinase M2 in breast cancer: A protocol for meta-analysis and bioinformatics validation analysis.
Neoplasms
Expression and clinical significance of ubiquitin?specific?processing protease 34 in diffuse large B?cell lymphoma.
Neoplasms
Expression and clinical significance profile analysis of S100 family members in human acute myeloid leukemia.
Neoplasms
Expression and clinical value of CD105 in renal cell carcinoma based on data mining in The Cancer Genome Atlas.
Neoplasms
Expression and clinicopathological implication of DcR3 in lung cancer tissues: a tissue microarray study with 365 cases.
Neoplasms
Expression and Function of Eicosanoid-Producing Cytochrome P450 Enzymes in Solid Tumors.
Neoplasms
Expression and Function of Toll-Like Receptor 10 (TLR10) in Diffuse Large B Cell Lymphoma, Acute Myeloid Leukemia, and Glioma.
Neoplasms
Expression and gene regulation network of RBM8A in hepatocellular carcinoma based on data mining.
Neoplasms
Expression and gene regulation network of TYMS and BCL2L1 in colorectal cancer based on data mining.
Neoplasms
Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups.
Neoplasms
Expression and Possible Molecular Mechanisms of microRNA-205-5p in Patients With Head and Neck Squamous Cell Carcinoma.
Neoplasms
Expression and potential molecular mechanisms of miR?204?5p in breast cancer, based on bioinformatics and a meta?analysis of 2,306 cases.
Neoplasms
Expression and potential prognostic value of histone family gene signature in breast cancer.
Neoplasms
Expression and prognostic analyses of the insulin-like growth factor 2 mRNA binding protein family in human pancreatic cancer.
Neoplasms
Expression and prognostic analysis of Rho GTPase-activating protein 11A in lung adenocarcinoma.
Neoplasms
Expression and Prognostic Characteristics of Ferroptosis-Related Genes in Colon Cancer.
Neoplasms
Expression and Prognostic Characteristics of m6 A RNA Methylation Regulators in Breast Cancer.
Neoplasms
Expression and Prognostic Characteristics of m6A RNA Methylation Regulators in Colon Cancer.
Neoplasms
Expression and prognostic roles of PIK3CA, JAK2, PD-L1, and PD-L2 in Epstein-Barr virus-associated gastric carcinoma.
Neoplasms
Expression and prognostic significance of CBX2 in colorectal cancer: database mining for CBX family members in malignancies and vitro analyses.
Neoplasms
Expression and prognostic significance of fatty acid synthase in clear cell renal cell carcinoma.
Neoplasms
Expression and Prognostic Significance of m6A-Related Genes in Lung Adenocarcinoma.
Neoplasms
Expression and prognostic significance of Niemann-Pick C1-Like 1 in colorectal cancer: a retrospective cohort study.
Neoplasms
Expression and prognostic significance of the autoimmune regulator gene in breast cancer cells.
Neoplasms
Expression and Prognostic Value of ARID5A and its Correlation With Tumor-Infiltrating Immune Cells in Glioma.
Neoplasms
Expression and prognostic value of E2F3 transcription factor in non-small cell lung cancer.
Neoplasms
Expression and prognostic value of microRNAs in lower-grade glioma depends on IDH1/2 status.
Neoplasms
Expression and Prognostic Values of the Roof Plate-Specific Spondin Family in Bladder Cancer.
Neoplasms
Expression and Regulatory Network Analysis of MiR-139-3p, a New Potential Serum Biomarker for Esophageal Squamous Cell Carcinoma Based on Bioinformatics Analysis.
Neoplasms
Expression and roles of system L amino acid transporters in human embryonal carcinoma cells.
Neoplasms
Expression Atlas update-an integrated database of gene and protein expression in humans, animals and plants.
Neoplasms
Expression based biomarkers and models to classify early and late-stage samples of Papillary Thyroid Carcinoma.
Neoplasms
Expression Changes Confirm Genomic Variants Predicted to Result in Allele-Specific, Alternative mRNA Splicing.
Neoplasms
Expression level and potential target pathways of miR-1-3p in colorectal carcinoma based on 645 cases from 9 microarray datasets.
Neoplasms
Expression level and prospective mechanism of miRNA-99a-3p in head and neck squamous cell carcinoma based on miRNA-chip and miRNA-sequencing data in 1, 167 cases.
Neoplasms
Expression level of ACOT7 influences the prognosis in acute myeloid leukemia patients.
Neoplasms
Expression level of long non-coding RNA colon adenocarcinoma hypermethylated serves as a novel prognostic biomarker in patients with thyroid carcinoma.
Neoplasms
Expression levels of chemokine (C-X-C motif) ligands CXCL1 and CXCL3 as prognostic biomarkers in rectal adenocarcinoma: evidence from Gene Expression Omnibus (GEO) analyses.
Neoplasms
Expression levels of lncRNAs are prognostic for hepatocellular carcinoma overall survival.
Neoplasms
Expression levels of SF3B3 correlate with prognosis and endocrine resistance in estrogen receptor-positive breast cancer.
Neoplasms
Expression of amyloid precursor-like protein 2 (APLP2) in glioblastoma is associated with patient prognosis.
Neoplasms
Expression of an estrogen-regulated variant transcript of the peroxisomal branched chain fatty acid oxidase ACOX2 in breast carcinomas.
Neoplasms
Expression of Bcl-2 is a favorable prognostic biomarker in lung squamous cell carcinoma.
Neoplasms
Expression of C19MC miRNAs in HCC associates with stem-cell features and the cancer-testis genes signature.
Neoplasms
Expression of cancer stem cell markers in tall cell variant papillary thyroid cancer identifies a molecular profile predictive of recurrence in classic papillary thyroid cancer.
Neoplasms
Expression of CD40 Correlates Negatively with Overall and Progression-Free Survival of Low- and High-Grade Gliomas.
Neoplasms
Expression of cell cycle/growth regulator genes in human hepatocellular carcinoma and adjacent normal liver tissues.
Neoplasms
Expression of Cell Division Cycle Protein 45 in Tissue Microarrays and the CDC45 Gene by Bioinformatics Analysis in Human Hepatocellular Carcinoma and Patient Outcomes.
Neoplasms
Expression of Class III Beta-Tubulin Is Associated with Invasive Potential and Poor Prognosis in Thyroid Carcinoma.
Neoplasms
Expression of Coiled-Coil Domain Containing 34 (CCDC34) and its Prognostic Significance in Pancreatic Adenocarcinoma.
Neoplasms
Expression of collagen type 1 alpha 1 indicates lymph node metastasis and poor outcomes in squamous cell carcinomas of the lung.
Neoplasms
Expression of Demethylase Genes, FTO and ALKBH1, Is Associated with Prognosis of Gastric Cancer.
Neoplasms
Expression of DUSP4 transcript variants as a potential biomarker for colorectal cancer.
Neoplasms
Expression of epithelial-mesenchymal transition-related genes increases with copy number in multiple cancer types.
Neoplasms
Expression of eukaryotic translation initiation factor 3 subunit B in liver cancer and its prognostic significance.
Neoplasms
Expression of exportin-1 in diffuse large B-cell lymphoma: immunohistochemistry and TCGA analyses.
Neoplasms
Expression of Free Fatty Acid Receptor 2 by Dendritic Cells Prevents Their Expression of Interleukin 27 and Is Required for Maintenance of Mucosal Barrier and Immune Response Against Colorectal Tumors in Mice.
Neoplasms
Expression of FSCN1 and FOXM1 are associated with poor prognosis of adrenocortical carcinoma patients.
Neoplasms
Expression of genes that control core fucosylation in hepatocellular carcinoma: Systematic review.
Neoplasms
Expression of Genomic Instability-Related Molecules: Cyclin F, RRM2 and SPDL1 and Their Prognostic Significance in Pancreatic Adenocarcinoma.
Neoplasms
Expression of Hippo pathway genes and their clinical significance in colon adenocarcinoma.
Neoplasms
Expression of HMGB2 indicates worse survival of patients and is required for the maintenance of Warburg effect in pancreatic cancer.
Neoplasms
Expression of Human Epidermal Growth Factor Receptor-2 Status and Programmed Cell Death Protein-1 Ligand Is Associated With Prognosis in Gastric Cancer.
Neoplasms
Expression of Immune System-Related Membrane Receptors CD40, RANK, BAFFR and LT?R is Associated with Clinical Outcome of Operated Non-Small-Cell Lung Cancer Patients.
Neoplasms
Expression of immunoproteasome genes is regulated by cell-intrinsic and -extrinsic factors in human cancers.
Neoplasms
Expression of KIF18A Is Associated with Increased Tumor Stage and Cell Proliferation in Prostate Cancer.
Neoplasms
Expression of La Ribonucleoprotein Domain Family Member 4B (LARP4B) in Liver Cancer and Their Clinical and Prognostic Significance.
Neoplasms
Expression of lactate/H? symporters MCT1 and MCT4 and their chaperone CD147 predicts tumor progression in clear cell renal cell carcinoma: immunohistochemical and The Cancer Genome Atlas data analyses.
Neoplasms
Expression of LDL receptor-related proteins (LRPs) in common solid malignancies correlates with patient survival.
Neoplasms
Expression of let-7i and miR-192 is associated with resistance to cisplatin-based chemoradiotherapy in patients with larynx and hypopharynx cancer.
Neoplasms
Expression of lncRNAs in Low-Grade Gliomas and Glioblastoma Multiforme: An In Silico Analysis.
Neoplasms
Expression of long non-coding RNA MFI2-AS1 is a strong predictor of recurrence in sporadic localized clear-cell renal cell carcinoma.
Neoplasms
Expression of long non-coding RNA SFTA1P and its function in non-small cell lung cancer.
Neoplasms
Expression of MHC class I, HLA-A and HLA-B identifies immune-activated breast tumors with favorable outcome.
Neoplasms
Expression of MicroRNA-9 is Associated With Overall Survival in Breast Cancer Patients.
Neoplasms
Expression of microRNA-99a-3p in Prostate Cancer Based on Bioinformatics Data and Meta-Analysis of a Literature Review of 965 Cases.
Neoplasms
Expression of miR-1304 in patients with esophageal carcinoma and risk factors for recurrence.
Neoplasms
Expression of miR-18a-5p, miR-144-3p, and miR-663b in colorectal cancer and their association with cholesterol homeostasis.
Neoplasms
Expression of NAD(P)H quinone dehydrogenase 1 (NQO1) is increased in the endometrium of women with endometrial cancer and women with polycystic ovary syndrome.
Neoplasms
Expression of neuropilin-1 is linked to glioma associated microglia and macrophages and correlates with unfavorable prognosis in high grade gliomas.
Neoplasms
Expression of neurotensin receptor 1 in endometrial adenocarcinoma is correlated with histological grade and clinical outcome.
Neoplasms
Expression of NF2 Modulates the Progression of BRAFV600E Mutated Thyroid Cancer Cells.
Neoplasms
Expression of Osteoprotegrin Is Enhanced in Lung Cancer Tissues and Promotes Aggressive Cellular Traits in H3122 Lung Cancer Cells.
Neoplasms
Expression of PAM50 Genes in Lung Cancer: Evidence that Interactions between Hormone Receptors and HER2/HER3 Contribute to Poor Outcome.
Neoplasms
Expression of PD-L1, cancer stem cell and epithelial-mesenchymal transition phenotype in non-small cell lung cancer.
Neoplasms
Expression of Programmed Cell Death-Ligands in Hepatocellular Carcinoma: Correlation With Immune Microenvironment and Survival Outcomes.
Neoplasms
Expression of Rho Guanine Nucleotide Exchange Factor 39 (ARHGEF39) and Its Prognostic Significance in Hepatocellular Carcinoma.
Neoplasms
Expression of RSK4 in lung adenocarcinoma tissue and its clinicopathological value: a study based on RNA-seq data and immunohistochemistry.
Neoplasms
Expression of serine peptidase inhibitor Kunitz type 1 in differentiated thyroid cancer.
Neoplasms
Expression of SESN1, UHRF1BP1, and miR-377-3p as prognostic markers in mutated TP53 squamous cell carcinoma of the head and neck.
Neoplasms
Expression of SREBP2 and cholesterol metabolism related genes in TCGA glioma cohorts.
Neoplasms
Expression of SUMO1P3 Compared with SUMO1 is an Independent Predictor of Patient Outcome in Lung Adenocarcinoma.
Neoplasms
Expression of the BAD pathway is a marker of triple-negative status and poor outcome.
Neoplasms
Expression of the Body-Weight Signaling Players: GDF15, GFRAL and RET and their clinical relevance in Gastric Cancer.
Neoplasms
Expression of the Carboxy-Terminal Portion of MUC16/CA125 Induces Transformation and Tumor Invasion.
Neoplasms
Expression of the Circadian Clock Gene BMAL1 Positively Correlates With Antitumor Immunity and Patient Survival in Metastatic Melanoma.
Neoplasms
Expression of the embryonic morphogen Nodal in differentiated thyroid carcinomas: Immunohistochemistry assay in tissue microarray and The Cancer Genome Atlas data analysis.
Neoplasms
Expression of the Long Intergenic Non-Protein Coding RNA 665 (LINC00665) Gene and the Cell Cycle in Hepatocellular Carcinoma Using The Cancer Genome Atlas, the Gene Expression Omnibus, and Quantitative Real-Time Polymerase Chain Reaction.
Neoplasms
Expression of the microRNA-143/145 cluster is decreased in hepatitis B virus-associated hepatocellular carcinoma and may serve as a biomarker for tumorigenesis in patients with chronic hepatitis B.
Neoplasms
Expression of the receptor for hyaluronic acid mediated motility (RHAMM) is associated with poor prognosis and metastasis in non-small cell lung carcinoma.
Neoplasms
Expression of the Receptor for Hyaluronic Acid-Mediated Motility (RHAMM) in Endometrial Cancer is Associated With Adverse Histologic Parameters and Tumor Progression.
Neoplasms
Expression of the Topoisomerase II Alpha (TOP2A) Gene in Lung Adenocarcinoma Cells and the Association with Patient Outcomes.
Neoplasms
Expression of the transcription factor Klf6 in cirrhosis, macronodules, and hepatocellular carcinoma.
Neoplasms
Expression of the Vesicular Monoamine Transporter Gene Solute Carrier Family 18 Member 1 (SLC18A1) in Lung Cancer.
Neoplasms
Expression of the Wnt ligands gene family and its relationship to prognosis in hepatocellular carcinoma.
Neoplasms
Expression of UBE2C in lung adenocarcinoma based on database analysis and its clinical significance.
Neoplasms
Expression of ubiquitin-conjugating enzyme E2T in colorectal cancers and clinical implications.
Neoplasms
Expression of WW domain-containing oxidoreductase and its clinical implication in endometrial adenocarcinoma patients with metabolic syndrome.
Neoplasms
Expression pattern analysis and drug differential sensitivity of cancer-associated fibroblasts in triple-negative breast cancer.
Neoplasms
Expression pattern and prognostic significance of myosin light chain 9 (MYL9): a novel biomarker in glioblastoma.
Neoplasms
Expression pattern and prognostic value of circadian clock genes in pancreatic adenocarcinoma.
Neoplasms
Expression Pattern and Prognostic Value of Key Regulators for m6A RNA Modification in Hepatocellular Carcinoma.
Neoplasms
Expression pattern and prognostic value of N6-methyladenosine RNA methylation key regulators in hepatocellular carcinoma.
Neoplasms
Expression pattern of m6A regulators is significantly correlated with malignancy and antitumor immune response of breast cancer.
Neoplasms
Expression patterns and a prognostic model of m6A-associated regulators in prostate adenocarcinoma.
Neoplasms
Expression patterns and prognostic value of m6A RNA methylation regulators in adrenocortical carcinoma.
Neoplasms
Expression patterns and prognostic value of m6A-related genes in colorectal cancer.
Neoplasms
Expression patterns and the prognostic value of the SMYD family members in human breast carcinoma using integrative bioinformatics analysis.
Neoplasms
Expression patterns of E2F transcription factors and their potential prognostic roles in breast cancer.
Neoplasms
Expression patterns of small numbers of transcripts from functionally-related pathways predict survival in multiple cancers.
Neoplasms
Expression Profile Analysis Identifies a Novel Five-Gene Signature to Improve Prognosis Prediction of Glioblastoma.
Neoplasms
Expression Profile Analysis Identifies a Novel Seven Immune-Related Gene Signature to Improve Prognosis Prediction of Glioblastoma.
Neoplasms
Expression profile analysis identifies a two-gene signature for prediction of head and neck squamous cell carcinoma patient survival.
Neoplasms
Expression profile analysis identifies IER3 to predict overall survival and promote lymph node metastasis in tongue cancer.
Neoplasms
Expression profile analysis of head and neck squamous cell carcinomas using data from The Cancer Genome Atlas.
Neoplasms
Expression Profile Analysis of m6A RNA Methylation Regulators Indicates They Are Immune Signature Associated and Can Predict Survival in Kidney Renal Cell Carcinoma.
Neoplasms
Expression profile analysis of prognostic long non-coding RNA in adult acute myeloid leukemia by weighted gene co-expression network analysis (WGCNA).
Neoplasms
Expression Profile and Prognostic Values of HOXA Family Members in Laryngeal Squamous Cell Cancer.
Neoplasms
Expression profile of SYNE3 and bioinformatic analysis of its prognostic value and functions in tumors.
Neoplasms
Expression profile, clinical significance, and biological function of insulin-like growth factor 2 messenger RNA-binding proteins in non-small cell lung cancer.
Neoplasms
Expression profiles analysis identifies a novel three-mRNA signature to predict overall survival in oral squamous cell carcinoma.
Neoplasms
Expression profiles analysis identifies the values of carcinogenesis and the prognostic prediction of three genes in adrenocortical carcinoma.
Neoplasms
Expression profiles analysis reveals an integrated miRNA-lncRNA signature to predict survival in ovarian cancer patients with wild-type BRCA1/2.
Neoplasms
Expression Profiles and Clinical Significance of MicroRNAs in Papillary Renal Cell Carcinoma: A STROBE-Compliant Observational Study.
Neoplasms
Expression profiles and prognostic roles of m6A writers, erasers and readers in gastric cancer.
Neoplasms
Expression profiles and prognostic significance of RNA N6-methyladenosine-related genes in patients with hepatocellular carcinoma: evidence from independent datasets.
Neoplasms
Expression profiles and prognostic significance of WNT family members in glioma via bioinformatic analysis.
Neoplasms
Expression Profiles of Endometrial Carcinoma by Integrative Analysis of TCGA Data.
Neoplasms
Expression Profiles of microRNAs in Drug-Resistant Non-Small Cell Lung Cancer Cell Lines Using microRNA Sequencing.
Neoplasms
Expression profiles of pivotal microRNAs and targets in thyroid papillary carcinoma: an analysis of The Cancer Genome Atlas.
Neoplasms
Expression Profiling of Calcium Channels and Calcium-Activated Potassium Channels in Colorectal Cancer.
Neoplasms
Expression Profiling of Driver Genes in Female Never-smokers With Non-adenocarcinoma Non-small-cell Lung Cancer in China.
Neoplasms
Expression Profiling of Glioblastoma Cell Lines Reveals Novel Extracellular Matrix-Receptor Genes Correlated With the Responsiveness of Glioma Patients to Ionizing Radiation.
Neoplasms
Expression profiling of long non-coding RNA identifies linc-RoR as a prognostic biomarker in oral cancer.
Neoplasms
Expression Profiling of the MAP Kinase Phosphatase Family Reveals a Role for DUSP1 in the Glioblastoma Stem Cell Niche.
Neoplasms
Expression profiling of ubiquitin-related genes in LKB1 mutant lung adenocarcinoma.
Neoplasms
Expression QTL-based analyses reveal candidate causal genes and loci across five tumor types.
Neoplasms
Expression QTL-based analyses reveal the mechanisms underlying colorectal cancer predisposition.
Neoplasms
Expression ratio of the TGF?-inducible gene MYO10 is prognostic for overall survival of squamous cell lung cancer patients and predicts chemotherapy response.
Neoplasms
Expression Signature and Role of miR-30d-5p in Non-Small Cell Lung Cancer: a Comprehensive Study Based on in Silico Analysis of Public Databases and in Vitro Experiments.
Neoplasms
Expression signature, prognosis value, and immune characteristics of Siglec-15 identified by pan-cancer analysis.
Neoplasms
Expression Status and Prognostic Value of m6A RNA Methylation Regulators in Lung Adenocarcinoma.
Neoplasms
Expression Status And Prognostic Value Of M6A-associated Genes in Gastric Cancer.
Neoplasms
Expression, Clinical Significance, and Functional Prediction of MNX1 in Breast Cancer.
Neoplasms
Expression, clinical significance, and receptor identification of the newest B7 family member HHLA2 protein.
Neoplasms
Expression, Function, and Prognostic Value of MAGE-D4 Protein in Esophageal Squamous Cell Carcinoma.
Neoplasms
Expressions of HLA Class II Genes in Cutaneous Melanoma Were Associated with Clinical Outcome: Bioinformatics Approaches and Systematic Analysis of Public Microarray and RNA-Seq Datasets.
Neoplasms
ExSurv: A Web Resource for Prognostic Analyses of Exons Across Human Cancers Using Clinical Transcriptomes.
Neoplasms
Extended application of genomic selection to screen multiomics data for prognostic signatures of prostate cancer.
Neoplasms
Extending information retrieval methods to personalized genomic-based studies of disease.
Neoplasms
Extending TCGA queries to automatically identify analogous genomic data from dbGaP.
Neoplasms
Extensive profiling of the expression of the indoleamine 2,3-dioxygenase 1 protein in normal and tumoral human tissues.
Neoplasms
Extensive rewiring of epithelial-stromal co-expression networks in breast cancer.
Neoplasms
Extracellular acidity in tumor tissue upregulates programmed cell death protein 1 expression on tumor cells via proton-sensing G protein-coupled receptors.
Neoplasms
Extracellular matrix-related genes play an important role in the progression of NMIBC to MIBC: a bioinformatics analysis study.
Neoplasms
Extracellular vesicles from human umbilical cord mesenchymal stem cells treated with siRNA against ELFN1-AS1 suppress colon adenocarcinoma proliferation and migration.
Neoplasms
Extracting a biologically relevant latent space from cancer transcriptomes with variational autoencoders.
Neoplasms
Extreme lateral transcondylar approach for resection of ventrally based meningioma of the craniovertebral junction and upper cervical spine.
Neoplasms
Eya2 Is Overexpressed in Human Prostate Cancer and Regulates Docetaxel Sensitivity and Mitochondrial Membrane Potential through AKT/Bcl-2 Signaling.
Neoplasms
Eya2, a Target Activated by Plzf, Is Critical for PLZF-RARA-Induced Leukemogenesis.
Neoplasms
EZH2 inhibition enhances the efficacy of an EGFR inhibitor in suppressing colon cancer cells.
Neoplasms
EZH2 inhibition suppresses endometrial cancer progression via miR-361/Twist axis.
Neoplasms
EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells.
Neoplasms
FABP5 regulates the proliferation of clear cell renal cell carcinoma cells via the PI3K/AKT signaling pathway.
Neoplasms
FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing.
Neoplasms
Factor analysis for survival time prediction with informative censoring and diverse covariates.
Neoplasms
Factor XIIIA-expressing inflammatory monocytes promote lung squamous cancer through fibrin cross-linking.
Neoplasms
FAM207BP, a pseudogene-derived lncRNA, facilitates proliferation, migration and invasion of lung adenocarcinoma cells and acts as an immune-related prognostic factor.
Neoplasms
FAM213A is linked to prognostic significance in acute myeloid leukemia through regulation of oxidative stress and myelopoiesis.
Neoplasms
FAM46A expression is elevated in glioblastoma and predicts poor prognosis of patients.
Neoplasms
FAM46B inhibits cell proliferation and cell cycle progression in prostate cancer through ubiquitination of ?-catenin.
Neoplasms
FAM64A: A Novel Oncogenic Target of Lung Adenocarcinoma Regulated by Both Strands of miR-99a (miR-99a-5p and miR-99a-3p).
Neoplasms
FAM83A as a Potential Biological Marker Is Regulated by miR-206 to Promote Cervical Cancer Progression Through PI3K/AKT/mTOR Pathway.
Neoplasms
FAM83A is amplified and promotes tumorigenicity in non-small cell lung cancer via ERK and PI3K/Akt/mTOR pathways.
Neoplasms
FAM83H-AS1 is a noncoding oncogenic driver and therapeutic target of lung adenocarcinoma.
Neoplasms
FAM84B, amplified in pancreatic ductal adenocarcinoma, promotes tumorigenesis through the Wnt/?-catenin pathway.
Neoplasms
FAM98A associates with DDX1-C14orf166-FAM98B in a novel complex involved in colorectal cancer progression.
Neoplasms
Family with Sequence Similarity 83 Member H Promotes the Viability and Metastasis of Cervical Cancer Cells and Indicates a Poor Prognosis.
Neoplasms
Family-based exome sequencing combined with linkage analyses identifies rare susceptibility variants of MUC4 for gastric cancer.
Neoplasms
FARP1 boosts CDC42 activity from integrin ?v?5 signaling and correlates with poor prognosis of advanced gastric cancer.
Neoplasms
FARP1 Facilitates Cell Proliferation Through Modulating MAPK Signaling Pathway in Cutaneous Melanoma.
Neoplasms
Fast approximate inference for variable selection in Dirichlet process mixtures, with an application to pan-cancer proteomics.
Neoplasms
Fastbreak: a tool for analysis and visualization of structural variations in genomic data.
Neoplasms
FastMM: an efficient toolbox for personalized constraint-based metabolic modeling.
Neoplasms
FAT1, a direct transcriptional target of E2F1, suppresses cell proliferation, migration and invasion in esophageal squamous cell carcinoma.
Neoplasms
FAT4-USP51 complex regulates the proliferation and invasion of endometrial cancer via Hippo pathway.
Neoplasms
Fatty acid binding protein 7 may be a marker and therapeutic targets in clear cell renal cell carcinoma.
Neoplasms
Fatty Acid Metabolism-Related lncRNAs Are Potential Biomarkers for Predicting the Overall Survival of Patients With Colorectal Cancer.
Neoplasms
Fatty Acid Synthase Correlates With Prognosis-Related Abdominal Adipose Distribution and Metabolic Disorders of Clear Cell Renal Cell Carcinoma.
Neoplasms
Fatty acid-binding protein 1 is preferentially lost in microsatellite instable colorectal carcinomas and is immune modulated via the interferon ? pathway.
Neoplasms
Fatty Acid-Binding Protein 4 (FABP4) Suppresses Proliferation and Migration of Endometrial Cancer Cells via PI3K/Akt Pathway.
Neoplasms
Fatty acid-binding protein 5 predicts poor prognosis in patients with uveal melanoma.
Neoplasms
Favorable outcome of patients with lung adenocarcinoma harboring POLE mutations and expressing high PD-L1.
Neoplasms
FBXO17 promotes cell proliferation through activation of Akt in lung adenocarcinoma cells.
Neoplasms
FBXO2 Promotes Proliferation of Endometrial Cancer by Ubiquitin-Mediated Degradation of FBN1 in the Regulation of the Cell Cycle and the Autophagy Pathway.
Neoplasms
FBXW7 deletion contributes to lung tumor development and confers resistance to gefitinib therapy.
Neoplasms
FBXW7? is a tumor-suppressive and prognosis-related FBXW7 transcript isoform in ovarian serous cystadenocarcinoma.
Neoplasms
Feasibility of deep learning-based fully automated classification of microsatellite instability in tissue slides of colorectal cancer.
Neoplasms
Feasibility of lung cancer RNA acquisition from a single transbronchial or transthoracic needle pass (FASTT trial).
Neoplasms
Feature genes in metastatic breast cancer identified by MetaDE and SVM classifier methods.
Neoplasms
Feature Selection for Breast Cancer Classification by Integrating Somatic Mutation and Gene Expression.
Neoplasms
Fermentable fiber-induced hepatocellular carcinoma in mice recapitulates gene signatures found in human liver cancer.
Neoplasms
Ferroportin and FBXL5 as Prognostic Markers in Advanced Stage Clear Cell Renal Cell Carcinoma.
Neoplasms
Ferroptosis Driver SOCS1 and Suppressor FTH1 Independently Correlate With M1 and M2 Macrophage Infiltration in Head and Neck Squamous Cell Carcinoma.
Neoplasms
Ferroptosis-Related Gene Signature Accurately Predicts Survival Outcomes in Patients With Clear-Cell Renal Cell Carcinoma.
Neoplasms
Ferroptosis-Related Gene Signature and Patterns of Immune Infiltration Predict the Overall Survival in Patients With Lung Adenocarcinoma.
Neoplasms
Ferroptosis-Related Gene Signature Predicts Glioma Cell Death and Glioma Patient Progression.
Neoplasms
Ferroptosis-Related Gene-Based Prognostic Model and Immune Infiltration in Clear Cell Renal Cell Carcinoma.
Neoplasms
Ferroptosis-Related Genes in Lung Adenocarcinoma: Prognostic Signature and Immune, Drug Resistance, Mutation Analysis.
Neoplasms
FEZF1 is an Independent Predictive Factor for Recurrence and Promotes Cell Proliferation and Migration in Cervical Cancer.
Neoplasms
FGD1 exhibits oncogenic properties in hepatocellular carcinoma through regulating cell morphology, autophagy and mitochondrial function.
Neoplasms
FGF2 induces breast cancer growth through ligand-independent activation and recruitment of ER? and PRB?4 isoform to MYC regulatory sequences.
Neoplasms
FGFR1 is associated with c-MYC and proangiogenic molecules in metastatic renal cell carcinoma under anti-angiogenic therapy.
Neoplasms
FGFR1 overexpression in non-small cell lung cancer is mediated by genetic and epigenetic mechanisms and is a determinant of FGFR1 inhibitor response.
Neoplasms
FGFR2 maintains cancer cell differentiation via AKT signaling in esophageal squamous cell carcinoma.
Neoplasms
FGFR3, as a receptor tyrosine kinase, is associated with differentiated biological functions and improved survival of glioma patients.
Neoplasms
FGFR4 Gene Polymorphism Reduces the Risk of Distant Metastasis in Lung Adenocarcinoma in Taiwan.
Neoplasms
FHIT loss-induced DNA damage creates optimal APOBEC substrates: Insights into APOBEC-mediated mutagenesis.
Neoplasms
FHOD1 is upregulated in gastric cancer and promotes the proliferation and invasion of gastric cancer cells.
Neoplasms
FI-Net: Identification of Cancer Driver Genes by Using Functional Impact Prediction Neural Network.
Neoplasms
Fiber feature map based landmark initialization for highly deformable DTI registration.
Neoplasms
Fibrinogen?like?protein 1 promotes the invasion and metastasis of gastric cancer and is associated with poor prognosis.
Neoplasms
Fibroblast growth factor 13 regulates glioma cell invasion and is important for bevacizumab-induced glioma invasion.
Neoplasms
Fibroblast growth factor family aberrations as a putative driver of head and neck squamous cell carcinoma in an epidemiologically low-risk patient as defined by targeted sequencing.
Neoplasms
Fibroblast Growth Factor Receptor 3 Alteration Status is Associated with Differential Sensitivity to Platinum-based Chemotherapy in Locally Advanced and Metastatic Urothelial Carcinoma.
Neoplasms
Fibroblast growth factor receptor 3 protein is overexpressed in oral and oropharyngeal squamous cell carcinoma.
Neoplasms
Fibroblast growth factor-2, derived from cancer-associated fibroblasts, stimulates growth and progression of human breast cancer cells via FGFR1 signaling.
Neoplasms
Fibroblast-specific ERK5 deficiency changes tumor vasculature and exacerbates tumor progression in a mouse model.
Neoplasms
Fibronectin is distinctly downregulated in murine mammary adenocarcinoma cells with high metastatic potential.
Neoplasms
Fifteen hub genes associated with progression and prognosis of clear cell renal cell carcinoma identified by coexpression analysis.
Neoplasms
Fifteen mRNA-lncRNA expression-based signature predicted the survival of late-staged head and neck squamous cell carcinoma.
Neoplasms
Fifteen-gene expression based model predicts the survival of clear cell renal cell carcinoma.
Neoplasms
Fifteen-MiRNA-Based Signature Is a Reliable Prognosis-Predicting Tool for Prostate Cancer Patients.
Neoplasms
Filtering High-Dimensional Methylation Marks With Extremely Small Sample Size: An Application to Gastric Cancer Data.
Neoplasms
Final Validation of the ProMisE Molecular Classifier for Endometrial Carcinoma in a Large Population-based Case Series.
Neoplasms
Financially Effective Test-Algorithm to Identify an Aggressive, EGFR-amplified Variant of IDH-Wildtype, Lower-Grade Diffuse Glioma.
Neoplasms
Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk.
Neoplasms
Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer.
Neoplasms
Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk.
Neoplasms
Fine-Tuning and training of densenet for histopathology image representation using TCGA diagnostic slides.
Neoplasms
Fine-Tuning Lipid Metabolism by Targeting Mitochondria-Associated Acetyl-CoA-Carboxylase 2 in BRAFV600E Papillary Thyroid Carcinoma.
Neoplasms
FIREVAT: finding reliable variants without artifacts in human cancer samples using etiologically relevant mutational signatures.
Neoplasms
Five extracellular matrix-associated genes upregulated in oral tongue squamous cell carcinoma: An integrated bioinformatics analysis.
Neoplasms
Five gene signatures were identified in the prediction of overall survival in resectable pancreatic cancer.
Neoplasms
Five genes as a novel signature for predicting the prognosis of patients with laryngeal cancer.
Neoplasms
Five key lncRNAs considered as prognostic targets for predicting pancreatic ductal adenocarcinoma.
Neoplasms
Five lncRNAs Associated With Prostate Cancer Prognosis Identified by Coexpression Network Analysis.
Neoplasms
Five lncRNAs associated with the survival of hepatocellular carcinoma: a comprehensive study based on WGCNA and competing endogenous RNA network.
Neoplasms
Five metastasis-related mRNAs signature predicting the survival of patients with liver hepatocellular carcinoma.
Neoplasms
Five Novel Oncogenic Signatures Could Be Utilized as AFP-Related Diagnostic Biomarkers for Hepatocellular Carcinoma Based on Next-Generation Sequencing.
Neoplasms
Five-CpG-based prognostic signature for predicting survival in hepatocellular carcinoma patients.
Neoplasms
Five-gene signature associating with Gleason score serve as novel biomarkers for identifying early recurring events and contributing to early diagnosis for Prostate Adenocarcinoma.
Neoplasms
Five-long non-coding RNA risk score system for the effective prediction of gastric cancer patient survival.
Neoplasms
Flap endonuclease 1 (FEN1) as a novel diagnostic and prognostic biomarker for gastric cancer.
Neoplasms
Flat cells come full sphere: Are mutant cytoskeletal-related proteins oncoprotein-monsters or useful immunogens?
Neoplasms
FMO1 gene expression independently predicts favorable recurrence-free survival of classical papillary thyroid cancer.
Neoplasms
Focal Adhesion Kinase and ?-Catenin Cooperate to Induce Hepatocellular Carcinoma.
Neoplasms
Focal adhesion kinase: an alternative focus for anti-angiogenesis therapy in ovarian cancer.
Neoplasms
Focal Recurrent Copy Number Alterations Characterize Disease Relapse in High Grade Serous Ovarian Cancer Patients with Good Clinical Prognosis: A Pilot Study.
Neoplasms
Follicular cell thyroid neoplasia: insights from genomics and The Cancer Genome Atlas research network.
Neoplasms
Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer.
Neoplasms
For robust big data analyses: a collection of 150 important pro-metastatic genes.
Neoplasms
Forkhead-box series expression network is associated with outcome of clear-cell renal cell carcinoma.
Neoplasms
Formin-like 1 (FMNL1) Is Associated with Glioblastoma Multiforme Mesenchymal Subtype and Independently Predicts Poor Prognosis.
Neoplasms
Four Immune-Related Genes (FN1, UGCG, CHPF2 and THBS2) as Potential Diagnostic and Prognostic Biomarkers for Carbon Nanotube-Induced Mesothelioma.
Neoplasms
Four Immune-Related Long Non-coding RNAs for Prognosis Prediction in Patients With Hepatocellular Carcinoma.
Neoplasms
Four lncRNAs associated with breast cancer prognosis identified by coexpression network analysis.
Neoplasms
Four long noncoding RNAs as potential prognostic biomarkers for hepatocellular carcinoma.
Neoplasms
Four Low Expression LncRNAs are Associated with Prognosis of Human Lung Adenocarcinoma.
Neoplasms
Four Novel Prognostic Genes Related to Prostate Cancer Identified Using Co-expression Structure Network Analysis.
Neoplasms
Four PTEN-targeting co-expressed miRNAs and ACTN4- targeting miR-548b are independent prognostic biomarkers in human squamous cell carcinoma of the oral tongue.
Neoplasms
Four specific biomarkers associated with the progression of glioblastoma multiforme in older adults identified using weighted gene co-expression network analysis.
Neoplasms
Four transcription profile-based models identify novel prognostic signatures in oesophageal cancer.
Neoplasms
FOXA1, GATA3 and PPAR? Cooperate to Drive Luminal Subtype in Bladder Cancer: A Molecular Analysis of Established Human Cell Lines.
Neoplasms
FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC.
Neoplasms
FOXC2 and CLIP4 : a potential biomarker for synchronous metastasis of ?7-cm clear cell renal cell carcinomas.
Neoplasms
FOXD1 expression in head and neck squamous carcinoma: a study based on TCGA, GEO and meta-analysis.
Neoplasms
FOXD1 is a prognostic biomarker and correlated with macrophages infiltration in head and neck squamous cell carcinoma.
Neoplasms
FOXD2-AS1 Predicts Dismal Prognosis for Oral Squamous Cell Carcinoma and Regulates Cell Proliferation.
Neoplasms
FOXF2 promoter methylation is associated with prognosis in esophageal squamous cell carcinoma.
Neoplasms
FOXH1 promotes lung cancer progression by activating the Wnt/?-catenin signaling pathway.
Neoplasms
FOXI1 expression in chromophobe renal cell carcinoma and renal oncocytoma: a study of The Cancer Genome Atlas transcriptome-based outlier mining and immunohistochemistry.
Neoplasms
FOXL2 expression might be a novel prognostic biomarker in patients with laryngeal squamous cell carcinoma.
Neoplasms
FoxM1 Drives a Feed-Forward STAT3-Activation Signaling Loop That Promotes the Self-Renewal and Tumorigenicity of Glioblastoma Stem-like Cells.
Neoplasms
FOXO1-regulated lncRNA LINC01197 inhibits pancreatic adenocarcinoma cell proliferation by restraining Wnt/?-catenin signaling.
Neoplasms
FOXO4 expression is associated with the occurrence and outcome of seizures: An RNA-sequencing analysis of low-grade gliomas.
Neoplasms
FOXP3?induced LINC00885 promotes the proliferation and invasion of cervical cancer cells.
Neoplasms
FRA1 contributes to MEK-ERK pathway-dependent PD-L1 upregulation by KRAS mutation in premalignant human bronchial epithelial cells.
Neoplasms
Frailness and resilience of gene networks predicted by detection of co-occurring mutations via a stochastic perturbative approach.
Neoplasms
Framing the potential of public frameshift peptides as immunotherapy targets in colon cancer.
Neoplasms
Frequency and prognostic value of mutations associated with the homologous recombination DNA repair pathway in a large pan cancer cohort.
Neoplasms
Frequent amplification of HDAC genes and efficacy of HDAC inhibitor chidamide and PD-1 blockade combination in soft tissue sarcoma.
Neoplasms
Frequent copy number gains of SLC2A3 and ETV1 in testicular embryonal carcinomas.
Neoplasms
Frequent Homologous Recombination Deficiency in High-grade Endometrial Carcinomas.
Neoplasms
Frequent KRAS Mutations in Oncocytic Papillary Renal Neoplasm with Inverted Nuclei.
Neoplasms
Frequent mutations in acetylation and ubiquitination sites suggest novel driver mechanisms of cancer.
Neoplasms
Frequent mutations in the RPL22 gene and its clinical and functional implications.
Neoplasms
Frequent PIK3CA Mutations in Colorectal and Endometrial Tumors With 2 or More Somatic Mutations in Mismatch Repair Genes.
Neoplasms
Frequent POLE-driven hypermutation in ovarian endometrioid cancer revealed by mutational signatures in RNA sequencing.
Neoplasms
Frequent promoter hypermethylation of PTPRT increases STAT3 activation and sensitivity to STAT3 inhibition in head and neck cancer.
Neoplasms
Frizzled-7 Identifies Platinum-Tolerant Ovarian Cancer Cells Susceptible to Ferroptosis.
Neoplasms
From big data to diagnosis and prognosis: gene expression signatures in liver hepatocellular carcinoma.
Neoplasms
From genome to phenome: Predicting multiple cancer phenotypes based on somatic genomic alterations via the genomic impact transformer.
Neoplasms
From molecular classification to targeted therapeutics: the changing face of systemic therapy in metastatic gastroesophageal cancer.
Neoplasms
From somatic variants towards precision oncology: Evidence-driven reporting of treatment options in molecular tumor boards.
Neoplasms
From tobacco smoking to cancer mutational signature: a mediation analysis strategy to explore the role of epigenetic changes.
Neoplasms
FTO mRNA expression in the lower quartile is associated with bad prognosis in clear cell renal cell carcinoma based on TCGA data mining.
Neoplasms
FUBP1 mediates the growth and metastasis through TGF?/Smad signaling in pancreatic adenocarcinoma.
Neoplasms
Functional analyses of ATM, ATR and Fanconi anemia proteins in lung carcinoma : ATM, ATR and FA in lung carcinoma.
Neoplasms
Functional analysis of lncRNAs based on competitive endogenous RNA in tongue squamous cell carcinoma.
Neoplasms
Functional analysis of low-grade glioma genetic variants predicts key target genes and transcription factors.
Neoplasms
Functional and genomic analyses reveal therapeutic potential of targeting ?-catenin/CBP activity in head and neck cancer.
Neoplasms
Functional Assessment of Four Novel Immune-Related Biomarkers in the Pathogenesis of Clear Cell Renal Cell Carcinoma.
Neoplasms
Functional characterization of somatic mutations in cancer using network-based inference of protein activity.
Neoplasms
Functional characterization of the 12p12.1 renal cancer-susceptibility locus implicates BHLHE41.
Neoplasms
Functional Common and Rare ERBB2 Germline Variants Cooperate in Familial and Sporadic Cancer Susceptibility.
Neoplasms
Functional Genomic Analyses of the 21q22.3 Locus Identifying Functional Variants and Candidate Gene YBEY for Breast Cancer Risk.
Neoplasms
Functional Genomics Profiling of Bladder Urothelial Carcinoma MicroRNAome as a Potential Biomarker.
Neoplasms
Functional Heterogeneity of Reelin in the Oral Squamous Cell Carcinoma Microenvironment.
Neoplasms
Functional Long Noncoding RNAs (lncRNAs) in Clear Cell Kidney Carcinoma Revealed by Reconstruction and Comprehensive Analysis of the lncRNA-miRNA-mRNA Regulatory Network.
Neoplasms
Functional normalization of 450k methylation array data improves replication in large cancer studies.
Neoplasms
Functional Signatures in Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis of Sex-Based Differences in Transcriptomic Studies.
Neoplasms
Functional Significance of Aurora Kinases-p53 Protein Family Interactions in Cancer.
Neoplasms
Functional Variant in 3'UTR of FAM13A Is Potentially Associated with Susceptibility and Survival of Lung Squamous Carcinoma.
Neoplasms
Functionally impactful TP53 mutations are associated with increased risk of extranodal extension in clinically advanced oral squamous cell carcinoma.
Neoplasms
Functions and clinical significance of KLRG1 in the development of lung adenocarcinoma and immunotherapy.
Neoplasms
Functions and Clinical Significance of UPF3a Expression in Human Colorectal Cancer.
Neoplasms
Functions of endothelin-1 in apoptosis and migration in hepatocellular carcinoma.
Neoplasms
FURIN correlated with immune infiltration serves as a potential biomarker in SARS-CoV-2 infection-related lung adenocarcinoma.
Neoplasms
Further Confirmation of Germline Glioma Risk Variant rs78378222 in TP53 and Its Implication in Tumor Tissues via Integrative Analysis of TCGA Data.
Neoplasms
FUT4 is involved in PD-1-related immunosuppression and leads to worse survival in patients with operable lung adenocarcinoma.
Neoplasms
FUT8-AS1 Inhibits the Malignancy of Melanoma Through Promoting miR-145-5p Biogenesis and Suppressing NRAS/MAPK Signaling.
Neoplasms
FXYD5 is a Marker for Poor Prognosis and a Potential Driver for Metastasis in Ovarian Carcinomas.
Neoplasms
FXYD5/Dysadherin, a Biomarker of Endometrial Cancer Myometrial Invasion and Aggressiveness: Its Relationship With TGF-?1 and NF-?B Pathways.
Neoplasms
FYN promotes gastric cancer metastasis by activating STAT3-mediated epithelial-mesenchymal transition.
Neoplasms
G3BP1 may serve as a potential biomarker of proliferation, apoptosis, and prognosis in oral squamous cell carcinoma.
Neoplasms
GABRP regulates chemokine signalling, macrophage recruitment and tumour progression in pancreatic cancer through tuning KCNN4-mediated Ca2+ signalling in a GABA-independent manner.
Neoplasms
GABRQ expression is a potential prognostic marker for patients with clear cell renal cell carcinoma.
Neoplasms
GADD45B Facilitates Metastasis of Ovarian Cancer Through Epithelial-Mesenchymal Transition.
Neoplasms
GADD45B Is a Potential Diagnostic and Therapeutic Target Gene in Chemotherapy-Resistant Prostate Cancer.
Neoplasms
Gain of function in somatic TP53 mutations is associated with immune-rich breast tumors and changes in tumor-associated macrophages.
Neoplasms
Gain-of-Function Mutant p53 R273H Interacts with Replicating DNA and PARP1 in Breast Cancer.
Neoplasms
GAL-9: A predictive biomarker negatively regulating immune response in glioma patients.
Neoplasms
Galectin-1 fosters an immunosuppressive microenvironment in colorectal cancer by reprogramming CD8+ regulatory T cells.
Neoplasms
Galectin-1 has potential prognostic significance and is implicated in clear cell renal cell carcinoma progression through the HIF/mTOR signaling axis.
Neoplasms
Galectin-1 Overexpression Activates the FAK/PI3K/AKT/mTOR Pathway and Is Correlated with Upper Urinary Urothelial Carcinoma Progression and Survival.
Neoplasms
Gankyrin as Potential Biomarker for Colorectal Cancer With Occult Liver Metastases.
Neoplasms
GARP Correlates With Tumor-Infiltrating T-Cells and Predicts the Outcome of Gastric Cancer.
Neoplasms
Gastric cancer in proximal site exerts poorer survival outcome with divergent genetic features than distal site.
Neoplasms
Gastric cancer molecular classification based on immunohistochemistry and in situ hybridization: Analysis in western patients after curative-intent surgery.
Neoplasms
Gastric Cancer With Primitive Enterocyte Phenotype: An Aggressive Subgroup of Intestinal-type Adenocarcinoma.
Neoplasms
Gastric cancer-associated microRNA expression signatures: integrated bioinformatics analysis, validation, and clinical significance.
Neoplasms
Gastric Carcinomas With Lymphoid Stroma: An Evaluation of the Histopathologic and Molecular Features.
Neoplasms
Gastric hepatoid adenocarcinomas are a genetically heterogenous group; most tumors show chromosomal instability, but MSI tumors do exist.
Neoplasms
Gastric Normal Adjacent Mucosa Versus Healthy and Cancer Tissues: Distinctive Transcriptomic Profiles and Biological Features.
Neoplasms
Gastric-type gene expression and phenotype in non-terminal respiratory unit type adenocarcinoma of the lung with invasive mucinous adenocarcinoma morphology.
Neoplasms
Gastritis-Infection-Cancer Sequence of Epstein-Barr Virus-Associated Gastric Cancer.
Neoplasms
Gastrointestinal adenocarcinoma analysis identifies promoter methylation-based cancer subtypes and signatures.
Neoplasms
GBX2 Methylation Is a Novel Prognostic Biomarker and Improves Prediction of Biochemical Recurrence Among Patients with Prostate Cancer Negative for Intraductal Carcinoma and Cribriform Architecture.
Neoplasms
GCNT4 is Associated with Prognosis and Suppress Cell Proliferation in Gastric Cancer.
Neoplasms
GDISC: a web portal for integrative analysis of gene-drug interaction for survival in cancer.
Neoplasms
GEJ cancers: gastric or esophageal tumors? searching for the answer according to molecular identity.
Neoplasms
GEMINI: a computationally-efficient search engine for large gene expression datasets.
Neoplasms
Gender-related prognostic value and genomic pattern of intra-tumor heterogeneity in colorectal cancer.
Neoplasms
Gender-specific Stratification of Survival Following Immune Checkpoint Inhibitor Therapy Based on Intratumoral Expression of a B cell Gene Signature.
Neoplasms
Gene Alterations of N6-Methyladenosine (m6A) Regulators in Colorectal Cancer: A TCGA Database Study.
Neoplasms
Gene Amplification-Driven Long Noncoding RNA SNHG17 Regulates Cell Proliferation and Migration in Human Non-Small-Cell Lung Cancer.
Neoplasms
Gene and lncRNA co-expression network analysis reveals novel ceRNA network for triple-negative breast cancer.
Neoplasms
Gene and MicroRNA Perturbations of Cellular Response to Pemetrexed Implicate Biological Networks and Enable Imputation of Response in Lung Adenocarcinoma.
Neoplasms
Gene and microRNA Signatures Are Associated with the Development and Survival of Glioblastoma Patients.
Neoplasms
Gene Characteristics and Prognostic Values of m6A RNA Methylation Regulators in Nonsmall Cell Lung Cancer.
Neoplasms
Gene Co-Expression Analysis of Human RNASEH2A Reveals Functional Networks Associated with DNA Replication, DNA Damage Response, and Cell Cycle Regulation.
Neoplasms
Gene Coexpression Analyses Differentiate Networks Associated with Diverse Cancers Harboring TP53 Missense or Null Mutations.
Neoplasms
Gene coexpression network analysis revealed biomarkers correlated with blast cells and survival in acute myeloid leukemia.
Neoplasms
Gene Copy Number and Post-Transductional Mechanisms Regulate TRAP1 Expression in Human Colorectal Carcinomas.
Neoplasms
Gene Expression Along with Genomic Copy Number Variation and Mutational Analysis Were Used to Develop a 9-Gene Signature for Estimating Prognosis of COAD.
Neoplasms
Gene expression analyses identify a relationship between stanniocalcin 2 and the malignant behavior of colorectal cancer.
Neoplasms
Gene expression analysis of combined RNA-seq experiments using a receiver operating characteristic calibrated procedure.
Neoplasms
Gene expression analysis reveals a pitfall in the molecular research of prostate tumors relevant to Gleason score.
Neoplasms
Gene expression and immune infiltration in melanoma patients with different mutation burden.
Neoplasms
Gene expression and methylation profiles identified CXCL3 and CXCL8 as key genes for diagnosis and prognosis of colon adenocarcinoma.
Neoplasms
Gene expression and mutation-guided synthetic lethality eradicates proliferating and quiescent leukemia cells.
Neoplasms
Gene expression and prognosis of x-ray repair cross-complementing family members in non-small cell lung cancer.
Neoplasms
Gene expression and promoter methylation of angiogenic and lymphangiogenic factors as prognostic markers in melanoma.
Neoplasms
Gene Expression Changes and Associated Pathways Involved in the Progression of Prostate Cancer Advanced Stages.
Neoplasms
Gene Expression Changes Associated with Dedifferentiation in Liposarcoma Predict Overall Survival.
Neoplasms
Gene expression network analysis of lymph node involvement in colon cancer identifies AHSA2, CDK10, and CWC22 as possible prognostic markers.
Neoplasms
Gene expression of adipokines and adipokine receptors in the tumor microenvironment: associations of lower expression with more aggressive breast tumor features.
Neoplasms
Gene expression patterns associated with tumor-infiltrating CD4+ and CD8+ T cells in invasive breast carcinomas.
Neoplasms
Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer.
Neoplasms
Gene Expression Profile and Prognostic Value of m6A RNA Methylation Regulators in Hepatocellular Carcinoma.
Neoplasms
Gene expression profile in oral squamous cell carcinomas and matching normal oral mucosal tissues from black Africans and white Caucasians: the case of the Sudan vs. Norway.
Neoplasms
Gene expression profile of leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy.
Neoplasms
Gene expression profiles analysis identifies a novel two-gene signature to predict overall survival in diffuse large B-cell lymphoma.
Neoplasms
Gene Expression Profiles Identified Novel Urine Biomarkers for Diagnosis and Prognosis of High-Grade Bladder Urothelial Carcinoma.
Neoplasms
Gene expression profiles in chondrosarcoma cells subjected to cyclic stretching and hydrostatic pressure. A cDNA array study.
Neoplasms
Gene expression profiles of human endometrial cancer samples using a cDNA-expression array technique: assessment of an analysis method.
Neoplasms
Gene expression profiles of liver cancer cell lines reveal two hepatocyte-like and fibroblast-like clusters.
Neoplasms
Gene expression profiling combined with functional analysis identify integrin beta1 (ITGB1) as a potential prognosis biomarker in triple negative breast cancer.
Neoplasms
Gene expression profiling distinguishes proneural glioma stem cells from mesenchymal glioma stem cells.
Neoplasms
Gene Expression Profiling Stratifies IDH-Wildtype Glioblastoma With Distinct Prognoses.
Neoplasms
Gene expression profiling, pathway analysis and subtype classification reveal molecular heterogeneity in hepatocellular carcinoma and suggest subtype specific therapeutic targets.
Neoplasms
Gene expression signature of Gleason score is associated with prostate cancer outcomes in a radical prostatectomy cohort.
Neoplasms
Gene expression signature predicts relapse in adult patients with cytogenetically normal acute myeloid leukemia.
Neoplasms
Gene Expression Signatures for Head and Neck Cancer Patient Stratification: Are Results Ready for Clinical Application?
Neoplasms
Gene Expression Subtype Predicts Nodal Metastasis and Survival in Human Papillomavirus-Negative Head and Neck Cancer.
Neoplasms
Gene Instability-Related lncRNA Prognostic Model of Melanoma Patients via Machine Learning Strategy.
Neoplasms
Gene landscape and correlation between B-cell infiltration and programmed death ligand 1 expression in lung adenocarcinoma patients from The Cancer Genome Atlas data set.
Neoplasms
Gene mutation patterns of Chinese acute myeloid leukemia patients by targeted next-generation sequencing and bioinformatic analysis.
Neoplasms
Gene network analysis using SWIM reveals interplay between the transcription factor-encoding genes HMGA1, FOXM1, and MYBL2 in triple-negative breast cancer.
Neoplasms
Gene network and biological pathways associated with susceptibility to differentiated thyroid carcinoma.
Neoplasms
Gene networks and expression quantitative trait loci associated with adjuvant chemotherapy response in high-grade serous ovarian cancer.
Neoplasms
Gene Panel of Persister Cells as a Prognostic Indicator for Tumor Repopulation After Radiation.
Neoplasms
Gene profiling of HepG2 cells following nitidine chloride treatment: An investigation with microarray and Connectivity Mapping.
Neoplasms
Gene promoter-associated CpG island hypermethylation in squamous cell carcinoma of the tongue.
Neoplasms
Gene regulation and prognostic indicators of lung squamous cell carcinoma: TCGA-derived miRNA/mRNA sequencing and DNA methylation data.
Neoplasms
Gene Regulatory Network Analysis for Triple-Negative Breast Neoplasms by Using Gene Expression Data.
Neoplasms
Gene Regulatory Network Analysis Identifies Sex-Linked Differences in Colon Cancer Drug Metabolism.
Neoplasms
Gene regulatory network analysis with drug sensitivity reveals synergistic effects of combinatory chemotherapy in gastric cancer.
Neoplasms
Gene set enrichment analysis and meta-analysis identified 12 key genes regulating and controlling the prognosis of lung adenocarcinoma.
Neoplasms
Gene set enrichment analysis and meta-analysis to identify six key genes regulating and controlling the prognosis of esophageal squamous cell carcinoma.
Neoplasms
Gene Signature and Identification of Clinical Trait-Related m6 A Regulators in Pancreatic Cancer.
Neoplasms
Gene Signature Associated With Bromodomain Genes Predicts the Prognosis of Kidney Renal Clear Cell Carcinoma.
Neoplasms
Gene signature associated with neuro-endocrine activity predicting prognosis of pancreatic carcinoma.
Neoplasms
Gene signature characteristic of elevated stromal infiltration and activation is associated with increased risk of hematogenous and lymphatic metastasis in serous ovarian cancer.
Neoplasms
Gene signature for prediction of radiosensitivity in human papillomavirus-negative head and neck squamous cell carcinoma.
Neoplasms
Gene signature for prognosis in comparison of pancreatic cancer patients with diabetes and non-diabetes.
Neoplasms
Gene Signatures and Prognostic Values of m6A Regulators in Hepatocellular Carcinoma.
Neoplasms
Gene Signatures and Prognostic Values of N6-Methyladenosine Related Genes in Ovarian Cancer.
Neoplasms
Gene signatures based on therapy responsiveness provide guidance for combined radiotherapy and chemotherapy for lower grade glioma.
Neoplasms
Gene signatures of 6-methyladenine regulators in women with lung adenocarcinoma and development of a risk scoring system: a retrospective study using the cancer genome atlas database.
Neoplasms
Gene signatures of m5C regulators may predict prognoses of patients with head and neck squamous cell carcinoma.
Neoplasms
Gene signatures predict biochemical recurrence-free survival in primary prostate cancer patients after radical therapy.
Neoplasms
Gene- and pathway-level analyses of iCOGS variants highlight novel signaling pathways underlying familial breast cancer susceptibility.
Neoplasms
Gene-based comparative analysis of tools for estimating copy number alterations using whole-exome sequencing data.
Neoplasms
Gene-expression signature predicts survival benefit from postoperative chemoradiotherapy in head and neck squamous cell carcinoma.
Neoplasms
Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer.
Neoplasms
Gene-Gene Interaction Analysis for the Survival Phenotype Based on the Kaplan-Meier Median Estimate.
Neoplasms
Gene-gene interaction network analysis of hepatocellular carcinoma using bioinformatic software.
Neoplasms
GeneGazer: A Toolkit Integrating Two Pipelines for Personalized Profiling and Biosignature Identification.
Neoplasms
Generating a focused view of disease ontology cancer terms for pan-cancer data integration and analysis.
Neoplasms
Generation of sphingosine-1-phosphate is enhanced in biliary tract cancer patients and is associated with lymphatic metastasis.
Neoplasms
Genes CEP55, FOXD3, FOXF2, GNAO1, GRIA4, and KCNA5 as potential diagnostic biomarkers in colorectal cancer.
Neoplasms
Genes Involved in the PD-L1 Pathway Might Associate with Radiosensitivity of Patients with Gastric Cancer.
Neoplasms
Genes Located on 18q23 Are Epigenetic Markers and Have Prognostic Significance for Patients with Head and Neck Cancer.
Neoplasms
Genes Regulated by HPV 16 E6 and High Expression of NFX1-123 in Cervical Cancers.
Neoplasms
Genetic alteration and clinical significance of SUMOylation regulators in multiple cancer types.
Neoplasms
Genetic alteration in notch pathway is associated with better prognosis in renal cell carcinoma.
Neoplasms
Genetic alteration in phosphofructokinase family promotes growth of muscle-invasive bladder cancer.
Neoplasms
Genetic alterations and functional networks of m6A RNA methylation regulators in pancreatic cancer based on data mining.
Neoplasms
Genetic alterations and PIK3CA gene mutations and amplifications analysis in cervical cancer by racial groups in the United States.
Neoplasms
Genetic Alterations and Transcriptional Expression of m6A RNA Methylation Regulators Drive a Malignant Phenotype and Have Clinical Prognostic Impact in Hepatocellular Carcinoma.
Neoplasms
Genetic alterations associated with 18F-fluorodeoxyglucose positron emission tomography/computed tomography in head and neck squamous cell carcinoma.
Neoplasms
Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset.
Neoplasms
Genetic analyses of differences between solid and nonsolid predominant lung adenocarcinomas.
Neoplasms
Genetic Analysis of Functional Rare Germline Variants across Nine Cancer Types from an Electronic Health Record Linked Biobank.
Neoplasms
Genetic analysis of microglandular adenosis and acinic cell carcinomas of the breast provides evidence for the existence of a low-grade triple-negative breast neoplasia family.
Neoplasms
Genetic analysis of pleomorphic and florid lobular carcinoma in situ variants: frequent ERBB2/ERBB3 alterations and clonal relationship to classic lobular carcinoma in situ and invasive lobular carcinoma.
Neoplasms
Genetic Analysis of Uveal Melanoma in 658 Patients Using the Cancer Genome Atlas Classification of Uveal Melanoma as A, B, C, and D.
Neoplasms
Genetic and clinical characterization of B7-H3 (CD276) expression and epigenetic regulation in diffuse brain glioma.
Neoplasms
Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate.
Neoplasms
Genetic and epigenetic differences of benign and malignant pheochromocytomas and paragangliomas (PPGLs).
Neoplasms
Genetic and epigenetic heterogeneity of epithelial ovarian cancer and the clinical implications for molecular targeted therapy.
Neoplasms
Genetic and epigenetic modifications of Sox2 contribute to the invasive phenotype of malignant gliomas.
Neoplasms
Genetic And Epigenetic Regulation Of E-Cadherin Signaling In Human Hepatocellular Carcinoma.
Neoplasms
Genetic and Immune Profiles of Solid Predominant Lung Adenocarcinoma Reveal Potential Immunotherapeutic Strategies.
Neoplasms
Genetic and Lineage Classification of Glioma-Initiating Cells Identifies a Clinically Relevant Glioblastoma Model.
Neoplasms
Genetic and microenvironmental differences in non-smoking lung adenocarcinoma patients compared with smoking patients.
Neoplasms
Genetic and molecular analyses reveal G6PC as a key element connecting glucose metabolism and cell cycle control in ovarian cancer.
Neoplasms
Genetic and transcriptomic analyses in a rare case of HPV-related oropharyngeal squamous cell carcinoma combined with small cell carcinoma.
Neoplasms
Genetic associations of T cell cancer immune response with tumor aggressiveness in localized prostate cancer patients and disease reclassification in an active surveillance cohort.
Neoplasms
Genetic characteristics and prognostic implications of m1A regulators in pancreatic cancer.
Neoplasms
Genetic characterization of adult primary pleomorphic uterine rhabdomyosarcoma and comparison with uterine carcinosarcoma.
Neoplasms
Genetic comprehension of organophosphate flame retardants, an emerging threat to prostate cancer.
Neoplasms
Genetic defects of the IRF1-mediated major histocompatibility complex class I antigen presentation pathway occur prevalently in the
Neoplasms
Genetic determinants of FOXM1 overexpression in epithelial ovarian cancer and functional contribution to cell cycle progression.
Neoplasms
Genetic Interaction-Based Biomarkers Identification for Drug Resistance and Sensitivity in Cancer Cells.
Neoplasms
Genetic Landscape of Human Papillomavirus-Associated Head and Neck Cancer and Comparison to Tobacco-Related Tumors.
Neoplasms
Genetic landscape of prognostic value in pancreatic ductal adenocarcinoma microenvironment.
Neoplasms
Genetic network and gene set enrichment analyses identify MND1 as potential diagnostic and therapeutic target gene for lung adenocarcinoma.
Neoplasms
Genetic polymorphism and carbonic anhydrase 9 expression can predict nodal metastatic prostate cancer risk in patients with prostate-specific antigen levels ?10 ng/ml at initial biopsy.
Neoplasms
Genetic polymorphisms associated with pancreatic cancer survival: a genome-wide association study.
Neoplasms
Genetic profile and biological implication of PIN2/TRF1-interacting telomerase inhibitor 1 (PinX1) in human cancers: an analysis using The Cancer Genome Atlas.
Neoplasms
Genetic Profiles Associated with Chemoresistance in Patient-Derived Xenograft Models of Ovarian Cancer.
Neoplasms
Genetic Profiling of Breast Cancer with and Without Preexisting Metabolic Disease.
Neoplasms
Genetic risk score for ovarian cancer based on chromosomal-scale length variation.
Neoplasms
Genetic variants in chromatin-remodeling pathway associated with lung cancer risk in a Chinese population.
Neoplasms
Genetic variants in ERBB4 is associated with chronic hepatitis B virus infection.
Neoplasms
Genetic variants in Hippo signalling pathway-related genes affect the risk of colorectal cancer.
Neoplasms
Genetic variants in regulatory regions of microRNAs are associated with lung cancer risk.
Neoplasms
Genetic variants in the cholesterol biosynthesis pathway genes and risk of prostate cancer.
Neoplasms
Genetic variants in the Folic acid Metabolic Pathway Genes predict outcomes of metastatic Colorectal Cancer patients receiving first-line Chemotherapy.
Neoplasms
Genetic Variants Were Associated With the Prognosis of Head and Neck Squamous Carcinoma.
Neoplasms
Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium.
Neoplasms
Genetic variations in cancer-related significantly mutated genes and lung cancer susceptibility.
Neoplasms
Genetic variations in Hippo pathway genes influence bladder cancer risk in a Chinese population.
Neoplasms
Genetic, epigenetic, and molecular landscapes of multifocal and multicentric glioblastoma.
Neoplasms
Genetics: New molecular classification of gastric adenocarcinoma proposed by The Cancer Genome Atlas.
Neoplasms
Genetics: new molecular classification of gastric adenocarcinoma proposed by The Cancer Genome Atlas.
Neoplasms
Genome-Scale Analysis Identified NID2, SPARC, and MFAP2 as Prognosis Markers of Overall Survival in Gastric Cancer.
Neoplasms
Genome-scale analysis identifies NEK2, DLGAP5 and ECT2 as promising diagnostic and prognostic biomarkers in human lung cancer.
Neoplasms
Genome-scale analysis of DNA methylation in colorectal cancer using Infinium HumanMethylation450 BeadChips.
Neoplasms
Genome-scale analysis to identify prognostic markers in patients with early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy.
Neoplasms
Genome-scale analysis to identify prognostic microRNA biomarkers in patients with early stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy.
Neoplasms
Genome-scale integrated analysis to identify prospective molecular mechanisms and therapeutic targets in isocitrate dehydrogenase 2 R140Q-mutated acute myeloid leukemia.
Neoplasms
Genome-Scale Metabolic Modeling of Glioblastoma Reveals Promising Targets for Drug Development.
Neoplasms
Genome-scale methylation assessment did not identify prognostic biomarkers in oral tongue carcinomas.
Neoplasms
Genome-wide age-related DNA methylation changes in blood and other tissues relate to histone modification, expression and cancer.
Neoplasms
Genome-wide analyses of long noncoding RNA expression profiles in lung adenocarcinoma.
Neoplasms
Genome-wide analyses of the prognosis-related mRNA alternative splicing landscape and novel splicing factors based on large-scale low grade glioma cohort.
Neoplasms
Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium.
Neoplasms
Genome-wide Analysis of Common Copy Number Variation and Epithelial Ovarian Cancer Risk.
Neoplasms
Genome-wide analysis of endogenously expressed ZEB2 binding sites reveals inverse correlations between ZEB2 and GalNAc-transferase GALNT3 in human tumors.
Neoplasms
Genome-wide analysis of gynecologic cancer: The Cancer Genome Atlas in ovarian and endometrial cancer.
Neoplasms
Genome-wide analysis of lncRNAs, miRNAs, and mRNAs forming a prognostic scoring system in esophageal squamous cell carcinoma.
Neoplasms
Genome-Wide Analysis of Lung Adenocarcinoma Identifies Novel Prognostic Factors and a Prognostic Score.
Neoplasms
Genome-Wide Analysis of Methylation-Driven Genes and Identification of an Eight-Gene Panel for Prognosis Prediction in Breast Cancer.
Neoplasms
Genome-Wide Analysis of Prognostic Alternative Splicing Signature and Splicing Factors in Lung Adenocarcinoma.
Neoplasms
Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
Neoplasms
Genome-wide analysis of prognostic-related lncRNAs, miRNAs and mRNAs forming a competing endogenous RNA network in lung squamous cell carcinoma.
Neoplasms
Genome-wide analysis reveals the association between alternative splicing and DNA methylation across human solid tumors.
Neoplasms
Genome-wide analysis to identify a novel distant metastasis-related gene signature predicting survival in patients with gastric cancer.
Neoplasms
Genome-wide analysis to identify a novel microRNA signature that predicts survival in patients with stomach adenocarcinoma.
Neoplasms
Genome-wide association analysis identifies genetic correlates of immune infiltrates in solid tumors.
Neoplasms
Genome-wide association analysis reveals regulation of at-risk loci by DNA methylation in prostate cancer.
Neoplasms
Genome-wide association studies of survival in 1,520 cancer patients treated with bevacizumab-containing regimens.
Neoplasms
Genome-wide cDNA microarray screening to correlate gene expression profile with survival in patients with advanced lung cancer.
Neoplasms
Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.
Neoplasms
Genome-Wide CRISPR Screen Reveals Cancer Cell Resistance to NK Cells Induced by NK-Derived IFN-?.
Neoplasms
Genome-wide discovery of viral microRNAs based on phylogenetic analysis and structural evolution of various human papillomavirus subtypes.
Neoplasms
Genome-wide DNA methylation analyses in lung adenocarcinomas: Association with EGFR, KRAS and TP53 mutation status, gene expression and prognosis.
Neoplasms
Genome-Wide DNA Methylation Analysis in Melanoma Reveals the Importance of CpG Methylation in MITF Regulation.
Neoplasms
Genome-wide DNA methylation measurements in prostate tissues uncovers novel prostate cancer diagnostic biomarkers and transcription factor binding patterns.
Neoplasms
Genome-wide DNA methylation profiles altered by Helicobacter pylori in gastric mucosa and blood leukocyte DNA.
Neoplasms
Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis.
Neoplasms
Genome-Wide DNA Methylation Profiling of Esophageal Squamous Cell Carcinoma from Global High-Incidence Regions Identifies Crucial Genes and Potential Cancer Markers.
Neoplasms
Genome-wide DNA methylation profiling reveals novel epigenetic signatures in squamous cell lung cancer.
Neoplasms
Genome-wide identification of a competing endogenous RNA network in cholangiocarcinoma.
Neoplasms
Genome-Wide Identification of a Novel Autophagy-Related Signature for Colorectal Cancer.
Neoplasms
Genome-wide identification of a novel miRNA-based signature to predict recurrence in patients with gastric cancer.
Neoplasms
Genome-Wide Identification of Autophagy Prognostic Signature in Pancreatic Cancer.
Neoplasms
Genome-wide identification of CpG island methylator phenotype related gene signature as a novel prognostic biomarker of gastric cancer.
Neoplasms
Genome-wide investigation of the clinical significance and prospective molecular mechanism of minichromosome maintenance protein family genes in patients with Lung Adenocarcinoma.
Neoplasms
GENOME-WIDE METHYLATION ANALYSIS IDENTIFIES GENES SPECIFIC TO BREAST CANCER HORMONE RECEPTOR STATUS AND RISK OF RECURRENCE.
Neoplasms
Genome-wide methylation and expression profiling identify a novel epigenetic signature in gastrointestinal pan-adenocarcinomas.
Neoplasms
Genome-wide methylation and expression profiling identify methylation-associated genes in colorectal cancer.
Neoplasms
Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer.
Neoplasms
Genome-wide methylomic and transcriptomic analyses identify subtype-specific epigenetic signatures commonly dysregulated in glioma stem cells and glioblastoma.
Neoplasms
Genome-wide microRNA analysis identifies miR-188-3p as novel prognostic marker and molecular factor involved in colorectal carcinogenesis.
Neoplasms
Genome-wide miRNA methylome analysis in oral cancer: possible biomarkers associated with patient survival.
Neoplasms
Genome-wide miRNA profiling reinforces the importance of miR-9 in human papillomavirus associated oral and oropharyngeal head and neck cancer.
Neoplasms
Genome-wide mutation profiling and related risk signature for prognosis of papillary renal cell carcinoma.
Neoplasms
Genome-Wide Profiling of Acquired Uniparental Disomy Reveals Prognostic Factors in Head and Neck Squamous Cell Carcinoma.
Neoplasms
Genome-Wide Profiling of Alternative Splicing Signatures Associated with Prognosis and Immune Microenvironment of Hepatocellular Carcinoma.
Neoplasms
Genome-wide profiling of prognosis-related alternative splicing signatures in sarcoma.
Neoplasms
Genome-Wide Profiling of Prognostic Alternative Splicing Pattern in Pancreatic Cancer.
Neoplasms
Genome-Wide Profiling of Prognostic Alternative Splicing Signature in Colorectal Cancer.
Neoplasms
Genome-wide RNA-sequencing dataset reveals the prognostic value and potential molecular mechanisms of lncRNA in non-homologous end joining pathway 1 in early stage Pancreatic Ductal Adenocarcinoma.
Neoplasms
Genome-Wide Screen for MicroRNAs Reveals a Role for miR-203 in Melanoma Metastasis.
Neoplasms
Genome-wide screening and cohorts validation identifying novel lncRNAs as prognostic biomarkers for clear cell renal cell carcinoma.
Neoplasms
Genome-wide screening for the G-protein-coupled receptor (GPCR) pathway-related therapeutic gene RGS19 (regulator of G protein signaling 19) in bladder cancer.
Neoplasms
Genome-Wide Transcriptional Analysis Reveals Alternative Splicing Event Profiles in Hepatocellular Carcinoma and Their Prognostic Significance.
Neoplasms
Genome?scale analysis to identify potential prognostic microRNA biomarkers for predicting overall survival in patients with colon adenocarcinoma.
Neoplasms
Genome?wide investigation of the clinical implications and molecular mechanism of long noncoding RNA LINC00668 and protein?coding genes in hepatocellular carcinoma.
Neoplasms
Genomewide cDNA microarray screening of genes related to benefits and toxicities of platinum-based chemotherapy in patients with advanced lung cancer.
Neoplasms
Genomic Alterations and Targeted Therapy in Gastric and Esophageal Adenocarcinoma.
Neoplasms
Genomic alterations in advanced gastric cancer endoscopic biopsy samples using targeted next-generation sequencing.
Neoplasms
Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of MED12 and RBM10 as Novel Thyroid Cancer Genes Associated with Tumor Virulence.
Neoplasms
Genomic alterations in gynecological malignancies: histotype-associated driver mutations, molecular subtyping schemes, and tumorigenic mechanisms.
Neoplasms
Genomic alterations in human epidermal growth factor receptor 2 (HER2/ERBB2) in head and neck squamous cell carcinoma.
Neoplasms
Genomic Alterations Observed in Colitis-Associated Cancers Are Distinct From Those Found in Sporadic Colorectal Cancers and Vary by Type of Inflammatory Bowel Disease.
Neoplasms
Genomic alterations of Tenascin C in highly aggressive prostate cancer: a meta-analysis.
Neoplasms
Genomic analyses based on pulmonary adenocarcinoma in situ reveal early lung cancer signature.
Neoplasms
Genomic analysis and clinical implications of immune cell infiltration in gastric cancer.
Neoplasms
Genomic analysis and selective small molecule inhibition identifies BCL-X(L) as a critical survival factor in a subset of colorectal cancer.
Neoplasms
Genomic analysis of biomarkers related to the prognosis of acute myeloid leukemia.
Neoplasms
Genomic analysis of exceptional responders to radiotherapy reveals somatic mutations in ATM.
Neoplasms
Genomic analysis of pancreatic cancer reveals 3 molecular subtypes with different clinical outcomes.
Neoplasms
Genomic analysis of the prognostic effect of tumor-associated neutrophil-related genes across 15 solid cancer types: an immune perspective.
Neoplasms
Genomic Analysis of Thymic Epithelial Tumors Identifies Novel Subtypes Associated with Distinct Clinical Features.
Neoplasms
Genomic Analysis of Tumor Microenvironment Immune Types across 14 Solid Cancer Types: Immunotherapeutic Implications.
Neoplasms
Genomic Analysis of Uterine Lavage Fluid Detects Early Endometrial Cancers and Reveals a Prevalent Landscape of Driver Mutations in Women without Histopathologic Evidence of Cancer: A Prospective Cross-Sectional Study.
Neoplasms
Genomic Analysis of Vascular Invasion in HCC Reveals Molecular Drivers and Predictive Biomarkers.
Neoplasms
Genomic and epigenetic aberrations of chromosome 1p36.13 have prognostic implications in malignancies.
Neoplasms
Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas.
Neoplasms
Genomic and human papillomavirus profiling of an oral cancer cohort identifies TP53 as a predictor of overall survival.
Neoplasms
Genomic and Immunologic Correlates of Indoleamine 2,3-Dioxygenase Pathway Expression in Cancer.
Neoplasms
Genomic and immunological features of microsatellite instability in colon cancer.
Neoplasms
Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas.
Neoplasms
Genomic and Transcriptomic Alterations Associated with STAT3 Activation in Head and Neck Cancer.
Neoplasms
Genomic and Transcriptomic Characteristics According to Size of Papillary Thyroid Microcarcinoma.
Neoplasms
Genomic and Transcriptomic Characterization Links Cell Lines with Aggressive Head and Neck Cancers.
Neoplasms
Genomic and transcriptomic characterization of the mitochondrial-rich oncocytic phenotype on a thyroid carcinoma background.
Neoplasms
Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.
Neoplasms
Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies.
Neoplasms
Genomic characteristics of trastuzumab-resistant Her2-positive metastatic breast cancer.
Neoplasms
Genomic characterization of genes encoding histone acetylation modulator proteins identifies therapeutic targets for cancer treatment.
Neoplasms
Genomic Characterization of Non-Invasive Differentiated-Type Gastric Cancer in the Japanese Population.
Neoplasms
Genomic Characterization of Renal Cell Carcinoma with Sarcomatoid Dedifferentiation Pinpoints Recurrent Genomic Alterations.
Neoplasms
Genomic Characterization of Six Virus-Associated Cancers Identifies Changes in the Tumor Immune Microenvironment and Altered Genetic Programs.
Neoplasms
Genomic clustering analysis identifies molecular subtypes of thymic epithelial tumors independent of World Health Organization histologic type.
Neoplasms
Genomic Common Data Model for Seamless Interoperation of Biomedical Data in Clinical Practice: Retrospective Study.
Neoplasms
Genomic copy number variation correlates with survival outcomes in WHO grade IV glioma.
Neoplasms
Genomic data analysis workflows for tumors from patient-derived xenografts (PDXs): challenges and guidelines.
Neoplasms
Genomic data from NSCLC tumors reveals correlation between SHP-2 activity and PD-L1 expression and suggests synergy in combining SHP-2 and PD-1/PD-L1 inhibitors.
Neoplasms
Genomic Differences Between "Primary" and "Secondary" Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy.
Neoplasms
Genomic differences between black and white patients implicate a distinct immune response to papillary renal cell carcinoma.
Neoplasms
Genomic Estimates of Aneuploid Content in Glioblastoma Multiforme and Improved Classification.
Neoplasms
Genomic evidence of reactive oxygen species elevation in papillary thyroid carcinoma with Hashimoto thyroiditis.
Neoplasms
Genomic Identification of RNA Editing Through Integrating Omics Datasets and the Clinical Relevance in Hepatocellular Carcinoma.
Neoplasms
Genomic Instability Promoted by Overexpression of Mismatch Repair Factors in Yeast: A Model for Understanding Cancer Progression.
Neoplasms
Genomic Landscape and Endocrine-Resistant Subgroup in Estrogen Receptor-Positive, Progesterone Receptor-Negative, and HER2-Negative Breast Cancer.
Neoplasms
Genomic landscape and mutational impacts of recurrently mutated genes in cancers.
Neoplasms
Genomic Landscape of Early-stage Colorectal Neoplasia Developing From the Ulcerative Colitis Mucosa in the Japanese Population.
Neoplasms
Genomic Landscape of Pancreatic Adenocarcinoma in Younger versus Older Patients: Does Age Matter?
Neoplasms
Genomic Landscape of Somatic Alterations in Esophageal Squamous Cell Carcinoma and Gastric Cancer.
Neoplasms
Genomic Mapping and Survival Prediction in Glioblastoma: Molecular Subclassification Strengthened by Hemodynamic Imaging Biomarkers.
Neoplasms
Genomic pattern of intratumor heterogeneity predicts the risk of progression in early stage diffuse large B-cell lymphoma.
Neoplasms
Genomic Profiling in Gastrointestinal Cancer: Are We Ready To Use These Data to Make Treatment Decisions?
Neoplasms
Genomic profiling in locally advanced and inflammatory breast cancer and its link to DCE-MRI and overall survival.
Neoplasms
Genomic profiling of lower-grade gliomas uncovers cohesive disease groups: implications for diagnosis and treatment.
Neoplasms
Genomic Profiling of the Steroidogenic Acute Regulatory Protein in Breast Cancer: In Silico Assessments and a Mechanistic Perspective.
Neoplasms
Genomic Rearrangement Signatures and Clinical Outcomes in High-Grade Serous Ovarian Cancer.
Neoplasms
Genomic Signature of Mismatch Repair Deficiency in Areca Nut-Related Oral Cancer.
Neoplasms
Genomic signatures defining responsiveness to allopurinol and combination therapy for lung cancer identified by systems therapeutics analyses.
Neoplasms
Genomic stability at the coding regions of the multidrug transporter gene ABCB1: insights into the development of alternative drug resistance mechanisms in human leukemia cells.
Neoplasms
Genomic stratification based on microenvironment immune types and PD-L1 for tailoring therapeutic strategies in bladder cancer.
Neoplasms
Genomic stratification based on radiosensitivity and PD-L1 for tailoring therapeutic strategies in cervical cancer.
Neoplasms
Genomic variations in the counterpart normal controls of lung squamous cell carcinomas.
Neoplasms
Genomic, Transcriptomic, and Functional Alterations in DNA Damage Response Pathways as Putative Biomarkers of Chemotherapy Response in Ovarian Cancer.
Neoplasms
Genomic, transcriptomic, epigenetic, and immune profiling of mucinous breast cancer.
Neoplasms
Genomic-wide cDNA microarray screening to correlate gene expression profile with chemoresistance in patients with advanced lung cancer.
Neoplasms
Genomically driven precision medicine to improve outcomes in anaplastic thyroid cancer.
Neoplasms
Genomics and advances towards precision medicine for head and neck squamous cell carcinoma.
Neoplasms
Genomics and prognosis analysis of epithelial-mesenchymal transition in colorectal cancer patients.
Neoplasms
Genomics Education for the Public: Perspectives of Genomic Researchers and ELSI Advisors.
Neoplasms
Genomics of chromophobe renal cell carcinoma: implications from a rare tumor for pan-cancer studies.
Neoplasms
Genomics Score Based on Genome-Wide Network Analysis for Prediction of Survival in Gastric Cancer: A Novel Prognostic Signature.
Neoplasms
Genotype prediction of ATRX mutation in lower-grade gliomas using an MRI radiomics signature.
Neoplasms
Geographic variation in prostate cancer mortality rates among white males in the united states.
Neoplasms
Geographical clusters and common patterns in cancer mortality of the Federal Republic of Germany.
Neoplasms
Geospatial disparities and the underlying causes of major cancers for women in Taiwan.
Neoplasms
Germ Cell-Specific Gene 1-Like Protein Regulated by Splicing Factor CUGBP Elav-Like Family Member 5 and Primary Bile Acid Biosynthesis are Prognostic in Glioblastoma Multiforme.
Neoplasms
Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer.
Neoplasms
Germline Alterations in RASAL1 in Cowden Syndrome Patients Presenting with Follicular Thyroid Cancer and in Individuals with Apparently Sporadic Epithelial Thyroid Cancer.
Neoplasms
Germline and somatic albinism variants in amelanotic/hypomelanotic melanoma: Increased carriage of TYR and OCA2 variants.
Neoplasms
Germline and somatic SDHx alterations in apparently sporadic differentiated thyroid cancer.
Neoplasms
Germline cytoskeletal and extra-cellular matrix-related single nucleotide variations associated with distinct cancer survival rates.
Neoplasms
Germline Genetic Association between Stromal Interaction Molecule 1 (STIM1) and Clinical Outcomes in Breast Cancer Patients.
Neoplasms
Germline genetic variants in somatically significantly mutated genes in tumors are associated with renal cell carcinoma risk and outcome.
Neoplasms
Germline Heterozygous Variants in SEC23B Are Associated with Cowden Syndrome and Enriched in Apparently Sporadic Thyroid Cancer.
Neoplasms
Germline whole exome sequencing and large-scale replication identifies FANCM as a likely high grade serous ovarian cancer susceptibility gene.
Neoplasms
Gestational arsenite exposure augments hepatic tumors of C3H mice by promoting senescence in F1 and F2 offspring via different pathways.
Neoplasms
Gestational high-fat diet and bisphenol A exposure heightens mammary cancer risk.
Neoplasms
Ghrelin promotes renal cell carcinoma metastasis via Snail activation and is associated with poor prognosis.
Neoplasms
GHSR DNA hypermethylation is a new epigenetic biomarker for gastric adenocarcinoma and beyond.
Neoplasms
Glandular orientation and shape determined by computational pathology could identify aggressive tumor for early colon carcinoma: a triple-center study.
Neoplasms
Gli1, a potential regulator of esophageal cancer stem cell, is identified as an independent adverse prognostic factor in esophageal squamous cell carcinoma.
Neoplasms
GLI3 repressor determines Hedgehog pathway activation and is required for response to SMO antagonist glasdegib in AML.
Neoplasms
Glioblastoma cell enrichment is critical for analysis of phosphorylated drug targets and proteomic-genomic correlations.
Neoplasms
Glioblastoma cell secretome: Analysis of three glioblastoma cell lines reveal 148 non-redundant proteins.
Neoplasms
Glioblastoma cells potentiate the induction of the Th1-like profile in phosphoantigen-stimulated ?? T lymphocytes.
Neoplasms
Glioblastoma Distance From the Subventricular Neural Stem Cell Niche Does Not Correlate With Survival.
Neoplasms
Glioblastoma Exhibits Inter-Individual Heterogeneity of TSPO and LAT1 Expression in Neoplastic and Parenchymal Cells.
Neoplasms
Glioblastoma multiforme: exploratory radiogenomic analysis by using quantitative image features.
Neoplasms
Glioblastoma radiomics: can genomic and molecular characteristics correlate with imaging response patterns?
Neoplasms
Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations.
Neoplasms
Glioblastoma: Imaging Genomic Mapping Reveals Sex-specific Oncogenic Associations of Cell Death.
Neoplasms
Glioma cells with the IDH1 mutation modulate metabolic fractional flux through pyruvate carboxylase.
Neoplasms
Glioma Grading Using Cell Nuclei Morphologic Features in Digital Pathology Images.
Neoplasms
Glioma stem cell (GSC)-derived autoschizis-like products confer GSC niche properties involving M1-like tumor-associated macrophages.
Neoplasms
Glioma stem cell-derived exosomal miR-944 reduces glioma growth and angiogenesis by inhibiting AKT/ERK signaling.
Neoplasms
Glioma Through the Looking GLASS: Molecular Evolution of Diffuse Gliomas and the Glioma Longitudinal AnalySiS Consortium.
Neoplasms
Glioma-Associated Stromal Cells Stimulate Glioma Malignancy by Regulating the Tumor Immune Microenvironment.
Neoplasms
GliomaDB: A Web Server for Integrating Glioma Omics Data and Interactive Analysis.
Neoplasms
Gliomas display distinct sex-based differential methylation patterns based on molecular subtype.
Neoplasms
Gliomasphere marker combinatorics: multidimensional flow cytometry detects CD44+/CD133+/ITGA6+/CD36+ signature.
Neoplasms
GLIS2 redundancy causes chemoresistance and poor prognosis of gastric cancer based on co?expression network analysis.
Neoplasms
Global analysis of gene expression signature and diagnostic/prognostic biomarker identification of hepatocellular carcinoma.
Neoplasms
Global Analysis of Microbiota Signatures in Four Major Types of Gastrointestinal Cancer.
Neoplasms
Global Analysis of miRNA-mRNA Interaction Network in Breast Cancer with Brain Metastasis.
Neoplasms
Global analysis of tRNA and translation factor expression reveals a dynamic landscape of translational regulation in human cancers.
Neoplasms
Global and Targeted miRNA Expression Profiling in Clear Cell Renal Cell Carcinoma Tissues Potentially Links miR-155-5p and miR-210-3p to Both Tumorigenesis and Recurrence.
Neoplasms
Global Cancer Transcriptome Quantifies Repeat Element Polarization between Immunotherapy Responsive and T Cell Suppressive Classes.
Neoplasms
Global Characterization of Immune Infiltration in Clear Cell Renal Cell Carcinoma.
Neoplasms
Global identification and characterization of tRNA-derived RNA fragment landscapes across human cancers.
Neoplasms
Global transcriptional downregulation of TREX and nuclear trafficking machinery as pan-senescence phenomena: evidence from human cells and tissues.
Neoplasms
Global Transcriptome Analysis of RNA Abundance Regulation by ADAR in Lung Adenocarcinoma.
Neoplasms
Global transcriptomic analysis identifies SERPINE1 as a prognostic biomarker associated with epithelial-to-mesenchymal transition in gastric cancer.
Neoplasms
Glucocorticoid receptor expression is associated with inferior overall survival independent of BRCA mutation status in ovarian cancer.
Neoplasms
Glucosamine-6-Phosphate Isomerase 1 Promotes Tumor Progression and Indicates Poor Prognosis in Hepatocellular Carcinoma.
Neoplasms
Glucose metabolic profiles evaluated by PET associated with molecular characteristic landscape of gastric cancer.
Neoplasms
Glucose-regulated protein 94 deficiency induces squamous cell metaplasia and suppresses PTEN-null driven endometrial epithelial tumor development.
Neoplasms
Glutaminase 1 expression in colorectal cancer cells is induced by hypoxia and required for tumor growth, invasion, and metastatic colonization.
Neoplasms
Glutamine synthetase promotes tumor invasion in hepatocellular carcinoma through mediating epithelial-mesenchymal transition.
Neoplasms
Glutamine-fructose-6-phosphate transaminase 2 (GFPT2) promotes the EMT of serous ovarian cancer by activating the hexosamine biosynthetic pathway to increase the nuclear location of ?-catenin.
Neoplasms
Glutathione Peroxidase 8 as a Prognostic Biomarker of Gastric Cancer: An Analysis of The Cancer Genome Atlas (TCGA) Data.
Neoplasms
Glycerophospholipids pathways and chromosomal instability in gastric cancer: Global lipidomics analysis.
Neoplasms
Glycogen phosphorylase B promotes ovarian cancer progression via Wnt/?-catenin signaling and is regulated by miR-133a-3p.
Neoplasms
Glycolysis Define Two Prognostic Subgroups of Lung Adenocarcinoma With Different Mutation Characteristics and Immune Infiltration Signatures.
Neoplasms
Glycolysis promotes the progression of pancreatic cancer and reduces cancer cell sensitivity to gemcitabine.
Neoplasms
Glycolysis-associated lncRNAs identify a subgroup of cancer patients with poor prognoses and a high-infiltration immune microenvironment.
Neoplasms
Glycolysis-Based Genes Associated with the Clinical Outcome of Pancreatic Ductal Adenocarcinoma Identified by The Cancer Genome Atlas Data Analysis.
Neoplasms
Glycolysis-Related Gene Expression Profiling Screen for Prognostic Risk Signature of Pancreatic Ductal Adenocarcinoma.
Neoplasms
Glycolysis-Related Genes Serve as Potential Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma.
Neoplasms
Glycolytic expression in lower-grade glioma reveals an epigenetic association between IDH mutation status and PDL1/2 expression.
Neoplasms
Glycosyltransferase Gene Expression Profiles Classify Cancer Types and Propose Prognostic Subtypes.
Neoplasms
Glycyrrhizic Acid-Induced Differentiation Repressed Stemness in Hepatocellular Carcinoma by Targeting c-Jun N-Terminal Kinase 1.
Neoplasms
Glypican 6 is a putative biomarker for metastatic progression of cutaneous melanoma.
Neoplasms
GPCRs show widespread differential mRNA expression and frequent mutation and copy number variation in solid tumors.
Neoplasms
GPR12 inhibits migration and promotes apoptosis in esophageal cancer and hypopharyngeal cancer cells.
Neoplasms
GPR68, a proton-sensing GPCR, mediates interaction of cancer-associated fibroblasts and cancer cells.
Neoplasms
GPRC5A is a potential oncogene in pancreatic ductal adenocarcinoma cells that is upregulated by gemcitabine with help from HuR.
Neoplasms
GPX3 hypermethylation in gastric cancer and its prognostic value in patients aged over 60.
Neoplasms
GRIK3: A novel oncogenic protein related to tumor TNM stage, lymph node metastasis, and poor prognosis of GC.
Neoplasms
GRNdb: decoding the gene regulatory networks in diverse human and mouse conditions.
Neoplasms
Group Lasso Regularized Deep Learning for Cancer Prognosis from Multi-Omics and Clinical Features.
Neoplasms
Growth Differentiation Factor 15 is a Cancer Cell-Induced Mitokine That Primes Thyroid Cancer Cells for Invasiveness.
Neoplasms
Growth-associated protein 43 promotes thyroid cancer cell lines progression via epithelial-mesenchymal transition.
Neoplasms
Growth-stimulatory activity of TIMP-2 is mediated through c-Src activation followed by activation of FAK, PI3-kinase/AKT, and ERK1/2 independent of MMP inhibition in lung adenocarcinoma cells.
Neoplasms
GRWD1 directly interacts with p53 and negatively regulates p53 transcriptional activity.
Neoplasms
GSVD comparison of patient-matched normal and tumor aCGH profiles reveals global copy-number alterations predicting glioblastoma multiforme survival.
Neoplasms
GTF2IRD1 on chromosome 7 is a novel oncogene regulating the tumor-suppressor gene TGF?R2 in colorectal cancer.
Neoplasms
Guanylate-binding protein-1 is a potential new therapeutic target for triple-negative breast cancer.
Neoplasms
Guidelines for Clinical Target Volume Definition for Perineural Spread of Major Salivary Gland Cancers.
Neoplasms
Guidelines for delineation of lymphatic clinical target volumes for high conformal radiotherapy: head and neck region.
Neoplasms
H19 Noncoding RNA, an Independent Prognostic Factor, Regulates Essential Rb-E2F and CDK8-?-Catenin Signaling in Colorectal Cancer.
Neoplasms
H19 overexpression promotes leukemogenesis and predicts unfavorable prognosis in acute myeloid leukemia.
Neoplasms
H19, a Long Non-coding RNA, Mediates Transcription Factors and Target Genes through Interference of MicroRNAs in Pan-Cancer.
Neoplasms
Hallmark microRNA signature in liquid biopsy identifies hepatocellular carcinoma and differentiates it from liver metastasis.
Neoplasms
HAMP Downregulation Contributes to Aggressive Hepatocellular Carcinoma via Mechanism Mediated by Cyclin4-Dependent Kinase-1/STAT3 Pathway.
Neoplasms
HAO2 inhibits malignancy of clear cell renal cell carcinoma by promoting lipid catabolic process.
Neoplasms
Haptoglobin expression correlates with tumor differentiation and five-year overall survival rate in hepatocellular carcinoma.
Neoplasms
Hard wiring of normal tissue-specific chromosome-wide gene expression levels is an additional factor driving cancer type-specific aneuploidies.
Neoplasms
Harnessing stemness and PD-L1 expression by AT-rich interaction domain-containing protein 3B in colorectal cancer.
Neoplasms
HARVESTMAN: a framework for hierarchical feature learning and selection from whole genome sequencing data.
Neoplasms
HAVCR1 Affects the MEK/ERK Pathway in Gastric Adenocarcinomas and Influences Tumor Progression and Patient Outcome.
Neoplasms
HAX1 enhances the survival and metastasis of non-small cell lung cancer through the AKT/mTOR and MDM2/p53 signaling pathway.
Neoplasms
HCG18 Participates in Vascular Invasion of Hepatocellular Carcinoma by Regulating Macrophages and Tumor Stem Cells.
Neoplasms
HDAC6-dependent ciliophagy is involved in ciliary loss and cholangiocarcinoma growth in human cells and murine models.
Neoplasms
HDAC9 Is Preferentially Expressed in Dedifferentiated Hepatocellular Carcinoma Cells and Is Involved in an Anchorage-Independent Growth.
Neoplasms
HDNA methylation data-based molecular subtype classification related to the prognosis of patients with hepatocellular carcinoma.
Neoplasms
Head and Neck Cancers Promote an Inflammatory Transcriptome through Coactivation of Classic and Alternative NF-?B Pathways.
Neoplasms
Head and neck squamous cancer progression is marked by CLIC4 attenuation in tumor epithelium and reciprocal stromal upregulation of miR-142-3p, a novel post-transcriptional regulator of CLIC4.
Neoplasms
Head and neck squamous cell carcinoma: Ambiguous human papillomavirus status, elevated p16, and deleted retinoblastoma 1.
Neoplasms
Heat shock factor 5 correlated with immune infiltration serves as a prognostic biomarker in lung adenocarcinoma.
Neoplasms
Heat shock protein 47 promotes tumor survival and therapy resistance by modulating AKT signaling via PHLPP1 in colorectal cancer.
Neoplasms
Heat Shock Protein Beta 1 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma.
Neoplasms
Heat shock proteins create a signature to predict the clinical outcome in breast cancer.
Neoplasms
Hedgehog Interacting Protein 1 is a Prognostic Marker and Suppresses Cell Metastasis in Gastric Cancer.
Neoplasms
HEDGEHOG/GLI Modulates the PRR11-SKA2 Bidirectional Transcription Unit in Lung Squamous Cell Carcinomas.
Neoplasms
HeLa nucleic acid contamination in The Cancer Genome Atlas leads to the misidentification of HPV18.
Neoplasms
Helicase POLQ-like (HELQ) as a novel indicator of platinum-based chemoresistance for epithelial ovarian cancer.
Neoplasms
Hematopoietic Gene Expression Regulation Through m6A Methylation Predicts Prognosis in Stage III Colorectal Cancer.
Neoplasms
Hematopoietic-substrate-1 associated protein X-1 (HAX-1) regulates liver cancer cells growth, metastasis, and angiogenesis through Akt.
Neoplasms
Heme Biosynthesis mRNA Expression Signature: Towards a Novel Prognostic Biomarker in Patients with Diffusely Infiltrating Gliomas.
Neoplasms
Hepatitis B virus-X protein regulates high mobility group box 1 to promote the formation of hepatocellular carcinoma.
Neoplasms
Hepatobiliary malignancies have distinct peripheral myeloid-derived suppressor cell signatures and tumor myeloid cell profiles.
Neoplasms
Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
Neoplasms
Hepatocyte growth factor receptor, matrix metalloproteinase-11, tissue inhibitor of metalloproteinase-1, and fibronectin are up-regulated in papillary thyroid carcinoma: a cDNA and tissue microarray study.
Neoplasms
Hepatocyte nuclear factor 1? suppresses steatosis-associated liver cancer by inhibiting PPAR? transcription.
Neoplasms
Hepcidin Downregulation Correlates With Disease Aggressiveness And Immune Infiltration in Liver Cancers.
Neoplasms
HER2 and APC Mutations Promote Altered Crypt-Villus Morphology and Marked Hyperplasia in the Intestinal Epithelium.
Neoplasms
HER2-Mutated Breast Cancer Responds to Treatment With Single-Agent Neratinib, a Second-Generation HER2/EGFR Tyrosine Kinase Inhibitor.
Neoplasms
HERC3-Mediated SMAD7 Ubiquitination Degradation Promotes Autophagy-Induced EMT and Chemoresistance in Glioblastoma.
Neoplasms
Hereditary multiple exostoses and cervical ventral protuberance causing dysphagia. A case report.
Neoplasms
Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinoma.
Neoplasms
Heterogeneity Analysis of Esophageal Squamous Cell Carcinoma in Cell Lines, Tumor Tissues and Patient-Derived Xenografts.
Neoplasms
Heterogeneity of PTEN and PPAR-? in cancer and their prognostic application to bladder cancer.
Neoplasms
Heterogeneity of tumor-infiltrating lymphocytes ascribed to local immune status rather than neoantigens by multi-omics analysis of glioblastoma multiforme.
Neoplasms
Heterogeneous Enhancement Patterns of Tumor-adjacent Parenchyma at MR Imaging Are Associated with Dysregulated Signaling Pathways and Poor Survival in Breast Cancer.
Neoplasms
Heterozygous IDH1R132H/WT created by "single base editing" inhibits human astroglial cell growth by downregulating YAP.
Neoplasms
Hexokinase 3 dysfunction promotes tumorigenesis and immune escape by upregulating monocyte/macrophage infiltration into the clear cell renal cell carcinoma microenvironment.
Neoplasms
Hexokinase-II Inhibition Synergistically Augments the Anti-tumor Efficacy of Sorafenib in Hepatocellular Carcinoma.
Neoplasms
HGT-ID: an efficient and sensitive workflow to detect human-viral insertion sites using next-generation sequencing data.
Neoplasms
HHLA2 is a novel prognostic predictor and potential therapeutic target in malignant glioma.
Neoplasms
Hierarchical Normalized Completely Random Measures for Robust Graphical Modeling.
Neoplasms
HIF1A expression correlates with increased tumor immune and stromal signatures and aggressive phenotypes in human cancers.
Neoplasms
HIF3A DNA methylation, obesity and weight gain, and breast cancer risk among Mexican American women.
Neoplasms
High Abundance of Intratumoral ?? T Cells Favors a Better Prognosis in Head and Neck Squamous Cell Carcinoma: A Bioinformatic Analysis.
Neoplasms
High ADAMTS18 expression is associated with poor prognosis in stomach adenocarcinoma.
Neoplasms
High ANKZF1 expression is associated with poor overall survival and recurrence-free survival in colon cancer.
Neoplasms
High APOBEC1 Complementation Factor Expression Positively Modulates the Proliferation, Invasion, and Migration of Endometrial Cancer Cells Through Regulating P53/P21 Signaling Pathway.
Neoplasms
High BIRC7 Expression Might Be an Independent Prognostic Indicator of Poor Recurrence-Free Survival in Patients With Prostate Cancer.
Neoplasms
High BLM Expression Predicts Poor Clinical Outcome and Contributes to Malignant Progression in Human Cholangiocarcinoma.
Neoplasms
High BMI1 Expression with Low CD8+ and CD4+ T Cell Activity Could Promote Breast Cancer Cell Survival: A Machine Learning Approach.
Neoplasms
High BRCA2 Gene Expression is Associated with Aggressive and Highly Proliferative Breast Cancer.
Neoplasms
High CXCR2 expression predicts poor prognosis in adult patients with acute myeloid leukemia.
Neoplasms
High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma.
Neoplasms
High EGFL7 expression may predict poor prognosis in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation.
Neoplasms
High EIF2B5 mRNA expression and its prognostic significance in liver cancer: a study based on the TCGA and GEO database.
Neoplasms
High EIF4E2 expression is an independent prognostic risk factor for poor overall survival and recurrence-free survival in uveal melanoma.
Neoplasms
High ELF4 expression in human cancers is associated with worse disease outcomes and increased resistance to anticancer drugs.
Neoplasms
High EMP3 expression might independently predict poor overall survival in glioblastoma and its expression is related to DNA methylation.
Neoplasms
High expression level of MMP9 is associated with poor prognosis in patients with clear cell renal carcinoma.
Neoplasms
High Expression Levels of ACTN1 and ACTN3 Indicate Unfavorable Prognosis in Acute Myeloid Leukemia.
Neoplasms
High Expression Levels of CDK1 and CDC20 in Patients With Lung Squamous Cell Carcinoma are Associated With Worse Prognosis.
Neoplasms
High expression levels of centromere protein A plus upregulation of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling pathway affect chemotherapy response and prognosis in patients with breast cancer.
Neoplasms
High expression levels of DEF6 predicts a poor prognosis for patients with clear cell renal cell carcinoma.
Neoplasms
High expression levels of pyrimidine metabolic rate-limiting enzymes are adverse prognostic factors in lung adenocarcinoma: a study based on The Cancer Genome Atlas and Gene Expression Omnibus datasets.
Neoplasms
High Expression of ABRACL Is Associated with Tumorigenesis and Affects Clinical Outcome in Gastric Cancer.
Neoplasms
High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa.
Neoplasms
High expression of ACTL8 is poor prognosis and accelerates cell progression in head and neck squamous cell carcinoma.
Neoplasms
High expression of AK1 predicts inferior prognosis in acute myeloid leukemia patients undergoing chemotherapy.
Neoplasms
High expression of AMPD2 and obesity are associated with poor prognosis in colorectal cancer.
Neoplasms
High expression of Annexin A2 is associated with DNA repair, metabolic alteration, and worse survival in pancreatic ductal adenocarcinoma.
Neoplasms
High Expression of ANXA2 Pseudogene ANXA2P2 Promotes an Aggressive Phenotype in Hepatocellular Carcinoma.
Neoplasms
High expression of ASPM correlates with tumor progression and predicts poor outcome in patients with prostate cancer.
Neoplasms
High Expression of BCAR1 by Circulating Tumor Cells and Tumor Tissues Is Predictive of a Poor Prognosis of Early-Stage Lung Adenocarcinoma Potentially Due to Regulation of Epithelial-Mesenchymal Transition.
Neoplasms
High expression of bone morphogenetic protein (BMP) 6 and BMP7 are associated with higher immune cell infiltration and better survival in estrogen receptor?positive breast cancer.
Neoplasms
High expression of CD56 may be associated with favorable overall survival in intermediate-risk acute myeloid leukemia.
Neoplasms
High expression of CDCA7 predicts poor prognosis for clear cell renal cell carcinoma and explores its associations with immunity.
Neoplasms
High Expression of CLEC11A Predicts Favorable Prognosis in Acute Myeloid Leukemia.
Neoplasms
High expression of COL5A2, a member of COL5 family, indicates the poor survival and facilitates cell migration in gastric cancer.
Neoplasms
High expression of COPB2 predicts adverse outcomes: A potential therapeutic target for glioma.
Neoplasms
High expression of DLC family proteins predicts better prognosis and inhibits tumor progression in NSCLC.
Neoplasms
High expression of DLG3 is associated with decreased survival from breast cancer.
Neoplasms
High expression of DLL3 is associated with a poor prognosis and immune infiltration in invasive breast cancer patients.
Neoplasms
High expression of EMP1 predicts a poor prognosis and correlates with immune infiltrates in bladder urothelial carcinoma.
Neoplasms
High Expression of FAP in Colorectal Cancer Is Associated With Angiogenesis and Immunoregulation Processes.
Neoplasms
High Expression of FGD3, a Putative Regulator of Cell Morphology and Motility, Is Prognostic of Favorable Outcome in Multiple Cancers.
Neoplasms
High expression of FOXO3 is associated with poor prognosis in patients with hepatocellular carcinoma.
Neoplasms
High expression of growth factor receptor-bound protein 14 predicts poor prognosis for colorectal cancer patients.
Neoplasms
High expression of HSP90 is associated with poor prognosis in patients with colorectal cancer.
Neoplasms
High Expression of Human AugminComplex Submit 3 Indicates Poor Prognosis and Associates with Tumor Progression in Hepatocellular Carcinoma.
Neoplasms
High Expression of Hyaluronan-Mediated Motility Receptor Predicts Adverse Outcomes: A Potential Therapeutic Target for Head and Neck Squamous Cell Carcinoma.
Neoplasms
High expression of interleukin-enhancer binding factor 3 predicts poor prognosis in patients with lung adenocarcinoma.
Neoplasms
High expression of IQGAP3 indicates poor prognosis in colorectal cancer patients.
Neoplasms
High Expression of KIF22/Kinesin-Like DNA Binding Protein (Kid) as a Poor Prognostic Factor in Prostate Cancer Patients.
Neoplasms
High expression of KITLG is a new hallmark activating the MAPK pathway in type A and AB thymoma.
Neoplasms
High Expression of lncRNA AFAP1-AS1 Promotes the Progression of Colon Cancer and Predicts Poor Prognosis.
Neoplasms
High Expression of Long Noncoding RNA 01410 Serves as a Potential Diagnostic and Prognostic Marker in Patients with Colorectal Cancer.
Neoplasms
High expression of matrix metalloproteinases 16 is associated with the aggressive malignant behavior and poor survival outcome in colorectal carcinoma.
Neoplasms
High Expression of microRNA-143 is Associated with Favorable Tumor Immune Microenvironment and Better Survival in Estrogen Receptor Positive Breast Cancer.
Neoplasms
High Expression of microRNA-223 Indicates a Good Prognosis in Triple-Negative Breast Cancer.
Neoplasms
High expression of microRNA-500 is associated with poor prognosis in patients with acute myeloid leukemia receiving allogeneic hematopoietic stem cell transplantation.
Neoplasms
High expression of miR-195 is related to favorable prognosis in cytogenetically normal acute myeloid leukemia.
Neoplasms
High Expression of miR-206 Predicts Adverse Outcomes: A Potential Therapeutic Target for Esophageal Cancer.
Neoplasms
High Expression of miR-34a Associated with Less Aggressive Cancer Biology but Not with Survival in Breast Cancer.
Neoplasms
High expression of miR-532-5p, a tumor suppressor, leads to better prognosis in ovarian cancer both in vivo and in vitro.
Neoplasms
High expression of MiR-98 is a good prognostic factor in acute myeloid leukemia patients treated with chemotherapy alone.
Neoplasms
High expression of MKK3 is associated with worse clinical outcomes in African American breast cancer patients.
Neoplasms
High expression of MMP14 is associated with progression and poor short-term prognosis in muscle-invasive bladder cancer.
Neoplasms
High expression of MMP19 is associated with poor prognosis in patients with colorectal cancer.
Neoplasms
High expression of MUC20 drives tumorigenesis and predicts poor survival in endometrial cancer.
Neoplasms
High expression of N-myc (and STAT) interactor predicts poor prognosis and promotes tumor growth in human glioblastoma.
Neoplasms
High expression of NME1 correlates with progression and poor prognosis in patients of hepatocellular carcinoma.
Neoplasms
High expression of oncogene cadherin-6 correlates with tumor progression and a poor prognosis in gastric cancer.
Neoplasms
High expression of PD-1 ligands is associated with kataegis mutational signature and APOBEC3 alterations.
Neoplasms
High expression of PIMREG predicts poor survival outcomes and is correlated with immune infiltrates in lung adenocarcinoma.
Neoplasms
High expression of PKM2 synergizes with PD-L1 in tumor cells and immune cells to predict worse survival in human lung adenocarcinoma.
Neoplasms
High expression of PLAC1 in colon cancer as a predictor of poor prognosis: A study based on TCGA data.
Neoplasms
High Expression of PLOD1 Drives Tumorigenesis and Affects Clinical Outcome in Gastrointestinal Carcinoma.
Neoplasms
High expression of PYCARD is an independent predictor of unfavorable prognosis and chemotherapy resistance in glioma.
Neoplasms
High Expression of Retinoic Acid Induced 14 (RAI14) in Gastric Cancer and Its Prognostic Value.
Neoplasms
High expression of RFX4 is associated with tumor progression and poor prognosis in patients with glioblastoma.
Neoplasms
High expression of RRM2 as an independent predictive factor of poor prognosis in patients with lung adenocarcinoma.
Neoplasms
High expression of SIX1 is an independent predictor of poor prognosis in endometrial cancer.
Neoplasms
High expression of SLCO2B1 is associated with prostate cancer recurrence after radical prostatectomy.
Neoplasms
High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer.
Neoplasms
High expression of spermatogenesis associated serine rich 2 promotes tumorigenicity in esophageal squamous cell carcinoma cells and is associated with poor patient prognosis.
Neoplasms
High expression of stromal signatures correlated with macrophage infiltration, angiogenesis and poor prognosis in glioma microenvironment.
Neoplasms
High expression of TCF12 contributes to gastric cancer development via being target regulated by miR-183 and activating PI3K/AKT pathway.
Neoplasms
High Expression of the Long Noncoding RNA SNHG15 in Cancer Tissue Samples Predicts an Unfavorable Prognosis of Cancer Patients: A Meta-Analysis.
Neoplasms
High Expression of the Sda Synthase B4GALNT2 Associates with Good Prognosis and Attenuates Stemness in Colon Cancer.
Neoplasms
High expression of TIG3 predicts poor survival in patients with primary glioblastoma.
Neoplasms
High expression of TOP2A in hepatocellular carcinoma is associated with disease progression and poor prognosis.
Neoplasms
High Expression of UBB, RAC1, and ITGB1 Predicts Worse Prognosis among Nonsmoking Patients with Lung Adenocarcinoma through Bioinformatics Analysis.
Neoplasms
High expression of WDR1 in primary glioblastoma is associated with poor prognosis.
Neoplasms
High expression of WTAP leads to poor prognosis of gastric cancer by influencing tumour-associated T lymphocyte infiltration.
Neoplasms
High filamin-C expression predicts enhanced invasiveness and poor outcome in glioblastoma multiforme.
Neoplasms
High FREM2 Gene and Protein Expression Are Associated with Favorable Prognosis of IDH-WT Glioblastomas.
Neoplasms
High gene expression of estrogen and progesterone receptors is associated with decreased t cell infiltration in patients with NSCLC.
Neoplasms
High GILT Expression and an Active and Intact MHC Class II Antigen Presentation Pathway Are Associated with Improved Survival in Melanoma.
Neoplasms
High GJB2 mRNA expression and its prognostic significance in lung adenocarcinoma: a study based on the TCGA database.
Neoplasms
High integrin ?3 expression is associated with poor prognosis in patients with non-small cell lung cancer.
Neoplasms
High KCNQ1OT1 expression might independently predict shorter survival of colon adenocarcinoma.
Neoplasms
High KDM1A Expression Associated with Decreased CD8+T Cells Reduces the Breast Cancer Survival Rate in Patients with Breast Cancer.
Neoplasms
High kinesin family member 18A expression correlates with poor prognosis in primary lung adenocarcinoma.
Neoplasms
High KRT8 Expression Independently Predicts Poor Prognosis for Lung Adenocarcinoma Patients.
Neoplasms
High Level Expression of MHC-II in HPV+ Head and Neck Cancers Suggests that Tumor Epithelial Cells Serve an Important Role as Accessory Antigen Presenting Cells.
Neoplasms
High level of chromosomal aberration in ovarian cancer genome correlates with poor clinical outcome.
Neoplasms
High Level of Legumain Was Correlated With Worse Prognosis and Peritoneal Metastasis in Gastric Cancer Patients.
Neoplasms
High Level of Plasma EGFL6 Is Associated with Clinicopathological Characteristics in Patients with Oral Squamous Cell Carcinoma.
Neoplasms
High levels of glioma tumor suppressor candidate region gene 1 predicts a poor prognosis for prostate cancer.
Neoplasms
High levels of WNT-5A in human glioma correlate with increased presence of tumor-associated microglia/monocytes.
Neoplasms
High MAST2 mRNA expression and its role in diagnosis and prognosis of liver cancer.
Neoplasms
High Matrix Metalloproteinase 28 Expression is Associated with Poor Prognosis in Pancreatic Adenocarcinoma.
Neoplasms
High Membranous Expression of Fatty Acid Transport Protein 4 Is Associated with Tumorigenesis and Tumor Progression in Clear Cell Renal Cell Carcinoma.
Neoplasms
High miR-139-3p expression predicts a better prognosis for hepatocellular carcinoma: a pooled analysis.
Neoplasms
High MMP-11 expression associated with low CD8+ T cells decreases the survival rate in patients with breast cancer.
Neoplasms
High mTORC1 activity drives glycolysis addiction and sensitivity to G6PD inhibition in acute myeloid leukemia cells.
Neoplasms
High MYBL2 expression and transcription regulatory activity is associated with poor overall survival in patients with hepatocellular carcinoma.
Neoplasms
High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia.
Neoplasms
High P4HA1 expression is an independent prognostic factor for poor overall survival and recurrent-free survival in head and neck squamous cell carcinoma.
Neoplasms
High PD-L1 expression in gastric cancer (GC) patients and correlation with molecular features.
Neoplasms
High peroxidasin-like expression is a potential and independent prognostic biomarker in breast cancer.
Neoplasms
High Phosphoglycerate Dehydrogenase Expression Induces Stemness and Aggressiveness in Thyroid Cancer.
Neoplasms
High polymerase ? expression associated with increased CD8+T cells improves survival in patients with non-small cell lung cancer.
Neoplasms
High preoperative levels of circulating SFRP5 predict better prognosis in colorectal cancer patients.
Neoplasms
High prevalence of TP53 loss and whole-genome doubling in early-onset colorectal cancer.
Neoplasms
High PRMT5 expression is associated with poor overall survival and tumor progression in bladder cancer.
Neoplasms
High risk human papilloma viruses (HPVs) are present in benign prostate tissues before development of HPV associated prostate cancer.
Neoplasms
High S100A9+ cell density predicts a poor prognosis in hepatocellular carcinoma patients after curative resection.
Neoplasms
High SEC61G expression predicts poor prognosis in patients with Head and Neck Squamous Cell Carcinomas.
Neoplasms
High selectivity of PI3K? inhibitors in SETD2-mutated renal clear cell carcinoma.
Neoplasms
High SGO2 Expression Predicts Poor Overall Survival: A Potential Therapeutic Target for Hepatocellular Carcinoma.
Neoplasms
High SLC2A1 expression associated with suppressing CD8 T cells and B cells promoted cancer survival in gastric cancer.
Neoplasms
High SLC4A11 expression is an independent predictor for poor overall survival in grade 3/4 serous ovarian cancer.
Neoplasms
High Somatic Mutation and Neoantigen Burden Do Not Correlate with Decreased Progression-Free Survival in HCC Patients not Undergoing Immunotherapy.
Neoplasms
High SPINK1 Expression Predicts Poor Prognosis and Promotes Cell Proliferation and Metastasis of Hepatocellular Carcinoma.
Neoplasms
High SQLE Expression and Gene Amplification Correlates with Poor Prognosis in Head and Neck Squamous Cell Carcinoma.
Neoplasms
High Squalene Epoxidase in Tumors Predicts Worse Survival in Patients With Hepatocellular Carcinoma: Integrated Bioinformatic Analysis on NAFLD and HCC.
Neoplasms
High stathmin expression is a marker for poor clinical outcome in endometrial cancer: An NRG oncology group/gynecologic oncology group study.
Neoplasms
High TGF-?1 expression predicts poor disease prognosis in hepatocellular carcinoma patients.
Neoplasms
High TRIAP1 expression in penile carcinoma is associated with high risk of recurrence and poor survival.
Neoplasms
High Trophinin-Associated Protein Expression Is an Independent Predictor of Poor Survival in Liver Cancer.
Neoplasms
High Tumor Mutation Burden and Other Immunotherapy Response Predictors in Breast Cancers: Associations and Therapeutic Opportunities.
Neoplasms
High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types.
Neoplasms
High ubiquitin conjugating enzyme E2 T mRNA expression and its prognostic significance in lung adenocarcinoma: A study based on the TCGA database.
Neoplasms
High VHL Expression Reverses Warburg Phenotype and Enhances Immunogenicity in Kidney Tumor Cells.
Neoplasms
High Vimentin Expression Predicts a Poor Prognosis and Progression in Colorectal Cancer: A Study with Meta-Analysis and TCGA Database.
Neoplasms
High-affinity peptide ligand LXY30 for targeting ?3?1 integrin in non-small cell lung cancer.
Neoplasms
High-definition CpG methylation of novel genes in gastric carcinogenesis identified by next-generation sequencing.
Neoplasms
High-depth, high-accuracy microsatellite genotyping enables precision lung cancer risk classification.
Neoplasms
High-dimensional covariance matrices tests for analyzing multi-tumor gene expression data.
Neoplasms
High-grade gliomas located in the right hemisphere are associated with worse quality of life.
Neoplasms
High-Performance Computational Analysis of Glioblastoma Pathology Images with Database Support Identifies Molecular and Survival Correlates.
Neoplasms
High-resolution profiling of histone h3 lysine 36 trimethylation in metastatic renal cell carcinoma.
Neoplasms
High-risk Stage III colon cancer patients identified by a novel five-gene mutational signature are characterized by upregulation of IL-23A and gut bacterial translocation of the tumor microenvironment.
Neoplasms
High-throughput adaptive sampling for whole-slide histopathology image analysis (HASHI) via convolutional neural networks: Application to invasive breast cancer detection.
Neoplasms
High-Throughput Genomic Profiling of Adult Solid Tumors Reveals Novel Insights into Cancer Pathogenesis.
Neoplasms
High-throughput Single-cell Mass Spectrometry Reveals Abnormal Lipid Metabolism in Pancreatic Ductal Adenocarcinoma.
Neoplasms
Higher cytolytic score correlates with an immunosuppressive tumor microenvironment and reduced survival in glioblastoma.
Neoplasms
Higher ETV5 Expression Associates With Poor 5-Florouracil-Based Adjuvant Therapy Response in Colon Cancer.
Neoplasms
Higher expression of cation transport regulator-like protein 1 (CHAC1) predicts of poor outcomes in uveal melanoma (UM) patients.
Neoplasms
Higher expression of cell division cycle-associated protein 5 predicts poorer survival outcomes in hepatocellular carcinoma.
Neoplasms
Higher programmed cell death 1 ligand 1 (PD-L1) mRNA level in clear cell renal cell carcinomas is associated with a favorable outcome due to the active immune responses in tumor tissues.
Neoplasms
Higher variety and quantity of microRNA-139-5p isoforms confer suppressive role in hepatocellular carcinoma.
Neoplasms
Highlights from the 15th St Gallen International Breast Cancer Conference 15-18 March, 2017, Vienna: tailored treatments for patients with early breast cancer.
Neoplasms
Highly accurate diagnosis of papillary thyroid carcinomas based on personalized pathways coupled with machine learning.
Neoplasms
Highly connected, non-redundant microRNA functional control in breast cancer molecular subtypes.
Neoplasms
Highly Expressed CYBRD1 Associated with Glioma Recurrence Regulates the Immune Response of Glioma Cells to Interferon.
Neoplasms
Highly robust model of transcription regulator activity predicts breast cancer overall survival.
Neoplasms
HILPDA Is a Prognostic Biomarker and Correlates With Macrophage Infiltration in Pan-Cancer.
Neoplasms
Hippo pathway affects survival of cancer patients: extensive analysis of TCGA data and review of literature.
Neoplasms
Hippo Pathway Core Genes Based Prognostic Signature and Immune Infiltration Patterns in Lung Squamous Cell Carcinoma.
Neoplasms
Hispanic/Latino Patients with Gastric Adenocarcinoma Have Distinct Molecular Profiles Including a High Rate of Germline CDH1 Variants.
Neoplasms
Histo- and immunohistochemistry-based estimation of the TCGA and ACRG molecular subtypes for gastric carcinoma and their prognostic significance: A single-institution study.
Neoplasms
Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification.
Neoplasms
Histone 2A Family Member J Drives Mesenchymal Transition and Temozolomide Resistance in Glioblastoma Multiforme.
Neoplasms
Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro.
Neoplasms
Histone deacetylase inhibitor-induced cell death in bladder cancer is associated with chromatin modification and modifying protein expression: A proteomic approach.
Neoplasms
Histone H3 lysine 23 acetylation is associated with oncogene TRIM24 expression and a poor prognosis in breast cancer.
Neoplasms
Histone Methyltransferase G9a-Promoted Progression of Hepatocellular Carcinoma Is Targeted by Liver-Specific Hsa-miR-122.
Neoplasms
Histone modifications affect differential regulation of TGF?- induced NADPH oxidase 4 (NOX4) by wild-type and mutant p53.
Neoplasms
Histone-Related Genes Are Hypermethylated in Lung Cancer and Hypermethylated HIST1H4F Could Serve as a Pan-Cancer Biomarker.
Neoplasms
Histopathological characteristics and artificial intelligence for predicting tumor mutational burden-high colorectal cancer.
Neoplasms
Histopathological image and gene expression pattern analysis for predicting molecular features and prognosis of head and neck squamous cell carcinoma.
Neoplasms
Histopathological Image Classification Using Discriminative Feature-Oriented Dictionary Learning.
Neoplasms
Histopathological imaging-based cancer heterogeneity analysis via penalized fusion with model averaging.
Neoplasms
Histopathological typing in diffuse malignant epithelioid mesothelioma: implication for prognosis and molecular basis.
Neoplasms
Histopathology classification and localization of colorectal cancer using global labels by weakly supervised deep learning.
Neoplasms
HJURP is a prognostic biomarker for clear cell renal cell carcinoma and is linked to immune infiltration.
Neoplasms
HK3 is correlated with immune infiltrates and predicts response to immunotherapy in non-small cell lung cancer.
Neoplasms
HK3 overexpression associated with epithelial-mesenchymal transition in colorectal cancer.
Neoplasms
HLA class I binding of mutant EGFR peptides in NSCLC is associated with improved survival.
Neoplasms
HLA class I restricted epitopes prediction of common tumor antigens in white and East Asian populations: Implication on antigen selection for cancer vaccine design.
Neoplasms
HLA class-I and class-II restricted neoantigen loads predict overall survival in breast cancer.
Neoplasms
HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy.
Neoplasms
HMGA1-Regulating microRNAs Let-7a and miR-26a are Downregulated in Human Seminomas.
Neoplasms
HMGCS2 in metabolic pathways was associated with overall survival in hepatocellular carcinoma: A LASSO-derived study.
Neoplasms
HN1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by interacting with STMN1.
Neoplasms
HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395.
Neoplasms
hnRNPA2B1 regulates the alternative splicing of BIRC5 to promote gastric cancer progression.
Neoplasms
HNRNPD interacts with ZHX2 regulating the vasculogenic mimicry formation of glioma cells via linc00707/miR-651-3p/SP2 axis.
Neoplasms
HNRNPH1-stabilized LINC00662 promotes ovarian cancer progression by activating the GRP78/p38 pathway.
Neoplasms
hnRNPK promotes gastric tumorigenesis through regulating CD44E alternative splicing.
Neoplasms
Homeobox B4 inhibits breast cancer cell migration by directly binding to StAR-related lipid transfer domain protein 13.
Neoplasms
Homeobox genes gain trimethylation of histone H3 lysine 4 in glioblastoma tissue.
Neoplasms
Homeodomain-containing gene 10 inhibits cell apoptosis and promotes cell invasion and migration in osteosarcoma cell lines.
Neoplasms
Homeodomain-interacting protein kinase 2 suppresses proliferation and aerobic glycolysis via ERK/cMyc axis in pancreatic cancer.
Neoplasms
Homologous recombination deficiency status-based classification of high-grade serous ovarian carcinoma.
Neoplasms
Homologous recombination repair rathway and RAD54L in early-stage lung adenocarcinoma.
Neoplasms
Homozygous deletions at 3p22, 5p14, 6q15, and 9p21 result in aberrant expression of tumor suppressor genes in gastric cancer.
Neoplasms
HOPX homeobox methylation in differentiated thyroid cancer and its clinical relevance.
Neoplasms
Hormone Receptor-Status Prediction in Breast Cancer Using Gene Expression Profiles and Their Macroscopic Landscape.
Neoplasms
Hormone therapy use and breast tissue DNA methylation: analysis of epigenome wide data from the normal breast study.
Neoplasms
HOTAIR rs7958904 polymorphism is associated with increased cervical cancer risk in a Chinese population.
Neoplasms
Hotspot mutations delineating diverse mutational signatures and biological utilities across cancer types.
Neoplasms
HotSpot3D web server: an integrated resource for mutation analysis in protein 3D structures.
Neoplasms
HOTTIP Functions as a Key Candidate Biomarker in Head and Neck Squamous Cell Carcinoma by Integrated Bioinformatic Analysis.
Neoplasms
How Can Gene-Expression Information Improve Prognostic Prediction in TCGA Cancers: An Empirical Comparison Study on Regularization and Mixed Cox Models.
Neoplasms
How Can Next-Generation Sequencing (Genomics) Help Us in Treating Colorectal Cancer?
Neoplasms
How Young Is Too Young in Breast Cancer?-Young Breast Cancer Is Not a Unique Biological Subtype.
Neoplasms
HOX Transcript Antisense RNA HOTAIR Abrogates Vasculogenic Mimicry by Targeting the AngiomiR-204/FAK Axis in Triple Negative Breast Cancer Cells.
Neoplasms
HOXA4/HOXB3 gene expression signature as a biomarker of recurrence in patients with high-grade serous ovarian cancer following primary cytoreductive surgery and first-line adjuvant chemotherapy.
Neoplasms
HOXB5 acts as an oncogenic driver in head and neck squamous cell carcinoma via EGFR/Akt/Wnt/?-catenin signaling axis.
Neoplasms
HOXB5 promotes malignant progression in pancreatic cancer via the miR-6732 pathway.
Neoplasms
HOXC10 promotes proliferation and invasion and induces immunosuppressive gene expression in glioma.
Neoplasms
HOXC11 Expression Is Associated with the Progression of Colon Adenocarcinoma and Is a Prognostic Biomarker.
Neoplasms
HOXC11 functions as a novel oncogene in human colon adenocarcinoma and kidney renal clear cell carcinoma.
Neoplasms
HOXC13 promotes cervical cancer proliferation, invasion and Warburg effect through ?-catenin/c-Myc signaling pathway.
Neoplasms
HOXC13 promotes proliferation of lung adenocarcinoma via modulation of CCND1 and CCNE1.
Neoplasms
HOXD1 functions as a novel tumor suppressor in kidney renal clear cell carcinoma.
Neoplasms
HOXD13 promotes the malignant progression of colon cancer by upregulating PTPRN2.
Neoplasms
HOXD8 exerts a tumor-suppressing role in colorectal cancer as an apoptotic inducer.
Neoplasms
HPASubC: A suite of tools for user subclassification of human protein atlas tissue images.
Neoplasms
HPSE enhancer RNA promotes cancer progression through driving chromatin looping and regulating hnRNPU/p300/EGR1/HPSE axis.
Neoplasms
HPV + HNSCC-derived exosomal miR-9 induces macrophage M1 polarization and increases tumor radiosensitivity.
Neoplasms
HPV induction of APOBEC3 enzymes mediate overall survival and response to cisplatin in head and neck cancer.
Neoplasms
HPV-related methylation-based reclassification and risk stratification of cervical cancer.
Neoplasms
HPV33+ HNSCC is associated with poor prognosis and has unique genomic and immunologic landscapes.
Neoplasms
HRAS as a potential therapeutic target of salirasib RAS inhibitor in bladder cancer.
Neoplasms
HS3ST2 and Its Related Molecules as Potential Biomarkers for Predicting Lymph Node Metastasis in Patients with Colorectal Cancer.
Neoplasms
Hsa-mir-127 impairs survival of patients with glioma and promotes proliferation, migration and invasion of cancerous cells by modulating replication initiator 1.
Neoplasms
hsa-miR-135a-1 inhibits prostate cancer cell growth and migration by targeting EGFR.
Neoplasms
hsa-mir-30c promotes the invasive phenotype of metastatic breast cancer cells by targeting NOV/CCN3.
Neoplasms
hsa_circ_0101119 facilitates the progression of cervical cancer via an interaction with EIF4A3 to inhibit TCEAL6 expression.
Neoplasms
HSD17B4, ACAA1, and PXMP4 in Peroxisome Pathway Are Down-Regulated and Have Clinical Significance in Non-small Cell Lung Cancer.
Neoplasms
hsegHMM: hidden Markov model-based allele-specific copy number alteration analysis accounting for hypersegmentation.
Neoplasms
HSF2 regulates aerobic glycolysis by suppression of FBP1 in hepatocellular carcinoma.
Neoplasms
HSP60 silencing promotes Warburg-like phenotypes and switches the mitochondrial function from ATP production to biosynthesis in ccRCC cells.
Neoplasms
HSP70 promotes tumor progression by stabilizing Skp2 expression in gastric cancer cells.
Neoplasms
HSP70/HSP90-Organizing Protein Contributes to Gastric Cancer Progression in an Autocrine Fashion and Predicts Poor Survival in Gastric Cancer.
Neoplasms
HSPD1 repressed E-cadherin expression to promote cell invasion and migration for poor prognosis in oral squamous cell carcinoma.
Neoplasms
HTR1D, TIMP1, SERPINE1, MMP3 and CNR2 affect the survival of patients with colon adenocarcinoma.
Neoplasms
HTRA3 Is a Prognostic Biomarker and Associated With Immune Infiltrates in Gastric Cancer.
Neoplasms
Huanglian decoction suppresses the growth of hepatocellular carcinoma cells by reducing CCNB1 expression.
Neoplasms
Hub Long Noncoding RNAs with m6A Modification for Signatures and Prognostic Values in Kidney Renal Clear Cell Carcinoma.
Neoplasms
Human ALKBH6 Is Required for Maintenance of Genomic Stability and Promoting Cell Survival During Exposure of Alkylating Agents in Pancreatic Cancer.
Neoplasms
Human Endogenous Retrovirus Expression Is Associated with Head and Neck Cancer and Differential Survival.
Neoplasms
Human epidermal growth factor receptor 2 expression in head and neck squamous cell carcinoma: Variation within and across primary tumor sites, and implications for antigen-specific immunotherapy.
Neoplasms
Human Hematopoietic Signal peptide-containing Secreted 1 (hHSS1) modulates genes and pathways in glioma: implications for the regulation of tumorigenicity and angiogenesis.
Neoplasms
Human nuclear receptors (NRs) genes have prognostic significance in hepatocellular carcinoma patients.
Neoplasms
Human Papillomavirus 16 E2 Regulates Keratinocyte Gene Expression Relevant to Cancer and the Viral Life Cycle.
Neoplasms
Human Papillomavirus Drives Tumor Development Throughout the Head and Neck: Improved Prognosis Is Associated With an Immune Response Largely Restricted to the Oropharynx.
Neoplasms
Human papillomavirus dysregulates the cellular apparatus controlling the methylation status of H3K27 in different human cancers to consistently alter gene expression regardless of tissue of origin.
Neoplasms
Human RECQL5 promotes metastasis and resistance to cisplatin in non-small cell lung cancer.
Neoplasms
Human Schlafen 5 regulates reversible epithelial and mesenchymal transitions in breast cancer by suppression of ZEB1 transcription.
Neoplasms
Human somatic cells deficient for RAD52 are impaired for viral integration and compromised for most aspects of homology-directed repair.
Neoplasms
Human sperm-associated antigen 4 as a potential biomarker of glioblastoma progression and prognosis.
Neoplasms
Human sperm-associated antigen 4 as a potential prognostic biomarker of lung squamous cell carcinoma.
Neoplasms
Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapy.
Neoplasms
Humanin Promotes Tumor Progression in Experimental Triple Negative Breast Cancer.
Neoplasms
Humanized yeast genetic interaction mapping predicts synthetic lethal interactions of FBXW7 in breast cancer.
Neoplasms
HuR Promotes Ovarian Cancer Cell Proliferation by Regulating TIMM44 mRNA Stability.
Neoplasms
HUWE1 controls the development of non-small cell lung cancer through down-regulation of p53.
Neoplasms
Hyaluronan-mediated motility receptor expression functions as a prognostic biomarker in uterine carcinosarcoma based on bioinformatics analysis.
Neoplasms
Hyaluronic acid family in bladder cancer: potential prognostic biomarkers and therapeutic targets.
Neoplasms
Hybrid Capture-based Genomic Profiling of Circulating Tumor DNA From Patients With Advanced Ovarian Cancer.
Neoplasms
Hybrid Stem Cell States: Insights Into the Relationship Between Mammary Development and Breast Cancer Using Single-Cell Transcriptomics.
Neoplasms
Hydroxysafflor Yellow A of Carthamus Tinctorius L., Represses the Malignant Development of Esophageal Cancer Cells via Regulating NF-?B Signaling Pathway.
Neoplasms
Hyper-Activation of STAT3 Sustains Progression of Non-Papillary Basal-Type Bladder Cancer via FOSL1 Regulome.
Neoplasms
Hyper-graph Regularized Constrained NMF for Selecting Differentially Expressed Genes and Tumor Classification.
Neoplasms
Hyperglycemia promotes Snail-induced epithelial-mesenchymal transition of gastric cancer via activating ENO1 expression.
Neoplasms
Hypermethylated and downregulated MEIS2 are involved in stemness properties and oxaliplatin-based chemotherapy resistance of colorectal cancer.
Neoplasms
Hypermethylated KLF9 Is An Independent Prognostic Factor For Favorable Outcome In Breast Cancer.
Neoplasms
Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction.
Neoplasms
Hypermethylation of APC2 Is a Predictive Epigenetic Biomarker for Chinese Colorectal Cancer.
Neoplasms
Hypermethylation of CCND2 in Lung and Breast Cancer Is a Potential Biomarker and Drug Target.
Neoplasms
Hypermethylation of DMTN promotes the metastasis of colorectal cancer cells by regulating the actin cytoskeleton through Rac1 signaling activation.
Neoplasms
Hypermethylation of EIF4E promoter is associated with early onset of gastric cancer.
Neoplasms
Hypermethylation of heparanase 2 promotes colorectal cancer proliferation and is associated with poor prognosis.
Neoplasms
Hypermethylation of LATS2 Promoter and Its Prognostic Value in IDH-Mutated Low-Grade Gliomas.
Neoplasms
Hypermethylation of MDFI promoter with NSCLC is specific for females, non-smokers and people younger than 65.
Neoplasms
Hypermethylation of N-Acetyltransferase 1 Is a Prognostic Biomarker in Colon Adenocarcinoma.
Neoplasms
Hypermethylation of the PTTG1IP promoter leads to low expression in early-stage non-small cell lung cancer.
Neoplasms
Hypermethylation of the PZP gene is associated with hepatocellular carcinoma cell proliferation, invasion and migration.
Neoplasms
Hypermethylation of tumor necrosis factor decoy receptor gene in non-small cell lung cancer.
Neoplasms
Hypermutation of DPYD Deregulates Pyrimidine Metabolism and Promotes Malignant Progression.
Neoplasms
Hypertext atlas of dermatopathology with expert system for epithelial tumors of the skin.
Neoplasms
Hypertonicity-Affected Genes Are Differentially Expressed in Clear Cell Renal Cell Carcinoma and Correlate with Cancer-Specific Survival.
Neoplasms
Hypervascular tumor volume estimated by comparison to a large-scale cerebral blood volume radiographic atlas predicts survival in recurrent glioblastoma treated with bevacizumab.
Neoplasms
Hypomethylation of CTCFL promoters as a noninvasive biomarker in plasma from patients with hepatocellular carcinoma.
Neoplasms
Hypomethylation of TET2 Target Genes Identifies a Curable Subset of Acute Myeloid Leukemia.
Neoplasms
Hypomethylation of the lncRNA SOX21-AS1 has clinical prognostic value in cervical cancer.
Neoplasms
Hypomethylation of the MMP7 promoter and increased expression of MMP7 distinguishes the basal-like breast cancer subtype from other triple-negative tumors.
Neoplasms
Hypomethylation-activated cancer-testis gene SPANXC promotes cell metastasis in lung adenocarcinoma.
Neoplasms
Hypothesis: Obesity Is Associated with a Lower Mutation Threshold in Colon Cancer.
Neoplasms
Hypoxia Constructing the Prognostic Model of Colorectal Adenocarcinoma and Related to the Immune Microenvironment.
Neoplasms
Hypoxia induces epithelial-mesenchymal transition in colorectal cancer cells through ubiquitin-specific protease 47-mediated stabilization of Snail: A potential role of Sox9.
Neoplasms
Hypoxia Inducible Factor 1 (HIF-1) Recruits Macrophage to Activate Pancreatic Stellate Cells in Pancreatic Ductal Adenocarcinoma.
Neoplasms
Hypoxia-Associated Prognostic Markers and Competing Endogenous RNA Co-Expression Networks in Breast Cancer.
Neoplasms
Hypoxia-driven splicing into noncoding isoforms regulates the DNA damage response.
Neoplasms
Hypoxia-induced acetylation of PAK1 enhances autophagy and promotes brain tumorigenesis via phosphorylating ATG5.
Neoplasms
Hypoxia-induced RNASEH2A limits activation of cGAS-STING signaling in HCC and predicts poor prognosis.
Neoplasms
Hypoxia-induced ZEB1 promotes cervical cancer progression via CCL8-dependent tumour-associated macrophage recruitment.
Neoplasms
Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS.
Neoplasms
Hypoxia-regulated lncRNA CRPAT4 promotes cell migration via regulating AVL9 in clear cell renal cell carcinomas.
Neoplasms
Hypoxia-related lncRNAs to build prognostic classifier and reveal the immune characteristics of EGFR wild type and low expression of PD-L1 squamous and adenocarcinoma NSCLC.
Neoplasms
Hypoxic Characteristic in the Immunosuppressive Microenvironment of Hepatocellular Carcinoma.
Neoplasms
Hypoxic microenvironment induced spatial transcriptome changes in pancreatic cancer.
Neoplasms
Hypoxic stress suppresses lung tumor-secreted exosomal miR101 to activate macrophages and induce inflammation.
Neoplasms
HYR-2 plays an anti-lung cancer role by regulating PD-L1 and Akkermansia muciniphila.
Neoplasms
I-Boost: an integrative boosting approach for predicting survival time with multiple genomics platforms.
Neoplasms
iCAGES: integrated CAncer GEnome Score for comprehensively prioritizing driver genes in personal cancer genomes.
Neoplasms
ID1 promotes hepatocellular carcinoma proliferation and confers chemoresistance to oxaliplatin by activating pentose phosphate pathway.
Neoplasms
ID2 promotes survival of glioblastoma cells during metabolic stress by regulating mitochondrial function.
Neoplasms
Id4 suppresses MMP2-mediated invasion of glioblastoma-derived cells by direct inactivation of Twist1 function.
Neoplasms
Identification a novel set of 6 differential expressed genes in prostate cancer that can potentially predict biochemical recurrence after curative surgery.
Neoplasms
Identification and analysis of genes associated with epithelial ovarian cancer by integrated bioinformatics methods.
Neoplasms
Identification and analysis of genes associated with head and neck squamous cell carcinoma by integrated bioinformatics methods.
Neoplasms
Identification and analysis of genes associated with lung adenocarcinoma by integrated bioinformatics methods.
Neoplasms
Identification and analysis of long non-coding RNA related miRNA sponge regulatory network in bladder urothelial carcinoma.
Neoplasms
Identification and Analysis of Potential Key Genes Associated With Hepatocellular Carcinoma Based on Integrated Bioinformatics Methods.
Neoplasms
Identification and analysis of survival-associated ceRNA triplets in prostate adenocarcinoma.
Neoplasms
Identification and Characterization of Alternatively Spliced Transcript Isoforms of IRX4 in Prostate Cancer.
Neoplasms
Identification and characterization of biomarkers and their functions for docetaxel-resistant prostate cancer cells.
Neoplasms
Identification and Characterization of MicroRNAs Associated with Somatic Copy Number Alterations in Cancer.
Neoplasms
Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma.
Neoplasms
Identification and Characterization of Senescence Phenotype in Lung Adenocarcinoma with High Drug Sensitivity.
Neoplasms
Identification and Clinical Validation of a Novel 4 Gene-Signature with Prognostic Utility in Colorectal Cancer.
Neoplasms
Identification and Comprehensive Validation of a DNA Methylation-Driven Gene-Based Prognostic Model for Clear Cell Renal Cell Carcinoma.
Neoplasms
Identification and Construction of a Long Noncoding RNA Prognostic Risk Model for Stomach Adenocarcinoma Patients.
Neoplasms
Identification and development of a novel invasion-related gene signature for prognosis prediction in colon adenocarcinoma.
Neoplasms
Identification and development of long non-coding RNA-associated regulatory network in colorectal cancer.
Neoplasms
Identification and Development of Subtypes With Poor Prognosis in Pan-Gynecological Cancer Based on Gene Expression in the Glycolysis-Cholesterol Synthesis Axis.
Neoplasms
Identification and Experimental Validation of Immune-Associate lncRNAs for Predicting Prognosis in Cervical Cancer.
Neoplasms
Identification and external validation of a novel miRNA signature for lymph node metastasis prediction in submucosal-invasive gastric cancer patients.
Neoplasms
Identification and Function Analysis of a Five-Long Noncoding RNA Prognostic Signature for Endometrial Cancer Patients.
Neoplasms
Identification and functional analysis of risk-related microRNAs for the prognosis of patients with bladder urothelial carcinoma.
Neoplasms
Identification and functional analysis of the risk microRNAs associated with cerebral low-grade glioma prognosis.
Neoplasms
Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression.
Neoplasms
Identification and Immunocorrelation of Prognosis-Related Genes Associated With Development of Muscle-Invasive Bladder Cancer.
Neoplasms
Identification and immunoprofiling of key prognostic genes in the tumor microenvironment of hepatocellular carcinoma.
Neoplasms
Identification and integrated analysis of hepatocellular carcinoma-related circular RNA signature.
Neoplasms
Identification and meta-analysis of copy number variation-driven circadian clock genes for colorectal cancer.
Neoplasms
Identification and potential mechanisms of a 4-lncRNA signature that predicts prognosis in patients with laryngeal cancer.
Neoplasms
Identification and prediction of novel non-coding and coding RNA-associated competing endogenous RNA networks in colorectal cancer.
Neoplasms
Identification and Prognostic Value Exploration of Radiotherapy Sensitivity-Associated Genes in Non-Small-Cell Lung Cancer.
Neoplasms
Identification and prognostic value of a glycolysis-related gene signature in patients with bladder cancer.
Neoplasms
Identification and prognostic value of anterior gradient protein 2 expression in breast cancer based on tissue microarray.
Neoplasms
Identification and prognostic value of metabolism-related genes in gastric cancer.
Neoplasms
Identification and validation a TGF-?-associated long non-coding RNA of head and neck squamous cell carcinoma by bioinformatics method.
Neoplasms
Identification and validation of 12 immune-related genes as a prognostic signature for colon adenocarcinoma.
Neoplasms
Identification and validation of a 44-gene expression signature for the classification of renal cell carcinomas.
Neoplasms
Identification and Validation of a Biomarker Signature in Patients With Resectable Pancreatic Cancer via Genome-Wide Screening for Functional Genetic Variants.
Neoplasms
Identification and validation of a combined hypoxia and immune index for triple-negative breast cancer.
Neoplasms
Identification and Validation of a Ferroptosis-Related Long Non-coding RNA Signature for Predicting the Outcome of Lung Adenocarcinoma.
Neoplasms
Identification and validation of a five apoptosis-related genes signature for prediction of disease-free survival for testicular germ cell tumors.
Neoplasms
Identification and Validation of a Four-Long Non-coding RNA Signature Associated With Immune Infiltration and Prognosis in Colon Cancer.
Neoplasms
Identification and validation of a four-miRNA (miRNA-21-5p, miRNA-9-5p, miR-149-5p, and miRNA-30b-5p) prognosis signature in clear cell renal cell carcinoma.
Neoplasms
Identification and validation of a Hedgehog pathway-based 3-gene prognostic signature for gastric cancers.
Neoplasms
Identification and validation of a hypoxia-related prognostic and immune microenvironment signature in bladder cancer.
Neoplasms
Identification and validation of a metabolism-related model and associated with tumor-infiltrating lymphocytes in p53 mutant lung adenocarcinoma patients.
Neoplasms
Identification and validation of a miRNA-based prognostic signature for cervical cancer through an integrated bioinformatics approach.
Neoplasms
Identification and validation of a novel ferroptosis-related gene model for predicting the prognosis of gastric cancer patients.
Neoplasms
Identification and validation of a novel glycolysis-related gene signature for predicting the prognosis in ovarian cancer.
Neoplasms
Identification and Validation of a Novel Immune-Related Four-lncRNA Signature for Lung Adenocarcinoma.
Neoplasms
Identification and Validation of a Novel Immune-Related lncRNA Signature for Bladder Cancer.
Neoplasms
Identification and validation of a novel redox-related lncRNA prognostic signature in lung adenocarcinoma.
Neoplasms
Identification and Validation of a Novel RNA-Binding Protein-Related Gene-Based Prognostic Model for Multiple Myeloma.
Neoplasms
Identification and Validation of a PPP1R12A-Related Five-Gene Signature Associated With Metabolism to Predict the Prognosis of Patients With Prostate Cancer.
Neoplasms
Identification and Validation of a Prognostic 5-Protein Signature for Biochemical Recurrence Following Radical Prostatectomy for Prostate Cancer.
Neoplasms
Identification and validation of a prognostic immune-related lncRNA signature in bladder cancer.
Neoplasms
Identification and validation of a prognostic index based on a metabolic-genomic landscape analysis of ovarian cancer.
Neoplasms
Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma.
Neoplasms
Identification and Validation of a Prognostic Model Based on Three Autophagy-Related Genes in Hepatocellular Carcinoma.
Neoplasms
Identification and validation of a prognostic proteomic signature for cervical cancer.
Neoplasms
Identification and validation of a risk signature based on extracellular matrix-related genes in gliomas.
Neoplasms
Identification and validation of a six immune-related gene signature for prediction of biochemical recurrence in localized prostate cancer following radical prostatectomy.
Neoplasms
Identification and Validation of a Six Immune-Related Genes Signature for Predicting Prognosis in Patients With Stage II Colorectal Cancer.
Neoplasms
Identification and validation of a ten-gene set variation score as a diagnostic and prognostic stratification tool in hepatocellular carcinoma.
Neoplasms
Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.
Neoplasms
Identification and validation of a tumor-infiltrating Treg transcriptional signature conserved across species and tumor types.
Neoplasms
Identification and validation of a two-gene metabolic signature for survival prediction in patients with kidney renal clear cell carcinoma.
Neoplasms
Identification and validation of ADME genes as prognosis and therapy markers for hepatocellular carcinoma patients.
Neoplasms
Identification and Validation of an 11-Ferroptosis Related Gene Signature and Its Correlation With Immune Checkpoint Molecules in Glioma.
Neoplasms
Identification and Validation of an Autophagy-Related lncRNA Signature for Patients With Breast Cancer.
Neoplasms
Identification and validation of an autophagy-related long non-coding RNA signature as a prognostic biomarker for patients with lung adenocarcinoma.
Neoplasms
Identification and validation of an eight-gene expression signature for predicting high Fuhrman grade renal cell carcinoma.
Neoplasms
Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma.
Neoplasms
Identification and validation of an excellent prognosis subtype of muscle-invasive bladder cancer patients with intratumoral CXCR5+ CD8+ T cell abundance.
Neoplasms
Identification and validation of an immune cell infiltrating score predicting survival in patients with lung adenocarcinoma.
Neoplasms
Identification and validation of an immune prognostic signature in colorectal cancer.
Neoplasms
Identification and Validation of an Immune-Associated RNA-Binding Proteins Signature to Predict Clinical Outcomes and Therapeutic Responses in Glioma Patients.
Neoplasms
Identification and Validation of an Immune-Related eRNA Prognostic Signature for Hepatocellular Carcinoma.
Neoplasms
Identification and validation of an immune-related prognostic signature and key gene in papillary thyroid carcinoma.
Neoplasms
Identification and Validation of an Immune-Related RNA Signature to Predict Survival of Patients With Head and Neck Squamous Cell Carcinoma.
Neoplasms
Identification and Validation of an Immunological Expression-Based Prognostic Signature in Breast Cancer.
Neoplasms
Identification and validation of an individualized autophagy-clinical prognostic index in bladder cancer patients.
Neoplasms
Identification and validation of an individualized autophagy-clinical prognostic index in gastric cancer patients.
Neoplasms
Identification and Validation of an Individualized EMT-Related Prognostic Risk Score Formula in Gastric Adenocarcinoma Patients.
Neoplasms
Identification and Validation of an Individualized Prognostic Signature of Bladder Cancer Based on Seven Immune Related Genes.
Neoplasms
Identification and validation of autophagy-related prognostic signature for head and neck squamous cell carcinoma.
Neoplasms
Identification and Validation of Circulating MicroRNA Signatures for Breast Cancer Early Detection Based on Large Scale Tissue-Derived Data.
Neoplasms
Identification and validation of core genes for serous ovarian adenocarcinoma via bioinformatics analysis.
Neoplasms
Identification and validation of expressed HLA-binding breast cancer neoepitopes for potential use in individualized cancer therapy.
Neoplasms
Identification and Validation of Fibroblast Growth Factor 12 Gene as a Novel Potential Biomarker in Esophageal Cancer Using Cancer Genomic Datasets.
Neoplasms
Identification and Validation of Hub Genes Associated With Hepatocellular Carcinoma Via Integrated Bioinformatics Analysis.
Neoplasms
Identification and validation of hypoxia-derived gene signatures to predict clinical outcomes and therapeutic responses in stage I lung adenocarcinoma patients.
Neoplasms
Identification and validation of hypoxic markers of glioblastoma multiforme in methylation, somatic CNV characteristics based on large-scale samples.
Neoplasms
Identification and Validation of Immune Molecular Subtypes in Pancreatic Ductal Adenocarcinoma: Implications for Prognosis and Immunotherapy.
Neoplasms
Identification and validation of immune-related lncRNA prognostic signatures for melanoma.
Neoplasms
Identification and Validation of Immune-Related lncRNA Signature as a Prognostic Model for Skin Cutaneous Melanoma.
Neoplasms
Identification and validation of key modules and hub genes associated with the pathological stage of oral squamous cell carcinoma by weighted gene co-expression network analysis.
Neoplasms
Identification and validation of L Antigen Family Member 3 as an immune-related biomarker associated with the progression of papillary thyroid cancer.
Neoplasms
Identification and validation of m6A RNA methylation regulators with clinical prognostic value in Papillary thyroid cancer.
Neoplasms
Identification and validation of methylated differentially expressed miRNAs and immune infiltrate profile in EBV-associated gastric cancer.
Neoplasms
Identification and validation of methylation-driven genes prognostic signature for recurrence of laryngeal squamous cell carcinoma by integrated bioinformatics analysis.
Neoplasms
Identification and validation of novel DNA methylation markers for early diagnosis of lung adenocarcinoma.
Neoplasms
Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapy.
Neoplasms
Identification and validation of obesity-related gene LEP methylation as a prognostic indicator in patients with acute myeloid leukemia.
Neoplasms
Identification and validation of potential long non-coding RNA biomarkers in predicting survival of patients with head and neck squamous cell carcinoma.
Neoplasms
Identification and validation of potential novel biomarkers to predict distant metastasis in differentiated thyroid cancer.
Neoplasms
Identification and validation of potential prognostic gene biomarkers for predicting survival in patients with acute myeloid leukemia.
Neoplasms
Identification and validation of potential target genes in papillary thyroid cancer.
Neoplasms
Identification and validation of prognosis-related DLX5 methylation as an epigenetic driver in myeloid neoplasms.
Neoplasms
Identification and validation of prognostic signature for breast cancer based on genes potentially involved in autophagy.
Neoplasms
Identification and Validation of Prognostically Relevant Gene Signature in Melanoma.
Neoplasms
Identification and validation of RNA-binding protein-related gene signature revealed potential associations with immunosuppression and drug sensitivity in glioma.
Neoplasms
Identification and validation of seven prognostic long non-coding RNAs in oral squamous cell carcinoma.
Neoplasms
Identification and validation of signal recognition particle 14 as a prognostic biomarker predicting overall survival in patients with acute myeloid leukemia.
Neoplasms
Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
Neoplasms
Identification and Validation of SNP-Containing Genes With Prognostic Value in Gastric Cancer via Integrated Bioinformatics Analysis.
Neoplasms
Identification and validation of soluble carrier family expression signature for predicting poor outcome of renal cell carcinoma.
Neoplasms
Identification and validation of SRY-box containing gene family member SOX30 methylation as a prognostic and predictive biomarker in myeloid malignancies.
Neoplasms
Identification and Validation of STAT6 as a Prognostic and Predictive Biomarker in Acute Myeloid Leukemia.
Neoplasms
Identification and validation of stemness-related lncRNA prognostic signature for breast cancer.
Neoplasms
Identification and validation of stromal-tumor microenvironment-based subtypes tightly associated with PD-1/PD-L1 immunotherapy and outcomes in patients with gastric cancer.
Neoplasms
Identification and Validation of the Immune Subtypes of Lung Adenocarcinoma: Implications for Immunotherapy.
Neoplasms
Identification and Validation of the N6-Methyladenosine RNA Methylation Regulator YTHDF1 as a Novel Prognostic Marker and Potential Target for Hepatocellular Carcinoma.
Neoplasms
Identification and Validation of the Prognostic Stemness Biomarkers in Bladder Cancer Bone Metastasis.
Neoplasms
Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
Neoplasms
Identification and validation of the prognostic value of immune-related genes in non-small cell lung cancer.
Neoplasms
Identification and validation of the role of matrix metalloproteinase-1 in cervical cancer.
Neoplasms
Identification and validation of tumor environment phenotypes in lung adenocarcinoma by integrative genome-scale analysis.
Neoplasms
Identification and validation of tumor microenvironment-related genes of prognostic value in lung adenocarcinoma.
Neoplasms
Identification and validation of tumor microenvironment-related lncRNA prognostic signature for uveal melanoma.
Neoplasms
Identification and Validation of Two Lung Adenocarcinoma-Development Characteristic Gene Sets for Diagnosing Lung Adenocarcinoma and Predicting Prognosis.
Neoplasms
Identification and Validation of Two Novel Prognostic lncRNAs in Kidney Renal Clear Cell Carcinoma.
Neoplasms
Identification and Validation of Ubiquitin-Specific Proteases as a Novel Prognostic Signature for Hepatocellular Carcinoma.
Neoplasms
Identification and validation of WISP1 as an epigenetic regulator of metastasis in oral squamous cell carcinoma.
Neoplasms
Identification and Verification of a 17 Immune-Related Gene Pair Prognostic Signature for Colon Cancer.
Neoplasms
Identification and verification of a ten-gene signature predicting overall survival for ovarian cancer.
Neoplasms
Identification and verification of an immune-related lncRNA signature for predicting the prognosis of patients with bladder cancer.
Neoplasms
Identification and verification of HCAR3 and INSL5 as new potential therapeutic targets of colorectal cancer.
Neoplasms
Identification and Verification of Molecular Subtypes with Enhanced Immune Infiltration Based on m6A Regulators in Cutaneous Melanoma.
Neoplasms
Identification and verification of the prognostic value of the glutathione S-transferase Mu genes in gastric cancer.
Neoplasms
Identification and Verification on Prognostic Index of Lower-Grade Glioma Immune-Related LncRNAs.
Neoplasms
Identification by TCGA database search of five genes that are aberrantly expressed and involved in hepatocellular carcinoma potentially via DNA methylation changes.
Neoplasms
Identification Hub Genes in Colorectal Cancer by Integrating Weighted Gene Co-Expression Network Analysis and Clinical Validation in vivo and vitro.
Neoplasms
Identification immunophenotyping of lung adenocarcinomas based on the tumor microenvironment.
Neoplasms
Identification key genes, key miRNAs and key transcription factors of lung adenocarcinoma.
Neoplasms
Identification METTL18 as a Potential Prognosis Biomarker and Associated With Immune Infiltrates in Hepatocellular Carcinoma.
Neoplasms
Identification novel prognostic signatures for Head and Neck Squamous Cell Carcinoma based on ceRNA network construction and immune infiltration analysis.
Neoplasms
Identification of "regulation of RhoA activity panel" as a prognostic and predictive biomarker for gastric cancer.
Neoplasms
Identification of 17 mRNAs and a miRNA as an integrated prognostic signature for lung squamous cell carcinoma.
Neoplasms
Identification of 4-genes model in papillary renal cell tumor microenvironment based on comprehensive analysis.
Neoplasms
Identification of 4-lncRNA prognostic signature in head and neck squamous cell carcinoma.
Neoplasms
Identification of 40S ribosomal protein S8 as a novel biomarker for alcohol?associated hepatocellular carcinoma using weighted gene co?expression network analysis.
Neoplasms
Identification of 5 Gene Signatures in Survival Prediction for Patients with Lung Squamous Cell Carcinoma Based on Integrated Multiomics Data Analysis.
Neoplasms
Identification of 9-Core Immune-Related Genes in Bladder Urothelial Carcinoma Prognosis.
Neoplasms
Identification of a 14-lncRNA Signature and Construction of a Prognostic Nomogram Predicting Overall Survival of Gastric Cancer.
Neoplasms
Identification of a 15-pseudogene based prognostic signature for predicting survival and antitumor immune response in breast cancer.
Neoplasms
Identification of a 26-lncRNAs Risk Model for Predicting Overall Survival of Cervical Squamous Cell Carcinoma Based on Integrated Bioinformatics Analysis.
Neoplasms
Identification of a 4-miRNA signature as a potential prognostic biomarker for pancreatic adenocarcinoma.
Neoplasms
Identification of a 5-Gene Metabolic Signature for Predicting Prognosis Based on an Integrated Analysis of Tumor Microenvironment in Lung Adenocarcinoma.
Neoplasms
Identification of a 5-Gene-Based Scoring System by WGCNA and LASSO to Predict Prognosis for Rectal Cancer Patients.
Neoplasms
Identification of a 5?lncRNA signature?based risk scoring system for survival prediction in colorectal cancer.
Neoplasms
Identification of a 5?microRNA signature and hub miRNA?mRNA interactions associated with pancreatic cancer.
Neoplasms
Identification of a 6-Gene Signature Associated with Resistance to Tyrosine Kinase Inhibitors: Prognosis for Clear Cell Renal Cell Carcinoma.
Neoplasms
Identification of a 6-gene signature for the survival prediction of breast cancer patients based on integrated multi-omics data analysis.
Neoplasms
Identification of a circadian gene signature that predicts overall survival in lung adenocarcinoma.
Neoplasms
Identification of a Combined RNA Prognostic Signature in Adenocarcinoma of the Lung.
Neoplasms
Identification of a competing endogenous RNA axis "SVIL-AS1/miR-103a/ICE1" associated with chemoresistance in lung adenocarcinoma by comprehensive bioinformatics analysis.
Neoplasms
Identification of a competing endogenous RNA network associated with prognosis of pancreatic adenocarcinoma.
Neoplasms
Identification of a Costimulatory Molecule Gene Signature to Predict Survival and Immunotherapy Response in Head and Neck Squamous Cell Carcinoma.
Neoplasms
Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma.
Neoplasms
Identification of a cullin5-RING E3 ligase transcriptome signature in glioblastoma multiforme.
Neoplasms
Identification of a DNA Methylation-Based Prognostic Signature for Patients with Triple-Negative Breast Cancer.
Neoplasms
Identification of a DNA Repair Gene Signature and Establishment of a Prognostic Nomogram Predicting Biochemical-Recurrence-Free Survival of Prostate Cancer.
Neoplasms
Identification of a DNA Repair-Related Multigene Signature as a Novel Prognostic Predictor of Glioblastoma.
Neoplasms
Identification of a Ferroptosis Gene Set That Mediates the Prognosis of Squamous Cell Carcinoma of the Head and Neck.
Neoplasms
Identification of a ferroptosis-related gene signature predictive model in colon cancer.
Neoplasms
Identification of a Ferroptosis-Related LncRNA Signature as a Novel Prognosis Model for Lung Adenocarcinoma.
Neoplasms
Identification of a Five-Autophagy-Related-lncRNA Signature as a Novel Prognostic Biomarker for Hepatocellular Carcinoma.
Neoplasms
Identification of a Five-Gene Prognostic Model and Its Potential Drug Repurposing in Colorectal Cancer Based on TCGA, GTEx and GEO Databases.
Neoplasms
Identification of a Five-Gene Signature and Establishment of a Prognostic Nomogram to Predict Progression-Free Interval of Papillary Thyroid Carcinoma.
Neoplasms
Identification of a Five-Gene Signature for Predicting Survival in Malignant Pleural Mesothelioma Patients.
Neoplasms
Identification of a five-gene signature for predicting the progression and prognosis of stage I endometrial carcinoma.
Neoplasms
Identification of a five-gene signature in association with overall survival for hepatocellular carcinoma.
Neoplasms
Identification of a five-gene signature of the RGS gene family with prognostic value in ovarian cancer.
Neoplasms
Identification of a five-gene signature with prognostic value in colorectal cancer.
Neoplasms
Identification of a five-immune gene model as an independent prognostic factor in hepatocellular carcinoma.
Neoplasms
Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Neoplasms
Identification of a five-miRNA signature predicting survival in cutaneous melanoma cancer patients.
Neoplasms
Identification of a Four Hypoxia-Associated Long Non-Coding RNA Signature and Establishment of a Nomogram Predicting Prognosis of Clear Cell Renal Cell Carcinoma.
Neoplasms
Identification of a four immune-related genes signature based on an immunogenomic landscape analysis of clear cell renal cell carcinoma.
Neoplasms
Identification of a four-long non-coding RNA signature in predicting breast cancer survival.
Neoplasms
Identification of a gene expression signature associated with the metastasis suppressor function of NME1: prognostic value in human melanoma.
Neoplasms
Identification of a gene expression signature predicting survival in oral cavity squamous cell carcinoma using Monte Carlo cross validation.
Neoplasms
Identification of a Gene Panel for Endometrioid Endometrial Cancer: a Possible Prognostic Value?
Neoplasms
Identification of a Gene Prognostic Signature for Oral Squamous Cell Carcinoma by RNA Sequencing and Bioinformatics.
Neoplasms
Identification of a Gene Set Correlated With Immune Status in Ovarian Cancer by Transcriptome-Wide Data Mining.
Neoplasms
Identification of a Gene Signature for Renal Cell Carcinoma-Associated Fibroblasts Mediating Cancer Progression and Affecting Prognosis.
Neoplasms
Identification of a Gene-Related Risk Signature in Melanoma Patients Using Bioinformatic Profiling.
Neoplasms
Identification of a Genome Instability-Associated LncRNA Signature for Prognosis Prediction in Colon Cancer.
Neoplasms
Identification of a glycolysis-related gene signature associated with clinical outcome for patients with lung squamous cell carcinoma.
Neoplasms
Identification of a glycolysis-related lncRNA prognostic signature for clear cell renal cell carcinoma.
Neoplasms
Identification of a Good-Prognosis IDH-Mutant-Like Population of Patients with Diffuse Gliomas.
Neoplasms
Identification of a histone family gene signature for predicting the prognosis of cervical cancer patients.
Neoplasms
Identification of a Human Papillomavirus-Associated Oncogenic miRNA Panel in Human Oropharyngeal Squamous Cell Carcinoma Validated by Bioinformatics Analysis of The Cancer Genome Atlas.
Neoplasms
Identification of a Hypoxia-Related Signature for Predicting Prognosis and the Immune Microenvironment in Bladder Cancer.
Neoplasms
Identification of a key role of widespread epigenetic drift in Barrett's esophagus and esophageal adenocarcinoma.
Neoplasms
Identification of a lncRNA prognostic signature-related to stem cell index and its significance in colorectal cancer.
Neoplasms
Identification of a long non-coding RNA signature for predicting prognosis and biomarkers in lung adenocarcinoma.
Neoplasms
Identification of a m6A RNA methylation regulators-based signature for predicting the prognosis of clear cell renal carcinoma.
Neoplasms
Identification of a MET-eIF4G1 translational regulation axis that controls HIF-1? levels under hypoxia.
Neoplasms
Identification of a metabolic-related gene signature predicting the overall survival for patients with stomach adenocarcinoma.
Neoplasms
Identification of a metabolism-related gene expression prognostic model in endometrial carcinoma patients.
Neoplasms
Identification of a Metabolism-Related Signature for the Prediction of Survival in Endometrial Cancer Patients.
Neoplasms
Identification of a methylomics-associated nomogram for predicting overall survival of stage I-II lung adenocarcinoma.
Neoplasms
Identification of a microRNA signature associated with survivability in cervical squamous cell carcinoma.
Neoplasms
Identification of a multi-cancer gene expression biomarker for cancer clinical outcomes using a network-based algorithm.
Neoplasms
Identification of a Multi-RNA-Type-Based Signature for Recurrence-Free Survival Prediction in Patients with Uterine Corpus Endometrial Carcinoma.
Neoplasms
Identification of a multidimensional transcriptome signature for survival prediction of postoperative glioblastoma multiforme patients.
Neoplasms
Identification of a new aggressive axis driven by ciliogenesis and absence of VDAC1-?C in clear cell Renal Cell Carcinoma patients.
Neoplasms
Identification of a New Eight-Long Noncoding RNA Molecular Signature for Breast Cancer Survival Prediction.
Neoplasms
Identification of a Nine Immune-Related lncRNA Signature as a Novel Diagnostic Biomarker for Hepatocellular Carcinoma.
Neoplasms
Identification of a nine-gene prognostic signature for gastric carcinoma using integrated bioinformatics analyses.
Neoplasms
Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
Neoplasms
Identification of a nomogram based on an 8-lncRNA signature as a novel diagnostic biomarker for head and neck squamous cell carcinoma.
Neoplasms
Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma.
Neoplasms
Identification of a Nomogram from Ferroptosis-Related Long Noncoding RNAs Signature to Analyze Overall Survival in Patients with Bladder Cancer.
Neoplasms
Identification of a novel autophagy signature for predicting survival in patients with lung adenocarcinoma.
Neoplasms
Identification of a novel cell cycle-related gene signature predicting survival in patients with gastric cancer.
Neoplasms
Identification of a novel CpG methylation signature to predict prognosis in lung squamous cell carcinoma.
Neoplasms
Identification of a novel DNA repair-related prognostic signature predicting survival of patients with hepatocellular carcinoma.
Neoplasms
Identification of a Novel Eight-lncRNA Prognostic Signature for HBV-HCC and Analysis of Their Functions Based on Coexpression and ceRNA Networks.
Neoplasms
Identification of a Novel Epigenetic Signature CHFR as a Potential Prognostic Gene Involved in Metastatic Clear Cell Renal Cell Carcinoma.
Neoplasms
Identification of a Novel Epithelial-Mesenchymal Transition Gene Signature Predicting Survival in Patients With HNSCC.
Neoplasms
Identification of a Novel Epithelial-to-Mesenchymal-related Gene Signature in Predicting Survival of Patients with Hepatocellular Carcinoma.
Neoplasms
Identification of a novel gene expression signature associated with overall survival in patients with lung adenocarcinoma: A comprehensive analysis based on TCGA and GEO databases.
Neoplasms
Identification of a Novel Glycolysis-Related Gene Signature Correlates With the Prognosis and Therapeutic Responses in Patients With Clear Cell Renal Cell Carcinoma.
Neoplasms
Identification of a novel glycolysis-related gene signature for predicting metastasis and survival in patients with lung adenocarcinoma.
Neoplasms
Identification of a novel glycolysis-related gene signature that can predict the survival of patients with lung adenocarcinoma.
Neoplasms
Identification of a Novel Glycolysis-Related LncRNA Signature for Predicting Overall Survival in Patients With Bladder Cancer.
Neoplasms
Identification of a Novel Immune Landscape Signature for Predicting Prognosis and Response of Endometrial Carcinoma to Immunotherapy and Chemotherapy.
Neoplasms
Identification of a Novel Immune-Related CpG Methylation Signature to Predict Prognosis in Stage II/III Colorectal Cancer.
Neoplasms
Identification of a novel immune-related microRNA prognostic model in clear cell renal cell carcinoma.
Neoplasms
Identification of a Novel Immune-Related Prognostic Biomarker and Small-Molecule Drugs in Clear Cell Renal Cell Carcinoma (ccRCC) by a Merged Microarray-Acquired Dataset and TCGA Database.
Neoplasms
Identification of a novel immune-related prognostic signature associated with tumor microenvironment for breast cancer.
Neoplasms
Identification of a novel microRNA recurrence-related signature and risk stratification system in breast cancer.
Neoplasms
Identification of a novel mutation gene signature HAMP for cholangiocarcinoma through comprehensive TCGA and GEO data mining.
Neoplasms
Identification of a novel prognostic DNA methylation signature for lung adenocarcinoma based on consensus clustering method.
Neoplasms
Identification of a Novel Prognostic Signature of Genome Instability-Related LncRNAs in Early Stage Lung Adenocarcinoma.
Neoplasms
Identification of a Novel Protein-Based Signature to Improve Prognosis Prediction in Renal Clear Cell Carcinoma.
Neoplasms
Identification of a novel six-gene signature with potential prognostic and therapeutic value in cervical cancer.
Neoplasms
Identification of a novel subgroup of endometrial cancer patients with loss of thyroid hormone receptor beta expression and improved survival.
Neoplasms
Identification of a Novel Transcription Factor Prognostic Index for Breast Cancer.
Neoplasms
Identification of a Novel Tumor Microenvironment Prognostic Signature for Advanced-Stage Serous Ovarian Cancer.
Neoplasms
Identification of a pan-cancer oncogenic microRNA superfamily anchored by a central core seed motif.
Neoplasms
Identification of a panel of mitotic spindle-related genes as a signature predicting survival in lung adenocarcinoma.
Neoplasms
Identification of a potential prognostic lncRNA-miRNA-mRNA signature in endometrial cancer based on the competing endogenous RNA network.
Neoplasms
Identification of a Potential Regulatory Variant for Colorectal Cancer Risk Mapping to 3p21.31 in Chinese Population.
Neoplasms
Identification of a potential target for treatment of squamous cell carcinoma of the tongue: follistatin.
Neoplasms
Identification of a Potentially Functional microRNA-mRNA Regulatory Network in Lung Adenocarcinoma Using a Bioinformatics Analysis.
Neoplasms
Identification of a prognosis?associated signature associated with energy metabolism in triple?negative breast cancer.
Neoplasms
Identification of a prognostic 4-mRNA signature in laryngeal squamous cell carcinoma.
Neoplasms
Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma.
Neoplasms
Identification of a Prognostic Colorectal Cancer Model Including LncRNA FOXP4-AS1 and LncRNA BBOX1-AS1 Based on Bioinformatics Analysis.
Neoplasms
Identification of a prognostic ferroptosis-related lncRNA signature in the tumor microenvironment of lung adenocarcinoma.
Neoplasms
Identification of a Prognostic Index Based on a Metabolic-Genomic Landscape Analysis of Hepatocellular Carcinoma (HCC).
Neoplasms
Identification of a prognostic long noncoding RNA signature in lung squamous cell carcinoma: a population-based study with a mean follow-up of 3.5?years.
Neoplasms
Identification of a Prognostic Model Based on Immune-Related Genes of Lung Squamous Cell Carcinoma.
Neoplasms
Identification of a Prognostic Signature Model with Tumor Microenvironment for predicting Disease-free Survival after Radical Prostatectomy.
Neoplasms
Identification of a prognostic signature of nine metabolism-related genes for hepatocellular carcinoma.
Neoplasms
Identification of a protein signature for predicting overall survival of hepatocellular carcinoma: a study based on data mining.
Neoplasms
Identification of a putative competitive endogenous RNA network for lung adenocarcinoma using TCGA datasets.
Neoplasms
Identification of a Rat Mammary Tumor Risk Locus That Is Syntenic with the Commonly Amplified 8q12.1 and 8q22.1 Regions in Human Breast Cancer Patients.
Neoplasms
Identification of a Recurrence Signature and Validation of Cell Infiltration Level of Thyroid Cancer Microenvironment.
Neoplasms
Identification of a RNA-Seq Based 8-Long Non-Coding RNA Signature Predicting Survival in Esophageal Cancer.
Neoplasms
Identification of a RNA-Seq based prognostic signature with five lncRNAs for lung squamous cell carcinoma.
Neoplasms
Identification of a RNA-Seq Based Prognostic Signature with Seven Immune-Related lncRNAs for Lung Adenocarcinoma.
Neoplasms
Identification of a RNA-seq-based signature to improve prognostics for uterine sarcoma.
Neoplasms
Identification of a robust subpathway-based signature for acute myeloid leukemia prognosis using an miRNA integrated strategy.
Neoplasms
Identification of a Set of Genes Improving Survival Prediction in Kidney Renal Clear Cell Carcinoma through Integrative Reanalysis of Transcriptomic Data.
Neoplasms
Identification of a Seven-lncRNA Immune Risk Signature and Construction of a Predictive Nomogram for Lung Adenocarcinoma.
Neoplasms
Identification of a seven-miRNA signature as prognostic biomarker for lung squamous cell carcinoma.
Neoplasms
Identification of a six lncRNAs signature as novel diagnostic biomarkers for cervical cancer.
Neoplasms
Identification of a six microRNA signature as a novel potential prognostic biomarker in patients with head and neck squamous cell carcinoma.
Neoplasms
Identification of a six-gene metabolic signature predicting overall survival for patients with lung adenocarcinoma.
Neoplasms
Identification of a six-gene prognostic signature for oral squamous cell carcinoma.
Neoplasms
Identification of a six-gene signature associated with tumor mutation burden for predicting prognosis in patients with invasive breast carcinoma.
Neoplasms
Identification of a Six-Gene Signature for Predicting the Overall Survival of Cervical Cancer Patients.
Neoplasms
Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma.
Neoplasms
Identification of a six-gene signature with prognostic value for patients with endometrial carcinoma.
Neoplasms
Identification of a six-lncRNA signature based on a competing endogenous RNA network for predicting the risk of tumour recurrence in bladder cancer patients.
Neoplasms
Identification of a Sixteen-gene Prognostic Biomarker for Lung Adenocarcinoma Using a Machine Learning Method.
Neoplasms
Identification of a small mutation panel of coding sequences to predict the efficacy of immunotherapy for lung adenocarcinoma.
Neoplasms
Identification of a Specific Gene Module for Predicting Prognosis in Glioblastoma Patients.
Neoplasms
Identification of a survival-related signature for sarcoma patients through integrated transcriptomic and proteomic profiling analyses.
Neoplasms
Identification of a thirteen-gene signature predicting overall survival for hepatocellular carcinoma.
Neoplasms
Identification of a three miRNA signature as a novel potential prognostic biomarker in patients with bladder cancer.
Neoplasms
Identification of a three-long noncoding RNA prognostic model involved competitive endogenous RNA in kidney renal clear cell carcinoma.
Neoplasms
Identification of a three-m6A related gene risk score model as a potential prognostic biomarker in clear cell renal cell carcinoma.
Neoplasms
Identification of a three-miRNA signature as a novel potential prognostic biomarker in patients with clear cell renal cell carcinoma.
Neoplasms
Identification of a three-miRNA signature as a novel prognostic model for papillary renal cell carcinoma.
Neoplasms
Identification of a Transcriptional Prognostic Signature From Five Metabolic Pathways in Oral Squamous Cell Carcinoma.
Neoplasms
Identification of a transcriptomic signature with excellent survival prediction for squamous cell carcinoma of the cervix.
Neoplasms
Identification of a TSPY co-expression network associated with DNA hypomethylation and tumor gene expression in somatic cancers.
Neoplasms
Identification of a tumor microenvironment-associated prognostic gene signature in bladder cancer by integrated bioinformatic analysis.
Neoplasms
Identification of a Tumor Microenvironment-Related Gene Signature Indicative of Disease Prognosis and Treatment Response in Colon Cancer.
Neoplasms
Identification of a tumor microenvironment-related gene signature to improve the prediction of cervical cancer prognosis.
Neoplasms
Identification of a tumor microenvironment-related seven-gene signature for predicting prognosis in bladder cancer.
Neoplasms
Identification of a Ubiquitination-Related Gene Risk Model for Predicting Survival in Patients With Pancreatic Cancer.
Neoplasms
Identification of a universal 6-lncRNA prognostic signature for three pathologic subtypes of renal cell carcinoma.
Neoplasms
Identification of aberrantly expressed F-box proteins in squamous-cell lung carcinoma.
Neoplasms
Identification of aberrantly expressed long non-coding RNAs in stomach adenocarcinoma.
Neoplasms
Identification of Aberrantly Methylated Differentially CpG Sites in Hepatocellular Carcinoma and Their Association With Patient Survival.
Neoplasms
Identification of aberrantly methylated differentially expressed genes and associated pathways in endometrial cancer using integrated bioinformatic analysis.
Neoplasms
Identification of aberrantly methylated differentially expressed genes in breast cancer by integrated bioinformatics analysis.
Neoplasms
Identification of aberrantly methylated differentially expressed genes in glioblastoma multiforme and their association with patient survival.
Neoplasms
Identification of aberrantly methylated differentially expressed genes in prostate carcinoma using integrated bioinformatics.
Neoplasms
Identification of Aging-Related Genes Associated With Clinical and Prognostic Features of Hepatocellular Carcinoma.
Neoplasms
Identification of ALDH3A2 as a novel prognostic biomarker in gastric adenocarcinoma using integrated bioinformatics analysis.
Neoplasms
Identification of an 11-Autophagy-Related-Gene Signature as Promising Prognostic Biomarker for Bladder Cancer Patients.
Neoplasms
Identification of an 11-lncRNA signature with high performance for predicting the prognosis of hepatocellular carcinoma using bioinformatics analysis.
Neoplasms
Identification of an alternative splicing signature as an independent factor in colon cancer.
Neoplasms
Identification of an apoptosis-related prognostic gene signature and molecular subtypes of clear cell renal cell carcinoma (ccRCC).
Neoplasms
Identification of an atypical etiological head and neck squamous carcinoma subtype featuring the CpG island methylator phenotype.
Neoplasms
Identification of an autophagy-related 10-lncRNA-mRNA signature for distinguishing glioblastoma multiforme from lower?grade glioma and prognosis prediction.
Neoplasms
Identification of an autophagy-related gene signature for survival prediction in patients with cervical cancer.
Neoplasms
Identification of an autophagy-related gene signature predicting overall survival for hepatocellular carcinoma.
Neoplasms
Identification of an autophagy-related gene signature that can improve prognosis of hepatocellular carcinoma patients.
Neoplasms
Identification of an Autophagy-Related Prognostic Signature for Clear Cell Renal Cell Carcinoma.
Neoplasms
Identification of an autophagy-related prognostic signature in head and neck squamous cell carcinoma.
Neoplasms
Identification of an Autophagy-Related Signature Predicting Overall Survival for Papillary Thyroid Carcinoma.
Neoplasms
Identification of an eight-gene signature for survival prediction for patients with hepatocellular carcinoma based on integrated bioinformatics analysis.
Neoplasms
Identification of an eleven-miRNA signature to predict the prognosis of endometrial cancer.
Neoplasms
Identification of an EMT-Related Gene Signature for Predicting Overall Survival in Gastric Cancer.
Neoplasms
Identification of an epithelial-mesenchymal transition related long non-coding RNA (LncRNA) signature in Glioma.
Neoplasms
Identification of an extracellular vesicle-related gene signature in the prediction of pancreatic cancer clinical prognosis.
Neoplasms
Identification of an IFN-?-associated gene signature for the prediction of overall survival among glioblastoma patients.
Neoplasms
Identification of an immune checkpoint gene signature that accurately predicts prognosis and immunotherapy response in endometrial carcinoma.
Neoplasms
Identification of an Immune Gene Signature Based on Tumor Microenvironment Characteristics in Colon Adenocarcinoma.
Neoplasms
Identification of an immune gene signature for predicting the prognosis of patients with uterine corpus endometrial carcinoma.
Neoplasms
Identification of an immune prognostic 11-gene signature for lung adenocarcinoma.
Neoplasms
Identification of an Immune Signature Predicting Prognosis Risk and Lymphocyte Infiltration in Colon Cancer.
Neoplasms
Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma.
Neoplasms
Identification of an Immune-Related Gene Signature to Improve Prognosis Prediction in Colorectal Cancer Patients.
Neoplasms
Identification of an immune-related gene-based signature to predict prognosis of patients with gastric cancer.
Neoplasms
Identification of an immune-related long non-coding RNA signature and nomogram as prognostic target for muscle-invasive bladder cancer.
Neoplasms
Identification of an immune-related long noncoding RNA signature that predicts prognosis in breast cancer patients.
Neoplasms
Identification of an Immune-Related Nine-lncRNA Signature Predictive of Overall Survival in Colon Cancer.
Neoplasms
Identification of an Immune-Related Prognostic Predictor in Hepatocellular Carcinoma.
Neoplasms
Identification of an immune-related risk signature and nomogram predicting the overall survival in patients with endometrial cancer.
Neoplasms
Identification of an Immune-Related Risk Signature Correlates With Immunophenotype and Predicts Anti-PD-L1 Efficacy of Urothelial Cancer.
Neoplasms
Identification of an immune-related RNA-binding protein signature to predict survival and targeted therapy responses in liver cancer.
Neoplasms
Identification of an immune-related signature indicating the dedifferentiation of thyroid cells.
Neoplasms
Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features.
Neoplasms
Identification of an Immunologic Signature of Lung Adenocarcinomas Based on Genome-Wide Immune Expression Profiles.
Neoplasms
Identification of an Individualized Immune-Related Prognostic Risk Score in Lung Squamous Cell Cancer.
Neoplasms
Identification of an IRGP Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer.
Neoplasms
Identification of an lncRNA?miRNA?mRNA interaction mechanism in breast cancer based on bioinformatic analysis.
Neoplasms
Identification of an m6A-Related lncRNA Signature for Predicting the Prognosis in Patients With Kidney Renal Clear Cell Carcinoma.
Neoplasms
Identification of an N6-methyladenosine (m6A)-related signature associated with clinical prognosis, immune response, and chemotherapy in primary glioblastomas.
Neoplasms
Identification of androgen-responsive lncRNAs as diagnostic and prognostic markers for prostate cancer.
Neoplasms
Identification of Aneuploid Circulating Tumor Cells in Soft-Tissue Sarcoma Patients: A Pilot Study.
Neoplasms
Identification of angiotensin-converting enzyme 2 (ACE2) protein as the potential biomarker in SARS-CoV-2 infection-related lung cancer using computational analysis.
Neoplasms
Identification of ARHGEF38, NETO2, GOLM1, and SAPCD2 Associated With Prostate Cancer Progression by Bioinformatic Analysis and Experimental Validation.
Neoplasms
Identification of ARL4C as a Peritoneal Dissemination-Associated Gene and Its Clinical Significance in Gastric Cancer.
Neoplasms
Identification of Arp2/3 Complex Subunits as Prognostic Biomarkers for Hepatocellular Carcinoma.
Neoplasms
Identification of ATP8B1 as a Tumor Suppressor Gene for Colorectal Cancer and Its Involvement in Phospholipid Homeostasis.
Neoplasms
Identification of Autophagy-Related Genes and Small-Molecule Drugs in Esophageal Carcinoma.
Neoplasms
Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
Neoplasms
Identification of biomarkers associated with diagnosis and prognosis of gastroesophageal junction adenocarcinoma-a study based on integrated bioinformatics analysis in GEO and TCGA database.
Neoplasms
Identification of biomarkers associated with histological grade and prognosis of gastric cancer by co-expression network analysis.
Neoplasms
Identification of Biomarkers Based on Differentially Expressed Genes in Papillary Thyroid Carcinoma.
Neoplasms
Identification of biomarkers correlated with diagnosis and prognosis of endometrial cancer using bioinformatics analysis.
Neoplasms
Identification of biomarkers for acute leukemia via machine learning-based stemness index.
Neoplasms
Identification of Biomarkers for Controlling Cancer Stem Cell Characteristics in Bladder Cancer by Network Analysis of Transcriptome Data Stemness Indices.
Neoplasms
Identification of biomarkers of chromophobe renal cell carcinoma by weighted gene co-expression network analysis.
Neoplasms
Identification of biomarkers of clear cell renal cell carcinoma by bioinformatics analysis.
Neoplasms
Identification of biomarkers predicting the chemotherapeutic outcomes of capecitabine and oxaliplatin in patients with gastric cancer.
Neoplasms
Identification of biomarkers related to CD8+ T cell infiltration with gene co-expression network in clear cell renal cell carcinoma.
Neoplasms
Identification of Biomarkers Related to Prognosis of Bladder Transitional Cell Carcinoma.
Neoplasms
Identification of breast cancer associated variants that modulate transcription factor binding.
Neoplasms
Identification of breast cancer prognostic modules via differential module selection based on weighted gene Co-expression network analysis.
Neoplasms
Identification of breast cancer-related circRNAs by analysis of microarray and RNA-sequencing data: An observational study.
Neoplasms
Identification of cancer risk lncRNAs and cancer risk pathways regulated by cancer risk lncRNAs based on genome sequencing data in human cancers.
Neoplasms
Identification of cancer stem cell-related biomarkers in intestinal-type and diffuse-type gastric cancer by stemness index and weighted correlation network analysis.
Neoplasms
Identification of cancer stem cell-related biomarkers in lung adenocarcinoma by stemness index and weighted correlation network analysis.
Neoplasms
Identification of Cancer-Specific Methylation of Gene Combination for the Diagnosis of Bladder Cancer.
Neoplasms
Identification of cancer/testis antigen 2 gene as a potential hepatocellular carcinoma therapeutic target by hub gene screening with topological analysis.
Neoplasms
Identification of candidate aberrantly methylated and differentially expressed genes in thyroid cancer.
Neoplasms
Identification of Candidate Biomarkers and Analysis of Prognostic Values in Oral Squamous Cell Carcinoma.
Neoplasms
Identification of Candidate Biomarkers and Prognostic Analysis in Colorectal Cancer Liver Metastases.
Neoplasms
Identification of candidate cancer drivers by integrative Epi-DNA and Gene Expression (iEDGE) data analysis.
Neoplasms
Identification of candidate genes and prognostic value analysis in patients with PDL1-positive and PDL1-negative lung adenocarcinoma.
Neoplasms
Identification of Candidate Genes Associated with Susceptibility to Ovarian Clear Cell Adenocarcinoma Using cis-eQTL Analysis.
Neoplasms
Identification of candidate genes encoding tumor-specific neoantigens in early- and late-stage colon adenocarcinoma.
Neoplasms
Identification of candidate RNA signatures in triple-negative breast cancer by the construction of a competing endogenous RNA network with integrative analyses of Gene Expression Omnibus and The Cancer Genome Atlas data.
Neoplasms
Identification of candidate target genes for endometrial cancer, such as ANO1, using weighted gene co-expression network analysis.
Neoplasms
Identification of Carbonic Anhydrase IX as a Novel Target for Endoscopic Molecular Imaging of Human Bladder Cancer.
Neoplasms
Identification of CAV1 and DCN as potential predictive biomarkers for lung adenocarcinoma.
Neoplasms
Identification of CDC20 as a Novel Biomarker in Diagnosis and Treatment of Wilms Tumor.
Neoplasms
Identification of CDC20 as an immune infiltration-correlated prognostic biomarker in hepatocellular carcinoma.
Neoplasms
Identification of CDK2-Related Immune Forecast Model and ceRNA in Lung Adenocarcinoma, a Pan-Cancer Analysis.
Neoplasms
Identification of cell surface targets for CAR-T cell therapies and antibody-drug conjugates in breast cancer.
Neoplasms
Identification of ceRNA network based on a RNA-seq shows prognostic lncRNA biomarkers in human lung adenocarcinoma.
Neoplasms
Identification of circRNA-lncRNA-miRNA-mRNA Competitive Endogenous RNA Network as Novel Prognostic Markers for Acute Myeloid Leukemia.
Neoplasms
Identification of circRNA-miRNA-mRNA networks contributes to explore underlying pathogenesis and therapy strategy of gastric cancer.
Neoplasms
Identification of circRNA-miRNA-mRNA regulatory network in gastric cancer by analysis of microarray data.
Neoplasms
Identification of circular RNA-microRNA-messenger RNA regulatory network in hepatocellular carcinoma by integrated analysis.
Neoplasms
Identification of clinical trait-related lncRNA and mRNA biomarkers with weighted gene co-expression network analysis as useful tool for personalized medicine in ovarian cancer.
Neoplasms
Identification of cluster of differentiation molecule-associated microRNAs as potential therapeutic targets for gastrointestinal cancer immunotherapy.
Neoplasms
Identification of Coding and Long Noncoding RNAs Differentially Expressed in Tumors and Preferentially Expressed in Healthy Tissues.
Neoplasms
Identification of COL6A1 as the Key Gene Associated with Antivascular Endothelial Growth Factor Therapy in Glioblastoma Multiforme.
Neoplasms
Identification of colorectal cancer-associated macrophage biomarkers by integrated bioinformatic analysis.
Neoplasms
Identification of common differentially-expressed miRNAs in ovarian cancer cells and their exosomes compared with normal ovarian surface epithelial cell cells.
Neoplasms
Identification of copy number variation-driven genes for liver cancer via bioinformatics analysis.
Neoplasms
Identification of core aberrantly expressed microRNAs in serous ovarian carcinoma.
Neoplasms
Identification of Core Genes and Key Pathways via Integrated Analysis of Gene Expression and DNA Methylation Profiles in Bladder Cancer.
Neoplasms
Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis.
Neoplasms
Identification of Core Genes and Pathways in Medulloblastoma by Integrated Bioinformatics Analysis.
Neoplasms
Identification of Core Genes and Screening of Potential Targets in Glioblastoma Multiforme by Integrated Bioinformatic Analysis.
Neoplasms
Identification of Core Genes Involved in the Progression of Cervical Cancer Using an Integrative mRNA Analysis.
Neoplasms
Identification of Core Genes Related to Progression and Prognosis of Hepatocellular Carcinoma and Small-Molecule Drug Predication.
Neoplasms
Identification of Critical Genes and Five Prognostic Biomarkers Associated with Colorectal Cancer.
Neoplasms
Identification of Crucial Genes Associated With Immune Cell Infiltration in Hepatocellular Carcinoma by Weighted Gene Co-expression Network Analysis.
Neoplasms
Identification of crucial genes based on expression profiles of hepatocellular carcinomas by bioinformatics analysis.
Neoplasms
Identification of crucial miRNAs and genes in esophageal squamous cell carcinoma by miRNA-mRNA integrated analysis.
Neoplasms
Identification of CTLA-4 associated with tumor microenvironment and competing interactions in triple negative breast cancer by co-expression network analysis.
Neoplasms
Identification of DAPK1 Promoter Hypermethylation as a Biomarker for Intra-Epithelial Lesion and Cervical Cancer: A Meta-Analysis of Published Studies, TCGA, and GEO Datasets.
Neoplasms
Identification of Deleterious NOTCH Mutation as Novel Predictor to Efficacious Immunotherapy in NSCLC.
Neoplasms
Identification of DGUOK-AS1 as a Prognostic Factor in Breast Cancer by Bioinformatics Analysis.
Neoplasms
Identification of diagnostic DNA methylation biomarkers specific for early-stage lung adenocarcinoma.
Neoplasms
Identification of diagnostic long non?coding RNA biomarkers in patients with hepatocellular carcinoma.
Neoplasms
Identification of differential expressed lncRNAs in human thyroid cancer by a genome-wide analyses.
Neoplasms
Identification of differentially expressed genes and biological characteristics of colorectal cancer by integrated bioinformatics analysis.
Neoplasms
Identification of Differentially Expressed Genes and miRNAs Associated with Esophageal Squamous Cell Carcinoma by Integrated Analysis of Microarray Data.
Neoplasms
Identification of differentially expressed genes and their upstream regulators in colorectal cancer.
Neoplasms
Identification of differentially expressed genes between triple and non-triple-negative breast cancer using bioinformatics analysis.
Neoplasms
Identification of differentially expressed genes in nasopharyngeal carcinoma by means of the Atlas human cancer cDNA expression array.
Neoplasms
Identification of differentially expressed genes in pancreatic ductal adenocarcinoma and normal pancreatic tissues based on microarray datasets.
Neoplasms
Identification of Differentially Expressed Genes Induced by Aberrant Methylation in Oral Squamous Cell Carcinomas Using Integrated Bioinformatic Analysis.
Neoplasms
Identification of differentially expressed genes regulated by methylation in colon cancer based on bioinformatics analysis.
Neoplasms
Identification of differentially expressed lncRNAs and mRNAs in luminal-B breast cancer by RNA-sequencing.
Neoplasms
Identification of differentially expressed metastatic genes and their signatures to predict the overall survival of uveal melanoma patients by bioinformatics analysis.
Neoplasms
Identification of differentially expressed miRNAs in early-stage cervical cancer with lymph node metastasis across The Cancer Genome Atlas datasets.
Neoplasms
Identification of differentially expressed miRNAs in individual breast cancer patient and application in personalized medicine.
Neoplasms
Identification of discrepancy between CTLA4 expression and CTLA4 activation in gastric cancer.
Neoplasms
Identification of Disease-miRNA Networks Across Different Cancer Types Using SWIM.
Neoplasms
Identification of Distinct Molecular Patterns and a Four-Gene Signature in Colon Cancer Based on Invasion-Related Genes.
Neoplasms
Identification of distinctive long noncoding RNA competitive interactions and a six-methylated-gene prognostic signature in acute myeloid leukemia with -5/del(5q) or -7/del(7q).
Neoplasms
Identification of Diverse Adenosine-to-Inosine RNA Editing Subtypes in Colorectal Cancer.
Neoplasms
Identification of DNA methylation associated gene signatures in endometrial cancer via integrated analysis of DNA methylation and gene expression systematically.
Neoplasms
Identification of DNA methylation markers for early detection of CRC indicates a role for nervous system-related genes in CRC.
Neoplasms
Identification of DNA methylation signature to predict prognosis in gastric adenocarcinoma.
Neoplasms
Identification of DNA methylation-driven genes in esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas.
Neoplasms
Identification of DNA methylation-regulated differentially-expressed genes and related pathways using Illumina 450K BeadChip and bioinformatic analysis in gastric cancer.
Neoplasms
Identification of DNA-Repair-Related Five-Gene Signature to Predict Prognosis in Patients with Esophageal Cancer.
Neoplasms
Identification of down-regulated microRNAs in thyroid cancer and their potential functions.
Neoplasms
Identification of downstream signaling cascades of ACK1 and prognostic classifiers in non-small cell lung cancer.
Neoplasms
Identification of driver copy number alterations in diverse cancer types and application in drug repositioning.
Neoplasms
Identification of driver genes regulating immune cell infiltration in cervical cancer by multiple omics integration.
Neoplasms
Identification of Dysregulated Competitive Endogenous RNA Networks Driven by Copy Number Variations in Malignant Gliomas.
Neoplasms
Identification of dysregulated lncRNAs profiling and metastasis-associated lncRNAs in colorectal cancer by genome-wide analysis.
Neoplasms
Identification of dysregulated long non-coding RNAs/microRNAs/mRNAs in TNM I stage lung adenocarcinoma.
Neoplasms
Identification of dysregulated miRNAs-genes network in ovarian cancer: An integrative approach to uncover the molecular interactions and oncomechanisms.
Neoplasms
Identification of dysregulated serum miR-508-3p and miR-885-5p as potential diagnostic biomarkers of clear cell renal carcinoma.
Neoplasms
Identification of early stage recurrence endometrial cancer biomarkers using bioinformatics tools.
Neoplasms
Identification of EMT-Related Gene Signatures to Predict the Prognosis of Patients With Endometrial Cancer.
Neoplasms
Identification of endometrial cancer methylation features using combined methylation analysis methods.
Neoplasms
Identification of Energy Metabolism Genes for the Prediction of Survival in Hepatocellular Carcinoma.
Neoplasms
Identification of ENTPD8 and cytidine in pancreatic cancer by metabolomic and transcriptomic conjoint analysis.
Neoplasms
Identification of epigenetic interactions between miRNA and DNA methylation associated with gene expression as potential prognostic markers in bladder cancer.
Neoplasms
Identification of epigenetic modulators in human breast cancer by integrated analysis of DNA methylation and RNA-Seq data.
Neoplasms
Identification of Epithelial-Mesenchymal Transition-Related lncRNA With Prognosis and Molecular Subtypes in Clear Cell Renal Cell Carcinoma.
Neoplasms
Identification of Epithelial-Mesenchymal Transition-Related lncRNAs that Associated With the Prognosis and Immune Microenvironment in Colorectal Cancer.
Neoplasms
Identification of Expression Signatures For Non-Small-Cell Lung Carcinoma Subtype Classification.
Neoplasms
Identification of FADS1 Through Common Gene Expression Profiles for Predicting Survival in Patients with Bladder Cancer.
Neoplasms
Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
Neoplasms
Identification of Five Genes as a Potential Biomarker for Predicting Progress and Prognosis in Adrenocortical Carcinoma.
Neoplasms
Identification of five hub genes as monitoring biomarkers for breast cancer metastasis in silico.
Neoplasms
Identification of Five Immune-Related lncRNAs Predicting Survival and Tumor Microenvironment Characteristics in Breast Cancer.
Neoplasms
Identification of five long noncoding RNAs signature and risk score for prognosis of bladder urothelial carcinoma.
Neoplasms
Identification of FOS as a Candidate Risk Gene for Liver Cancer by Integrated Bioinformatic Analysis.
Neoplasms
Identification of four differentially methylated genes as prognostic signatures for stage I lung adenocarcinoma.
Neoplasms
Identification of Four Enhancer-Associated Genes as Risk Signature for Diffuse Glioma Patients.
Neoplasms
Identification of four gastric cancer subtypes based on genetic analysis of cholesterogenic and glycolytic pathways.
Neoplasms
Identification of Four Genes as Prognosis Signatures in Lung Adenocarcinoma Microenvironment.
Neoplasms
Identification of four hub genes associated with adrenocortical carcinoma progression by WGCNA.
Neoplasms
Identification of four key prognostic genes and three potential drugs in human papillomavirus negative head and neck squamous cell carcinoma.
Neoplasms
Identification of four methylation-driven genes as candidate biomarkers for monitoring single-walled carbon nanotube-induced malignant transformation of the lung.
Neoplasms
Identification of Four Pathological Stage-Relevant Genes in Association with Progression and Prognosis in Clear Cell Renal Cell Carcinoma by Integrated Bioinformatics Analysis.
Neoplasms
Identification of FPR3 as a Unique Biomarker for Targeted Therapy in the Immune Microenvironment of Breast Cancer.
Neoplasms
Identification of functional lncRNAs in gastric cancer by integrative analysis of GEO and TCGA data.
Neoplasms
Identification of functional long non-coding RNAs in gastric cancer by bioinformatics analysis.
Neoplasms
Identification of G-protein signaling modulator 2 as a diagnostic and prognostic biomarker of pancreatic adenocarcinoma: an exploration of its regulatory mechanisms.
Neoplasms
Identification of G2 and S Phase-Expressed-1 as a Potential Biomarker in Patients with Prostate Cancer.
Neoplasms
Identification of gene biomarkers and immune cell infiltration characteristics in rectal cancer.
Neoplasms
Identification of gene co-expression modules and hub genes associated with lymph node metastasis of papillary thyroid cancer.
Neoplasms
Identification of gene expression levels in primary melanoma associated with clinically meaningful characteristics.
Neoplasms
Identification of gene expression profiles and immune cell infiltration signatures between low and high tumor mutation burden groups in bladder cancer.
Neoplasms
Identification of Gene Signatures for Diagnosis and Prognosis of Hepatocellular Carcinomas Patients at Early Stage.
Neoplasms
Identification of genes and pathways involved in kidney renal clear cell carcinoma.
Neoplasms
Identification of genes associated with cancer prognosis in glioma: In silico data analyses of Chinese Glioma Genome Atlas (CGGA) and The Cancer Genome Atlas (TCGA).
Neoplasms
Identification of genes associated with cancer progression and prognosis in lung adenocarcinoma: Analyses based on microarray from Oncomine and The Cancer Genome Atlas databases.
Neoplasms
Identification of genes associated with gastric cancer survival and construction of a nomogram to improve risk stratification for patients with gastric cancer.
Neoplasms
Identification of genes associated with histologic tumor grade of esophageal squamous cell carcinoma.
Neoplasms
Identification of Genes Associated with the Metastasis of Pheochromocytoma/Paraganglioma Based on Weighted Gene Coexpression Network Analysis.
Neoplasms
Identification of genes involved in the regulation of TERT in hepatocellular carcinoma.
Neoplasms
Identification of genes of prognostic value in the ccRCC microenvironment from TCGA database.
Neoplasms
Identification of Genes Related to Clinicopathological Characteristics and Prognosis of Patients with Colorectal Cancer.
Neoplasms
Identification of Genes Related to Immune Infiltration in the Tumor Microenvironment of Cutaneous Melanoma.
Neoplasms
Identification of genes responsible for RelA-dependent proliferation arrest in human mammary epithelial cells conditionally expressing RelA.
Neoplasms
Identification of genes that correlate clear cell renal cell carcinoma and obesity and exhibit potential prognostic value.
Neoplasms
Identification of genes that predict the biochemical recurrence of prostate cancer.
Neoplasms
Identification of Genes Whose Expression Overlaps Age Boundaries and Correlates with Risk Groups in Paediatric and Adult Acute Myeloid Leukaemia.
Neoplasms
Identification of Genetic and Epigenetic Variants Associated with Breast Cancer Prognosis by Integrative Bioinformatics Analysis.
Neoplasms
Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis.
Neoplasms
Identification of genomic alterations and associated transcriptomic profiling reveal the prognostic significance of MMP14 and PKM2 in patients with pancreatic cancer.
Neoplasms
Identification of genomic features associated with immunotherapy response in gastrointestinal cancers.
Neoplasms
Identification of glioblastoma-specific prognostic biomarkers via an integrative analysis of DNA methylation and gene expression.
Neoplasms
Identification of Glioma Cancer Stem Cell Characteristics Based on Weighted Gene Prognosis Module Co-Expression Network Analysis of Transcriptome Data Stemness Indices.
Neoplasms
Identification of glycolysis related pathways in pancreatic adenocarcinoma and liver hepatocellular carcinoma based on TCGA and GEO datasets.
Neoplasms
Identification of Glycolysis-Related lncRNAs and the Novel lncRNA WAC-AS1 Promotes Glycolysis and Tumor Progression in Hepatocellular Carcinoma.
Neoplasms
Identification of GSN and LAMC2 as Key Prognostic Genes of Bladder Cancer by Integrated Bioinformatics Analysis.
Neoplasms
Identification of HCC-Related Genes Based on Differential Partial Correlation Network.
Neoplasms
Identification of hedgehog signaling as a potential oncogenic driver in an aggressive subclass of human hepatocellular carcinoma: A reanalysis of the TCGA cohort.
Neoplasms
Identification of hepatocellular carcinoma prognostic markers based on 10-immune gene signature.
Neoplasms
Identification of hepatocellular carcinoma-related genes associated with macrophage differentiation based on bioinformatics analyses.
Neoplasms
Identification of Hepatocellular Carcinoma-Related Potential Genes and Pathways Through Bioinformatic-Based Analyses.
Neoplasms
Identification of highly connected and differentially expressed gene subnetworks in metastasizing endometrial cancer.
Neoplasms
Identification of Histological Correlates of Overall Survival in Lower Grade Gliomas Using a Bag-of-words Paradigm: A Preliminary Analysis Based on Hematoxylin & Eosin Stained Slides from the Lower Grade Glioma Cohort of The Cancer Genome Atlas.
Neoplasms
Identification of hsa_circ_0002024 as a prognostic competing endogenous RNA (ceRNA) through the hsa_miR_129-5p/Anti-Silencing Function 1B Histone Chaperone (ASF1B) axis in renal cell carcinoma.
Neoplasms
Identification of Hub Driving Genes and Regulators of Lung Adenocarcinoma based on the Gene Co-expression Network.
Neoplasms
Identification of Hub Gene TIMP1 and Relative ceRNAs Regulatory Network in Colorectal Cancer.
Neoplasms
Identification of Hub Genes and Analysis of Prognostic Values in Hepatocellular Carcinoma by Bioinformatics Analysis.
Neoplasms
Identification of hub genes and compounds controlling ovarian cancer stem cell characteristics via stemness indices analysis.
Neoplasms
Identification of Hub Genes and Construction of a Transcriptional Regulatory Network Associated With Tumor Recurrence in Colorectal Cancer by Weighted Gene Co-expression Network Analysis.
Neoplasms
Identification of hub genes and construction of transcriptional regulatory network for the progression of colon adenocarcinoma hub genes and TF regulatory network of colon adenocarcinoma.
Neoplasms
Identification of Hub Genes and Pathways of Triple Negative Breast Cancer by Expression Profiles Analysis.
Neoplasms
Identification of hub genes and small molecule therapeutic drugs related to breast cancer with comprehensive bioinformatics analysis.
Neoplasms
Identification of hub genes associated with adult acute myeloid leukemia progression through weighted gene co-expression network analysis.
Neoplasms
Identification of Hub Genes Associated With Development and Microenvironment of Hepatocellular Carcinoma by Weighted Gene Co-expression Network Analysis and Differential Gene Expression Analysis.
Neoplasms
Identification of Hub Genes Associated With Development of Head and Neck Squamous Cell Carcinoma by Integrated Bioinformatics Analysis.
Neoplasms
Identification of hub genes associated with esophageal cancer progression using bioinformatics analysis.
Neoplasms
Identification of hub genes associated with neutrophils infiltration in colorectal cancer.
Neoplasms
Identification of hub genes associated with outcome of clear cell renal cell carcinoma.
Neoplasms
Identification of hub genes associated with prognosis, diagnosis, immune infiltration and therapeutic drug in liver cancer by integrated analysis.
Neoplasms
Identification of hub genes associated with the pathogenesis of diffuse large B-cell lymphoma subtype one characterized by host response via integrated bioinformatic analyses.
Neoplasms
Identification of hub genes in bladder cancer based on weighted gene co-expression network analysis from TCGA database.
Neoplasms
Identification of hub genes in colorectal cancer based on weighted gene co-expression network analysis and clinical data from The Cancer Genome Atlas.
Neoplasms
Identification of hub genes in colorectal cancer based on weighted gene co-expression network analysis.
Neoplasms
Identification of Hub Genes in Gastric Cancer with High Heterogeneity Based on Weighted Gene Co-Expression Network.
Neoplasms
Identification of hub genes in hepatocellular carcinoma using integrated bioinformatic analysis.
Neoplasms
Identification of hub genes in thyroid carcinoma to predict prognosis by integrated bioinformatics analysis.
Neoplasms
Identification of hub genes involved in the occurrence and development of hepatocellular carcinoma via bioinformatics analysis.
Neoplasms
Identification of Hub Genes Related to Carcinogenesis and Prognosis in Colorectal Cancer Based on Integrated Bioinformatics.
Neoplasms
Identification of hub genes with diagnostic values in pancreatic cancer by bioinformatics analyses and supervised learning methods.
Neoplasms
Identification of hub lncRNAs in head and neck cancer based on weighted gene co-expression network analysis and experiments.
Neoplasms
Identification of Hub Prognosis-Associated Oxidative Stress Genes in Pancreatic Cancer Using Integrated Bioinformatics Analysis.
Neoplasms
Identification of hub prognosis-associated oxidative stress genes in skin cutaneous melanoma using integrated bioinformatic analysis.
Neoplasms
Identification of hyper-rewired genomic stress non-oncogene addiction genes across 15 cancer types.
Neoplasms
Identification of IDH-mutant gliomas by a prognostic signature according to gene expression profiling.
Neoplasms
Identification of IGF-1-enhanced cytokine expressions targeted by miR-181d in glioblastomas via an integrative miRNA/mRNA regulatory network analysis.
Neoplasms
Identification of Immune Cell Infiltration and Immune-Related Genes in the Tumor Microenvironment of Glioblastomas.
Neoplasms
Identification of Immune Cell Infiltration Landscape and Their Prognostic Significance in Uveal Melanoma.
Neoplasms
Identification of immune microenvironment subtypes that predicted the prognosis of patients with ovarian cancer.
Neoplasms
Identification of immune subtypes and prognosis of hepatocellular carcinoma based on immune checkpoint gene expression profile.
Neoplasms
Identification of immune-enhanced molecular subtype associated with BRCA1 mutations, immune checkpoints and clinical outcome in ovarian carcinoma.
Neoplasms
Identification of immune-infiltrating cell-related biomarkers in hepatocellular carcinoma based on gene co-expression network analysis.
Neoplasms
Identification of Immune-Related Cells and Genes in Tumor Microenvironment of Clear Cell Renal Cell Carcinoma.
Neoplasms
Identification of Immune-Related Genes Contributing to the Development of Glioblastoma Using Weighted Gene Co-expression Network Analysis.
Neoplasms
Identification of immune-related LncRNA for predicting prognosis and immunotherapeutic response in bladder cancer.
Neoplasms
Identification of Immune-Related lncRNA Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer.
Neoplasms
Identification of immune-related lncRNAs to improve the prognosis prediction for patients with papillary thyroid cancer.
Neoplasms
Identification of Immune-Related Prognostic Biomarkers Associated with HPV-Positive Head and Neck Squamous Cell Carcinoma.
Neoplasms
Identification of Immune-Related Prognostic Biomarkers Based on the Tumor Microenvironment in 20 Malignant Tumor Types With Poor Prognosis.
Neoplasms
Identification of Immune-Related Risk Signatures for the Prognostic Prediction in Oral Squamous Cell Carcinoma.
Neoplasms
Identification of Immune-Related Therapeutically Relevant Biomarkers in Breast Cancer and Breast Cancer Stem Cells by Transcriptome-Wide Analysis: A Clinical Prospective Study.
Neoplasms
Identification of immunohistochemical markers for distinguishing lung adenocarcinoma from squamous cell carcinoma.
Neoplasms
Identification of immunologic subtype and prognosis of GBM based on TNFSF14 and immune checkpoint gene expression profiling.
Neoplasms
Identification of immunological subtypes of hepatocellular carcinoma with expression profiling of immune-modulating genes.
Neoplasms
Identification of important invasion and proliferation related genes in adrenocortical carcinoma.
Neoplasms
Identification of Important Modules and Biomarkers in Breast Cancer Based on WGCNA.
Neoplasms
Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus.
Neoplasms
Identification of influential observations in high-dimensional cancer survival data through the rank product test.
Neoplasms
Identification of inhibitory immune checkpoints and relevant regulatory pathways in breast cancer stem cells.
Neoplasms
Identification of intestinal flora-related key genes and therapeutic drugs in colorectal cancer.
Neoplasms
Identification of ITGA3 as an Oncogene in Human Tongue Cancer via Integrated Bioinformatics Analysis.
Neoplasms
Identification of JAK2 and FOXM1 expression as novel candidate biomarkers for predicting the benefit of immunotherapy in lung squamous cell carcinoma.
Neoplasms
Identification of Jun loss promotes resistance to histone deacetylase inhibitor entinostat through Myc signaling in luminal breast cancer.
Neoplasms
Identification of key candidate genes and pathways in glioblastoma by integrated bioinformatical analysis.
Neoplasms
Identification of key classification features of early cervical squamous cell carcinoma.
Neoplasms
Identification of key differentially expressed MicroRNAs in cancer patients through pan-cancer analysis.
Neoplasms
Identification of key differentially expressed mRNAs and microRNAs in non-small cell lung cancer using bioinformatics analysis.
Neoplasms
Identification of Key Differentially Expressed Transcription Factors in Glioblastoma.
Neoplasms
Identification of key DNA methylation-driven genes in prostate adenocarcinoma: an integrative analysis of TCGA methylation data.
Neoplasms
Identification of Key Functional Gene Signatures Indicative of Dedifferentiation in Papillary Thyroid Cancer.
Neoplasms
Identification of Key Gene and Pathways for the Prediction of Peritoneal Metastasis of Gastric Cancer by Co-expression Analysis.
Neoplasms
Identification of key genes and biological processes contributing to colitis associated dysplasia in ulcerative colitis.
Neoplasms
Identification of key genes and microRNA regulatory network in development and progression of urothelial bladder carcinoma.
Neoplasms
Identification of key genes and microRNAs involved in kidney Wilms tumor by integrated bioinformatics analysis.
Neoplasms
Identification of key genes and multiple molecular pathways of metastatic process in prostate cancer.
Neoplasms
Identification of key genes and pathways associated with cholangiocarcinoma development based on weighted gene correlation network analysis.
Neoplasms
Identification of Key Genes and Pathways Associated With Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma Based on Bioinformatics Analysis.
Neoplasms
Identification of Key Genes and Pathways Associated with RUNX1 Mutations in Acute Myeloid Leukemia Using Bioinformatics Analysis.
Neoplasms
Identification of key genes and pathways associated with topotecan treatment using multiple bioinformatics tools.
Neoplasms
Identification of key genes and pathways between type I and type II endometrial cancer using bioinformatics analysis.
Neoplasms
Identification of key genes and pathways by bioinformatics analysis with TCGA RNA sequencing data in hepatocellular carcinoma.
Neoplasms
Identification of key genes and pathways downstream of the ?-catenin-TCF7L1 complex in pancreatic cancer cells using bioinformatics analysis.
Neoplasms
Identification of Key Genes and Pathways in Female Lung Cancer Patients Who Never Smoked by a Bioinformatics Analysis.
Neoplasms
Identification of Key Genes and Pathways in Pancreatic Cancer Gene Expression Profile by Integrative Analysis.
Neoplasms
Identification of Key Genes and Pathways in Triple-Negative Breast Cancer by Integrated Bioinformatics Analysis.
Neoplasms
Identification of key genes and pathways of thyroid cancer by integrated bioinformatics analysis.
Neoplasms
Identification of key genes as potential biomarkers for triple?negative breast cancer using integrating genomics analysis.
Neoplasms
Identification of key genes associated with progression and prognosis for lung squamous cell carcinoma.
Neoplasms
Identification of key genes controlling breast cancer stem cell characteristics via stemness indices analysis.
Neoplasms
Identification of key genes controlling cancer stem cell characteristics in gastric cancer.
Neoplasms
Identification of key genes for guiding chemotherapeutic management in ovarian cancer using translational bioinformatics.
Neoplasms
Identification of key genes for predicting colorectal cancer prognosis by integrated bioinformatics analysis.
Neoplasms
Identification of Key Genes in Association with Progression and Prognosis in Cervical Squamous Cell Carcinoma.
Neoplasms
Identification of key genes in endometrioid endometrial adenocarcinoma via TCGA database.
Neoplasms
Identification of key genes in prostate cancer gene expression profile by bioinformatics.
Neoplasms
Identification of key genes in the tumor microenvironment of lung adenocarcinoma.
Neoplasms
Identification of key genes involved in the development and progression of early-onset colorectal cancer by co-expression network analysis.
Neoplasms
Identification of key genes involved in the metastasis of clear cell renal cell carcinoma.
Neoplasms
Identification of key genes involved in the recurrence of glioblastoma multiforme using weighted gene co-expression network analysis and differential expression analysis.
Neoplasms
Identification of key genes involved in tumor immune cell infiltration and cetuximab resistance in colorectal cancer.
Neoplasms
Identification of key genes of papillary thyroid cancer using integrated bioinformatics analysis.
Neoplasms
Identification of Key Genes Related to Lung Squamous Cell Carcinoma Using Bioinformatics Analysis.
Neoplasms
Identification of key genes unique to the luminal a and basal-like breast cancer subtypes via bioinformatic analysis.
Neoplasms
Identification of Key Genes With Differential Correlations in Lung Adenocarcinoma.
Neoplasms
Identification of Key lncRNA-mRNA Pairs and Functional lncRNAs in Breast Cancer by Integrative Analysis of TCGA Data.
Neoplasms
Identification of key lncRNAs as prognostic prediction models for colorectal cancer based on LASSO.
Neoplasms
Identification of key miRNAs and genes associated with stomach adenocarcinoma from The Cancer Genome Atlas database.
Neoplasms
Identification of key modules and genes associated with breast cancer prognosis using WGCNA and ceRNA network analysis.
Neoplasms
Identification of key modules and hub genes in glioblastoma multiforme based on co-expression network analysis.
Neoplasms
Identification of key modules and prognostic markers in adrenocortical carcinoma by weighted gene co-expression network analysis.
Neoplasms
Identification of Key mRNAs as Prediction Models for Early Metastasis of Pancreatic Cancer Based on LASSO.
Neoplasms
Identification of key pathways and genes in colorectal cancer to predict the prognosis based on mRNA interaction network.
Neoplasms
Identification of key pathways and genes in endometrial cancer using bioinformatics analyses.
Neoplasms
Identification of Key Pathways and Genes in the Orai2 Mediated Classical and Mesenchymal Subtype of Glioblastoma by Bioinformatic Analyses.
Neoplasms
Identification of key pathways and genes influencing prognosis in bladder urothelial carcinoma.
Neoplasms
Identification of Key Prognostic Biomarker and Its Correlation with Immune Infiltrates in Pancreatic Ductal Adenocarcinoma.
Neoplasms
Identification of key transcription factors in endometrial cancer by systems bioinformatics analysis.
Neoplasms
Identification of KIF18B as a Hub Candidate Gene in the Metastasis of Clear Cell Renal Cell Carcinoma by Weighted Gene Co-expression Network Analysis.
Neoplasms
Identification of laminin ?2 as a prognostic and predictive biomarker for determining response to gemcitabine-based therapy in pancreatic ductal adenocarcinoma.
Neoplasms
Identification of latent biomarkers in connection with progression and prognosis in oral cancer by comprehensive bioinformatics analysis.
Neoplasms
Identification of LINC01615 as potential metastasis-related long noncoding RNA in hepatocellular carcinoma.
Neoplasms
Identification of LINC02310 as an enhancer in lung adenocarcinoma and investigation of its regulatory network via comprehensive analyses.
Neoplasms
Identification of liver metastasis-associated genes in human colon carcinoma by mRNA profiling.
Neoplasms
Identification of lnc RNAs Related to Prognosis of Patients With Colorectal Cancer.
Neoplasms
Identification of lncRNA biomarkers for lung cancer through integrative cross-platform data analyses.
Neoplasms
Identification of lncRNA biomarkers in lung squamous cell carcinoma using comprehensive analysis of lncRNA mediated ceRNA network.
Neoplasms
Identification of lncRNA FAM83H-AS1 as a novel prognostic marker in luminal subtype breast cancer.
Neoplasms
Identification of lncRNA functions in lung cancer based on associated protein-protein interaction modules.
Neoplasms
Identification of lncRNA TRPM2-AS/miR-140-3p/PYCR1 axis's proliferates and anti-apoptotic effect on breast cancer using co-expression network analysis.
Neoplasms
Identification of lncRNAs associated with lung squamous cell carcinoma prognosis in the competitive endogenous RNA network.
Neoplasms
Identification of Long Non-coding and Messenger RNAs Differentially Expressed Between Primary and Metastatic Melanoma.
Neoplasms
Identification of long non-coding RNA competing interactions and biological pathways associated with prognosis in pediatric and adolescent cytogenetically normal acute myeloid leukemia.
Neoplasms
Identification of Long Non-Coding RNA Expression Profiles and Co-Expression Genes in Thyroid Carcinoma Based on The Cancer Genome Atlas (TCGA) Database.
Neoplasms
Identification of long non-coding RNA signatures in triple-negative breast cancer.
Neoplasms
Identification of long non-coding RNAs biomarkers associated with progression of endometrial carcinoma and patient outcomes.
Neoplasms
Identification of Long Non-Coding RNAs for Predicting Prognosis Among Patients with Thymoma.
Neoplasms
Identification of long non-coding RNAs that stimulate cell survival in bladder cancer.
Neoplasms
Identification of Long Noncoding RNA Biomarkers for Hepatocellular Carcinoma Using Single-Sample Networks.
Neoplasms
Identification of long noncoding RNA RP11-89K21.1 and RP11-357H14.17 as prognostic signature of endometrial carcinoma via integrated bioinformatics analysis.
Neoplasms
Identification of long noncoding RNAs biomarkers for diagnosis and prognosis in patients with colon adenocarcinoma.
Neoplasms
Identification of long noncoding RNAs biomarkers in patients with hepatitis B virus-associated hepatocellular carcinoma.
Neoplasms
Identification of low abundance microbiome in clinical samples using whole genome sequencing.
Neoplasms
Identification of LOXL3-associating immune infiltration landscape and prognostic value in hepatocellular carcinoma.
Neoplasms
Identification of LPCAT1 expression as a potential prognostic biomarker guiding treatment choice in acute myeloid leukemia.
Neoplasms
Identification of Lymph Node Metastasis-Related Key Genes and Prognostic Risk Model in Bladder Cancer by Co-Expression Analysis.
Neoplasms
Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma.
Neoplasms
Identification of m6A-related genes and m6A RNA methylation regulators in pancreatic cancer and their association with survival.
Neoplasms
Identification of markers associated with brain metastasis from breast cancer through bioinformatics analysis and verification in clinical samples.
Neoplasms
Identification of markers associated with global changes in DNA methylation regulation in cancers.
Neoplasms
Identification of MEG8/miR-378d/SOBP axis as a novel regulatory network and associated with immune infiltrates in ovarian carcinoma by integrated bioinformatics analysis.
Neoplasms
Identification of metabolism genes related to hepatocarcinogenesis and progression in type 2 diabetes mellitus via co-expression networks analysis.
Neoplasms
Identification of metabolism-associated genes and construction of a prognostic signature in bladder cancer.
Neoplasms
Identification of metabolism-associated genes and pathways involved in different stages of clear cell renal cell carcinoma.
Neoplasms
Identification of Metabolism-Associated Prostate Cancer Subtypes and Construction of a Prognostic Risk Model.
Neoplasms
Identification of metastasis and prognosis-associated genes for serous ovarian cancer.
Neoplasms
Identification of Metastasis-Associated Genes in Triple-Negative Breast Cancer Using Weighted Gene Co-expression Network Analysis.
Neoplasms
Identification of methylation sites and signature genes with prognostic value for luminal breast cancer.
Neoplasms
Identification of methylation-driven genes related to prognosis in clear-cell renal cell carcinoma.
Neoplasms
Identification of methylation-driven genes related to the prognosis of papillary renal cell carcinoma: a study based on The Cancer Genome Atlas.
Neoplasms
Identification of Methylation-Regulated Differentially Expressed Genes and Related Pathways in Hepatocellular Carcinoma: A Study Based on TCGA Database and Bioinformatics Analysis.
Neoplasms
Identification of METTL3 as an Adverse Prognostic Biomarker in Hepatocellular Carcinoma.
Neoplasms
Identification of microenvironment-related genes with prognostic value in clear cell renal cell carcinoma.
Neoplasms
Identification of microR-106b as a prognostic biomarker of p53-like bladder cancers by ActMiR.
Neoplasms
Identification of MicroRNA-Related Tumorigenesis Variants and Genes in the Cancer Genome Atlas (TCGA) Data.
Neoplasms
Identification of MicroRNAs as Breast Cancer Prognosis Markers through the Cancer Genome Atlas.
Neoplasms
Identification of MicroRNAs as Diagnostic Biomarkers for Breast Cancer Based on the Cancer Genome Atlas.
Neoplasms
Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
Neoplasms
Identification of miR-101-3p targets and functional features based on bioinformatics, meta-analysis and experimental verification in hepatocellular carcinoma.
Neoplasms
Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers.
Neoplasms
Identification of miR-200c and miR141-Mediated lncRNA-mRNA Crosstalks in Muscle-Invasive Bladder Cancer Subtypes.
Neoplasms
Identification of miR-21-5p and miR-210-3p serum levels as biomarkers for patients with papillary renal cell carcinoma: a multicenter analysis.
Neoplasms
Identification of miR-379/miR-656 (C14MC) cluster downregulation and associated epigenetic and transcription regulatory mechanism in oligodendrogliomas.
Neoplasms
Identification of miRNA Biomarkers for Diverse Cancer Types Using Statistical Learning Methods at the Whole-Genome Scale.
Neoplasms
Identification of miRNA-Based Signature as a Novel Potential Prognostic Biomarker in Patients with Breast Cancer.
Neoplasms
Identification of miRNA-Mediated Subpathways as Prostate Cancer Biomarkers Based on Topological Inference in a Machine Learning Process Using Integrated Gene and miRNA Expression Data.
Neoplasms
Identification of miRNA-mRNA Network Associated with Acute Myeloid Leukemia Survival.
Neoplasms
Identification of miRNAs, mRNAs, lncRNAs, and circRNAs associated with hepatocellular carcinoma recurrence after interferon treatment.
Neoplasms
Identification of Mitochondrial-Related Prognostic Biomarkers Associated With Primary Bile Acid Biosynthesis and Tumor Microenvironment of Hepatocellular Carcinoma.
Neoplasms
Identification of modules and novel prognostic biomarkers in liver cancer through integrated bioinformatics analysis.
Neoplasms
Identification of molecular heterogeneity of hepatocellular carcinoma based on immune gene expression signatures.
Neoplasms
Identification of molecular targets for esophageal carcinoma diagnosis using miRNA-seq and RNA-seq data from The Cancer Genome Atlas: a study of 187 cases.
Neoplasms
Identification of MTHFD2 as a novel prognosis biomarker in esophageal carcinoma patients based on transcriptomic data and methylation profiling.
Neoplasms
Identification of Multiple Hub Genes and Pathways in Hepatocellular Carcinoma: A Bioinformatics Analysis.
Neoplasms
Identification of mutated driver pathways in cancer using a multi-objective optimization model.
Neoplasms
Identification of Mutated Peptides in Bladder Cancer From Exomic Sequencing Data Reveals Negative Correlation Between Mutation-Specific Immunoreactivity and Inflammation.
Neoplasms
Identification of Mutations Related to Cisplatin-Resistance and Prognosis of Patients With Lung Adenocarcinoma.
Neoplasms
Identification of Mutator-Derived Alternative Splicing Signatures of Genomic Instability for Improving the Clinical Outcome of Cholangiocarcinoma.
Neoplasms
Identification of NAA40 as a Potential Prognostic Marker for Aggressive Liver Cancer Subtypes.
Neoplasms
Identification of NEO1 as a prognostic biomarker and its effects on the progression of colorectal cancer.
Neoplasms
Identification of new biomarkers in immune microenvironment of testicular germ cell tumour.
Neoplasms
Identification of new Wilms tumour predisposition genes: an exome sequencing study.
Neoplasms
Identification of nine microRNAs as potential biomarkers for lung adenocarcinoma.
Neoplasms
Identification of Notch signaling pathway gene mutations as a prognostic biomarker for bladder cancer.
Neoplasms
Identification of novel alternative splicing isoform biomarkers and their association with overall survival in colorectal cancer.
Neoplasms
Identification of novel antioxidant gene signature to predict the prognosis of patients with gastric cancer.
Neoplasms
Identification of novel autophagy-related lncRNAs associated with a poor prognosis of colon adenocarcinoma through bioinformatics analysis.
Neoplasms
Identification of novel biomarkers affecting the metastasis of colorectal cancer through bioinformatics analysis and validation through qRT-PCR.
Neoplasms
Identification of novel biomarkers correlated with prostate cancer progression by an integrated bioinformatic analysis.
Neoplasms
Identification of Novel CD74-NRG2? Fusion From Comprehensive Profiling of Lung Adenocarcinoma in Japanese Never or Light Smokers.
Neoplasms
Identification of novel cell glycolysis related gene signature predicting survival in patients with breast cancer.
Neoplasms
Identification of novel cell glycolysis related gene signature predicting survival in patients with endometrial cancer.
Neoplasms
Identification of novel diagnostic and prognostic biomarkers for hepatocellular carcinoma.
Neoplasms
Identification of novel epigenetic abnormalities as sputum biomarkers for lung cancer risk among smokers and COPD patients.
Neoplasms
Identification of novel gene targets and putative regulators of arsenic-associated DNA methylation in human urothelial cells and bladder cancer.
Neoplasms
Identification of novel genes in testicular cancer microenvironment based on ESTIMATE algorithm-derived immune scores.
Neoplasms
Identification of novel lipid metabolic biomarkers associated with poor adrenocortical carcinoma prognosis using integrated bioinformatics.
Neoplasms
Identification of Novel lncRNA Markers in Glioblastoma Multiforme and Their Clinical Significance: A Study Based on Multiple Sequencing Data.
Neoplasms
Identification of novel long non-coding RNA biomarkers for prognosis prediction of papillary thyroid cancer.
Neoplasms
Identification of Novel Metabolism-Associated Subtypes for Pancreatic Cancer to Establish an Eighteen-Gene Risk Prediction Model.
Neoplasms
Identification of novel methylated DNA marker ZNF569 for head and neck squamous cell carcinoma.
Neoplasms
Identification of Novel microRNA Prognostic Markers Using Cascaded Wx, a Neural Network-Based Framework, in Lung Adenocarcinoma Patients.
Neoplasms
Identification of novel mRNA-miRNA-lncRNA competing endogenous RNA network associated with prognosis of breast cancer.
Neoplasms
Identification of novel mutations in endometrial cancer patients by whole-exome sequencing.
Neoplasms
Identification of novel oncogenic events occurring early in prostate carcinogenesis using purified autologous malignant and non-malignant prostate epithelial cells.
Neoplasms
Identification of novel prognosis-related genes associated with cancer using integrative network analysis.
Neoplasms
Identification of novel prognosis-related genes in the endometrial cancer immune microenvironment.
Neoplasms
Identification of novel prognostic alternative splicing signature in papillary renal cell carcinoma.
Neoplasms
Identification of novel prognostic biomarkers by integrating multi-omics data in gastric cancer.
Neoplasms
Identification of novel prognostic genes of triple-negative breast cancer using meta-analysis and weighted gene co-expressed network analysis.
Neoplasms
Identification of novel prognostic indicators for triple-negative breast cancer patients through integrative analysis of cancer genomics data and protein interactome data.
Neoplasms
Identification of novel synergistic targets for rational drug combinations with PI3 kinase inhibitors using siRNA synthetic lethality screening against GBM.
Neoplasms
Identification of Novel Transcriptome Signature as a Potential Prognostic Biomarker for Anti-Angiogenic Therapy in Glioblastoma Multiforme.
Neoplasms
Identification of NTRK3 as a potential prognostic biomarker associated with tumor mutation burden and immune infiltration in bladder cancer.
Neoplasms
Identification of nuclear export signal in KLLN suggests potential role in proteasomal degradation in cancer cells.
Neoplasms
Identification of oncogenic long noncoding RNA SNHG12 and DUXAP8 in human bladder cancer through a comprehensive profiling analysis.
Neoplasms
Identification of oncogenic long noncoding RNAs CASC9 and LINC00152 in oral carcinoma through genome-wide comprehensive analysis.
Neoplasms
Identification of ovarian cancer driver genes by using module network integration of multi-omics data.
Neoplasms
Identification of P2RY13 as an immune-related prognostic biomarker in lung adenocarcinoma: A public database-based retrospective study.
Neoplasms
Identification of PAFAH1B3 as Candidate Prognosis Marker and Potential Therapeutic Target for Hepatocellular Carcinoma.
Neoplasms
Identification of Periostin as a Potential Biomarker in Gliomas by Database Mining.
Neoplasms
Identification of PGRMC1 as a Candidate Oncogene for Head and Neck Cancers and Its Involvement in Metabolic Activities.
Neoplasms
Identification of PIK3CA multigene mutation patterns associated with superior prognosis in stomach cancer.
Neoplasms
Identification of pivotal genes associated with the prognosis of gastric carcinoma through integrated analysis.
Neoplasms
Identification of Plasma Glycosphingolipids as Potential Biomarkers for Prostate Cancer (PCa) Status.
Neoplasms
Identification of potential biomarkers and candidate small molecule drugs in glioblastoma.
Neoplasms
Identification of potential biomarkers and pivotal biological pathways for prostate cancer using bioinformatics analysis methods.
Neoplasms
Identification of Potential Biomarkers and Survival Analysis for Head and Neck Squamous Cell Carcinoma Using Bioinformatics Strategy: A Study Based on TCGA and GEO Datasets.
Neoplasms
Identification of potential biomarkers and their clinical significance in gastric cancer using bioinformatics analysis methods.
Neoplasms
Identification of Potential Biomarkers From Hepatocellular Carcinoma With MT1 Deletion.
Neoplasms
Identification of potential biomarkers in cervical cancer with combined public mRNA and miRNA expression microarray data analysis.
Neoplasms
Identification of Potential Biomarkers Involved in Gastric Cancer Through Integrated Analysis of Non-Coding RNA Associated Competing Endogenous RNAs Network.
Neoplasms
Identification of potential biomarkers of peripheral blood mononuclear cell in hepatocellular carcinoma using bioinformatic analysis: A protocol for systematic review and meta-analysis.
Neoplasms
Identification of potential biomarkers related to glioma survival by gene expression profile analysis.
Neoplasms
Identification of Potential Bisphenol A (BPA) Exposure Biomarkers in Ovarian Cancer.
Neoplasms
Identification of Potential BRAF Inhibitor Joint Therapy Targets in PTC based on WGCAN and DCGA.
Neoplasms
Identification of potential CpG sites for oral squamous cell carcinoma diagnosis via integrated analysis of DNA methylation and gene expression.
Neoplasms
Identification of Potential Crucial Genes and Key Pathways in Breast Cancer Using Bioinformatic Analysis.
Neoplasms
Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis.
Neoplasms
Identification of Potential Crucial Genes Associated with Carcinogenesis of Clear Cell Renal Cell Carcinoma.
Neoplasms
Identification of Potential Crucial Genes Associated With the Pathogenesis and Prognosis of Endometrial Cancer.
Neoplasms
Identification of potential crucial genes associated with the pathogenesis and prognosis of pancreatic adenocarcinoma.
Neoplasms
Identification of potential crucial genes associated with the pathogenesis and prognosis of prostate cancer.
Neoplasms
Identification of Potential Diagnostic and Prognostic Pseudogenes in Hepatocellular Carcinoma Based on Pseudogene-miRNA-mRNA Competitive Network.
Neoplasms
Identification of Potential Diagnostic and Prognostic Values of P4HA1 Expression in Lung Cancer, Breast Cancer, and Head and Neck Cancer.
Neoplasms
Identification of potential diagnostic and therapeutic target genes for lung squamous cell carcinoma.
Neoplasms
Identification of Potential Driver Genes Based on Multi-Genomic Data in Cervical Cancer.
Neoplasms
Identification of potential drugs for diffuse large b-cell lymphoma based on bioinformatics and Connectivity Map database.
Neoplasms
Identification of potential hub genes associated with the pathogenesis and prognosis of pancreatic duct adenocarcinoma using bioinformatics meta-analysis of multi-platform datasets.
Neoplasms
Identification of potential hub genes related to the progression and prognosis of hepatocellular carcinoma through integrated bioinformatics analysis.
Neoplasms
Identification of potential key genes and pathways predicting pathogenesis and prognosis for triple-negative breast cancer.
Neoplasms
Identification of Potential Key Genes Associated With the Pathogenesis, Metastasis, and Prognosis of Triple-Negative Breast Cancer on the Basis of Integrated Bioinformatics Analysis.
Neoplasms
Identification of Potential Key Genes for Pathogenesis and Prognosis in Prostate Cancer by Integrated Analysis of Gene Expression Profiles and the Cancer Genome Atlas.
Neoplasms
Identification of potential key genes in esophageal adenocarcinoma using bioinformatics.
Neoplasms
Identification of Potential lncRNAs and miRNAs as Diagnostic Biomarkers for Papillary Thyroid Carcinoma Based on Machine Learning.
Neoplasms
Identification of potential oncogenes in triple-negative breast cancer based on bioinformatics analyses.
Neoplasms
Identification of potential prognostic biomarkers for breast cancer using WGCNA and PPI integrated techniques.
Neoplasms
Identification of Potential Prognostic Long Non-Coding RNA Biomarkers for Predicting Recurrence in Patients with Cervical Cancer.
Neoplasms
Identification of Potential Prognostic Long Non-Coding RNA Biomarkers for Predicting Survival in Patients with Hepatocellular Carcinoma.
Neoplasms
Identification of potential prognostic long non-coding RNA for predicting survival in intrahepatic cholangiocarcinoma.
Neoplasms
Identification of potential prognostic long non?coding RNA signatures based on a competing endogenous RNA network in lung adenocarcinoma.
Neoplasms
Identification of potential prognostic markers associated with lung metastasis in breast cancer by coexpression network analysis.
Neoplasms
Identification of potential prognostic microRNA biomarkers for predicting survival in patients with hepatocellular carcinoma.
Neoplasms
Identification of potential prognostic small nucleolar RNA biomarkers for predicting overall survival in patients with sarcoma.
Neoplasms
Identification of potential prognostic TF-associated lncRNAs for predicting survival in ovarian cancer.
Neoplasms
Identification of Potential Prostate Cancer-Related Pseudogenes Based on Competitive Endogenous RNA Network Hypothesis.
Neoplasms
Identification of Potential Signatures and Their Functions for Acute Lymphoblastic Leukemia: A Study Based on the Cancer Genome Atlas.
Neoplasms
Identification of potential target genes in pancreatic ductal adenocarcinoma by bioinformatics analysis.
Neoplasms
Identification of potential targets of triptolide in regulating the tumor microenvironment of stomach adenocarcinoma patients using bioinformatics.
Neoplasms
Identification of Potentially Functional CircRNA-miRNA-mRNA Regulatory Network in Gastric Carcinoma using Bioinformatics Analysis.
Neoplasms
Identification of Prion Disease-Related Somatic Mutations in the Prion Protein Gene (PRNP) in Cancer Patients.
Neoplasms
Identification of Prognosis Associated microRNAs in HNSCC Subtypes Based on TCGA Dataset.
Neoplasms
Identification of prognosis-associated immune genes and exploration of immune cell infiltration in colorectal cancer.
Neoplasms
Identification of prognosis-related alternative splicing events in kidney renal clear cell carcinoma.
Neoplasms
Identification of prognosis-related genes and construction of multi-regulatory networks in pancreatic cancer microenvironment by bioinformatics analysis.
Neoplasms
Identification of Prognosis-Related Genes in Bladder Cancer Microenvironment across TCGA Database.
Neoplasms
Identification of prognosis-related molecular subgroups based on DNA methylation in pancreatic cancer.
Neoplasms
Identification of prognostic aging-related genes associated with immunosuppression and inflammation in head and neck squamous cell carcinoma.
Neoplasms
Identification of Prognostic alternative splicing signatures and their clinical significance in uveal melanoma.
Neoplasms
Identification of prognostic and bone metastatic alternative splicing signatures in bladder cancer.
Neoplasms
Identification of Prognostic and Chemopredictive microRNAs for Non-Small-Cell Lung Cancer by Integrating SEER-Medicare Data.
Neoplasms
Identification of prognostic and metastasis-related alternative splicing signatures in hepatocellular carcinoma.
Neoplasms
Identification of prognostic biomarkers and correlations with immune infiltrates among cGAS-STING in hepatocellular carcinoma.
Neoplasms
Identification of prognostic biomarkers and drug target prediction for colon cancer according to a competitive endogenous RNA network.
Neoplasms
Identification of Prognostic Biomarkers and Drugs Targeting Them in Colon Adenocarcinoma: A Bioinformatic Analysis.
Neoplasms
Identification of Prognostic Biomarkers Associated with Cancer Stem Cell Features in Prostate Adenocarcinoma.
Neoplasms
Identification of prognostic biomarkers associated with metastasis and immune infiltration in osteosarcoma.
Neoplasms
Identification of prognostic biomarkers associated with stromal cell infiltration in muscle-invasive bladder cancer by bioinformatics analyses.
Neoplasms
Identification of prognostic biomarkers for breast cancer based on miRNA and mRNA co-expression network.
Neoplasms
Identification of prognostic biomarkers in glioblastoma using a long non-coding RNA-mediated, competitive endogenous RNA network.
Neoplasms
Identification of Prognostic Biomarkers of Cutaneous Melanoma Based on Analysis of Tumor Mutation Burden.
Neoplasms
Identification of prognostic biomarkers of hepatocellular carcinoma via long noncoding RNA expression and copy number alterations.
Neoplasms
Identification of Prognostic Candidate Genes in Breast Cancer by Integrated Bioinformatic Analysis.
Neoplasms
Identification of prognostic claudins signature in hepatocellular carcinoma from a hepatocyte differentiation model.
Neoplasms
Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma.
Neoplasms
Identification of prognostic gene signatures of glioblastoma: a study based on TCGA data analysis.
Neoplasms
Identification of prognostic genes and construction of a novel gene signature in the skin melanoma based on the tumor microenvironment.
Neoplasms
Identification of Prognostic Genes and Pathways in Lung Adenocarcinoma Using a Bayesian Approach.
Neoplasms
Identification of prognostic genes in adrenocortical carcinoma microenvironment based on bioinformatic methods.
Neoplasms
Identification of prognostic genes in kidney renal clear cell carcinoma by RNA?seq data analysis.
Neoplasms
Identification of Prognostic Genes in Leiomyosarcoma by Gene Co-Expression Network Analysis.
Neoplasms
Identification of prognostic genes in the acute myeloid leukemia immune microenvironment based on TCGA data analysis.
Neoplasms
Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
Neoplasms
Identification of Prognostic Glycolysis-Related lncRNA Signature in Tumor Immune Microenvironment of Hepatocellular Carcinoma.
Neoplasms
Identification of Prognostic Immune-Related Genes by Integrating mRNA Expression and Methylation in Lung Adenocarcinoma.
Neoplasms
Identification of Prognostic Immune-Related Genes in Pancreatic Adenocarcinoma and Establishment of a Prognostic Nomogram: A Bioinformatic Study.
Neoplasms
Identification of prognostic immune-related signature predicting the overall survival for colorectal cancer.
Neoplasms
Identification of prognostic long intergenic non-coding RNAs as competing endogenous RNAs with KRAS mutations in colorectal cancer.
Neoplasms
Identification of prognostic marker genes in head and neck squamous cell carcinoma: A study based on The Cancer Genome Atlas database and experimental validation.
Neoplasms
Identification of prognostic markers for hepatocellular carcinoma based on miRNA expression profiles.
Neoplasms
Identification of Prognostic Markers in Cholangiocarcinoma Using Altered DNA Methylation and Gene Expression Profiles.
Neoplasms
Identification of prognostic markers of high grade prostate cancer through an integrated bioinformatics approach.
Neoplasms
Identification of prognostic microRNA candidates for head and neck squamous cell carcinoma.
Neoplasms
Identification of prognostic miRNA biomarkers for esophageal cancer based on The Cancer Genome Atlas and Gene Expression Omnibus.
Neoplasms
Identification of prognostic miRNA biomarkers for predicting overall survival of colon adenocarcinoma and bioinformatics analysis: A study based on The Cancer Genome Atlas database.
Neoplasms
Identification of Prognostic miRNA Signature and Lymph Node Metastasis-Related Key Genes in Cervical Cancer.
Neoplasms
Identification of Prognostic miRNAs Associated With Immune Cell Tumor Infiltration Predictive of Clinical Outcomes in Patients With Non-Small Cell Lung Cancer.
Neoplasms
Identification of Prognostic Related Genes of Tumor Microenvironment Derived From Esophageal Cancer Patients.
Neoplasms
Identification of prognostic risk factors for esophageal adenocarcinoma using bioinformatics analysis.
Neoplasms
Identification of Prognostic Signature and Gliclazide as Candidate Drugs in Lung Adenocarcinoma.
Neoplasms
Identification of prognostic signature of non-small cell lung cancer based on TCGA methylation data.
Neoplasms
Identification of Prognostic Signatures for Predicting the Overall Survival of Uveal Melanoma Patients.
Neoplasms
Identification of prognostic significance of BIRC5 in breast cancer using integrative bioinformatics analysis.
Neoplasms
Identification of Prognostic Stromal-Immune Score-Based Genes in Hepatocellular Carcinoma Microenvironment.
Neoplasms
Identification of prognostic tumor-infiltrating immune cells in endometrial adenocarcinoma.
Neoplasms
Identification of Prostate Cancer-Related Circular RNA Through Bioinformatics Analysis.
Neoplasms
Identification of Protein Expression Changes in Hepatocellular Carcinoma through iTRAQ.
Neoplasms
Identification of putative actionable alterations in clinically relevant genes in breast cancer.
Neoplasms
Identification of putative drugs for gastric adenocarcinoma utilizing differentially expressed genes and connectivity map.
Neoplasms
Identification of Rad51 as a prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma.
Neoplasms
Identification of Radioresponsive Genes in Esophageal Cancer from Longitudinal and Single Cell Exome Sequencing.
Neoplasms
Identification of Radiotherapy-Associated Genes in Lung Adenocarcinoma by an Integrated Bioinformatics Analysis Approach.
Neoplasms
Identification of rare germline copy number variations over-represented in five human cancer types.
Neoplasms
Identification of RASSF1A promoter hypermethylation as a biomarker for hepatocellular carcinoma.
Neoplasms
Identification of recurrence-associated microRNAs in stage I lung adenocarcinoma.
Neoplasms
Identification of recurrent and novel mutations by whole?genome sequencing of colorectal tumors from the Han population in Shanghai, eastern China.
Neoplasms
Identification of reference genes and miRNAs for qRT-PCR in human esophageal squamous cell carcinoma.
Neoplasms
Identification of regulatory role of DNA methylation in colon cancer gene expression via systematic bioinformatics analysis.
Neoplasms
Identification of Retinol Binding Protein 1 Promoter Hypermethylation in Isocitrate Dehydrogenase 1 and 2 Mutant Gliomas.
Neoplasms
Identification of RHOBTB2 aberration as an independent prognostic indicator in acute myeloid leukemia.
Neoplasms
Identification of RNA binding protein interacting with circular RNA and hub candidate network for hepatocellular carcinoma.
Neoplasms
Identification of RNA Expression Profiles in Thyroid Cancer to Construct a Competing Endogenous RNA (ceRNA) Network of mRNAs, Long Noncoding RNAs (lncRNAs), and microRNAs (miRNAs).
Neoplasms
Identification of RNA Transcript Makers Associated With Prognosis of Kidney Renal Clear Cell Carcinoma by a Competing Endogenous RNA Network Analysis.
Neoplasms
Identification of RNA: 5-Methylcytosine Methyltransferases-Related Signature for Predicting Prognosis in Glioma.
Neoplasms
Identification of robust diagnostic and prognostic gene signatures in different grades of gliomas: a retrospective study.
Neoplasms
Identification of SARS-CoV-2 Proteins Binding Human mRNAs As a Novel Signature Predicting Overall Survival in Hepatocellular Carcinoma.
Neoplasms
Identification of SCARA5 Gene as a Potential Immune-Related Biomarker for Triple-Negative Breast Cancer by Integrated Analysis.
Neoplasms
Identification of SEC61G as a Novel Prognostic Marker for Predicting Survival and Response to Therapies in Patients with Glioblastoma.
Neoplasms
Identification of Secreted Phosphoprotein 1 (SPP1) as a Prognostic Factor in Lower-Grade Gliomas.
Neoplasms
Identification of SERPINE1, PLAU and ACTA1 as biomarkers of head and neck squamous cell carcinoma based on integrated bioinformatics analysis.
Neoplasms
Identification of Serum miRNA Signature and Establishment of a Nomogram for Risk Stratification in Patients With Pancreatic Ductal Adenocarcinoma.
Neoplasms
Identification of serum prognostic marker miRNAs and construction of microRNA-mRNA networks of esophageal cancer.
Neoplasms
Identification of Sets of Cytoskeletal Related and Adhesion-related Coding Region Mutations in the TCGA Melanoma Dataset that Correlate with a Negative Outcome.
Neoplasms
Identification of Seven Aberrantly Methylated and Expressed Genes in Adrenocortical Carcinoma.
Neoplasms
Identification of Signatures of Prognosis Prediction for Melanoma Using a Hypoxia Score.
Neoplasms
Identification of Significant Gene Signatures and Prognostic Biomarkers for Patients With Cervical Cancer by Integrated Bioinformatic Methods.
Neoplasms
Identification of Six Autophagy-Related-lncRNA Prognostic Biomarkers in Uveal Melanoma.
Neoplasms
Identification of Six Potentially Long Noncoding RNAs as Biomarkers Involved Competitive Endogenous RNA in Clear Cell Renal Cell Carcinoma.
Neoplasms
Identification of small molecule drugs and development of a novel autophagy-related prognostic signature for kidney renal clear cell carcinoma.
Neoplasms
Identification of Somatic Mutations in Dementia-related Genes in Cancer Patients.
Neoplasms
Identification of Somatic Mutations in Papanicolaou Smear DNA and Plasma Circulating Cell-Free DNA for Detection of Endometrial and Epithelial Ovarian Cancers: A Pilot Study.
Neoplasms
Identification of special key genes for alcohol-related hepatocellular carcinoma through bioinformatic analysis.
Neoplasms
Identification of Specific Candidate Diagnostic Biomarkers for Lung Squamous Cell Carcinoma Based on Methylation.
Neoplasms
Identification of specific feed-forward apoptosis mechanisms and associated higher survival rates for low grade glioma and lung squamous cell carcinoma.
Neoplasms
Identification of stage-specific biomarkers in lung adenocarcinoma based on RNA-seq data.
Neoplasms
Identification of Stemness Characteristics Associated With the Immune Microenvironment and Prognosis in Gastric Cancer.
Neoplasms
Identification of Stemness-Related Genes for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma by Integrated Bioinformatics Analysis.
Neoplasms
Identification of subgroups along the glycolysis-cholesterol synthesis axis and the development of an associated prognostic risk model.
Neoplasms
Identification of Subpathway Signatures For Ovarian Cancer Prognosis by Integrated Analyses of High-Throughput miRNA and mRNA Expression.
Neoplasms
Identification of subtype-specific genes signature by WGCNA for prognostic prediction in diffuse type gastric cancer.
Neoplasms
Identification of Survival-Associated Alternative Splicing Signatures in Lung Squamous Cell Carcinoma.
Neoplasms
Identification of Survival-Associated Gene Signature in Lung Cancer Coexisting With COPD.
Neoplasms
Identification of survival-related genes and a novel gene-based prognostic signature involving the tumor microenvironment of uveal melanoma.
Neoplasms
Identification of survival-related predictors in hepatocellular carcinoma through integrated genomic, transcriptomic, and proteomic analyses.
Neoplasms
Identification of synthetic chemosensitivity genes paired with BRAF for BRAF/MAPK inhibitors.
Neoplasms
Identification of Target Genes Related to Sulfasalazine in Triple-Negative Breast Cancer Through Network Pharmacology.
Neoplasms
Identification of Targetable ERBB2 Aberrations in Head and Neck Squamous Cell Carcinoma.
Neoplasms
Identification of Targetable Kinase Alterations in Patients with Colorectal Carcinoma That are Preferentially Associated with Wild-Type RAS/RAF.
Neoplasms
Identification of Targetable Recurrent MAP3K8 Rearrangements in Melanomas Lacking Known Driver Mutations.
Neoplasms
Identification of targeted therapy options for gastric adenocarcinoma by comprehensive analysis of genomic data.
Neoplasms
Identification of the 3-lncRNA Signature as a Prognostic Biomarker for Colorectal Cancer.
Neoplasms
Identification of the Active Compounds and Significant Pathways of Artemisia Annua in the Treatment of Non-Small Cell Lung Carcinoma based on Network Pharmacology.
Neoplasms
Identification of the angiogenesis related genes for predicting prognosis of patients with gastric cancer.
Neoplasms
Identification of the circRNA-miRNA-mRNA regulatory network and its prognostic effect in colorectal cancer.
Neoplasms
Identification of the EMT-Related Genes Signature for Predicting Occurrence and Progression in Thyroid Cancer.
Neoplasms
Identification of the Functions and Prognostic Values of RNA Binding Proteins in Bladder Cancer.
Neoplasms
Identification of the HMMR Gene as a Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma Based on Integrated Bioinformatics Analysis.
Neoplasms
Identification of the hub genes and prognostic indicators of gastric cancer and correlation of indicators with tumor-infiltrating immune cell levels.
Neoplasms
Identification of the immune cell infiltration landscape in pancreatic cancer to assist immunotherapy.
Neoplasms
Identification of the Immune-Related Genes in Tumor Microenvironment That Associated With the Recurrence of Head and Neck Squamous Cell Carcinoma.
Neoplasms
Identification of the JNK-Active Triple-Negative Breast Cancer Cluster Associated with an Immunosuppressive Tumor Microenvironment.
Neoplasms
Identification of the key genes and microRNAs in adult acute myeloid leukemia with FLT3 mutation by bioinformatics analysis.
Neoplasms
Identification of the key miRNAs associated with survival time in stomach adenocarcinoma.
Neoplasms
Identification of the key transcription factors in esophageal squamous cell carcinoma.
Neoplasms
Identification of the miRNA signature and key genes in colorectal cancer lymph node metastasis.
Neoplasms
Identification of the miRNA signature associated with survival in patients with ovarian cancer.
Neoplasms
Identification of the miRNA-mRNA regulatory pathways and a miR-21-5p based nomogram model in clear cell renal cell carcinoma.
Neoplasms
Identification of the Novel Oncogenic Role of SAAL1 and Its Therapeutic Potential in Hepatocellular Carcinoma.
Neoplasms
Identification of the potential biomarkers for the metastasis of rectal adenocarcinoma.
Neoplasms
Identification of the potential therapeutic target gene UBE2C in human hepatocellular carcinoma: An investigation based on GEO and TCGA databases.
Neoplasms
Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.
Neoplasms
Identification of the prognostic value of immune gene signature and infiltrating immune cells for esophageal cancer patients.
Neoplasms
Identification of the Prognostic Value of Immune-Related Genes in Esophageal Cancer.
Neoplasms
Identification of the Real Hub Gene and Construction of a Novel Prognostic Signature for Pancreatic Adenocarcinoma Based on the Weighted Gene Co-expression Network Analysis and Least Absolute Shrinkage and Selection Operator Algorithms.
Neoplasms
Identification of the RP11-21C4.1/SVEP1 gene pair associated with FAT2 mutations as a potential biomarker in gastric cancer.
Neoplasms
Identification of the Six-RNA-Binding Protein Signature for Prognosis Prediction in Bladder Cancer.
Neoplasms
Identification of therapeutic targets applicable to clinical strategies in ovarian cancer.
Neoplasms
Identification of Three Autophagy-Related Long Non-Coding RNAs as a Novel Head and Neck Squamous Cell Carcinoma Prognostic Signature.
Neoplasms
Identification of Three Key Genes Associated with Hepatocellular Carcinoma Progression Based on Co-expression Analysis.
Neoplasms
Identification of three m6A-related mRNAs signature and risk score for the prognostication of hepatocellular carcinoma.
Neoplasms
Identification of three molecular subtypes based on immune infiltration in ovarian cancer and its prognostic value.
Neoplasms
Identification of TNIK as a novel potential drug target in thyroid cancer based on protein druggability prediction.
Neoplasms
Identification of topological features in renal tumor microenvironment associated with patient survival.
Neoplasms
Identification of TP53 mutation associated-immunotype and prediction of survival in patients with hepatocellular carcinoma.
Neoplasms
Identification of transcriptional isoforms associated with survival in cancer patient.
Neoplasms
Identification of tRNA-derived ncRNAs in TCGA and NCI-60 panel cell lines and development of the public database tRFexplorer.
Neoplasms
Identification of Tumor Antigens and Immune Landscape in Glioblastoma for mRNA Vaccine Development.
Neoplasms
Identification of Tumor Microenvironment-Related Alternative Splicing Events to Predict the Prognosis of Endometrial Cancer.
Neoplasms
Identification of Tumor Microenvironment-Related Prognostic Biomarkers in Luminal Breast Cancer.
Neoplasms
Identification of tumor microenvironment-related prognostic genes in colorectal cancer based on bioinformatic methods.
Neoplasms
Identification of tumor suppressor miRNAs by integrative miRNA and mRNA sequencing of matched tumor-normal samples in lung adenocarcinoma.
Neoplasms
Identification of tumor suppressors and oncogenes from genomic and epigenetic features in ovarian cancer.
Neoplasms
Identification of Tumor Tissue of Origin with RNA-Seq Data and Using Gradient Boosting Strategy.
Neoplasms
Identification of tumor-infiltrating immune cells and prognostic validation of tumor-infiltrating mast cells in adrenocortical carcinoma: results from bioinformatics and real-world data.
Neoplasms
Identification of two methylated fragments of an SDC2 CpG island using a sliding window technique for early detection of colorectal cancer.
Neoplasms
Identification of two molecular subtypes of dysregulated immune lncRNAs in ovarian cancer.
Neoplasms
Identification of two novel biomarkers of rectal carcinoma progression and prognosis via co-expression network analysis.
Neoplasms
Identification of two poorly prognosed ovarian carcinoma subtypes associated with CHEK2 germ-line mutation and non-CHEK2 somatic mutation gene signatures.
Neoplasms
Identification of TYROBP and C1QB as Two Novel Key Genes With Prognostic Value in Gastric Cancer by Network Analysis.
Neoplasms
Identification of ubiquitination-related genes in human glioma as indicators of patient prognosis.
Neoplasms
Identification of UGP2 as a progression marker that promotes cell growth and motility in human glioma.
Neoplasms
Identification of unanimous immune subtypes for different hormone receptor phenotypes of human breast cancer with potential prognostic significance.
Neoplasms
Identification of Vitamin D-related gene signature to predict colorectal cancer prognosis.
Neoplasms
Identification of VWF as a Novel Biomarker in Lung Adenocarcinoma by Comprehensive Analysis.
Neoplasms
Identification of WHO II/III gliomas by 16 prognostic-related gene signatures using machine learning methods.
Neoplasms
Identification the ferroptosis-related gene signature in patients with esophageal adenocarcinoma.
Neoplasms
Identification three LncRNA prognostic signature of ovarian cancer based on genome-wide copy number variation.
Neoplasms
Identification, Review, and Systematic Cross-Validation of microRNA Prognostic Signatures in Metastatic Melanoma.
Neoplasms
Identification, Validation, and Utilization of Immune Cells in Pancreatic Ductal Adenocarcinoma Based on Marker Genes.
Neoplasms
Identified a disintegrin and metalloproteinase with thrombospondin motifs 6 serve as a novel gastric cancer prognostic biomarker by bioinformatics analysis.
Neoplasms
Identified GNGT1 and NMU as Combined Diagnosis Biomarker of Non-Small-Cell Lung Cancer Utilizing Bioinformatics and Logistic Regression.
Neoplasms
Identify potential clinical significance of long noncoding RNA forkhead box P4 antisense RNA 1 in patients with early stage pancreatic ductal adenocarcinoma.
Neoplasms
Identifying a novel 5-gene signature predicting clinical outcomes in acute myeloid leukemia.
Neoplasms
Identifying a Potential Key Gene, TIMP1, Associated with Liver Metastases of Uveal Melanoma by Weight Gene Co-Expression Network Analysis.
Neoplasms
Identifying an Eight-Gene Signature to Optimize Overall Survival Prediction of Esophageal Adenocarcinoma Using Bioinformatics Analysis of ceRNA Network.
Neoplasms
Identifying biomarkers of papillary renal cell carcinoma associated with pathological stage by weighted gene co-expression network analysis.
Neoplasms
Identifying Cancer Driver lncRNAs Bridged by Functional Effectors through Integrating Multi-omics Data in Human Cancers.
Neoplasms
Identifying Cancer Drivers Using DRIVE: A Feature-Based Machine Learning Model for a Pan-Cancer Assessment of Somatic Missense Mutations.
Neoplasms
Identifying cancer type specific oncogenes and tumor suppressors using limited size data.
Neoplasms
Identifying candidate agents for lung adenocarcinoma by walking the human interactome.
Neoplasms
Identifying candidate drivers of drug response in heterogeneous cancer by mining high throughput genomics data.
Neoplasms
Identifying causal networks linking cancer processes and anti-tumor immunity using Bayesian network inference and metagene constructs.
Neoplasms
Identifying Clear Cell Renal Cell Carcinoma Coexpression Networks Associated with Opioid Signaling and Survival.
Neoplasms
Identifying Common Genes Related to Platelet and Immunity for Lung Adenocarcinoma Prognosis Prediction.
Neoplasms
Identifying CpG sites with different differential methylation frequencies in colorectal cancer tissues based on individualized differential methylation analysis.
Neoplasms
Identifying differentially expressed genes from cross-site integrated data based on relative expression orderings.
Neoplasms
Identifying Differentially Expressed MicroRNAs Between Cirrhotic and Non-Cirrhotic Hepatocellular Carcinoma and Exploring Their Functions Using Bioinformatic Analysis.
Neoplasms
Identifying drug candidates for hepatocellular carcinoma based on differentially expressed genes.
Neoplasms
Identifying FBLN1 (Gene ID: 2192) as a Potential Melanoma Biomarker for Melanoma based on an Analysis of microRNA Expression Profiles in the GEO and TCGA Databases.
Neoplasms
Identifying Functional Modules in Co-Regulatory Networks Through Overlapping Spectral Clustering.
Neoplasms
Identifying gene expression patterns associated with drug-specific survival in cancer patients.
Neoplasms
Identifying gene modules of thyroid cancer associated with pathological stage by weighted gene co-expression network analysis.
Neoplasms
Identifying Gene Network Rewiring by Integrating Gene Expression and Gene Network Data.
Neoplasms
Identifying hub genes of clear cell renal cell carcinoma associated with the proportion of regulatory T cells by weighted gene co-expression network analysis.
Neoplasms
Identifying hub genes of papillary thyroid carcinoma in the TCGA and GEO database using bioinformatics analysis.
Neoplasms
Identifying Hypoxia Characteristics to Stratify Prognosis and Assess the Tumor Immune Microenvironment in Renal Cell Carcinoma.
Neoplasms
Identifying Long Non-coding RNA of Prostate Cancer Associated With Radioresponse by Comprehensive Bioinformatics Analysis.
Neoplasms
Identifying M1 Macrophage-Related Genes Through a Co-expression Network to Construct a Four-Gene Risk-Scoring Model for Predicting Thyroid Cancer Prognosis.
Neoplasms
Identifying microRNA panels specifically associated with hepatocellular carcinoma and its different etiologies.
Neoplasms
Identifying miRNA and gene modules of colon cancer associated with pathological stage by weighted gene co-expression network analysis.
Neoplasms
Identifying miRNA-mRNA Pairs and Novel miRNAs from Hepatocelluar Carcinoma miRNomes and TCGA Database.
Neoplasms
Identifying MMP14 and COL12A1 as a potential combination of prognostic biomarkers in pancreatic ductal adenocarcinoma using integrated bioinformatics analysis.
Neoplasms
Identifying molecular genetic features and oncogenic pathways of clear cell renal cell carcinoma through the anatomical (PADUA) scoring system.
Neoplasms
Identifying Molecular Markers of Cervical Cancer Based on Competing Endogenous RNA Network Analysis.
Neoplasms
Identifying molecular subtypes in human colon cancer using gene expression and DNA methylation microarray data.
Neoplasms
Identifying Mutually Exclusive Gene Sets with Prognostic Value and Novel Potential Driver Genes in Patients with Glioblastoma.
Neoplasms
Identifying novel biomarkers in hepatocellular carcinoma by weighted gene co-expression network analysis.
Neoplasms
Identifying Novel Cell Glycolysis-Related Gene Signature Predictive of Overall Survival in Gastric Cancer.
Neoplasms
Identifying Novel Susceptibility Genes for Colorectal Cancer Risk From a Transcriptome-Wide Association Study of 125,478 Subjects.
Neoplasms
Identifying potential prognostic biomarkers in head and neck cancer based on the analysis of microRNA expression profiles in TCGA database.
Neoplasms
Identifying Predictive Gene Expression and Signature Related to Temozolomide Sensitivity of Glioblastomas.
Neoplasms
Identifying predictors of HPV-related head and neck squamous cell carcinoma progression and survival through patient-derived models.
Neoplasms
Identifying prognostic biomarkers based on aberrant DNA methylation in kidney renal clear cell carcinoma.
Neoplasms
Identifying prognostic biomarkers in endometrial carcinoma based on ceRNA network.
Neoplasms
Identifying prognostic biomarkers of non-small cell lung cancer by transcriptome analysis.
Neoplasms
Identifying prognostic lncRNAs based on a ceRNA regulatory network in laryngeal squamous cell carcinoma.
Neoplasms
Identifying Prognostic Significance of RCL1 and Four-Gene Signature as Novel Potential Biomarkers in HCC Patients.
Neoplasms
Identifying Putative Susceptibility Genes and Evaluating Their Associations with Somatic Mutations in Human Cancers.
Neoplasms
Identifying relations between imaging phenotypes and molecular subtypes of breast cancer: Model discovery and external validation.
Neoplasms
Identifying the Antiproliferative Effect of Astragalus Polysaccharides on Breast Cancer: Coupling Network Pharmacology With Targetable Screening From the Cancer Genome Atlas.
Neoplasms
Identifying the clonal origin of synchronous multifocal tumors in the hepatobiliary and pancreatic system using multi-omic platforms.
Neoplasms
Identifying the p65-Dependent Effect of Sulforaphene on Esophageal Squamous Cell Carcinoma Progression via Bioinformatics Analysis.
Neoplasms
Identifying the prognostic significance of B3GNT3 with PD-L1 expression in lung adenocarcinoma.
Neoplasms
Identifying the Transcriptional Regulatory Network Associated With Extrathyroidal Extension in Papillary Thyroid Carcinoma by Comprehensive Bioinformatics Analysis.
Neoplasms
Identifying the tumor-progressive gene expression profile in high-risk papillary thyroid cancer.
Neoplasms
Identifying Tumorigenesis and Prognosis-Related Genes of Lung Adenocarcinoma: Based on Weighted Gene Coexpression Network Analysis.
Neoplasms
IDH clonal heterogeneity segregates a subgroup of non-1p/19q codeleted gliomas with unfavourable clinical outcome.
Neoplasms
IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligand expression.
Neoplasms
IDH mutation status is associated with distinct vascular gene expression signatures in lower-grade gliomas.
Neoplasms
IDH-mutated astrocytomas with 19q-loss constitute a subgroup that confers better prognosis.
Neoplasms
IDH1 gene mutation activates Smad signaling molecules to regulate the expression levels of cell cycle and biological rhythm genes in human glioma U87?MG cells.
Neoplasms
IDH1-R132H mutation radiosensitizes U87MG glioma cells via epigenetic downregulation of TIGAR.
Neoplasms
IFI30 expression predicts patient prognosis in breast cancer and dictates breast cancer cells proliferation via regulating autophagy.
Neoplasms
IFI30 Is a Novel Immune-Related Target with Predicting Value of Prognosis and Treatment Response in Glioblastoma.
Neoplasms
IGF-1-enhanced miR-513a-5p signaling desensitizes glioma cells to temozolomide by targeting the NEDD4L-inhibited Wnt/?-catenin pathway.
Neoplasms
IGF2BP2 Polymorphisms Are Associated with Clinical Characteristics and Development of Oral Cancer.
Neoplasms
IGFBP3 as an indicator of lymph node metastasis and unfavorable prognosis for papillary thyroid carcinoma.
Neoplasms
IGFLR1 as a Novel Prognostic Biomarker in Clear Cell Renal Cell Cancer Correlating With Immune Infiltrates.
Neoplasms
IgG Fc Binding Protein (FCGBP) is Down-Regulated in Metastatic Lesions and Predicts Survival in Metastatic Colorectal Cancer Patients.
Neoplasms
iGlioSub: an integrative transcriptomic and epigenomic classifier for glioblastoma molecular subtypes.
Neoplasms
IGLL5 is correlated with tumor-infiltrating immune cells in clear cell renal cell carcinoma.
Neoplasms
IL-10 and integrin signaling pathways are associated with head and neck cancer progression.
Neoplasms
IL-13R?2 gene expression is a biomarker of adverse outcome in patients with adrenocortical carcinoma.
Neoplasms
IL-17 signaling pathway plays a key role in laryngeal squamous cell carcinoma with ethnic specificity.
Neoplasms
IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells.
Neoplasms
ILK silencing inhibits migration and invasion of more invasive glioblastoma cells by downregulating ROCK1 and Fascin-1.
Neoplasms
ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Neoplasms
Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning.
Neoplasms
Imaging-AMARETTO: An Imaging Genomics Software Tool to Interrogate Multiomics Networks for Relevance to Radiography and Histopathology Imaging Biomarkers of Clinical Outcomes.
Neoplasms
Imaging-genomic pipeline for identifying gene mutations using three-dimensional intra-tumor heterogeneity features.
Neoplasms
Imaging-Genomic Study of Head and Neck Squamous Cell Carcinoma: Associations Between Radiomic Phenotypes and Genomic Mechanisms via Integration of The Cancer Genome Atlas and The Cancer Imaging Archive.
Neoplasms
IMIX: a multivariate mixture model approach to association analysis through multi-omics data integration.
Neoplasms
Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer.
Neoplasms
Immune and Stroma Related Genes in Breast Cancer: A Comprehensive Analysis of Tumor Microenvironment Based on the Cancer Genome Atlas (TCGA) Database.
Neoplasms
Immune cell infiltrate-associated dysregulation of DNA repair machinery may predispose to papillary thyroid carcinogenesis.
Neoplasms
Immune Cell Infiltration and Identifying Genes of Prognostic Value in the Papillary Renal Cell Carcinoma Microenvironment by Bioinformatics Analysis.
Neoplasms
Immune cell landscape analysis reveals prognostic immune cells and its potential mechanism in squamous cell lung carcinoma.
Neoplasms
Immune cells and signatures characterize tumor microenvironment and predict outcome in ovarian and endometrial cancers.
Neoplasms
Immune classifier-based signatures provide good prognostic stratification and predict the clinical benefits of immune-based therapies for hepatocellular carcinoma.
Neoplasms
Immune Cluster and PPI Network Analyses Identified CXCR3 as a Key Node of Immunoregulation in Head and Neck Cancer.
Neoplasms
Immune contexture defined by single cell technology for prognosis prediction and immunotherapy guidance in cancer.
Neoplasms
Immune Cytolytic Activity for Comprehensive Understanding of Immune Landscape in Hepatocellular Carcinoma.
Neoplasms
Immune Gene Signature Delineates a Subclass of Papillary Thyroid Cancer with Unfavorable Clinical Outcomes.
Neoplasms
Immune Heterogeneity of Glioblastoma Subtypes: Extrapolation from the Cancer Genome Atlas.
Neoplasms
Immune implication of an autophagy-related prognostic signature in uveal melanoma.
Neoplasms
Immune infiltration and a ferroptosis-associated gene signature for predicting the prognosis of patients with endometrial cancer.
Neoplasms
Immune Infiltration Profiling in Nonsmall Cell Lung Cancer and Their Clinical Significance: Study Based on Gene Expression Measurements.
Neoplasms
Immune landscape and a novel immunotherapy-related gene signature associated with clinical outcome in early-stage lung adenocarcinoma.
Neoplasms
Immune Landscape of Colorectal Cancer Tumor Microenvironment from Different Primary Tumor Location.
Neoplasms
Immune landscape of human prostate cancer: immune evasion mechanisms and biomarkers for personalized immunotherapy.
Neoplasms
Immune Landscape of Invasive Ductal Carcinoma Tumor Microenvironment Identifies a Prognostic and Immunotherapeutically Relevant Gene Signature.
Neoplasms
Immune microenvironment of the gene signature reflecting the standardised uptake value on 18F-fluorodeoxyglucose positron emission tomography/computed tomography in head and neck squamous cell carcinoma.
Neoplasms
Immune microenvironment of triple-negative breast cancer in African-American and Caucasian women.
Neoplasms
Immune microenvironment profiling of gastrointestinal stromal tumors (GIST) shows gene expression patterns associated to immune checkpoint inhibitors response.
Neoplasms
Immune Microenvironment Related Competitive Endogenous RNA Network as Powerful Predictors for Melanoma Prognosis Based on WGCNA Analysis.
Neoplasms
Immune Modeling Analysis Reveals Immunologic Signatures Associated With Improved Outcomes in High Grade Serous Ovarian Cancer.
Neoplasms
Immune overdrive signature in colorectal tumor subset predicts poor clinical outcome.
Neoplasms
Immune profile of the tumor microenvironment and the identification of a four-gene signature for lung adenocarcinoma.
Neoplasms
Immune Profiles of Tumor Microenvironment and Clinical Prognosis among Women with Triple-Negative Breast Cancer.
Neoplasms
Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy.
Neoplasms
Immune prognostic risk score model in acute myeloid leukemia with normal karyotype.
Neoplasms
Immune receptor recombinations from breast cancer exome files, independently and in combination with specific HLA alleles, correlate with better survival rates.
Neoplasms
Immune signature of tumor-infiltrating immune cells predicts the prognosis and therapeutic effects in squamous cell carcinoma.
Neoplasms
Immune signature-based hepatocellular carcinoma subtypes may provide novel insights into therapy and prognosis predictions.
Neoplasms
Immune Suppression by PD-L2 against Spontaneous and Treatment-Related Antitumor Immunity.
Neoplasms
Immune-focused multi-omics analysis of prostate cancer: leukocyte Ig-Like receptors are associated with disease progression.
Neoplasms
Immune-Inhibitory Gene Expression is Positively Correlated with Overall Immune Activity and Predicts Increased Survival Probability of Cervical and Head and Neck Cancer Patients.
Neoplasms
Immune-related gene data-based molecular subtyping related to the prognosis of breast cancer patients.
Neoplasms
Immune-related gene signature predicts overall survival of gastric cancer patients with varying microsatellite instability status.
Neoplasms
Immune-Related Gene-Based Novel Subtypes to Establish a Model Predicting the Risk of Prostate Cancer.
Neoplasms
Immune-related genes have prognostic significance in head and neck squamous cell carcinoma.
Neoplasms
Immune-related key gene CLDN10 correlates with lymph node metastasis but predicts favorable prognosis in papillary thyroid carcinoma.
Neoplasms
Immune-Related lncRNA to Construct Novel Signature and Predict the Immune Landscape of Human Hepatocellular Carcinoma.
Neoplasms
Immune-related lncRNAs as predictors of survival in breast cancer: a prognostic signature.
Neoplasms
Immune-related long non-coding RNAs can serve as prognostic biomarkers for clear cell renal cell carcinoma.
Neoplasms
Immune-Related Nine-MicroRNA Signature for Predicting the Prognosis of Gastric Cancer.
Neoplasms
Immune-Stromal Score Signature: Novel Prognostic Tool of the Tumor Microenvironment in Lung Adenocarcinoma.
Neoplasms
Immunity-Related Gene Signature Identifies Subtypes Benefitting From Adjuvant Chemotherapy or Potentially Responding to PD1/PD-L1 Blockage in Pancreatic Cancer.
Neoplasms
Immuno-stimultory/regulatory gene expression patterns in advanced ovarian cancer.
Neoplasms
Immunodeficiency in Pancreatic Adenocarcinoma with Diabetes Revealed by Comparative Genomics.
Neoplasms
Immunogenic characteristics of microsatellite instability-low esophagogastric junction adenocarcinoma based on clinicopathological, molecular, immunological, and survival analyses.
Neoplasms
Immunogenomic correlates of response to cetuximab monotherapy in head and neck squamous cell carcinoma.
Neoplasms
Immunogenomic Gene Signature of Cell-Death Associated Genes with Prognostic Implications in Lung Cancer.
Neoplasms
Immunogenomic Identification for Predicting the Prognosis of Cervical Cancer Patients.
Neoplasms
Immunogenomic pathways associated with cytotoxic lymphocyte infiltration and survival in colorectal cancer.
Neoplasms
Immunogenomic Profiling Demonstrate AC003092.1 as an Immune-Related eRNA in Glioblastoma Multiforme.
Neoplasms
Immunogenomics of colorectal adenocarcinoma: Survival distinctions represented by immune receptor, CDR3 chemical features and high expression of BTN gene family members.
Neoplasms
Immunogenomics: A Negative Prostate Cancer Outcome Associated with TcR-?/? Recombinations.
Neoplasms
Immunoglobulin superfamily genes are novel prognostic biomarkers for breast cancer.
Neoplasms
Immunoglobulin superfamily member 10 is a novel prognostic biomarker for breast cancer.
Neoplasms
Immunohistochemical analysis of SLFN11 expression uncovers potential non-responders to DNA-damaging agents overlooked by tissue RNA-seq.
Neoplasms
Immunohistochemical analysis of T-type calcium channels in acquired melanocytic naevi and melanoma.
Neoplasms
Immunohistochemical Analysis Revealed a Correlation between Musashi-2 and Cyclin-D1 Expression in Patients with Oral Squamous Cells Carcinoma.
Neoplasms
Immunohistochemical analysis-based proteomic subclassification of newly diagnosed glioblastomas.
Neoplasms
Immunohistochemical assessment of basal and luminal markers in non-muscle invasive urothelial carcinoma of bladder.
Neoplasms
Immunohistochemical Expression of Five Protein Combinations Revealed as Prognostic Markers in Asian Oral Cancer.
Neoplasms
Immunohistochemistry as a surrogate for molecular subtyping of gastric adenocarcinoma.
Neoplasms
Immunological analyses reveal an immune subtype of uveal melanoma with a poor prognosis.
Neoplasms
Immunological Differences Between Immune-Rich Estrogen Receptor-Positive and Immune-Rich Triple-Negative Breast Cancers.
Neoplasms
Immunological network analysis in HPV associated head and neck squamous cancer and implications for disease prognosis.
Neoplasms
Immunological profiling of molecularly classified high-risk endometrial cancers identifies POLE-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibition.
Neoplasms
Immunometabolic Determinants of Chemoradiotherapy Response and Survival in Head and Neck Squamous Cell Carcinoma.
Neoplasms
Immunoregulatory gene expression and response to bevacizumab in ovarian cancer - An analysis of the cancer genome atlas.
Neoplasms
Immunoscoring by correlating MHC class II and TCR expression: high level immune functions represented by the KIRP dataset of TCGA.
Neoplasms
Impact of accumulated alterations in driver and passenger genes on response to radiation therapy.
Neoplasms
Impact of aging on host immune response and survival in melanoma: an analysis of 3 patient cohorts.
Neoplasms
Impact of cancer atlases on cancer epidemiology: experience of the Danish Atlas of Cancer Incidence.
Neoplasms
Impact of CD144 gene expression on outcomes in stage III gastric cancer patients.
Neoplasms
Impact of Concurrent Genomic Alterations Detected by Comprehensive Genomic Sequencing on Clinical Outcomes in East-Asian Patients with EGFR-Mutated Lung Adenocarcinoma.
Neoplasms
Impact of DLK1-DIO3 imprinted cluster hypomethylation in smoker patients with lung cancer.
Neoplasms
Impact of endometrial carcinoma histotype on the prognostic value of the TCGA molecular subgroups.
Neoplasms
Impact of endothelial nitric oxide synthase polymorphisms on urothelial cell carcinoma development.
Neoplasms
Impact of Gene Polymorphisms in GAS5 on Urothelial Cell Carcinoma Development and Clinical Characteristics.
Neoplasms
Impact of genetic alterations on outcomes of patients with stage I nonsmall cell lung cancer: An analysis of the cancer genome atlas data.
Neoplasms
Impact of glioblastoma multiforme associated mutations on the structure and function of MAP/microtubule affinity regulating kinase 4.
Neoplasms
Impact of Interferon-? Receptor-1 Promoter Polymorphisms on the Transcriptome of the Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Neoplasms
Impact of intratumoural CD73 expression on prognosis and therapeutic response in patients with gastric cancer.
Neoplasms
Impact of KMN network genes on progression and prognosis of non-small cell lung cancer.
Neoplasms
Impact of Long Non-coding RNAs Associated With Microenvironment on Survival for Bladder Cancer Patients.
Neoplasms
Impact of miRNA sequence on miRNA expression and correlation between miRNA expression and cell cycle regulation in breast cancer cells.
Neoplasms
Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer.
Neoplasms
Impact of mutations in DNA methylation modification genes on genome-wide methylation landscapes and downstream gene activations in pan-cancer.
Neoplasms
Impact of negative lymph nodes on colon cancer survival and exploring relevant transcriptomics differences through real-world data analyses.
Neoplasms
Impact of novel oncogenic pathways regulated by antitumor miR-451a in renal cell carcinoma.
Neoplasms
Impact of sex, body mass index and initial pathologic diagnosis age on the incidence and prognosis of different types of cancer.
Neoplasms
Impact of sialyltransferase ST6GAL1 overexpression on different colon cancer cell types.
Neoplasms
Impact of somatic PI3K pathway and ERBB family mutations on pathological complete response (pCR) in HER2-positive breast cancer patients who received neoadjuvant HER2-targeted therapies.
Neoplasms
Impact of Sonic Hedgehog Pathway Expression on Outcome in HPV Negative Head and Neck Carcinoma Patients after Surgery and Adjuvant Radiotherapy.
Neoplasms
Impact of SRY-Box Transcription Factor 11 Gene Polymorphisms on Oral Cancer Risk and Clinicopathologic Characteristics.
Neoplasms
Impact of the SPOP Mutant Subtype on the Interpretation of Clinical Parameters in Prostate Cancer.
Neoplasms
Impact of Tumor Purity on Immune Gene Expression and Clustering Analyses across Multiple Cancer Types.
Neoplasms
IMPACT: a whole-exome sequencing analysis pipeline for integrating molecular profiles with actionable therapeutics in clinical samples.
Neoplasms
Impaired expression of the cell cycle regulator BTG2 is common in clear cell renal cell carcinoma.
Neoplasms
Impaired microRNA processing by DICER1 downregulation endows thyroid cancer with increased aggressiveness.
Neoplasms
IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
Neoplasms
Implication for Cancer Stem Cells in Solid Cancer Chemo-Resistance: Promising Therapeutic Strategies Based on the Use of HDAC Inhibitors.
Neoplasms
Implication of downregulation and prospective pathway signaling of microRNA-375 in lung squamous cell carcinoma.
Neoplasms
Implications of driver genes associated with a high tumor mutation burden identified using next-generation sequencing on immunotherapy in hepatocellular carcinoma.
Neoplasms
Improved detection of gene fusions by applying statistical methods reveals oncogenic RNA cancer drivers.
Neoplasms
Improved risk stratification in younger IDH wild-type glioblastoma patients by combining a 4-miRNA signature with MGMT promoter methylation status.
Neoplasms
Improved survival associated with somatic PIK3CA mutations in copy-number low endometrioid endometrial adenocarcinoma.
Neoplasms
Improved T-cell Receptor Diversity Estimates Associate with Survival and Response to Anti-PD-1 Therapy.
Neoplasms
Improvement in prediction of prostate cancer prognosis with somatic mutational signatures.
Neoplasms
Improving Gemcitabine Sensitivity in Pancreatic Cancer Cells by Restoring miRNA-217 Levels.
Neoplasms
Improving our understanding of papillary renal cell carcinoma with integrative genomic analysis.
Neoplasms
Improving prediction performance of colon cancer prognosis based on the integration of clinical and multi-omics data.
Neoplasms
Improving the overall survival prognosis prediction accuracy: A 9-gene signature in CRC patients.
Neoplasms
Improving the Prognosis of Colon Cancer through Knowledge-Based Clinical-Molecular Integrated Analysis.
Neoplasms
Imputing missing RNA-sequencing data from DNA methylation by using a transfer learning-based neural network.
Neoplasms
In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.
Neoplasms
In human glioblastomas transcript elongation by alternative polyadenylation and miRNA targeting is a potent mechanism of MGMT silencing.
Neoplasms
In North America, Some Ovarian Cancers Express the Oncogenes of Preventable Human Papillomavirus HPV-18.
Neoplasms
In silico analysis excavates potential biomarkers by constructing miRNA-mRNA networks between non-cirrhotic HCC and cirrhotic HCC.
Neoplasms
In Silico Analysis of Gene Expression Change Associated with Copy Number of Enhancers in Pancreatic Adenocarcinoma.
Neoplasms
In silico analysis reveals a shared immune signature in CASP8-mutated carcinomas with varying correlations to prognosis.
Neoplasms
In silico gene expression analysis reveals glycolysis and acetate anaplerosis in IDH1 wild-type glioma and lactate and glutamate anaplerosis in IDH1-mutated glioma.
Neoplasms
In Silico Identification of Contradictory Role of ADAMTS5 in Hepatocellular Carcinoma.
Neoplasms
In Silico Identification of Crucial Genes and Specific Pathways in Hepatocellular Cancer.
Neoplasms
In silico identification of drug target pathways in breast cancer subtypes using pathway cross-talk inhibition.
Neoplasms
In silico Identification of SFRP1 as a Hypermethylated Gene in Colorectal Cancers.
Neoplasms
In silico identification of the prognostic biomarkers and therapeutic targets associated with cancer stem cell characteristics of glioma.
Neoplasms
In Silico Inference of Synthetic Cytotoxic Interactions from Paclitaxel Responses.
Neoplasms
In silico investigation of heparanase-correlated genes in breast cancer subtypes.
Neoplasms
In silico pathway analysis and tissue specific cis-eQTL for colorectal cancer GWAS risk variants.
Neoplasms
In silico prediction of housekeeping long intergenic non-coding RNAs reveals HKlincR1 as an essential player in lung cancer cell survival.
Neoplasms
In silico repurposing the Rac1 inhibitor NSC23766 for treating PTTG1-high expressing clear cell renal carcinoma.
Neoplasms
In silico study of cancer stage-specific DNA methylation pattern in White breast cancer patients based on TCGA dataset.
Neoplasms
In Vitro and In Silico Mechanistic Insights into miR-21-5p-Mediated Topoisomerase Drug Resistance in Human Colorectal Cancer Cells.
Neoplasms
In Vivo Assessment of VCAM-1 Expression by SPECT/CT Imaging in Mice Models of Human Triple Negative Breast Cancer.
Neoplasms
In-depth genomic data analyses revealed complex transcriptional and epigenetic dysregulations of BRAFV600E in melanoma.
Neoplasms
In-Depth Proteomics Analysis to Identify Biomarkers of Papillary Thyroid Cancer Patients Older Than 45 Years with Different Degrees of Lymph Node Metastases.
Neoplasms
Inactivating Mutations of the IK Gene Weaken Ku80/Ku70-Mediated DNA Repair and Sensitize Endometrial Cancer to Chemotherapy.
Neoplasms
Inactivation of SMARCA2 by promoter hypermethylation drives lung cancer development.
Neoplasms
INAVA promotes aggressiveness of papillary thyroid cancer by upregulating MMP9 expression.
Neoplasms
Incidence and mortality of bone cancer among children, adolescents and young adults of Brazil.
Neoplasms
Incorporating genetic networks into case-control association studies with high-dimensional DNA methylation data.
Neoplasms
Increased CMTM6 can predict the clinical response to PD-1 inhibitors in non-small cell lung cancer patients.
Neoplasms
Increased co-expression of PSMA2 and GLP-1 receptor in cervical cancer models in type 2 diabetes attenuated by Exendin-4: A translational case-control study.
Neoplasms
Increased CX3CL1 mRNA expression level is a positive prognostic factor in patients with lung adenocarcinoma.
Neoplasms
Increased DHRS12 expression independently predicts poor survival in patients with high-grade serous ovarian cancer.
Neoplasms
Increased DSG2 plasmatic levels identified by transcriptomic-based secretome analysis is a potential prognostic biomarker in laryngeal carcinoma.
Neoplasms
Increased epithelial membrane protein 2 expression in glioblastoma after treatment with bevacizumab.
Neoplasms
Increased expression of Cyclin F in liver cancer predicts poor prognosis: A study based on TCGA database.
Neoplasms
Increased Expression of Gremlin1 Promotes Proliferation and Epithelial Mesenchymal Transition in Gastric Cancer Cells and Correlates With Poor Prognosis of Patients With Gastric Cancer.
Neoplasms
Increased expression of heat shock factor 1 (HSF1) is associated with poor survival in gastric cancer patients.
Neoplasms
Increased Expression of KNSTRN in Lung Adenocarcinoma Predicts Poor Prognosis: A Bioinformatics Analysis Based on TCGA Data.
Neoplasms
Increased Expression of Long Non-coding RNA H19 is Associated With Colon Cancer Recurrence.
Neoplasms
Increased Expression of LYNX1 in Ovarian Serous Cystadenocarcinoma Predicts Poor Prognosis.
Neoplasms
Increased expression of methionine sulfoxide reductases B3 is associated with poor prognosis in gastric cancer.
Neoplasms
Increased Expression of miR-23a Mediates a Loss of Expression in the RAF Kinase Inhibitor Protein RKIP.
Neoplasms
Increased Expression of PDK4 Was Displayed in Gastric Cancer and Exhibited an Association With Glucose Metabolism.
Neoplasms
Increased expression of POLR3G predicts poor prognosis in transitional cell carcinoma.
Neoplasms
Increased expression of RUNX1 in clear cell renal cell carcinoma predicts poor prognosis.
Neoplasms
Increased Expression of SHMT2 Is Associated With Poor Prognosis and Advanced Pathological Grade in Oral Squamous Cell Carcinoma.
Neoplasms
Increased Expression of T-Box Transcription Factor Protein 21 (TBX21) in Skin Cutaneous Melanoma Predicts Better Prognosis: A Study Based on The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) Databases.
Neoplasms
Increased Expression of TICRR Predicts Poor Clinical Outcomes: A Potential Therapeutic Target for Papillary Renal Cell Carcinoma.
Neoplasms
Increased expression of TNFRSF14 indicates good prognosis and inhibits bladder cancer proliferation by promoting apoptosis.
Neoplasms
Increased expression of von Willebrand factor gene is associated with poorer survival in primary lower grade glioma.
Neoplasms
Increased expression of zinc transporter ZIP4, ZIP11, ZnT1, and ZnT6 predicts poor prognosis in pancreatic cancer.
Neoplasms
Increased EXT1 gene copy number correlates with increased mRNA level predicts short disease-free survival in hepatocellular carcinoma without vascular invasion.
Neoplasms
Increased glycolysis correlates with elevated immune activity in tumor immune microenvironment.
Neoplasms
Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma.
Neoplasms
Increased IGFBP7 Expression Correlates with Poor Prognosis and Immune Infiltration in Gastric Cancer.
Neoplasms
Increased incidence of FBXW7 and POLE proofreading domain mutations in young adult colorectal cancers.
Neoplasms
Increased KIF15 Expression Predicts a Poor Prognosis in Patients with Lung Adenocarcinoma.
Neoplasms
Increased KIF21B expression is a potential prognostic biomarker in hepatocellular carcinoma.
Neoplasms
Increased MAPK1/3 Phosphorylation in Luminal Breast Cancer Related with PIK3CA Hotspot Mutations and Prognosis.
Neoplasms
Increased microglia/macrophage gene expression in a subset of adult and pediatric astrocytomas.
Neoplasms
Increased Non-Homologous End Joining Makes DNA-PK a Promising Target for Therapeutic Intervention in Uveal Melanoma.
Neoplasms
Increased Proportion of Variance Explained and Prediction Accuracy of Survival of Breast Cancer Patients with Use of Whole-Genome Multiomic Profiles.
Neoplasms
Increased RBM12 expression predicts poor prognosis in hepatocellular carcinoma based on bioinformatics.
Neoplasms
Increased Risk of Acute Myelogenous Leukemia After Early Onset but Not Late-Onset Colorectal Cancer.
Neoplasms
Increased RNA Expression of von Willebrand Factor Gene Is Associated With Infiltrating Lobular Breast Cancer and Normal PAM50 Subtype.
Neoplasms
Increased SPC24 in prostatic diseases and diagnostic value of SPC24 and its interacting partners in prostate cancer.
Neoplasms
Increased Vascular Adhesion Protein 1 (VAP-1) Levels are Associated with Alternative M2 Macrophage Activation and Poor Prognosis for Human Gliomas.
Neoplasms
Increased VEGF-A in solid type of lung adenocarcinoma reduces the patients' survival.
Neoplasms
Independent validation of early-stage NSCLC prognostic scores incorporating epigenetic and transcriptional biomarkers with gene-gene interactions and main effects.
Neoplasms
Index of Cancer-Associated Fibroblasts Is Superior to the Epithelial-Mesenchymal Transition Score in Prognosis Prediction.
Neoplasms
Individualized analysis of differentially expressed miRNAs with application to the identification of miRNAs deregulated commonly in lung cancer tissues.
Neoplasms
Individualized genetic network analysis reveals new therapeutic vulnerabilities in 6,700 cancer genomes.
Neoplasms
Individualized network-based drug repositioning infrastructure for precision oncology in the panomics era.
Neoplasms
Individualized Prediction of Survival by a 10-Long Non-coding RNA-Based Prognostic Model for Patients With Breast Cancer.
Neoplasms
Indoleamine 2, 3-Dioxygenase 1 and CD8 Expression Profiling Revealed an Immunological Subtype of Colon Cancer With a Poor Prognosis.
Neoplasms
Indoleamine 2,3-dioxygenase 1 and overall survival of patients diagnosed with esophageal cancer.
Neoplasms
Indoleamine 2,3-dioxygenase 1, Increased in Human Gastric Pre-Neoplasia, Promotes Inflammation and Metaplasia in Mice and is Associated with Type II Hypersensitivity/Autoimmunity.
Neoplasms
Indoleamine 2,3-Dioxygenase Expression Pattern in the Tumor Microenvironment Predicts Clinical Outcome in Early Stage Cervical Cancer.
Neoplasms
Induction of Wnt-inducible signaling protein-1 correlates with invasive breast cancer oncogenesis and reduced type 1 cell-mediated cytotoxic immunity: a retrospective study.
Neoplasms
Inference of phenotype-relevant transcriptional regulatory networks elucidates cancer type-specific regulatory mechanisms in a pan-cancer study.
Neoplasms
Inferred miRNA activity identifies miRNA-mediated regulatory networks underlying multiple cancers.
Neoplasms
Inferring Aberrant Signal Transduction Pathways in Ovarian Cancer from TCGA Data.
Neoplasms
Inferring active and prognostic ligand-receptor pairs with interactions in survival regression models.
Neoplasms
Inferring gene expression networks with hubs using a degree weighted Lasso approach.
Neoplasms
Inferring Personalized and Race-Specific Causal Effects of Genomic Aberrations on Gleason Scores: A Deep Latent Variable Model.
Neoplasms
Inferring regulatory element landscapes and transcription factor networks from cancer methylomes.
Neoplasms
Inferring synthetic lethal interactions from mutual exclusivity of genetic events in cancer.
Neoplasms
Inferring tumour purity and stromal and immune cell admixture from expression data.
Neoplasms
Infiltrating T cells increase IDO1 expression in glioblastoma and contribute to decreased patient survival.
Neoplasms
Infiltrating T-cell abundance combined with EMT-related gene expression as a prognostic factor of colon cancer.
Neoplasms
Infiltrative tumour growth pattern correlates with poor outcome in oesophageal cancer.
Neoplasms
Inflammation and lymphocyte infiltration are associated with shorter survival in patients with high-grade glioma.
Neoplasms
Influence of BRCA1 Germline Mutations in the Somatic Mutational Burden of Triple-Negative Breast Cancer.
Neoplasms
Influence of Different Age Cutoff Points on the Prediction of Prognosis of Cancer Patients Receiving ICIs and Potential Mechanistic Exploration.
Neoplasms
Influence of Hormone Receptor Status on Spinal Metastatic Lesions in Breast Cancer Patients.
Neoplasms
Influence of Immune Microenvironment on Diagnosis and Prognosis of Head and Neck Squamous Cell Carcinoma.
Neoplasms
Information theoretic sub-network mining characterizes breast cancer subtypes in terms of cancer core mechanisms.
Neoplasms
ING5 activity in self-renewal of glioblastoma stem cells via calcium and follicle stimulating hormone pathways.
Neoplasms
INHBA is a novel mediator regulating cellular senescence and immune evasion in colorectal cancer.
Neoplasms
INHBB Is a Novel Prognostic Biomarker Associated with Cancer-Promoting Pathways in Colorectal Cancer.
Neoplasms
Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses.
Neoplasms
Inhibition of 17beta-hydroxysteroid dehydrogenase type 7 modulates breast cancer protein profile and enhances apoptosis by down-regulating GRP78.
Neoplasms
Inhibition of DKC1 induces telomere-related senescence and apoptosis in lung adenocarcinoma.
Neoplasms
Inhibition of EPS8L3 suppresses liver cancer progression and enhances efficacy of sorafenib treatment.
Neoplasms
Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer.
Neoplasms
Inhibition of Glycolysis in Prostate Cancer Chemoprevention by Phenethyl Isothiocyanate.
Neoplasms
Inhibition of histone deacetylase 2 reduces MDM2 expression and reduces tumor growth in dedifferentiated liposarcoma.
Neoplasms
Inhibition of histone lysine-specific demethylase 1 elicits breast tumor immunity and enhances antitumor efficacy of immune checkpoint blockade.
Neoplasms
Inhibition of insulin-like growth factor 1 signaling synergistically enhances the tumor suppressive role of triptolide in triple-negative breast cancer cells.
Neoplasms
Inhibition of lung cancer cells and Ras/Raf/MEK/ERK signal transduction by ectonucleoside triphosphate phosphohydrolase-7 (ENTPD7).
Neoplasms
Inhibition of miR-21 Regulates Mutant KRAS Effector Pathways and Intercepts Pancreatic Ductal Adenocarcinoma Development.
Neoplasms
Inhibition of MIR4435-2HG on Invasion, Migration, and EMT of Gastric Carcinoma Cells by Mediating MiR-138-5p/Sox4 Axis.
Neoplasms
Inhibition of Proliferation by Knockdown of Transmembrane (TMEM) 168 in Glioblastoma Cells via Suppression of Wnt/?-Catenin Pathway.
Neoplasms
Inhibition of Splicing Factor 3b Subunit 1 (SF3B1) Reduced Cell Proliferation, Induced Apoptosis and Resulted in Cell Cycle Arrest by Regulating Homeobox A10 (HOXA10) Splicing in AGS and MKN28 Human Gastric Cancer Cells.
Neoplasms
Inhibition of the ATM/Chk2 axis promotes cGAS/STING signaling in ARID1A-deficient tumors.
Neoplasms
Inhibition of the Spectraplakin Protein Microtubule Actin Crosslinking Factor 1 Sensitizes Glioblastomas to Radiation.
Neoplasms
Inhibition of the Wnt/?-catenin pathway enhances antitumor immunity in ovarian cancer.
Neoplasms
Inhibition of Thioredoxin/Thioredoxin Reductase Induces Synthetic Lethality in Lung Cancers with Compromised Glutathione Homeostasis.
Neoplasms
Inhibition of TMEM45A suppresses proliferation, induces cell cycle arrest and reduces cell invasion in human ovarian cancer cells.
Neoplasms
Inhibitors of STAT3, ?-catenin, and IGF-1R sensitize mouse PIK3CA-mutant breast cancer to PI3K inhibitors.
Neoplasms
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses.
Neoplasms
INPP4B As A Prognostic And Diagnostic Marker Regulates Cell Growth Of Pancreatic Cancer Via Activating AKT.
Neoplasms
Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis.
Neoplasms
Insights from multidimensional analyses of the pan-cancer DNA methylome heterogeneity and the uncanonical CpG-gene associations.
Neoplasms
Insights into Impact of DNA Copy Number Alteration and Methylation on the Proteogenomic Landscape of Human Ovarian Cancer via a Multi-omics Integrative Analysis.
Neoplasms
Insights into the etiology-associated gene regulatory networks in hepatocellular carcinoma from The Cancer Genome Atlas.
Neoplasms
Insights into the Genetic Basis of the Renal Cell Carcinomas from The Cancer Genome Atlas.
Neoplasms
Insulin-Like Growth Factor 2 mRNA-Binding Protein 1 (IGF2BP1) Is a Prognostic Biomarker and Associated with Chemotherapy Responsiveness in Colorectal Cancer.
Neoplasms
Insulin-like growth factor 2 silencing restores taxol sensitivity in drug resistant ovarian cancer.
Neoplasms
Insulin-Like Growth Factor and SLC12A7 Dysregulation: A Novel Signaling Hallmark of Non-Functional Adrenocortical Carcinoma.
Neoplasms
Insulin-Like Growth Factor Binding Protein 5-A Probable Target of Kidney Renal Papillary Renal Cell Carcinoma.
Neoplasms
Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer.
Neoplasms
Integrated analyses identify miR-34c-3p/MAGI3 axis for the Warburg metabolism in hepatocellular carcinoma.
Neoplasms
Integrated analyses of microRNAs demonstrate their widespread influence on gene expression in high-grade serous ovarian carcinoma.
Neoplasms
Integrated analysis highlights multiple long non?coding RNAs and their potential roles in the progression of human esophageal squamous cell carcinoma.
Neoplasms
Integrated analysis identified core signal pathways and hypoxic characteristics of human glioblastoma.
Neoplasms
Integrated analysis identifies microRNA-195 as a suppressor of Hippo-YAP pathway in colorectal cancer.
Neoplasms
Integrated analysis identifies oxidative stress genes associated with progression and prognosis in gastric cancer.
Neoplasms
Integrated analysis of a ceRNA network reveals potential prognostic lncRNAs in gastric cancer.
Neoplasms
Integrated analysis of a competing endogenous RNA network in renal cell carcinoma using bioinformatics tools.
Neoplasms
Integrated Analysis of a Competing Endogenous RNA Network Revealing a Prognostic Signature for Cervical Cancer.
Neoplasms
Integrated analysis of a competing endogenous RNA network reveals key lncRNAs as potential prognostic biomarkers for human bladder cancer.
Neoplasms
Integrated analysis of a competing endogenous RNA network reveals key long noncoding RNAs as potential prognostic biomarkers for hepatocellular carcinoma.
Neoplasms
Integrated Analysis of a Risk Score System Predicting Prognosis and a ceRNA Network for Differentially Expressed lncRNAs in Multiple Myeloma.
Neoplasms
Integrated analysis of ceRNA network and tumor-infiltrating immune cells in esophageal cancer.
Neoplasms
Integrated Analysis of ceRNA Network Reveals Prognostic and Metastasis Associated Biomarkers in Breast Cancer.
Neoplasms
Integrated analysis of circular RNA-associated ceRNA network in cervical cancer: Observational Study.
Neoplasms
Integrated analysis of clinical significance and functional involvement of microRNAs in hepatocellular carcinoma.
Neoplasms
Integrated analysis of competing endogenous RNA network revealing lncRNAs as potential prognostic biomarkers in human lung squamous cell carcinoma.
Neoplasms
Integrated analysis of competing endogenous RNA network revealing potential prognostic biomarkers of hepatocellular carcinoma.
Neoplasms
Integrated analysis of competing endogenous RNA networks revealing five prognostic biomarkers associated with colorectal cancer.
Neoplasms
Integrated Analysis of DEAD-Box Helicase 56: A Potential Oncogene in Osteosarcoma.
Neoplasms
Integrated analysis of deregulation microRNA expression in head and neck squamous cell carcinoma.
Neoplasms
Integrated analysis of differentially expressed profiles and construction of a competing endogenous long non-coding RNA network in renal cell carcinoma.
Neoplasms
Integrated Analysis of Distant Metastasis-Associated Genes and Potential Drugs in Colon Adenocarcinoma.
Neoplasms
Integrated analysis of DNA methylation and mRNA expression profiling reveals candidate genes associated with cisplatin resistance in non-small cell lung cancer.
Neoplasms
Integrated analysis of dysregulated long non-coding RNAs/microRNAs/mRNAs in metastasis of lung adenocarcinoma.
Neoplasms
Integrated analysis of epigenomic and genomic changes by DNA methylation dependent mechanisms provides potential novel biomarkers for prostate cancer.
Neoplasms
Integrated analysis of gene expression signatures associated with colon cancer from three datasets.
Neoplasms
Integrated Analysis of Genetic Abnormalities of the Histone Lysine Methyltransferases in Prostate Cancer.
Neoplasms
Integrated analysis of genetic and epigenetic alterations reveals CpG island methylator phenotype associated with distinct clinical characters of lung adenocarcinoma.
Neoplasms
Integrated analysis of hypoxia-associated lncRNA signature to predict prognosis and immune microenvironment of lung adenocarcinoma patients.
Neoplasms
Integrated analysis of hypoxia-induced miR-210 signature as a potential prognostic biomarker of hepatocellular carcinoma: a study based on The Cancer Genome Atlas.
Neoplasms
Integrated Analysis of Immunity- and Ferroptosis-Related Biomarker Signatures to Improve the Prognosis Prediction of Hepatocellular Carcinoma.
Neoplasms
Integrated analysis of lncRNA CTD-2357A8.3 expression and its potential roles in head and neck squamous cell carcinoma.
Neoplasms
Integrated analysis of lncRNA-associated ceRNA network reveals potential biomarkers for the prognosis of hepatitis B virus-related hepatocellular carcinoma.
Neoplasms
Integrated Analysis of lncRNA-Mediated ceRNA Network Reveals a Prognostic Signature for Hepatocellular Carcinoma.
Neoplasms
Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue.
Neoplasms
Integrated analysis of long non-coding RNA competing interactions reveals the potential role in progression of human gastric cancer.
Neoplasms
Integrated analysis of long non-coding RNA?associated ceRNA network reveals potential lncRNA biomarkers in human lung adenocarcinoma.
Neoplasms
Integrated analysis of long non-coding RNAs in human gastric cancer: An in silico study.
Neoplasms
Integrated analysis of long non?coding RNA competing interactions revealed potential biomarkers in cervical cancer: Based on a public database.
Neoplasms
Integrated analysis of long noncoding RNA associated-competing endogenous RNA as prognostic biomarkers in clear cell renal carcinoma.
Neoplasms
Integrated analysis of long noncoding RNA interactions reveals the potential role in progression of human papillary thyroid cancer.
Neoplasms
Integrated analysis of lymphocyte infiltration-associated lncRNA for ovarian cancer via TCGA, GTEx and GEO datasets.
Neoplasms
Integrated analysis of metabolome in a EUS-FNA sample with transcriptome in the TCGA cohort of pancreatic head and body/tail adenocarcinoma.
Neoplasms
Integrated analysis of methylation-driven genes and pretreatment prognostic factors in patients with hepatocellular carcinoma.
Neoplasms
Integrated Analysis of Microarray and RNA-Seq Data for the Identification of Hub Genes and Networks Involved in the Pancreatic Cancer.
Neoplasms
Integrated Analysis of MicroRNA (miRNA) and mRNA Profiles Reveals Reduced Correlation between MicroRNA and Target Gene in Cancer.
Neoplasms
Integrated analysis of miRNAs and DNA methylation identifies miR-132-3p as a tumor suppressor in lung adenocarcinoma.
Neoplasms
Integrated Analysis of mRNA-miRNA-lncRNA ceRNA Network in Human HR+/Her-2- Breast Cancer and Triple Negative Breast Cancer.
Neoplasms
Integrated Analysis of Nine Prognostic RNA-Binding Proteins in Soft Tissue Sarcoma.
Neoplasms
Integrated Analysis of RNA-Binding Proteins Associated With the Prognosis and Immunosuppression in Squamous Cell Carcinoma of Head and Neck.
Neoplasms
Integrated analysis of single-cell RNA-seq and bulk RNA-seq reveals distinct cancer-associated fibroblasts in head and neck squamous cell carcinoma.
Neoplasms
Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels tumour heterogeneity plus M2-like tumour-associated macrophage infiltration and aggressiveness in TNBC.
Neoplasms
Integrated Analysis of the Functions and Prognostic Values of RNA Binding Proteins in Lung Squamous Cell Carcinoma.
Neoplasms
Integrated analysis of the functions of RNA binding proteins in clear cell renal cell carcinoma.
Neoplasms
Integrated analysis of the genomic and transcriptional profile of high-grade gliomas in different age groups.
Neoplasms
Integrated Analysis of the Immune Infiltrates and PD-L1 Expression of N6-Methyladenosine-Related Long Non-Coding RNAs in Colorectal Cancer.
Neoplasms
Integrated Analysis of the Prognosis-Associated RNA-Binding Protein Genes and Candidate Drugs in Renal Papillary Cell Carcinoma.
Neoplasms
Integrated analysis of the prognostic values of RNA-binding proteins in head and neck squamous cell carcinoma.
Neoplasms
Integrated analysis of the roles and prognostic value of RNA binding proteins in lung adenocarcinoma.
Neoplasms
Integrated Analysis of the Roles of RNA Binding Proteins and Their Prognostic Value in Clear Cell Renal Cell Carcinoma.
Neoplasms
Integrated Analysis of the Transcriptome Profile Reveals the Potential Roles Played by Long Noncoding RNAs in Immunotherapy for Sarcoma.
Neoplasms
Integrated Analysis of Thyroid Cancer Public Datasets Reveals Role of Post-Transcriptional Regulation on Tumor Progression by Targeting of Immune System Mediators.
Neoplasms
Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas.
Neoplasms
Integrated analysis of transcription factors and targets co-expression profiles reveals reduced correlation between transcription factors and target genes in cancer.
Neoplasms
Integrated analysis of two-lncRNA signature as a potential prognostic biomarker in cervical cancer: a study based on public database.
Neoplasms
Integrated analysis on the N6-methyladenosine-related long noncoding RNAs prognostic signature, immune checkpoints, and immune cell infiltration in clear cell renal cell carcinoma.
Neoplasms
Integrated analysis reveals critical glycolytic regulators in hepatocellular carcinoma.
Neoplasms
Integrated analysis reveals down-regulation of SPARCL1 is correlated with cervical cancer development and progression.
Neoplasms
Integrated Analysis Reveals hsa-miR-142 as a Representative of a Lymphocyte-Specific Gene Expression and Methylation Signature.
Neoplasms
Integrated Analysis Reveals Prognostic Value and Immune Correlates of CD86 Expression in Lower Grade Glioma.
Neoplasms
Integrated Analysis Reveals together miR-182, miR-200c and miR-221 Can Help in the Diagnosis of Prostate Cancer.
Neoplasms
Integrated Analysis to Evaluate the Prognostic Value of Signature mRNAs in Glioblastoma Multiforme.
Neoplasms
Integrated Analysis to Identify a Redox-Related Prognostic Signature for Clear Cell Renal Cell Carcinoma.
Neoplasms
Integrated Approaches for the Use of Large Datasets to Identify Rational Therapies for the Treatment of Lung Cancers.
Neoplasms
Integrated Bioinformatic Analysis of a Competing Endogenous RNA Network Reveals a Prognostic Signature in Endometrial Cancer.
Neoplasms
Integrated bioinformatic analysis of RNA binding proteins in hepatocellular carcinoma.
Neoplasms
Integrated Bioinformatical Analysis Identifies GIMAP4 as an Immune-Related Prognostic Biomarker Associated With Remodeling in Cervical Cancer Tumor Microenvironment.
Neoplasms
Integrated Bioinformatics analysis and clinical validation reveals that high expression of mucin 1 in intrahepatic cholangiocarcinoma predicts recurrence after curative resection.
Neoplasms
Integrated bioinformatics analysis for the identification of potential key genes affecting the pathogenesis of clear cell renal cell carcinoma.
Neoplasms
Integrated bioinformatics analysis identified MTHFD1L as a potential biomarker and correlated with immune infiltrates in hepatocellular carcinoma.
Neoplasms
Integrated Bioinformatics Analysis of DNA Methylation Biomarkers in Thyroid Cancer Based on TCGA Database.
Neoplasms
Integrated bioinformatics analysis of the association between apolipoprotein E expression and patient prognosis in papillary thyroid carcinoma.
Neoplasms
Integrated bioinformatics analysis revealing independent prognostic long non-coding RNAs DNAH17-AS1 and RP11-400N13.2 and their potential oncogenic roles in colorectal cancer.
Neoplasms
Integrated bioinformatics analysis reveals CDK1 and PLK1 as potential therapeutic targets of lung adenocarcinoma.
Neoplasms
Integrated bioinformatics analysis reveals that the expression of cathepsin S is associated with lymph node metastasis and poor prognosis in papillary thyroid cancer.
Neoplasms
Integrated Bioinformatics Analysis the Function of RNA Binding Proteins (RBPs) and Their Prognostic Value in Breast Cancer.
Neoplasms
Integrated Bioinformatics Analysis to Identify Abnormal Methylated Differentially Expressed Genes for Predicting Prognosis of Human Colon Cancer.
Neoplasms
Integrated bioinformatics analysis to screen hub genes in the lymph node metastasis of thyroid cancer.
Neoplasms
Integrated case-control and somatic-germline interaction analyses of melanoma susceptibility genes.
Neoplasms
Integrated case-control and somatic-germline interaction analyses of soft-tissue sarcoma.
Neoplasms
Integrated data analysis reveals potential drivers and pathways disrupted by DNA methylation in papillary thyroid carcinomas.
Neoplasms
Integrated Dissection of lncRNA-Perturbated Triplets Reveals Novel Prognostic Signatures Across Cancer Types.
Neoplasms
Integrated epigenomic profiling reveals endogenous retrovirus reactivation in renal cell carcinoma.
Neoplasms
Integrated Expression Profiles Analysis Reveals Correlations Between the IL-33/ST2 Axis and CD8+ T Cells, Regulatory T Cells, and Myeloid-Derived Suppressor Cells in Soft Tissue Sarcoma.
Neoplasms
Integrated Gene Expression and Methylation Analyses Identify DLL3 as a Biomarker for Prognosis of Malignant Glioma.
Neoplasms
Integrated genomic analyses of lung squamous cell carcinoma for identification of a possible competitive endogenous RNA network by means of TCGA datasets.
Neoplasms
Integrated genomic analysis for prediction of survival for patients with liver cancer using The Cancer Genome Atlas.
Neoplasms
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.
Neoplasms
Integrated genomic analysis identifies clinically relevant subtypes of renal clear cell carcinoma.
Neoplasms
Integrated genomic analysis identifies subclasses and prognosis signatures of kidney cancer.
Neoplasms
Integrated genomic and functional microRNA analysis identifies miR-30-5p as a tumor suppressor and potential therapeutic nanomedicine in head and neck cancer.
Neoplasms
Integrated genomic and methylation profile analysis to identify candidate tumor marker genes in patients with colorectal cancer.
Neoplasms
Integrated genomic profiling and modelling for risk stratification in patients with advanced oesophagogastric adenocarcinoma.
Neoplasms
Integrated genomic profiling identifies microRNA-92a regulation of IQGAP2 in locally advanced rectal cancer.
Neoplasms
Integrated Genomics for Pinpointing Survival Loci within Arm-Level Somatic Copy Number Alterations.
Neoplasms
Integrated immune gene expression signature and molecular classification in gastric cancer: New insights.
Neoplasms
Integrated metabolomics and lipidomics analyses reveal metabolic reprogramming in human glioma with IDH1 mutation.
Neoplasms
Integrated microenvironment-associated genomic profiles identify LRRC15 mediating recurrent glioblastoma-associated macrophages infiltration.
Neoplasms
Integrated microRNA, gene expression and transcription factors signature in papillary thyroid cancer with lymph node metastasis.
Neoplasms
Integrated MicroRNA-mRNA Analysis Reveals miR-204 Inhibits Cell Proliferation in Gastric Cancer by Targeting CKS1B, CXCL1 and GPRC5A.
Neoplasms
Integrated miRNA profiling and bioinformatics analyses reveal upregulated miRNAs in gastric cancer.
Neoplasms
Integrated morphologic analysis for the identification and characterization of disease subtypes.
Neoplasms
Integrated multi-omics analysis of the clinical relevance and potential regulatory mechanisms of splicing factors in hepatocellular carcinoma.
Neoplasms
Integrated multi-omics data analyses for exploring the co-occurring and mutually exclusive gene alteration events in colorectal cancer.
Neoplasms
Integrated omic analysis of lung cancer reveals metabolism proteome signatures with prognostic impact.
Neoplasms
Integrated omic analysis of oropharyngeal carcinomas reveals human papillomavirus (HPV)-dependent regulation of the activator protein 1 (AP-1) pathway.
Neoplasms
Integrated omics-based pathway analyses uncover CYP epoxygenase-associated networks as theranostic targets for metastatic triple negative breast cancer.
Neoplasms
Integrated pan-cancer of AURKA expression and drug sensitivity analysis reveals increased expression of AURKA is responsible for drug resistance.
Neoplasms
Integrated Phenotypic/Genotypic Analysis of Papillary Renal Cell Carcinoma Subtypes: Identification of Prognostic Markers, Cancer-related Pathways, and Implications for Therapy.
Neoplasms
Integrated PPI- and WGCNA-Retrieval of Hub Gene Signatures Shared Between Barrett's Esophagus and Esophageal Adenocarcinoma.
Neoplasms
Integrated profiling identifies caveolae-associated protein 1 as a prognostic biomarker of malignancy in glioblastoma patients.
Neoplasms
Integrated Profiling Identifies CCNA2 as a Potential Biomarker of Immunotherapy in Breast Cancer.
Neoplasms
Integrated profiling identifies ITGB3BP as prognostic biomarker for hepatocellular carcinoma.
Neoplasms
Integrated profiling identifies SLC5A6 and MFAP2 as novel diagnostic and prognostic biomarkers in gastric cancer patients.
Neoplasms
Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer.
Neoplasms
Integrated Proteomics and Bioinformatics to Identify Potential Prognostic Biomarkers in Hepatocellular Carcinoma.
Neoplasms
Integrated TCGA analysis implicates lncRNA CTB-193M12.5 as a prognostic factor in lung adenocarcinoma.
Neoplasms
Integrated Theory- and Data-driven Feature Selection in Gene Expression Data Analysis.
Neoplasms
Integrated transcriptional profiling and genomic analyses reveal RPN2 and HMGB1 as promising biomarkers in colorectal cancer.
Neoplasms
Integrated transcriptional-phenotypic analysis captures systemic immunomodulation following antiangiogenic therapy in renal cell carcinoma patients.
Neoplasms
Integrated transcriptomic analysis of distance-related field cancerization in rectal cancer patients.
Neoplasms
Integrating Clinical and Genetic Analysis of Perineural Invasion in Head and Neck Squamous Cell Carcinoma.
Neoplasms
Integrating cullin2-RING E3 ligase as a potential biomarker for glioblastoma multiforme prognosis and radiosensitivity profiling.
Neoplasms
Integrating genetic mutations and expression profiles for survival prediction of lung adenocarcinoma.
Neoplasms
Integrating Genomic Data with Transcriptomic Data for Improved Survival Prediction for Adult Diffuse Glioma.
Neoplasms
Integrating germline and somatic genetics to identify genes associated with lung cancer.
Neoplasms
Integrating Germline and Somatic Mutation Information for the Discovery of Biomarkers in Triple-Negative Breast Cancer.
Neoplasms
Integrating germline and somatic variation information using genomic data for the discovery of biomarkers in prostate cancer.
Neoplasms
Integrating HECW1 expression into the clinical indicators exhibits high accuracy in assessing the prognosis of patients with clear cell renal cell carcinoma.
Neoplasms
Integrating high-throughput microRNA and mRNA expression data to identify risk mRNA signature for pancreatic cancer prognosis.
Neoplasms
Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognostic Significance with the Cancer Genome Atlas Data.
Neoplasms
Integrating multi-omics data through deep learning for accurate cancer prognosis prediction.
Neoplasms
Integrating multi-omics for uncovering the architecture of cross-talking pathways in breast cancer.
Neoplasms
Integrating multi-platform genomic datasets for kidney renal clear cell carcinoma subtyping using stacked denoising autoencoders.
Neoplasms
Integrating multiple omics data for the discovery of potential Beclin-1 interactions in breast cancer.
Neoplasms
Integrating mutation and gene expression cross-sectional data to infer cancer progression.
Neoplasms
Integrating of genomic and transcriptomic profiles for the prognostic assessment of breast cancer.
Neoplasms
Integrating omics data and protein interaction networks to prioritize driver genes in cancer.
Neoplasms
Integrating Protein-Protein Interaction Networks and Somatic Mutation Data to Detect Driver Modules in Pan-Cancer.
Neoplasms
Integrating spatial gene expression and breast tumour morphology via deep learning.
Neoplasms
Integrating Transcriptomic Data with Mechanistic Systems Pharmacology Models for Virtual Drug Combination Trials.
Neoplasms
Integration analysis for novel lncRNA markers predicting tumor recurrence in human colon adenocarcinoma.
Neoplasms
Integration and Analysis of CPTAC Proteomics Data in the Context of Cancer Genomics in the cBioPortal.
Neoplasms
Integration and Analysis of Heterogeneous Colorectal Cancer Data for Translational Research.
Neoplasms
Integration and comparison of different genomic data for outcome prediction in cancer.
Neoplasms
Integration of a bacterial gene sequence into a chronic eosinophilic leukemia patient's genome as part of a fusion gene linker.
Neoplasms
Integration of gene profile to explore the hub genes of lung adenocarcinoma: A quasi-experimental study.
Neoplasms
Integration of Genomic and Transcriptomic Markers Improves the Prognosis Prediction of Acute Promyelocytic Leukemia.
Neoplasms
Integration of genomics and histology revises diagnosis and enables effective therapy of refractory cancer of unknown primary with PDL1 amplification.
Neoplasms
Integration of histopathological images and multi-dimensional omics analyses predicts molecular features and prognosis in high-grade serous ovarian cancer.
Neoplasms
Integration of machine learning and genome-scale metabolic modeling identifies multi-omics biomarkers for radiation resistance.
Neoplasms
Integration of metabolomic and transcriptomic data reveals metabolic pathway alteration in breast cancer and impact of related signature on survival.
Neoplasms
Integration of microRNA signatures of distinct mammary epithelial cell types with their gene expression and epigenetic portraits.
Neoplasms
Integration of miRNA-regulatory networks in hepatic stellate cells identifies TIMP3 as a key factor in chronic liver disease.
Neoplasms
Integration of Multi-Modal Biomedical Data to Predict Cancer Grade and Patient Survival.
Neoplasms
Integration of Multi-omics Data for Gene Regulatory Network Inference and Application to Breast Cancer.
Neoplasms
Integration of somatic mutation, expression and functional data reveals potential driver genes predictive of breast cancer survival.
Neoplasms
Integration of Survival and Binary Data for Variable Selection and Prediction: A Bayesian Approach.
Neoplasms
Integration of transcriptomic data and metabolic networks in cancer samples reveals highly significant prognostic power.
Neoplasms
Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy.
Neoplasms
Integrative analysis and machine learning on cancer genomics data using the Cancer Systems Biology Database (CancerSysDB).
Neoplasms
Integrative analysis and validation of dysregulated long non-coding RNAs in colon cancer.
Neoplasms
Integrative Analysis Identified MCT4 as an Independent Prognostic Factor for Bladder Cancer.
Neoplasms
Integrative analysis identifies key mRNA biomarkers for diagnosis, prognosis, and therapeutic targets of HCV-associated hepatocellular carcinoma.
Neoplasms
Integrative analysis of breast cancer profiles in TCGA by TNBC subgrouping reveals novel microRNA-specific clusters, including miR-17-92a, distinguishing basal-like 1 and basal-like 2 TNBC subtypes.
Neoplasms
Integrative analysis of BSG expression in NPC through immunohistochemistry and public high-throughput gene expression data.
Neoplasms
Integrative Analysis of Cellular Morphometric Context Reveals Clinically Relevant Signatures in Lower Grade Glioma.
Neoplasms
Integrative analysis of ceRNA network and DNA methylation associated with gene expression in malignant pheochromocytomas: a study based on The Cancer Genome Atlas.
Neoplasms
Integrative Analysis of ceRNA Network Reveals Functional lncRNAs in Intrahepatic Cholangiocarcinoma.
Neoplasms
Integrative analysis of common genes and driver mutations implicated in hormone stimulation for four cancers in women.
Neoplasms
Integrative analysis of diffusion-weighted MRI and genomic data to inform treatment of glioblastoma.
Neoplasms
Integrative analysis of DNA methylation and gene expression identify a six epigenetic driver signature for predicting prognosis in hepatocellular carcinoma.
Neoplasms
Integrative analysis of DNA methylation and gene expression in papillary renal cell carcinoma.
Neoplasms
Integrative analysis of DNA methylation and gene expression profiles identified potential breast cancer-specific diagnostic markers.
Neoplasms
Integrative Analysis of DNA Methylation and Gene Expression Profiles Identifies Colorectal Cancer-Related Diagnostic Biomarkers.
Neoplasms
Integrative analysis of DNA methylation and gene expression reveals distinct hepatocellular carcinoma subtypes with therapeutic implications.
Neoplasms
Integrative Analysis of DNA Methylation and Gene Expression to Determine Specific Diagnostic Biomarkers and Prognostic Biomarkers of Breast Cancer.
Neoplasms
Integrative analysis of DNA methylation and gene expression to identify key epigenetic genes in glioblastoma.
Neoplasms
Integrative analysis of dysregulated lncRNA-associated ceRNA network reveals potential lncRNA biomarkers for human hepatocellular carcinoma.
Neoplasms
Integrative analysis of gene alterations and immunoexpression profiles of cell cycle checkpoints in oral squamous cell carcinoma.
Neoplasms
Integrative analysis of gene expression profiles reveals specific signaling pathways associated with pancreatic duct adenocarcinoma.
Neoplasms
Integrative analysis of genetic and epigenetic profiling of lung squamous cell carcinoma (LSCC) patients to identify smoking level relevant biomarkers.
Neoplasms
Integrative analysis of genomic alteration, immune cells infiltration and prognosis of lung squamous cell carcinoma (LUSC) to identify smoking-related biomarkers.
Neoplasms
Integrative Analysis of Genomic and Clinical Data Reveals Intrinsic Characteristics of Bladder Urothelial Carcinoma Progression.
Neoplasms
Integrative analysis of h-prune as a potential therapeutic target for hepatocellular carcinoma.
Neoplasms
Integrative Analysis of Histopathological Images and Genomic Data Predicts Clear Cell Renal Cell Carcinoma Prognosis.
Neoplasms
Integrative Analysis of Identifying Methylation-Driven Genes Signature Predicts Prognosis in Colorectal Carcinoma.
Neoplasms
Integrative analysis of immune molecular subtypes and microenvironment characteristics of bladder cancer.
Neoplasms
Integrative analysis of lncRNAs and miRNAs with coding RNAs associated with ceRNA crosstalk network in triple negative breast cancer.
Neoplasms
Integrative Analysis of Long Noncoding RNA (lncRNA), microRNA (miRNA) and mRNA Expression and Construction of a Competing Endogenous RNA (ceRNA) Network in Metastatic Melanoma.
Neoplasms
Integrative Analysis of Methylation and Copy Number Variations of Prostate Adenocarcinoma Based on Weighted Gene Co-expression Network Analysis.
Neoplasms
Integrative Analysis of MicroRNA and Gene Interactions for Revealing Candidate Signatures in Prostate Cancer.
Neoplasms
Integrative analysis of miRNA and mRNA expression profiles reveals a novel mRNA/miRNA signature to improve risk classification for patients with gastric cancer.
Neoplasms
Integrative analysis of miRNA and mRNA sequencing data reveals potential regulatory mechanisms of ACE2 and TMPRSS2.
Neoplasms
Integrative Analysis of miRNAs Identifies Clinically Relevant Epithelial and Stromal Subtypes of Head and Neck Squamous Cell Carcinoma.
Neoplasms
Integrative Analysis of mRNA, microRNA, and Protein Correlates of Relative Cerebral Blood Volume Values in GBM Reveals the Role for Modulators of Angiogenesis and Tumor Proliferation.
Neoplasms
Integrative Analysis of Multi-Omics Data Based on Blockwise Sparse Principal Components.
Neoplasms
Integrative analysis of multi-omics data for identifying multi-markers for diagnosing pancreatic cancer.
Neoplasms
Integrative Analysis of Neuregulin Family Members-Related Tumor Microenvironment for Predicting the Prognosis in Gliomas.
Neoplasms
Integrative analysis of pathological images and multi-dimensional genomic data for early-stage cancer prognosis.
Neoplasms
Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4/MUC16/MUC20 signature is associated with poor survival in human carcinomas.
Neoplasms
Integrative analysis of the epigenetic basis of muscle-invasive urothelial carcinoma.
Neoplasms
Integrative analysis of the gastric cancer long non-coding RNA-associated competing endogenous RNA network.
Neoplasms
Integrative analysis of the lncRNA-associated ceRNA network reveals lncRNAs as potential prognostic biomarkers in human muscle-invasive bladder cancer.
Neoplasms
Integrative Analysis of Three Novel Competing Endogenous RNA Biomarkers with a Prognostic Value in Lung Adenocarcinoma.
Neoplasms
Integrative analysis of TNFRSF6B as a potential therapeutic target for pancreatic cancer.
Neoplasms
Integrative Analysis Reveals Comprehensive Altered Metabolic Genes Linking with Tumor Epigenetics Modification in Pan-Cancer.
Neoplasms
Integrative analysis reveals CRHBP inhibits renal cell carcinoma progression by regulating inflammation and apoptosis.
Neoplasms
Integrative analysis reveals disrupted pathways regulated by microRNAs in cancer.
Neoplasms
Integrative analysis with a system of semiparametric projection non-linear regression models.
Neoplasms
Integrative and Comprehensive Pancancer Analysis of Regulator of Chromatin Condensation 1 (RCC1).
Neoplasms
Integrative Bioinformatics Analysis Identifies NEK2 as a Potential Biomarker in Head and Neck Squamous Cell Carcinoma.
Neoplasms
Integrative bioinformatics analysis of prognostic alternative splicing signatures in gastric cancer.
Neoplasms
Integrative Bioinformatics Approaches to Screen Potential Prognostic Immune-Related Genes and Drugs in the Cervical Cancer Microenvironment.
Neoplasms
Integrative CAGE and DNA Methylation Profiling Identify Epigenetically Regulated Genes in NSCLC.
Neoplasms
Integrative Characterization of Immune-relevant Genes in Hepatocellular Carcinoma.
Neoplasms
Integrative clustering of high-dimensional data with joint and individual clusters.
Neoplasms
Integrative clustering of multi-level 'omic data based on non-negative matrix factorization algorithm.
Neoplasms
Integrative Clustering Reveals a Novel Subtype of Soft Tissue Sarcoma With Poor Prognosis.
Neoplasms
Integrative Comparison of mRNA Expression Patterns in Breast Cancers from Caucasian and Asian Americans with Implications for Precision Medicine.
Neoplasms
Integrative comparison of the genomic and transcriptomic landscape between prostate cancer patients of predominantly African or European genetic ancestry.
Neoplasms
Integrative data mining and meta-analysis to investigate the prognostic role of microRNA-200 family in various human malignant neoplasms: A consideration on heterogeneity.
Neoplasms
Integrative Epigenetic Analysis Reveals Therapeutic Targets to the DNA Methyltransferase Inhibitor Guadecitabine (SGI-110) in Hepatocellular Carcinoma.
Neoplasms
Integrative Epigenetic and Gene Expression Analysis of Renal Tumor Progression to Metastasis.
Neoplasms
Integrative exploration of genomic profiles for triple negative breast cancer identifies potential drug targets.
Neoplasms
Integrative expression quantitative trait locus-based analysis of colorectal cancer identified a functional polymorphism regulating SLC22A5 expression.
Neoplasms
Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship.
Neoplasms
Integrative genome-scale analysis of immune infiltration in esophageal carcinoma.
Neoplasms
Integrative Genome-Scale DNA Methylation Analysis of a Large and Unselected Cohort Reveals 5 Distinct Subtypes of Colorectal Adenocarcinomas.
Neoplasms
Integrative genome-wide gene expression profiling of clear cell renal cell carcinoma in czech republic and in the United States.
Neoplasms
Integrative genomic analyses identify WDR12 as a novel oncogene involved in glioblastoma.
Neoplasms
Integrative genomic analysis identifies associations of molecular alterations to APOBEC and BRCA1/2 mutational signatures in breast cancer.
Neoplasms
Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles.
Neoplasms
Integrative genomic and functional analysis of human oral squamous cell carcinoma cell lines reveals synergistic effects of FAT1 and CASP8 inactivation.
Neoplasms
Integrative Genomic and Transcriptomic Analyses of Tumor Suppressor Genes and Their Role on Tumor Microenvironment and Immunity in Lung Squamous Cell Carcinoma.
Neoplasms
Integrative genomic approaches to dissect clinically-significant relationships between the VDR cistrome and gene expression in primary colon cancer.
Neoplasms
Integrative genomics analysis of hub genes and their relationship with prognosis and signaling pathways in esophageal squamous cell carcinoma.
Neoplasms
Integrative Genomics and Transcriptomics Analysis Reveals Potential Mechanisms for Favorable Prognosis of Patients with HPV-Positive Head and Neck Carcinomas.
Neoplasms
Integrative Histologic and Bioinformatics Analysis of BIRC5/Survivin Expression in Oral Squamous Cell Carcinoma.
Neoplasms
Integrative modeling identifies genetic ancestry-associated molecular correlates in human cancer.
Neoplasms
Integrative Models of Histopathological Image Features and Omics Data Predict Survival in Head and Neck Squamous Cell Carcinoma.
Neoplasms
Integrative molecular profiling identifies a novel cluster of estrogen receptor-positive breast cancer in very young women.
Neoplasms
Integrative network analysis for survival-associated gene-gene interactions across multiple genomic profiles in ovarian cancer.
Neoplasms
Integrative Network Analysis Reveals a MicroRNA-Based Signature for Prognosis Prediction of Epithelial Ovarian Cancer.
Neoplasms
Integrative omics analysis reveals effective stratification and potential prognosis markers of pan-gastrointestinal cancers.
Neoplasms
Integrative Omics Analysis Reveals Post-Transcriptionally Enhanced Protective Host Response in Colorectal Cancers with Microsatellite Instability.
Neoplasms
Integrative pan cancer analysis reveals epigenomic variation in cancer type and cell specific chromatin domains.
Neoplasms
Integrative pan-cancer analysis of MEK1 aberrations and the potential clinical implications.
Neoplasms
Integrative proteomic and transcriptomic analysis provides evidence for TrkB (NTRK2) as a therapeutic target in combination with tyrosine kinase inhibitors for non-small cell lung cancer.
Neoplasms
Integrative radiogenomics analysis for predicting molecular features and survival in clear cell renal cell carcinoma.
Neoplasms
Integrative transcriptome analysis identified a BMP signaling pathway-regulated lncRNA AC068643.1 in IDH mutant and wild-type glioblastomas.
Neoplasms
Integrative transcriptome data mining for identification of core lncRNAs in breast cancer.
Neoplasms
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer.
Neoplasms
Integrative, multi-omics, analysis of blood samples improves model predictions: applications to cancer.
Neoplasms
Integrative, multimodal analysis of glioblastoma using TCGA molecular data, pathology images, and clinical outcomes.
Neoplasms
Integrin ?1 orchestrates the abnormal cell-matrix attachment and invasive behaviour of E-cadherin dysfunctional cells.
Neoplasms
Integrin ?11 in non-small cell lung cancer is associated with tumor progression and postoperative recurrence.
Neoplasms
Integrin ?4 promotes invasion and anoikis resistance of papillary thyroid carcinoma and is consistently overexpressed in lymphovascular tumor thrombus.
Neoplasms
Integrin ?5 subunit is required for the tumor supportive role of fibroblasts in colorectal adenocarcinoma and serves as a potential stroma prognostic marker.
Neoplasms
Integrin ?6?4 Promotes Autocrine Epidermal Growth Factor Receptor (EGFR) Signaling to Stimulate Migration and Invasion toward Hepatocyte Growth Factor (HGF).
Neoplasms
Integrin alphavbeta3 enhances ?-catenin signaling in acute myeloid leukemia harboring Fms-like tyrosine kinase-3 internal tandem duplication mutations: implications for microenvironment influence on sorafenib sensitivity.
Neoplasms
Integrin and gene network analysis reveals that ITGA5 and ITGB1 are prognostic in non-small-cell lung cancer.
Neoplasms
Integrin Beta 5 Is a Prognostic Biomarker and Potential Therapeutic Target in Glioblastoma.
Neoplasms
Integrin Subunit beta 8 (ITGB8) Upregulation Is an Independent Predictor of Unfavorable Survival of High-Grade Serous Ovarian Carcinoma Patients.
Neoplasms
Inter- and intra-tumor heterogeneity of SMAD4 loss in head and neck squamous cell carcinomas.
Neoplasms
Interaction of Age at Diagnosis with Transcriptional Profiling in Papillary Thyroid Cancer.
Neoplasms
Interaction of BRAF-induced ETS factors with mutant TERT promoter in papillary thyroid cancer.
Neoplasms
Interaction-Based Feature Selection for Uncovering Cancer Driver Genes Through Copy Number-Driven Expression Level.
Neoplasms
Interactions between Germline and Somatic Mutated Genes in Aggressive Prostate Cancer.
Neoplasms
Interactions between tumor mutation burden and immune infiltration in ovarian cancer.
Neoplasms
Interactive online consensus survival tool for esophageal squamous cell carcinoma prognosis analysis.
Neoplasms
Interference of tumour mutational burden with outcome of patients with head and neck cancer treated with definitive chemoradiation: a multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group.
Neoplasms
Interferon Gamma Messenger RNA Signature in Tumor Biopsies Predicts Outcomes in Patients with Non-Small Cell Lung Carcinoma or Urothelial Cancer Treated with Durvalumab.
Neoplasms
Interferon Regulatory Factor 4 Correlated With Immune Cells Infiltration Could Predict Prognosis for Patients With Lung Adenocarcinoma.
Neoplasms
Interferon regulatory factor 6 correlates with the progression of non-small cell lung cancer and can be regulated by miR-320.
Neoplasms
Interferon regulatory factor family influences tumor immunity and prognosis of patients with colorectal cancer.
Neoplasms
Interferon-?-induced p27KIP1 binds to and targets MYC for proteasome-mediated degradation.
Neoplasms
Interferon-Induced Protein 44 Correlated With Immune Infiltration Serves as a Potential Prognostic Indicator in Head and Neck Squamous Cell Carcinoma.
Neoplasms
Interferon-Induced Transmembrane Protein 3 Shapes an Inflamed Tumor Microenvironment and Identifies Immuno-Hot Tumors.
Neoplasms
Interferon-lambda (IFNL) germline variations and their significance for HCC and PDAC progression: an analysis of The Cancer Genome Atlas (TCGA) data.
Neoplasms
Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor.
Neoplasms
Interfocal heterogeneity challenges the clinical usefulness of molecular classification of primary prostate cancer.
Neoplasms
Interhemispheric transcallosal approach for resection of intraventricular central neurocytoma.
Neoplasms
Interleukin 1?/1RA axis in colorectal cancer regulates tumor invasion, proliferation and apoptosis via autophagy.
Neoplasms
Interleukin 35 Expression Correlates With Microvessel Density in Pancreatic Ductal Adenocarcinoma, Recruits Monocytes, and Promotes Growth and Angiogenesis of Xenograft Tumors in Mice.
Neoplasms
Interleukin-1 receptor-associated kinase 1 correlates with metastasis and invasion in endometrial carcinoma.
Neoplasms
Interleukin-2 inducible T-cell kinase: a potential prognostic biomarker and tumor microenvironment remodeling indicator for hepatocellular carcinoma.
Neoplasms
Interleukin-33 modulates immune responses in cutaneous melanoma in a context-specific way.
Neoplasms
Interleukin-6 and tumor necrosis factor alpha in synovial fluid are associated with progression of radiographic knee osteoarthritis in subjects with previous meniscectomy.
Neoplasms
Interleukin-7 Contributes to the Invasiveness of Prostate Cancer Cells by Promoting Epithelial-Mesenchymal Transition.
Neoplasms
Interleukin-8/CXCR2 signaling regulates therapy-induced plasticity and enhances tumorigenicity in glioblastoma.
Neoplasms
International Cancer Genome Consortium Data Portal--a one-stop shop for cancer genomics data.
Neoplasms
Interobserver Agreement in Endometrial Carcinoma Histotype Diagnosis Varies Depending on The Cancer Genome Atlas (TCGA)-based Molecular Subgroup.
Neoplasms
Interplay between base excision repair protein XRCC1 and ALDH2 predicts overall survival in lung and liver cancer patients.
Neoplasms
Interplay Between EGFR and the Platelet-Activating Factor/PAF Receptor Signaling Axis Mediates Aggressive Behavior of Cervical Cancer.
Neoplasms
Interpretation of EBV infection in pan-cancer genome considering viral life cycle: LiEB (Life cycle of Epstein-Barr virus).
Neoplasms
Interpretation of personal genome sequencing data in terms of disease ranks based on mutual information.
Neoplasms
Interpretation of T cell states from single-cell transcriptomics data using reference atlases.
Neoplasms
Interpreting the Molecular Mechanisms of Yinchenhao Decoction on Hepatocellular Carcinoma through Absorbed Components Based on Network Pharmacology.
Neoplasms
Intestinal Epithelial TBK1 Prevents Differentiation of T-helper 17 Cells and Tumorigenesis in Mice.
Neoplasms
Intra-tumor Genetic Heterogeneity and Mortality in Head and Neck Cancer: Analysis of Data from The Cancer Genome Atlas.
Neoplasms
Intra-Tumoral Angiogenesis Is Associated with Inflammation, Immune Reaction and Metastatic Recurrence in Breast Cancer.
Neoplasms
Intra-tumoral heterogeneity and immune responses predicts prognosis of gastric cancer.
Neoplasms
Intracellular matrix Gla protein promotes tumor progression by activating JAK2/STAT5 signaling in gastric cancer.
Neoplasms
Intragenic DNA methylation of PITX1 and the adjacent long non-coding RNA C5orf66-AS1 are prognostic biomarkers in patients with head and neck squamous cell carcinomas.
Neoplasms
Intratumor heterogeneity and homologous recombination deficiency of high-grade serous ovarian cancer are associated with prognosis and molecular subtype and change in treatment course.
Neoplasms
Intratumor Heterogeneity Correlates With Reduced Immune Activity and Worse Survival in Melanoma Patients.
Neoplasms
Intratumor heterogeneity could inform the use and type of postoperative adjuvant therapy in patients with head and neck squamous cell carcinoma.
Neoplasms
Intratumor heterogeneity of HMCN1 mutant alleles associated with poor prognosis in patients with breast cancer.
Neoplasms
Intratumoral Adipocyte-High Breast Cancer Enrich for Metastatic and Inflammation-Related Pathways but Associated with Less Cancer Cell Proliferation.
Neoplasms
Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion.
Neoplasms
Intratumoral CXCL13+CD8+T cell infiltration determines poor clinical outcomes and immunoevasive contexture in patients with clear cell renal cell carcinoma.
Neoplasms
Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response.
Neoplasms
Intratumoral IL17-producing cells infiltration correlate with antitumor immune contexture and improved response to adjuvant chemotherapy in gastric cancer.
Neoplasms
Intrinsic cisplatin resistance in lung and ovarian cancer cells propagating in medium acutely depleted of folate.
Neoplasms
Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology.
Neoplasms
Intrinsic Genomic Differences Between African American and White Patients With Clear Cell Renal Cell Carcinoma.
Neoplasms
Intrinsic Molecular Subclassification of Urothelial Carcinoma of the Bladder: Are We Finally there?
Neoplasms
Introduction: an histology atlas of the rodent mammary gland and human breast during normal postnatal development and in cancer.
Neoplasms
Invalidation of mitophagy by FBP1-mediated repression promotes apoptosis in breast cancer.
Neoplasms
Invariant Delineation of Nuclear Architecture in Glioblastoma Multiforme from The Cancer Genome Atlas Cohort.
Neoplasms
Inverse correlation between Naa10p and Pirh2 expression and the combined prognostic value in oral squamous cell carcinoma patients.
Neoplasms
Inverse Relationship between Progesterone Receptor and Myc in Endometrial Cancer.
Neoplasms
Investigate the mechanisms of Chinese medicine Fuzhengkangai towards EGFR mutation-positive lung adenocarcinomas by network pharmacology.
Neoplasms
Investigating a multigene prognostic assay based on significant pathways for Luminal A breast cancer through gene expression profile analysis.
Neoplasms
Investigating cellular network heterogeneity and modularity in cancer: a network entropy and unbalanced motif approach.
Neoplasms
Investigating MicroRNA and transcription factor co-regulatory networks in colorectal cancer.
Neoplasms
Investigating resistin like beta (RETNLB) as a tumor promoter for oral squamous cell carcinoma.
Neoplasms
Investigating skewness to understand gene expression heterogeneity in large patient cohorts.
Neoplasms
Investigating the functional implications of reinforcing feedback loops in transcriptional regulatory networks.
Neoplasms
Investigating the natural history and prognostic nature of NTRK gene fusions in solid tumors.
Neoplasms
Investigating the Role of Telomere and Telomerase Associated Genes and Proteins in Endometrial Cancer.
Neoplasms
Investigation and verification of the clinical significance and perspective of natural killer group 2 member D ligands in colon adenocarcinoma.
Neoplasms
Investigation of Genetic Determinants of Glioma Immune Phenotype by Integrative Immunogenomic Scale Analysis.
Neoplasms
Investigation of miR-136-5p key target genes and pathways in lung squamous cell cancer based on TCGA database and bioinformatics analysis.
Neoplasms
Investigation of miR-490-3p Expression in Hepatocellular Carcinoma Based on Reverse Transcription-Polymerase Chain Reaction (RT-qPCR) and a Meta-Analysis of 749 Cases.
Neoplasms
Investigation of miRNA- and lncRNA-mediated competing endogenous RNA network in cholangiocarcinoma.
Neoplasms
Investigation of Potential Mechanisms Associated with Non-small Cell Lung Cancer.
Neoplasms
Investigation of the clinical significance and molecular mechanism of miR-21-5p in hepatocellular carcinoma: A systematic review based on 24 studies and bioinformatics investigation.
Neoplasms
Investigation of the putative role of antisense transcripts as regulators of sense transcripts by correlation analysis of sense-antisense pairs in colorectal cancers.
Neoplasms
Investigation on tissue specific effects of pro-apoptotic micro RNAs revealed miR-147b as a potential biomarker in ovarian cancer prognosis.
Neoplasms
Involvement of Differentially Expressed microRNAs in the PEGylated Liposome Encapsulated 188Rhenium-Mediated Suppression of Orthotopic Hypopharyngeal Tumor.
Neoplasms
Involvement of dual-strand of the miR-144 duplex and their targets in the pathogenesis of lung squamous cell carcinoma.
Neoplasms
IODNE: An integrated optimization method for identifying the deregulated subnetwork for precision medicine in cancer.
Neoplasms
Ion channel expression patterns in glioblastoma stem cells with functional and therapeutic implications for malignancy.
Neoplasms
IPCT: Integrated Pharmacogenomic Platform of Human Cancer Cell Lines and Tissues.
Neoplasms
IPI59: An Actionable Biomarker to Improve Treatment Response in Serous Ovarian Carcinoma Patients.
Neoplasms
IRE1? and IGF signaling predict resistance to an endoplasmic reticulum stress-inducing drug in glioblastoma cells.
Neoplasms
IRF1 association with tumor immune microenvironment and use as a diagnostic biomarker for colorectal cancer recurrence.
Neoplasms
IRF1-mediated immune cell infiltration is associated with metastasis in colon adenocarcinoma.
Neoplasms
IRF7 as an Immune-Related Prognostic Biomarker and Associated with Tumor Microenvironment in Low-Grade Glioma.
Neoplasms
Iron metabolism gene expression and prognostic features of hepatocellular carcinoma.
Neoplasms
Is papillary thyroid microcarcinoma a biologically different disease? A propensity score-matched analysis.
Neoplasms
Is The Cancer Genome Atlas (TCGA) bladder cancer cohort representative of invasive bladder cancer?
Neoplasms
Ischemia Induces Quiescence and Autophagy Dependence in Hepatocellular Carcinoma.
Neoplasms
isma: an R package for the integrative analysis of mutations detected by multiple pipelines.
Neoplasms
Isocitrate dehydrogenase 1 (IDH1) mutation-specific microRNA signature predicts favorable prognosis in glioblastoma patients with IDH1 wild type.
Neoplasms
Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas.
Neoplasms
Isoform specific gene expression analysis of KRAS in the prognosis of lung adenocarcinoma patients.
Neoplasms
Isoform switch of pyruvate kinase m1 indeed occurs but not to pyruvate kinase m2 in human tumorigenesis.
Neoplasms
IsoformSwitchAnalyzeR: Analysis of changes in genome-wide patterns of alternative splicing and its functional consequences.
Neoplasms
IsoMiRmap-fast, deterministic, and exhaustive mining of isomiRs from short RNA-seq datasets.
Neoplasms
ITD assembler: an algorithm for internal tandem duplication discovery from short-read sequencing data.
Neoplasms
ITGA2B and ITGA8 are predictive of prognosis in clear cell renal cell carcinoma patients.
Neoplasms
ITGA3 Is Associated With Immune Cell Infiltration and Serves as a Favorable Prognostic Biomarker for Breast Cancer.
Neoplasms
ITGBL1 promotes EMT, invasion and migration by activating NF-?B signaling pathway in prostate cancer.
Neoplasms
ITPKA Gene Body Methylation Regulates Gene Expression and Serves as an Early Diagnostic Marker in Lung and Other Cancers.
Neoplasms
ITPKA1 Promotes Growth, Migration and Invasion of Renal Cell Carcinoma via Activation of mTOR Signaling Pathway.
Neoplasms
iTRAQ-based quantitative proteomic analysis reveals potential early diagnostic markers of clear-cell Renal cell carcinoma.
Neoplasms
Jagged1 is Clinically Prognostic and Promotes Invasion of Glioma-Initiating Cells by Activating NF-?B(p65) Signaling.
Neoplasms
JAK1 as a prognostic marker and its correlation with immune infiltrates in breast cancer.
Neoplasms
JAK2 expression is correlated with the molecular and clinical features of breast cancer as a favorable prognostic factor.
Neoplasms
JAK2/PD-L1/PD-L2 (9p24.1) amplifications in renal cell carcinomas with sarcomatoid transformation: implications for clinical management.
Neoplasms
Japanese version of The Cancer Genome Atlas, JCGA, established using fresh frozen tumors obtained from 5143 cancer patients.
Neoplasms
Joint analysis of expression profiles from multiple cancers improves the identification of microRNA-gene interactions.
Neoplasms
Joint analysis of multiple high-dimensional data types using sparse matrix approximations of rank-1 with applications to ovarian and liver cancer.
Neoplasms
JOINT AND INDIVIDUAL VARIATION EXPLAINED (JIVE) FOR INTEGRATED ANALYSIS OF MULTIPLE DATA TYPES.
Neoplasms
Joint bioinformatics analysis of underlying potential functions of hsa-let-7b-5p and core genes in human glioma.
Neoplasms
Joint estimation of multiple mixed graphical models for pan-cancer network analysis.
Neoplasms
Joint Lp-Norm and L2,1-Norm Constrained Graph Laplacian PCA for Robust Tumor Sample Clustering and Gene Network Module Discovery.
Neoplasms
Joint reconstruction of multiple gene networks by simultaneously capturing inter-tumor and intra-tumor heterogeneity.
Neoplasms
Joint segmentation and deformable registration of brain scans guided by a tumor growth model.
Neoplasms
JOSD1 promotes proliferation and chemoresistance of head and neck squamous cell carcinoma under the epigenetic regulation of BRD4.
Neoplasms
Jumonji domain-containing protein 6 functions as a marker of head and neck squamous cell carcinoma at advanced stage with no effect on prognosis.
Neoplasms
Kallikrein-related peptidase 5 induces miRNA-mediated anti-oncogenic pathways in breast cancer.
Neoplasms
Karyopherin Alpha 2 Is an Adverse Prognostic Factor in Clear-Cell and Papillary Renal-Cell Carcinoma.
Neoplasms
Karyopherin subunit-? 2 expression accelerates cell cycle progression by upregulating CCNB2 and CDK1 in hepatocellular carcinoma.
Neoplasms
KAT2B is an immune infiltration-associated biomarker predicting prognosis and response to immunotherapy in non-small cell lung cancer.
Neoplasms
KAT6A amplifications are associated with shorter progression-free survival and overall survival in patients with endometrial serous carcinoma.
Neoplasms
KCNN4 is a potential prognostic marker and critical factor affecting the immune status of the tumor microenvironment in kidney renal clear cell carcinoma.
Neoplasms
KCNQ1OT1 facilitates progression of non-small-cell lung carcinoma via modulating miRNA-27b-3p/HSP90AA1 axis.
Neoplasms
KDELC1 and TRMT1 Serve as Prognosis-Related SARS-CoV-2 Proteins Binding Human mRNAs and Promising Biomarkers in Clear Cell Renal Cell Carcinoma.
Neoplasms
KDM1A Promotes Immunosuppression in Hepatocellular Carcinoma by Regulating PD-L1 through Demethylating MEF2D.
Neoplasms
KDM4A as a prognostic marker of oral squamous cell carcinoma: Evidence from tissue microarray studies in a multicenter cohort.
Neoplasms
KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burden.
Neoplasms
KEAP1/NFE2L2 Mutations of Liquid Biopsy as Prognostic Biomarkers in Patients With Advanced Non-Small Cell Lung Cancer: Results From Two Multicenter, Randomized Clinical Trials.
Neoplasms
Kelch-like protein 14 promotes proliferation and migration of ovarian cancer cells.
Neoplasms
Keratin 17 is a negative prognostic biomarker in high-grade endometrial carcinomas.
Neoplasms
Keratin 80 promotes migration and invasion of colorectal carcinoma by interacting with PRKDC via activating the AKT pathway.
Neoplasms
Kernel Fusion Method for Detecting Cancer Subtypes via Selecting Relevant Expression Data.
Neoplasms
Key Candidate Genes - VSIG2 of Colon Cancer Identified by Weighted Gene Co-Expression Network Analysis.
Neoplasms
Key Common Genes in Obstructive Sleep Apnea and Lung Cancer are Associated with Prognosis of Lung Cancer Patients.
Neoplasms
Key factors and potential drug combinations of nonalcoholic steatohepatitis: Bioinformatic analysis and experimental validation-based study.
Neoplasms
Key Genes in Stomach Adenocarcinoma Identified via Network Analysis of RNA-Seq Data.
Neoplasms
Key genes in youth colorectal cancer based on data mining and verification by reverse transcription-quantitative PCR.
Neoplasms
Key microRNAs and hub genes associated with poor prognosis in lung adenocarcinoma.
Neoplasms
Key miRNAs and target genes played roles in the development of clear cell renal cell carcinoma.
Neoplasms
Key molecular alterations in endothelial cells in human glioblastoma uncovered through single-cell RNA sequencing.
Neoplasms
Key necroptotic proteins are required for Smac mimetic-mediated sensitization of cholangiocarcinoma cells to TNF-? and chemotherapeutic gemcitabine-induced necroptosis.
Neoplasms
Key nodes of a microRNA network associated with the integrated mesenchymal subtype of high-grade serous ovarian cancer.
Neoplasms
Key pathways in prostate cancer with SPOP mutation identified by bioinformatic analysis.
Neoplasms
Ki-67 and MCM6 labeling indices are correlated with overall survival in anaplastic oligodendroglioma, IDH1-mutant and 1p/19q-codeleted: a multicenter study from the French POLA network.
Neoplasms
KIAA0101 in Malignant Pleural Mesothelioma: a Potential Diagnostic and Prognostic Marker.
Neoplasms
KIAA1199, a Target of MicoRNA-486-5p, Promotes Papillary Thyroid Cancer Invasion by Influencing Epithelial-Mesenchymal Transition (EMT).
Neoplasms
KIAA1429 regulates the migration and invasion of hepatocellular carcinoma by altering m6A modification of ID2 mRNA.
Neoplasms
KIAA1522 Promotes the Progression of Hepatocellular Carcinoma via the Activation of the Wnt/?-Catenin Signaling Pathway.
Neoplasms
KIF11 Functions as an Oncogene and Is Associated with Poor Outcomes from Breast Cancer.
Neoplasms
KIF11 Promotes Proliferation of Hepatocellular Carcinoma among Patients with Liver Cancers.
Neoplasms
KIF11 Serves as an Independent Prognostic Factor and Therapeutic Target for Patients With Lung Adenocarcinoma.
Neoplasms
KIF15 facilitates gastric cancer via enhancing proliferation, inhibiting apoptosis, and predict poor prognosis.
Neoplasms
KIF15 promotes the evolution of gastric cancer cells through inhibition of reactive oxygen species-mediated apoptosis.
Neoplasms
KIF15 upregulation promotes leiomyosarcoma cell growth via promoting USP15-mediated DEK deubiquitylation.
Neoplasms
KIF18B as a regulator in microtubule movement accelerates tumor progression and triggers poor outcome in lung adenocarcinoma.
Neoplasms
KIF18B promotes tumor progression through activating the Wnt/?-catenin pathway in cervical cancer.
Neoplasms
KIF20A promotes cellular malignant behavior and enhances resistance to chemotherapy in colorectal cancer through regulation of the JAK/STAT3 signaling pathway.
Neoplasms
KIF2C promotes the proliferation of hepatocellular carcinoma cells in vitro and in vivo.
Neoplasms
KIF3C is associated with favorable prognosis in glioma patients and may be regulated by PI3K/AKT/mTOR pathway.
Neoplasms
KIF4A enhanced cell proliferation and migration via Hippo signaling and predicted a poor prognosis in esophageal squamous cell carcinoma.
Neoplasms
Kinase Gene Expression Profiling of Metastatic Clear Cell Renal Cell Carcinoma Tissue Identifies Potential New Therapeutic Targets.
Neoplasms
Kinase-substrate Edge Biomarkers Provide a More Accurate Prognostic Prediction in ER-negative Breast Cancer.
Neoplasms
Kinesin Family Member 11 Enhances the Self-Renewal Ability of Breast Cancer Cells by Participating in the Wnt/?-Catenin Pathway.
Neoplasms
Kinesin family member 18B: A contributor and facilitator in the proliferation and metastasis of cutaneous melanoma.
Neoplasms
Kinesin Family Member C1 (KIFC1) Accelerates Proliferation and Invasion of Endometrial Cancer Cells Through Modulating the PI3K/AKT Signaling Pathway.
Neoplasms
Kinesin superfamily protein expression and its association with progression and prognosis in hepatocellular carcinoma.
Neoplasms
Kinome-Wide Screening with Small Interfering RNA Identified Polo-like Kinase 1 as a Key Regulator of Proliferation in Oral Cancer Cells.
Neoplasms
Kinome-Wide siRNA Screening Identifies Src-Enhanced Resistance of Chemotherapeutic Drugs in Triple-Negative Breast Cancer Cells.
Neoplasms
KIT performed as a driver gene candidate affecting the survival status of patients with stomach adenocarcinoma.
Neoplasms
KLF13 suppresses the proliferation and growth of colorectal cancer cells through transcriptionally inhibiting HMGCS1-mediated cholesterol biosynthesis.
Neoplasms
KLF4 regulates adult lung tumor-initiating cells and represses K-Ras-mediated lung cancer.
Neoplasms
KLF9 suppresses gastric cancer cell invasion and metastasis through transcriptional inhibition of MMP28.
Neoplasms
KM-express: an integrated online patient survival and gene expression analysis tool for the identification and functional characterization of prognostic markers in breast and prostate cancers.
Neoplasms
KMT2C is a potential biomarker of prognosis and chemotherapy sensitivity in breast cancer.
Neoplasms
Knockdown of Anillin Actin Binding Protein Blocks Cytokinesis in Hepatocytes and Reduces Liver Tumor Development in Mice Without Affecting Regeneration.
Neoplasms
Knockdown of anion exchanger 2 suppressed the growth of ovarian cancer cells via mTOR/p70S6K1 signaling.
Neoplasms
Knockdown of anti-silencing function 1B histone chaperone induces cell apoptosis via repressing PI3K/Akt pathway in prostate cancer.
Neoplasms
Knockdown of carbohydrate sulfotransferase 12 decreases the proliferation and mobility of glioblastoma cells via the WNT/?-catenin pathway.
Neoplasms
Knockdown of CCNO decreases the tumorigenicity of gastric cancer by inducing apoptosis.
Neoplasms
Knockdown of CDCA8 inhibits the proliferation and enhances the apoptosis of bladder cancer cells.
Neoplasms
Knockdown of CLDN6 inhibits cell proliferation and migration via PI3K/AKT/mTOR signaling pathway in endometrial carcinoma cell line HEC-1-B.
Neoplasms
Knockdown of GTF2E2 inhibits the growth and progression of lung adenocarcinoma via RPS4X in vitro and in vivo.
Neoplasms
Knockdown of long non-coding RNA PVT1 induces apoptosis and cell cycle arrest in clear cell renal cell carcinoma through the epidermal growth factor receptor pathway.
Neoplasms
Knockdown of long non-coding RNA SLC8A1-AS1 attenuates cell invasion and migration in glioma via suppression of Wnt/?-catenin signaling pathways.
Neoplasms
Knockdown of MAPK14 inhibits the proliferation and migration of clear cell renal cell carcinoma by downregulating the expression of CDC25B.
Neoplasms
Knockdown of MRPL42 suppresses glioma cell proliferation by inducing cell cycle arrest and apoptosis.
Neoplasms
Knockdown of MUC16 (CA125) Enhances the Migration and Invasion of Hepatocellular Carcinoma Cells.
Neoplasms
Knockdown of PGM1 enhances anticancer effects of orlistat in gastric cancer under glucose deprivation.
Neoplasms
Knockdown of POLQ interferes the development and progression of hepatocellular carcinoma through regulating cell proliferation, apoptosis and migration.
Neoplasms
Knockdown of RAC1 and VASP gene expression inhibits breast cancer cell migration.
Neoplasms
Knockdown of RhoC Inhibits Oral Squamous Cell Carcinoma Cell Invasion and Metastasis via Regulation of HMGA2.
Neoplasms
Knockdown of SLCO4C1 inhibits cell proliferation and metastasis in endometrial cancer through inactivating the PI3K/Akt signaling pathway.
Neoplasms
Knockdown of SOX12 expression inhibits the proliferation and metastasis of lung cancer cells.
Neoplasms
Knockdown of spindle pole body component 25 homolog inhibits cell proliferation and cycle progression in prostate cancer.
Neoplasms
Knockdown of STIL suppresses the progression of gastric cancer by down-regulating the IGF-1/PI3K/AKT pathway.
Neoplasms
Knockdown of THOC1 reduces the proliferation of hepatocellular carcinoma and increases the sensitivity to cisplatin.
Neoplasms
Knockdown of thrombospondin 2 inhibits metastasis through modulation of PI3K signaling pathway in uveal melanoma cell line M23.
Neoplasms
Knockdown of TMEM14A expression by RNAi inhibits the proliferation and invasion of human ovarian cancer cells.
Neoplasms
Knockdown of TNF receptor-associated factor 2 (TRAF2) modulates in vitro growth of TRAIL-treated prostate cancer cells.
Neoplasms
Knockdown of TOR signaling pathway regulator suppresses cell migration and invasion in non-small cell lung cancer via the regulation of epithelial-to-mesenchymal transition.
Neoplasms
Knockdown of TRIM65 inhibits lung cancer cell proliferation, migration and invasion: A therapeutic target in human lung cancer.
Neoplasms
Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
Neoplasms
Knockdown of tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta (YWHAZ) enhances tumorigenesis both in vivo and in vitro in bladder cancer.
Neoplasms
KPNA2-Associated Immune Analyses Highlight the Dysregulation and Prognostic Effects of GRB2, NRAS, and Their RNA-Binding Proteins in Hepatocellular Carcinoma.
Neoplasms
KRAB ZNF explorer - the online tool for the exploration of the transcriptomic profiles of KRAB-ZNF factors in The Cancer Genome Atlas.
Neoplasms
KRAS G12D mutation predicts lower TMB and drives immune suppression in lung adenocarcinoma.
Neoplasms
KRAS gene status in gastric signet-ring cell carcinoma patients and acts as biomarker of MEK inhibitor.
Neoplasms
KRAS mutant rectal cancer cells interact with surrounding fibroblasts to deplete the extracellular matrix.
Neoplasms
KRAS mutation and epithelial-macrophage interplay in pancreatic neoplastic transformation.
Neoplasms
KRAS signaling enriched triple negative breast cancer is associated with favorable tumor immune microenvironment and better survival.
Neoplasms
KRAS-Driven Lung Adenocarcinoma and B Cell Infiltration: Novel Insights for Immunotherapy.
Neoplasms
KRASG12C Mutation Is Associated with Increased Risk of Recurrence in Surgically Resected Lung Adenocarcinoma.
Neoplasms
KRT15, INHBA, MATN3, and AGT are aberrantly methylated and differentially expressed in gastric cancer and associated with prognosis.
Neoplasms
KRT7 promotes epithelial?mesenchymal transition in ovarian cancer via the TGF??/Smad2/3 signaling pathway.
Neoplasms
KRT84 is a potential tumor suppressor and good prognosis signature of oral squamous cell carcinoma.
Neoplasms
Kruppel-like factor 2 mediated anti-proliferative and anti-metastasis effects of simvastatin in p53 mutant colon cancer.
Neoplasms
Krüppel-like factor 4 is a novel prognostic predictor for urothelial carcinoma of bladder and it regulates TWIST1-mediated epithelial-mesenchymal transition.
Neoplasms
Krüppel-Like Factor 7 is a Marker of Aggressive Gastric Cancer and Poor Prognosis.
Neoplasms
L1CAM is an independent predictor of poor survival in endometrial cancer - An analysis of The Cancer Genome Atlas (TCGA).
Neoplasms
L2,1-Extreme Learning Machine: An Efficient Robust Classifier for Tumor Classification.
Neoplasms
Label propagation defines signaling networks associated with recurrently mutated cancer genes.
Neoplasms
Label-free quantitative proteomic analysis identifies the oncogenic role of FOXA1 in BaP-transformed 16HBE cells.
Neoplasms
Lack of APC somatic mutation is associated with early-onset colorectal cancer in African Americans.
Neoplasms
Lactate Dehydrogenase-A (LDH-A) Preserves Cancer Stemness and Recruitment of Tumor-Associated Macrophages to Promote Breast Cancer Progression.
Neoplasms
Lactate-mediated mitoribosomal defects impair mitochondrial oxidative phosphorylation and promote hepatoma cell invasiveness.
Neoplasms
Lactic acidosis caused by repressed lactate dehydrogenase subunit B expression down-regulates mitochondrial oxidative phosphorylation via the pyruvate dehydrogenase (PDH)-PDH kinase axis.
Neoplasms
Lactotransferrin Downregulation Drives the Metastatic Progression in Clear Cell Renal Cell Carcinoma.
Neoplasms
LAG3 (LAG-3, CD223) DNA methylation correlates with LAG3 expression by tumor and immune cells, immune cell infiltration, and overall survival in clear cell renal cell carcinoma.
Neoplasms
LAGE3 correlates with tumorigenic immune infiltrates in the clear cell renal cell carcinoma microenvironment.
Neoplasms
LAMC1 upregulation via TGF? induces inflammatory cancer-associated fibroblasts in esophageal squamous cell carcinoma via NF-?B-CXCL1-STAT3.
Neoplasms
Lamin B2 binding to minichromosome maintenance complex component 7 promotes non-small cell lung carcinogenesis.
Neoplasms
Lamin B2 promotes the progression of triple negative breast cancer via mediating cell proliferation and apoptosis.
Neoplasms
Laminin C1 expression by uterine carcinoma cells is associated with tumor progression.
Neoplasms
Landscape of Bone Marrow Metastasis in Human Neuroblastoma Unraveled by Transcriptomics and Deep Multiplex Imaging.
Neoplasms
Landscape of cell heterogeneity and evolutionary trajectory in ulcerative colitis-associated colon cancer revealed by single-cell RNA sequencing.
Neoplasms
Landscape of DNA virus associations across human malignant cancers: analysis of 3,775 cases using RNA-Seq.
Neoplasms
Landscape of epigenetically regulated lncRNAs and DNA methylation in smokers with lung adenocarcinoma.
Neoplasms
Landscape of expression profiles in esophageal carcinoma by The Cancer Genome Atlas data.
Neoplasms
Landscape of Germline Genetic Variants in AGT, MGMT, and TP53 in Mexican Adult Patients with Astrocytoma.
Neoplasms
Large Scale Comparison of Gene Expression Levels by Microarrays and RNAseq Using TCGA Data.
Neoplasms
Large-scale analyses identify a cluster of novel long noncoding RNAs as potential competitive endogenous RNAs in progression of hepatocellular carcinoma.
Neoplasms
Large-scale analysis of acquired chromosomal alterations in non-tumor samples from patients with cancer.
Neoplasms
Large-Scale Analysis of Gene Expression Data Reveals a Novel Gene Expression Signature Associated with Colorectal Cancer Distant Recurrence.
Neoplasms
Large-scale analysis reveals a novel risk score to predict overall survival in hepatocellular carcinoma.
Neoplasms
Large-scale analysis reveals the specific clinical and immune features of B7-H3 in glioma.
Neoplasms
Large-Scale Analysis Reveals the Specific Clinical and Immune Features of DGCR5 in Glioma.
Neoplasms
Large-scale DNA methylation expression analysis across 12 solid cancers reveals hypermethylation in the calcium-signaling pathway.
Neoplasms
Large-scale inference of competing endogenous RNA networks with sparse partial correlation.
Neoplasms
Large-scale profiling of serum metabolites in African American and European American patients with bladder cancer reveals metabolic pathways associated with patient survival.
Neoplasms
Large-scale RNA-Seq Transcriptome Analysis of 4043 Cancers and 548 Normal Tissue Controls across 12 TCGA Cancer Types.
Neoplasms
Large-Scale Transcriptome Analysis Identified a Novel Cancer Driver Genes Signature for Predicting the Prognostic of Patients With Hepatocellular Carcinoma.
Neoplasms
Large-scale transcriptome analysis identified RNA methylation regulators as novel prognostic signatures for lung adenocarcinoma.
Neoplasms
Large-Scale Transcriptomics-Driven Approach Revealed Overexpression of CRNDE as a Poor Survival Prognosis Biomarker in Glioblastoma.
Neoplasms
Laryngeal Squamous Cell Carcinoma: Potential Molecular Mechanism and Prognostic Signature Based on Immune-Related Genes.
Neoplasms
Laser-assisted microsurgical resection of thoracic intramedullary spinal cord ependymoma.
Neoplasms
LASSO?based Cox?PH model identifies an 11?lncRNA signature for prognosis prediction in gastric cancer.
Neoplasms
LAT, HOXD3 and NFE2L3 identified as novel DNA methylation-driven genes and prognostic markers in human clear cell renal cell carcinoma by integrative bioinformatics approaches.
Neoplasms
Latency-associated Peptide Identifies Immunoevasive Subtype Gastric Cancer With Poor Prognosis and Inferior Chemotherapeutic Responsiveness.
Neoplasms
Latency-associated peptide identifies therapeutically resistant muscle-invasive bladder cancer with poor prognosis.
Neoplasms
Latent Feature Decompositions for Integrative Analysis of Multi-Platform Genomic Data.
Neoplasms
Lauren classification identifies distinct prognostic value and functional status of intratumoral CD8+ T cells in gastric cancer.
Neoplasms
LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
Neoplasms
LC-MS/MS analysis of differentially expressed glioblastoma membrane proteome reveals altered calcium signalling and other protein groups of regulatory functions.
Neoplasms
LCK expression is a potential biomarker for distinguishing primary central nervous system lymphoma from glioblastoma multiforme.
Neoplasms
LCL161, a SMAC-mimetic, Preferentially Radiosensitizes Human Papillomavirus-negative Head and Neck Squamous Cell Carcinoma.
Neoplasms
LDHA induces EMT gene transcription and regulates autophagy to promote the metastasis and tumorigenesis of papillary thyroid carcinoma.
Neoplasms
LDHA Promotes Oral Squamous Cell Carcinoma Progression Through Facilitating Glycolysis and Epithelial-Mesenchymal Transition.
Neoplasms
Leadership perspectives in multidisciplinary team meetings; observational assessment based on the ATLAS instrument in cancer care.
Neoplasms
Learning MRI-based classification models for MGMT methylation status prediction in glioblastoma.
Neoplasms
Learning subgroup-specific regulatory interactions and regulator independence with PARADIGM.
Neoplasms
LEM domain containing 1 promotes proliferation via activating the PI3K/Akt signaling pathway in gastric cancer.
Neoplasms
LEM domain containing 1 promotes thyroid cancer cell proliferation and migration by activating the Wnt/?-catenin signaling pathway and epithelial-mesenchymal transition.
Neoplasms
Lentivirus-mediated overexpression of HSDL2 suppresses cell proliferation and induces apoptosis in cholangiocarcinoma.
Neoplasms
Lentivirus-mediated shRNA targeting MUTYH inhibits malignant phenotypes of bladder cancer SW780 cells.
Neoplasms
Leptin Is Associated with Poor Clinical Outcomes and Promotes Clear Cell Renal Cell Carcinoma Progression.
Neoplasms
Leptin Signaling Affects Survival and Chemoresistance of Estrogen Receptor Negative Breast Cancer.
Neoplasms
Leptin signaling axis specifically associates with clinical prognosis and is multifunctional in regulating cancer progression.
Neoplasms
Leptin stimulates migration and invasion and maintains cancer stem-like properties in ovarian cancer cells: an explanation for poor outcomes in obese women.
Neoplasms
Lesion-Function Analysis from Multimodal Imaging and Normative Brain Atlases for Prediction of Cognitive Deficits in Glioma Patients.
Neoplasms
Let-7i-5p enhances cell proliferation, migration and invasion of ccRCC by targeting HABP4.
Neoplasms
Letrozole targets the human ether-a-go-go-related gene potassium current in glioblastoma.
Neoplasms
Leukocyte immunoglobulin-like receptor subfamily B member 1 potentially acts as a diagnostic and prognostic target in certain subtypes of adenocarcinoma.
Neoplasms
Levels of 4EBP1/eIF4E Activation in Renal Cell Carcinoma Could Differentially Predict Its Early and Late Recurrence.
Neoplasms
Leveraging global gene expression patterns to predict expression of unmeasured genes.
Neoplasms
Leveraging methylation to identify the potential causal genes associated with survival in lung adenocarcinoma and lung squamous cell carcinoma.
Neoplasms
Leveraging molecular datasets for biomarker-based clinical trial design in glioblastoma.
Neoplasms
Leveraging protein dynamics to identify cancer mutational hotspots using 3D structures.
Neoplasms
LGALS4 as a Prognostic Factor in Urothelial Carcinoma of Bladder Affects Cell Functions.
Neoplasms
LGR6 activates the Wnt/?-catenin signaling pathway and forms a ?-catenin/TCF7L2/LGR6 feedback loop in LGR6high cervical cancer stem cells.
Neoplasms
LHX6, An Independent Prognostic Factor, Inhibits Lung Adenocarcinoma Progression through Transcriptional Silencing of ?-catenin.
Neoplasms
Ligand-receptor interaction atlas within and between tumor cells and T cells in lung adenocarcinoma.
Neoplasms
LIM and SH3 protein 1 regulates cell growth and chemosensitivity of human glioblastoma via the PI3K/AKT pathway.
Neoplasms
Limb-bud and heart as a novel biomarker for gastric intestinal type adenocarcinoma.
Neoplasms
LIMCH1 suppress the growth of lung cancer by interacting with HUWE1 to sustain p53 stability.
Neoplasms
LIMD2 Is Overexpressed in BRAF V600E-Positive Papillary Thyroid Carcinomas and Matched Lymph Node Metastases.
Neoplasms
LIMS1 Promotes Pancreatic Cancer Cell Survival Under Oxygen-Glucose Deprivation Conditions by Enhancing HIF1A Protein Translation.
Neoplasms
LINC00240 sponges miR-4465 to promote proliferation, migration, and invasion of hepatocellular carcinoma cells via HGF/c-MET signaling pathway.
Neoplasms
LINC00261 inhibits progression of pancreatic cancer by down-regulating miR-23a-3p.
Neoplasms
LINC00294 induced by GRP78 promotes cervical cancer development by promoting cell cycle transition.
Neoplasms
LINC00346 promotes pancreatic cancer progression through the CTCF-mediated Myc transcription.
Neoplasms
LINC00460 promotes proliferation and inhibits apoptosis of non-small cell lung cancer cells through targeted regulation of miR-539.
Neoplasms
LINC00461 affects the survival of patients with renal cell carcinoma by acting as a competing endogenous RNA for microRNA?942.
Neoplasms
LINC00467 promotes proliferation and invasion in glioma via interacting with miRNA-485-5p.
Neoplasms
LINC00491 as a new molecular marker can promote the proliferation, migration and invasion of colon adenocarcinoma cells.
Neoplasms
LINC00501 Inhibits the Growth and Metastasis of Lung Cancer by Mediating miR-129-5p/HMGB1.
Neoplasms
LINC00565 promotes proliferation and inhibits apoptosis of gastric cancer by targeting miR-665/AKT3 axis.
Neoplasms
LINC00662 promotes gastric cancer cell growth by modulating the Hippo-YAP1 pathway.
Neoplasms
Linc00662 Promotes Tumorigenesis and Progression by Regulating miR-497-5p/AVL9 Axis in Colorectal Cancer.
Neoplasms
LINC00665 promotes cell proliferation, invasion, and metastasis by activating the TGF-? pathway in gastric cancer.
Neoplasms
LINC00675 Suppresses Cell Proliferation and Migration via Downregulating the H3K4me2 Level at the SPRY4 Promoter in Gastric Cancer.
Neoplasms
LINC00675 suppresses proliferative, migration and invasion of clear cell renal cell carcinoma via the Wnt/?-catenin pathway.
Neoplasms
LINC00707 accelerates the proliferation, migration and invasion of clear cell renal cell carcinoma.
Neoplasms
LINC00844 promotes proliferation and migration of hepatocellular carcinoma by regulating NDRG1 expression.
Neoplasms
Linc00941 Is a Novel Transforming Growth Factor ? Target That Primes Papillary Thyroid Cancer Metastatic Behavior by Regulating the Expression of Cadherin 6.
Neoplasms
LINC00963 Functions as an Oncogene in Bladder Cancer by Regulating the miR-766-3p/MTA1 Axis.
Neoplasms
LINC00968 can inhibit the progression of lung adenocarcinoma through the miR-21-5p/SMAD7 signal axis.
Neoplasms
LINC01133 promotes the progression of cervical cancer by sponging miR-4784 to up-regulate AHDC1.
Neoplasms
LINC01234/MicroRNA-31-5p/MAGEA3 Axis Mediates the Proliferation and Chemoresistance of Hepatocellular Carcinoma Cells.
Neoplasms
LINC01296 promotes proliferation, migration, and invasion of HCC cells by targeting miR-122-5P and modulating EMT activity.
Neoplasms
LINC01305 inhibits malignant progression of cervical cancer via miR-129-5p/Sox4 axis.
Neoplasms
LINC01410-miR-532-NCF2-NF-kB feedback loop promotes gastric cancer angiogenesis and metastasis.
Neoplasms
LINC01426 contributes to clear cell renal cell carcinoma progression by modulating CTBP1/miR-423-5p/FOXM1 axis via interacting with IGF2BP1.
Neoplasms
LINC01816 promotes the migration, invasion and epithelial?mesenchymal transition of thyroid carcinoma cells by sponging miR?34c?5p and regulating CRABP2 expression levels.
Neoplasms
LINC02257, an Enhancer RNA of Prognostic Value in Colon Adenocarcinoma, Correlates With Multi-Omics Immunotherapy-Related Analysis in 33 Cancers.
Neoplasms
LINC02499, a novel liver-specific long non-coding RNA with potential diagnostic and prognostic value, inhibits hepatocellular carcinoma cell proliferation, migration, and invasion.
Neoplasms
LINC02535 co-functions with PCBP2 to regulate DNA damage repair in cervical cancer by stabilizing RRM1 mRNA.
Neoplasms
LINC02595 promotes tumor progression in colorectal cancer by inhibiting miR-203b-3p activity and facilitating BCL2L1 expression.
Neoplasms
LINC02678 as a Novel Prognostic Marker Promotes Aggressive Non-small-cell Lung Cancer.
Neoplasms
LINC02738 Participates in the Development of Kidney Cancer Through the miR-20b/Sox4 Axis.
Neoplasms
LincIN, a novel NF90-binding long non-coding RNA, is overexpressed in advanced breast tumors and involved in metastasis.
Neoplasms
LincK contributes to breast tumorigenesis by promoting proliferation and epithelial-to-mesenchymal transition.
Neoplasms
LincRNA-ROR promotes metastasis and invasion of esophageal squamous cell carcinoma by regulating miR-145/FSCN1.
Neoplasms
LINE-1 Retrotransposition Promotes the Development and Progression of Lung Squamous Cell Carcinoma by Disrupting the Tumor-Suppressor Gene FGGY.
Neoplasms
Lineage-Specific Epigenomic and Genomic Activation of Oncogene HNF4A Promotes Gastrointestinal Adenocarcinomas.
Neoplasms
Linking patient outcome to high throughput protein expression data identifies novel regulators of colorectal adenocarcinoma aggressiveness.
Neoplasms
Lipase member H is a downstream molecular target of hypoxia inducible factor-1? and promotes papillary thyroid carcinoma cell migration in BCPAP and KTC-1 cell lines.
Neoplasms
Lipid metabolism gene-wide profile and survival signature of lung adenocarcinoma.
Neoplasms
Lipocalin-1 Expression as a Prognosticator Marker of Survival in Breast Cancer Patients.
Neoplasms
Lipopolysaccharide promotes metastasis via acceleration of glycolysis by the nuclear factor-?B/snail/hexokinase3 signaling axis in colorectal cancer.
Neoplasms
Liprin-?1 modulates cancer cell signaling by transmembrane protein CD82 in adhesive membrane domains linked to cytoskeleton.
Neoplasms
Liver X Receptor ? Related to Tumor Progression and Ribosome Gene Expression in Papillary Thyroid Cancer.
Neoplasms
Liver-enriched Genes are Associated with the Prognosis of Patients with Hepatocellular Carcinoma.
Neoplasms
Liver-Metastasis-Related Genes are Potential Biomarkers for Predicting the Clinical Outcomes of Patients with Pancreatic Adenocarcinoma.
Neoplasms
LKB1 Down-Modulation by miR-17 Identifies Patients With NSCLC Having Worse Prognosis Eligible for Energy-Stress-Based Treatments.
Neoplasms
LKB1 inactivation occurs in a subset of esophageal adenocarcinomas and is sufficient to drive tumor cell proliferation.
Neoplasms
LMSM: A modular approach for identifying lncRNA related miRNA sponge modules in breast cancer.
Neoplasms
LMX1B mRNA expression and its gene body CpG methylation are valuable prognostic biomarkers for laryngeal squamous cell carcinoma.
Neoplasms
LNCAROD is stabilized by m6A methylation and promotes cancer progression via forming a ternary complex with HSPA1A and YBX1 in head and neck squamous cell carcinoma.
Neoplasms
LnCeCell: a comprehensive database of predicted lncRNA-associated ceRNA networks at single-cell resolution.
Neoplasms
lncExplore: a database of pan-cancer analysis and systematic functional annotation for lncRNAs from RNA-sequencing data.
Neoplasms
LncNetP, a systematical lncRNA prioritization approach based on ceRNA and disease phenotype association assumptions.
Neoplasms
lncRNA A1BG-AS1 suppresses proliferation and invasion of hepatocellular carcinoma cells by targeting miR-216a-5p.
Neoplasms
LncRNA and mRNA expression profiles of glioblastoma multiforme (GBM) reveal the potential roles of lncRNAs in GBM pathogenesis.
Neoplasms
LncRNA and mRNA signatures associated with neoadjuvant chemoradiotherapy downstaging effects in rectal cancer.
Neoplasms
LncRNA CASC9 interacts with CPSF3 to regulate TGF-? signaling in colorectal cancer.
Neoplasms
LncRNA CCAT2 promotes proliferation and suppresses apoptosis of colorectal cancer cells.
Neoplasms
LncRNA CYTOR affects the proliferation, cell cycle and apoptosis of hepatocellular carcinoma cells by regulating the miR-125b-5p/KIAA1522 axis.
Neoplasms
LncRNA DCST1-AS1 functions as a competing endogenous RNA to regulate FAIM2 expression by sponging miR-1254 in hepatocellular carcinoma.
Neoplasms
LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network.
Neoplasms
lncRNA DUXAP8 inhibits papillary thyroid carcinoma cell apoptosis via sponging the miR?20b?5p/SOS1 axis.
Neoplasms
LncRNA ELFN1-AS1 promotes esophageal cancer progression by up-regulating GFPT1 via sponging miR-183-3p.
Neoplasms
LncRNA ENST00000539653 acts as an oncogenic factor via MAPK signalling in papillary thyroid cancer.
Neoplasms
LncRNA Expression Signature in Prediction of the Prognosis of Lung Adenocarcinoma.
Neoplasms
LncRNA FAM83A-AS1 promotes lung adenocarcinoma progression by enhancing the pre-mRNA stability of FAM83A.
Neoplasms
lncRNA FLVCR1-AS1 silencing inhibits lung cancer cell proliferation, migration, and invasion by inhibiting the activity of the Wnt/?-catenin signaling pathway.
Neoplasms
LncRNA FOXD2-AS1 Functions as a Competing Endogenous RNA to Regulate TERT Expression by Sponging miR-7-5p in Thyroid Cancer.
Neoplasms
lncRNA FOXD3-AS1 is associated with clinical progression and regulates cell migration and invasion in breast cancer.
Neoplasms
LncRNA H19 regulates PI3K-Akt signal pathway by functioning as a ceRNA and predicts poor prognosis in colorectal cancer: integrative analysis of dysregulated ncRNA-associated ceRNA network.
Neoplasms
LncRNA H19/miR-194/PFTK1 axis modulates the cell proliferation and migration of pancreatic cancer.
Neoplasms
LncRNA HMMR-AS1 promotes proliferation and metastasis of lung adenocarcinoma by regulating MiR-138/sirt6 axis.
Neoplasms
LncRNA HOTAIR influences cell growth, migration, invasion, and apoptosis via the miR-20a-5p/HMGA2 axis in breast cancer.
Neoplasms
LncRNA HOTAIR promotes the growth and metastasis of gastric cancer by sponging miR-1277-5p and upregulating COL5A1.
Neoplasms
LncRNA HOXA11-AS drives cisplatin resistance of human LUAD cells via modulating miR-454-3p/Stat3.
Neoplasms
LncRNA HOXA11-AS Promotes Proliferation and Invasion of Gastric Cancer by Scaffolding the Chromatin Modification Factors PRC2, LSD1, and DNMT1.
Neoplasms
LncRNA KCNQ1OT1 activated by c-Myc promotes cell proliferation via interacting with FUS to stabilize MAP3K1 in acute promyelocytic leukemia.
Neoplasms
LncRNA LINC00668 promotes the progression of breast cancer by inhibiting apoptosis and accelerating cell cycle.
Neoplasms
LncRNA LINC00888 upregulation predicts a worse survival of laryngeal cancer patients and accelerates the growth and mobility of laryngeal cancer cells through regulation of miR-378g/TFRC.
Neoplasms
LncRNA LINC01857 promotes cell growth and diminishes apoptosis via PI3K/mTOR pathway and EMT process by regulating miR-141-3p/MAP4K4 axis in diffuse large B-cell lymphoma.
Neoplasms
LncRNA MAGI2-AS3 Is Regulated by BRD4 and Promotes Gastric Cancer Progression via Maintaining ZEB1 Overexpression by Sponging miR-141/200a.
Neoplasms
LncRNA MALAT1 functions as a competing endogenous RNA to regulate ZEB2 expression by sponging miR-200s in clear cell kidney carcinoma.
Neoplasms
LncRNA MCM3AP-AS1 Regulates Epidermal Growth Factor Receptor and Autophagy to Promote Hepatocellular Carcinoma Metastasis by Interacting with miR-455.
Neoplasms
LncRNA MFI2-AS1 promotes HCC progression and metastasis by acting as a competing endogenous RNA of miR-134 to upregulate FOXM1 expression.
Neoplasms
LncRNA MIR100HG promotes cell proliferation in triple-negative breast cancer through triplex formation with p27 loci.
Neoplasms
LncRNA NEAT1 promotes autophagy via regulating miR-204/ATG3 and enhanced cell resistance to sorafenib in hepatocellular carcinoma.
Neoplasms
LncRNA NEAT1 Promotes Deterioration of Hepatocellular Carcinoma Based on In Vitro Experiments, Data Mining, and RT-qPCR Analysis.
Neoplasms
LncRNA PCAT6: A potential biomarker for diagnosis and prognosis of bladder cancer.
Neoplasms
LncRNA PCED1B-AS1 activates the proliferation and restricts the apoptosis of glioma through cooperating with miR-194-5p/PCED1B axis.
Neoplasms
LncRNA PPP1R14B-AS1 Promotes Tumor Cell Proliferation and Migration via the Enhancement of Mitochondrial Respiration.
Neoplasms
LncRNA PVT1 as an effective biomarker for cancer diagnosis and detection based on transcriptome data and meta-analysis.
Neoplasms
lncRNA PVT1 identified as an independent biomarker for prognosis surveillance of solid tumors based on transcriptome data and meta-analysis.
Neoplasms
LncRNA RAD51-AS1/miR-29b/c-3p/NDRG2 crosstalk repressed proliferation, invasion and glycolysis of colorectal cancer.
Neoplasms
LncRNA RP11-19E11 is an E2F1 target required for proliferation and survival of basal breast cancer.
Neoplasms
lncRNA RPPH1 promotes non-small cell lung cancer progression through the miR-326/WNT2B axis.
Neoplasms
lncRNA small nucleolar RNA host gene 12 promotes renal cell carcinoma progression by modulating the miR?200c?5p/collagen type XI ?1 chain pathway.
Neoplasms
LncRNA SNHG15 predicts poor prognosis in uveal melanoma and its potential pathways.
Neoplasms
LncRNA SNHG4 regulates miR-138/c-Met axis to promote the proliferation of glioblastoma cells.
Neoplasms
LncRNA SNHG6 plays an oncogenic role in colorectal cancer and can be used as a prognostic biomarker for solid tumors.
Neoplasms
LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-?/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1.
Neoplasms
LncRNA SNHG6/miR-125b-5p/BMPR1B Axis: A New Therapeutic Target for Triple-Negative Breast Cancer.
Neoplasms
lncRNA SNHG7 affects malignant tumor behaviors through downregulation of EZH2 in uveal melanoma cell lines.
Neoplasms
lncRNA SNHG8 Promotes the Tumorigenesis and Metastasis by Sponging miR-149-5p and Predicts Tumor Recurrence in Hepatocellular Carcinoma.
Neoplasms
LncRNA SNHG9 is a prognostic biomarker and correlated with immune infiltrates in prostate cancer.
Neoplasms
LncRNA ST7-AS1 is a Potential Novel Biomarker and Correlated With Immune Infiltrates for Breast Cancer.
Neoplasms
LncRNA ST8SIA6-AS1 promotes proliferation, migration and invasion in breast cancer through the p38 MAPK ssignalling pathway.
Neoplasms
lncRNA TP73-AS1 Regulates miR-21/PTEN Axis to Affect Cell Proliferation in Acute Myeloid Leukemia.
Neoplasms
lncRNA TPTEP1 inhibits stemness and radioresistance of glioma through miR?106a?5p?mediated P38 MAPK signaling.
Neoplasms
LncRNA VPS9D1-AS1 promotes cell proliferation in acute lymphoblastic leukemia through modulating GPX1 expression by miR-491-5p and miR-214-3p evasion.
Neoplasms
LncRNA-Associated ceRNA Network Reveals Novel Potential Biomarkers of Laryngeal Squamous Cell Carcinoma.
Neoplasms
LncRNA-LINC01089 inhibits lung adenocarcinoma cell proliferation and promotes apoptosis via sponging miR-543.
Neoplasms
lncRNAs classifier to accurately predict the recurrence of thymic epithelial tumors.
Neoplasms
LncRNAs KB-1836B5, LINC00566 and FAM27L are associated with the survival time of patients with ovarian cancer.
Neoplasms
LncRNAs SNHG12 and LINC00152 were associated with progression of patients with papillary thyroid carcinoma.
Neoplasms
LOC550643, a Long Non-coding RNA, Acts as Novel Oncogene in Regulating Breast Cancer Growth and Metastasis.
Neoplasms
Local Delivery of Minocycline and Vorinostat Targets the Tumor Microenvironment to Inhibit the Recurrence of Glioma.
Neoplasms
Local sequence assembly reveals a high-resolution profile of somatic structural variations in 97 cancer genomes.
Neoplasms
Locus-Specific Characterization of Human Endogenous Retrovirus Expression in Prostate, Breast, and Colon Cancers.
Neoplasms
Long intergenic non-coding RNA 271 is predictive of a poorer prognosis of papillary thyroid cancer.
Neoplasms
Long Intergenic Non-Coding RNA LINC00885 Promotes Tumorigenesis of Cervical Cancer by Upregulating MACC1 Expression Through Serving as a Competitive Endogenous RNA for microRNA-432-5p.
Neoplasms
Long Intergenic Non-coding RNA Profiles of Pheochromocytoma and Paraganglioma: A Novel Prognostic Biomarker.
Neoplasms
Long ncRNA MALAT1 promotes cell proliferation, migration, and invasion in prostate cancer via sponging miR-145.
Neoplasms
Long non-coding RNA (lncRNA) transcriptional landscape in breast cancer identifies LINC01614 as non-favorable prognostic biomarker regulated by TGF? and focal adhesion kinase (FAK) signaling.
Neoplasms
Long non-coding RNA 01559 mediates the malignant phenotypes of hepatocellular carcinoma cells through targeting miR-511.
Neoplasms
Long non-coding RNA AB007962 is downregulated in gastric cancer and associated with poor prognosis.
Neoplasms
Long non-coding RNA ADAMTS9-AS1 suppresses colorectal cancer by inhibiting the Wnt/?-catenin signalling pathway and is a potential diagnostic biomarker.
Neoplasms
Long non-coding RNA BACE1-AS is an independent unfavorable prognostic factor in liver cancer.
Neoplasms
Long Non-coding RNA BTG3-7:1 and JUND Co-regulate C21ORF91 to Promote Triple-Negative Breast Cancer Progress.
Neoplasms
Long non-coding RNA C5orf66-AS1 promotes cell proliferation in cervical cancer by targeting miR-637/RING1 axis.
Neoplasms
Long non-coding RNA CASC19 is associated with the progression and prognosis of advanced gastric cancer.
Neoplasms
Long non-coding RNA CCAT1 promotes colorectal cancer progression by regulating miR-181a-5p expression.
Neoplasms
Long non-coding RNA ERICH3-AS1 is an unfavorable prognostic factor for gastric cancer.
Neoplasms
Long non-coding RNA EWSAT1 contributes to the proliferation and invasion of glioma by sponging miR-152-3p.
Neoplasms
Long non-coding RNA expression profile can predict early recurrence in hepatocellular carcinoma after curative resection.
Neoplasms
Long Non-Coding RNA Expression Profiles for the Characterization of Different Bladder Cancer Grade.
Neoplasms
Long Non-coding RNA Expression Profiling Identifies a Four-Long Non-coding RNA Prognostic Signature for Isocitrate Dehydrogenase Mutant Glioma.
Neoplasms
Long non-coding RNA FAM66C is associated with clinical progression and promotes cell proliferation by inhibiting proteasome pathway in prostate cancer.
Neoplasms
Long non-coding RNA Fer-1-like family member 4 is overexpressed in human glioblastoma and regulates the tumorigenicity of glioma cells.
Neoplasms
Long non-coding RNA FLJ33360 participates in ovarian cancer progression by sponging miR-30b-3p.
Neoplasms
Long non-coding RNA FOXP4-AS1 acts as an adverse prognostic factor and regulates proliferation and apoptosis in nasopharyngeal carcinoma.
Neoplasms
Long non-coding RNA HCG11 modulates glioma progression through cooperating with miR-496/CPEB3 axis.
Neoplasms
Long non-coding RNA HOTAIR promotes cell migration by upregulating insulin growth factor-binding protein 2 in renal cell carcinoma.
Neoplasms
Long non-coding RNA Linc00152 is a positive prognostic factor for and demonstrates malignant biological behavior in clear cell renal cell carcinoma.
Neoplasms
Long non-coding RNA LINC00346 regulates proliferation and apoptosis by targeting miR-128-3p/SZRD1 axis in glioma.
Neoplasms
Long non-coding RNA LINC00460 predicts poor survival and promotes cell viability in pancreatic cancer.
Neoplasms
Long non-coding RNA LINC00520 promotes the proliferation and metastasis of malignant melanoma by inducing the miR-125b-5p/EIF5A2 axis.
Neoplasms
Long Non-Coding RNA LINC00662 Regulated Proliferation and Migration by Targeting miR-34a-5p/LMAN2L Axis in Glioma.
Neoplasms
Long Non-coding RNA LINC00941 as a Potential Biomarker Promotes the Proliferation and Metastasis of Gastric Cancer.
Neoplasms
Long non-coding RNA LINC00997 silencing inhibits the progression and metastasis of colorectal cancer by sponging miR-512-3p.
Neoplasms
Long non-coding RNA LINC01234 regulates proliferation, migration and invasion via HIF-2? pathways in clear cell renal cell carcinoma cells.
Neoplasms
Long Non-coding RNA LINC01969 Promotes Ovarian Cancer by Regulating the miR-144-5p/LARP1 Axis as a Competing Endogenous RNA.
Neoplasms
Long Non-coding RNA LINC02195 as a Regulator of MHC I Molecules and Favorable Prognostic Marker for Head and Neck Squamous Cell Carcinoma.
Neoplasms
Long Non-Coding RNA LINC02747 Promotes the Proliferation of Clear Cell Renal Cell Carcinoma by Inhibiting miR-608 and Activating TFE3.
Neoplasms
Long non-coding RNA Lucat1 is a poor prognostic factor and demonstrates malignant biological behavior in clear cell renal cell carcinoma.
Neoplasms
Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3? Signaling Pathway.
Neoplasms
Long non-coding RNA MALAT1 regulates BLCAP mRNA expression through binding to miR-339-5p and promotes poor prognosis in breast cancer.
Neoplasms
Long non-coding RNA MEG3 suppresses the development of bladder urothelial carcinoma by regulating miR-96 and TPM1.
Neoplasms
Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 regulates renal cancer cell migration via cofilin-1.
Neoplasms
Long non-coding RNA MIAT promotes breast cancer progression and functions as ceRNA to regulate DUSP7 expression by sponging miR-155-5p.
Neoplasms
Long non-coding RNA MSC-AS1 facilitates the proliferation and glycolysis of gastric cancer cells by regulating PFKFB3 expression.
Neoplasms
Long non-coding RNA MYOSLID functions as a competing endogenous RNA to regulate MCL-1 expression by sponging miR-29c-3p in gastric cancer.
Neoplasms
Long non-coding RNA OTUD6B-AS1 overexpression inhibits the proliferation, invasion and migration of colorectal cancer cells via downregulation of microRNA-3171.
Neoplasms
Long Non-Coding RNA PANTR1 is Associated with Poor Prognosis and Influences Angiogenesis and Apoptosis in Clear-Cell Renal Cell Cancer.
Neoplasms
Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer.
Neoplasms
Long Non-Coding RNA Profile Study Identifies an Immune-Related lncRNA Prognostic Signature for Kidney Renal Clear Cell Carcinoma.
Neoplasms
Long non-coding RNA profiling links subgroup classification of endometrioid endometrial carcinomas with trithorax and polycomb complex aberrations.
Neoplasms
Long Non-coding RNA RP11-480I12.5 Promotes the Proliferation, Migration, and Invasion of Breast Cancer Cells Through the miR-490-3p-AURKA-Wnt/?-Catenin Axis.
Neoplasms
Long Non-Coding RNA SH3PXD2A-AS1 Promotes Cell Progression Partly Through Epigenetic Silencing P57 and KLF2 in Colorectal Cancer.
Neoplasms
Long non-coding RNA SLC25A25-AS1 exhibits oncogenic roles in non-small cell lung cancer by regulating the microRNA-195-5p/ITGA2 axis.
Neoplasms
Long non-coding RNA small nucleolar RNA host gene 7 is upregulated and promotes cell proliferation in thyroid cancer.
Neoplasms
Long Non-coding RNA SNHG12 Functions as a Competing Endogenous RNA to Regulate MDM4 Expression by Sponging miR-129-5p in Clear Cell Renal Cell Carcinoma.
Neoplasms
Long Non-Coding RNA SNHG14 Impedes Viability, Migration and Invasion of Endometrial Carcinoma Cells Through Modulating miR-93-5p/ZBTB7A Axis.
Neoplasms
Long non-coding RNA SNHG15 in various cancers: a meta and bioinformatic analysis.
Neoplasms
Long non-coding RNA SNHG15 interacts with and stabilizes transcription factor Slug and promotes colon cancer progression.
Neoplasms
Long non-coding RNA SNHG16 as a potential biomarker in hepatocellular carcinoma: A meta-analysis.
Neoplasms
Long non-coding RNA SNHG6 is upregulated in prostate cancer and predicts poor prognosis.
Neoplasms
Long non-coding RNA SNHG8 promotes autophagy as a ceRNA to upregulate ATG7 by sponging microRNA-588 in colorectal cancer.
Neoplasms
Long non-coding RNA TCL6 enhances preferential toxicity of paclitaxel to renal cell carcinoma cells.
Neoplasms
Long Non-coding RNA TMEM220-AS1 Suppressed Hepatocellular Carcinoma by Regulating the miR-484/MAGI1 Axis as a Competing Endogenous RNA.
Neoplasms
Long non-coding RNA TP73-AS1 is a potential immune related prognostic biomarker for glioma.
Neoplasms
Long Non-Coding RNA TUG1 Expression Is Associated with Different Subtypes in Human Breast Cancer.
Neoplasms
Long Non-Coding RNA UBA6-AS1 Promotes the Malignant Properties of Glioblastoma by Competitively Binding to microRNA-760 and Enhancing Homeobox A2 Expression.
Neoplasms
Long non-coding RNA USP30-AS1 aggravates the malignant progression of cervical cancer by sequestering microRNA-299-3p and thereby overexpressing PTP4A1.
Neoplasms
Long non-coding RNA WT1-AS inhibits cell aggressiveness via miR-203a-5p/FOXN2 axis and is associated with prognosis in cervical cancer.
Neoplasms
Long non-coding RNA, HOTAIRM1, promotes glioma malignancy by forming a ceRNA network.
Neoplasms
Long non-coding RNA-based signature for predicting prognosis of hepatocellular carcinoma.
Neoplasms
Long non-coding RNA-based signatures to improve prognostic prediction of breast cancer.
Neoplasms
Long non-coding RNA-HAGLR suppressed tumor growth of lung adenocarcinoma through epigenetically silencing E2F1.
Neoplasms
Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosis.
Neoplasms
Long non-coding RNAs may serve as biomarkers in breast cancer combined with primary lung cancer.
Neoplasms
Long non-coding RNAs RP5-821D11.7, APCDD1L-AS1 and RP11-277P12.9 were associated with the prognosis of lung squamous cell carcinoma.
Neoplasms
Long non?coding RNA DLEU1 promotes cell proliferation of glioblastoma multiforme.
Neoplasms
Long non?coding RNA HOTTIP promotes hepatocellular carcinoma tumorigenesis and development: A comprehensive investigation based on bioinformatics, qRT?PCR and meta?analysis of 393 cases.
Neoplasms
Long non?coding RNA JPX promotes gastric cancer progression by regulating CXCR6 and autophagy via inhibiting miR?197.
Neoplasms
Long non?coding RNA MLK7?AS1 promotes proliferation in human colorectal cancer via downregulation of p21 expression.
Neoplasms
Long non?coding RNA SNHG1 promotes breast cancer progression by regulation of LMO4.
Neoplasms
Long non?coding RNA ZSCAN16?AS1 promotes the malignant properties of hepatocellular carcinoma by decoying microRNA?451a and consequently increasing ATF2 expression.
Neoplasms
Long non?coding RNA?based risk scoring system predicts prognosis of alcohol?related hepatocellular carcinoma.
Neoplasms
Long noncoding RNA ABHD11-AS1 functions as a competing endogenous RNA to regulate papillary thyroid cancer progression by miR-199a-5p/SLC1A5 axis.
Neoplasms
Long noncoding RNA ALOX12-AS1 inhibits cervical cancer cells proliferation via targeting miR-3171.
Neoplasms
Long Noncoding RNA ASB16-AS1 Promotes Proliferation, Migration, and Invasion in Glioma Cells.
Neoplasms
Long noncoding RNA DDX11-AS1 induced by YY1 accelerates colorectal cancer progression through targeting miR-873/CLDN7 axis.
Neoplasms
Long noncoding RNA DLEU2 predicts a poor prognosis and enhances malignant properties in laryngeal squamous cell carcinoma through the miR-30c-5p/PIK3CD/Akt axis.
Neoplasms
Long noncoding RNA expression signature to predict platinum-based chemotherapeutic sensitivity of ovarian cancer patients.
Neoplasms
Long noncoding RNA FOXD3-AS1 promotes colon adenocarcinoma progression and functions as a competing endogenous RNA to regulate SIRT1 by sponging miR-135a-5p.
Neoplasms
Long noncoding RNA H19 participates in metformin-mediated inhibition of gastric cancer cell invasion.
Neoplasms
Long noncoding RNA HCG22 suppresses proliferation and metastasis of bladder cancer cells by regulation of PTBP1.
Neoplasms
Long noncoding RNA HCP5 suppresses skin cutaneous melanoma development by regulating RARRES3 gene expression via sponging miR-12.
Neoplasms
Long Noncoding RNA HOTTIP Serves as an Independent Predictive Biomarker for the Prognosis of Patients with Clear Cell Renal Cell Carcinoma.
Neoplasms
Long noncoding RNA HOXC13-AS positively affects cell proliferation and invasion in nasopharyngeal carcinoma via modulating miR-383-3p/HMGA2 axis.
Neoplasms
Long noncoding RNA HOXD-AS1 in various cancers: a meta-analysis and TCGA data review.
Neoplasms
Long noncoding RNA KTN1 antisense RNA 1exerts an oncogenic function in lung adenocarcinoma by regulating DEP domain containing 1 expression via activating epithelial-mesenchymal transition.
Neoplasms
Long Noncoding RNA LINC-PINT Suppresses Cell Proliferation, Invasion, and EMT by Blocking Wnt/?-Catenin Signaling in Glioblastoma.
Neoplasms
Long noncoding RNA LINC00173 is downregulated in cervical cancer and inhibits cell proliferation and invasion by modulating the miR-182-5p/FBXW7 axis.
Neoplasms
Long Noncoding RNA LINC00265 Targets EGFR and Promotes Deterioration of Colorectal Cancer: A Comprehensive Study Based on Data Mining and in vitro Validation.
Neoplasms
Long noncoding RNA LINC00284 facilitates cell proliferation in papillary thyroid cancer via impairing miR-3127-5p targeted E2F7 suppression.
Neoplasms
Long noncoding RNA Linc00339 promotes triple-negative breast cancer progression through miR-377-3p/HOXC6 signaling pathway.
Neoplasms
Long noncoding RNA LINC00518 acts as a competing endogenous RNA to promote the metastasis of malignant melanoma via miR-204-5p/AP1S2 axis.
Neoplasms
Long noncoding RNA LINC00958 regulates cell sensitivity to radiotherapy through RRM2 by binding to microRNA-5095 in cervical cancer.
Neoplasms
Long Noncoding RNA LINC01134 Promotes Hepatocellular Carcinoma Metastasis via Activating AKT1S1 and NF-?B Signaling.
Neoplasms
Long noncoding RNA LINC01234 promotes serine hydroxymethyltransferase 2 expression and proliferation by competitively binding miR-642a-5p in colon cancer.
Neoplasms
Long noncoding RNA LINC01291 promotes the aggressive properties of melanoma by functioning as a competing endogenous RNA for microRNA-625-5p and subsequently increasing IGF-1R expression.
Neoplasms
Long noncoding RNA LINC01426 promotes glioma progression through PI3K/AKT signaling pathway and serves as a prognostic biomarker.
Neoplasms
Long noncoding RNA LINC02418 regulates MELK expression by acting as a ceRNA and may serve as a diagnostic marker for colorectal cancer.
Neoplasms
Long Noncoding RNA LIPE-AS1 Drives Prostate Cancer Progression by Functioning as a Competing Endogenous RNA for microRNA-654-3p and Thereby Upregulating Hepatoma-Derived Growth Factor.
Neoplasms
Long noncoding RNA lung cancer associated transcript 1 promotes proliferation and invasion of clear cell renal cell carcinoma cells by negatively regulating miR-495-3p.
Neoplasms
Long noncoding RNA MAFG-AS1 promotes proliferation, migration and invasion of hepatocellular carcinoma cells through downregulation of miR-6852.
Neoplasms
Long noncoding RNA MEG3 play an important role in osteosarcoma development through sponging microRNAs.
Neoplasms
Long noncoding RNA MGC27382 inhibits proliferation and metastasis of non-small cell lung cancer cells via down-regulating AKT/GSK3? pathway.
Neoplasms
Long Noncoding RNA MIR210HG Promotes the Warburg Effect and Tumor Growth by Enhancing HIF-1? Translation in Triple-Negative Breast Cancer.
Neoplasms
Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma.
Neoplasms
Long noncoding RNA NALT1-induced gastric cancer invasion and metastasis via NOTCH signaling pathway.
Neoplasms
Long noncoding RNA PCA3 regulates prostate cancer through sponging miR-218-5p and modulating high mobility group box 1.
Neoplasms
Long noncoding RNA POU6F2-AS1 regulates lung cancer aggressiveness through sponging miR-34c-5p to modulate KCNJ4 expression.
Neoplasms
Long noncoding RNA PVT1 inhibits renal cancer cell apoptosis by up-regulating Mcl-1.
Neoplasms
Long Noncoding RNA RP11-334E6.12 Promotes the Proliferation, Migration and Invasion of Breast Cancer Cells Through the EMT Pathway by Activating the STAT3 Cascade.
Neoplasms
Long Noncoding RNA RP11-357H14.17 Plays an Oncogene Role in Gastric Cancer by Activating ATF2 Signaling and Enhancing Treg Cells.
Neoplasms
Long noncoding RNA RP11-547D24.1 regulates proliferation and migration in papillary thyroid carcinoma: Identification and validation of a novel long noncoding RNA through integrated analysis of TCGA database.
Neoplasms
Long Noncoding RNA SBF2-AS1 Is Critical for Tumorigenesis of Early-Stage Lung Adenocarcinoma.
Neoplasms
Long Noncoding RNA SNHG10 Sponges miR-543 to Upregulate Tumor Suppressive SIRT1 in Nonsmall Cell Lung Cancer.
Neoplasms
Long noncoding RNA SNHG12 indicates the prognosis of prostate cancer and accelerates tumorigenesis via sponging miR-133b.
Neoplasms
Long noncoding RNA SNHG12 suppresses esophageal squamous cell carcinoma progression through competing endogenous RNA networks.
Neoplasms
Long noncoding RNA SNHG6 promotes carcinogenesis by enhancing YBX1-mediated translation of HIF1? in clear cell renal cell carcinoma.
Neoplasms
Long noncoding RNA TRPM2-AS acts as a microRNA sponge of miR-612 to promote gastric cancer progression and radioresistance.
Neoplasms
Long Noncoding RNA TTC39A-AS1 Promotes Breast Cancer Tumorigenicity by Sponging MicroRNA-483-3p and Thereby Upregulating MTA2.
Neoplasms
Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
Neoplasms
Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
Neoplasms
Long noncoding RNA, LINC00460, as a prognostic biomarker in head and neck squamous cell carcinoma (HNSCC).
Neoplasms
Long Noncoding RNAs Control the Modulation of Immune Checkpoint Molecules in Cancer.
Neoplasms
Long-chain non-coding RNA LINC01554 promotes NGFR expression and inhibits cell proliferation, migration, and invasion in hepatocellular carcinoma by binding to microRNA-3681-3p.
Neoplasms
Long-chain noncoding ribonucleic acids affect the survival and prognosis of patients with esophageal adenocarcinoma through the autophagy pathway: construction of a prognostic model.
Neoplasms
Long-Noncoding RNA FGD5-AS1 Enhances the Viability, Migration, and Invasion of Glioblastoma Cells by Regulating the miR-103a-3p/TPD52 Axis.
Neoplasms
Long-term Realism and Cost-effectiveness: Primary Prevention in Combatting Cancer and Associated Inequalities Worldwide.
Neoplasms
Long-term Survival and Clinical Benefit from Adoptive T-cell Transfer in Stage IV Melanoma Patients Is Determined by a Four-Parameter Tumor Immune Signature.
Neoplasms
Longer genotypically-estimated leukocyte telomere length is associated with increased adult glioma risk.
Neoplasms
Longitudinal Analysis of Gene Expression Changes During Cervical Carcinogenesis Reveals Potential Therapeutic Targets.
Neoplasms
Longitudinal Analysis of Human Pancreatic Adenocarcinoma Development Reveals Transient Gene Expression Signatures.
Neoplasms
Longitudinal assessment of tumor development using cancer avatars derived from genetically engineered pluripotent stem cells.
Neoplasms
Longitudinal detection of somatic mutations in saliva and plasma for the surveillance of oral squamous cell carcinomas.
Neoplasms
Loss of ALDH1A1 expression is an early event in the pathogenesis of ovarian high-grade serous carcinoma.
Neoplasms
Loss of amphiregulin reduces myoepithelial cell coverage of mammary ducts and alters breast tumor growth.
Neoplasms
Loss of ARID1A Expression is Related to Gastric Cancer Progression, Epstein-Barr Virus Infection, and Mismatch Repair Deficiency.
Neoplasms
Loss of BAP1 Results in Growth Inhibition and Enhances Mesenchymal-Epithelial Transition in Kidney Tumor Cells.
Neoplasms
Loss of CDKN1A mRNA and Protein Expression Are Independent Predictors of Poor Outcome in Chromophobe Renal Cell Carcinoma Patients.
Neoplasms
Loss of CDKN2A and CDKN2B expression is associated with disease recurrence in oral cancer.
Neoplasms
Loss of CDKN2A at chromosome 9 has a poor clinical prognosis and promotes lung cancer progression.
Neoplasms
Loss of COPZ1 induces NCOA4 mediated autophagy and ferroptosis in glioblastoma cell lines.
Neoplasms
Loss of Estrogen Receptors is Associated with Increased Tumor Aggression in Laryngeal Squamous Cell Carcinoma.
Neoplasms
Loss of estrogen-regulated microRNA expression increases HER2 signaling and is prognostic of poor outcome in luminal breast cancer.
Neoplasms
Loss of Expression of a Novel Chromatin Remodeler SMARCA1 in Soft Tissue Sarcoma.
Neoplasms
Loss of FGL1 induces epithelial?mesenchymal transition and angiogenesis in LKB1 mutant lung adenocarcinoma.
Neoplasms
Loss of FOXA1 Drives Sexually Dimorphic Changes in Urothelial Differentiation and Is an Independent Predictor of Poor Prognosis in Bladder Cancer.
Neoplasms
Loss of function JAK1 mutations occur at high frequency in cancers with microsatellite instability and are suggestive of immune evasion.
Neoplasms
Loss of HIF1A From Pancreatic Cancer Cells Increases Expression of PPP1R1B and Degradation of p53 to Promote Invasion and Metastasis.
Neoplasms
Loss of histone H3 lysine 36 trimethylation is associated with an increased risk of renal cell carcinoma-specific death.
Neoplasms
Loss of Integrase Interactor 1 (INI1) Expression in a Subset of Differentiated Thyroid Cancer.
Neoplasms
Loss of MAP3K7 Sensitizes Prostate Cancer Cells to CDK1/2 Inhibition and DNA Damage by Disrupting Homologous Recombination.
Neoplasms
Loss of microRNA-21 leads to profound stromal remodeling and short survival in K-Ras-driven mouse models of pancreatic cancer.
Neoplasms
Loss of MLH1 confers resistance to PI3K? inhibitors in renal clear cell carcinoma with SETD2 mutation.
Neoplasms
Loss of progesterone receptor through epigenetic regulation is associated with poor prognosis in solid tumors.
Neoplasms
Loss of SETD2, but not H3K36me3, correlates with aggressive clinicopathological features of clear cell renal cell carcinoma patients.
Neoplasms
Loss of Trop2 causes ErbB3 activation through a neuregulin-1-dependent mechanism in the mesenchymal subtype of HNSCC.
Neoplasms
Loss of TXNIP enhances peritoneal metastasis and can be abrogated by dual TORC1/2 inhibition.
Neoplasms
Loss of ZG16 is associated with molecular and clinicopathological phenotypes of colorectal cancer.
Neoplasms
Loss of ZG16 is regulated by miR-196a and contributes to stemness and progression of colorectal cancer.
Neoplasms
Loss-of-Function Genetic Screening Identifies Aldolase A as an Essential Driver for Liver Cancer Cell Growth Under Hypoxia.
Neoplasms
Loss-of-Function PTPRD Mutations Lead to Increased STAT3 Activation and Sensitivity to STAT3 Inhibition in Head and Neck Cancer.
Neoplasms
Low ARID1A Expression is Associated with Poor Prognosis in Hepatocellular Carcinoma.
Neoplasms
Low CBS expression can identify patients who benefit from adjuvant chemotherapy in gastric cancer.
Neoplasms
Low CFB expression is independently associated with poor overall and disease-free survival in patients with lung adenocarcinoma.
Neoplasms
Low DMT1 Expression Associates With Increased Oxidative Phosphorylation and Early Recurrence in Hepatocellular Carcinoma.
Neoplasms
Low Expression Levels of SLC22A12 Indicates a Poor Prognosis and Progresses Clear Cell Renal Cell Carcinoma.
Neoplasms
Low expression of A-kinase anchor protein 5 predicts poor prognosis in non-mucin producing stomach adenocarcinoma based on TCGA data.
Neoplasms
Low Expression of APOB mRNA or Its Hypermethylation Predicts Favorable Overall Survival in Patients with Low-Grade Glioma.
Neoplasms
Low expression of CDHR1 is an independent unfavorable prognostic factor in glioma.
Neoplasms
Low expression of CHRDL1 and SPARCL1 predicts poor prognosis of lung adenocarcinoma based on comprehensive analysis and immunohistochemical validation.
Neoplasms
Low expression of developing brain homeobox 2 (Dbx2) may serve as a biomarker to predict poor prognosis in endometrial cancer.
Neoplasms
Low expression of ferritinophagy-related NCOA4 gene in relation to unfavorable outcome and defective immune cells infiltration in clear cell renal carcinoma.
Neoplasms
Low expression of ITIH5 in adenocarcinoma of the lung is associated with unfavorable patients' outcome.
Neoplasms
Low expression of LACTB promotes tumor progression and predicts poor prognosis in hepatocellular carcinoma.
Neoplasms
Low expression of long noncoding RNA CTC-297N7.9 predicts poor prognosis in patients with hepatocellular carcinoma.
Neoplasms
Low expression of microRNA-1908 predicts a poor prognosis for patients with ovarian cancer.
Neoplasms
Low expression of miR-125a-5p is associated with poor prognosis in patients with gastric cancer.
Neoplasms
Low Expression of miR-375 and miR-190b Differentiates Grade 3 Patients with Endometrial Cancer.
Neoplasms
Low expression of NSD1, NSD2, and NSD3 define a subset of human papillomavirus-positive oral squamous carcinomas with unfavorable prognosis.
Neoplasms
Low expression of pro-apoptotic proteins Bax, Bak and Smac indicates prolonged progression-free survival in chemotherapy-treated metastatic melanoma.
Neoplasms
Low expression of RGL4 is associated with a poor prognosis and immune infiltration in lung adenocarcinoma patients.
Neoplasms
Low Expression of RILPL2 Predicts Poor Prognosis and Correlates With Immune Infiltration in Endometrial Carcinoma.
Neoplasms
Low expression of ryanodine receptor 2 is associated with poor prognosis in thyroid carcinoma.
Neoplasms
Low expression of the androgen-induced tumor suppressor gene PLZF and lethal prostate cancer.
Neoplasms
Low expression of VSIG4 is associated with poor prognosis in hepatocellular carcinoma patients with hepatitis B infection.
Neoplasms
Low expression of WWC1, a tumor suppressor gene, is associated with aggressive breast cancer and poor survival outcome.
Neoplasms
Low expression or hypermethylation of PLK2 might predict favorable prognosis for patients with glioblastoma multiforme.
Neoplasms
Low intratumor heterogeneity correlates with increased response to PD-1 blockade in renal cell carcinoma.
Neoplasms
Low junctional adhesion molecule-A expression is associated with an epithelial to mesenchymal transition and poorer outcomes in high-grade serous carcinoma of uterine adnexa.
Neoplasms
Low KRT15 expression is associated with poor prognosis in patients with breast invasive carcinoma.
Neoplasms
Low level of Cyclin-D1 correlates with worse prognosis of clear cell renal cell carcinoma patients.
Neoplasms
Low Mast Cell Density Predicts Poor Prognosis in Oral Squamous Cell Carcinoma and Reduces Survival in Head and Neck Squamous Cell Carcinoma.
Neoplasms
Low metallothionein 1M (MT1M) is associated with thyroid cancer cell lines progression.
Neoplasms
Low microRNA-139 expression associates with poor prognosis in patients with tumors: A meta-analysis.
Neoplasms
Low microRNA150 expression is associated with activated carcinogenic pathways and a poor prognosis in patients with breast cancer.
Neoplasms
Low mutation burden and differential tumor-infiltrating immune cells correlate with lymph node metastasis in colorectal cancer.
Neoplasms
Low Mutation Burden in Ovarian Cancer May Limit the Utility of Neoantigen-Targeted Vaccines.
Neoplasms
Low neighbor of Brca1 gene expression predicts poor clinical outcome and resistance of sunitinib in clear cell renal cell carcinoma.
Neoplasms
Low NR3C2 levels correlate with aggressive features and poor prognosis in non-distant metastatic clear-cell renal cell carcinoma.
Neoplasms
Low-dose mono(2-ethylhexyl) phthalate promotes ovarian cancer development through PPAR?-dependent PI3K/Akt/NF-?B pathway.
Neoplasms
Low-Level Expression of MTUS1 Is Associated with Poor Survival in Patients with Lung Adenocarcinoma.
Neoplasms
Lower DSC1 expression is related to the poor differentiation and prognosis of head and neck squamous cell carcinoma (HNSCC).
Neoplasms
Lower expression of LINC00092 in lung adenocarcinoma might mean poorer prognosis: A study based on data mining and bioinformatics.
Neoplasms
Lower frequency of TLR9 variant associated with protection from breast cancer among African Americans.
Neoplasms
Lower Levels of Adiponectin and Its Receptor Adipor1 in the Uveal Melanomas With Monosomy-3.
Neoplasms
Lower mutant-allele tumor heterogeneity is a biomarker in FGFR3-mutant bladder cancer for better prognosis.
Neoplasms
Lowly methylated region analysis identifies EBF1 as a potential epigenetic modifier in breast cancer.
Neoplasms
LOXL2 Expression Status Is Correlated With Molecular Characterizations of Cervical Carcinoma and Associated With Poor Cancer Survival via Epithelial-Mesenchymal Transition (EMT) Phenotype.
Neoplasms
LPAR1, Correlated With Immune Infiltrates, Is a Potential Prognostic Biomarker in Prostate Cancer.
Neoplasms
LPAR5 promotes thyroid carcinoma cell proliferation and migration by activating class IA PI3K catalytic subunit p110?.
Neoplasms
LPRP: A Gene-Gene Interaction Network Construction Algorithm and Its Application in Breast Cancer Data Analysis.
Neoplasms
LRP4 promotes proliferation, migration, and invasion in papillary thyroid cancer.
Neoplasms
LRRC17 Is Linked to Prognosis of Ovarian Cancer Through a p53-dependent Anti-apoptotic Function.
Neoplasms
LRRC19-A Bridge between Selenium Adjuvant Therapy and Renal Clear Cell Carcinoma: A Study Based on Datamining.
Neoplasms
LRRC52-AS1 is associated with clinical progression and regulates cell migration and invasion in papillary thyroid cancer.
Neoplasms
LSD1 and Aberrant DNA Methylation Mediate Persistence of Enteroendocrine Progenitors That Support BRAF-Mutant Colorectal Cancer.
Neoplasms
LSD1 dual function in mediating epigenetic corruption of the vitamin D signaling in prostate cancer.
Neoplasms
LUAD transcriptomic profile analysis of d-limonene and potential lncRNA chemopreventive target.
Neoplasms
LUADpp: an effective prediction model on prognosis of lung adenocarcinomas based on somatic mutational features.
Neoplasms
Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune Landscape.
Neoplasms
Lung adenocarcinoma patients with KEAP1 mutation harboring low immune cell infiltration and low activity of immune environment.
Neoplasms
Lung Master Protocol (Lung-MAP)-A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400.
Neoplasms
Lung tumorspheres reveal cancer stem cell-like properties and a score with prognostic impact in resected non-small-cell lung cancer.
Neoplasms
LYL1 gene amplification predicts poor survival of patients with uterine corpus endometrial carcinoma: analysis of the Cancer genome atlas data.
Neoplasms
Lymph node metastasis in lung squamous cell carcinoma and identification of metastasis-related genes based on the Cancer Genome Atlas.
Neoplasms
Lymphocyte-specific kinase expression is a prognostic indicator in ovarian cancer and correlates with a prominent B cell transcriptional signature.
Neoplasms
Lymphotoxin-? receptor-NIK signaling induces alternative RELB/NF-?B2 activation to promote metastatic gene expression and cell migration in head and neck cancer.
Neoplasms
Lymphovascular invasion in breast cancer is associated with gene expression signatures of cell proliferation but not lymphangiogenesis or immune response.
Neoplasms
LYN-activating mutations mediate antiestrogen resistance in estrogen receptor-positive breast cancer.
Neoplasms
Lysyl oxidase assists tumor?initiating cells to enhance angiogenesis in hepatocellular carcinoma.
Neoplasms
Lysyl Oxidase Is a Key Player in BRAF/MAPK Pathway-Driven Thyroid Cancer Aggressiveness.
Neoplasms
LZAP promotes the proliferation and invasiveness of cervical carcinoma cells by targeting AKT and EMT.
Neoplasms
M1 Polarization Markers Are Upregulated in Basal-Like Breast Cancer Molecular Subtype and Associated With Favorable Patient Outcome.
Neoplasms
M2 subtype tumor associated macrophages (M2-TAMs) infiltration predicts poor response rate of immune checkpoint inhibitors treatment for prostate cancer.
Neoplasms
m5C RNA Methylation Regulators Predict Prognosis and Regulate the Immune Microenvironment in Lung Squamous Cell Carcinoma.
Neoplasms
m6A demethylase FTO facilitates tumor progression in lung squamous cell carcinoma by regulating MZF1 expression.
Neoplasms
m6A Reader HNRNPA2B1 Promotes Esophageal Cancer Progression via Up-Regulation of ACLY and ACC1.
Neoplasms
m6A regulators are associated with osteosarcoma metastasis and have prognostic significance: A study based on public databases.
Neoplasms
m6A RNA Methylation Regulator YTHDF1 Correlated With Immune Microenvironment Predicts Clinical Outcomes and Therapeutic Efficacy in Breast Cancer.
Neoplasms
m6A RNA methylation regulators can contribute to malignant progression and impact the prognosis of bladder cancer.
Neoplasms
m6A RNA Methylation Regulators Elicit Malignant Progression and Predict Clinical Outcome in Hepatocellular Carcinoma.
Neoplasms
m6A RNA methylation regulators have prognostic value in papillary thyroid carcinoma.
Neoplasms
m6A RNA Methylation Regulators Impact Prognosis and Tumor Microenvironment in Renal Papillary Cell Carcinoma.
Neoplasms
m6A RNA Methylation Regulators Participate in the Malignant Progression and Have Clinical Prognostic Value in Lung Adenocarcinoma.
Neoplasms
m6A RNA methylation regulators play an important role in the prognosis of patients with testicular germ cell tumor.
Neoplasms
m6A RNA modification modulates PI3K/Akt/mTOR signal pathway in Gastrointestinal Cancer.
Neoplasms
M6A-related bioinformatics analysis reveals that HNRNPC facilitates progression of OSCC via EMT.
Neoplasms
Machine learning analysis identifies genes differentiating triple negative breast cancers.
Neoplasms
Machine learning analysis of gene expression data reveals novel diagnostic and prognostic biomarkers and identifies therapeutic targets for soft tissue sarcomas.
Neoplasms
Machine learning and bioinformatics models to identify gene expression patterns of ovarian cancer associated with disease progression and mortality.
Neoplasms
Machine Learning and Network Analyses Reveal Disease Subtypes of Pancreatic Cancer and their Molecular Characteristics.
Neoplasms
Machine learning and network-based models to identify genetic risk factors to the progression and survival of colorectal cancer.
Neoplasms
Machine learning and radiomic phenotyping of lower grade gliomas: improving survival prediction.
Neoplasms
Machine Learning Approaches to Classify Primary and Metastatic Cancers Using Tissue of Origin-Based DNA Methylation Profiles.
Neoplasms
Machine learning approaches to decipher hormone and HER2 receptor status phenotypes in breast cancer.
Neoplasms
Machine Learning Classification and Structure-Functional Analysis of Cancer Mutations Reveal Unique Dynamic and Network Signatures of Driver Sites in Oncogenes and Tumor Suppressor Genes.
Neoplasms
Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas.
Neoplasms
Machine Learning for Better Prognostic Stratification and Driver Gene Identification Using Somatic Copy Number Variations in Anaplastic Oligodendroglioma.
Neoplasms
Machine Learning for Building Immune Genetic Model in Hepatocellular Carcinoma Patients.
Neoplasms
Machine Learning Identifies Robust Matrisome Markers and Regulatory Mechanisms in Cancer.
Neoplasms
Machine Learning Models to Predict Primary Sites of Metastatic Cervical Carcinoma From Unknown Primary.
Neoplasms
Machine learning revealed stemness features and a novel stemness-based classification with appealing implications in discriminating the prognosis, immunotherapy and temozolomide responses of 906 glioblastoma patients.
Neoplasms
Machine Learning Supports Long Noncoding RNAs as Expression Markers for Endometrial Carcinoma.
Neoplasms
Machine learning workflows to estimate class probabilities for precision cancer diagnostics on DNA methylation microarray data.
Neoplasms
Machine-based morphologic analysis of glioblastoma using whole-slide pathology images uncovers clinically relevant molecular correlates.
Neoplasms
Machine-Learning Prediction of Tumor Antigen Immunogenicity in the Selection of Therapeutic Epitopes.
Neoplasms
Macrophage migration inhibitory factor (MIF) inhibitor 4-IPP downregulates stemness phenotype and mesenchymal trans-differentiation after irradiation in glioblastoma multiforme.
Neoplasms
MAFG-AS1 is a novel clinical biomarker for clinical progression and unfavorable prognosis in gastric cancer.
Neoplasms
MAGE-A11 Expression Predicts Patient Prognosis in Head and Neck Squamous Cell Carcinoma.
Neoplasms
MAGE-A3 is a Clinically Relevant Target in Undifferentiated Pleomorphic Sarcoma/Myxofibrosarcoma.
Neoplasms
MAGEC2 Correlates With Unfavorable Prognosis And Promotes Tumor Development In HCC Via Epithelial-Mesenchymal Transition.
Neoplasms
MAGI-2 downregulation: a potential predictor of tumor progression and early recurrence in Han Chinese patients with prostate cancer.
Neoplasms
Magnetic Resonance Features of Lower-grade Gliomas in Prediction of the Reverse Phase Protein A.
Neoplasms
Magnetic resonance image features identify glioblastoma phenotypic subtypes with distinct molecular pathway activities.
Neoplasms
Magnetic resonance imaging and molecular features associated with tumor-infiltrating lymphocytes in breast cancer.
Neoplasms
Magnetic resonance imaging-based radiomic features for extrapolating infiltration levels of immune cells in lower-grade gliomas.
Neoplasms
Major Contribution of Caspase-9 to Honokiol-Induced Apoptotic Insults to Human Drug-Resistant Glioblastoma Cells.
Neoplasms
MAL2 promotes proliferation, migration, and invasion through regulating epithelial-mesenchymal transition in breast cancer cell lines.
Neoplasms
Malignancy in Pheochromocytoma or Paraganglioma: Integrative Analysis of 176 Cases in TCGA.
Neoplasms
Malignant Evaluation and Clinical Prognostic Values of M6A RNA Methylation Regulators in Prostate Cancer.
Neoplasms
Mammaglobin B may be a prognostic biomarker of uterine corpus endometrial cancer.
Neoplasms
Mammary cell gene expression atlas links epithelial cell remodeling events to breast carcinogenesis.
Neoplasms
Mammary epithelial morphogenesis and early breast cancer. Evidence of involvement of basal components of the RNA Polymerase I transcription machinery.
Neoplasms
MAN1B1 is associated with poor prognosis and modulates proliferation and apoptosis in bladder cancer.
Neoplasms
Manganese Superoxide Dismutase Expression Regulates the Switch Between an Epithelial and a Mesenchymal-Like Phenotype in Breast Carcinoma.
Neoplasms
MAP2K1 Mutations in Advanced Colorectal Cancer Predict Poor Response to Anti-EGFR Therapy and to Vertical Targeting of MAPK Pathway.
Neoplasms
MAPK Activation Predicts Poor Outcome and the MEK Inhibitor, Selumetinib, Reverses Antiestrogen Resistance in ER-Positive High-Grade Serous Ovarian Cancer.
Neoplasms
MAPK-RAP1A Signaling Enriched in Hepatocellular Carcinoma Is Associated With Favorable Tumor-Infiltrating Immune Cells and Clinical Prognosis.
Neoplasms
MAPK4 overexpression promotes tumor progression via noncanonical activation of AKT/mTOR signaling.
Neoplasms
MAPK4 silencing together with a PARP1 inhibitor as a combination therapy in triple?negative breast cancer cells.
Neoplasms
Mapping a functional cancer genome atlas of tumor suppressors in mouse liver using AAV-CRISPR-mediated direct in vivo screening.
Neoplasms
Mapping Driver Mutations to Histopathological Subtypes in Papillary Thyroid Carcinoma: Applying a Deep Convolutional Neural Network.
Neoplasms
Mapping in epidemiological studies and control of cancer: experiences from Slovakia.
Neoplasms
Mapping the Germline and Somatic Mutation Interaction Landscape in Indolent and Aggressive Prostate Cancers.
Neoplasms
Maps and atlases of cancer mortality: a review of a useful tool to trigger new questions.
Neoplasms
MAPT (Tau) expression is a biomarker for an increased rate of survival for low?grade glioma.
Neoplasms
MAPT (Tau) expression is a biomarker for an increased rate of survival in pediatric neuroblastoma.
Neoplasms
MARCH8 Suppresses Tumor Metastasis and Mediates Degradation of STAT3 and CD44 in Breast Cancer Cells.
Neoplasms
MARCKS contributes to stromal cancer-associated fibroblast activation and facilitates ovarian cancer metastasis.
Neoplasms
MARCKS on Tumor-Associated Macrophages is Correlated with Immune Infiltrates and Poor Prognosis in Hepatocellular Carcinoma.
Neoplasms
Marked Global DNA Hypomethylation Is Associated with Constitutive PD-L1 Expression in Melanoma.
Neoplasms
Markers of the p53 pathway further refine molecular profiling in high-risk endometrial cancer: A TransPORTEC initiative.
Neoplasms
Martrilin-3 (MATN3) Overexpression in Gastric Adenocarcinoma and its Prognostic Significance.
Neoplasms
Mass spectrometric analysis of SOX11-binding proteins in head and neck cancer cells demonstrates the interaction of SOX11 and HSP90?.
Neoplasms
Massive computational identification of somatic variants in exonic splicing enhancers using The Cancer Genome Atlas.
Neoplasms
Massively parallel sequencing analysis of 68 gastric-type cervical adenocarcinomas reveals mutations in cell cycle-related genes and potentially targetable mutations.
Neoplasms
Mastermind Like Transcriptional Coactivator 3 (MAML3) Drives Neuroendocrine Tumor Progression.
Neoplasms
Maternal embryonic leucine zipper kinase: A novel biomarker and a potential therapeutic target in lung adenocarcinoma.
Neoplasms
Matrix-metalloproteinases in head and neck carcinoma-cancer genome atlas analysis and fluorescence imaging in mice.
Neoplasms
MBD3/NuRD loss participates with KDM6A program to promote DOCK5/8 expression and Rac GTPase activation in human acute myeloid leukemia.
Neoplasms
MCAM abnormal expression and clinical outcome associations are highly cancer dependent as revealed through pan-cancer analysis.
Neoplasms
MCM2 and NUSAP1 Are Potential Biomarkers for the Diagnosis and Prognosis of Pancreatic Cancer.
Neoplasms
MCM2-regulated functional networks in lung cancer by multi-dimensional proteomic approach.
Neoplasms
MCM6 promotes metastasis of hepatocellular carcinoma via MEK/ERK pathway and serves as a novel serum biomarker for early recurrence.
Neoplasms
MCMC implementation of the optimal Bayesian classifier for non-Gaussian models: model-based RNA-Seq classification.
Neoplasms
MCTS1 Directly Binds to TWF1 and Synergistically Modulate Cyclin D1 and C-Myc Translation in Luminal A/B Breast Cancer Cells.
Neoplasms
MDEHT: a Multivariate Approach for Detecting Differential Expression of MicroRNA Isoform Data in RNA Sequencing Studies.
Neoplasms
MDM2 gene amplification as selection tool for innovative targeted approaches in PD-L1 positive or negative muscle-invasive urothelial bladder carcinoma.
Neoplasms
Mechanism of Fuzheng Kang'ai Formula () Regulating Tumor Microenvironment in Non-Small Cell Lung Cancer.
Neoplasms
Mechanism- and Immune Landscape-Based Ranking of Therapeutic Responsiveness of 22 Major Human Cancers to Next Generation Anti-CTLA-4 Antibodies.
Neoplasms
Mechanistic Modeling of Gene Regulation and Metabolism Identifies Potential Targets for Hepatocellular Carcinoma.
Neoplasms
MeCP2 facilitates breast cancer growth via promoting ubiquitination-mediated P53 degradation by inhibiting RPL5/RPL11 transcription.
Neoplasms
MedCo: Enabling Secure and Privacy-Preserving Exploration of Distributed Clinical and Genomic Data.
Neoplasms
Medullary carcinoma of the colon: a distinct morphology reveals a distinctive immunoregulatory microenvironment.
Neoplasms
MEGF6 Promotes the Epithelial-to-Mesenchymal Transition via the TGF?/SMAD Signaling Pathway in Colorectal Cancer Metastasis.
Neoplasms
MEGSA: A Powerful and Flexible Framework for Analyzing Mutual Exclusivity of Tumor Mutations.
Neoplasms
Meiotic nuclear divisions 1 (MND1) fuels cell cycle progression by activating a KLF6/E2F1 positive feedback loop in lung adenocarcinoma.
Neoplasms
MEK1 Inhibitor Combined with Irradiation Reduces Migration of Breast Cancer Cells Including miR-221 and ZEB1 EMT Marker Expression.
Neoplasms
Melanoma long non-coding RNA signature predicts prognostic survival and directs clinical risk-specific treatments.
Neoplasms
Melanoma-associated antigen A11 reduces erlotinib and afatinib efficacy in head and neck cancer.
Neoplasms
Melatonin/PGC1A/UCP1 promotes tumor slimming and represses tumor progression by initiating autophagy and lipid browning.
Neoplasms
Melittin inhibits proliferation, migration and invasion of bladder cancer cells by regulating key genes based on bioinformatics and experimental assays.
Neoplasms
MELK is Upregulated in Advanced Clear Cell Renal Cell Carcinoma and Promotes Disease Progression by Phosphorylating PRAS40.
Neoplasms
Membrane expression of thymidine kinase 1 and potential clinical relevance in lung, breast, and colorectal malignancies.
Neoplasms
Merged Affinity Network Association Clustering: Joint multi-omic/clinical clustering to identify disease endotypes.
Neoplasms
Mesenchymal stem cells as natural biofactories for exosomes carrying miR-124a in the treatment of gliomas.
Neoplasms
MET gene exon 14 deletion created using the CRISPR/Cas9 system enhances cellular growth and sensitivity to a MET inhibitor.
Neoplasms
MET in gastric cancer with liver metastasis: The relationship between MET amplification and Met overexpression in primary stomach tumors and liver metastasis.
Neoplasms
MET Receptor Tyrosine Kinase Regulates the Expression of Co-Stimulatory and Co-Inhibitory Molecules in Tumor Cells and Contributes to PD-L1-Mediated Suppression of Immune Cell Function.
Neoplasms
Meta-Analyses of Microarray Datasets Identifies ANO1 and FADD as Prognostic Markers of Head and Neck Cancer.
Neoplasms
Meta-analysis of gene expression and integrin-associated signaling pathways in papillary renal cell carcinoma subtypes.
Neoplasms
Meta-analysis of gene expression studies in endometrial cancer identifies gene expression profiles associated with aggressive disease and patient outcome.
Neoplasms
Meta-analysis of microarray datasets identify several chromosome segregation-related cancer/testis genes potentially contributing to anaplastic thyroid carcinoma.
Neoplasms
Meta-analysis of prostate cancer gene expression data identifies a novel discriminatory signature enriched for glycosylating enzymes.
Neoplasms
Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use.
Neoplasms
Meta-Analysis Reveals the Prognostic Relevance of Nuclear and Membrane-Associated Bile Acid Receptors in Gastric Cancer.
Neoplasms
Meta-dimensional data integration identifies critical pathways for susceptibility, tumorigenesis and progression of endometrial cancer.
Neoplasms
Metabolic and Lipidomic Reprogramming in Renal Cell Carcinoma Subtypes Reflects Regions of Tumor Origin.
Neoplasms
Metabolic and signalling network maps integration: application to cross-talk studies and omics data analysis in cancer.
Neoplasms
Metabolic classification of bladder cancer based on multi-omics integrated analysis to predict patient prognosis and treatment response.
Neoplasms
Metabolic expression profiling stratifies diffuse lower-grade glioma into three distinct tumour subtypes.
Neoplasms
Metabolic gene signature for predicting breast cancer recurrence using transcriptome analysis.
Neoplasms
Metabolic Pathways Enhancement Confers Poor Prognosis in p53 Exon Mutant Hepatocellular Carcinoma.
Neoplasms
Metabolic reprogramming-associated genes predict overall survival for rectal cancer.
Neoplasms
Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation.
Neoplasms
MetaCancer: A deep learning-based pan-cancer metastasis prediction model developed using multi-omics data.
Neoplasms
Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/?-catenin signaling pathway.
Neoplasms
Metastasis of Uveal Melanoma with Monosomy-3 Is Associated with a Less Glycogenetic Gene Expression Profile and the Dysregulation of Glycogen Storage.
Neoplasms
Metastasis suppressor 1 (MTSS1) expression is associated with reduced in-vivo metastasis and enhanced patient survival in lung adenocarcinoma.
Neoplasms
Metformin induces cell cycle arrest at the G1 phase through E2F8 suppression in lung cancer cells.
Neoplasms
MethCORR infers gene expression from DNA methylation and allows molecular analysis of ten common cancer types using fresh-frozen and formalin-fixed paraffin-embedded tumor samples.
Neoplasms
Methodology to study the three-dimensional spatial distribution of prostate cancer and their dependence on clinical parameters.
Neoplasms
Methods for Systematic Identification of Membrane Proteins for Specific Capture of Cancer-Derived Extracellular Vesicles.
Neoplasms
Methylated of genes behaving as potential biomarkers in evaluating malignant degree of glioblastoma.
Neoplasms
Methylation analysis highlights novel prognostic criteria in human-metastasized melanoma.
Neoplasms
Methylation analysis of Gasdermin E shows great promise as a biomarker for colorectal cancer.
Neoplasms
Methylation and expression of non-clustered protocadherins encoding genes and risk of precancerous gastric lesions in a high-risk population.
Neoplasms
Methylation and transcription patterns are distinct in IDH mutant gliomas compared to other IDH mutant cancers.
Neoplasms
Methylation associated transcriptional repression of ELOVL5 in novel colorectal cancer cell lines.
Neoplasms
Methylation changes in the TFAP2E promoter region are associated with BRAF mutation and poorer overall & disease free survival in colorectal cancer.
Neoplasms
Methylation dependent down-regulation of G0S2 leads to suppression of invasion and improved prognosis of IDH1-mutant glioma.
Neoplasms
Methylation deregulation of miRNA promoters identifies miR124-2 as a survival biomarker in Breast Cancer in very young women.
Neoplasms
Methylation gene KCNC1 is associated with overall survival in patients with seminoma.
Neoplasms
Methylation of MGMT and ADAMTS14 in normal colon MUCOSA: biomarkers of a field defect for cancerization preferentially targeting elder African-Americans.
Neoplasms
Methylation of RAD51B, XRCC3 and other homologous recombination genes is associated with expression of immune checkpoints and an inflammatory signature in squamous cell carcinoma of the head and neck, lung and cervix.
Neoplasms
Methylation of RILP in lung cancer promotes tumor cell proliferation and invasion.
Neoplasms
Methylation of the claudin 1 promoter is associated with loss of expression in estrogen receptor positive breast cancer.
Neoplasms
Methylation of the Promoter Region of the Tight Junction Protein-1 by DNMT1 Induces EMT-like Features in Multiple Myeloma.
Neoplasms
Methylation profiling identifies 2 groups of gliomas according to their tumorigenesis.
Neoplasms
Methylation Signature Genes Identification of the Lung Squamous Cell Carcinoma Occurrence and Recognition Research.
Neoplasms
Methylation silencing of TGF-? receptor type II is involved in malignant transformation of esophageal squamous cell carcinoma.
Neoplasms
Methylation-associated miR-193b silencing activates master drivers of aggressive prostate cancer.
Neoplasms
Methylation-Based Classification of Cervical Squamous Cell Carcinoma into Two New Subclasses Differing in Immune-Related Gene Expression.
Neoplasms
Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma.
Neoplasms
Methylation-driven genes and their prognostic value in cervical squamous cell carcinoma.
Neoplasms
Methylation-Driven Genes Identified as Novel Prognostic Indicators for Thyroid Carcinoma.
Neoplasms
Methylation-independent CRIP1 expression is a potential biomarker affecting prognosis in cytogenetically normal acute myeloid leukemia.
Neoplasms
Methylation?driven genes PMPCAP1, SOWAHC and ZNF454 as potential prognostic biomarkers in lung squamous cell carcinoma.
Neoplasms
Methylome and transcriptome analyses reveal insights into the epigenetic basis for the good survival of hypomethylated ER-positive breast cancer subtype.
Neoplasms
MethyMer: Design of combinations of specific primers for bisulfite sequencing of complete CpG islands.
Neoplasms
MEX3C regulates lipid metabolism to promote bladder tumorigenesis through JNK pathway.
Neoplasms
MFAP2 is a Potential Diagnostic and Prognostic Biomarker That Correlates with the Progression of Papillary Thyroid Cancer.
Neoplasms
MFG-E8 overexpression promotes colorectal cancer progression via AKT/MMPs signalling.
Neoplasms
MGA Mutation as a Novel Biomarker for Immune Checkpoint Therapies in Non-Squamous Non-Small Cell Lung Cancer.
Neoplasms
MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status.
Neoplasms
MGP Promotes Colon Cancer Proliferation by Activating the NF-?B Pathway through Upregulation of the Calcium Signaling Pathway.
Neoplasms
MHC class II associated stomach cancer mutations correlate with lack of subsequent tumor development.
Neoplasms
MHC class II restricted neoantigen peptides predicted by clonal mutation analysis in lung adenocarcinoma patients: implications on prognostic immunological biomarker and vaccine design.
Neoplasms
Micro-ribonucleic acid expression signature of metastatic castration-resistant prostate cancer: Regulation of NCAPH by antitumor miR-199a/b-3p.
Neoplasms
Microarray analyses reveal genes related to progression and prognosis of esophageal squamous cell carcinoma.
Neoplasms
Microarray analysis of metastasis-associated gene expression profiling in a murine model of thyroid carcinoma pulmonary metastasis: identification of S100A4 (Mts1) gene overexpression as a poor prognostic marker for thyroid carcinoma.
Neoplasms
Microarray analysis of the differential transformation mediated by Kirsten and Harvey Ras oncogenes in a human colorectal adenocarcinoma cell line.
Neoplasms
Microarray Data Mining and Preliminary Bioinformatics Analysis of Hepatitis D Virus-Associated Hepatocellular Carcinoma.
Neoplasms
Microarray expression profile of microRNAs in lung adenocarcinoma patients with the Cancer Genome Atlas and its clinical validation.
Neoplasms
Microarray profiling of differentially expressed lncRNAs and mRNAs in lung adenocarcinomas and bioinformatics analysis.
Neoplasms
Microarray-based analysis of whole-genome DNA methylation profiling in early detection of breast cancer.
Neoplasms
Microarray-based data mining reveals key genes and potential therapeutic drugs for Cadmium-induced prostate cell malignant transformation.
Neoplasms
Microarray-based identification of genes associated with cancer progression and prognosis in hepatocellular carcinoma.
Neoplasms
Microarray-based identification of genes associated with prognosis and drug resistance in ovarian cancer.
Neoplasms
Microenvironment-related gene TNFSF13B predicts poor prognosis in kidney renal clear cell carcinoma.
Neoplasms
MicroRNA and transcription factor co-regulatory networks and subtype classification of seminoma and non-seminoma in testicular germ cell tumors.
Neoplasms
microRNA and transcription factor mediated regulatory network for ovarian cancer : Regulatory network of ovarian cancer.
Neoplasms
MicroRNA Biomarkers for Patients With Muscle-Invasive Bladder Cancer Undergoing Selective Bladder-Sparing Trimodality Treatment.
Neoplasms
MicroRNA expression correlates with disease recurrence and overall survival in oral squamous cell carcinoma.
Neoplasms
microRNA expression patterns across seven cancers are highly correlated and dominated by evolutionarily ancient families.
Neoplasms
MicroRNA expression patterns in oral squamous cell carcinoma: hsa-mir-99b-3p and hsa-mir-100-5p as novel prognostic markers for oral cancer.
Neoplasms
MicroRNA expression profile and TNM staging system predict survival in patients with lung adenocarcinoma.
Neoplasms
MicroRNA Expression Profile Distinguishes Glioblastoma Stem Cells from Differentiated Tumor Cells.
Neoplasms
microRNA Expression Profile in Single Hormone Receptor-Positive Breast Cancers is Mainly Dependent on HER2 Status-A Pilot Study.
Neoplasms
MicroRNA expression profiles in molecular subtypes of clear-cell renal cell carcinoma are associated with clinical outcome and repression of specific mRNA targets.
Neoplasms
MicroRNA expression profiles in muscle-invasive bladder cancer: identification of a four-microRNA signature associated with patient survival.
Neoplasms
MicroRNA expression profiles predict clinical phenotypes and prognosis in chromophobe renal cell carcinoma.
Neoplasms
MicroRNA expression profiles predict progression and clinical outcome in lung adenocarcinoma.
Neoplasms
microRNA from brush biopsy to characterize oral squamous cell carcinoma epithelium.
Neoplasms
MicroRNA hsa-mir-3923 serves as a diagnostic and prognostic biomarker for gastric carcinoma.
Neoplasms
MicroRNA induction by copy number gain is associated with poor outcome in squamous cell carcinoma of the lung.
Neoplasms
MicroRNA let-7d targets thrombospondin-1 and inhibits the activation of human pancreatic stellate cells.
Neoplasms
MicroRNA modulated networks of adaptive and innate immune response in pancreatic ductal adenocarcinoma.
Neoplasms
MicroRNA profiles in five pairs of early gastric cancer tissues and adjacent non-cancerous tissues.
Neoplasms
microRNA regulation of mammalian target of rapamycin expression and activity controls estrogen receptor function and RAD001 sensitivity.
Neoplasms
microRNA Regulatory Network Inference Identifies miR-34a as a Novel Regulator of TGF-? Signaling in Glioblastoma.
Neoplasms
MicroRNA related prognosis biomarkers from high throughput sequencing data of kidney renal clear cell carcinoma.
Neoplasms
MicroRNA related prognosis biomarkers from high throughput sequencing data of kidney renal papillary cell carcinoma.
Neoplasms
MicroRNA signatures predict prognosis of patients with glioblastoma multiforme through the Cancer Genome Atlas.
Neoplasms
MicroRNA-1 acts as a tumor suppressor microRNA by inhibiting angiogenesis-related growth factors in human gastric cancer.
Neoplasms
MicroRNA-101 suppresses colorectal cancer progression by negative regulation of Rap1b.
Neoplasms
MicroRNA-10b inhibition reduces E2F1-mediated transcription and miR-15/16 activity in glioblastoma.
Neoplasms
MicroRNA-122 as a diagnostic biomarker for hepatocellular carcinoma related to hepatitis C virus: a meta-analysis and systematic review.
Neoplasms
MicroRNA-1224 Inhibits Tumor Metastasis in Intestinal-Type Gastric Cancer by Directly Targeting FAK.
Neoplasms
MicroRNA-1249 targets four-jointed box kinase 1 and reduces cell proliferation, migration and invasion of colon adenocarcinoma.
Neoplasms
microRNA-1271-5p/TIAM1 suppresses the progression of ovarian cancer through inactivating Notch signaling pathway.
Neoplasms
MicroRNA-128 expression not associated with glioma-associated epilepsy in WHO grades 2 glioma: Data from the Cancer Genome Atlas (TCGA) project.
Neoplasms
MicroRNA-1296 Facilitates Proliferation, Migration And Invasion Of Colorectal Cancer Cells By Targeting SFPQ.
Neoplasms
MicroRNA-1298-3p inhibits proliferation and invasion of glioma cells by downregulating Nidogen-1.
Neoplasms
MicroRNA-139 is a predictor of prostate cancer recurrence and inhibits growth and migration of prostate cancer cells through cell cycle arrest and targeting IGF1R and AXL.
Neoplasms
MicroRNA-144 inhibits cell proliferation, migration and invasion in human hepatocellular carcinoma by targeting CCNB1.
Neoplasms
MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients.
Neoplasms
MicroRNA-153 Decreases Tryptophan Catabolism and Inhibits Angiogenesis in Bladder Cancer by Targeting Indoleamine 2,3-Dioxygenase 1.
Neoplasms
MicroRNA-153 inhibits tumor progression in esophageal squamous cell carcinoma by targeting SNAI1.
Neoplasms
MicroRNA-155 coordinates the immunological landscape within murine melanoma and correlates with immunity in human cancers.
Neoplasms
MicroRNA-17 as a promising diagnostic biomarker of gastric cancer: An investigation combining TCGA, GEO, meta-analysis, and bioinformatics.
Neoplasms
MicroRNA-182 is a potential biomarker for prognosis of gastric cancer: A protocol for meta-analysis and bioinformatics analysis.
Neoplasms
MicroRNA-182 targets protein phosphatase 1 regulatory inhibitor subunit 1C in glioblastoma.
Neoplasms
MicroRNA-191 promotes hepatocellular carcinoma cell proliferation by has_circ_0000204/miR-191/KLF6 axis.
Neoplasms
MicroRNA-195 reverses the resistance to temozolomide through targeting cyclin E1 in glioma cells.
Neoplasms
MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma.
Neoplasms
microRNA-200c/141 upregulates SerpinB2 to promote breast cancer cell metastasis and reduce patient survival.
Neoplasms
MicroRNA-203 Increases Cell Radiosensitivity via Directly Targeting Bmi-1 in Hepatocellular Carcinoma.
Neoplasms
MicroRNA-204 deregulation in lung adenocarcinoma controls the biological behaviors of endothelial cells potentially by modulating Janus kinase 2-signal transducer and activator of transcription 3 pathway.
Neoplasms
MicroRNA-20a-mediated loss of autophagy contributes to breast tumorigenesis by promoting genomic damage and instability.
Neoplasms
MicroRNA-21 expression in the prognosis of low-grade gliomas: data from the cancer genome atlas (TCGA) project.
Neoplasms
microRNA-21 promotes breast cancer proliferation and metastasis by targeting LZTFL1.
Neoplasms
MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastoma.
Neoplasms
microRNA-210-3p depletion by CRISPR/Cas9 promoted tumorigenesis through revival of TWIST1 in renal cell carcinoma.
Neoplasms
MicroRNA-211 Enhances the Oncogenicity of Carcinogen-Induced Oral Carcinoma by Repressing TCF12 and Increasing Antioxidant Activity.
Neoplasms
MicroRNA-215-5p Treatment Suppresses Mesothelioma Progression via the MDM2-p53-Signaling Axis.
Neoplasms
MicroRNA-218 functions as a tumor suppressor in lung cancer by targeting IL-6/STAT3 and negatively correlates with poor prognosis.
Neoplasms
MicroRNA-221-3p is related to survival and promotes tumour progression in pancreatic cancer: a comprehensive study on functions and clinicopathological value.
Neoplasms
MicroRNA-223-5p targets long non-coding RNA TP73 antisense RNA1 to promote the invasion of gastric cancer.
Neoplasms
MicroRNA-301a-3p promotes triple-negative breast cancer progression through downregulating MEOX2.
Neoplasms
MicroRNA-301b and its target gene synaptosome-associated protein 91 as important modulators in esophageal cancer: functional experiments.
Neoplasms
microRNA-30a arbitrates intestinal-type early gastric carcinogenesis by directly targeting ITGA2.
Neoplasms
MicroRNA-30a-5p Inhibits the Growth of Renal Cell Carcinoma by Modulating GRP78 Expression.
Neoplasms
MicroRNA-30a-5pme: a novel diagnostic and prognostic biomarker for clear cell renal cell carcinoma in tissue and urine samples.
Neoplasms
MicroRNA-34a Attenuates Metastasis and Chemoresistance of Bladder Cancer Cells by Targeting the TCF1/LEF1 Axis.
Neoplasms
MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis.
Neoplasms
MicroRNA-3613-3p functions as a tumor suppressor and represents a novel therapeutic target in breast cancer.
Neoplasms
MicroRNA-363 targets myosin 1B to reduce cellular migration in head and neck cancer.
Neoplasms
MicroRNA-363-3p promote the development of acute myeloid leukemia with RUNX1 mutation by targeting SPRYD4 and FNDC3B.
Neoplasms
MicroRNA-365 Inhibits Cell Growth and Promotes Apoptosis in Melanoma by Targeting BCL2 and Cyclin D1 (CCND1).
Neoplasms
MicroRNA-3690 promotes cell proliferation and cell cycle progression by altering DKK3 expression in human thyroid cancer.
Neoplasms
MicroRNA-374a Inhibits Aggressive Tumor Biological Behavior in Bladder Carcinoma by Suppressing Wnt/?-Catenin Signaling.
Neoplasms
MicroRNA-490-3p inhibits proliferation and stimulates apoptosis of ESCC cells via MAPK1 downregulation.
Neoplasms
MicroRNA-495-3p functions as a tumor suppressor by regulating multiple epigenetic modifiers in gastric carcinogenesis.
Neoplasms
MicroRNA-496 inhibits triple negative breast cancer cell proliferation by targeting Del-1.
Neoplasms
MicroRNA-497-5p Is Downregulated in Hepatocellular Carcinoma and Associated with Tumorigenesis and Poor Prognosis in Patients.
Neoplasms
MicroRNA-500a Promotes the Progression of Hepatocellular Carcinoma by Post-Transcriptionally Targeting BID.
Neoplasms
MicroRNA-543 inhibits the proliferation, migration, invasion, and epithelial-mesenchymal transition of triple-negative breast cancer cells via down-regulation of ACTL6A gene.
Neoplasms
MicroRNA-548ac induces apoptosis in laryngeal squamous cell carcinoma cells by targeting transmembrane protein 158.
Neoplasms
MicroRNA-550a is associated with muscle system conferring poorer survival for esophageal cancer.
Neoplasms
MicroRNA-587 Functions as a Tumor Suppressor in Hepatocellular Carcinoma by Targeting Ribosomal Protein SA.
Neoplasms
MicroRNA-6071 Suppresses Glioblastoma Progression Through the Inhibition of PI3K/AKT/mTOR Pathway by Binding to ULBP2.
Neoplasms
MicroRNA-7 directly targets insulin-like growth factor 1 receptor to inhibit cellular growth and glucose metabolism in gliomas.
Neoplasms
MicroRNA-876-5p inhibits epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by targeting BCL6 corepressor like 1.
Neoplasms
MicroRNA-9-5p-CDX2 Axis: A Useful Prognostic Biomarker for Patients with Stage II/III Colorectal Cancer.
Neoplasms
MicroRNA-92 Expression in CD133+ Melanoma Stem Cells Regulates Immunosuppression in the Tumor Microenvironment via Integrin-Dependent Activation of TGF?.
Neoplasms
MicroRNA-96 is a potential tumor repressor by inhibiting NPTX2 in renal cell carcinoma.
Neoplasms
MicroRNA-99a-5p suppresses breast cancer progression and cell-cycle pathway through downregulating CDC25A.
Neoplasms
MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study.
Neoplasms
MicroRNA-driven deregulation of cytokine expression helps development of drug resistance in metastatic melanoma.
Neoplasms
MicroRNA-mediated networks underlie immune response regulation in papillary thyroid carcinoma.
Neoplasms
MicroRNA-mRNA Pairs Associated with Outcome in AML: From In Vitro Cell-Based Studies to AML Patients.
Neoplasms
MicroRNA-regulated transcriptome analysis identifies four major subtypes with prognostic and therapeutic implications in prostate cancer.
Neoplasms
MicroRNA-Related Genetic Variants Associated with Survival of Head and Neck Squamous Cell Carcinoma.
Neoplasms
MicroRNA-Related Prognosis Biomarkers from High-Throughput Sequencing Data of Colorectal Cancer.
Neoplasms
MicroRNA-Target Network Inference and Local Network Enrichment Analysis Identify Two microRNA Clusters with Distinct Functions in Head and Neck Squamous Cell Carcinoma.
Neoplasms
MicroRNA?29?3p regulates the ??catenin pathway by targeting IGF1 to inhibit the proliferation of prolactinoma cells.
Neoplasms
MicroRNA?301a/ZNRF3/wnt/??catenin signal regulatory crosstalk mediates glioma progression.
Neoplasms
MicroRNA?34a attenuates the proliferation, invasion and metastasis of gastric cancer cells via downregulation of MET.
Neoplasms
MicroRNA?34a?5p serves as a tumor suppressor by regulating the cell motility of bladder cancer cells through matrix metalloproteinase?2 silencing.
Neoplasms
MicroRNA?486?5p functions as a tumor suppressor of proliferation and cancer stem?like cell properties by targeting Sirt1 in liver cancer.
Neoplasms
MicroRNA?mRNA integrated analysis based on a case of well?differentiated thyroid cancer with both metastasis and metastatic recurrence.
Neoplasms
MicroRNAs as Biomarkers for Diagnosis, Prognosis and Theranostics in Prostate Cancer.
Neoplasms
MicroRNAs Associated With Biological Pathways of Left- and Right-sided Colorectal Cancer.
Neoplasms
MicroRNAs Associated With Colon Cancer: New Potential Prognostic Markers and Targets for Therapy.
Neoplasms
MicroRNAs associated with lung squamous cell carcinoma: New prognostic biomarkers and therapeutic targets.
Neoplasms
MicroRNAs associated with microvascular invasion in hepatocellular carcinoma and their prognostic impacts in patients undergoing hepatic resection.
Neoplasms
MicroRNAs Expression Patterns Predict Tumor Mutational Burden in Colorectal Cancer.
Neoplasms
MicroRNAs Mediated Regulation of Expression of Nucleoside Analog Pathway Genes in Acute Myeloid Leukemia.
Neoplasms
Microsatellite Instability-Related ACVR2A Mutations Partially Account for Decreased Lymph Node Metastasis in MSI-H Gastric Cancers.
Neoplasms
Migration of mitochondrial DNA in the nuclear genome of colorectal adenocarcinoma.
Neoplasms
MIIP haploinsufficiency induces chromosomal instability and promotes tumour progression in colorectal cancer.
Neoplasms
Min-redundancy and max-relevance multi-view feature selection for predicting ovarian cancer survival using multi-omics data.
Neoplasms
Mind Bomb 1 Promotes Pancreatic Cancer Proliferation by Activating ?-Catenin Signaling.
Neoplasms
Minichromosome maintenance complex component 6 (MCM6) expression correlates with histological grade and survival in endometrioid endometrial adenocarcinoma.
Neoplasms
Minichromosome maintenance protein 10 as a marker for proliferation and prognosis in lung cancer.
Neoplasms
Minimalist approaches to cancer tissue-of-origin classification by DNA methylation.
Neoplasms
Mining and validating the expression pattern and prognostic value of acetylcholine receptors in non-small cell lung cancer.
Neoplasms
Mining Database for the Clinical Significance and Prognostic Value of ESRP1 in Cutaneous Malignant Melanoma.
Neoplasms
Mining featured biomarkers associated with vascular invasion in HCC by bioinformatics analysis with TCGA RNA sequencing data.
Neoplasms
Mining immune-related genes with prognostic value in the tumor microenvironment of breast invasive ductal carcinoma.
Neoplasms
Mining novel cell glycolysis related gene markers that can predict the survival of colon adenocarcinoma patients.
Neoplasms
Mining of prognosis-related genes in cervical squamous cell carcinoma immune microenvironment.
Neoplasms
Mining prognostic markers of Asian hepatocellular carcinoma patients based on the apoptosis-related genes.
Neoplasms
Mining TCGA Data for Key Biomarkers Related to Immune Microenvironment in Endometrial cancer by Immune Score and Weighted Correlation Network Analysis.
Neoplasms
Mining TCGA database for genes of prognostic value in glioblastoma microenvironment.
Neoplasms
Mining TCGA database for screening and identification of hub genes in kidney renal clear cell carcinoma microenvironment.
Neoplasms
Mining TCGA Database for Tumor Microenvironment-Related Genes of Prognostic Value in Hepatocellular Carcinoma.
Neoplasms
Mining TCGA database for tumor mutation burden and their clinical significance in bladder cancer.
Neoplasms
Mining The Cancer Genome Atlas database for tumor mutation burden and its clinical implications in gastric cancer.
Neoplasms
Mining The Cancer Genome Atlas gene expression data for lineage markers in distinguishing bladder urothelial carcinoma and prostate adenocarcinoma.
Neoplasms
Mining the plasma-proteome associated genes in patients with gastro-esophageal cancers for biomarker discovery.
Neoplasms
Mining the potential prognostic value of synaptosomal-associated protein 25 (SNAP25) in colon cancer based on stromal-immune score.
Neoplasms
Minor Changes in Expression of the Mismatch Repair Protein MSH2 Exert a Major Impact on Glioblastoma Response to Temozolomide.
Neoplasms
MINTbase v2.0: a comprehensive database for tRNA-derived fragments that includes nuclear and mitochondrial fragments from all The Cancer Genome Atlas projects.
Neoplasms
MiR-1-3p inhibits cell proliferation and invasion by regulating BDNF-TrkB signaling pathway in bladder cancer.
Neoplasms
MiR-100 is a predictor of endocrine responsiveness and prognosis in patients with operable luminal breast cancer.
Neoplasms
miR-101-3p sensitizes lung adenocarcinoma cells to irradiation via targeting BIRC5.
Neoplasms
miR-124 suppresses the migration and invasion of glioma cells in vitro via Capn4.
Neoplasms
miR-125a-5p Functions as Tumor Suppressor microRNA And Is a Marker of Locoregional Recurrence And Poor prognosis in Head And Neck Cancer.
Neoplasms
miR-125b-5p inhibits cell proliferation, migration, and invasion in hepatocellular carcinoma via targeting TXNRD1.
Neoplasms
miR-126-3p Inhibits Thyroid Cancer Cell Growth and Metastasis, and Is Associated with Aggressive Thyroid Cancer.
Neoplasms
MIR-1265 regulates cellular proliferation and apoptosis by targeting calcium binding protein 39 in gastric cancer and, thereby, impairing oncogenic autophagy.
Neoplasms
miR-1269 promotes cell survival and proliferation by targeting tp53 and caspase-9 in lung cancer.
Neoplasms
MiR-1275 promotes cell migration, invasion and proliferation in squamous cell carcinoma of head and neck via up-regulating IGF-1R and CCR7.
Neoplasms
Mir-1287 suppresses the proliferation, invasion, and migration in hepatocellular carcinoma by targeting PIK3R3.
Neoplasms
miR-1293 Suppresses Tumor Malignancy by Targeting Hydrocyanic Oxidase 2: Therapeutic Potential of a miR-1293/Hydrocyanic Oxidase 2 Axis in Renal Cell Carcinoma.
Neoplasms
miR-1307-3p overexpression inhibits cell proliferation and promotes cell apoptosis by targeting ISM1 in colon cancer.
Neoplasms
miR-130a can predict response to temozolomide in patients with glioblastoma multiforme, independently of O6-methylguanine-DNA methyltransferase.
Neoplasms
MiR-133a-3p inhibits the malignant progression of esophageal cancer by targeting CDCA8.
Neoplasms
MiR-137 inhibits the proliferation, invasion and migration of glioma via targeting to regulate EZH2.
Neoplasms
MiR-139 in digestive system tumor diagnosis and detection: Bioinformatics and meta-analysis.
Neoplasms
miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1.
Neoplasms
miR-140 targeting CTSB signaling suppresses the mesenchymal transition and enhances temozolomide cytotoxicity in glioblastoma multiforme.
Neoplasms
miR-142-3p as a novel biomarker for predicting poor prognosis in renal cell carcinoma patients after surgery.
Neoplasms
miR-142-3p inhibits aerobic glycolysis and cell proliferation in hepatocellular carcinoma via targeting LDHA.
Neoplasms
miR-142-5p enhances cisplatin-induced apoptosis in ovarian cancer cells by targeting multiple anti-apoptotic genes.
Neoplasms
miR-143 inhibits renal cell carcinoma cells metastatic potential by suppressing ABL2.
Neoplasms
MiR-144 suppresses proliferation, invasion, and migration of breast cancer cells through inhibiting CEP55.
Neoplasms
miR-148b-3p, miR-190b, and miR-429 Regulate Cell Progression and Act as Potential Biomarkers for Breast Cancer.
Neoplasms
miR-149-5p inhibits cell growth by regulating TWEAK/Fn14/PI3K/AKT pathway and predicts favorable survival in human osteosarcoma.
Neoplasms
miR-155-5p Promotes Cell Proliferation and Migration of Clear Cell Renal Cell Carcinoma by Targeting PEG3.
Neoplasms
miR-17-5p promotes migration and invasion in breast cancer cells by repressing netrin 4.
Neoplasms
miR-181d: a predictive glioblastoma biomarker that downregulates MGMT expression.
Neoplasms
miR-184 delays cell proliferation, migration and invasion in prostate cancer by directly suppressing DLX1.
Neoplasms
miR-186 downregulates protein phosphatase PPM1B in bladder cancer and mediates G1-S phase transition.
Neoplasms
MiR-188-3p/GPR26 modulation functions as a potential regulator in manipulating glioma cell properties.
Neoplasms
miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma.
Neoplasms
miR-192/215-5p act as tumor suppressors and link Crohn's disease and colorectal cancer by targeting common metabolic pathways: An integrated informatics analysis and experimental study.
Neoplasms
MiR-193a-5p and -3p Play a Distinct Role in Gastric Cancer: miR-193a-3p Suppresses Gastric Cancer Cell Growth by Targeting ETS1 and CCND1.
Neoplasms
MiR-195 Inhibits Tumor Growth and Metastasis in Papillary Thyroid Carcinoma Cell Lines by Targeting CCND1 and FGF2.
Neoplasms
MiR-195 restrains lung adenocarcinoma by regulating CD4+ T cell activation via the CCDC88C/Wnt signaling pathway: a study based on the Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO) and bioinformatic analysis.
Neoplasms
miR-195 targets cyclin D3 and survivin to modulate the tumorigenesis of non-small cell lung cancer.
Neoplasms
miR-195/miR-497 Regulate CD274 Expression of Immune Regulatory Ligands in Triple-Negative Breast Cancer.
Neoplasms
miR-199b, a novel tumor suppressor miRNA in acute myeloid leukemia with prognostic implications.
Neoplasms
MiR-200a regulates epithelial to mesenchymal transition-related gene expression and determines prognosis in colorectal cancer patients.
Neoplasms
MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process.
Neoplasms
miR-205 regulates the proliferation and invasion of ovarian cancer cells via suppressing PTEN/SMAD4 expression.
Neoplasms
miR-205 regulation of ICT1 has an oncogenic potential via promoting the migration and invasion of gastric cancer cells.
Neoplasms
miR-210 is induced by hypoxia and regulates neural cell adhesion molecule in prostate cells.
Neoplasms
miR-22 Regulates Invasion, Gene Expression and Predicts Overall Survival in Patients with Clear Cell Renal Cell Carcinoma.
Neoplasms
miR-22 targets YWHAZ to inhibit metastasis of hepatocellular carcinoma and its down-regulation predicts a poor survival.
Neoplasms
miR-223 regulates oral squamous cell carcinoma metastasis through the Wnt/?-catenin signaling pathway.
Neoplasms
miR-224, miR-147b and miR-31 associated with lymph node metastasis and prognosis for lung adenocarcinoma by regulating PRPF4B, WDR82 or NR3C2.
Neoplasms
miR-23a-5p inhibits cell proliferation and invasion in pancreatic ductal adenocarcinoma by suppressing ECM1 expression.
Neoplasms
miR-25 Promotes Cell Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer by Targeting the LATS2/YAP Signaling Pathway.
Neoplasms
MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2.
Neoplasms
miR-27b-3p Inhibits Invasion, Migration and Epithelial-mesenchymal Transition in Gastric Cancer by Targeting RUNX1 and Activation of the Hippo Signaling Pathway.
Neoplasms
MiR-29a-5p inhibits proliferation and invasion and induces apoptosis in endometrial carcinoma via targeting TPX2.
Neoplasms
MiR-29b-3p cooperates with miR-29c-3p to affect the malignant biological behaviors in T-cell acute lymphoblastic leukemia via TFAP2C/GPX1 axis.
Neoplasms
miR-301b and NR3C2 co-regulate cells malignant properties and have the potential to be independent prognostic factors in breast cancer.
Neoplasms
MiR-301b-3p Promotes the Occurrence and Development of Breast Cancer Cells via Targeting HOXA5.
Neoplasms
miR-30a-5p Regulates Viability, Migration, and Invasion of Lung Adenocarcinoma Cells via Targeting ECT2.
Neoplasms
miR-30b-5p acts as a tumor suppressor microRNA in esophageal squamous cell carcinoma.
Neoplasms
miR-30e-5p represses angiogenesis and metastasis by directly targeting AEG-1 in squamous cell carcinoma of the head and neck.
Neoplasms
miR-3174 Contributes to Apoptosis and Autophagic Cell Death Defects in Gastric Cancer Cells by Targeting ARHGAP10.
Neoplasms
MiR-3174 promotes proliferation and inhibits apoptosis by targeting FOXO1 in hepatocellular carcinoma.
Neoplasms
miR-3187-3p enhances migration and invasion by targeting PER2 in head and neck squamous cell carcinomas.
Neoplasms
MiR-320a is associated with cisplatin resistance in lung adenocarcinoma and its clinical value in non-small cell lung cancer: A comprehensive analysis based on microarray data.
Neoplasms
MiR-328 promotes glioma cell invasion via SFRP1-dependent Wnt-signaling activation.
Neoplasms
miR-339-5p inhibits migration and invasion in ovarian cancer cell lines by targeting NACC1 and BCL6.
Neoplasms
MiR-34a and miR-34b/c have distinct effects on the suppression of lung adenocarcinomas.
Neoplasms
miR-34a repression in proneural malignant gliomas upregulates expression of its target PDGFRA and promotes tumorigenesis.
Neoplasms
miR-3607, a biomarker of hepatocellular carcinoma invasion and aggressiveness: Its relationship with epithelial-mesenchymal transition process.
Neoplasms
miR-3677-5p promotes the proliferation, migration and invasion of hepatocellular carcinoma cells and is associated with prognosis.
Neoplasms
miR-3687 Overexpression Promotes Bladder Cancer Cell Growth by Inhibiting the Negative Effect of FOXP1 on Cyclin E2 Transcription.
Neoplasms
miR-372 and miR-373 enhance the stemness of colorectal cancer cells by repressing differentiation signaling pathways.
Neoplasms
MiR-374a suppresses lung adenocarcinoma cell proliferation and invasion by targeting TGFA gene expression.
Neoplasms
MiR-374b-5p inhibits KDM5B-induced epithelial-mesenchymal transition in pancreatic cancer.
Neoplasms
miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1.
Neoplasms
MiR-375: A prospective regulator in medullary thyroid cancer based on microarray data and bioinformatics analyses.
Neoplasms
miR-424-5p Promotes Anoikis Resistance and Lung Metastasis by Inactivating Hippo Signaling in Thyroid Cancer.
Neoplasms
miR-4286 is Involved in Connections Between IGF-1 and TGF-? Signaling for the Mesenchymal Transition and Invasion by Glioblastomas.
Neoplasms
miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma.
Neoplasms
miR-4709 overexpression facilitates cancer proliferation and invasion via downregulating NR3C2 and is an unfavorable prognosis factor in colon adenocarcinoma.
Neoplasms
miR-4725-3p targeting stromal interacting molecule 1 signaling is involved in xanthohumol inhibition of glioma cell invasion.
Neoplasms
miR-484 is associated with disease recurrence and promotes migration in prostate cancer.
Neoplasms
miR-486 is involved in the pathogenesis of acute myeloid leukemia by regulating JAK-STAT signaling.
Neoplasms
miR-497 inhibited proliferation, migration and invasion of thyroid papillary carcinoma cells by negatively regulating YAP1 expression.
Neoplasms
miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-?-catenin pathway.
Neoplasms
miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer.
Neoplasms
MiR-516a-5p inhibits the proliferation of non-small cell lung cancer by targeting HIST3H2A.
Neoplasms
MiR-519a functions as a tumor suppressor in glioma by targeting the oncogenic STAT3 pathway.
Neoplasms
miR-542-3p Contributes to the HK2-Mediated High Glycolytic Phenotype in Human Glioma Cells.
Neoplasms
MiR-5683 suppresses glycolysis and proliferation through targeting pyruvate dehydrogenase kinase 4 in gastric cancer.
Neoplasms
miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
Neoplasms
miR-663a inhibits tumor growth and invasion by regulating TGF-?1 in hepatocellular carcinoma.
Neoplasms
MiR-760 suppresses human colorectal cancer growth by targeting BATF3/AP-1/cyclinD1 signaling.
Neoplasms
MiR-765 functions as a tumour suppressor and eliminates lipids in clear cell renal cell carcinoma by downregulating PLP2.
Neoplasms
miR-888: A Novel Cancer-Testis Antigen that Targets the Progesterone Receptor in Endometrial Cancer.
Neoplasms
MiR-9-5p could promote angiogenesis and radiosensitivity in cervical cancer by targeting SOCS5.
Neoplasms
MiR-92a promotes tumorigenesis of colorectal cancer, a transcriptomic and functional based study.
Neoplasms
miR-93-5p may be an important oncogene in prostate cancer by bioinformatics analysis.
Neoplasms
MiR-93-5p Promotes Cell Proliferation through Down-Regulating PPARGC1A in Hepatocellular Carcinoma Cells by Bioinformatics Analysis and Experimental Verification.
Neoplasms
miR-934 as a Prognostic Marker Facilitates Cell Proliferation and Migration of Pancreatic Tumor by Targeting PROX1.
Neoplasms
miR-939-3p promotes epithelial-mesenchymal transition and may be used as a prognostic marker in hepatocellular carcinoma.
Neoplasms
miR-940 potentially promotes proliferation and metastasis of endometrial carcinoma through regulation of MRVI1.
Neoplasms
MiR-942-3p Promotes the Proliferation and Invasion of Hepatocellular Carcinoma Cells by Targeting MBL2.
Neoplasms
miR-944 Suppresses EGF-Induced EMT in Colorectal Cancer Cells by Directly Targeting GATA6.
Neoplasms
MiR-99a Enhances the Radiation Sensitivity of Non-Small Cell Lung Cancer by Targeting mTOR.
Neoplasms
miR-TV: an interactive microRNA Target Viewer for microRNA and target gene expression interrogation for human cancer studies.
Neoplasms
MIR100HG: a credible prognostic biomarker and an oncogenic lncRNA in gastric cancer.
Neoplasms
MIR106A-5p upregulation suppresses autophagy and accelerates malignant phenotype in nasopharyngeal carcinoma.
Neoplasms
miR129-1 regulates protein phosphatase 1D protein expression under hypoxic conditions in non-small cell lung cancer cells harboring a TP53 mutation.
Neoplasms
MIR22HG As A Tumor Suppressive lncRNA In HCC: A Comprehensive Analysis Integrating RT-qPCR, mRNA-Seq, And Microarrays.
Neoplasms
MIR93 (microRNA -93) regulates tumorigenicity and therapy response of glioblastoma by targeting autophagy.
Neoplasms
miR?146a?5p targets TCSF and influences cell growth and apoptosis to repress NSCLC progression.
Neoplasms
miR?223?3p regulates cell growth and apoptosis via FBXW7 suggesting an oncogenic role in human testicular germ cell tumors.
Neoplasms
miR?888 regulates cancer progression by targeting multiple targets in lung adenocarcinoma.
Neoplasms
MIRAGAA--a methodology for finding coordinated effects of microRNA expression changes and genome aberrations in cancer.
Neoplasms
miRCancerdb: a database for correlation analysis between microRNA and gene expression in cancer.
Neoplasms
miRConnect 2.0: identification of oncogenic, antagonistic miRNA families in three human cancers.
Neoplasms
miRcorrNet: machine learning-based integration of miRNA and mRNA expression profiles, combined with feature grouping and ranking.
Neoplasms
miRFA: an automated pipeline for microRNA functional analysis with correlation support from TCGA and TCPA expression data in pancreatic cancer.
Neoplasms
miRGTF-net: Integrative miRNA-gene-TF network analysis reveals key drivers of breast cancer recurrence.
Neoplasms
miRNA and mRNA expression analysis reveals potential sex-biased miRNA expression.
Neoplasms
miRNA and mRNA expression profiling reveals potential biomarkers for metastatic cutaneous melanoma.
Neoplasms
miRNA array screening reveals cooperative MGMT-regulation between miR-181d-5p and miR-409-3p in glioblastoma.
Neoplasms
miRNA biomarkers for predicting overall survival outcomes for head and neck squamous cell carcinoma.
Neoplasms
MiRNA expression patterns are associated with tumor mutational burden in lung adenocarcinoma.
Neoplasms
miRNA profiling of primary lung and head and neck squamous cell carcinomas: Addressing a diagnostic dilemma.
Neoplasms
miRNA-103a-3p Promotes Human Gastric Cancer Cell Proliferation by Targeting and Suppressing ATF7 in vitro.
Neoplasms
miRNA-106a and prostate cancer radioresistance: a novel role for LITAF in ATM regulation.
Neoplasms
miRNA-145/miRNA-205 inhibits proliferation and invasion of uveal melanoma cells by targeting NPR1/CDC42.
Neoplasms
miRNA-148a-3p Regulates Immunosuppression in DNA Mismatch Repair-Deficient Colorectal Cancer by Targeting PD-L1.
Neoplasms
MiRNA-181d Expression Significantly Affects Treatment Responses to Carmustine Wafer Implantation.
Neoplasms
miRNA-182 and the regulation of the glioblastoma phenotype - toward miRNA-based precision therapeutics.
Neoplasms
miRNA-194 predicts favorable prognosis in gastric cancer and inhibits gastric cancer cell growth by targeting CCND1.
Neoplasms
miRNA-21 and miRNA-223 expression signature as a predictor for lymph node metastasis, distant metastasis and survival in kidney renal clear cell carcinoma.
Neoplasms
MiRNA-based model for predicting the TMB level in colon adenocarcinoma based on a LASSO logistic regression method.
Neoplasms
miRNA-mRNA Regulatory Network and Factors Associated with Prediction of Prognosis in Hepatocellular Carcinoma.
Neoplasms
miRNA-target gene regulatory networks: A Bayesian integrative approach to biomarker selection with application to kidney cancer.
Neoplasms
miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database.
Neoplasms
miRTissue: a web application for the analysis of miRNA-target interactions in human tissues.
Neoplasms
Misannotated Multi-Nucleotide Variants in Public Cancer Genomics Datasets Lead to Inaccurate Mutation Calls with Significant Implications.
Neoplasms
Mismatch Repair Deficiency as a Predictive and Prognostic Biomarker in Molecularly Classified Endometrial Carcinoma.
Neoplasms
Mismatch repair deficiency as a predictive marker for response to adjuvant radiotherapy in endometrial cancer.
Neoplasms
Mitochondrial Acetyl-CoA Synthetase 3 is Biosignature of Gastric Cancer Progression.
Neoplasms
Mitochondrial fission regulator 2 (MTFR2) promotes growth, migration, invasion and tumour progression in breast cancer cells.
Neoplasms
Mitochondrial Respiratory Defect Enhances Hepatoma Cell Invasiveness via STAT3/NFE2L1/STX12 Axis.
Neoplasms
Mitofusin-2 Promotes the Epithelial-Mesenchymal Transition-Induced Cervical Cancer Progression.
Neoplasms
Mitotically associated long non-coding RNA is a tumor promoter in anaplastic thyroid cancer.
Neoplasms
Mixed endometrial carcinomas with a "low-grade serous"-like component: a clinicopathologic, immunohistochemical, and molecular genetic study.
Neoplasms
MI_DenseNetCAM: A Novel Pan-Cancer Classification and Prediction Method Based on Mutual Information and Deep Learning Model.
Neoplasms
MKP-1 is required to limit myeloid-cell mediated oral squamous cell carcinoma progression and regional extension.
Neoplasms
MLH1 Promoter Methylation and Prediction/Prognosis of Gastric Cancer: A Systematic Review and Meta and Bioinformatic Analysis.
Neoplasms
MLH1-Silenced and Non-Silenced Subgroups of Hypermutated Colorectal Carcinomas Have Distinct Mutational Landscapes.
Neoplasms
MLN4924 inhibits cell proliferation by targeting the activated neddylation pathway in endometrial carcinoma.
Neoplasms
MMP16 is a marker of poor prognosis in gastric cancer promoting proliferation and invasion.
Neoplasms
MMP25 Regulates Immune Infiltration Level and Survival Outcome in Head and Neck Cancer Patients.
Neoplasms
MMP7 sensitivity of mutant ECM proteins: An indicator of melanoma survival rates and T-cell infiltration.
Neoplasms
MNK Inhibition Disrupts Mesenchymal Glioma Stem Cells and Prolongs Survival in a Mouse Model of Glioblastoma.
Neoplasms
MNX1-AS1 is a novel biomarker for predicting clinical progression and poor prognosis in lung adenocarcinoma.
Neoplasms
Model based on five tumour immune microenvironment-related genes for predicting hepatocellular carcinoma immunotherapy outcomes.
Neoplasms
Model based on GA and DNN for prediction of mRNA-Smad7 expression regulated by miRNAs in breast cancer.
Neoplasms
Model establishment of prognostic-related immune genes in laryngeal squamous cell carcinoma.
Neoplasms
Modeling clinical and molecular covariates of mutational process activity in cancer.
Neoplasms
Modeling Gene-Wise Dependencies Improves the Identification of Drug Response Biomarkers in Cancer Studies.
Neoplasms
Modeling the Dynamics of Let-7-Coupled Gene Regulatory Networks Linking Cell Proliferation to Malignant Transformation.
Neoplasms
Modeling the Genetic Regulation of Cancer Metabolism: Interplay between Glycolysis and Oxidative Phosphorylation.
Neoplasms
Models for Predicting Stage in Head and Neck Squamous Cell Carcinoma using Proteomic and Transcriptomic Data.
Neoplasms
Modification of platinum sensitivity by KEAP1/NRF2 signals in non-small cell lung cancer.
Neoplasms
Modification of the base excision repair enzyme MBD4 by the small ubiquitin-like molecule SUMO1.
Neoplasms
Modularity of the metabolic gene network as a prognostic biomarker for hepatocellular carcinoma.
Neoplasms
Modulating ATP binding cassette transporters in papillary renal cell carcinoma type 2 enhances its response to targeted molecular therapy.
Neoplasms
Modulation of IMPDH2, survivin, topoisomerase I and vimentin increases sensitivity to methotrexate in HT29 human colon cancer cells.
Neoplasms
Modulation of proliferation factors in lung adenocarcinoma with an analysis of the transcriptional consequences of genomic EGFR activation.
Neoplasms
Molecular Alterations of TP53 are a Defining Feature of Ovarian High-Grade Serous Carcinoma: A Rereview of Cases Lacking TP53 Mutations in The Cancer Genome Atlas Ovarian Study.
Neoplasms
Molecular analysis of Chinese oesophageal squamous cell carcinoma identifies novel subtypes associated with distinct clinical outcomes.
Neoplasms
Molecular analysis of urothelial cancer cell lines for modeling tumor biology and drug response.
Neoplasms
Molecular and Clinical Characterization of a Novel Prognostic and Immunologic Biomarker FAM111A in Diffuse Lower-Grade Glioma.
Neoplasms
Molecular and Clinical Characterization of CCT2 Expression and Prognosis via Large-Scale Transcriptome Profile of Breast Cancer.
Neoplasms
Molecular and clinical characterization of CD163 expression via large-scale analysis in glioma.
Neoplasms
Molecular and clinical characterization of IDH associated immune signature in lower-grade gliomas.
Neoplasms
Molecular and clinical characterization of PTPN2 expression from RNA-seq data of 996 brain gliomas.
Neoplasms
Molecular and Clinical Characterization of UBE2S in Glioma as a Biomarker for Poor Prognosis and Resistance to Chemo-Radiotherapy.
Neoplasms
Molecular and Clinicopathological Characterization of a Prognostic Immune Gene Signature Associated With MGMT Methylation in Glioblastoma.
Neoplasms
Molecular and epigenetic profiles of BRCA1-like hormone-receptor-positive breast tumors identified with development and application of a copy-number-based classifier.
Neoplasms
Molecular and Functional Characterization of the Somatic PIWIL1/piRNA Pathway in Colorectal Cancer Cells.
Neoplasms
Molecular and Immune Characteristics for Lung Adenocarcinoma Patients With ERLIN2 Overexpression.
Neoplasms
Molecular and Immune Correlates of PDCD1 (PD-1), PD-L1 (CD274), and PD-L2 (PDCD1LG2) DNA Methylation in Triple Negative Breast Cancer.
Neoplasms
Molecular and Morphological Profiling of Lung Cancer: A Foundation for "Next-Generation" Pathologists and Oncologists.
Neoplasms
Molecular basis of distinct oestrogen responses in endometrial and breast cancer.
Neoplasms
Molecular characterisation of cutaneous melanoma: creating a framework for targeted and immune therapies.
Neoplasms
Molecular characteristics associated with ferroptosis in hepatocellular carcinoma progression.
Neoplasms
Molecular characteristics of non-small cell lung cancer with reduced CHFR expression in The Cancer Genome Atlas (TCGA) project.
Neoplasms
Molecular characteristics of primary pulmonary lymphoepithelioma-like carcinoma based on integrated genomic analyses.
Neoplasms
Molecular Characteristics of Uveal Melanoma: Insights from the Cancer Genome Atlas (TCGA) Project.
Neoplasms
Molecular Characteristics, Prognostic Value, and Immune Characteristics of m6A Regulators Identified in Head and Neck Squamous Cell Carcinoma.
Neoplasms
Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers.
Neoplasms
Molecular Characterization and Clinical Relevance of RNA Binding Proteins in Colorectal Cancer.
Neoplasms
Molecular characterization in the prediction of disease extent in endometrial carcinoma.
Neoplasms
Molecular characterization of breast cancer: a potential novel immune-related lncRNAs signature.
Neoplasms
Molecular characterization of colorectal cancer using whole-exome sequencing in a Taiwanese population.
Neoplasms
Molecular characterization of colorectal cancer: A five-gene prognostic signature based on RNA-binding proteins.
Neoplasms
Molecular characterization of established human colon carcinoma cell lines (HCT-8) made resistant to 5-fluorouracil by different selection schedules.
Neoplasms
Molecular Characterization of Gastric Carcinoma: Therapeutic Implications for Biomarkers and Targets.
Neoplasms
Molecular characterization of high-grade serous ovarian cancers occurring in younger and older women.
Neoplasms
Molecular characterization of lung adenocarcinoma from Korean patients using next generation sequencing.
Neoplasms
Molecular characterization of lung adenocarcinoma: A potential four-long noncoding RNA prognostic signature.
Neoplasms
Molecular characterization of lung cancer: A two-miRNA prognostic signature based on cancer stem-like cells related genes.
Neoplasms
Molecular Characterization of Neuroendocrine Carcinomas of the Endometrium: Representation in All 4 TCGA Groups.
Neoplasms
Molecular Characterization of Non-responders to Chemotherapy in Serous Ovarian Cancer.
Neoplasms
Molecular characterization of papillary thyroid carcinoma: a potential three-lncRNA prognostic signature.
Neoplasms
Molecular characterization of tumors meeting diagnostic criteria for the non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP).
Neoplasms
Molecular characterization of ulcerative colitis-associated colorectal carcinomas.
Neoplasms
Molecular Classification and Future Therapeutic Challenges of Triple-negative Breast Cancer.
Neoplasms
Molecular classification of gastric adenocarcinoma: translating new insights from the cancer genome atlas research network.
Neoplasms
Molecular classification of gastric cancer predicts survival in patients undergoing radical gastrectomy based on project HOPE.
Neoplasms
Molecular classification of gliomas based on whole genome gene expression: a systematic report of 225 samples from the Chinese Glioma Cooperative Group.
Neoplasms
Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy.
Neoplasms
Molecular Correlates of Metastasis by Systematic Pan-Cancer Analysis Across The Cancer Genome Atlas.
Neoplasms
Molecular data show conserved DNA locations distinguishing lung cancer subtypes and regulation of immune genes.
Neoplasms
Molecular differences across invasive lung adenocarcinoma morphological subgroups.
Neoplasms
Molecular differences in IDH wildtype glioblastoma according to MGMT promoter methylation.
Neoplasms
Molecular differential analysis of uterine leiomyomas and leiomyosarcomas through weighted gene network and pathway tracing approaches.
Neoplasms
Molecular features and survival outcomes of the intrinsic subtypes within HER2-positive breast cancer.
Neoplasms
Molecular features in young vs elderly breast cancer patients and the impacts on survival disparities by age at diagnosis.
Neoplasms
Molecular features of the basal-like breast cancer subtype based on BRCA1 mutation status.
Neoplasms
Molecular gene mutation profiles, TMB and the impact of prognosis in Caucasians and east Asian patients with lung adenocarcinoma.
Neoplasms
Molecular heterogeneity at the network level: high-dimensional testing, clustering and a TCGA case study.
Neoplasms
Molecular heterogeneity of guanine nucleotide binding-protein ? subunit 4 in left- and right-sided colon cancer.
Neoplasms
Molecular homology between canine spontaneous oral squamous cell carcinomas and human head-and-neck squamous cell carcinomas reveals disease drivers and therapeutic vulnerabilities.
Neoplasms
Molecular identification of an immunity- and Ferroptosis-related gene signature in non-small cell lung Cancer.
Neoplasms
Molecular Insights into the Classification of Luminal Breast Cancers: The Genomic Heterogeneity of Progesterone-Negative Tumors.
Neoplasms
Molecular insights into the transcriptional regulatory role of thyroid hormones in ovarian cancer.
Neoplasms
Molecular Landscape and Actionable Alterations in a Genomically Guided Cancer Clinical Trial: National Cancer Institute Molecular Analysis for Therapy Choice (NCI-MATCH).
Neoplasms
Molecular Markers of Regulatory T Cells in Cancer Immunotherapy with Special Focus on Acute Myeloid Leukemia (AML) - A Systematic Review
Neoplasms
Molecular mechanisms linking high body mass index to breast cancer etiology in post-menopausal breast tumor and tumor-adjacent tissues.
Neoplasms
Molecular Mechanisms of KDELC2 on Glioblastoma Tumorigenesis and Temozolomide Resistance.
Neoplasms
Molecular mechanisms, immune cell infiltration, and potential drugs for prostate cancer.
Neoplasms
Molecular modelling and docking of Mus musculus HMGB1 inflammatory protein with CGA.
Neoplasms
Molecular Network-Based Identification of Circular RNA-Associated ceRNA Network in Papillary Thyroid Cancer.
Neoplasms
Molecular network-based identification of competing endogenous RNAs in bladder cancer.
Neoplasms
Molecular Network-Based Identification of Competing Endogenous RNAs in Thyroid Carcinoma.
Neoplasms
Molecular Pap smear: HPV genotype and DNA methylation of ADCY8, CDH8, and ZNF582 as an integrated biomarker for high-grade cervical cytology.
Neoplasms
Molecular pathogenesis of breast cancer: impact of miR-99a-5p and miR-99a-3p regulation on oncogenic genes.
Neoplasms
Molecular pathogenesis of renal cell carcinoma: Impact of the anti-tumor miR-29 family on gene regulation.
Neoplasms
Molecular Pathology of Patient Tumors, Patient-Derived Xenografts, and Cancer Cell Lines.
Neoplasms
Molecular Pathway Analysis of Mutation Data for Biomarkers Discovery and Scoring of Target Cancer Drugs.
Neoplasms
Molecular Pathways Associated with Kallikrein 6 Overexpression in Colorectal Cancer.
Neoplasms
Molecular phenotypes in triple negative breast cancer from African American patients suggest targets for therapy.
Neoplasms
Molecular phenotyping using networks, diffusion, and topology: soft tissue sarcoma.
Neoplasms
Molecular portraits and trastuzumab responsiveness of estrogen receptor-positive, progesterone receptor-positive, and HER2-positive breast cancer.
Neoplasms
Molecular profile reveals immune-associated markers of lymphatic invasion in human colon adenocarcinoma.
Neoplasms
Molecular profiles of tumor contrast enhancement: A radiogenomic analysis in anaplastic gliomas.
Neoplasms
Molecular profiling and molecular classification of endometrioid ovarian carcinomas.
Neoplasms
Molecular profiling identifies synchronous endometrial and ovarian cancers as metastatic endometrial cancer with favorable clinical outcome.
Neoplasms
Molecular profiling of colorectal tumors stratified by the histological tumor-stroma ratio - Increased expression of galectin-1 in tumors with high stromal content.
Neoplasms
Molecular profiling of transcription factors pinpoints MYC-estrogen related receptor ?-regulatory factor X5 panel for characterizing the immune microenvironment and predicting the efficacy of immune checkpoint inhibitors in renal cell carcinoma.
Neoplasms
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma.
Neoplasms
Molecular prognosticators in clinically and pathologically distinct cohorts of head and neck squamous cell carcinoma-A meta-analysis approach.
Neoplasms
Molecular Scoring of Hepatocellular Carcinoma for Predicting Metastatic Recurrence and Requirements of Systemic Chemotherapy.
Neoplasms
Molecular Signature for Lymphatic Invasion Associated with Survival of Epithelial Ovarian Cancer.
Neoplasms
Molecular Signatures for Tumor Classification: An Analysis of The Cancer Genome Atlas Data.
Neoplasms
Molecular signatures of BRCAness analysis identifies PARP inhibitor Niraparib as a novel targeted therapeutic strategy for soft tissue Sarcomas.
Neoplasms
Molecular Signatures of Epithelial Ovarian Cancer: Analysis of Associations with Tumor Characteristics and Epidemiologic Risk Factors.
Neoplasms
Molecular Subgroups of Glioblastoma- an Assessment by Immunohistochemical Markers.
Neoplasms
Molecular subtype classification of papillary renal cell cancer using miRNA expression.
Neoplasms
Molecular Subtype-Specific Expression of MicroRNA-29c in Breast Cancer Is Associated with CpG Dinucleotide Methylation of the Promoter.
Neoplasms
Molecular subtypes based on CNVs related gene signatures identify candidate prognostic biomarkers in lung adenocarcinoma.
Neoplasms
Molecular subtypes based on DNA methylation predict prognosis in colon adenocarcinoma patients.
Neoplasms
Molecular subtypes based on DNA methylation predict prognosis in lung squamous cell carcinoma.
Neoplasms
Molecular subtypes based on DNA promoter methylation predict prognosis in lung adenocarcinoma patients.
Neoplasms
Molecular subtypes based on immune-related genes predict the prognosis for hepatocellular carcinoma patients.
Neoplasms
Molecular Subtypes Based on the Stemness Index Predict Prognosis in Glioma Patients.
Neoplasms
Molecular Subtypes of Oral Squamous Cell Carcinoma Based on Immunosuppression Genes Using a Deep Learning Approach.
Neoplasms
Molecular Subtypes of Urothelial Bladder Cancer: Results from a Meta-cohort Analysis of 2411 Tumors.
Neoplasms
Molecular Subtyping of Triple-Negative Breast Cancers by Immunohistochemistry: Molecular Basis and Clinical Relevance.
Neoplasms
Molecular subtyping reveals immune alterations in IDH wild-type lower-grade diffuse glioma.
Neoplasms
Molecular, clinicopathological, and immune correlates of LAG3 promoter DNA methylation in melanoma.
Neoplasms
Molecular-based classification algorithm for endometrial carcinoma categorizes ovarian endometrioid carcinoma into prognostically significant groups.
Neoplasms
Monitoring methylation-driven genes as prognostic biomarkers in patients with lung squamous cell cancer.
Neoplasms
Monitoring response to transarterial chemoembolization in hepatocellular carcinoma using 18F-Fluorothymidine Positron Emission Tomography.
Neoplasms
Monocarboxylate transporters in breast cancer and adipose tissue are novel biomarkers and potential therapeutic targets.
Neoplasms
Monocarboxylate transporter 1 is an independent prognostic factor in esophageal squamous cell carcinoma.
Neoplasms
Monosomy of chromosome 10 associated with dysregulation of epidermal growth factor signaling in glioblastomas.
Neoplasms
MORC4 Promotes Chemoresistance of Luminal A/B Breast Cancer via STAT3-Mediated MID2 Upregulation.
Neoplasms
Morphologic and molecular correlates of EZH2 as a predictor of platinum resistance in high-grade ovarian serous carcinoma.
Neoplasms
Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma.
Neoplasms
Morphologic, Immunophenotypic and Molecular Features of Hypermutation in Colorectal Carcinomas with Mutations in DNA Polymerase ? (POLE).
Neoplasms
Morphological characterization of colorectal cancers in The Cancer Genome Atlas reveals distinct morphology-molecular associations: clinical and biological implications.
Neoplasms
Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriers.
Neoplasms
Morphoproteomic characterization of lung squamous cell carcinoma fragmentation, a histological marker of increased tumor invasiveness.
Neoplasms
Most Commonly Mutated Genes in High-Grade Serous Ovarian Carcinoma Are Nonessential for Ovarian Surface Epithelial Stem Cell Transformation.
Neoplasms
motifbreakR: an R/Bioconductor package for predicting variant effects at transcription factor binding sites.
Neoplasms
MPC1 deletion is associated with poor prognosis and temozolomide resistance in glioblastoma.
Neoplasms
MR Imaging Predictors of Molecular Profile and Survival: Multi-institutional Study of the TCGA Glioblastoma Data Set.
Neoplasms
MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays.
Neoplasms
MRE11A Isoform Expression Associated with Outcome Following Radiotherapy in Muscle-Invasive Bladder Cancer does not Alter Cell Survival and DNA Double-Strand Break Repair Following Ionising Radiation.
Neoplasms
MRGBP is a potential novel prognostic biomarker and is correlated with immune infiltrates in hepatocellular carcinoma.
Neoplasms
MRI Atlas of IDH Wild-Type Supratentorial Glioblastoma: Probabilistic Maps of Phenotype, Management, and Outcomes.
Neoplasms
MRI Features May Predict Molecular Features of Glioblastoma in Isocitrate Dehydrogenase Wild-Type Lower-Grade Gliomas.
Neoplasms
MRI to MGMT: predicting methylation status in glioblastoma patients using convolutional recurrent neural networks.
Neoplasms
MRI-Based Deep-Learning Method for Determining Glioma MGMT Promoter Methylation Status.
Neoplasms
MRI-localized biopsies reveal subtype-specific differences in molecular and cellular composition at the margins of glioblastoma.
Neoplasms
mRNA Expression of SLC5A5 and SLC2A Family Genes in Papillary Thyroid Cancer: An Analysis of The Cancer Genome Atlas.
Neoplasms
mRNAsi Index: Machine Learning in Mining Lung Adenocarcinoma Stem Cell Biomarkers.
Neoplasms
MRPL13 Promotes Tumor Cell Proliferation, Migration and EMT Process in Breast Cancer Through the PI3K-AKT-mTOR Pathway.
Neoplasms
MRPL15 is a novel prognostic biomarker and therapeutic target for epithelial ovarian cancer.
Neoplasms
MRPL27 contributes to unfavorable overall survival and disease-free survival from cholangiocarcinoma patients.
Neoplasms
MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance.
Neoplasms
MSI and EBV Positive Gastric Cancer's Subgroups and Their Link With Novel Immunotherapy.
Neoplasms
MST1R (RON) expression is a novel prognostic biomarker for metastatic progression in breast cancer patients.
Neoplasms
MTA2 as a Potential Biomarker and Its Involvement in Metastatic Progression of Human Renal Cancer by miR-133b Targeting MMP-9.
Neoplasms
MTAP deficiency-induced metabolic reprogramming creates a vulnerability to co-targeting de novo purine synthesis and glycolysis in pancreatic cancer.
Neoplasms
MTBP Is Overexpressed in Triple-Negative Breast Cancer and Contributes to Its Growth and Survival.
Neoplasms
MUC1-C integrates activation of the IFN-? pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer.
Neoplasms
Mucin 17 inhibits the progression of human gastric cancer by limiting inflammatory responses through a MYH9-p53-RhoA regulatory feedback loop.
Neoplasms
Mucin 4 mutation is associated with tumor mutation burden and promotes antitumor immunity in colon cancer patients.
Neoplasms
Mucin O-glycosylating enzyme GALNT2 facilitates the malignant character of glioma by activating the EGFR/PI3K/Akt/mTOR axis.
Neoplasms
Mucinous adenocarcinoma is a pharmacogenomically distinct subtype of colorectal cancer.
Neoplasms
Mucinous and non-mucinous colorectal cancers show differential expression of chemotherapy metabolism and resistance genes.
Neoplasms
MUDENG Expression Profiling in Cohorts and Brain Tumor Biospecimens to Evaluate Its Role in Cancer.
Neoplasms
Multi-center study finds postoperative residual non-enhancing component of glioblastoma as a new determinant of patient outcome.
Neoplasms
Multi-dimensional omics characterization in glioblastoma identifies the purity-associated pattern and prognostic gene signatures.
Neoplasms
Multi-faceted computational assessment of risk and progression in oligodendroglioma implicates NOTCH and PI3K pathways.
Neoplasms
Multi-institutional re-evaluation of prognostic factors in chromophobe renal cell carcinoma: proposal of a novel two-tiered grading scheme.
Neoplasms
Multi-Institutional Validation of Deep Learning for Pretreatment Identification of Extranodal Extension in Head and Neck Squamous Cell Carcinoma.
Neoplasms
Multi-kinase inhibitors and cisplatin for head and neck cancer treatment in vitro.
Neoplasms
Multi-marker analysis of genomic annotation on gastric cancer GWAS data from Chinese populations.
Neoplasms
Multi-network approach to identify differentially methylated gene communities in cancer.
Neoplasms
Multi-Objective Optimization Algorithm to Discover Condition-Specific Modules in Multiple Networks.
Neoplasms
Multi-omic analyses of hepatocellular carcinoma to determine immunological characteristics and key nodes in gene-expression network.
Neoplasms
Multi-Omic Analyses of the m5C Regulator ALYREF Reveal Its Essential Roles in Hepatocellular Carcinoma.
Neoplasms
Multi-Omic Regulation of the PAM50 Gene Signature in Breast Cancer Molecular Subtypes.
Neoplasms
Multi-omics analysis based on integrated genomics, epigenomics and transcriptomics in pancreatic cancer.
Neoplasms
Multi-omics analysis identifies potential mechanisms of AURKB in mediating poor outcome of lung adenocarcinoma.
Neoplasms
Multi-omics analysis of copy number variations of RNA regulatory genes in soft tissue sarcoma.
Neoplasms
Multi-omics analysis of genomics, epigenomics and transcriptomics for molecular subtypes and core genes for lung adenocarcinoma.
Neoplasms
Multi-omics Analysis of Microenvironment Characteristics and Immune Escape Mechanisms of Hepatocellular Carcinoma.
Neoplasms
Multi-Omics Analysis of the Expression and Prognosis for FKBP Gene Family in Renal Cancer.
Neoplasms
Multi-omics analysis of tumor angiogenesis characteristics and potential epigenetic regulation mechanisms in renal clear cell carcinoma.
Neoplasms
Multi-omics analysis of tumor mutation burden combined with immune infiltrates in bladder urothelial carcinoma.
Neoplasms
Multi-omics analysis of tumor mutation burden combined with immune infiltrates in melanoma.
Neoplasms
Multi-omics analysis of tumor mutational burden combined with prognostic assessment in epithelial ovarian cancer based on TCGA database.
Neoplasms
Multi-omics Approach Reveals Distinct Differences in Left- and Right-Sided Colon Cancer.
Neoplasms
Multi-omics approach to infer cancer therapeutic targets on chromosome 20q across tumor types.
Neoplasms
Multi-omics approaches identify SF3B3 and SIRT3 as candidate autophagic regulators and druggable targets in invasive breast carcinoma.
Neoplasms
Multi-omics characterization and validation of invasiveness-related molecular features across multiple cancer types.
Neoplasms
Multi-omics characterization and validation of MSI-related molecular features across multiple malignancies.
Neoplasms
Multi-Omics Data Analyses Construct a Six Immune-Related Genes Prognostic Model for Cervical Cancer in Tumor Microenvironment.
Neoplasms
Multi-omics Data Analyses Construct TME and Identify the Immune-Related Prognosis Signatures in Human LUAD.
Neoplasms
Multi-omics integrative analysis and survival risk model construction of non-small cell lung cancer based on The Cancer Genome Atlas datasets.
Neoplasms
Multi-Omics Integrative Analysis Uncovers Molecular Subtypes and mRNAs as Therapeutic Targets for Liver Cancer.
Neoplasms
Multi-omics landscapes of colorectal cancer subtypes discriminated by an individualized prognostic signature for 5-fluorouracil-based chemotherapy.
Neoplasms
Multi-omics mapping of human papillomavirus integration sites illuminates novel cervical cancer target genes.
Neoplasms
Multi-omics Perspective on the Tumor Microenvironment based on PD-L1 and CD8 T-Cell Infiltration in Urothelial Cancer.
Neoplasms
Multi-Omics Profiling Reveals Distinct Microenvironment Characterization and Suggests Immune Escape Mechanisms of Triple-Negative Breast Cancer.
Neoplasms
Multi-omics reveals novel prognostic implication of SRC protein expression in bladder cancer and its correlation with immunotherapy response.
Neoplasms
Multi-platform analysis of methylation-regulated genes in human lung adenocarcinoma.
Neoplasms
Multi-Platform Omics Analysis for Identification of Molecular Characteristics and Therapeutic Targets of Uveal Melanoma.
Neoplasms
Multi-project and Multi-profile joint Non-negative Matrix Factorization for cancer omic datasets.
Neoplasms
Multi-slice low-rank tensor decomposition based multi-atlas segmentation: Application to automatic pathological liver CT segmentation.
Neoplasms
Multi-Stability and Consequent Phenotypic Plasticity in AMPK-Akt Double Negative Feedback Loop in Cancer Cells.
Neoplasms
Multi-step screening of neoantigens' HLA- and TCR-interfaces improves prediction of survival.
Neoplasms
Multi-task multi-modal learning for joint diagnosis and prognosis of human cancers.
Neoplasms
Multicellular gene network analysis identifies a macrophage-related gene signature predictive of therapeutic response and prognosis of gliomas.
Neoplasms
Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival.
Neoplasms
Multicenter Validation of Enhancer of Zeste Homolog 2 Expression as an Independent Prognostic Marker in Localized Clear Cell Renal Cell Carcinoma.
Neoplasms
Multicenter validation of prostate tumor localization using multiparametric MRI and prior knowledge.
Neoplasms
Multidimensional Analyses of Tumor Immune Microenvironment Reveal the Possible Rationality of Immunotherapy and Identify High Immunotherapy Response Subtypes for Renal Papillary Cell Carcinoma.
Neoplasms
Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery.
Neoplasms
Multifactorial deep learning reveals pan-cancer genomic tumor clusters with distinct immunogenomic landscape and response to immunotherapy.
Neoplasms
Multigene signature for predicting prognosis of patients with 1p19q co-deletion diffuse glioma.
Neoplasms
Multilayer modelling of the human transcriptome and biological mechanisms of complex diseases and traits.
Neoplasms
Multilevel omic data clustering reveals variable contribution of methylator phenotype to integrative cancer subtypes.
Neoplasms
Multilevel regulation of RUVBL2 expression predicts poor prognosis in hepatocellular carcinoma.
Neoplasms
Multiomic Analysis of Methylation and Transcriptome Reveals a Novel Signature in Esophageal Cancer.
Neoplasms
Multiomic Analysis of Subtype Evolution and Heterogeneity in High-Grade Serous Ovarian Carcinoma.
Neoplasms
Multiomic analysis of the function of SPOCK1 across cancers: an integrated bioinformatics approach.
Neoplasms
Multiomics analysis reveals CT83 is the most specific gene for triple negative breast cancer and its hypomethylation is oncogenic in breast cancer.
Neoplasms
Multiomics Differences in Lung Squamous Cell Carcinoma Patients with High Radiosensitivity Index Compared with Those with Low Radiosensitivity Index.
Neoplasms
Multiomics integrative analysis for gene signatures and prognostic values of m6A regulators in pancreatic adenocarcinoma: a retrospective study in The Cancer Genome Atlas project.
Neoplasms
Multiomics Prediction of Response Rates to Therapies to Inhibit Programmed Cell Death 1 and Programmed Cell Death 1 Ligand 1.
Neoplasms
Multiomics profile and prognostic gene signature of m6A regulators in uterine corpus endometrial carcinoma.
Neoplasms
Multiomics Profiling and Clustering of Low-Grade Gliomas Based on the Integrated Stress Status.
Neoplasms
Multiplatform computational analysis of mast cells in adrenocortical carcinoma tumor microenvironment.
Neoplasms
Multiple breast cancer risk variants are associated with differential transcript isoform expression in tumors.
Neoplasms
Multiple gene dysfunctions lead to high cancer-susceptibility: evidences from a whole-exome sequencing study.
Neoplasms
Multiple genetic variants predict the progression-free survival of bevacizumab plus chemotherapy in advanced ovarian cancer: A retrospective study.
Neoplasms
Multiple m6A RNA methylation modulators promote the malignant progression of hepatocellular carcinoma and affect its clinical prognosis.
Neoplasms
Multiple network algorithm for epigenetic modules via the integration of genome-wide DNA methylation and gene expression data.
Neoplasms
Multiple Omics Data Integration to Identify Long Noncoding RNA Responsible for Breast Cancer-Related Mortality.
Neoplasms
Multiregion single-cell sequencing reveals the transcriptional landscape of the immune microenvironment of colorectal cancer.
Neoplasms
Multiresolution Application of Artificial Intelligence in Digital Pathology for Prediction of Positive Lymph Nodes From Primary Tumors in Bladder Cancer.
Neoplasms
Multiscale integration of -omic, imaging, and clinical data in biomedical informatics.
Neoplasms
Multiscale Modeling of Inflammation-Induced Tumorigenesis Reveals Competing Oncogenic and Oncoprotective Roles for Inflammation.
Neoplasms
Multiscale mutation clustering algorithm identifies pan-cancer mutational clusters associated with pathway-level changes in gene expression.
Neoplasms
Multiscale-omic assessment of EWSR1-NFATc2 fusion positive sarcomas identifies the mTOR pathway as a potential therapeutic target.
Neoplasms
Multivariate Analysis of Preoperative Magnetic Resonance Imaging Reveals Transcriptomic Classification of de novo Glioblastoma Patients.
Neoplasms
Multivariate Bayesian meta-analysis: joint modelling of multiple cancer types using summary statistics.
Neoplasms
Multivariate gene expression-based survival predictor model in esophageal adenocarcinoma.
Neoplasms
MuPIT interactive: webserver for mapping variant positions to annotated, interactive 3D structures.
Neoplasms
Muscle-invasive bladder cancer is characterized by overexpression of thymidine kinase 1.
Neoplasms
Mutant allele tumor heterogeneity (MATH) and head and neck squamous cell carcinoma.
Neoplasms
Mutant IDH1 Differently Affects Redox State and Metabolism in Glial Cells of Normal and Tumor Origin.
Neoplasms
Mutant IDH1 expression is associated with down-regulation of monocarboxylate transporters.
Neoplasms
Mutant POLQ and POLZ/REV3L DNA polymerases may contribute to the favorable survival of patients with tumors with POLE mutations outside the exonuclease domain.
Neoplasms
Mutant WT1 is associated with DNA hypermethylation of PRC2 targets in AML and responds to EZH2 inhibition.
Neoplasms
Mutant-allele fraction heterogeneity is associated with non-small cell lung cancer patient survival.
Neoplasms
Mutant-allele tumor heterogeneity in malignant glioma effectively predicts neoplastic recurrence.
Neoplasms
muTarget: A platform linking gene expression changes and mutation status in solid tumors.
Neoplasms
Mutated CEACAMs Disrupt Transforming Growth Factor Beta Signaling and Alter the Intestinal Microbiome to Promote Colorectal Carcinogenesis.
Neoplasms
Mutation load estimation model as a predictor of the response to cancer immunotherapy.
Neoplasms
Mutation of chromatin regulators and focal hotspot alterations characterize human papillomavirus-positive oropharyngeal squamous cell carcinoma.
Neoplasms
Mutation Profile of Aggressive Pheochromocytoma and Paraganglioma with Comparison of TCGA Data.
Neoplasms
Mutation profile of non-small cell lung cancer revealed by next generation sequencing.
Neoplasms
Mutation signatures to Pan-Cancer Atlas: Investigation of the genomic landscape of muscle-invasive bladder cancer.
Neoplasms
Mutation-specific non-canonical pathway of PTEN as a distinct therapeutic target for glioblastoma.
Neoplasms
Mutational analysis of head and neck squamous cell carcinoma stratified by smoking status.
Neoplasms
Mutational landscape differences between young-onset and older-onset breast cancer patients.
Neoplasms
Mutational landscape of gastric adenocarcinoma in Chinese: Implications for prognosis and therapy.
Neoplasms
Mutational Landscapes of Smoking-Related Cancers in Caucasians and African Americans: Precision Oncology Perspectives at Wake Forest Baptist Comprehensive Cancer Center.
Neoplasms
Mutational load and mutational patterns in relation to age in head and neck cancer.
Neoplasms
Mutational Profiling Can Establish Clonal or Independent Origin in Synchronous Bilateral Breast and Other Tumors.
Neoplasms
Mutational Signature and Transcriptomic Classification Analyses as the Decisive Diagnostic Tools for a Cancer of Unknown Primary.
Neoplasms
Mutational Signatures Are Critical for Proper Estimation of Purifying Selection Pressures in Cancer Somatic Mutation Data When Using the dN/dS Metric.
Neoplasms
Mutational spectrum and prognostic stratification of intermediate-risk acute myeloid leukemia.
Neoplasms
Mutations in DNA repair genes are associated with increased neoantigen burden and a distinct immunophenotype in lung squamous cell carcinoma.
Neoplasms
Mutations in DNMT3A, U2AF1, and EZH2 identify intermediate-risk acute myeloid leukemia patients with poor outcome after CR1.
Neoplasms
Mutations in genes connected with the TCF7L2 transcription factor are associated with a poor prognosis in non-small cell lung cancer.
Neoplasms
Mutations in the KEAP1-NFE2L2 Pathway Define a Molecular Subset of Rapidly Progressing Lung Adenocarcinoma.
Neoplasms
Mutations in the notch signalling pathway are associated with enhanced anti-tumour immunity in colorectal cancer.
Neoplasms
MXRA5 Is a Novel Immune-Related Biomarker That Predicts Poor Prognosis in Glioma.
Neoplasms
My personal mutanome: a computational genomic medicine platform for searching network perturbing alleles linking genotype to phenotype.
Neoplasms
MYBL2 disrupts the Hippo-YAP pathway and confers castration resistance and metastatic potential in prostate cancer.
Neoplasms
MYCT1 Inhibits the Adhesion and Migration of Laryngeal Cancer Cells Potentially Through Repressing Collagen VI.
Neoplasms
MYD88 Is a Potential Prognostic Gene and Immune Signature of Tumor Microenvironment for Gliomas.
Neoplasms
Myeloid cell-targeted miR-146a mimic inhibits NF-?B-driven inflammation and leukemia progression in vivo.
Neoplasms
Myeloid-Derived Suppressor Cells in Immune Microenvironment Promote Progression of Esophagogastric Junction Adenocarcinoma.
Neoplasms
MYST1/KAT8 contributes to tumor progression by activating EGFR signaling in glioblastoma cells.
Neoplasms
N-glycan fingerprint predicts alpha-fetoprotein negative hepatocellular carcinoma: A large-scale multicenter study.
Neoplasms
N-myc downstream-regulated gene 2 promotes the protein stability of estrogen receptor beta via inhibition of ubiquitin-protein ligase E3A to suppress colorectal cancer.
Neoplasms
N6 -methyladenosine (m6 A) RNA modification of G protein-coupled receptor 133 increases proliferation of lung adenocarcinoma.
Neoplasms
N6-methyladenosine (m6A) regulatory gene divides hepatocellular carcinoma into three subtypes.
Neoplasms
N6-methyladenosine (m6A) RNA methylation regulator SNRPC is a prognostic biomarker and is correlated with immunotherapy in hepatocellular carcinoma.
Neoplasms
N6-methyladenosine (m6A) RNA methylation signature as a predictor of stomach adenocarcinoma outcomes and its association with immune checkpoint molecules.
Neoplasms
N6-methyladenosine (m6A)-mediated messenger RNA signatures and the tumor immune microenvironment can predict the prognosis of hepatocellular carcinoma.
Neoplasms
N6-Methyladenosine Regulators and Related LncRNAs Are Potential to be Prognostic Markers for Uveal Melanoma and Indicators of Tumor Microenvironment Remodeling.
Neoplasms
N6-Methyladenosine Regulators Are Involved in the Progression of and Have Clinical Impact on Breast Cancer.
Neoplasms
N6-Methyladenosine Related Long Non-Coding RNAs and Immune Cell Infiltration in the Tumor Microenvironment of Gastric Cancer.
Neoplasms
N6-Methyladenosine RNA Methylation Regulator-Related Alternative Splicing (AS) Gene Signature Predicts Non-Small Cell Lung Cancer Prognosis.
Neoplasms
N6-Methyladenosine Writer Gene ZC3H13 Predicts Immune Phenotype and Therapeutic Opportunities in Kidney Renal Clear Cell Carcinoma.
Neoplasms
N6-methyladenosine-related Genomic Targets are Altered in Breast Cancer Tissue and Associated with Poor Survival.
Neoplasms
N6-Methylandenosine-Related lncRNA Signature Is a Novel Biomarkers of Prognosis and Immune Response in Colon Adenocarcinoma Patients.
Neoplasms
N6-Methylandenosine-Related lncRNAs Are Potential Biomarkers for Predicting the Overall Survival of Lower-Grade Glioma Patients.
Neoplasms
N6-methylandenosine-related lncRNAs play an important role in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma.
Neoplasms
N6-Methylandenosine-Related lncRNAs Predict Prognosis and Immunotherapy Response in Bladder Cancer.
Neoplasms
N6?methyladenosine RNA methylation regulators participate in malignant progression and have prognostic value in clear cell renal cell carcinoma.
Neoplasms
Naa20, the catalytic subunit of NatB complex, contributes to hepatocellular carcinoma by regulating the LKB1-AMPK-mTOR axis.
Neoplasms
NAMPT Over-Expression Recapitulates the BRAF Inhibitor Resistant Phenotype Plasticity in Melanoma.
Neoplasms
NAP1L1 Functions as a Tumor Promoter via Recruiting Hepatoma-Derived Growth Factor/c-Jun Signal in Hepatocellular Carcinoma.
Neoplasms
Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy.
Neoplasms
NAT1 is a critical prognostic biomarker and inhibits proliferation of colorectal cancer through modulation of PI3K/Akt/mTOR.
Neoplasms
NaviCom: a web application to create interactive molecular network portraits using multi-level omics data.
Neoplasms
NCALD affects drug resistance and prognosis by acting as a ceRNA of CX3CL1 in ovarian cancer.
Neoplasms
NCAPG promotes the progression of lung adenocarcinoma via the TGF-? signaling pathway.
Neoplasms
NCAPH is upregulated in endometrial cancer and associated with poor clinicopathologic characteristics.
Neoplasms
ncRNA therapy with miRNA-22-3p suppresses the growth of triple-negative breast cancer.
Neoplasms
ncRNA-eQTL: a database to systematically evaluate the effects of SNPs on non-coding RNA expression across cancer types.
Neoplasms
ncRNAs-mediated high expression of SEMA3F correlates with poor prognosis and tumor immune infiltration of hepatocellular carcinoma.
Neoplasms
NDRG1 suppresses vasculogenic mimicry and tumor aggressiveness in gastric carcinoma.
Neoplasms
NDRG2 and TLR7 as novel DNA methylation prognostic signatures for acute myelocytic leukemia.
Neoplasms
NDRG4 hypermethylation is a potential biomarker for diagnosis and prognosis of gastric cancer in Chinese population.
Neoplasms
NDUFA4L2 is associated with clear cell renal cell carcinoma malignancy and is regulated by ELK1.
Neoplasms
Near haploidization is a genomic hallmark which defines a molecular subgroup of giant cell glioblastoma.
Neoplasms
NECTIN4 promotes papillary thyroid cancer cell proliferation, migration, and invasion and triggers EMT by activating AKT.
Neoplasms
NEDD4 Negatively Regulates GITR via Ubiquitination in Immune Microenvironment of Melanoma.
Neoplasms
Negative Correlation between miR-200c and Decorin Plays an Important Role in the Pathogenesis of Colorectal Carcinoma.
Neoplasms
Negative prognostic impact of epidermal growth factor receptor copy number gain in young adults with isocitrate dehydrogenase wild-type glioblastoma.
Neoplasms
NEIL1 p.Gln282Stop variant is predominantly localized in the cytoplasm and exhibits reduced activity in suppressing mutations.
Neoplasms
Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival.
Neoplasms
Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer.
Neoplasms
Neonatal aphakia retards ocular growth and alters scleral gene expression in rhesus monkeys.
Neoplasms
Neoplastic Transformation of Human Mesenchymal Stromal Cells Mediated via LIN28B.
Neoplasms
NEpiC: a network-assisted algorithm for epigenetic studies using mean and variance combined signals.
Neoplasms
Nestin and CD34 expression in colorectal cancer predicts improved overall survival.
Neoplasms
Nestin+/CD31+ cells in the hypoxic perivascular niche regulate glioblastoma chemoresistance by upregulating JAG1 and DLL4.
Neoplasms
netboxr: Automated discovery of biological process modules by network analysis in R.
Neoplasms
NetNorM: Capturing cancer-relevant information in somatic exome mutation data with gene networks for cancer stratification and prognosis.
Neoplasms
Network analysis based on low-rank method for mining information on integrated data of multi-cancers.
Neoplasms
Network analysis identifies DAPK3 as a potential biomarker for lymphatic invasion and colon adenocarcinoma prognosis.
Neoplasms
Network analysis of aging acceleration reveals systematic properties of 11 types of cancers.
Neoplasms
Network analysis of genomic alteration profiles reveals co-altered functional modules and driver genes for glioblastoma.
Neoplasms
Network analysis of miRNA targeting m6A-related genes in patients with esophageal cancer.
Neoplasms
Network integration of multi-tumour omics data suggests novel targeting strategies.
Neoplasms
Network Meta-Analysis on the Effects of DNA Damage Response-Related Gene Mutations on Overall Survival of Breast Cancer Based on TCGA Database.
Neoplasms
Network modeling of the transcriptional effects of copy number aberrations in glioblastoma.
Neoplasms
Network Rewiring in Cancer: Applications to Melanoma Cell Lines and the Cancer Genome Atlas Patients.
Neoplasms
Network-adjusted Kendall's Tau Measure for Feature Screening with Application to High-dimensional Survival Genomic Data.
Neoplasms
Network-Based Approach to Identify the Antiproliferative Mechanisms of Bruceine D in Breast Cancer From the Cancer Genome Atlas.
Neoplasms
Network-based identification of key master regulators associated with an immune-silent cancer phenotype.
Neoplasms
Network-Based Integration of Disparate Omic Data To Identify "Silent Players" in Cancer.
Neoplasms
Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk.
Neoplasms
Network-based integrative clustering of multiple types of genomic data using non-negative matrix factorization.
Neoplasms
Network-Based Isoform Quantification with RNA-Seq Data for Cancer Transcriptome Analysis.
Neoplasms
Network-based machine learning and graph theory algorithms for precision oncology.
Neoplasms
Network-based meta-analysis in the identification of biomarkers for papillary thyroid cancer.
Neoplasms
Network-based multi-task learning models for biomarker selection and cancer outcome prediction.
Neoplasms
Network-Based Predictors of Progression in Head and Neck Squamous Cell Carcinoma.
Neoplasms
Neural precursor cell expressed, developmentally downregulated 8 promotes tumor progression and predicts poor prognosis of patients with bladder cancer.
Neoplasms
Neurexophilin and PC-esterase domain family member 4 (NXPE4) and prostate androgen-regulated mucin-like protein 1 (PARM1) as prognostic biomarkers for colorectal cancer.
Neoplasms
Neurofibromin knockdown in glioma cell lines is associated with changes in cytokine and chemokine secretion in vitro.
Neoplasms
Neuroimaging-Based Classification Algorithm for Predicting 1p/19q-Codeletion Status in IDH-Mutant Lower Grade Gliomas.
Neoplasms
Neuromedin U induces an invasive phenotype in CRC cells expressing the NMUR2 receptor.
Neoplasms
Neuropilin-1 predicts poor prognosis and promotes tumor metastasis through epithelial-mesenchymal transition in gastric cancer.
Neoplasms
Neutrophil Extracellular Traps (NETs) Promote Pro-Metastatic Phenotype in Human Breast Cancer Cells through Epithelial-Mesenchymal Transition.
Neoplasms
Neutrophils Alter DNA Repair Landscape to Impact Survival and Shape Distinct Therapeutic Phenotypes of Colorectal Cancer.
Neoplasms
New Analysis Framework Incorporating Mixed Mutual Information and Scalable Bayesian Networks for Multimodal High Dimensional Genomic and Epigenomic Cancer Data.
Neoplasms
New classification of endometrial cancers: the development and potential applications of genomic-based classification in research and clinical care.
Neoplasms
New functionalities in the TCGAbiolinks package for the study and integration of cancer data from GDC and GTEx.
Neoplasms
New global analysis of the microRNA transcriptome of primary tumors and lymph node metastases of papillary thyroid cancer.
Neoplasms
New insight into BIRC3: A novel prognostic indicator and a potential therapeutic target for liver cancer.
Neoplasms
New insights into the molecular profile of lung adenocarcinoma and implications for therapy.
Neoplasms
New mechanistic insights of clear cell renal cell carcinoma from integrated miRNA and mRNA expression profiling studies.
Neoplasms
New Pathological and Clinical Insights in Endometrial Cancer in View of the Updated ESGO/ESTRO/ESP Guidelines.
Neoplasms
New Perspectives on Pheochromocytoma and Paraganglioma: Towards a Molecular Classification.
Neoplasms
New strategies in the molecular targeting of glioblastoma: how do you hit a moving target?
Neoplasms
Next Generation Sequencing and Genetic Alterations in Squamous Cell Lung Carcinoma: Where Are We Today?
Neoplasms
Next generation sequencing approach for detecting 491 fusion genes from human cancer.
Neoplasms
Next generation sequencing has lower sequence coverage and poorer SNP-detection capability in the regulatory regions.
Neoplasms
Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer.
Neoplasms
Next Generation Sequencing: The Next Iteration of Personalized Medicine: Next generation sequencing, along with expanding databases like The Cancer Genome Atlas, has the potential to aid rational drug discovery and streamline clinical trials.
Neoplasms
Next-generation prostate cancer biobanking: toward a processing protocol amenable for the International Cancer Genome Consortium.
Neoplasms
Next-generation RNA Sequencing-based Biomarker Characterization of Chromophobe Renal Cell Carcinoma and Related Oncocytic Neoplasms.
Neoplasms
Next-Generation Sequencing Reveals High Uncommon EGFR Mutations and Tumour Mutation Burden in a Subgroup of Lung Cancer Patients.
Neoplasms
Next-generation sequencing, cancer and molecular diagnostics: an interview with Elaine Mardis.
Neoplasms
Next-Generation Sequencing-Based Assessment of JAK2, PD-L1, and PD-L2 Copy Number Alterations at 9p24.1 in Breast Cancer: Potential Implications for Clinical Management.
Neoplasms
Next-generation sequencing-based identification of EGFR and NOTCH2 complementary mutations in non-small cell lung cancer.
Neoplasms
NF-kappa B Signaling-Related Signatures Are Connected with the Mesenchymal Phenotype of Circulating Tumor Cells in Non-Metastatic Breast Cancer.
Neoplasms
NF2 and Canonical Hippo-YAP Pathway Define Distinct Tumor Subsets Characterized by Different Immune Deficiency and Treatment Implications in Human Pleural Mesothelioma.
Neoplasms
NFAT Overexpression Correlates with CA72-4 and Poor Prognosis of Ovarian Clear-Cell Carcinoma Subtype.
Neoplasms
NFIB promotes the migration and progression of kidney renal clear cell carcinoma by regulating PINK1 transcription.
Neoplasms
NFIX downregulation independently predicts poor prognosis in lung adenocarcinoma, but not in squamous cell carcinoma.
Neoplasms
NHERF1, a novel GPER associated protein, increases stability and activation of GPER in ER-positive breast cancer.
Neoplasms
NICE-3-knockdown induces cell cycle arrest and autophagy in lung adenocarcinoma cells via the AKT/mTORC1 signaling pathway.
Neoplasms
Nicotinamide N-Methyltransferase Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric Cancer.
Neoplasms
Nicotinamide nucleotide transhydrogenase acts as a new prognosis biomarker in hepatocellular carcinoma.
Neoplasms
Nicotine and oxidative stress induced exomic variations are concordant and overrepresented in cancer-associated genes.
Neoplasms
Nicotine promotes the development of non-small cell lung cancer through activating LINC00460 and PI3K/Akt signaling.
Neoplasms
NIMA related kinase 2 promotes gastric cancer cell proliferation via ERK/MAPK signaling.
Neoplasms
Nine Genes Mediate the Therapeutic Effects of Iodine-131 Radiotherapy in Thyroid Carcinoma Patients.
Neoplasms
Nine-long non-coding ribonucleic acid signature can improve the survival prediction of colorectal cancer.
Neoplasms
Niraparib Suppresses Cholangiocarcinoma Tumor Growth by Inducing Oxidative and Replication Stress.
Neoplasms
NK Cell Infiltrates and HLA Class I Expression in Primary HER2+ Breast Cancer Predict and Uncouple Pathological Response and Disease-free Survival.
Neoplasms
NK homeobox 2.2 functions as tumor suppressor in colorectal cancer due to DNA methylation.
Neoplasms
NK- and T-cell subsets in malignant mesothelioma patients: Baseline pattern and changes in the context of anti-CTLA-4 therapy.
Neoplasms
NKCC1 involvement in the epithelial-to-mesenchymal transition is a prognostic biomarker in gliomas.
Neoplasms
NKX6-1 mediates cancer stem-like properties and regulates sonic hedgehog signaling in leiomyosarcoma.
Neoplasms
NLRC and NLRX gene family mRNA expression and prognostic value in hepatocellular carcinoma.
Neoplasms
NLRC5 mediates cell proliferation, migration, and invasion by regulating the Wnt/?-catenin signalling pathway in clear cell renal cell carcinoma.
Neoplasms
NME4 may enhance non?small cell lung cancer progression by overcoming cell cycle arrest and promoting cellular proliferation.
Neoplasms
NMIIA promotes tumor growth and metastasis by activating the Wnt/?-catenin signaling pathway and EMT in pancreatic cancer.
Neoplasms
NNMT Silencing Activates Tumor Suppressor PP2A, Inactivates Oncogenic STKs, and Inhibits Tumor Forming Ability.
Neoplasms
Noggin is associated with a poor prognosis of gastric cancer by promoting the proliferation of gastric cancer cells via the upregulation of EGFR.
Neoplasms
Nomogram based on immune scores for predicting the survival of patients with esophageal squamous cell carcinoma.
Neoplasms
Nomogram Based on microRNA Signature Contributes to Improve Survival Prediction of Clear Cell Renal Cell Carcinoma.
Neoplasms
Nomogram model characterized by mutant genes and clinical indexes to identify high-risk patients with stage III/IV colorectal cancer.
Neoplasms
Non-coding single nucleotide variants affecting estrogen receptor binding and activity.
Neoplasms
Non-diffeomorphic registration of brain tumor images by simulating tissue loss and tumor growth.
Neoplasms
Non-Negative Symmetric Low-Rank Representation Graph Regularized Method for Cancer Clustering Based on Score Function.
Neoplasms
Non-small cell lung cancer associated microRNA expression signature: integrated bioinformatics analysis, validation and clinical significance.
Neoplasms
Non-SMC Condensin I Complex, Subunit G (NCAPG) is a Novel Mitotic Gene Required for Hepatocellular Cancer Cell Proliferation and Migration.
Neoplasms
Noncoding RNA Expression and Targeted Next-Generation Sequencing Distinguish Tubulocystic Renal Cell Carcinoma (TC-RCC) from Other Renal Neoplasms.
Neoplasms
Nonpromoter methylation of the CDKN2A gene with active transcription is associated with improved locoregional control in laryngeal squamous cell carcinoma.
Neoplasms
Nonredundant, Highly Connected MicroRNAs Control Functionality in Breast Cancer Networks.
Neoplasms
Nonsense-mediated decay factor SMG7 sensitizes cells to TNF?-induced apoptosis via CYLD tumor suppressor and the noncoding oncogene Pvt1.
Neoplasms
Norepinephrine Enhances Aerobic Glycolysis and May Act as a Predictive Factor for Immunotherapy in Gastric Cancer.
Neoplasms
Norepinephrine inhibits migration and invasion of human glioblastoma cell cultures possibly via MMP-11 inhibition.
Neoplasms
Normal tissue adjacent to tumor expression profile analysis developed and validated a prognostic model based on Hippo-related genes in hepatocellular carcinoma.
Neoplasms
Normalized lmQCM: An Algorithm for Detecting Weak Quasi-Cliques in Weighted Graph with Applications in Gene Co-Expression Module Discovery in Cancers.
Neoplasms
Notch and mTOR Signaling Pathways Promote Human Gastric Cancer Cell Proliferation.
Neoplasms
Notch Signaling Activation Is Associated with Patient Mortality and Increased FGF1-Mediated Invasion in Squamous Cell Carcinoma of the Oral Cavity.
Neoplasms
Notch1 Deficiency Induces Tumor Cell Accumulation Inside the Bronchiolar Lumen and Increases TAZ Expression in an Autochthonous Kras LSL-G12V Driven Lung Cancer Mouse Model.
Neoplasms
Notch1 is a prognostic factor that is distinctly activated in the classical and proneural subtype of glioblastoma and that promotes glioma cell survival via the NF-?B(p65) pathway.
Neoplasms
Notch3 interactome analysis identified WWP2 as a negative regulator of Notch3 signaling in ovarian cancer.
Neoplasms
NOTCH3 is a Prognostic Factor and Is Correlated With Immune Tolerance in Gastric Cancer.
Neoplasms
NOTCH4 Is a Novel Prognostic Marker that Correlates with Colorectal Cancer Progression and Prognosis.
Neoplasms
Novel Application of Junction Trees to the Interpretation of Epigenetic Differences among Lung Cancer Subtypes.
Neoplasms
Novel Autophagy-Related Gene Signature Investigation for Patients With Oral Squamous Cell Carcinoma.
Neoplasms
Novel Biomarkers Associated With Progression and Prognosis of Bladder Cancer Identified by Co-expression Analysis.
Neoplasms
Novel CpG-SNPs in the gastric acid secretion pathway GNAI3 and susceptibility to gastric cancer.
Neoplasms
Novel deep learning-based survival prediction for oral cancer by analyzing tumor-infiltrating lymphocyte profiles through CIBERSORT.
Neoplasms
Novel dopamine receptor 3 antagonists inhibit the growth of primary and temozolomide resistant glioblastoma cells.
Neoplasms
Novel drug candidate for the treatment of several soft?tissue sarcoma histologic subtypes: A computational method using survival?associated gene signatures for drug repurposing.
Neoplasms
Novel drug candidates for treating esophageal carcinoma: A study on differentially expressed genes, using connectivity mapping and molecular docking.
Neoplasms
Novel Epigenetic Eight-Gene Signature Predictive of Poor Prognosis and MSI-Like Phenotype in Human Metastatic Colorectal Carcinomas.
Neoplasms
Novel functional variants in the Notch pathway and survival of Chinese colorectal cancer.
Neoplasms
Novel genotype-phenotype associations in human cancers enabled by advanced molecular platforms and computational analysis of whole slide images.
Neoplasms
Novel Hypoxia-Related Gene Signature for Risk Stratification and Prognosis in Hepatocellular Carcinoma.
Neoplasms
Novel immune subtypes of lung adenocarcinoma identified through bioinformatic analysis.
Neoplasms
Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma.
Neoplasms
Novel immune-related genes in the tumor microenvironment with prognostic value in breast cancer.
Neoplasms
Novel immune-related signature for risk stratification and prognosis in prostatic adenocarcinoma.
Neoplasms
Novel insights into clear cell renal cell carcinoma prognosis by comprehensive characterization of aberrant alternative splicing signature: a study based on large-scale sequencing data.
Neoplasms
Novel Insights Into Triple-Negative Breast Cancer Prognosis by Comprehensive Characterization of Aberrant Alternative Splicing.
Neoplasms
Novel internal regulators and candidate miRNAs within miR-379/miR-656 miRNA cluster can alter cellular phenotype of human glioblastoma.
Neoplasms
Novel LncRNA OXCT1-AS1 indicates poor prognosis and contributes to tumorigenesis by regulating miR-195/CDC25A axis in glioblastoma.
Neoplasms
Novel long non-coding RNA LINC02323 promotes epithelial-mesenchymal transition and metastasis via sponging miR-1343-3p in lung adenocarcinoma.
Neoplasms
Novel long non-coding RNA LINC02532 promotes gastric cancer cell proliferation, migration, and invasion in vitro.
Neoplasms
Novel LRRK2 mutations and other rare, non-BAP1-related candidate tumor predisposition gene variants in high-risk cancer families with mesothelioma and other tumors.
Neoplasms
Novel mechanistic targets of forkhead box Q1 transcription factor in human breast cancer cells.
Neoplasms
Novel methylated biomarkers and a robust assay to detect circulating tumor DNA in metastatic breast cancer.
Neoplasms
Novel methylation-driven genes identified as prognostic indicators for lung squamous cell carcinoma.
Neoplasms
Novel MicroRNA-Based Risk Score Identified by Integrated Analyses to Predict Metastasis and Poor Prognosis in Breast Cancer.
Neoplasms
Novel miRNA Predicts Survival and Prognosis of Cholangiocarcinoma Based on RNA-seq Data and In Vitro Experiments.
Neoplasms
Novel Molecular Subtypes Associated With 5mC Methylation and Their Role in Hepatocellular Carcinoma Immunotherapy.
Neoplasms
Novel nomograms based on immune and stromal scores for predicting the disease-free and overall survival of patients with hepatocellular carcinoma undergoing radical surgery.
Neoplasms
Novel oxidative stress-related prognostic biomarkers for melanoma associated with tumor metastasis.
Neoplasms
Novel prognostic genes and subclasses of acute myeloid leukemia revealed by survival analysis of gene expression data.
Neoplasms
Novel prognostic prediction model constructed through machine learning on the basis of methylation-driven genes in kidney renal clear cell carcinoma.
Neoplasms
Novel RB1-Loss Transcriptomic Signature Is Associated with Poor Clinical Outcomes across Cancer Types.
Neoplasms
Novel targets identified by integrated cancer-stromal interactome analysis of pancreatic adenocarcinoma.
Neoplasms
Novel Therapies for Tongue Squamous Cell Carcinoma Patients with High-Grade Tumors.
Neoplasms
Novel three?lncRNA signature predicts survival in patients with pancreatic cancer.
Neoplasms
NPRL2 reduces the niraparib sensitivity of castration-resistant prostate cancer via interacting with UBE2M and enhancing neddylation.
Neoplasms
NR1H3 Expression is a Prognostic Factor of Overall Survival for Patients with Muscle-Invasive Bladder Cancer.
Neoplasms
NR2F2 Orphan Nuclear Receptor is Involved in Estrogen Receptor Alpha-Mediated Transcriptional Regulation in Luminal A Breast Cancer Cells.
Neoplasms
NR3C2-Related Transcriptome Profile and Clinical Outcome in Invasive Breast Carcinoma.
Neoplasms
NRAS and EPHB6 mutation rates differ in metastatic melanomas of patients in the North Island versus South Island of New Zealand.
Neoplasms
NRASQ61K melanoma tumor formation is reduced by p38-MAPK14 activation in zebrafish models and NRAS-mutated human melanoma cells.
Neoplasms
Nrf2 and SQSTM1/p62 jointly contribute to mesenchymal transition and invasion in glioblastoma.
Neoplasms
NSD1 mutations by HPV status in head and neck cancer: differences in survival and response to DNA-damaging agents.
Neoplasms
NSD1- and NSD2-damaging mutations define a subset of laryngeal tumors with favorable prognosis.
Neoplasms
NT5DC2 promotes leiomyosarcoma tumour cell growth via stabilizing unpalmitoylated TEAD4 and generating a positive feedback loop.
Neoplasms
NT5E/CD73 as Correlative Factor of Patient Survival and Natural Killer Cell Infiltration in Glioblastoma.
Neoplasms
Nuclear envelope structural defect underlies the main cause of aneuploidy in ovarian carcinogenesis.
Neoplasms
Nuclear exclusion of TET1 is associated with loss of 5-hydroxymethylcytosine in IDH1 wild-type gliomas.
Neoplasms
Nuclear Localization of PTTG1 Promotes Migration and Invasion of Seminoma Tumor through Activation of MMP-2.
Neoplasms
Nuclear Receptor Coactivator 5 is Correlated with Progression in Breast Carcinoma.
Neoplasms
Nuclear Transglutaminase 2 interacts with topoisomerase II? to promote DNA damage repair in lung cancer cells.
Neoplasms
Nuclear-encoded cytochrome c oxidase subunit 4 regulates BMI1 expression and determines proliferative capacity of high-grade gliomas.
Neoplasms
Nucleolar protein NOP2 could serve as a potential prognostic predictor for clear cell renal cell carcinoma.
Neoplasms
Nucleophosmin 1 overexpression correlates with 18F-FDG PET/CT metabolic parameters and improves diagnostic accuracy in patients with lung adenocarcinoma.
Neoplasms
Nucleophosmin Mutants Promote Adhesion, Migration and Invasion of Human Leukemia THP-1 Cells through MMPs Up-regulation via Ras/ERK MAPK Signaling.
Neoplasms
Nucleophosmin Mutations Induce Chemosensitivity in THP-1 Leukemia Cells by Suppressing NF-?B Activity and Regulating Bax/Bcl-2 Expression.
Neoplasms
Nucleoporin TPR (translocated promoter region, nuclear basket protein) upregulation alters MTOR-HSF1 trails and suppresses autophagy induction in ependymoma.
Neoplasms
NUDT expression is predictive of prognosis in patients with clear cell renal cell carcinoma.
Neoplasms
NUDT5 as a novel drug target and prognostic biomarker for ER-positive breast cancer.
Neoplasms
NUF2 is a valuable prognostic biomarker to predict early recurrence of hepatocellular carcinoma after surgical resection.
Neoplasms
NUPR1 is a novel potential biomarker and confers resistance to sorafenib in clear cell renal cell carcinoma by increasing stemness and targeting the PTEN/AKT/mTOR pathway.
Neoplasms
NUT midline carcinomas and their differentials by a single molecular profiling method: a new promising diagnostic strategy illustrated by a case report.
Neoplasms
Obesity and genes related to lipid metabolism predict poor survival in oral squamous cell carcinoma.
Neoplasms
Obesity is a risk factor for acute promyelocytic leukemia: evidence from population and cross-sectional studies studies and correlation with flt3 mutations and polyunsaturated fatty acid metabolism.
Neoplasms
Obg-like ATPase 1 (OLA1) overexpression predicts poor prognosis and promotes tumor progression by regulating P21/CDK2 in hepatocellular carcinoma.
Neoplasms
Object-oriented regression for building predictive models with high dimensional omics data from translational studies.
Neoplasms
Observed correlation between the expression levels of catalytic subunit, C?2, of cyclic adenosine monophosphate-dependent protein kinase and prostate cancer aggressiveness.
Neoplasms
Observed Survival Interval: A Supplement to TCGA Pan-Cancer Clinical Data Resource.
Neoplasms
Occipito-cervical Reconstruction Through Direct Lateral and Posterior Approach or the Treatment of Primary Osteosarcoma in the Atlas: A Case Report.
Neoplasms
Occupation and cancer in London: an investigation into nasal and bladder cancer using the Cancer Atlas.
Neoplasms
OCIAD2 suppressed tumor growth and invasion via AKT pathway in Hepatocelluar carcinoma.
Neoplasms
Octogenarians' Breast Cancer Is Associated with an Unfavorable Tumor Immune Microenvironment and Worse Disease-Free Survival.
Neoplasms
ODC1 promotes proliferation and mobility via the AKT/GSK3?/?-catenin pathway and modulation of acidotic microenvironment in human hepatocellular carcinoma.
Neoplasms
Oestrogen receptor alpha in papillary thyroid carcinoma: association with clinical features and BRAFV600E mutation.
Neoplasms
Of fractal and Fourier: A measure for local shape complexity for neurological applications.
Neoplasms
OGDHL closely associates with tumor microenvironment and can serve as a prognostic biomarker for papillary thyroid cancer.
Neoplasms
OIP5-AS1 modulates epigenetic regulator HDAC7 to enhance non-small cell lung cancer metastasis via miR-140-5p.
Neoplasms
OLA1 is a potential prognostic molecular biomarker for endometrial cancer and promotes tumor progression.
Neoplasms
Oligodendroglial tumours: subventricular zone involvement and seizure history are associated with CIC mutation status.
Neoplasms
Omics AnalySIs System for PRecision Oncology (OASISPRO): A Web-based Omics Analysis Tool for Clinical Phenotype Prediction.
Neoplasms
Omics data-driven analysis identifies laminin-integrin-mediated signaling pathway as a determinant for cell differentiation in oral squamous cell carcinoma.
Neoplasms
Omics Pipe: a community-based framework for reproducible multi-omics data analysis.
Neoplasms
Omics-based integrated analysis identified ATRX as a biomarker associated with glioma diagnosis and prognosis.
Neoplasms
OncoBinder facilitates interpretation of proteomic interaction data by capturing coactivation pairs in cancer.
Neoplasms
Oncofetal gene SALL4 and prognosis in cancer: A systematic review with meta-analysis.
Neoplasms
Oncogene inference optimization using constraint-based modelling incorporated with protein expression in normal and tumour tissues.
Neoplasms
Oncogene or tumor suppressor? Long noncoding RNAs role in patient's prognosis varies depending on disease type.
Neoplasms
Oncogenes without a Neighboring Tumor-Suppressor Gene Are More Prone to Amplification.
Neoplasms
Oncogenic Activity of Wrap53 in Human Colorectal Cancer In Vitro and in Nude Mouse Xenografts.
Neoplasms
Oncogenic B-Myb Is Associated With Deregulation of the DREAM-Mediated Cell Cycle Gene Expression Program in High Grade Serous Ovarian Carcinoma Clinical Tumor Samples.
Neoplasms
Oncogenic Chromatin Modifier KAT2A Activates MCT1 to Drive the Glycolytic Process and Tumor Progression in Renal Cell Carcinoma.
Neoplasms
Oncogenic effect of PHLDB2 is associated with epithelial-mesenchymal transition and E-cadherin regulation in colorectal cancer.
Neoplasms
Oncogenic function of the homeobox A13-long noncoding RNA HOTTIP-insulin growth factor-binding protein 3 axis in human gastric cancer.
Neoplasms
Oncogenic HSP60 regulates mitochondrial oxidative phosphorylation to support Erk1/2 activation during pancreatic cancer cell growth.
Neoplasms
Oncogenic K-Ras4B Dimerization Enhances Downstream Mitogen-activated Protein Kinase Signaling.
Neoplasms
Oncogenic miR?132 sustains proliferation and self?renewal potential by inhibition of polypyrimidine tract?binding protein 2 in glioblastoma cells.
Neoplasms
Oncogenic Properties of NEAT1 in Prostate Cancer Cells Depend on the CDC5L-AGRN Transcriptional Regulation Circuit.
Neoplasms
Oncogenic Properties of the Antisense lncRNA COMET in BRAF- and RET-Driven Papillary Thyroid Carcinomas.
Neoplasms
Oncogenic Role and Prognostic Value of MicroRNA-937-3p in Patients with Breast Cancer.
Neoplasms
Oncogenic Roles of RAD51AP1 in Tumor Tissues Related to Overall Survival and Disease-Free Survival in Hepatocellular Carcinoma.
Neoplasms
Oncogenic SNORD12B activates the AKT-mTOR-4EBP1 signaling in esophageal squamous cell carcinoma via nucleus partitioning of PP-1?.
Neoplasms
Oncogenic splicing abnormalities induced by DEAD-Box Helicase 56 amplification in colorectal cancer.
Neoplasms
Oncogenic tuftelin 1 as a potential molecular-targeted for inhibiting hepatocellular carcinoma growth.
Neoplasms
Oncogenic value of microRNA-15b-5p in hepatocellular carcinoma and a bioinformatics investigation.
Neoplasms
Oncogenic Wnt3a: A Candidate Specific Marker and Novel Molecular Target for Hepatocellular Carcinoma.
Neoplasms
Oncogenomic portals for the visualization and analysis of genome-wide cancer data.
Neoplasms
Oncogenomics of c-Myc transgenic mice reveal novel regulators of extracellular signaling, angiogenesis and invasion with clinical significance for human lung adenocarcinoma.
Neoplasms
Oncological and prognostic impact of lymphovascular invasion in Colorectal Cancer patients.
Neoplasms
Oncomorphic TP53 Mutations in Gynecologic Cancers Lose the Normal Protein:Protein Interactions with the microRNA Microprocessing Complex.
Neoplasms
oncoNcRNA: A Web Portal for Exploring the Non-Coding RNAs with Oncogenic Potentials in Human Cancers.
Neoplasms
Oncoplastic surgery for breast cancer based on tumour location and a quadrant-per-quadrant atlas.
Neoplasms
OncotRF: an online resource for exploration of tRNA-derived fragments in human cancers.
Neoplasms
OncoVar: an integrated database and analysis platform for oncogenic driver variants in cancers.
Neoplasms
One-carbon metabolism biomarkers and genetic variants in relation to colorectal cancer risk by KRAS and BRAF mutation status.
Neoplasms
OPCML Methylation and the Risk of Ovarian Cancer: A Meta and Bioinformatics Analysis.
Neoplasms
OpenHealth Platform for Interactive Contextualization of Population Health Open Data.
Neoplasms
Opportunities of next-generation sequencing in non-muscle invasive bladder cancer outcome prediction.
Neoplasms
Opposing roles of the aldo-keto reductases AKR1B1 and AKR1B10 in colorectal cancer.
Neoplasms
Opposite Roles of BAP1 in Overall Survival of Uveal Melanoma and Cutaneous Melanoma.
Neoplasms
Opposite Roles of Tumor Cell Proliferation and Immune Cell Infiltration in Postoperative Liver Metastasis of PDAC.
Neoplasms
Optical Coherence Tomography: A Novel Imaging Method for Post-lumpectomy Breast Margin Assessment-A Multi-reader Study.
Neoplasms
Optimal cutoff age for predicting prognosis associated with serous epithelial ovarian cancer: what is the best age cutoff?
Neoplasms
Optimal selection of genetic variants for adjustment of population stratification in European association studies.
Neoplasms
Optimal subset of signature miRNAs consisting of 7 miRNAs that can serve as a novel diagnostic and prognostic predictor for the progression of cervical cancer.
Neoplasms
Optimisation of cancer classification by machine learning generates an enriched list of candidate drug targets and biomarkers.
Neoplasms
Optimization of deep learning methods for visualization of tumor heterogeneity and brain tumor grading through digital pathology.
Neoplasms
Optimization of Population Frequency Cutoffs for Filtering Common Germline Polymorphisms from Tumor-Only Next-Generation Sequencing Data.
Neoplasms
Optimization of Signal Decomposition Matched Filtering (SDMF) for Improved Detection of Copy-Number Variations.
Neoplasms
Optimization to detect TP53 mutations in circulating cell-free tumor DNA from patients with serous epithelial ovarian cancer.
Neoplasms
Optimized prostate biopsy via a statistical atlas of cancer spatial distribution.
Neoplasms
Oral submucous fibrosis stimulates invasion and epithelial-mesenchymal transition in oral squamous cell carcinoma by activating MMP-2 and IGF-IR.
Neoplasms
ORBIT: a multiresolution framework for deformable registration of brain tumor images.
Neoplasms
Ordino: a visual cancer analysis tool for ranking and exploring genes, cell lines, and tissue samples.
Neoplasms
Original Article/Liver hMex-3A is associated with poor prognosis and contributes to the progression of hepatocellular carcinoma.
Neoplasms
Original tumour suppressor gene polycystic kidney and hepatic disease 1-like 1 is associated with thyroid cancer cell progression.
Neoplasms
Orphan nuclear receptor TLX promotes immunosuppression via its transcriptional activation of PD-L1 in glioma.
Neoplasms
OSacc: Gene Expression-Based Survival Analysis Web Tool For Adrenocortical Carcinoma.
Neoplasms
OSbrca: A Web Server for Breast Cancer Prognostic Biomarker Investigation With Massive Data From Tens of Cohorts.
Neoplasms
OScc: an online survival analysis web server to evaluate the prognostic value of biomarkers in cervical cancer.
Neoplasms
OSdlbcl: An online consensus survival analysis web server based on gene expression profiles of diffuse large B-cell lymphoma.
Neoplasms
OSkirc: a web tool for identifying prognostic biomarkers in kidney renal clear cell carcinoma.
Neoplasms
OSmfs: An Online Interactive Tool to Evaluate Prognostic Markers for Myxofibrosarcoma.
Neoplasms
Otoferlin is a prognostic biomarker in patients with clear cell renal cell carcinoma: A systematic expression analysis.
Neoplasms
Outcome prediction with the revised American joint committee on cancer staging system and American thyroid association guidelines for thyroid cancer.
Neoplasms
Outcomes of patients with sarcoma enrolled in clinical trials of pazopanib combined with histone deacetylase, mTOR, Her2, or MEK inhibitors.
Neoplasms
Outer Radial Glia-like Cancer Stem Cells Contribute to Heterogeneity of Glioblastoma.
Neoplasms
Outlier response to anti-PD1 in uveal melanoma reveals germline MBD4 mutations in hypermutated tumors.
Neoplasms
Over expression of DNA damage and cell cycle dependent proteins are associated with poor survival in patients with adrenocortical carcinoma.
Neoplasms
Over-Expression and Prognostic Significance of HHLA2, a New Immune Checkpoint Molecule, in Human Clear Cell Renal Cell Carcinoma.
Neoplasms
Over-expression of EGFR regulated by RARA contributes to 5-FU resistance in colon cancer.
Neoplasms
Over-expression of long non-coding RNA insulin-like growth factor 2-antisense suppressed hepatocellular carcinoma cell proliferation and metastasis by regulating the microRNA-520h/cyclin-dependent kinase inhibitor 1A signaling pathway.
Neoplasms
Over-expression of TFB2M facilitates cell growth and metastasis via activating ROS-Akt-NF-?B signaling in hepatocellular carcinoma.
Neoplasms
Over-expression of Thrombospondin 4 correlates with loss of miR-142 and contributes to migration and vascular invasion of advanced hepatocellular carcinoma.
Neoplasms
Over-expression of vitronectin correlates with impaired survival in gastric cancers.
Neoplasms
Overcoming Intrinsic and Acquired Cetuximab Resistance in RAS Wild-Type Colorectal Cancer: An In Vitro Study on the Expression of HER Receptors and the Potential of Afatinib.
Neoplasms
Overexpressed lncRNA CDKN2B-AS1 is an independent prognostic factor for liver cancer and promotes its proliferation.
Neoplasms
Overexpressed NEDD8 as a potential therapeutic target in esophageal squamous cell carcinoma.
Neoplasms
Overexpressed somatic alleles are enriched in functional elements in Breast Cancer.
Neoplasms
Overexpression and gene amplification of PD-L1 in cancer cells and PD-L1(+) immune cells in Epstein-Barr virus-associated gastric cancer: the prognostic implications.
Neoplasms
Overexpression of MYBL2 predicts poor prognosis and promotes oncogenesis in endometrial carcinoma.
Neoplasms
Overexpression of ?3, ?3 and ?2 chains of laminin-332 is associated with poor prognosis in pancreatic ductal adenocarcinoma.
Neoplasms
Overexpression of ADAR1 into the cytoplasm correlates with a better prognosis of patients with oral squamous cells carcinoma.
Neoplasms
Overexpression of ARID4B predicts poor survival in patients with hepatocellular carcinoma.
Neoplasms
Overexpression of ASPM, CDC20, and TTK Confer a Poorer Prognosis in Breast Cancer Identified by Gene Co-expression Network Analysis.
Neoplasms
Overexpression of B7-H4 promotes renal cell carcinoma progression by recruiting tumor-associated neutrophils via upregulation of CXCL8.
Neoplasms
Overexpression of BHLHE41, correlated with DNA hypomethylation in 3'UTR region, promotes the growth of human clear cell renal cell carcinoma.
Neoplasms
Overexpression of BMP1 reflects poor prognosis in clear cell renal cell carcinoma.
Neoplasms
Overexpression of Canonical Prefoldin Associates with the Risk of Mortality and Metastasis in Non-Small Cell Lung Cancer.
Neoplasms
Overexpression of carbonic anhydrase IX induces cell motility by activating matrix metalloproteinase-9 in human oral squamous cell carcinoma cells.
Neoplasms
Overexpression of CCDC69 activates p14ARF/MDM2/p53 pathway and confers cisplatin sensitivity.
Neoplasms
Overexpression of CD44 is associated with a poor prognosis in grade II/III gliomas.
Neoplasms
Overexpression of CD97 confers an invasive phenotype in glioblastoma cells and is associated with decreased survival of glioblastoma patients.
Neoplasms
Overexpression of Cell-Surface Marker SLC16A1 Shortened Survival in Human High-Grade Gliomas.
Neoplasms
Overexpression of chemokine receptor lymphotactin receptor 1 has prognostic value in clear cell renal cell carcinoma.
Neoplasms
Overexpression of CKS2 is associated with a poor prognosis and promotes cell proliferation and invasion in breast cancer.
Neoplasms
Overexpression of CLEC18B Associates With the Proliferation, Migration, and Prognosis of Glioblastoma.
Neoplasms
Overexpression of CLEC3A promotes tumor progression and poor prognosis in breast invasive ductal cancer.
Neoplasms
Overexpression of COL24A1 in Hepatocellular Carcinoma Predicts Poor Prognosis: A Study Based on Multiple Databases, Clinical Samples and Cell Lines.
Neoplasms
Overexpression of CPXM2 predicts an unfavorable prognosis and promotes the proliferation and migration of gastric cancer.
Neoplasms
Overexpression of E74-like transformation-specific transcription factor 3 promotes cellular proliferation and predicts poor prognosis in ovarian cancer.
Neoplasms
Overexpression of eIF3D in Lung Adenocarcinoma Is a New Independent Prognostic Marker of Poor Survival.
Neoplasms
Overexpression of endothelin B receptor in glioblastoma: a prognostic marker and therapeutic target?
Neoplasms
Overexpression of EP300-interacting inhibitor of differentiation 3 predicts poor prognosis in patients with glioblastoma multiforme.
Neoplasms
Overexpression of ERCC3 is associated with poor prognosis in patients with pancreatic cancer.
Neoplasms
Overexpression of FABP7 promotes cell growth and predicts poor prognosis of clear cell renal cell carcinoma.
Neoplasms
Overexpression of flavin-containing monooxygenase 5 predicts poor prognosis in patients with colorectal cancer.
Neoplasms
Overexpression of G-protein-coupled receptors 65 in glioblastoma predicts poor patient prognosis.
Neoplasms
Overexpression of G6PD Represents a Potential Prognostic Factor in Clear Cell Renal Cell Carcinoma.
Neoplasms
Overexpression of GBP1 predicts poor prognosis and promotes tumor growth in human glioblastoma multiforme.
Neoplasms
Overexpression of GIHCG is Associated with a Poor Prognosis and Immune Infiltration in Hepatocellular Carcinoma.
Neoplasms
Overexpression of GUCY1A2 Correlates With Poor Prognosis in Gastric Cancer Patients.
Neoplasms
Overexpression of HMGA1 Figures as a Potential Prognostic Factor in Endometrioid Endometrial Carcinoma (EEC).
Neoplasms
Overexpression of HOTTIP promotes proliferation and drug resistance of lung adenocarcinoma by regulating AKT signaling pathway.
Neoplasms
Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
Neoplasms
Overexpression of hsa-miR-125a-5p enhances proliferation, migration and invasion of head and neck squamous cell carcinoma cell lines by upregulating C-C chemokine receptor type 7.
Neoplasms
Overexpression of HSD17B4 exerts tumor suppressive function in adrenocortical carcinoma and is not associated with hormone excess.
Neoplasms
Overexpression of ICAM-1 Predicts Poor Survival in High-Grade Serous Ovarian Carcinoma: A Study Based on TCGA and GEO Databases and Tissue Microarray.
Neoplasms
Overexpression of ING3 is associated with attenuation of migration and invasion in breast cancer.
Neoplasms
Overexpression of Karyopherin Subunit alpha 2 (KPNA2) Predicts Unfavorable Prognosis and Promotes Bladder Cancer Tumorigenicity via the P53 Pathway.
Neoplasms
Overexpression of KCNJ4 correlates with cancer progression and unfavorable prognosis in lung adenocarcinoma.
Neoplasms
Overexpression of KIAA0101 Promotes the Progression of Non-small Cell Lung Cancer.
Neoplasms
Overexpression of KIF18A promotes cell proliferation, inhibits apoptosis, and independently predicts unfavorable prognosis in lung adenocarcinoma.
Neoplasms
Overexpression of KLF5 is associated with poor survival and G1/S progression in pancreatic cancer.
Neoplasms
Overexpression of KRT17 promotes proliferation and invasion of non-small cell lung cancer and indicates poor prognosis.
Neoplasms
Overexpression of LBX2 associated with tumor progression and poor prognosis in colorectal cancer.
Neoplasms
Overexpression of LINC00691 promotes the proliferation and invasion of gastric cancer cells via the Janus kinase/signal transducer and activator of transcription signalling pathway.
Neoplasms
Overexpression of LncRNA HOTAIR is Associated with Poor Prognosis in Thyroid Carcinoma: A Study Based on TCGA and GEO Data.
Neoplasms
Overexpression of lncRNA SNGH3 Predicts Unfavorable Prognosis and Clinical Outcomes in Human Cancers: Evidence from a Meta-Analysis.
Neoplasms
Overexpression of LncRNA-UCA1 Correlates with Lung Adenocarcinoma Progression and Poor Prognosis.
Neoplasms
Overexpression of long non-coding RNA KCNQ1OT1 is related to good prognosis via inhibiting cell proliferation in non-small cell lung cancer.
Neoplasms
Overexpression of long noncoding RNA LINC01419 in esophageal squamous cell carcinoma and its relation to the sensitivity to 5-fluorouracil by mediating GSTP1 methylation.
Neoplasms
Overexpression of macrophage migration inhibitory factor and functionally-related genes, D-DT, CD74, CD44, CXCR2 and CXCR4, in glioblastoma.
Neoplasms
Overexpression of major CDKN3 transcripts is associated with poor survival in lung adenocarcinoma.
Neoplasms
Overexpression of malignant brain tumor domain containing protein 1 predicts a poor prognosis of prostate cancer.
Neoplasms
Overexpression of MAX dimerization protein 3 (MXD3) predicts poor prognosis in clear cell renal cell carcinoma.
Neoplasms
Overexpression of MCM10 promotes cell proliferation and predicts poor prognosis in prostate cancer.
Neoplasms
Overexpression of METTL3 associated with the metabolic status on 18F-FDG PET/CT in patients with Esophageal Carcinoma.
Neoplasms
Overexpression of MiR-452-5p in hepatocellular carcinoma tissues and its prospective signaling pathways.
Neoplasms
Overexpression of MMP14 predicts the poor prognosis in gastric cancer: Meta-analysis and database validation.
Neoplasms
Overexpression of MUC16 predicts favourable prognosis in MUC16-mutant cervical cancer related to immune response.
Neoplasms
Overexpression of NCAPH is upregulated and predicts a poor prognosis in prostate cancer.
Neoplasms
Overexpression of Nicotinamide N-methyltransferase mainly covers stroma of colorectal cancer and correlates with unfavorable survival by its product 1-MNA.
Neoplasms
Overexpression of NOP58 as a Prognostic Marker in Hepatocellular Carcinoma: A TCGA Data-Based Analysis.
Neoplasms
Overexpression of novel long intergenic non?coding RNA LINC02454 is associated with a poor prognosis in papillary thyroid cancer.
Neoplasms
Overexpression of Nucleolin is a Potential Prognostic Marker in Endometrial Carcinoma.
Neoplasms
Overexpression of NuSAP1 is predictive of an unfavourable prognosis and promotes proliferation and invasion of triple-negative breast cancer cells via the Wnt/?-catenin/EMT signalling axis.
Neoplasms
Overexpression of oncostatin M receptor regulates local immune response in glioblastoma.
Neoplasms
Overexpression of P4HB is correlated with poor prognosis in human clear cell renal cell carcinoma.
Neoplasms
Overexpression of PARPBP Correlates with Tumor Progression and Poor Prognosis in Hepatocellular Carcinoma.
Neoplasms
Overexpression of PDK2 and PDK3 reflects poor prognosis in acute myeloid leukemia.
Neoplasms
Overexpression of PIK3CA in head and neck squamous cell carcinoma is associated with poor outcome and activation of the YAP pathway.
Neoplasms
Overexpression of PKMYT1 Facilitates Tumor Development and Is Correlated with Poor Prognosis in Clear Cell Renal Cell Carcinoma.
Neoplasms
Overexpression of PLIN2 is a prognostic marker and attenuates tumor progression in clear cell renal cell carcinoma.
Neoplasms
Overexpression of PLXDC2 in Stromal Cell-Associated M2 Macrophages Is Related to EMT and the Progression of Gastric Cancer.
Neoplasms
Overexpression of PSAT1 Gene is a Favorable Prognostic Marker in Lower-Grade Gliomas and Predicts a Favorable Outcome in Patients with IDH1 Mutations and Chromosome 1p19q Codeletion.
Neoplasms
Overexpression of PTPRN Promotes Metastasis of Lung Adenocarcinoma and Suppresses NK Cell Cytotoxicity.
Neoplasms
Overexpression of RALY promotes migration and predicts poor prognosis in hepatocellular carcinoma.
Neoplasms
Overexpression of RIPK4 Predicts Poor Prognosis and Promotes Metastasis in Ovarian Cancer.
Neoplasms
Overexpression of S100A14 contributes to malignant progression and predicts poor prognosis of lung adenocarcinoma.
Neoplasms
Overexpression of SERPINA3 promotes tumor invasion and migration, epithelial-mesenchymal-transition in triple-negative breast cancer cells.
Neoplasms
Overexpression of SHMT2 Predicts a Poor Prognosis and Promotes Tumor Cell Growth in Bladder Cancer.
Neoplasms
Overexpression of stathmin/oncoprotein 18 correlates with poorer prognosis and interacts with p53 in oral squamous cell carcinoma.
Neoplasms
Overexpression of suppressive microRNAs, miR-30a and miR-200c are associated with improved survival of breast cancer patients.
Neoplasms
Overexpression of the ASPM gene is associated with aggressiveness and poor outcome in bladder cancer.
Neoplasms
Overexpression of the Kininogen-1 inhibits proliferation and induces apoptosis of glioma cells.
Neoplasms
Overexpression of the SARS-CoV-2 receptor ACE2 is induced by cigarette smoke in bronchial and alveolar epithelia.
Neoplasms
Overexpression of the transcription factor ATF3 with a regulatory molecular signature associates with the pathogenic development of colorectal cancer.
Neoplasms
Overexpression of TICRR and PPIF confer poor prognosis in endometrial cancer identified by gene co-expression network analysis.
Neoplasms
Overexpression of TONSL might be an independent unfavorable prognostic indicator in hepatocellular carcinoma.
Neoplasms
Overexpression of transcription factor activating enhancer binding protein 4 (TFAP4) predicts poor prognosis for colorectal cancer patients.
Neoplasms
Overexpression of transposable elements is associated with immune evasion and poor outcome in colorectal cancer.
Neoplasms
Overexpression of TREM2 enhances glioma cell proliferation and invasion: a therapeutic target in human glioma.
Neoplasms
Overexpression of trophoblast cell surface antigen 2 is associated with BRAF V600E mutation and aggressive behavior in papillary thyroid cancer.
Neoplasms
Overexpression of Tumor Protein p53-regulated Apoptosis-inducing Protein 1 Regulates Proliferation and Apoptosis of Breast Cancer Cells through the PI3K/Akt Pathway.
Neoplasms
Overexpression of ULK1 Represents a Potential Diagnostic Marker for Clear Cell Renal Carcinoma and the Antitumor Effects of SBI-0206965.
Neoplasms
Overexpression of VEGF-C and MMP-9 predicts poor prognosis in Kazakh patients with esophageal squamous cell carcinoma.
Neoplasms
Overlapping clustering of gene expression data using penalized weighted normalized cut.
Neoplasms
Overproduction of IGF-2 drives a subset of colorectal cancer cells, which specifically respond to an anti-IGF therapeutic antibody and combination therapies.
Neoplasms
Overview of Epstein-Barr-Virus-Associated Gastric Cancer Correlated with Prognostic Classification and Development of Therapeutic Options.
Neoplasms
OX40 expression in hepatocellular carcinoma is associated with a distinct immune microenvironment, specific mutation signature, and poor prognosis.
Neoplasms
Oxidative Stress Gene Expression Profile Correlates with Cancer Patient Poor Prognosis: Identification of Crucial Pathways Might Select Novel Therapeutic Approaches.
Neoplasms
Oxidative Stress-Part of the Solution or Part of the Problem in the Hypoxic Environment of a Brain Tumor.
Neoplasms
Oxidized low-density lipoprotein is associated with advanced-stage prostate cancer.
Neoplasms
Oxytocin and oxytocin receptor alterations, decreased survival, and increased chemoresistance in patients with pancreatic cancer.
Neoplasms
p120-Catenin Downregulation and PIK3CA Mutations Cooperate to Induce Invasion through MMP1 in HNSCC.
Neoplasms
p16 methylation is a potential predictive marker for abemaciclib sensitivity in gastric cancer.
Neoplasms
p27 inhibits CDK6/CCND1 complex formation resulting in cell cycle arrest and inhibition of cell proliferation.
Neoplasms
P38 delta MAPK promotes breast cancer progression and lung metastasis by enhancing cell proliferation and cell detachment.
Neoplasms
P38 pathway as a key downstream signal of connective tissue growth factor to regulate metastatic potential in non-small-cell lung cancer.
Neoplasms
P3H4 is correlated with clinicopathological features and prognosis in bladder cancer.
Neoplasms
P4HA1/HIF1? feedback loop drives the glycolytic and malignant phenotypes of pancreatic cancer.
Neoplasms
p53 affects epigenetic signature on SOCS1 promoter in response to TLR4 inhibition.
Neoplasms
p53 and miR-210 regulated NeuroD2, a neuronal basic helix-loop-helix transcription factor, is downregulated in glioblastoma patients and functions as a tumor suppressor under hypoxic microenvironment.
Neoplasms
p53 is functionally inhibited in clear cell renal cell carcinoma (ccRCC): a mechanistic and correlative investigation into genetic and molecular characteristics.
Neoplasms
p53-inducible gene 3 promotes cell migration and invasion by activating the FAK/Src pathway in lung adenocarcinoma.
Neoplasms
p53/PGC?1??mediated mitochondrial dysfunction promotes PC3 prostate cancer cell apoptosis.
Neoplasms
p53abn Endometrial Cancer: understanding the most aggressive endometrial cancers in the era of molecular classification.
Neoplasms
PABPC1L depletion inhibits proliferation and migration via blockage of AKT pathway in human colorectal cancer cells.
Neoplasms
PAFAH1B3 Expression Is Correlated With Gastric Cancer Cell Proliferation and Immune Infiltration.
Neoplasms
PAGE-Net: Interpretable and Integrative Deep Learning for Survival Analysis Using Histopathological Images and Genomic Data.
Neoplasms
PAK1 expression determines poor prognosis and immune evasion in metastatic renal cell carcinoma patients.
Neoplasms
Pan cancer patterns of allelic imbalance from chromosomal alterations in 33 tumor types.
Neoplasms
Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA).
Neoplasms
Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas.
Neoplasms
Pan-cancer analyses of human nuclear receptors reveal transcriptome diversity and prognostic value across cancer types.
Neoplasms
Pan-cancer analyses reveal genomics and clinical characteristics of the melatonergic regulators in cancer.
Neoplasms
Pan-Cancer Analyses Reveal Long Intergenic Non-Coding RNAs Relevant to Tumor Diagnosis, Subtyping and Prognosis.
Neoplasms
Pan-Cancer Analyses Reveal Prognostic Value of Osteomimicry Across 20 Solid Cancer Types.
Neoplasms
Pan-cancer analyses reveal regulation and clinical outcome association of the shelterin complex in cancer.
Neoplasms
Pan-Cancer Analysis Identified C1ORF112 as a Potential Biomarker for Multiple Tumor Types.
Neoplasms
Pan-cancer analysis identifies telomerase-associated signatures and cancer subtypes.
Neoplasms
Pan-cancer analysis of bi-allelic alterations in homologous recombination DNA repair genes.
Neoplasms
Pan-cancer analysis of clinical significance and associated molecular features of glycolysis.
Neoplasms
Pan-cancer analysis of copy number changes in programmed death-ligand 1 (PD-L1, CD274) - associations with gene expression, mutational load, and survival.
Neoplasms
Pan-Cancer Analysis of Genomic and Prognostic Characteristics Associated With Coronavirus Disease 2019 Regulators.
Neoplasms
Pan-cancer analysis of genomic scar signatures associated with homologous recombination deficiency suggests novel indications for existing cancer drugs.
Neoplasms
Pan-Cancer Analysis of Head-to-Head Gene Pairs in Terms of Transcriptional Activity, Co-expression and Regulation.
Neoplasms
Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
Neoplasms
Pan-cancer analysis of intratumor heterogeneity associated with patient prognosis using multidimensional measures.
Neoplasms
Pan-cancer analysis of m5C regulator genes reveals consistent epigenetic landscape changes in multiple cancers.
Neoplasms
Pan-Cancer Analysis of Mitochondria Chaperone-Client Co-Expression Reveals Chaperone Functional Partitioning.
Neoplasms
Pan-cancer Analysis of NEDD4L and Its Tumor Suppressor Effects in Clear Cell Renal Cell Carcinoma.
Neoplasms
Pan-cancer analysis of non-coding recurrent mutations and their possible involvement in cancer pathogenesis.
Neoplasms
Pan-Cancer Analysis of NOS3 Identifies Its Expression and Clinical Relevance in Gastric Cancer.
Neoplasms
Pan-cancer analysis of SETD2 mutation and its association with the efficacy of immunotherapy.
Neoplasms
Pan-Cancer Analysis of TCGA Data Revealed Promising Reference Genes for qPCR Normalization.
Neoplasms
Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas.
Neoplasms
Pan-cancer analysis of transcripts encoding novel open-reading frames (nORFs) and their potential biological functions.
Neoplasms
Pan-cancer analysis reveals an immunological role and prognostic potential of PXN in human cancer.
Neoplasms
Pan-Cancer Analysis Reveals Distinct Metabolic Reprogramming in Different Epithelial-Mesenchymal Transition Activity States.
Neoplasms
Pan-cancer analysis reveals presence of pronounced DNA methylation drift in CpG island methylator phenotype clusters.
Neoplasms
Pan-Cancer Analysis Shows TP53 Mutations Modulate the Association of NOX4 with Genetic Programs of Cancer Progression and Clinical Outcome.
Neoplasms
Pan-cancer association of a centrosome amplification gene expression signature with genomic alterations and clinical outcome.
Neoplasms
Pan-cancer characterisation of microRNA across cancer hallmarks reveals microRNA-mediated downregulation of tumour suppressors.
Neoplasms
Pan-cancer characterization of metabolism-related biomarkers identifies potential therapeutic targets.
Neoplasms
Pan-cancer chromatin analysis of the human vtRNA genes uncovers their association with cancer biology.
Neoplasms
Pan-cancer diagnostic consensus through searching archival histopathology images using artificial intelligence.
Neoplasms
Pan-cancer driver copy number alterations identified by joint expression/CNA data analysis.
Neoplasms
Pan-Cancer Genome-Wide DNA Methylation Analyses Revealed That Hypermethylation Influences 3D Architecture and Gene Expression Dysregulation in HOXA Locus During Carcinogenesis of Cancers.
Neoplasms
Pan-cancer genomic analyses reveal prognostic and immunogenic features of the tumor melatonergic microenvironment across 14 solid cancer types.
Neoplasms
Pan-cancer identification of clinically relevant genomic subtypes using outcome-weighted integrative clustering.
Neoplasms
Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade.
Neoplasms
Pan-cancer immunogenomic perspective on the tumor microenvironment based on PD-L1 and CD8 T cell infiltration.
Neoplasms
Pan-cancer methylation analysis reveals an inverse correlation of tumor immunogenicity with methylation aberrancy.
Neoplasms
Pan-cancer methylation and expression profiling of adenocarcinomas revealed epigenetic silencing in the WNT signaling pathway.
Neoplasms
Pan-Cancer Molecular Characterization of m6A Regulators and Immunogenomic Perspective on the Tumor Microenvironment.
Neoplasms
Pan-Cancer Multiomics Analysis of TC2N Gene Suggests its Important Role(s) in Tumourigenesis of Many Cancers.
Neoplasms
Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes.
Neoplasms
Pan-cancer survey of epithelial-mesenchymal transition markers across the Cancer Genome Atlas.
Neoplasms
Pan-Cancer Survival Classification With Clinicopathological and Targeted Gene Expression Features.
Neoplasms
Pan-cancer transcriptional signatures predictive of oncogenic mutations reveal that Fbw7 regulates cancer cell oxidative metabolism.
Neoplasms
Pancan-meQTL: a database to systematically evaluate the effects of genetic variants on methylation in human cancer.
Neoplasms
Pancancer analysis identifies prognostic high-APOBEC1 expression level implicated in cancer in-frame insertions and deletions.
Neoplasms
PancanQTL: systematic identification of cis-eQTLs and trans-eQTLs in 33 cancer types.
Neoplasms
Pancreatic adenocarcinomas with mature blood vessels have better overall survival.
Neoplasms
Pancreatic cancer induces muscle wasting by promoting the release of pancreatic adenocarcinoma upregulated factor.
Neoplasms
Pancreatic stellate cells regulate branched-chain amino acid metabolism in pancreatic cancer.
Neoplasms
Pannexin1 Is Associated with Enhanced Epithelial-To-Mesenchymal Transition in Human Patient Breast Cancer Tissues and in Breast Cancer Cell Lines.
Neoplasms
Panobinostat sensitizes cyclin E high, homologous recombination-proficient ovarian cancer to olaparib.
Neoplasms
PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.
Neoplasms
Papillary renal cell carcinoma-derived chemerin, IL-8, and CXCL16 promote monocyte recruitment and differentiation into foam-cell macrophages.
Neoplasms
Papillary Renal Cell Carcinomas Rewire Glutathione Metabolism and Are Deficient in Both Anabolic Glucose Synthesis and Oxidative Phosphorylation.
Neoplasms
Papillary Thyroid Carcinoma Variants are Characterized by Co-dysregulation of Immune and Cancer Associated Genes.
Neoplasms
Papillary thyroid carcinoma with a high tumor mutation burden has a poor prognosis.
Neoplasms
Paradoxical effects of cellular senescence-inhibited gene involved in hepatocellular carcinoma migration and proliferation by ERK pathway and mesenchymal-like markers.
Neoplasms
Parameter optimization for constructing competing endogenous RNA regulatory network in glioblastoma multiforme and other cancers.
Neoplasms
PARP-1 serves as a novel molecular marker for hepatocellular carcinoma in a Southern Chinese Zhuang population.
Neoplasms
PARP1 expression and its correlation with survival is tumour molecular subtype dependent in glioblastoma.
Neoplasms
Passenger strand of miR-145-3p acts as a tumor-suppressor by targeting MYO1B in head and neck squamous cell carcinoma.
Neoplasms
Paternally Expressed Gene 10 (PEG10) Promotes Growth, Invasion, and Survival of Bladder Cancer.
Neoplasms
Pathogenic germline variants are associated with poor survival in stage III/IV melanoma patients.
Neoplasms
Pathogenicity assessment of variants for breast cancer susceptibility genes based on BRCAness of tumor sample.
Neoplasms
Pathologic evolution-related Gene Analysis based on both single-cell and bulk transcriptomics in Colorectal Cancer.
Neoplasms
Pathologic Prognostic Factors in Endometrial Carcinoma (Other Than Tumor Type and Grade).
Neoplasms
Pathological significance of MAD2L1 in breast cancer: an immunohistochemical study and meta analysis.
Neoplasms
Pathomic Fusion: An Integrated Framework for Fusing Histopathology and Genomic Features for Cancer Diagnosis and Prognosis.
Neoplasms
Pathomorphologic atlas for differential diagnosis of skin diseases, with particular regard to tumors. Part II. Neoplasms and pseudo-neoplastic proliferations.
Neoplasms
Pathophysiological Role of Histamine H4 Receptor in Cancer: Therapeutic Implications.
Neoplasms
Pathway Based Analysis of Mutation Data Is Efficient for Scoring Target Cancer Drugs.
Neoplasms
Pathway Instability Is an Effective New Mutation-Based Type of Cancer Biomarkers.
Neoplasms
Pathway Relevance Ranking for Tumor Samples through Network-Based Data Integration.
Neoplasms
Pathway- and clinical-factor-based risk model predicts the prognosis of patients with gastric cancer.
Neoplasms
Pathway-Structured Predictive Model for Cancer Survival Prediction: A Two-Stage Approach.
Neoplasms
PathwayMapper: a collaborative visual web editor for cancer pathways and genomic data.
Neoplasms
Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors.
Neoplasms
Patient-Specific Cell Communication Networks Associate With Disease Progression in Cancer.
Neoplasms
Patients with mesenchymal tumours and high Fusobacteriales prevalence have worse prognosis in colorectal cancer (CRC).
Neoplasms
Pattern discovery and cancer gene identification in integrated cancer genomic data.
Neoplasms
Pattern fusion analysis by adaptive alignment of multiple heterogeneous omics data.
Neoplasms
Patterns and functional implications of rare germline variants across 12 cancer types.
Neoplasms
Patterns of somatic uniparental disomy identify novel tumor suppressor genes in colorectal cancer.
Neoplasms
PBK/TOPK promotes chemoresistance to oxaliplatin in hepatocellular carcinoma cells by regulating PTEN.
Neoplasms
PCBP2 Posttranscriptional Modifications Induce Breast Cancer Progression via Upregulation of UFD1 and NT5E.
Neoplasms
PD-1 (PDCD1) Promoter Methylation Is a Prognostic Factor in Patients With Diffuse Lower-Grade Gliomas Harboring Isocitrate Dehydrogenase (IDH) Mutations.
Neoplasms
PD-1 blockade in recurrent or metastatic cervical cancer: Data from cemiplimab phase I expansion cohorts and characterization of PD-L1 expression in cervical cancer.
Neoplasms
PD-L1 and PD-L2 Expression in Cervical Cancer: Regulation and Biomarker Potential.
Neoplasms
PD-L1 and prognosis in patients with malignant pleural mesothelioma: a meta-analysis and bioinformatics study.
Neoplasms
PD-L1 correlated gene expression profiles and tumor infiltrating lymphocytes in pancreatic cancer.
Neoplasms
PD-L1 Expression in Endometrial Carcinoma Cells and Intratumoral Immune Cells: Differences Across Histologic and TCGA-based Molecular Subgroups.
Neoplasms
PD-L1 expression is associated with epithelial-mesenchymal transition in head and neck squamous cell carcinoma.
Neoplasms
PD-L1 expression is associated with tumor-infiltrating T cells and favorable prognosis in high-grade serous ovarian cancer.
Neoplasms
PD-L1 is a direct target of cancer-FOXP3 in pancreatic ductal adenocarcinoma (PDAC), and combined immunotherapy with antibodies against PD-L1 and CCL5 is effective in the treatment of PDAC.
Neoplasms
PD-L1 overexpression in EBV-positive gastric cancer is caused by unique genomic or epigenomic mechanisms.
Neoplasms
PD-L1 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients following radical prostatectomy.
Neoplasms
PD-L1 protein expression in non-small-cell lung cancer and its relationship with the hypoxia-related signaling pathways: A study based on immunohistochemistry and RNA sequencing data.
Neoplasms
PD-L2 expression is correlated with the molecular and clinical features of glioma, and acts as an unfavorable prognostic factor.
Neoplasms
PDAC-ANN: an artificial neural network to predict pancreatic ductal adenocarcinoma based on gene expression.
Neoplasms
PDCD1 (PD-1) promoter methylation predicts outcome in head and neck squamous cell carcinoma patients.
Neoplasms
PDCD4 Is an Androgen-Repressed Tumor Suppressor that Regulates Prostate Cancer Growth and Castration Resistance.
Neoplasms
PDIA3 Expression in Glioblastoma Modulates Macrophage/Microglia Pro-Tumor Activation.
Neoplasms
Pediatric giant cell tumor of the tendon sheath of the craniocervical junction involving the occipital condyle.
Neoplasms
PEG3 mutation is associated with elevated tumor mutation burden and poor prognosis in breast cancer.
Neoplasms
Penalized integrative semiparametric interaction analysis for multiple genetic datasets.
Neoplasms
Peptidyl Arginine Deiminase, Type II (PADI2) Is Involved in Urothelial Bladder Cancer.
Neoplasms
Percentage of mesenchymal stem cells in high-grade glioma tumor samples correlates with patient survival.
Neoplasms
Performance Comparison of Deep Learning Autoencoders for Cancer Subtype Detection Using Multi-Omics Data.
Neoplasms
Performance of Next-Generation Sequencing for the Detection of Microsatellite Instability in Colorectal Cancer With Deficient DNA Mismatch Repair.
Neoplasms
Perifosine, an AKT inhibitor, modulates ovarian cancer cell line sensitivity to cisplatin-induced growth arrest.
Neoplasms
PERK-Phosphorylated eIF2? Pathway Suppresses Tumor Metastasis Through Downregulating Expression of Programmed Death Ligand 1 and CXCL5 in Triple-Negative Breast Cancer.
Neoplasms
Permutation-based identification of important biomarkers for complex diseases via machine learning models.
Neoplasms
Peroxiredoxins and Immune Infiltrations in Colon Adenocarcinoma: Their Negative Correlations and Clinical Significances, an In Silico Analysis.
Neoplasms
Peroxisome proliferator-activated receptor gamma as a theragnostic target for mesenchymal-type glioblastoma patients.
Neoplasms
Personal Health Information Inference Using Machine Learning on RNA Expression Data from Patients With Cancer: Algorithm Validation Study.
Neoplasms
Personalized Network Modeling of the Pan-Cancer Patient and Cell Line Interactome.
Neoplasms
Personalized Prediction of Proliferation Rates and Metabolic Liabilities in Cancer Biopsies.
Neoplasms
Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics.
Neoplasms
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma.
Neoplasms
PF4V1, an miRNA-875-3p target, suppresses cell proliferation, migration, and invasion in prostate cancer and serves as a potential prognostic biomarker.
Neoplasms
PFKFB4 Promotes Breast Cancer Metastasis via Induction of Hyaluronan Production in a p38-Dependent Manner.
Neoplasms
Pharmacologic IL-6R? inhibition in cholangiocarcinoma promotes cancer cell growth and survival.
Neoplasms
Pharmacologic induction of innate immune signaling directly drives homologous recombination deficiency.
Neoplasms
Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma.
Neoplasms
Phenethyl Isothiocyanate Suppresses Stemness in the Chemo- and Radio-Resistant Triple-Negative Breast Cancer Cell Line MDA-MB-231/IR Via Downregulation of Metadherin.
Neoplasms
Phenotype-Based Screens with Conformation-Specific Inhibitors Reveal p38 Gamma and Delta as Targets for HCC Polypharmacology.
Neoplasms
PHENOTYPIC CHARACTERIZATION OF BREAST INVASIVE CARCINOMA VIA TRANSFERABLE TISSUE MORPHOMETRIC PATTERNS LEARNED FROM GLIOBLASTOMA MULTIFORME.
Neoplasms
Phenotypically Dormant and Immature Leukaemia Cells Display Increased Ribosomal Protein S6 Phosphorylation.
Neoplasms
Phillygenin, a MELK Inhibitor, Inhibits Cell Survival and Epithelial-Mesenchymal Transition in Pancreatic Cancer Cells.
Neoplasms
PHLPP2 as a novel metastatic and prognostic biomarker in non-small cell lung cancer patients.
Neoplasms
PHLPP2 is a novel biomarker and epigenetic target for the treatment of vitamin C in pancreatic cancer.
Neoplasms
Phosphatase and Tensin Homolog Is a Potential Target for Ovarian Cancer Sensitization to Cytotoxic Agents.
Neoplasms
Phosphatase and Tensin Homolog Mutation in Immune Cell Infiltration and Clinicopathological Features of Low-Grade Gliomas.
Neoplasms
Phospho-T356RB1 predicts survival in HPV-negative squamous cell carcinoma of the head and neck.
Neoplasms
Phospho?STAT1 expression as a potential biomarker for anti?PD?1/anti?PD?L1 immunotherapy for breast cancer.
Neoplasms
Phosphodiesterase 4A confers resistance to PGE2-mediated suppression in CD25+ /CD54+ NK cells.
Neoplasms
Phosphodiesterase SMPDL3B Gene Expression as Independent Outcome Prediction Marker in Localized Prostate Cancer.
Neoplasms
Phosphoinositide specific phospholipase C?1 inhibition-driven autophagy caused cell death in human lung adenocarcinoma A549 cells in vivo and in vitro.
Neoplasms
Phospholipase C Beta 1: a Candidate Signature Gene for Proneural Subtype High-Grade Glioma.
Neoplasms
Phospholipase C Delta 3 inhibits apoptosis and promotes proliferation, migration, and invasion of thyroid cancer cells via Hippo pathway.
Neoplasms
Phosphoserine Phosphatase Is a Novel Prognostic Biomarker on Chromosome 7 in Colorectal Cancer.
Neoplasms
Phosphotyrosine signaling analysis in human tumors is confounded by systemic Ischemia-driven artifacts and intra-specimen heterogeneity.
Neoplasms
Phytanoyl-CoA 2-Hydroxylase-Interacting Protein-Like Gene Is a Therapeutic Target Gene for Glioblastoma Multiforme.
Neoplasms
PIAS3 expression in squamous cell lung cancer is low and predicts overall survival.
Neoplasms
PICOT binding to chromatin-associated EED negatively regulates cyclin D2 expression by increasing H3K27me3 at the CCND2 gene promoter.
Neoplasms
PIK3CA activating mutations are associated with more disseminated disease at presentation and earlier recurrence in glioblastoma.
Neoplasms
PIK3CA Amplification Associates with Aggressive Phenotype but Not Markers of AKT-MTOR Signaling in Endometrial Carcinoma.
Neoplasms
PIK3CA somatic alterations in invasive breast cancers: different spectrum from Caucasians to Chinese detected by next generation sequencing.
Neoplasms
Pilot studies for personalized cancer medicine: focusing on the patient for treatment selection.
Neoplasms
Pilot Study to Establish a Novel Five-Gene Biomarker Panel for Predicting Lymph Node Metastasis in Patients With Early Stage Endometrial Cancer.
Neoplasms
PINCAGE: Probabilistic integration of cancer genomics data for perturbed gene identification and sample classification.
Neoplasms
Pinin acts as a poor prognostic indicator for renal cell carcinoma by reducing apoptosis and promoting cell migration and invasion.
Neoplasms
PIP4K2A and PIP4K2C transcript levels are associated with cytogenetic risk and survival outcomes in acute myeloid leukemia.
Neoplasms
PIPKI? Regulates CCL2 Expression in Colorectal Cancer by Activating AKT-STAT3 Signaling.
Neoplasms
Pirin: a potential novel therapeutic target for castration-resistant prostate cancer regulated by miR-455-5p.
Neoplasms
PITX3 DNA methylation is an independent predictor of overall survival in patients with head and neck squamous cell carcinoma.
Neoplasms
PITX3 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients after radical prostatectomy.
Neoplasms
PIWI-interacting RNAs piR-13643 and piR-21238 are promising diagnostic biomarkers of papillary thyroid carcinoma.
Neoplasms
PKMYT1 is associated with prostate cancer malignancy and may serve as a therapeutic target.
Neoplasms
PLA2G16 is a mutant p53/KLF5 transcriptional target and promotes glycolysis of pancreatic cancer.
Neoplasms
Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma.
Neoplasms
Plakophilin-2 Promotes Lung Adenocarcinoma Development via Enhancing Focal Adhesion and Epithelial-Mesenchymal Transition.
Neoplasms
Plasma and Tissue Specific miRNA Expression Pattern and Functional Analysis Associated to Colorectal Cancer Patients.
Neoplasms
Plasma cell marker, immunoglobulin J polypeptide, predicts early disease-specific mortality in HPV+ HNSCC.
Neoplasms
Plasma Levels of Endothelial Cell-Specific Molecule-1 as a Potential Biomarker of Oral Cancer Progression.
Neoplasms
Plasma levels of the tissue inhibitor matrix metalloproteinase-3 as a potential biomarker in oral cancer progression.
Neoplasms
Plasma miRNA Biomarkers in Limited Volume Samples for Detection of Early-stage Pancreatic Cancer.
Neoplasms
Plasma proteome atlas for differentiating tumor stage and post-surgical prognosis of hepatocellular carcinoma and cholangiocarcinoma.
Neoplasms
Plasmin(ogen) serves as a favorable biomarker for prediction of survival in advanced high-grade serous ovarian cancer.
Neoplasms
Plasminogen Activator Urokinase Receptor Implies Immunosuppressive Features and Acts as an Unfavorable Prognostic Biomarker in Glioma.
Neoplasms
Plasminogen Receptors in Human Malignancies: Effects on Prognosis and Feasibility as Targets for Drug Development.
Neoplasms
Platform-Independent Classification System to Predict Molecular Subtypes of High-Grade Serous Ovarian Carcinoma.
Neoplasms
Platinum Sensitivity-Related Germline Polymorphism Discovered via a Cell-Based Approach and Analysis of Its Association with Outcome in Ovarian Cancer Patients.
Neoplasms
PLC? regulates prostate cancer mitochondrial oxidative metabolism and migration via upregulation of Twist1.
Neoplasms
PLCG2 as a potential indicator of tumor microenvironment remodeling in soft tissue sarcoma.
Neoplasms
Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancer.
Neoplasms
PLEK2 Gene Upregulation Might Independently Predict Shorter Progression-Free Survival in Lung Adenocarcinoma.
Neoplasms
PLK1 and NOTCH Positively Correlate in Melanoma and Their Combined Inhibition Results in Synergistic Modulations of Key Melanoma Pathways.
Neoplasms
Plk2 Loss Commonly Occurs in Colorectal Carcinomas but not Adenomas: Relationship to mTOR Signaling.
Neoplasms
PLOD3 is Upregulated in Gastric Cancer and Correlated with Clinicopathologic Characteristics.
Neoplasms
PLODs are overexpressed in ovarian cancer and are associated with gap junctions via connexin 43.
Neoplasms
Point mutation screening of tumor neoantigens and peptide-induced specific cytotoxic T lymphocytes using The Cancer Genome Atlas database.
Neoplasms
Pokemon Inhibits Transforming Growth Factor ?-Smad4-Related Cell Proliferation Arrest in Breast Cancer through Specificity Protein 1.
Neoplasms
POLE, MMR, and MSI Testing in Endometrial Cancer: Proceedings of the ISGyP Companion Society Session at the USCAP 2020 Annual Meeting.
Neoplasms
Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction.
Neoplasms
Polo-like kinase 3 is associated with poor prognosis and regulates proliferation and metastasis in prostate cancer.
Neoplasms
POLQ Overexpression Is Associated with an Increased Somatic Mutation Load and PLK4 Overexpression in Lung Adenocarcinoma.
Neoplasms
Polycomb-like 2 regulates PRC2 components to affect proliferation in glioma cells.
Neoplasms
Polymerase ? (POLE) mutations in endometrial cancer: clinical outcomes and implications for Lynch syndrome testing.
Neoplasms
Polymerase Epsilon Exonuclease Domain Mutations in Ovarian Endometrioid Carcinoma.
Neoplasms
Polymeric immunoglobulin receptor (PIGR) exerts oncogenic functions via activating ribosome pathway in hepatocellular carcinoma.
Neoplasms
Polymorphisms in matricellular SPP1 and SPARC contribute to susceptibility to papillary thyroid cancer.
Neoplasms
Polymorphisms involving gain or loss of CpG sites are significantly enriched in trait-associated SNPs.
Neoplasms
Polymorphisms of the Highly Expressed IL-6 Gene in the Papillary Thyroid Cancer Susceptibility Among Chinese.
Neoplasms
Polyphyllin I promotes cell death via suppressing UPR-mediated CHOP ubiquitination and degradation in non-small cell lung cancer.
Neoplasms
Pooling analysis reveals that galectin-1 is a reliable prognostic biomarker in various cancers.
Neoplasms
Poor clinical outcomes and immunoevasive contexture in interleukin-9 abundant muscle-invasive bladder cancer.
Neoplasms
Poor Clinical Outcomes and Immunoevasive Contexture in Intratumoral IL-10-Producing Macrophages Enriched Gastric Cancer Patients.
Neoplasms
Poor prognosis of male triple-positive breast Cancer patients: a propensity score matched SEER analysis and molecular portraits.
Neoplasms
POPDC3 is a potential biomarker for prognosis and radioresistance in patients with head and neck squamous cell carcinoma.
Neoplasms
PopInf: An Approach for Reproducibly Visualizing and Assigning Population Affiliation in Genomic Samples of Uncertain Origin.
Neoplasms
Population analysis of microsatellite genotypes reveals a signature associated with ovarian cancer.
Neoplasms
Population Substructure Has Implications in Validating Next-Generation Cancer Genomics Studies with TCGA.
Neoplasms
Positive crosstalk between EGFR and the TF-PAR2 pathway mediates resistance to cisplatin and poor survival in cervical cancer.
Neoplasms
Positive expression of PAX7 indicates poor prognosis of pediatric and adolescent AML patients.
Neoplasms
Positive feedback loop of FAM83A/PI3K/AKT/c-Jun induces migration, invasion and metastasis in hepatocellular carcinoma.
Neoplasms
Positron emission tomography/computed tomography imaging of head and neck tumors: an atlas.
Neoplasms
Possible Human Papillomavirus 38 Contamination of Endometrial Cancer RNA Sequencing Samples in The Cancer Genome Atlas Database.
Neoplasms
Posterior fixation and fusion with atlas pedicle screw system for upper cervical diseases.
Neoplasms
Posterior interhemispheric transtentorial approach for resection of a meningioma at the posteromedial tentorial incisura.
Neoplasms
Postoperative elevation in the plasma CCL2 level is a predictive biomarker of colorectal cancer recurrence.
Neoplasms
Potassium voltage-gated channel subfamily D member 2 induces an aggressive phenotype in lung adenocarcinoma.
Neoplasms
Potential Benefits of Bevacizumab Combined With Platinum-Based Chemotherapy in Advanced Non-Small-Cell Lung Cancer Patients With EGFR Mutation.
Neoplasms
Potential clinical value and putative biological function of miR-122-5p in hepatocellular carcinoma: A comprehensive study using microarray and RNA sequencing data.
Neoplasms
Potential Drug Prediction of Glioblastoma Based on Drug Perturbation-Induced Gene Expression Signatures.
Neoplasms
Potential five-mRNA signature model for the prediction of prognosis in patients with papillary thyroid carcinoma.
Neoplasms
Potential four?miRNA signature associated with T stage and prognosis of patients with pancreatic ductal adenocarcinoma identified by co?expression analysis.
Neoplasms
Potential functional variants of KIAA genes are associated with breast cancer risk in a case control study.
Neoplasms
Potential mechanism of RRM2 for promoting Cervical Cancer based on weighted gene co-expression network analysis.
Neoplasms
Potential microRNA-mediated oncogenic intercellular communication revealed by pan-cancer analysis.
Neoplasms
Potential of the cell-free blood-based biomarker uroplakin 2 RNA to detect recurrence after surgical resection of lung adenocarcinoma.
Neoplasms
Potential Onco-Suppressive Role of miR122 and miR144 in Uveal Melanoma through ADAM10 and C-Met Inhibition.
Neoplasms
Potential prognostic biomarkers related to immunity in clear cell renal cell carcinoma using bioinformatic strategy.
Neoplasms
Potential prognostic impact of EBV RNA-seq reads in gastric cancer: a reanalysis of The Cancer Genome Atlas cohort.
Neoplasms
Potential Prognostic Predictors and Molecular Targets for Skin Melanoma Screened by Weighted Gene Co-expression Network Analysis.
Neoplasms
Potential Prognostic Value and Mechanism of Stromal-Immune Signature in Tumor Microenvironment for Stomach Adenocarcinoma.
Neoplasms
Potential role for targeted therapy in muscle-invasive bladder cancer: lessons from the cancer genome atlas and beyond.
Neoplasms
Potential role of cyclin F mRNA expression in the survival of skin melanoma patients: Comprehensive analysis of the pathways altered due to cyclin F upregulation.
Neoplasms
Potential role of LINC00996 in colorectal cancer: a study based on data mining and bioinformatics.
Neoplasms
Potential role of m6A RNA methylation regulators in osteosarcoma and its clinical prognostic value.
Neoplasms
Potential Role of microRNA-183 as a Tumor Suppressor in Hepatocellular Carcinoma.
Neoplasms
Potential role of microRNA?223?3p in the tumorigenesis of hepatocellular carcinoma: A comprehensive study based on data mining and bioinformatics.
Neoplasms
Potential Role of NEU1 in Hepatocellular Carcinoma: A Study Based on Comprehensive Bioinformatical Analysis.
Neoplasms
Potential Targets and Clinical Value of MiR-224-5p in Cancers of the Digestive Tract.
Neoplasms
Potential targets and clinical value of miR-490-5p in hepatocellular carcinoma: a study based on TCGA, qRT-PCR and bioinformatics analyses.
Neoplasms
Potential targets and molecular mechanism of miR-331-3p in hepatocellular carcinoma identified by weighted gene coexpression network analysis.
Neoplasms
Potential therapeutic targets of TP53 gene in the context of its classically canonical functions and its latest non-canonical functions in human cancer.
Neoplasms
Potential value of MicroRNA-21 as a biomarker for predicting the prognosis of patients with breast cancer: A protocol for meta-analysis and bioinformatics analysis.
Neoplasms
Potentially functional genetic variants in the TNF/TNFR signaling pathway genes predict survival of patients with non-small cell lung cancer in the PLCO cancer screening trial.
Neoplasms
PP2A and E3 ubiquitin ligase deficiencies: Seminal biological drivers in endometrial cancer.
Neoplasms
PP2A Deficiency Enhances Carcinogenesis of Lgr5+ Intestinal Stem Cells Both in Organoids and In Vivo.
Neoplasms
PPAR-Responsive Elements Enriched with Alu Repeats May Contribute to Distinctive PPAR?-DNMT1 Interactions in the Genome.
Neoplasms
PPFIA4 Promotes Colon Cancer Cell Proliferation and Migration by Enhancing Tumor Glycolysis.
Neoplasms
Pre-treatment neutrophils count as a prognostic marker to predict chemotherapeutic response and survival outcomes in glioma: a single-center analysis of 288 cases.
Neoplasms
Precision cancer therapy: profiting from tumor specific defects in the DNA damage tolerance system.
Neoplasms
Preclinical analysis of novel prognostic transcription factors and immune-related gene signatures for bladder cancer via TCGA-based bioinformatic analysis.
Neoplasms
Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.
Neoplasms
Preclinical strategies to define predictive biomarkers for therapeutically relevant cancer subtypes.
Neoplasms
Predicted CD4+ T cell infiltration levels could indicate better overall survival in sarcoma patients.
Neoplasms
Predicting breast cancer drug response using a multiple-layer cell line drug response network model.
Neoplasms
Predicting Cancer Cell Line Dependencies From the Protein Expression Data of Reverse-Phase Protein Arrays.
Neoplasms
Predicting cancer origins with a DNA methylation-based deep neural network model.
Neoplasms
Predicting cell invasion in breast tumor microenvironment from radiological imaging phenotypes.
Neoplasms
Predicting censored survival data based on the interactions between meta-dimensional omics data in breast cancer.
Neoplasms
Predicting Deep Learning Based Multi-Omics Parallel Integration Survival Subtypes in Lung Cancer Using Reverse Phase Protein Array Data.
Neoplasms
Predicting DNA methylation from genetic data lacking racial diversity using shared classified random effects.
Neoplasms
Predicting drug response of tumors from integrated genomic profiles by deep neural networks.
Neoplasms
Predicting Functional Modules of Liver Cancer Based on Differential Network Analysis.
Neoplasms
Predicting Genotype and Survival in Glioma Using Standard Clinical MR Imaging Apparent Diffusion Coefficient Images: A Pilot Study from The Cancer Genome Atlas.
Neoplasms
Predicting lung adenocarcinoma disease progression using methylation-correlated blocks and ensemble machine learning classifiers.
Neoplasms
Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image features.
Neoplasms
Predicting prognosis and IDH mutation status for patients with lower-grade gliomas using whole slide images.
Neoplasms
Predicting prognosis of endometrioid endometrial adenocarcinoma on the basis of gene expression and clinical features using Random Forest.
Neoplasms
Predicting radiotherapy response for patients with soft tissue sarcoma by developing a molecular signature.
Neoplasms
Predicting responses to platin chemotherapy agents with biochemically-inspired machine learning.
Neoplasms
Predicting survival from colorectal cancer histology slides using deep learning: A retrospective multicenter study.
Neoplasms
Predicting the Clinical Outcome of Lung Adenocarcinoma Using a Novel Gene Pair Signature Related to RNA-Binding Protein.
Neoplasms
Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.
Neoplasms
Predicting the effect of 5-fluorouracil-based adjuvant chemotherapy on colorectal cancer recurrence: A model using gene expression profiles.
Neoplasms
Predicting the immune landscape of invasive breast carcinoma based on the novel signature of immune-related lncRNA.
Neoplasms
Predicting the Lung Squamous Cell Carcinoma Diagnosis and Prognosis Markers by Unique DNA Methylation and Gene Expression Profiles.
Neoplasms
Predicting the Presence of Oral Squamous Cell Carcinoma Using Commonly Dysregulated MicroRNA in Oral Swirls.
Neoplasms
Predicting the radiosensitivity of HPV-negative oropharyngeal squamous cell carcinoma using miR-130b.
Neoplasms
Predicting the Risk of Melanoma Metastasis Using an Immune Risk Score in the Melanoma Cohort.
Neoplasms
Predicting the survival of patients with lung adenocarcinoma using a four-gene prognosis risk model.
Neoplasms
Predicting tumor response to drugs based on gene-expression biomarkers of sensitivity learned from cancer cell lines.
Neoplasms
Prediction and analysis of hub genes between glioblastoma and low-grade glioma using bioinformatics analysis.
Neoplasms
Prediction and analysis of novel key genes ITGAX, LAPTM5, SERPINE1 in clear cell renal cell carcinoma through bioinformatics analysis.
Neoplasms
Prediction and analysis of weighted genes in hepatocellular carcinoma using bioinformatics analysis.
Neoplasms
Prediction and Validation of Hub Genes Associated with Colorectal Cancer by Integrating PPI Network and Gene Expression Data.
Neoplasms
Prediction of a competing endogenous RNA co-expression network as a prognostic marker in glioblastoma.
Neoplasms
Prediction of ATPase cation transporting 13A2 molecule in Petromyzon marinus and pan-cancer analysis into human tumors from an evolutionary perspective.
Neoplasms
Prediction of bladder cancer outcome by identifying and validating a mutation-derived genomic instability-associated long noncoding RNA (lncRNA) signature.
Neoplasms
Prediction of clinical outcome and survival in soft-tissue sarcoma using a ten-lncRNA signature.
Neoplasms
Prediction of clinical phenotypes in invasive breast carcinomas from the integration of radiomics and genomics data.
Neoplasms
Prediction of clinical prognosis in cutaneous melanoma using an immune-related gene pair signature.
Neoplasms
Prediction of clinically actionable genetic alterations from colorectal cancer histopathology images using deep learning.
Neoplasms
Prediction of Driver Modules via Balancing Exclusive Coverages of Mutations in Cancer Samples.
Neoplasms
Prediction of head and neck squamous cell carcinoma survival based on the expression of 15 lncRNAs.
Neoplasms
Prediction of hepatocellular carcinoma prognosis based on expression of an immune-related gene set.
Neoplasms
Prediction of individualized therapeutic vulnerabilities in cancer from genomic profiles.
Neoplasms
Prediction of key genes and pathways involved in trastuzumab-resistant gastric cancer.
Neoplasms
Prediction of MiR-21-5p in Promoting the Development of Lung Adenocarcinoma via PDZD2 Regulation.
Neoplasms
Prediction of novel target genes and pathways involved in irinotecan-resistant colorectal cancer.
Neoplasms
Prediction of novel target genes and pathways involved in tall cell variant papillary thyroid carcinoma.
Neoplasms
Prediction of Overall Survival Among Female Patients With Breast Cancer Using a Prognostic Signature Based on 8 DNA Repair-Related Genes.
Neoplasms
Prediction of Pathological Stage in Patients with Prostate Cancer: A Neuro-Fuzzy Model.
Neoplasms
Prediction of Poor Prognosis of HCC by Early Warning Model for Co-Expression of miRNA and mRNA Based on Bioinformatics Analysis.
Neoplasms
Prediction of prognosis of patients with lung cancer in combination with the immune score.
Neoplasms
Prediction of Prognostic Biomarkers and Construction of an Autophagy Prognostic Model for Colorectal Cancer Using Bioinformatics.
Neoplasms
Prediction of radiosensitive patients with gastric cancer by developing gene signature.
Neoplasms
Prediction of Radiosensitivity in Head and Neck Squamous Cell Carcinoma Based on Multiple Omics Data.
Neoplasms
Prediction of radiotherapy response with a 5-microRNA signature-based nomogram in head and neck squamous cell carcinoma.
Neoplasms
Prediction of response to anti-cancer drugs becomes robust via network integration of molecular data.
Neoplasms
Prediction of survival and recurrence in patients with pancreatic cancer by integrating multi-omics data.
Neoplasms
Prediction of Target Genes and Pathways Associated With Cetuximab Insensitivity in Colorectal Cancer.
Neoplasms
Prediction of Target-Drug Therapy by Identifying Gene Mutations in Lung Cancer With Histopathological Stained Image and Deep Learning Techniques.
Neoplasms
Prediction of taxane and platinum sensitivity in ovarian cancer based on gene expression profiles.
Neoplasms
Prediction of the Outcome for Patients with Glioblastoma with lncRNA Expression Profiles.
Neoplasms
Prediction of the Prognosis Based on Chromosomal Instability-Related DNA Methylation Patterns of ELOVL2 and UBAC2 in PTCs.
Neoplasms
Prediction of transcription factors binding events based on epigenetic modifications in different human cells.
Neoplasms
Prediction of tumor recurrence and therapy monitoring using ultrasound-guided photoacoustic imaging.
Neoplasms
Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
Neoplasms
Predictive and prognostic value of EPIC1 in patients with breast cancer receiving neoadjuvant chemotherapy.
Neoplasms
Predictive modeling using a somatic mutational profile in ovarian high grade serous carcinoma.
Neoplasms
Predictive value of protease-activated receptor-2 (PAR2 ) in cervical cancer metastasis.
Neoplasms
Predictive value of single-nucleotide polymorphism signature for recurrence in localised renal cell carcinoma: a retrospective analysis and multicentre validation study.
Neoplasms
Predictive value of WHO classification for PD-L1 and Her2/Neu expression and distinct associations with protein expression based classification in gastric carcinoma.
Neoplasms
Predictors of Chemosensitivity in Triple Negative Breast Cancer: An Integrated Genomic Analysis.
Neoplasms
Predictors of disease aggressiveness influence outcome from immunotherapy treatment in renal clear cell carcinoma.
Neoplasms
Predictors of ribociclib-mediated antitumour effects in native and sorafenib-resistant human hepatocellular carcinoma cells.
Neoplasms
Preferential tumor localization in relation to 18F-FDOPA uptake for lower-grade gliomas.
Neoplasms
Preliminary investigation of five novel long non-coding RNAs in hepatocellular carcinoma cell lines.
Neoplasms
PreMSIm: An R package for predicting microsatellite instability from the expression profiling of a gene panel in cancer.
Neoplasms
Presence of viral DNA in whole-genome sequencing of brain tumor tissues from the cancer genome atlas.
Neoplasms
Preserved SCN4B expression is an independent indicator of favorable recurrence-free survival in classical papillary thyroid cancer.
Neoplasms
PretiMeth: precise prediction models for DNA methylation based on single methylation mark.
Neoplasms
Prevalence and clinical relevance of tumor-associated tissue eosinophilia (TATE) in breast cancer.
Neoplasms
Prevalence and Landscape of Actionable Genomic Alterations in Renal Cell Carcinoma.
Neoplasms
Prevalence of actionable mutations and copy number alterations and the price of a genomic testing panel.
Neoplasms
Prevalence of comprehensive DNA damage repair gene germline mutations in Chinese prostate cancer patients.
Neoplasms
Prevalence of Homologous Recombination Pathway Gene Mutations in Melanoma: Rationale for a New Targeted Therapeutic Approach.
Neoplasms
Prevalence of PRKDC mutations and association with response to immune checkpoint inhibitors in solid tumors.
Neoplasms
Prevalent Homozygous Deletions of Type I Interferon and Defensin Genes in Human Cancers Associate with Immunotherapy Resistance.
Neoplasms
PRF1 is a prognostic marker and correlated with immune infiltration in head and neck squamous cell carcinoma.
Neoplasms
PRIM1 promotes the proliferation of hepatocellular carcinoma cells in vitro and in vivo.
Neoplasms
Primary Cilia Blockage Promotes the Malignant Behaviors of Hepatocellular Carcinoma via Induction of Autophagy.
Neoplasms
Primary glioblastoma cultures: can profiling of stem cell markers predict radiotherapy sensitivity?
Neoplasms
Primary Renal Paragangliomas and Renal Neoplasia Associated with Pheochromocytoma/Paraganglioma: Analysis of von Hippel-Lindau (VHL), Succinate Dehydrogenase (SDHX) and Transmembrane Protein 127 (TMEM127).
Neoplasms
PRINS lncRNA Is a New Biomarker Candidate for HPV Infection and Prognosis of Head and Neck Squamous Cell Carcinomas.
Neoplasms
Prion protein is associated with a worse prognosis of head and neck squamous cell carcinoma.
Neoplasms
Prioritization of cancer marker candidates based on the immunohistochemistry staining images deposited in the human protein atlas.
Neoplasms
Prioritizing Potentially Druggable Mutations with dGene: An Annotation Tool for Cancer Genome Sequencing Data.
Neoplasms
PRKAR1B-AS2 Long Noncoding RNA Promotes Tumorigenesis, Survival, and Chemoresistance via the PI3K/AKT/mTOR Pathway.
Neoplasms
PRKCA Overexpression Is Frequent in Young Oral Tongue Squamous Cell Carcinoma Patients and Is Associated with Poor Prognosis.
Neoplasms
PRMT1 expression in renal cell tumors- application in differential diagnosis and prognostic relevance.
Neoplasms
PRMT5 Circular RNA Promotes Metastasis of Urothelial Carcinoma of the Bladder through Sponging miR-30c to Induce Epithelial-Mesenchymal Transition.
Neoplasms
PRMT5 enhances tumorigenicity and glycolysis in pancreatic cancer via the FBW7/cMyc axis.
Neoplasms
PRMT8 demonstrates variant-specific expression in cancer cells and correlates with patient survival in breast, ovarian and gastric cancer.
Neoplasms
ProcessDriver: A computational pipeline to identify copy number drivers and associated disrupted biological processes in cancer.
Neoplasms
Procollagen-lysine, 2-oxoglutarate 5-dioxygenases 1, 2, and 3 are potential prognostic indicators in patients with clear cell renal cell carcinoma.
Neoplasms
Production of tissue microarrays, immunohistochemistry staining and digitalization within the human protein atlas.
Neoplasms
Profile of sphingolipid-related genes and its association with prognosis highlights sphingolipid metabolism in oral cancer.
Neoplasms
Profile of the breast cancer susceptibility marker rs4245739 identifies a role for miRNAs.
Neoplasms
Profiles of Immune Infiltration in Bladder Cancer and its Clinical Significance: an Integrative Genomic Analysis.
Neoplasms
Profiles of immune infiltration in lung adenocarcinoma and their clinical significant: A gene-expression-based retrospective study.
Neoplasms
Profiles of immune infiltration in the tumor microenvironment of hepatocellular carcinoma.
Neoplasms
Profiles of immune-related genes and immune cell infiltration in the tumor microenvironment of diffuse lower-grade gliomas.
Neoplasms
Profiles of m6A RNA methylation regulators for the prognosis of hepatocellular carcinoma.
Neoplasms
Profiles of overall survival-related gene expression-based risk signature and their prognostic implications in clear cell renal cell carcinoma.
Neoplasms
Profiles of prognostic alternative splicing signature in hepatocellular carcinoma.
Neoplasms
Profiles of tumor-infiltrating immune cells and prognostic genes associated with the microenvironment of bladder cancer.
Neoplasms
Profiles of tumor-infiltrating immune cells in renal cell carcinoma and their clinical implications.
Neoplasms
Profiling age-related epigenetic markers of stomach adenocarcinoma in young and old subjects.
Neoplasms
Profiling cancer-associated genetic alterations and molecular classification of cancer in Korean gastric cancer patients.
Neoplasms
Profiling cytochrome P450 family 4 gene expression in human hepatocellular carcinoma.
Neoplasms
Profiling of differential gene expression in Wilms tumor by cDNA expression array.
Neoplasms
Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC.
Neoplasms
Profiling of differentially expressed genes in human gastric carcinoma by cDNA expression array.
Neoplasms
Profiling of differentially expressed genes in LRRC4 overexpressed glioblastoma cells by cDNA array.
Neoplasms
Profiling of gastric cancer cell-surface markers to achieve tumour-normal discrimination.
Neoplasms
Profiling of lung microbiota discloses differences in adenocarcinoma and squamous cell carcinoma.
Neoplasms
Profiling pro-neural to mesenchymal transition identifies a lncRNA signature in glioma.
Neoplasms
Profiling the Mutational Landscape in Known Driver Genes and Novel Genes in African American Non-Small Cell Lung Cancer Patients.
Neoplasms
Progesterone Receptor Is a Haploinsufficient Tumor-Suppressor Gene in Cervical Cancer.
Neoplasms
Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness.
Neoplasms
Prognosis and modulation mechanisms of COMMD6 in human tumours based on expression profiling and comprehensive bioinformatics analysis.
Neoplasms
Prognosis model of colorectal cancer patients based on NOTCH3, KMT2C, and CREBBP mutations.
Neoplasms
Prognosis of clear cell renal cell carcinoma (ccRCC) based on a six-lncRNA-based risk score: an investigation based on RNA-sequencing data.
Neoplasms
Prognosis of Non-small-cell Lung Cancer Patients With Lipid Metabolism Pathway Alternations to Immunotherapy.
Neoplasms
Prognosis prediction model based on competing endogenous RNAs for recurrence of colon adenocarcinoma.
Neoplasms
Prognosis-Predictive Signature and Nomogram Based on Autophagy-Related Long Non-coding RNAs for Hepatocellular Carcinoma.
Neoplasms
Prognosis of Lung Adenocarcinoma Patients With NTRK3 Mutations to Immune Checkpoint Inhibitors.
Neoplasms
Prognostic 4-lncRNA-based risk model predicts survival time of patients with head and neck squamous cell carcinoma.
Neoplasms
Prognostic Alternative mRNA Splicing Signature and a Novel Biomarker in Triple-Negative Breast Cancer.
Neoplasms
Prognostic alternative splicing regulatory network of RBM25 in hepatocellular carcinoma.
Neoplasms
Prognostic alternative splicing regulatory network of splicing events in acute myeloid leukemia patients based on SpliceSeq data from 136 cases.
Neoplasms
Prognostic alternative splicing signatures and underlying regulatory network in esophageal carcinoma.
Neoplasms
Prognostic analysis of tumor mutation burden and immune infiltration in hepatocellular carcinoma based on TCGA data.
Neoplasms
Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers.
Neoplasms
Prognostic and Clinicopathological Significance of Long Non-Coding RNA BLACAT1 in Cancer: An Updated Meta-Analysis and TCGA Data Review.
Neoplasms
Prognostic and clinicopathological significance of long noncoding RNA CTD-2510F5.4 in gastric cancer.
Neoplasms
Prognostic and diagnostic roles of prolyl 4-hydroxylase subunit ? members in breast cancer.
Neoplasms
Prognostic and immune regulating roles of YIF1B in Pan-Cancer: a potential target for both survival and therapy response evaluation.
Neoplasms
Prognostic and predicted significance of Ubqln2 in patients with hepatocellular carcinoma.
Neoplasms
Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy.
Neoplasms
Prognostic and Predictive Value of a 15 Transcription Factors (TFs) Panel for Hepatocellular Carcinoma.
Neoplasms
Prognostic and Predictive Value of Immune-Related Gene Pair Signature in Primary Lower-Grade Glioma Patients.
Neoplasms
Prognostic and predictive value of immune/stromal-related gene biomarkers in renal cell carcinoma.
Neoplasms
Prognostic and predictive value of PD-L2 DNA methylation and mRNA expression in melanoma.
Neoplasms
Prognostic and Predictive Value of Three DNA Methylation Signatures in Lung Adenocarcinoma.
Neoplasms
Prognostic autophagy model based on CASP4 and BIRC5 expression in patients with renal cancer: independent datasets-based study.
Neoplasms
Prognostic biomarker identification and tumor classification in breast cancer patients by methylation and transcriptome analysis.
Neoplasms
Prognostic biomarker MITD1 and its correlation with immune infiltrates in hepatocellular carcinoma (HCC).
Neoplasms
Prognostic Biomarker TP53 Mutations for Immune Checkpoint Blockade Therapy and Its Association With Tumor Microenvironment of Lung Adenocarcinoma.
Neoplasms
Prognostic biomarker TUBA1C is correlated to immune cell infiltration in the tumor microenvironment of lung adenocarcinoma.
Neoplasms
Prognostic Biomarker-Based Identification of Drugs for Managing the Treatment of Endometrial Cancer.
Neoplasms
Prognostic biomarkers and therapeutic targets in oral squamous cell carcinoma: a study based on cross-database analysis.
Neoplasms
Prognostic Biomarkers in Pancreatic Cancer: Avoiding Errata When Using the TCGA Dataset.
Neoplasms
Prognostic classification of endometrial cancer using a molecular approach based on a twelve-gene NGS panel.
Neoplasms
Prognostic classifier based on genome-wide DNA methylation profiling in well-differentiated thyroid tumors.
Neoplasms
Prognostic Correlation of an Autophagy-Related Gene Signature in Patients with Head and Neck Squamous Cell Carcinoma.
Neoplasms
Prognostic Correlation of Autophagy-Related Gene Expression-Based Risk Signature in Patients with Glioblastoma.
Neoplasms
Prognostic Correlation of Glycolysis-Related Gene Signature in Patients with Laryngeal Cancer.
Neoplasms
Prognostic Effect of Comorbid Disease and Immune Gene Expression on Mortality in Kidney Cancer-A Population Based Study.
Neoplasms
Prognostic Effect of Inflammatory Genes on Stage I-III Colorectal Cancer-Integrative Analysis of TCGA Data.
Neoplasms
Prognostic effect of programmed death-ligand 1 (PD-L1) in ovarian cancer: a systematic review, meta-analysis and bioinformatics study.
Neoplasms
Prognostic factors modifying the treatment-free interval in recurrent ovarian cancer.
Neoplasms
Prognostic Factors of Malignant Pheochromocytoma and Paraganglioma: A Combined SEER and TCGA Databases Review.
Neoplasms
Prognostic gene signature identification using causal structure learning: applications in kidney cancer.
Neoplasms
Prognostic Genes of Breast Cancer Identified by Gene Co-expression Network Analysis.
Neoplasms
Prognostic genes of melanoma identified by weighted gene co-expression network analysis and drug repositioning using a network-based method.
Neoplasms
Prognostic genes of triple-negative breast cancer identified by weighted gene co-expression network analysis.
Neoplasms
Prognostic Immunity and Therapeutic Sensitivity Analyses Based on Differential Genomic Instability-Associated LncRNAs in Left- and Right-Sided Colon Adenocarcinoma.
Neoplasms
Prognostic impact of cancer stem cell markers ABCB1, NEO1 and HIST1H2AE in colorectal cancer.
Neoplasms
Prognostic Impact of HOTAIR Expression is Restricted to ER-Negative Breast Cancers.
Neoplasms
Prognostic Impact of IGF2BP3 Expression in Patients with Surgically Resected Lung Adenocarcinoma.
Neoplasms
Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma.
Neoplasms
Prognostic impact of p53 and/or NY-ESO-1 autoantibody induction in patients with gastroenterological cancers.
Neoplasms
Prognostic Impact of PD-1 and Tim-3 Expression in Tumor Tissue in Stage I-III Colorectal Cancer.
Neoplasms
Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer.
Neoplasms
Prognostic impact of programmed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor-infiltrating lymphocytes in ovarian high grade serous carcinoma.
Neoplasms
Prognostic impact of tumor budding in endometrial carcinoma within distinct molecular subgroups.
Neoplasms
Prognostic implication and functional annotations of APOBEC3G expression in patients with Melanoma.
Neoplasms
Prognostic implication and functional annotations of Rad50 expression in patients with prostate cancer.
Neoplasms
Prognostic Implication of a Metabolism-Associated Gene Signature in Lung Adenocarcinoma.
Neoplasms
Prognostic implication of glycolysis related gene signature in non-small cell lung cancer.
Neoplasms
Prognostic implication of histological features associated with EHD2 expression in papillary thyroid carcinoma.
Neoplasms
Prognostic implication of proteomic profiles in head and neck squamous cell carcinoma.
Neoplasms
Prognostic Implication of SOX2 Expression Associated with p16 in Oropharyngeal Cancer: A Study of Consecutive Tissue Microarrays and TCGA.
Neoplasms
Prognostic Implication of the Expression Level of PECAM-1 in Non-small Cell Lung Cancer.
Neoplasms
Prognostic implications of aberrantly expressed methylation?driven genes in hepatocellular carcinoma: A study based on The Cancer Genome Atlas.
Neoplasms
Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma.
Neoplasms
Prognostic Implications of CD10 and CD15 Expression in Papillary Thyroid Carcinoma.
Neoplasms
Prognostic Implications of Metabolism Related Gene Signature in Cutaneous Melanoma.
Neoplasms
Prognostic implications of metabolism-associated gene signatures in colorectal cancer.
Neoplasms
Prognostic Implications of Novel Gene Signatures in Gastric Cancer Microenvironment.
Neoplasms
Prognostic Implications of Pan-Cancer CMTM6 Expression and Its Relationship with the Immune Microenvironment.
Neoplasms
Prognostic implications of programmed death ligand 1 expression in resected lung adenocarcinoma: a systematic review and meta-analysis.
Neoplasms
Prognostic implications of the BRAF-V600E mutation in papillary thyroid carcinoma based on a new cut-off age stratification.
Neoplasms
Prognostic Importance of Age, Tumor Location, and Tumor Grade in Grade II Astrocytomas: An Integrated Analysis of the Cancer Genome Atlas and the Surveillance, Epidemiology, and End Results Database.
Neoplasms
Prognostic index of aberrant mRNA splicing profiling acts as a predictive indicator for hepatocellular carcinoma based on TCGA SpliceSeq data.
Neoplasms
Prognostic Inflammasome-Related Signature Construction in Kidney Renal Clear Cell Carcinoma Based on a Pan-Cancer Landscape.
Neoplasms
PROGNOSTIC INTEGRATED IMAGE-BASED IMMUNE AND MOLECULAR PROFILING IN EARLY-STAGE ENDOMETRIAL CANCER.
Neoplasms
Prognostic landscape of tumor-infiltrating immune cells and immune-related genes in the tumor microenvironment of gastric cancer.
Neoplasms
Prognostic lncRNAs, miRNAs, and mRNAs Form a Competing Endogenous RNA Network in Colon Cancer.
Neoplasms
Prognostic methylation markers for overall survival in cytogenetically normal patients with acute myeloid leukemia treated on SWOG trials.
Neoplasms
Prognostic microRNA signatures derived from The Cancer Genome Atlas for head and neck squamous cell carcinomas.
Neoplasms
Prognostic microRNA/mRNA signature from the integrated analysis of patients with invasive breast cancer.
Neoplasms
Prognostic microRNAs and their potential molecular mechanism in pancreatic cancer: A study based on The Cancer Genome Atlas and bioinformatics investigation.
Neoplasms
Prognostic microRNAs in high-grade glioma reveal a link to oligodendrocyte precursor differentiation.
Neoplasms
Prognostic model of invasive ductal carcinoma of the breast based on differentially expressed glycolysis-related genes.
Neoplasms
Prognostic model of patients with liver cancer based on tumor stem cell content and immune process.
Neoplasms
Prognostic nomogram for previously untreated adult patients with acute myeloid leukemia.
Neoplasms
Prognostic nomogram of hypoxia-related genes predicting overall survival of colorectal cancer-Analysis of TCGA database.
Neoplasms
Prognostic Nomogram of Prognosis-Related Genes and Clinicopathological Characteristics to Predict the 5-Year Survival Rate of Colon Cancer Patients.
Neoplasms
Prognostic nomograms based on immune scores for head-neck squamous cell carcinoma patients.
Neoplasms
Prognostic Power of a Chaperonin Containing TCP-1 Subunit Genes Panel for Hepatocellular Carcinoma.
Neoplasms
Prognostic Power of a Tumor Differentiation Gene Signature for Bladder Urothelial Carcinomas.
Neoplasms
Prognostic Prediction Model for Glioblastoma: A Metabolic Gene Signature and Independent External Validation.
Neoplasms
Prognostic prediction of a 12-methylation gene-based risk score system on pancreatic adenocarcinoma.
Neoplasms
Prognostic Prediction, Immune Microenvironment, and Drug Resistance Value of Collagen Type I Alpha 1 Chain: From Gastrointestinal Cancers to Pan-Cancer Analysis.
Neoplasms
Prognostic relevance of miR-137 and its liver microenvironment regulatory target gene AFM in hepatocellular carcinoma.
Neoplasms
Prognostic risk model construction and molecular marker identification in glioblastoma multiforme based on mRNA/microRNA/long non-coding RNA analysis using random survival forest method.
Neoplasms
Prognostic risk signature based on the expression of three m6A RNA methylation regulatory genes in kidney renal papillary cell carcinoma.
Neoplasms
Prognostic Role and Potential Mechanisms of the Ferroptosis-Related Metabolic Gene Signature in Hepatocellular Carcinoma.
Neoplasms
Prognostic Role of Chicken Ovalbumin Upstream Promoter Transcription Factor II in Isocitrate Dehydrogenase-Mutant Glioma with 1p19q Co-Deletion.
Neoplasms
Prognostic role of elevated mir-24-3p in breast cancer and its association with the metastatic process.
Neoplasms
Prognostic role of Epidermal growth factor receptor variant III (EGFRvIII) positivity in EGFR-amplified primary and recurrent glioblastomas.
Neoplasms
Prognostic Role of EYA4 in Lower Grade Glioma with IDH1 Mutation and 1p19q Co-Deletion.
Neoplasms
Prognostic role of long non-coding RNA HNF1A-AS1 in Chinese cancer patients: a meta-analysis.
Neoplasms
Prognostic role of mitochondrial pyruvate carrier in isocitrate dehydrogenase-mutant glioma.
Neoplasms
Prognostic role of PHYH for overall survival (OS) in clear cell renal cell carcinoma (ccRCC).
Neoplasms
Prognostic Role of Receptor Tyrosine Kinase-Like Orphan Receptors in Intestinal-Type Gastric Cancer.
Neoplasms
Prognostic role of the beta-2 adrenergic receptor in clear cell renal cell carcinoma.
Neoplasms
Prognostic Role of TMED3 in Clear Cell Renal Cell Carcinoma: A Retrospective Multi-Cohort Analysis.
Neoplasms
Prognostic role of TPD52 in acute myeloid leukemia: A retrospective multicohort analysis.
Neoplasms
Prognostic Role of Tumor Mutation Burden Combined With Immune Infiltrates in Skin Cutaneous Melanoma Based on Multi-Omics Analysis.
Neoplasms
Prognostic roles of metabolic reprogramming-associated genes in patients with hepatocellular carcinoma.
Neoplasms
Prognostic Roles of N6-Methyladenosine METTL3 in Different Cancers: A System Review and Meta-Analysis.
Neoplasms
Prognostic roles of the transcriptional expression of exportins in hepatocellular carcinoma.
Neoplasms
Prognostic Score Model Based on Ten Differentially Methylated Genes for Predicting Clinical Outcomes in Patients with Adenocarcinoma of the Colon.
Neoplasms
Prognostic score model-based signature genes for predicting the prognosis of metastatic skin cutaneous melanoma.
Neoplasms
Prognostic Score Predicts Survival in HPV-Negative Head and Neck Squamous Cell Cancer Patients.
Neoplasms
Prognostic Score-based Clinical Factors and Metabolism-related Biomarkers for Predicting the Progression of Hepatocellular Carcinoma.
Neoplasms
Prognostic signature associated with radioresistance in head and neck cancer via transcriptomic and bioinformatic analyses.
Neoplasms
Prognostic signature composed of transcription factors accurately predicts the prognosis of gastric cancer patients.
Neoplasms
Prognostic Signature for Lung Adenocarcinoma Patients Based on Cell-Cycle-Related Genes.
Neoplasms
Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases.
Neoplasms
Prognostic signature of ovarian cancer based on 14 tumor microenvironment-related genes.
Neoplasms
Prognostic Signatures Based on Thirteen Immune-Related Genes in Colorectal Cancer.
Neoplasms
Prognostic significance and function of the vacuolar H+-ATPase subunit V1E1 in esophageal squamous cell carcinoma.
Neoplasms
Prognostic significance and immune correlates of CD73 expression in renal cell carcinoma.
Neoplasms
Prognostic significance and oncogene function of cathepsin A in hepatocellular carcinoma.
Neoplasms
Prognostic Significance and Related Mechanisms of Hexokinase 1 in Ovarian Cancer.
Neoplasms
Prognostic significance and therapeutic potential of the immune checkpoint VISTA in pancreatic cancer.
Neoplasms
Prognostic Significance and Tumor Immune Microenvironment Heterogenicity of m5C RNA Methylation Regulators in Triple-Negative Breast Cancer.
Neoplasms
Prognostic significance of age related genes in patients with lower grade glioma.
Neoplasms
Prognostic significance of an autophagy-related long non-coding RNA signature in patients with oral and oropharyngeal squamous cell carcinoma.
Neoplasms
Prognostic significance of an invasive leader cell-derived mutation cluster on chromosome 16q.
Neoplasms
Prognostic Significance of Blood-Based Multi-cancer Detection in Plasma Cell-Free DNA.
Neoplasms
Prognostic significance of CD8+ T-cells density in stage III colorectal cancer depends on SDF-1 expression.
Neoplasms
Prognostic significance of CDC25C in lung adenocarcinoma: An analysis of TCGA data.
Neoplasms
Prognostic significance of chemokines CCL11 and CCL5 modulated by low-density lipoprotein cholesterol in colon cancer patients with normal body mass index.
Neoplasms
Prognostic significance of contactin 3 expression and associated genes in glioblastoma multiforme.
Neoplasms
Prognostic Significance of COVID-19 Receptor ACE2 and Recommendation for Antihypertensive Drug in Renal Cell Carcinoma.
Neoplasms
Prognostic significance of EIF4G1 in patients with pancreatic ductal adenocarcinoma.
Neoplasms
Prognostic significance of heat shock protein 90AA1 (HSP90?) in invasive breast cancer.
Neoplasms
Prognostic significance of immune landscape in tumour microenvironment of endometrial cancer.
Neoplasms
Prognostic significance of KN motif and ankyrin repeat domains 1 (KANK1) in invasive breast cancer.
Neoplasms
Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancer.
Neoplasms
Prognostic Significance of LncRNA GHET1 Expression in Various Cancers: A Systematic Review and Meta-analysis.
Neoplasms
Prognostic Significance of LncRNA PVT1 and Its Potential Target Gene Network in Human Cancers: a Comprehensive Inquiry Based Upon 21 Cancer Types and 9972 Cases.
Neoplasms
Prognostic significance of microRNA-135 in patients with digestive system cancers: a systematic review and meta-analysis.
Neoplasms
Prognostic significance of microRNA-99a in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation.
Neoplasms
Prognostic significance of microsatellite instability?associated pathways and genes in gastric cancer.
Neoplasms
Prognostic significance of mutant-allele tumor heterogeneity in uterine corpus endometrial carcinoma.
Neoplasms
Prognostic Significance of Oxidation Pathway Mutations in Recurrent Laryngeal Squamous Cell Carcinoma.
Neoplasms
Prognostic significance of PI3K/AKT/ mTOR signaling pathway members in clear cell renal cell carcinoma.
Neoplasms
Prognostic significance of promoter CpG island methylation of obesity-related genes in patients with nonmetastatic renal cell carcinoma.
Neoplasms
Prognostic significance of SOCS1 and SOCS3 tumor suppressors and oncogenic signaling pathway genes in hepatocellular carcinoma.
Neoplasms
Prognostic significance of Spinster homolog gene family in acute myeloid leukemia.
Neoplasms
Prognostic Significance of the Pluripotency Factors NANOG, SOX2, and OCT4 in Head and Neck Squamous Cell Carcinomas.
Neoplasms
Prognostic significance of tumor-infiltrating immune cells in muscle-invasive bladder cancer.
Neoplasms
Prognostic SLC family genes promote cell proliferation, migration, and invasion in hepatocellular carcinoma.
Neoplasms
Prognostic targets recognition of rectal adenocarcinoma based on transcriptomics.
Neoplasms
Prognostic thirteen-long non-coding RNAs (IncRNAs) could improve the survival prediction of gastric cancer.
Neoplasms
Prognostic value and functional bioinformatic analysis of spindle- and kinetochore-associated protein 1 in stage IIA esophageal squamous cell carcinoma.
Neoplasms
Prognostic value and immune cell infiltration of hypoxic phenotype-related gene signatures in glioblastoma microenvironment.
Neoplasms
Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironment.
Neoplasms
Prognostic value and immunological characteristics of a novel autophagy-related signature in pancreatic cancer.
Neoplasms
Prognostic Value and Immunological Characteristics of a Novel RNA Binding Protein Signature in Cutaneous Melanoma.
Neoplasms
Prognostic Value and Molecular Regulatory Mechanism of MSTO2P in Hepatocellular Carcinoma: A Comprehensive Study Based on Bioinformatics, Clinical Analysis and in vitro Validation.
Neoplasms
Prognostic Value and Potential Biological Functions of CLDN8 in Patients with Clear Cell Renal Cell Carcinoma.
Neoplasms
Prognostic value and potential function of splicing events in prostate adenocarcinoma.
Neoplasms
Prognostic Value and Potential Immunoregulatory Role of SCARF1 in Hepatocellular Carcinoma.
Neoplasms
Prognostic Value and Potential Regulatory Mechanism of Alternative Splicing in Geriatric Breast Cancer.
Neoplasms
Prognostic Value and Potential Role of Alternative mRNA Splicing Events in Cervical Cancer.
Neoplasms
Prognostic value and prospective molecular mechanism of miR-100-5p in hepatocellular carcinoma: A comprehensive study based on 1,258 samples.
Neoplasms
Prognostic value of a hypoxia-related microRNA signature in patients with colorectal cancer.
Neoplasms
Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma.
Neoplasms
Prognostic value of a microRNA signature as a novel biomarker in patients with lower-grade gliomas.
Neoplasms
Prognostic value of a nine-gene signature in glioma patients based on tumor-associated macrophages expression profiling.
Neoplasms
Prognostic value of a novel glycolysis-related gene expression signature for gastrointestinal cancer in the Asian population.
Neoplasms
Prognostic Value of a Novel Signature With Nine Hepatitis C Virus-Induced Genes in Hepatic Cancer by Mining GEO and TCGA Databases.
Neoplasms
Prognostic Value of a Stemness Index-Associated Signature in Primary Lower-Grade Glioma.
Neoplasms
Prognostic Value of a Three-DNA Methylation Biomarker in Patients with Soft Tissue Sarcoma.
Neoplasms
Prognostic value of a two-microRNA signature for papillary thyroid cancer and a bioinformatic analysis of their possible functions.
Neoplasms
Prognostic value of aberrantly expressed methylation gene profiles in lung squamous cell carcinoma: A study based on The Cancer Genome Atlas.
Neoplasms
Prognostic Value of an Autophagy-Related Five-Gene Signature for Lower-Grade Glioma Patients.
Neoplasms
Prognostic value of an autophagy-related gene expression signature for endometrial cancer patients.
Neoplasms
Prognostic Value of an m5C RNA Methylation Regulator-Related Signature for Clear Cell Renal Cell Carcinoma.
Neoplasms
Prognostic Value of an m6A RNA Methylation Regulator-Based Signature in Patients with Hepatocellular Carcinoma.
Neoplasms
Prognostic Value of BIRC5 in Lung Adenocarcinoma Lacking EGFR, KRAS, and ALK Mutations by Integrated Bioinformatics Analysis.
Neoplasms
Prognostic value of carbonic anhydrase XII (CA XII) overexpression in hepatocellular carcinoma.
Neoplasms
Prognostic value of CCR2 as an immune indicator in lung adenocarcinoma: A study based on tumor-infiltrating immune cell analysis.
Neoplasms
Prognostic value of D-lactate dehydrogenase in patients with clear cell renal cell carcinoma.
Neoplasms
Prognostic Value of DNA Damage Response Genomic Alterations in Relapsed/Advanced Urothelial Cancer.
Neoplasms
Prognostic Value of DNA Methylation-Driven Genes in Clear Cell Renal Cell Carcinoma: A Study Based on Methylation and Transcriptome Analyses.
Neoplasms
Prognostic value of epithelial-mesenchymal transition markers in clear cell renal cell carcinoma.
Neoplasms
Prognostic value of estrogen receptor ? and estrogen receptor ? in gastric cancer based on a meta-analysis and The Cancer Genome Atlas (TCGA) datasets.
Neoplasms
Prognostic value of estrogen receptor-? and progesterone receptor in curatively resected colorectal cancer: a retrospective analysis with independent validations.
Neoplasms
Prognostic Value of EZH2 in Non-Small-Cell Lung Cancers: A Meta-Analysis and Bioinformatics Analysis.
Neoplasms
Prognostic value of fatty acid metabolism-related genes in patients with hepatocellular carcinoma.
Neoplasms
Prognostic value of ferroptosis-related genes in patients with lung adenocarcinoma.
Neoplasms
Prognostic Value of Genes and Immune Infiltration in Prostate Tumor Microenvironment.
Neoplasms
Prognostic value of genome-wide DNA methylation patterns in noncoding miRNAs and lncRNAs in uveal melanomas.
Neoplasms
Prognostic value of Glypican family genes in early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy and possible mechanisms.
Neoplasms
Prognostic Value of HMGA2 in Human Cancers: A Meta-Analysis Based on Literatures and TCGA Datasets.
Neoplasms
Prognostic value of IL-6R mRNA in lung adenocarcinoma and squamous cell carcinoma.
Neoplasms
Prognostic value of immune-related genes and immune cell infiltration analysis in the tumor microenvironment of head and neck squamous cell carcinoma.
Neoplasms
Prognostic Value of Immune-Related Genes in the Tumor Microenvironment of Bladder Cancer.
Neoplasms
Prognostic value of immune-related genes in the tumor microenvironment of lung adenocarcinoma and lung squamous cell carcinoma.
Neoplasms
Prognostic Value of Immune-Related lncRNA SBF2-AS1 in Diffuse Lower-Grade Glioma.
Neoplasms
Prognostic value of intratumoral lymphocyte-to-monocyte ratio and M0 macrophage enrichment in tumor immune microenvironment of melanoma.
Neoplasms
Prognostic value of key genes of the JAK-STAT signaling pathway in patients with cutaneous melanoma.
Neoplasms
Prognostic value of lipid metabolism-related genes in head and neck squamous cell carcinoma.
Neoplasms
Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors.
Neoplasms
Prognostic value of long noncoding RNA urothelial carcinoma-associated 1 in esophageal carcinoma: A protocol for meta-analysis, TCGA data and bioinformatics analysis.
Neoplasms
Prognostic Value of microRNA-133a Expression and Its Clinicopathologic Significance in Non-Small Cell Lung Cancer: A Comprehensive Study Based on Meta-Analysis and the TCGA Database.
Neoplasms
Prognostic Value of microRNA-221/2 and 17-92 Families in Primary Glioblastoma Patients Treated with Postoperative Radiotherapy.
Neoplasms
Prognostic value of minichromosome maintenance mRNA expression in early-stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy.
Neoplasms
Prognostic value of miR-21 in gliomas: comprehensive study based on meta-analysis and TCGA dataset validation.
Neoplasms
Prognostic value of monocarboxylate transporter 4 in patients with esophageal squamous cell carcinoma.
Neoplasms
Prognostic value of myometrial invasion and TCGA groups of endometrial carcinoma.
Neoplasms
Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma.
Neoplasms
Prognostic Value of Preoperative MRI Metrics for Diffuse Lower-Grade Glioma Molecular Subtypes.
Neoplasms
Prognostic Value of RNASEH2A-, CDK1-, and CD151-Related Pathway Gene Profiling for Kidney Cancers.
Neoplasms
Prognostic Value of SLC4A4 and its Correlation with Immune Infiltration in Colon Adenocarcinoma.
Neoplasms
Prognostic value of small nuclear RNAs (snRNAs) for digestive tract pan- adenocarcinomas identified by RNA sequencing data.
Neoplasms
Prognostic value of sorting nexin 10 weak expression in stomach adenocarcinoma revealed by weighted gene co-expression network analysis.
Neoplasms
Prognostic Value of Survival of MicroRNAs Signatures in Non-small Cell Lung Cancer.
Neoplasms
Prognostic value of the expression of chemokines and their receptors in regional lymph nodes of melanoma patients.
Neoplasms
Prognostic Value of the Tumor Immune Microenvironment for Early-stage, Non-Small Cell Lung Cancer.
Neoplasms
Prognostic value of TP53 co-mutation status combined with EGFR mutation in patients with lung adenocarcinoma.
Neoplasms
Prognostic value of tumour microenvironment-related genes by TCGA database in rectal cancer.
Neoplasms
Prognostic value of ubiquitin-conjugating enzyme E2 S overexpression in hepatocellular carcinoma.
Neoplasms
Prognostic values and clinical relationship of TYK2 in laryngeal squamous cell cancer.
Neoplasms
Prognostic values of a novel multi-mRNA signature for predicting relapse of cholangiocarcinoma.
Neoplasms
Prognostic Values of E2F1/2 Transcriptional Expressions in Chromophobe Renal Cell Carcinoma Patients: Evidence from Bioinformatics Analysis.
Neoplasms
Prognostic Values of Radiosensitivity Genes and CD19 Status in Gastric Cancer: A Retrospective Study Using TCGA Database.
Neoplasms
Prognostication of uveal melanoma is simple and highly predictive using The Cancer Genome Atlas (TCGA) classification: A review.
Neoplasms
Programmed Cell Death Ligand-1 (PD-L1) and CD8 Expression Profiling Identify an Immunologic Subtype of Pancreatic Ductal Adenocarcinomas with Favorable Survival.
Neoplasms
Programmed cell death ligand-1-mediated enhancement of hexokinase 2 expression is inversely related to T-cell effector gene expression in non-small-cell lung cancer.
Neoplasms
Programmed cell death ligands expression in phaeochromocytomas and paragangliomas: Relationship with the hypoxic response, immune evasion and malignant behavior.
Neoplasms
Programmed death 1, ligand 1 and 2 correlated genes and their association with mutation, immune infiltration and clinical outcomes of hepatocellular carcinoma.
Neoplasms
Programmed Death Ligand 1 Is a Negative Prognostic Marker in Recurrent Isocitrate Dehydrogenase-Wildtype Glioblastoma.
Neoplasms
Programmed Death-Ligand 1 and Vimentin: A Tandem Marker as Prognostic Factor in NSCLC.
Neoplasms
Programmed death-ligand 1 expression level as a predictor of EGFR tyrosine kinase inhibitor efficacy in lung adenocarcinoma.
Neoplasms
Progressive and Prognostic Performance of an Extracellular Matrix-Receptor Interaction Signature in Gastric Cancer.
Neoplasms
Proliferation-associated long noncoding RNA, TMPO-AS1, is a potential therapeutic target for triple-negative breast cancer.
Neoplasms
Proliferative and Invasive Colorectal Tumors in Pet Dogs Provide Unique Insights into Human Colorectal Cancer.
Neoplasms
Promising diagnostic and prognostic value of E2Fs in human hepatocellular carcinoma.
Neoplasms
Promising key genes associated with tumor microenvironments and prognosis of hepatocellular carcinoma.
Neoplasms
Promising significance of the association of miR-204-5p expression with clinicopathological features of hepatocellular carcinoma.
Neoplasms
Promoter aberrant methylation status of ADRA1A is associated with hepatocellular carcinoma.
Neoplasms
Promoter CpG Island Methylation of Genes in Key Cancer Pathways Associates with Clinical Outcome in High-Grade Serous Ovarian Cancer.
Neoplasms
Promoter DNA methylation analysis reveals a combined diagnosis of CpG-based biomarker for prostate cancer.
Neoplasms
Promoter Hypermethylation of CHODL Contributes to Carcinogenesis and Indicates Poor Survival in Patients with Early-stage Colorectal Cancer.
Neoplasms
Promoter hypermethylation of PIEZO2 is a risk factor and potential clinical biomarker for laryngeal squamous cell carcinoma.
Neoplasms
Promoter Methylation of CDO1 Identifies Clear-Cell Renal Cell Cancer Patients with Poor Survival Outcome.
Neoplasms
Promoter Methylation of DNA Repair Genes Predicts Disease-free Survival of Gastric Adenocarcinoma after Adjuvant Radiotherapy.
Neoplasms
Promoter Methylation of PRKCB, ADAMTS12, and NAALAD2 Is Specific to Prostate Cancer and Predicts Biochemical Disease Recurrence.
Neoplasms
Promoter Methylation of PTEN Is a Significant Prognostic Factor in Melanoma Survival.
Neoplasms
Promoter methylation of SEPT9 as a potential biomarker for early detection of cervical cancer and its overexpression predicts radioresistance.
Neoplasms
Promoter methylation of the candidate tumor suppressor gene TCF21 in myelodysplastic syndrome and acute myeloid leukemia.
Neoplasms
Promoter methylation of the immune checkpoint receptor PD-1 (PDCD1) is an independent prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients following radical prostatectomy.
Neoplasms
Promoting cell proliferation, cell cycle progression, and glycolysis: Glycometabolism-related genes act as prognostic signatures for prostate cancer.
Neoplasms
Proper Use of Allele-Specific Expression Improves Statistical Power for cis-eQTL Mapping with RNA-Seq Data.
Neoplasms
Proportional Upregulation of CD97 Isoforms in Glioblastoma and Glioblastoma-Derived Brain Tumor Initiating Cells.
Neoplasms
Proposal for the delineation of neoadjuvant target volumes in oesophageal cancer.
Neoplasms
Prospective lncRNA-miRNA-mRNA regulatory network of long non-coding RNA LINC00968 in non-small cell lung cancer A549 cells: A miRNA microarray and bioinformatics investigation.
Neoplasms
Prospective molecular mechanism of COL5A1 in breast cancer based on a microarray, RNA sequencing and immunohistochemistry.
Neoplasms
Prospective Randomized Double-Blind Pilot Study of Site-Specific Consensus Atlas Implementation for Rectal Cancer Target Volume Delineation in the Cooperative Group Setting.
Neoplasms
Prospective Series of Nine Long Noncoding RNAs Associated with Survival of Patients with Glioblastoma.
Neoplasms
Prostate epithelial genes define therapy-relevant prostate cancer molecular subtype.
Neoplasms
Prostate-specific membrane antigen expression in hepatocellular carcinoma: potential use for prognosis and diagnostic imaging.
Neoplasms
Prostate-specific membrane antigen in breast cancer: a comprehensive evaluation of expression and a case report of radionuclide therapy.
Neoplasms
ProstaTrend-A Multivariable Prognostic RNA Expression Score for Aggressive Prostate Cancer.
Neoplasms
Protective potential of miR-146a-5p and its underlying molecular mechanism in diverse cancers: a comprehensive meta-analysis and bioinformatics analysis.
Neoplasms
Protein anabolism is key to long-term survival in high-grade serous ovarian cancer.
Neoplasms
Protein and gene expression characteristics of heterogeneous nuclear ribonucleoprotein H1 in esophageal squamous cell carcinoma.
Neoplasms
Protein disulphide isomerase can predict the clinical prognostic value and contribute to malignant progression in gliomas.
Neoplasms
Protein dynamics analysis identifies candidate cancer driver genes and mutations in TCGA data.
Neoplasms
Protein Expression of Cyclin B1, Transferrin Receptor, and Fibronectin Is Correlated with the Prognosis of Adrenal Cortical Carcinoma.
Neoplasms
Protein expression-based classification of gastric cancer by immunohistochemistry of tissue microarray.
Neoplasms
Protein Kinase C Isozymes Associated With Relapse Free Survival in Non-Small Cell Lung Cancer Patients.
Neoplasms
Protein Kinase D3 Promotes the Reconstruction of OSCC Immune Escape Niche Via Regulating MHC-I and Immune Inhibit Molecules Expression.
Neoplasms
Protein kinases that phosphorylate splicing factors: Roles in cancer development, progression and possible therapeutic options.
Neoplasms
Protein tyrosine phosphatase, receptor type B is a potential biomarker and facilitates cervical cancer metastasis via epithelial-mesenchymal transition.
Neoplasms
Proteins S100A8 and S100A9 are potential biomarkers for renal cell carcinoma in the early stages: Results from a proteomic study integrated with bioinformatics analysis.
Neoplasms
Proteins with Evolutionarily Hypervariable Domains are Associated with Immune Response and Better Survival of Basal-like Breast Cancer Patients.
Neoplasms
Proteogenomic analysis of melanoma brain metastases from distinct anatomical sites identifies pathways of metastatic progression.
Neoplasms
Proteome mapping of epidermal growth factor induced hepatocellular carcinomas identifies novel cell metabolism targets and mitogen activated protein kinase signalling events.
Neoplasms
Proteome Profiling Outperforms Transcriptome Profiling for Coexpression Based Gene Function Prediction.
Neoplasms
Proteomic analyses identify differentially expressed proteins and pathways between low-risk and high-risk subtypes of early-stage lung adenocarcinoma and their prognostic impacts.
Neoplasms
Proteomic analysis of colon and rectal carcinoma using standard and customized databases.
Neoplasms
Proteomic analysis of hypopharyngeal and laryngeal squamous cell carcinoma sheds light on differences in survival.
Neoplasms
Proteomic analysis of malignant and benign endometrium according to obesity and insulin-resistance status using Reverse Phase Protein Array.
Neoplasms
Proteomic Analysis of Ubiquitin Ligase KEAP1 Reveals Associated Proteins That Inhibit NRF2 Ubiquitination.
Neoplasms
Proteomic analysis of urinary biomarker candidates for nonmuscle invasive bladder cancer.
Neoplasms
Proteomic characterization of paired non-malignant and malignant African-American prostate epithelial cell lines distinguishes them by structural proteins.
Neoplasms
Proteomic characterization of peroxisome proliferator-activated receptor-? (PPAR?) overexpressing or silenced colorectal cancer cells unveils a novel protein network associated with an aggressive phenotype.
Neoplasms
Proteomic Features of Colorectal Cancer Identify Tumor Subtypes Independent of Oncogenic Mutations and Independently Predict Relapse-Free Survival.
Neoplasms
Proteomic profiling identifies PTK2/FAK as a driver of radioresistance in HPV negative head and neck cancer.
Neoplasms
Proteomic profiling of patient-derived glioblastoma xenografts identifies a subset with activated EGFR: implications for drug development.
Neoplasms
Proteomic profiling reveals a signature for optimizing prognostic prediction in Colon Cancer.
Neoplasms
Proteomic Studies on the Management of High-Grade Serous Ovarian Cancer Patients: A Mini-Review.
Neoplasms
Proteomics analysis to reveal biological pathways and predictive proteins in the survival of high-grade serous ovarian cancer.
Neoplasms
Proteomics of Colorectal Cancer in a Genomic Context: First Large-Scale Mass Spectrometry-Based Analysis from the Cancer Genome Atlas.
Neoplasms
Proto-oncogene RTL4 promotes tumorigenesis and invasiveness of papillary thyroid cancer.
Neoplasms
Protocadherin ?-A7 is down-regulated in colorectal cancer and associated with the prognosis in patients with wild-type KRAS.
Neoplasms
Protocadherin alpha 3 inhibits lung squamous cell carcinoma metastasis and epithelial-mesenchymal transition.
Neoplasms
PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status.
Neoplasms
PRPF40A as a potential diagnostic and prognostic marker is upregulated in pancreatic cancer tissues and cell lines: an integrated bioinformatics data analysis.
Neoplasms
PRR11 unveiled as a top candidate biomarker within the RBM3-regulated transcriptome in pancreatic cancer.
Neoplasms
PRRG4 promotes breast cancer metastasis through the recruitment of NEDD4 and downregulation of Robo1.
Neoplasms
PSD3 is an oncogene that promotes proliferation, migration, invasion, and G1/S transition while inhibits apoptotic in papillary thyroid cancer.
Neoplasms
PseudoFuN: Deriving functional potentials of pseudogenes from integrative relationships with genes and microRNAs across 32 cancers.
Neoplasms
Pseudogene CHIAP2 inhibits proliferation and invasion of lung adenocarcinoma cells by means of the WNT pathway.
Neoplasms
Pseudogene DUXAP10 acts as a diagnostic and prognostic marker and promotes cell proliferation by activating PI3K/AKT pathway in hepatocellular carcinoma.
Neoplasms
Pseudogene DUXAP10 can be used as a diagnostic and prognostic biomarker in human cancers.
Neoplasms
Pseudogene Transcripts in Head and Neck Cancer: Literature Review and In Silico Analysis.
Neoplasms
Pseudohypoxia induced by miR-126 deactivation promotes migration and therapeutic resistance in renal cell carcinoma.
Neoplasms
Pseudouridylate Synthase 7 Promotes Cell Proliferation and Invasion in Colon Cancer Through Activating PI3K/AKT/mTOR Signaling Pathway.
Neoplasms
psichomics: graphical application for alternative splicing quantification and analysis.
Neoplasms
PSMC2, ORC5 and KRTDAP are specific biomarkers for HPV-negative head and neck squamous cell carcinoma.
Neoplasms
PSMD2 regulates breast cancer cell proliferation and cell cycle progression by modulating p21 and p27 proteasomal degradation.
Neoplasms
PTBP3 promotes migration of non-small cell lung cancer through regulating E-cadherin in EMT signaling pathway.
Neoplasms
PTEN mutation: A potential prognostic factor associated with immune infiltration in endometrial carcinoma.
Neoplasms
PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis.
Neoplasms
PTHrP, A Biomarker for CNS Metastasis in Triple-Negative Breast Cancer and Selection for Adjuvant Chemotherapy in Node-Negative Disease.
Neoplasms
PTPN1 promotes the progression of glioma by activating the MAPK/ERK and PI3K/AKT pathways and is associated with poor patient survival.
Neoplasms
PTRF independently predicts progression and survival in multiracial upper tract urothelial carcinoma following radical nephroureterectomy.
Neoplasms
PTRF/CAVIN1, regulated by SHC1 through the EGFR pathway, is found in urine exosomes as a potential biomarker of ccRCC.
Neoplasms
PTTG3P promotes gastric tumour cell proliferation and invasion and is an indicator of poor prognosis.
Neoplasms
Purine Metabolites in Tumor-Derived Exosomes May Facilitate Immune Escape of Head and Neck Squamous Cell Carcinoma.
Neoplasms
Putative Breast Cancer Driver Mutations in TBX3 Cause Impaired Transcriptional Repression.
Neoplasms
Putative DNA/RNA helicase Schlafen-11 (SLFN11) sensitizes cancer cells to DNA-damaging agents.
Neoplasms
Putative Drivers of Aggressiveness in TCEB1-mutant Renal Cell Carcinoma: An Emerging Entity with Variable Clinical Course.
Neoplasms
Putatively cancer-specific exon-exon junctions are shared across patients and present in developmental and other non-cancer cells.
Neoplasms
pyCancerSig: subclassifying human cancer with comprehensive single nucleotide, structural and microsatellite mutational signature deconstruction from whole genome sequencing.
Neoplasms
Pyrroline-5-Carboxylate Reductase-2 Promotes Colorectal Cancer Progression via Activating PI3K/AKT/mTOR Pathway.
Neoplasms
QKI, a miR-200 target gene, suppresses epithelial-to-mesenchymal transition and tumor growth.
Neoplasms
Quality and concordance of genotyping array data of 12,064 samples from 5840 cancer patients.
Neoplasms
Quality Assurance of Cancer Study Common Data Elements Using A Post-Coordination Approach.
Neoplasms
Quality control of single amino acid variations detected by tandem mass spectrometry.
Neoplasms
Quality of leadership in multidisciplinary cancer tumor boards: development and evaluation of a leadership assessment instrument (ATLAS).
Neoplasms
Quantification of BRAF V600E alleles predicts papillary thyroid cancer progression.
Neoplasms
Quantification of read species behavior within whole genome sequencing of cancer genomes for the stratification and visualization of genomic variation.
Neoplasms
Quantitative analysis of CMTM6 expression in tumor microenvironment in metastatic melanoma and association with outcome on immunotherapy.
Neoplasms
Quantitative Analysis of Differential Expression of HOX Genes in Multiple Cancers.
Neoplasms
Quantitative analysis of insulin-like growth factor 2 receptor and insulin-like growth factor binding proteins to identify control mechanisms for insulin-like growth factor 1 receptor phosphorylation.
Neoplasms
Quantitative and qualitative impairments in dendritic cell subsets of patients with ovarian or prostate cancer.
Neoplasms
Quantitative assessment and clinical relevance of kallikrein-related peptidase 5 mRNA expression in advanced high-grade serous ovarian cancer.
Neoplasms
Quantitative assessment of aberrant P16INK4a methylation in ovarian cancer: a meta-analysis based on literature and TCGA datasets.
Neoplasms
Quantitative assessment of intragenic receptor tyrosine kinase deletions in primary glioblastomas: their prevalence and molecular correlates.
Neoplasms
Quantitative assessment of target delineation variability for thymic cancers: Agreement evaluation of a prospective segmentation challenge.
Neoplasms
Quantitative assessment of the relationship between RASSF1A gene promoter methylation and bladder cancer (PRISMA).
Neoplasms
Quantitative characterization of metastatic disease in the spine. Part I. Semiautomated segmentation using atlas-based deformable registration and the level set method.
Neoplasms
Quantitative methodology is critical for assessing DNA methylation and impacts on correlation with patient outcome.
Neoplasms
Quantitative phosphoproteomic analysis identifies novel functional pathways of tumor suppressor DLC1 in estrogen receptor positive breast cancer.
Neoplasms
Quantitative Proteomic Analysis Identifies AHNAK (Neuroblast Differentiation-associated Protein AHNAK) as a Novel Candidate Biomarker for Bladder Urothelial Carcinoma Diagnosis by Liquid-based Cytology.
Neoplasms
Quantitative tumour necrosis is an independent predictor of overall survival in clear cell renal cell carcinoma.
Neoplasms
Questioning the role of selected somatic PIK3C2B mutations in squamous non-small cell lung cancer oncogenesis.
Neoplasms
Quiescin Sulfhydryl Oxidase 1 Regulates the Proliferation, Migration and Invasion of Human Glioblastoma Cells via PI3K/Akt Pathway.
Neoplasms
Rab18 Regulates Proliferation, Invasion and Cisplatin Sensitivity Through STAT3 Signaling in Head and Neck Squamous Cell Carcinoma.
Neoplasms
RAB25 expression is epigenetically downregulated in oral and oropharyngeal squamous cell carcinoma with lymph node metastasis.
Neoplasms
Rabeprazole has efficacy per se and reduces resistance to temozolomide in glioma via EMT inhibition.
Neoplasms
Rac Family Small GTPase 3 Correlates with Progression and Poor Prognosis in Bladder Cancer.
Neoplasms
Rac3 Expression and its Clinicopathological Significance in Patients With Bladder Cancer.
Neoplasms
Race disparities in the contribution of miRNA isoforms and tRNA-derived fragments to triple-negative breast cancer.
Neoplasms
Race influences survival in glioblastoma patients with KPS ??80 and associates with genetic markers of retinoic acid metabolism.
Neoplasms
Racial differences in endometrial cancer molecular portraits in The Cancer Genome Atlas.
Neoplasms
Racial Differences in Expression Levels of miRNA Machinery-Related Genes, Dicer, Drosha, DGCR8, and AGO2, in Asian Korean Papillary Thyroid Carcinoma and Comparative Validation Using the Cancer Genome Atlas.
Neoplasms
Racial disparities in patient survival and tumor mutation burden, and the association between tumor mutation burden and cancer incidence rate.
Neoplasms
Rad18 mediates specific mutational signatures and shapes the genomic landscape of carcinogen-induced tumors in vivo.
Neoplasms
RADIO-IBAG: RADIOMICS-BASED INTEGRATIVE BAYESIAN ANALYSIS OF MULTIPLATFORM GENOMIC DATA.
Neoplasms
Radiogenomic Analysis of Breast Cancer: Luminal B Molecular Subtype Is Associated with Enhancement Dynamics at MR Imaging.
Neoplasms
Radiogenomic analysis of PTEN mutation in glioblastoma using preoperative multi-parametric magnetic resonance imaging.
Neoplasms
Radiogenomics correlation between MR imaging features and mRNA-based subtypes in lower-grade glioma.
Neoplasms
Radiogenomics of High-Grade Serous Ovarian Cancer: Multireader Multi-Institutional Study from the Cancer Genome Atlas Ovarian Cancer Imaging Research Group.
Neoplasms
Radiogenomics of lower-grade glioma: algorithmically-assessed tumor shape is associated with tumor genomic subtypes and patient outcomes in a multi-institutional study with The Cancer Genome Atlas data.
Neoplasms
Radiologically defined ecological dynamics and clinical outcomes in glioblastoma multiforme: preliminary results.
Neoplasms
Radiomic analysis identifies tumor subtypes associated with distinct molecular and microenvironmental factors in head and neck squamous cell carcinoma.
Neoplasms
Radiomics MRI Phenotyping with Machine Learning to Predict the Grade of Lower-Grade Gliomas: A Study Focused on Nonenhancing Tumors.
Neoplasms
Radiomics risk score may be a potential imaging biomarker for predicting survival in isocitrate dehydrogenase wild-type lower-grade gliomas.
Neoplasms
Radiosensitivity index emerges as a potential biomarker for combined radiotherapy and immunotherapy.
Neoplasms
RAI14 Regulated by circNFATC3/miR-23b-3p axis Facilitates Cell Growth and Invasion in Gastric Cancer.
Neoplasms
RAI14 silencing suppresses progression of esophageal cancer via the STAT3 pathway.
Neoplasms
Random-forest algorithm based biomarkers in predicting prognosis in the patients with hepatocellular carcinoma.
Neoplasms
RANK-c attenuates aggressive properties of ER-negative breast cancer by inhibiting NF-?B activation and EGFR signaling.
Neoplasms
Rap2B promotes the proliferation and migration of human glioma cells via activation of the ERK pathway.
Neoplasms
Rapidly and Slowly Growing Lineages in Chromosomal Instability-Type Gland-Forming Gastric Carcinomas as Revealed by Multisampling Analysis of DNA Copy-Number Profile.
Neoplasms
Rare but recurrent ROS1 fusions resulting from chromosome 6q22 microdeletions are targetable oncogenes in glioma.
Neoplasms
Rare Variant, Gene-Based Association Study of Hereditary Melanoma Using Whole-Exome Sequencing.
Neoplasms
Ras association domain family member 10 suppresses gastric cancer growth by cooperating with GSTP1 to regulate JNK/c-Jun/AP-1 pathway.
Neoplasms
Ras related GTP binding D promotes aerobic glycolysis of hepatocellular carcinoma.
Neoplasms
RASSF1A promoter methylation correlates development, progression, and poor cancer-specific survival of renal cell carcinoma: trial sequential analysis.
Neoplasms
RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancer.
Neoplasms
RBAK is upregulated in non-small cell lung cancer and promotes cell migration and invasion.
Neoplasms
RBBP7 is a prognostic biomarker in patients with esophageal squamous cell carcinoma.
Neoplasms
RBM10 Deficiency Is Associated With Increased Immune Activity in Lung Adenocarcinoma.
Neoplasms
RBM3-Regulated Genes Promote DNA Integrity and Affect Clinical Outcome in Epithelial Ovarian Cancer.
Neoplasms
Re-Clustering and Profiling of Digestive System Tumors According to Microenvironment Components.
Neoplasms
Re-emerging role of macroscopic appearance in treatment strategy for gastric cancer.
Neoplasms
Re-Evaluating E-Cadherin and ?-Catenin: A Pan-Cancer Proteomic Approach with an Emphasis on Breast Cancer.
Neoplasms
Re: Woonyoung Choi, Andrea Ochoa, David J. McConkey, et al. Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset. Eur Urol 2017;72:354-65.
Neoplasms
Reactive Oxygen Species Are Involved in the Development of Gastric Cancer and Gastric Cancer-Related Depression through ABL1-Mediated Inflammation Signaling Pathway.
Neoplasms
Reannotation and Analysis of Clinical and Chemotherapy Outcomes in the Ovarian Data Set From The Cancer Genome Atlas.
Neoplasms
REC8 functions as a tumor suppressor and is epigenetically downregulated in gastric cancer, especially in EBV-positive subtype.
Neoplasms
Recent advances in genitourinary tumors: A review focused on biology and systemic treatment.
Neoplasms
Recent Advances on the Molecular Pathology of Glial Neoplasms in Children and Adults.
Neoplasms
Recent Incidence Trend of Surgically Resected Esophagogastric Junction Adenocarcinoma and Microsatellite Instability Status in Japanese Patients.
Neoplasms
Receptor Activator of NF Kappa B (RANK) Expression Indicates Favorable Prognosis in Patients with Muscle-invasive Bladder Cancer.
Neoplasms
Receptor tyrosine kinase expression in high-grade gliomas before and after chemoradiotherapy.
Neoplasms
Reciprocal activation of cancer-associated fibroblasts and oral squamous carcinoma cells through CXCL1.
Neoplasms
Reciprocal loop of hypoxia-inducible factor-1? (HIF-1?) and metastasis-associated protein 2 (MTA2) contributes to the progression of pancreatic carcinoma by suppressing E-cadherin transcription.
Neoplasms
Reciprocal regulation of HIF-1? and Uroplakin 1A promotes glycolysis and proliferation in Hepatocellular Carcinoma.
Neoplasms
RECK expression is associated with angiogenesis and immunogenic Tumor Microenvironment in Hepatocellular Carcinoma, and is a prognostic factor for better survival.
Neoplasms
Reclassifying endometrial carcinomas with a combined morphological and molecular approach.
Neoplasms
Recognizing the Continuous Nature of Expression Heterogeneity and Clinical Outcomes in Clear Cell Renal Cell Carcinoma.
Neoplasms
Reconstruction and analysis of circRNA?miRNA?mRNA network in the pathology of cervical cancer.
Neoplasms
Reconstruction and Analysis of the Differentially Expressed IncRNA-miRNA-mRNA Network Based on Competitive Endogenous RNA in Hepatocellular Carcinoma.
Neoplasms
Reconstruction and Analysis of the Immune-Related LINC00987/A2M Axis in Lung Adenocarcinoma.
Neoplasms
Recovery of Immunoglobulin VJ Recombinations from Pancreatic Cancer Exome Files Strongly Correlates with Reduced Survival.
Neoplasms
Recovery of T-cell receptor V(D)J recombination reads from lower grade glioma exome files correlates with reduced survival and advanced cancer grade.
Neoplasms
Recurrence-associated genes in papillary thyroid cancer: An analysis of data from The Cancer Genome Atlas.
Neoplasms
Recurrence-Associated Multi-RNA Signature to Predict Disease-Free Survival for Ovarian Cancer Patients.
Neoplasms
Recurrent Amplification of the Osmotic Stress Transcription Factor NFAT5 in Adrenocortical Carcinoma.
Neoplasms
Recurrent epigenetic silencing of the PTPRD tumor suppressor in laryngeal squamous cell carcinoma.
Neoplasms
Recurrent hormone-binding domain truncated ESR1 amplifications in primary endometrial cancers suggest their implication in hormone independent growth.
Neoplasms
Recurrent human papillomavirus-related head and neck cancer undergoes metabolic re-programming and is driven by oxidative phosphorylation.
Neoplasms
Recurrent tumor-specific regulation of alternative polyadenylation of cancer-related genes.
Neoplasms
Reduced aquaporin-1 transcript expression in colorectal carcinoma is associated with promoter hypermethylation.
Neoplasms
Reduced expression of DNA repair genes and chemosensitivity in 1p19q codeleted lower-grade gliomas.
Neoplasms
Reduced expression of ferroportin1 and ceruloplasmin predicts poor prognosis in adrenocortical carcinoma.
Neoplasms
Reduced Expression of Histone Methyltransferases KMT2C and KMT2D Correlates with Improved Outcome in Pancreatic Ductal Adenocarcinoma.
Neoplasms
Reduced expression of microRNA-139-5p in hepatocellular carcinoma results in a poor outcome: An exploration the roles of microRNA-139-5p in tumorigenesis, advancement and prognosis at the molecular biological level using an integrated meta-analysis and bioinformatic investigation.
Neoplasms
Reduced expression of the DNA glycosylase gene MUTYH is associated with an increased number of somatic mutations via a reduction in the DNA repair capacity in prostate adenocarcinoma.
Neoplasms
Reduced GRAMD1C expression correlates to poor prognosis and immune infiltrates in kidney renal clear cell carcinoma.
Neoplasms
Reduced levels of actin gamma 1 predict poor prognosis in ovarian cancer patients.
Neoplasms
Reduced mRNA expression levels of NFE2L2 are associated with poor outcome in breast cancer patients.
Neoplasms
Reduced protocadherin17 expression in leukemia stem cells: the clinical and biological effect in acute myeloid leukemia.
Neoplasms
Reduced Smad4 expression and DNA topoisomerase inhibitor chemosensitivity in non-small cell lung cancer.
Neoplasms
Reducing confounding and suppression effects in TCGA data: an integrated analysis of chemotherapy response in ovarian cancer.
Neoplasms
Reference genome and annotation updates lead to contradictory prognostic predictions in gene expression signatures: a case study of resected stage I lung adenocarcinoma.
Neoplasms
Reference-free deconvolution, visualization and interpretation of complex DNA methylation data using DecompPipeline, MeDeCom and FactorViz.
Neoplasms
Reference-free transcriptome exploration reveals novel RNAs for prostate cancer diagnosis.
Neoplasms
Regional specificity of matrix metalloproteinase-9 expression in the brain: voxel-level mapping in primary glioblastomas.
Neoplasms
Regorafenib Promotes Antitumor Immunity via Inhibiting PD-L1 and IDO1 Expression in Melanoma.
Neoplasms
regQTLs: Single nucleotide polymorphisms that modulate microRNA regulation of gene expression in tumors.
Neoplasms
Regression analysis of combined gene expression regulation in acute myeloid leukemia.
Neoplasms
Regulation Network and Prognostic Significance of Aldo-Keto Reductase (AKR) Superfamily Genes in Hepatocellular Carcinoma.
Neoplasms
Regulation of aberrantly expressed SERPINH1 by antitumor miR-148a-5p inhibits cancer cell aggressiveness in gastric cancer.
Neoplasms
Regulation of HMGB3 by antitumor miR-205-5p inhibits cancer cell aggressiveness and is involved in prostate cancer pathogenesis.
Neoplasms
Regulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer.
Neoplasms
Regulation of periostin expression by Notch signaling in hepatocytes and liver cancer cell lines.
Neoplasms
Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia.
Neoplasms
Regulation of Pharmacogene Expression by microRNA in The Cancer Genome Atlas (TCGA) Research Network.
Neoplasms
Regulation of proliferation and invasion by the IGF signalling pathway in Epstein-Barr virus-positive gastric cancer.
Neoplasms
Regulation of spindle and kinetochore-associated protein 1 by antitumor miR-10a-5p in renal cell carcinoma.
Neoplasms
Regulation of UDP-Glucuronosyltransferases UGT2B4 and UGT2B7 by MicroRNAs in Liver Cancer Cells.
Neoplasms
Regulation of Wnt receptor activity: Implications for therapeutic development in colon cancer.
Neoplasms
Regulation rewiring analysis reveals mutual regulation between STAT1 and miR-155-5p in tumor immunosurveillance in seven major cancers.
Neoplasms
Regulator of G protein signaling 20 correlates with clinicopathological features and prognosis in triple-negative breast cancer.
Neoplasms
Regulators associated with clinical outcomes revealed by DNA methylation data in breast cancer.
Neoplasms
Regulatory effects of noncoding RNAs on the interplay of oxidative stress and autophagy in cancer malignancy and therapy.
Neoplasms
Regulatory factor X5 promotes hepatocellular carcinoma progression by transactivating tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta and suppressing apoptosis.
Neoplasms
Regulatory interactions between long noncoding RNA LINC00968 and miR-9-3p in non-small cell lung cancer: A bioinformatic analysis based on miRNA microarray, GEO and TCGA.
Neoplasms
Regulatory network of PD1 signaling is associated with prognosis in glioblastoma multiforme.
Neoplasms
Regulatory network reconstruction of five essential microRNAs for survival analysis in breast cancer by integrating miRNA and mRNA expression datasets.
Neoplasms
Relapse-related molecular signature in early-stage lung adenocarcinomas based on base excision repair, stimulator of interferon genes pathway and tumor-infiltrating lymphocytes.
Neoplasms
Relating hepatocellular carcinoma tumor samples and cell lines using gene expression data in translational research.
Neoplasms
Relating pancreatic ductal adenocarcinoma tumor samples and cell lines using gene expression data in translational research.
Neoplasms
Relation between Established Glioma Risk Variants and DNA Methylation in the Tumor.
Neoplasms
Relation-aware Shared Representation Learning for Cancer Prognosis Analysis with Auxiliary Clinical Variables and Incomplete Multi-modality Data.
Neoplasms
Relationship between a 7-mRNA signature of the pancreatic adenocarcinoma microenvironment and patient prognosis (a STROBE-compliant article).
Neoplasms
Relationship between Glioblastoma Heterogeneity and Survival Time: An MR Imaging Texture Analysis.
Neoplasms
Relationship between podoplanin-expressing cancer-associated fibroblasts and the immune microenvironment of early lung squamous cell carcinoma.
Neoplasms
Relationships Between Human-Extracted MRI Tumor Phenotypes of Breast Cancer and Clinical Prognostic Indicators Including Receptor Status and Molecular Subtype.
Neoplasms
Relevance of STK11 Mutations Regarding Immune Cell Infiltration, Drug Sensitivity, and Cellular Processes in Lung Adenocarcinoma.
Neoplasms
RELL1, a novel oncogene, accelerates tumor progression and regulates immune infiltrates in glioma.
Neoplasms
Renal Cell Carcinoma With Chromosome 6p Amplification Including the TFEB Gene: A Novel Mechanism of Tumor Pathogenesis?
Neoplasms
Renal Cell Carcinoma-Infiltrating CD3low V?9V?1 T Cells Represent Potentially Novel Anti-Tumor Immune Players.
Neoplasms
Renal cell carcinoma: molecular characterization and evolving treatment paradigms.
Neoplasms
Renal cell tumors with clear cell histology and intact VHL and chromosome 3p: a histological review of tumors from the Cancer Genome Atlas database.
Neoplasms
Replisome genes regulation by antitumor miR-101-5p in clear cell renal cell carcinoma.
Neoplasms
Reply to Joshua A. Linscott, Angela B. Smith, and Jesse D. Sammon's Letter to the Editor re: Woonyoung Choi, Andrea Ochoa, David J. McConkey, et al. Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset. Eur Urol 2017;72:354-65.
Neoplasms
Repression of GCN5 expression or activity attenuates c-MYC expression in non-small cell lung cancer.
Neoplasms
Reprimo, a Potential p53-Dependent Tumor Suppressor Gene, Is Frequently Hypermethylated in Estrogen Receptor ?-Positive Breast Cancer.
Neoplasms
Reproducibility of Differential Proteomic Technologies in CPTAC Fractionated Xenografts.
Neoplasms
Reproducible imaging-based prediction of molecular subtype and risk stratification of gliomas across different experience levels using a structured reporting system.
Neoplasms
Reproduction of the Cancer Genome Atlas (TCGA) and Asian Cancer Research Group (ACRG) Gastric Cancer Molecular Classifications and Their Association with Clinicopathological Characteristics and Overall Survival in Moroccan Patients.
Neoplasms
REPURPOSING GERMLINE EXOMES OF THE CANCER GENOME ATLAS DEMANDS A CAUTIOUS APPROACH AND SAMPLE-SPECIFIC VARIANT FILTERING.
Neoplasms
Repurposing Methotrexate in Dampening SARS-CoV2-S1-Mediated IL6 Expression: Lessons Learnt from Lung Cancer.
Neoplasms
Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis.
Neoplasms
Requirement for ssbp2 in hematopoietic stem cell maintenance and stress response.
Neoplasms
Research Resource: Global Identification of Estrogen Receptor ? Target Genes in Triple Negative Breast Cancer Cells.
Neoplasms
Researches on the Correlation Between Estrogen and Progesterone Receptors Expression and Disease-Free Survival of Endometrial Cancer.
Neoplasms
Resistance to CTLA-4 checkpoint inhibition reversed through selective elimination of granulocytic myeloid cells.
Neoplasms
Resolvin D1 reduces cancer growth stimulating a protective neutrophil-dependent recruitment of anti-tumor monocytes.
Neoplasms
Response to Comment on "DNA damage is a pervasive cause of sequencing errors, directly confounding variant identification".
Neoplasms
Restoring the epigenetically silenced PCK2 suppresses renal cell carcinoma progression and increases sensitivity to sunitinib by promoting endoplasmic reticulum stress.
Neoplasms
Retinal dehydrogenase 5 (RHD5) attenuates metastasis via regulating HIPPO/YAP signaling pathway in Hepatocellular Carcinoma.
Neoplasms
Retinoblastoma binding protein 4 up-regulation is correlated with hepatic metastasis and poor prognosis in colon cancer patients.
Neoplasms
Retrospective clinical trial experimentally validates glioblastoma genome-wide pattern of DNA copy-number alterations predictor of survival.
Neoplasms
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples.
Neoplasms
Retrospective Review of a Mobile Mammography Screening Program in an Underserved Population within a Large Metropolitan Area.
Neoplasms
Retrospective study of gene signatures and prognostic value of m6A regulatory factor in non-small cell lung cancer using TCGA database and the verification of FTO.
Neoplasms
Retrospective Validation of a 168-Gene Expression Signature for Glioma Classification on a Single Molecule Counting Platform.
Neoplasms
Retrotransposition of gene transcripts leads to structural variation in mammalian genomes.
Neoplasms
Reusability and composability in process description maps: RAS-RAF-MEK-ERK signalling.
Neoplasms
Reveal the Regulation Patterns of Prognosis-Related miRNAs and lncRNAs Across Solid Tumors in the Cancer Genome Atlas.
Neoplasms
Revealing Biological Pathways Implicated in Lung Cancer from TCGA Gene Expression Data Using Gene Set Enrichment Analysis.
Neoplasms
Revealing Prognosis-Related Pathways at the Individual Level by a Comprehensive Analysis of Different Cancer Transcription Data.
Neoplasms
Revisiting the transcriptional analysis of primary tumours and associated nodal metastases with enhanced biological and statistical controls: application to thyroid cancer.
Neoplasms
Revisiting vimentin: a negative surrogate marker of molecularly defined oligodendroglioma in adult type diffuse glioma.
Neoplasms
RFC2, a direct target of miR-744, modulates the cell cycle and promotes the proliferation of CRC cells.
Neoplasms
Rho guanine nucleotide exchange factor 39 increases the viability, migration and invasion of clear cell renal cell carcinoma cells via the activation of the AKT/ERK signaling pathway.
Neoplasms
Ribosomal L22-like1 (RPL22L1) Promotes Ovarian Cancer Metastasis by Inducing Epithelial-to-Mesenchymal Transition.
Neoplasms
Ribosomal Proteins RPS11 and RPS20, Two Stress-Response Markers of Glioblastoma Stem Cells, Are Novel Predictors of Poor Prognosis in Glioblastoma Patients.
Neoplasms
Ribosome Assembly Factor URB1 Contributes to Colorectal Cancer Proliferation via Transcriptional Activation of ATF4.
Neoplasms
RICTOR Amplification Defines a Novel Subset of Patients with Lung Cancer Who May Benefit from Treatment with mTORC1/2 Inhibitors.
Neoplasms
RIF1 promotes tumor growth and cancer stem cell-like traits in NSCLC by protein phosphatase 1-mediated activation of Wnt/?-catenin signaling.
Neoplasms
RIPK2 is an unfavorable prognosis marker and a potential therapeutic target in human kidney renal clear cell carcinoma.
Neoplasms
Risk characteristics with seven epithelial-mesenchymal transition-related genes are used to predict the prognosis of patients with hepatocellular carcinoma.
Neoplasms
Risk factors predisposing to cardia gastric adenocarcinoma: Insights and new perspectives.
Neoplasms
Risk of cognition alteration and emotional frailty via circulating transcriptome in treatment naïve head and neck squamous cell cancer patients.
Neoplasms
Risk score based on expression of five novel genes predicts survival in soft tissue sarcoma.
Neoplasms
Risk score based on three mRNA expression predicts the survival of bladder cancer.
Neoplasms
Risk Score Based on Two microRNAs as a Prognostic Marker of Hepatocellular Carcinoma and the Corresponding Competitive Endogenous RNA Network.
Neoplasms
Risk scoring based on expression of long non?coding RNAs can effectively predict survival in hepatocellular carcinoma patients with or without fibrosis.
Neoplasms
Risk Scoring System based on lncRNA Expression for Predicting Survival in Hepatocellular Carcinoma with Cirrhosis.
Neoplasms
Risk stratification of cutaneous melanoma reveals carcinogen metabolism enrichment and immune inhibition in high-risk patients.
Neoplasms
RMEL3, a novel BRAFV600E-associated long noncoding RNA, is required for MAPK and PI3K signaling in melanoma.
Neoplasms
RNA binding motif protein 10 suppresses lung cancer progression by controlling alternative splicing of eukaryotic translation initiation factor 4H.
Neoplasms
RNA Expression of DNA Damage Response Genes in Muscle-Invasive Bladder Cancer: Influence on Outcome and Response to Adjuvant Cisplatin-Based Chemotherapy.
Neoplasms
RNA Immune Signatures from Pan-Cancer Analysis Are Prognostic for High-Grade Serous Ovarian Cancer and Other Female Cancers.
Neoplasms
RNA N6-methyladenosine reader IGF2BP3 regulates cell cycle and angiogenesis in colon cancer.
Neoplasms
RNA processing genes characterize RNA splicing and further stratify lower-grade glioma.
Neoplasms
RNA sequencing analysis reveals protective role of kruppel-like factor 3 in colorectal cancer.
Neoplasms
RNA sequencing and Immunohistochemistry Reveal ZFN7 as a Stronger Marker of Survival than Molecular Subtypes in G-CIMP-negative Glioblastoma.
Neoplasms
RNA Sequencing of Collecting Duct Renal Cell Carcinoma Suggests an Interaction between miRNA and Target Genes and a Predominance of Deregulated Solute Carrier Genes.
Neoplasms
RNA sequencing-based cell proliferation analysis across 19 cancers identifies a subset of proliferation-informative cancers with a common survival signature.
Neoplasms
RNA splicing and aggregate gene expression differences in lung squamous cell carcinoma between patients of West African and European ancestry.
Neoplasms
RNA-Associated Co-expression Network Identifies Novel Biomarkers for Digestive System Cancer.
Neoplasms
RNA-binding protein RALY reprogrammes mitochondrial metabolism via mediating miRNA processing in colorectal cancer.
Neoplasms
RNA-Binding Proteins Play an Important Role in the Prognosis of Patients With Testicular Germ Cell Tumor.
Neoplasms
RNA-Seq accurately identifies cancer biomarker signatures to distinguish tissue of origin.
Neoplasms
RNA-seq analysis identified hormone-related genes associated with prognosis of triple negative breast cancer.
Neoplasms
RNA-Seq Analysis of Colorectal Tumor-Infiltrating Myeloid-Derived Suppressor Cell Subsets Revealed Gene Signatures of Poor Prognosis.
Neoplasms
RNA-seq for identification of therapeutically targetable determinants of immune activation in human glioblastoma.
Neoplasms
RNA-seq Identification of RACGAP1 as a Metastatic Driver in Uterine Carcinosarcoma.
Neoplasms
RNA-Sequencing Analysis of Adrenocortical Carcinoma, Pheochromocytoma and Paraganglioma from a Pan-Cancer Perspective.
Neoplasms
RNA-Sequencing Data Reveal a Prognostic Four-lncRNA-Based Risk Score for Bladder Urothelial Carcinoma: An in Silico Update.
Neoplasms
RNA-sequencing investigation identifies an effective risk score generated by three novel lncRNAs for the survival of papillary thyroid cancer patients.
Neoplasms
RNASeq analysis reveals biological processes governing the clinical behaviour of endometrioid and serous endometrial cancers.
Neoplasms
RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation.
Neoplasms
Roadmap of DNA methylation in breast cancer identifies novel prognostic biomarkers.
Neoplasms
Robust analysis of novel mRNA-lncRNA cross talk based on ceRNA hypothesis uncovers carcinogenic mechanism and promotes diagnostic accuracy in esophageal cancer.
Neoplasms
Robust and Efficient Biomolecular Clustering of Tumor Based on ${p}$ -Norm Singular Value Decomposition.
Neoplasms
Robust biomarker discovery for hepatocellular carcinoma from high-throughput data by multiple feature selection methods.
Neoplasms
Robust clustering of noisy high-dimensional gene expression data for patients subtyping.
Neoplasms
Robust expression of tumor suppressor miRNA's let-7 and miR-195 detected in plasma of Saudi female breast cancer patients.
Neoplasms
Robust identification of target genes and outliers in triple-negative breast cancer data.
Neoplasms
Robust Principal Component Analysis Regularized by Truncated Nuclear Norm for Identifying Differentially Expressed Genes.
Neoplasms
Robust semiparametric gene-environment interaction analysis using sparse boosting.
Neoplasms
Roentgen anatomy. III. A cross section atlas for the radiation therapy of the cancer of cervix uteri.
Neoplasms
Role of Akt2 in regulation of metastasis suppressor 1 expression and colorectal cancer metastasis.
Neoplasms
Role of ATG10 expression quantitative trait loci in non-small cell lung cancer survival.
Neoplasms
Role of B7-H4 siRNA in Proliferation, Migration, and Invasion of LOVO Colorectal Carcinoma Cell Line.
Neoplasms
Role of Bclaf1 in Promoting Adrenocortical Carcinoma Proliferation: A Study Combining the Use of Bioinformatics and Molecular Events.
Neoplasms
Role of BRAF and RAS Mutations in Extrathyroidal Extension in Papillary Thyroid Cancer.
Neoplasms
Role of cancer stem-cell marker doublecortin-like kinase 1 in head and neck squamous cell carcinoma.
Neoplasms
Role of CYP4F2 as a novel biomarker regulating malignant phenotypes of liver cancer cells via the Nrf2 signaling axis.
Neoplasms
Role of DNA methylation regulation of miR-130b expression in human lung cancer using bioinformatics analysis.
Neoplasms
Role of Elevated PHIP Copy Number as a Prognostic and Progression Marker for Cutaneous Melanoma.
Neoplasms
Role of EphB3 Receptor in Mediating Head and Neck Tumor Growth, Cell Migration, and Response to PI3K Inhibitor.
Neoplasms
Role of exchange protein directly activated by cAMP (EPAC1) in breast cancer cell migration and apoptosis.
Neoplasms
Role of Immune Cell-Specific Hypermethylation Signatures in Classification and Risk Stratification of Breast Cancer.
Neoplasms
Role of Immune Response, Inflammation, and Tumor Immune Response-Related Cytokines/Chemokines in Melanoma Progression.
Neoplasms
Role of INSL4 Signaling in Sustaining the Growth and Viability of LKB1-Inactivated Lung Cancer.
Neoplasms
Role of Krüppel-like Factor 4-p21CIP1 Axis in Breast Cancer Stem-like Cell Inhibition by Benzyl Isothiocyanate.
Neoplasms
Role of m5C-related regulatory genes in the diagnosis and prognosis of hepatocellular carcinoma.
Neoplasms
Role of miR-1 expression in clear cell renal cell carcinoma (ccRCC): A bioinformatics study based on GEO, ArrayExpress microarrays and TCGA database.
Neoplasms
Role of miR-182-5p overexpression in trichloroethylene-induced abnormal cell cycle functions in human HepG2 cells.
Neoplasms
Role of NADH Dehydrogenase (Ubiquinone) 1 Alpha Subcomplex 4-Like 2 in Clear Cell Renal Cell Carcinoma.
Neoplasms
Role of oncogene PIM-1 in the development and progression of papillary thyroid carcinoma: Involvement of oxidative stress.
Neoplasms
Role of pre-miR-532 (miR-532-5p and miR-532-3p) in regulation of gene expression and molecular pathogenesis in renal cell carcinoma.
Neoplasms
Role of RHOC in evaluating an adverse prognosis in patients with glioma and its potential prognostic value.
Neoplasms
Role of SIRT1/AMPK signaling in the proliferation, migration and invasion of renal cell carcinoma cells.
Neoplasms
Role of ultraviolet mutational signature versus tumor mutation burden in predicting response to immunotherapy.
Neoplasms
Role of upregulated miR-136-5p in lung adenocarcinoma: A study of 1242 samples utilizing bioinformatics analysis.
Neoplasms
Roles of MYC-targeting long non-coding RNA MINCR in cell cycle regulation and apoptosis in non-small cell lung Cancer.
Neoplasms
RPL19 Is a Prognostic Biomarker and Promotes Tumor Progression in Hepatocellular Carcinoma.
Neoplasms
RSPO3 is a marker candidate for predicting tumor aggressiveness in ovarian cancer.
Neoplasms
RTOG Sarcoma Radiation Oncologists Reach Consensus on Gross Tumor Volume and Clinical Target Volume on Computed Tomographic Images for Preoperative Radiotherapy of Primary Soft Tissue Sarcoma of Extremity in Radiation Therapy Oncology Group Studies.
Neoplasms
RTVP-1 promotes mesenchymal transformation of glioma via a STAT-3/IL-6-dependent positive feedback loop.
Neoplasms
RUNX1 and REXO2 are associated with the heterogeneity and prognosis of IDH wild type lower grade glioma.
Neoplasms
RUNX1 contributes to the mesenchymal subtype of glioblastoma in a TGF? pathway-dependent manner.
Neoplasms
RUVBL1 is an amplified epigenetic factor promoting proliferation and inhibiting differentiation program in head and neck squamous cancers.
Neoplasms
S-score: a scoring system for the identification and prioritization of predicted cancer genes.
Neoplasms
S100 Calcium Binding Protein A10, A Novel Oncogene, Promotes the Proliferation, Invasion, and Migration of Hepatocellular Carcinoma.
Neoplasms
S100A10 Accelerates Aerobic Glycolysis and Malignant Growth by Activating mTOR-Signaling Pathway in Gastric Cancer.
Neoplasms
S100A16 induces epithelial-mesenchymal transition in human PDAC cells and is a new therapeutic target for pancreatic cancer treatment that synergizes with gemcitabine.
Neoplasms
S100A16 regulated by Snail promotes the chemoresistance of nonmuscle invasive bladder cancer through the AKT/Bcl-2 pathway.
Neoplasms
S100P acts as a target of miR-495 in pancreatic cancer through bioinformatics analysis and experimental verification.
Neoplasms
Salt-inducible kinase 2 functions as a tumor suppressor in hepatocellular carcinoma.
Neoplasms
SAMD5 mRNA was overexpressed in prostate cancer and can predict biochemical recurrence after radical prostatectomy.
Neoplasms
Sampling Based Tumor Recognition in Whole-slide Histology Image with Deep Learning Approaches.
Neoplasms
SAMQA: error classification and validation of high-throughput sequenced read data.
Neoplasms
Sanguinarine inhibits the tumorigenesis of gastric cancer by regulating the TOX/DNA-PKcs/ KU70/80 pathway.
Neoplasms
SASS6 overexpression is associated with mitotic chromosomal abnormalities and a poor prognosis in patients with colorectal cancer.
Neoplasms
Scalable Nonparametric Prescreening Method for Searching Higher-Order Genetic Interactions Underlying Quantitative Traits.
Neoplasms
Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines.
Neoplasms
scan_tcga tools for integrated epigenomic and transcriptomic analysis of tumor subgroups.
Neoplasms
Scavenger Receptor A1 Prevents Metastasis of Non-Small Cell Lung Cancer via Suppression of Macrophage Serum Amyloid A1.
Neoplasms
Scavenger receptor class A, member 5 is associated with thyroid cancer cell lines progression via epithelial-mesenchymal transition.
Neoplasms
SCG3 Protein Expression in Glioma Associates With less Malignancy and Favorable Clinical Outcomes.
Neoplasms
Screening a Prognosis-Related Target Gene in Patients with HER-2-Positive Breast Cancer by Bioinformatics Analysis.
Neoplasms
Screening and bioinformatics analysis of a ceRNA network based on the circular RNAs, miRNAs, and mRNAs in pan-cancer.
Neoplasms
Screening and discrimination of optimal prognostic genes for pancreatic cancer based on a prognostic prediction model.
Neoplasms
Screening and Identification of an Immune-Associated lncRNA Prognostic Signature in Ovarian Carcinoma: Evidence from Bioinformatic Analysis.
Neoplasms
Screening and identification of angiogenesis-related genes as potential novel prognostic biomarkers of hepatocellular carcinoma through bioinformatics analysis.
Neoplasms
Screening and identification of autophagy-related biomarkers for oral squamous cell carcinoma (OSCC) via integrated bioinformatics analysis.
Neoplasms
Screening and identification of biomarkers associated with clinicopathological parameters and prognosis in oral squamous cell carcinoma.
Neoplasms
Screening and identification of biomarkers associated with the diagnosis and prognosis of lung adenocarcinoma.
Neoplasms
Screening and Identification of Key Biomarkers in Inflammatory Breast Cancer Through Integrated Bioinformatic Analyses.
Neoplasms
Screening and Identification of Potential Biomarkers for Hepatocellular Carcinoma: An Analysis of TCGA Database and Clinical Validation.
Neoplasms
Screening and Identification of Potential Biomarkers in Hepatitis B Virus-Related Hepatocellular Carcinoma by Bioinformatics Analysis.
Neoplasms
Screening and Identification of Prognostic Tumor-Infiltrating Immune Cells and Genes of Endometrioid Endometrial Adenocarcinoma: Based on The Cancer Genome Atlas Database and Bioinformatics.
Neoplasms
Screening and Identifying Cisplatin-Related Gene Mutations in Lung Squamous Cell Carcinoma.
Neoplasms
Screening and Identifying Immune-Related Cells and Genes in the Tumor Microenvironment of Bladder Urothelial Carcinoma: Based on TCGA Database and Bioinformatics.
Neoplasms
Screening and Identifying m6A Regulators as an Independent Prognostic Biomarker in Pancreatic Cancer Based on The Cancer Genome Atlas Database.
Neoplasms
Screening and Interaction Analysis of Key Genes in miR-542-3p Over- Expressed Osteosarcoma Cells by Bioinformatics.
Neoplasms
Screening and Validation of Independent Predictors of Poor Survival in Pancreatic Cancer.
Neoplasms
Screening and Validation of the Hypoxia-Related Signature of Evaluating Tumor Immune Microenvironment and Predicting Prognosis in Gastric Cancer.
Neoplasms
Screening and verification of long noncoding RNA promoter methylation sites in hepatocellular carcinoma.
Neoplasms
Screening and verification of microRNA promoter methylation sites in hepatocellular carcinoma.
Neoplasms
Screening for tumor suppressors: Loss of ephrin receptor A2 cooperates with oncogenic KRas in promoting lung adenocarcinoma.
Neoplasms
Screening key genes and miRNAs in early-stage colon adenocarcinoma by RNA-sequencing.
Neoplasms
Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis.
Neoplasms
Screening key lncRNAs for human lung adenocarcinoma based on machine learning and weighted gene co-expression network analysis.
Neoplasms
Screening key long non-coding RNAs in early-stage colon adenocarcinoma by RNA-sequencing.
Neoplasms
Screening of cervical cancer-related hub genes based on comprehensive bioinformatics analysis.
Neoplasms
Screening of differentially expressed genes and identification of NUF2 as a prognostic marker in breast cancer.
Neoplasms
Screening of differentially methylated genes in breast cancer and risk model construction based on TCGA database.
Neoplasms
Screening of DNA Damage Repair Genes Involved in the Prognosis of Triple-Negative Breast Cancer Patients Based on Bioinformatics.
Neoplasms
Screening of gene markers related to the prognosis of metastatic skin cutaneous melanoma based on Logit regression and survival analysis.
Neoplasms
Screening of genes related to survival prognosis of cervical squamous cell carcinoma and construction of prognosis prediction model.
Neoplasms
Screening of immunosuppressive cells from colorectal adenocarcinoma and identification of prognostic markers.
Neoplasms
Screening of important lncRNAs associated with the prognosis of lung adenocarcinoma, based on integrated bioinformatics analysis.
Neoplasms
Screening of key genes and prediction of therapeutic agents in Arsenic-induced lung carcinoma.
Neoplasms
Screening of Methylation Gene Sites as Prognostic Signature in Lung Adenocarcinoma.
Neoplasms
Screening of miRNAs associated with lymph node metastasis in Her-2-positive breast cancer and their relationship with prognosis.
Neoplasms
Screening of Prognosis-Related Genes in Primary Breast Carcinoma Using Genomic Expression Data.
Neoplasms
Screening of Target Genes and Regulatory Function of miRNAs as Prognostic Indicators for Prostate Cancer.
Neoplasms
Screening of tumor grade-related mRNAs and lncRNAs for Esophagus Squamous Cell Carcinoma.
Neoplasms
Screening potential microRNAs associated with pancreatic cancer: Data mining based on RNA sequencing and microarrays.
Neoplasms
Screening potential prognostic biomarkers for portal vein emboli in patients with hepatocellular carcinoma.
Neoplasms
Screening Prognosis-Related lncRNAs Based on WGCNA to Establish a New Risk Score for Predicting Prognosis in Patients with Hepatocellular Carcinoma.
Neoplasms
Screening responsive or resistant biomarkers of immune checkpoint inhibitors based on online databases.
Neoplasms
Screening TCGA database for prognostic genes in lower grade glioma microenvironment.
Neoplasms
Screening the Cancer Genome Atlas Database for Genes of Prognostic Value in Acute Myeloid Leukemia.
Neoplasms
Screening the genome for HCC-specific CpG methylation signatures as biomarkers for diagnosis and prognosis evaluation.
Neoplasms
Screening the key genes of prognostic value in the microenvironment for head and neck squamous cell carcinoma.
Neoplasms
SCRIB Promotes Proliferation and Metastasis by Targeting Hippo/YAP Signalling in Colorectal Cancer.
Neoplasms
SEaCorAl: Identifying and contrasting the regulation-correlation bias in RNA-Seq paired expression data of patient groups.
Neoplasms
Searching for a signature involving 10 genes to predict the survival of patients with acute myelocytic leukemia through a combined multi-omics analysis.
Neoplasms
Sec23a mediates miR-200c augmented oligometastatic to polymetastatic progression.
Neoplasms
SEC61G promotes breast cancer development and metastasis via modulating glycolysis and is transcriptionally regulated by E2F1.
Neoplasms
Second edition of 'The Bethesda System for reporting cervical cytology' - atlas, website, and Bethesda interobserver reproducibility project.
Neoplasms
Secondary chronic respiratory acidosis in a dog following the cervical cord compression by an intradural glioma.
Neoplasms
SEGreg: a database for human specifically expressed genes and their regulations in cancer and normal tissue.
Neoplasms
Selection of endogenous control genes for normalising gene expression data derived from formalin-fixed paraffin-embedded tumour tissue.
Neoplasms
Selection of three miRNA signatures with prognostic value in non-M3 acute myeloid leukemia.
Neoplasms
Selective coexpression of VEGF receptor 2 in EGFRvIII-positive glioblastoma cells prevents cellular senescence and contributes to their aggressive nature.
Neoplasms
Selective expression of long non-coding RNAs in a breast cancer cell progression model.
Neoplasms
Selective inhibition of TGF?1 activation overcomes primary resistance to checkpoint blockade therapy by altering tumor immune landscape.
Neoplasms
Selective inhibition of the lactate transporter MCT4 reduces growth of invasive bladder cancer.
Neoplasms
Selenium-binding protein 1 transcriptionally activates p21 expression via p53-independent mechanism and its frequent reduction associates with poor prognosis in bladder cancer.
Neoplasms
SEMA3F prevents metastasis of colorectal cancer by PI3K-AKT-dependent down-regulation of the ASCL2-CXCR4 axis.
Neoplasms
SEMA3F Promotes Liver Hepatocellular Carcinoma Metastasis by Activating Focal Adhesion Pathway.
Neoplasms
Sema4D correlates with tumour immune infiltration and is a prognostic biomarker in bladder cancer, renal clear cell carcinoma, melanoma and thymoma.
Neoplasms
Semi-supervised identification of cancer subgroups using survival outcomes and overlapping grouping information.
Neoplasms
Sensitivity to differential NRF1 gene signatures contributes to breast cancer disparities.
Neoplasms
Sensitization of human erythroleukemia K562 cells resistant to methotrexate by inhibiting IMPDH.
Neoplasms
Separated Siamese Twins: Intronic Small Nucleolar RNAs and Matched Host Genes May be Altered in Conjunction or Separately in Multiple Cancer Types.
Neoplasms
Sequential analysis of transcript expression patterns improves survival prediction in multiple cancers.
Neoplasms
Serine hydroxymethyl transferase 1 stimulates pro-oncogenic cytokine expression through sialic acid to promote ovarian cancer tumor growth and progression.
Neoplasms
Serine Incorporator 2 (SERINC2) Expression Predicts an Unfavorable Prognosis of Low-Grade Glioma (LGG): Evidence from Bioinformatics Analysis.
Neoplasms
Serine/Arginine-Rich Splicing Factor 3 Modulates the Alternative Splicing of Cytoplasmic Polyadenylation Element Binding Protein 2.
Neoplasms
Serological response to Epstein-Barr virus early antigen is associated with gastric cancer and human immunodeficiency virus infection in Zambian adults: a case-control study.
Neoplasms
Serous BMP8A has clinical significance in ultrasonic diagnosis of thyroid cancer and promotes thyroid cancer cell progression.
Neoplasms
Serous IFNA3 predicts unfavorable prognosis in lung cancer via abnormal activation of AKT signaling.
Neoplasms
SERPINE1 associated with remodeling of the tumor microenvironment in colon cancer progression: a novel therapeutic target.
Neoplasms
Serum deprivation response functions as a tumor suppressor gene in papillary thyroid cancer.
Neoplasms
Serum deprivation-response protein induces apoptosis in hepatocellular carcinoma through ASK1-JNK/p38 MAPK pathways.
Neoplasms
Serum exosomal miR-1269a serves as a diagnostic marker and plays an oncogenic role in non-small cell lung cancer.
Neoplasms
Serum Irisin Predicts Posthepatectomy Complications in Patients with Hepatocellular Carcinoma.
Neoplasms
Serum KIAA1199 is an advanced-stage prognostic biomarker and metastatic oncogene in cholangiocarcinoma.
Neoplasms
Serum long non-coding RNA LOC553103 as non-specific diagnostic and prognostic biomarker for common types of human cancer.
Neoplasms
Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study.
Neoplasms
Serum proteome profiling reveals SOX3 as a candidate prognostic marker for gastric cancer.
Neoplasms
Serum small extracellular vesicle-derived LINC00853 as a novel diagnostic marker for early hepatocellular carcinoma.
Neoplasms
Serum Type XIX Collagen is Significantly Elevated in Non-Small Cell Lung Cancer: A Preliminary Study on Biomarker Potential.
Neoplasms
Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients.
Neoplasms
Serum-free culture success of glial tumors is related to specific molecular profiles and expression of extracellular matrix-associated gene modules.
Neoplasms
Set-Wise Differential Interaction Between Copy Number Alterations and Gene Expressions of Lower-Grade Glioma Reveals Prognosis-Associated Pathways.
Neoplasms
SETD7 is a prognosis predicting factor of breast cancer and regulates redox homeostasis.
Neoplasms
Seven-CpG-based prognostic signature coupled with gene expression predicts survival of oral squamous cell carcinoma.
Neoplasms
Seven-Gene Signature Based on Glycolysis Is Closely Related to the Prognosis and Tumor Immune Infiltration of Patients With Gastric Cancer.
Neoplasms
Seven-gene signature on tumor microenvironment for predicting the prognosis of patients with pancreatic cancer.
Neoplasms
Seven-senescence-associated gene signature predicts overall survival for Asian patients with hepatocellular carcinoma.
Neoplasms
Several microRNAs could predict survival in patients with hepatitis B-related liver cancer.
Neoplasms
Sex Differences in Using Systemic Inflammatory Markers to Prognosticate Patients with Head and Neck Squamous Cell Carcinoma.
Neoplasms
Sex-Associated Gene Expression Alterations Correlate With Esophageal Cancer Survival.
Neoplasms
Sex-biased differences in the correlation between epithelial-to-mesenchymal transition-associated genes in cancer cell lines.
Neoplasms
SFTA1P, LINC00968, GATA6-AS1, TBX5-AS1, and FEZF1-AS1 are crucial long non-coding RNAs associated with the prognosis of lung squamous cell carcinoma.
Neoplasms
SGK2 promotes renal cancer progression via enhancing ERK 1/2 and AKT phosphorylation.
Neoplasms
SHARPIN regulates the development of clear cell renal cell carcinoma by promoting von Hippel-Lindau protein ubiquitination and degradation.
Neoplasms
Shift in GATA3 functions, and GATA3 mutations, control progression and clinical presentation in breast cancer.
Neoplasms
Shikonin inhibits migration and invasion of triple-negative breast cancer cells by suppressing epithelial-mesenchymal transition via miR-17-5p/PTEN/Akt pathway.
Neoplasms
shinyMethyl: interactive quality control of Illumina 450k DNA methylation arrays in R.
Neoplasms
Short hairpin RNA-mediated knockdown of nuclear factor erythroid 2-like 3 exhibits tumor-suppressing effects in hepatocellular carcinoma cells.
Neoplasms
Short-term RANKL exposure initiates a neoplastic transcriptional program in the basal epithelium of the murine salivary gland.
Neoplasms
SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.
Neoplasms
Shp2 Inhibits Proliferation of Esophageal Squamous Cell Cancer via Dephosphorylation of Stat3.
Neoplasms
shRNA knockdown of DNA helicase ERCC6L expression inhibits human breast cancer growth.
Neoplasms
Shugosin 2 is a biomarker for pathological grading and survival prediction in patients with gliomas.
Neoplasms
SIFORM: shared informative factor models for integration of multi-platform bioinformatic data.
Neoplasms
SigFuge: single gene clustering of RNA-seq reveals differential isoform usage among cancer samples.
Neoplasms
Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancer.
Neoplasms
Signaling Complexity Measured by Shannon Entropy and Its Application in Personalized Medicine.
Neoplasms
Signaling pathway network alterations in human ovarian cancers identified with quantitative mitochondrial proteomics.
Neoplasms
Signature based on molecular subtypes of deoxyribonucleic acid methylation predicts overall survival in gastric cancer.
Neoplasms
Signature identification of relapse-related overall survival of early lung adenocarcinoma after radical surgery.
Neoplasms
Signature microRNAs and long noncoding RNAs in laryngeal cancer recurrence identified using a competing endogenous RNA network.
Neoplasms
Signature of prognostic epithelial-mesenchymal transition related long noncoding RNAs (ERLs) in hepatocellular carcinoma.
Neoplasms
Signature Panel of 11 Methylated mRNAs and 3 Methylated lncRNAs for Prediction of Recurrence-Free Survival in Prostate Cancer Patients.
Neoplasms
Signatures of gene expression, DNA methylation and microRNAs of hepatocellular carcinoma with vascular invasion.
Neoplasms
Signatures of somatic mutations and gene expression from p16INK4A positive head and neck squamous cell carcinomas (HNSCC).
Neoplasms
Significance of Alpha-inhibin Expression in Pheochromocytomas and Paragangliomas.
Neoplasms
Significance of DMBT1 in Papillary Thyroid Carcinoma Concurrent With Hashimoto's Thyroiditis.
Neoplasms
Significance of N6-Methyladenosine RNA Methylation Regulators in Immune Infiltrates of Ovarian Cancer.
Neoplasms
Significance of positive and inhibitory regulators in the TGF-? signaling pathway in colorectal cancers.
Neoplasms
Significance of survivin as a prognostic factor and a therapeutic target in endometrial cancer.
Neoplasms
Significance of the BRAF mRNA Expression Level in Papillary Thyroid Carcinoma: An Analysis of The Cancer Genome Atlas Data.
Neoplasms
Significance of TP53 mutation in bladder cancer disease progression and drug selection.
Neoplasms
Significance of TP53 Mutation in Cellular Process and Disease Progression in Lung Adenocarcinoma.
Neoplasms
Significance of TP53 mutation in treatment and prognosis in head and neck squamous cell carcinoma.
Neoplasms
Significance of tumor mutation burden and immune infiltration in thymic epithelial tumors.
Neoplasms
Significance of Tumor Mutation Burden Combined With Immune Infiltrates in the Progression and Prognosis of Advanced Gastric Cancer.
Neoplasms
Significance of Tumor Mutation Burden in Immune Infiltration and Prognosis in Cutaneous Melanoma.
Neoplasms
Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma.
Neoplasms
Significant association of DIRC1 overexpression with tumor progression and poor prognosis in gastric cancer.
Neoplasms
Significant association of YAP1 and HSPC111 proteins with poor prognosis in Chinese gastric cancer patients.
Neoplasms
Significant Prognostic Features and Patterns of Somatic TP53 Mutations in Human Cancers.
Neoplasms
Significant Prognostic Value of the Autophagy-Related Gene P4HB in Bladder Urothelial Carcinoma.
Neoplasms
Significantly different expression levels of microRNAs associated with vascular invasion in hepatocellular carcinoma and their prognostic significance after surgical resection.
Neoplasms
Silence of Hippo Pathway Associates with Pro-Tumoral Immunosuppression: Potential Therapeutic Target of Glioblastomas.
Neoplasms
Silenced PITX1 promotes chemotherapeutic resistance to 5-fluorocytosine and cisplatin in gastric cancer cells.
Neoplasms
Silencing DSCAM-AS1 suppresses the growth and invasion of ER-positive breast cancer cells by downregulating both DCTPP1 and QPRT.
Neoplasms
Silencing KIF18B enhances radiosensitivity: identification of a promising therapeutic target in sarcoma.
Neoplasms
Silencing of CASC8 inhibits non-small cell lung cancer cells function and promotes sensitivity to osimertinib via FOXM1.
Neoplasms
Silencing of Growth Differentiation Factor-15 Promotes Breast Cancer Cell Invasion by Down-regulating Focal Adhesion Genes.
Neoplasms
Silencing of HAS2-AS1 mediates PI3K/AKT signaling pathway to inhibit cell proliferation, migration, and invasion in glioma.
Neoplasms
Silencing of ITGB6 inhibits the progression of cervical carcinoma via regulating JAK/STAT3 signaling pathway.
Neoplasms
Silencing of LINC00461 enhances radiosensitivity of lung adenocarcinoma cells by down-regulating HOXA10 via microRNA-195.
Neoplasms
Silencing of lncRNA MIR497HG via CRISPR/Cas13d Induces Bladder Cancer Progression Through Promoting the Crosstalk Between Hippo/Yap and TGF-?/Smad Signaling.
Neoplasms
Silencing of long non-coding RNA LINC00520 promotes radiosensitivity of head and neck squamous cell carcinoma cells.
Neoplasms
Silencing of long noncoding RNA HOXD-AS1 inhibits proliferation, cell cycle progression, migration and invasion of hepatocellular carcinoma cells through MEK/ERK pathway.
Neoplasms
Silencing of SmgGDS, a Novel mTORC1 Inducer That Binds to RHEBs, Inhibits Malignant Mesothelioma Cell Proliferation.
Neoplasms
Silencing of the long non-coding RNA RHPN1-AS1 suppresses the epithelial-to-mesenchymal transition and inhibits breast cancer progression.
Neoplasms
Silencing of WWP2 inhibits adhesion, invasion, and migration in liver cancer cells.
Neoplasms
Silencing Smad4 attenuates sensitivity of colorectal cancer cells to cetuximab by promoting epithelial?mesenchymal transition.
Neoplasms
Silencing the long noncoding RNA NORAD inhibits gastric cancer cell proliferation and invasion by the RhoA/ROCK1 pathway.
Neoplasms
Silent information regulator 2 promotes clear cell renal cell carcinoma progression through deacetylation and small ubiquitin-related modifier 1 modification of glucose 6-phosphate dehydrogenase.
Neoplasms
Similar incidence of DNA damage response pathway alterations between clinically localized and metastatic prostate cancer.
Neoplasms
Similar Squamous Cell Carcinoma Epithelium microRNA Expression in Never Smokers and Ever Smokers.
Neoplasms
Similarities and Differences in Gene Expression Networks Between the Breast Cancer Cell Line Michigan Cancer Foundation-7 and Invasive Human Breast Cancer Tissues.
Neoplasms
Simultaneous blockade of interacting CK2 and EGFR pathways by tumor-targeting nanobioconjugates increases therapeutic efficacy against glioblastoma multiforme.
Neoplasms
Simultaneous Expression of Long Non-Coding RNA FAL1 and Extracellular Matrix Protein 1 Defines Tumour Behaviour in Young Patients with Papillary Thyroid Cancer.
Neoplasms
Simultaneous inference of cancer pathways and tumor progression from cross-sectional mutation data.
Neoplasms
Simultaneous targeting PI3K and PERK pathways promotes cell death and improves the clinical prognosis in esophageal squamous carcinoma.
Neoplasms
Simultaneously Inhibiting BCL2 and MCL1 Is a Therapeutic Option for Patients with Advanced Melanoma.
Neoplasms
Single Nucleotide Polymorphism rs6942067 Is a Risk Factor in Young and in Non-Smoking Patients with HPV Negative Head and Neck Squamous Cell Carcinoma.
Neoplasms
Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy response.
Neoplasms
Single-cell analyses reveal mechanisms of cancer stem cell maintenance and epithelial-mesenchymal transition in recurrent bladder cancer.
Neoplasms
Single-cell analysis of a tumor-derived exosome signature correlates with prognosis and immunotherapy response.
Neoplasms
Single-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Neoplasms
Single-cell genomic profile-based analysis of tissue differentiation in colorectal cancer.
Neoplasms
Single-cell protein activity analysis identifies recurrence-associated renal tumor macrophages.
Neoplasms
Single-Cell RNA Sequencing of a Postmenopausal Normal Breast Tissue Identifies Multiple Cell Types That Contribute to Breast Cancer.
Neoplasms
Single-cell RNA sequencing reveals cellular and molecular immune profile in a Pembrolizumab-responsive PD-L1-negative lung cancer patient.
Neoplasms
Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma.
Neoplasms
Single-cell RNA-seq reveals invasive trajectory and determines cancer stem cell-related prognostic genes in pancreatic cancer.
Neoplasms
Single-Cell Sequencing to Identify Six Heat Shock Protein (HSP) Genes-Mediated Progression Subtypes of Clear Cell Renal Cell Carcinoma.
Neoplasms
Single-Cell Spatial Analysis of Tumor and Immune Microenvironment on Whole-Slide Image Reveals Hepatocellular Carcinoma Subtypes.
Neoplasms
Single-cell Spatial Proteomic Revelations on the Multiparametric MRI Heterogeneity of Clinically Significant Prostate Cancer.
Neoplasms
Single-Cell Transcriptome Analysis Reveals Intratumoral Heterogeneity in ccRCC, which Results in Different Clinical Outcomes.
Neoplasms
Single-nucleotide polymorphism rs13426236 contributes to an increased prostate cancer risk via regulating MLPH splicing variant 4.
Neoplasms
Single-sample expression-based chemo-sensitivity score improves survival associations independently from genomic mutations for ovarian cancer Patients.
Neoplasms
SIPA1L3 methylation modifies the benefit of smoking cessation on lung adenocarcinoma survival: an epigenomic-smoking interaction analysis.
Neoplasms
siRNA Library Screening Identifies a Druggable Immune-Signature Driving Esophageal Adenocarcinoma Cell Growth.
Neoplasms
SIRT2 is an unfavorable prognostic biomarker in patients with acute myeloid leukemia.
Neoplasms
SIRT6 is upregulated and associated with cancer aggressiveness in papillary thyroid cancer via BRAF/ERK/Mcl?1 pathway.
Neoplasms
SIRT7 Is a Prognostic Biomarker Associated With Immune Infiltration in Luminal Breast Cancer.
Neoplasms
Sirtuin7 has an oncogenic potential via promoting the growth of cholangiocarcinoma cells.
Neoplasms
Six genes as potential diagnosis and prognosis biomarkers for hepatocellular carcinoma through data mining.
Neoplasms
Six Glycolysis-Related Genes as Prognostic Risk Markers Can Predict the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma.
Neoplasms
Six Immune Associated Genes Construct Prognostic Model Evaluate Low-Grade Glioma.
Neoplasms
Six long noncoding RNAs as potentially biomarkers involved in competitive endogenous RNA of hepatocellular carcinoma.
Neoplasms
Six Metabolism Related mRNAs Predict the Prognosis of Patients With Hepatocellular Carcinoma.
Neoplasms
Six Novel Biomarkers for Diagnosis and Prognosis of Esophageal squamous cell carcinoma: validated by scRNA-seq and qPCR.
Neoplasms
Six RNA binding proteins (RBPs) related prognostic model predicts overall survival for clear cell renal cell carcinoma and it is associated with immune infiltration.
Neoplasms
Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Neoplasms
Six-mRNA risk score system and nomogram constructed for patients with ovarian cancer.
Neoplasms
SIX4 promotes metastasis via activation of the PI3K-AKT pathway in colorectal cancer.
Neoplasms
SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma.
Neoplasms
SKA3 Promotes tumor growth by regulating CDK2/P53 phosphorylation in hepatocellular carcinoma.
Neoplasms
Skp2 expression has different clinicopathological and prognostic implications in lung adenocarcinoma and squamous cell carcinoma.
Neoplasms
SL-BioDP: Multi-Cancer Interactive Tool for Prediction of Synthetic Lethality and Response to Cancer Treatment.
Neoplasms
SLAMF7 Signaling Reprograms T Cells toward Exhaustion in the Tumor Microenvironment.
Neoplasms
SLC22A16 upregulation is an independent unfavorable prognostic indicator in gastric cancer.
Neoplasms
SLC25A18 has prognostic value in colorectal cancer and represses Warburg effect and cell proliferation via Wnt signaling.
Neoplasms
SLC34A2 Up-regulation And SLC4A4 Down-regulation Correlates With Invasion, Metastasis, And The MAPK Signaling Pathway In Papillary Thyroid Carcinomas.
Neoplasms
SLC39A4 as a Novel Prognosis Marker Promotes Tumor Progression in Esophageal Squamous Cell Carcinoma.
Neoplasms
SLC39A5 promotes lung adenocarcinoma cell proliferation by activating PI3K/AKT signaling.
Neoplasms
SLC6A8 is involved in the progression of non-small cell lung cancer through the Notch signaling pathway.
Neoplasms
SLC7A5 serves as a prognostic factor of breast cancer and promotes cell proliferation through activating AKT/mTORC1 signaling pathway.
Neoplasms
SLCO4C1 promoter methylation is a potential biomarker for prognosis associated with biochemical recurrence-free survival after radical prostatectomy.
Neoplasms
Sleeping Beauty transposon insertional mutagenesis based mouse models for cancer gene discovery.
Neoplasms
SLUG-related partial epithelial-to-mesenchymal transition is a transcriptomic prognosticator of head and neck cancer survival.
Neoplasms
SMAC Mimetic Birinapant plus Radiation Eradicates Human Head and Neck Cancers with Genomic Amplifications of Cell Death Genes FADD and BIRC2.
Neoplasms
Small interfering RNA-mediated knockdown of KRT80 suppresses colorectal cancer proliferation.
Neoplasms
Small Nucleolar RNA Host Gene 1 (SNHG1) and Chromosome 2 Open Reading Frame 48 (C2orf48) as Potential Prognostic Signatures for Liver Cancer by Constructing Regulatory Networks.
Neoplasms
Small RNA sequencing of sessile serrated polyps identifies microRNA profile associated with colon cancer.
Neoplasms
Small RNA sequencing reveals a comprehensive miRNA signature of BRCA1-associated high-grade serous ovarian cancer.
Neoplasms
Small-molecule binding sites to explore protein-protein interactions in the cancer proteome.
Neoplasms
Small-molecule inhibition of prostaglandin E receptor 2 impairs cyclooxygenase-associated malignant glioma growth.
Neoplasms
SMG9 Serves as an Oncogene to Promote the Tumor Progression via EMT and Wnt/?-Catenin Signaling Pathway in Hepatocellular Carcinoma.
Neoplasms
Smoking correlates with increased cytoskeletal protein-related coding region mutations in the lung and head and neck datasets of the cancer genome atlas.
Neoplasms
Smoking is Associated with Lung Adenocarcinoma and Lung Squamous Cell Carcinoma Progression through Inducing Distinguishing lncRNA Alterations in Different Genders.
Neoplasms
Smoking status regulates a novel panel of PIWI-interacting RNAs in head and neck squamous cell carcinoma.
Neoplasms
Smoking status, usual adult occupation, and risk of recurrent urothelial bladder carcinoma: data from The Cancer Genome Atlas (TCGA) Project.
Neoplasms
Smoking-Mediated Upregulation of the Androgen Pathway Leads to Increased SARS-CoV-2 Susceptibility.
Neoplasms
SmulTCan: A Shiny application for multivariate survival analysis of TCGA data with gene sets.
Neoplasms
SMYD3 promotes colon adenocarcinoma (COAD) progression by mediating cell proliferation and apoptosis.
Neoplasms
SNAP25 Inhibits Glioma Progression by Regulating Synapse Plasticity via GLS-Mediated Glutaminolysis.
Neoplasms
SNHG3 correlates with malignant status and poor prognosis in hepatocellular carcinoma.
Neoplasms
SNHG5 enhances Paclitaxel sensitivity of ovarian cancer cells through sponging miR-23a.
Neoplasms
SNiPER: a novel hypermethylation biomarker panel for liquid biopsy based early breast cancer detection.
Neoplasms
Snowball: resampling combined with distance-based regression to discover transcriptional consequences of a driver mutation.
Neoplasms
SNP2APA: a database for evaluating effects of genetic variants on alternative polyadenylation in human cancers.
Neoplasms
SNX6 predicts poor prognosis and contributes to the metastasis of pancreatic cancer cells via activating epithelial-mesenchymal transition.
Neoplasms
Social attention of the top 50 scientific articles on gastric cancer: Bibliometric and altmetric analysis.
Neoplasms
SOD2- and NRF2-associated Gene Signature to Predict Radioresistance in Head and Neck Cancer.
Neoplasms
SOD3 induces a HIF-2?-dependent program in endothelial cells that provides a selective signal for tumor infiltration by T cells.
Neoplasms
Somatic copy number alterations are predictive of progression-free survival in patients with lung adenocarcinoma undergoing radiotherapy.
Neoplasms
Somatic Copy Number Alterations at Oncogenic Loci Show Diverse Correlations with Gene Expression.
Neoplasms
Somatic copy number alterations in gastric adenocarcinomas among Asian and Western patients.
Neoplasms
Somatic Copy Number Alterations in Human Cancers: An Analysis of Publicly Available Data From The Cancer Genome Atlas.
Neoplasms
Somatic copy number alterations predict response to platinum therapy in epithelial ovarian cancer.
Neoplasms
Somatic Copy Number Amplification and Hyperactivating Somatic Mutations of EZH2 Correlate With DNA Methylation and Drive Epigenetic Silencing of Genes Involved in Tumor Suppression and Immune Responses in Melanoma.
Neoplasms
Somatic copy number profiling from hepatocellular carcinoma circulating tumor cells.
Neoplasms
Somatic Epigenetic Silencing of RIPK3 Inactivates Necroptosis and Contributes to Chemoresistance in Malignant Mesothelioma.
Neoplasms
Somatic Functional Deletions of Upstream Open Reading Frame-Associated Initiation and Termination Codons in Human Cancer.
Neoplasms
Somatic HNF1A mutations in the malignant transformation of hepatocellular adenomas: a retrospective analysis of data from MSK-IMPACT and TCGA.
Neoplasms
Somatic intronic microsatellite loci differentiate glioblastoma from lower-grade gliomas.
Neoplasms
Somatic microsatellite variability as a predictive marker for colorectal cancer and liver cancer progression.
Neoplasms
Somatic Mutation Allelic Ratio Test Using ddPCR (SMART-ddPCR): An Accurate Method for Assessment of Preferential Allelic Imbalance in Tumor DNA.
Neoplasms
Somatic mutation load of estrogen receptor-positive breast tumors predicts overall survival: an analysis of genome sequence data.
Neoplasms
Somatic mutation of DNAH genes implicated higher chemotherapy response rate in gastric adenocarcinoma patients.
Neoplasms
Somatic mutation profiling of liver and biliary cancer by targeted next generation sequencing.
Neoplasms
Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types.
Neoplasms
Somatic mutations and promotor methylation of the ryanodine receptor 2 is a common event in the pathogenesis of head and neck cancer.
Neoplasms
Somatic Mutations and Splicing Variants of Focal Adhesion Kinase in Non-Small Cell Lung Cancer.
Neoplasms
Somatic mutations favorable to patient survival are predominant in ovarian carcinomas.
Neoplasms
Somatic mutations in arachidonic acid metabolism pathway genes enhance oral cancer post-treatment disease-free survival.
Neoplasms
Somatic Mutations in LRRK2 Identify a Subset of Invasive Mammary Carcinomas Associated with High Mutation Burden.
Neoplasms
Somatic Mutations in miRNA Genes in Lung Cancer-Potential Functional Consequences of Non-Coding Sequence Variants.
Neoplasms
Somatic retrotransposition in human cancer revealed by whole-genome and exome sequencing.
Neoplasms
Somatostatin receptor 2A protein expression characterizes anaplastic oligodendrogliomas with favorable outcome.
Neoplasms
Sonographic features of invasive ductal breast carcinomas predictive of malignancy grade.
Neoplasms
Sorafenib Activity and Disposition in Liver Cancer Does Not Depend on Organic Cation Transporter 1.
Neoplasms
Sorting Five Human Tumor Types Reveals Specific Biomarkers and Background Classification Genes.
Neoplasms
Sorting Nexin 5 Controls Head and Neck Squamous Cell Carcinoma Progression by Modulating FBW7.
Neoplasms
Sorting nexin-1 is a candidate tumor suppressor and potential prognostic marker in gastric cancer.
Neoplasms
SOX2 and SOX12 are predictive of prognosis in patients with clear cell renal cell carcinoma.
Neoplasms
Sox2 Gene Amplification Significantly Impacts Overall Survival in Serous Epithelial Ovarian Cancer.
Neoplasms
SOX2 promotes resistance of melanoma with PD-L1 high expression to T-cell-mediated cytotoxicity that can be reversed by SAHA.
Neoplasms
SOX9 in prostate cancer is upregulated by cancer-associated fibroblasts to promote tumor progression through HGF/c-Met-FRA1 signaling.
Neoplasms
SP3 is associated with migration, invasion, and Akt/PKB signalling in MDA-MB-231 breast cancer cells.
Neoplasms
SPAG5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer.
Neoplasms
SPAG6 promotes cell proliferation and inhibits apoptosis through the PTEN/PI3K/AKT pathway in Burkitt lymphoma.
Neoplasms
sPAGM: inferring subpathway activity by integrating gene and miRNA expression-robust functional signature identification for melanoma prognoses.
Neoplasms
SPARC promotes pancreatic cancer cell proliferation and migration through autocrine secretion into the extracellular milieu.
Neoplasms
Sparse Graph Regularization Non-Negative Matrix Factorization Based on Huber Loss Model for Cancer Data Analysis.
Neoplasms
Sparse robust graph-regularized non-negative matrix factorization based on correntropy.
Neoplasms
Spatial EGFR Dynamics and Metastatic Phenotypes Modulated by Upregulated EphB2 and Src Pathways in Advanced Prostate Cancer.
Neoplasms
Spatial habitats from multiparametric MR imaging are associated with signaling pathway activities and survival in glioblastoma.
Neoplasms
Spatial immunoprofiling of the intratumoral and peritumoral tissue of renal cell carcinoma patients.
Neoplasms
Spatial statistical analysis of Chinese cancer mortality: a comparison study of the D statistic.
Neoplasms
Spatially resolved analyses link genomic and immune diversity and reveal unfavorable neutrophil activation in melanoma.
Neoplasms
Spatiotemporal trends in oral cancer mortality and potential risks associated with heavy metal content in Taiwan soil.
Neoplasms
SPC25 upregulation increases cancer stem cell properties in non-small cell lung adenocarcinoma cells and independently predicts poor survival.
Neoplasms
Special AT-rich sequence-binding protein 2 acts as a negative regulator of stemness in colorectal cancer cells.
Neoplasms
Specific DNA methylation markers in the diagnosis and prognosis of esophageal cancer.
Neoplasms
Specific expression and methylation of SLIT1, SLIT2, SLIT3, and miR-218 in gastric cancer subtypes.
Neoplasms
Specific glioblastoma multiforme prognostic-subtype distinctions based on DNA methylation patterns.
Neoplasms
Specific Glioma Prognostic Subtype Distinctions Based on DNA Methylation Patterns.
Neoplasms
Specific Lung Squamous Cell Carcinoma Prognosis-Subtype Distinctions Based on DNA Methylation Patterns.
Neoplasms
Specific TP53 Mutants Overrepresented in Ovarian Cancer Impact CNV, TP53 Activity, Responses to Nutlin-3a, and Cell Survival.
Neoplasms
Spectrum of EGFR aberrations and potential clinical implications: insights from integrative pan-cancer analysis.
Neoplasms
Spectrum of malignant renal and urinary bladder tumors on 18F-FDG PET/CT: a pictorial essay.
Neoplasms
Spectrum of Mesenchymal-Epithelial Transition Aberrations and Potential Clinical Implications: Insights From Integrative Pancancer Analysis.
Neoplasms
Spheroid glioblastoma culture conditions as antigen source for dendritic cell-based immunotherapy: spheroid proteins are survival-relevant targets but can impair immunogenic interferon ? production.
Neoplasms
Sphingosine Kinase 1 is Associated With Immune Cell-Related Gene Expressions in Human Breast Cancer.
Neoplasms
Spindle pole body component 25 homolog expressed by ECM stiffening is required for lung cancer cell proliferation.
Neoplasms
Splicing factor PRPF6 upregulates oncogenic androgen receptor signaling pathway in hepatocellular carcinoma.
Neoplasms
Splicing mutation analysis reveals previously unrecognized pathways in lymph node-invasive breast cancer.
Neoplasms
SPOP suppresses testicular germ cell tumors progression through ubiquitination and degradation of DPPA2.
Neoplasms
Sporadic Early-Onset Diffuse Gastric Cancers Have High Frequency of Somatic CDH1 Alterations, but Low Frequency of Somatic RHOA Mutations Compared With Late-Onset Cancers.
Neoplasms
SRSF5 regulates alternative splicing of DMTF1 pre-mRNA through modulating SF1 binding.
Neoplasms
SRSF6 regulates alternative splicing of genes involved in DNA damage response and DNA repair in HeLa cells.
Neoplasms
SRSF6-regulated alternative splicing that promotes tumour progression offers a therapy target for colorectal cancer.
Neoplasms
SRY-related high-mobility-group box 6 suppresses cell proliferation and is downregulated in breast cancer.
Neoplasms
ssExpression level of GAS6-mRNA influences the prognosis of acute myeloid leukemia patients with allogeneic hematopoietic stem cell transplantation.
Neoplasms
ssGSEA score-based Ras dependency indexes derived from gene expression data reveal potential Ras addiction mechanisms with possible clinical implications.
Neoplasms
SSRP1 influences colorectal cancer cell growth and apoptosis via the AKT pathway.
Neoplasms
SST gene hypermethylation acts as a pan-cancer marker for pancreatic ductal adenocarcinoma and multiple other tumors: toward its use for blood-based diagnosis.
Neoplasms
SSTR5?AS1 functions as a ceRNA to regulate CA2 by sponging miR?15b?5p for the development and prognosis of HBV?related hepatocellular carcinoma.
Neoplasms
ST8SIA1 inhibits the proliferation, migration and invasion of bladder cancer cells by blocking the JAK/STAT signaling pathway.
Neoplasms
Stable and discriminating radiomic predictor of recurrence in early stage non-small cell lung cancer: Multi-site study.
Neoplasms
Stacked Predictive Sparse Coding for Classification of Distinct Regions of Tumor Histopathology.
Neoplasms
STAM Prolongs Clear Cell Renal Cell Carcinoma Patients' Survival via Inhibiting Cell Growth and Invasion.
Neoplasms
STAR RNA-binding protein Quaking suppresses cancer via stabilization of specific miRNA.
Neoplasms
STARD13 promotes hepatocellular carcinoma apoptosis by acting as a ceRNA for Fas.
Neoplasms
STARD13-correlated ceRNA network-directed inhibition on YAP/TAZ activity suppresses stemness of breast cancer via co-regulating Hippo and Rho-GTPase/F-actin signaling.
Neoplasms
STAT gene family mRNA expression and prognostic value in hepatocellular carcinoma.
Neoplasms
STAT1 as a potential prognosis marker for poor outcomes of early stage colorectal cancer with microsatellite instability.
Neoplasms
STAT1-induced upregulation of lncRNA LINC01123 predicts poor prognosis and promotes the progression of endometrial cancer through miR-516b/KIF4A.
Neoplasms
STAT1-induced upregulation of lncRNA RHPN1-AS1 predicts a poor prognosis of hepatocellular carcinoma and contributes to tumor progression via the miR-485/CDCA5 axis.
Neoplasms
STAT3 polymorphisms may predict an unfavorable response to first-line platinum-based therapy for women with advanced serous epithelial ovarian cancer.
Neoplasms
STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT signalling pathway.
Neoplasms
STAT3-induced upregulation of lncRNA CASC11 promotes the cell migration, invasion and epithelial-mesenchymal transition in hepatocellular carcinoma by epigenetically silencing PTEN and activating PI3K/AKT signaling pathway.
Neoplasms
STAT5A reprograms fatty acid metabolism and promotes tumorigenesis of gastric cancer cells.
Neoplasms
STATegra: Multi-Omics Data Integration - A Conceptual Scheme With a Bioinformatics Pipeline.
Neoplasms
Statin use, HMGCR expression, and breast cancer survival - The Malmö Diet and Cancer Study.
Neoplasms
Statistical 3D Prostate Imaging Atlas Construction via Anatomically Constrained Registration.
Neoplasms
STC1 is a Novel Biomarker Associated with Immune Characteristics and Prognosis of Bladder Cancer.
Neoplasms
Stem/progenitor cell marker expression in clear cell renal cell carcinoma: a potential relationship with the immune microenvironment to be explored.
Neoplasms
Steroid receptor RNA activator gene footprint in the progression and drug resistance of colorectal cancer through oxidative phosphorylation pathway.
Neoplasms
STIL is upregulated in nasopharyngeal carcinoma tissues and promotes nasopharyngeal carcinoma proliferation, migration and invasion.
Neoplasms
Stimulator of interferon response cGAMP interactor overcomes ERBB2-mediated apatinib resistance in head and neck squamous cell carcinoma.
Neoplasms
STING activation enhances cetuximab-mediated NK cell activation and DC maturation and correlates with HPV
Neoplasms
STIP1 down-regulation inhibits glycolysis by suppressing PKM2 and LDHA and inactivating the Wnt/?-catenin pathway in cervical carcinoma cells.
Neoplasms
STK11/LKB1 Loss of Function Is Associated with Global DNA Hypomethylation and S-Adenosyl-Methionine Depletion in Human Lung Adenocarcinoma.
Neoplasms
STMN1 upregulation mediates hepatocellular carcinoma and hepatic stellate cell crosstalk to aggravate cancer by triggering the MET pathway.
Neoplasms
Strand Orientation Bias Detector to determine the probability of FFPE sequencing artifacts.
Neoplasms
Stratification of Digestive Cancers with Different Pathological Features and Survival Outcomes by MicroRNA Expression.
Neoplasms
Stratification of endometrioid endometrial cancer patients into risk levels using somatic mutations.
Neoplasms
Stratification of HPV-associated and HPV-negative oropharyngeal squamous cell carcinomas based on DNA methylation epigenotypes.
Neoplasms
Stratifying melanoma and breast cancer TCGA datasets on the basis of the CNV of transcription factor binding sites common to proliferation- and apoptosis-effector genes.
Neoplasms
Stress-triggered atavistic reprogramming (STAR) addiction: driving force behind head and neck cancer?
Neoplasms
STRIP2, a member of the striatin-interacting phosphatase and kinase complex, is implicated in lung adenocarcinoma cell growth and migration.
Neoplasms
Stroma-associated master regulators of molecular subtypes predict patient prognosis in ovarian cancer.
Neoplasms
Stromal iodothyronine deiodinase 2 (DIO2) promotes the growth of intestinal tumors in Apc?716 mutant mice.
Neoplasms
Stromal LAG-3+ cells infiltration defines poor prognosis subtype muscle-invasive bladder cancer with immunoevasive contexture.
Neoplasms
Stromal tumor-infiltrating lymphocytes evaluated on H&E-stained slides are an independent prognostic factor in epithelial ovarian cancer and ovarian serous carcinoma.
Neoplasms
Stromal-associated cytokines bias the interplay between gene expression and DNA methylation in human breast cancers.
Neoplasms
Structure-based predictions broadly link transcription factor mutations to gene expression changes in cancers.
Neoplasms
Study of the Female Sex Survival Advantage in Melanoma-A Focus on X-Linked Epigenetic Regulators and Immune Responses in Two Cohorts.
Neoplasms
Study of the G Protein Nucleolar 2 Value in Liver Hepatocellular Carcinoma Treatment and Prognosis.
Neoplasms
Study on Attenuating Angiogenesis and Epithelial-Mesenchymal Transition (EMT) of Non-Small Cell Lung Carcinoma (NSCLC) by Regulating MAGEC2.
Neoplasms
Study on miRNAs in Pan-Cancer of the Digestive Tract Based on the Illumina HiSeq System Data Sequencing.
Neoplasms
Study on the anti-tumor mechanism related to immune microenvironment of Bombyx Batryticatus on viral and non-viral infections of hepatocellular carcinoma.
Neoplasms
Study on the gene signature related to immune microenvironment on viral and nonviral infections of hepatocellular carcinoma.
Neoplasms
Study on the mechanism behind lncRNA MEG3 affecting clear cell renal cell carcinoma by regulating miR-7/RASL11B signaling.
Neoplasms
Study on the Selection of the Targets of Esophageal Carcinoma and Interventions of Ginsenosides Based on Network Pharmacology and Bioinformatics.
Neoplasms
Studying tumorigenesis through network evolution and somatic mutational perturbations in the cancer interactome.
Neoplasms
STYK1 promotes autophagy through enhancing the assembly of autophagy-specific class III phosphatidylinositol 3-kinase complex I.
Neoplasms
Subependymal giant cell astrocytomas are characterized by mTORC1 hyperactivation, a very low somatic mutation rate, and a unique gene expression profile.
Neoplasms
Subgroup analysis reveals molecular heterogeneity and provides potential precise treatment for pancreatic cancers.
Neoplasms
Subgrouping breast cancer patients based on immune evasion mechanisms unravels a high involvement of transforming growth factor-beta and decoy receptor 3.
Neoplasms
Substantial batch effects in TCGA exome sequences undermine pan-cancer analysis of germline variants.
Neoplasms
Subtraction of Epstein-Barr virus and microsatellite instability genotypes from the Lauren histotypes: combined molecular and histologic subtyping with clinicopathological and prognostic significance validated in a cohort of 1,248 cases.
Neoplasms
Subtype identification from heterogeneous TCGA datasets on a genomic scale by multi-view clustering with enhanced consensus.
Neoplasms
Subtyping glioblastoma by combining miRNA and mRNA expression data using compressed sensing-based approach.
Neoplasms
SUCO as a Promising Diagnostic Biomarker of Hepatocellular Carcinoma: Integrated Analysis and Experimental Validation.
Neoplasms
Sulfatase 2-Induced Cancer-Associated Fibroblasts Promote Hepatocellular Carcinoma Progression via Inhibition of Apoptosis and Induction of Epithelial-to-Mesenchymal Transition.
Neoplasms
SUMO1P3 is associated clinical progression and facilitates cell migration and invasion through regulating miR-136 in non-small cell lung cancer.
Neoplasms
SUMOylation Regulator-Related Molecules Can Be Used as Prognostic Biomarkers for Glioblastoma.
Neoplasms
SUN-MKL1 Crosstalk Regulates Nuclear Deformation and Fast Motility of Breast Carcinoma Cells in Fibrillar ECM Microenvironment.
Neoplasms
Super.FELT: supervised feature extraction learning using triplet loss for drug response prediction with multi-omics data.
Neoplasms
Superpixel-Based Conditional Random Fields (SuperCRF): Incorporating Global and Local Context for Enhanced Deep Learning in Melanoma Histopathology.
Neoplasms
Support vector machine classifier for prediction of the metastasis of colorectal cancer.
Neoplasms
Suppression of ABHD2, identified through a functional genomics screen, causes anoikis resistance, chemoresistance and poor prognosis in ovarian cancer.
Neoplasms
Suppression of cleavage factor Im 25 promotes the proliferation of lung cancer cells through alternative polyadenylation.
Neoplasms
Suppression of G-protein-coupled receptor kinase 3 expression is a feature of classical GBM that is required for maximal growth.
Neoplasms
Suppression of Mig-6 overcomes the acquired EGFR-TKI resistance of lung adenocarcinoma.
Neoplasms
Suppression of tumorigenicity by microRNA-138 through inhibition of EZH2-CDK4/6-pRb-E2F1 signal loop in glioblastoma multiforme.
Neoplasms
Surgical approaches: postoperative care and complications "posterolateral-far lateral transcondylar approach to the ventral foramen magnum and upper cervical spinal canal".
Neoplasms
Surgical treatment of craniovertebral junction instability : clinical outcomes and effectiveness in personal experience.
Neoplasms
SurvBoost: An R Package for High-Dimensional Variable Selection in the Stratified Proportional Hazards Model via Gradient Boosting.
Neoplasms
Survival analysis and functional annotation of long non-coding RNAs in lung adenocarcinoma.
Neoplasms
Survival analysis for long noncoding RNAs identifies TP53TG1 as an antioncogenic target for the breast cancer.
Neoplasms
Survival analysis of genome-wide profiles coupled with Connectivity Map database mining to identify potential therapeutic targets for cholangiocarcinoma.
Neoplasms
Survival differences and associated molecular signatures of DNMT3A-mutant acute myeloid leukemia patients.
Neoplasms
Survival differences of CIMP subtypes integrated with CNA information in human breast cancer.
Neoplasms
Survival impact of time to initiation of chemoradiotherapy after resection of newly diagnosed glioblastoma.
Neoplasms
Survival of glioblastoma in relation to tumor location: a statistical tumor atlas of a population-based cohort.
Neoplasms
Survival of microsatellite-stable endometrioid endometrial cancer patients after minimally invasive surgery: An analysis of the Cancer Genome Atlas data.
Neoplasms
Survival of Patients with Gastrointestinal Cancers Can Be Predicted by a Surrogate microRNA Signature for Cancer Stem-like Cells Marked by DCLK1 Kinase.
Neoplasms
Survival of patients with structurally-grouped TP53 mutations in ovarian and breast cancers.
Neoplasms
Survival prediction and response to immune checkpoint inhibitors: A prognostic immune signature for hepatocellular carcinoma.
Neoplasms
Survival prediction in patients with colon adenocarcinoma via multi-omics data integration using a deep learning algorithm.
Neoplasms
Survival Prediction of Clear Cell Renal Cell Carcinoma Based on Gene Expression Similarity to the Proximal Tubule of the Nephron.
Neoplasms
Survival prediction of kidney renal papillary cell carcinoma by comprehensive LncRNA characterization.
Neoplasms
Survival-Associated Alternative Messenger RNA Splicing Signatures in Pancreatic Ductal Adenocarcinoma: A Study Based on RNA-Sequencing Data.
Neoplasms
Survival-associated alternative splicing signatures in non-small cell lung cancer.
Neoplasms
Survival-Associated Metabolic Genes in Human Papillomavirus-Positive Head and Neck Cancers.
Neoplasms
Survival-related risk score of lung adenocarcinoma identified by weight gene co-expression network analysis.
Neoplasms
SVD identifies transcript length distribution functions from DNA microarray data and reveals evolutionary forces globally affecting GBM metabolism.
Neoplasms
SVExpress: identifying gene features altered recurrently in expression with nearby structural variant breakpoints.
Neoplasms
SWI/SNF aberrations sensitize pancreatic cancer cells to DNA crosslinking agents.
Neoplasms
SWIM: a computational tool to unveiling crucial nodes in complex biological networks.
Neoplasms
Synaptopodin-2 promotes hepatocellular carcinoma metastasis via calcineurin-induced nuclear-cytoplasmic translocation.
Neoplasms
Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
Neoplasms
Syndecan Family Gene and Protein Expression and Their Prognostic Values for Prostate Cancer.
Neoplasms
Syndecan-1 knockdown inhibits glioma cell proliferation and invasion by deregulating a c-src/FAK-associated signaling pathway.
Neoplasms
SYNE1 mutation may enhance the response to immune checkpoint blockade therapy in clear cell renal cell carcinoma patients.
Neoplasms
Synergistic Drug Combination Prediction by Integrating Multiomics Data in Deep Learning Models.
Neoplasms
Synergistic effect of fasting-mimicking diet and vitamin C against KRAS mutated cancers.
Neoplasms
Synergy of Sex Differences in Visceral Fat Measured with CT and Tumor Metabolism Helps Predict Overall Survival in Patients with Renal Cell Carcinoma.
Neoplasms
Syntaxin 6-mediated exosome secretion regulates enzalutamide resistance in prostate cancer.
Neoplasms
Syntaxin 6: A novel predictive and prognostic biomarker in papillary renal cell carcinoma.
Neoplasms
Syntenin-1 is a promoter and prognostic marker of head and neck squamous cell carcinoma invasion and metastasis.
Neoplasms
Synthesis of diagnostic quality cancer pathology images by generative adversarial networks.
Neoplasms
Synthetic Evaluation of MicroRNA-1-3p Expression in Head and Neck Squamous Cell Carcinoma Based on Microarray Chips and MicroRNA Sequencing.
Neoplasms
Systematic analyses of a novel lncRNA-associated signature as the prognostic biomarker for Hepatocellular Carcinoma.
Neoplasms
Systematic Analyses of the Role of the Reader Protein of N 6-Methyladenosine RNA Methylation, YTH Domain Family 2, in Liver Hepatocellular Carcinoma.
Neoplasms
Systematic analysis and prediction model construction of alternative splicing events in hepatocellular carcinoma: a study on the basis of large-scale spliceseq data from The Cancer Genome Atlas.
Neoplasms
Systematic analysis identifies three-lncRNA signature as a potentially prognostic biomarker for lung squamous cell carcinoma using bioinformatics strategy.
Neoplasms
Systematic Analysis of Alternative Splicing Landscape in Pancreatic Adenocarcinoma Reveals Regulatory Network Associated with Tumorigenesis and Immune Response.
Neoplasms
Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma.
Neoplasms
Systematic Analysis of AU-Rich Element Expression in Cancer Reveals Common Functional Clusters Regulated by Key RNA-Binding Proteins.
Neoplasms
Systematic Analysis of Autophagy-Related Signature Uncovers Prognostic Predictor for Acute Myeloid Leukemia.
Neoplasms
Systematic analysis of differentially methylated expressed genes and site-speci?c methylation as potential prognostic markers in head and neck cancer.
Neoplasms
Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Neoplasms
Systematic analysis of somatic mutations impacting gene expression in 12 tumour types.
Neoplasms
Systematic analysis of survival-associated alternative splicing signatures in clear cell renal cell carcinoma.
Neoplasms
Systematic analysis of survival-associated alternative splicing signatures uncovers prognostic predictors for head and neck cancer.
Neoplasms
Systematic Analysis of the Aberrances and Functional Implications of Ferroptosis in Cancer.
Neoplasms
Systematic analysis of the function and prognostic value of RNA binding protein in head and neck squamous cell carcinoma.
Neoplasms
Systematic analysis of the function and prognostic value of RNA binding proteins in Colon Adenocarcinoma.
Neoplasms
Systematic analysis of the intersection of disease mutations with protein modifications.
Neoplasms
Systematic analysis reveals a functional role for STAMBPL1 in the epithelial-mesenchymal transition process across multiple carcinomas.
Neoplasms
Systematic analysis reveals a lncRNA-mRNA co-expression network associated with platinum resistance in high-grade serous ovarian cancer.
Neoplasms
Systematic analysis using a bioinformatics strategy identifies SFTA1P and LINC00519 as potential prognostic biomarkers for lung squamous cell carcinoma.
Neoplasms
Systematic and Multi-Omics Prognostic Analysis of Lysine Acetylation Regulators in Glioma.
Neoplasms
Systematic assessment of the clinicopathological prognostic significance of tissue cytokine expression for lung adenocarcinoma based on integrative analysis of TCGA data.
Neoplasms
Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancers.
Neoplasms
Systematic characterization of germline variants from the DiscovEHR study endometrial carcinoma population.
Neoplasms
Systematic Chromatin Accessibility Analysis Based on Different Immunological Subtypes of Clear Cell Renal Cell Carcinoma.
Neoplasms
Systematic construction and validation of an epithelial-mesenchymal transition risk model to predict prognosis of lung adenocarcinoma.
Neoplasms
Systematic construction and validation of an immune prognostic model for lung adenocarcinoma.
Neoplasms
Systematic Construction and Validation of an RNA-Binding Protein-Associated Model for Prognosis Prediction in Hepatocellular Carcinoma.
Neoplasms
Systematic discovery of the functional impact of somatic genome alterations in individual tumors through tumor-specific causal inference.
Neoplasms
Systematic dissection of dysregulated transcription factor-miRNA feed-forward loops across tumor types.
Neoplasms
Systematic dissection of the mechanisms underlying progesterone receptor downregulation in endometrial cancer.
Neoplasms
Systematic evaluation of cancer-specific genetic risk score for 11 types of cancer in The Cancer Genome Atlas and Electronic Medical Records and Genomics cohorts.
Neoplasms
Systematic evaluation of the effects of genetic variants on PIWI-interacting RNA expression across 33 cancer types.
Neoplasms
Systematic Expression Analysis of Mitochondrial Complex I Identifies NDUFS1 as a Biomarker in Clear-Cell Renal-Cell Carcinoma.
Neoplasms
Systematic expression analysis of the mitochondrial complex III subunits identifies UQCRC1 as biomarker in clear cell renal cell carcinoma.
Neoplasms
Systematic expression analysis of the mitochondrial respiratory chain protein subunits identifies COX5B as a prognostic marker in clear cell renal cell carcinoma.
Neoplasms
Systematic genetic analysis identifies Cis-eQTL target genes associated with glioblastoma patient survival.
Neoplasms
Systematic Identification and Assessment of Therapeutic Targets for Breast Cancer Based on Genome-Wide RNA Interference Transcriptomes.
Neoplasms
Systematic identification of clinically relevant miRNAs for potential miRNA-based therapy in lung adenocarcinoma.
Neoplasms
Systematic identification of dysregulated lncRNAs associated with platinum-based chemotherapy response across 11 cancer types.
Neoplasms
Systematic identification of lncRNA-based prognostic biomarkers for glioblastoma.
Neoplasms
Systematic Identification of Survival-Associated Alternative Splicing Events in Kidney Renal Clear Cell Carcinoma.
Neoplasms
Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
Neoplasms
Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer.
Neoplasms
Systematic Multiomics Analysis of Alterations in C1QBP mRNA Expression and Relevance for Clinical Outcomes in Cancers.
Neoplasms
Systematic mutation analysis in rare colorectal cancer presenting ovarian metastases.
Neoplasms
Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker.
Neoplasms
Systematic Pan-Cancer Analysis Reveals Immune Cell Interactions in the Tumor Microenvironment.
Neoplasms
Systematic prediction of key genes for ovarian cancer by co-expression network analysis.
Neoplasms
Systematic prediction of the biological functions of TAS2R10 using positive co-expression analysis.
Neoplasms
Systematic Prioritization of Druggable Mutations in ?5000 Genomes Across 16 Cancer Types Using a Structural Genomics-based Approach.
Neoplasms
Systematic Profile Analysis of Prognostic Alternative Messenger RNA Splicing Signatures and Splicing Factors in Head and Neck Squamous Cell Carcinoma.
Neoplasms
Systematic profiling identifies PDLIM2 as a novel prognostic predictor for oesophageal squamous cell carcinoma (ESCC).
Neoplasms
Systematic profiling of a novel prognostic alternative splicing signature in hepatocellular carcinoma.
Neoplasms
Systematic profiling of alternative splicing in Helicobacter pylori-negative gastric cancer and their clinical significance.
Neoplasms
Systematic profiling of alternative splicing signature reveals prognostic predictor for prostate cancer.
Neoplasms
Systematic profiling of diagnostic and prognostic value of autophagy-related genes for sarcoma patients.
Neoplasms
Systematic profiling of ferroptosis gene signatures predicts prognostic factors in esophageal squamous cell carcinoma.
Neoplasms
Systematic Profiling of Immune Risk Model to Predict Survival and Immunotherapy Response in Head and Neck Squamous Cell Carcinoma.
Neoplasms
Systematic profiling of invasion-related gene signature predicts prognostic features of lung adenocarcinoma.
Neoplasms
Systematic screening identifies a 2-gene signature as a high-potential prognostic marker of undifferentiated pleomorphic sarcoma/myxofibrosarcoma.
Neoplasms
Systematic screening identifies a TEAD4-S100A13 axis modulating cisplatin sensitivity of oral squamous cell carcinoma cells.
Neoplasms
Systematic screening reveals synergistic interactions that overcome MAPK inhibitor resistance in cancer cells.
Neoplasms
Systematical Analysis of the Cancer Genome Atlas Database Reveals EMCN/MUC15 Combination as a Prognostic Signature for Gastric Cancer.
Neoplasms
Systematical identifications of prognostic meaningful lung adenocarcinoma subtypes and the underlying mutational and expressional characters.
Neoplasms
Systematically characterize the clinical and biological significances of 1p19q genes in 1p/19q non-codeletion glioma.
Neoplasms
Systematically profiling the expression of eIF3 subunits in glioma reveals the expression of eIF3i has prognostic value in IDH-mutant lower grade glioma.
Neoplasms
Systemic analysis of different colorectal cancer cell lines and TCGA datasets identified IGF-1R/EGFR-PPAR-CASPASE axis as important indicator for radiotherapy sensitivity.
Neoplasms
Systemic Analysis of the Prognosis-Associated Alternative Polyadenylation Events in Breast Cancer.
Neoplasms
Systemic Analysis of the Prognosis-Related RNA Alternative Splicing Signals in Melanoma.
Neoplasms
Systemic Expression Analysis Reveals Prognostic Significance of WIPI3 in Hepatocellular Carcinoma.
Neoplasms
Systemic screening identifies GABRD, a subunit gene of GABAA receptor as a prognostic marker in adult IDH wild-type diffuse low-grade glioma.
Neoplasms
Systems analysis of barrier molecule and ARNT-related gene expression regulation in melanoma.
Neoplasms
T cell immune regulator 1 is a prognostic marker associated with immune infiltration in glioblastoma multiforme.
Neoplasms
T cell receptor gene recombinations in human tumor specimen exome files: detection of T cell receptor-? VDJ recombinations associates with a favorable oncologic outcome for bladder cancer.
Neoplasms
T-Cell Exhaustion Status Under High and Low Levels of Hypoxia-Inducible Factor 1? Expression in Glioma.
Neoplasms
TAGLN2 is a candidate prognostic biomarker promoting tumorigenesis in human gliomas.
Neoplasms
Tamoxifen sensitivity-related microRNA-342 is a useful biomarker for breast cancer survival.
Neoplasms
Tamoxifen therapy benefit predictive signature combining with prognostic signature in surgical-only ER-positive breast cancer.
Neoplasms
Tandem CAR-T cells targeting CD70 and B7-H3 exhibit potent preclinical activity against multiple solid tumors.
Neoplasms
Tandem histone methyltransferase upregulation defines a unique aggressive prostate cancer phenotype.
Neoplasms
Tankyrases/?-catenin Signaling Pathway as an Anti-proliferation and Anti-metastatic Target in Hepatocarcinoma Cell Lines.
Neoplasms
TANRIC: An Interactive Open Platform to Explore the Function of lncRNAs in Cancer.
Neoplasms
Tapping microRNA regulation networks through integrated analysis of microRNA-mRNA high-throughput profiles.
Neoplasms
Target identification in Fusobacterium nucleatum by subtractive genomics approach and enrichment analysis of host-pathogen protein-protein interactions.
Neoplasms
Targeted assessment of G0S2 methylation identifies a rapidly recurrent, routinely fatal molecular subtype of adrenocortical carcinoma.
Neoplasms
Targeted bisulfite sequencing identified a panel of DNA methylation-based biomarkers for esophageal squamous cell carcinoma (ESCC).
Neoplasms
Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
Neoplasms
Targeted DNA profiling and the prevalence of NTRK aberrations in Chinese patients with head and neck cancer.
Neoplasms
Targeted Exome Sequencing of the Cancer Genome in Patients with Very High-risk Bladder Cancer.
Neoplasms
Targeted Imaging of the Atypical Chemokine Receptor 3 (ACKR3/CXCR7) in Human Cancer Xenografts.
Neoplasms
Targeted inhibition of ATR or CHEK1 reverses radioresistance in oral squamous cell carcinoma cells with distal chromosome arm 11q loss.
Neoplasms
Targeted Inhibition of P4HB Promotes Cell Sensitivity to Gemcitabine in Urothelial Carcinoma of the Bladder.
Neoplasms
Targeted methylation sequencing of plasma cell-free DNA for cancer detection and classification.
Neoplasms
Targeted Molecular and Immunohistochemical Analyses of Endometrial Clear Cell Carcinoma Show that POLE Mutations and DNA Mismatch Repair Protein Deficiencies are Uncommon.
Neoplasms
Targeted mutational analysis of inflammatory bowel disease-associated colorectal cancers.
Neoplasms
Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade.
Neoplasms
Targeted next-generation sequencing for locally advanced prostate cancer in the Korean population.
Neoplasms
Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancer.
Neoplasms
Targeted next-generation sequencing reveals high frequency of mutations in epigenetic regulators across treatment-naïve patient melanomas.
Neoplasms
Targeted next-generation sequencing reveals recurrence-associated genomic alterations in early-stage non-small cell lung cancer.
Neoplasms
Targeted Proteomics-Based Quantitative Protein Atlas of Pannexin and Connexin Subtypes in Mouse and Human Tissues and Cancer Cell Lines.
Neoplasms
Targeted therapies in metastatic gastric cancer: Current knowledge and future perspectives.
Neoplasms
Targeted therapy for upper gastrointestinal tract cancer: current and future prospects.
Neoplasms
Targeted therapy: its status and promise in selected solid tumors. Part II: Impact on selected tumor subsets, and areas of evolving integration.
Neoplasms
Targeting 14-3-3? Overcomes Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Lung Adenocarcinoma via BMP2/Smad/ID1 Signaling.
Neoplasms
Targeting adenosinergic pathway enhances the anti-tumor efficacy of sorafenib in hepatocellular carcinoma.
Neoplasms
Targeting CD146 with a 64Cu-labeled antibody enables in vivo immunoPET imaging of high-grade gliomas.
Neoplasms
Targeting CMTM6 Suppresses Stem Cell-Like Properties and Enhances Antitumor Immunity in Head and Neck Squamous Cell Carcinoma.
Neoplasms
Targeting CPT1B as a potential therapeutic strategy in castration-resistant and enzalutamide-resistant prostate cancer.
Neoplasms
Targeting deubiquitinating enzyme USP26 by microRNA-203 regulates Snail1's pro-metastatic functions in esophageal cancer.
Neoplasms
Targeting dopamine receptor D2 as a novel therapeutic strategy in endometrial cancer.
Neoplasms
Targeting EZH2 Enhances Antigen Presentation, Antitumor Immunity, and Circumvents Anti-PD-1 Resistance in Head and Neck Cancer.
Neoplasms
Targeting EZH2 regulates tumor growth and apoptosis through modulating mitochondria dependent cell-death pathway in HNSCC.
Neoplasms
Targeting fibroblast growth factor receptors and immune checkpoint inhibitors for the treatment of advanced bladder cancer: New direction and New Hope.
Neoplasms
Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway.
Neoplasms
Targeting glypican-4 overcomes 5-FU resistance and attenuates stem cell-like properties via suppression of Wnt/?-catenin pathway in pancreatic cancer cells.
Neoplasms
Targeting Lymphotoxin Beta and Paired Box 5: a potential therapeutic strategy for soft tissue sarcoma metastasis.
Neoplasms
Targeting NPL4 via drug repositioning using disulfiram for the treatment of clear cell renal cell carcinoma.
Neoplasms
Targeting of lactate dehydrogenase C dysregulates the cell cycle and sensitizes breast cancer cells to DNA damage response targeted therapy.
Neoplasms
Targeting of TGF? signature and its essential component CTGF by miR-18 correlates with improved survival in glioblastoma.
Neoplasms
Targeting of TLE3 by miR-3677 in human breast cancer promotes cell proliferation, migration and invasion.
Neoplasms
Targeting POLE2 Creates a Novel Vulnerability in Renal Cell Carcinoma via Modulating Stanniocalcin 1.
Neoplasms
Targeting Protein Kinase CK2 Suppresses Pro-survival Signaling Pathways and Growth of Glioblastoma.
Neoplasms
Targeting SET to restore PP2A activity disrupts an oncogenic CIP2A-feedforward loop and impairs triple negative breast cancer progression.
Neoplasms
Targeting STAT3 Abrogates Tim-3 Upregulation of Adaptive Resistance to PD-1 Blockade on Regulatory T Cells of Melanoma.
Neoplasms
Targeting the CDK4/6-Rb Pathway Enhances Response to PI3K Inhibition in PIK3CA-Mutant Lung Squamous Cell Carcinoma.
Neoplasms
Targeting the coding sequence: opposing roles in regulating classical and non-classical MHC class I molecules by miR-16 and miR-744.
Neoplasms
Targeting the YAP/TAZ Pathway in Uveal and Conjunctival Melanoma With Verteporfin.
Neoplasms
Taxane-mediated radiosensitization derives from chromosomal missegregation on tripolar mitotic spindles orchestrated by AURKA and TPX2.
Neoplasms
TBX5-AS1, an enhancer RNA, is a potential novel prognostic biomarker for lung adenocarcinoma.
Neoplasms
TCF19 contributes to cell proliferation of non-small cell lung cancer by inhibiting FOXO1.
Neoplasms
TCF4 promotes colorectal cancer drug resistance and stemness via regulating ZEB1/ZEB2 expression.
Neoplasms
TCF7L1 indicates prognosis and promotes proliferation through activation of Keap1/NRF2 in gastric cancer.
Neoplasms
TCGA and ESTIMATE data mining to identify potential prognostic biomarkers in HCC patients.
Neoplasms
TCGA based integrated genomic analyses of ceRNA network and novel subtypes revealing potential biomarkers for the prognosis and target therapy of tongue squamous cell carcinoma.
Neoplasms
TCGA data and patient-derived orthotopic xenografts highlight pancreatic cancer-associated angiogenesis.
Neoplasms
TCGA dataset screening for genes implicated in endometrial cancer using RNA-seq profiling.
Neoplasms
TCGA dataset?based construction and integrated analysis of aberrantly expressed long non?coding RNA mediated competing endogenous RNA network in gastric cancer.
Neoplasms
TCGA divides gastric cancer into four molecular subtypes: implications for individualized therapeutics.
Neoplasms
TCGA mRNA Expression Analysis of the Heme Biosynthesis Pathway in Diffusely Infiltrating Gliomas: A Comparison of Typically 5-ALA Fluorescent and Non-Fluorescent Gliomas.
Neoplasms
TCGA Pan-Cancer Genomic Analysis of Alternative Lengthening of Telomeres (ALT) Related Genes.
Neoplasms
TCGA Workflow: Analyze cancer genomics and epigenomics data using Bioconductor packages.
Neoplasms
TCGA-Assembler 2: Software Pipeline for Retrieval and Processing of TCGA/CPTAC Data.
Neoplasms
TCGA-TCIA-Based CT Radiomics Study for Noninvasively Predicting Epstein-Barr Virus Status in Gastric Cancer.
Neoplasms
TCGA2BED: extracting, extending, integrating, and querying The Cancer Genome Atlas.
Neoplasms
TCPA v3.0: An Integrative Platform to Explore the Pan-Cancer Analysis of Functional Proteomic Data.
Neoplasms
TDO2 overexpression correlates with poor prognosis, cancer stemness, and resistance to cetuximab in bladder cancer.
Neoplasms
TEAD4 is a novel independent predictor of prognosis in LGG patients with IDH mutation.
Neoplasms
Telomerase reverse transcriptase mutations in plasma DNA in patients with hepatocellular carcinoma or cirrhosis: Prevalence and risk factors.
Neoplasms
Telomerase reverse transcriptase regulates DNMT3B expression/aberrant DNA methylation phenotype and AKT activation in hepatocellular carcinoma.
Neoplasms
Telomere Length Variation in Tumor cells and Cancer-Associated Fibroblasts: Potential Biomarker for Hepatocellular Carcinoma.
Neoplasms
Telomere-associated genes and telomeric lncRNAs are biomarker candidates in lung squamous cell carcinoma (LUSC).
Neoplasms
Telomeric zinc-finger associated protein (TZAP) in cancer biology: friend or foe?
Neoplasms
Temozolomide resistance in glioblastoma cells occurs partly through epidermal growth factor receptor-mediated induction of connexin 43.
Neoplasms
Ten genes associated with MGMT promoter methylation predict the prognosis of patients with glioma.
Neoplasms
Ten-year outcomes of uveal melanoma based on The Cancer Genome Atlas (TCGA) classification in 1001 cases.
Neoplasms
Teratomas produced from human pluripotent stem cells xenografted into immunodeficient mice - a histopathology atlas.
Neoplasms
TERT Mutation Is Accompanied by Neutrophil Infiltration and Contributes to Poor Survival in Isocitrate Dehydrogenase Wild-Type Glioma.
Neoplasms
Tescalcin is an unfavorable prognosis factor that regulats cell proliferation and survival in hepatocellular carcinoma patients.
Neoplasms
Testing equality of means in partially paired data with incompleteness in single response.
Neoplasms
Testis-specific protein, Y-linked 1 activates PI3K/AKT and RAS signaling pathways through suppressing IGFBP3 expression during tumor progression.
Neoplasms
Texture Feature Ratios from Relative CBV Maps of Perfusion MRI Are Associated with Patient Survival in Glioblastoma.
Neoplasms
TFAP2A is a novel regulator that modulates ferroptosis in gallbladder carcinoma cells via the Nrf2 signalling axis.
Neoplasms
TFEB Expression Profiling in Renal Cell Carcinomas: Clinicopathologic Correlations.
Neoplasms
TFEB-VEGFA (6p21.1) co-amplified renal cell carcinoma: a distinct entity with potential implications for clinical management.
Neoplasms
TGF-? receptor inhibitor LY2109761 enhances the radiosensitivity of gastric cancer by inactivating the TGF-?/SMAD4 signaling pathway.
Neoplasms
TGF? isoforms and receptors mRNA expression in breast tumours: prognostic value and clinical implications.
Neoplasms
TGF?1 overexpression is associated with improved survival and low tumor cell proliferation in patients with early-stage pancreatic ductal adenocarcinoma.
Neoplasms
TGF?1- miR-140-5p axis mediated up-regulation of Flap Endonuclease 1 promotes epithelial-mesenchymal transition in hepatocellular carcinoma.
Neoplasms
TGF?1: An Indicator for Tumor Immune Microenvironment of Colon Cancer From a Comprehensive Analysis of TCGA.
Neoplasms
TGF?2 is a prognostic-related biomarker and correlated with immune infiltrates in gastric cancer.
Neoplasms
TGF?2-mediated epithelial-mesenchymal transition and NF-?B pathway activation contribute to osimertinib resistance.
Neoplasms
TGFB1-induced autophagy affects the pattern of pancreatic cancer progression in distinct ways depending on SMAD4 status.
Neoplasms
Th2 cell infiltrations predict neoadjuvant chemotherapy response of estrogen receptor-positive breast cancer.
Neoplasms
THBS4 predicts poor outcomes and promotes proliferation and metastasis in gastric cancer.
Neoplasms
The "go or grow" potential of gliomas is linked to the neuropeptide processing enzyme carboxypeptidase E and mediated by metabolic stress.
Neoplasms
The (pro)renin receptor: a novel biomarker and potential therapeutic target for various cancers.
Neoplasms
The 2nd Conference and Workshop of The Cancer Genome Atlas (TCGA) in India: Towards Team Science for Multi-omics Cancer Research in South Asia.
Neoplasms
The ?-catenin/TCF-4-LINC01278-miR-1258-Smad2/3 axis promotes hepatocellular carcinoma metastasis.
Neoplasms
The ability of human nuclear DNA to cause false positive low-abundance heteroplasmy calls varies across the mitochondrial genome.
Neoplasms
The ADRB1 (Adrenoceptor Beta 1) and ADRB2 genes significantly co-express with commonly mutated genes in prostate cancer.
Neoplasms
The Aged Microenvironment Influences the Tumorigenic Potential of Malignant Prostate Epithelial Cells.
Neoplasms
The alternatively spliced RECK transcript variant 3 is a predictor of poor survival for melanoma patients being upregulated in aggressive cell lines and modulating MMP gene expression in vitro.
Neoplasms
The analysis of surgical prognostic factors and molecular typing of locally advanced lung squamous cell carcinomas.
Neoplasms
The androgen receptor expression and association with patient's survival in different cancers.
Neoplasms
The androgen receptor expression and its activity have different relationships with prognosis in hepatocellular carcinoma.
Neoplasms
The AP2M1 gene expression is a promising biomarker for predicting survival of patients with hepatocellular carcinoma.
Neoplasms
The Arkadia-ESRP2 axis suppresses tumor progression: analyses in clear-cell renal cell carcinoma.
Neoplasms
The Art and Science of Thyroid Surgery in the Age of Genomics: 100 years after Theodor Kocher.
Neoplasms
The ASH1-miR-375-YWHAZ Signaling Axis Regulates Tumor Properties in Hepatocellular Carcinoma.
Neoplasms
The association between copper transporters and the prognosis of cancer patients undergoing chemotherapy: a meta-analysis of literatures and datasets.
Neoplasms
The association between copy number aberration, DNA methylation and gene expression in tumor samples.
Neoplasms
The association between the expression of PD-L1 and CMTM6 in undifferentiated pleomorphic sarcoma.
Neoplasms
The association of CMTM6 expression with prognosis and PD-L1 expression in triple-negative breast cancer.
Neoplasms
The Association of Long Non-Coding RNA SNHG6 Expression with Clinicopathological Features and Prognosis in Cancer.
Neoplasms
The Association of Modifiable Breast Cancer Risk Factors and Somatic Genomic Alterations in Breast Tumors: The Cancer Genome Atlas Network.
Neoplasms
The Association of MUC16 Mutation with Tumor Mutation Burden and Its Prognostic Implications in Cutaneous Melanoma.
Neoplasms
The association of renin-angiotensin system genes with the progression of hepatocellular carcinoma.
Neoplasms
The association of sex-biased ATRX mutation in female gastric cancer patients with enhanced immunotherapy-related anticancer immunity.
Neoplasms
The Australian experience with the Bethesda classification system for thyroid fine needle aspiration biopsies.
Neoplasms
The Autocrine FGF/FGFR System in both Skin and Uveal Melanoma: FGF Trapping as a Possible Therapeutic Approach.
Neoplasms
The Beneficial Role of Sunitinib in Tumor Immune Surveillance by Regulating Tumor PD-L1.
Neoplasms
The benefits of smoking cessation on survival in cancer patients by integrative analysis of multi-omics data.
Neoplasms
The Better Survival of MSI Subtype Is Associated With the Oxidative Stress Related Pathways in Gastric Cancer.
Neoplasms
The biobank of barretos cancer hospital: 14 years of experience in cancer research.
Neoplasms
The Biological Function Delineated Across Pan-Cancer Levels Through lncRNA-Based Prognostic Risk Assessment Factors for Pancreatic Cancer.
Neoplasms
The biological functions of target genes in pan-cancers and cell lines were predicted by miR-375 microarray data from GEO database and bioinformatics.
Neoplasms
The Biological Role of Sponge Circular RNAs in Gastric Cancer: Main Players or Coadjuvants?
Neoplasms
The brave new world of endometrial cancer : Future implications for adjuvant treatment decisions.
Neoplasms
The Breast Imaging Reporting and Data System (BI-RADS) in the Dutch breast cancer screening programme: its role as an assessment and stratification tool.
Neoplasms
The Burden of Post-Translational Modification (PTM)-Disrupting Mutations in the Tumor Matrisome.
Neoplasms
The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Neoplasms
The Cancer Editome Atlas: A Resource for Exploratory Analysis of the Adenosine-to-Inosine RNA Editome in Cancer.
Neoplasms
The Cancer Genome Atlas (TCGA) based m6A methylation-related genes predict prognosis in hepatocellular carcinoma.
Neoplasms
The Cancer Genome Atlas Analysis Predicts MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma.
Neoplasms
The Cancer Genome Atlas Clinical Explorer: a web and mobile interface for identifying clinical-genomic driver associations.
Neoplasms
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.
Neoplasms
The Cancer Genome Atlas dataset-based analysis of aberrantly expressed genes by GeneAnalytics in thymoma associated myasthenia gravis: focusing on T cells.
Neoplasms
The Cancer Genome Atlas Expression Subtypes Stratify Response to Checkpoint Inhibition in Advanced Urothelial Cancer and Identify a Subset of Patients with High Survival Probability.
Neoplasms
The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications.
Neoplasms
The Cancer Genomics Cloud: Collaborative, Reproducible, and Democratized-A New Paradigm in Large-Scale Computational Research.
Neoplasms
The Cancer Genomics Hub (CGHub): overcoming cancer through the power of torrential data.
Neoplasms
The cancer microbiome atlas: a pan-cancer comparative analysis to distinguish tissue-resident microbiota from contaminants.
Neoplasms
The cancer-testis gene, MEIOB, sensitizes triple-negative breast cancer to PARP1 inhibitors by inducing homologous recombination deficiency.
Neoplasms
The catalytically defective receptor protein tyrosine kinase EphA10 promotes tumorigenesis in pancreatic cancer cells.
Neoplasms
The cholesterol biosynthesis enzyme oxidosqualene cyclase is a new target to impair tumour angiogenesis and metastasis dissemination.
Neoplasms
The chromosome 19 microRNA cluster, regulated by promoter hypomethylation, is associated with tumour burden and poor prognosis in patients with hepatocellular carcinoma.
Neoplasms
The CIMP-high phenotype is associated with energy metabolism alterations in colon adenocarcinoma.
Neoplasms
The clinical and biological significance of MICA in clear cell renal cell carcinoma patients.
Neoplasms
The Clinical and Molecular Characterization of Gastric Cancer Patients in Qinghai-Tibetan Plateau.
Neoplasms
The clinical and prognostic significance of paraoxonase-2 in gastric cancer patients: immunohistochemical analysis.
Neoplasms
The clinical implications of immunogenomics in colorectal cancer: A path for precision medicine.
Neoplasms
The Clinical Kinase Index: A Method to Prioritize Understudied Kinases as Drug Targets for the Treatment of Cancer.
Neoplasms
The Clinical Prognostic Value of lncRNA SBF2-AS1 in Cancer Patients: A Meta-Analysis.
Neoplasms
The clinical significance of apolipoprotein L1 in head and neck squamous cell carcinoma.
Neoplasms
The clinical significance of collagen family gene expression in esophageal squamous cell carcinoma.
Neoplasms
The clinical significance of endothelin receptor type B in hepatocellular carcinoma and its potential molecular mechanism.
Neoplasms
The clinical significance of glutathione peroxidase 2 in glioblastoma multiforme.
Neoplasms
The clinical significance of HOXA9 promoter hypermethylation in head and neck squamous cell carcinoma.
Neoplasms
The clinical significance of Interleukin 24 and its potential molecular mechanism in laryngeal squamous cell carcinoma.
Neoplasms
The clinical significance of microRNA-122 in predicting the prognosis of patients with hepatocellular carcinoma: A meta-analysis validated by the Cancer Genome Atlas dataset.
Neoplasms
The clinical value of Fibulin-1 for prognosis and its prospective mechanism in intrahepatic cholangiocarcinoma.
Neoplasms
The clinical value of miR-193a-3p in non-small cell lung cancer and its potential molecular mechanism explored
Neoplasms
The clinicomolecular landscape of de novo versus relapsed stage IV metastatic breast cancer.
Neoplasms
The clinicopathological and prognostic value of CD44 expression in bladder cancer: a study based on meta-analysis and TCGA data.
Neoplasms
The Clinicopathological Characteristics of Alpha-Fetoprotein-Producing Adenocarcinoma of the Gastrointestinal Tract-A Single-Center Retrospective Study.
Neoplasms
The Clinicopathological Significance and Correlative Signaling Pathways of an Autophagy-Related Gene, Ambra1, in Breast Cancer: a Study of 25 Microarray RNA-Seq Datasets and in-House Gene Silencing.
Neoplasms
The clinicopathological significance and predictive value for immunotherapy of programmed death ligand-1 expression in Epstein-Barr virus-associated gastric cancer.
Neoplasms
The clinicopathological significance of UBE2C in breast cancer: a study based on immunohistochemistry, microarray and RNA-sequencing data.
Neoplasms
The CNPY2 enhances epithelial-mesenchymal transition via activating the AKT/GSK3? pathway in non-small cell lung cancer.
Neoplasms
The Combination of Low Skeletal Muscle Mass and High Tumor Interleukin-6 Associates with Decreased Survival in Clear Cell Renal Cell Carcinoma.
Neoplasms
The Combined Detection of Immune Genes for Predicting the Prognosis of Patients With Non-Small Cell Lung Cancer.
Neoplasms
The conformational and mutational landscape of the ubiquitin-like marker for autophagosome formation in cancer.
Neoplasms
The construction and analysis of a ferroptosis-related gene prognostic signature for pancreatic cancer.
Neoplasms
The construction and analysis of ceRNA networks in invasive breast cancer: a study based on The Cancer Genome Atlas.
Neoplasms
The construction and analysis of competitive endogenous RNA (ceRNA) networks in metastatic renal cell carcinoma: a study based on The Cancer Genome Atlas.
Neoplasms
The construction and analysis of the aberrant lncRNA-miRNA-mRNA network in non-small cell lung cancer.
Neoplasms
The Construction and Analysis of Tumor-Infiltrating Immune Cells and ceRNA Networks in Bladder Cancer.
Neoplasms
The Construction and Comprehensive Analysis of ceRNA Networks and Tumor-Infiltrating Immune Cells in Bone Metastatic Melanoma.
Neoplasms
The Construction and Comprehensive Prognostic Analysis of the LncRNA-Associated Competitive Endogenous RNAs Network in Colorectal Cancer.
Neoplasms
The construction and validation of an RNA binding protein-related prognostic model for bladder cancer.
Neoplasms
The conundrum of the Epstein-Barr virus-associated gastric carcinoma in the Americas.
Neoplasms
The coordination between ZNF217 and LSD1 contributes to hepatocellular carcinoma progress and is negatively regulated by miR-101.
Neoplasms
The correlation between immune subtypes and consensus molecular subtypes in colorectal cancer identifies novel tumour microenvironment profiles, with prognostic and therapeutic implications.
Neoplasms
The Correlation Between the Immune and Epithelial-Mesenchymal Transition Signatures Suggests Potential Therapeutic Targets and Prognosis Prediction Approaches in Kidney Cancer.
Neoplasms
The cox-filter method identifies respective subtype-specific lncRNA prognostic signatures for two human cancers.
Neoplasms
The crosstalk between AXL and YAP promotes tumor progression through STAT3 activation in head and neck squamous cell carcinoma.
Neoplasms
The degree of intratumor mutational heterogeneity varies by primary tumor sub-site.
Neoplasms
The Development of Three-DNA Methylation Signature as a Novel Prognostic Biomarker in Patients with Colorectal Cancer.
Neoplasms
The diagnosis and prognosis values of WNT mRNA expression in colon adenocarcinoma.
Neoplasms
The diagnostic and prognostic significance of long non-coding RNA CRNDE in pan-cancer based on TCGA, GEO and comprehensive meta-analysis.
Neoplasms
The diagnostic application of RNA sequencing in patients with thyroid cancer: an analysis of 851 variants and 133 fusions in 524 genes.
Neoplasms
The Differential Expression of Core Genes in Nucleotide Excision Repair Pathway Indicates Colorectal Carcinogenesis and Prognosis.
Neoplasms
The discovery of a novel eight-mRNA-lncRNA signature predicting survival of hepatocellular carcinoma patients.
Neoplasms
The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition.
Neoplasms
The DNA methylation profile of liver tumors in C3H mice and identification of differentially methylated regions involved in the regulation of tumorigenic genes.
Neoplasms
The DNA methylome of DDR genes and benefit from RT or TMZ in IDH mutant low-grade glioma treated in EORTC 22033.
Neoplasms
The Doppelgänger Effect: Hidden Duplicates in Databases of Transcriptome Profiles.
Neoplasms
The downregulated long noncoding RNA DHRS4-AS1 is protumoral and associated with the prognosis of clear cell renal cell carcinoma.
Neoplasms
The Downregulation of eIF3a Contributes to Vemurafenib Resistance in Melanoma by Activating ERK via PPP2R1B.
Neoplasms
The Dysregulated Expression of KCNQ1OT1 and Its Interaction with Downstream Factors miR-145/CCNE2 in Breast Cancer Cells.
Neoplasms
The Early Diagnostic and Prognostic Value of BIRC5 in Clear-Cell Renal Cell Carcinoma Based on the Cancer Genome Atlas Data.
Neoplasms
The Early Diagnostic Value of Serum Interleukin-8 in Esophagogastric Junction Adenocarcinoma.
Neoplasms
The effect of CCL5 on the immune cells infiltration and the prognosis of patients with kidney renal clear cell carcinoma.
Neoplasms
The effect of centromere protein U silencing by lentiviral mediated RNA interference on the proliferation and apoptosis of breast cancer.
Neoplasms
The effect of glioblastoma heterogeneity on survival stratification: a multimodal MR imaging texture analysis.
Neoplasms
The effect of HMGB1 on the clinicopathological and prognostic features of non-small cell lung cancer.
Neoplasms
The effect of the TP53 and RB1 mutations on the survival of hepatocellular carcinoma patients with different racial backgrounds.
Neoplasms
The effects of ephrinB2 signaling on proliferation and invasion in glioblastoma multiforme.
Neoplasms
The Effects of Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer-The Impact in Intratumoral Heterogeneity.
Neoplasms
The efficacy of anti-EGFR therapy in treating metastatic colorectal cancer differs between the middle/low rectum and the left-sided colon.
Neoplasms
The efficacy of immune checkpoint inhibitors in anaplastic lymphoma kinase-positive non-small cell lung cancer.
Neoplasms
The emerging role of molecular pathology in directing the systemic treatment of endometrial cancer.
Neoplasms
The ERR?-VDR axis promotes calcitriol degradation and estrogen signaling in breast cancer cells, while VDR-CYP24A1-ERR? overexpression correlates with poor prognosis in patients with basal-like breast cancer.
Neoplasms
The eSNV-detect: a computational system to identify expressed single nucleotide variants from transcriptome sequencing data.
Neoplasms
The essential role of MTDH in the progression of HCC: a study with immunohistochemistry, TCGA, meta-analysis and in vitro investigation.
Neoplasms
The establishment of a prognostic scoring model based on the new tumor immune microenvironment classification in acute myeloid leukemia.
Neoplasms
The evolution of endometrial carcinoma classification through application of immunohistochemistry and molecular diagnostics: past, present and future.
Neoplasms
The evolving role of cancer cell line-based screens to define the impact of cancer genomes on drug response.
Neoplasms
The Evolving Role of Checkpoint Inhibitors in the Management of Gastroesophageal Cancer.
Neoplasms
The exploration of new therapeutic targets for HPV-negative head and neck squamous cell cancer through the construction of a ceRNA network and immune microenvironment analysis.
Neoplasms
The expression and biological information analysis of miR-375-3p in head and neck squamous cell carcinoma based on 1825 samples from GEO, TCGA, and peer-reviewed publications.
Neoplasms
The Expression and Effection of MicroRNA-499a in High-Tobacco Exposed Head and Neck Squamous Cell Carcinoma: A Bioinformatic Analysis.
Neoplasms
The Expression and Prognostic Impact of Immune Cytolytic Activity-Related Markers in Human Malignancies: A Comprehensive Meta-analysis.
Neoplasms
The expression and prognostic impact of proinflammatory cytokines and their associations with carcinogens in oropharyngeal squamous cell carcinoma.
Neoplasms
The Expression and Prognostic Significance of Claudin-8 and Androgen Receptor in Breast Cancer.
Neoplasms
The expression and prognostic significance of Drp1 in lung cancer: A bioinformatics analysis and immunohistochemistry.
Neoplasms
The expression and prognostic value of GLYATL1 and its potential role in hepatocellular carcinoma.
Neoplasms
The Expression and Survival Significance of Glucose Transporter-1 in Pancreatic Cancer: Meta-Analysis, Bioinformatics Analysis and Retrospective Study.
Neoplasms
The Expression and Therapeutic Potential of Checkpoint Kinase 2 in Laryngeal Squamous Cell Carcinoma.
Neoplasms
The expression characteristics and prognostic roles of autophagy-related genes in gastric cancer.
Neoplasms
The Expression Level of PD-L1 (CD274) mRNA in Peripheral Blood Is a Potential Biomarker for Predicting Recurrence in Breast Cancer.
Neoplasms
The expression level of small non-coding RNAs derived from the first exon of protein-coding genes is predictive of cancer status.
Neoplasms
The expression of HOXA13 in lung adenocarcinoma and its clinical significance: A study based on The Cancer Genome Atlas, Oncomine and reverse transcription-quantitative polymerase chain reaction.
Neoplasms
The expression of long noncoding RNA CRCAL-3 in colorectal cancer and its impacts on cell proliferation and migration.
Neoplasms
The expression of miR-375 in prostate cancer: A study based on GEO, TCGA data and bioinformatics analysis.
Neoplasms
The Expression of PD-L1 and B7-H4 in Thymic Epithelial Tumor and Its Relationship With Tumor Immune-Infiltrating Cells.
Neoplasms
The expression of SALL4 in patients with gliomas: high level of SALL4 expression is correlated with poor outcome.
Neoplasms
The Expression of the SLIT-ROBO Family in Adult Patients with Acute Myeloid Leukemia.
Neoplasms
The expression of the tumour suppressor HBP1 is down-regulated by growth factors via the PI3K/PKB/FOXO pathway.
Neoplasms
The Expression of Tripartite Motif Protein 36 and ?-Catenin Correlates with the Prognosis of Esophageal Cancer.
Neoplasms
The expression patterns and the diagnostic/prognostic roles of PTPN family members in digestive tract cancers.
Neoplasms
The Expression Profiles of ADME Genes in Human Cancers and Their Associations with Clinical Outcomes.
Neoplasms
The expression signature of cancer-associated KRAB-ZNF factors identified in TCGA pan-cancer transcriptomic data.
Neoplasms
The expression, induction and pharmacological activity of CYP1A2 are post-transcriptionally regulated by microRNA hsa-miR-132-5p.
Neoplasms
The expression, significance and function of cancer susceptibility candidate 9 in lung squamous cell carcinoma: A bioinformatics and in vitro investigation.
Neoplasms
The FOXC1/FBP1 signaling axis promotes colorectal cancer proliferation by enhancing the Warburg effect.
Neoplasms
The FOXC2 Transcription Factor Promotes Melanoma Outgrowth and Regulates Expression of Genes Associated With Drug Resistance and Interferon Responsiveness.
Neoplasms
The frequency of promoter DNA hypermethylation is decreased in colorectal neoplasms of familial adenomatous polyposis.
Neoplasms
The Functional Impact of Alternative Splicing on the Survival Prognosis of Triple-Negative Breast Cancer.
Neoplasms
The functional landscape of Golgi membrane protein 1 (GOLM1) phosphoproteome reveal GOLM1 regulating P53 that promotes malignancy.
Neoplasms
The functions and prognostic values of m6A RNA methylation regulators in thyroid carcinoma.
Neoplasms
The future of bladder cancer therapy: Optimizing the inhibition of the fibroblast growth factor receptor.
Neoplasms
The G Protein-Coupled Estrogen Receptor (GPER) Expression Correlates with Pro-Metastatic Pathways in ER-Negative Breast Cancer: A Bioinformatics Analysis.
Neoplasms
The Gasdermin E Gene Has Potential as a Pan-Cancer Biomarker, While Discriminating between Different Tumor Types.
Neoplasms
The genetic landscape of programmed death ligand-1 (PD-L1) alterations in head and neck cancer.
Neoplasms
The genetic landscapes of urological cancers and their clinical implications in the era of high-throughput genome analysis.
Neoplasms
The genetics of ductal adenocarcinoma of the pancreas in the year 2020: dramatic progress, but far to go.
Neoplasms
The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.
Neoplasms
The genomic alterations of lung adenocarcinoma and lung squamous cell carcinoma can explain the differences of their overall survival rates.
Neoplasms
The genomic and transcriptomic landscape of anaplastic thyroid cancer: implications for therapy.
Neoplasms
The Genomic Heterogeneity of FIGO Grade 3 Endometrioid Carcinoma Impacts Diagnostic Accuracy and Reproducibility.
Neoplasms
The Genomic Impact of DNA CpG Methylation on Gene Expression; Relationships in Prostate Cancer.
Neoplasms
The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers.
Neoplasms
The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis.
Neoplasms
The Genomic Landscape and Pharmacogenomic Interactions of Clock Genes in Cancer Chronotherapy.
Neoplasms
The Germline Variants rs61757955 and rs34988193 Are Predictive of Survival in Lower Grade Glioma Patients.
Neoplasms
The glycosyltransferase LARGE2 is repressed by Snail and ZEB1 in prostate cancer.
Neoplasms
The GNAQ T96S Mutation Affects Cell Signaling and Enhances the Oncogenic Properties of Hepatocellular Carcinoma.
Neoplasms
The head and neck cancer immune landscape and its immunotherapeutic implications.
Neoplasms
The heterogeneity of plasma miRNA profiles in hepatocellular carcinoma patients and the exploration of diagnostic circulating miRNAs for hepatocellular carcinoma.
Neoplasms
The HGF-MET axis coordinates liver cancer metabolism and autophagy for chemotherapeutic resistance.
Neoplasms
The hidden genomic landscape of acute myeloid leukemia: subclonal structure revealed by undetected mutations.
Neoplasms
The High Expression of PTPRH Is Associated with Poor Prognosis of Human Lung Adenocarcinoma.
Neoplasms
The Histone Demethylase KDM3A, Increased in Human Pancreatic Tumors, Regulates Expression of DCLK1 in and Promotes Tumorigenesis in Mice.
Neoplasms
The Human Cancer Pathology Atlas: An open-access source for more than 900,000 Kaplan-Meier plots and 5 million cancer tissue images.
Neoplasms
The human nucleophosmin 1 mutation A inhibits myeloid differentiation of leukemia cells by modulating miR-10b.
Neoplasms
The Human Protein Atlas-Spatial localization of the human proteome in health and disease.
Neoplasms
The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution.
Neoplasms
The Identification and Validation of a Robust Immune-Associated Gene Signature in Cutaneous Melanoma.
Neoplasms
The identification of autophagy-related genes in the prognosis of oral squamous cell carcinoma.
Neoplasms
The Identification of Critical m6A RNA Methylation Regulators as Malignant Prognosis Factors in Prostate Adenocarcinoma.
Neoplasms
The Identification of Differentially Expressed Genes Showing Aberrant Methylation Patterns in Pheochromocytoma by Integrated Bioinformatics Analysis.
Neoplasms
The Identification of Stemness-Related Genes in the Risk of Head and Neck Squamous Cell Carcinoma.
Neoplasms
The Identification of Zinc-Finger Protein 433 as a Possible Prognostic Biomarker for Clear-Cell Renal Cell Carcinoma.
Neoplasms
The IL1?-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs).
Neoplasms
The immune checkpoint protein PD-L1 induces and maintains regulatory T cells in glioblastoma.
Neoplasms
The Immune Heterogeneity Between Pulmonary Adenocarcinoma and Squamous Cell Carcinoma: A Comprehensive Analysis Based on lncRNA Model.
Neoplasms
The Immune Landscape and Prognostic Immune Key Genes Potentially Involved in Modulating Synaptic Functions in Prostate Cancer.
Neoplasms
The immune microenvironment of HPV-negative oral squamous cell carcinoma from never-smokers and never-drinkers patients suggests higher clinical benefit of IDO1 and PD1/PD-L1 blockade.
Neoplasms
The immune phenotype of tongue squamous cell carcinoma predicts early relapse and poor prognosis.
Neoplasms
The Immune Subtypes and Landscape of Gastric Cancer and to Predict Based on the Whole-Slide Images Using Deep Learning.
Neoplasms
The immune suppressive factors CD155 and PD-L1 show contrasting expression patterns and immune correlates in ovarian and other cancers.
Neoplasms
The immune-related biomarker TEK inhibits the development of clear cell renal cell carcinoma (ccRCC) by regulating AKT phosphorylation.
Neoplasms
The immune-related gene CD52 is a favorable biomarker for breast cancer prognosis.
Neoplasms
The Immune-Related Gene HCST as a Novel Biomarker for the Diagnosis and Prognosis of Clear Cell Renal Cell Carcinoma.
Neoplasms
The Impact of Age and Sex in DLBCL: Systems Biology Analyses Identify Distinct Molecular Changes and Signaling Networks.
Neoplasms
The impact of estimated tumour purity on gene expression-based drug repositioning of Clear Cell Renal Cell Carcinoma samples.
Neoplasms
The impact of HER2 overexpression on the miRNA and circRNA transcriptomes in two breast cell lines and their vesicles.
Neoplasms
The impact of high co-expression of Sp1 and HIF1? on prognosis of patients with hepatocellular cancer.
Neoplasms
The impact of MCM6 on hepatocellular carcinoma in a Southern Chinese Zhuang population.
Neoplasms
The Impact of MicroRNA-133a on Prognosis and Clinicopathological Parameters for Digestive System Cancers: a Comprehensive Study Based on Meta-Analysis and TCGA Database.
Neoplasms
The Impact of Normalization Approaches to Automatically Detect Radiogenomic Phenotypes Characterizing Breast Cancer Receptors Status.
Neoplasms
The Impact of NOTCH Pathway Alteration on Tumor Microenvironment and Clinical Survival of Immune Checkpoint Inhibitors in NSCLC.
Neoplasms
The impact of site-specific digital histology signatures on deep learning model accuracy and bias.
Neoplasms
The impact on high-grade serous ovarian cancer of obesity and lipid metabolism-related gene expression patterns: the underestimated driving force affecting prognosis.
Neoplasms
The Importance of Sex in the Discovery of Colorectal Cancer Prognostic Biomarkers.
Neoplasms
The Importance of the PI3K/AKT/MTOR Pathway in the Progression of Ovarian Cancer.
Neoplasms
The Integrated Analyses of Driver Genes Identify Key Biomarkers in Thyroid Cancer.
Neoplasms
The integration of differentially expressed genes based on multiple microarray datasets for prediction of the prognosis in oral squamous cell carcinoma.
Neoplasms
The Integrative Analysis Identifies Three Cancer Subtypes and Stemness Features in Cutaneous Melanoma.
Neoplasms
The integrative epigenomic-transcriptomic landscape of ER positive breast cancer.
Neoplasms
The interplay between AR, EGF receptor and MMP-9 signaling pathways in invasive prostate cancer.
Neoplasms
The Intersection between Oral Microbiota, Host Gene Methylation and Patient Outcomes in Head and Neck Squamous Cell Carcinoma.
Neoplasms
The ISB Cancer Genomics Cloud: A Flexible Cloud-Based Platform for Cancer Genomics Research.
Neoplasms
The landscape and prognostic value of immune characteristics in uterine corpus endometrial cancer.
Neoplasms
The landscape and prognostic value of tumor-infiltrating immune cells in gastric cancer.
Neoplasms
The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients.
Neoplasms
The landscape of CD28, CD80, CD86, CTLA4, and ICOS DNA methylation in head and neck squamous cell carcinomas.
Neoplasms
The Landscape of Chromosome Instability in Breast Cancers and Associations with the Tumor Mutation Burden: An Analysis of Data from TCGA.
Neoplasms
The landscape of immune cell infiltration and its clinical implications of pancreatic ductal adenocarcinoma.
Neoplasms
The Landscape of Iron Metabolism-Related and Methylated Genes in the Prognosis Prediction of Clear Cell Renal Cell Carcinoma.
Neoplasms
The Landscape of Long Non-Coding RNA Dysregulation and Clinical Relevance in Muscle Invasive Bladder Urothelial Carcinoma.
Neoplasms
The landscape of miRNA-related ceRNA networks for marking different renal cell carcinoma subtypes.
Neoplasms
The landscape of viral expression and host gene fusion and adaptation in human cancer.
Neoplasms
The Landscape of Whole-genome Alterations and Pathologic Features in Genitourinary Malignancies: An Analysis of the Cancer Genome Atlas.
Neoplasms
The level of zinc finger of the cerebellum 2 is predictive of overall survival in clear cell renal cell carcinoma.
Neoplasms
The lipid peroxidation product EKODE exacerbates colonic inflammation and colon tumorigenesis.
Neoplasms
The Liver Microbiome Is Implicated in Cancer Prognosis and Modulated by Alcohol and Hepatitis B.
Neoplasms
The LncRNA AL161431.1 targets miR-1252-5p and facilitates cellular proliferation and migration via MAPK signaling in endometrial carcinoma.
Neoplasms
The lncRNA myocardial infarction associated transcript-centric competing endogenous RNA network in non-small-cell lung cancer.
Neoplasms
The LncRNA NEAT1 Accelerates Lung Adenocarcinoma Deterioration and Binds to Mir-193a-3p as a Competitive Endogenous RNA.
Neoplasms
The lncRNA RP3-439F8.1 promotes GBM cell proliferation and progression by sponging miR-139-5p to upregulate NR5A2.
Neoplasms
The lncRNA SNHG3 regulates energy metabolism of ovarian cancer by an analysis of mitochondrial proteomes.
Neoplasms
The lncRNAs LINC00261 and LINC00665 are upregulated in long-term prostate cancer adaptation after radiotherapy.
Neoplasms
The long non-coding RNA EPB41L4A-AS2 inhibits tumor proliferation and is associated with favorable prognoses in breast cancer and other solid tumors.
Neoplasms
The long non-coding RNA maternally expressed gene 3 activates p53 and is downregulated in esophageal squamous cell cancer.
Neoplasms
The long non-coding RNA PIK3CD-AS2 promotes lung adenocarcinoma progression via YBX1-mediated suppression of p53 pathway.
Neoplasms
The long non-coding RNA SNHG12 promotes gastric cancer by activating the phosphatidylinositol 3-kinase/AKT pathway.
Neoplasms
The long noncoding RNA DLGAP1-AS2 facilitates cholangiocarcinoma progression via miR-505 and GALNT10.
Neoplasms
The long noncoding RNA urothelial carcinoma-associated 1 overexpression as a poor prognostic biomarker in clear cell renal cell carcinoma.
Neoplasms
The Long Noncoding RNA ZFAS1 Potentiates the Development of Hepatocellular Carcinoma via the microRNA-624/MDK/ERK/JNK/P38 Signaling Pathway.
Neoplasms
The Long Noncoding RNA, LINC01555, Promotes Invasion and Metastasis of Colorectal Cancer by Activating the Neuropeptide, Neuromedin U.
Neoplasms
The Long-To-Short-Axis Ratio and Multifocality are Associated With TP53 Mutation Status in Surgically Resected Hepatocellular Carcinomas.
Neoplasms
The loss of nuclear expression of single-stranded DNA binding protein 2 of gastric adenocarcinoma and its prognostic role: Analysis of molecular subtype.
Neoplasms
The low expression of NUP62CL indicates good prognosis and high level of immune infiltration in lung adenocarcinoma.
Neoplasms
The Lung Cancer Associated MicroRNAs and Single Nucleotides Polymorphisms: a Mendelian Randomization Analysis.
Neoplasms
The M1/M2 spectrum and plasticity of malignant pleural effusion-macrophage in advanced lung cancer.
Neoplasms
The m6A readers YTHDF1 and YTHDF3 aberrations associated with metastasis and predict poor prognosis in breast cancer patients.
Neoplasms
The m6A-Related mRNA Signature Predicts the Prognosis of Pancreatic Cancer Patients.
Neoplasms
The Mammalian Ecdysoneless Protein Interacts with RNA Helicase DDX39A To Regulate Nuclear mRNA Export.
Neoplasms
The management of localized esophageal squamous cell carcinoma: Western approach.
Neoplasms
The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy Development.
Neoplasms
The Metallophosphoesterase-Domain-Containing Protein 2 (MPPED2) Gene Acts as Tumor Suppressor in Breast Cancer.
Neoplasms
The methylation modification of m6A regulators contributes to the prognosis of head and neck squamous cell carcinoma.
Neoplasms
The microRNA target site landscape is a novel molecular feature associating alternative polyadenylation with immune evasion activity in breast cancer.
Neoplasms
The miR-106b/NR2F2-AS1/PLEKHO2 Axis Regulates Migration and Invasion of Colorectal Cancer through the MAPK Pathway.
Neoplasms
The miR-183/182/96 cluster functions as a potential carcinogenic factor and prognostic factor in kidney renal clear cell carcinoma.
Neoplasms
The miR-503 cluster is coordinately under-expressed in endometrial endometrioid adenocarcinoma and targets many oncogenes, cell cycle genes, DNA repair genes and chemotherapy response genes.
Neoplasms
The miR-608 rs4919510 polymorphism may modify cancer susceptibility based on type.
Neoplasms
The mir-767-105 cluster: a crucial factor related to the poor prognosis of hepatocellular carcinoma.
Neoplasms
The miRNA, miR-125b, Inhibited Invasion and Metastasis of Gastric-Cancer Cells by Triggering the STAT3 Signaling Pathway.
Neoplasms
The mitochondrial fission factor FIS1 promotes stemness of human lung cancer stem cells via mitophagy.
Neoplasms
The modularity and dynamicity of miRNA-mRNA interactions in high-grade serous ovarian carcinomas and the prognostic implication.
Neoplasms
The modulation relationship of genomic pattern of intratumor heterogeneity and immunity microenvironment heterogeneity in hepatocellular carcinoma.
Neoplasms
The modulatory properties of Astragalus membranaceus treatment on endometrial cancer: an integrated pharmacological method.
Neoplasms
The Molecular Context of Vulnerability for CDK9 Suppression in Triple Wild-Type Melanoma.
Neoplasms
The molecular genetic basis of ovarian cancer and its roadmap towards a better treatment.
Neoplasms
The molecular landscape of the University of Michigan laryngeal squamous cell carcinoma cell line panel.
Neoplasms
The mRNA-edited form of GABRA3 suppresses GABRA3-mediated Akt activation and breast cancer metastasis.
Neoplasms
The MS-lincRNA landscape reveals a novel lincRNA BCLIN25 that contributes to tumorigenesis by upregulating ERBB2 expression via epigenetic modification and RNA-RNA interactions in breast cancer.
Neoplasms
The mutational landscape of early- and typical-onset oral tongue squamous cell carcinoma.
Neoplasms
The mutational spectrum of FOXA2 in endometrioid endometrial cancer points to a tumor suppressor role.
Neoplasms
The mutational spectrum of squamous-cell carcinoma of the head and neck: Targetable genetic events and clinical impact.
Neoplasms
The Nanocind Signature Is an Independent Prognosticator of Recurrence and Death in Uterine Leiomyosarcomas.
Neoplasms
The natural compound neobractatin inhibits tumor metastasis by upregulating the RNA-binding-protein MBNL2.
Neoplasms
The Nedd8-activating enzyme inhibitor MLN4924 (TAK-924/Pevonedistat) induces apoptosis via c-Myc-Noxa axis in head and neck squamous cell carcinoma.
Neoplasms
The Neurogenic Compound P7C3 Regulates the Aerobic Glycolysis by Targeting Phosphoglycerate Kinase 1 in Glioma.
Neoplasms
The new world of poly-(ADP)-ribose polymerase inhibitors (PARPi) used in the treatment of gynecological cancers.
Neoplasms
The next horizon in precision oncology: Proteogenomics to inform cancer diagnosis and treatment.
Neoplasms
The nine ADAMs family members serve as potential biomarkers for immune infiltration in pancreatic adenocarcinoma.
Neoplasms
The novel immune-related genes predict the prognosis of patients with hepatocellular carcinoma.
Neoplasms
The Novel Marker GATA3 is Significantly More Sensitive Than Traditional Markers Mammaglobin and GCDFP15 for Identifying Breast Cancer in Surgical and Cytology Specimens of Metastatic and Matched Primary Tumors.
Neoplasms
The NRF2 transcriptional target NQO1 has low mRNA levels in TP53-mutated endometrial carcinomas.
Neoplasms
The Nuclear Receptor Signaling Atlas: development of a functional atlas of nuclear receptors.
Neoplasms
The nucleolar-related protein Dyskerin pseudouridine synthase 1 (DKC1) predicts poor prognosis in breast cancer.
Neoplasms
The nucleosome remodeling and deacetylase complex has prognostic significance and associates with immune microenvironment in skin cutaneous melanoma.
Neoplasms
The oncogenic potentials and diagnostic significance of long non-coding RNA LINC00310 in breast cancer.
Neoplasms
The Oncogenic Role of CENPA in Hepatocellular Carcinoma Development: Evidence from Bioinformatic Analysis.
Neoplasms
The Outer Retinal Membrane Protein 1 Could Inhibit Lung Cancer Progression as a Tumor Suppressor.
Neoplasms
The overexpression of GRASP might inhibit cell proliferation and invasion in hepatocellular carcinoma.
Neoplasms
The Overexpression of NMHC IIA Promoted Invasion and Metastasis of Nasopharyngeal Carcinoma Cells.
Neoplasms
The p53-inducible CLDN7 regulates colorectal tumorigenesis and has prognostic significance.
Neoplasms
The Pan-Cancer analysis of pseudogene expression reveals biologically and clinically relevant tumour subtypes.
Neoplasms
The pan-cancer analysis of the two types of uterine cancer uncovered clinical and prognostic associations with m6A RNA methylation regulators.
Neoplasms
The Pancancer DNA Methylation Trackhub: A Window to The Cancer Genome Atlas Epigenomics Data.
Neoplasms
The Pancreatic Microbiome is Associated with Carcinogenesis and Worse Prognosis in Males and Smokers.
Neoplasms
The PD-1/PD-L1 axis and human papilloma virus in patients with head and neck cancer after adjuvant chemoradiotherapy: A multicentre study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
Neoplasms
The PD-L1 metabolic interactome intersects with choline metabolism and inflammation.
Neoplasms
The Perspective of Diagnostic and Prognostic Values of Lipoxygenases mRNA Expression in Colon Adenocarcinoma.
Neoplasms
The Pharmacological Effects of Spatholobi Caulis Tannin in Cervical Cancer and Its Precise Therapeutic Effect on Related circRNA.
Neoplasms
The PI3K/mTOR Pathway Is Targeted by Rare Germline Variants in Patients with Both Melanoma and Renal Cell Carcinoma.
Neoplasms
The polo-like kinase 1 inhibitor volasertib synergistically increases radiation efficacy in glioma stem cells.
Neoplasms
The polyoma virus large T binding protein p150 is a transcriptional repressor of c-MYC.
Neoplasms
The possible roles of B-cell novel protein-1 (BCNP1) in cellular signalling pathways and in cancer.
Neoplasms
The potential of biologic network models in understanding the etiopathogenesis of ovarian cancer.
Neoplasms
The Potential of Five Immune-Related Prognostic Genes to Predict Survival and Response to Immune Checkpoint Inhibitors for Soft Tissue Sarcomas Based on Multi-Omic Study.
Neoplasms
The Potential Role of Selected miRNA in Uveal Melanoma Primary Tumors as Early Biomarkers of Disease Progression.
Neoplasms
The Prediction and Prognostic Significance of INPP5K Expression in Patients with Liver Cancer.
Neoplasms
The prediction of survival in Gastric Cancer based on a Robust 13-Gene Signature.
Neoplasms
The Prediction of Survival in Hepatocellular Carcinoma Based on A Four Long Non-coding RNAs Expression Signature.
Neoplasms
The presence of TIM-3 positive cells in WHO grade III and IV astrocytic gliomas correlates with isocitrate dehydrogenase mutation status.
Neoplasms
The presence of tumour-infiltrating neutrophils is an independent adverse prognostic feature in clear cell renal cell carcinoma.
Neoplasms
The prognostic and diagnostic value of tissue inhibitor of metalloproteinases gene family and potential function in gastric cancer.
Neoplasms
The prognostic and immunological effects of ZBTB7C across cancers: friend or foe?
Neoplasms
The prognostic and predictive value of tumor infiltrating Macrophage and Neutrophil in patient with clear cell renal cell carcinoma: Tumor infiltrating lymphocytes in renal cell carcinoma.
Neoplasms
The prognostic landscape of adaptive immune resistance signatures and infiltrating immune cells in the tumor microenvironment of uveal melanoma.
Neoplasms
The prognostic landscape of tumor-infiltrating immune cell and immunomodulators in lung cancer.
Neoplasms
The prognostic landscape of tumor-infiltrating immune cells in lung squamous cell carcinoma.
Neoplasms
The prognostic potential of alpha-1 type I collagen expression in papillary thyroid cancer.
Neoplasms
The Prognostic Role of Glutathione Peroxidase 1 and Immune Infiltrates in Glioma Investigated Using Public Datasets.
Neoplasms
The prognostic role of the Transducin-like Enhancer of split protein family in lung adenocarcinoma.
Neoplasms
The Prognostic Signature and Potential Target Genes of Six Long Non-coding RNA in Laryngeal Squamous Cell Carcinoma.
Neoplasms
The prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: hormone receptors in risk stratification.
Neoplasms
The prognostic significance of fibroblast activation protein-? in human lung adenocarcinoma.
Neoplasms
The prognostic significance of FOXC2 gene expression in cancer: A comprehensive analysis of RNA-seq data from the cancer genome atlas.
Neoplasms
The Prognostic Significance of Immune-Related Metabolic Enzyme MTHFD2 in Head and Neck Squamous Cell Carcinoma.
Neoplasms
The Prognostic Significance of Low-Frequency Somatic Mutations in Metastatic Cutaneous Melanoma.
Neoplasms
The Prognostic Significance of PDE7B in Cytogenetically Normal Acute Myeloid Leukemia.
Neoplasms
The prognostic value and potential subtypes of immune activity scores in three major urological cancers.
Neoplasms
The prognostic value of a seven-microRNA classifier as a novel biomarker for the prediction and detection of recurrence in glioma patients.
Neoplasms
The prognostic value of circular RNA regulatory genes in competitive endogenous RNA network in gastric cancer.
Neoplasms
The prognostic value of differentially expressed CYP3A subfamily members for hepatocellular carcinoma.
Neoplasms
The Prognostic Value of EMT in Glioma and its Role in the Glioma Immune Microenvironment.
Neoplasms
The prognostic value of faciogenital dysplasias as biomarkers in head and neck squamous cell carcinoma.
Neoplasms
The prognostic value of LINC01296 in pan-cancers and the molecular regulatory mechanism in hepatocellular carcinoma: a comprehensive study based on data mining, bioinformatics, and in vitro validation.
Neoplasms
The prognostic value of lncRNA SNHG4 and its potential mechanism in liver cancer.
Neoplasms
The prognostic value of long non-coding RNA H19 in various cancers: A meta-analysis based on 15 studies with 1584 patients and the Cancer Genome Atlas data.
Neoplasms
The prognostic value of long noncoding RNA SNHG16 on clinical outcomes in human cancers: a systematic review and meta-analysis.
Neoplasms
The prognostic value of matrix metalloproteinase-7 and matrix metalloproteinase-15 in acute myeloid leukemia.
Neoplasms
The prognostic value of Piezo1 in breast cancer patients with various clinicopathological features.
Neoplasms
The prognostic value of PKM2 and its correlation with tumour cell PD-L1 in lung adenocarcinoma.
Neoplasms
The Prognostic Value of the DNA Repair Gene Signature in Head and Neck Squamous Cell Carcinoma.
Neoplasms
The prognostic value of TMB and the relationship between TMB and immune infiltration in head and neck squamous cell carcinoma: A gene expression-based study.
Neoplasms
The prognostic value of TP53 and its correlation with EGFR mutation in advanced non-small cell lung cancer, an analysis based on cBioPortal data base.
Neoplasms
The Prognostic Value of Tumor Mutation Burden and Immune Cell Infiltration in Thymic Epithelial Tumors.
Neoplasms
The prognostic value of tumor mutation burden in EGFR-mutant advanced lung adenocarcinoma, an analysis based on cBioPortal data base.
Neoplasms
The proneural molecular signature is enriched in oligodendrogliomas and predicts improved survival among diffuse gliomas.
Neoplasms
The proteasome deubiquitinase inhibitor bAP15 downregulates TGF-?/Smad signaling and induces apoptosis via UCHL5 inhibition in ovarian cancer.
Neoplasms
The protective value of miR-204-5p for prognosis and its potential gene network in various malignancies: a comprehensive exploration based on RNA-seq high-throughput data and bioinformatics.
Neoplasms
The Proteomic Landscape of Growth Factor Signaling Networks Associated with FAT1 Mutations in Head and Neck Cancers.
Neoplasms
The pseudogene PRELID1P6 promotes glioma progression via the hnHNPH1-Akt/mTOR axis.
Neoplasms
The pseudogene-derived long noncoding RNA SFTA1P is down-regulated and suppresses cell migration and invasion in lung adenocarcinoma.
Neoplasms
The PVT1/miR-612/CENP-H/CDK1 axis promotes malignant progression of advanced endometrial cancer.
Neoplasms
The R132H mutation in IDH1 promotes the recruitment of NK cells through CX3CL1/CX3CR1 chemotaxis and is correlated with a better prognosis in gliomas.
Neoplasms
The radiotherapy-sensitization effect of cantharidin: Mechanisms involving cell cycle regulation, enhanced DNA damage, and inhibited DNA damage repair.
Neoplasms
The REASON score: an epigenetic and clinicopathologic score to predict risk of poor survival in patients with early stage oral squamous cell carcinoma.
Neoplasms
The Regulatory Network and Potential Role of LINC00973-miRNA-mRNA ceRNA in the Progression of Non-Small-Cell Lung Cancer.
Neoplasms
The relationship among Girdin DNA methylation, its high expression, and immune infiltration in hepatocellular carcinoma: Clues from in silico analysis.
Neoplasms
The relationship between autophagy-related genes and the staging and prognosis of thyroid cancer: a bioinformatics analysis.
Neoplasms
The Relationship Between Mismatch Repair Deficiency and PD-L1 Expression in Breast Carcinoma.
Neoplasms
The relationship between PLOD1 expression level and glioma prognosis investigated using public databases.
Neoplasms
The relationship between RASSF1A gene promoter methylation and the susceptibility and prognosis of melanoma: A meta-analysis and bioinformatics.
Neoplasms
The relationship between RASSF1A promoter methylation and thyroid carcinoma: A meta-analysis of 14 articles and a bioinformatics of 2 databases (PRISMA).
Neoplasms
The RNA-binding protein DDX1 promotes primary microRNA maturation and inhibits ovarian tumor progression.
Neoplasms
The RNA-Binding Protein DDX18 Promotes Gastric Cancer by Affecting the Maturation of MicroRNA-21.
Neoplasms
The role of an immune signature for prognosis and immunotherapy response in endometrial cancer.
Neoplasms
The role of ARHGAP9: clinical implication and potential function in acute myeloid leukemia.
Neoplasms
The role of CCR2 in prognosis of patients with endometrial cancer and tumor microenvironment remodeling.
Neoplasms
The Role of CHK1 Varies with the Status of Oestrogen-receptor and Progesterone-receptor in the Targeted Therapy for Breast Cancer.
Neoplasms
The Role of DNA/Histone Modifying Enzymes and Chromatin Remodeling Complexes in Testicular Germ Cell Tumors.
Neoplasms
The Role of Early Growth Response Family Members 1-4 in Prognostic Value of Breast Cancer.
Neoplasms
The role of ferroptosis regulators in the prognosis, immune activity and gemcitabine resistance of pancreatic cancer.
Neoplasms
The Role of Fibrinogen-Like Protein 2 on Immunosuppression and Malignant Progression in Glioma.
Neoplasms
The role of FOXD2-AS1 in cancer: a comprehensive study based on data mining and published articles.
Neoplasms
The Role of High-Risk Human Papillomavirus-Related Long Non-Coding RNAs in the Prognosis of Cervical Squamous Cell Carcinoma.
Neoplasms
The Role of Interleukin-33 in Head and Neck Squamous Cell Carcinoma Is Determined by Its Cellular Sources in the Tumor Microenvironment.
Neoplasms
The role of IRAK1 in breast cancer patients treated with neoadjuvant chemotherapy.
Neoplasms
The role of lncRNA CASC2 on prognosis of malignant tumors: a meta-analysis and bioinformatics.
Neoplasms
The Role of Lysosome-associated Membrane Protein 2 in Prostate Cancer Chemopreventive Mechanisms of Sulforaphane.
Neoplasms
The role of miR-106p-5p in cervical cancer: from expression to molecular mechanism.
Neoplasms
The role of miR-122 in the dysregulation of glucose-6-phosphate dehydrogenase (G6PD) expression in hepatocellular cancer.
Neoplasms
The Role of N6-Methyladenosine Methylation in the Progression of Endometrial Cancer.
Neoplasms
The Role of Serine Peptidase Inhibitor Kazal Type 13 (SPINK13) as a Clinicopathological and Prognostic Biomarker in Patients with Clear Cell Renal Cell Carcinoma.
Neoplasms
The Role of Significantly Deregulated MicroRNAs in Recurrent Cervical Cancer Based on Bioinformatic Analysis of the Cancer Genome Atlas Data.
Neoplasms
The role of tandem duplicator phenotype in tumour evolution in high-grade serous ovarian cancer.
Neoplasms
The Role of Upregulated DDX11 as A Potential Prognostic and Diagnostic Biomarker in Lung Adenocarcinoma.
Neoplasms
The role of upregulated miR-375 expression in breast cancer: An in vitro and in silico study.
Neoplasms
The role of visfatin in cancer proliferation, angiogenesis, metastasis, drug resistance and clinical prognosis.
Neoplasms
The roles and prognostic significance of ABI1-TSV-11 expression in patients with left-sided colorectal cancer.
Neoplasms
The rs599839 A>G Variant Disentangles Cardiovascular Risk and Hepatocellular Carcinoma in NAFLD Patients.
Neoplasms
The SARS-CoV-2 host cell receptor ACE2 correlates positively with immunotherapy response and is a potential protective factor for cancer progression.
Neoplasms
The shape of gene expression distributions matter: how incorporating distribution shape improves the interpretation of cancer transcriptomic data.
Neoplasms
The shortest path is not the one you know: application of biological network resources in precision oncology research.
Neoplasms
The signature lncRNAs associated with the lung adenocarcinoma patients prognosis.
Neoplasms
The significance of m6A RNA methylation regulators in predicting the prognosis and clinical course of HBV-related hepatocellular carcinoma.
Neoplasms
The silencing of FNDC1 inhibits the tumorigenesis of breast cancer cells via modulation of the PI3K/Akt signaling pathway.
Neoplasms
The SLC Family Are Candidate Diagnostic and Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma.
Neoplasms
The SMART App: an interactive web application for comprehensive DNA methylation analysis and visualization.
Neoplasms
The Solute Carrier Family 2 Genes Are Potential Prognostic Biomarkers in Acute Myeloid Leukemia.
Neoplasms
The Somatic Mutation Landscape and RNA Prognostic Markers in Stomach Adenocarcinoma.
Neoplasms
The Superior Ability of Human BDCA3+ (CD141+) Dendritic Cells (DCs) to Cross-Present Antigens Derived From Necrotic Lung Cancer Cells.
Neoplasms
The TCP1 ring complex is associated with malignancy and poor prognosis in hepatocellular carcinoma.
Neoplasms
The ternary complex factor protein ELK1 is an independent prognosticator of disease recurrence in prostate cancer.
Neoplasms
The TERT hypermethylated oncologic region predicts recurrence and survival in pancreatic cancer.
Neoplasms
The Thyroid Hormone Receptor-RUNX2 Axis: A Novel Tumor Suppressive Pathway in Breast Cancer.
Neoplasms
The TNF receptor family member Fn14 is highly expressed in recurrent glioblastoma and in GBM patient-derived xenografts with acquired temozolomide resistance.
Neoplasms
The transcription factor CBFB mutations indicate an improved survival in HR+/HER2- breast cancer.
Neoplasms
The transcription factor PPAR? is overexpressed and is associated with a favourable prognosis in IDH-wildtype primary glioblastoma.
Neoplasms
The transcription factor RUNX2 fuels YAP1 signaling and gastric cancer tumorigenesis.
Neoplasms
The transcription factor USF1 promotes glioma cell invasion and migration by activating lncRNA HAS2-AS1.
Neoplasms
The transcription levels and prognostic values of seven proteasome alpha subunits in human cancers.
Neoplasms
The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma.
Neoplasms
The transcriptional landscape of lncRNAs reveals the oncogenic function of LINC00511 in ER-negative breast cancer.
Neoplasms
The transcriptome-wide landscape of molecular subtype-specific mRNA expression profiles in acute myeloid leukemia.
Neoplasms
The transcriptomic and proteomic landscapes of bone marrow and secondary lymphoid tissues.
Neoplasms
The tumor immune microenvironment transcriptomic subtypes of colorectal cancer for prognosis and development of precise immunotherapy.
Neoplasms
The tumor immune microenvironmental analysis of 2,033 transcriptomes across 7 cancer types.
Neoplasms
The tumor microenvironment strongly impacts master transcriptional regulators and gene expression class of glioblastoma.
Neoplasms
The tumor suppressive effect of long non-coding RNA FRMD6-AS2 in uteri corpus endometrial carcinoma.
Neoplasms
The Tumor Suppressive Roles and Prognostic Values of STEAP Family Members in Breast Cancer.
Neoplasms
The tumor suppressor prostate apoptosis response-4 (Par-4) is regulated by mutant IDH1 and kills glioma stem cells.
Neoplasms
The Tumor Suppressor SASH1 Interacts With the Signal Adaptor CRKL to Inhibit Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer.
Neoplasms
The ubiquitin ligase TRIM25 inhibits hepatocellular carcinoma progression by targeting metastasis associated 1 protein.
Neoplasms
The ubiquitin-associated (UBA) domain of SCCRO/DCUN1D1 protein serves as a feedback regulator of biochemical and oncogenic activity.
Neoplasms
The Ubiquitin-Specific Peptidase USP18 Promotes Lipolysis, Fatty Acid Oxidation, and Lung Cancer Growth.
Neoplasms
The underlying pathophysiology association between the Type 2-diabetic and hepatocellular carcinoma.
Neoplasms
The up-regulation of Myb may help mediate EGCG inhibition effect on mouse lung adenocarcinoma.
Neoplasms
The Updated AJCC/TNM Staging System for Papillary Thyroid Cancer (8th Edition): From the Perspective of Genomic Analysis.
Neoplasms
The upregulation of hypoxia-related miRNA 210 in primary tumor of lymphogenic metastatic prostate cancer.
Neoplasms
The upregulation of PYCR2 is associated with aggressive colon cancer progression and a poor prognosis.
Neoplasms
The urokinase-type plasminogen activator and inhibitors in resectable lung adenocarcinoma.
Neoplasms
The use of a next-generation sequencing-derived machine-learning risk-prediction model (OncoCast-MPM) for malignant pleural mesothelioma: a retrospective study.
Neoplasms
The USP10-HDAC6 axis confers cisplatin resistance in non-small cell lung cancer lacking wild-type p53.
Neoplasms
The USP21/YY1/SNHG16 axis contributes to tumor proliferation, migration, and invasion of non-small-cell lung cancer.
Neoplasms
The utility of regional cancer mortality data for identifying occupations at high risk.
Neoplasms
The value of Angipoietin-2 as a biomarker for the prognosis of osteosarcoma: A protocol for systematic review and meta-analysis.
Neoplasms
The variable association between expression and methylation of estrogen receptors and the survival of patients with different tumors.
Neoplasms
The X-linked tumor suppressor TSPX downregulates cancer-drivers/oncogenes in prostate cancer in a C-terminal acidic domain dependent manner.
Neoplasms
The Y-linked proto-oncogene TSPY contributes to poor prognosis of the male hepatocellular carcinoma patients by promoting the pro-oncogenic and suppressing the anti-oncogenic gene expression.
Neoplasms
The YAP1-NMU Axis Is Associated with Pancreatic Cancer Progression and Poor Outcome: Identification of a Novel Diagnostic Biomarker and Therapeutic Target.
Neoplasms
The YTH Domain Family of N6-Methyladenosine "Readers" in the Diagnosis and Prognosis of Colonic Adenocarcinoma.
Neoplasms
Theoretical and in silico Analyses Reveal MYC as a Dynamic Network Biomarker in Colon and Rectal Cancer.
Neoplasms
Therapeutic CK2 inhibition attenuates diverse prosurvival signaling cascades and decreases cell viability in human breast cancer cells.
Neoplasms
Therapeutic insights from genomic studies of head and neck squamous cell carcinomas.
Neoplasms
Therapeutic potential of anti-VEGF receptor 2 therapy targeting for M2-tumor-associated macrophages in colorectal cancer.
Neoplasms
Therapeutic potential of the human endogenous retroviral envelope protein HEMO: a pan-cancer analysis.
Neoplasms
Therapeutic Small Molecules Target Inhibitor of Apoptosis Proteins in Cancers with Deregulation of Extrinsic and Intrinsic Cell Death Pathways.
Neoplasms
Therapeutic Targeting of AXL Receptor Tyrosine Kinase Inhibits Tumor Growth and Intraperitoneal Metastasis in Ovarian Cancer Models.
Neoplasms
Therapeutic Targeting of Histone Modifications in Adult and Pediatric High-Grade Glioma.
Neoplasms
The DNA methylation landscape of PD-1 (PDCD1) and adjacent lncRNA AC131097.3 in head and neck squamous cell carcinoma.
Neoplasms
Thirty biologically interpretable clusters of transcription factors distinguish cancer type.
Neoplasms
Three Biomarkers Predict Gastric Cancer Patients' Susceptibility To Fluorouracil-based Chemotherapy.
Neoplasms
Three differential expression profiles of miRNAs as potential biomarkers for lung adenocarcinoma.
Neoplasms
Three differentially expressed miRNAs as potential biomarkers for lung adenocarcinoma prognosis.
Neoplasms
Three Immune-Associated Subtypes of Diffuse Glioma Differ in Immune Infiltration, Immune Checkpoint Molecules, and Prognosis.
Neoplasms
Three-antibody classifier for muscle invasive urothelial carcinoma and its correlation with p53 expression.
Neoplasms
Three-dimensional atlas of lymph node topography based on the visible human data set.
Neoplasms
Three-lncRNA signature is a potential prognostic biomarker for pancreatic adenocarcinoma.
Neoplasms
Three-microRNA expression signature predicts survival in triple-negative breast cancer.
Neoplasms
Threonine Tyrosine Kinase Inhibition Eliminates Lung Cancers by Augmenting Apoptosis and Polyploidy.
Neoplasms
Thrombospondin 2 promotes tumor metastasis by inducing matrix metalloproteinase-13 production in lung cancer cells.
Neoplasms
Thrombospondin 2/Toll-Like Receptor 4 Axis Contributes to HIF-1?-Derived Glycolysis in Colorectal Cancer.
Neoplasms
Thrombospondin-1 is a prognostic biomarker and is correlated with tumor immune microenvironment in glioblastoma.
Neoplasms
Thymosin beta 10 is overexpressed and associated with unfavorable prognosis in hepatocellular carcinoma.
Neoplasms
Thyrotroph embryonic factor is downregulated in bladder cancer and suppresses proliferation and tumorigenesis via the AKT/FOXOs signalling pathway.
Neoplasms
Tight Junction Protein 1 Dysfunction Contributes to Cell Motility in Bladder Cancer.
Neoplasms
TIGIT and PD-1 Immune Checkpoint Pathways Are Associated With Patient Outcome and Anti-Tumor Immunity in Glioblastoma.
Neoplasms
TIGIT-related transcriptome profile and its association with tumor immune microenvironment in breast cancer.
Neoplasms
TIM-3 as a Prognostic Marker and a Potential Immunotherapy Target in Human Malignant Tumors: A Meta-Analysis and Bioinformatics Validation.
Neoplasms
Tim-3 promotes cell aggressiveness and paclitaxel resistance through NF-?B/STAT3 signalling pathway in breast cancer cells.
Neoplasms
Time to recurrence and survival in serous ovarian tumors predicted from integrated genomic profiles.
Neoplasms
Time-Varying Differential Network Analysis for Revealing Network Rewiring over Cancer Progression.
Neoplasms
TISCH: a comprehensive web resource enabling interactive single-cell transcriptome visualization of tumor microenvironment.
Neoplasms
Tissue Proteome Analysis of Different Grades of Human Gliomas Provides Major Cues for Glioma Pathogenesis.
Neoplasms
Tissue-resident memory T cells correlate with the inflammatory tumor microenvironment and improved prognosis in head and neck squamous cell carcinoma.
Neoplasms
Tissue-specific isoform switch and DNA hypomethylation of the pyruvate kinase PKM gene in human cancers.
Neoplasms
Tissue-specific signaling networks rewired by major somatic mutations in human cancer revealed by proteome-wide discovery.
Neoplasms
TLE2 is associated with favorable prognosis and regulates cell growth and gemcitabine sensitivity in pancreatic cancer.
Neoplasms
TLE3 represses colorectal cancer proliferation by inhibiting MAPK and AKT signaling pathways.
Neoplasms
TLR2 promotes development and progression of human glioma via enhancing autophagy.
Neoplasms
TM4SF1 promotes EMT and cancer stemness via the Wnt/?-catenin/SOX2 pathway in colorectal cancer.
Neoplasms
TMEM100 induces cell death in non?small cell lung cancer via the activation of autophagy and apoptosis.
Neoplasms
TMEM196 hypermethylation as a novel diagnostic and prognostic biomarker for lung cancer.
Neoplasms
TMEM205 Is an Independent Prognostic Factor and Is Associated With Immune Cell Infiltrates in Hepatocellular Carcinoma.
Neoplasms
TMEM213 as a novel prognostic and predictive biomarker for patients with lung adenocarcinoma after curative resection: a study based on bioinformatics analysis.
Neoplasms
TMEM45B, up-regulated in human lung cancer, enhances tumorigenicity of lung cancer cells.
Neoplasms
TMEM52B suppression promotes cancer cell survival and invasion through modulating E-cadherin stability and EGFR activity.
Neoplasms
TMEM88, CCL14 and CLEC3B as prognostic biomarkers for prognosis and palindromia of human hepatocellular carcinoma.
Neoplasms
TMPRSS4 induces invasion and proliferation of prostate cancer cells through induction of Slug and cyclin D1.
Neoplasms
TMSB10 acts as a biomarker and promotes progression of clear cell renal cell carcinoma.
Neoplasms
TNF-? modulates genome-wide redistribution of ?Np63?/TAp73 and NF-?B cREL interactive binding on TP53 and AP-1 motifs to promote an oncogenic gene program in squamous cancer.
Neoplasms
TNF-like ligand 1A is associated with progression and prognosis of human gastric cancer.
Neoplasms
TNFAIP3 inhibits migration and invasion in nasopharyngeal carcinoma by suppressing epithelial mesenchymal transition.
Neoplasms
TNFSF4 (OX40L) expression and survival in locally advanced and metastatic melanoma.
Neoplasms
TNMplot.com: A Web Tool for the Comparison of Gene Expression in Normal, Tumor and Metastatic Tissues.
Neoplasms
TNNT1, negatively regulated by miR-873, promotes the progression of colorectal cancer.
Neoplasms
TNNT2 as a potential biomarker for the progression and prognosis of colorectal cancer.
Neoplasms
To construct a ceRNA regulatory network as prognostic biomarkers for bladder cancer.
Neoplasms
To Develop and Validate the Combination of RNA Methylation Regulators for the Prognosis of Patients with Gastric Cancer.
Neoplasms
Tobacco Smoke and Electronic Cigarette Vapor Alter Enhancer RNA Expression That Can Regulate the Pathogenesis of Lung Squamous Cell Carcinoma.
Neoplasms
Tobacco Smoking-Associated Alterations in the Immune Microenvironment of Squamous Cell Carcinomas.
Neoplasms
TOD-CUP: a gene expression rank-based majority vote algorithm for tissue origin diagnosis of cancers of unknown primary.
Neoplasms
Toll-like receptor 2 (TLR2) is a candidate prognostic factor in testicular germ cell tumors as well as an indicator of immune function in the tumor microenvironment.
Neoplasms
Toll-Like Receptor 4 as a Favorable Prognostic Marker in Bladder Cancer: A Multi-Omics Analysis.
Neoplasms
Toll-like receptors 7 and 8 expression correlates with the expression of immune biomarkers and positively predicts the clinical outcome of patients with melanoma.
Neoplasms
Tools for translational epigenetic studies involving formalin-fixed paraffin-embedded human tissue: applying the Infinium HumanMethyation450 Beadchip assay to large population-based studies.
Neoplasms
TOOme: A Novel Computational Framework to Infer Cancer Tissue-of-Origin by Integrating Both Gene Mutation and Expression.
Neoplasms
Topographic correlates of driver mutations and endogenous gene expression in pediatric diffuse midline gliomas and hemispheric high-grade gliomas.
Neoplasms
Topoisomerase II-binding protein 1 promotes the progression of prostate cancer via ATR-CHK1 signaling pathway.
Neoplasms
Topological integration of RPPA proteomic data with multi-omics data for survival prediction in breast cancer via pathway activity inference.
Neoplasms
Topological Tumor Graphs: A Graph-Based Spatial Model to Infer Stromal Recruitment for Immunosuppression in Melanoma Histology.
Neoplasms
Toponostics of invasive ductal breast carcinoma: combination of spatial protein expression imaging and quantitative proteome signature analysis.
Neoplasms
Total copy number variation as a prognostic factor in adult astrocytoma subtypes.
Neoplasms
Toward atlas-assisted automatic interpretation of MRI morphological brain scans in the presence of tumor.
Neoplasms
Toward predicting metastatic progression of melanoma based on gene expression data.
Neoplasms
Toward the precision breast cancer survival prediction utilizing combined whole genome-wide expression and somatic mutation analysis.
Neoplasms
Towards clinically more relevant dissection of patient heterogeneity via survival-based Bayesian clustering.
Neoplasms
Towards precision medicine-based therapies for glioblastoma: interrogating human disease genomics and mouse phenotypes.
Neoplasms
Toxicogenomic outcomes predictive of forestomach carcinogenesis following exposure to benzo(a)pyrene: Relevance to human cancer risk.
Neoplasms
TP53 and CDKN2A mutations in patients with early-stage lung squamous cell carcinoma: an analysis of the correlations and prognostic outcomes.
Neoplasms
TP53 hot spot mutations in ovarian cancer: selective resistance to microtubule stabilizers in vitro and differential survival outcomes from The Cancer Genome Atlas.
Neoplasms
TP53 missense mutations in PDAC are associated with enhanced fibrosis and an immunosuppressive microenvironment.
Neoplasms
TP53 Mutation and Extraneural Metastasis of Glioblastoma: Insights From an Institutional Experience and Comprehensive Literature Review.
Neoplasms
TP53 Mutation as Potential Negative Predictor for Response of Anti-CTLA-4 Therapy in Metastatic Melanoma.
Neoplasms
TP53 Mutation Related and Directly Regulated lncRNA Prognosis Markers in Hepatocellular Carcinoma.
Neoplasms
TP53 Mutational Status-Based Genomic Signature for Prognosis and Predicting Therapeutic Response in Pancreatic Cancer.
Neoplasms
TP53 mutations and CDKN2A mutations/deletions are highly recurrent molecular alterations in the malignant progression of sinonasal papillomas.
Neoplasms
TP53 mutations as potential prognostic markers for specific cancers: analysis of data from The Cancer Genome Atlas and the International Agency for Research on Cancer TP53 Database.
Neoplasms
TP53 Mutations in Head and Neck Squamous Cell Carcinoma and Their Impact on Disease Progression and Treatment Response.
Neoplasms
TP53 Mutations Predict Sensitivity to Adjuvant Gemcitabine in Patients with Pancreatic Ductal Adenocarcinoma: Next-Generation Sequencing Results from the CONKO-001 Trial.
Neoplasms
TP53 mutations, tetraploidy and homologous recombination repair defects in early stage high-grade serous ovarian cancer.
Neoplasms
TP53 oncomorphic mutations predict resistance to platinum? and taxane?based standard chemotherapy in patients diagnosed with advanced serous ovarian carcinoma.
Neoplasms
TP53 protein levels, RNA-based pathway assessment, and race among invasive breast cancer cases.
Neoplasms
TP53 Status, Patient Sex, and the Immune Response as Determinants of Lung Cancer Patient Survival.
Neoplasms
TP53, ATRX alterations, and low tumor mutation load feature IDH-wildtype giant cell glioblastoma despite exceptional ultra-mutated tumors.
Neoplasms
TP73 is a credible biomarker for predicting clinical progression and prognosis in cervical cancer patients.
Neoplasms
TPX2 as a prognostic indicator and potential therapeutic target in clear cell renal cell carcinoma.
Neoplasms
TRAF2 Cooperates with Focal Adhesion Signaling to Regulate Cancer Cell Susceptibility to Anoikis.
Neoplasms
TRAF3/CYLD mutations identify a distinct subset of human papilloma virus-associated head and neck squamous cell carcinoma.
Neoplasms
Transcript Isoform Variation Associated with Cytosine Modification in Human Lymphoblastoid Cell Lines.
Neoplasms
Transcription factor AP-4 (TFAP4)-upstream ORF coding 66 aa inhibits the malignant behaviors of glioma cells by suppressing the TFAP4/long noncoding RNA 00520/microRNA-520f-3p feedback loop.
Neoplasms
Transcription factor E2F4 is an indicator of poor prognosis and is related to immune infiltration in hepatocellular carcinoma.
Neoplasms
Transcription factor networks of oligodendrogliomas treated with adjuvant radiotherapy or observation inform prognosis.
Neoplasms
Transcription factor NRF2 uses the Hippo pathway effector TAZ to induce tumorigenesis in glioblastomas.
Neoplasms
Transcription factor profiling reveals molecular choreography and key regulators of human retrotransposon expression.
Neoplasms
Transcription Factor Profiling to Predict Recurrence-Free Survival in Breast Cancer: Development and Validation of a Nomogram to Optimize Clinical Management.
Neoplasms
Transcription factor RUNX3 promotes CD8+ T cell recruitment by CCL3 and CCL20 in lung adenocarcinoma immune microenvironment.
Neoplasms
Transcription Factors BARX1 and DLX4 Contribute to Progression of Clear Cell Renal Cell Carcinoma via Promoting Proliferation and Epithelial-Mesenchymal Transition.
Neoplasms
Transcription factors CP2 and YY1 as prognostic markers in head and neck squamous cell carcinoma: analysis of The Cancer Genome Atlas and a second independent cohort.
Neoplasms
Transcription of human papillomavirus oncogenes in head and neck squamous cell carcinomas.
Neoplasms
Transcriptional analysis of metastatic uveal melanoma survival nominates NRP1 as a therapeutic target.
Neoplasms
Transcriptional analysis of multiple ovarian cancer cohorts reveals prognostic and immunomodulatory consequences of ERV expression.
Neoplasms
Transcriptional Biomarkers in Oral Cancer: An Integrative Analysis and the Cancer Genome Atlas Validation.
Neoplasms
Transcriptional characterization of immunological infiltrates and their relation with glioblastoma patients overall survival.
Neoplasms
Transcriptional Characterization Of The Tumor Immune Microenvironment And Its Prognostic Value For Locally Advanced Lung Adenocarcinoma In A Chinese Population.
Neoplasms
Transcriptional Enhancer Factor Domain Family member 4 Exerts an Oncogenic Role in Hepatocellular Carcinoma by Hippo-Independent Regulation of Heat Shock Protein 70 Family Members.
Neoplasms
Transcriptional information underlying the generation of CSCs and the construction of a nine-mRNA signature to improve prognosis prediction in colorectal cancer.
Neoplasms
Transcriptional Profiles from Paired Normal Samples Offer Complementary Information on Cancer Patient Survival--Evidence from TCGA Pan-Cancer Data.
Neoplasms
Transcriptional Profiling of Advanced Urothelial Cancer Predicts Prognosis and Response to Immunotherapy.
Neoplasms
Transcriptional profiling revealed the anti-proliferative effect of MFN2 deficiency and identified risk factors in lung adenocarcinoma.
Neoplasms
Transcriptional regulation of Bcl-2 gene by the PR/SET domain family member PRDM10.
Neoplasms
Transcriptional signatures in histologic structures within glioblastoma tumors may predict personalized drug sensitivity and survival.
Neoplasms
Transcriptome Analyses Identify a Metabolic Gene Signature Indicative of Dedifferentiation of Papillary Thyroid Cancer.
Neoplasms
Transcriptome Analyses Identify an RNA Binding Protein Related Prognostic Model for Clear Cell Renal Cell Carcinoma.
Neoplasms
Transcriptome analyses of tumor-adjacent somatic tissues reveal genes co-expressed with transposable elements.
Neoplasms
Transcriptome analysis and prognostic model construction based on splicing profiling in glioblastoma.
Neoplasms
Transcriptome Analysis Identifies ALCAM Overexpression as a Prognosis Biomarker in Laryngeal Squamous Cell Carcinoma.
Neoplasms
Transcriptome analysis of copper homeostasis genes reveals coordinated upregulation of SLC31A1,SCO1, and COX11 in colorectal cancer.
Neoplasms
Transcriptome analysis of distinct long non-coding RNA transcriptional fingerprints in lung adenocarcinoma and squamous cell carcinoma.
Neoplasms
Transcriptome analysis of papillary thyroid cancer harboring telomerase reverse transcriptase promoter mutation.
Neoplasms
Transcriptome Analysis of Recurrently Deregulated Genes across Multiple Cancers Identifies New Pan-Cancer Biomarkers.
Neoplasms
Transcriptome analysis reveals gender-specific differences in overall metabolic response of male and female patients in lung adenocarcinoma.
Neoplasms
Transcriptome analysis reveals GPNMB as a potential therapeutic target for gastric cancer.
Neoplasms
Transcriptome Analysis Reveals Significant Differences in Gene Expression of Malignant Pheochromocytoma or Paraganglioma.
Neoplasms
Transcriptome analysis reveals the effect of oral contraceptive use on cervical cancer.
Neoplasms
Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma.
Neoplasms
Transcriptome Based Estrogen Related Genes Biomarkers for Diagnosis and Prognosis in Non-small Cell Lung Cancer.
Neoplasms
Transcriptome Based System Biology Exploration Reveals Homogeneous Tumorigenicity of Alimentary Tract Malignancy.
Neoplasms
Transcriptome meta-analysis of lung cancer reveals recurrent aberrations in NRG1 and Hippo pathway genes.
Neoplasms
Transcriptome of Tumor-Infiltrating T Cells in Colorectal Cancer Patients Uncovered a Unique Gene Signature in CD4+ T Cells Associated with Poor Disease-Specific Survival.
Neoplasms
Transcriptome profiling and pathway analysis in squamous cell carcinoma of buccal mucosa.
Neoplasms
Transcriptome profiling by combined machine learning and statistical R analysis identifies TMEM236 as a potential novel diagnostic biomarker for colorectal cancer.
Neoplasms
Transcriptome profiling reveals liver metastasis-associated genes in pancreatic ductal adenocarcinoma.
Neoplasms
Transcriptome sequencing identifies key pathways and genes involved in gastric adenocarcinoma.
Neoplasms
Transcriptome sequencing uncovers a three-long noncoding RNA signature in predicting breast cancer survival.
Neoplasms
Transcriptome- and proteome-oriented identification of dysregulated eIF4G, STAT3, and Hippo pathways altered by PIK3CA (H1047R) in HER2/ER-positive breast cancer.
Neoplasms
Transcriptome-Based Co-Expression of BRD4 and PD-1/PD-L1 Predicts Poor Overall Survival in Patients With Acute Myeloid Leukemia.
Neoplasms
Transcriptome-based signature predicts the effect of taxol in serous ovarian cancer.
Neoplasms
Transcriptome-based stemness indices analysis reveals platinum-based chemo-theraputic response indicators in advanced-stage serous ovarian cancer.
Neoplasms
Transcriptome-wide analysis and modelling of prognostic alternative splicing signatures in invasive breast cancer: a prospective clinical study.
Neoplasms
Transcriptome-wide analysis of alternative mRNA splicing signature in the diagnosis and prognosis of stomach adenocarcinoma.
Neoplasms
Transcriptome-wide identification and study of cancer-specific splicing events across multiple tumors.
Neoplasms
Transcriptomic analyses of RNA-binding proteins reveal eIF3c promotes cell proliferation in hepatocellular carcinoma.
Neoplasms
Transcriptomic analysis links hepatocellular carcinoma (HCC) in HZE ion irradiated mice to a human HCC subtype with favorable outcomes.
Neoplasms
Transcriptomic Analysis of Glycolysis-Related Genes Reveals an Independent Signature of Bladder Carcinoma.
Neoplasms
Transcriptomic analysis of the aquaporin gene family and associated interactors in rectal cancer.
Neoplasms
Transcriptomic analysis reveals key lncRNAs associated with ribosomal biogenesis and epidermis differentiation in head and neck squamous cell carcinoma.
Neoplasms
Transcriptomic analysis reveals that heat shock protein 90? is a potential diagnostic and prognostic biomarker for cancer.
Neoplasms
Transcriptomic analysis reveals tumor stage- or grade-dependent expression of miRNAs in serous ovarian cancer.
Neoplasms
Transcriptomic and Clinical Characterization of Neuropeptide Y Expression in Localized and Metastatic Prostate Cancer: Identification of Novel Prostate Cancer Subtype with Clinical Implications.
Neoplasms
Transcriptomic and functional network features of lung squamous cell carcinoma through integrative analysis of GEO and TCGA data.
Neoplasms
Transcriptomic and Proteomic Analysis of Steatohepatitic Hepatocellular Carcinoma Reveals Novel Distinct Biologic Features.
Neoplasms
Transcriptomic characterization and innovative molecular classification of clear cell renal cell carcinoma in the Chinese population.
Neoplasms
Transcriptomic heterogeneity of driver gene mutations reveals novel mutual exclusivity and improves exploration of functional associations.
Neoplasms
Transcriptomic model-based lncRNAs and mRNAs serve as independent prognostic indicators in head and neck squamous cell carcinoma.
Neoplasms
Transcriptomic Profile of Lymphovascular Invasion, a Known Risk Factor of Pancreatic Ductal Adenocarcinoma Metastasis.
Neoplasms
Transcriptomic profiling identifies a DNA repair-related signature as a novel prognostic marker in lower-grade gliomas.
Neoplasms
Transcriptomic profiling of Forkhead box transcription factors in adult glioblastoma multiforme.
Neoplasms
Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort study.
Neoplasms
Transcriptomics analysis for the identification of potential age-related genes and cells associated with three major urogenital cancers.
Neoplasms
Transcriptomics-based validation of the relatedness of heterogeneous nuclear ribonucleoproteins to chronic lymphocytic leukemia as potential biomarkers of the disease aggressiveness.
Neoplasms
Transfer-RNA-Derived Fragments Are Potential Prognostic Factors in Patients with Squamous Cell Carcinoma of the Head and Neck.
Neoplasms
Transforming Growth Factor Beta Promotes Liver Tumorigenesis in Mice via Upregulation of Snail.
Neoplasms
Transgelin-2 expression in breast cancer and its relationships with clinicopathological features and patient outcome.
Neoplasms
Translational Bioinformatics and Clinical Research (Biomedical) Informatics.
Neoplasms
Translational genomics in pancreatic ductal adenocarcinoma: A review with re-analysis of TCGA dataset.
Neoplasms
Translational validation of personalized treatment strategy based on genetic characteristics of glioblastoma.
Neoplasms
Transmembrane Channel-Like 5 (TMC5) promotes prostate cancer cell proliferation through cell cycle regulation.
Neoplasms
Transmembrane protein 92 performs a tumor-promoting function in breast carcinoma by contributing to the cell growth, invasion, migration and epithelial-mesenchymal transition.
Neoplasms
Transmembrane protein DCBLD2 is correlated with poor prognosis and affects phenotype by regulating epithelial-mesenchymal transition in human glioblastoma cells.
Neoplasms
Transmembrane protein GRINA modulates aerobic glycolysis and promotes tumor progression in gastric cancer.
Neoplasms
Transnasal Endoscopic Biopsy Approach to Atlas Tumor with X-ray Assisted and Related Radiographic Measure.
Neoplasms
Transoral approach for percutaneous vertebroplasty in the treatment of osteolytic tumor lesions of the lateral mass of the atlas: feasibility and initial experience in 2 patients.
Neoplasms
Transposable Element Expression in Acute Myeloid Leukemia Transcriptome and Prognosis.
Neoplasms
Transposable element expression in tumors is associated with immune infiltration and increased antigenicity.
Neoplasms
Transposon mutagenesis screen in mice identifies TM9SF2 as a novel colorectal cancer oncogene.
Neoplasms
Trastuzumab upregulates PD-L1 as a potential mechanism of trastuzumab resistance through engagement of immune effector cells and stimulation of IFN? secretion.
Neoplasms
TRBV and TRBJ usage, when paired with specific HLA alleles, associates with distinct head and neck cancer survival rates.
Neoplasms
Treatment Response Monitoring in Patients with Advanced Malignancies Using Cell-Free SHOX2 and SEPT9 DNA Methylation in Blood: An Observational Prospective Study.
Neoplasms
Tree-based machine learning algorithms identified minimal set of miRNA biomarkers for breast cancer diagnosis and molecular subtyping.
Neoplasms
TRGAted: A web tool for survival analysis using protein data in the Cancer Genome Atlas.
Neoplasms
Tribbles pseudokinase 3 (TRIB3) contributes to the progression of hepatocellular carcinoma by activating the mitogen-activated protein kinase pathway.
Neoplasms
Tribbles Pseudokinase 3 Contributes to Cancer Stemness of Endometrial Cancer Cells by Regulating ?-Catenin Expression.
Neoplasms
tRic: a user-friendly data portal to explore the expression landscape of tRNAs in human cancers.
Neoplasms
TRIM2 downregulation in clear cell renal cell carcinoma affects cell proliferation, migration, and invasion and predicts poor patients' survival.
Neoplasms
TRIM25 blockade by RNA interference inhibited migration and invasion of gastric cancer cells through TGF-? signaling.
Neoplasms
TRIM27 interacts with I?b? to promote the growth of human renal cancer cells through regulating the NF-?B pathway.
Neoplasms
TRIM28 is a distinct prognostic biomarker that worsens the tumor immune microenvironment in lung adenocarcinoma.
Neoplasms
TRIM33 Overexpression Inhibits the Progression of Clear Cell Renal Cell Carcinoma In Vivo and In Vitro.
Neoplasms
TRIM59 as a novel molecular biomarker to predict the prognosis of patients with NSCLC.
Neoplasms
TRIM65 supports bladder urothelial carcinoma cell aggressiveness by promoting ANXA2 ubiquitination and degradation.
Neoplasms
TRIP12 as a mediator of human papillomavirus/p16-related radiation enhancement effects.
Neoplasms
TRIP13 promotes lung cancer cell growth and metastasis through AKT/mTORC1/c-Myc signaling.
Neoplasms
Tripartite motif-containing 15 overexpression in non-small cell lung cancer is associated with poor patient prognoses.
Neoplasms
Triple-high expression of phosphatase and tensin homolog (PTEN), estrogen receptor (ER) and progesterone receptor (PR) may predict favorable prognosis for patients with Type I endometrial carcinoma.
Neoplasms
Triple-Negative Breast Cancer with High Levels of Annexin A1 Expression Is Associated with Mast Cell Infiltration, Inflammation, and Angiogenesis.
Neoplasms
Triptolide inhibits pancreatic cancer cell proliferation and migration via down-regulating PLAU based on network pharmacology of Tripterygium wilfordii Hook F.
Neoplasms
tRNA Fragments Show Intertwining with mRNAs of Specific Repeat Content and Have Links to Disparities.
Neoplasms
Trop2 enhances invasion of thyroid cancer by inducing MMP2 through ERK and JNK pathways.
Neoplasms
Trophinin Is an Important Biomarker and Prognostic Factor in Osteosarcoma: Data Mining from Oncomine and the Cancer Genome Atlas Databases.
Neoplasms
Trophinin-associated protein expression is an independent prognostic biomarker in lung adenocarcinoma.
Neoplasms
TRPM4 is overexpressed in breast cancer associated with estrogen response and epithelial-mesenchymal transition gene sets.
Neoplasms
TRPV4 is a Prognostic Biomarker that Correlates with the Immunosuppressive Microenvironment and Chemoresistance of Anti-Cancer Drugs.
Neoplasms
Truncation- and motif-based pan-cancer analysis reveals tumor-suppressing kinases.
Neoplasms
Tryptophan 2, 3?dioxygenase promotes proliferation, migration and invasion of ovarian cancer cells.
Neoplasms
Tryptophanyl-tRNA synthetase (WARS) expression in uveal melanoma - possible contributor during uveal melanoma progression.
Neoplasms
TSDLPP: A Novel Two-stage Deep Learning Framework for Prognosis Prediction Based on Whole Slide Histopathological Images.
Neoplasms
TSGene 2.0: an updated literature-based knowledgebase for tumor suppressor genes.
Neoplasms
TSNAdb: A Database for Tumor-specific Neoantigens from Immunogenomics Data Analysis.
Neoplasms
TSP50 promotes hepatocyte proliferation and tumour formation by activating glucose-6-phosphate dehydrogenase (G6PD).
Neoplasms
Tsukushi is a novel prognostic biomarker and correlates with tumor-infiltrating B cells in non-small cell lung cancer.
Neoplasms
TTPAL Promotes Colorectal Tumorigenesis by Stabilizing TRIP6 to Activate Wnt/?-Catenin Signaling.
Neoplasms
Tumor Atlas of the Gastrointestinal Tract: The Duodenum, Small Intestine and Colon.
Neoplasms
Tumor CDKN2A-Associated JAK2 Loss and Susceptibility to Immunotherapy Resistance.
Neoplasms
Tumor cell-imposed iron restriction drives immunosuppressive polarization of tumor-associated macrophages.
Neoplasms
Tumor cells in light-chain amyloidosis and myeloma show different transcriptional rewiring of normal plasma cell development.
Neoplasms
Tumor copy-number alterations predict response to immune-checkpoint-blockade in gastrointestinal cancer.
Neoplasms
Tumor Expression Profile Analysis Developed and Validated a Prognostic Model Based on Immune-Related Genes in Bladder Cancer.
Neoplasms
Tumor Fibroblast Growth Factor Receptor 4 Level Predicts the Efficacy of Lenvatinib in Patients With Advanced Hepatocellular Carcinoma.
Neoplasms
Tumor fitness, immune exhaustion and clinical outcomes: impact of immune checkpoint inhibitors.
Neoplasms
Tumor genotype and immune microenvironment in POLE-ultramutated and MSI-hypermutated Endometrial Cancers: New candidates for checkpoint blockade immunotherapy?
Neoplasms
Tumor Habitat-derived Radiomic Features at Pretreatment MRI That Are Prognostic for Progression-free Survival in Glioblastoma Are Associated with Key Morphologic Attributes at Histopathologic Examination: A Feasibility Study.
Neoplasms
Tumor hepatitis B virus RNA identifies a clinically and molecularly distinct subset of hepatocellular carcinoma.
Neoplasms
Tumor Heterogeneity Correlates with Less Immune Response and Worse Survival in Breast Cancer Patients.
Neoplasms
Tumor image-derived texture features are associated with CD3 T-cell infiltration status in glioblastoma.
Neoplasms
Tumor Immune Microenvironment Clusters in Localized Prostate Adenocarcinoma: Prognostic Impact of Macrophage Enriched/Plasma Cell Non-Enriched Subtypes.
Neoplasms
Tumor immune microenvironment-based classifications of bladder cancer for enhancing the response rate of immunotherapy.
Neoplasms
Tumor immune profiles noninvasively estimated by FDG PET with deep learning correlate with immunotherapy response in lung adenocarcinoma.
Neoplasms
Tumor Immunometabolism Characterization in Ovarian Cancer With Prognostic and Therapeutic Implications.
Neoplasms
Tumor Infiltrating Lymphocytes and Macrophages Improve Survival in Microsatellite Unstable Colorectal Cancer.
Neoplasms
Tumor infiltrating lymphocytes associated competitive endogenous RNA networks as predictors of outcome in hepatic carcinoma based on WGCNA analysis.
Neoplasms
Tumor Infiltrating Lymphocytes Signature as a New Pan-Cancer Predictive Biomarker of Anti PD-1/PD-L1 Efficacy.
Neoplasms
Tumor infiltrating plasma cells are associated with tertiary lymphoid structures, cytolytic T cell responses, and superior prognosis in ovarian cancer.
Neoplasms
Tumor Microenvironment Analysis Identified Subtypes Associated With the Prognosis and the Tumor Response to Immunotherapy in Bladder Cancer.
Neoplasms
Tumor Microenvironment Characteristics of Pancreatic Cancer to Determine Prognosis and Immune-Related Gene Signatures.
Neoplasms
Tumor Microenvironment Characterization in Glioblastoma Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures.
Neoplasms
Tumor microenvironment evaluation promotes precise checkpoint immunotherapy of advanced gastric cancer.
Neoplasms
Tumor microenvironment immune-related lncRNA signature for patients with melanoma.
Neoplasms
Tumor microenvironment is associated with clinical and genetic properties of diffuse gliomas and predicts overall survival.
Neoplasms
Tumor Microenvironment Properties are Associated With Low CD68-positive Cell Infiltration and Favorable Disease-free Survival in EGFR-mutant Lung Adenocarcinoma.
Neoplasms
Tumor microenvironment related novel signature predict lung adenocarcinoma survival.
Neoplasms
Tumor Microenvironment Subtypes and Immune-Related Signatures for the Prognosis of Breast Cancer.
Neoplasms
Tumor Microenvironment-Associated Immune-Related Genes for the Prognosis of Malignant Pleural Mesothelioma.
Neoplasms
Tumor Microenvironmental Competitive Endogenous RNA Network and Immune Cells Act as Robust Prognostic Predictor of Acute Myeloid Leukemia.
Neoplasms
Tumor Molecular Features Predict Endometrial Cancer Patients' Survival After Open or Minimally Invasive Surgeries.
Neoplasms
Tumor mutation burden (TMB)-associated signature constructed to predict survival of lung squamous cell carcinoma patients.
Neoplasms
Tumor Mutation Burden and Immune Invasion Characteristics in Triple Negative Breast Cancer: Genome High-Throughput Data Analysis.
Neoplasms
Tumor mutation burden as a biomarker in resected gastric cancer via its association with immune infiltration and hypoxia.
Neoplasms
Tumor Mutation Burden Computation in Two Pan-Cancer Precision Medicine Next-Generation Sequencing Panels.
Neoplasms
Tumor mutation burden estimated by a 69-gene-panel is associated with overall survival in patients with diffuse large B-cell lymphoma.
Neoplasms
Tumor mutation burden in Chinese cancer patients and the underlying driving pathways of high tumor mutation burden across different cancer types.
Neoplasms
Tumor Mutation Burden Predicts Relapse in Papillary Thyroid Carcinoma With Changes in Genes and Immune Microenvironment.
Neoplasms
Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
Neoplasms
Tumor mutational and indel burden: a systematic pan-cancer evaluation as prognostic biomarkers.
Neoplasms
Tumor Mutational Burden From Tumor-Only Sequencing Compared With Germline Subtraction From Paired Tumor and Normal Specimens.
Neoplasms
Tumor mutational burden is a determinant of immune-mediated survival in breast cancer.
Neoplasms
Tumor mutational burden is polygenic and genetically associated with complex traits and diseases.
Neoplasms
Tumor mutational burden predicts survival in patients with low-grade gliomas expressing mutated IDH1.
Neoplasms
Tumor mutational load and immune parameters across metastatic Renal Cell Carcinoma (mRCC) risk groups.
Neoplasms
Tumor necrosis factor in lung cancer: Complex roles in biology and resistance to treatment.
Neoplasms
Tumor Progression Locus 2 (Tpl2) Kinase Contributes Tumor Growth and Metastasis of Clear Cell Renal Cell Carcinoma.
Neoplasms
Tumor promoting effects of glucagon receptor: a promising biomarker of papillary thyroid carcinoma via regulating EMT and P38/ERK pathways.
Neoplasms
Tumor purity as a prognosis and immunotherapy relevant feature in gastric cancer.
Neoplasms
Tumor RAS Gene Expression Levels Are Influenced by the Mutational Status of RAS Genes and Both Upstream and Downstream RAS Pathway Genes.
Neoplasms
Tumor resident stromal cells promote breast cancer invasion through regulation of the basal phenotype.
Neoplasms
Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast Cancer.
Neoplasms
Tumor Signature Analysis Implicates Hereditary Cancer Genes in Endometrial Cancer Development.
Neoplasms
Tumor specific methylome in Chinese high-grade serous ovarian cancer characterized by gene expression profile and tumor genotype.
Neoplasms
Tumor stem-like cell-derived exosomal RNAs prime neutrophils for facilitating tumorigenesis of colon cancer.
Neoplasms
Tumor subtype-specific cancer-testis antigens as potential biomarkers and immunotherapeutic targets for cancers.
Neoplasms
Tumor Suppressive Role of ARHGAP17 in Colon Cancer Through Wnt/?-Catenin Signaling.
Neoplasms
Tumor suppressor miR-181c attenuates proliferation, invasion, and self-renewal abilities in glioblastoma.
Neoplasms
Tumor suppressor miR-33b-5p regulates cellular function and acts a prognostic biomarker in RCC.
Neoplasms
Tumor suppressor properties of the small C-terminal domain phosphatases in non-small cell lung cancer.
Neoplasms
Tumor Type Agnostic Therapy Carrying BRAF Mutation: Case Reports and Review of Literature.
Neoplasms
Tumor xenograft modeling identifies an association between TCF4 loss and breast cancer chemoresistance.
Neoplasms
Tumor-associated Macrophage-derived Interleukin-23 Interlinks Kidney Cancer Glutamine Addiction with Immune Evasion.
Neoplasms
Tumor-associated macrophages and macrophage-related immune checkpoint expression in sarcomas.
Neoplasms
Tumor-associated macrophages based signaling pathway analysis and hub genes identification in glioma.
Neoplasms
Tumor-Derived Exosomal eIF4E as a Biomarker for Survival Prediction in Patients with Non-Small Cell Lung Cancer.
Neoplasms
Tumor-Infiltrating Lymphoid Cells in Colorectal Cancer Patients with Varying Disease Stages and Microsatellite Instability-High/Stable Tumors.
Neoplasms
Tumor-Infiltrating Neutrophils and Non-Classical Monocytes May Be Potential Therapeutic Targets for HER2negative Gastric Cancer.
Neoplasms
Tumor-infiltrating podoplanin+ cells in gastric cancer: clinical outcomes and association with immune contexture.
Neoplasms
Tumor-Naïve Multimodal Profiling of Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma.
Neoplasms
Tumor-suppressor microRNA-139-5p restrains bladder cancer cell line ECV-304 properties via targeting Connexin 43.
Neoplasms
Tumor-suppressor NF?B2 p100 interacts with ERK2 and stabilizes PTEN mRNA via inhibition of miR-494.
Neoplasms
Tumor-targeted IL-12 combined with tumor resection yields a survival-favorable immune profile.
Neoplasms
Tumorigenesis-related key genes in adolescents and young adults with HR(+)/HER2(-) breast cancer.
Neoplasms
TumorMap: Exploring the Molecular Similarities of Cancer Samples in an Interactive Portal.
Neoplasms
Tumors masquerading as type 2 papillary renal cell carcinoma: pathologists' ever-expanding differential diagnosis for a heterogeneous group of entities.
Neoplasms
Tumors of the atlas. 3 incidental cases of osteochondroma, benign osteoblastoma, and atypical Ewing's sarcoma.
Neoplasms
Tumors of the Central Nervous System (AFIP Atlas of Tumor Pathology, Series 4. Fascicle 7).
Neoplasms
Tumors of the eye and ocular adnexa AFIP atlas of tumor pathology, series 4, fascicle 5.
Neoplasms
Tumors of the Major Salivary Glands. (Fascicle 10, Second Series, Atlas of Tumor Pathology.).
Neoplasms
Tumour heterogeneity revealed by unsupervised decomposition of dynamic contrast-enhanced magnetic resonance imaging is associated with underlying gene expression patterns and poor survival in breast cancer patients.
Neoplasms
Tumour-specific Causal Inference Discovers Distinct Disease Mechanisms Underlying Cancer Subtypes.
Neoplasms
Tumours of the atlas and axis: a 37-year experience with diagnosis and management.
Neoplasms
Tuning Parameter Selection in Cox Proportional Hazards Model with a Diverging Number of Parameters.
Neoplasms
Twist1 and AP-1 cooperatively upregulate integrin ?5 expression to induce invasion and the epithelial-mesenchymal transition.
Neoplasms
TWIST1 transcriptionally regulates glycolytic genes to promote the Warburg metabolism in pancreatic cancer.
Neoplasms
Twist1/2 activates MMP2 expression via binding to its promoter in colorectal cancer.
Neoplasms
Two critical positions in zinc finger domains are heavily mutated in three human cancer types.
Neoplasms
Two immune-enhanced molecular subtypes differ in inflammation, checkpoint signaling and outcome of advanced head and neck squamous cell carcinoma.
Neoplasms
Two immune-enhanced molecular subtypes differ in inflammation, immune checkpoints, mutations, and prognostic outcome in stage I-II colonic carcinoma.
Neoplasms
Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma.
Neoplasms
Two members of the TRiC chaperonin complex, CCT2 and TCP1 are essential for survival of breast cancer cells and are linked to driving oncogenes.
Neoplasms
Two microRNA signatures for malignancy and immune infiltration predict overall survival in advanced epithelial ovarian cancer.
Neoplasms
Two protein-coding genes act as a novel clinical signature to predict prognosis in patients with ovarian serous cystadenocarcinoma.
Neoplasms
TYMS presents a novel biomarker for diagnosis and prognosis in patients with pancreatic cancer.
Neoplasms
Type 1 Insulin-Like Growth Factor Receptor/Insulin Receptor Substrate 1 Signaling Confers Pathogenic Activity on Breast Tumor Cells Lacking REST.
Neoplasms
Tyrosine Kinase c-MET as Therapeutic Target for Radiosensitization of Head and Neck Squamous Cell Carcinomas.
Neoplasms
Tyrosine kinase Eph receptor A6 sensitizes glioma-initiating cells towards bone morphogenetic protein-induced apoptosis.
Neoplasms
U2AF1 mutation promotes tumorigenicity through facilitating autophagy flux mediated by FOXO3a activation in myelodysplastic syndromes.
Neoplasms
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses.
Neoplasms
UBE2C functions as a potential oncogene by enhancing cell proliferation, migration, invasion, and drug resistance in hepatocellular carcinoma cells.
Neoplasms
UBE2C is a Potential Biomarker for Tumorigenesis and Prognosis in Tongue Squamous Cell Carcinoma.
Neoplasms
UBE2D1 RNA Expression Was an Independent Unfavorable Prognostic Indicator in Lung Adenocarcinoma, but Not in Lung Squamous Cell Carcinoma.
Neoplasms
UBE2L3, a susceptibility gene that plays oncogenic role in hepatitis B-related hepatocellular carcinoma.
Neoplasms
UBE2O Promotes Progression and Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma.
Neoplasms
UBE2T promotes autophagy via the p53/AMPK/mTOR signaling pathway in lung adenocarcinoma.
Neoplasms
UBE2T promotes proliferation, invasion and glycolysis of breast cancer cells by regualting the PI3K/AKT signaling pathway.
Neoplasms
UBE2V2 Positively Correlates With PD-L1 Expression and Confers Poor Patient Survival in Lung Adenocarcinoma.
Neoplasms
Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) Promotes Uterine Serous Cancer Cell Proliferation and Cell Cycle Progression.
Neoplasms
Ubiquitin specific peptidase 19 is a prognostic biomarker and affect the proliferation and migration of clear cell renal cell carcinoma.
Neoplasms
Ubiquitin-Like Modifier Activating Enzyme 1 as a Novel Diagnostic and Prognostic Indicator That Correlates With Ferroptosis and the Malignant Phenotypes of Liver Cancer Cells.
Neoplasms
Ubiquitin-like modifier-activating enzyme 7 as a marker for the diagnosis and prognosis of breast cancer.
Neoplasms
Ubiquitin-specific protease-44 inhibits the proliferation and migration of cells via inhibition of JNK pathway in clear cell renal cell carcinoma.
Neoplasms
Ubiquitination of PPAR-gamma by pVHL inhibits ACLY expression and lipid metabolism, is implicated in tumor progression.
Neoplasms
UBN2 promotes tumor progression via the Ras/MAPK pathway and predicts poor prognosis in colorectal cancer.
Neoplasms
UCK2 upregulation might serve as an indicator of unfavorable prognosis of hepatocellular carcinoma.
Neoplasms
UHRF1 promotes aerobic glycolysis and proliferation via suppression of SIRT4 in pancreatic cancer.
Neoplasms
Ultra-mutated colorectal cancer patients with POLE driver mutations exhibit distinct clinical patterns.
Neoplasms
Ultrasensitive immunoprofiling of plasma extracellular vesicles identifies syndecan-1 as a potential tool for minimally invasive diagnosis of glioma.
Neoplasms
Ultraviolet-A radiation induces changes in cyclin G gene expression in mouse melanoma B16-F1 cells.
Neoplasms
Unbalanced YAP-SOX9 circuit drives stemness and malignant progression in esophageal squamous cell carcinoma.
Neoplasms
UNC5B-AS1 promoted ovarian cancer progression by regulating the H3K27me on NDRG2 via EZH2.
Neoplasms
Uncoupling of gene expression from copy number presents therapeutic opportunities in aneuploid cancers.
Neoplasms
Uncovering biomarker genes with enriched classification potential from Hallmark gene sets.
Neoplasms
Uncovering genetic mechanisms of kidney aging through transcriptomics, genomics, and epigenomics.
Neoplasms
Uncovering Prognosis-Related Genes and Pathways by Multi-Omics Analysis in Lung Cancer.
Neoplasms
Uncovering robust patterns of microRNA co-expression across cancers using Bayesian Relevance Networks.
Neoplasms
Uncovering synthetic lethal interactions for therapeutic targets and predictive markers in lung adenocarcinoma.
Neoplasms
Uncovering the Pharmacological Mechanism of 2-Dodecyl-6-Methoxycyclohexa-2,5 -Diene-1,4-Dione Against Lung Cancer Based on Network Pharmacology and Experimental Evaluation.
Neoplasms
Uncovering the potential differentially expressed miRNAs as diagnostic biomarkers for hepatocellular carcinoma based on machine learning in The Cancer Genome Atlas database.
Neoplasms
Uncovering the Subtype-Specific Molecular Characteristics of Breast Cancer by Multiomics Analysis of Prognosis-Associated Genes, Driver Genes, Signaling Pathways, and Immune Activity.
Neoplasms
Underexpression of INPPL1 is associated with aggressive clinicopathologic characteristics in papillary thyroid carcinoma.
Neoplasms
Underexpression of Specific Interferon Genes Is Associated with Poor Prognosis of Melanoma.
Neoplasms
Unexpected cancer-predisposition gene variants in Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome patients without underlying germline PTEN mutations.
Neoplasms
Unforeseen clonal evolution of tumor cell population in recurrent and metastatic dermatofibrosarcoma protuberans.
Neoplasms
Unique DNA methylation signature in HPV-positive head and neck squamous cell carcinomas.
Neoplasms
Unique Genetic and Survival Characteristics of Invasive Mucinous Adenocarcinoma of the Lung.
Neoplasms
Unique genome-wide map of TCF4 and STAT3 targets using ChIP-seq reveals their association with new molecular subtypes of glioblastoma.
Neoplasms
Unique metastasis-associated lncRNA signature optimizes prediction of tumor relapse in lung adenocarcinoma.
Neoplasms
Unique pattern of component gene disruption in the NRF2 inhibitor KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex in serous ovarian cancer.
Neoplasms
Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening.
Neoplasms
Unleashing the full potential of Hsp90 inhibitors as cancer therapeutics through simultaneous inactivation of Hsp90, Grp94, and TRAP1.
Neoplasms
Unraveling the Genomic-Epigenomic Interaction Landscape in Triple Negative and Non-Triple Negative Breast Cancer.
Neoplasms
Unraveling the oral cancer lncRNAome: Identification of novel lncRNAs associated with malignant progression and HPV infection.
Neoplasms
Unravelling the Role of LncRNA WT1-AS/miR-206/NAMPT Axis as Prognostic Biomarkers in Lung Adenocarcinoma.
Neoplasms
Unravelling triple-negative breast cancer molecular heterogeneity using an integrative multiomic analysis.
Neoplasms
Unsupervised Feature Selection Using an Integrated Strategy of Hierarchical Clustering with Singular Value Decomposition: An Integrative Biomarker Discovery Method with Application to Acute Myeloid Leukemia.
Neoplasms
Unsupervised Hierarchical Clustering of Pancreatic Adenocarcinoma Dataset from TCGA Defines a Mucin Expression Profile that Impacts Overall Survival.
Neoplasms
Unsupervised Resolution of Histomorphologic Heterogeneity in Renal Cell Carcinoma Using a Brain Tumor-Educated Neural Network.
Neoplasms
Unveiling new interdependencies between significant DNA methylation sites, gene expression profiles and glioma patients survival.
Neoplasms
Unveiling prognostics biomarkers of tyrosine metabolism reprogramming in liver cancer by cross-platform gene expression analyses.
Neoplasms
Up-regulated long non-coding RNA DUXAP8 promotes cell growth through repressing Krüppel-like factor 2 expression in human hepatocellular carcinoma.
Neoplasms
Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer.
Neoplasms
Up-regulation of ANKDR49, a poor prognostic factor, regulates cell proliferation of gliomas.
Neoplasms
Up-regulation of CKAP2L expression promotes lung adenocarcinoma invasion and is associated with poor prognosis.
Neoplasms
Up-regulation of CTD-2547G23.4 in hepatocellular carcinoma tissues and its prospective molecular regulatory mechanism: a novel qRT-PCR and bioinformatics analysis study.
Neoplasms
Up-regulation of IGF2BP2 by multiple mechanisms in pancreatic cancer promotes cancer proliferation by activating the PI3K/Akt signaling pathway.
Neoplasms
Up-regulation of L Antigen Family Member 3 Associates With Aggressive Progression of Breast Cancer.
Neoplasms
Up-regulation of long non-coding RNA SPRY4-IT1 promotes tumor cell migration and invasion in lung adenocarcinoma.
Neoplasms
Up-regulation of MARVEL domain-containing protein 1 (MARVELD1) accelerated the malignant phenotype of glioma cancer cells via mediating JAK/STAT signaling pathway.
Neoplasms
Up-Regulation of miR-26a-5p Inhibits E2F7 to Regulate the Progression of Renal Carcinoma Cells.
Neoplasms
Up-regulation of REG3A in colorectal cancer cells confers proliferation and correlates with colorectal cancer risk.
Neoplasms
Update on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine Tumours.
Neoplasms
Upgrading the Repertoire of miRNAs in Gastric Adenocarcinoma to Provide a New Resource for Biomarker Discovery.
Neoplasms
Upregulated delta-like protein 3 expression is a diagnostic and prognostic marker in endometrial cancer: A retrospective study.
Neoplasms
Upregulated expression of MMP family genes is associated with poor survival in patients with esophageal squamous cell carcinoma via regulation of proliferation and epithelial?mesenchymal transition.
Neoplasms
Upregulated Expression of TUBA1C Predicts Poor Prognosis and Promotes Oncogenesis in Pancreatic Ductal Adenocarcinoma via Regulating the Cell Cycle.
Neoplasms
Upregulated forkhead-box A3 elevates the expression of forkhead-box A1 and forkhead-box A2 to promote metastasis in esophageal cancer.
Neoplasms
Upregulated GAPLINC predicts a poor prognosis in bladder cancer patients and promotes tumor proliferation and invasion.
Neoplasms
Upregulated glycolysis correlates with tumor progression and immune evasion in head and neck squamous cell carcinoma.
Neoplasms
Upregulated GRB7 promotes proliferation and tumorigenesis of Bladder Cancer via Phospho-AKT Pathway.
Neoplasms
Upregulated KPNA2 promotes hepatocellular carcinoma progression and indicates prognostic significance across human cancer types.
Neoplasms
Upregulated LINC01667 Expression Is Correlated With Poor Prognosis in Hepatocellular Carcinoma.
Neoplasms
Upregulated long intergenic noncoding RNA KRT18P55 acts as a novel biomarker for the progression of intestinal-type gastric cancer.
Neoplasms
Upregulated long non-coding RNA LOC90784 promotes cell proliferation and invasion and is associated with poor clinical features in HCC.
Neoplasms
Upregulated long noncoding RNAs LINC02163 and FEZF1-AS1 exert oncogenic roles in colorectal cancer.
Neoplasms
Upregulated long-non-coding RNA DLEU2 exon 9 expression was an independent indicator of unfavorable overall survival in patients with esophageal adenocarcinoma.
Neoplasms
Upregulated miR-483-5p expression as a prognostic biomarker for esophageal squamous cell carcinoma.
Neoplasms
Upregulated miR?203a?3p and its potential molecular mechanism in breast cancer: A study based on bioinformatics analyses and a comprehensive meta?analysis.
Neoplasms
Upregulated Seizure-Related 6 Homolog-Like 2 Is a Prognostic Predictor of Hepatocellular Carcinoma.
Neoplasms
Upregulated Tripartite Motif 47 Could Facilitate Glioma Cell Proliferation and Metastasis as a Tumorigenesis Promoter.
Neoplasms
Upregulated VEGFA and DLL4 act as potential prognostic genes for clear cell renal cell carcinoma.
Neoplasms
Upregulation of ASPM, BUB1B and SPDL1 in tumor tissues predicts poor survival in patients with pancreatic ductal adenocarcinoma.
Neoplasms
Upregulation of c-MYC in WT1-mutant tumors: assessment of WT1 putative transcriptional targets using cDNA microarray expression profiling of genetically defined Wilms' tumors.
Neoplasms
Upregulation of centromere protein K is crucial for lung adenocarcinoma cell viability and invasion.
Neoplasms
Upregulation of centromere protein M promotes tumorigenesis: A potential predictive target for cancer in humans.
Neoplasms
Upregulation of COL6A1 is predictive of poor prognosis in clear cell renal cell carcinoma patients.
Neoplasms
Upregulation of desmoglein 2 and its clinical value in lung adenocarcinoma: a comprehensive analysis by multiple bioinformatics methods.
Neoplasms
Upregulation of DLEU1 expression by epigenetic modification promotes tumorigenesis in human cancer.
Neoplasms
Upregulation of DLX2 Confers a Poor Prognosis in Glioblastoma Patients by Inducing a Proliferative Phenotype.
Neoplasms
Upregulation of ERCC6L is associated with tumor progression and unfavorable prognosis in hepatocellular carcinoma.
Neoplasms
Upregulation of Excision Repair Cross-Complementation Group 6-Like (ERCC6L) Promotes Tumor Growth in Hepatocellular Carcinoma.
Neoplasms
Upregulation of exosomal microRNA?21 in pancreatic stellate cells promotes pancreatic cancer cell migration and enhances Ras/ERK pathway activity.
Neoplasms
Upregulation of FAM83D promotes malignant phenotypes of lung adenocarcinoma by regulating cell cycle.
Neoplasms
Upregulation of glucosamine-phosphate N-acetyltransferase 1 is a promising diagnostic and predictive indicator for poor survival in patients with lung adenocarcinoma.
Neoplasms
Upregulation of Glutamic-Oxaloacetic Transaminase 1 Predicts Poor Prognosis in Acute Myeloid Leukemia.
Neoplasms
Upregulation of GNPNAT1 Predicts Poor Prognosis and Correlates With Immune Infiltration in Lung Adenocarcinoma.
Neoplasms
Upregulation of GPNCA is associated with poor prognosis through enhancement of tumor growth via regulating GSK3B.
Neoplasms
Upregulation of HOXA1 promotes tumorigenesis and development of non?small cell lung cancer: A comprehensive investigation based on reverse transcription-quantitative polymerase chain reaction and bioinformatics analysis.
Neoplasms
Upregulation of HOXA11 during the progression of lung adenocarcinoma detected via multiple approaches.
Neoplasms
Upregulation of HOXA13 as a potential tumorigenesis and progression promoter of LUSC based on qRT-PCR and bioinformatics.
Neoplasms
Upregulation of KIF20A promotes tumor proliferation and invasion in renal clear cell carcinoma and is associated with adverse clinical outcome.
Neoplasms
Upregulation of LAGE3 correlates with prognosis and immune infiltrates in colorectal cancer: A bioinformatic analysis.
Neoplasms
Upregulation of LIMK1 Is Correlated With Poor Prognosis and Immune Infiltrates in Lung Adenocarcinoma.
Neoplasms
Upregulation of lncRNA AGAP2-AS1 is an independent predictor of poor survival in patients with clear cell renal carcinoma.
Neoplasms
Upregulation of lncRNA CALML3-AS1 promotes cell proliferation and metastasis in cervical cancer via activation of the Wnt/?-catenin pathway.
Neoplasms
Upregulation of lncRNA DARS-AS1 accelerates tumor malignancy in cervical cancer by activating cGMP-PKG pathway.
Neoplasms
Upregulation of Long Non-Coding RNA DRAIC Correlates with Adverse Features of Breast Cancer.
Neoplasms
Upregulation of MIAT Regulates LOXL2 Expression by Competitively Binding MiR-29c in Clear Cell Renal Cell Carcinoma.
Neoplasms
Upregulation of microfibrillar-associated protein 2 is closely associated with tumor angiogenesis and poor prognosis in hepatocellular carcinoma.
Neoplasms
Upregulation of microRNA-31 is associated with poor prognosis in patients with advanced colorectal cancer.
Neoplasms
Upregulation of miR-183-5p predicts worse survival in patients with renal cell cancer after surgery.
Neoplasms
Upregulation of miR-200b Inhibits Hepatocellular Carcinoma Cell Proliferation and Migration by Targeting HMGB3 Protein.
Neoplasms
Upregulation of miR?132?3p in cholangiocarcinoma tissues: A study based on RT?qPCR, The Cancer Genome Atlas miRNA sequencing, Gene Expression Omnibus microarray data and bioinformatics analyses.
Neoplasms
Upregulation of miR?598 promotes cell proliferation and cell cycle progression in human colorectal carcinoma by suppressing INPP5E expression.
Neoplasms
Upregulation of MYBL2 independently predicts a poorer prognosis in patients with clear cell renal cell carcinoma.
Neoplasms
Upregulation of nectin-4 is associated with ITGB1 and vasculogenic mimicry and may serve as a predictor of poor prognosis in colorectal cancer.
Neoplasms
Upregulation of oncogene Activin A receptor type I by Helicobacter pylori infection promotes gastric intestinal metaplasia via regulating CDX2.
Neoplasms
Upregulation of PD-L1 predicts poor prognosis and is associated with miR-191-5p dysregulation in colon adenocarcinoma.
Neoplasms
Upregulation of proline rich 11 is an independent unfavorable prognostic factor for survival of tongue squamous cell carcinoma patients.
Neoplasms
Upregulation Of Protein Tyrosine Phosphatase Receptor Type C Associates To The Combination Of Hashimoto's Thyroiditis And Papillary Thyroid Carcinoma And Is Predictive Of A Poor Prognosis.
Neoplasms
Upregulation of RAC3 in bladder cancer predicts adverse clinical outcome and increased tumor immune response.
Neoplasms
Upregulation of serum exosomal SUMO1P3 predicts unfavorable prognosis in triple negative breast cancer.
Neoplasms
Upregulation of SLC2 (GLUT) family genes is related to poor survival outcomes in papillary thyroid carcinoma: Analysis of data from The Cancer Genome Atlas.
Neoplasms
Upregulation of SLC2A3 gene and prognosis in colorectal carcinoma: analysis of TCGA data.
Neoplasms
Upregulation of SPP1 Is a Marker for Poor Lung Cancer Prognosis and Contributes to Cancer Progression and Cisplatin Resistance.
Neoplasms
Upregulation of STC2 in colorectal cancer and its clinicopathological significance.
Neoplasms
Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
Neoplasms
Upregulation of the adipokine genes ADIPOR1 and SPP1 is related to poor survival outcomes in colorectal cancer.
Neoplasms
Upregulation of the ESR1 Gene and ESR Ratio (ESR1/ESR2) is Associated with a Worse Prognosis in Papillary Thyroid Carcinoma: The Impact of the Estrogen Receptor ?/? Expression on Clinical Outcomes in Papillary Thyroid Carcinoma Patients.
Neoplasms
Upregulation of the NLRC4 inflammasome contributes to poor prognosis in glioma patients.
Neoplasms
Upregulation of the solute carrier family 7 genes is indicative of poor prognosis in papillary thyroid carcinoma.
Neoplasms
Upregulation of thyroid hormone receptor interactor 13 is associated with human hepatocellular carcinoma.
Neoplasms
Upregulation of TRIP13 promotes the malignant progression of lung cancer via the EMT pathway.
Neoplasms
Upregulation of ubiquitin-conjugating enzyme E2T (UBE2T) predicts poor prognosis and promotes hepatocellular carcinoma progression.
Neoplasms
Upregulation of ubiquitin-conjugating enzyme E2Z is associated with human hepatocellular carcinoma.
Neoplasms
Upregulation of ZBTB7A exhibits a tumor suppressive role in gastric cancer cells.
Neoplasms
Upregulation of ZHX2 predicts poor prognosis and is correlated with immune infiltration in gastric cancer.
Neoplasms
Uridine phosphorylase 1 associates to biological and clinical significance in thyroid carcinoma cell lines.
Neoplasms
Uridine phosphorylase 1 is a novel immune-related target and predicts worse survival in brain glioma.
Neoplasms
Urine Endocannabinoids as Novel Non-Invasive Biomarkers for Bladder Cancer at Early Stage.
Neoplasms
Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: A cohort study.
Neoplasms
Urokinase plasminogen activator predicts poor prognosis in hepatocellular carcinoma.
Neoplasms
Uronic acid metabolic process-related gene expression-based signature predicts overall survival of glioma.
Neoplasms
Urothelial Cancers with Small Cell Variant Histology Have Confirmed High Tumor Mutational Burden, Frequent TP53 and RB Mutations, and a Unique Gene Expression Profile.
Neoplasms
Urothelial Carcinoma and Prostate-specific Membrane Antigen: Cellular, Imaging, and Prognostic Implications.
Neoplasms
Urothelial Carcinoma Detection Based on Copy Number Profiles of Urinary Cell-Free DNA by Shallow Whole-Genome Sequencing.
Neoplasms
Ursolic Acid Regulates Cell Cycle and Proliferation in Colon Adenocarcinoma by Suppressing Cyclin B1.
Neoplasms
Use of bioinformatic database analysis and specimen verification to identify novel biomarkers predicting gastric cancer metastasis.
Neoplasms
Use of four genes in exosomes as biomarkers for the identification of lung adenocarcinoma and lung squamous cell carcinoma.
Neoplasms
Use of Genome-Scale Integrated Analysis to Identify Key Genes and Potential Molecular Mechanisms in Recurrence of Lower-Grade Brain Glioma.
Neoplasms
Using a machine learning approach to identify key prognostic molecules for esophageal squamous cell carcinoma.
Neoplasms
Using bioinformatics approaches to investigate driver genes and identify BCL7A as a prognostic gene in colorectal cancer.
Neoplasms
Using deep learning to identify bladder cancers with FGFR-activating mutations from histology images.
Neoplasms
Using drug response data to identify molecular effectors, and molecular "omic" data to identify candidate drugs in cancer.
Neoplasms
Using Integrated Bioinformatics Analysis to Identify Abnormally Methylated Differentially Expressed Genes in Hepatocellular Carcinoma.
Neoplasms
Using knowledge-driven genomic interactions for multi-omics data analysis: metadimensional models for predicting clinical outcomes in ovarian carcinoma.
Neoplasms
Using machine learning method to identify MYLK as a novel marker to predict biochemical recurrence in prostate cancer.
Neoplasms
Using Semantic Web Technologies to Enable Cancer Genomics Discovery at Petabyte Scale.
Neoplasms
Using The Cancer Genome Atlas as a Tool to Improve Undergraduate Student Understanding of Cancer Genetics and the Hallmarks of Cancer Progression.
Neoplasms
Using The Cancer Genome Atlas data to refine the 8th edition of the American Joint Committee on Cancer staging for papillary thyroid carcinoma.
Neoplasms
Using the Seven Bridges Cancer Genomics Cloud to Access and Analyze Petabytes of Cancer Data.
Neoplasms
USP18 promotes breast cancer growth by upregulating EGFR and activating the AKT/Skp2 pathway.
Neoplasms
USP19 and RPL23 as Candidate Prognostic Markers for Advanced-Stage High-Grade Serous Ovarian Carcinoma.
Neoplasms
USP22 promotes hypoxia-induced hepatocellular carcinoma stemness by a HIF1?/USP22 positive feedback loop upon TP53 inactivation.
Neoplasms
USP4 expression independently predicts favorable survival in lung adenocarcinoma.
Neoplasms
USP5 Promotes Uterine Corpus Endometrial Carcinoma Cell Growth and Migration via mTOR/4EBP1 Activation.
Neoplasms
Utility of a custom designed next generation DNA sequencing gene panel to molecularly classify endometrial cancers according to The Cancer Genome Atlas subgroups.
Neoplasms
Utility of ankyrin 3 as a prognostic marker in androgen-receptor-positive breast cancer.
Neoplasms
Utility of GDF-15 as a diagnostic biomarker in gastric cancer: an investigation combining GEO, TCGA and meta-analysis.
Neoplasms
Utility of miR?133a?3p as a diagnostic indicator for hepatocellular carcinoma: An investigation combined with GEO, TCGA, meta?analysis and bioinformatics.
Neoplasms
Utilizing Automated Breast Cancer Detection to Identify Spatial Distributions of Tumor-Infiltrating Lymphocytes in Invasive Breast Cancer.
Neoplasms
Utilizing somatic mutation data from numerous studies for cancer research: proof of concept and applications.
Neoplasms
UXT antisense RNA 1 sever as a novel prognostic long non-coding RNA in early stage pancreatic ductal adenocarcinoma patients after receiving pancreaticoduodenectomy.
Neoplasms
V-domain Ig-containing suppressor of T-cell activation (VISTA), a potentially targetable immune checkpoint molecule, is highly expressed in epithelioid malignant pleural mesothelioma.
Neoplasms
Validating a Predictive Atlas of Tumor Shrinkage for Adaptive Radiotherapy of Locally Advanced Lung Cancer.
Neoplasms
Validating HMMR Expression and Its Prognostic Significance in Lung Adenocarcinoma Based on Data Mining and Bioinformatics Methods.
Neoplasms
Validating the RTOG-endorsed brachial plexus contouring atlas: an evaluation of reproducibility among patients treated by intensity-modulated radiotherapy for head-and-neck cancer.
Neoplasms
Validation and calibration of next-generation sequencing to identify Epstein-Barr virus-positive gastric cancer in The Cancer Genome Atlas.
Neoplasms
Validation and genomic interrogation of the MET variant rs11762213 as a predictor of adverse outcomes in clear cell renal cell carcinoma.
Neoplasms
Validation of DAB2IP methylation and its relative significance in predicting outcome in renal cell carcinoma.
Neoplasms
Validation of Gene Profiles for Analysis of Regional Lymphatic Metastases in Head and Neck Squamous Cell Carcinoma.
Neoplasms
Validation of risk stratification models in acute myeloid leukemia using sequencing-based molecular profiling.
Neoplasms
Validation of Selected Head and Neck Cancer Prognostic Markers from the Pathology Atlas in an Oral Tongue Cancer Cohort.
Neoplasms
Valproic acid inhibits glioblastoma multiforme cell growth via paraoxonase 2 expression.
Neoplasms
Value of Collaboration among Multi-Domain Experts in Analysis of High-Throughput Genomics Data.
Neoplasms
Value of Ferritin Heavy Chain (FTH1) Expression in Diagnosis and Prognosis of Renal Cell Carcinoma.
Neoplasms
VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research.
Neoplasms
Variability in clinical target volume delineation for intensity modulated radiation therapy in 3 challenging cervix cancer scenarios.
Neoplasms
Variable maternal methylation overlapping the nc886/vtRNA2-1 locus is locked between hypermethylated repeats and is frequently altered in cancer.
Neoplasms
Variance component tests of multivariate mediation effects under composite null hypotheses.
Neoplasms
Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.
Neoplasms
Varied clinical significance of ATP-binding cassette C sub-family members for lung adenocarcinoma.
Neoplasms
VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing.
Neoplasms
Vascular endothelial growth factor receptor 1 in glioblastoma?associated microglia/macrophages.
Neoplasms
Vascular endothelial growth factor receptor-2 and its association with tumor immune regulatory gene expression in hepatocellular carcinoma.
Neoplasms
VDR mRNA overexpression is associated with worse prognostic factors in papillary thyroid carcinoma.
Neoplasms
VECTOR: An Integrated Correlation Network Database for the Identification of CeRNA Axes in Uveal Melanoma.
Neoplasms
VegaMC: A R/Bioconductor Package for Fast Downstream Analysis of Large Array Comparative Genomic Hybridization Datasets.
Neoplasms
Verification of expressions of lncRNA FOXCUT in gastric adenocarcinoma patients and its effects on cell biological function based on TCGA database.
Neoplasms
Verrucous carcinoma of the oesophagus is a genetically distinct subtype of oesophageal squamous cell carcinoma.
Neoplasms
Verrucous esophageal carcinoma is a unique indolent subtype of squamous cell carcinoma: a systematic review and individual patient regression analysis.
Neoplasms
VGLL1 expression is associated with a triple-negative basal-like phenotype in breast cancer.
Neoplasms
Vimentin acetylation is involved in SIRT5-mediated hepatocellular carcinoma migration.
Neoplasms
Viral status, immune microenvironment and immunological response to checkpoint inhibitors in hepatocellular carcinoma.
Neoplasms
VirusSeq: software to identify viruses and their integration sites using next-generation sequencing of human cancer tissue.
Neoplasms
VISTA expression associated with CD8 confers a favorable immune microenvironment and better overall survival in hepatocellular carcinoma.
Neoplasms
VISTA Expression on Immune Cells Correlates With Favorable Prognosis in Patients With Triple-Negative Breast Cancer.
Neoplasms
Visual histological assessment of morphological features reflects the underlying molecular profile in invasive breast cancer: a morphomolecular study.
Neoplasms
Visualization and Analysis in the Field of Pan-Cancer Studies and Its Application in Breast Cancer Treatment.
Neoplasms
Visually Meaningful Histopathological Features for Automatic Grading of Prostate Cancer.
Neoplasms
Vitamin D-VDR Signaling Inhibits Wnt/?-Catenin-Mediated Melanoma Progression and Promotes Antitumor Immunity.
Neoplasms
VNN3 is a potential novel biomarker for predicting prognosis in clear cell renal cell carcinoma.
Neoplasms
Volume of high-risk intratumoral subregions at multi-parametric MR imaging predicts overall survival and complements molecular analysis of glioblastoma.
Neoplasms
von Willebrand Factor Gene Expression in Primary Lower Grade Glioma: Mutually Co-Occurring Mutations in von Willebrand Factor, ATRX, and TP53.
Neoplasms
VSIG4 is highly expressed and correlated with poor prognosis of high-grade glioma patients.
Neoplasms
VSTM2A Overexpression Is a Sensitive and Specific Biomarker for Mucinous Tubular and Spindle Cell Carcinoma (MTSCC) of the Kidney.
Neoplasms
Wanderer, an interactive viewer to explore DNA methylation and gene expression data in human cancer.
Neoplasms
WBP2 promotes BTRC mRNA stability to drive migration and invasion in triple-negative breast cancer via NF-?B activation.
Neoplasms
WDR5 Promotes Proliferation and Correlates with Poor Prognosis in Oesophageal Squamous Cell Carcinoma.
Neoplasms
WDR62 overexpression is associated with a poor prognosis in patients with lung adenocarcinoma.
Neoplasms
Weakly Supervised Deep Ordinal Cox Model for Survival Prediction from Whole-slide Pathological Images.
Neoplasms
Web-TCGA: an online platform for integrated analysis of molecular cancer data sets.
Neoplasms
Weighted correlation network analysis of triple-negative breast cancer progression: Identifying specific modules and hub genes based on the GEO and TCGA database.
Neoplasms
Weighted dimensionality reduction and robust Gaussian mixture model based cancer patient subtyping from gene expression data.
Neoplasms
Weighted Gene Co-expression Network Analysis Identified a Novel Thirteen-Gene Signature Associated With Progression, Prognosis, and Immune Microenvironment of Colon Adenocarcinoma Patients.
Neoplasms
Weighted gene co-expression network analysis in identification of metastasis-related genes of lung squamous cell carcinoma based on the Cancer Genome Atlas database.
Neoplasms
Weighted gene co-expression network analysis of gene modules for the prognosis of esophageal cancer.
Neoplasms
Weighted gene co-expression network analysis of hub genes in lung adenocarcinoma.
Neoplasms
Weighted gene co-expression network analysis of the association between upregulated AMD1, EN1 and VGLL1 and the progression and poor prognosis of breast cancer.
Neoplasms
Weighted gene co?expression network analysis for identifying hub genes in association with prognosis in Wilms tumor.
Neoplasms
Weighted Gene Coexpression Network Analysis Identifies Cysteine-Rich Intestinal Protein 1 (CRIP1) as a Prognostic Gene Associated with Relapse in Patients with Acute Myeloid Leukemia.
Neoplasms
Weighted gene coexpression network analysis identifies hub genes related to KRAS mutant lung adenocarcinoma.
Neoplasms
Weighted Gene Coexpression Network Analysis of Features That Control Cancer Stem Cells Reveals Prognostic Biomarkers in Lung Adenocarcinoma.
Neoplasms
Weighted gene coexpression network analysis reveals hub genes involved in cholangiocarcinoma progression and prognosis.
Neoplasms
Weighted Gene Coexpression Network Analysis Reveals the Dynamic Transcriptome Regulation and Prognostic Biomarkers of Hepatocellular Carcinoma.
Neoplasms
Weighted Gene Coexpression Network Analysis to Construct Competitive Endogenous RNA Network in Chromogenic Renal Cell Carcinoma.
Neoplasms
Weighted gene correlation network analysis identifies microenvironment-related genes signature as prognostic candidate for Grade II/III glioma.
Neoplasms
What "The Cancer Genome Atlas" database tells us about the role of ATP-binding cassette (ABC) proteins in chemoresistance to anticancer drugs.
Neoplasms
What Mediates Fibrosis in the Tumor Microenvironment of Clear Renal Cell Carcinoma.
Neoplasms
What's New in Gastric Cancer: The Therapeutic Implications of Molecular Classifications and Future Perspectives.
Neoplasms
What's new in the AFIP fascicle on salivary gland tumors: a few highlights from the 4th Series Atlas.
Neoplasms
Where is the limit of prostate cancer biomarker research? Systematic investigation of potential prognostic and diagnostic biomarkers.
Neoplasms
Where you live = how you die: 'Geography is destiny' for end-of-life care, which often is costly, aggressive.
Neoplasms
Whole exome and target sequencing identifies MAP2K5 as novel susceptibility gene for familial non-medullary thyroid carcinoma.
Neoplasms
Whole exome sequencing characterization of individuals presenting extreme phenotypes of high and low risk of developing tobacco-induced lung adenocarcinoma.
Neoplasms
Whole exome sequencing identifies PLEC, EXO5 and DNAH7 as novel susceptibility genes in testicular cancer.
Neoplasms
Whole Exome Sequencing in Penile Squamous Cell Carcinoma Uncovers Novel Prognostic Categorization and Drug Targets Similar to Head and Neck Squamous Cell Carcinoma.
Neoplasms
Whole Exome Sequencing of Ulcerative Colitis-associated Colorectal Cancer Based on Novel Somatic Mutations Identified in Chinese Patients.
Neoplasms
Whole exome sequencing-based analysis to identify DNA damage repair deficiency as a major contributor to gliomagenesis in adult diffuse gliomas.
Neoplasms
Whole Genome Messenger RNA Profiling Identifies a Novel Signature to Predict Gastric Cancer Survival.
Neoplasms
Whole transcriptome analysis reveals correlation of long noncoding RNA ZEB1-AS1 with invasive profile in melanoma.
Neoplasms
Whole transcriptome targeted gene quantification provides new insights on pulmonary sarcomatoid carcinomas.
Neoplasms
Whole-exome and RNA sequencing reveal novel insights into the pathogenesis of HPV associated cervical cancer.
Neoplasms
Whole-exome mutational and transcriptional landscapes of combined hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma reveal molecular diversity.
Neoplasms
Whole-Exome Sequencing Analysis of the Progression from Non-Low-Grade Ductal Carcinoma In Situ to Invasive Ductal Carcinoma.
Neoplasms
Whole-exome sequencing capture kit biases yield false negative mutation calls in TCGA cohorts.
Neoplasms
Whole-Exome Sequencing Characterized the Landscape of Somatic Mutations and Pathways in Colorectal Cancer Liver Metastasis.
Neoplasms
Whole-exome sequencing identifies somatic mutations associated with lung cancer metastasis to the brain.
Neoplasms
Whole-Exome Sequencing Identifies Somatic Mutations Associated With Mortality in Metastatic Clear Cell Kidney Carcinoma.
Neoplasms
Whole-exome sequencing of alpha-fetoprotein producing gastric carcinoma reveals genomic profile and therapeutic targets.
Neoplasms
Whole-exome sequencing of ovarian cancer families uncovers putative predisposition genes.
Neoplasms
Whole-exome Sequencing of Prostate Cancer in Sardinian Identify Recurrent UDP-glucuronosyltransferase Amplifications.
Neoplasms
Whole-exome sequencing reveals critical genes underlying metastasis in oesophageal squamous cell carcinoma.
Neoplasms
Whole-genome and transcriptome profiling of a metastatic thyroid-like follicular renal cell carcinoma.
Neoplasms
Whole-genome characterization of lung adenocarcinomas lacking the RTK/RAS/RAF pathway.
Neoplasms
Whole-genome microRNA expression profiling identifies a 5-microRNA signature as a prognostic biomarker in Chinese patients with primary glioblastoma multiforme.
Neoplasms
Whole-genome mRNA expression profiling identifies functional and prognostic signatures in patients with mesenchymal glioblastoma multiforme.
Neoplasms
Whole-Genome Multi-omic Study of Survival in Patients with Glioblastoma Multiforme.
Neoplasms
Whole-genome sequencing of phenotypically distinct inflammatory breast cancers reveals similar genomic alterations to non-inflammatory breast cancers.
Neoplasms
Whole-Slide Mitosis Detection in H&E Breast Histology Using PHH3 as a Reference to Train Distilled Stain-Invariant Convolutional Networks.
Neoplasms
Whole-transcriptome and proteome analyses identify key differentially expressed mRNAs, miRNAs, lncRNAs and circRNAs associated with HCC.
Neoplasms
Whole-transcriptome sequencing identified gene expression signatures associated with aggressive clear cell renal cell carcinoma.
Neoplasms
Whole-Transcriptome Sequencing Identifies Key Differentially Expressed mRNAs, miRNAs, lncRNAs, and circRNAs Associated with CHOL.
Neoplasms
WHSC1 Promotes Cell Proliferation, Migration, and Invasion in Hepatocellular Carcinoma by Activating mTORC1 Signaling.
Neoplasms
Why MUC16 mutations lead to a better prognosis: A study based on The Cancer Genome Atlas gastric cancer cohort.
Neoplasms
Widespread alternative exon usage in clinically distinct subtypes of Invasive Ductal Carcinoma.
Neoplasms
Widespread expression of Sonic hedgehog (Shh) and Nrf2 in patients treated with cisplatin predicts outcome in resected tumors and are potential therapeutic targets for HPV-negative head and neck cancer.
Neoplasms
Widespread inference of weighted microRNA-mediated gene regulation in cancer transcriptome analysis.
Neoplasms
Wild-type p53 regulates OTOP2 transcription through DNA loop alteration of the promoter in colorectal cancer.
Neoplasms
Will Chinese ovarian cancer patients benefit from knowing the BRCA2 mutation status?
Neoplasms
WIPF1 antagonizes the tumor suppressive effect of miR-141/200c and is associated with poor survival in patients with PDAC.
Neoplasms
WISP-1 Promotes Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma Cells Via the miR-153-3p/Snail Axis.
Neoplasms
WISP3 is highly expressed in a subset of colorectal carcinomas with a better prognosis.
Neoplasms
With me or against me: Tumor suppressor and drug resistance activities of SAMHD1.
Neoplasms
Wnt Signaling and Survival of Women With High-Grade Serous Ovarian Cancer: A Brief Report.
Neoplasms
WNT signaling pathway regulator-FRAT2 affects oncogenesis and prognosis of basal-like breast cancer.
Neoplasms
Wnt signalling in gynaecological cancers: A future target for personalised medicine?
Neoplasms
Wnt/?-catenin activation cooperates with loss of p53 to cause adrenocortical carcinoma in mice.
Neoplasms
WNT/?-catenin pathway activation correlates with immune exclusion across human cancers.
Neoplasms
WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
Neoplasms
Xanthine dehydrogenase as a prognostic biomarker related to tumor immunology in hepatocellular carcinoma.
Neoplasms
XRCC1 promotes replication restart, nascent fork degradation and mutagenic DNA repair in BRCA2-deficient cells.
Neoplasms
Y-box binding protein 1 acts as a negative regulator of stearoyl CoA desaturase 1 in clear cell renal cell carcinoma.
Neoplasms
Y-Box Binding Protein-1 Promotes Epithelial-Mesenchymal Transition in Sorafenib-Resistant Hepatocellular Carcinoma Cells.
Neoplasms
YAP Activity is Not Associated with Survival of Uveal Melanoma Patients and Cell Lines.
Neoplasms
YAP Promotes VEGFA Expression and Tumor Angiogenesis Though Gli2 in Human Renal Cell Carcinoma.
Neoplasms
YAP1 is a Prognostic Biomarker and Correlated with Immune Cell Infiltration in Pancreatic Cancer.
Neoplasms
YAP1 is an independent prognostic marker in pancreatic cancer and associated with extracellular matrix remodeling.
Neoplasms
Yes-associated protein (YAP) binds to HIF-1? and sustains HIF-1? protein stability to promote hepatocellular carcinoma cell glycolysis under hypoxic stress.
Neoplasms
Yin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implication.
Neoplasms
Yottixel - An Image Search Engine for Large Archives of Histopathology Whole Slide Images.
Neoplasms
Young-onset gastric cancer and Epstein-Barr Virus (EBV) - a major player in the pathogenesis?
Neoplasms
YRDC is upregulated in non-small cell lung cancer and promotes cell proliferation by decreasing cell apoptosis.
Neoplasms
YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation.
Neoplasms
ZBTB7A acts as a tumor suppressor through the transcriptional repression of glycolysis.
Neoplasms
ZEB1 induces EPB41L5 in the cancer mesenchymal program that drives ARF6-based invasion, metastasis and drug resistance.
Neoplasms
ZGRF1 Is Associated with Poor Prognosis in Triple-Negative Breast Cancer and Promotes Cancer Stemness Based on Bioinformatics.
Neoplasms
ZHX3 promotes the progression of urothelial carcinoma of the bladder via repressing of RGS2 and is a novel substrate of TRIM21.
Neoplasms
Zic Family Member 2 (ZIC2): a Potential Diagnostic and Prognostic Biomarker for Pan-Cancer.
Neoplasms
Zinc finger and BTB domain-containing protein 46 is essential for survival and proliferation of acute myeloid leukemia cell line but dispensable for normal hematopoiesis.
Neoplasms
Zinc finger C3H1 domain-containing protein (ZFC3H1) evaluates the prognosis and treatment of prostate adenocarcinoma (PRAD): A study based on TCGA data.
Neoplasms
Zinc transporter genes and urological cancers: integrated analysis suggests a role for ZIP11 in bladder cancer.
Neoplasms
ZMYND8 promotes the growth and metastasis of hepatocellular carcinoma by promoting HK2-mediated glycolysis.
Neoplasms
ZNF154 is a promising diagnosis biomarker and predicts biochemical recurrence in prostate cancer.
Neoplasms
ZNF277 regulates ovarian cancer cell proliferation and invasion through inhibition of PTEN.
Neoplasms
ZNF492 and GPR149 methylation patterns as prognostic markers for clear cell renal cell carcinoma: Array?based DNA methylation profiling.
Neoplasms
ZNF671 DNA methylation as a molecular predictor for the early recurrence of serous ovarian cancer.
Neoplasms
ZNF677 downregulation by promoter hypermethylation as a driver event through gastric tumorigenesis.
Neoplasms
Zodiac: A Comprehensive Depiction of Genetic Interactions in Cancer by Integrating TCGA Data.
Neoplasms
Zooming-in on cancer metabolic rewiring with tissue specific constraint-based models.
Neoplasms
ZYG11A serves as an oncogene in non-small cell lung cancer and influences CCNE1 expression.
Neoplasms
Zyxin (ZYX) promotes invasion and acts as a biomarker for aggressive phenotypes of human glioblastoma multiforme.
Neoplasms
[2 Cases of sudden death caused by spontaneous dislocation of the atlas; metastatic cancer & Grisel's disease.]
Neoplasms
[2 Cases of sudden death caused by spontaneous dislocation of the atlas; metastatic cancer and Grisel's disease.]
Neoplasms
[A cancer mortality atlas on a small geographic scale: procedure, validity and possibilities for its use]
Neoplasms
[A new bioinformatics approach for prediction of potential tumor neoantigens based on the cancer genome atlas dataset].
Neoplasms
[Analysis of characteristics of gene expression in pericancerous stromal cells of nasopharyngeal carcinoma by cDNA array]
Neoplasms
[Analysis of key genes and signal pathways of human papilloma virus-related head and neck squamous cell carcinoma].
Neoplasms
[Application of atlas pedicle screw system fixation and fusion for treatment of upper cervical disease]
Neoplasms
[Application of posterior arch of the atlasrch resection for high-level cervical dumbbell schwannoma surgery].
Neoplasms
[Atlas for pathomorphologic differential diagnosis of skin diseases, especially neoplasms. Part II. Neoplasms and pseudo-neoplastic proliferations]
Neoplasms
[Atlas for pathomorphologic differential diagnosis of skin diseases, especially tumors. Part I. Non-neoplastic diseases]
Neoplasms
[Atlas for pathomorphologic differential diagnosis of skin diseases, especially tumors. Part II. Neoplasms and pseudo-neoplastic proliferations]
Neoplasms
[Bioinformatics analysis of genes related to poor prognosis of human hepatocellular carcinoma and its clinical significance].
Neoplasms
[Cartography as an instrument in epidemiology: methodologic considerations for the new Swiss cancer atlas]
Neoplasms
[Cathepsin S (CTSS) is highly expressed in temozolomide-resistant glioblastoma T98G cells and associated with poor prognosis].
Neoplasms
[cDNA expression array in the differential expression profiles of p53 regulated genes in nasopharyngeal carcinoma and the human normal nasopharynx]
Neoplasms
[Citron Rho-interacting serine/threonine kinase knockdown suppresses prostate cancer cell proliferation and metastasis by blocking Hippo-YAP pathway].
Neoplasms
[Clinical application of TCGA molecular classification in endometrial endometrioid carcinoma].
Neoplasms
[Clinical aspects and therapy of lid tumors; a clinical and pathological study of 300 cases: a textbook and atlas, 116 illustrations, 4 color charts, 7 tables]
Neoplasms
[Clinical significance of ?1 receptor over-expression in cervical cancer and the effect of its synthetic ligands on the growth of cervical cancer cells].
Neoplasms
[Clinicopathological and molecular characteristics of Epstein-Barr virus associated gastric cancer: a single center large sample case investigation].
Neoplasms
[Common cancer genetic analysis methods and application study based on TCGA database].
Neoplasms
[Comprehensive analysis of the aberrantly expressed profiles of lncRNAs, miRNAs and the regulation network of the associated ceRNAs in clear cell renal cell carcinoma].
Neoplasms
[Construction and Validation of Prognostic Risk Score Model of Autophagy Related Genes in Lung Adenocarcinoma].
Neoplasms
[Construction of prognostic model and identification of prognostic biomarkers based on the expression of long non-coding RNA in bladder cancer via bioinformatics].
Neoplasms
[Correlation studies of distinct mutational signatures with common cancer pathological subtyping].
Neoplasms
[Crohn's disease-associated colorectal carcinogenesis : TP53 mutations and copy number gains of chromosome arm 5p as (early) markers of tumor progression].
Neoplasms
[Current status and research progress of perioperative chemotherapy in advanced gastric cancer].
Neoplasms
[Data mining of esophageal squamous cell carcinoma from The Cancer Genome Atlas database].
Neoplasms
[Developing a small-area cancer atlas: process, validity and possible applications]
Neoplasms
[Difference in gene expression profile of human polymeric immunoglobulin receptor-transfected mouse nasopharyngeal epithelial cells before and after EBV infection]
Neoplasms
[Differential analysis of gene expression profiles in hepatocellular carcinoma patients with high and low levels of alpha-fetoprotein].
Neoplasms
[DNA damage associated genetic variants contribute to lung cancer susceptibility in a Han Chinese population].
Neoplasms
[Downregulation of OGDHL expression is associated with promoter hypermethylation in colorectal cancer].
Neoplasms
[Effect of long non-coding RNA MBNL1-AS1 expression on prognosis of acute myeloid leukemia patients].
Neoplasms
[Endoscopic transnasal approach for surgical treatment of skull base clival area chordomas (Report of 2 cases)].
Neoplasms
[Establishment and validation of prognostic risk score model for esophageal squamous cell carcinoma based on immune related genes].
Neoplasms
[Evaluation of Gene Expression of Hexokinases in Colorectal Cancer with the Use of Bioinformatics Methods].
Neoplasms
[Exploratory screening of potential pan-cancer biomarkers based on The Cancer Genome Atlas database].
Neoplasms
[Exploring of a prognostic long non-coding RNA signature of hepatocellular carcinoma by using public database].
Neoplasms
[Expression and clinical significance of chemokine CXCL10 and its receptor CXCR3 in hepatocellular carcinoma].
Neoplasms
[Expression and clinical significance of SETD2 in maligant pleural mesothelioma].
Neoplasms
[Expression of microRNA-107 in hepatocellular carcinoma and its clinical significance].
Neoplasms
[Expression of RASGRP2 in Lung Adenocarcinoma and Its Effect ?on Immune Microenvironment].
Neoplasms
[Expression of Toll-like receptors in human hepatocellular carcinoma and its correlation with inflammasome-associated cytokines].
Neoplasms
[Expression of TRIM59 in Non-small Cell Lung Cancer and Its Correlation with Prognosis].
Neoplasms
[Gene apoptosis expression profiles in liver cancer and their comparison to normal peri-cancerous liver tissues]
Neoplasms
[Gene expression profiles in squamous esophageal cancer tissues and adjacent almost normal tissues]
Neoplasms
[Genome-wide analysis of DNA methylation in prostate cancer using the technology of Infinium HumanMethylation450 BeadChip (HM450)].
Neoplasms
[High expression of activated CD4+ memory T cells and CD8+ T cells and low expression of M0 macrophage are associated with better clinical prognosis in bladder cancer patients].
Neoplasms
[High-throughput molecular analysis of urothelial carcinoma: potential clinical applications].
Neoplasms
[Histological and molecular classification of endometrial carcinoma and therapeutical implications].
Neoplasms
[HPV-associated head and neck cancer : mutational signature and genomic aberrations].
Neoplasms
[Identifying Molecular Subtypes of Whole-Slide Image in Colorectal Cancer via Deep Learning].
Neoplasms
[Immune Microenvironment Comparation Study between EGFR Mutant and EGFR Wild Type Lung Adenocarcinoma Patients Based on TCGA Database].
Neoplasms
[Implications of TCGA Network Data on 2nd Generation Immunotherapy Concepts Based on PD-L1 and PD-1 Target Structures].
Neoplasms
[Increased TRIM5 is associated with a poor prognosis and immune infiltration in glioma patients].
Neoplasms
[Integrated analysis of DNA methylation and gene expression profiles of hepatocellular carcinoma to construct miR-1180-3p relevant ceRNA regulatory network].
Neoplasms
[MicroRNA model that can predict the prognosis of oral squamous cell carcinoma based on bioinformatics analysis].
Neoplasms
[Mutation signatures in head and neck squamous cell carcinoma : Pathogenesis and therapeutic potential].
Neoplasms
[Mutational tumor profiles beyond organ and tissue specificity: implications for diagnostics and clinical study design].
Neoplasms
[Overexpression of histone deacetylase 11 suppresses basal-like breast cancer cell invasion and metastasis].
Neoplasms
[Plerosis of cDNA array of normal human nasopharyngeal tissue and nasopharyngeal carcinoma]
Neoplasms
[Preliminary analysis on the gene expression profiles of medulloblastomas by use of cDNA array]
Neoplasms
[Preliminary study on the gene expression profiles of ependymomas with cDNA array]
Neoplasms
[Prognosis-related miRNA bioinformatics screening of lung adenocarcinoma and its clinical significance].
Neoplasms
[Regional distribution of stomach and colon cancer mortality in the Dithmarschen and Nordfriesland districts--cartographic presentation]
Neoplasms
[Studies on the role of chromobox protein homolog 2 in the inhibition of progression of hepatoma].
Neoplasms
[Study on the development of a choropleth atlas on cancer mortality using the inverse distance weight interpolation in the 1990's]
Neoplasms
[Study on the Difference of Gene Expression between Central and Peripheral Lung Squamous Cell Carcinoma Based on TCGA Database].
Neoplasms
[The cartographic depiction of regional variation in morbidity : Data analysis options using the example of the small-scale cancer atlas for Schleswig-Holstein].
Neoplasms
[The general rules for clinical and pathological management of ovarian tumors part 1: histological classification and color atlas of ovarian tumors].
Neoplasms
[Update on molecular classifications and new histological classification of bladder cancer].
Neoplasms, Germ Cell and Embryonal
SPOP suppresses testicular germ cell tumors progression through ubiquitination and degradation of DPPA2.
Neoplasms, Germ Cell and Embryonal
The Study of the Expression of CGB1 and CGB2 in Human Cancer Tissues.
Neoplasms, Glandular and Epithelial
Gastritis-Infection-Cancer Sequence of Epstein-Barr Virus-Associated Gastric Cancer.
Neoplasms, Second Primary
[Breast cancer mortality in women in the Schleswig-Holstein district 1981 to 1995]
Neoplasms, Squamous Cell
Atlas of the thoracic lymph nodal delineation and recommendations for lymph nodal CTV of esophageal squamous cell cancer in radiation therapy from China.
Neoplasms, Squamous Cell
Integrative CAGE and DNA Methylation Profiling Identify Epigenetically Regulated Genes in NSCLC.
Neoplasms, Squamous Cell
Threonine Tyrosine Kinase Inhibition Eliminates Lung Cancers by Augmenting Apoptosis and Polyploidy.
Nephritis, Interstitial
AJKD Atlas of Renal Pathology: Tubulointerstitial Nephritis With Uveitis.
Nephrocalcinosis
AJKD Atlas of Renal Pathology: Nephrocalcinosis and Acute Phosphate Nephropathy.
Nephrosis, Lipoid
Histopathological atlas of renal diseases: Minimal Change disease and focal glomerulosclerosis.
Nephrotic Syndrome
AJKD Atlas of Renal Pathology: Congenital Nephrotic Syndrome of Finnish Type.
Nervous System Diseases
A Comprehensive Atlas of E3 Ubiquitin Ligase Mutations in Neurological Disorders.
Nervous System Diseases
A single-cell atlas of the human substantia nigra reveals cell-specific pathways associated with neurological disorders.
Nervous System Diseases
Bridging neuroanatomy, neuroradiology and neurology: three-dimensional interactive atlas of neurological disorders.
Nervous System Diseases
Genomic atlas of the proteome from brain, CSF and plasma prioritizes proteins implicated in neurological disorders.
Nervous System Diseases
Joint functional brain network atlas estimation and feature selection for neurological disorder diagnosis with application to autism.
Nervous System Diseases
Multi-contrast human neonatal brain atlas: Application to normal neonate development analysis.
Nervous System Diseases
NSDNA: a manually curated database of experimentally supported ncRNAs associated with nervous system diseases.
Nervous System Diseases
Three-dimensional interactive atlas of cranial nerve-related disorders.
Nervous System Diseases
Ultra-high spatial resolution basal and evoked cerebral blood flow MRI of the rat brain.
Nervous System Diseases
[Atlas of nervous system diseases. 10. Giant aneurysm of the cranial base]
Nervous System Diseases
[Atlas of nervous system diseases. 11. A case of hemorrhage of the cerebellar hemisphere]
Nervous System Diseases
[Atlas of nervous system diseases. 4. Autopsy case of progressive spinal muscular atrophy]
Nervous System Diseases
[Atlas of nervous system diseases. 6. Autopsy case of subacute necrotic encephalitis]
Nervous System Diseases
[Atlas of nervous system diseases. 7. Autopsy case of obstruction of vertibrobasilar artery]
Nervous System Diseases
[Atlas of nervous system diseases. 9. Hypoplasia of the internal carotid artery with recurrent cerebral ischemic syndrome]
Nervous System Malformations
Exencephaly and axial skeletal dysmorphogenesis induced by maternal exposure to cadmium in the mouse.
Neuralgia
Occipital neuralgia secondary to hypermobile posterior arch of atlas. Case report.
Neuralgia
[Surgical decompression for the C-1 and C-2 sensory roots and upper cervical cord in a case with cervical myelopathy and occipital neuralgia due to bilateral fenestration of vertebral artery: a case report]
Neurilemmoma
Expanded endoscopic endonasal transcribriform approach for resection of anterior skull base olfactory schwannoma.
Neurilemmoma
Posterior fixation and fusion with atlas pedicle screw system for upper cervical diseases.
Neurilemmoma
[Application of atlas pedicle screw system fixation and fusion for treatment of upper cervical disease]
Neurilemmoma
[Application of posterior arch of the atlasrch resection for high-level cervical dumbbell schwannoma surgery].
Neuroblastoma
Single-cell atlas of developing murine adrenal gland reveals relation of Schwann cell precursor signature to neuroblastoma phenotype.
Neurodegenerative Diseases
Atlas-based anatomic labeling in neurodegenerative disease via structure-driven atlas warping.
Neurodegenerative Diseases
Construction of a neuroanatomical shape complex atlas from 3D MRI brain structures.
Neurodegenerative Diseases
High-resolution magnetic resonance imaging reveals nuclei of the human amygdala: manual segmentation to automatic atlas.
Neurodegenerative Diseases
In vivo normative atlas of the hippocampal subfields using multi-echo susceptibility imaging at 7 Tesla.
Neurodegenerative Diseases
Use of brain MRI atlases to determine boundaries of age-related pathology: the importance of statistical method.
Neuroendocrine Tumors
[Scintigraphy atlas of somatostatin receptors in neuroendocrine tumors of the pancreas and carcinoid tumors]
Neurofibroma
[Posterior arch of the atlas bone on x-ray; a study on spinal neurofibroma on C2.]
Neurofibromatoses
Intermittent atlantoaxial subluxation caused by a prolapsing neurofibroma. Case report.
Neurofibromatosis 1
Intermittent atlantoaxial subluxation caused by a prolapsing neurofibroma. Case report.
Neuroinflammatory Diseases
A chemical proteomic atlas of brain serine hydrolases identifies cell type-specific pathways regulating neuroinflammation.
Neuroinflammatory Diseases
Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation.
Neurologic Manifestations
3- to 11-year followup of occipitocervical fusion for rheumatoid arthritis.
Neurologic Manifestations
Neurologic dysfunction in patients with rheumatoid arthritis of the cervical spine. Predictive value of clinical, radiographic and MR imaging parameters.
Neurologic Manifestations
[Comparative study on indirect decompression versus open decompression to vertebral canal in treating thoracolumbar burst fractures without neurologic deficit]
Neurologic Manifestations
[The neurologic manifestations of malformations of the occipito-atloid joint; a case of occipitalization of the atlas accompanied by cystic arachnoiditis, and treated surgically.]
Neuroma, Acoustic
Retractorless translabyrinthine approach for resection of a large acoustic neuroma: operative video and technical nuances.
Neuroma, Acoustic
Retrosigmoid Transmeatal Approach for Resection of Acoustic Neuroma: Operative Video and Technical Nuances of Subperineural Dissection for Facial Nerve Preservation.
Neuroma, Acoustic
Translabyrinthine Approach for Resection of Large Cystic Acoustic Neuroma: Operative Video and Technical Nuances of Subperineural Dissection for Facial Nerve Preservation.
Neuromuscular Diseases
Exploration of New Contrasts, Targets, and MR Imaging and Spectroscopy Techniques for Neuromuscular Disease - A Workshop Report of Working Group 3 of the Biomedicine and Molecular Biosciences COST Action BM1304 MYO-MRI.
Nevi and Melanomas
ALDH1A3 is epigenetically regulated during melanocyte transformation and is a target for melanoma treatment.
Nevus
ALDH1A3 is epigenetically regulated during melanocyte transformation and is a target for melanoma treatment.
Non-alcoholic Fatty Liver Disease
Nutrigenetic Interactions Might Modulate the Antioxidant and Anti-Inflammatory Status in Mastiha-Supplemented Patients With NAFLD.
Non-alcoholic Fatty Liver Disease
The rs599839 A>G Variant Disentangles Cardiovascular Risk and Hepatocellular Carcinoma in NAFLD Patients.
Noonan Syndrome
Imaging of lymphatic dysplasia in Noonan syndrome: Case studies and historical atlas.
Obesity
Assessing the sustained impact of a school-based obesity prevention program for adolescent boys: the ATLAS cluster randomized controlled trial.
Obesity
Association of cancer mortality with postdiagnosis overweight and obesity using body mass index.
Obesity
Association of Processed Meats and Alcohol Consumption with Renal Cell Carcinoma: A Worldwide Population-Based Study.
Obesity
Examining Associations among Obesity and Per Capita Farmers' Markets, Grocery Stores/Supermarkets, and Supercenters in US Counties.
Obesity
Mediators of change in screen-time in a school-based intervention for adolescent boys: findings from the ATLAS cluster randomized controlled trial.
Obesity
Obesity atlas and methodbox: towards an open framework for sharing public health intelligence workflows.
Obesity
Obesity is a risk factor for acute promyelocytic leukemia: evidence from population and cross-sectional studies studies and correlation with flt3 mutations and polyunsaturated fatty acid metabolism.
Obesity
Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor Immunity.
Obesity
Obesity, overweight and body-weight perception in a High Atlas Moroccan population.
Obesity
Small area estimation and childhood obesity surveillance using electronic health records.
Obesity
Smart-phone obesity prevention trial for adolescent boys in low-income communities: the ATLAS RCT.
Obesity, Morbid
NASH-related increases in plasma bile acid levels depend on insulin resistance.
Oligodendroglioma
Comparative analysis of histologically classified oligodendrogliomas reveals characteristic molecular differences between subgroups.
Oligodendroglioma
Multi-faceted computational assessment of risk and progression in oligodendroglioma implicates NOTCH and PI3K pathways.
Oligodendroglioma
Transcription factor networks of oligodendrogliomas treated with adjuvant radiotherapy or observation inform prognosis.
Oligodendroglioma
[Preliminary analysis on the gene expression profiles of different types of gliomas with cDNA array]
Oligodendroglioma
[Preliminary study on the gene expression profiles of oligodendrogliom as with cDNA array]
Onchocerciasis
Complex emergencies and the control and elimination of neglected tropical diseases in Africa: developing a practical approach for implementing safe and effective mapping and intervention strategies.
Oropharyngeal Neoplasms
Estrogen Attenuates the Growth of Human Papillomavirus-Positive Epithelial Cells.
Oropharyngeal Neoplasms
Optimising volumetric arc radiotherapy for dental rehabilitation in oropharynx cancer - A retrospective dosimetry review and feasibility planning study.
Osteoarthritis
A radiological survey of the hips and knees in female specialist teachers of physical education.
Osteoarthritis
A Standardized, Pragmatic Approach to Knee Ultrasound for Clinical Research in Osteoarthritis: The Johnston County Osteoarthritis Project.
Osteoarthritis
Arthroscopic partial meniscectomy for a degenerative meniscus tear: a 5 year follow-up of the placebo-surgery controlled FIDELITY (Finnish Degenerative Meniscus Lesion Study) trial.
Osteoarthritis
Assessing progression of patellofemoral osteoarthritis: a comparison between two radiographic methods.
Osteoarthritis
Assessing the prevalence of hand osteoarthritis in epidemiological studies. The reliability of a radiological hand scale.
Osteoarthritis
Association between Dietary Magnesium Intake and Radiographic Knee Osteoarthritis.
Osteoarthritis
Association Between Infrapatellar Fat Pad Volume and Knee Structural Changes in Patients with Knee Osteoarthritis.
Osteoarthritis
Association between leptin, adiponectin and resistin and long-term progression of hand osteoarthritis.
Osteoarthritis
Association between MRI-detected osteophytes and changes in knee structures and pain in older adults: a cohort study.
Osteoarthritis
Association Between Preoperative Radiographic Severity of Osteoarthritis and Patient-Reported Outcomes of Total Knee Replacement.
Osteoarthritis
Association of varus thrust with prevalent patellofemoral osteoarthritis: A cross-sectional study.
Osteoarthritis
Associations between serum ghrelin and knee symptoms, joint structures and cartilage or bone biomarkers in patients with knee osteoarthritis.
Osteoarthritis
Automatic Grading of Individual Knee Osteoarthritis Features in Plain Radiographs Using Deep Convolutional Neural Networks.
Osteoarthritis
Case definitions of knee osteoarthritis in 4,151 unselected subjects: relevance for epidemiological studies : The Copenhagen Osteoarthritis Study.
Osteoarthritis
Changes in outcome measures for impairment, activity limitation, and participation restriction over two years in osteoarthritis of the lower extremities.
Osteoarthritis
Classification of four distinct osteoarthritis subtypes with a knee joint tissue transcriptome atlas.
Osteoarthritis
Clinical and radiographic disease course of hand osteoarthritis and determinants of outcome after 6 years.
Osteoarthritis
Clinical Significance of Medial Versus Lateral Compartment Patellofemoral Osteoarthritis: Cross-Sectional Analyses in an Adult Population With Knee Pain.
Osteoarthritis
Clustering of hand osteoarthritis progression and its relationship to progression of osteoarthritis at the knee.
Osteoarthritis
Coexisting lateral tibiofemoral osteoarthritis is associated with worse knee pain in patients with mild medial osteoarthritis.
Osteoarthritis
Comparison of radiographic and MRI osteoarthritis definitions and their combination for prediction of tibial cartilage loss, knee symptoms and total knee replacement: a longitudinal study.
Osteoarthritis
Correction: Atlas for the OMERACT thumb base osteoarthritis MRI scoring system (TOMS--).
Osteoarthritis
Defining the presence of radiographic knee osteoarthritis: a comparison between the Kellgren and Lawrence system and OARSI atlas criteria.
Osteoarthritis
Degeneration of the scaphoid-trapezium joint: a useful finding to differentiate calcium pyrophosphate deposition disease from osteoarthritis.
Osteoarthritis
Development and reproducibility of a first metatarsophalangeal joint osteoarthritis magnetic resonance imaging scoring system.
Osteoarthritis
Development and Validation of a Multitask Deep Learning Model for Severity Grading of Hip Osteoarthritis Features on Radiographs.
Osteoarthritis
Development of a logically devised line drawing atlas for grading of knee osteoarthritis.
Osteoarthritis
Differences in the radiological characteristics between post-traumatic and non-traumatic knee osteoarthritis.
Osteoarthritis
Differential Contribution of the Medial and the Lateral Side of the Joint to Symptoms in Knee Osteoarthritis: A Radiographic and Laboratory Analysis in the Nagahama Study.
Osteoarthritis
Do MRI features at baseline predict radiographic joint space narrowing in the medial compartment of the osteoarthritic knee 2 years later?
Osteoarthritis
Does Patellofemoral Disease Affect Outcomes in Contemporary Medial Fixed-Bearing Unicompartmental Knee Arthroplasty?
Osteoarthritis
Effect of medial tibial plateau alignment on serial radiographs on the capacity to predict progression of knee osteoarthritis.
Osteoarthritis
Effect of vitamin D levels on radiographic knee osteoarthritis and functional status.
Osteoarthritis
Factors influencing osteological changes in the hands and fingers of rock climbers.
Osteoarthritis
Fully automatic analysis of the knee articular cartilage T1? relaxation time using voxel-based relaxometry.
Osteoarthritis
Future of Chondroprotectors in the Treatment of Degenerative Processes of Connective Tissue.
Osteoarthritis
Genome-wide analysis of aberrant methylation of enhancer DNA in human osteoarthritis.
Osteoarthritis
High prevalence of knee osteoarthritis, pain, and functional limitations in female soccer players twelve years after anterior cruciate ligament injury.
Osteoarthritis
Hypointense signals in the infrapatellar fat pad assessed by magnetic resonance imaging are associated with knee symptoms and structure in older adults: a cohort study.
Osteoarthritis
Identification of Radiographic Foot Osteoarthritis: Sensitivity of Views and Features Using The La Trobe Radiographic Atlas.
Osteoarthritis
Initial results on development and application of statistical atlas of femoral cartilage in osteoarthritis to determine sex differences in structure: Data from the osteoarthritis initiative.
Osteoarthritis
Interleukin-6 and tumor necrosis factor alpha in synovial fluid are associated with progression of radiographic knee osteoarthritis in subjects with previous meniscectomy.
Osteoarthritis
Is loss in femorotibial cartilage thickness related to severity of contra-lateral radiographic knee osteoarthritis?--longitudinal data from the Osteoarthritis Initiative.
Osteoarthritis
Knee Osteoarthritis in Type 2 Diabetes Mellitus: Does Insulin Therapy Retard Osteophyte Formation?
Osteoarthritis
Lateral-compartment Osteophytes are not Associated With Lateral-compartment Cartilage Degeneration in Arthritic Varus Knees.
Osteoarthritis
Osteophytes, juxta-articular radiolucencies and cancellous bone changes in the proximal tibia of patients with knee osteoarthritis.
Osteoarthritis
Patella malalignment, pain and patellofemoral progression: the Health ABC Study.
Osteoarthritis
Patellofemoral osteoarthritis 15 years after anterior cruciate ligament injury - a prospective cohort study.
Osteoarthritis
Predictors of Radiographic Osteoarthritis 2 to 3 Years After Anterior Cruciate Ligament Reconstruction: Data From the MOON On-site Nested Cohort.
Osteoarthritis
Quadriceps Weakness in Individuals with Coexisting Medial and Lateral Osteoarthritis.
Osteoarthritis
Radiographic assessment of the femorotibial joint of the CCLT rabbit experimental model of osteoarthritis.
Osteoarthritis
Radiographic classification of osteoarthritis in commonly affected joints of the foot.
Osteoarthritis
Radiographic evaluation of foot osteoarthritis: sensitivity of radiographic variables and relationship to symptoms.
Osteoarthritis
Reconstruction of the health status in a past human population: the Iron Age necropolis of Monte Bibele (Bologna, Italy).
Osteoarthritis
Relationship between soy milk intake and radiographic knee joint space narrowing and osteophytes.
Osteoarthritis
Reliability of Assessing Hand Osteoarthritis on Digital Photographs and Associations With Radiographic and Clinical Findings.
Osteoarthritis
Reliability of grading scales for individual radiographic features of osteoarthritis of the knee. The Baltimore longitudinal study of aging atlas of knee osteoarthritis.
Osteoarthritis
Sensitivity-to-change and validity of semi-automatic joint space width measurements in hand osteoarthritis: a follow-up study.
Osteoarthritis
Should return to pivoting sport be avoided for the secondary prevention of osteoarthritis after anterior cruciate ligament reconstruction? A prospective cohort study with MRI, radiographic and symptomatic outcomes.
Osteoarthritis
Synovial cyst of the transverse ligament of the atlas causing tetraparesia in a context of generalized osteoarthritis.
Osteoarthritis
The association between changes in synovial fluid levels of ARGS-aggrecan fragments, progression of radiographic osteoarthritis and self-reported outcomes: a cohort study.
Osteoarthritis
The association between radiographic severity and pre-operative function in patients undergoing primary knee replacement for osteoarthritis.
Osteoarthritis
The associations of serum uric acid level and hyperuricemia with knee osteoarthritis.
Osteoarthritis
The effect of variation in interpretation of the La Trobe radiographic foot atlas on the prevalence of foot osteoarthritis in older women: the Chingford general population cohort.
Osteoarthritis
The third occipital condyle, a constituent part of a median occipito-atlanto-odontoid joint: a case report.
Osteoarthritis
TNF inhibitor treatment is associated with a lower risk of hand osteoarthritis progression in rheumatoid arthritis patients after 10 years.
Osteoarthritis
Treatment with TNF-? inhibitor infliximab might reduce hand osteoarthritis in patients with rheumatoid arthritis.
Osteoarthritis
Two-Year Results of the PHANTOM High Flex Trial: A Single-Arm Study on the Atlas Unicompartmental Knee System Load Absorber in Patients With Medial Compartment Osteoarthritis of the Knee.
Osteoarthritis
Validating a new computed tomography atlas for grading ankle osteoarthritis.
Osteoarthritis
Variations in the pre-operative status of patients coming to primary hip replacement for osteoarthritis in European orthopaedic centres.
Osteoarthritis, Hip
Scoring hip osteoarthritis with MRI (SHOMRI): A whole joint osteoarthritis evaluation system.
Osteoarthritis, Knee
A Standardized, Pragmatic Approach to Knee Ultrasound for Clinical Research in Osteoarthritis: The Johnston County Osteoarthritis Project.
Osteoarthritis, Knee
Arthroscopic partial meniscectomy for a degenerative meniscus tear: a 5 year follow-up of the placebo-surgery controlled FIDELITY (Finnish Degenerative Meniscus Lesion Study) trial.
Osteoarthritis, Knee
Defining the presence of radiographic knee osteoarthritis: a comparison between the Kellgren and Lawrence system and OARSI atlas criteria.
Osteoarthritis, Knee
Development of a logically devised line drawing atlas for grading of knee osteoarthritis.
Osteoarthritis, Knee
Does increasing the grades of the knee osteoarthritis line drawing atlas alter its clinimetric properties?
Osteoarthritis, Knee
Reliability of grading scales for individual radiographic features of osteoarthritis of the knee. The Baltimore longitudinal study of aging atlas of knee osteoarthritis.
Osteoarthritis, Knee
Two-Year Results of the PHANTOM High Flex Trial: A Single-Arm Study on the Atlas Unicompartmental Knee System Load Absorber in Patients With Medial Compartment Osteoarthritis of the Knee.
Osteoblastoma
Bilateral C-1 lateral mass reconstruction following radical resection of a giant osteoblastoma of the atlas: case report.
Osteoblastoma
Recurrent burner syndrome due to presumed cervical spine osteoblastoma in a collision sport athlete - a case report.
Osteoblastoma
Transoral-transpharyngeal approach to the anterior craniocervical junction. Ten-year experience with 72 patients.
Osteoblastoma
Tumors of the atlas. 3 incidental cases of osteochondroma, benign osteoblastoma, and atypical Ewing's sarcoma.
Osteoblastoma
Tumours of the atlas and axis: a 37-year experience with diagnosis and management.
Osteochondroma
A case of osteochondroma of the atlas causing obstructive sleep apnea syndrome.
Osteochondroma
Cervical myelopathy caused by atlas osteochondroma and pseudoarthrosis between the osteochondroma and lamina of the axis: case report.
Osteochondroma
Compressive Myelopathy due to Osteochondroma of the Atlas and Review of the Literature.
Osteochondroma
Myelopathy and Quadriparesis due to Spinal Cord Compression of C1 Laminar Osteochondroma.
Osteochondroma
Solitary osteochondroma of the atlas causing spinal cord compression: a case report and literature review.
Osteochondroma
Tumors of the atlas. 3 incidental cases of osteochondroma, benign osteoblastoma, and atypical Ewing's sarcoma.
Osteoma
"Dynamic" Rotational Canal Stenosis Caused by Osteoma of the Atlas: A Case Report and Review of Literature.
Osteoma, Osteoid
Osteoid Osteoma of the Atlas in a Boy: Clinical and Imaging Features-A Case Report and Review of the Literature.
Osteomyelitis
Actinomycotic osteomyelitis of the skull and atlas with late dissemination. A case of transient neurosurgical syndrome.
Osteomyelitis
Multiple Abscesses With Osteomyelitis and Destruction of Both the Atlas and the Axis in a 4-week-old Infant.
Osteomyelitis
Neonatal retropharyngeal abscess with complications: Apnea and cervical osteomyelitis.
Osteomyelitis
Osteomyelitis of the atlanto-occipital region as a sequela to a pharyngeal stick injury.
Osteomyelitis
Pyogenic osteomyelitis of the occiput, the atlas, and the axis. A report of five cases.
Osteomyelitis
[Primary, chronic, hematogenic osteomyelitis of the posterior tubercle of the atlas.]
Osteonecrosis
Imaging atlas for eligibility and on-study safety of potential shoulder adverse events in anti-NGF studies (Part 3).
Osteophyte
A comparison of the semiflexed (MTP) view with the standing extended view (SEV) in the radiographic assessment of knee osteoarthritis in a busy routine X-ray department.
Osteophyte
A cross sectional study of the association between sex, smoking, and other lifestyle factors and osteoarthritis of the hand.
Osteophyte
A cross-sectional study of the association between Heberden's nodes, radiographic osteoarthritis of the hands, grip strength, disability and pain.
Osteophyte
A randomised controlled trial of intra-articular corticosteroid injection of the carpometacarpal joint of the thumb in osteoarthritis.
Osteophyte
Age and sex differences in hip joint space among asymptomatic subjects without structural change: implications for epidemiologic studies.
Osteophyte
Arthroscopic partial meniscectomy for a degenerative meniscus tear: a 5 year follow-up of the placebo-surgery controlled FIDELITY (Finnish Degenerative Meniscus Lesion Study) trial.
Osteophyte
Association Between Infrapatellar Fat Pad Volume and Knee Structural Changes in Patients with Knee Osteoarthritis.
Osteophyte
Association between KLOTHO gene and hand osteoarthritis in a female Caucasian population.
Osteophyte
Association of pain with radiological changes in different compartments and views of the knee joint.
Osteophyte
Associations between obesity and the radiographic phenotype in knee osteoarthritis.
Osteophyte
Associations between serum ghrelin and knee symptoms, joint structures and cartilage or bone biomarkers in patients with knee osteoarthritis.
Osteophyte
Atlas-based knee osteophyte assessment with ultrasonography and radiography: relationship to arthroscopic degeneration of articular cartilage.
Osteophyte
Automatic Grading of Individual Knee Osteoarthritis Features in Plain Radiographs Using Deep Convolutional Neural Networks.
Osteophyte
Beauty parlor stroke syndrome due to a bone fragment from an osteophyte of the atlas: case report.
Osteophyte
Cervical myelopathy caused by atlas osteochondroma and pseudoarthrosis between the osteochondroma and lamina of the axis: case report.
Osteophyte
Cervical myelopathy caused by pseudoarthrosis between posterior arch of the atlas and lamina of the axis in Klippel-Feil syndrome: a case report.
Osteophyte
Characterisation of first metatarsophalangeal joint osteoarthritis using magnetic resonance imaging.
Osteophyte
Characterisation of size and direction of osteophyte in knee osteoarthritis: a radiographic study.
Osteophyte
Choosing the best method for radiological assessment of patellofemoral osteoarthritis.
Osteophyte
Clinical and radiographic disease course of hand osteoarthritis and determinants of outcome after 6 years.
Osteophyte
Clinical Significance of Medial Versus Lateral Compartment Patellofemoral Osteoarthritis: Cross-Sectional Analyses in an Adult Population With Knee Pain.
Osteophyte
Clustering of hand osteoarthritis progression and its relationship to progression of osteoarthritis at the knee.
Osteophyte
Complex cervical spondylotic myelopathy: a report of two cases and literature review.
Osteophyte
Defining the presence of radiographic knee osteoarthritis: a comparison between the Kellgren and Lawrence system and OARSI atlas criteria.
Osteophyte
Development and reproducibility of a first metatarsophalangeal joint osteoarthritis magnetic resonance imaging scoring system.
Osteophyte
Development and Validation of a Multitask Deep Learning Model for Severity Grading of Hip Osteoarthritis Features on Radiographs.
Osteophyte
Development of a logically devised line drawing atlas for grading of knee osteoarthritis.
Osteophyte
Development of osteoarthritis in patients with degenerative meniscal tears treated with exercise therapy or surgery. A randomized controlled trial.
Osteophyte
Differences in the radiological characteristics between post-traumatic and non-traumatic knee osteoarthritis.
Osteophyte
Effect of medial tibial plateau alignment on serial radiographs on the capacity to predict progression of knee osteoarthritis.
Osteophyte
Foot osteoarthritis frequency and associated factors in a community-based cross-sectional study of White and African American adults.
Osteophyte
Genetic influence on the progression of radiographic knee osteoarthritis: a longitudinal twin study.
Osteophyte
High Bone Mass is associated with bone-forming features of osteoarthritis in non-weight bearing joints independent of body mass index.
Osteophyte
High prevalence of knee osteoarthritis, pain, and functional limitations in female soccer players twelve years after anterior cruciate ligament injury.
Osteophyte
Identification of Radiographic Foot Osteoarthritis: Sensitivity of Views and Features Using The La Trobe Radiographic Atlas.
Osteophyte
Individuals with high bone mass have an increased prevalence of radiographic knee osteoarthritis.
Osteophyte
Knee and Hip Radiographic Osteoarthritis Predict Total Hip Bone Loss in Older Adults: A Prospective Study.
Osteophyte
Lateral-compartment Osteophytes are not Associated With Lateral-compartment Cartilage Degeneration in Arthritic Varus Knees.
Osteophyte
Osteophytes, juxta-articular radiolucencies and cancellous bone changes in the proximal tibia of patients with knee osteoarthritis.
Osteophyte
Patella malalignment, pain and patellofemoral progression: the Health ABC Study.
Osteophyte
Quantification of hip effusion-synovitis and its cross-sectional and longitudinal associations with hip pain, MRI findings and early radiographic hip OA.
Osteophyte
Radiographic classification of osteoarthritis in commonly affected joints of the foot.
Osteophyte
Radiographic osteoarthritis and pain are independent predictors of knee cartilage loss: a prospective study.
Osteophyte
Reduction of leucocyte telomere length in radiographic hand osteoarthritis: a population-based study.
Osteophyte
Relation between Heberden's nodes and distal interphalangeal joint osteophytes and their role as markers of generalised disease.
Osteophyte
Relation between insulin-like growth factor-I concentrations, osteoarthritis, bone density, and fractures in the general population: the Chingford study.
Osteophyte
Relationship between Heberden's nodes and underlying radiographic changes of osteoarthritis.
Osteophyte
Reversal of longstanding musculoskeletal changes in basilar invagination after surgical decompression and stabilization.
Osteophyte
Risk factors for osteoarthritis in the tibiofemoral and patellofemoral joints of the knee.
Osteophyte
Risk factors for progression of lumbar spine disc degeneration: the Chingford Study.
Osteophyte
The association between hormonal and reproductive factors and hand osteoarthritis.
Osteophyte
The natural history of radiographic first metatarsophalangeal joint osteoarthritis: a nineteen-year population based cohort study.
Osteophyte
TNF inhibitor treatment is associated with a lower risk of hand osteoarthritis progression in rheumatoid arthritis patients after 10 years.
Osteophyte
Trabecular morphometry by fractal signature analysis is a novel marker of osteoarthritis progression.
Osteophyte
Treatment with TNF-? inhibitor infliximab might reduce hand osteoarthritis in patients with rheumatoid arthritis.
Osteophyte
Ultrasonographic assessment of osteophytes in 127 patients with hand osteoarthritis: exploring reliability and associations with MRI, radiographs and clinical joint findings.
Osteophyte
["Crowned" odontoid process and osteoarthrosis of the anterior atlantoaxial joint (author's transl)]
Osteoporosis
Author Correction: An atlas of genetic influences on osteoporosis in humans and mice.
Osteoporosis
Odontoid fractures complicated by fractures of the posterior arch of the atlas in the elderly over 85 years with severe thoracic kyphosis secondary to osteoporosis.
Osteosarcoma
A comprehensive analysis of immune infiltration in the tumor microenvironment of osteosarcoma.
Osteosarcoma
A DNA methylation-associated nomogram predicts the overall survival of osteosarcoma.
Osteosarcoma
Analyzing the disease module associated with osteosarcoma via a network- and pathway-based approach.
Osteosarcoma
Comprehensive Analysis of Aerobic Exercise-Related Genes Identifies CDCA4 That Promotes the Progression of Osteosarcoma.
Osteosarcoma
DNA Methylation-Based Classifier for Accurate Molecular Diagnosis of Bone Sarcomas.
Osteosarcoma
Exploration of Immune-Related Gene Expression in Osteosarcoma and Association With Outcomes.
Osteosarcoma
Homeodomain-containing gene 10 inhibits cell apoptosis and promotes cell invasion and migration in osteosarcoma cell lines.
Osteosarcoma
Identification of prognostic biomarkers associated with metastasis and immune infiltration in osteosarcoma.
Osteosarcoma
Long noncoding RNA MEG3 play an important role in osteosarcoma development through sponging microRNAs.
Osteosarcoma
Long term survival of an atlas osteosarcoma treated by surgery, chemotherapy and robotic stereotactic radiotherapy: a case report.
Osteosarcoma
m6A regulators are associated with osteosarcoma metastasis and have prognostic significance: A study based on public databases.
Osteosarcoma
Occipito-cervical Reconstruction Through Direct Lateral and Posterior Approach or the Treatment of Primary Osteosarcoma in the Atlas: A Case Report.
Osteosarcoma
Potential role of m6A RNA methylation regulators in osteosarcoma and its clinical prognostic value.
Osteosarcoma
Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma.
Osteosarcoma
The value of Angipoietin-2 as a biomarker for the prognosis of osteosarcoma: A protocol for systematic review and meta-analysis.
Osteosarcoma
Trophinin Is an Important Biomarker and Prognostic Factor in Osteosarcoma: Data Mining from Oncomine and the Cancer Genome Atlas Databases.
Otitis Media
Unusual presentations of craniovertebral junction tuberculosis: a report of 2 cases and literature review.
Otorhinolaryngologic Diseases
[Otorhinolaryngological diseases in radiography. A clinical and practical atlas]
Ovarian Neoplasms
'BRCAness' and its implications for platinum action in gynecologic cancer.
Ovarian Neoplasms
A bioinformatic analysis: the overexpression and clinical significance of FCGBP in ovarian cancer.
Ovarian Neoplasms
A FXYD5/TGF??/SMAD positive feedback loop drives epithelial?to?mesenchymal transition and promotes tumor growth and metastasis in ovarian cancer.
Ovarian Neoplasms
A gene signature for immune subtyping of desert, excluded, and inflamed ovarian tumors.
Ovarian Neoplasms
A graph-based multi-sample test for identifying pathways associated with cancer progression.
Ovarian Neoplasms
A network-pathway based module identification for predicting the prognosis of ovarian cancer patients.
Ovarian Neoplasms
A new spontaneously transformed syngeneic model of high-grade serous ovarian cancer with a tumor-initiating cell population.
Ovarian Neoplasms
A non-negative matrix factorization method for detecting modules in heterogeneous omics multi-modal data.
Ovarian Neoplasms
A reactive oxygen species scoring system predicts cisplatin sensitivity and prognosis in ovarian cancer patients.
Ovarian Neoplasms
ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: A comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas.
Ovarian Neoplasms
Adverse Drug Events-based Tumor Stratification for Ovarian Cancer Patients Receiving Platinum Therapy.
Ovarian Neoplasms
Age-related copy number variations and expression levels of F-box protein FBXL20 predict ovarian cancer prognosis.
Ovarian Neoplasms
An epigenetic signature of adhesion molecules predicts poor prognosis of ovarian cancer patients.
Ovarian Neoplasms
An integrated analysis reveals the oncogenic function of lncRNA LINC00511 in human ovarian cancer.
Ovarian Neoplasms
Analysis and comparison of somatic mutations in paired primary and recurrent epithelial ovarian cancer samples.
Ovarian Neoplasms
ARHGAP10, downregulated in ovarian cancer, suppresses tumorigenicity of ovarian cancer cells.
Ovarian Neoplasms
Association analysis of a chemo-response signature identified within The Cancer Genome Atlas aimed at predicting genetic risk for chemo-response in ovarian cancer.
Ovarian Neoplasms
Association of Copy Number Variation Signature and Survival in Patients With Serous Ovarian Cancer.
Ovarian Neoplasms
Association of Somatic Mutations of ADAMTS Genes With Chemotherapy Sensitivity and Survival in High-Grade Serous Ovarian Carcinoma.
Ovarian Neoplasms
ATP binding cassette subfamily B member 9 (ABCB9) is a prognostic indicator of overall survival in ovarian cancer.
Ovarian Neoplasms
Beyond genomics: critical evaluation of cell line utility for ovarian cancer research.
Ovarian Neoplasms
Big data-based identification of methylated genes associated with drug resistance and prognosis in ovarian cancer.
Ovarian Neoplasms
BNIP3 contributes to cisplatin-induced apoptosis in ovarian cancer cells.
Ovarian Neoplasms
BRCA 1/2-Mutation Related and Sporadic Breast and Ovarian Cancers: More Alike than Different.
Ovarian Neoplasms
Cancer Progression Prediction Using Gene Interaction Regularized Elastic Net.
Ovarian Neoplasms
CHD4 regulates platinum sensitivity through MDR1 expression in ovarian cancer: A potential role of CHD4 inhibition as a combination therapy with platinum agents.
Ovarian Neoplasms
Clinical and prognostic effects of CDKN2A, CDKN2B and CDH13 promoter methylation in ovarian cancer: a study using meta-analysis and TCGA data.
Ovarian Neoplasms
Comparative transcriptome analysis of matched primary and distant metastatic ovarian carcinoma.
Ovarian Neoplasms
Comprehensive Landscape of Ovarian Cancer Immune Microenvironment Based on Integrated Multi-Omics Analysis.
Ovarian Neoplasms
Construction of integrated microRNA and mRNA immune cell signatures to predict survival of patients with breast and ovarian cancer.
Ovarian Neoplasms
Cooperative driver pathway discovery via fusion of multi-relational data of genes, miRNAs and pathways.
Ovarian Neoplasms
Correlation between gene expression and mutator phenotype predicts homologous recombination deficiency and outcome in ovarian cancer.
Ovarian Neoplasms
Cysteine-Rich Intestinal Protein 1 Served as an Epithelial Ovarian Cancer Marker via Promoting Wnt/?-Catenin-Mediated EMT and Tumour Metastasis.
Ovarian Neoplasms
Depletion of UBE2C reduces ovarian cancer malignancy and reverses cisplatin resistance via downregulating CDK1.
Ovarian Neoplasms
Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study.
Ovarian Neoplasms
Development and Validation of a Novel 11-Gene Prognostic Model for Serous Ovarian Carcinomas Based on Lipid Metabolism Expression Profile.
Ovarian Neoplasms
Development and Validation of an Immune-Related Prognostic Signature for Ovarian Cancer Based on Weighted Gene Coexpression Network Analysis.
Ovarian Neoplasms
Development of a multi-gene-based immune prognostic signature in ovarian Cancer.
Ovarian Neoplasms
DGAT1 Expression Promotes Ovarian Cancer Progression and Is Associated with Poor Prognosis.
Ovarian Neoplasms
Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells.
Ovarian Neoplasms
Direct impact of cisplatin on mitochondria induces ROS production that dictates cell fate of ovarian cancer cells.
Ovarian Neoplasms
Discovering drugs to overcome chemoresistance in ovarian cancers based on the cancer genome atlas tumor transcriptome profile.
Ovarian Neoplasms
Discovery of candidate tumor biomarkers for treatment with intraperitoneal chemotherapy for ovarian cancer.
Ovarian Neoplasms
Discovery of multi-dimensional modules by integrative analysis of cancer genomic data.
Ovarian Neoplasms
Discovery of mutated subnetworks associated with clinical data in cancer.
Ovarian Neoplasms
Does tumour biology determine surgical success in the treatment of epithelial ovarian cancer? A systematic literature review.
Ovarian Neoplasms
Effects of Kras activation and Pten deletion alone or in combination on MUC1 biology and epithelial-to-mesenchymal transition in ovarian cancer.
Ovarian Neoplasms
ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cells.
Ovarian Neoplasms
Enhanced GAB2 Expression Is Associated with Improved Survival in High-Grade Serous Ovarian Cancer and Sensitivity to PI3K Inhibition.
Ovarian Neoplasms
Enhancing the sensitivity of ovarian cancer cells to olaparib via microRNA-20b-mediated cyclin D1 targeting.
Ovarian Neoplasms
Epigenetic regulation of IQGAP2 promotes ovarian cancer progression via activating Wnt/?-catenin signaling.
Ovarian Neoplasms
Establishment of a novel glycolysis-related prognostic gene signature for ovarian cancer and its relationships with immune infiltration of the tumor microenvironment.
Ovarian Neoplasms
Establishment of a Novel Histopathological Classification of High-Grade Serous Ovarian Carcinoma Correlated with Prognostically Distinct Gene Expression Subtypes.
Ovarian Neoplasms
Estimation of Heterogeneous Restricted Mean Survival Time Using Random Forest.
Ovarian Neoplasms
Estrogen-related receptor alpha copy number variation is associated with ovarian cancer histological grade.
Ovarian Neoplasms
Evaluation of Epigenetic Drug Targeting of Heterogenous Tumor Cell Fractions Using Potential Biomarkers of Response in Ovarian Cancer.
Ovarian Neoplasms
Exploration of Genomic, Proteomic, and Histopathological Image Data Integration Methods for Clinical Prediction.
Ovarian Neoplasms
Exploring prognostic genes in ovarian cancer stage-related coexpression network modules.
Ovarian Neoplasms
Expression of the Carboxy-Terminal Portion of MUC16/CA125 Induces Transformation and Tumor Invasion.
Ovarian Neoplasms
Expression profiles and prognostic values of BolA family members in ovarian cancer.
Ovarian Neoplasms
Frizzled-7 Identifies Platinum-Tolerant Ovarian Cancer Cells Susceptible to Ferroptosis.
Ovarian Neoplasms
GEMINI: a computationally-efficient search engine for large gene expression datasets.
Ovarian Neoplasms
Gene-Gene Interaction Analysis for the Survival Phenotype Based on the Kaplan-Meier Median Estimate.
Ovarian Neoplasms
Genome-wide association studies of survival in 1,520 cancer patients treated with bevacizumab-containing regimens.
Ovarian Neoplasms
Genomic Rearrangement Signatures and Clinical Outcomes in High-Grade Serous Ovarian Cancer.
Ovarian Neoplasms
Genomic, Transcriptomic, and Functional Alterations in DNA Damage Response Pathways as Putative Biomarkers of Chemotherapy Response in Ovarian Cancer.
Ovarian Neoplasms
Germline whole exome sequencing and large-scale replication identifies FANCM as a likely high grade serous ovarian cancer susceptibility gene.
Ovarian Neoplasms
Glucocorticoid receptor expression is associated with inferior overall survival independent of BRCA mutation status in ovarian cancer.
Ovarian Neoplasms
Glutamine-fructose-6-phosphate transaminase 2 (GFPT2) promotes the EMT of serous ovarian cancer by activating the hexosamine biosynthetic pathway to increase the nuclear location of ?-catenin.
Ovarian Neoplasms
Glycogen phosphorylase B promotes ovarian cancer progression via Wnt/?-catenin signaling and is regulated by miR-133a-3p.
Ovarian Neoplasms
Graph-based semi-supervised learning with genomic data integration using condition-responsive genes applied to phenotype classification.
Ovarian Neoplasms
High expression of miR-532-5p, a tumor suppressor, leads to better prognosis in ovarian cancer both in vivo and in vitro.
Ovarian Neoplasms
Hybrid Capture-based Genomic Profiling of Circulating Tumor DNA From Patients With Advanced Ovarian Cancer.
Ovarian Neoplasms
Identification of a five-gene signature of the RGS gene family with prognostic value in ovarian cancer.
Ovarian Neoplasms
Identification of a Novel Tumor Microenvironment Prognostic Signature for Advanced-Stage Serous Ovarian Cancer.
Ovarian Neoplasms
Identification of influential observations in high-dimensional cancer survival data through the rank product test.
Ovarian Neoplasms
Identification of key genes and pathways associated with topotecan treatment using multiple bioinformatics tools.
Ovarian Neoplasms
Identification of metastasis and prognosis-associated genes for serous ovarian cancer.
Ovarian Neoplasms
Identification of rare germline copy number variations over-represented in five human cancer types.
Ovarian Neoplasms
Identification of the miRNA signature associated with survival in patients with ovarian cancer.
Ovarian Neoplasms
Identification of tumor suppressors and oncogenes from genomic and epigenetic features in ovarian cancer.
Ovarian Neoplasms
Identification of two molecular subtypes of dysregulated immune lncRNAs in ovarian cancer.
Ovarian Neoplasms
Identification three LncRNA prognostic signature of ovarian cancer based on genome-wide copy number variation.
Ovarian Neoplasms
Identifying candidate drivers of drug response in heterogeneous cancer by mining high throughput genomics data.
Ovarian Neoplasms
Identifying Functional Modules in Co-Regulatory Networks Through Overlapping Spectral Clustering.
Ovarian Neoplasms
Identifying Gene Network Rewiring by Integrating Gene Expression and Gene Network Data.
Ovarian Neoplasms
Immune Modeling Analysis Reveals Immunologic Signatures Associated With Improved Outcomes in High Grade Serous Ovarian Cancer.
Ovarian Neoplasms
Immunoregulatory gene expression and response to bevacizumab in ovarian cancer - An analysis of the cancer genome atlas.
Ovarian Neoplasms
In North America, Some Ovarian Cancers Express the Oncogenes of Preventable Human Papillomavirus HPV-18.
Ovarian Neoplasms
Increased Expression of LYNX1 in Ovarian Serous Cystadenocarcinoma Predicts Poor Prognosis.
Ovarian Neoplasms
Inferring active and prognostic ligand-receptor pairs with interactions in survival regression models.
Ovarian Neoplasms
Inhibition of TMEM45A suppresses proliferation, induces cell cycle arrest and reduces cell invasion in human ovarian cancer cells.
Ovarian Neoplasms
Insulin-like growth factor 2 silencing restores taxol sensitivity in drug resistant ovarian cancer.
Ovarian Neoplasms
Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer.
Ovarian Neoplasms
Integrated analyses of microRNAs demonstrate their widespread influence on gene expression in high-grade serous ovarian carcinoma.
Ovarian Neoplasms
Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer.
Ovarian Neoplasms
Integrative network analysis for survival-associated gene-gene interactions across multiple genomic profiles in ovarian cancer.
Ovarian Neoplasms
Interactions between tumor mutation burden and immune infiltration in ovarian cancer.
Ovarian Neoplasms
Investigation on tissue specific effects of pro-apoptotic micro RNAs revealed miR-147b as a potential biomarker in ovarian cancer prognosis.
Ovarian Neoplasms
Kelch-like protein 14 promotes proliferation and migration of ovarian cancer cells.
Ovarian Neoplasms
Key nodes of a microRNA network associated with the integrated mesenchymal subtype of high-grade serous ovarian cancer.
Ovarian Neoplasms
Knockdown of TMEM14A expression by RNAi inhibits the proliferation and invasion of human ovarian cancer cells.
Ovarian Neoplasms
KRT7 promotes epithelial?mesenchymal transition in ovarian cancer via the TGF??/Smad2/3 signaling pathway.
Ovarian Neoplasms
Leptin stimulates migration and invasion and maintains cancer stem-like properties in ovarian cancer cells: an explanation for poor outcomes in obese women.
Ovarian Neoplasms
Loss of TXNIP enhances peritoneal metastasis and can be abrogated by dual TORC1/2 inhibition.
Ovarian Neoplasms
Low-dose mono(2-ethylhexyl) phthalate promotes ovarian cancer development through PPAR?-dependent PI3K/Akt/NF-?B pathway.
Ovarian Neoplasms
MAPT (Tau) expression is a biomarker for an increased rate of survival in pediatric neuroblastoma.
Ovarian Neoplasms
miR-142-5p enhances cisplatin-induced apoptosis in ovarian cancer cells by targeting multiple anti-apoptotic genes.
Ovarian Neoplasms
miR-205 regulates the proliferation and invasion of ovarian cancer cells via suppressing PTEN/SMAD4 expression.
Ovarian Neoplasms
miR-339-5p inhibits migration and invasion in ovarian cancer cell lines by targeting NACC1 and BCL6.
Ovarian Neoplasms
miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer.
Ovarian Neoplasms
Molecular insights into the transcriptional regulatory role of thyroid hormones in ovarian cancer.
Ovarian Neoplasms
Molecular profiling and molecular classification of endometrioid ovarian carcinomas.
Ovarian Neoplasms
MRPL15 is a novel prognostic biomarker and therapeutic target for epithelial ovarian cancer.
Ovarian Neoplasms
Network-Based Isoform Quantification with RNA-Seq Data for Cancer Transcriptome Analysis.
Ovarian Neoplasms
Network-based machine learning and graph theory algorithms for precision oncology.
Ovarian Neoplasms
Overexpression of CCDC69 activates p14ARF/MDM2/p53 pathway and confers cisplatin sensitivity.
Ovarian Neoplasms
Pathway Relevance Ranking for Tumor Samples through Network-Based Data Integration.
Ovarian Neoplasms
Pathway-Structured Predictive Model for Cancer Survival Prediction: A Two-Stage Approach.
Ovarian Neoplasms
Platinum Sensitivity-Related Germline Polymorphism Discovered via a Cell-Based Approach and Analysis of Its Association with Outcome in Ovarian Cancer Patients.
Ovarian Neoplasms
Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancer.
Ovarian Neoplasms
PLODs are overexpressed in ovarian cancer and are associated with gap junctions via connexin 43.
Ovarian Neoplasms
ProcessDriver: A computational pipeline to identify copy number drivers and associated disrupted biological processes in cancer.
Ovarian Neoplasms
Prognostic relevance of acquired uniparental disomy in serous ovarian cancer.
Ovarian Neoplasms
Prognostic signature of ovarian cancer based on 14 tumor microenvironment-related genes.
Ovarian Neoplasms
Protein anabolism is key to long-term survival in high-grade serous ovarian cancer.
Ovarian Neoplasms
Proteomics analysis to reveal biological pathways and predictive proteins in the survival of high-grade serous ovarian cancer.
Ovarian Neoplasms
PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis.
Ovarian Neoplasms
Radiogenomics of High-Grade Serous Ovarian Cancer: Multireader Multi-Institutional Study from the Cancer Genome Atlas Ovarian Cancer Imaging Research Group.
Ovarian Neoplasms
Reannotation and Analysis of Clinical and Chemotherapy Outcomes in the Ovarian Data Set From The Cancer Genome Atlas.
Ovarian Neoplasms
Reduced levels of actin gamma 1 predict poor prognosis in ovarian cancer patients.
Ovarian Neoplasms
Reducing confounding and suppression effects in TCGA data: an integrated analysis of chemotherapy response in ovarian cancer.
Ovarian Neoplasms
RSPO3 is a marker candidate for predicting tumor aggressiveness in ovarian cancer.
Ovarian Neoplasms
S-score: a scoring system for the identification and prioritization of predicted cancer genes.
Ovarian Neoplasms
Semi-supervised identification of cancer subgroups using survival outcomes and overlapping grouping information.
Ovarian Neoplasms
Serine hydroxymethyl transferase 1 stimulates pro-oncogenic cytokine expression through sialic acid to promote ovarian cancer tumor growth and progression.
Ovarian Neoplasms
Single gold-bridged nanoprobes for identification of single point DNA mutations.
Ovarian Neoplasms
Single-cell transcriptomes reveal heterogeneity of high-grade serous ovarian carcinoma.
Ovarian Neoplasms
Single-sample expression-based chemo-sensitivity score improves survival associations independently from genomic mutations for ovarian cancer Patients.
Ovarian Neoplasms
Specific TP53 Mutants Overrepresented in Ovarian Cancer Impact CNV, TP53 Activity, Responses to Nutlin-3a, and Cell Survival.
Ovarian Neoplasms
Suppression of ABHD2, identified through a functional genomics screen, causes anoikis resistance, chemoresistance and poor prognosis in ovarian cancer.
Ovarian Neoplasms
Survival of patients with structurally-grouped TP53 mutations in ovarian and breast cancers.
Ovarian Neoplasms
The impact on high-grade serous ovarian cancer of obesity and lipid metabolism-related gene expression patterns: the underestimated driving force affecting prognosis.
Ovarian Neoplasms
The Importance of the PI3K/AKT/MTOR Pathway in the Progression of Ovarian Cancer.
Ovarian Neoplasms
The lncRNA SNHG3 regulates energy metabolism of ovarian cancer by an analysis of mitochondrial proteomes.
Ovarian Neoplasms
The molecular genetic basis of ovarian cancer and its roadmap towards a better treatment.
Ovarian Neoplasms
The potential of biologic network models in understanding the etiopathogenesis of ovarian cancer.
Ovarian Neoplasms
The proteasome deubiquitinase inhibitor bAP15 downregulates TGF-?/Smad signaling and induces apoptosis via UCHL5 inhibition in ovarian cancer.
Ovarian Neoplasms
The RNA-binding protein DDX1 promotes primary microRNA maturation and inhibits ovarian tumor progression.
Ovarian Neoplasms
TP53 hot spot mutations in ovarian cancer: selective resistance to microtubule stabilizers in vitro and differential survival outcomes from The Cancer Genome Atlas.
Ovarian Neoplasms
TP53 oncomorphic mutations predict resistance to platinum? and taxane?based standard chemotherapy in patients diagnosed with advanced serous ovarian carcinoma.
Ovarian Neoplasms
Tryptophan 2, 3?dioxygenase promotes proliferation, migration and invasion of ovarian cancer cells.
Ovarian Neoplasms
Tumor Immunometabolism Characterization in Ovarian Cancer With Prognostic and Therapeutic Implications.
Ovarian Neoplasms
Tumor infiltrating plasma cells are associated with tertiary lymphoid structures, cytolytic T cell responses, and superior prognosis in ovarian cancer.
Ovarian Neoplasms
Tumor specific methylome in Chinese high-grade serous ovarian cancer characterized by gene expression profile and tumor genotype.
Ovarian Neoplasms
Using knowledge-driven genomic interactions for multi-omics data analysis: metadimensional models for predicting clinical outcomes in ovarian carcinoma.
Ovarian Neoplasms
Will Chinese ovarian cancer patients benefit from knowing the BRCA2 mutation status?
Ovarian Neoplasms
Wnt Signaling and Survival of Women With High-Grade Serous Ovarian Cancer: A Brief Report.
Ovarian Neoplasms
ZNF671 DNA methylation as a molecular predictor for the early recurrence of serous ovarian cancer.
Overweight
Association of cancer mortality with postdiagnosis overweight and obesity using body mass index.
Overweight
Obesity, overweight and body-weight perception in a High Atlas Moroccan population.
Overweight
Sci-Fri AM: Imaging - 06: The role of body mass and gender in atlas construction for attenuation correction in PET/MRI.
Pancreatic Diseases
Single-Nucleus and In Situ RNA-Sequencing Reveal Cell Topographies in the Human Pancreas.
Pancreatic Diseases
The Mouse Model of Pancreatic Cancer Atlas (MMPCA) for classification of pancreatic cancer lesions: A large histological investigation of the Ptf1aCre/+;LSL-KrasG12D/+ transgenic mouse model of pancreatic cancer.
Pancreatic Neoplasms
??elemene inhibits the generation of peritoneum effusion in pancreatic cancer via suppression of the HIF1A?VEGFA pathway based on network pharmacology.
Pancreatic Neoplasms
A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study.
Pancreatic Neoplasms
A Novel Four-Gene Score to Predict Pathologically Complete (R0) Resection and Survival in Pancreatic Cancer.
Pancreatic Neoplasms
A novel sensitive detection method for DNA methylation in circulating free DNA of pancreatic cancer.
Pancreatic Neoplasms
A potential signaling axis between RON kinase receptor and hypoxia-inducible factor-1 alpha in pancreatic cancer.
Pancreatic Neoplasms
A signature of 18 immune-related gene pairs to predict the prognosis of pancreatic cancer patients.
Pancreatic Neoplasms
Aberrant FAM64A mRNA expression is an independent predictor of poor survival in pancreatic cancer.
Pancreatic Neoplasms
An overactive neddylation pathway serves as a therapeutic target and MLN4924 enhances the anticancer activity of cisplatin in pancreatic cancer.
Pancreatic Neoplasms
ARF6, induced by mutant Kras, promotes proliferation and Warburg effect in pancreatic cancer.
Pancreatic Neoplasms
B3GNT3: A prognostic biomarker associated with immune cell infiltration in pancreatic adenocarcinoma.
Pancreatic Neoplasms
Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer.
Pancreatic Neoplasms
CDK1/2/5 inhibition overcomes IFNG-mediated adaptive immune resistance in pancreatic cancer.
Pancreatic Neoplasms
Construction of a novel risk model based on the random forest algorithm to distinguish pancreatic cancers with different prognoses and immune microenvironment features.
Pancreatic Neoplasms
CSE1L, as a novel prognostic marker, promotes pancreatic cancer proliferation by regulating the AKT/mTOR signaling pathway.
Pancreatic Neoplasms
Deep learning-based gene selection in comprehensive gene analysis in pancreatic cancer.
Pancreatic Neoplasms
Development and validation of a ferroptosis-related prognostic model in pancreatic cancer.
Pancreatic Neoplasms
Development and validation of a four-lipid metabolism gene signature for diagnosis of pancreatic cancer.
Pancreatic Neoplasms
Development and Validation of a Novel Metabolic-Related Signature Predicting Overall Survival for Pancreatic Cancer.
Pancreatic Neoplasms
Development of a 12-biomarkers-based prognostic model for pancreatic cancer using multi-omics integrated analysis.
Pancreatic Neoplasms
Downregulation of miR-374b-5p promotes chemotherapeutic resistance in pancreatic cancer by upregulating multiple anti-apoptotic proteins.
Pancreatic Neoplasms
Expression and prognostic analyses of the insulin-like growth factor 2 mRNA binding protein family in human pancreatic cancer.
Pancreatic Neoplasms
Expression of HMGB2 indicates worse survival of patients and is required for the maintenance of Warburg effect in pancreatic cancer.
Pancreatic Neoplasms
Genetic alterations and functional networks of m6A RNA methylation regulators in pancreatic cancer based on data mining.
Pancreatic Neoplasms
Genetic characteristics and prognostic implications of m1A regulators in pancreatic cancer.
Pancreatic Neoplasms
Genetic landscape of prognostic value in pancreatic ductal adenocarcinoma microenvironment.
Pancreatic Neoplasms
Genomic analysis of pancreatic cancer reveals 3 molecular subtypes with different clinical outcomes.
Pancreatic Neoplasms
GPRC5A is a potential oncogene in pancreatic ductal adenocarcinoma cells that is upregulated by gemcitabine with help from HuR.
Pancreatic Neoplasms
HELLS serves as a poor prognostic biomarker and its downregulation reserves the malignant phenotype in pancreatic cancer.
Pancreatic Neoplasms
High expression of MMP14 is associated with progression and poor short-term prognosis in muscle-invasive bladder cancer.
Pancreatic Neoplasms
High expression of MMP28 indicates unfavorable prognosis in pancreatic cancer.
Pancreatic Neoplasms
Homeodomain-interacting protein kinase 2 suppresses proliferation and aerobic glycolysis via ERK/cMyc axis in pancreatic cancer.
Pancreatic Neoplasms
HOXB5 promotes malignant progression in pancreatic cancer via the miR-6732 pathway.
Pancreatic Neoplasms
Human ALKBH6 Is Required for Maintenance of Genomic Stability and Promoting Cell Survival During Exposure of Alkylating Agents in Pancreatic Cancer.
Pancreatic Neoplasms
Identification of a Ubiquitination-Related Gene Risk Model for Predicting Survival in Patients With Pancreatic Cancer.
Pancreatic Neoplasms
Identification of genomic alterations and associated transcriptomic profiling reveal the prognostic significance of MMP14 and PKM2 in patients with pancreatic cancer.
Pancreatic Neoplasms
Identification of Key mRNAs as Prediction Models for Early Metastasis of Pancreatic Cancer Based on LASSO.
Pancreatic Neoplasms
Imaging and Pathology of Pancreatic Neoplasms: A Pictorial Atlas Edited by Mirko D'Onofrio , Paola Capelli , and Paolo Pederzoli New York, NY , Springer Science & Business Media , 2015 . ISBN: 978-88-470-5677-0 . Hardcover, $109.00; pp 432 .
Pancreatic Neoplasms
IMIX: a multivariate mixture model approach to association analysis through multi-omics data integration.
Pancreatic Neoplasms
Improving Gemcitabine Sensitivity in Pancreatic Cancer Cells by Restoring miRNA-217 Levels.
Pancreatic Neoplasms
Integrating high-throughput microRNA and mRNA expression data to identify risk mRNA signature for pancreatic cancer prognosis.
Pancreatic Neoplasms
Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognostic Significance with the Cancer Genome Atlas Data.
Pancreatic Neoplasms
Integrin ?6?4 Promotes Autocrine Epidermal Growth Factor Receptor (EGFR) Signaling to Stimulate Migration and Invasion toward Hepatocyte Growth Factor (HGF).
Pancreatic Neoplasms
ITGA3 serves as a diagnostic and prognostic biomarker for pancreatic cancer.
Pancreatic Neoplasms
Knockdown of ISOC1 suppresses cell proliferation in pancreatic cancer in vitro.
Pancreatic Neoplasms
LINC00261 inhibits progression of pancreatic cancer by down-regulating miR-23a-3p.
Pancreatic Neoplasms
Long non-coding RNA LINC00460 predicts poor survival and promotes cell viability in pancreatic cancer.
Pancreatic Neoplasms
MicroRNA modulated networks of adaptive and innate immune response in pancreatic ductal adenocarcinoma.
Pancreatic Neoplasms
MicroRNA-221-3p is related to survival and promotes tumour progression in pancreatic cancer: a comprehensive study on functions and clinicopathological value.
Pancreatic Neoplasms
MicroRNA-7 as a Potential Biomarker for Prognosis in Pancreatic Cancer.
Pancreatic Neoplasms
Mind Bomb 1 Promotes Pancreatic Cancer Proliferation by Activating ?-Catenin Signaling.
Pancreatic Neoplasms
Mirko D'Onofrio, Paola Capelli and Paolo Pederzoli (Eds) Imaging and Pathology of Pancreatic Neoplasms. A Pictorial Atlas : Springer-Verlag Italia, 2015 ISBN 978-88-470-5677-0.
Pancreatic Neoplasms
Multi-omics analysis based on integrated genomics, epigenomics and transcriptomics in pancreatic cancer.
Pancreatic Neoplasms
Mutations of p53 associated with pancreatic cancer and therapeutic implications.
Pancreatic Neoplasms
Novel targets identified by integrated cancer-stromal interactome analysis of pancreatic adenocarcinoma.
Pancreatic Neoplasms
Novel three?lncRNA signature predicts survival in patients with pancreatic cancer.
Pancreatic Neoplasms
Oncogenic HSP60 regulates mitochondrial oxidative phosphorylation to support Erk1/2 activation during pancreatic cancer cell growth.
Pancreatic Neoplasms
Orchestrating a biomarker panel with lncRNAs and mRNAs for predicting survival in pancreatic ductal adenocarcinoma.
Pancreatic Neoplasms
Overexpression and biological function of IQGAP3 in human pancreatic cancer.
Pancreatic Neoplasms
Overexpression of ERCC3 is associated with poor prognosis in patients with pancreatic cancer.
Pancreatic Neoplasms
Pancreatic adenocarcinomas with mature blood vessels have better overall survival.
Pancreatic Neoplasms
PD-L1 correlated gene expression profiles and tumor infiltrating lymphocytes in pancreatic cancer.
Pancreatic Neoplasms
PRMT5 enhances tumorigenicity and glycolysis in pancreatic cancer via the FBW7/cMyc axis.
Pancreatic Neoplasms
Prognostic Biomarkers and Immunotherapeutic Targets Among CXC Chemokines in Pancreatic Adenocarcinoma.
Pancreatic Neoplasms
Prognostic microRNAs and their potential molecular mechanism in pancreatic cancer: A study based on The Cancer Genome Atlas and bioinformatics investigation.
Pancreatic Neoplasms
Prognostic value and immunological characteristics of a novel autophagy-related signature in pancreatic cancer.
Pancreatic Neoplasms
Relating pancreatic ductal adenocarcinoma tumor samples and cell lines using gene expression data in translational research.
Pancreatic Neoplasms
Roles of OCT4 in tumorigenesis, cancer therapy resistance and prognosis.
Pancreatic Neoplasms
Screening and Identifying m6A Regulators as an Independent Prognostic Biomarker in Pancreatic Cancer Based on The Cancer Genome Atlas Database.
Pancreatic Neoplasms
Screening and Validation of Independent Predictors of Poor Survival in Pancreatic Cancer.
Pancreatic Neoplasms
SNX6 predicts poor prognosis and contributes to the metastasis of pancreatic cancer cells via activating epithelial-mesenchymal transition.
Pancreatic Neoplasms
Structural impact due to PPQEE deletion in multiple cancer associated protein - Integrin ?V: An In silico exploration.
Pancreatic Neoplasms
SWI/SNF aberrations sensitize pancreatic cancer cells to DNA crosslinking agents.
Pancreatic Neoplasms
Targeting glypican-4 overcomes 5-FU resistance and attenuates stem cell-like properties via suppression of Wnt/?-catenin pathway in pancreatic cancer cells.
Pancreatic Neoplasms
The Biological Function Delineated Across Pan-Cancer Levels Through lncRNA-Based Prognostic Risk Assessment Factors for Pancreatic Cancer.
Pancreatic Neoplasms
The catalytically defective receptor protein tyrosine kinase EphA10 promotes tumorigenesis in pancreatic cancer cells.
Pancreatic Neoplasms
The construction and analysis of a ferroptosis-related gene prognostic signature for pancreatic cancer.
Pancreatic Neoplasms
The Expression and Survival Significance of Glucose Transporter-1 in Pancreatic Cancer: Meta-Analysis, Bioinformatics Analysis and Retrospective Study.
Pancreatic Neoplasms
The genetics of ductal adenocarcinoma of the pancreas in the year 2020: dramatic progress, but far to go.
Pancreatic Neoplasms
The Mouse Model of Pancreatic Cancer Atlas (MMPCA) for classification of pancreatic cancer lesions: A large histological investigation of the Ptf1aCre/+;LSL-KrasG12D/+ transgenic mouse model of pancreatic cancer.
Pancreatic Neoplasms
The radiotherapy-sensitization effect of cantharidin: Mechanisms involving cell cycle regulation, enhanced DNA damage, and inhibited DNA damage repair.
Pancreatic Neoplasms
The TERT hypermethylated oncologic region predicts recurrence and survival in pancreatic cancer.
Pancreatic Neoplasms
TYMS presents a novel biomarker for diagnosis and prognosis in patients with pancreatic cancer.
Pancreatic Neoplasms
YAP1 is a Prognostic Biomarker and Correlated with Immune Cell Infiltration in Pancreatic Cancer.
Pancreatic Neoplasms
YAP1 is an independent prognostic marker in pancreatic cancer and associated with extracellular matrix remodeling.
Papilloma
Detailed analysis of adenosine A2a receptor (ADORA2A) and CD73 (5'-nucleotidase, ecto, NT5E) methylation and gene expression in head and neck squamous cell carcinoma patients.
Papilloma
PDCD1 (PD-1) promoter methylation predicts outcome in head and neck squamous cell carcinoma patients.
Papillomavirus Infections
Genome-wide discovery of viral microRNAs based on phylogenetic analysis and structural evolution of various human papillomavirus subtypes.
Paraganglioma
A long noncoding RNA-microRNA expression signature predicts metastatic signature in pheochromocytomas and paragangliomas.
Paraganglioma
The tumor immune microenvironmental analysis of 2,033 transcriptomes across 7 cancer types.
Paralysis
Bone Age in Children With Obstetrical Brachial Plexus Palsy: Effect of Peripheral Nerve Injury on Skeletal Maturation.
Paralysis
Plasmacytoma of the atlas presenting as hoarseness: a rare cause of unilateral vocal fold palsy.
Paralysis
Selective paralysis of the upper extremities after odontoid fracture: acute central cord syndrome or cruciate paralysis?
Paralysis
[Hypoglossal nerve palsy caused by hypoplasia of the atlas and ossification of the posterior longitudinal ligament]
Paraproteinemias
Exploration of the personalized immune checkpoint atlas of plasma cell dyscrasias patients using high?dimensional single?cell analysis.
Parasitic Diseases
An Atlas of Infectious and Parasitic Diseases of the Central Nervous System. A Cooperative Study of SILAN (Sociedad Iberolatinoamericana de Neurorradiologia).
Paresthesia
Clinical Paresthesia Atlas Illustrates Likelihood of Coverage Based on Spinal Cord Stimulator Electrode Location.
Parkinson Disease
3D Textural, Morphological and Statistical Analysis of Voxel of Interests in 3T MRI Scans for the Detection of Parkinson's Disease Using Artificial Neural Networks.
Parkinson Disease
A Probabilistic Functional Atlas of the VIM Nucleus Constructed from Pre-, Intra- and Postoperative Electrophysiological and Neuroimaging Data Acquired during the Surgical Treatment of Parkinson's Disease Patients.
Parkinson Disease
A three-dimensional histological atlas of the human basal ganglia. II. Atlas deformation strategy and evaluation in deep brain stimulation for Parkinson disease.
Parkinson Disease
Analyzing the co-localization of substantia nigra hyper-echogenicities and iron accumulation in Parkinson's disease: A multi-modal atlas study with transcranial ultrasound and MRI.
Parkinson Disease
Computed three-dimensional atlas of subthalamic nucleus and its adjacent structures for deep brain stimulation in Parkinson's disease.
Parkinson Disease
Correlated regions of cerebral blood flow with clinical parameters in Parkinson's disease; comparison using 'Anatomy' and 'Talairach Daemon' software.
Parkinson Disease
Creation of Computerized 3D MRI-Integrated Atlases of the Human Basal Ganglia and Thalamus.
Parkinson Disease
Development and Implementation of a Corriedale Ovine Brain Atlas for Use in Atlas-Based Segmentation.
Parkinson Disease
Dynamic Atlas-based segmentation and quantification of Neuromelanin-rich brainstem structures in Parkinson disease.
Parkinson Disease
Gene expression analysis in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice model of Parkinson's disease using cDNA microarray: effect of R-apomorphine.
Parkinson Disease
HybraPD atlas: Towards precise subcortical nuclei segmentation using multimodality medical images in patients with Parkinson disease.
Parkinson Disease
In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson's disease.
Parkinson Disease
Is the subthalamic nucleus hypointense on T2-weighted images? A correlation study using MR imaging and stereotactic atlas data.
Parkinson Disease
Longitudinal Connectomes as a Candidate Progression Marker for Prodromal Parkinson's Disease.
Parkinson Disease
Microstructural abnormalities of substantia nigra in Parkinson's disease: A neuromelanin sensitive MRI atlas based study.
Parkinson Disease
Modeling of Electric Fields in Individual Imaging Atlas for Capsular Threshold Prediction of Deep Brain Stimulation in Parkinson's Disease: A Pilot Study.
Parkinson Disease
Multi-parametric analysis assists in STN localization in Parkinson's patients.
Parkinson Disease
Optimal location of thalamotomy lesions for tremor associated with Parkinson disease: a probabilistic analysis based on postoperative magnetic resonance imaging and an integrated digital atlas.
Parkinson Disease
Regional transcriptional architecture of Parkinson's disease pathogenesis and network spread.
Parkinson Disease
Subthalamic nucleus stimulation for advanced Parkinson's disease: how to find a far medial STN.
Parkinsonian Disorders
[Atlas of cranial and spinal MRI--magnetic resonance imaging in carbon monoxide poisoning and Parkinsonian syndrome]
Penile Induration
Surgical Atlas. Correction of Peyronie's disease: plaque incision and grafting.
Periodontitis
Human oral mucosa cell atlas reveals a stromal-neutrophil axis regulating tissue immunity.
Periodontitis
Identification of the Bacterial Biosynthetic Gene Clusters of the Oral Microbiome Illuminates the Unexplored Social Language of Bacteria during Health and Disease.
Periodontitis
Immune landscape of periodontitis unveils alterations of infiltrating immunocytes and molecular networks-aggregating into an interactive web-tool for periodontitis related immune analysis and visualization.
Peroxisomal Disorders
Atlas of common lysosomal and peroxisomal disorders - manual of metabolic diseases
Persistent Infection
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing.
Pheochromocytoma
A long noncoding RNA-microRNA expression signature predicts metastatic signature in pheochromocytomas and paragangliomas.
Pheochromocytoma
Integrative analysis of ceRNA network and DNA methylation associated with gene expression in malignant pheochromocytomas: a study based on The Cancer Genome Atlas.
Pheochromocytoma
The tumor immune microenvironmental analysis of 2,033 transcriptomes across 7 cancer types.
Pierre Robin Syndrome
Combined occipitoatlantoaxial hypermobility with anterior and posterior arch defects of the atlas in Pierre-Robin syndrome.
Plague
Atlas occipitalisation associated with other anomalies in a 16th century skeleton from Sardinia (Italy).
Plasmacytoma
Comprehensive investigation of the clinical significance and molecular mechanisms of plasmacytoma variant translocation 1 in sarcoma using genome-wide RNA sequencing data.
Plasmacytoma
Plasmacytoma of the atlas presenting as hoarseness: a rare cause of unilateral vocal fold palsy.
Plasmacytoma
Surgical Resection of Solitary Bone Plasmacytoma of Atlas and Reconstruction with 3-Dimensional-Printed Titanium Patient-Specific Implant.
Platybasia
Assimilation of the atlas and basilar impression: a review of 1,500 skull and cervical spine radiographs.
Platybasia
Successful treatment of adult Arnold-Chiari malformation associated with basilar impression and syringomyelia by the transoral anterior approach.
Platybasia
[2 cases of bone deformity at the cranio-vertebral junction, accompanying occipitalization of atlas and basilar impression]
Platybasia
[A case of hypoplasia and unilateral assimilation of the atlas with platybasia, basilar impression and Arnold-Chiari deformity.]
Platybasia
[An alternative dorsal fusion technique after transoral dens resection in basilar impression with atlas assimilation]
Platybasia
[Biomechanism of intracranial and spinal trauma of child born in occipitoanterior presentation as used in forensic examination]
Platybasia
[Clinical picture of congenital atlas assimilation with basilar impression; with a contribution on the theme, neural pathology of spine.]
Platybasia
[Early diagnosis of basilar impression and atlas assimilation from clinical manifestations.]
Platybasia
[Occipitalization of the atlas (Wackenheim III), basilar impression, chiari malformation (I) and paracondyloid process]
Pleural Effusion
A panel of novel detection and prognostic methylated DNA markers in primary non-small cell lung cancer and serum DNA.
Pleural Effusion
Radiogenomics of High-Grade Serous Ovarian Cancer: Multireader Multi-Institutional Study from the Cancer Genome Atlas Ovarian Cancer Imaging Research Group.
Pneumocystis Infections
Signatures of B Cell Receptor Repertoire Following Pneumocystis Infection.
Pneumonia
Association of hospice utilization and publicly reported outcomes following hospitalization for pneumonia or heart failure: a retrospective cohort study.
Pneumonia
Gene expression profiling in inflammatory airway disease associated with elevated adenosine.
Pneumonia
Impact of hospitals' Referral Region racial and ethnic diversity on 30-day readmission rates of older adults.
Pneumonia, Ventilator-Associated
First year of mandatory reporting of healthcare-associated infections, pennsylvania: an infection control-chart abstractor collaboration.
Pneumoperitoneum
[Pneumoperitoneum: diagnostic value. II. Exploration of the abdomen. Atlas de radiologie clinique.]
Post-Traumatic Headache
Can atlas spina bifida-occulta be a cause of cervicogenic headaches?
Post-Traumatic Headache
Incidence of ponticulus posterior of the atlas in migraine and cervicogenic headache.
Pre-Eclampsia
Translational analysis of mouse and human placental protein and mRNA reveals distinct molecular pathologies in human preeclampsia.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Identification of Potential Signatures and Their Functions for Acute Lymphoblastic Leukemia: A Study Based on the Cancer Genome Atlas.
Pregnancy Complications
Visualizing Dynamic Changes at the Maternal-Fetal Interface Throughout Human Pregnancy by Mass Cytometry.
Pregnancy, Tubal
[Radiological diagnosis of tubal pregnancies. Atlas de radiologie clinique.]
Premature Birth
Multi-contrast human neonatal brain atlas: Application to normal neonate development analysis.
Primary Myelofibrosis
Images from the Haematologica Atlas of Hematologic Cytology: primary myelofibrosis, micromegakaryocytic transformation.
Prognathism
Upper spine morphology in hypophosphatemic rickets and healthy controls: a radiographic study.
Prolactinoma
MicroRNA?29?3p regulates the ??catenin pathway by targeting IGF1 to inhibit the proliferation of prolactinoma cells.
Prostatic Hyperplasia
Histopathological Terminology Standards for the Reporting of Prostatic Epithelial Lesions in Dogs.
Prostatic Neoplasms
A genomic and epigenomic atlas of prostate cancer in Asian populations.
Prostatic Neoplasms
A geographic analysis of prostate cancer mortality in the United States, 1970-89.
Prostatic Neoplasms
A meta-analysis and The Cancer Genome Atlas data of prostate cancer risk and prognosis using epithelial cell adhesion molecule (EpCAM) expression.
Prostatic Neoplasms
A Multiphase Validation of Atlas-Based Automatic and Semiautomatic Segmentation Strategies for Prostate MRI.
Prostatic Neoplasms
A novel metabolic function of Myc in regulation of fatty acid synthesis in prostate cancer.
Prostatic Neoplasms
Adaptation of a 3D prostate cancer atlas for transrectal ultrasound guided target-specific biopsy.
Prostatic Neoplasms
Almost 10 years of PET/MR attenuation correction: the effect on lesion quantification with PSMA: clinical evaluation on 200 prostate cancer patients.
Prostatic Neoplasms
Alzheimer Gene BIN1 may Simultaneously Influence Dementia Risk and Androgen Deprivation Therapy Dosage in Prostate Cancer.
Prostatic Neoplasms
Analysis of interactions between the epigenome and structural mutability of the genome using Genboree Workbench tools.
Prostatic Neoplasms
Analysis of Over 140,000 European Descendants Identifies Genetically Predicted Blood Protein Biomarkers Associated with Prostate Cancer Risk.
Prostatic Neoplasms
Androgen attenuates the inactivating phospho-Ser-127 modification of yes-associated protein 1 (YAP1) and promotes YAP1 nuclear abundance and activity.
Prostatic Neoplasms
Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation.
Prostatic Neoplasms
Autophagy-related genes are potential diagnostic and prognostic biomarkers in prostate cancer.
Prostatic Neoplasms
BAP1 functions as a tumor promoter in prostate cancer cells through EMT regulation.
Prostatic Neoplasms
Characterization of unique PMEPA1 gene splice variants (isoforms d and e) from RNA Seq profiling provides novel insights into prognostic evaluation of prostate cancer.
Prostatic Neoplasms
Cholesterol uptake and regulation in high-grade and lethal prostate cancers.
Prostatic Neoplasms
Chromosomal instability in untreated primary prostate cancer as an indicator of metastatic potential.
Prostatic Neoplasms
Co-occurrent Alterations of Alzheimer's Genes and Prostate Cancer Genes in Prostate Cancer.
Prostatic Neoplasms
Coexpression Analysis of the EZH2 Gene Using The Cancer Genome Atlas and Oncomine Databases Identifies Coexpressed Genes Involved in Biological Networks in Breast Cancer, Glioblastoma, and Prostate Cancer.
Prostatic Neoplasms
Comprehensive analysis of biomarkers for prostate cancer based on weighted gene co-expression network analysis.
Prostatic Neoplasms
Comprehensive Analysis of the Relationship Between Metabolic Reprogramming and Immune Function in Prostate Cancer.
Prostatic Neoplasms
Comprehensive investigation of alternative splicing and development of a prognostic risk score for prostate cancer based on six-gene signatures.
Prostatic Neoplasms
Comprehensive microRNA profiling of prostate cancer cells after ionizing radiation treatment.
Prostatic Neoplasms
Computational Methods and Correlation of Exon-skipping Events with Splicing, Transcription, and Epigenetic Factors.
Prostatic Neoplasms
Computer-Assisted, Atlas-Based Segmentation for Target Volume Delineation in Whole Pelvic IMRT for Prostate Cancer.
Prostatic Neoplasms
Computerized Classification of Prostate Cancer Gleason Scores from Whole Slide Images.
Prostatic Neoplasms
CPNE1 Is a Useful Prognostic Marker and Is Associated with TNF Receptor-Associated Factor 2 (TRAF2) Expression in Prostate Cancer.
Prostatic Neoplasms
Creation of RTOG compliant patient CT-atlases for automated atlas based contouring of local regional breast and high-risk prostate cancers.
Prostatic Neoplasms
Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations.
Prostatic Neoplasms
Development and Validation of an Individualized Immune Prognostic Signature for Recurrent Prostate Cancer.
Prostatic Neoplasms
Development of an autophagy-related gene expression signature for prognosis prediction in prostate cancer patients.
Prostatic Neoplasms
Differentially Expressed Genes and Signature Pathways of Human Prostate Cancer.
Prostatic Neoplasms
Differentially Expressed Genes Associated With Prognosis in Locally Advanced Lymph Node-Negative Prostate Cancer.
Prostatic Neoplasms
Distribution of prostate nodes: a PET/CT-derived anatomic atlas of prostate cancer patients before and after surgical treatment.
Prostatic Neoplasms
Downregulation of CDCA5 Can Inhibit Cell Proliferation, Migration, and Invasion, and Induce Apoptosis of Prostate Cancer Cells.
Prostatic Neoplasms
Downregulation of Collagen COL4A6 Is Associated with Prostate Cancer Progression and Metastasis.
Prostatic Neoplasms
Dysregulation of cystathionine ?-lyase promotes prostate cancer progression and metastasis.
Prostatic Neoplasms
Early growth response 3 (Egr3) is highly over-expressed in non-relapsing prostate cancer but not in relapsing prostate cancer.
Prostatic Neoplasms
Epigenetic Suppression of SERPINB1 Promotes Inflammation-Mediated Prostate Cancer Progression.
Prostatic Neoplasms
Epithelial Splicing Regulatory Protein (ESPR1) Expression in an Unfavorable Prognostic Factor in Prostate Cancer Patients.
Prostatic Neoplasms
Expression array analysis of the hepatocyte growth factor invasive program.
Prostatic Neoplasms
Expression of microRNA-99a-3p in Prostate Cancer Based on Bioinformatics Data and Meta-Analysis of a Literature Review of 965 Cases.
Prostatic Neoplasms
Eya2 Is Overexpressed in Human Prostate Cancer and Regulates Docetaxel Sensitivity and Mitochondrial Membrane Potential through AKT/Bcl-2 Signaling.
Prostatic Neoplasms
Gene expression profiling to identify the toxicities and potentially relevant disease outcomes due to endosulfan exposure.
Prostatic Neoplasms
Genetic associations of T cell cancer immune response with tumor aggressiveness in localized prostate cancer patients and disease reclassification in an active surveillance cohort.
Prostatic Neoplasms
Genome and transcriptome profiling of FBXW family in human prostate cancer.
Prostatic Neoplasms
Genome atlas analysis based profiling of Akt pathway genes in the early and advanced human prostate cancer.
Prostatic Neoplasms
Genomic alterations of Tenascin C in highly aggressive prostate cancer: a meta-analysis.
Prostatic Neoplasms
Geographic variation in prostate cancer mortality rates among white males in the united states.
Prostatic Neoplasms
High levels of glioma tumor suppressor candidate region gene 1 predicts a poor prognosis for prostate cancer.
Prostatic Neoplasms
High risk human papilloma viruses (HPVs) are present in benign prostate tissues before development of HPV associated prostate cancer.
Prostatic Neoplasms
hsa-miR-135a-1 inhibits prostate cancer cell growth and migration by targeting EGFR.
Prostatic Neoplasms
Identification and characterization of biomarkers and their functions for docetaxel-resistant prostate cancer cells.
Prostatic Neoplasms
Identification of core genes associated with prostate cancer progression and outcome via bioinformatics analysis in multiple databases.
Prostatic Neoplasms
Identification of miRNA-Mediated Subpathways as Prostate Cancer Biomarkers Based on Topological Inference in a Machine Learning Process Using Integrated Gene and miRNA Expression Data.
Prostatic Neoplasms
Identification of novel biomarkers correlated with prostate cancer progression by an integrated bioinformatic analysis.
Prostatic Neoplasms
Identification of novel oncogenic events occurring early in prostate carcinogenesis using purified autologous malignant and non-malignant prostate epithelial cells.
Prostatic Neoplasms
Identification of potential autophagy-associated lncRNA in prostate cancer.
Prostatic Neoplasms
Identification of Potential Key Genes for Pathogenesis and Prognosis in Prostate Cancer by Integrated Analysis of Gene Expression Profiles and the Cancer Genome Atlas.
Prostatic Neoplasms
Identification of Potential Prostate Cancer-Related Pseudogenes Based on Competitive Endogenous RNA Network Hypothesis.
Prostatic Neoplasms
Identification of RNA-binding protein SNRPA1 for prognosis in prostate cancer.
Prostatic Neoplasms
Immune landscape of human prostate cancer: immune evasion mechanisms and biomarkers for personalized immunotherapy.
Prostatic Neoplasms
Immunogenomics: A Negative Prostate Cancer Outcome Associated with TcR-?/? Recombinations.
Prostatic Neoplasms
Impact of the SPOP Mutant Subtype on the Interpretation of Clinical Parameters in Prostate Cancer.
Prostatic Neoplasms
Improvement in prediction of prostate cancer prognosis with somatic mutational signatures.
Prostatic Neoplasms
ING3 promotes prostate cancer growth by activating the androgen receptor.
Prostatic Neoplasms
Integrated Analysis of Genetic Abnormalities of the Histone Lysine Methyltransferases in Prostate Cancer.
Prostatic Neoplasms
Integrated Analysis Reveals together miR-182, miR-200c and miR-221 Can Help in the Diagnosis of Prostate Cancer.
Prostatic Neoplasms
Integrative Analysis of MicroRNA and Gene Interactions for Revealing Candidate Signatures in Prostate Cancer.
Prostatic Neoplasms
Interfocal heterogeneity challenges the clinical usefulness of molecular classification of primary prostate cancer.
Prostatic Neoplasms
Interleukin-7 Contributes to the Invasiveness of Prostate Cancer Cells by Promoting Epithelial-Mesenchymal Transition.
Prostatic Neoplasms
KAT5 Negatively regulates the proliferation of prostate cancer LNCaP cells via the caspase 3-dependent apoptosis pathway.
Prostatic Neoplasms
Knockdown of TNF receptor-associated factor 2 (TRAF2) modulates in vitro growth of TRAIL-treated prostate cancer cells.
Prostatic Neoplasms
LNCaP Atlas: gene expression associated with in vivo progression to castration-recurrent prostate cancer.
Prostatic Neoplasms
Loss of MAP3K7 Sensitizes Prostate Cancer Cells to CDK1/2 Inhibition and DNA Damage by Disrupting Homologous Recombination.
Prostatic Neoplasms
Low expression of the androgen-induced tumor suppressor gene PLZF and lethal prostate cancer.
Prostatic Neoplasms
Meta-analysis of prostate cancer gene expression data identifies a novel discriminatory signature enriched for glycosylating enzymes.
Prostatic Neoplasms
Microarray-based data mining reveals key genes and potential therapeutic drugs for Cadmium-induced prostate cell malignant transformation.
Prostatic Neoplasms
MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis.
Prostatic Neoplasms
miR-210 is induced by hypoxia and regulates neural cell adhesion molecule in prostate cells.
Prostatic Neoplasms
miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1.
Prostatic Neoplasms
miR-484 is associated with disease recurrence and promotes migration in prostate cancer.
Prostatic Neoplasms
miR-93-5p may be an important oncogene in prostate cancer by bioinformatics analysis.
Prostatic Neoplasms
miRNA-106a and prostate cancer radioresistance: a novel role for LITAF in ATM regulation.
Prostatic Neoplasms
Molecular Changes in Tissue Proteome during Prostate Cancer Development: Proof-of-Principle Investigation.
Prostatic Neoplasms
Molecular mechanisms, immune cell infiltration, and potential drugs for prostate cancer.
Prostatic Neoplasms
Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy.
Prostatic Neoplasms
Network-based multi-task learning models for biomarker selection and cancer outcome prediction.
Prostatic Neoplasms
Next-generation prostate cancer biobanking: toward a processing protocol amenable for the International Cancer Genome Consortium.
Prostatic Neoplasms
NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Post-Operative Prostate Cancer.
Prostatic Neoplasms
Oncogenic Properties of NEAT1 in Prostate Cancer Cells Depend on the CDC5L-AGRN Transcriptional Regulation Circuit.
Prostatic Neoplasms
Optimized prostate biopsy via a statistical atlas of cancer spatial distribution.
Prostatic Neoplasms
Overexpression of MCM10 promotes cell proliferation and predicts poor prognosis in prostate cancer.
Prostatic Neoplasms
p53/PGC?1??mediated mitochondrial dysfunction promotes PC3 prostate cancer cell apoptosis.
Prostatic Neoplasms
PDCD4 Is an Androgen-Repressed Tumor Suppressor that Regulates Prostate Cancer Growth and Castration Resistance.
Prostatic Neoplasms
Physiological 68Ga-RM2 uptake in patients with biochemically recurrent prostate cancer: an atlas of semi-quantitative measurements.
Prostatic Neoplasms
Prediction of Pathological Stage in Patients with Prostate Cancer: A Neuro-Fuzzy Model.
Prostatic Neoplasms
Promoter Methylation of PRKCB, ADAMTS12, and NAALAD2 Is Specific to Prostate Cancer and Predicts Biochemical Disease Recurrence.
Prostatic Neoplasms
Proteomic characterization of paired non-malignant and malignant African-American prostate epithelial cell lines distinguishes them by structural proteins.
Prostatic Neoplasms
PSMA-PET/CT-based Lymph Node Atlas for Prostate Cancer Patients Recurring After Primary Treatment: Clinical Implications for Salvage Radiation Therapy.
Prostatic Neoplasms
regQTLs: Single nucleotide polymorphisms that modulate microRNA regulation of gene expression in tumors.
Prostatic Neoplasms
Revisiting Prostate Cancer Recurrence with PSMA PET: Atlas of Typical and Atypical Patterns of Spread.
Prostatic Neoplasms
SAMD5 mRNA was overexpressed in prostate cancer and can predict biochemical recurrence after radical prostatectomy.
Prostatic Neoplasms
Single-cell Spatial Proteomic Revelations on the Multiparametric MRI Heterogeneity of Clinically Significant Prostate Cancer.
Prostatic Neoplasms
Spatial EGFR Dynamics and Metastatic Phenotypes Modulated by Upregulated EphB2 and Src Pathways in Advanced Prostate Cancer.
Prostatic Neoplasms
Statistical 3D Prostate Imaging Atlas Construction via Anatomically Constrained Registration.
Prostatic Neoplasms
Systematic profiling of alternative splicing signature reveals prognostic predictor for prostate cancer.
Prostatic Neoplasms
The association between copy number aberration, DNA methylation and gene expression in tumor samples.
Prostatic Neoplasms
The lncRNAs LINC00261 and LINC00665 are upregulated in long-term prostate cancer adaptation after radiotherapy.
Prostatic Neoplasms
The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy Development.
Prostatic Neoplasms
The Role of Lysosome-associated Membrane Protein 2 in Prostate Cancer Chemopreventive Mechanisms of Sulforaphane.
Prostatic Neoplasms
The X-linked tumor suppressor TSPX downregulates cancer-drivers/oncogenes in prostate cancer in a C-terminal acidic domain dependent manner.
Prostatic Neoplasms
TMPRSS4 induces invasion and proliferation of prostate cancer cells through induction of Slug and cyclin D1.
Prostatic Neoplasms
TRAF2 is a Valuable Prognostic Biomarker in Patients with Prostate Cancer.
Prostatic Neoplasms
Transcriptomic and Clinical Characterization of Neuropeptide Y Expression in Localized and Metastatic Prostate Cancer: Identification of Novel Prostate Cancer Subtype with Clinical Implications.
Prostatic Neoplasms
Transcriptomics analysis for the identification of potential age-related genes and cells associated with three major urogenital cancers.
Prostatic Neoplasms
Unleashing the full potential of Hsp90 inhibitors as cancer therapeutics through simultaneous inactivation of Hsp90, Grp94, and TRAP1.
Prostatic Neoplasms
Whole-exome Sequencing of Prostate Cancer in Sardinian Identify Recurrent UDP-glucuronosyltransferase Amplifications.
Prostatic Neoplasms
[Genome-wide analysis of DNA methylation in prostate cancer using the technology of Infinium HumanMethylation450 BeadChip (HM450)].
Prostatitis
Histopathological Terminology Standards for the Reporting of Prostatic Epithelial Lesions in Dogs.
Proteinuria
Diagnostic accuracy study of urine dipstick in relation to 24-hour measurement as a screening tool for proteinuria in lupus nephritis.
Pseudarthrosis
A paracondylar process and early onset cervical osteoarthritis in a California Amerind adult.
Pseudarthrosis
Bony observations of some morphological variations and anomalies of the craniovertebral region.
Pseudarthrosis
Cervical myelopathy caused by atlas osteochondroma and pseudoarthrosis between the osteochondroma and lamina of the axis: case report.
Pseudarthrosis
Cervical myelopathy caused by pseudoarthrosis between posterior arch of the atlas and lamina of the axis in Klippel-Feil syndrome: a case report.
Pseudarthrosis
Cervical myelopathy caused by pseudoarthrosis between the atlas and axis associated with diffuse idiopathic skeletal hyperostosis.
Pseudarthrosis
Cervical vertebral malformations in 9 dogs: radiological findings, treatment options and outcomes.
Pseudarthrosis
Fracture of the odontoid process in a male individual from the medieval necropolis of Maro (Málaga, Spain).
Pseudarthrosis
Paleopathological features of the cervical spine in the early middle ages: natural history of degenerative diseases.
Pseudarthrosis
Regeneration of the skeleton by recombinant human bone morphogenetic proteins.
Pseudarthrosis
[Treatment of pseudarthrosis of the odontoid process of the axis and complicated transodontoid posterior subluxation of the atlas]
Psoriasis
PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.
Psoriasis
Patient-dermatologist agreement in psoriasis severity, symptoms and satisfaction: results from a real-world multinational survey.
Psoriasis
Upward subluxation of the axis in ankylosing spondylitis. A clinical pathologic report.
Puberty, Precocious
Letter to the Editor From Gabby Atlas et al: "Long-term Outcomes of Treatments for Central Precocious Puberty or Early and Fast Puberty in Chinese Girls".
Pulmonary Disease, Chronic Obstructive
A 6 lncRNA-Based Risk Score System for Predicting the Recurrence of Colon Adenocarcinoma Patients.
Pulmonary Disease, Chronic Obstructive
A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures.
Pulmonary Disease, Chronic Obstructive
Analysis of Interleukin-1 Signaling Alterations of Colon Adenocarcinoma Identified Implications for Immunotherapy.
Pulmonary Disease, Chronic Obstructive
Autophagy-related genes contribute to malignant progression and have a clinical prognostic impact in colon adenocarcinoma.
Pulmonary Disease, Chronic Obstructive
Bioinformatics analysis of RNA-seq data revealed critical genes in colon adenocarcinoma.
Pulmonary Disease, Chronic Obstructive
Chaperonin-Containing TCP1 Subunit 6A Is a Prognostic Potential Biomarker That Correlates With the Presence of Immune Infiltrates in Colorectal Cancer.
Pulmonary Disease, Chronic Obstructive
Clinical Correlation of Wnt2 and COL8A1 With Colon Adenocarcinoma Prognosis.
Pulmonary Disease, Chronic Obstructive
Comparative Proteome Identifies Complement Component 3-Mediated Immune Response as Key Difference of Colon Adenocarcinoma and Rectal Adenocarcinoma.
Pulmonary Disease, Chronic Obstructive
Comprehensive analysis of microRNA/mRNA signature in colon adenocarcinoma.
Pulmonary Disease, Chronic Obstructive
Development and Characterization of a Chest CT Atlas.
Pulmonary Disease, Chronic Obstructive
Development and validation of a lipogenic genes panel for diagnosis and recurrence of colorectal cancer.
Pulmonary Disease, Chronic Obstructive
Diagnosis and prognostic value of C-X-C motif chemokine ligand 1 in colon adenocarcinoma based on The Cancer Genome Atlas and Guangxi cohort.
Pulmonary Disease, Chronic Obstructive
Diagnostic and prognostic values of integrin ? subfamily mRNA expression in colon adenocarcinoma.
Pulmonary Disease, Chronic Obstructive
Disparities in access to food and chronic obstructive pulmonary disease (COPD)-related outcomes: a cross-sectional analysis.
Pulmonary Disease, Chronic Obstructive
Distinct prognostic value of dynactin subunit 4 (DCTN4) and diagnostic value of DCTN1, DCTN2, and DCTN4 in colon adenocarcinoma.
Pulmonary Disease, Chronic Obstructive
Establishment of a 12-gene expression signature to predict colon cancer prognosis.
Pulmonary Disease, Chronic Obstructive
Exploration of the relationship between tumor mutation burden and immune infiltrates in colon adenocarcinoma.
Pulmonary Disease, Chronic Obstructive
Extracellular vesicles from human umbilical cord mesenchymal stem cells treated with siRNA against ELFN1-AS1 suppress colon adenocarcinoma proliferation and migration.
Pulmonary Disease, Chronic Obstructive
Gene Expression Along with Genomic Copy Number Variation and Mutational Analysis Were Used to Develop a 9-Gene Signature for Estimating Prognosis of COAD.
Pulmonary Disease, Chronic Obstructive
High expression of CDH3 predicts a good prognosis for colon adenocarcinoma patients.
Pulmonary Disease, Chronic Obstructive
HOXC11 Expression Is Associated with the Progression of Colon Adenocarcinoma and Is a Prognostic Biomarker.
Pulmonary Disease, Chronic Obstructive
HTR1D, TIMP1, SERPINE1, MMP3 and CNR2 affect the survival of patients with colon adenocarcinoma.
Pulmonary Disease, Chronic Obstructive
Hypermethylation of N-Acetyltransferase 1 Is a Prognostic Biomarker in Colon Adenocarcinoma.
Pulmonary Disease, Chronic Obstructive
Hypoxia Constructing the Prognostic Model of Colorectal Adenocarcinoma and Related to the Immune Microenvironment.
Pulmonary Disease, Chronic Obstructive
Identification and Clinical Validation of a Novel 4 Gene-Signature with Prognostic Utility in Colorectal Cancer.
Pulmonary Disease, Chronic Obstructive
Identification and development of a novel invasion-related gene signature for prognosis prediction in colon adenocarcinoma.
Pulmonary Disease, Chronic Obstructive
Identification of long noncoding RNAs biomarkers for diagnosis and prognosis in patients with colon adenocarcinoma.
Pulmonary Disease, Chronic Obstructive
Identification prognosis-associated immune genes in colon adenocarcinoma.
Pulmonary Disease, Chronic Obstructive
Investigation and verification of the clinical significance and perspective of natural killer group 2 member D ligands in colon adenocarcinoma.
Pulmonary Disease, Chronic Obstructive
Key Candidate Genes - VSIG2 of Colon Cancer Identified by Weighted Gene Co-Expression Network Analysis.
Pulmonary Disease, Chronic Obstructive
LncRNA RAD51-AS1/miR-29b/c-3p/NDRG2 crosstalk repressed proliferation, invasion and glycolysis of colorectal cancer.
Pulmonary Disease, Chronic Obstructive
MicroRNA-1249 targets four-jointed box kinase 1 and reduces cell proliferation, migration and invasion of colon adenocarcinoma.
Pulmonary Disease, Chronic Obstructive
MicroRNAs Associated With Colon Cancer: New Potential Prognostic Markers and Targets for Therapy.
Pulmonary Disease, Chronic Obstructive
Mining novel cell glycolysis related gene markers that can predict the survival of colon adenocarcinoma patients.
Pulmonary Disease, Chronic Obstructive
miR-1307-3p overexpression inhibits cell proliferation and promotes cell apoptosis by targeting ISM1 in colon cancer.
Pulmonary Disease, Chronic Obstructive
MiRNA-based model for predicting the TMB level in colon adenocarcinoma based on a LASSO logistic regression method.
Pulmonary Disease, Chronic Obstructive
Peroxiredoxins and Immune Infiltrations in Colon Adenocarcinoma: Their Negative Correlations and Clinical Significances, an In Silico Analysis.
Pulmonary Disease, Chronic Obstructive
Prognosis prediction model based on competing endogenous RNAs for recurrence of colon adenocarcinoma.
Pulmonary Disease, Chronic Obstructive
Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers.
Pulmonary Disease, Chronic Obstructive
Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis.
Pulmonary Disease, Chronic Obstructive
SMYD3 promotes colon adenocarcinoma (COAD) progression by mediating cell proliferation and apoptosis.
Pulmonary Disease, Chronic Obstructive
SOD3 induces a HIF-2?-dependent program in endothelial cells that provides a selective signal for tumor infiltration by T cells.
Pulmonary Disease, Chronic Obstructive
Survival prediction in patients with colon adenocarcinoma via multi-omics data integration using a deep learning algorithm.
Pulmonary Disease, Chronic Obstructive
The CIMP-high phenotype is associated with energy metabolism alterations in colon adenocarcinoma.
Pulmonary Disease, Chronic Obstructive
The diagnosis and prognosis values of WNT mRNA expression in colon adenocarcinoma.
Pulmonary Disease, Chronic Obstructive
The Perspective of Diagnostic and Prognostic Values of Lipoxygenases mRNA Expression in Colon Adenocarcinoma.
Pulmonary Disease, Chronic Obstructive
The YTH Domain Family of N6-Methyladenosine "Readers" in the Diagnosis and Prognosis of Colonic Adenocarcinoma.
Pulmonary Disease, Chronic Obstructive
Upregulation of PD-L1 predicts poor prognosis and is associated with miR-191-5p dysregulation in colon adenocarcinoma.
Pulmonary Disease, Chronic Obstructive
Ursolic Acid Regulates Cell Cycle and Proliferation in Colon Adenocarcinoma by Suppressing Cyclin B1.
Pulmonary Disease, Chronic Obstructive
Weighted Gene Co-expression Network Analysis Identified a Novel Thirteen-Gene Signature Associated With Progression, Prognosis, and Immune Microenvironment of Colon Adenocarcinoma Patients.
Pulmonary Fibrosis
New reference atlas for pulmonary fibrosis severity score in systemic sclerosis.
Pulmonary Fibrosis
Single-Cell Transcriptomic Analysis of Human Lung Provides Insights into the Pathobiology of Pulmonary Fibrosis.
Purpura, Thrombotic Thrombocytopenic
Transfusion medicine illustrated: a microscopic atlas of thrombotic thrombocytopenic purpura.
Pyoderma
[Presentation of pyoderma gangraenosum in a dermatologic atlas of the early 19th century]
Pyoderma Gangrenosum
[Presentation of pyoderma gangraenosum in a dermatologic atlas of the early 19th century]
Quadriplegia
Bipartite atlas with os odontoideum and synovial cyst: case report and review literature.
Quadriplegia
Cervical neurofibromatosis with quadriparesis: Management by fibular strut graft.
Quadriplegia
Congenital deformation of the posterior arch of the atlas: Subluxation of the atlanto-axial joint with temporary quadriplegia.
Quadriplegia
Intermittent quadriparesis associated with a congenital anomaly of the posterior arch of the atlas. Case report.
Quadriplegia
Recurrent transient quadriparesis after minor cervical trauma associated with bilateral partial agenesis of the posterior arch of the atlas. Case report.
Quadriplegia
Spinal cord compression caused by ossification of the transverse ligament of the atlas.
Quadriplegia
[Non-reducible anterior luxation of the atlas; quadriplegia; cure by C1 and C2 laminectomy.]
Rabies
A whole-brain map of long-range inputs to GABAergic interneurons in the mouse medial prefrontal cortex.
Rabies
Mapping and Analysis of the Connectome of Sympathetic Premotor Neurons in the Rostral Ventrolateral Medulla of the Rat Using a Volumetric Brain Atlas.
Rabies
Sex-Related Differential Whole-Brain Input Atlas of Locus Coeruleus Noradrenaline Neurons.
Radiation Pneumonitis
Using Generalized Equivalent Uniform Dose Atlases to Combine and Analyze Prospective Dosimetric and Radiation Pneumonitis Data From 2 Non-Small Cell Lung Cancer Dose Escalation Protocols.
Radiculopathy
Mineralization of the transverse ligament of the atlas causing compressive radiculopathy. Resolution following odontoidectomy and atlantoaxial arthrodesis.
Radiculopathy
Occipital neuralgia secondary to hypermobile posterior arch of atlas. Case report.
Rectal Neoplasms
A prognostic five long-noncoding RNA signature for patients with rectal cancer.
Rectal Neoplasms
Altered mRNA expression levels of the major components of sphingolipid metabolism, ceramide synthases and their clinical implication in colorectal cancer.
Rectal Neoplasms
Automatic segmentation software in locally advanced rectal cancer: READY (REsearch program in Auto Delineation sYstem)-RECTAL 02: prospective study.
Rectal Neoplasms
Characterizing the cancer-associated microbiome with small RNA sequencing data.
Rectal Neoplasms
Clinicopathologic significance of legumain overexpression in cancer: a systematic review and meta-analysis.
Rectal Neoplasms
Distinguishing Rectal Cancer from Colon Cancer Based on the Support Vector Machine Method and RNA-sequencing Data.
Rectal Neoplasms
Elective Clinical Target Volumes for Conformal Therapy in Anorectal Cancer: An Radiation Therapy Oncology Group Consensus Panel Contouring Atlas.
Rectal Neoplasms
Identification and verification of HCAR3 and INSL5 as new potential therapeutic targets of colorectal cancer.
Rectal Neoplasms
Identification of gene biomarkers and immune cell infiltration characteristics in rectal cancer.
Rectal Neoplasms
Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning.
Rectal Neoplasms
Loss of PTPN4 activates STAT3 to promote the tumor growth in rectal cancer.
Rectal Neoplasms
Pan-cancer methylation and expression profiling of adenocarcinomas revealed epigenetic silencing in the WNT signaling pathway.
Rectal Neoplasms
Prognostic Implication of the m6A RNA Methylation Regulators in Rectal Cancer.
Rectal Neoplasms
Prognostic value of tumour microenvironment-related genes by TCGA database in rectal cancer.
Rectal Neoplasms
Prospective Randomized Double-Blind Pilot Study of Site-Specific Consensus Atlas Implementation for Rectal Cancer Target Volume Delineation in the Cooperative Group Setting.
Rectal Neoplasms
Rectal MRI after neoadjuvant chemoradiation therapy: a pictorial guide to interpretation.
Rectal Neoplasms
Stratification of Digestive Cancers with Different Pathological Features and Survival Outcomes by MicroRNA Expression.
Rectal Neoplasms
The Effects of Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer-The Impact in Intratumoral Heterogeneity.
Rectal Neoplasms
[A misleading mistake in the classification of colonic and rectal cancers, in the 4th edition of the TNM Atlas, published in French by Springer]
Relative Energy Deficiency in Sport
Atlas of rat fetal skeleton double stained for bone and cartilage.
Renal Insufficiency
Ethnicity and socioeconomic status influence use of primary angioplasty in patients presenting with acute myocardial infarction.
Renal Insufficiency
International Society of Nephrology Global Kidney Health Atlas: structures, organization and services for the management of kidney failure in North and East Asia.
Renal Insufficiency
International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Africa.
Renal Insufficiency
International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Eastern and Central Europe.
Renal Insufficiency
International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Latin America.
Renal Insufficiency
International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Newly Independent States and Russia.
Renal Insufficiency
International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in North America and the Caribbean.
Renal Insufficiency
International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Oceania and South East Asia.
Renal Insufficiency
International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in South Asia.
Renal Insufficiency
International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in the Middle East.
Renal Insufficiency
International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Western Europe.
Renal Insufficiency, Chronic
'United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States.
Respiratory Tract Infections
Susceptibility of clinical isolates of meticillin-resistant Staphylococcus aureus and phenotypic non-extended-spectrum ?-lactamase-producing Klebsiella pneumoniae to ceftaroline in Taiwan: Results from Antimicrobial Testing Leadership and Surveillance (ATLAS) in 2012-2018 and Surveillance of Multicentre Antimicrobial Resistance in Taiwan (SMART) in 2018-2019.
Retinal Diseases
INFECTIOUS RETINITIS AND RETINAL DISEASE IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED INDIVIDUALS: A Photographic Atlas.
Retinitis
INFECTIOUS RETINITIS AND RETINAL DISEASE IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED INDIVIDUALS: A Photographic Atlas.
Retinitis Pigmentosa
A high-resolution RNA expression atlas of retinitis pigmentosa genes in human and mouse retinas.
Retinoblastoma
Interferon-induces expression of cyclin-dependent kinase-inhibitors p21WAF1 and p27Kip1 that prevent activation of cyclin-dependent kinase by CDK-activating kinase (CAK).
Retinoblastoma
MR Imaging Features of Retinoblastoma: Association with Gene Expression Profiles.
Retinopathy of Prematurity
Atlas of Fluorescein Angiographic Findings in Eyes Undergoing Laser for Retinopathy of Prematurity.
Rhabdomyolysis
Drug-Induced Rhabdomyolysis Atlas (DIRA) for idiosyncratic adverse drug reaction management.
Rhabdomyolysis
Quantitative Structure-Activity Relationship (QSAR) Model for the Severity Prediction of Drug-Induced Rhabdomyolysis by Using Random Forest.
Rheumatic Fever
Treatment of nontraumatic atlantoaxial dislocation and fibrous fusion. Case report.
Sacroiliitis
Atlas of MRI findings of sacroiliitis in pediatric sacroiliac joints to accompany the updated preliminary OMERACT pediatric JAMRIS (Juvenile Idiopathic Arthritis MRI Score) scoring system: Part I: Active lesions.
Sacroiliitis
Atlas of MRI findings of sacroiliitis in pediatric sacroiliac joints to accompany the updated preliminary OMERACT pediatric JAMRIS (Juvenile Idiopathic Arthritis MRI Score) scoring system: Part II: Structural damage lesions.
Salivary Gland Neoplasms
Guidelines for Clinical Target Volume Definition for Perineural Spread of Major Salivary Gland Cancers.
Sarcoma
A 3-DNA methylation signature as a novel prognostic biomarker in patients with sarcoma by bioinformatics analysis.
Sarcoma
A clinico-genomic analysis of soft tissue sarcoma patients reveals CDKN2A deletion as a biomarker for poor prognosis.
Sarcoma
A Prognostic Molecular Signature of N?-Methyladenosine Methylation Regulators for Soft-Tissue Sarcoma from The Cancer Genome Atlas Database.
Sarcoma
A Rapid and Cost-Effective Gene Expression Assay for the Diagnosis of Well-Differentiated and Dedifferentiated Liposarcomas.
Sarcoma
Analysis of tumor-infiltrating NK and T cells highlights IL-15 stimulation and TIGIT blockade as a combination immunotherapy strategy for soft tissue sarcomas.
Sarcoma
Angiosarcoma heterogeneity and potential therapeutic vulnerability to immune checkpoint blockade: insights from genomic sequencing.
Sarcoma
BCL7B is a potential novel diagnosis and prognosis biomarker for sarcomas using bioinformatics analysis.
Sarcoma
Blood and tissue biomarker analysis in dogs with osteosarcoma treated with palliative radiation and intra-tumoral autologous natural killer cell transfer.
Sarcoma
Case Report: Exome sequencing reveals recurrent RETSAT mutations and a loss-of-function POLDIP2 mutation in a rare undifferentiated tongue sarcoma.
Sarcoma
CBX2 is a functional target of miRNA let-7a and acts as a tumor promoter in osteosarcoma.
Sarcoma
Colorectal Cancer Prognosis is Not Associated with BRAF and KRAS Mutations-A STROBE Compliant Study.
Sarcoma
Comprehensive investigation of the clinical significance and molecular mechanisms of plasmacytoma variant translocation 1 in sarcoma using genome-wide RNA sequencing data.
Sarcoma
Deformable Imaging Capability for the Radiation Therapy Oncology Group (RTOG) Consensus Atlas of Musculoskeletal Anatomy (CAMAS) for Soft Tissue Sarcoma of the Lower Extremities.
Sarcoma
Determining the prognostic significance of alternative splicing events in soft tissue sarcoma using data from The Cancer Genome Atlas.
Sarcoma
Development and validation of an immune gene-set based prognostic signature for soft tissue sarcoma.
Sarcoma
Development of a Novel Immune Infiltration-Related ceRNA Network and Prognostic Model for Sarcoma.
Sarcoma
Development of a radiosensitivity gene signature for patients with soft tissue sarcoma.
Sarcoma
Electrostatic Complementarity of T-Cell Receptor-Alpha CDR3 Domains and Mutant Amino Acids Is Associated with Better Survival Rates for Sarcomas.
Sarcoma
Frequent amplification of HDAC genes and efficacy of HDAC inhibitor chidamide and PD-1 blockade combination in soft tissue sarcoma.
Sarcoma
Hippo pathway affects survival of cancer patients: extensive analysis of TCGA data and review of literature.
Sarcoma
Identification of potential prognostic small nucleolar RNA biomarkers for predicting overall survival in patients with sarcoma.
Sarcoma
Integrated Analysis of the Transcriptome Profile Reveals the Potential Roles Played by Long Noncoding RNAs in Immunotherapy for Sarcoma.
Sarcoma
Integrated Expression Profiles Analysis Reveals Correlations Between the IL-33/ST2 Axis and CD8+ T Cells, Regulatory T Cells, and Myeloid-Derived Suppressor Cells in Soft Tissue Sarcoma.
Sarcoma
Leadership perspectives in multidisciplinary team meetings; observational assessment based on the ATLAS instrument in cancer care.
Sarcoma
Machine learning analysis of gene expression data reveals novel diagnostic and prognostic biomarkers and identifies therapeutic targets for soft tissue sarcomas.
Sarcoma
MAGE-A3 is a Clinically Relevant Target in Undifferentiated Pleomorphic Sarcoma/Myxofibrosarcoma.
Sarcoma
miR-149-5p inhibits cell growth by regulating TWEAK/Fn14/PI3K/AKT pathway and predicts favorable survival in human osteosarcoma.
Sarcoma
Molecular phenotyping using networks, diffusion, and topology: soft tissue sarcoma.
Sarcoma
Outcomes of patients with sarcoma enrolled in clinical trials of pazopanib combined with histone deacetylase, mTOR, Her2, or MEK inhibitors.
Sarcoma
Predicted CD4+ T cell infiltration levels could indicate better overall survival in sarcoma patients.
Sarcoma
Predicting radiotherapy response for patients with soft tissue sarcoma by developing a molecular signature.
Sarcoma
Prediction of clinical outcome and survival in soft-tissue sarcoma using a ten-lncRNA signature.
Sarcoma
Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers.
Sarcoma
Risk score based on expression of five novel genes predicts survival in soft tissue sarcoma.
Sarcoma
RTOG Sarcoma Radiation Oncologists Reach Consensus on Gross Tumor Volume and Clinical Target Volume on Computed Tomographic Images for Preoperative Radiotherapy of Primary Soft Tissue Sarcoma of Extremity in Radiation Therapy Oncology Group Studies.
Sarcoma
Systematic screening identifies a 2-gene signature as a high-potential prognostic marker of undifferentiated pleomorphic sarcoma/myxofibrosarcoma.
Sarcoma
The tumor immune microenvironmental analysis of 2,033 transcriptomes across 7 cancer types.
Sarcoma
Tumors of the atlas. 3 incidental cases of osteochondroma, benign osteoblastoma, and atypical Ewing's sarcoma.
Sarcoma
[Sarcoma of the proximal end of the humerus; metastasis to the atlas, localized by tomography.]
Sarcoma, Ewing
DNA Methylation-Based Classifier for Accurate Molecular Diagnosis of Bone Sarcomas.
Sarcoma, Ewing
Tumors of the atlas. 3 incidental cases of osteochondroma, benign osteoblastoma, and atypical Ewing's sarcoma.
Sarcoma, Ewing
[Clinical manifestation of Ewing's sarcoma as a retrotonsillar pharyngeal tumor]
Sarcoma, Synovial
Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.
Sarcoma, Synovial
DNA Methylation-Based Classifier for Accurate Molecular Diagnosis of Bone Sarcomas.
Schistosomiasis
Complex emergencies and the control and elimination of neglected tropical diseases in Africa: developing a practical approach for implementing safe and effective mapping and intervention strategies.
Schistosomiasis
The colposcopic atlas of schistosomiasis in the lower female genital tract based on studies in Malawi,Zimbabwe, Madagascar and South Africa.
Schistosomiasis
The Three Gorges Dam: Does the Flooding Time Determine the Distribution of Schistosome-Transmitting Snails in the Middle and Lower Reaches of the Yangtze River, China?
Sciatica
Inflammatory biomarkers do not distinguish between patients with sciatica and referred leg pain within a primary care population: results from a nested study within the ATLAS cohort.
Sciatica
Prognosis of sciatica and back-related leg pain in primary care: the ATLAS cohort.
Scleroderma, Systemic
New reference atlas for pulmonary fibrosis severity score in systemic sclerosis.
Scoliosis
Another "new" form, the palagonia type of acrofacial dysostosis in a Sicilian family.
Scoliosis
Clinical application of three-dimensional printing in the personalized treatment of complex spinal disorders.
Scoliosis
Complex Chiari Malformation Presenting with Bulbar Symptoms in an Adult: Single-stage Posterior Fusion and Foramen Magnum Decompression: A Rare Case Report.
Scoliosis
Is Cervical Stabilization for All Cases of Chiari-I Malformation an Overkill? Evidence Speaks Louder Than Words!
Scoliosis
Obex position is associated with syringomyelia and use of posterior fossa decompression among patients with Chiari I malformation.
Sea-Blue Histiocyte Syndrome
Images from the Haematologica Atlas of Hematologic Cytology: sea-blue histiocytosis.
Seizures
Anterior temporal lobe white matter abnormal signal (ATLAS) as an indicator of seizure focus laterality in temporal lobe epilepsy: comparison of double inversion recovery, FLAIR and T2W MR imaging.
Seizures
Assessment of Acute Hospital Use and Transfers for Management of Pediatric Seizures.
Seizures
Clinical validation of automated hippocampal segmentation in temporal lobe epilepsy.
Seizures
Partial epileptic seizure with versive movements examined by [99m Tc] HM-PAO brain single photon emission computed tomography: an early post study analyzed by computerized brain atlas methods.
Seizures
Predicting the likelihood of postoperative seizure status based on mRNA sequencing in low-grade gliomas.
Seizures
Quantitative analysis of double inversion recovery and FLAIR signals in temporal lobe epilepsy.
Seizures
Semiologic subgroups of insulo-opercular seizures based on connectional architecture atlas.
Seizures
Through diffusion tensor magnetic resonance imaging to evaluate the original properties of neural pathways of patients with partial seizures and secondary generalization by individual anatomic reference atlas.
Seminoma
Distinct Metabolic Features of Seminoma and Embryonal Carcinoma Revealed by Combined Transcriptome and Metabolome Analyses.
Seminoma
HMGA1-Regulating microRNAs Let-7a and miR-26a are Downregulated in Human Seminomas.
Seminoma
Methylation gene KCNC1 is associated with overall survival in patients with seminoma.
Seminoma
Nuclear Localization of PTTG1 Promotes Migration and Invasion of Seminoma Tumor through Activation of MMP-2.
Sepsis
Antimicrobial resistance prevalence, rates of hospitalization with septicemia and rates of mortality with sepsis in adults in different US states.
Sexually Transmitted Diseases
A Complete Practical Treatise on Venereal Diseases, and their immediate and remote Consequences; including Observations on certain Affections of the Uterus, attended with Discharges. With an Atlas of Plates.
Sexually Transmitted Diseases
Data harmonization process for creating the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Atlas.
Sexually Transmitted Diseases
Describing, analysing and understanding the effects of the introduction of HIV self-testing in West Africa through the ATLAS programme in Côte d'Ivoire, Mali and Senegal.
Sexually Transmitted Diseases
Performance of the Atlas Genetics Rapid Test for Chlamydia trachomatis and Women's Attitudes Toward Point-Of-Care Testing.
Situs Inversus
Hypoplasia of the atlas causing cervical myelopathy with situs inversus totalis.
Skin Diseases
A Pictorial Atlas of Skin Diseases and Syphilitic Affections in Photo-Lithochromes, from Models in the Museum of the St Louis Hospital, Paris.
Skin Diseases
A Pictorial Atlas of Skin Diseases and Syphilitic Affections, from Models in the Museum of the Saint Louis Hospital, Paris, with Explanatory Woodcuts and Text.
Skin Diseases
A Pictorial Atlas of Skin Diseases and Syphilitic Affections, in Photo-Lithochromes.
Skin Diseases
Ackerman AB, Kerl H, Sanchez J, editors. A Clinical Atlas of 101 Common Skin Diseases. Ardor Scribendi Ltd., New York, 2000, 662 pages.
Skin Diseases
Atlas of Skin Diseases of the Horse: Diagnosis and Treatment in Equine Dermatology.
Skin Diseases
Atlas of Skin Diseases.
Skin Diseases
Book and new media reviews: An atlas of histopathology of skin diseases: An illustrated textbook and reference for clinicians
Skin Diseases
Finding Dr. Olavide Inside The Atlas of Clinical Images of the Skin and Skin Diseases.
Skin Diseases
Pathomorphologic atlas for differential diagnosis of skin diseases, with particular regard to tumors. Part II. Neoplasms and pseudo-neoplastic proliferations.
Skin Diseases
Valentin Barrecheguren (1853-1893) - Painter of the Granada Illustrations in Olavide's Atlas of Clinical Images of the Skin and Skin Diseases.
Skin Diseases
[Atlas for pathomorphologic differential diagnosis of skin diseases, especially neoplasms. Part II. Neoplasms and pseudo-neoplastic proliferations]
Skin Diseases
[Atlas for pathomorphologic differential diagnosis of skin diseases, especially tumors. Part I. Non-neoplastic diseases]
Skin Diseases
[Atlas for pathomorphologic differential diagnosis of skin diseases, especially tumors. Part II. Neoplasms and pseudo-neoplastic proliferations]
Skin Neoplasms
Gene Coexpression Analyses Differentiate Networks Associated with Diverse Cancers Harboring TP53 Missense or Null Mutations.
Skin Neoplasms
Lymphoscintigraphy for sentinel lymph node mapping in Japanese patients with malignant skin neoplasms of the lower extremities: comparison with previously investigated Japanese lymphatic anatomy.
Skin Neoplasms
Pathophysiological Role of Histamine H4 Receptor in Cancer: Therapeutic Implications.
Skin Neoplasms
Somatic Functional Deletions of Upstream Open Reading Frame-Associated Initiation and Termination Codons in Human Cancer.
Sleep Apnea, Obstructive
A case of osteochondroma of the atlas causing obstructive sleep apnea syndrome.
Sleep Apnea, Obstructive
Evaluation of cerebral microstructural changes in adult patients with obstructive sleep apnea by MR diffusion kurtosis imaging using a whole-brain atlas.
Sleep Wake Disorders
EEG arousals: scoring rules and examples: a preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association.
Soft Tissue Infections
Susceptibility of clinical isolates of meticillin-resistant Staphylococcus aureus and phenotypic non-extended-spectrum ?-lactamase-producing Klebsiella pneumoniae to ceftaroline in Taiwan: Results from Antimicrobial Testing Leadership and Surveillance (ATLAS) in 2012-2018 and Surveillance of Multicentre Antimicrobial Resistance in Taiwan (SMART) in 2018-2019.
Solitary Fibrous Tumors
Surgical treatment for recurrent solitary fibrous tumor invading atlas.
Spina Bifida Occulta
A cervical myelopathy caused by invaginated anomaly of laminae of the axis in spina bifida occulta with hypoplasia of the atlas: case report.
Spina Bifida Occulta
Another "new" form, the palagonia type of acrofacial dysostosis in a Sicilian family.
Spinal Cord Compression
Accidental or linked: separated odontoid process fused to the enlarged anterior arch of the atlas associated with atlantoaxial subluxation in a Kashin-Beck disease patient.
Spinal Cord Compression
An unusual form of occipitocervical assimilation presenting with spastic tetraparesis in a child.
Spinal Cord Compression
Anteroposterior spondyloschisis of atlas with incurving of the posterior arch causing compressive myelopathy.
Spinal Cord Compression
Atlanto-axial approach for cervical myelography in a Thoroughbred horse with complete fusion of the atlanto-occipital bones.
Spinal Cord Compression
C1-2 Pedicle Screw Fixation for Ponticulus Posticus and Duplication of Vertebral Artery: 2-Dimensional Operative Video.
Spinal Cord Compression
Cervical myelopathy caused by atlas osteochondroma and pseudoarthrosis between the osteochondroma and lamina of the axis: case report.
Spinal Cord Compression
Compressive Myelopathy due to Osteochondroma of the Atlas and Review of the Literature.
Spinal Cord Compression
Concurrent Ossification of the Posterior Atlantoaxial Interlaminar Membrane and Atlas Hypoplasia: A Case Report.
Spinal Cord Compression
Congenital anterior midline cleft of the atlas and posterior atlanto-occipital fusion associated with symptomatic anterior atlantoaxial subluxation.
Spinal Cord Compression
Elongated Clivus with Deficient Anterior Atlantal Arch and Congenital Posterior Atlantooccipital Dislocation: Pathoembryology and Management Nuances of a Rare Form of Proatlas Segmentation Anomaly.
Spinal Cord Compression
Evaluation of clinical outcomes of one-stage anterior and posterior surgical treatment for atlantoaxial tuberculosis complicated with neurological damage.
Spinal Cord Compression
Solitary osteochondroma of the atlas causing spinal cord compression: a case report and literature review.
Spinal Cord Compression
Spinal compression due to atlantal vertebral malformation in two African lions (Panthera leo).
Spinal Cord Compression
Spinal cord compression caused by ossification of the transverse ligament of the atlas.
Spinal Cord Compression
Subluxation of the atlas causing spinal cord compression in a case of Down's syndrome with a "manifestation of an occipital vertebra".
Spinal Cord Compression
Upper cervical spine surgery in rheumatoid arthritis: retrospective study of 30 patients followed for two years or more after Cotrel-Dubousset instrumentation.
Spinal Cord Compression
[Effects of decompression combined with electro-acupuncture on rat with acute severe upper cervical spinal cord compression injury].
Spinal Cord Diseases
3- to 11-year followup of occipitocervical fusion for rheumatoid arthritis.
Spinal Cord Diseases
A case of cervical myelopathy with developmental canal stenosis at the level of the atlas. A case report.
Spinal Cord Diseases
A case of progressive myelopathy with atlas hypoplasia in an infant: controversy in the surgical strategy.
Spinal Cord Diseases
A cervical myelopathy caused by invaginated anomaly of laminae of the axis in spina bifida occulta with hypoplasia of the atlas: case report.
Spinal Cord Diseases
A rare cause of cervical spinal stenosis: posterior arch hypoplasia in a bipartite atlas.
Spinal Cord Diseases
A surgical case of C1 arch stenosis: A case report and review of literature.
Spinal Cord Diseases
Acute Spinal Cord Contusion in a Patient with Multiple Upper Cervical Fractures, Parkinson's Disease, and Torticollis: Surgical Management.
Spinal Cord Diseases
Atlantoaxial subluxation-induced myelopathy in cleidocranial dysplasia. Case report.
Spinal Cord Diseases
Atlantodental osteoarthritis as a cause of upper cervical myelopathy: a case report.
Spinal Cord Diseases
Atlas hypoplasia and ossification of the transverse atlantal ligament: a rare cause of cervical myelopathy.
Spinal Cord Diseases
Atlas shrugged: cervical myelopathy caused by congenital atlantoaxial dislocation aggravated by child labor.
Spinal Cord Diseases
C1-2 Pedicle Screw Fixation for Ponticulus Posticus and Duplication of Vertebral Artery: 2-Dimensional Operative Video.
Spinal Cord Diseases
Calcium pyrophosphate dihydrate deposition in the transverse ligament of the atlas: an unusual cause of cervical myelopathy.
Spinal Cord Diseases
Cervical myelopathy accompanied with hypoplasia of the posterior arch of the atlas: case report.
Spinal Cord Diseases
Cervical myelopathy and congenital stenosis from hypoplasia of the atlas: report of three cases and literature review.
Spinal Cord Diseases
Cervical myelopathy associated with congenital C2/3 canal stenosis and deficiencies of the posterior arch of the atlas and laminae of the axis: case report and review of the literature.
Spinal Cord Diseases
Cervical myelopathy caused by atlantoaxial instability in a patient with an os odontoideum and total aplasia of the posterior arch of the atlas: a case report.
Spinal Cord Diseases
Cervical myelopathy caused by atlas osteochondroma and pseudoarthrosis between the osteochondroma and lamina of the axis: case report.
Spinal Cord Diseases
Cervical myelopathy caused by hypoplasia of the atlas and ossification of the transverse ligament--case report.
Spinal Cord Diseases
Cervical myelopathy caused by hypoplasia of the atlas: two case reports and review of the literature.
Spinal Cord Diseases
Cervical myelopathy caused by invaginated laminae of the axis associated with occipitalizaion of the atlas: Case report and literature review.
Spinal Cord Diseases
Cervical myelopathy caused by pseudoarthrosis between posterior arch of the atlas and lamina of the axis in Klippel-Feil syndrome: a case report.
Spinal Cord Diseases
Cervical myelopathy caused by pseudoarthrosis between the atlas and axis associated with diffuse idiopathic skeletal hyperostosis.
Spinal Cord Diseases
Cervical Myelopathy Secondary to Atlanto-occipital Assimilation: The Usefulness of the Simple Decompressive Surgery.
Spinal Cord Diseases
Cervical myelopathy secondary to atlas hypoplasia - reports of 3 adult cases -.
Spinal Cord Diseases
Complete Atlantooccipital Assimilation with Basilar Invagination and Atlantoaxial Subluxation Treated Non-Surgically: A Case Report.
Spinal Cord Diseases
Concurrent Ossification of the Posterior Atlantoaxial Interlaminar Membrane and Atlas Hypoplasia: A Case Report.
Spinal Cord Diseases
Congenital malformed posterior arch of atlas with fusion defect: a case of developmental canal stenosis causing cervical myelopathy.
Spinal Cord Diseases
Congenital Malrotation of the Atlas with Unilateral Hypertrophy of the Atlanto-occipital Joint-A Rare Anomaly of the Craniovertebral Junction and Its Management.
Spinal Cord Diseases
Congenital partial aplasia of the posterior arch of the atlas causing myelopathy: case report and review of the literature.
Spinal Cord Diseases
Development of bilateral collateral circulation after fracture of the axis.
Spinal Cord Diseases
Enlarging retro-odontoid pseudotumor after expanding cervical laminoplasty in the presence of kyphosis.
Spinal Cord Diseases
Hypertrophic dens resulting in cervical myelopathy: histologic features of the hypertrophic dens.
Spinal Cord Diseases
Hypoplasia of the atlas causing cervical myelopathy with situs inversus totalis.
Spinal Cord Diseases
Imaging diagnosis--traumatic myelopathy in a dog with incomplete ossification of the dorsal lamina of the atlas.
Spinal Cord Diseases
Isolated cervical spinal canal stenosis at C-1 in the pediatric population and in Williams syndrome.
Spinal Cord Diseases
Myelopathy resulting from the atlantodental hypertrophic osteoarthritis accompanying the dens hypertrophy. Two case reports.
Spinal Cord Diseases
Ossification of the Cruciform Ligament of Atlas; a Rare Cause of Cervical Myelopathy: Case Report and Review of Literature.
Spinal Cord Diseases
Ossification of the posterior atlantoaxial membrane associated with atlas hypoplasia: A case report.
Spinal Cord Diseases
Ossification of transverse ligament of atlas causing cervical myelopathy: a case report and review of the literature.
Spinal Cord Diseases
Surgical treatment for atlantoaxial subluxation with myelopathy in spondyloepiphyseal dysplasia congenita.
Spinal Cord Diseases
Symptomatic Atlas Hypoplasia in a Latin-American Patient: Case Report and Literature Review.
Spinal Cord Diseases
The relationship between atlas hypoplasia and os odontoideum in children with Down syndrome: a preliminary case report.
Spinal Cord Diseases
Transoral Approach to the Craniovertebral Junction: A Neuronavigated Cadaver Study.
Spinal Cord Diseases
Unilateral lateral mass hypertrophy: An extremely rare congenital anomaly of atlas.
Spinal Cord Diseases
Ventral cervicomedullary junction compression secondary to condylus occipitalis (median occipital condyle), a rare entity.
Spinal Cord Diseases
[Delayed myelopathy secondary to dislocation of the atlas on the epistropheus of the odontoid apophysis. Presentation of a case.]
Spinal Cord Diseases
[Mucopolysaccharidosis 6-A (Maroteaux-Lamy disease): comparison of clinical and pathologico-anatomic findings in a 27-year-old patient]
Spinal Cord Diseases
[Post-traumatic delayed cervical myelopathy, as sequela of an unrecognized old fracture of the dens epistrophei with luxation of the atlas.]
Spinal Cord Diseases
[Spinal stenosis at the level of atlas in a boy with Down syndrome. A case report and literature review.]
Spinal Cord Diseases
[Surgical decompression for the C-1 and C-2 sensory roots and upper cervical cord in a case with cervical myelopathy and occipital neuralgia due to bilateral fenestration of vertebral artery: a case report]
Spinal Cord Injuries
Atlantal stenosis: a rare cause of quadriparesis in a child. Case report.
Spinal Cord Injuries
Injury volume extracted from MRI predicts neurologic outcome in acute spinal cord injury: A prospective TRACK-SCI pilot study.
Spinal Cord Injuries
[Assessment of the risk of occipitocervical dislocation in inflammatory rheumatic diseases]
Spinal Cord Injuries
[Clinical diagnosis and treatment of multiple-level injuries of the cervical spine.]
Spinal Diseases
Eosinophilic granuloma of the spine involving C1 and pulmonary infiltration in young children - Presentation of two cases with a follow-up over 10 years including review of the literature.
Spinal Dysraphism
"Split atlas" in a trauma and nontrauma patient: two different case reports for a rare congenital malformation.
Spinal Dysraphism
Clinical management of cranio-vertebral instability after whiplash, when guidelines should be adapted: A case report.
Spinal Dysraphism
Congenital posterior atlas defect associated with anterior rachischisis and early cervical degenerative disc disease: a case study and review of the literature.
Spinal Dysraphism
Craniovertebral junction: normal anatomy, craniometry, and congenital anomalies.
Spinal Dysraphism
Dislocation and/or congenital malformation of the shoulder joint. Observations on a Mediaeval skeleton from Denmark.
Spinal Dysraphism
Odontoid fracture with spina bifida posterior of the atlas. A case report.
Spinal Dysraphism
Persistent torticollis, facial asymmetry, grooved tongue, and dolicho-odontoid process in connection with atlas malformation complex in three family subjects.
Spinal Dysraphism
Reconstruction of the health status in a past human population: the Iron Age necropolis of Monte Bibele (Bologna, Italy).
Spinal Stenosis
A rare cause of cervical spinal stenosis: posterior arch hypoplasia in a bipartite atlas.
Spinal Stenosis
Atlantoaxial dislocation with congenital "sandwich fusion" in the craniovertebral junction: a retrospective case series of 70 patients.
Spinal Stenosis
Cervical myelopathy caused by hypoplasia of the atlas: two case reports and review of the literature.
Spinal Stenosis
[Spinal stenosis at the level of atlas in a boy with Down syndrome. A case report and literature review.]
Spinocerebellar Degenerations
[Atlas of mental pathology. 15. Changes in the central nervous system. Spinocerebellar degeneration]
Spondylarthritis
Similarities and differences between non-radiographic and radiographic axial spondyloarthritis: The patient perspective from the Spanish atlas.
Spondylitis
Spondylitis of Upper Cervical Vertebræ including Atlas and Axis, with Cord Compression. Typhoid Origin.
Spondylitis
[Ventral decompression techniques in patients with traumatic and non-traumatic atlanto-axial dislocations].
Spondylitis, Ankylosing
Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial.
Spondylitis, Ankylosing
Paleopathological features of the cervical spine in the early middle ages: natural history of degenerative diseases.
Spondylitis, Ankylosing
Upward subluxation of the axis in ankylosing spondylitis. A clinical pathologic report.
Spondylolisthesis
Combined injuries in the upper cervical spine: clinical and epidemiological data over a 14-year period.
Spondylolisthesis
Congenital Spondylolytic Spondylolisthesis of C2 Vertebra Associated With Atlanto-Axial Dislocation, Chiari Type I Malformation, and Anomalous Vertebral Artery: Case Report With Review Literature.
Spondylolisthesis
Multiple unstable cervical fractures with cord compromise treated nonoperatively: a case report.
Spondylolisthesis
Posterior arthrodesis of C1-C3 for the stabilization of multiple unstable upper cervical fractures with spinal cord compromise: A case report and literature review.
Spondylolisthesis
Prognosis of neurological deficits associated with upper cervical spine injuries.
Spondylosis
[Syringomyelic syndrome secondary to cervical canal stenosis and cervical spondylosis]
Squamous Cell Carcinoma of Head and Neck
(S,R)3-(4-Hydroxyphenyl)-4,5-Dihydro-5-Isoxazole Acetic Acid Methyl Ester Inhibits Epithelial-to-Mesenchymal Transition through TGF-?/Smad4 Axis in Nasopharyngeal Carcinoma.
Squamous Cell Carcinoma of Head and Neck
?Np63?/SRC/Slug Signaling Axis Promotes Epithelial-to-Mesenchymal Transition in Squamous Cancers.
Squamous Cell Carcinoma of Head and Neck
A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes.
Squamous Cell Carcinoma of Head and Neck
A ceRNA-associated risk model predicts the poor prognosis for head and neck squamous cell carcinoma patients.
Squamous Cell Carcinoma of Head and Neck
A combination of intra-tumor genetic heterogeneity, estrogen receptor alpha and human papillomavirus status predicts outcomes in head and neck squamous cell carcinoma following chemoradiotherapy.
Squamous Cell Carcinoma of Head and Neck
A comprehensive investigation using meta-analysis and bioinformatics on miR-34a-5p expression and its potential role in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
A gene expression profile associated with perineural invasion identifies a subset of HNSCC at risk of post-surgical recurrence.
Squamous Cell Carcinoma of Head and Neck
A HPV16-related prognostic indicator for head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
A molecular signature of well-differentiated oral squamous cell carcinoma reveals a resistance mechanism to metronomic chemotherapy and novel therapeutic candidates.
Squamous Cell Carcinoma of Head and Neck
A novel immune-related long non-coding RNA signature improves the prognosis prediction in the context of head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
A Novel Immune-Related Prognostic Signature in Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
A Novel Prognostic Index Based on the Analysis of Glycolysis-Related Genes in Head and Neck Squamous Cell Carcinomas.
Squamous Cell Carcinoma of Head and Neck
A novel saliva-based microRNA biomarker panel to detect head and neck cancers.
Squamous Cell Carcinoma of Head and Neck
A novel seven?miRNA prognostic model to predict overall survival in head and neck squamous cell carcinoma patients.
Squamous Cell Carcinoma of Head and Neck
A novel splice variant of LOXL2 promotes progression of human papillomavirus-negative head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
A Novel Three-lncRNA Signature Predicts the Overall Survival of HNSCC Patients.
Squamous Cell Carcinoma of Head and Neck
A panel of Transcription factors identified by data mining can predict the prognosis of head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
A prognostic long non-coding RNA-associated competing endogenous RNA network in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
A prognostic mRNA expression signature of four 16q24.3 genes in radio(chemo)therapy-treated head and neck squamous cell carcinoma (HNSCC).
Squamous Cell Carcinoma of Head and Neck
A radiosensitivity MiRNA signature validated by the TCGA database for head and neck squamous cell carcinomas.
Squamous Cell Carcinoma of Head and Neck
A risk score system based on DNA methylation levels and a nomogram survival model for lung squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
A robust six-miRNA prognostic signature for head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
A six-gene expression signature related to angiolymphatic invasion is associated with poor survival in laryngeal squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
A six-mRNA prognostic model to predict survival in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
A three-gene expression signature associated with positive surgical margins in tongue squamous cell carcinomas: Predicting surgical resectability from tumour biology?
Squamous Cell Carcinoma of Head and Neck
A three-lncRNA expression signature predicts survival in head and neck squamous cell carcinoma (HNSCC).
Squamous Cell Carcinoma of Head and Neck
A three-lncRNA signature derived from the Atlas of ncRNA in cancer (TANRIC) database predicts the survival of patients with head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
A Transcriptomic Analysis of Head and Neck Squamous Cell Carcinomas for Prognostic Indications.
Squamous Cell Carcinoma of Head and Neck
Aberrant expression of CPSF1 promotes head and neck squamous cell carcinoma via regulating alternative splicing.
Squamous Cell Carcinoma of Head and Neck
Aberrations of m6A regulators are associated with tumorigenesis and metastasis in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
ACLY (ATP Citrate Lyase) Mediates Radioresistance in Head and Neck Squamous Cell Carcinomas and is a Novel Predictive Radiotherapy Biomarker.
Squamous Cell Carcinoma of Head and Neck
AKT3 Is a Novel Regulator of Cancer-Associated Fibroblasts in Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
An 11-lncRNA expression could be potential prognostic biomarkers in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
An aberrant DNA methylation signature for predicting the prognosis of head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
An eleven gene molecular signature for extra-capsular spread in oral squamous cell carcinoma serves as a prognosticator of outcome in patients without nodal metastases.
Squamous Cell Carcinoma of Head and Neck
An Immune-Related Gene Prognostic Index for Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
An immune-related seven-lncRNA signature for head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Analysis of DNA methylation and gene expression in radiation-resistant head and neck tumors.
Squamous Cell Carcinoma of Head and Neck
Analysis of Genetic Alteration Signatures and Prognostic Values of m6A Regulatory Genes in Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Analysis of methylation-driven genes for predicting the prognosis of patients with head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Analysis of The Cancer Genome Atlas sequencing data reveals novel properties of the human papillomavirus 16 genome in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
APOBEC-mediated cytosine deamination links PIK3CA helical domain mutations to human papillomavirus-driven tumor development.
Squamous Cell Carcinoma of Head and Neck
Apoptosis signaling molecules as treatment targets in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Association between loss of Y chromosome and poor prognosis in male head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Association of LINC00673 Genetic Variants with Progression of Oral Cancer.
Squamous Cell Carcinoma of Head and Neck
Association of lnc-IL17RA-11 with increased radiation sensitivity and improved prognosis of HPV-positive HNSCC.
Squamous Cell Carcinoma of Head and Neck
Bioinformatics analysis of the expression and role of microRNA-221-3p in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Biological information and functional analysis reveal the role of discoidin domain receptor 1 in oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Biological role and clinical value of miR-99a-5p in head and neck squamous cell carcinoma (HNSCC): A bioinformatics-based study.
Squamous Cell Carcinoma of Head and Neck
Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.
Squamous Cell Carcinoma of Head and Neck
Cannabinoids promote progression of HPV positive head and neck squamous cell carcinoma via p38 MAPK activation.
Squamous Cell Carcinoma of Head and Neck
Carbonyl reductase 1 is a new target to improve the effect of radiotherapy on head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
CDK6 inhibits lymphoid cell infiltration and represents a prognostic marker in HPV+ squamous cell carcinoma of head and neck.
Squamous Cell Carcinoma of Head and Neck
CDKN2A Copy Number Loss Is an Independent Prognostic Factor in HPV-Negative Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Characteristic miRNA expression signature and random forest survival analysis identify potential cancer-driving miRNAs in a broad range of head and neck squamous cell carcinoma subtypes.
Squamous Cell Carcinoma of Head and Neck
Characteristics of B lymphocyte infiltration in HPV+ head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Characterization of a prognostic four?gene methylation signature associated with radiotherapy for head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Characterization of Alternative Splicing Events in HPV-Negative Head and Neck Squamous Cell Carcinoma Identifies an Oncogenic DOCK5 Variant.
Squamous Cell Carcinoma of Head and Neck
Characterization of functionally active gene fusions in human papillomavirus related oropharyngeal squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Chromosome 3p loss in the progression and prognosis of head and neck cancer.
Squamous Cell Carcinoma of Head and Neck
Clinical and genomic characterization of neutral tumor evolution in Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Clinical performance validation of PITX2 DNA methylation as prognostic biomarker in patients with head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Clinical Significance of an m6A Reader Gene, IGF2BP2, in Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Clinicopathological Significance of FOXO4 Expression and Correlation with Prx1 in Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Clusterization in head and neck squamous carcinomas based on lncRNA expression: molecular and clinical correlates.
Squamous Cell Carcinoma of Head and Neck
Combined identification of three miRNAs in serum as effective diagnostic biomarkers for HNSCC.
Squamous Cell Carcinoma of Head and Neck
Combined Transcriptome and Proteome Analysis of Immortalized Human Keratinocytes Expressing Human Papillomavirus 16 (HPV16) Oncogenes Reveals Novel Key Factors and Networks in HPV-Induced Carcinogenesis.
Squamous Cell Carcinoma of Head and Neck
Comprehensive analysis of competitive endogenous RNAs network associated with head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Comprehensive Analysis of the PD-L1 and Immune Infiltrates of m6A RNA Methylation Regulators in Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Comprehensive Analysis of the Roles and Prognostic Value of RNA-Binding Proteins in Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Comprehensive characterization of the tumor microenvironment for assessing immunotherapy outcome in patients with head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Comprehensive genomic characterization of head and neck squamous cell carcinomas.
Squamous Cell Carcinoma of Head and Neck
Comprehensive immunogenomic landscape analysis of prognosis-related genes in head and neck cancer.
Squamous Cell Carcinoma of Head and Neck
Computational analysis of TP53 mutational landscape unveils key prognostic signatures and distinct pathobiological pathways in head and neck squamous cell cancer.
Squamous Cell Carcinoma of Head and Neck
Construction of an 11-microRNA-based signature and a prognostic nomogram to predict the overall survival of head and neck squamous cell carcinoma patients.
Squamous Cell Carcinoma of Head and Neck
Copy number alterations identify a smoking-associated expression signature predictive of poor outcome in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Critical genes in head and neck squamous cell carcinoma revealed by bioinformatic analysis of gene expression data.
Squamous Cell Carcinoma of Head and Neck
CT-based Radiomic Signatures for Predicting Histopathologic Features in Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
CXCL11-CXCR3 Axis Mediates Tumor Lymphatic Cross Talk and Inflammation-Induced Tumor, Promoting Pathways in Head and Neck Cancers.
Squamous Cell Carcinoma of Head and Neck
Cytogenetic alterations and their molecular genetic correlates in head and neck squamous cell carcinoma: a next generation window to the biology of disease.
Squamous Cell Carcinoma of Head and Neck
Decreased SMAD4 expression is associated with induction of epithelial-to-mesenchymal transition and cetuximab resistance in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Determining the molecular landscape and impact on prognosis in HPV-associated head and neck cancer.
Squamous Cell Carcinoma of Head and Neck
Development and validation of a m6A RNA methylation regulators-based signature for predicting the prognosis of head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Development and Validation of a Robust Immune Prognostic Signature for Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Development and validation of radiomic signatures of head and neck squamous cell carcinoma molecular features and subtypes.
Squamous Cell Carcinoma of Head and Neck
Development of a five-protein signature for predicting the prognosis of head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Development of a Prognostic Signature Based on Autophagy-related Genes for Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Development of an Immunogenomic Landscape-Based Prognostic Index of Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Diagnostic and prognostic value of FOXD1 expression in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Differential Effect of Smoking on Gene Expression in Head and Neck Cancer Patients.
Squamous Cell Carcinoma of Head and Neck
Differential mutation spectrum and immune landscape in African Americans versus Whites: A possible determinant to health disparity in head and neck cancer.
Squamous Cell Carcinoma of Head and Neck
Disruption of KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex components by multiple genetic mechanisms is associated with poor prognosis in head and neck cancer.
Squamous Cell Carcinoma of Head and Neck
Disruption of TP63-miR-27a* feedback loop by mutant TP53 in head and neck cancer.
Squamous Cell Carcinoma of Head and Neck
Distinctive Expression and Amplification of Genes at 11q13 in Relation to HPV Status with Impact on Survival in Head and Neck Cancer Patients.
Squamous Cell Carcinoma of Head and Neck
DNA Methylation Markers from Negative Surgical Margins Can Predict Recurrence of Oral Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
DNA methylation of indoleamine 2,3-dioxygenase 1 (IDO1) in head and neck squamous cell carcinomas correlates with IDO1 expression, HPV status, patients' survival, immune cell infiltrates, mutational load, and interferon ? signature.
Squamous Cell Carcinoma of Head and Neck
DNA methylation-mediated Klotho silencing is an independent prognostic biomarker of head and neck squamous carcinoma.
Squamous Cell Carcinoma of Head and Neck
Down-regulation of the tumor suppressor miR-34a contributes to head and neck cancer by up-regulating the MET oncogene and modulating tumor immune evasion.
Squamous Cell Carcinoma of Head and Neck
Drug repositioning in head and neck squamous cell carcinoma: An integrated pathway analysis based on connectivity map and differential gene expression.
Squamous Cell Carcinoma of Head and Neck
Dysregulation of miR-200 family microRNAs and epithelial-mesenchymal transition markers in oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Early Growth Response 1-Dependent Downregulation of Matrix Metalloproteinase 9 and Mouse Double Minute 2 Attenuates Head and Neck Squamous Cell Carcinoma Metastasis.
Squamous Cell Carcinoma of Head and Neck
Effect of serpinE1 overexpression on the primary tumor and lymph node, and lung metastases in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
EGFR and PI3K Pathway Activities Might Guide Drug Repurposing in HPV-Negative Head and Neck Cancers.
Squamous Cell Carcinoma of Head and Neck
EGOT lncRNA in head and neck squamous cell carcinomas.
Squamous Cell Carcinoma of Head and Neck
Elevated DKK1 expression is an independent unfavorable prognostic indicator of survival in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Elevated ZNF703 Protein Expression Is an Independent Unfavorable Prognostic Factor for Survival of the Patients with Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Enhanced cell migration and apoptosis resistance may underlie the association between high SERPINE1 expression and poor outcome in head and neck carcinoma patients.
Squamous Cell Carcinoma of Head and Neck
Establishment and Validation of a Comprehensive Prognostic Model for Patients With HNSCC Metastasis.
Squamous Cell Carcinoma of Head and Neck
Establishment and validation of immune microenvironmental gene signatures for predicting prognosis in patients with head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Evaluation of FGFR3 as a Therapeutic Target in Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Evaluation of the Risk of Grade 3 Oral and Pharyngeal Dysphagia Using Atlas-Based Method and Multivariate Analyses of Individual Patient Dose Distributions.
Squamous Cell Carcinoma of Head and Neck
Evidence for APOBEC3B mRNA and protein expression in oral squamous cell carcinomas.
Squamous Cell Carcinoma of Head and Neck
Expression and Possible Molecular Mechanisms of microRNA-205-5p in Patients With Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Expression level and prospective mechanism of miRNA-99a-3p in head and neck squamous cell carcinoma based on miRNA-chip and miRNA-sequencing data in 1, 167 cases.
Squamous Cell Carcinoma of Head and Neck
Expression of SESN1, UHRF1BP1, and miR-377-3p as prognostic markers in mutated TP53 squamous cell carcinoma of the head and neck.
Squamous Cell Carcinoma of Head and Neck
Expression profile analysis of head and neck squamous cell carcinomas using data from The Cancer Genome Atlas.
Squamous Cell Carcinoma of Head and Neck
Fewer tumour-specific PD-1+CD8+ TILs in high-risk "Infiltrating" HPV- HNSCC.
Squamous Cell Carcinoma of Head and Neck
Fibroblast growth factor receptor 3 protein is overexpressed in oral and oropharyngeal squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Fifteen mRNA-lncRNA expression-based signature predicted the survival of late-staged head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Five extracellular matrix-associated genes upregulated in oral tongue squamous cell carcinoma: An integrated bioinformatics analysis.
Squamous Cell Carcinoma of Head and Neck
FOXL2 expression might be a novel prognostic biomarker in patients with laryngeal squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Frequent promoter hypermethylation of PTPRT increases STAT3 activation and sensitivity to STAT3 inhibition in head and neck cancer.
Squamous Cell Carcinoma of Head and Neck
G3BP1 may serve as a potential biomarker of proliferation, apoptosis, and prognosis in oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Gene expression profile in oral squamous cell carcinoma: a pilot study.
Squamous Cell Carcinoma of Head and Neck
Gene expression profile in oral squamous cell carcinomas and matching normal oral mucosal tissues from black Africans and white Caucasians: the case of the Sudan vs. Norway.
Squamous Cell Carcinoma of Head and Neck
Gene Expression Signatures for Head and Neck Cancer Patient Stratification: Are Results Ready for Clinical Application?
Squamous Cell Carcinoma of Head and Neck
Gene promoter-associated CpG island hypermethylation in squamous cell carcinoma of the tongue.
Squamous Cell Carcinoma of Head and Neck
Gene signatures of m5C regulators may predict prognoses of patients with head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Genetic Variants Were Associated With the Prognosis of Head and Neck Squamous Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Genome-scale methylation assessment did not identify prognostic biomarkers in oral tongue carcinomas.
Squamous Cell Carcinoma of Head and Neck
Genome-wide miRNA profiling reinforces the importance of miR-9 in human papillomavirus associated oral and oropharyngeal head and neck cancer.
Squamous Cell Carcinoma of Head and Neck
Genome-Wide Profiling of Acquired Uniparental Disomy Reveals Prognostic Factors in Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Genomic alterations in human epidermal growth factor receptor 2 (HER2/ERBB2) in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Genomic and Transcriptomic Characterization Links Cell Lines with Aggressive Head and Neck Cancers.
Squamous Cell Carcinoma of Head and Neck
Head and Neck Cancers Promote an Inflammatory Transcriptome through Coactivation of Classic and Alternative NF-?B Pathways.
Squamous Cell Carcinoma of Head and Neck
Head and neck squamous cell carcinoma: Ambiguous human papillomavirus status, elevated p16, and deleted retinoblastoma 1.
Squamous Cell Carcinoma of Head and Neck
Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
High Abundance of Intratumoral ?? T Cells Favors a Better Prognosis in Head and Neck Squamous Cell Carcinoma: A Bioinformatic Analysis.
Squamous Cell Carcinoma of Head and Neck
High expression of ACTL8 is poor prognosis and accelerates cell progression in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
High Level Expression of MHC-II in HPV+ Head and Neck Cancers Suggests that Tumor Epithelial Cells Serve an Important Role as Accessory Antigen Presenting Cells.
Squamous Cell Carcinoma of Head and Neck
High SEC61G expression predicts poor prognosis in patients with Head and Neck Squamous Cell Carcinomas.
Squamous Cell Carcinoma of Head and Neck
Histopathological image and gene expression pattern analysis for predicting molecular features and prognosis of head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
HOTTIP Functions as a Key Candidate Biomarker in Head and Neck Squamous Cell Carcinoma by Integrated Bioinformatic Analysis.
Squamous Cell Carcinoma of Head and Neck
HOXB5 acts as an oncogenic driver in head and neck squamous cell carcinoma via EGFR/Akt/Wnt/?-catenin signaling axis.
Squamous Cell Carcinoma of Head and Neck
HPV + HNSCC-derived exosomal miR-9 induces macrophage M1 polarization and increases tumor radiosensitivity.
Squamous Cell Carcinoma of Head and Neck
HPV33+ HNSCC is associated with poor prognosis and has unique genomic and immunologic landscapes.
Squamous Cell Carcinoma of Head and Neck
Human epidermal growth factor receptor 2 expression in head and neck squamous cell carcinoma: Variation within and across primary tumor sites, and implications for antigen-specific immunotherapy.
Squamous Cell Carcinoma of Head and Neck
Identification and analysis of genes associated with head and neck squamous cell carcinoma by integrated bioinformatics methods.
Squamous Cell Carcinoma of Head and Neck
Identification and validation of autophagy-related prognostic signature for head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Identification and validation of potential long non-coding RNA biomarkers in predicting survival of patients with head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Identification novel prognostic signatures for Head and Neck Squamous Cell Carcinoma based on ceRNA network construction and immune infiltration analysis.
Squamous Cell Carcinoma of Head and Neck
Identification of 4-lncRNA prognostic signature in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Identification of a Costimulatory Molecule Gene Signature to Predict Survival and Immunotherapy Response in Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Identification of a Ferroptosis Gene Set That Mediates the Prognosis of Squamous Cell Carcinoma of the Head and Neck.
Squamous Cell Carcinoma of Head and Neck
Identification of a Gene Prognostic Signature for Oral Squamous Cell Carcinoma by RNA Sequencing and Bioinformatics.
Squamous Cell Carcinoma of Head and Neck
Identification of a Human Papillomavirus-Associated Oncogenic miRNA Panel in Human Oropharyngeal Squamous Cell Carcinoma Validated by Bioinformatics Analysis of The Cancer Genome Atlas.
Squamous Cell Carcinoma of Head and Neck
Identification of a Novel Epithelial-Mesenchymal Transition Gene Signature Predicting Survival in Patients With HNSCC.
Squamous Cell Carcinoma of Head and Neck
Identification of a six microRNA signature as a novel potential prognostic biomarker in patients with head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Identification of an atypical etiological head and neck squamous carcinoma subtype featuring the CpG island methylator phenotype.
Squamous Cell Carcinoma of Head and Neck
Identification of an autophagy-related prognostic signature in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Identification of ESM1 overexpressed in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Identification of Hub Genes Associated With Development of Head and Neck Squamous Cell Carcinoma by Integrated Bioinformatics Analysis.
Squamous Cell Carcinoma of Head and Neck
Identification of Immune-Related Prognostic Biomarkers Associated with HPV-Positive Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Identification of ITGA3 as an Oncogene in Human Tongue Cancer via Integrated Bioinformatics Analysis.
Squamous Cell Carcinoma of Head and Neck
Identification of Potential Biomarkers and Survival Analysis for Head and Neck Squamous Cell Carcinoma Using Bioinformatics Strategy: A Study Based on TCGA and GEO Datasets.
Squamous Cell Carcinoma of Head and Neck
Identification of prognostic marker genes in head and neck squamous cell carcinoma: A study based on The Cancer Genome Atlas database and experimental validation.
Squamous Cell Carcinoma of Head and Neck
Identification of prognostic microRNA candidates for head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Identification of PSMD7 as a prognostic factor correlated with immune infiltration in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Identification of SERPINE1, PLAU and ACTA1 as biomarkers of head and neck squamous cell carcinoma based on integrated bioinformatics analysis.
Squamous Cell Carcinoma of Head and Neck
Identification of Targetable ERBB2 Aberrations in Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Identification of Three Autophagy-Related Long Non-Coding RNAs as a Novel Head and Neck Squamous Cell Carcinoma Prognostic Signature.
Squamous Cell Carcinoma of Head and Neck
IGF2BP2 Polymorphisms Are Associated with Clinical Characteristics and Development of Oral Cancer.
Squamous Cell Carcinoma of Head and Neck
Imaging-Genomic Study of Head and Neck Squamous Cell Carcinoma: Associations Between Radiomic Phenotypes and Genomic Mechanisms via Integration of The Cancer Genome Atlas and The Cancer Imaging Archive.
Squamous Cell Carcinoma of Head and Neck
Immune-related genes have prognostic significance in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Immunogenomic correlates of response to cetuximab monotherapy in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Immunohistochemical Expression of Five Protein Combinations Revealed as Prognostic Markers in Asian Oral Cancer.
Squamous Cell Carcinoma of Head and Neck
Immunological network analysis in HPV associated head and neck squamous cancer and implications for disease prognosis.
Squamous Cell Carcinoma of Head and Neck
Influence of Immune Microenvironment on Diagnosis and Prognosis of Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Integrated analysis of deregulation microRNA expression in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Integrated analysis of lncRNA CTD-2357A8.3 expression and its potential roles in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Integrated analysis of single-cell RNA-seq and bulk RNA-seq reveals distinct cancer-associated fibroblasts in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Integrated analysis of the prognostic values of RNA-binding proteins in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Integrating Clinical and Genetic Analysis of Perineural Invasion in Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Integrative Analysis of miRNAs Identifies Clinically Relevant Epithelial and Stromal Subtypes of Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Integrative Genomics and Transcriptomics Analysis Reveals Potential Mechanisms for Favorable Prognosis of Patients with HPV-Positive Head and Neck Carcinomas.
Squamous Cell Carcinoma of Head and Neck
Integrative Models of Histopathological Image Features and Omics Data Predict Survival in Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Integrin ?-5 as a potential biomarker of head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Interference of tumour mutational burden with outcome of patients with head and neck cancer treated with definitive chemoradiation: a multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group.
Squamous Cell Carcinoma of Head and Neck
Intragenic DNA methylation of PITX1 and the adjacent long non-coding RNA C5orf66-AS1 are prognostic biomarkers in patients with head and neck squamous cell carcinomas.
Squamous Cell Carcinoma of Head and Neck
Investigating resistin like beta (RETNLB) as a tumor promoter for oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Involvement of Differentially Expressed microRNAs in the PEGylated Liposome Encapsulated 188Rhenium-Mediated Suppression of Orthotopic Hypopharyngeal Tumor.
Squamous Cell Carcinoma of Head and Neck
JOSD1 promotes proliferation and chemoresistance of head and neck squamous cell carcinoma under the epigenetic regulation of BRD4.
Squamous Cell Carcinoma of Head and Neck
Jumonji domain-containing protein 6 functions as a marker of head and neck squamous cell carcinoma at advanced stage with no effect on prognosis.
Squamous Cell Carcinoma of Head and Neck
LCL161, a SMAC-mimetic, Preferentially Radiosensitizes Human Papillomavirus-negative Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Liprin-?1 modulates cancer cell signaling by transmembrane protein CD82 in adhesive membrane domains linked to cytoskeleton.
Squamous Cell Carcinoma of Head and Neck
LNCAROD is stabilized by m6A methylation and promotes cancer progression via forming a ternary complex with HSPA1A and YBX1 in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Long Non-coding RNA LINC02195 as a Regulator of MHC I Molecules and Favorable Prognostic Marker for Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Long noncoding RNA, LINC00460, as a prognostic biomarker in head and neck squamous cell carcinoma (HNSCC).
Squamous Cell Carcinoma of Head and Neck
Loss of Trop2 causes ErbB3 activation through a neuregulin-1-dependent mechanism in the mesenchymal subtype of HNSCC.
Squamous Cell Carcinoma of Head and Neck
Loss-of-Function PTPRD Mutations Lead to Increased STAT3 Activation and Sensitivity to STAT3 Inhibition in Head and Neck Cancer.
Squamous Cell Carcinoma of Head and Neck
Low expression of NSD1, NSD2, and NSD3 define a subset of human papillomavirus-positive oral squamous carcinomas with unfavorable prognosis.
Squamous Cell Carcinoma of Head and Neck
Low Mast Cell Density Predicts Poor Prognosis in Oral Squamous Cell Carcinoma and Reduces Survival in Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Lower DSC1 expression is related to the poor differentiation and prognosis of head and neck squamous cell carcinoma (HNSCC).
Squamous Cell Carcinoma of Head and Neck
Lymphotoxin-? receptor-NIK signaling induces alternative RELB/NF-?B2 activation to promote metastatic gene expression and cell migration in head and neck cancer.
Squamous Cell Carcinoma of Head and Neck
Matrix-metalloproteinases in head and neck carcinoma-cancer genome atlas analysis and fluorescence imaging in mice.
Squamous Cell Carcinoma of Head and Neck
Melanoma-associated antigen A11 reduces erlotinib and afatinib efficacy in head and neck cancer.
Squamous Cell Carcinoma of Head and Neck
Methylation of RAD51B, XRCC3 and other homologous recombination genes is associated with expression of immune checkpoints and an inflammatory signature in squamous cell carcinoma of the head and neck, lung and cervix.
Squamous Cell Carcinoma of Head and Neck
miR-125a-5p Functions as Tumor Suppressor microRNA And Is a Marker of Locoregional Recurrence And Poor prognosis in Head And Neck Cancer.
Squamous Cell Carcinoma of Head and Neck
miR-375 Regulates Invasion-Related Proteins Vimentin and L-Plastin.
Squamous Cell Carcinoma of Head and Neck
miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
Squamous Cell Carcinoma of Head and Neck
MKP-1 is required to limit myeloid-cell mediated oral squamous cell carcinoma progression and regional extension.
Squamous Cell Carcinoma of Head and Neck
Model establishment of prognostic-related immune genes in laryngeal squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Models for Predicting Stage in Head and Neck Squamous Cell Carcinoma using Proteomic and Transcriptomic Data.
Squamous Cell Carcinoma of Head and Neck
Molecular homology between canine spontaneous oral squamous cell carcinomas and human head-and-neck squamous cell carcinomas reveals disease drivers and therapeutic vulnerabilities.
Squamous Cell Carcinoma of Head and Neck
Multi-Institutional Validation of Deep Learning for Pretreatment Identification of Extranodal Extension in Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Mutation of chromatin regulators and focal hotspot alterations characterize human papillomavirus-positive oropharyngeal squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Mutational analysis of head and neck squamous cell carcinoma stratified by smoking status.
Squamous Cell Carcinoma of Head and Neck
Mutational load and mutational patterns in relation to age in head and neck cancer.
Squamous Cell Carcinoma of Head and Neck
Mutational profiles of persistent/recurrent laryngeal squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
MYCT1 Inhibits the Adhesion and Migration of Laryngeal Cancer Cells Potentially Through Repressing Collagen VI.
Squamous Cell Carcinoma of Head and Neck
NGFI-A Binding Protein 2 Promotes EGF-Dependent HNSCC Cell Invasion.
Squamous Cell Carcinoma of Head and Neck
Non-coding RNAs profiling in head and neck cancers.
Squamous Cell Carcinoma of Head and Neck
Notch Signaling Activation Is Associated with Patient Mortality and Increased FGF1-Mediated Invasion in Squamous Cell Carcinoma of the Oral Cavity.
Squamous Cell Carcinoma of Head and Neck
NSD1 mutations by HPV status in head and neck cancer: differences in survival and response to DNA-damaging agents.
Squamous Cell Carcinoma of Head and Neck
Overexpression of hsa-miR-125a-5p enhances proliferation, migration and invasion of head and neck squamous cell carcinoma cell lines by upregulating C-C chemokine receptor type 7.
Squamous Cell Carcinoma of Head and Neck
Overexpression of PIK3CA in head and neck squamous cell carcinoma is associated with poor outcome and activation of the YAP pathway.
Squamous Cell Carcinoma of Head and Neck
p120-Catenin Downregulation and PIK3CA Mutations Cooperate to Induce Invasion through MMP1 in HNSCC.
Squamous Cell Carcinoma of Head and Neck
Passenger strand of miR-145-3p acts as a tumor-suppressor by targeting MYO1B in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Patterns of Transposable Element Expression and Insertion in Cancer.
Squamous Cell Carcinoma of Head and Neck
PD-L1 expression is associated with epithelial-mesenchymal transition in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
PDCD1 (PD-1) promoter methylation predicts outcome in head and neck squamous cell carcinoma patients.
Squamous Cell Carcinoma of Head and Neck
PDGFR? Is a Novel Marker of Stromal Activation in Oral Squamous Cell Carcinomas.
Squamous Cell Carcinoma of Head and Neck
PITX3 DNA methylation is an independent predictor of overall survival in patients with head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Plasma cell marker, immunoglobulin J polypeptide, predicts early disease-specific mortality in HPV+ HNSCC.
Squamous Cell Carcinoma of Head and Neck
Predicting the radiosensitivity of HPV-negative oropharyngeal squamous cell carcinoma using miR-130b.
Squamous Cell Carcinoma of Head and Neck
Prediction of head and neck squamous cell carcinoma survival based on the expression of 15 lncRNAs.
Squamous Cell Carcinoma of Head and Neck
Prediction of Radiosensitivity in Head and Neck Squamous Cell Carcinoma Based on Multiple Omics Data.
Squamous Cell Carcinoma of Head and Neck
PRF1 is a prognostic marker and correlated with immune infiltration in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Prognostic Correlation of an Autophagy-Related Gene Signature in Patients with Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Prognostic implication of proteomic profiles in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Prognostic microRNA signatures derived from The Cancer Genome Atlas for head and neck squamous cell carcinomas.
Squamous Cell Carcinoma of Head and Neck
Prognostic Significance of the Pluripotency Factors NANOG, SOX2, and OCT4 in Head and Neck Squamous Cell Carcinomas.
Squamous Cell Carcinoma of Head and Neck
Prognostic value of immune-related genes and immune cell infiltration analysis in the tumor microenvironment of head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Prognostic value of lipid metabolism-related genes in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Proteomic Characterization of Head and Neck Cancer Patient-Derived Xenografts.
Squamous Cell Carcinoma of Head and Neck
PSMC2, ORC5 and KRTDAP are specific biomarkers for HPV-negative head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
QKI, a miR-200 target gene, suppresses epithelial-to-mesenchymal transition and tumor growth.
Squamous Cell Carcinoma of Head and Neck
Quantitative methodology is critical for assessing DNA methylation and impacts on correlation with patient outcome.
Squamous Cell Carcinoma of Head and Neck
Rab18 Regulates Proliferation, Invasion and Cisplatin Sensitivity Through STAT3 Signaling in Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Radiomic analysis identifies tumor subtypes associated with distinct molecular and microenvironmental factors in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Rare occurrence of EGFRvIII deletion in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Reciprocal activation of cancer-associated fibroblasts and oral squamous carcinoma cells through CXCL1.
Squamous Cell Carcinoma of Head and Neck
Recurrent human papillomavirus-related head and neck cancer undergoes metabolic re-programming and is driven by oxidative phosphorylation.
Squamous Cell Carcinoma of Head and Neck
Resistance to CTLA-4 checkpoint inhibition reversed through selective elimination of granulocytic myeloid cells.
Squamous Cell Carcinoma of Head and Neck
Risk of cognition alteration and emotional frailty via circulating transcriptome in treatment naïve head and neck squamous cell cancer patients.
Squamous Cell Carcinoma of Head and Neck
Role of EphB3 Receptor in Mediating Head and Neck Tumor Growth, Cell Migration, and Response to PI3K Inhibitor.
Squamous Cell Carcinoma of Head and Neck
Screening the key genes of prognostic value in the microenvironment for head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Sex Differences in Using Systemic Inflammatory Markers to Prognosticate Patients with Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Short-term RANKL exposure initiates a neoplastic transcriptional program in the basal epithelium of the murine salivary gland.
Squamous Cell Carcinoma of Head and Neck
SigFuge: single gene clustering of RNA-seq reveals differential isoform usage among cancer samples.
Squamous Cell Carcinoma of Head and Neck
Silencing of long non-coding RNA LINC00520 promotes radiosensitivity of head and neck squamous cell carcinoma cells.
Squamous Cell Carcinoma of Head and Neck
Single Nucleotide Polymorphism rs6942067 Is a Risk Factor in Young and in Non-Smoking Patients with HPV Negative Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Single-Cell Deconvolution of Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Six Glycolysis-Related Genes as Prognostic Risk Markers Can Predict the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
SLUG-related partial epithelial-to-mesenchymal transition is a transcriptomic prognosticator of head and neck cancer survival.
Squamous Cell Carcinoma of Head and Neck
SMAC Mimetic Birinapant plus Radiation Eradicates Human Head and Neck Cancers with Genomic Amplifications of Cell Death Genes FADD and BIRC2.
Squamous Cell Carcinoma of Head and Neck
Sorting Nexin 5 Controls Head and Neck Squamous Cell Carcinoma Progression by Modulating FBW7.
Squamous Cell Carcinoma of Head and Neck
Stimulator of interferon response cGAMP interactor overcomes ERBB2-mediated apatinib resistance in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
STING activation enhances cetuximab-mediated NK cell activation and DC maturation and correlates with HPV
Squamous Cell Carcinoma of Head and Neck
Stress-triggered atavistic reprogramming (STAR) addiction: driving force behind head and neck cancer?
Squamous Cell Carcinoma of Head and Neck
Survival-Associated Metabolic Genes in Human Papillomavirus-Positive Head and Neck Cancers.
Squamous Cell Carcinoma of Head and Neck
Systematic Profiling of Immune Risk Model to Predict Survival and Immunotherapy Response in Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Targeted inhibition of ATR or CHEK1 reverses radioresistance in oral squamous cell carcinoma cells with distal chromosome arm 11q loss.
Squamous Cell Carcinoma of Head and Neck
Targeting EZH2 Enhances Antigen Presentation, Antitumor Immunity, and Circumvents Anti-PD-1 Resistance in Head and Neck Cancer.
Squamous Cell Carcinoma of Head and Neck
Targeting EZH2 regulates tumor growth and apoptosis through modulating mitochondria dependent cell-death pathway in HNSCC.
Squamous Cell Carcinoma of Head and Neck
The clinical significance of apolipoprotein L1 in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
The clinical significance of HOXA9 promoter hypermethylation in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
The cox-filter method identifies respective subtype-specific lncRNA prognostic signatures for two human cancers.
Squamous Cell Carcinoma of Head and Neck
The crosstalk between AXL and YAP promotes tumor progression through STAT3 activation in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
The exploration of new therapeutic targets for HPV-negative head and neck squamous cell cancer through the construction of a ceRNA network and immune microenvironment analysis.
Squamous Cell Carcinoma of Head and Neck
The Expression and Effection of MicroRNA-499a in High-Tobacco Exposed Head and Neck Squamous Cell Carcinoma: A Bioinformatic Analysis.
Squamous Cell Carcinoma of Head and Neck
The head and neck cancer immune landscape and its immunotherapeutic implications.
Squamous Cell Carcinoma of Head and Neck
The Intersection between Oral Microbiota, Host Gene Methylation and Patient Outcomes in Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
The landscape of CD28, CD80, CD86, CTLA4, and ICOS DNA methylation in head and neck squamous cell carcinomas.
Squamous Cell Carcinoma of Head and Neck
The management of localized esophageal squamous cell carcinoma: Western approach.
Squamous Cell Carcinoma of Head and Neck
The molecular landscape of the University of Michigan laryngeal squamous cell carcinoma cell line panel.
Squamous Cell Carcinoma of Head and Neck
The Nedd8-activating enzyme inhibitor MLN4924 (TAK-924/Pevonedistat) induces apoptosis via c-Myc-Noxa axis in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
The non-coding landscape of head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
The Overexpression of NMHC IIA Promoted Invasion and Metastasis of Nasopharyngeal Carcinoma Cells.
Squamous Cell Carcinoma of Head and Neck
The Prognostic Significance of Immune-Related Metabolic Enzyme MTHFD2 in Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
The Prognostic Value of the DNA Repair Gene Signature in Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
The prognostic value of TMB and the relationship between TMB and immune infiltration in head and neck squamous cell carcinoma: A gene expression-based study.
Squamous Cell Carcinoma of Head and Neck
The Proteomic Landscape of Growth Factor Signaling Networks Associated with FAT1 Mutations in Head and Neck Cancers.
Squamous Cell Carcinoma of Head and Neck
The role of Glial cell derived neurotrophic factor in head and neck cancer.
Squamous Cell Carcinoma of Head and Neck
The Role of Interleukin-33 in Head and Neck Squamous Cell Carcinoma Is Determined by Its Cellular Sources in the Tumor Microenvironment.
Squamous Cell Carcinoma of Head and Neck
The Study of the Expression of CGB1 and CGB2 in Human Cancer Tissues.
Squamous Cell Carcinoma of Head and Neck
TP53 Mutations in Head and Neck Squamous Cell Carcinoma and Their Impact on Disease Progression and Treatment Response.
Squamous Cell Carcinoma of Head and Neck
TRAF3/CYLD mutations identify a distinct subset of human papilloma virus-associated head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Transcription factors CP2 and YY1 as prognostic markers in head and neck squamous cell carcinoma: analysis of The Cancer Genome Atlas and a second independent cohort.
Squamous Cell Carcinoma of Head and Neck
Transcription of human papillomavirus oncogenes in head and neck squamous cell carcinomas.
Squamous Cell Carcinoma of Head and Neck
Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Transcriptomic analysis reveals key lncRNAs associated with ribosomal biogenesis and epidermis differentiation in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
TRIP12 as a mediator of human papillomavirus/p16-related radiation enhancement effects.
Squamous Cell Carcinoma of Head and Neck
Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
Squamous Cell Carcinoma of Head and Neck
Tyrosine Kinase c-MET as Therapeutic Target for Radiosensitization of Head and Neck Squamous Cell Carcinomas.
Squamous Cell Carcinoma of Head and Neck
UBE2C promotes the progression of head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
UBE2O Promotes Progression and Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Unraveling the oral cancer lncRNAome: Identification of novel lncRNAs associated with malignant progression and HPV infection.
Squamous Cell Carcinoma of Head and Neck
Upregulated glycolysis correlates with tumor progression and immune evasion in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Validation of Selected Head and Neck Cancer Prognostic Markers from the Pathology Atlas in an Oral Tongue Cancer Cohort.
Squamous Cell Carcinoma of Head and Neck
Widespread expression of Sonic hedgehog (Shh) and Nrf2 in patients treated with cisplatin predicts outcome in resected tumors and are potential therapeutic targets for HPV-negative head and neck cancer.
Squamous Cell Carcinoma of Head and Neck
[Mutation signatures in head and neck squamous cell carcinoma : Pathogenesis and therapeutic potential].
ST Elevation Myocardial Infarction
Mortality in the TRACER and ATLAS ACS 2 Trials: Two More Reasons to Audit Vital Records in PLATO.
ST Elevation Myocardial Infarction
Rivaroxaban in Patients Stabilized after a ST-Elevation Myocardial Infarction: Results from the ATLAS ACS 2-TIMI 51 Trial.
Starvation
Can Aluminum Tolerant Wheat Cultivar Perform Better under Phosphate Deficient Conditions?
Starvation
Endocytosis-mediated siderophore uptake as a strategy for Fe acquisition in diatoms.
Status Epilepticus
Ex vivo characterization of neuroinflammatory and neuroreceptor changes during epileptogenesis using candidate positron emission tomography biomarkers.
steroid 11beta-monooxygenase deficiency
High frequency of congenital adrenal hyperplasia (classic 11 beta-hydroxylase deficiency) among Jews from Morocco.
Stomach Neoplasms
"3G" Trial: An RNA Editing Signature to Guide Gastric Cancer Chemotherapy.
Stomach Neoplasms
20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes: A Systematic Review of 157,258 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
Stomach Neoplasms
?-Actinin1 promotes tumorigenesis and epithelial-mesenchymal transition of gastric cancer via the AKT/GSK3?/?-Catenin pathway.
Stomach Neoplasms
A ceRNA network and a potential regulatory axis in gastric cancer with different degrees of immune cell infiltration.
Stomach Neoplasms
A Comprehensive PDX Gastric Cancer Collection Captures Cancer Cell-Intrinsic Transcriptional MSI Traits.
Stomach Neoplasms
A DNA methylation signature to improve survival prediction of gastric cancer.
Stomach Neoplasms
A functional network of gastric-cancer-associated splicing events controlled by dysregulated splicing factors.
Stomach Neoplasms
A Novel RNA-Binding Protein-Based Nomogram for Predicting Survival of Patients with Gastric Cancer.
Stomach Neoplasms
A Pipeline to Call Multilevel Expression Changes between Cancer and Normal Tissues and Its Applications in Repurposing Drugs Effective for Gastric Cancer.
Stomach Neoplasms
ACBD3 is up-regulated in gastric cancer and promotes cell cycle G1-to-S transition in an AKT-dependent manner.
Stomach Neoplasms
Acute Tumor Transition Angle on Computed Tomography Predicts Chromosomal Instability Status of Primary Gastric Cancer: Radiogenomics Analysis from TCGA and Independent Validation.
Stomach Neoplasms
Ajuba overexpression regulates mitochondrial potential and glucose uptake through YAP/Bcl-xL/GLUT1 in human gastric cancer.
Stomach Neoplasms
An atlas of gastric PIWI-interacting RNA transcriptomes and their utility for identifying signatures of gastric cancer recurrence.
Stomach Neoplasms
An individualized prognostic signature for gastric cancer patients treated with 5-Fluorouracil-based chemotherapy and distinct multi-omics characteristics of prognostic groups.
Stomach Neoplasms
Analysis of Collagen type X alpha 1 (COL10A1) expression and prognostic significance in gastric cancer based on bioinformatics.
Stomach Neoplasms
Analysis of key genes and signaling pathways involved in Helicobacter pylori-associated gastric cancer based on The Cancer Genome Atlas database and RNA sequencing data.
Stomach Neoplasms
Are Immunohistochemical Markers Useful in Phenotypic Gastric Cancer Classification?
Stomach Neoplasms
Association between angiogenesis and cytotoxic signatures in the tumor microenvironment of gastric cancer.
Stomach Neoplasms
Bayesian semi-nonnegative matrix tri-factorization to identify pathways associated with cancer phenotypes.
Stomach Neoplasms
BICC1 as a novel prognostic biomarker in gastric cancer correlating with immune infiltrates.
Stomach Neoplasms
Bioinformatics analysis for the identification of differentially expressed genes and related signaling pathways in H. pylori-CagA transfected gastric cancer cells.
Stomach Neoplasms
Biomarkers in Tumor Microenvironment? Upregulation of Fibroblast Activation Protein-? Correlates with Gastric Cancer Progression and Poor Prognosis.
Stomach Neoplasms
Cancer Stem Cell Marker DCLK1 Correlates with Tumorigenic Immune Infiltrates in the Colon and Gastric Adenocarcinoma Microenvironments.
Stomach Neoplasms
CBX3 Promotes Gastric Cancer Progression and Affects Factors Related to Immunotherapeutic Responses.
Stomach Neoplasms
CGB5 expression is independently associated with poor overall survival and recurrence-free survival in patients with advanced gastric cancer.
Stomach Neoplasms
Challenges in molecular targeted therapy for gastric cancer: considerations for efficacy and safety.
Stomach Neoplasms
Clinical characteristics and prognostic significance of TCGA and ACRG classification in gastric cancer among the Chinese population.
Stomach Neoplasms
Clinical Significance of Four Molecular Subtypes of Gastric Cancer Identified by The Cancer Genome Atlas Project.
Stomach Neoplasms
Common polymorphic inversions at 17q21.31 and 8p23.1 associate with cancer prognosis.
Stomach Neoplasms
Comparison between two amplicon-based sequencing panels of different scales in the detection of somatic mutations associated with gastric cancer.
Stomach Neoplasms
Comprehensive Analysis of Alternative Splicing Signature in Gastric Cancer Prognosis Based on The Cancer Genome Atlas (TCGA) and SpliceSeq Databases.
Stomach Neoplasms
Comprehensive analysis of expression profiles of long non?coding RNAs with associated ceRNA network involved in gastric cancer progression.
Stomach Neoplasms
Comprehensive Analysis of Survival-Related lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Gastric Cancer.
Stomach Neoplasms
Construction and Comprehensive Analysis for Dysregulated Long Non-Coding RNA (lncRNA)-Associated Competing Endogenous RNA (ceRNA) Network in Gastric Cancer.
Stomach Neoplasms
Construction of a Nomogram Based on a Hypoxia-Related lncRNA Signature to Improve the Prediction of Gastric Cancer Prognosis.
Stomach Neoplasms
Correlation Between Infection Status of Epstein-Barr Virus and (18)F-Fluorodeoxyglucose Uptake in Patients with Advanced Gastric Cancer.
Stomach Neoplasms
Depletion of FOXM1 via MET targeting underlies establishment of a DNA damage-induced senescence program in gastric cancer.
Stomach Neoplasms
Development of a novel gene signature in patients without Helicobacter pylori infection gastric cancer.
Stomach Neoplasms
Development of RNA binding proteins expression signature for prognosis prediction in gastric cancer patients.
Stomach Neoplasms
Diagnostic and therapeutic potencies of miR-18a-5p in mixed-type gastric adenocarcinoma.
Stomach Neoplasms
Differences in the prognosis of gastric cancer patients of different sexes and races and the molecular mechanisms involved.
Stomach Neoplasms
Discovering the mechanism and involvement of the methylation of cyclin-dependent kinase inhibitor 2A (CDKN2A) gene and its special locus region in gastric cancer.
Stomach Neoplasms
Dissecting the Single-Cell Transcriptome Network Underlying Gastric Premalignant Lesions and Early Gastric Cancer.
Stomach Neoplasms
Downregulation of FOXK2 is associated with poor prognosis in patients with gastric cancer.
Stomach Neoplasms
Downregulation of G Protein-Coupled Estrogen Receptor (GPER) is Associated with Reduced Prognosis in Patients with Gastric Cancer.
Stomach Neoplasms
Early detection of gastric cancer using global, genome-wide and IRF4, ELMO1, CLIP4 and MSC DNA methylation in endoscopic biopsies.
Stomach Neoplasms
Early-onset gastric cancer is a distinct disease with worrisome trends and oncogenic features.
Stomach Neoplasms
Elevated FAM3C promotes cell epithelial- mesenchymal transition and cell migration in gastric cancer.
Stomach Neoplasms
Emerging role of microRNAs in modulating endothelin-1 expression in gastric cancer.
Stomach Neoplasms
Establishment of an immune microenvironment-based prognostic predictive model for gastric cancer.
Stomach Neoplasms
Evaluation of 30 DNA damage response and 6 mismatch repair gene mutations as biomarkers for immunotherapy outcomes across multiple solid tumor types.
Stomach Neoplasms
Expression of NGF family and their receptors in gastric carcinoma: a cDNA microarray study.
Stomach Neoplasms
FARP1 boosts CDC42 activity from integrin ?v?5 signaling and correlates with poor prognosis of advanced gastric cancer.
Stomach Neoplasms
From molecular classification to targeted therapeutics: the changing face of systemic therapy in metastatic gastroesophageal cancer.
Stomach Neoplasms
GARP Correlates With Tumor-Infiltrating T-Cells and Predicts the Outcome of Gastric Cancer.
Stomach Neoplasms
Gastric Carcinomas With Lymphoid Stroma: An Evaluation of the Histopathologic and Molecular Features.
Stomach Neoplasms
Gastric lymph node contouring atlas: A tool to aid in clinical target volume definition in 3-dimensional treatment planning for gastric cancer.
Stomach Neoplasms
Gastritis-Infection-Cancer Sequence of Epstein-Barr Virus-Associated Gastric Cancer.
Stomach Neoplasms
Gene regulatory network analysis with drug sensitivity reveals synergistic effects of combinatory chemotherapy in gastric cancer.
Stomach Neoplasms
Genome-wide analysis to identify a novel distant metastasis-related gene signature predicting survival in patients with gastric cancer.
Stomach Neoplasms
Genomic Alterations and Targeted Therapy in Gastric and Esophageal Adenocarcinoma.
Stomach Neoplasms
Genomic Characterization of Non-Invasive Differentiated-Type Gastric Cancer in the Japanese Population.
Stomach Neoplasms
GHSR DNA hypermethylation is a new epigenetic biomarker for gastric adenocarcinoma and beyond.
Stomach Neoplasms
GLIS2 redundancy causes chemoresistance and poor prognosis of gastric cancer based on co?expression network analysis.
Stomach Neoplasms
Glutathione Peroxidase 8 as a Prognostic Biomarker of Gastric Cancer: An Analysis of The Cancer Genome Atlas (TCGA) Data.
Stomach Neoplasms
Glycerophospholipids pathways and chromosomal instability in gastric cancer: Global lipidomics analysis.
Stomach Neoplasms
GRIK3: A novel oncogenic protein related to tumor TNM stage, lymph node metastasis, and poor prognosis of GC.
Stomach Neoplasms
High Expression of ABRACL Is Associated with Tumorigenesis and Affects Clinical Outcome in Gastric Cancer.
Stomach Neoplasms
High SLC2A1 expression associated with suppressing CD8 T cells and B cells promoted cancer survival in gastric cancer.
Stomach Neoplasms
Histo- and immunohistochemistry-based estimation of the TCGA and ACRG molecular subtypes for gastric carcinoma and their prognostic significance: A single-institution study.
Stomach Neoplasms
Identification and validation of an individualized autophagy-clinical prognostic index in gastric cancer patients.
Stomach Neoplasms
Identification and Validation of SNP-Containing Genes With Prognostic Value in Gastric Cancer via Integrated Bioinformatics Analysis.
Stomach Neoplasms
Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
Stomach Neoplasms
Identification of "regulation of RhoA activity panel" as a prognostic and predictive biomarker for gastric cancer.
Stomach Neoplasms
Identification of an immune-related gene-based signature to predict prognosis of patients with gastric cancer.
Stomach Neoplasms
Identification of DNA methylation-regulated differentially-expressed genes and related pathways using Illumina 450K BeadChip and bioinformatic analysis in gastric cancer.
Stomach Neoplasms
Identification of four gastric cancer subtypes based on genetic analysis of cholesterogenic and glycolytic pathways.
Stomach Neoplasms
Identification of genes associated with gastric cancer survival and construction of a nomogram to improve risk stratification for patients with gastric cancer.
Stomach Neoplasms
Identification of novel prognostic biomarkers by integrating multi-omics data in gastric cancer.
Stomach Neoplasms
Identification of Potential Biomarkers Involved in Gastric Cancer Through Integrated Analysis of Non-Coding RNA Associated Competing Endogenous RNAs Network.
Stomach Neoplasms
Identification of subtype-specific genes signature by WGCNA for prognostic prediction in diffuse type gastric cancer.
Stomach Neoplasms
Identification of the angiogenesis related genes for predicting prognosis of patients with gastric cancer.
Stomach Neoplasms
Immune Activation and Benefit From Avelumab in EBV-Positive Gastric Cancer.
Stomach Neoplasms
Immune-Related Nine-MicroRNA Signature for Predicting the Prognosis of Gastric Cancer.
Stomach Neoplasms
Indoleamine 2,3-dioxygenase 1, Increased in Human Gastric Pre-Neoplasia, Promotes Inflammation and Metaplasia in Mice and is Associated with Type II Hypersensitivity/Autoimmunity.
Stomach Neoplasms
Integrated analysis of long non-coding RNAs in human gastric cancer: An in silico study.
Stomach Neoplasms
Integrated MicroRNA-mRNA Analysis Reveals miR-204 Inhibits Cell Proliferation in Gastric Cancer by Targeting CKS1B, CXCL1 and GPRC5A.
Stomach Neoplasms
Interobserver Variation of Clinical Target Volume Delineation in Gastric Cancer.
Stomach Neoplasms
Japanese version of The Cancer Genome Atlas, JCGA, established using fresh frozen tumors obtained from 5143 cancer patients.
Stomach Neoplasms
LAMB1 Is Related to the T Stage and Indicates Poor Prognosis in Gastric Cancer.
Stomach Neoplasms
Latency-associated Peptide Identifies Immunoevasive Subtype Gastric Cancer With Poor Prognosis and Inferior Chemotherapeutic Responsiveness.
Stomach Neoplasms
Lauren classification identifies distinct prognostic value and functional status of intratumoral CD8+ T cells in gastric cancer.
Stomach Neoplasms
LINC00662 promotes gastric cancer cell growth by modulating the Hippo-YAP1 pathway.
Stomach Neoplasms
LINC00675 Suppresses Cell Proliferation and Migration via Downregulating the H3K4me2 Level at the SPRY4 Promoter in Gastric Cancer.
Stomach Neoplasms
LncRNA HOXA11-AS Promotes Proliferation and Invasion of Gastric Cancer by Scaffolding the Chromatin Modification Factors PRC2, LSD1, and DNMT1.
Stomach Neoplasms
LncRNA MAGI2-AS3 Is Regulated by BRD4 and Promotes Gastric Cancer Progression via Maintaining ZEB1 Overexpression by Sponging miR-141/200a.
Stomach Neoplasms
LncRNA UCA1 promotes development of gastric cancer via the miR-145/MYO6 axis.
Stomach Neoplasms
Long noncoding RNA H19 participates in metformin-mediated inhibition of gastric cancer cell invasion.
Stomach Neoplasms
Long noncoding RNA TRPM2-AS acts as a microRNA sponge of miR-612 to promote gastric cancer progression and radioresistance.
Stomach Neoplasms
Low CBS expression can identify patients who benefit from adjuvant chemotherapy in gastric cancer.
Stomach Neoplasms
MAFG-AS1 is a novel clinical biomarker for clinical progression and unfavorable prognosis in gastric cancer.
Stomach Neoplasms
MicroRNA profiles in five pairs of early gastric cancer tissues and adjacent non-cancerous tissues.
Stomach Neoplasms
MicroRNA-1 acts as a tumor suppressor microRNA by inhibiting angiogenesis-related growth factors in human gastric cancer.
Stomach Neoplasms
MicroRNA-182 is a potential biomarker for prognosis of gastric cancer: A protocol for meta-analysis and bioinformatics analysis.
Stomach Neoplasms
MicroRNA-495-3p functions as a tumor suppressor by regulating multiple epigenetic modifiers in gastric carcinogenesis.
Stomach Neoplasms
Mining The Cancer Genome Atlas database for tumor mutation burden and its clinical implications in gastric cancer.
Stomach Neoplasms
MIR-1265 regulates cellular proliferation and apoptosis by targeting calcium binding protein 39 in gastric cancer and, thereby, impairing oncogenic autophagy.
Stomach Neoplasms
MiR-193a-5p and -3p Play a Distinct Role in Gastric Cancer: miR-193a-3p Suppresses Gastric Cancer Cell Growth by Targeting ETS1 and CCND1.
Stomach Neoplasms
MIR100HG: a credible prognostic biomarker and an oncogenic lncRNA in gastric cancer.
Stomach Neoplasms
miRNA-103a-3p Promotes Human Gastric Cancer Cell Proliferation by Targeting and Suppressing ATF7 in vitro.
Stomach Neoplasms
Molecular classification of gastric adenocarcinoma: translating new insights from the cancer genome atlas research network.
Stomach Neoplasms
Molecular classification of gastric cancer predicts survival in patients undergoing radical gastrectomy based on project HOPE.
Stomach Neoplasms
Molecular Dimensions of Gastric Cancer: Translational and Clinical Perspectives.
Stomach Neoplasms
MSI and EBV Positive Gastric Cancer's Subgroups and Their Link With Novel Immunotherapy.
Stomach Neoplasms
Mucin 17 inhibits the progression of human gastric cancer by limiting inflammatory responses through a MYH9-p53-RhoA regulatory feedback loop.
Stomach Neoplasms
Next generation sequencing in gastric or gastroesophageal adenocarcinoma.
Stomach Neoplasms
Norepinephrine Enhances Aerobic Glycolysis and May Act as a Predictive Factor for Immunotherapy in Gastric Cancer.
Stomach Neoplasms
Notch and mTOR Signaling Pathways Promote Human Gastric Cancer Cell Proliferation.
Stomach Neoplasms
Novel CpG-SNPs in the gastric acid secretion pathway GNAI3 and susceptibility to gastric cancer.
Stomach Neoplasms
Novel targets in the treatment of advanced gastric cancer: a perspective review.
Stomach Neoplasms
OncoBinder facilitates interpretation of proteomic interaction data by capturing coactivation pairs in cancer.
Stomach Neoplasms
Oncogenic function of the homeobox A13-long noncoding RNA HOTTIP-insulin growth factor-binding protein 3 axis in human gastric cancer.
Stomach Neoplasms
Over-expression of vitronectin correlates with impaired survival in gastric cancers.
Stomach Neoplasms
Overexpression of PLXDC2 in Stromal Cell-Associated M2 Macrophages Is Related to EMT and the Progression of Gastric Cancer.
Stomach Neoplasms
P4HA3 is Epigenetically Activated by Slug in Gastric Cancer and its Deregulation is Associated With Enhanced Metastasis and Poor Survival.
Stomach Neoplasms
Perioperative chemotherapy for resectable gastric cancer - what is the evidence?
Stomach Neoplasms
Personalized medicine in gastric cancer: Where are we and where are we going?
Stomach Neoplasms
Poor Clinical Outcomes and Immunoevasive Contexture in Intratumoral IL-10-Producing Macrophages Enriched Gastric Cancer Patients.
Stomach Neoplasms
Potential prognostic impact of EBV RNA-seq reads in gastric cancer: a reanalysis of The Cancer Genome Atlas cohort.
Stomach Neoplasms
Prediction of radiosensitive patients with gastric cancer by developing gene signature.
Stomach Neoplasms
Profiling cancer-associated genetic alterations and molecular classification of cancer in Korean gastric cancer patients.
Stomach Neoplasms
Prognostic and clinicopathological significance of long noncoding RNA CTD-2510F5.4 in gastric cancer.
Stomach Neoplasms
Prognostic Implications of Novel Gene Signatures in Gastric Cancer Microenvironment.
Stomach Neoplasms
Prognostic landscape of tumor-infiltrating immune cells and immune-related genes in the tumor microenvironment of gastric cancer.
Stomach Neoplasms
Prognostic value of estrogen receptor ? and estrogen receptor ? in gastric cancer based on a meta-analysis and The Cancer Genome Atlas (TCGA) datasets.
Stomach Neoplasms
Prognostic Values of Radiosensitivity Genes and CD19 Status in Gastric Cancer: A Retrospective Study Using TCGA Database.
Stomach Neoplasms
Protein expression-based classification of gastric cancer by immunohistochemistry of tissue microarray.
Stomach Neoplasms
Regulation of aberrantly expressed SERPINH1 by antitumor miR-148a-5p inhibits cancer cell aggressiveness in gastric cancer.
Stomach Neoplasms
Regulation of proliferation and invasion by the IGF signalling pathway in Epstein-Barr virus-positive gastric cancer.
Stomach Neoplasms
Reproduction of the Cancer Genome Atlas (TCGA) and Asian Cancer Research Group (ACRG) Gastric Cancer Molecular Classifications and Their Association with Clinicopathological Characteristics and Overall Survival in Moroccan Patients.
Stomach Neoplasms
Social attention of the top 50 scientific articles on gastric cancer: Bibliometric and altmetric analysis.
Stomach Neoplasms
Somatic copy number alterations in gastric adenocarcinomas among Asian and Western patients.
Stomach Neoplasms
Somatic mutation of DNAH genes implicated higher chemotherapy response rate in gastric adenocarcinoma patients.
Stomach Neoplasms
Specific expression and methylation of SLIT1, SLIT2, SLIT3, and miR-218 in gastric cancer subtypes.
Stomach Neoplasms
STAT5A reprograms fatty acid metabolism and promotes tumorigenesis of gastric cancer cells.
Stomach Neoplasms
Subtraction of Epstein-Barr virus and microsatellite instability genotypes from the Lauren histotypes: combined molecular and histologic subtyping with clinicopathological and prognostic significance validated in a cohort of 1,248 cases.
Stomach Neoplasms
Survival of Patients with Gastrointestinal Cancers Can Be Predicted by a Surrogate microRNA Signature for Cancer Stem-like Cells Marked by DCLK1 Kinase.
Stomach Neoplasms
Systematical Analysis of the Cancer Genome Atlas Database Reveals EMCN/MUC15 Combination as a Prognostic Signature for Gastric Cancer.
Stomach Neoplasms
T cell receptor gene recombinations in human tumor specimen exome files: detection of T cell receptor-? VDJ recombinations associates with a favorable oncologic outcome for bladder cancer.
Stomach Neoplasms
TCGA divides gastric cancer into four molecular subtypes: implications for individualized therapeutics.
Stomach Neoplasms
TCGA-TCIA-Based CT Radiomics Study for Noninvasively Predicting Epstein-Barr Virus Status in Gastric Cancer.
Stomach Neoplasms
TGF?2 is a prognostic-related biomarker and correlated with immune infiltrates in gastric cancer.
Stomach Neoplasms
The association of sex-biased ATRX mutation in female gastric cancer patients with enhanced immunotherapy-related anticancer immunity.
Stomach Neoplasms
The Clinicopathological Characteristics of Alpha-Fetoprotein-Producing Adenocarcinoma of the Gastrointestinal Tract-A Single-Center Retrospective Study.
Stomach Neoplasms
The management of localized esophageal squamous cell carcinoma: Western approach.
Stomach Neoplasms
The miR-608 rs4919510 polymorphism may modify cancer susceptibility based on type.
Stomach Neoplasms
Tumor-infiltrating podoplanin+ cells in gastric cancer: clinical outcomes and association with immune contexture.
Stomach Neoplasms
Validation and calibration of next-generation sequencing to identify Epstein-Barr virus-positive gastric cancer in The Cancer Genome Atlas.
Stomach Neoplasms
What Will We Expect From Novel Therapies to Esophageal and Gastric Malignancies?
Stomach Neoplasms
Whole-exome sequencing of alpha-fetoprotein producing gastric carcinoma reveals genomic profile and therapeutic targets.
Stomach Neoplasms
Why MUC16 mutations lead to a better prognosis: A study based on The Cancer Genome Atlas gastric cancer cohort.
Stomach Neoplasms
[Current status and research progress of perioperative chemotherapy in advanced gastric cancer].
Stomach Neoplasms
[Identification of characteristic methylation sites in gastric cancer using genomics-based machine learning].
Stomach Neoplasms
[KDM6A mutation and expression in gastric cancer are associated with prognosis].
Stomach Neoplasms
[Regional distribution of stomach and colon cancer mortality in the Dithmarschen and Nordfriesland districts--cartographic presentation]
Stomatitis
Evaluation of the Risk of Grade 3 Oral and Pharyngeal Dysphagia Using Atlas-Based Method and Multivariate Analyses of Individual Patient Dose Distributions.
Strabismus
Color Atlas of Strabismus Surgery: Strategies and Techniques Third Edition: Kenneth W. Wright, M.D. Sonal Farzavandi, Editor, Springer, New York, NY, 2006, 233 pages, 255 illustrations (80 color), $199.00.
Strabismus
Practical Atlas of the Surgery of Strabismus. Operative Indications, Surgical Technique.
Stroke
'Whose atlas I use, his song I sing?' - The impact of anatomical atlases on fiber tract contributions to cognitive deficits after stroke.
Stroke
A comparison of automated segmentation and manual tracing in estimating hippocampal volume in ischemic stroke and healthy control participants.
Stroke
A randomized trial to compare the safety of rivaroxaban vs aspirin in addition to either clopidogrel or ticagrelor in acute coronary syndrome: The design of the GEMINI-ACS-1 phase II study.
Stroke
Beauty parlor stroke syndrome due to a bone fragment from an osteophyte of the atlas: case report.
Stroke
Better Diffusion Segmentation in Acute Ischemic Stroke Through Automatic Tree Learning Anomaly Segmentation.
Stroke
Blink reflex R2 changes and localisation of lesions in the lower brainstem (Wallenberg's syndrome): an electrophysiological and MRI study.
Stroke
Clinically accessible neuroimaging predictors of post-stroke neurocognitive disorder: a prospective observational study.
Stroke
Community and Hospital Factors Associated With Stroke Center Certification in the United States, 2009 to 2017.
Stroke
Congenital anomaly of the posterior arch of the atlas: a rare risk factor for posterior circulation stroke.
Stroke
Grey and white matter network disruption is associated with sensory deficits after stroke.
Stroke
Healthcare Resource Availability, Quality of Care, and Acute Ischemic Stroke Outcomes.
Stroke
Isolated right temporal lobe stroke patients present with Geschwind Gastaut syndrome, frontal network syndrome and delusional misidentification syndromes.
Stroke
Of fractal and Fourier: A measure for local shape complexity for neurological applications.
Stroke
Population-based Stroke Atlas for outcome prediction: method and preliminary results for ischemic stroke from CT.
Stroke
Poverty, a risk factor overlooked: a cross-sectional cohort study comparing poverty rate and cardiovascular disease outcomes in the state of Florida.
Stroke
Regional cerebral blood flow changes in stroke imaged by Tc-99m HMPAO SPECT with corresponding anatomic image comparison.
Stroke
Regional implementation of the stroke systems of care model: recommendations of the northeast cerebrovascular consortium.
Stroke
Safety and efficacy of rivaroxaban for the secondary prevention following acute coronary syndromes among biomarker-positive patients: Insights from the ATLAS ACS 2-TIMI 51 trial.
Stroke
Spatiotemporal Protein Atlas of Cell Death-Related Molecules in the Rat MCAO Stroke Model.
Stroke
Statistical atlas of acute stroke from magnetic resonance diffusion-weighted-images of the brain.
Stroke
Stroke atlas of the brain: Voxel-wise density-based clustering of infarct lesions topographic distribution.
Stroke
Stroke atlas: a 3D interactive tool correlating cerebrovascular pathology with underlying neuroanatomy and resulting neurological deficits.
Stroke
Structural and Social Determinants of Health Factors Associated with County-Level Variation in Non-Adherence to Antihypertensive Medication Treatment.
Stroke
The "Dual-Pathway" Strategy after Acute Coronary Syndrome: Rivaroxaban and Antiplatelet Agents in the ATLAS ACS 2-TIMI 51 Trial.
Stroke
The ATLAS ACS 2-TIMI 51 Trial and the Burden of Missing Data: (Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects With Acute Coronary Syndrome ACS 2-Thrombolysis In Myocardial Infarction 51).
Stroke
The cerefy brain atlases: continuous enhancement of the electronic talairach-tournoux brain atlas.
Stroke
The extreme capsule and aphasia: proof-of-concept of a new way relating structure to neurological symptoms.
Stroke
The pupillary light reflex pathway: cytoarchitectonic probabilistic maps in hemianopic patients.
Stroke
The real estate factor: quantifying the impact of infarct location on stroke severity.
Stroke
[A Dangerous Combination for Stroke in Young Patient: Assimilation of the Atlas and Anti beta2-Glycoprotein I Antibodies.]
Stroke
[Contribution of the new oral anticoagulants to the treatment of acute coronary syndrome].
Stroke, Lacunar
Cortical degeneration detected by neurite orientation dispersion and density imaging in chronic lacunar infarcts.
Stuttering
Neurofilament-lysosomal genetic intersections in the cortical network of stuttering.
Subarachnoid Hemorrhage
Associated injuries and mechanism of atlanto-occipital dislocation caused by trauma.
Subarachnoid Hemorrhage
Massive subarachnoid hemorrhage due to laceration of the vertebral artery associated with fracture of the transverse process of the atlas.
Subarachnoid Hemorrhage
[Biomechanism of intracranial and spinal trauma of child born in occipitoanterior presentation as used in forensic examination]
Surgical Wound Infection
First year of mandatory reporting of healthcare-associated infections, pennsylvania: an infection control-chart abstractor collaboration.
Syndactyly
Another "new" form, the palagonia type of acrofacial dysostosis in a Sicilian family.
Synostosis
An osteological study of occipitocervical synostosis: its embryological and clinical significance.
Synostosis
Atlantooccipital Fusion: Prevalence and its Developmental and Clinical Correlation.
Synostosis
Complete occipitalization of the atlas with bilateral external auditory canal atresia.
Synostosis
[Atloido-occipital synostosis; narrowing of occipital foramen and bulbo-medullary compression by an osseous prominence, vestige of the lateral masses of the atlas.]
Synovial Cyst
Bipartite atlas with os odontoideum and synovial cyst: case report and review literature.
Synovial Cyst
Synovial cyst of the transverse ligament of the atlas causing tetraparesia in a context of generalized osteoarthritis.
Synovial Cyst
Synovial cyst of the transverse ligament of the atlas in a patient with os odontoideum and atlantoaxial instability.
Synovitis
An introduction to the EULAR-OMERACT rheumatoid arthritis MRI reference image atlas.
Synovitis
Development and reliability of a novel ultrasonographic joint-specific scoring system for synovitis with reference atlas for patients with juvenile idiopathic arthritis.
Synovitis
Examination of intra and interrater reliability with a new ultrasonographic reference atlas for scoring of synovitis in patients with rheumatoid arthritis.
Synovitis
The very early inflammatory triquetral lesion by MRI - is this the first sign in Rheumatoid Arthritis?
Syringomyelia
Assimilation of the atlas with associated syringomyelia and Chiari 1 malformation (Klippel-Feil type 2).
Syringomyelia
Atlantoaxial dislocation with congenital "sandwich fusion" in the craniovertebral junction: a retrospective case series of 70 patients.
Syringomyelia
Chiari I malformation accompanied by assimilation of the atlas, Klippel-Feil syndrome, and syringomyelia: case report.
Syringomyelia
Complex Chiari Malformation Presenting with Bulbar Symptoms in an Adult: Single-stage Posterior Fusion and Foramen Magnum Decompression: A Rare Case Report.
Syringomyelia
Magnetic resonance imaging-based measures of atlas position: Relationship to canine atlantooccipital overlapping, syringomyelia and clinical signs.
Syringomyelia
Obex position is associated with syringomyelia and use of posterior fossa decompression among patients with Chiari I malformation.
Syringomyelia
SPONTANEOUS DISLOCATION OF THE ATLAS. REPORT OF A CASE SIMULATING SYRINGOMYELIA WITH A DISCUSSION OF ETIOLOGY AND METHODS OF TREATMENT.
Syringomyelia
Successful treatment of adult Arnold-Chiari malformation associated with basilar impression and syringomyelia by the transoral anterior approach.
Systemic Vasculitis
Pulmonary vasculitis in Hughes-Stovin syndrome (HSS): a reference atlas and computed tomography pulmonary angiography guide-a report by the HSS International Study Group.
Tachycardia
Body surface mapping of atrial arrhythmias: atlas of paced P wave integral maps to localize the focal origin of right atrial tachycardia.
Tachycardia
Localization of abnormal conduction pathways for tachyarrhythmia treatment using tagged MRI.
Tachycardia, Ventricular
Atlas of paced body surface QRS integral maps for localization of the site of origin of postinfarction ventricular tachycardia.
Temporomandibular Joint Disorders
Chiropractic care of a patient with temporomandibular disorder and atlas subluxation.
Temporomandibular Joint Disorders
The role of soft tissue mobilization in reducing orofacial and general complaints in a patient with Kimmerle anomaly and temporomandibular joint disorder: A case report.
Tendinopathy
Retropharyngeal calcific tendinitis: report of five cases and review of the literature.
Tendinopathy
Single-cell Transcriptomic Analyses Identifies Extensive Heterogeneity in the Cellular Composition of Mouse Achilles Tendons.
Teratoma
Teratomas produced from human pluripotent stem cells xenografted into immunodeficient mice - a histopathology atlas.
Testicular Neoplasms
ASH2L drives proliferation and sensitivity to bleomycin and other genotoxins in Hodgkin's lymphoma and testicular cancer cells.
Testicular Neoplasms
Identification of novel genes in testicular cancer microenvironment based on ESTIMATE algorithm-derived immune scores.
Testicular Neoplasms
Nuclear Localization of PTTG1 Promotes Migration and Invasion of Seminoma Tumor through Activation of MMP-2.
Thoracic Outlet Syndrome
Thermal asymmetry of the upper extremity in scalenus anticus syndrome, leg-length inequality and response to chiropractic adjustment.
Thromboembolism
Preliminary experience of stent salvage using Neuroform Atlas stent for procedure-related complication during coil embolization of intracranial aneurysms.
Thrombosis
Highlights of the hotline sessions presented at the scientific sessions 2008 of the American Heart Association.
Thrombosis
Preliminary experience of stent salvage using Neuroform Atlas stent for procedure-related complication during coil embolization of intracranial aneurysms.
Thrombosis
Pulmonary vasculitis in Hughes-Stovin syndrome (HSS): a reference atlas and computed tomography pulmonary angiography guide-a report by the HSS International Study Group.
Thrombosis
Safety of the Atlas Gold Balloon in Treating Iliofemoral Veins: Experience From a Single Center.
Thrombosis
The "Dual-Pathway" Strategy after Acute Coronary Syndrome: Rivaroxaban and Antiplatelet Agents in the ATLAS ACS 2-TIMI 51 Trial.
Thrombosis
[Multiple fractures of the atlas with delayed fatal thrombosis of vertebral artery following "whiplash" injury of the neck (author's transl)]
Thrombosis
[Vertebrobasilar arterial thrombosis secondary to aneurysmatic cysts of the atlas and the epistropheus]
Thymoma
A novel prognostic signature of seven genes for the prediction in patients with thymoma.
Thymoma
High expression of KITLG is a new hallmark activating the MAPK pathway in type A and AB thymoma.
Thymoma
Identification of Long Non-Coding RNAs for Predicting Prognosis Among Patients with Thymoma.
Thymoma
The Cancer Genome Atlas dataset-based analysis of aberrantly expressed genes by GeneAnalytics in thymoma associated myasthenia gravis: focusing on T cells.
Thymus Neoplasms
Quantitative assessment of target delineation variability for thymic cancers: Agreement evaluation of a prospective segmentation challenge.
Thyroid Cancer, Papillary
A novel gene panel for prediction of lymph-node metastasis and recurrence in patients with thyroid cancer.
Thyroid Cancer, Papillary
Absence of EIF1AX, PPM1D, and CHEK2 mutations reported in Thyroid Cancer Genome Atlas (TCGA) in a large series of thyroid cancer.
Thyroid Cancer, Papillary
ALDH5A1 acts as a tumour promoter and has a prognostic impact in papillary thyroid carcinoma.
Thyroid Cancer, Papillary
Characterization of TERT and BRAF copy number variation in papillary thyroid carcinoma: An analysis of the cancer genome atlas study.
Thyroid Cancer, Papillary
Construction and investigation of lncRNA-associated ceRNA regulatory network in papillary thyroid cancer.
Thyroid Cancer, Papillary
Correlation between telomerase reverse transcriptase messenger RNA expression and survival of patients with papillary thyroid carcinoma.
Thyroid Cancer, Papillary
Distinctive Desmoplastic 3D Morphology Associated With BRAFV600E in Papillary Thyroid Cancers.
Thyroid Cancer, Papillary
Downregulation of TSPAN13 by miR-369-3p inhibits cell proliferation in papillary thyroid cancer (PTC).
Thyroid Cancer, Papillary
E26 transformation (ETS)?specific related transcription factor?3 (ELF3) orchestrates a positive feedback loop that constitutively activates the MAPK/Erk pathway to drive thyroid cancer.
Thyroid Cancer, Papillary
Evidence of Cooperation between Hippo Pathway and RAS Mutation in Thyroid Carcinomas.
Thyroid Cancer, Papillary
Exploration of DNA Methylation-Driven Genes in Papillary Thyroid Carcinoma Based on the Cancer Genome Atlas.
Thyroid Cancer, Papillary
Expression of cancer stem cell markers in tall cell variant papillary thyroid cancer identifies a molecular profile predictive of recurrence in classic papillary thyroid cancer.
Thyroid Cancer, Papillary
Expression of NF2 Modulates the Progression of BRAFV600E Mutated Thyroid Cancer Cells.
Thyroid Cancer, Papillary
Expression profiles of pivotal microRNAs and targets in thyroid papillary carcinoma: an analysis of The Cancer Genome Atlas.
Thyroid Cancer, Papillary
FMO1 gene expression independently predicts favorable recurrence-free survival of classical papillary thyroid cancer.
Thyroid Cancer, Papillary
Follicular cell thyroid neoplasia: insights from genomics and The Cancer Genome Atlas research network.
Thyroid Cancer, Papillary
Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of MED12 and RBM10 as Novel Thyroid Cancer Genes Associated with Tumor Virulence.
Thyroid Cancer, Papillary
Genomic and transcriptomic characterization of the mitochondrial-rich oncocytic phenotype on a thyroid carcinoma background.
Thyroid Cancer, Papillary
Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.
Thyroid Cancer, Papillary
Identification of an Autophagy-Related Signature Predicting Overall Survival for Papillary Thyroid Carcinoma.
Thyroid Cancer, Papillary
Immune cell infiltrate-associated dysregulation of DNA repair machinery may predispose to papillary thyroid carcinogenesis.
Thyroid Cancer, Papillary
Is papillary thyroid microcarcinoma a biologically different disease? A propensity score-matched analysis.
Thyroid Cancer, Papillary
Long noncoding RNA RP11-547D24.1 regulates proliferation and migration in papillary thyroid carcinoma: Identification and validation of a novel long noncoding RNA through integrated analysis of TCGA database.
Thyroid Cancer, Papillary
Loss of Integrase Interactor 1 (INI1) Expression in a Subset of Differentiated Thyroid Cancer.
Thyroid Cancer, Papillary
LPAR5 promotes thyroid carcinoma cell proliferation and migration by activating class IA PI3K catalytic subunit p110?.
Thyroid Cancer, Papillary
miR-126-3p Inhibits Thyroid Cancer Cell Growth and Metastasis, and Is Associated with Aggressive Thyroid Cancer.
Thyroid Cancer, Papillary
MiR-195 Inhibits Tumor Growth and Metastasis in Papillary Thyroid Carcinoma Cell Lines by Targeting CCND1 and FGF2.
Thyroid Cancer, Papillary
mRNA Expression of SLC5A5 and SLC2A Family Genes in Papillary Thyroid Cancer: An Analysis of The Cancer Genome Atlas.
Thyroid Cancer, Papillary
Racial Differences in Expression Levels of miRNA Machinery-Related Genes, Dicer, Drosha, DGCR8, and AGO2, in Asian Korean Papillary Thyroid Carcinoma and Comparative Validation Using the Cancer Genome Atlas.
Thyroid Cancer, Papillary
Recurrence-associated genes in papillary thyroid cancer: An analysis of data from The Cancer Genome Atlas.
Thyroid Cancer, Papillary
Significance of the BRAF mRNA Expression Level in Papillary Thyroid Carcinoma: An Analysis of The Cancer Genome Atlas Data.
Thyroid Cancer, Papillary
The contribution of molecular pathology to the classification of thyroid tumors.
Thyroid Cancer, Papillary
The diagnostic application of RNA sequencing in patients with thyroid cancer: an analysis of 851 variants and 133 fusions in 524 genes.
Thyroid Cancer, Papillary
The genomic and transcriptomic landscape of anaplastic thyroid cancer: implications for therapy.
Thyroid Cancer, Papillary
Transcriptome analysis of papillary thyroid cancer harboring telomerase reverse transcriptase promoter mutation.
Thyroid Cancer, Papillary
Up-Regulated AKR1C2 is correlated with favorable prognosis in thyroid carcinoma.
Thyroid Cancer, Papillary
Upregulation of SLC2 (GLUT) family genes is related to poor survival outcomes in papillary thyroid carcinoma: Analysis of data from The Cancer Genome Atlas.
Thyroid Cancer, Papillary
Using The Cancer Genome Atlas data to refine the 8th edition of the American Joint Committee on Cancer staging for papillary thyroid carcinoma.
Thyroid Cancer, Papillary
VDR mRNA overexpression is associated with worse prognostic factors in papillary thyroid carcinoma.
Thyroid Neoplasms
HABP2 gene mutations do not cause familial or sporadic non-medullary thyroid cancer in a highly inbred Middle Eastern population.
Thyroid Neoplasms
A Concise Atlas of Thyroid Cancer Next-Generation Sequencing Panel ThyroSeq v.2.
Thyroid Neoplasms
A miRNA-clinicopathological nomogram for the prediction of central lymph node metastasis in papillary thyroid carcinoma-analysis from TCGA database.
Thyroid Neoplasms
A novel RNA sequencing-based risk score model to predict papillary thyroid carcinoma recurrence.
Thyroid Neoplasms
A Positive Feedback Loop Between DICER1 and Differentiation Transcription Factors Is Important for Thyroid Tumorigenesis.
Thyroid Neoplasms
Absence of EIF1AX, PPM1D, and CHEK2 mutations reported in Thyroid Cancer Genome Atlas (TCGA) in a large series of thyroid cancer.
Thyroid Neoplasms
ANGPTL1 is a potential biomarker for differentiated thyroid cancer diagnosis and recurrence.
Thyroid Neoplasms
BRAFV600E-induced KRT19 expression in thyroid cancer promotes lymph node metastasis via EMT.
Thyroid Neoplasms
Brn3a/Pou4f1 Functions as a Tumor Suppressor by Targeting c-MET/STAT3 Signaling in Thyroid Cancer.
Thyroid Neoplasms
Cancer-Associated Fibroblasts Positively Correlate with Dedifferentiation and Aggressiveness of Thyroid Cancer.
Thyroid Neoplasms
Characterization of TERT and BRAF copy number variation in papillary thyroid carcinoma: An analysis of the cancer genome atlas study.
Thyroid Neoplasms
Combining DNA methylation and RNA sequencing data of cancer for supervised knowledge extraction.
Thyroid Neoplasms
Correction to: Absence of EIF1AX, PPM1D, and CHEK2 mutations reported in Thyroid Cancer Genome Atlas (TCGA) in a large series of thyroid cancer.
Thyroid Neoplasms
Deep learning prediction of BRAF-RAS gene expression signature identifies noninvasive follicular thyroid neoplasms with papillary-like nuclear features.
Thyroid Neoplasms
Differences in miRNA and mRNA Profile of Papillary Thyroid Cancer Variants.
Thyroid Neoplasms
Downregulation of TSPAN13 by miR-369-3p inhibits cell proliferation in papillary thyroid cancer (PTC).
Thyroid Neoplasms
Epithelial-to-mesenchymal transition and its association with PD-L1 and CD8 in thyroid cancer.
Thyroid Neoplasms
Evaluation of immune infiltrating of thyroid cancer based on the intrinsic correlation between pair-wise immune genes.
Thyroid Neoplasms
Expression level of long non-coding RNA colon adenocarcinoma hypermethylated serves as a novel prognostic biomarker in patients with thyroid carcinoma.
Thyroid Neoplasms
Expression of cancer stem cell markers in tall cell variant papillary thyroid cancer identifies a molecular profile predictive of recurrence in classic papillary thyroid cancer.
Thyroid Neoplasms
Expression of the embryonic morphogen Nodal in differentiated thyroid carcinomas: Immunohistochemistry assay in tissue microarray and The Cancer Genome Atlas data analysis.
Thyroid Neoplasms
G Protein-coupled Receptors in Radioiodine-refractory Thyroid Cancer in the Era of Precision Medicine.
Thyroid Neoplasms
Gene Expression Patterns Unveil New Insights in Papillary Thyroid Cancer.
Thyroid Neoplasms
Germline and somatic SDHx alterations in apparently sporadic differentiated thyroid cancer.
Thyroid Neoplasms
Germline Heterozygous Variants in SEC23B Are Associated with Cowden Syndrome and Enriched in Apparently Sporadic Thyroid Cancer.
Thyroid Neoplasms
GPCR-mediated PI3K pathway mutations in pediatric and adult thyroid cancer.
Thyroid Neoplasms
Growth Differentiation Factor 15 is a Cancer Cell-Induced Mitokine That Primes Thyroid Cancer Cells for Invasiveness.
Thyroid Neoplasms
Growth-associated protein 43 promotes thyroid cancer cell lines progression via epithelial-mesenchymal transition.
Thyroid Neoplasms
HN1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by interacting with STMN1.
Thyroid Neoplasms
HOPX homeobox methylation in differentiated thyroid cancer and its clinical relevance.
Thyroid Neoplasms
Identification of a Five-Gene Signature and Establishment of a Prognostic Nomogram to Predict Progression-Free Interval of Papillary Thyroid Carcinoma.
Thyroid Neoplasms
Identification of differential expressed lncRNAs in human thyroid cancer by a genome-wide analyses.
Thyroid Neoplasms
Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
Thyroid Neoplasms
Identification of Long Non-Coding RNA Expression Profiles and Co-Expression Genes in Thyroid Carcinoma Based on The Cancer Genome Atlas (TCGA) Database.
Thyroid Neoplasms
Identification of RNA Expression Profiles in Thyroid Cancer to Construct a Competing Endogenous RNA (ceRNA) Network of mRNAs, Long Noncoding RNAs (lncRNAs), and microRNAs (miRNAs).
Thyroid Neoplasms
Identification of the EMT-Related Genes Signature for Predicting Occurrence and Progression in Thyroid Cancer.
Thyroid Neoplasms
Identification of TNIK as a novel potential drug target in thyroid cancer based on protein druggability prediction.
Thyroid Neoplasms
Identifying differentially expressed genes associated with metastasis of follicular thyroid cancer by cDNA expression array.
Thyroid Neoplasms
Identifying M1 Macrophage-Related Genes Through a Co-expression Network to Construct a Four-Gene Risk-Scoring Model for Predicting Thyroid Cancer Prognosis.
Thyroid Neoplasms
Immune Gene Signature Delineates a Subclass of Papillary Thyroid Cancer with Unfavorable Clinical Outcomes.
Thyroid Neoplasms
Impaired microRNA processing by DICER1 downregulation endows thyroid cancer with increased aggressiveness.
Thyroid Neoplasms
Integrating omics data and protein interaction networks to prioritize driver genes in cancer.
Thyroid Neoplasms
Linc00941 Is a Novel Transforming Growth Factor ? Target That Primes Papillary Thyroid Cancer Metastatic Behavior by Regulating the Expression of Cadherin 6.
Thyroid Neoplasms
LncRNA FOXD2-AS1 Functions as a Competing Endogenous RNA to Regulate TERT Expression by Sponging miR-7-5p in Thyroid Cancer.
Thyroid Neoplasms
Long noncoding RNA LINC00284 facilitates cell proliferation in papillary thyroid cancer via impairing miR-3127-5p targeted E2F7 suppression.
Thyroid Neoplasms
Low expression of ryanodine receptor 2 is associated with poor prognosis in thyroid carcinoma.
Thyroid Neoplasms
LPAR5 promotes thyroid carcinoma cell proliferation and migration by activating class IA PI3K catalytic subunit p110?.
Thyroid Neoplasms
MAPK4 overexpression promotes tumor progression via noncanonical activation of AKT/mTOR signaling.
Thyroid Neoplasms
Methylation-Driven Genes Identified as Novel Prognostic Indicators for Thyroid Carcinoma.
Thyroid Neoplasms
MicroRNA-3690 promotes cell proliferation and cell cycle progression by altering DKK3 expression in human thyroid cancer.
Thyroid Neoplasms
Microsatellite Instability Occurs in a Subset of Follicular Thyroid Cancers.
Thyroid Neoplasms
miR-126-3p Inhibits Thyroid Cancer Cell Growth and Metastasis, and Is Associated with Aggressive Thyroid Cancer.
Thyroid Neoplasms
miR-424-5p Promotes Anoikis Resistance and Lung Metastasis by Inactivating Hippo Signaling in Thyroid Cancer.
Thyroid Neoplasms
Molecular Network-Based Identification of Competing Endogenous RNAs in Thyroid Carcinoma.
Thyroid Neoplasms
nc886, a non-coding RNA and suppressor of PKR, exerts an oncogenic function in thyroid cancer.
Thyroid Neoplasms
Overexpression of novel long intergenic non?coding RNA LINC02454 is associated with a poor prognosis in papillary thyroid cancer.
Thyroid Neoplasms
Plasma-Derived miRNA-222 as a Candidate Marker for Papillary Thyroid Cancer.
Thyroid Neoplasms
Polymorphisms of the Highly Expressed IL-6 Gene in the Papillary Thyroid Cancer Susceptibility Among Chinese.
Thyroid Neoplasms
Serous BMP8A has clinical significance in ultrasonic diagnosis of thyroid cancer and promotes thyroid cancer cell progression.
Thyroid Neoplasms
Sirt1 induction confers resistance to etoposide-induced genotoxic apoptosis in thyroid cancers.
Thyroid Neoplasms
The Afirma Xpression Atlas for thyroid nodules and thyroid cancer metastases: Insights to inform clinical decision-making from a fine-needle aspiration sample.
Thyroid Neoplasms
The Integrated Analyses of Driver Genes Identify Key Biomarkers in Thyroid Cancer.
Thyroid Neoplasms
The relationship between RASSF1A promoter methylation and thyroid carcinoma: A meta-analysis of 14 articles and a bioinformatics of 2 databases (PRISMA).
Thyroid Neoplasms
Trop2 enhances invasion of thyroid cancer by inducing MMP2 through ERK and JNK pathways.
Thyroid Neoplasms
Uridine phosphorylase 1 associates to biological and clinical significance in thyroid carcinoma cell lines.
Thyroid Neoplasms
Using The Cancer Genome Atlas data to refine the 8th edition of the American Joint Committee on Cancer staging for papillary thyroid carcinoma.
Thyroid Neoplasms
VASN promotes YAP/TAZ and EMT pathway in thyroid carcinogenesis in vitro.
Thyroid Nodule
Afirma Genomic Sequencing Classifier and Xpression Atlas Molecular Findings in Consecutive Bethesda III-VI Thyroid Nodules.
Thyroid Nodule
Analytical and Clinical Validation of Expressed Variants and Fusions From the Whole Transcriptome of Thyroid FNA Samples.
Thyroid Nodule
The Afirma Xpression Atlas for thyroid nodules and thyroid cancer metastases: Insights to inform clinical decision-making from a fine-needle aspiration sample.
Tics
IGLL5 is correlated with tumor-infiltrating immune cells in clear cell renal cell carcinoma.
Tics
Immune signature of tumor-infiltrating immune cells predicts the prognosis and therapeutic effects in squamous cell carcinoma.
Tics
TGF?1: An Indicator for Tumor Immune Microenvironment of Colon Cancer From a Comprehensive Analysis of TCGA.
Tinea
Prevalence and distribution of ringworm by Trichophyton verrucosum in sheep in the high atlas of Morocco.
Tinnitus
Differences in resting state regional cerebral blood flow assessed with 99mTc-HMPAO SPECT and brain atlas matching between depressed patients with and without tinnitus.
Tongue Neoplasms
Actin-Associated Gene Expression is Associated with Early Regional Metastasis of Tongue Cancer.
Tongue Neoplasms
Expression profile analysis identifies IER3 to predict overall survival and promote lymph node metastasis in tongue cancer.
Tongue Neoplasms
SMARCD1 is a transcriptional target of specific non-hotspot mutant p53 forms.
Tongue Neoplasms
The mutational landscape of early- and typical-onset oral tongue squamous cell carcinoma.
Tongue Neoplasms
Validation of Selected Head and Neck Cancer Prognostic Markers from the Pathology Atlas in an Oral Tongue Cancer Cohort.
Toxic Optic Neuropathy
Design and evaluation of a novel series of 2,3-oxidosqualene cyclase inhibitors with low systemic exposure, relationship between pharmacokinetic properties and ocular toxicity.
Trachoma
Complex emergencies and the control and elimination of neglected tropical diseases in Africa: developing a practical approach for implementing safe and effective mapping and intervention strategies.
Trachoma
Progress Towards Elimination of Trachoma as a Public Health Problem in Eritrea: Results of a Systematic Review and Nine Population-based Prevalence Surveys Conducted in 2014.
Tremor
136?Field-Steering Rescue Lead Therapy for Patients With Essential Tremor Refractory to Ventralis Intermedius Deep Brain Stimulation.
Tremor
Individual fiber anatomy of the subthalamic region revealed with DTI - A concept to identify the DBS target for tremor suppression.
Tremor
Optimal location of thalamotomy lesions for tremor associated with Parkinson disease: a probabilistic analysis based on postoperative magnetic resonance imaging and an integrated digital atlas.
Tremor
Stereotactic gamma-thalamotomy with a computerized brain atlas: technical case report.
Triple Negative Breast Neoplasms
Accurate Segmentation of Nuclear Regions with Multi-Organ Histopathology Images Using Artificial Intelligence for Cancer Diagnosis in Personalized Medicine.
Triple Negative Breast Neoplasms
Associations of two-pore domain potassium channels and triple negative breast cancer subtype in The Cancer Genome Atlas: systematic evaluation of gene expression and methylation.
Triple Negative Breast Neoplasms
Atlas of breast cancer infiltrated B-lymphocytes revealed by paired single-cell RNA-sequencing and antigen receptor profiling.
Triple Negative Breast Neoplasms
Causal Network Models for Predicting Compound Targets and Driving Pathways in Cancer.
Triple Negative Breast Neoplasms
Crumbs protein homolog 3 (CRB3) expression is associated with oestrogen and progesterone receptor positivity in breast cancer.
Triple Negative Breast Neoplasms
Discovery of a small molecule targeting ULK1-modulated cell death of triple negative breast cancer in vitro and in vivo.
Triple Negative Breast Neoplasms
Elevated expression of protein arginine methyltransferase 5 predicts the poor prognosis of breast cancer.
Triple Negative Breast Neoplasms
Enhanced expression of histone chaperone APLF associate with breast cancer.
Triple Negative Breast Neoplasms
Ensemble outlier detection and gene selection in triple-negative breast cancer data.
Triple Negative Breast Neoplasms
Identification and validation of a combined hypoxia and immune index for triple-negative breast cancer.
Triple Negative Breast Neoplasms
Identification of candidate RNA signatures in triple-negative breast cancer by the construction of a competing endogenous RNA network with integrative analyses of Gene Expression Omnibus and The Cancer Genome Atlas data.
Triple Negative Breast Neoplasms
Insulin-Induced Gene 2 Expression Is Associated with Breast Cancer Metastasis.
Triple Negative Breast Neoplasms
Integrated Analysis of mRNA-miRNA-lncRNA ceRNA Network in Human HR+/Her-2- Breast Cancer and Triple Negative Breast Cancer.
Triple Negative Breast Neoplasms
MEK1 Inhibitor Combined with Irradiation Reduces Migration of Breast Cancer Cells Including miR-221 and ZEB1 EMT Marker Expression.
Triple Negative Breast Neoplasms
ncRNA therapy with miRNA-22-3p suppresses the growth of triple-negative breast cancer.
Triple Negative Breast Neoplasms
p120 catenin is a key effector of a Ras-PKC? oncogenic signaling axis.
Triple Negative Breast Neoplasms
Robust genomic copy number predictor of pan cancer metastasis.
Triple Negative Breast Neoplasms
The human intermediate prolactin receptor is a mammary proto-oncogene.
Triple Negative Breast Neoplasms
The IL1?-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs).
Triple Negative Breast Neoplasms
VISTA Expression on Immune Cells Correlates With Favorable Prognosis in Patients With Triple-Negative Breast Cancer.
Trypanosomiasis, African
An atlas of tsetse and animal African trypanosomiasis in Zimbabwe.
Trypanosomiasis, African
Mapping sleeping sickness in Western Africa in a context of demographic transition and climate change.
Trypanosomiasis, African
The Atlas of human African trypanosomiasis: a contribution to global mapping of neglected tropical diseases.
Tuberculosis
Abasy Atlas v2.2: The most comprehensive and up-to-date inventory of meta-curated, historical, bacterial regulatory networks, their completeness and system-level characterization.
Tuberculosis
An atlas overview of characteristic features of tuberculosis that may be encountered at autopsy.
Tuberculosis
Cervical tuberculous vertebral osteomyelitis: case report and discussion of the literature.
Tuberculosis
Data harmonization process for creating the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Atlas.
Tuberculosis
Evaluation of clinical outcomes of one-stage anterior and posterior surgical treatment for atlantoaxial tuberculosis complicated with neurological damage.
Tuberculosis, Meningeal
[Atlas series in neuropathology. (14). Pathology of encephalomyelitis. (2). Tuberculous meningitis]
Tuberculosis, Spinal
Head-supporting sign during reclining: an indication of craniovertebral junction involvement.
Typhoid Fever
Spondylitis of Upper Cervical Vertebræ including Atlas and Axis, with Cord Compression. Typhoid Origin.
Unilateral Breast Neoplasms
Radiotherapy dose distribution prediction for breast cancer using deformable image registration.
Urinary Bladder Neoplasms
A Competing Endogenous RNA Network and an 8-lncRNA Prognostic Signature Identify MYO16-AS1 as an Oncogenic lncRNA in Bladder Cancer.
Urinary Bladder Neoplasms
A glycolysis-based 4-mRNA signature correlates with the prognosis and cell cycle process in patients with bladder cancer.
Urinary Bladder Neoplasms
A novel clinical multidimensional transcriptome signature predicts prognosis in bladder cancer.
Urinary Bladder Neoplasms
A Novel Ferroptosis-Related Gene Model for Overall Survival Predictions of Bladder Urothelial Carcinoma Patients.
Urinary Bladder Neoplasms
A novel gene signature combination improves the prediction of overall survival in urinary bladder cancer.
Urinary Bladder Neoplasms
A novel strategy based on histological protein profiling in-silico for identifying potential biomarkers in urinary bladder cancer.
Urinary Bladder Neoplasms
A potential prognostic model based on miRNA expression profile in The Cancer Genome Atlas for bladder cancer patients.
Urinary Bladder Neoplasms
A robust 11-genes prognostic model can predict overall survival in bladder cancer patients based on five cohorts.
Urinary Bladder Neoplasms
A robust signature of immune-related long non-coding RNA to predict the prognosis of bladder cancer.
Urinary Bladder Neoplasms
A TP53-Associated Immune Prognostic Signature for the Prediction of Overall Survival and Therapeutic Responses in Muscle-Invasive Bladder Cancer.
Urinary Bladder Neoplasms
Analysis of bladder cancer tumor CpG methylation and gene expression within The Cancer Genome Atlas identifies
Urinary Bladder Neoplasms
Androgen Receptor mRNA Expression in Urothelial Carcinoma of the Bladder: A Retrospective Analysis of Two Independent Cohorts.
Urinary Bladder Neoplasms
ANLN and TLE2 in Muscle Invasive Bladder Cancer: A Functional and Clinical Evaluation Based on In Silico and In Vitro Data.
Urinary Bladder Neoplasms
APOBEC-mediated mutagenesis in urothelial carcinoma is associated with improved survival, mutations in DNA damage response genes, and immune response.
Urinary Bladder Neoplasms
Artificial Intelligence-based Detection of FGFR3 Mutational Status Directly from Routine Histology in Bladder Cancer: A Possible Preselection for Molecular Testing?
Urinary Bladder Neoplasms
Assessment of prognostic implication of a panel of oncogenes in bladder cancer and identification of a 3-gene signature associated with recurrence and progression risk in non-muscle-invasive bladder cancer.
Urinary Bladder Neoplasms
ATM Mutations Benefit Bladder Cancer Patients Treated With Immune Checkpoint Inhibitors by Acting on the Tumor Immune Microenvironment.
Urinary Bladder Neoplasms
Autophagy-related long noncoding RNAs can predict prognosis in patients with bladder cancer.
Urinary Bladder Neoplasms
Biased Expression of the FOXP3?3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance.
Urinary Bladder Neoplasms
Bioinformatic identification of prognostic signature defined by copy number alteration and expression of CCNE1 in non-muscle invasive bladder cancer.
Urinary Bladder Neoplasms
Bioinformatics Analysis Finds Immune Gene Markers Related to the Prognosis of Bladder Cancer.
Urinary Bladder Neoplasms
Bioinformatics Analysis of the Expression of Key Long Intergenic Non-Protein Coding RNA Genes in Bladder Cancer.
Urinary Bladder Neoplasms
Biological and Clinical Significance of GATA3 Detected from TCGA Database and FFPE Sample in Bladder Cancer Patients.
Urinary Bladder Neoplasms
BMI1 activates P-glycoprotein via transcription repression of miR-3682-3p and enhances chemoresistance of bladder cancer cell.
Urinary Bladder Neoplasms
Characterization of mRNA Expression and Endogenous RNA Profiles in Bladder Cancer Based on The Cancer Genome Atlas (TCGA) Database.
Urinary Bladder Neoplasms
Characterization of Tumor Blood Vasculature Expression of Human Invasive Bladder Cancer by Laser Capture Microdissection and Transcriptional Profiling.
Urinary Bladder Neoplasms
Checkpoint Genes at the Cancer Side of the Immunological Synapse in Bladder Cancer.
Urinary Bladder Neoplasms
Chromatin-regulatory genes served as potential therapeutic targets for patients with urothelial bladder carcinoma.
Urinary Bladder Neoplasms
Clinical value and potential pathways of miR-183-5p in bladder cancer: A study based on miRNA-seq data and bioinformatics analysis.
Urinary Bladder Neoplasms
Combination of cyclin-dependent kinase and immune checkpoint inhibitors for the treatment of bladder cancer.
Urinary Bladder Neoplasms
Competitive glucose metabolism as a target to boost bladder cancer immunotherapy.
Urinary Bladder Neoplasms
Comprehensive analysis of aberrantly expressed profiles of lncRNAs and miRNAs with associated ceRNA network in muscle-invasive bladder cancer.
Urinary Bladder Neoplasms
Correlation of BRCA2 gene mutation and prognosis as well as variant genes in invasive urothelial carcinoma of the bladder.
Urinary Bladder Neoplasms
Development and Validation of a Hypoxia-Related Signature for Predicting Survival Outcomes in Patients With Bladder Cancer.
Urinary Bladder Neoplasms
Development of a novel prognostic signature for predicting the overall survival of bladder cancer patients.
Urinary Bladder Neoplasms
Enrichment of FGFR3-TACC3 Fusions in Patients With Bladder Cancer Who Are Young, Asian, or Have Never Smoked.
Urinary Bladder Neoplasms
EP300 mutation is associated with tumor mutation burden and promotes antitumor immunity in bladder cancer patients.
Urinary Bladder Neoplasms
Evaluating the biological functions of the prognostic genes identified by the Pathology Atlas in bladder cancer.
Urinary Bladder Neoplasms
Evaluation of the Cancer of Bladder Risk Assessment (COBRA) Score in the Cancer Genome Atlas (TCGA) Bladder Cancer Cohort.
Urinary Bladder Neoplasms
Exploring the Pathological Mechanism of Bladder Cancer Based on Tumor Mutational Burden Analysis.
Urinary Bladder Neoplasms
Extracellular matrix-related genes play an important role in the progression of NMIBC to MIBC: a bioinformatics analysis study.
Urinary Bladder Neoplasms
FADS1 is a Prognostic Biomarker in Bladder Cancer: A Study Based on TCGA Data.
Urinary Bladder Neoplasms
FOXA1, GATA3 and PPAR? Cooperate to Drive Luminal Subtype in Bladder Cancer: A Molecular Analysis of Established Human Cell Lines.
Urinary Bladder Neoplasms
Gender-specific Stratification of Survival Following Immune Checkpoint Inhibitor Therapy Based on Intratumoral Expression of a B cell Gene Signature.
Urinary Bladder Neoplasms
Genetic alteration in phosphofructokinase family promotes growth of muscle-invasive bladder cancer.
Urinary Bladder Neoplasms
Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset.
Urinary Bladder Neoplasms
Genetic variations in Hippo pathway genes influence bladder cancer risk in a Chinese population.
Urinary Bladder Neoplasms
Heterogeneity of PTEN and PPAR-? in cancer and their prognostic application to bladder cancer.
Urinary Bladder Neoplasms
Identification and validation of a hypoxia-related prognostic and immune microenvironment signature in bladder cancer.
Urinary Bladder Neoplasms
Identification of Cancer-Specific Methylation of Gene Combination for the Diagnosis of Bladder Cancer.
Urinary Bladder Neoplasms
Identification of deregulation mechanisms specific to cancer subtypes.
Urinary Bladder Neoplasms
Identification of epigenetic interactions between miRNA and DNA methylation associated with gene expression as potential prognostic markers in bladder cancer.
Urinary Bladder Neoplasms
Identification of immune-related LncRNA for predicting prognosis and immunotherapeutic response in bladder cancer.
Urinary Bladder Neoplasms
Identification of microR-106b as a prognostic biomarker of p53-like bladder cancers by ActMiR.
Urinary Bladder Neoplasms
Identification of Mutated Peptides in Bladder Cancer From Exomic Sequencing Data Reveals Negative Correlation Between Mutation-Specific Immunoreactivity and Inflammation.
Urinary Bladder Neoplasms
Identification of novel gene targets and putative regulators of arsenic-associated DNA methylation in human urothelial cells and bladder cancer.
Urinary Bladder Neoplasms
Identification of oncogenic long noncoding RNA SNHG12 and DUXAP8 in human bladder cancer through a comprehensive profiling analysis.
Urinary Bladder Neoplasms
Identification of Prognosis-Related Genes in Bladder Cancer Microenvironment across TCGA Database.
Urinary Bladder Neoplasms
Identifying superficial, muscle-invasive, and metastasizing transitional cell carcinoma of the bladder: use of cDNA array analysis of gene expression profiles.
Urinary Bladder Neoplasms
IMIX: a multivariate mixture model approach to association analysis through multi-omics data integration.
Urinary Bladder Neoplasms
Immunohistochemical assessment of basal and luminal markers in non-muscle invasive urothelial carcinoma of bladder.
Urinary Bladder Neoplasms
Increased expression of TNFRSF14 indicates good prognosis and inhibits bladder cancer proliferation by promoting apoptosis.
Urinary Bladder Neoplasms
Integrative Analysis Identified MCT4 as an Independent Prognostic Factor for Bladder Cancer.
Urinary Bladder Neoplasms
Integrative Analysis of Genomic and Clinical Data Reveals Intrinsic Characteristics of Bladder Urothelial Carcinoma Progression.
Urinary Bladder Neoplasms
Is The Cancer Genome Atlas (TCGA) bladder cancer cohort representative of invasive bladder cancer?
Urinary Bladder Neoplasms
Knockdown of CDCA8 inhibits the proliferation and enhances the apoptosis of bladder cancer cells.
Urinary Bladder Neoplasms
Krüppel-like factor 4 is a novel prognostic predictor for urothelial carcinoma of bladder and it regulates TWIST1-mediated epithelial-mesenchymal transition.
Urinary Bladder Neoplasms
LINC00963 Functions as an Oncogene in Bladder Cancer by Regulating the miR-766-3p/MTA1 Axis.
Urinary Bladder Neoplasms
Long Non-Coding RNA Expression Profiles for the Characterization of Different Bladder Cancer Grade.
Urinary Bladder Neoplasms
Loss of FOXA1 Drives Sexually Dimorphic Changes in Urothelial Differentiation and Is an Independent Predictor of Poor Prognosis in Bladder Cancer.
Urinary Bladder Neoplasms
Lower mutant-allele tumor heterogeneity is a biomarker in FGFR3-mutant bladder cancer for better prognosis.
Urinary Bladder Neoplasms
MAPK4 overexpression promotes tumor progression via noncanonical activation of AKT/mTOR signaling.
Urinary Bladder Neoplasms
Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use.
Urinary Bladder Neoplasms
Metabolic classification of bladder cancer based on multi-omics integrated analysis to predict patient prognosis and treatment response.
Urinary Bladder Neoplasms
MicroRNA-153 Decreases Tryptophan Catabolism and Inhibits Angiogenesis in Bladder Cancer by Targeting Indoleamine 2,3-Dioxygenase 1.
Urinary Bladder Neoplasms
MicroRNA-34a Attenuates Metastasis and Chemoresistance of Bladder Cancer Cells by Targeting the TCF1/LEF1 Axis.
Urinary Bladder Neoplasms
Mining TCGA database for tumor mutation burden and their clinical significance in bladder cancer.
Urinary Bladder Neoplasms
miR-3687 Overexpression Promotes Bladder Cancer Cell Growth by Inhibiting the Negative Effect of FOXP1 on Cyclin E2 Transcription.
Urinary Bladder Neoplasms
MOGSA: Integrative Single Sample Gene-set Analysis of Multiple Omics Data.
Urinary Bladder Neoplasms
Molecular analysis of urothelial cancer cell lines for modeling tumor biology and drug response.
Urinary Bladder Neoplasms
Multi-omics Perspective on the Tumor Microenvironment based on PD-L1 and CD8 T-Cell Infiltration in Urothelial Cancer.
Urinary Bladder Neoplasms
Mutation signatures to Pan-Cancer Atlas: Investigation of the genomic landscape of muscle-invasive bladder cancer.
Urinary Bladder Neoplasms
Occupation and cancer in London: an investigation into nasal and bladder cancer using the Cancer Atlas.
Urinary Bladder Neoplasms
Overexpression of the ASPM gene is associated with aggressiveness and poor outcome in bladder cancer.
Urinary Bladder Neoplasms
P3H4 is correlated with clinicopathological features and prognosis in bladder cancer.
Urinary Bladder Neoplasms
Pathophysiological Role of Histamine H4 Receptor in Cancer: Therapeutic Implications.
Urinary Bladder Neoplasms
Peptidyl Arginine Deiminase, Type II (PADI2) Is Involved in Urothelial Bladder Cancer.
Urinary Bladder Neoplasms
Potential role for targeted therapy in muscle-invasive bladder cancer: lessons from the cancer genome atlas and beyond.
Urinary Bladder Neoplasms
Prediction of bladder cancer outcome by identifying and validating a mutation-derived genomic instability-associated long noncoding RNA (lncRNA) signature.
Urinary Bladder Neoplasms
Prognostic value of differentially methylated gene profiles in bladder cancer.
Urinary Bladder Neoplasms
Proteomic analysis of urinary biomarker candidates for nonmuscle invasive bladder cancer.
Urinary Bladder Neoplasms
PTRF independently predicts progression and survival in multiracial upper tract urothelial carcinoma following radical nephroureterectomy.
Urinary Bladder Neoplasms
RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancer.
Urinary Bladder Neoplasms
Re: Woonyoung Choi, Andrea Ochoa, David J. McConkey, et al. Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset. Eur Urol 2017;72:354-65.
Urinary Bladder Neoplasms
Reply to Joshua A. Linscott, Angela B. Smith, and Jesse D. Sammon's Letter to the Editor re: Woonyoung Choi, Andrea Ochoa, David J. McConkey, et al. Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset. Eur Urol 2017;72:354-65.
Urinary Bladder Neoplasms
Robotic-assisted laparoscopic pelvic lymphadenectomy for bladder cancer: a surgical atlas.
Urinary Bladder Neoplasms
Screening of MicroRNA Biomarkers Related to the Progression of Bladder Cancer.
Urinary Bladder Neoplasms
Selenium-binding protein 1 transcriptionally activates p21 expression via p53-independent mechanism and its frequent reduction associates with poor prognosis in bladder cancer.
Urinary Bladder Neoplasms
Smoking status, usual adult occupation, and risk of recurrent urothelial bladder carcinoma: data from The Cancer Genome Atlas (TCGA) Project.
Urinary Bladder Neoplasms
Surgical atlas: Orthotopic bladder substitution in women after cystectomy for bladder cancer.
Urinary Bladder Neoplasms
Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
Urinary Bladder Neoplasms
Targeted Inhibition of P4HB Promotes Cell Sensitivity to Gemcitabine in Urothelial Carcinoma of the Bladder.
Urinary Bladder Neoplasms
The Cancer Genome Atlas Project on Muscle-invasive Bladder Cancer.
Urinary Bladder Neoplasms
The clinical applications of The Cancer Genome Atlas project for bladder cancer.
Urinary Bladder Neoplasms
The effects of alternative splicing on miRNA binding sites in bladder cancer.
Urinary Bladder Neoplasms
The future of bladder cancer therapy: Optimizing the inhibition of the fibroblast growth factor receptor.
Urinary Bladder Neoplasms
Thyrotroph embryonic factor is downregulated in bladder cancer and suppresses proliferation and tumorigenesis via the AKT/FOXOs signalling pathway.
Urinary Bladder Neoplasms
To construct a ceRNA regulatory network as prognostic biomarkers for bladder cancer.
Urinary Bladder Neoplasms
Toll-Like Receptor 4 as a Favorable Prognostic Marker in Bladder Cancer: A Multi-Omics Analysis.
Urinary Bladder Neoplasms
Transcriptomics analysis for the identification of potential age-related genes and cells associated with three major urogenital cancers.
Urinary Bladder Neoplasms
Unraveling UCA1 lncRNA prognostic utility in urothelial bladder cancer.
Urinary Bladder Neoplasms
Update on The Cancer Genome Atlas Project on Muscle-invasive Bladder Cancer.
Urinary Bladder Neoplasms
Upregulated GAPLINC predicts a poor prognosis in bladder cancer patients and promotes tumor proliferation and invasion.
Urinary Bladder Neoplasms
Upregulated GRB7 promotes proliferation and tumorigenesis of Bladder Cancer via Phospho-AKT Pathway.
Urinary Bladder Neoplasms
Urine Endocannabinoids as Novel Non-Invasive Biomarkers for Bladder Cancer at Early Stage.
Urinary Bladder Neoplasms
Urothelial-to-Neural Plasticity Drives Progression to Small Cell Bladder Cancer.
Urinary Bladder Neoplasms
Using deep learning to identify bladder cancers with FGFR-activating mutations from histology images.
Urinary Bladder Neoplasms
ZFAS1 functions as an oncogenic long non-coding RNA in bladder cancer.
Urinary Bladder Neoplasms
[Construction of prognostic model and identification of prognostic biomarkers based on the expression of long non-coding RNA in bladder cancer via bioinformatics].
Urinary Bladder Neoplasms
[High expression of activated CD4+ memory T cells and CD8+ T cells and low expression of M0 macrophage are associated with better clinical prognosis in bladder cancer patients].
Urinary Bladder Neoplasms
[Update on molecular classifications and new histological classification of bladder cancer].
Urinary Calculi
[Analysis of urinary calculi in adults from the Moroccan Medium Atlas by Fourier transform infrared spectrophotometry]
Urinary Incontinence
Isolated atlantal stenosis in a patient with idiopathic growth hormone deficiency, and Klippel-Feil and Duane's syndromes.
Urinary Tract Infections
Antimicrobial resistance prevalence, rates of hospitalization with septicemia and rates of mortality with sepsis in adults in different US states.
Urinary Tract Infections
First year of mandatory reporting of healthcare-associated infections, pennsylvania: an infection control-chart abstractor collaboration.
Urogenital Neoplasms
In Silico Inference of Synthetic Cytotoxic Interactions from Paclitaxel Responses.
Urologic Neoplasms
Diagnostic and prognostic biomarkers of common urological cancers based on aberrant DNA methylation.
Uterine Cervical Neoplasms
A consensus-based guideline defining the clinical target volume for pelvic lymph nodes in external beam radiotherapy for uterine cervical cancer.
Uterine Cervical Neoplasms
A Five-Genes-Based Prognostic Signature for Cervical Cancer Overall Survival Prediction.
Uterine Cervical Neoplasms
An 8-gene DNA methylation signature predicts the recurrence risk of cervical cancer.
Uterine Cervical Neoplasms
An atlas to aid delineation of para-aortic lymph node region in cervical cancer: Design and validation of contouring guidelines.
Uterine Cervical Neoplasms
An Innovative Immune Score-Based Prognostic Nomogram for Patients with Cervical Cancer.
Uterine Cervical Neoplasms
Analysis of the Role and Regulatory Mechanism of hsa-miR-504 in Cervical Cancer Based on The Cancer Genome Atlas Database.
Uterine Cervical Neoplasms
Assessment of circularized E7 RNA, GLUT1, and PD-L1 in anal squamous cell carcinoma.
Uterine Cervical Neoplasms
Association between dense PAX1 promoter methylation and HPV16 infection in cervical squamous epithelial neoplasms of Xin Jiang Uyghur and Han women.
Uterine Cervical Neoplasms
Characterization of DNA hydroxymethylation profile in cervical cancer.
Uterine Cervical Neoplasms
Chromosomal instability as a prognostic marker in cervical cancer.
Uterine Cervical Neoplasms
Comparison of normalization approaches for gene expression studies completed with high-throughput sequencing.
Uterine Cervical Neoplasms
Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer.
Uterine Cervical Neoplasms
Construction of Gene Modules and Analysis of Prognostic Biomarkers for Cervical Cancer by Weighted Gene Co-Expression Network Analysis.
Uterine Cervical Neoplasms
Development and Validation of a Prognostic Signature Based on Immune Genes in Cervical Cancer.
Uterine Cervical Neoplasms
DNA methylation data-based molecular subtype classification related to the prognosis of patients with cervical cancer.
Uterine Cervical Neoplasms
DNA repair gene expression is associated with differential prognosis between HPV16 and HPV18 positive cervical cancer patients following radiation therapy.
Uterine Cervical Neoplasms
Down-regulated serum microRNA-101 is associated with aggressive progression and poor prognosis of cervical cancer.
Uterine Cervical Neoplasms
Dual oxidase 1 and NADPH oxidase 2 exert favorable effects in cervical cancer patients by activating immune response.
Uterine Cervical Neoplasms
Effects of ABT-737 combined with irradiation treatment on uterine cervical cancer cells.
Uterine Cervical Neoplasms
Elastic Net-Based Identification of a Multigene Combination Predicting the Survival of Patients with Cervical Cancer.
Uterine Cervical Neoplasms
Elevated MYO10 Predicts Poor Prognosis and its Deletion Hampers Proliferation and Migration Potentials of Cells Through Rewiring PI3K/Akt Signaling in Cervical Cancer.
Uterine Cervical Neoplasms
Emerging role of mutations in epigenetic regulators including MLL2 derived from The Cancer Genome Atlas for cervical cancer.
Uterine Cervical Neoplasms
Exogenous regucalcin negatively regulates the progression of cervical adenocarcinoma.
Uterine Cervical Neoplasms
FEZF1 is an Independent Predictive Factor for Recurrence and Promotes Cell Proliferation and Migration in Cervical Cancer.
Uterine Cervical Neoplasms
Hypoxia-induced ZEB1 promotes cervical cancer progression via CCL8-dependent tumour-associated macrophage recruitment.
Uterine Cervical Neoplasms
Identification and characterization of HPV-independent cervical cancers.
Uterine Cervical Neoplasms
Identification and validation of a miRNA-based prognostic signature for cervical cancer through an integrated bioinformatics approach.
Uterine Cervical Neoplasms
Identification and validation of a prognostic proteomic signature for cervical cancer.
Uterine Cervical Neoplasms
Identification and validation of the role of matrix metalloproteinase-1 in cervical cancer.
Uterine Cervical Neoplasms
Identification of a histone family gene signature for predicting the prognosis of cervical cancer patients.
Uterine Cervical Neoplasms
Identification of a six lncRNAs signature as novel diagnostic biomarkers for cervical cancer.
Uterine Cervical Neoplasms
Identification of differentially expressed miRNAs in early-stage cervical cancer with lymph node metastasis across The Cancer Genome Atlas datasets.
Uterine Cervical Neoplasms
Identification of driver genes regulating immune cell infiltration in cervical cancer by multiple omics integration.
Uterine Cervical Neoplasms
Identification of potential biomarkers in cervical cancer with combined public mRNA and miRNA expression microarray data analysis.
Uterine Cervical Neoplasms
Identification of Potential Driver Genes Based on Multi-Genomic Data in Cervical Cancer.
Uterine Cervical Neoplasms
Identifying Molecular Markers of Cervical Cancer Based on Competing Endogenous RNA Network Analysis.
Uterine Cervical Neoplasms
Increased co-expression of PSMA2 and GLP-1 receptor in cervical cancer models in type 2 diabetes attenuated by Exendin-4: A translational case-control study.
Uterine Cervical Neoplasms
Integrated Analysis of a Competing Endogenous RNA Network Revealing a Prognostic Signature for Cervical Cancer.
Uterine Cervical Neoplasms
Integrated analysis of HPV-mediated immune alterations in cervical cancer.
Uterine Cervical Neoplasms
Integrated analysis reveals down-regulation of SPARCL1 is correlated with cervical cancer development and progression.
Uterine Cervical Neoplasms
Integrative Bioinformatics Approaches to Screen Potential Prognostic Immune-Related Genes and Drugs in the Cervical Cancer Microenvironment.
Uterine Cervical Neoplasms
Interplay Between EGFR and the Platelet-Activating Factor/PAF Receptor Signaling Axis Mediates Aggressive Behavior of Cervical Cancer.
Uterine Cervical Neoplasms
LGR6 activates the Wnt/?-catenin signaling pathway and forms a ?-catenin/TCF7L2/LGR6 feedback loop in LGR6high cervical cancer stem cells.
Uterine Cervical Neoplasms
LINC00294 induced by GRP78 promotes cervical cancer development by promoting cell cycle transition.
Uterine Cervical Neoplasms
Long Intergenic Non-Coding RNA LINC00885 Promotes Tumorigenesis of Cervical Cancer by Upregulating MACC1 Expression Through Serving as a Competitive Endogenous RNA for microRNA-432-5p.
Uterine Cervical Neoplasms
Long non-coding RNA C5orf66-AS1 promotes cell proliferation in cervical cancer by targeting miR-637/RING1 axis.
Uterine Cervical Neoplasms
Long non-coding RNA USP30-AS1 aggravates the malignant progression of cervical cancer by sequestering microRNA-299-3p and thereby overexpressing PTP4A1.
Uterine Cervical Neoplasms
Long noncoding RNA ALOX12-AS1 inhibits cervical cancer cells proliferation via targeting miR-3171.
Uterine Cervical Neoplasms
Long noncoding RNA LINC00958 regulates cell sensitivity to radiotherapy through RRM2 by binding to microRNA-5095 in cervical cancer.
Uterine Cervical Neoplasms
Machine learning-based prediction of survival prognosis in cervical cancer.
Uterine Cervical Neoplasms
Methylation-Based Classification of Cervical Squamous Cell Carcinoma into Two New Subclasses Differing in Immune-Related Gene Expression.
Uterine Cervical Neoplasms
MiR-9-5p could promote angiogenesis and radiosensitivity in cervical cancer by targeting SOCS5.
Uterine Cervical Neoplasms
Molecular Pap smear: HPV genotype and DNA methylation of ADCY8, CDH8, and ZNF582 as an integrated biomarker for high-grade cervical cytology.
Uterine Cervical Neoplasms
NHERF1 Enhances Cisplatin Sensitivity in Human Cervical Cancer Cells.
Uterine Cervical Neoplasms
NRG Oncology /RTOG Consensus Guidelines for Delineation of Clinical Target Volume for Intensity-Modulated Pelvic Radiation Therapy in Postoperative Treatment of Endometrial and Cervical Cancer- An Update.
Uterine Cervical Neoplasms
Optimal subset of signature miRNAs consisting of 7 miRNAs that can serve as a novel diagnostic and prognostic predictor for the progression of cervical cancer.
Uterine Cervical Neoplasms
Overlapping clustering of gene expression data using penalized weighted normalized cut.
Uterine Cervical Neoplasms
Polo like kinase 1 expression in cervical cancer tissues generated from multiple detection methods.
Uterine Cervical Neoplasms
Positive crosstalk between EGFR and the TF-PAR2 pathway mediates resistance to cisplatin and poor survival in cervical cancer.
Uterine Cervical Neoplasms
Potential mechanism of RRM2 for promoting Cervical Cancer based on weighted gene co-expression network analysis.
Uterine Cervical Neoplasms
Predicting DNA methylation from genetic data lacking racial diversity using shared classified random effects.
Uterine Cervical Neoplasms
Roentgen anatomy. III. A cross section atlas for the radiation therapy of the cancer of cervix uteri.
Uterine Cervical Neoplasms
Role of host-microRNA Hsa-miR-139-3p in HPV-16 induced carcinomas.
Uterine Cervical Neoplasms
SOX14 hypermethylation as a tumour biomarker in cervical cancer.
Uterine Cervical Neoplasms
The Landscape and Implications of Chimeric RNAs in Cervical Cancer.
Uterine Cervical Neoplasms
The role of miR-106p-5p in cervical cancer: from expression to molecular mechanism.
Uterine Cervical Neoplasms
The Role of Significantly Deregulated MicroRNAs in Recurrent Cervical Cancer Based on Bioinformatic Analysis of the Cancer Genome Atlas Data.
Uterine Cervical Neoplasms
TP73 is a credible biomarker for predicting clinical progression and prognosis in cervical cancer patients.
Uterine Cervical Neoplasms
Transferrin receptor-involved HIF-1 signaling pathway in cervical cancer.
Uterine Cervical Neoplasms
Updating and Optimizing Anatomic Atlases for Elective Radiation of Para-Aortic Lymph Nodes in Cervical Cancer.
Uterine Cervical Neoplasms
Variability in clinical target volume delineation for intensity modulated radiation therapy in 3 challenging cervix cancer scenarios.
Uterine Cervical Neoplasms
Whole-exome and RNA sequencing reveal novel insights into the pathogenesis of HPV associated cervical cancer.
Uterine Cervical Neoplasms
[Knockdown of YTH N6-methyladenosine RNA binding protein 2 (YTHDF2) inhibits cell proliferation and promotes apoptosis in cervical cancer cells].
Uterine Neoplasms
Blockade of the Short Form of Prolactin Receptor Induces FOXO3a/EIF-4EBP1-Mediated Cell Death in Uterine Cancer.
Uterine Neoplasms
Chemical complementarity between immune receptors and cancer mutants, independent of antigen presentation protein binding, is associated with increased survival rates.
Uterine Neoplasms
DNMT3A/3B overexpression might be correlated with poor patient survival, hypermethylation and low expression of ESR1/PGR in endometrioid carcinoma: an analysis of The Cancer Genome Atlas.
Uterine Neoplasms
Eps15 Homology Domain-Containing Protein 3 Hypermethylation as a Prognostic and Predictive Marker for Colorectal Cancer.
Uveitis
Prednisone Reprograms the Transcriptional Immune Cell Landscape in CNS Autoimmune Disease.
Varicose Veins
A Colour Atlas of Surgery for Varicose Veins: Single Surgical Procedures, vol 8.
Vascular Diseases
Three-dimensional stereotactic atlas of the extracranial vasculature correlated with the intracranial vasculature, cranial nerves, skull and muscles.
Vascular Headaches
[Radiography of the transverse foramen of the atlas; contribution to the study of occipital vascular headaches.]
Vascular Ring
AN ATLAS OF VASCULAR RINGS AND RELATED MALFORMATIONS OF THE AORTIC ARCH SYSTEM.
Vasculitis
Pulmonary vasculitis in Hughes-Stovin syndrome (HSS): a reference atlas and computed tomography pulmonary angiography guide-a report by the HSS International Study Group.
Vertebral Artery Dissection
Congenital anomaly of the posterior arch of the atlas: a rare risk factor for posterior circulation stroke.
Vertebral Artery Dissection
Evaluation of Rotational Vertebral Artery Occlusion Using Ultrasound Facilitates the Detection of Arterial Dissection in the Atlas Loop.
Vertebral Artery Dissection
Occipital to Vertebral Artery Bypass to Stop Transient Ischemic Attacks Caused by Traumatic Vertebral Artery Dissection: A Case Report.
Vertebral Artery Dissection
Tethering of the vertebral artery in the congenital arcuate foramen of the atlas vertebra: a possible cause of vertebral artery dissection in children.
Vesico-Ureteral Reflux
Surgery Illustrated - Surgical Atlas Endoscopic treatment of vesicoureteral reflux.
Viremia
Characterization of HIV-induced remodeling reveals differences in infection susceptibility of memory CD4+ T cell subsets in vivo.
Virus Diseases
Atlas of brain proton magnetic resonance spectra. Part III: Viral infections.
Virus Diseases
Charting a shared epigenetic pathway to CD8+ T cell dysfunction in infection and cancer.
Virus Diseases
Genomic Characterization of Six Virus-Associated Cancers Identifies Changes in the Tumor Immune Microenvironment and Altered Genetic Programs.
Virus Diseases
Interpretation of EBV infection in pan-cancer genome considering viral life cycle: LiEB (Life cycle of Epstein-Barr virus).
Virus Diseases
Interpretation of T cell states from single-cell transcriptomics data using reference atlases.
Vitamin D Deficiency
Vitamin D-VDR Signaling Inhibits Wnt/?-Catenin-Mediated Melanoma Progression and Promotes Antitumor Immunity.
Vitiligo
Repigmentation in vitiligo: position paper of the Vitiligo Global Issues Consensus Conference.
Vocal Cord Paralysis
Plasmacytoma of the atlas presenting as hoarseness: a rare cause of unilateral vocal fold palsy.
Williams Syndrome
Effect of nonrigid registration algorithms on deformation-based morphometry: a comparative study with control and Williams syndrome subjects.
Williams Syndrome
Isolated cervical spinal canal stenosis at C-1 in the pediatric population and in Williams syndrome.
Wilms Tumor
Profiling of differential gene expression in Wilms tumor by cDNA expression array.
Zoonoses
[Actual problems of creation of informational-analytical system for rapid control of epidemics of infectious diseases].
html completed